data_3zqd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3zqd _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.58 0.705 . . . . 1.3300000000000001 112.661 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.9 tt -98.99 129.05 45.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.581 -1.19 . . . . 1.0700000000000001 110.466 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.32 162.18 13.45 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.076 0.941 . . . . 1.03 113.347 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 82.6 t80 -131.96 141.5 49.32 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.676 -1.602 . . . . 1.0800000000000001 107.973 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.9 tt0 -114.64 115.23 26.79 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.198 -1.038 . . . . 0.93000000000000005 108.198 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.577 HG11 ' HB2' ' A' ' 13' ' ' ASP . 99.5 t -67.01 148.84 11.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 122.482 1.134 . . . . 1.1000000000000001 113.125 -172.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -103.1 158.84 16.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.171 -1.831 . . . . 2.4399999999999999 108.12 171.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -60.98 106.26 0.57 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 120.808 0.337 . . . . 2.4300000000000002 111.754 -175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.35 11.67 38.18 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.689 -0.767 . . . . 0.51000000000000001 113.553 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.577 ' HB2' HG11 ' A' ' 9' ' ' VAL . 65.3 m-20 -53.15 165.14 0.35 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.169 0.485 . . . . 1.46 111.646 172.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.1 147.69 47.72 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.43 0.633 . . . . 1.1599999999999999 111.171 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.4 HD22 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.89 -40.69 87.84 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.901 -1.045 . . . . 1.47 108.446 -176.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -84.28 -18.08 37.58 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.576 -1.193 . . . . 1.78 110.266 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.9 t -71.66 -43.31 66.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.151 -0.685 . . . . 1.74 109.151 170.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.405 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 15.0 mt -72.19 -27.66 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.37 0.605 . . . . 1.04 109.502 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.573 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.07 -9.04 59.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.161 -0.472 . . . . 1.0600000000000001 110.942 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.678 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.52 -40.79 8.48 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 122.631 1.205 . . . . 0.97999999999999998 107.965 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.1 m-20 -62.2 -45.8 91.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 112.417 -2.174 . . . . 0.53000000000000003 111.883 174.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.545 ' C ' HD11 ' A' ' 101' ' ' ILE . 60.6 m-85 -96.23 5.63 50.59 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 118.624 -1.23 . . . . 0.20000000000000001 111.213 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.7 mpt_? 54.2 45.86 26.5 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.648 0.737 . . . . 2.46 109.772 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.573 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 37.1 pt -120.53 -165.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.671 -1.149 . . . . 1.04 110.206 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.91 142.94 40.55 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.998 -1.001 . . . . 1.3400000000000001 110.252 174.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.523 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 68.4 p -71.4 -33.38 69.43 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.914 -1.143 . . . . 1.0900000000000001 107.914 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.01 68.08 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.443 -0.799 . . . . 1.0700000000000001 111.954 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.63 -27.73 16.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.717 0.77 . . . . 1.04 109.198 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.553 HD21 ' CD1' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -74.83 -29.75 61.16 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.707 -1.133 . . . . 1.8100000000000001 109.357 174.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 26' ' ' THR . 48.2 mt -76.6 -33.02 58.44 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.83 0.824 . . . . 1.6399999999999999 110.117 171.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 5.2 tt0 -61.49 -39.21 90.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.356 -1.293 . . . . 2.3300000000000001 109.522 172.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.572 ' HB3' HG11 ' A' ' 47' ' ' VAL . . . -86.47 -19.31 29.76 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.337 -0.545 . . . . 1.0600000000000001 112.217 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.588 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 26.4 m-80 -149.61 81.32 7.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.359 0.6 . . . . 0.23000000000000001 110.448 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.1 Cg_endo -56.63 -14.74 13.97 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 124.328 3.352 . . . . 0.52000000000000002 114.054 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -73.69 -23.92 59.88 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.16 -0.337 . . . . 1.6499999999999999 111.766 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.588 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 29.0 mt -67.91 -37.14 81.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.346 0.593 . . . . 1.25 112.199 -170.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -63.43 -44.14 95.44 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 123.01 1.386 . . . . 2.52 110.764 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.3 -47.71 81.13 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 111.722 -2.49 . . . . 1.1899999999999999 110.705 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.57 48.44 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.887 -1.051 . . . . 0.44 111.488 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.94 157.83 20.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.424 0.631 . . . . 1.1699999999999999 111.217 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 58.1 m -139.09 128.9 24.84 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.118 -0.946 . . . . 1.1499999999999999 110.193 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.96 120.44 21.3 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.035 -0.666 . . . . 1.1200000000000001 109.916 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 97.73 2.44 58.53 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 110.365 -1.094 . . . . 0.44 110.365 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.3 OUTLIER -78.15 124.53 28.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.228 -0.656 . . . . 1.3 109.228 178.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 37.4 p -81.48 124.12 29.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.956 0.884 . . . . 1.3200000000000001 110.842 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.519 HG22 HD23 ' A' ' 36' ' ' LEU . 1.4 pp -129.87 132.8 65.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 113.933 -1.485 . . . . 1.0700000000000001 108.974 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.572 HG11 ' HB3' ' A' ' 32' ' ' ALA . 14.7 p -93.79 163.65 2.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 114.857 -1.065 . . . . 1.3 111.025 -169.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.493 ' H ' HG23 ' A' ' 47' ' ' VAL . 39.3 mm -121.24 102.48 43.13 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 114.698 -1.137 . . . . 1.03 109.894 -173.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HA ' HD23 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -66.27 135.85 41.56 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.928 1.752 . . . . 0.20000000000000001 112.341 -175.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.45 -5.94 80.52 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.065 -0.97 . . . . 0.26000000000000001 112.42 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 36.1 tp -122.72 116.1 29.28 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-O 121.218 0.532 . . . . 1.27 111.408 -177.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 53.5 Cg_endo -78.12 -176.91 3.5 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.918 3.079 . . . . 0.31 114.362 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.481 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 8.9 t70 -84.96 128.02 62.16 Favored Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-N 114.302 -1.317 . . . . 0.48999999999999999 111.975 -169.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 37.4 Cg_endo -69.94 -18.19 36.3 Favored 'Trans proline' 0 CA--C 1.519 -0.248 0 C-N-CA 123.619 2.879 . . . . 0.48999999999999999 112.69 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.408 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 69.3 m-85 -96.09 2.36 53.17 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.529 0.681 . . . . 1.8 111.451 -173.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.481 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 18.5 p -98.45 -20.58 17.03 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.897 -1.149 . . . . 1.1299999999999999 107.897 171.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.534 HG23 ' H ' ' A' ' 59' ' ' TYR . 19.4 mt -73.17 133.02 81.66 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 113.254 -1.794 . . . . 1.24 111.335 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 92.4 Cg_endo -79.33 -15.86 12.42 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.381 2.054 . . . . 0.47999999999999998 113.883 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' H ' HG23 ' A' ' 57' ' ' ILE . 50.7 m-85 -104.09 164.04 11.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.023 0.749 . . . . 0.94999999999999996 113.023 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -147.67 139.48 24.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.982 -1.008 . . . . 3.7400000000000002 108.795 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 71' ' ' THR . 79.2 mt -116.09 132.27 66.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.316 -0.402 . . . . 1.05 111.718 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.23 116.57 27.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.897 -0.721 . . . . 1.0800000000000001 111.122 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 65.0 t -98.57 112.99 32.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.647 0.737 . . . . 1.04 111.163 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 68' ' ' LYS . 53.3 m -95.74 100.87 12.53 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.893 -1.049 . . . . 0.83999999999999997 110.748 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.53 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.1 mm -48.93 -58.76 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.987 0.899 . . . . 1.0600000000000001 111.788 171.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.58 -9.38 3.44 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 112.925 -1.943 . . . . 0.16 113.055 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.57 -19.57 4.55 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.581 0.752 . . . . 1.02 112.087 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.548 ' HB2' ' HZ2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.68 55.93 4.47 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.27 0.486 . . . . 1.3 111.236 -173.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.7 p -137.24 159.67 41.26 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 112.861 0.689 . . . . 0.98999999999999999 112.861 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.401 HD21 ' C ' ' A' ' 70' ' ' LEU . 8.7 tt -126.77 112.58 15.56 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.559 -1.2 . . . . 1.1799999999999999 110.004 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.672 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 29.6 m -93.62 122.4 36.04 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.226 0.536 . . . . 1.04 111.288 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.5 tp -98.0 103.74 15.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.003 -0.998 . . . . 1.3200000000000001 109.464 172.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 82.2 p -105.75 161.11 14.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 119.086 -1.045 . . . . 1.05 110.612 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.581 HD11 ' ND2' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -127.08 128.23 45.93 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.541 -0.911 . . . . 1.1000000000000001 108.541 170.285 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.581 ' ND2' HD11 ' A' ' 74' ' ' LEU . 7.9 p30 43.8 51.15 6.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.303 -1.317 . . . . 1.97 111.892 -166.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.7 t30 74.76 -13.19 0.85 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.1 -0.954 . . . . 2.5499999999999998 111.382 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -95.76 121.37 37.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.92 -0.582 . . . . 4.0199999999999996 109.888 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 78.0 t -59.55 132.48 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 122.362 1.077 . . . . 1.0600000000000001 112.499 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 18.3 mtm -100.55 -46.91 5.05 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 113.022 -1.899 . . . . 1.47 108.805 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -155.56 172.97 17.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.42 -1.718 . . . . 1.98 110.019 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 78.6 m -148.75 123.02 9.58 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.082 -1.417 . . . . 1.0 109.783 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -108.01 145.34 31.22 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.487 -0.779 . . . . 1.3999999999999999 109.274 -176.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HB2' HG23 ' A' ' 134' ' ' ILE . 42.7 Cg_endo -74.94 141.96 27.47 Favored 'Trans proline' 0 CA--C 1.499 -1.238 0 C-N-CA 122.031 1.82 . . . . 0.23999999999999999 111.285 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.537 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.44 175.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.92 -0.582 . . . . 1.04 111.051 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.869 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.13 147.32 44.31 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.306 -0.406 . . . . 1.03 110.15 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.472 HG23 ' HG3' ' A' ' 68' ' ' LYS . 11.4 m -129.64 128.44 65.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.47 0.653 . . . . 1.26 112.004 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -89.06 157.9 27.53 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 110.624 -0.99 . . . . 0.20000000000000001 110.624 173.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -56.37 2.68 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.309 0.855 . . . . 3.48 113.309 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.538 HG21 ' CD2' ' A' ' 90' ' ' LEU . 1.3 tp -89.9 -20.52 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 121.83 0.824 . . . . 1.0700000000000001 110.149 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.538 ' CD2' HG21 ' A' ' 89' ' ' ILE . 3.7 mm? -90.85 -19.53 23.29 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.442 -0.799 . . . . 1.02 109.211 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -66.74 -16.51 64.29 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.419 -1.264 . . . . 1.05 111.715 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -64.64 -42.32 95.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.841 -1.072 . . . . 2.0299999999999998 112.343 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.31 119.42 56.39 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.574 -0.45 . . . . 1.1499999999999999 110.966 -175.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 1.1 Cg_endo -78.8 -1.92 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.839 2.359 . . . . 1.04 113.239 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.0 t -119.73 -42.46 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.838 0.351 . . . . 1.1299999999999999 110.408 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.469 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.68 38.87 22.84 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.717 -1.129 . . . . 0.35999999999999999 114.063 168.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.443 ' HG2' HG21 ' A' ' 164' ' ' THR . 45.9 mt-10 -83.86 113.02 20.65 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.969 0.89 . . . . 1.0800000000000001 109.606 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 23.6 m-85 -137.61 176.15 8.97 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.909 -1.496 . . . . 0.26000000000000001 111.914 -170.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.595 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 82.7 m-85 -140.95 136.9 32.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.243 -0.435 . . . . 0.78000000000000003 110.603 -173.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.553 HD13 ' HB ' ' A' ' 161' ' ' THR . 81.6 mt -61.24 117.56 2.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.23 -0.895 . . . . 1.02 110.816 172.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.545 HD11 ' C ' ' A' ' 22' ' ' PHE . 20.8 pt -84.5 -35.43 10.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 112.766 0.654 . . . . 1.03 112.766 -176.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.481 ' ND2' HG13 ' A' ' 101' ' ' ILE . 9.3 p30 178.82 179.18 0.41 Allowed 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.32 -1.363 . . . . 2.0299999999999998 107.32 -176.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.462 ' HG2' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.16 155.58 49.4 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.873 -0.731 . . . . 2.02 112.303 -174.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -128.21 100.69 5.94 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.048 -0.978 . . . . 0.83999999999999997 109.872 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.505 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 71.2 ttt180 -62.77 166.31 5.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.162 -0.926 . . . . 3.2799999999999998 110.693 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.465 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 18.1 m-80 -34.75 102.97 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 125.189 1.395 . . . . 0.34999999999999998 113.195 -155.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.8 Cg_endo . . . . . 0 N--CA 1.457 -0.627 0 C-N-CA 123.045 2.496 . . . . 0.63 111.695 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.507 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.502 0 N-CA-C 117.177 2.288 . . . . 1.1699999999999999 117.177 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.642 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.4 OUTLIER -165.4 158.41 16.02 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.204 -0.935 . . . . 0.60999999999999999 110.297 -175.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -138.54 98.1 3.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.241 -1.022 . . . . 0.56999999999999995 108.241 167.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.536 HD13 ' CG2' ' A' ' 150' ' ' VAL . 2.4 mt -89.02 114.27 25.46 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.033 -0.728 . . . . 1.3600000000000001 109.033 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.41 ' C ' HG12 ' A' ' 101' ' ' ILE . 20.0 m -85.24 143.58 28.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.808 -0.633 . . . . 0.42999999999999999 111.424 -169.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.771 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.9 mm? -108.3 166.4 10.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.893 -0.594 . . . . 1.02 111.7 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.0 t -60.52 -13.27 12.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.793 -1.094 . . . . 1.79 112.816 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.666 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 4.9 tptm -126.27 130.27 50.54 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 120.492 -0.483 . . . . 1.8100000000000001 110.138 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 52.9 mt-30 -34.44 -57.61 0.5 Allowed 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.548 1.155 . . . . 1.76 113.994 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.519 ' CB ' HG12 ' A' ' 89' ' ' ILE . 32.5 m-70 -88.91 -1.78 58.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.317 0.58 . . . . 3.2000000000000002 111.635 -171.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.771 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -91.31 38.16 0.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.523 0.934 . . . . 0.83999999999999997 113.523 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -112.97 145.08 18.19 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 117.222 -2.418 . . . . 0.96999999999999997 112.783 -152.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -98.69 116.32 41.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 123.739 0.816 . . . . 1.04 110.833 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.628 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 27.5 p80 -145.62 171.15 15.12 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.229 -0.896 . . . . 0.20999999999999999 109.585 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.1 -168.62 39.19 Favored Glycine 0 C--N 1.316 -0.563 0 C-N-CA 120.107 -1.044 . . . . 0.34999999999999998 111.51 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -153.23 175.0 13.55 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.962 -0.728 . . . . 1.1100000000000001 110.27 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -116.79 0.41 12.52 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.61 -0.885 . . . . 2.1899999999999999 108.61 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -118.9 86.75 31.74 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 114.928 -1.033 . . . . 1.8400000000000001 108.476 172.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -72.72 -17.52 25.91 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.293 1.996 . . . . 0.39000000000000001 113.283 -169.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.37 -1.1 35.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.968 -0.56 . . . . 1.0800000000000001 111.094 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 98.1 p -91.57 -6.8 51.78 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.983 -0.747 . . . . 1.9399999999999999 108.983 170.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.455 HG23 ' HB2' ' A' ' 83' ' ' PRO . 44.2 mm -80.49 136.42 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.54 -0.755 . . . . 1.04 110.217 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.61 80.14 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.906 -1.277 . . . . 0.16 109.906 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 5.7 tttt -111.67 161.64 16.05 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 122.952 1.358 . . . . 3.0299999999999998 113.743 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.426 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -97.44 124.27 41.58 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 112.193 -2.276 . . . . 1.01 107.659 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.435 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -120.74 160.86 21.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.894 -0.78 . . . . 1.3400000000000001 108.894 -173.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.9 m -51.5 -58.76 5.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.688 0.625 . . . . 0.87 112.688 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.488 ' HB2' ' HZ2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -132.56 -43.32 0.92 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 118.329 -1.348 . . . . 2.5499999999999998 113.555 -176.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.447 ' N ' ' HD3' ' A' ' 140' ' ' LYS . . . -31.5 133.23 0.14 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 116.958 1.543 . . . . 0.19 116.958 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.544 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 2.7 p -74.5 164.84 26.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.489 -1.855 . . . . 0.20000000000000001 111.571 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.869 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.0 mt -59.9 98.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 122.48 1.133 . . . . 1.1299999999999999 112.111 -162.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.628 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 79.9 mtt180 -84.33 151.66 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.601 -1.636 . . . . 2.3300000000000001 110.537 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.537 ' HG2' HG21 ' A' ' 84' ' ' ILE . 14.7 mtp -130.94 -166.57 1.71 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.799 -0.637 . . . . 1.0900000000000001 109.333 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.64 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 15.8 t-80 -97.81 152.89 18.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.825 -0.806 . . . . 2.9900000000000002 108.825 172.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.599 ' O ' HD11 ' A' ' 151' ' ' ILE . 2.3 m120 -56.17 -53.39 57.63 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 118.247 -0.882 . . . . 0.73999999999999999 110.629 -175.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -64.66 -24.18 67.5 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 121.6 2.0 . . . . 2.6899999999999999 112.04 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.64 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 4.6 m-20 -81.59 -43.36 18.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.661 -0.7 . . . . 0.68999999999999995 110.818 -176.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.536 ' CG2' HD13 ' A' ' 116' ' ' LEU . 14.6 p -68.58 -23.03 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.731 -0.668 . . . . 1.02 111.297 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.599 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.68 -37.9 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 119.062 -0.494 . . . . 1.1699999999999999 110.091 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 156' ' ' ILE . 9.3 mm-40 -45.09 -72.71 0.05 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.279 0.945 . . . . 1.99 112.022 167.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 157' ' ' VAL . 52.4 mt -46.81 -40.42 13.73 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 123.85 0.719 . . . . 1.9099999999999999 111.479 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.73 -37.07 80.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.119 -1.4 . . . . 1.04 111.758 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.0 t -88.16 -31.94 18.88 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.51 -0.744 . . . . 0.88 112.506 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.2 mt -81.07 -59.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.561 0.695 . . . . 1.0 111.561 -172.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 153' ' ' LEU . 3.1 m -89.38 142.96 30.11 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.871 -1.059 . . . . 1.0700000000000001 112.097 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -90.72 175.03 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 124.015 3.143 . . . . 0.23999999999999999 110.939 172.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.425 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 37.1 m-20 -65.99 157.86 29.74 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.655 -0.818 . . . . 1.1000000000000001 109.078 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.35 -18.53 57.31 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.119 -1.038 . . . . 0.17999999999999999 112.423 -174.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.553 ' HB ' HD13 ' A' ' 100' ' ' ILE . 78.2 m -65.12 138.89 58.58 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.035 -0.728 . . . . 1.05 109.035 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.595 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 11.3 ptm180 -92.44 127.25 37.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.741 1.258 . . . . 4.1100000000000003 111.211 -170.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.4 t -109.02 107.45 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 112.088 -2.324 . . . . 1.02 108.631 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.443 HG21 ' HG2' ' A' ' 97' ' ' GLU . 13.8 m -94.35 104.72 16.7 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.49 0.552 . . . . 1.0700000000000001 112.49 -171.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.469 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -83.36 96.47 4.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 122.342 1.068 . . . . 1.05 109.955 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -107.6 132.49 53.23 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.009 -1.451 . . . . 1.0900000000000001 109.215 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.53 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 19.2 mmm180 . . . . . 0 C--N 1.317 -0.809 0 N-CA-C 109.2 -0.667 . . . . 2.4900000000000002 109.2 174.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.289 0.566 . . . . 1.3300000000000001 111.392 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.0 tt -92.12 130.08 37.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.284 -0.871 . . . . 1.0700000000000001 110.445 -175.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.33 162.14 13.33 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.36 1.076 . . . . 1.03 113.239 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 72.0 t80 -131.96 142.25 49.56 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.294 -1.776 . . . . 1.0800000000000001 107.89 175.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.453 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 33.8 tt0 -113.25 112.71 24.2 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.091 -1.078 . . . . 0.93000000000000005 108.091 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' A' ' 41' ' ' THR . 96.1 t -66.67 151.35 10.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.364 1.078 . . . . 1.1000000000000001 112.74 -170.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -106.58 158.21 17.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.431 -1.713 . . . . 2.4399999999999999 108.372 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.23 107.68 0.51 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.782 0.325 . . . . 2.4300000000000002 111.819 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.77 46.23 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.857 -0.687 . . . . 0.51000000000000001 113.895 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.574 ' HB2' HG11 ' A' ' 9' ' ' VAL . 68.9 m-20 -54.46 170.16 0.16 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 117.181 0.49 . . . . 1.46 111.391 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.4 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -129.23 152.07 49.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.086 0.469 . . . . 1.1599999999999999 111.603 176.136 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.51 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -66.03 -36.37 83.07 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.044 -0.98 . . . . 1.47 108.574 -177.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.466 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 4.5 t30 -87.62 -26.04 23.26 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.764 -1.107 . . . . 1.78 110.552 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.4 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 13.0 t -66.05 -40.92 91.33 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.515 -0.55 . . . . 1.74 109.515 174.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.46 HG21 ' CE1' ' A' ' 22' ' ' PHE . 13.8 mt -73.86 -28.15 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.116 0.484 . . . . 1.04 109.783 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.608 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.43 -11.37 59.91 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.699 -0.4 . . . . 1.0600000000000001 110.896 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.709 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -93.12 -40.98 10.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.406 0.622 . . . . 0.97999999999999998 109.784 174.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.63 ' HB3' ' O ' ' A' ' 119' ' ' SER . 23.0 m-20 -63.42 -42.87 98.73 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.485 -1.234 . . . . 0.53000000000000003 111.922 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.539 ' C ' HD11 ' A' ' 101' ' ' ILE . 47.8 m-85 -96.33 4.85 51.99 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 118.597 -1.241 . . . . 0.20000000000000001 111.112 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.709 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER 54.51 40.77 32.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.961 0.886 . . . . 2.46 109.418 176.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.608 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.6 pt -114.3 -165.52 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.102 -1.408 . . . . 1.04 109.86 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.48 142.91 41.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.205 -0.907 . . . . 1.3400000000000001 110.212 175.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.521 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 71.4 p -73.21 -32.72 64.95 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.057 -1.09 . . . . 1.0900000000000001 108.057 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.7 -27.06 67.6 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.182 -0.917 . . . . 1.0700000000000001 111.796 170.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.95 -27.28 16.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.972 -0.751 . . . . 1.04 108.972 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.64 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 17.8 tp -74.71 -26.2 59.65 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.298 -0.865 . . . . 1.8100000000000001 109.331 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 26' ' ' THR . 35.9 mt -77.31 -29.98 53.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.695 0.759 . . . . 1.6399999999999999 110.076 171.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 4.7 tt0 -65.14 -41.63 94.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.393 -1.276 . . . . 2.3300000000000001 110.103 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -84.27 -20.67 31.8 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.937 -0.705 . . . . 1.0600000000000001 111.594 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.61 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.8 m-80 -147.15 80.67 9.25 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 121.615 0.721 . . . . 0.23000000000000001 110.693 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.8 Cg_endo -56.79 -14.89 14.87 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 C-N-CA 124.099 3.199 . . . . 0.52000000000000002 114.199 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.2 t -79.59 -20.9 45.79 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.809 -0.356 . . . . 1.6499999999999999 111.115 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.64 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 67.6 mt -65.31 -39.19 92.18 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.542 0.687 . . . . 1.25 111.826 -172.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -64.05 -44.59 91.98 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 122.88 1.324 . . . . 2.52 110.251 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.05 -50.15 74.43 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 111.795 -2.457 . . . . 1.1899999999999999 110.439 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.23 175.16 46.97 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 114.779 -1.101 . . . . 0.44 111.74 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -107.9 155.99 19.67 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.229 0.538 . . . . 1.1699999999999999 110.876 178.178 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 34.5 m -139.46 128.64 23.9 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.218 -0.901 . . . . 1.1499999999999999 110.513 -175.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 119.99 20.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.634 0.731 . . . . 1.1200000000000001 110.396 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 98.13 0.73 58.44 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 114.738 -1.119 . . . . 0.44 110.325 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.2 tt0 -74.8 123.41 24.95 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.672 -0.764 . . . . 1.3 109.654 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 54.8 p -82.34 128.49 34.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.776 0.798 . . . . 1.3200000000000001 110.067 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.593 HG13 ' HB3' ' A' ' 7' ' ' TYR . 9.0 pt -128.52 142.35 44.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.306 -1.316 . . . . 1.0700000000000001 109.477 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.465 HG13 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.77 151.27 3.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.208 0.527 . . . . 1.3 111.019 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.1 mm -115.13 92.71 32.46 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 114.842 -1.072 . . . . 1.03 109.439 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HA ' HD23 ' A' ' 4' ' ' LEU . 2.4 Cg_endo -58.46 134.89 64.13 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.812 2.341 . . . . 0.20000000000000001 112.693 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.03 -4.06 81.09 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 114.948 -1.023 . . . . 0.26000000000000001 112.405 -176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.68 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.7 tp -129.28 117.97 19.07 Favored Pre-proline 0 N--CA 1.446 -0.638 0 CA-C-O 121.223 0.535 . . . . 1.27 111.341 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.662 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 55.5 Cg_endo -79.23 -177.96 4.27 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.585 2.857 . . . . 0.31 114.155 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.494 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 12.4 t0 -80.72 126.64 77.55 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.513 -1.222 . . . . 0.48999999999999999 111.542 -171.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.596 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 60.5 Cg_endo -73.22 -16.73 24.92 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.204 2.603 . . . . 0.48999999999999999 112.459 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -89.22 -10.33 47.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.842 -0.617 . . . . 1.8 110.438 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.494 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 25.1 p -88.15 -23.35 23.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.535 1.159 . . . . 1.1299999999999999 108.427 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.475 HG23 ' H ' ' A' ' 59' ' ' TYR . 15.3 mt -72.94 129.51 86.42 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 112.973 -1.922 . . . . 1.24 111.354 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.69 -19.73 14.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.336 2.024 . . . . 0.47999999999999998 113.386 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.475 ' H ' HG23 ' A' ' 57' ' ' ILE . 60.5 m-85 -91.91 158.68 16.16 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.546 -0.462 . . . . 0.94999999999999996 111.558 -176.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -148.77 129.87 14.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.026 -0.731 . . . . 3.7400000000000002 109.026 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.5 mt -111.38 130.96 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.946 -0.57 . . . . 1.05 111.609 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.96 119.88 38.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.001 -0.68 . . . . 1.0800000000000001 111.028 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.85 116.42 41.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.446 0.641 . . . . 1.04 110.833 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 68' ' ' LYS . 69.0 m -95.81 104.27 16.2 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.011 -0.995 . . . . 0.83999999999999997 110.8 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.9 mm -51.64 -59.38 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.937 0.875 . . . . 1.0600000000000001 111.59 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.82 -11.94 4.72 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 113.051 -1.886 . . . . 0.16 113.18 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.18 -18.87 4.87 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.369 0.668 . . . . 1.02 112.444 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HB2' ' HZ2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.89 54.97 4.79 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.522 0.601 . . . . 1.3 111.26 -173.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.5 p -136.77 160.99 37.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.811 0.671 . . . . 0.98999999999999999 112.811 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.424 ' C ' HD21 ' A' ' 70' ' ' LEU . 8.1 tt -129.04 113.51 15.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.765 -1.107 . . . . 1.1799999999999999 110.044 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.702 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.4 m -93.77 123.67 37.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.976 0.417 . . . . 1.04 111.337 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.8 tp -98.78 104.92 17.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.58 -0.737 . . . . 1.3200000000000001 109.434 171.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.6 m -104.96 159.61 15.67 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.541 -0.863 . . . . 1.05 110.519 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -127.88 127.26 43.09 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.903 -0.777 . . . . 1.1000000000000001 108.903 168.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.539 ' N ' HD23 ' A' ' 74' ' ' LEU . 46.4 m-80 48.21 50.36 16.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.584 -1.189 . . . . 1.97 111.076 -171.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 71.9 -10.03 0.91 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.755 0.822 . . . . 2.5499999999999998 111.662 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 75' ' ' ASN . 15.3 tpt180 -96.43 120.52 36.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.067 -0.515 . . . . 4.0199999999999996 109.893 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 55.8 t -59.31 131.58 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-O 122.295 1.045 . . . . 1.0600000000000001 112.017 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 5.4 mtm -103.08 -43.85 5.37 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.342 -1.754 . . . . 1.47 109.368 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -157.94 170.69 21.75 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.264 -1.789 . . . . 1.98 110.209 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 83.5 m -149.38 128.03 12.41 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.129 -1.396 . . . . 1.0 109.517 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -115.94 147.46 39.22 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 116.243 -0.435 . . . . 1.3999999999999999 110.729 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.42 ' HB2' HG23 ' A' ' 134' ' ' ILE . 36.8 Cg_endo -71.86 144.33 43.16 Favored 'Trans proline' 0 CA--C 1.491 -1.645 0 C-N-CA 122.333 2.022 . . . . 0.23999999999999999 110.284 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.519 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.3 pp -139.34 166.33 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-N 115.902 -0.59 . . . . 1.04 110.797 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.792 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -112.85 128.17 56.38 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.732 -0.84 . . . . 1.03 108.732 -176.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.15 130.93 73.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 114.076 -1.42 . . . . 1.26 111.168 -162.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -96.03 151.05 19.82 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.277 -1.329 . . . . 0.20000000000000001 111.896 -175.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 139' ' ' SER . 45.7 mmtm -57.71 2.7 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.525 -0.838 . . . . 3.48 113.145 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.581 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.6 tp -89.79 -19.65 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.725 0.774 . . . . 1.0700000000000001 110.27 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.538 ' CD2' HG21 ' A' ' 89' ' ' ILE . 3.8 mm? -88.4 -11.56 45.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.396 -0.82 . . . . 1.02 109.431 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -70.11 -16.53 63.13 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.952 -1.022 . . . . 1.05 111.55 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -71.83 -27.33 62.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.8 -1.091 . . . . 2.0299999999999998 112.972 -172.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.8 130.7 22.64 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 119.976 -0.69 . . . . 1.1499999999999999 110.771 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.459 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 89.9 Cg_endo -88.48 -2.24 6.74 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.707 2.271 . . . . 1.04 112.357 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 t -122.99 -41.83 2.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.884 -0.598 . . . . 1.1299999999999999 109.634 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.443 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 47.16 42.79 17.47 Favored Glycine 0 N--CA 1.45 -0.377 0 O-C-N 123.832 0.708 . . . . 0.35999999999999999 113.89 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.84 112.64 20.72 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.729 0.776 . . . . 1.0800000000000001 109.484 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.742 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 25.2 m-85 -137.06 177.76 7.61 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.158 -1.383 . . . . 0.26000000000000001 111.985 -170.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CG ' HD13 ' A' ' 5' ' ' LEU . 21.2 m-85 -140.4 143.05 35.46 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.78000000000000003 110.521 -174.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.565 HD13 ' HB ' ' A' ' 161' ' ' THR . 76.6 mt -66.98 113.72 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 115.488 -0.778 . . . . 1.02 110.132 169.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.559 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 26.0 pt -84.33 -34.25 9.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 112.967 0.728 . . . . 1.03 112.967 -175.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.486 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 10.0 p30 179.97 177.79 0.63 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.488 -1.301 . . . . 2.0299999999999998 107.488 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.439 ' HG2' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.11 153.81 50.44 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.177 -0.609 . . . . 2.02 111.959 -175.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -125.38 100.97 6.74 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.097 -0.956 . . . . 0.83999999999999997 109.655 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.473 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 34.1 ttp180 -60.85 166.33 3.46 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.151 -0.931 . . . . 3.2799999999999998 110.59 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.462 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 20.6 m-80 -34.86 102.33 0.22 Allowed Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 124.997 1.319 . . . . 0.34999999999999998 113.33 -155.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 8.6 Cg_endo . . . . . 0 N--CA 1.457 -0.656 0 C-N-CA 123.075 2.517 . . . . 0.63 111.365 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.514 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.493 0 N-CA-C 117.216 2.302 . . . . 1.1699999999999999 117.216 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.473 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -165.69 164.76 18.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.426 -0.796 . . . . 0.60999999999999999 109.929 -177.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -145.09 96.72 2.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.054 -1.091 . . . . 0.56999999999999995 108.054 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.522 HD13 ' CG2' ' A' ' 150' ' ' VAL . 2.0 mt -87.28 114.12 23.6 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.24 -0.652 . . . . 1.3600000000000001 109.24 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.423 ' C ' HG12 ' A' ' 101' ' ' ILE . 27.1 m -83.48 143.89 29.93 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.684 -0.689 . . . . 0.42999999999999999 111.044 -170.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.78 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -108.99 165.26 11.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.032 -0.531 . . . . 1.02 110.789 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.63 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 8.8 m -64.73 -1.8 2.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.171 0.804 . . . . 1.79 113.171 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.743 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 3.6 tmtm? -129.71 132.19 46.56 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.958 -0.386 . . . . 1.8100000000000001 109.958 167.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.743 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 55.5 mt-30 -33.27 -57.97 0.4 Allowed 'General case' 0 C--N 1.309 -1.17 0 O-C-N 124.692 1.245 . . . . 1.76 114.324 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.581 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -94.51 5.04 53.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.315 0.578 . . . . 3.2000000000000002 111.423 -170.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.78 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -94.8 37.42 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.504 0.927 . . . . 0.83999999999999997 113.504 -174.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -113.23 144.2 18.02 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 116.963 -2.542 . . . . 0.96999999999999997 112.749 -152.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.79 115.13 35.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.895 0.855 . . . . 1.04 110.644 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.725 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.9 p80 -144.96 173.48 11.84 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.262 -0.881 . . . . 0.20999999999999999 109.648 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.26 -168.03 38.73 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.252 -0.975 . . . . 0.34999999999999998 111.57 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.2 t -155.01 172.06 18.73 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.942 -0.74 . . . . 1.1100000000000001 110.756 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -114.08 -2.06 13.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.961 0.886 . . . . 2.1899999999999999 108.652 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -115.92 86.55 16.65 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 114.754 -1.112 . . . . 1.8400000000000001 108.09 170.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -73.3 -19.47 22.3 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.225 1.95 . . . . 0.39000000000000001 113.191 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.27 -2.72 42.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.788 -0.642 . . . . 1.0800000000000001 110.869 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 33.4 t -90.25 -6.79 54.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.275 -0.639 . . . . 1.9399999999999999 109.275 171.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.42 HG23 ' HB2' ' A' ' 83' ' ' PRO . 38.2 mm -78.6 132.48 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.855 -0.611 . . . . 1.04 111.209 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.61 1.84 63.65 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.109 -1.196 . . . . 0.16 110.109 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.503 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 23.9 mttp -112.44 169.96 8.51 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 122.798 1.285 . . . . 3.0299999999999998 114.047 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.17 126.56 44.98 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.317 -2.22 . . . . 1.01 108.248 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.56 158.66 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.473 -0.936 . . . . 1.3400000000000001 108.473 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 49.4 m -51.46 -59.29 4.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.286 0.476 . . . . 0.87 112.286 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -131.17 -44.59 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.628 -1.229 . . . . 2.5499999999999998 113.813 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.29 133.58 0.19 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 116.999 1.56 . . . . 0.19 116.999 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.584 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 1.8 p -73.23 166.06 23.86 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.519 -1.84 . . . . 0.20000000000000001 112.13 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.792 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 44.7 mt -59.75 96.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 122.406 1.098 . . . . 1.1299999999999999 112.027 -163.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.725 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 79.1 mtt180 -86.08 146.75 26.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.53 -1.668 . . . . 2.3300000000000001 110.724 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.519 ' HG2' HG21 ' A' ' 84' ' ' ILE . 13.1 mtp -126.45 -164.82 1.37 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.901 -0.777 . . . . 1.0900000000000001 108.901 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -91.53 162.9 14.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.575 -0.528 . . . . 2.9900000000000002 109.575 169.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.65 ' O ' HD11 ' A' ' 151' ' ' ILE . 2.2 m120 -62.03 -49.92 74.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 118.537 -0.745 . . . . 0.73999999999999999 110.007 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -63.81 -28.27 69.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 121.021 1.737 . . . . 2.6899999999999999 112.106 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.424 ' CB ' ' HE3' ' A' ' 145' ' ' MET . 58.4 m-20 -78.1 -46.46 20.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.157 0.503 . . . . 0.68999999999999995 110.401 -176.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.557 HG12 HD13 ' A' ' 151' ' ' ILE . 13.4 p -67.11 -23.21 30.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.248 -0.887 . . . . 1.02 111.62 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.65 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -84.27 -42.63 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 118.764 -0.636 . . . . 1.1699999999999999 110.409 172.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.471 ' O ' HG13 ' A' ' 156' ' ' ILE . 24.9 mt-10 -47.98 -68.69 0.16 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 119.514 1.052 . . . . 1.99 112.467 171.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 157' ' ' VAL . 27.4 mt -47.6 -39.89 17.96 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.638 0.732 . . . . 1.9099999999999999 111.463 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.33 72.09 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.156 -1.384 . . . . 1.04 111.57 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 24.6 t -88.37 -32.07 18.57 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.573 -0.704 . . . . 0.88 112.523 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.8 mt -82.01 -59.93 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.673 0.749 . . . . 1.0 111.506 -172.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.9 m -90.42 143.79 29.85 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 114.739 -1.119 . . . . 1.0700000000000001 111.918 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -90.98 175.21 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 124.174 3.249 . . . . 0.23999999999999999 111.136 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 73.4 m-20 -66.8 157.24 33.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 119.668 -0.813 . . . . 1.1000000000000001 109.196 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.16 -24.29 32.46 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.042 -1.075 . . . . 0.17999999999999999 112.154 -172.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.565 ' HB ' HD13 ' A' ' 100' ' ' ILE . 84.6 m -60.35 132.07 52.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.675 -0.861 . . . . 1.05 108.675 -176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.541 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -93.59 128.98 39.99 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 122.581 1.182 . . . . 4.1100000000000003 111.012 -166.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.24 110.77 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 112.337 -2.21 . . . . 1.02 109.706 -173.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.407 HG23 ' ND2' ' A' ' 166' ' ' ASN . 24.5 m -94.79 108.89 20.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.045 -0.525 . . . . 1.0700000000000001 112.172 -173.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 165' ' ' ILE . 2.3 mp -82.51 100.68 6.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 122.51 1.148 . . . . 1.05 109.687 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.407 ' ND2' HG23 ' A' ' 164' ' ' THR . 60.7 m-80 -104.33 129.92 52.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 113.688 -1.597 . . . . 1.0900000000000001 108.749 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.486 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 16.1 mmm180 . . . . . 0 C--N 1.321 -0.674 0 CA-C-O 120.995 0.426 . . . . 2.4900000000000002 110.029 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.753 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 121.247 0.546 . . . . 1.3300000000000001 111.307 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.3 tt -94.54 127.52 40.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.222 -0.899 . . . . 1.0700000000000001 110.437 -174.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 162.64 13.33 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.265 1.031 . . . . 1.03 113.347 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.65 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 87.4 t80 -130.82 140.77 50.29 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.622 -1.626 . . . . 1.0800000000000001 107.876 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -114.03 113.46 24.8 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.353 -0.98 . . . . 0.93000000000000005 108.353 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.565 ' HB ' ' O ' ' A' ' 41' ' ' THR . 96.7 t -67.88 150.89 10.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.553 1.168 . . . . 1.1000000000000001 113.325 -168.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -105.43 158.58 16.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.096 -1.866 . . . . 2.4399999999999999 108.211 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -63.42 104.69 0.65 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.416 0.524 . . . . 2.4300000000000002 112.416 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.87 10.7 27.91 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.885 -0.674 . . . . 0.51000000000000001 113.203 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.532 ' HB2' HG11 ' A' ' 9' ' ' VAL . 82.1 m-20 -54.94 167.53 0.38 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.871 0.367 . . . . 1.46 111.172 172.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.78 153.1 46.03 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.485 0.66 . . . . 1.1599999999999999 111.419 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.546 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -66.26 -34.88 79.0 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.466 -0.939 . . . . 1.47 108.466 -179.211 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.453 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 32.6 t-20 -88.8 -25.87 22.0 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.878 -1.056 . . . . 1.78 111.098 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p -66.99 -41.02 87.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 119.866 -0.734 . . . . 1.74 109.402 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.8 mt -72.82 -26.63 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.285 0.564 . . . . 1.04 109.747 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.594 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.34 -9.94 59.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.374 -0.375 . . . . 1.0600000000000001 111.199 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.633 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.43 -39.08 9.76 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.683 1.23 . . . . 0.97999999999999998 107.911 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.766 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 7.8 m-20 -63.96 -46.42 84.72 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.097 -2.319 . . . . 0.53000000000000003 112.239 173.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.568 ' C ' HD11 ' A' ' 101' ' ' ILE . 58.5 m-85 -95.92 5.91 50.12 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 118.58 -1.248 . . . . 0.20000000000000001 111.183 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 6.0 mpt_? 54.06 43.12 31.2 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.82 0.819 . . . . 2.46 109.69 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.594 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.1 pt -116.78 -165.78 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 114.521 -1.218 . . . . 1.04 110.121 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.49 142.57 40.34 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.912 -1.04 . . . . 1.3400000000000001 110.067 175.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.55 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 66.9 p -73.11 -31.62 64.44 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.089 -1.078 . . . . 1.0900000000000001 108.089 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 -29.79 69.99 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.314 -0.857 . . . . 1.0700000000000001 111.64 169.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.75 -26.83 18.4 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.991 -0.744 . . . . 1.04 108.991 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.602 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.5 tp -74.9 -27.28 60.16 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.198 -0.91 . . . . 1.8100000000000001 109.528 173.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 26' ' ' THR . 32.3 mt -76.98 -30.84 56.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.745 0.784 . . . . 1.6399999999999999 109.822 171.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 27.6 tt0 -62.92 -43.32 99.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.374 -1.284 . . . . 2.3300000000000001 109.867 173.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -83.62 -20.08 34.33 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.072 -0.651 . . . . 1.0600000000000001 111.716 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.594 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 30.0 m-80 -146.62 81.76 9.11 Favored Pre-proline 0 N--CA 1.449 -0.485 0 CA-C-O 121.578 0.704 . . . . 0.23000000000000001 110.932 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -58.24 -9.94 7.45 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 124.26 3.306 . . . . 0.52000000000000002 113.971 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 t -79.16 -24.92 42.95 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.175 -0.328 . . . . 1.6499999999999999 110.83 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.602 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 45.0 mt -67.11 -35.46 79.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.425 0.631 . . . . 1.25 111.913 -170.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.479 ' NE2' ' HB1' ' A' ' 38' ' ' ALA . 1.6 pp0? -63.02 -46.05 89.42 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 122.96 1.362 . . . . 2.52 110.147 -174.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.479 ' HB1' ' NE2' ' A' ' 37' ' ' GLN . . . -64.9 -47.42 77.86 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 111.554 -2.566 . . . . 1.1899999999999999 110.749 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.33 177.86 48.49 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.246 -0.888 . . . . 0.44 111.858 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.99 157.77 22.04 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.322 0.582 . . . . 1.1699999999999999 110.786 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.579 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 43.2 m -141.6 130.07 22.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.252 -0.886 . . . . 1.1499999999999999 110.336 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.43 120.37 20.78 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 119.956 -0.698 . . . . 1.1200000000000001 109.518 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.66 1.38 57.6 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.331 -1.108 . . . . 0.44 110.331 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.579 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -75.9 126.19 30.54 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.14 -0.689 . . . . 1.3 109.14 177.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 16.1 m -88.87 127.58 35.64 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.789 0.804 . . . . 1.3200000000000001 109.987 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.579 HG13 ' HB3' ' A' ' 7' ' ' TYR . 7.5 pt -127.07 142.72 42.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.246 -1.343 . . . . 1.0700000000000001 109.565 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.18 153.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.073 0.463 . . . . 1.3 111.141 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.2 mm -116.93 92.5 39.07 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.836 -1.075 . . . . 1.03 109.152 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.458 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . 2.1 Cg_endo -58.47 136.15 72.38 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.953 2.436 . . . . 0.20000000000000001 112.723 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.49 -6.02 83.48 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.116 -0.947 . . . . 0.26000000000000001 112.19 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.753 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.1 tp -123.91 114.03 28.24 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-O 121.35 0.595 . . . . 1.27 111.232 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD11 ' A' ' 51' ' ' LEU . 50.0 Cg_endo -78.11 -176.88 3.48 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.713 2.942 . . . . 0.31 113.965 -171.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.46 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 14.8 t70 -80.46 129.7 67.98 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 114.656 -1.156 . . . . 0.48999999999999999 112.007 -171.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.591 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.4 Cg_endo -76.5 -13.58 18.32 Favored 'Trans proline' 0 CA--C 1.518 -0.295 0 C-N-CA 123.632 2.888 . . . . 0.48999999999999999 112.881 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.442 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 18.1 m-30 -93.48 -9.59 37.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.663 -0.699 . . . . 1.8 110.037 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.46 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 29.5 p -87.96 -25.52 23.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.61 1.195 . . . . 1.1299999999999999 108.183 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.503 HG23 ' H ' ' A' ' 59' ' ' TYR . 33.4 mt -67.79 129.18 93.41 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 112.988 -1.914 . . . . 1.24 111.553 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.25 -19.64 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.571 2.181 . . . . 0.47999999999999998 113.557 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.503 ' H ' HG23 ' A' ' 57' ' ' ILE . 58.6 m-85 -98.17 163.31 12.79 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.29 -0.564 . . . . 0.94999999999999996 112.134 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -150.91 131.69 14.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.188 -0.915 . . . . 3.7400000000000002 108.858 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 71' ' ' THR . 96.9 mt -112.9 131.75 63.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.384 -0.371 . . . . 1.05 111.844 -176.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.39 117.62 31.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 120.044 -0.663 . . . . 1.0800000000000001 110.975 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 64.4 t -95.82 119.72 44.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.62 0.724 . . . . 1.04 110.681 175.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.469 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 38.5 m -96.66 107.63 20.11 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.004 -0.998 . . . . 0.83999999999999997 110.689 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.537 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 38.6 mm -54.01 -59.33 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 122.187 0.994 . . . . 1.0600000000000001 111.074 165.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.7 -12.77 7.01 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 112.72 -2.036 . . . . 0.16 113.379 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.469 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -126.34 -17.27 5.21 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.161 0.584 . . . . 1.02 112.548 -178.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.5 ' HD2' ' CG2' ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.41 55.52 5.7 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.703 0.683 . . . . 1.3 111.419 -174.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 45.8 p -137.59 163.7 30.56 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 113.09 0.774 . . . . 0.98999999999999999 113.09 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 81' ' ' THR . 8.0 tt -127.78 115.42 18.63 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.51 -1.223 . . . . 1.1799999999999999 109.443 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 48.0 m -95.53 119.63 34.37 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.304 0.573 . . . . 1.04 111.313 177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 79' ' ' MET . 0.5 OUTLIER -92.32 103.83 16.24 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.726 -1.212 . . . . 1.3200000000000001 107.726 174.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.6 m -106.8 158.32 17.08 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 118.924 -1.111 . . . . 1.05 111.371 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -127.96 124.63 37.76 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.462 0.648 . . . . 1.1000000000000001 109.622 170.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.587 ' N ' HD23 ' A' ' 74' ' ' LEU . 8.7 p30 30.97 68.07 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 113.918 -1.492 . . . . 1.97 112.804 -166.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 72.09 -9.41 1.0 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.034 -0.984 . . . . 2.5499999999999998 112.887 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -107.58 120.3 41.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.148 0.499 . . . . 4.0199999999999996 110.776 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 41.9 t -55.64 131.91 19.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.618 1.199 . . . . 1.0600000000000001 112.862 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.615 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 22.4 mmm -97.56 -46.86 5.87 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 112.816 -1.993 . . . . 1.47 108.538 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.643 ' HG2' ' CZ ' ' A' ' 82' ' ' TYR . 2.3 tptm -157.39 174.41 15.45 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.277 -1.783 . . . . 1.98 110.5 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 55.3 m -150.2 123.93 9.19 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.498 -1.683 . . . . 1.0 109.575 168.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.643 ' CZ ' ' HG2' ' A' ' 80' ' ' LYS . 29.9 m-85 -115.46 152.18 46.79 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.996 -0.547 . . . . 1.3999999999999999 110.163 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.47 ' HB2' HG23 ' A' ' 134' ' ' ILE . 55.2 Cg_endo -76.06 144.03 26.46 Favored 'Trans proline' 0 CA--C 1.496 -1.414 0 C-N-CA 122.003 1.802 . . . . 0.23999999999999999 110.981 176.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.561 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -141.31 172.62 10.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.685 -0.689 . . . . 1.04 110.496 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.948 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -116.87 140.41 49.48 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.852 -0.339 . . . . 1.03 110.215 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.5 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 12.9 m -124.02 126.08 71.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.618 0.723 . . . . 1.26 111.702 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.77 157.03 29.42 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 114.954 -1.021 . . . . 0.20000000000000001 110.621 173.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 139' ' ' SER . 27.6 mtpp -57.13 3.6 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.013 0.745 . . . . 3.48 113.013 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.524 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.1 tp -89.12 -20.72 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 O-C-N 121.467 -0.771 . . . . 1.0700000000000001 109.821 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.469 HD23 HG22 ' A' ' 89' ' ' ILE . 3.3 mm? -88.78 -21.62 23.69 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.545 -0.909 . . . . 1.02 108.545 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.2 p -69.17 -13.32 62.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.209 -1.36 . . . . 1.05 111.297 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -66.51 -42.95 86.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.103 -0.953 . . . . 2.0299999999999998 112.225 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.41 134.12 22.99 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.378 -0.529 . . . . 1.1499999999999999 110.49 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.536 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 93.9 Cg_endo -86.44 -6.58 8.01 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.452 2.101 . . . . 1.04 112.307 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -123.92 -38.71 2.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.55 . . . . 1.1299999999999999 110.317 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.437 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 44.98 46.22 9.42 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 124.165 0.915 . . . . 0.35999999999999999 114.131 171.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.73 112.91 20.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.741 0.781 . . . . 1.0800000000000001 109.874 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 17.5 m-85 -137.7 174.21 10.83 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.355 -1.293 . . . . 0.26000000000000001 112.86 -170.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.648 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 37.4 m-85 -141.99 137.31 31.08 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.589 -0.732 . . . . 0.78000000000000003 110.527 -175.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.552 HD13 ' HB ' ' A' ' 161' ' ' THR . 84.9 mt -61.33 123.88 14.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.779 -0.646 . . . . 1.02 110.444 171.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.568 HD11 ' C ' ' A' ' 22' ' ' PHE . 17.7 pt -87.44 -43.75 15.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 112.637 0.606 . . . . 1.03 112.637 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.509 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 55.3 m-80 -172.1 176.09 3.57 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 106.72 -1.585 . . . . 2.0299999999999998 106.72 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HB3' HD21 ' A' ' 116' ' ' LEU . 5.2 mtt180 -133.01 155.96 48.21 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.878 -0.729 . . . . 2.02 112.122 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -129.31 99.86 5.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.218 -0.901 . . . . 0.83999999999999997 109.538 172.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.476 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 20.7 ttt180 -66.33 166.26 12.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.427 -0.806 . . . . 3.2799999999999998 110.504 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.476 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 23.5 m-80 -35.27 104.9 0.27 Allowed Pre-proline 0 C--O 1.234 0.247 0 C-N-CA 125.198 1.399 . . . . 0.34999999999999998 113.605 -156.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.8 Cg_endo . . . . . 0 N--CA 1.459 -0.534 0 C-N-CA 122.847 2.365 . . . . 0.63 111.215 170.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.529 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.566 1.575 0 N-CA-C 117.392 2.367 . . . . 1.1699999999999999 117.392 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.653 ' HE1' ' CE2' ' A' ' 114' ' ' TYR . 0.4 OUTLIER -166.01 154.14 10.76 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.243 -0.91 . . . . 0.60999999999999999 110.549 -175.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -134.23 98.59 4.15 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.064 -1.087 . . . . 0.56999999999999995 108.064 167.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 103' ' ' ARG . 4.5 mt -89.6 114.11 25.64 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.017 -0.735 . . . . 1.3600000000000001 109.017 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.7 m -84.46 144.27 28.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.76 -0.654 . . . . 0.42999999999999999 111.385 -167.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.767 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.5 mm? -108.84 171.61 7.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.975 -0.557 . . . . 1.02 110.625 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.605 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.5 OUTLIER -63.14 -13.84 41.56 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.93 0.715 . . . . 1.79 112.93 -179.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HD3' ' OD1' ' A' ' 21' ' ' ASP . 5.3 tppp? -126.3 132.29 51.68 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.094 0.473 . . . . 1.8100000000000001 110.828 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.485 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 56.3 mt-30 -33.29 -57.42 0.41 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.907 -1.497 . . . . 1.76 114.308 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.524 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -99.74 12.13 37.42 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.569 -0.852 . . . . 3.2000000000000002 111.547 -172.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.767 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.1 m-85 -96.33 37.5 1.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.857 0.688 . . . . 0.83999999999999997 112.857 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -117.04 144.2 18.32 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 117.328 -2.367 . . . . 0.96999999999999997 112.649 -152.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -95.57 114.53 32.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.754 0.788 . . . . 1.04 110.778 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.563 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 27.5 p80 -143.34 171.97 13.39 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.389 -0.823 . . . . 0.20999999999999999 109.372 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.98 -169.4 38.08 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 119.847 -1.168 . . . . 0.34999999999999998 112.067 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -154.13 172.64 17.22 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.472 -0.428 . . . . 1.1100000000000001 110.009 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -113.0 -2.52 14.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.442 -0.947 . . . . 2.1899999999999999 108.442 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -115.71 88.17 19.76 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.004 -0.998 . . . . 1.8400000000000001 108.532 170.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -72.74 -16.87 26.37 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.248 1.965 . . . . 0.39000000000000001 112.779 -171.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.41 -0.61 33.58 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.546 -0.752 . . . . 1.0800000000000001 111.215 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.0 p -93.42 -6.45 47.04 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.134 -0.691 . . . . 1.9399999999999999 109.134 169.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 83' ' ' PRO . 42.5 mm -81.18 130.78 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.255 -0.884 . . . . 1.04 110.627 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.73 2.58 59.76 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 109.944 -1.263 . . . . 0.16 109.944 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.421 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 23.3 mttp -114.81 170.57 8.23 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 123.146 1.45 . . . . 3.0299999999999998 114.431 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.421 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -101.91 127.66 48.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 111.887 -2.415 . . . . 1.01 108.006 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.411 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -123.23 162.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.643 -0.873 . . . . 1.3400000000000001 108.643 -176.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 58.7 m -52.18 -59.38 4.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.471 0.545 . . . . 0.87 112.471 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.93 -45.57 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 118.766 -1.174 . . . . 2.5499999999999998 113.726 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.83 133.54 0.16 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 116.955 1.542 . . . . 0.19 116.955 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.563 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 4.2 p -73.85 166.65 22.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 112.606 -1.797 . . . . 0.20000000000000001 112.066 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.948 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 54.0 mt -59.87 97.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 122.468 1.127 . . . . 1.1299999999999999 112.034 -163.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.546 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 34.3 mtt180 -84.12 152.98 24.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.694 -1.594 . . . . 2.3300000000000001 110.054 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.561 ' HG2' HG21 ' A' ' 84' ' ' ILE . 11.1 mtp -133.26 -165.88 1.68 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.545 -0.539 . . . . 1.0900000000000001 109.545 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.621 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 24.8 t-80 -97.54 151.3 20.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.569 -0.741 . . . . 2.9900000000000002 109.181 173.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.623 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.3 m120 -55.35 -53.52 55.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 118.132 -0.937 . . . . 0.73999999999999999 111.043 -174.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.452 ' HZ3' ' CG ' ' A' ' 149' ' ' ASP . 15.2 pttp -62.28 -28.23 69.57 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 121.592 1.996 . . . . 2.6899999999999999 111.827 -175.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.621 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 3.5 m-20 -78.23 -44.36 25.8 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.773 -0.649 . . . . 0.68999999999999995 110.903 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.534 HG12 HD13 ' A' ' 151' ' ' ILE . 14.2 p -67.27 -21.78 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.598 -0.728 . . . . 1.02 111.342 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.623 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.86 -42.37 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 119.124 -0.465 . . . . 1.1699999999999999 110.069 171.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.424 ' O ' HG13 ' A' ' 156' ' ' ILE . 31.2 mt-10 -46.84 -71.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.904 0.774 . . . . 1.99 112.87 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 149' ' ' ASP . 11.5 mt -43.54 -43.85 5.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.702 0.763 . . . . 1.9099999999999999 110.61 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.19 -37.35 74.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.701 -1.591 . . . . 1.04 111.722 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.3 t -85.94 -32.28 21.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.678 0.672 . . . . 0.88 112.032 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 152' ' ' GLU . 52.0 mt -81.13 -59.87 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.561 0.696 . . . . 1.0 111.408 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 153' ' ' LEU . 3.6 m -88.61 144.77 33.99 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 114.76 -1.109 . . . . 1.0700000000000001 111.728 175.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -91.63 177.21 1.89 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 124.09 3.193 . . . . 0.23999999999999999 111.266 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 61.0 m-20 -67.13 159.46 28.84 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.532 -0.867 . . . . 1.1000000000000001 109.339 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 94.84 -19.63 52.95 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.213 -0.994 . . . . 0.17999999999999999 112.125 -174.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.552 ' HB ' HD13 ' A' ' 100' ' ' ILE . 87.0 m -60.62 137.72 58.14 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.472 -0.566 . . . . 1.05 109.472 -175.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.472 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 1.9 ptt180 -92.05 116.4 28.9 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.769 1.271 . . . . 4.1100000000000003 110.51 -168.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.5 t -107.42 107.05 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 112.056 -2.338 . . . . 1.02 109.158 -175.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.0 m -94.74 109.92 21.82 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.038 -0.528 . . . . 1.0700000000000001 112.148 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.459 HD13 ' N ' ' A' ' 165' ' ' ILE . 2.4 mp -82.65 95.07 3.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 122.47 1.129 . . . . 1.05 109.694 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -101.58 136.57 41.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.607 -1.633 . . . . 1.0900000000000001 108.879 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.537 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 5.8 mmt85 . . . . . 0 C--N 1.317 -0.84 0 N-CA-C 109.446 -0.576 . . . . 2.4900000000000002 109.446 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.192 0.52 . . . . 1.3300000000000001 110.988 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.2 tt -95.47 126.26 40.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.529 -0.76 . . . . 1.0700000000000001 110.338 -174.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.68 161.68 13.93 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.787 -1.097 . . . . 1.03 112.511 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.657 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 80.8 t80 -129.34 140.98 51.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.152 -1.386 . . . . 1.0800000000000001 107.987 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -112.92 112.74 24.43 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.936 -1.135 . . . . 0.93000000000000005 107.936 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' A' ' 13' ' ' ASP . 99.6 t -65.37 148.16 12.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 122.556 1.17 . . . . 1.1000000000000001 112.372 -170.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -106.29 158.16 17.07 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.287 -1.779 . . . . 2.4399999999999999 108.184 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -59.65 111.96 1.63 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.952 0.406 . . . . 2.4300000000000002 111.786 -173.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.53 54.13 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.744 -0.662 . . . . 0.51000000000000001 113.827 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.556 ' HB2' HG11 ' A' ' 9' ' ' VAL . 91.8 m-20 -55.61 168.2 0.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.198 0.499 . . . . 1.46 111.255 172.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.82 151.85 47.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.858 0.361 . . . . 1.1599999999999999 110.95 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -40.53 97.24 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.097 -1.075 . . . . 1.47 108.097 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.439 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 64.4 t30 -84.21 -22.65 30.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.353 -1.294 . . . . 1.78 110.434 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -65.09 -45.3 85.81 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.958 -0.756 . . . . 1.74 108.958 171.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.427 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 15.4 mt -72.52 -27.06 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.201 0.524 . . . . 1.04 109.84 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.617 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.27 -10.56 59.76 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.481 -0.327 . . . . 1.0600000000000001 110.912 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.639 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.5 -39.63 9.06 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 122.669 1.223 . . . . 0.97999999999999998 108.092 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 119' ' ' SER . 8.8 m-20 -62.46 -46.01 90.46 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 112.293 -2.23 . . . . 0.53000000000000003 111.904 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.629 ' C ' HD11 ' A' ' 101' ' ' ILE . 55.3 m-85 -95.83 5.68 50.72 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 118.81 -1.156 . . . . 0.20000000000000001 111.551 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.639 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.1 mpt_? 54.13 43.33 30.83 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.758 0.79 . . . . 2.46 109.838 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.617 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.5 pt -118.34 -165.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 114.442 -1.254 . . . . 1.04 109.799 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.7 142.73 42.22 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.156 -0.929 . . . . 1.3400000000000001 110.429 174.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.566 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 82.3 p -71.01 -33.34 70.29 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.198 -1.038 . . . . 1.0900000000000001 108.198 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.91 69.27 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.373 -0.831 . . . . 1.0700000000000001 112.008 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.42 -27.76 16.53 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.914 -0.773 . . . . 1.04 108.914 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.557 HD21 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -73.95 -28.86 61.7 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.956 -1.02 . . . . 1.8100000000000001 109.113 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 26' ' ' THR . 40.5 mt -76.1 -31.66 58.81 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.659 0.742 . . . . 1.6399999999999999 110.071 171.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 5.5 tt0 -63.78 -37.57 87.85 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.335 -1.302 . . . . 2.3300000000000001 110.084 174.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.46 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -85.97 -20.35 29.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 120.001 -0.68 . . . . 1.0600000000000001 111.679 176.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.592 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.7 m-80 -149.78 83.08 6.41 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-O 121.194 0.521 . . . . 0.23000000000000001 110.751 -172.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.2 Cg_endo -56.26 -15.46 14.75 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 123.927 3.085 . . . . 0.52000000000000002 113.834 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -73.2 -25.12 60.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.684 0.278 . . . . 1.6499999999999999 111.31 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 29.7 mt -67.88 -39.84 83.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.324 0.583 . . . . 1.25 112.397 -170.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -63.6 -44.79 92.96 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.933 1.349 . . . . 2.52 110.275 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.16 82.63 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 111.691 -2.504 . . . . 1.1899999999999999 110.614 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.06 176.55 48.01 Favored Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 115.048 -0.978 . . . . 0.44 111.951 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.03 157.69 19.05 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.163 0.506 . . . . 1.1699999999999999 110.791 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.569 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 49.9 m -141.39 127.93 20.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.33 -0.85 . . . . 1.1499999999999999 110.222 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 11' ' ' GLN . . . -76.45 117.21 17.87 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.492 0.663 . . . . 1.1200000000000001 109.986 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.66 -0.12 49.26 Favored Glycine 0 N--CA 1.429 -1.818 0 CA-C-N 114.775 -1.102 . . . . 0.44 110.389 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.569 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -75.14 124.69 27.47 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.921 -0.639 . . . . 1.3 109.63 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 61.8 p -85.67 131.79 34.27 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 122.099 0.952 . . . . 1.3200000000000001 110.448 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.576 HG13 ' HB3' ' A' ' 7' ' ' TYR . 10.2 pt -132.3 143.78 38.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.157 -1.383 . . . . 1.0700000000000001 109.521 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.24 151.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.2 0.524 . . . . 1.3 111.224 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.3 mm -116.74 93.37 40.89 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 114.614 -1.175 . . . . 1.03 108.948 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 2.3 Cg_endo -60.12 136.89 71.95 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.705 2.27 . . . . 0.20000000000000001 112.881 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.12 -6.23 83.79 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.114 -0.948 . . . . 0.26000000000000001 112.269 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.735 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 28.9 tp -121.46 114.53 31.6 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.287 0.565 . . . . 1.27 111.077 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.613 ' HD2' HD11 ' A' ' 51' ' ' LEU . 53.8 Cg_endo -78.67 -177.07 3.63 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.702 2.935 . . . . 0.31 114.135 -171.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.479 ' OD1' ' HB2' ' A' ' 55' ' ' TYR . 12.0 t70 -82.81 131.96 52.88 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 114.028 -1.442 . . . . 0.48999999999999999 112.317 -169.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 57.1 Cg_endo -73.98 -14.69 23.71 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 123.571 2.847 . . . . 0.48999999999999999 112.89 -177.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.479 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 22.0 m-85 -89.61 -15.47 32.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.082 -0.508 . . . . 1.8 110.73 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 20.8 p -83.22 -20.71 34.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 122.481 1.134 . . . . 1.1299999999999999 108.147 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.503 HG23 ' H ' ' A' ' 59' ' ' TYR . 26.4 mt -76.34 135.45 69.3 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 113.06 -1.882 . . . . 1.24 110.99 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.495 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 30.5 Cg_endo -84.7 -17.26 5.14 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 122.361 2.041 . . . . 0.47999999999999998 112.863 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.503 ' H ' HG23 ' A' ' 57' ' ' ILE . 42.9 m-85 -100.6 155.83 17.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.91 0.386 . . . . 0.94999999999999996 111.541 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -144.98 135.05 23.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.555 -0.748 . . . . 3.7400000000000002 109.102 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.64 ' HA ' ' O ' ' A' ' 71' ' ' THR . 84.1 mt -114.19 134.88 55.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.25 -0.432 . . . . 1.05 111.891 -175.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.05 118.88 33.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 119.89 -0.724 . . . . 1.0800000000000001 111.124 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.5 t -98.3 113.9 34.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.748 0.785 . . . . 1.04 111.166 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 68' ' ' LYS . 40.2 m -92.29 105.35 17.57 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.783 -1.099 . . . . 0.83999999999999997 110.336 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.7 mm -53.14 -58.73 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 122.055 0.931 . . . . 1.0600000000000001 111.314 168.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.01 -11.2 4.31 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 112.701 -2.045 . . . . 0.16 113.082 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -126.23 -16.53 5.45 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.653 0.781 . . . . 1.02 112.19 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.511 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 57.01 54.94 6.48 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.412 0.551 . . . . 1.3 111.28 -174.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.3 p -137.0 165.65 25.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.928 0.714 . . . . 0.98999999999999999 112.928 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.9 tt -132.8 111.66 11.29 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.68 -1.146 . . . . 1.1799999999999999 109.822 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.9 m -93.31 123.25 36.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.924 0.392 . . . . 1.04 111.101 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.575 ' O ' ' HB2' ' A' ' 79' ' ' MET . 11.6 tp -98.97 107.29 19.68 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.322 -0.854 . . . . 1.3200000000000001 108.791 172.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 88.3 p -105.37 161.89 13.92 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.324 -0.95 . . . . 1.05 110.591 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.599 HD11 ' ND2' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -126.31 126.33 43.76 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.522 -0.918 . . . . 1.1000000000000001 108.522 169.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.599 ' ND2' HD11 ' A' ' 74' ' ' LEU . 9.8 p30 43.0 48.1 5.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.021 -1.445 . . . . 1.97 111.647 -165.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.8 t30 78.15 -13.89 0.91 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.794 -1.094 . . . . 2.5499999999999998 111.591 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -92.51 122.78 35.28 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.193 -0.669 . . . . 4.0199999999999996 109.193 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 53.6 t -56.66 132.52 20.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.37 1.081 . . . . 1.0600000000000001 112.834 -173.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.575 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 57.2 mmm -96.91 -47.63 5.75 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.096 -1.865 . . . . 1.47 107.838 175.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -163.3 174.05 12.53 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 112.871 -1.968 . . . . 1.98 110.358 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.3 m -148.47 124.57 10.74 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.029 -1.441 . . . . 1.0 109.395 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -111.59 151.02 43.05 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 109.56 -0.533 . . . . 1.3999999999999999 109.56 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HB2' HG23 ' A' ' 134' ' ' ILE . 44.3 Cg_endo -76.63 140.82 21.5 Favored 'Trans proline' 0 CA--C 1.499 -1.247 0 C-N-CA 122.103 1.869 . . . . 0.23999999999999999 111.235 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.548 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.33 173.07 12.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.495 -0.775 . . . . 1.04 110.584 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.907 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.94 144.3 45.61 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 110.13 -0.322 . . . . 1.03 110.13 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.455 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 9.0 m -126.39 126.71 69.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.676 0.75 . . . . 1.26 111.801 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.28 152.41 29.41 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 109.771 -1.332 . . . . 0.20000000000000001 109.771 171.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 31.9 mmtp -57.27 4.63 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.06 0.763 . . . . 3.48 113.06 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.484 ' H ' ' C ' ' A' ' 87' ' ' GLY . 1.1 tp -89.57 -19.65 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.504 0.669 . . . . 1.0700000000000001 110.235 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.7 mm? -88.09 -16.73 32.73 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.749 0.785 . . . . 1.02 109.097 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.9 p -68.95 -16.43 63.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.396 -1.274 . . . . 1.05 111.352 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -62.03 -42.06 98.76 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 114.945 -1.025 . . . . 2.0299999999999998 111.788 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.33 116.75 56.08 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 1.1499999999999999 110.644 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 6.0 Cg_exo -72.62 -21.25 22.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.604 2.202 . . . . 1.04 112.842 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -99.88 -40.44 7.69 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.529 -0.545 . . . . 1.1299999999999999 109.529 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.521 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 45.42 48.09 11.58 Favored Glycine 0 N--CA 1.446 -0.639 0 O-C-N 124.393 1.058 . . . . 0.35999999999999999 113.557 171.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -82.75 110.98 18.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.738 0.78 . . . . 1.0800000000000001 109.172 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.726 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 21.5 m-85 -139.53 169.29 18.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.01 -1.45 . . . . 0.26000000000000001 112.49 -171.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.669 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 43.6 m-85 -139.11 139.06 37.56 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.863 -0.608 . . . . 0.78000000000000003 110.377 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.561 HD13 ' HB ' ' A' ' 161' ' ' THR . 80.9 mt -61.63 118.93 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 115.412 -0.813 . . . . 1.02 110.492 172.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.629 HD11 ' C ' ' A' ' 22' ' ' PHE . 21.4 pt -85.28 -32.76 7.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 113.198 0.814 . . . . 1.03 113.198 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.589 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 10.4 p30 177.99 176.05 0.47 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.613 -1.254 . . . . 2.0299999999999998 107.613 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.698 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 19.6 mtt180 -125.2 161.25 27.29 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.509 -0.876 . . . . 2.02 111.914 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 107' ' ' PRO . 52.0 tt0 -135.99 100.17 4.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.216 -0.902 . . . . 0.83999999999999997 109.832 170.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.485 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 24.8 ttp180 -67.5 165.48 16.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.378 -0.828 . . . . 3.2799999999999998 110.843 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.737 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 34.5 m-80 -36.1 101.08 0.21 Allowed Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 125.32 1.448 . . . . 0.34999999999999998 112.706 -156.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 18.1 Cg_endo . . . . . 0 C--N 1.343 0.245 0 C-N-CA 122.985 2.456 . . . . 0.63 112.392 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.737 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . . . . . . . . 0 N--CA 1.439 -0.998 0 CA-C-O 120.71 0.291 . . . . 1.1699999999999999 110.518 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.485 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.8 OUTLIER -162.09 157.3 23.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.786 0.327 . . . . 0.60999999999999999 110.424 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -135.39 99.84 4.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.627 -1.249 . . . . 0.56999999999999995 107.627 164.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 103' ' ' ARG . 5.7 mt -92.18 113.95 26.36 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.579 -0.897 . . . . 1.3600000000000001 108.579 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.423 ' C ' HG12 ' A' ' 101' ' ' ILE . 13.2 m -83.55 144.88 29.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.775 -0.648 . . . . 0.42999999999999999 111.561 -166.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.9 mm? -110.28 166.53 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 1.02 110.936 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.596 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -62.65 -8.2 6.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.028 0.751 . . . . 1.79 113.028 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.76 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.9 tmtm? -126.84 133.01 50.84 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.362 1.077 . . . . 1.8100000000000001 109.833 172.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.76 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 52.9 mt-30 -39.08 -46.39 1.4 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 112.439 -2.164 . . . . 1.76 114.227 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.471 ' CB ' HG12 ' A' ' 89' ' ' ILE . 79.6 m-70 -97.38 -0.67 45.95 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.212 -0.595 . . . . 3.2000000000000002 111.51 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.728 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -97.21 38.19 1.27 Allowed 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.365 1.246 . . . . 0.83999999999999997 114.365 -169.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.454 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -117.19 146.0 18.73 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 116.457 -2.783 . . . . 0.96999999999999997 113.111 -153.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.73 116.58 39.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 124.053 0.941 . . . . 1.04 111.004 -176.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.558 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 29.5 p80 -146.23 -177.05 5.41 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 112.593 0.59 . . . . 0.20999999999999999 112.593 -176.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.98 -167.19 37.4 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.436 -0.666 . . . . 0.34999999999999998 111.436 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.6 t -161.68 164.05 29.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 117.727 0.764 . . . . 1.1100000000000001 110.589 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -115.18 -3.79 12.51 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.118 -1.067 . . . . 2.1899999999999999 108.118 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -121.74 91.43 48.62 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 114.148 -1.387 . . . . 1.8400000000000001 108.673 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.66 -22.27 18.2 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.346 2.031 . . . . 0.39000000000000001 113.769 -172.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.24 2.26 25.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.103 0.477 . . . . 1.0800000000000001 111.163 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.456 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 43.6 t -95.07 -4.89 45.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 1.9399999999999999 109.364 170.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 31.8 mm -78.76 138.17 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 115.899 -0.591 . . . . 1.04 110.106 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.56 1.81 80.19 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.119 -1.192 . . . . 0.16 110.119 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 91.8 mttt -113.36 167.94 10.15 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 123.161 1.457 . . . . 3.0299999999999998 114.253 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.1 126.63 46.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 111.699 -2.501 . . . . 1.01 107.961 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.417 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -125.24 161.95 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.909 -0.774 . . . . 1.3400000000000001 108.909 -174.418 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.7 m -49.72 -60.35 2.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.114 0.783 . . . . 0.87 113.114 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -133.52 -43.99 0.83 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 118.533 -1.267 . . . . 2.5499999999999998 113.619 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.42 133.49 0.2 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 117.055 1.582 . . . . 0.19 117.055 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.558 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 2.9 p -70.05 165.19 22.41 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 112.575 -1.813 . . . . 0.20000000000000001 112.419 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.907 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 49.4 mt -60.61 97.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 114.494 -1.23 . . . . 1.1299999999999999 112.077 -163.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.493 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 10.4 mtp180 -83.97 144.06 29.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.702 -1.59 . . . . 2.3300000000000001 109.501 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.548 ' HG2' HG21 ' A' ' 84' ' ' ILE . 14.9 mtp -121.38 -169.0 1.78 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.188 -0.671 . . . . 1.0900000000000001 109.188 173.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.606 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 1.5 t60 -89.85 153.91 20.28 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.158 -1.053 . . . . 2.9900000000000002 108.158 170.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.886 ' O ' HD12 ' A' ' 151' ' ' ILE . 9.2 m120 -72.45 -20.29 61.42 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 118.474 -0.774 . . . . 0.73999999999999999 113.069 -171.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -81.61 -28.75 33.58 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 121.364 1.893 . . . . 2.6899999999999999 112.734 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.606 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 5.0 m-20 -77.62 -41.21 39.34 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.186 0.517 . . . . 0.68999999999999995 110.63 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.507 HG12 HD11 ' A' ' 151' ' ' ILE . 12.5 p -66.34 -19.69 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.245 -0.889 . . . . 1.02 111.349 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.886 HD12 ' O ' ' A' ' 147' ' ' ASN . 1.6 mp -86.26 -42.98 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 118.801 -0.618 . . . . 1.1699999999999999 110.727 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.433 ' O ' HG13 ' A' ' 156' ' ' ILE . 16.2 mt-10 -45.12 -70.87 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.369 0.986 . . . . 1.99 112.578 170.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.514 ' O ' HG23 ' A' ' 157' ' ' VAL . 48.0 mt -46.07 -39.9 9.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.627 0.727 . . . . 1.9099999999999999 111.53 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.26 -36.07 79.0 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.01 -1.45 . . . . 1.04 111.775 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.3 t -86.97 -31.11 20.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 118.811 0.732 . . . . 0.88 112.501 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.1 mt -82.49 -60.35 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.652 0.739 . . . . 1.0 111.756 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -88.38 141.93 31.02 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.837 -1.074 . . . . 1.0700000000000001 112.252 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.698 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 56.9 Cg_endo -89.28 175.38 3.37 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 124.024 3.149 . . . . 0.23999999999999999 110.997 174.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.589 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 75.3 m-20 -65.53 156.04 33.81 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 119.371 -0.931 . . . . 1.1000000000000001 108.972 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 97.91 -19.78 53.21 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.008 -1.091 . . . . 0.17999999999999999 112.358 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.561 ' HB ' HD13 ' A' ' 100' ' ' ILE . 50.5 m -64.1 137.4 57.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.902 -0.777 . . . . 1.05 108.902 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.518 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 20.0 ttt180 -92.15 127.6 37.68 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 122.52 1.152 . . . . 4.1100000000000003 110.745 -169.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.31 107.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 112.374 -2.193 . . . . 1.02 109.086 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.1 m -93.92 107.91 19.77 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.377 0.51 . . . . 1.0700000000000001 112.377 -172.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.521 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.04 99.63 5.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 122.171 0.986 . . . . 1.05 109.955 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -110.77 133.38 53.39 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.391 -1.277 . . . . 1.0900000000000001 109.879 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.557 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 19.5 mmm180 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 116.239 -0.437 . . . . 2.4900000000000002 110.394 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.408 0.623 . . . . 1.3300000000000001 111.643 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.0 tt -98.18 128.67 44.79 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.904 -1.043 . . . . 1.0700000000000001 110.392 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.19 162.96 13.3 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.209 1.004 . . . . 1.03 113.075 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.639 ' HD1' ' CD2' ' A' ' 7' ' ' TYR . 86.9 t80 -130.32 139.36 50.7 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.768 -1.56 . . . . 1.0800000000000001 107.753 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -112.39 113.14 25.18 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.013 -1.106 . . . . 0.93000000000000005 108.013 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' A' ' 13' ' ' ASP . 94.9 t -67.23 148.15 12.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 122.528 1.156 . . . . 1.1000000000000001 113.283 -169.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -102.35 158.6 16.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 113.312 -1.767 . . . . 2.4399999999999999 108.367 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.61 104.22 0.4 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.059 0.457 . . . . 2.4300000000000002 112.068 -174.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.83 10.96 36.11 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.718 -0.674 . . . . 0.51000000000000001 113.502 174.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.617 ' HB2' HG11 ' A' ' 9' ' ' VAL . 29.8 m-20 -53.06 169.3 0.1 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.137 0.494 . . . . 1.46 111.671 173.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.35 150.47 50.7 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.105 0.479 . . . . 1.1599999999999999 111.95 177.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.515 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.56 -36.45 83.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.055 -0.975 . . . . 1.47 108.808 -177.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.42 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 2.7 t-20 -87.75 -24.5 23.79 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.812 -1.086 . . . . 1.78 110.855 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.0 m -70.1 -38.1 75.55 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.322 -0.551 . . . . 1.74 110.176 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 mt -74.67 -28.39 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.43 -0.581 . . . . 1.04 109.43 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.66 -9.54 59.43 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.281 -0.418 . . . . 1.0600000000000001 110.81 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.667 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.64 -40.8 8.83 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.38 1.086 . . . . 0.97999999999999998 108.116 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 119' ' ' SER . 7.5 m-20 -62.39 -44.41 96.52 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.462 -2.154 . . . . 0.53000000000000003 112.19 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.486 ' O ' HD11 ' A' ' 101' ' ' ILE . 53.0 m-85 -96.98 6.39 48.72 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 118.627 -1.229 . . . . 0.20000000000000001 111.03 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.667 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER 54.3 41.44 31.98 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.916 0.865 . . . . 2.46 109.25 176.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.62 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.1 pt -113.87 -165.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.442 -1.254 . . . . 1.04 110.214 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.06 142.61 41.28 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.206 -0.906 . . . . 1.3400000000000001 110.225 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.48 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 60.3 p -72.97 -33.29 65.77 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.804 -1.184 . . . . 1.0900000000000001 107.804 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.04 -27.2 66.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.34 -0.845 . . . . 1.0700000000000001 111.824 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.495 ' HA ' ' HB2' ' A' ' 31' ' ' GLN . . . -95.21 -25.3 16.43 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.649 0.737 . . . . 1.04 109.636 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.593 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 17.5 tp -75.23 -27.43 59.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.241 -0.89 . . . . 1.8100000000000001 109.054 173.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 36' ' ' LEU . 35.3 mt -78.04 -26.69 48.51 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.36 0.6 . . . . 1.6399999999999999 110.372 172.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.495 ' HB2' ' HA ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -59.81 -61.56 2.52 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 108.129 -1.063 . . . . 2.3300000000000001 108.129 169.471 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.465 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -71.29 -18.57 62.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.491 -0.777 . . . . 1.0600000000000001 110.86 -170.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.568 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 28.5 m-80 -147.61 80.65 8.93 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-N 115.642 -0.708 . . . . 0.23000000000000001 110.385 -174.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.5 -4.41 2.49 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 123.787 2.991 . . . . 0.52000000000000002 113.145 174.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 p -79.96 -25.75 40.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.052 0.453 . . . . 1.6499999999999999 111.542 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.593 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 33.6 mt -70.81 -33.66 70.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.733 -0.667 . . . . 1.25 112.387 -170.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.425 ' H ' ' HG3' ' A' ' 37' ' ' GLN . 1.7 pp0? -63.56 -44.72 93.3 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.822 1.296 . . . . 2.52 110.76 -172.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.416 ' HB1' ' NE2' ' A' ' 37' ' ' GLN . . . -64.19 -49.12 73.28 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 111.795 -2.457 . . . . 1.1899999999999999 110.404 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.6 176.23 47.87 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 114.683 -1.144 . . . . 0.44 111.405 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -109.51 157.99 18.44 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.37 0.605 . . . . 1.1699999999999999 110.626 179.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.606 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 53.2 m -138.39 128.8 26.1 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.317 -0.856 . . . . 1.1499999999999999 110.192 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.25 119.74 19.79 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 119.996 -0.682 . . . . 1.1200000000000001 109.535 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.44 1.51 56.67 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.254 -1.138 . . . . 0.44 110.254 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.606 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -76.65 123.6 26.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.918 -0.641 . . . . 1.3 109.824 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 29.8 p -84.32 125.93 32.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.491 -0.777 . . . . 1.3200000000000001 110.771 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.594 HG13 ' HB3' ' A' ' 7' ' ' TYR . 8.9 pt -126.3 143.23 40.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 114.241 -1.345 . . . . 1.0700000000000001 109.443 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.64 152.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 121.164 0.507 . . . . 1.3 111.185 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.9 mm -116.28 92.03 34.75 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.648 -1.16 . . . . 1.03 109.268 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 1.9 Cg_endo -57.98 135.06 66.38 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.811 2.341 . . . . 0.20000000000000001 112.71 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.98 -5.77 83.06 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.067 -0.97 . . . . 0.26000000000000001 112.279 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.707 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 27.7 tp -122.54 113.37 30.61 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 121.253 0.549 . . . . 1.27 110.978 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.623 ' HD2' HD11 ' A' ' 51' ' ' LEU . 48.6 Cg_endo -78.05 -176.22 3.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.77 2.98 . . . . 0.31 114.295 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.531 ' OD2' ' HB2' ' A' ' 55' ' ' TYR . 22.5 t70 -79.9 129.76 69.4 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 113.967 -1.47 . . . . 0.48999999999999999 112.648 -169.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 41.1 Cg_endo -73.06 -14.01 26.11 Favored 'Trans proline' 0 C--N 1.34 0.118 0 C-N-CA 123.396 2.731 . . . . 0.48999999999999999 112.687 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.531 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 75.5 m-85 -92.58 -10.28 38.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.971 -0.558 . . . . 1.8 111.332 -174.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 30.0 p -85.46 -24.69 27.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.586 1.184 . . . . 1.1299999999999999 108.153 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.528 HG23 ' H ' ' A' ' 59' ' ' TYR . 15.9 mt -72.53 136.34 80.98 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.82 -1.991 . . . . 1.24 111.246 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.518 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 36.8 Cg_endo -86.38 -16.49 3.94 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.459 2.106 . . . . 0.47999999999999998 113.319 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.528 ' H ' HG23 ' A' ' 57' ' ' ILE . 56.0 m-85 -98.43 158.15 15.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.199 0.444 . . . . 0.94999999999999996 112.199 -174.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.579 ' CD2' ' HE ' ' A' ' 162' ' ' ARG . 40.5 m80 -147.01 132.44 18.61 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.67 -0.695 . . . . 3.7400000000000002 109.15 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.703 ' HA ' ' O ' ' A' ' 71' ' ' THR . 76.1 mt -114.99 135.93 53.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.261 -0.427 . . . . 1.05 111.914 -176.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.79 117.6 28.63 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.11 -0.636 . . . . 1.0800000000000001 111.249 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 69' ' ' THR . 88.9 t -96.77 117.93 42.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.511 0.672 . . . . 1.04 111.168 175.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.46 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 65.1 m -92.84 109.56 21.0 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.253 -0.885 . . . . 0.83999999999999997 111.262 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 36.2 mm -54.48 -59.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 122.255 1.026 . . . . 1.0600000000000001 111.081 165.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.13 -12.75 6.0 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 112.783 -2.008 . . . . 0.16 113.362 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.46 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -126.94 -18.62 4.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.866 0.691 . . . . 1.02 112.866 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HB2' ' HZ2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.96 56.3 4.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.811 0.732 . . . . 1.3 111.438 -172.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 46.8 p -137.89 164.6 28.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.897 0.703 . . . . 0.98999999999999999 112.897 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.436 ' C ' HD21 ' A' ' 70' ' ' LEU . 7.4 tt -133.13 110.67 10.34 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.713 -1.131 . . . . 1.1799999999999999 109.81 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 53.1 m -93.42 121.77 35.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.288 0.566 . . . . 1.04 111.188 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.1 tp -96.5 107.37 19.77 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.909 -1.041 . . . . 1.3200000000000001 109.054 173.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 4.3 m -107.61 158.11 17.52 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.453 -0.899 . . . . 1.05 110.645 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.574 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -126.19 126.15 43.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.826 -0.805 . . . . 1.1000000000000001 108.826 170.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.574 ' N ' HD23 ' A' ' 74' ' ' LEU . 8.9 p30 41.48 54.81 3.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.04 -1.436 . . . . 1.97 111.539 -165.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.5 t30 73.86 -14.98 0.61 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.173 -0.921 . . . . 2.5499999999999998 111.709 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -91.84 118.99 31.23 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.81 -0.441 . . . . 4.0199999999999996 109.81 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.0 t -58.05 130.32 21.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 122.479 1.133 . . . . 1.0600000000000001 112.412 -175.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.53 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 64.0 mmm -96.27 -48.68 5.52 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.014 -1.903 . . . . 1.47 108.214 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 14.3 mmmt -160.72 174.06 14.49 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 112.669 -2.06 . . . . 1.98 109.477 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.3 m -148.58 124.49 10.62 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.602 -1.181 . . . . 1.0 109.072 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 1.622 ' HD1' ' CD2' ' A' ' 82' ' ' TYR . 12.9 m-85 -106.01 147.21 34.39 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.118 -0.946 . . . . 1.3999999999999999 109.588 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.44 ' HB2' HG23 ' A' ' 134' ' ' ILE . 37.4 Cg_endo -75.12 140.61 25.33 Favored 'Trans proline' 0 CA--C 1.498 -1.305 0 C-N-CA 121.445 1.43 . . . . 0.23999999999999999 110.24 168.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.524 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -141.06 174.68 6.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.764 -0.653 . . . . 1.04 110.554 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.889 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.16 143.55 47.16 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.793 0.33 . . . . 1.03 110.424 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.461 HG23 ' HG3' ' A' ' 68' ' ' LYS . 8.7 m -125.64 126.21 69.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.525 0.678 . . . . 1.26 111.779 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.03 154.41 31.91 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.609 -1.396 . . . . 0.20000000000000001 109.609 171.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -55.79 0.18 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.042 0.756 . . . . 3.48 113.042 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.549 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.2 tp -85.04 -19.11 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 O-C-N 121.353 -0.842 . . . . 1.0700000000000001 110.068 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.427 HD23 HG22 ' A' ' 89' ' ' ILE . 3.5 mm? -87.17 -17.25 33.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.766 -0.827 . . . . 1.02 108.766 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.6 p -70.41 -15.66 62.86 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.461 -1.245 . . . . 1.05 111.23 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.17 -43.21 98.9 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.477 -0.783 . . . . 2.0299999999999998 111.594 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.07 132.95 27.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.477 -0.489 . . . . 1.1499999999999999 110.72 -174.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.48 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 84.3 Cg_endo -88.7 4.3 5.51 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.73 2.286 . . . . 1.04 111.66 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -128.39 -41.51 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.161 -0.681 . . . . 1.1299999999999999 109.161 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.604 ' O ' ' HB ' ' A' ' 165' ' ' ILE . . . 53.13 16.92 4.86 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 124.595 1.184 . . . . 0.35999999999999999 114.377 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.642 ' CB ' HG21 ' A' ' 164' ' ' THR . 12.9 pt-20 -86.3 119.64 26.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.331 1.062 . . . . 1.0800000000000001 110.223 -171.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.66 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 9.3 m-85 -138.67 -170.56 2.87 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.679 -1.601 . . . . 0.26000000000000001 111.764 -163.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.596 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 85.7 m-85 -142.9 139.2 30.68 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.237 0.541 . . . . 0.78000000000000003 110.938 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.541 HD13 ' HB ' ' A' ' 161' ' ' THR . 85.5 mt -63.74 123.4 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.463 -0.79 . . . . 1.02 110.39 168.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.544 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.8 pt -89.64 -43.9 14.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 113.621 0.971 . . . . 1.03 113.621 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.601 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 49.1 m-80 -171.22 174.14 4.69 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.047 -1.464 . . . . 2.0299999999999998 107.047 -169.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.648 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 40.3 mtt180 -127.1 169.47 13.38 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.252 -0.979 . . . . 2.02 111.961 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 55.0 tt0 -147.13 99.8 3.21 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.075 -0.966 . . . . 0.83999999999999997 109.629 170.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.499 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 46.5 ttt180 -65.74 166.11 11.52 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.205 -0.907 . . . . 3.2799999999999998 110.826 175.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.47 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 19.3 m-80 -35.41 102.74 0.23 Allowed Pre-proline 0 C--O 1.232 0.168 0 C-N-CA 125.269 1.428 . . . . 0.34999999999999998 113.305 -157.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.4 Cg_endo . . . . . 0 C--N 1.345 0.372 0 C-N-CA 123.153 2.568 . . . . 0.63 111.78 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.485 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.565 1.554 0 N-CA-C 117.482 2.401 . . . . 1.1699999999999999 117.482 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.652 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.3 OUTLIER -165.83 154.78 11.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.417 -0.802 . . . . 0.60999999999999999 110.449 -176.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.405 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.3 t-105 -135.25 99.28 4.2 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.115 -1.069 . . . . 0.56999999999999995 108.115 168.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 103' ' ' ARG . 4.9 mt -93.15 114.69 27.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.584 0.707 . . . . 1.3600000000000001 109.245 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.423 ' C ' HG12 ' A' ' 101' ' ' ILE . 19.6 m -83.54 144.23 29.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.666 -0.697 . . . . 0.42999999999999999 111.502 -167.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.517 ' N ' HD21 ' A' ' 118' ' ' LEU . 1.7 mm? -108.72 165.04 11.85 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.454 -0.794 . . . . 1.02 110.791 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.465 ' OG ' ' HD2' ' A' ' 98' ' ' PHE . 3.7 p -68.16 -4.58 14.3 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 124.008 0.817 . . . . 1.79 112.546 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.677 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 4.3 tmtm? -126.66 128.33 46.56 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 120.213 -0.595 . . . . 1.8100000000000001 109.581 166.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.677 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 52.9 mt-30 -33.19 -58.28 0.39 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.431 -1.713 . . . . 1.76 113.847 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.549 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -96.67 13.18 29.2 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.964 -0.694 . . . . 3.2000000000000002 112.17 -170.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.569 ' CG ' ' HB3' ' A' ' 120' ' ' LYS . 2.8 m-30 -90.38 -34.29 15.72 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-O 121.923 0.868 . . . . 0.83999999999999997 111.081 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.451 ' HA2' HD21 ' A' ' 118' ' ' LEU . . . -6.87 128.71 0.01 OUTLIER Glycine 0 C--N 1.297 -1.601 0 N-CA-C 119.262 2.465 . . . . 0.96999999999999997 119.262 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -99.96 115.67 41.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 112.822 -1.689 . . . . 1.04 109.815 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.696 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.0 p80 -143.27 175.16 10.11 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.501 -0.772 . . . . 0.20999999999999999 109.653 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.58 -168.81 38.52 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 120.016 -1.088 . . . . 0.34999999999999998 111.991 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.0 t -156.03 168.04 28.53 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.89 -0.771 . . . . 1.1100000000000001 110.367 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -110.33 -9.21 14.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.507 -0.923 . . . . 2.1899999999999999 108.507 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -111.21 88.33 8.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 114.816 -1.084 . . . . 1.8400000000000001 108.356 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -72.89 -19.64 23.27 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.754 2.303 . . . . 0.39000000000000001 113.326 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.6 -2.07 33.94 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.03 -0.532 . . . . 1.0800000000000001 111.002 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.5 m -91.97 -4.16 54.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.544 -0.539 . . . . 1.9399999999999999 109.544 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 83' ' ' PRO . 43.5 mm -82.31 131.4 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.845 -0.616 . . . . 1.04 110.401 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.7 1.4 65.87 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.811 -1.316 . . . . 0.16 109.811 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 137' ' ' ALA . 2.0 tttm -114.29 163.27 15.5 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 122.759 1.266 . . . . 3.0299999999999998 113.388 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -94.54 126.9 40.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 112.424 -2.171 . . . . 1.01 107.889 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.429 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -121.64 159.25 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 108.6 -0.889 . . . . 1.3400000000000001 108.6 -175.176 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 m -49.34 -59.35 3.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.406 0.521 . . . . 0.87 112.406 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.419 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 21.0 pttm -132.36 -45.96 0.91 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.506 -1.278 . . . . 2.5499999999999998 114.186 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.34 134.01 0.18 Allowed Glycine 0 N--CA 1.468 0.815 0 N-CA-C 117.648 1.819 . . . . 0.19 117.648 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.587 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 2.1 p -69.77 165.5 21.28 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 112.601 -1.8 . . . . 0.20000000000000001 111.916 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.889 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 57.8 mt -60.37 99.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 114.711 -1.131 . . . . 1.1299999999999999 112.008 -162.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.696 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 60.8 mtt180 -87.69 148.97 24.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.988 -1.46 . . . . 2.3300000000000001 110.685 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.524 ' HG2' HG21 ' A' ' 84' ' ' ILE . 17.5 mtp -126.34 -165.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.217 -0.661 . . . . 1.0900000000000001 109.217 173.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.617 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 12.8 t-80 -93.77 153.39 18.33 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.068 -0.715 . . . . 2.9900000000000002 109.068 172.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.625 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.2 m120 -57.41 -54.8 42.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 118.188 -0.911 . . . . 0.73999999999999999 110.907 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -65.22 -21.97 66.82 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 121.543 1.974 . . . . 2.6899999999999999 112.149 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.617 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.9 m-20 -80.9 -45.79 16.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.096 -0.956 . . . . 0.68999999999999995 111.169 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.526 HG12 HD13 ' A' ' 151' ' ' ILE . 14.9 p -65.8 -20.73 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.554 -0.748 . . . . 1.02 111.052 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.625 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.26 -41.0 16.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 119.006 -0.521 . . . . 1.1699999999999999 109.889 170.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.406 ' O ' HG13 ' A' ' 156' ' ' ILE . 28.7 mt-10 -45.92 -70.73 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.164 0.893 . . . . 1.99 112.339 168.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.464 HD23 ' SD ' ' A' ' 145' ' ' MET . 9.4 mp -46.18 -38.56 8.48 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.49 0.662 . . . . 1.9099999999999999 111.486 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.75 -33.52 76.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.376 -1.284 . . . . 1.04 111.598 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -88.79 -31.68 18.25 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.487 -0.758 . . . . 0.88 112.711 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 152' ' ' GLU . 35.2 mt -83.38 -60.1 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.451 0.643 . . . . 1.0 111.679 -172.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 153' ' ' LEU . 3.1 m -91.26 139.99 25.6 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 114.969 -1.014 . . . . 1.0700000000000001 112.158 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.648 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 61.2 Cg_endo -89.09 174.4 3.74 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 123.899 3.066 . . . . 0.23999999999999999 111.286 174.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.601 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 58.5 m-20 -67.75 156.07 37.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.423 -0.911 . . . . 1.1000000000000001 108.876 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.69 -20.53 50.02 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.246 -0.978 . . . . 0.17999999999999999 112.523 -172.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.541 ' HB ' HD13 ' A' ' 100' ' ' ILE . 53.2 m -63.75 137.74 58.19 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.006 -0.739 . . . . 1.05 109.006 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.596 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 18.8 ptt180 -92.48 120.6 33.12 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.944 1.354 . . . . 4.1100000000000003 111.22 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.6 t -102.78 106.48 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 111.951 -2.386 . . . . 1.02 108.875 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.642 HG21 ' CB ' ' A' ' 97' ' ' GLU . 1.8 m -93.74 104.59 16.68 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.257 -0.577 . . . . 1.0700000000000001 112.327 -170.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 2.4 mp -81.45 93.29 2.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 122.509 1.147 . . . . 1.05 109.552 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -103.31 139.15 39.12 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.865 -1.516 . . . . 1.0900000000000001 109.432 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.482 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 6.5 mmt85 . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 116.057 -0.52 . . . . 2.4900000000000002 111.115 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.488 0.661 . . . . 1.3300000000000001 111.969 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.646 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.2 tt -99.09 131.82 44.86 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.717 -1.129 . . . . 1.0700000000000001 110.238 -175.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.7 162.37 13.47 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 122.218 1.008 . . . . 1.03 113.201 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' A' ' 7' ' ' TYR . 80.8 t80 -130.72 144.86 51.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.723 -1.581 . . . . 1.0800000000000001 107.859 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -115.85 113.53 23.48 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 108.483 -0.932 . . . . 0.93000000000000005 108.483 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.576 ' HB ' ' O ' ' A' ' 41' ' ' THR . 86.0 t -66.39 152.32 9.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 122.735 1.255 . . . . 1.1000000000000001 113.27 -171.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.0 mtmm -108.68 159.35 16.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.036 -1.893 . . . . 2.4399999999999999 108.54 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.452 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 2.2 mm-40 -62.13 113.8 3.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.041 0.448 . . . . 2.4300000000000002 112.044 -174.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.38 10.76 56.73 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.582 -0.735 . . . . 0.51000000000000001 113.669 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.514 ' HB2' HG11 ' A' ' 9' ' ' VAL . 86.3 m-20 -56.2 169.38 0.41 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.109 0.454 . . . . 1.46 111.161 173.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.81 156.69 43.19 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.432 -0.507 . . . . 1.1599999999999999 110.916 173.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.477 HD13 HD22 ' A' ' 29' ' ' LEU . 3.0 tp -66.07 -36.36 83.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.986 0.898 . . . . 1.47 109.539 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 5.1 t30 -85.87 -24.98 26.46 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.342 -1.299 . . . . 1.78 110.248 -176.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.6 t -65.88 -42.11 90.71 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.127 -0.694 . . . . 1.74 109.127 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 14.8 mt -74.69 -27.01 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.171 0.51 . . . . 1.04 109.908 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.32 -9.98 59.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.532 -0.304 . . . . 1.0600000000000001 110.679 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.61 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.73 -38.62 9.83 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.642 1.21 . . . . 0.97999999999999998 108.155 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.3 m-20 -62.28 -45.55 92.76 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.277 -2.238 . . . . 0.53000000000000003 111.689 172.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.578 ' C ' HD11 ' A' ' 101' ' ' ILE . 58.8 m-85 -98.62 4.8 48.06 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 118.685 -1.206 . . . . 0.20000000000000001 111.667 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.61 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.0 mpt_? 54.78 42.84 30.86 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.689 0.757 . . . . 2.46 109.738 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.6 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.7 pt -115.41 -165.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.548 -1.205 . . . . 1.04 109.883 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.39 142.82 39.8 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.123 -0.944 . . . . 1.3400000000000001 110.118 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.457 ' HB ' HD23 ' A' ' 15' ' ' LEU . 70.6 p -73.23 -31.95 64.44 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.364 -0.976 . . . . 1.0900000000000001 108.364 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.67 68.16 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.049 -0.978 . . . . 1.0700000000000001 111.512 169.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -92.89 -27.66 16.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.359 0.599 . . . . 1.04 109.461 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.634 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 15.2 tp -74.79 -26.64 59.89 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.662 -0.699 . . . . 1.8100000000000001 109.299 174.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.493 HD21 ' HB2' ' A' ' 36' ' ' LEU . 42.8 mt -77.62 -30.51 52.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.62 0.724 . . . . 1.6399999999999999 109.772 171.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 22.6 tt0 -63.74 -43.16 97.3 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.326 -1.306 . . . . 2.3300000000000001 110.002 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.428 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -83.47 -21.35 32.88 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.357 -0.537 . . . . 1.0600000000000001 111.715 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.557 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.1 m-80 -145.96 82.74 9.07 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-O 121.571 0.7 . . . . 0.23000000000000001 110.642 -171.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.84 -6.13 3.19 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 123.803 3.002 . . . . 0.52000000000000002 113.675 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.9 t -80.17 -25.78 39.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.651 0.263 . . . . 1.6499999999999999 111.297 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.634 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 32.0 mt -70.11 -35.1 73.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.57 0.7 . . . . 1.25 112.158 -170.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.35 -46.98 78.08 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 122.847 1.308 . . . . 2.52 110.296 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.67 -49.74 74.17 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 111.982 -2.372 . . . . 1.1899999999999999 110.479 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.26 179.36 48.89 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 114.715 -1.129 . . . . 0.44 111.332 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 157.09 19.76 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.39 0.614 . . . . 1.1699999999999999 110.895 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.576 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 39.7 m -143.31 126.26 16.27 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.231 -0.895 . . . . 1.1499999999999999 110.706 -176.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' CB ' ' HG2' ' A' ' 11' ' ' GLN . . . -75.86 116.62 16.75 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.561 0.696 . . . . 1.1200000000000001 109.735 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.34 -0.85 40.26 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.192 -1.163 . . . . 0.44 110.192 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.543 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.4 tt0 -75.51 123.82 26.11 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.961 -0.62 . . . . 1.3 109.733 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 58.8 p -80.89 133.13 35.51 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.589 -0.732 . . . . 1.3200000000000001 109.864 176.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.594 HG13 ' HB3' ' A' ' 7' ' ' TYR . 11.7 pt -134.28 141.61 43.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.498 -1.228 . . . . 1.0700000000000001 109.22 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.68 152.22 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.173 0.511 . . . . 1.3 110.713 -179.392 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.413 HG22 ' CD2' ' A' ' 22' ' ' PHE . 38.0 mm -115.89 92.5 34.78 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.97 -1.014 . . . . 1.03 109.412 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.519 ' HA ' HD23 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -57.41 132.69 52.32 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.727 2.285 . . . . 0.20000000000000001 112.598 -175.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.65 -2.27 80.01 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 114.825 -1.079 . . . . 0.26000000000000001 112.527 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.632 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 34.0 tp -125.4 114.94 25.5 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-O 121.314 0.578 . . . . 1.27 111.139 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.646 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_endo -79.79 -177.64 3.98 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.716 2.944 . . . . 0.31 114.577 -171.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.492 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 11.7 t70 -80.52 130.97 62.79 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 114.055 -1.429 . . . . 0.48999999999999999 111.602 -173.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.513 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 44.1 Cg_endo -71.29 -20.01 28.48 Favored 'Trans proline' 0 CA--C 1.519 -0.263 0 C-N-CA 123.381 2.72 . . . . 0.48999999999999999 113.121 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -96.79 -0.89 47.33 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.418 0.628 . . . . 1.8 111.88 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.492 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 29.5 p -89.31 -15.58 33.13 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.228 -1.397 . . . . 1.1299999999999999 107.228 169.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.507 HG23 ' H ' ' A' ' 59' ' ' TYR . 18.2 mt -82.53 134.36 48.1 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 112.5 -2.136 . . . . 1.24 110.317 175.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -84.1 -16.95 5.93 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.282 1.988 . . . . 0.47999999999999998 113.239 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.507 ' H ' HG23 ' A' ' 57' ' ' ILE . 61.2 m-85 -93.93 155.15 17.31 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.751 -0.38 . . . . 0.94999999999999996 111.859 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -146.33 131.72 18.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.77 -0.826 . . . . 3.7400000000000002 108.77 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 71' ' ' THR . 91.1 mt -114.95 133.98 59.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.072 0.397 . . . . 1.05 112.072 -175.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.1 121.55 42.48 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.17 -0.612 . . . . 1.0800000000000001 110.903 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.43 114.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.884 0.85 . . . . 1.04 111.444 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 68' ' ' LYS . 46.9 m -95.02 102.29 14.09 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.606 -1.179 . . . . 0.83999999999999997 110.743 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.9 mm -50.99 -57.74 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 122.25 1.024 . . . . 1.0600000000000001 111.536 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.25 -10.13 5.08 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 112.788 -2.005 . . . . 0.16 113.414 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.57 -18.54 4.79 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.51 0.724 . . . . 1.02 112.318 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.509 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.26 56.27 4.58 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.325 0.511 . . . . 1.3 111.003 -173.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.7 p -137.31 161.73 35.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 112.719 0.636 . . . . 0.98999999999999999 112.719 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.409 ' C ' HD21 ' A' ' 70' ' ' LEU . 7.5 tt -130.54 110.74 11.65 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.659 -1.155 . . . . 1.1799999999999999 109.928 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 36.2 m -92.12 123.47 35.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.022 0.439 . . . . 1.04 111.126 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.3 tp -98.88 104.32 16.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.413 -0.812 . . . . 1.3200000000000001 109.481 172.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 19.4 m -105.22 160.18 15.29 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.324 -0.95 . . . . 1.05 110.814 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.603 HD11 ' ND2' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -125.85 127.4 46.01 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.476 -0.935 . . . . 1.1000000000000001 108.476 169.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.603 ' ND2' HD11 ' A' ' 74' ' ' LEU . 8.6 p30 44.64 50.65 8.4 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.075 1.35 . . . . 1.97 111.419 -166.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 52.3 m-80 72.84 -11.83 0.82 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.892 -1.049 . . . . 2.5499999999999998 112.041 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -94.56 120.68 35.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.249 0.547 . . . . 4.0199999999999996 110.009 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 57.5 t -57.67 132.54 22.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 122.38 1.086 . . . . 1.0600000000000001 112.869 -173.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 6.9 mtm -103.46 -42.86 5.56 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 112.995 -1.911 . . . . 1.47 109.447 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -158.53 172.81 17.64 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 113.215 -1.811 . . . . 1.98 109.84 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.3 m -148.65 123.23 9.78 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.228 -1.351 . . . . 1.0 109.41 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 1.61 ' HD1' ' CD2' ' A' ' 82' ' ' TYR . 25.1 m-85 -103.93 148.55 36.03 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.312 -0.858 . . . . 1.3999999999999999 109.453 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.439 ' HB2' HG23 ' A' ' 134' ' ' ILE . 46.5 Cg_endo -77.58 141.06 19.45 Favored 'Trans proline' 0 CA--C 1.5 -1.209 0 C-N-CA 121.497 1.465 . . . . 0.23999999999999999 110.488 169.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.528 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -139.9 173.25 11.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.934 -0.575 . . . . 1.04 110.907 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.903 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.83 143.34 47.01 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.227 -0.442 . . . . 1.03 110.436 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.48 HG23 ' HG3' ' A' ' 68' ' ' LYS . 7.5 m -126.58 126.04 68.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.451 0.643 . . . . 1.26 112.057 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -89.16 157.17 26.77 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.71 -1.356 . . . . 0.20000000000000001 109.71 173.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -57.05 6.61 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 114.582 1.327 . . . . 3.48 114.582 -177.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.597 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.2 tp -96.88 -14.08 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.525 0.679 . . . . 1.0700000000000001 110.565 -177.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.509 HD23 HG21 ' A' ' 89' ' ' ILE . 3.3 mm? -91.2 -18.09 25.0 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.146 -0.687 . . . . 1.02 109.146 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.3 p -67.09 -24.52 65.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.777 -1.101 . . . . 1.05 112.132 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.479 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 8.7 mp0 -56.26 -44.35 79.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.118 1.367 . . . . 2.0299999999999998 111.61 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.45 119.7 58.17 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.471 -0.786 . . . . 1.1499999999999999 111.635 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.608 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 1.9 Cg_endo -77.36 -19.64 13.12 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.874 2.383 . . . . 1.04 113.068 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 t -105.48 -40.52 5.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.358 -0.608 . . . . 1.1299999999999999 109.358 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.419 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 43.69 45.89 7.23 Favored Glycine 0 C--N 1.338 0.682 0 O-C-N 124.565 1.165 . . . . 0.35999999999999999 113.903 170.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -83.59 113.09 20.59 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.901 0.858 . . . . 1.0800000000000001 109.723 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 15.9 m-85 -137.32 175.85 9.24 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.065 -1.425 . . . . 0.26000000000000001 112.484 -170.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.662 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 79.9 m-85 -142.85 133.07 24.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.78000000000000003 110.896 -174.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.561 HD11 ' HB ' ' A' ' 161' ' ' THR . 82.6 mt -58.02 121.85 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.576 -0.738 . . . . 1.02 110.84 172.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.578 HD11 ' C ' ' A' ' 22' ' ' PHE . 22.7 pt -86.8 -35.25 8.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 113.157 0.799 . . . . 1.03 113.157 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.543 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 11.6 p30 179.97 174.03 0.91 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.932 -1.136 . . . . 2.0299999999999998 107.932 -176.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.569 ' CB ' HD11 ' A' ' 116' ' ' LEU . 6.7 mtt180 -122.21 161.66 22.82 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.112 -0.635 . . . . 2.02 111.503 -170.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -143.84 102.41 3.9 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.222 0.534 . . . . 0.83999999999999997 110.898 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.502 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 63.7 ttt180 -65.95 166.89 10.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.38 -0.827 . . . . 3.2799999999999998 110.63 173.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.47 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 24.6 m-80 -35.49 104.52 0.26 Allowed Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 125.529 1.532 . . . . 0.34999999999999998 113.806 -160.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.3 Cg_endo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.785 2.324 . . . . 0.63 111.745 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.56 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.569 1.675 0 N-CA-C 117.97 2.582 . . . . 1.1699999999999999 117.97 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.622 ' CE2' ' HB3' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -163.29 151.77 13.97 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.085 0.857 . . . . 0.60999999999999999 110.117 -176.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -135.16 98.3 3.95 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.227 -1.027 . . . . 0.56999999999999995 108.227 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.569 HD11 ' CB ' ' A' ' 103' ' ' ARG . 0.6 OUTLIER -85.79 118.56 25.37 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 121.097 -1.002 . . . . 1.3600000000000001 109.877 174.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.42 ' C ' HG12 ' A' ' 101' ' ' ILE . 36.9 m -83.45 145.63 28.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.638 -0.71 . . . . 0.42999999999999999 111.411 -170.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -109.73 170.5 8.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 1.02 110.797 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.539 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -62.87 -13.11 30.02 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.936 0.717 . . . . 1.79 112.936 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.591 ' HB3' ' CG ' ' A' ' 123' ' ' TYR . 5.2 tptp -126.06 130.9 52.05 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.52 -0.472 . . . . 1.8100000000000001 110.756 175.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.413 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 67.6 mt-30 -30.97 -58.99 0.22 Allowed 'General case' 0 C--N 1.317 -0.827 0 O-C-N 124.733 1.271 . . . . 1.76 114.054 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.597 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -96.08 8.19 44.42 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.551 -0.86 . . . . 3.2000000000000002 111.706 -171.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.745 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.3 m-85 -94.88 37.48 1.14 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.877 1.065 . . . . 0.83999999999999997 113.877 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.553 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -114.57 143.74 18.13 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 116.865 -2.588 . . . . 0.96999999999999997 112.665 -153.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -97.09 112.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.937 0.875 . . . . 1.04 110.451 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.75 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.0 p80 -142.64 172.21 13.0 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.078 -0.964 . . . . 0.20999999999999999 109.592 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.7 -179.92 38.87 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 119.969 -1.11 . . . . 0.34999999999999998 111.791 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.5 t -142.89 170.96 14.73 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.79 -0.448 . . . . 1.1100000000000001 109.79 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -114.48 -4.75 12.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.9 0.857 . . . . 2.1899999999999999 108.705 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -112.26 87.91 9.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.563 -1.198 . . . . 1.8400000000000001 108.178 168.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -73.4 -19.69 21.77 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.744 2.296 . . . . 0.39000000000000001 113.601 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.97 0.19 28.52 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.227 0.537 . . . . 1.0800000000000001 111.112 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 52.6 m -94.51 -1.49 53.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 1.9399999999999999 109.628 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.439 HG23 ' HB2' ' A' ' 83' ' ' PRO . 44.0 mm -82.83 137.82 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.98 -0.555 . . . . 1.04 110.5 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.89 0.82 77.54 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.922 -1.271 . . . . 0.16 109.922 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -111.68 167.42 10.36 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 122.932 1.349 . . . . 3.0299999999999998 113.73 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.457 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -96.27 120.06 35.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.174 -2.285 . . . . 1.01 107.442 173.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.35 160.47 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.508 -0.923 . . . . 1.3400000000000001 108.508 -172.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.549 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.1 m -52.55 -60.93 2.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 111.974 0.361 . . . . 0.87 111.974 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -131.62 -46.57 0.97 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.09 -1.444 . . . . 2.5499999999999998 113.78 -172.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.48 133.69 0.2 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 117.758 1.863 . . . . 0.19 117.758 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.62 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 6.3 p -68.56 166.02 17.93 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 112.291 -1.954 . . . . 0.20000000000000001 111.756 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.903 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 59.5 mt -59.48 98.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 122.596 1.189 . . . . 1.1299999999999999 112.114 -163.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.75 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 75.5 mtt180 -87.06 147.76 25.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.461 -1.7 . . . . 2.3300000000000001 110.7 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.528 ' HG2' HG21 ' A' ' 84' ' ' ILE . 12.7 mtp -125.29 -165.5 1.41 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.295 -0.632 . . . . 1.0900000000000001 109.295 173.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.661 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 25.4 t-80 -95.86 153.99 17.46 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.538 -0.755 . . . . 2.9900000000000002 108.997 173.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.614 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.5 m120 -57.11 -54.4 47.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.193 -0.908 . . . . 0.73999999999999999 110.856 -174.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.489 ' HB3' ' HZ1' ' A' ' 148' ' ' LYS . 0.8 OUTLIER -63.93 -23.81 67.49 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 121.516 1.962 . . . . 2.6899999999999999 111.823 -175.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.661 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.3 m-20 -78.5 -46.72 18.95 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.01 -0.996 . . . . 0.68999999999999995 110.725 -176.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.52 HG12 HD13 ' A' ' 151' ' ' ILE . 13.7 p -67.97 -24.15 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.094 -0.957 . . . . 1.02 111.663 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.614 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -78.71 -39.41 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.483 -0.562 . . . . 1.1699999999999999 109.483 171.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 156' ' ' ILE . 22.7 mt-10 -46.54 -72.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.901 0.773 . . . . 1.99 112.261 168.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.417 HD23 ' CE1' ' A' ' 82' ' ' TYR . 43.4 mt -49.79 -40.31 41.16 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.751 0.786 . . . . 1.9099999999999999 111.532 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.622 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . . . -56.14 -39.97 73.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.968 -1.469 . . . . 1.04 111.415 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.2 t -87.86 -33.65 18.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.542 0.942 . . . . 0.88 113.542 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 152' ' ' GLU . 43.7 mt -80.57 -60.2 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.617 0.723 . . . . 1.0 112.034 -170.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.9 m -86.61 145.69 39.91 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.793 -1.094 . . . . 1.0700000000000001 112.049 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.515 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 63.8 Cg_endo -90.72 173.0 3.13 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.875 3.05 . . . . 0.23999999999999999 110.91 172.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.543 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 22.0 m-20 -64.87 158.23 25.72 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.744 -0.782 . . . . 1.1000000000000001 109.134 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 97.41 -19.63 53.95 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.079 -1.058 . . . . 0.17999999999999999 112.529 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.561 ' HB ' HD11 ' A' ' 100' ' ' ILE . 59.1 m -62.76 136.81 58.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.15 -0.685 . . . . 1.05 109.15 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.662 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -92.61 122.7 35.28 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.771 1.272 . . . . 4.1100000000000003 111.18 -169.272 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.13 108.63 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 112.25 -2.25 . . . . 1.02 109.159 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.3 m -94.23 107.7 19.62 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.521 0.563 . . . . 1.0700000000000001 112.521 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 165' ' ' ILE . 2.6 mp -86.14 97.41 5.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.991 0.9 . . . . 1.05 110.253 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -110.98 135.52 51.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.853 -1.067 . . . . 1.0900000000000001 111.203 -173.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.608 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 14.8 mmm-85 . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.474 0.654 . . . . 2.4900000000000002 109.701 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.517 ' CD1' ' HA ' ' A' ' 49' ' ' PRO . 20.3 mt . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.047 0.451 . . . . 1.3300000000000001 110.872 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.8 tt -88.81 129.18 35.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.505 -0.77 . . . . 1.0700000000000001 109.756 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.14 161.11 14.11 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.138 -0.937 . . . . 1.03 112.944 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.645 ' HE2' ' CE1' ' A' ' 7' ' ' TYR . 86.2 t80 -129.6 140.66 51.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.715 -1.584 . . . . 1.0800000000000001 107.781 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.401 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 63.3 tt0 -114.23 111.79 22.09 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.907 -1.145 . . . . 0.93000000000000005 107.907 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 13' ' ' ASP . 97.7 t -66.2 151.2 10.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.353 1.073 . . . . 1.1000000000000001 112.697 -169.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -108.02 158.07 17.7 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.554 -1.657 . . . . 2.4399999999999999 108.325 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.62 107.34 0.38 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.183 0.516 . . . . 2.4300000000000002 112.092 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.77 11.79 39.49 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.686 -0.688 . . . . 0.51000000000000001 113.57 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.588 ' HB2' HG11 ' A' ' 9' ' ' VAL . 70.9 m-20 -55.97 167.63 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.953 0.376 . . . . 1.46 110.961 172.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -128.19 152.96 47.42 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.914 0.388 . . . . 1.1599999999999999 111.176 174.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.415 HD22 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -64.38 -38.86 92.52 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.103 -1.073 . . . . 1.47 108.103 -177.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.437 ' HA ' HG23 ' A' ' 26' ' ' THR . 65.3 t30 -86.44 -22.04 26.74 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.512 -1.222 . . . . 1.78 110.715 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.424 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 17.4 t -67.98 -40.12 83.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.177 -0.675 . . . . 1.74 109.177 171.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.2 mt -75.32 -27.78 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.146 0.498 . . . . 1.04 109.937 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.54 -10.01 59.72 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.517 -0.31 . . . . 1.0600000000000001 110.795 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.697 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.09 -40.27 9.31 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 107.929 -1.137 . . . . 0.97999999999999998 107.929 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.435 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 3.0 m-20 -62.19 -42.77 99.59 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.544 -2.116 . . . . 0.53000000000000003 112.303 173.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.53 ' CE2' ' HB3' ' A' ' 119' ' ' SER . 57.5 m-85 -99.42 6.73 45.93 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 118.876 -1.13 . . . . 0.20000000000000001 111.129 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.697 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.76 41.06 32.2 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.765 0.793 . . . . 2.46 109.541 176.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.583 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.8 pt -116.8 -165.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.287 -1.324 . . . . 1.04 110.215 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.52 143.88 40.19 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.99 -1.005 . . . . 1.3400000000000001 110.244 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.511 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 44.3 p -72.18 -31.76 66.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.037 -1.097 . . . . 1.0900000000000001 108.037 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -31.09 69.98 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.703 -0.68 . . . . 1.0700000000000001 111.659 171.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.32 -28.27 17.85 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.641 0.734 . . . . 1.04 109.029 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.537 ' HG ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -73.67 -28.04 61.55 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.046 -0.979 . . . . 1.8100000000000001 109.404 174.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 26' ' ' THR . 42.5 mt -76.63 -30.99 57.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.836 0.827 . . . . 1.6399999999999999 109.991 170.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 43.3 tt0 -65.61 -33.75 76.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.19 -1.368 . . . . 2.3300000000000001 110.095 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.448 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -88.57 -22.74 23.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 119.849 -0.74 . . . . 1.0600000000000001 111.805 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.6 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 19.1 m-80 -147.85 82.7 7.76 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.41 0.624 . . . . 0.23000000000000001 110.517 -171.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.26 -15.93 16.07 Favored 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 124.124 3.216 . . . . 0.52000000000000002 114.03 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 t -74.72 -22.65 58.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.75 0.31 . . . . 1.6499999999999999 111.391 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.6 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 35.6 mt -69.45 -36.11 76.31 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.568 0.581 . . . . 1.25 112.568 -169.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -64.07 -45.17 89.93 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 122.917 1.342 . . . . 2.52 110.135 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.64 -49.04 79.12 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 111.796 -2.456 . . . . 1.1899999999999999 110.712 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.87 -179.85 48.11 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 114.932 -1.031 . . . . 0.44 111.693 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.43 158.97 22.69 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.204 0.526 . . . . 1.1699999999999999 110.66 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.528 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 60.4 m -139.35 127.89 23.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.542 -0.754 . . . . 1.1499999999999999 110.385 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.49 121.51 21.61 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.576 0.703 . . . . 1.1200000000000001 110.313 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.401 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.7 3.56 60.89 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 114.733 -1.121 . . . . 0.44 110.468 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.528 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -80.22 124.93 29.24 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.202 -0.499 . . . . 1.3 109.91 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.8 m -77.7 130.35 36.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.152 -0.931 . . . . 1.3200000000000001 109.781 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.563 HG13 ' HB3' ' A' ' 7' ' ' TYR . 6.7 pt -132.01 143.63 39.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.671 -1.15 . . . . 1.0700000000000001 109.085 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -90.69 153.74 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.311 0.576 . . . . 1.3 111.612 -178.168 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.5 mm -118.24 93.6 45.3 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.597 -1.183 . . . . 1.03 109.03 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . 2.5 Cg_endo -59.05 137.39 79.28 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.775 2.316 . . . . 0.20000000000000001 112.745 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.46 -6.24 83.8 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.906 -1.043 . . . . 0.26000000000000001 112.387 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.597 HD11 ' HD2' ' A' ' 52' ' ' PRO . 26.9 tp -122.73 118.05 28.57 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.904 0.383 . . . . 1.27 110.721 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 57.9 Cg_endo -80.3 -176.68 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.649 2.9 . . . . 0.31 114.037 -172.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.463 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 13.3 t70 -80.69 132.25 58.48 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.726 -1.124 . . . . 0.48999999999999999 111.629 -171.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.577 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.8 Cg_endo -76.28 -16.13 17.63 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 123.395 2.73 . . . . 0.48999999999999999 112.694 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -95.58 -1.04 51.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.706 0.765 . . . . 1.8 110.135 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 27.1 p -94.66 -16.98 22.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.657 1.217 . . . . 1.1299999999999999 107.822 173.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.485 HG23 ' H ' ' A' ' 59' ' ' TYR . 25.6 mt -78.64 128.73 76.35 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 112.947 -1.933 . . . . 1.24 111.132 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 97.8 Cg_endo -76.75 -17.23 15.99 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.444 2.096 . . . . 0.47999999999999998 113.194 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.485 ' H ' HG23 ' A' ' 57' ' ' ILE . 61.4 m-85 -94.74 164.91 12.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.392 -0.523 . . . . 0.94999999999999996 112.153 -176.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -152.68 128.01 9.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.533 -0.914 . . . . 3.7400000000000002 108.533 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.687 ' HA ' ' O ' ' A' ' 71' ' ' THR . 95.4 mt -110.02 132.67 57.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.135 -0.484 . . . . 1.05 111.759 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.21 117.01 28.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.004 -0.678 . . . . 1.0800000000000001 111.09 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.84 112.85 31.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.814 0.816 . . . . 1.04 111.273 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 68' ' ' LYS . 16.5 m -93.23 102.73 15.02 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.682 -1.145 . . . . 0.83999999999999997 110.543 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.503 HG22 HH11 ' A' ' 167' ' ' ARG . 50.5 mm -52.15 -58.49 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 122.04 0.924 . . . . 1.0600000000000001 111.213 169.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.22 -11.39 3.34 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 112.955 -1.93 . . . . 0.16 113.244 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -126.72 -18.6 4.71 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.572 0.749 . . . . 1.02 112.455 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER 57.77 56.39 4.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.555 0.616 . . . . 1.3 111.431 -172.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.5 p -137.66 161.49 36.34 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 112.669 0.618 . . . . 0.98999999999999999 112.669 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.408 HD21 ' C ' ' A' ' 70' ' ' LEU . 8.5 tt -131.49 113.4 13.64 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.704 -1.135 . . . . 1.1799999999999999 110.122 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.687 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 66.7 m -94.23 122.95 37.3 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.324 0.583 . . . . 1.04 111.542 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 79' ' ' MET . 15.5 tp -97.56 103.2 15.12 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.906 -1.043 . . . . 1.3200000000000001 109.369 172.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.2 m -105.47 159.93 15.54 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.475 -0.89 . . . . 1.05 110.579 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.2 tm? -126.73 128.37 46.55 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.853 -0.795 . . . . 1.1000000000000001 108.853 169.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.556 ' N ' HD23 ' A' ' 74' ' ' LEU . 6.6 p30 43.61 49.01 6.53 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.128 1.371 . . . . 1.97 111.574 -167.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 84.2 m-20 75.85 -11.99 1.05 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.127 -0.942 . . . . 2.5499999999999998 112.317 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -96.99 120.82 38.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.207 0.527 . . . . 4.0199999999999996 110.095 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 55.1 t -56.15 132.44 20.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 122.316 1.055 . . . . 1.0600000000000001 112.998 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 7.9 mtm -102.59 -43.83 5.51 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.074 -1.875 . . . . 1.47 109.285 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.6 mmtt -157.92 172.15 18.98 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 113.107 -1.861 . . . . 1.98 109.874 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.0 m -149.8 122.28 8.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.417 -1.265 . . . . 1.0 109.808 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -109.71 145.82 32.77 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 115.454 -0.794 . . . . 1.3999999999999999 109.637 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.457 ' HB2' HG23 ' A' ' 134' ' ' ILE . 41.7 Cg_endo -74.61 142.12 28.78 Favored 'Trans proline' 0 CA--C 1.499 -1.26 0 C-N-CA 121.902 1.734 . . . . 0.23999999999999999 110.903 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.532 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.01 175.71 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.922 -0.581 . . . . 1.04 110.717 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.868 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -120.76 148.55 43.82 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.418 -0.355 . . . . 1.03 110.092 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.468 HG12 HD11 ' A' ' 65' ' ' ILE . 9.6 m -128.75 129.76 68.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.481 0.658 . . . . 1.26 111.899 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.6 154.6 27.23 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.21 -1.156 . . . . 0.20000000000000001 110.21 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -56.27 3.08 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.321 0.86 . . . . 3.48 113.321 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.571 HG12 ' CB ' ' A' ' 122' ' ' HIS . 1.3 tp -89.17 -19.96 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 121.534 0.683 . . . . 1.0700000000000001 110.417 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.491 ' CD2' HG21 ' A' ' 89' ' ' ILE . 3.8 mm? -89.72 -18.25 26.73 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.716 0.77 . . . . 1.02 109.288 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.9 p -66.81 -14.47 62.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.385 -1.279 . . . . 1.05 111.649 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.3 -39.56 89.41 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.74 -1.118 . . . . 2.0299999999999998 111.973 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.51 130.97 22.17 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.571 -0.452 . . . . 1.1499999999999999 111.028 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.671 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 87.0 Cg_endo -90.1 -13.87 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.7 2.267 . . . . 1.04 112.73 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.0 t -104.92 -41.0 5.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.758 -0.656 . . . . 1.1299999999999999 109.25 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.535 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 44.87 46.04 9.21 Favored Glycine 0 N--CA 1.446 -0.644 0 O-C-N 124.404 1.065 . . . . 0.35999999999999999 113.692 171.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.79 111.37 19.13 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.891 0.853 . . . . 1.0800000000000001 109.557 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.706 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 21.4 m-85 -139.41 171.94 13.53 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.89 -1.505 . . . . 0.26000000000000001 112.366 -171.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 162' ' ' ARG . 28.2 m-85 -140.99 136.15 31.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.739 -0.664 . . . . 0.78000000000000003 110.131 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.534 HD11 ' HB ' ' A' ' 161' ' ' THR . 80.1 mt -58.62 123.23 10.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.421 -0.809 . . . . 1.02 110.55 172.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.547 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.8 pt -88.05 -44.08 15.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 113.014 0.746 . . . . 1.03 113.014 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.464 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 56.2 m-80 -171.69 169.54 5.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 106.783 -1.562 . . . . 2.0299999999999998 106.783 -169.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.481 ' HB3' HD21 ' A' ' 116' ' ' LEU . 5.6 mtt180 -128.17 163.45 24.65 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.773 -0.771 . . . . 2.02 112.198 -173.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.4 tt0 -136.85 99.91 4.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.921 -1.036 . . . . 0.83999999999999997 109.713 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.494 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 30.8 ttp180 -67.05 166.52 13.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.24 -0.891 . . . . 3.2799999999999998 111.006 176.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.494 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 29.1 m-80 -36.44 102.23 0.23 Allowed Pre-proline 0 CA--C 1.518 -0.28 0 C-N-CA 125.439 1.496 . . . . 0.34999999999999998 113.951 -152.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo . . . . . 0 N--CA 1.457 -0.648 0 C-N-CA 123.513 2.809 . . . . 0.63 111.528 170.221 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.516 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.489 0 N-CA-C 116.915 2.191 . . . . 1.1699999999999999 116.915 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.659 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.3 OUTLIER -166.06 161.35 17.2 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.385 -0.822 . . . . 0.60999999999999999 110.028 -177.007 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 12.6 t-105 -141.83 98.93 3.43 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.25 -1.018 . . . . 0.56999999999999995 108.25 166.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' A' ' 103' ' ' ARG . 4.4 mt -91.95 114.49 27.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.521 0.677 . . . . 1.3600000000000001 109.414 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.0 m -84.23 144.55 28.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.986 -0.552 . . . . 0.42999999999999999 111.368 -169.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.759 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -108.35 172.14 7.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.903 -0.59 . . . . 1.02 110.568 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.53 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -64.49 -11.14 30.77 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.894 0.701 . . . . 1.79 112.894 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.726 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.3 tmtp? -126.51 130.61 50.94 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 120.626 -0.43 . . . . 1.8100000000000001 110.405 174.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.726 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.2 mt-30 -34.77 -54.88 0.57 Allowed 'General case' 0 C--N 1.311 -1.074 0 O-C-N 124.953 1.408 . . . . 1.76 113.555 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.571 ' CB ' HG12 ' A' ' 89' ' ' ILE . 46.8 m80 -91.19 -1.49 57.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.867 -0.606 . . . . 3.2000000000000002 111.216 -169.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.759 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -94.29 37.88 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.534 0.938 . . . . 0.83999999999999997 113.534 -171.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.23 144.41 18.42 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 117.026 -2.511 . . . . 0.96999999999999997 112.601 -153.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.78 114.89 34.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 123.775 0.83 . . . . 1.04 110.763 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.558 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 26.8 p80 -143.53 175.97 9.54 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.4 -0.818 . . . . 0.20999999999999999 109.721 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.65 -166.98 37.8 Favored Glycine 0 C--N 1.314 -0.672 0 C-N-CA 120.49 -0.862 . . . . 0.34999999999999998 111.816 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 t -157.24 171.4 20.49 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.063 -0.669 . . . . 1.1100000000000001 110.627 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -115.12 -2.16 12.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.286 -1.005 . . . . 2.1899999999999999 108.286 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -113.19 85.78 8.75 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.506 -1.224 . . . . 1.8400000000000001 108.669 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -74.25 -19.07 20.2 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.363 2.042 . . . . 0.39000000000000001 113.102 -170.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.51 -2.29 49.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.733 -0.667 . . . . 1.0800000000000001 110.35 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.2 t -89.33 -6.33 56.77 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.042 -0.725 . . . . 1.9399999999999999 109.042 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.457 HG23 ' HB2' ' A' ' 83' ' ' PRO . 39.6 mm -81.82 137.11 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.485 -0.78 . . . . 1.04 110.392 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.91 2.19 69.5 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.172 -1.171 . . . . 0.16 110.172 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -115.12 171.77 7.47 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 123.178 1.466 . . . . 3.0299999999999998 114.0 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.51 126.73 50.84 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 111.613 -2.54 . . . . 1.01 107.736 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.402 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -122.5 159.73 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 108.662 -0.866 . . . . 1.3400000000000001 108.662 -174.467 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.9 m -49.5 -60.01 3.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.699 0.629 . . . . 0.87 112.699 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -132.74 -44.79 0.88 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.614 -1.234 . . . . 2.5499999999999998 113.549 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.46 133.19 0.21 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 117.077 1.591 . . . . 0.19 117.077 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.558 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 1.8 p -70.59 165.72 22.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.353 -1.923 . . . . 0.20000000000000001 111.808 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.868 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 57.6 mt -59.7 98.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 122.393 1.092 . . . . 1.1299999999999999 112.002 -163.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -85.06 148.52 26.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.515 -1.675 . . . . 2.3300000000000001 109.937 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.532 ' HG2' HG21 ' A' ' 84' ' ' ILE . 14.8 mtp -127.52 -165.9 1.54 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.33 -0.619 . . . . 1.0900000000000001 109.33 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.72 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 10.5 t-160 -95.96 154.49 17.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.523 -0.917 . . . . 2.9900000000000002 108.523 172.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.613 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.9 m120 -58.2 -51.1 71.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 118.388 -0.815 . . . . 0.73999999999999999 110.641 -176.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -64.42 -22.64 67.02 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 121.223 1.829 . . . . 2.6899999999999999 112.516 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.72 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 13.3 m-20 -85.3 -42.46 14.59 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.036 -0.529 . . . . 0.68999999999999995 111.263 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.548 HG12 HD13 ' A' ' 151' ' ' ILE . 14.7 p -67.78 -23.03 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.913 -0.585 . . . . 1.02 111.193 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.613 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.78 -40.66 16.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 118.846 -0.597 . . . . 1.1699999999999999 110.02 171.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.8 mm-40 -44.59 -72.57 0.06 Allowed 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 119.426 1.012 . . . . 1.99 112.293 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 157' ' ' VAL . 49.7 mt -47.42 -40.08 17.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.686 0.755 . . . . 1.9099999999999999 111.269 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.05 77.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.098 -1.41 . . . . 1.04 111.785 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.3 t -89.01 -31.78 17.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.56 -0.713 . . . . 0.88 112.694 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 152' ' ' GLU . 28.5 mt -82.0 -60.53 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.612 0.72 . . . . 1.0 111.339 -172.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 153' ' ' LEU . 3.3 m -89.19 140.74 28.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.786 -1.097 . . . . 1.0700000000000001 111.907 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -88.17 173.84 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.969 3.113 . . . . 0.23999999999999999 111.062 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.464 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 77.4 m-20 -65.41 155.76 34.41 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 119.723 -0.791 . . . . 1.1000000000000001 109.187 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.6 -20.02 52.07 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.125 -1.036 . . . . 0.17999999999999999 112.494 -173.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.534 ' HB ' HD11 ' A' ' 100' ' ' ILE . 91.2 m -63.21 138.03 58.41 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 117.419 0.61 . . . . 1.05 109.476 -174.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.566 ' HB3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -93.03 123.31 36.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.784 1.278 . . . . 4.1100000000000003 111.002 -169.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.95 108.56 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 111.94 -2.391 . . . . 1.02 109.022 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.405 HG23 ' ND2' ' A' ' 166' ' ' ASN . 8.8 m -94.43 108.05 19.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.069 -0.514 . . . . 1.0700000000000001 112.307 -171.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.535 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.19 101.15 7.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.152 0.977 . . . . 1.05 109.963 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.405 ' ND2' HG23 ' A' ' 164' ' ' THR . 66.5 m-80 -108.43 128.36 54.71 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.389 -1.278 . . . . 1.0900000000000001 109.794 -175.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.671 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 18.3 mmm180 . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 120.838 0.351 . . . . 2.4900000000000002 111.008 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp . . . . . 0 CA--C 1.52 -0.201 0 CA-C-O 121.701 0.762 . . . . 1.3300000000000001 112.824 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.0 tt -102.54 133.04 48.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.5 -1.227 . . . . 1.0700000000000001 110.265 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.39 162.96 12.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.41 1.1 . . . . 1.03 113.839 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.652 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 87.8 t80 -129.14 140.29 51.6 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.243 -1.799 . . . . 1.0800000000000001 107.596 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.417 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.9 tt0 -112.89 112.64 24.26 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.185 -1.042 . . . . 0.93000000000000005 108.185 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 41' ' ' THR . 92.7 t -65.7 149.67 11.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 122.264 1.031 . . . . 1.1000000000000001 112.679 -171.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -106.27 159.48 16.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.768 -1.56 . . . . 2.4399999999999999 108.487 171.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -61.41 106.06 0.59 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.213 0.53 . . . . 2.4300000000000002 112.379 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.7 11.2 35.84 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.518 -0.765 . . . . 0.51000000000000001 113.395 172.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.522 ' HB2' HG11 ' A' ' 9' ' ' VAL . 84.1 m-20 -53.69 167.62 0.23 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.829 0.347 . . . . 1.46 111.006 172.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -125.95 150.86 47.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.229 0.538 . . . . 1.1599999999999999 111.145 175.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.502 HD22 HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.95 -38.14 89.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.16 -1.052 . . . . 1.47 108.16 -178.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.521 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -84.69 -25.9 28.09 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.37 -1.286 . . . . 1.78 110.532 -177.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.442 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 30.7 t -64.62 -43.25 94.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.396 -0.594 . . . . 1.74 109.396 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.7 mt -72.8 -26.69 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.15 0.5 . . . . 1.04 109.692 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.561 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.73 -11.18 59.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.251 -0.431 . . . . 1.0600000000000001 110.531 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.673 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -90.9 -41.94 10.87 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.595 0.712 . . . . 0.97999999999999998 109.77 171.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.723 ' HB3' ' O ' ' A' ' 119' ' ' SER . 83.6 m-20 -61.65 -44.65 96.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.247 -1.342 . . . . 0.53000000000000003 111.473 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 119' ' ' SER . 54.3 m-85 -99.47 6.63 45.88 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.69 -1.204 . . . . 0.20000000000000001 111.471 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.673 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER 53.87 43.26 31.18 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.71 0.767 . . . . 2.46 109.616 177.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.561 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 36.2 pt -115.75 -165.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.773 -1.103 . . . . 1.04 110.35 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.71 142.87 40.29 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.916 -1.038 . . . . 1.3400000000000001 109.801 174.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.562 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 68.2 p -72.95 -30.88 64.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.626 -0.879 . . . . 1.0900000000000001 108.626 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.05 -27.06 69.15 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.494 -0.776 . . . . 1.0700000000000001 111.625 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.614 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -94.31 -27.11 16.28 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.573 0.701 . . . . 1.04 109.148 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.518 HD12 HD13 ' A' ' 46' ' ' ILE . 17.8 tp -73.55 -28.43 61.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.153 -0.93 . . . . 1.8100000000000001 108.636 172.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 26' ' ' THR . 7.7 tp -78.52 -28.79 46.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.582 0.706 . . . . 1.6399999999999999 109.769 175.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.614 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -58.48 -60.48 3.74 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.472 -1.307 . . . . 2.3300000000000001 107.472 167.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.466 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -71.57 -17.41 62.3 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 120.313 -0.555 . . . . 1.0600000000000001 110.973 -169.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.567 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.7 m-80 -146.99 81.04 9.19 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 115.729 -0.669 . . . . 0.23000000000000001 110.532 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.87 -10.32 5.41 Favored 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 124.065 3.177 . . . . 0.52000000000000002 113.411 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -78.62 -19.91 51.59 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.841 0.312 . . . . 1.6499999999999999 111.841 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.567 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 63.1 mt -70.63 -34.49 72.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.312 0.577 . . . . 1.25 112.205 -171.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.461 ' HB3' HD12 ' A' ' 30' ' ' LEU . 3.8 pt20 -64.4 -47.21 80.07 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 122.805 1.288 . . . . 2.52 110.539 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.59 -49.67 75.65 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 111.729 -2.487 . . . . 1.1899999999999999 110.242 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.38 178.93 48.65 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 114.775 -1.102 . . . . 0.44 111.912 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 157.35 19.43 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.392 0.615 . . . . 1.1699999999999999 110.619 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 44' ' ' GLN . 83.5 m -143.62 130.89 20.83 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.169 -0.923 . . . . 1.1499999999999999 110.062 -176.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.75 120.08 20.64 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.526 0.679 . . . . 1.1200000000000001 110.221 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.417 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 101.35 0.97 53.82 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.709 -1.356 . . . . 0.44 109.709 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 47.4 tt0 -72.74 123.62 23.68 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.148 -1.026 . . . . 1.3 109.915 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 15.7 p -84.11 127.28 33.81 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 122.019 0.914 . . . . 1.3200000000000001 110.068 175.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.605 HG13 ' HB3' ' A' ' 7' ' ' TYR . 10.9 pt -127.33 140.72 48.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.178 -1.374 . . . . 1.0700000000000001 109.033 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.15 150.7 3.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 120.995 0.426 . . . . 1.3 110.885 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.2 mm -114.83 92.9 31.84 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.731 -1.122 . . . . 1.03 108.845 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HA ' HD23 ' A' ' 4' ' ' LEU . 1.8 Cg_endo -58.65 132.96 51.13 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.69 2.26 . . . . 0.20000000000000001 112.835 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.05 -5.79 72.3 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 114.703 -1.135 . . . . 0.26000000000000001 111.983 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.643 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 38.7 tp -123.82 115.67 27.89 Favored Pre-proline 0 N--CA 1.448 -0.569 0 CA-C-O 121.222 0.534 . . . . 1.27 111.75 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.638 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 61.1 Cg_endo -81.57 -176.74 3.22 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 124.204 3.27 . . . . 0.31 114.808 -172.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.473 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 12.6 t70 -81.04 128.96 69.3 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 113.968 -1.469 . . . . 0.48999999999999999 112.269 -170.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 52.3 Cg_endo -73.87 -14.36 24.03 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.629 2.886 . . . . 0.48999999999999999 113.139 -177.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.84 -5.6 37.92 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.891 -0.595 . . . . 1.8 111.402 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 28.0 p -89.15 -21.87 23.11 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.49 -1.3 . . . . 1.1299999999999999 107.49 171.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.487 HG23 ' H ' ' A' ' 59' ' ' TYR . 21.2 mt -75.23 128.04 85.32 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 112.847 -1.979 . . . . 1.24 111.119 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.4 -18.29 15.93 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.473 2.115 . . . . 0.47999999999999998 113.216 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.487 ' H ' HG23 ' A' ' 57' ' ' ILE . 56.4 m-85 -94.82 161.48 14.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.297 -0.561 . . . . 0.94999999999999996 111.628 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -151.15 124.65 8.95 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.655 -0.869 . . . . 3.7400000000000002 108.655 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.713 ' HA ' ' O ' ' A' ' 71' ' ' THR . 97.5 mt -106.44 131.38 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.867 -0.606 . . . . 1.05 111.391 -176.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.66 117.28 29.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.834 -0.746 . . . . 1.0800000000000001 111.341 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 69' ' ' THR . 60.0 t -97.5 117.04 41.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.573 0.702 . . . . 1.04 111.207 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 68' ' ' LYS . 19.3 m -95.31 106.2 18.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.974 -1.012 . . . . 0.83999999999999997 110.61 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.6 mm -54.46 -58.65 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 122.202 1.001 . . . . 1.0600000000000001 111.099 167.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.95 -7.86 3.94 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 112.836 -1.984 . . . . 0.16 113.292 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -127.96 -19.4 4.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.399 0.679 . . . . 1.02 112.671 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.504 ' HD2' ' CG2' ' A' ' 86' ' ' VAL . 0.0 OUTLIER 58.5 56.37 4.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.669 0.668 . . . . 1.3 111.624 -171.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 42.4 p -137.62 162.23 34.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.009 0.744 . . . . 0.98999999999999999 113.009 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.416 ' C ' HD21 ' A' ' 70' ' ' LEU . 8.5 tt -130.16 113.83 14.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.632 -1.167 . . . . 1.1799999999999999 110.023 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 22.0 m -94.81 122.97 37.98 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.172 0.511 . . . . 1.04 111.391 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 79' ' ' MET . 15.3 tp -98.35 104.39 16.42 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.416 -0.811 . . . . 1.3200000000000001 109.628 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 7.7 m -105.22 159.98 15.45 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.531 -0.867 . . . . 1.05 110.78 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.58 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.1 tm? -128.92 128.55 44.01 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.856 -0.794 . . . . 1.1000000000000001 108.856 169.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.58 ' N ' HD23 ' A' ' 74' ' ' LEU . 8.9 p30 46.54 48.64 14.01 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.132 1.373 . . . . 1.97 111.287 -166.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.9 t30 72.93 -9.45 1.11 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.038 -0.983 . . . . 2.5499999999999998 111.333 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.418 ' H ' ' C ' ' A' ' 75' ' ' ASN . 11.2 tpp180 -96.3 120.7 37.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.737 -0.665 . . . . 4.0199999999999996 109.764 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 69.7 t -58.3 132.25 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-O 122.311 1.053 . . . . 1.0600000000000001 112.606 -174.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 12.1 mtm -101.18 -45.5 5.35 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.206 -1.816 . . . . 1.47 109.151 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 13.7 mmmt -157.75 171.15 20.83 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.423 -1.717 . . . . 1.98 109.571 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -148.74 123.33 9.79 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.677 -1.147 . . . . 1.0 109.848 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -111.11 148.29 38.38 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.743 -0.662 . . . . 1.3999999999999999 109.995 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.444 ' HB2' HG23 ' A' ' 134' ' ' ILE . 48.1 Cg_endo -75.43 142.71 26.91 Favored 'Trans proline' 0 CA--C 1.498 -1.295 0 C-N-CA 122.113 1.875 . . . . 0.23999999999999999 110.848 175.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.527 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.6 175.0 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.718 -0.674 . . . . 1.04 110.754 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.875 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.17 146.39 45.2 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.311 -0.404 . . . . 1.03 110.153 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.504 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 7.5 m -127.23 130.18 70.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.558 0.694 . . . . 1.26 111.625 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.4 153.38 26.27 Favored Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 110.012 -1.235 . . . . 0.20000000000000001 110.012 172.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -56.12 3.3 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.238 0.829 . . . . 3.48 113.238 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.506 HG21 HD23 ' A' ' 90' ' ' LEU . 1.8 tp -91.48 -18.55 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 121.555 0.693 . . . . 1.0700000000000001 110.46 -178.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.506 HD23 HG21 ' A' ' 89' ' ' ILE . 3.8 mm? -88.86 -18.19 28.12 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.757 -0.656 . . . . 1.02 109.398 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.8 p -65.56 -19.4 65.91 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.627 -1.17 . . . . 1.05 111.778 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -57.64 -42.47 83.47 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.14 -0.936 . . . . 2.0299999999999998 111.941 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.37 120.9 48.03 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-O 120.867 0.365 . . . . 1.1499999999999999 111.582 -174.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.505 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 2.2 Cg_endo -76.84 -16.18 16.41 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.794 2.329 . . . . 1.04 113.262 177.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 t -106.58 -41.25 5.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.491 -0.559 . . . . 1.1299999999999999 109.491 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.46 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 46.6 48.6 17.12 Favored Glycine 0 N--CA 1.446 -0.636 0 O-C-N 124.374 1.047 . . . . 0.35999999999999999 113.585 170.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.01 111.83 19.22 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.808 0.813 . . . . 1.0800000000000001 109.728 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -137.7 169.44 17.78 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.141 -1.391 . . . . 0.26000000000000001 112.326 -172.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.658 ' HE1' ' CE2' ' A' ' 99' ' ' TYR . 19.3 m-85 -141.25 134.84 30.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.656 -0.702 . . . . 0.78000000000000003 110.241 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.521 HD11 ' HB ' ' A' ' 161' ' ' THR . 81.1 mt -58.62 117.83 2.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.507 -0.77 . . . . 1.02 110.695 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.538 HD11 ' C ' ' A' ' 22' ' ' PHE . 22.4 pt -82.87 -43.56 18.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 112.604 0.594 . . . . 1.03 112.604 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.554 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 52.9 m-80 -170.7 168.97 7.27 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.787 -1.56 . . . . 2.0299999999999998 106.787 -170.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.436 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 0.2 OUTLIER -133.95 152.97 52.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.207 -0.597 . . . . 2.02 111.944 -175.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -128.46 103.0 6.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.45 -0.796 . . . . 0.83999999999999997 110.161 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.475 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 38.0 ttt180 -62.92 166.85 5.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.334 -0.848 . . . . 3.2799999999999998 110.411 173.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.475 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 19.9 m-80 -35.32 103.51 0.24 Allowed Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 125.097 1.359 . . . . 0.34999999999999998 113.373 -156.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.8 Cg_endo . . . . . 0 C--N 1.347 0.457 0 C-N-CA 123.026 2.484 . . . . 0.63 111.084 172.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.537 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.563 1.47 0 N-CA-C 117.334 2.346 . . . . 1.1699999999999999 117.334 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.473 ' CD1' HG13 ' A' ' 151' ' ' ILE . 0.5 OUTLIER -164.63 160.79 20.44 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.426 -0.796 . . . . 0.60999999999999999 110.372 -175.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -141.62 98.67 3.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.693 -0.854 . . . . 0.56999999999999995 108.693 168.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.516 HD13 ' CG2' ' A' ' 150' ' ' VAL . 2.4 mt -90.69 114.49 26.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.342 0.591 . . . . 1.3600000000000001 109.428 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.432 ' C ' HG12 ' A' ' 101' ' ' ILE . 14.5 m -84.8 144.83 28.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.014 -0.539 . . . . 0.42999999999999999 111.384 -170.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.773 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -109.58 168.98 9.0 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.32 -0.4 . . . . 1.02 111.145 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.723 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -60.68 -10.87 5.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.074 0.768 . . . . 1.79 113.074 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' HG2' ' CE1' ' A' ' 123' ' ' TYR . 14.8 tppt? -127.38 131.38 50.34 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.642 0.734 . . . . 1.8100000000000001 110.185 171.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.495 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 8.5 pt20 -47.44 -31.61 4.3 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.323 -1.762 . . . . 1.76 114.872 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.481 ' H ' ' HG3' ' A' ' 120' ' ' LYS . 60.5 m80 -97.37 -8.48 29.46 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.692 -0.803 . . . . 3.2000000000000002 112.312 -177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.773 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.4 m-30 -94.82 40.07 1.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.185 1.18 . . . . 0.83999999999999997 114.185 -168.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.466 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -112.0 145.17 17.85 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 116.376 -2.821 . . . . 0.96999999999999997 112.509 -153.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.32 115.99 37.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.787 0.803 . . . . 1.04 110.762 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.654 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 30.3 p80 -145.12 172.2 13.43 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.344 -0.844 . . . . 0.20999999999999999 109.462 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.28 -168.2 38.76 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 120.157 -1.021 . . . . 0.34999999999999998 111.724 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.7 t -154.6 171.45 19.45 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.908 -0.76 . . . . 1.1100000000000001 111.325 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -113.48 -11.44 13.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.564 -0.902 . . . . 2.1899999999999999 108.564 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -107.45 86.97 3.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.216 -1.031 . . . . 1.8400000000000001 108.216 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.37 -18.6 29.75 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.355 2.037 . . . . 0.39000000000000001 112.906 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.46 -0.12 40.28 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.402 -0.817 . . . . 1.0800000000000001 111.077 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.464 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 98.2 p -91.59 -6.58 52.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.022 -0.733 . . . . 1.9399999999999999 109.022 171.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.444 HG23 ' HB2' ' A' ' 83' ' ' PRO . 40.5 mm -78.82 135.69 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.399 -0.819 . . . . 1.04 110.141 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.18 0.71 70.48 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.366 -1.093 . . . . 0.16 110.366 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.464 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 50.3 mttm -115.02 176.31 5.12 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 123.629 1.68 . . . . 3.0299999999999998 114.088 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -105.61 129.31 53.88 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.655 -2.975 . . . . 1.01 108.157 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -125.22 158.85 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.95 -0.759 . . . . 1.3400000000000001 108.95 -175.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 67.9 m -47.45 -59.61 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.712 0.634 . . . . 0.87 112.712 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -131.44 -44.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.014 -1.075 . . . . 2.5499999999999998 113.304 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.27 132.7 0.21 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 117.082 1.593 . . . . 0.19 117.082 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.654 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 1.9 p -71.5 165.15 24.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.359 -1.921 . . . . 0.20000000000000001 111.874 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.875 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 60.6 mt -59.83 98.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 114.841 -1.072 . . . . 1.1299999999999999 111.857 -163.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.635 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 74.8 mtt180 -84.52 149.58 25.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.676 -1.602 . . . . 2.3300000000000001 110.33 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.527 ' HG2' HG21 ' A' ' 84' ' ' ILE . 15.9 mtp -129.29 -165.4 1.51 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.002 -0.74 . . . . 1.0900000000000001 109.002 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.632 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 3.5 t-160 -96.28 157.36 15.93 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.59 -0.893 . . . . 2.9900000000000002 108.59 171.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.63 ' O ' HD11 ' A' ' 151' ' ' ILE . 3.7 m120 -59.03 -51.07 71.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 118.285 -0.864 . . . . 0.73999999999999999 110.549 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -64.42 -27.09 68.76 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 121.562 1.983 . . . . 2.6899999999999999 112.491 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.632 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 5.8 m-20 -79.03 -43.23 24.68 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.048 0.452 . . . . 0.68999999999999995 110.658 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.527 HG12 HD13 ' A' ' 151' ' ' ILE . 14.4 p -69.08 -23.85 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.645 -0.707 . . . . 1.02 111.539 177.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.63 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.06 -42.09 18.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 119.126 -0.464 . . . . 1.1699999999999999 109.954 171.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.461 ' O ' HG13 ' A' ' 156' ' ' ILE . 22.5 mt-10 -46.79 -69.42 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 119.058 0.845 . . . . 1.99 112.407 170.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 157' ' ' VAL . 37.0 mt -47.71 -40.2 19.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.509 0.671 . . . . 1.9099999999999999 111.517 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.68 -35.6 76.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.21 -1.359 . . . . 1.04 111.41 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.8 t -87.29 -29.77 21.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.603 0.638 . . . . 0.88 112.521 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.6 mt -84.87 -60.38 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.471 0.653 . . . . 1.0 112.025 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.1 m -90.51 143.01 28.6 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 114.994 -1.003 . . . . 1.0700000000000001 112.161 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.436 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 44.0 Cg_endo -91.91 176.1 1.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 124.273 3.315 . . . . 0.23999999999999999 111.378 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 77.0 m-20 -66.92 157.94 31.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.554 -0.859 . . . . 1.1000000000000001 109.454 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 95.85 -16.64 60.79 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.238 -0.982 . . . . 0.17999999999999999 112.02 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.521 ' HB ' HD11 ' A' ' 100' ' ' ILE . 91.5 m -66.38 139.0 57.98 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.199 -0.667 . . . . 1.05 109.199 -175.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.479 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 2.2 ptt180 -92.69 117.72 30.29 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.665 1.221 . . . . 4.1100000000000003 110.932 -169.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.77 107.2 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 111.992 -2.367 . . . . 1.02 108.806 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.473 HG23 ' ND2' ' A' ' 166' ' ' ASN . 6.4 m -95.24 109.48 21.59 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.609 0.596 . . . . 1.0700000000000001 112.609 -170.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.46 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.48 100.58 7.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 122.215 1.007 . . . . 1.05 110.062 178.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.473 ' ND2' HG23 ' A' ' 164' ' ' THR . 57.5 m-80 -109.44 134.64 51.61 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.234 -1.348 . . . . 1.0900000000000001 109.795 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.532 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.7 mmm180 . . . . . 0 C--N 1.32 -0.699 0 N-CA-C 109.867 -0.42 . . . . 2.4900000000000002 109.867 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 121.33 0.586 . . . . 1.3300000000000001 111.851 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.626 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.8 tt -99.69 129.53 45.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.018 -0.992 . . . . 1.0700000000000001 110.32 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.39 162.2 13.59 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.02 0.914 . . . . 1.03 112.88 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 7' ' ' TYR . 80.9 t80 -130.38 143.84 51.02 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.106 -1.406 . . . . 1.0800000000000001 108.122 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -114.74 114.53 25.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.464 -0.939 . . . . 0.93000000000000005 108.464 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 41' ' ' THR . 95.2 t -67.97 151.44 10.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 122.383 1.087 . . . . 1.1000000000000001 113.611 -171.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -106.55 158.47 16.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.359 -1.746 . . . . 2.4399999999999999 108.392 172.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -61.89 115.42 4.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.058 0.456 . . . . 2.4300000000000002 111.799 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.33 12.86 47.15 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.976 -0.63 . . . . 0.51000000000000001 113.255 173.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.427 ' OD1' ' HG ' ' A' ' 40' ' ' LEU . 1.8 p-10 -50.63 170.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.019 0.914 . . . . 1.46 111.864 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.8 150.02 52.17 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.186 -0.915 . . . . 1.1599999999999999 110.959 169.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.492 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.66 -34.27 77.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.519 -1.219 . . . . 1.47 108.242 -178.204 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.52 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 4.2 t30 -85.02 -27.74 26.2 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.621 -1.172 . . . . 1.78 111.192 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.9 t -65.32 -42.31 93.11 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.307 -0.557 . . . . 1.74 109.921 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.6 mt -74.4 -25.93 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 121.381 0.61 . . . . 1.04 109.822 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.613 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.93 -9.94 59.66 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.269 -0.423 . . . . 1.0600000000000001 110.793 174.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.627 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.45 -40.14 9.23 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.399 1.095 . . . . 0.97999999999999998 108.079 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -61.84 -40.89 96.91 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 112.885 -1.962 . . . . 0.53000000000000003 111.897 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.583 ' C ' HD11 ' A' ' 101' ' ' ILE . 65.5 m-85 -101.46 5.51 42.03 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 118.611 -1.235 . . . . 0.20000000000000001 111.872 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.627 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.9 mpt_? 54.53 40.43 31.82 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.828 0.823 . . . . 2.46 109.553 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.613 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.0 pt -112.99 -165.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.486 -1.234 . . . . 1.04 109.957 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.32 142.26 42.2 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.086 -0.961 . . . . 1.3400000000000001 110.106 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.642 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 43.4 p -72.95 -30.7 64.06 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.383 -0.969 . . . . 1.0900000000000001 108.383 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.3 -24.25 67.59 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.559 -0.746 . . . . 1.0700000000000001 111.872 170.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.35 -29.2 14.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.993 -0.743 . . . . 1.04 108.993 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.494 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 21.7 tp -71.9 -28.49 63.53 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.96 -1.018 . . . . 1.8100000000000001 108.414 172.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' A' ' 26' ' ' THR . 8.2 tp -76.75 -31.73 57.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.939 0.876 . . . . 1.6399999999999999 109.575 175.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 44.6 tt0 -65.9 -43.23 88.81 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.112 -1.404 . . . . 2.3300000000000001 110.603 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -80.35 -17.98 50.41 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.193 -0.603 . . . . 1.0600000000000001 111.42 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.572 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 38.7 m-80 -144.21 81.59 11.37 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-O 121.554 0.692 . . . . 0.23000000000000001 110.641 -173.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.6 Cg_endo -56.57 -10.07 4.64 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 124.124 3.216 . . . . 0.52000000000000002 113.829 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.5 m -79.0 -24.84 43.44 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 122.097 -0.377 . . . . 1.6499999999999999 111.409 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.572 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 61.5 mt -67.12 -33.38 75.34 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.553 0.692 . . . . 1.25 111.92 -170.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.4 ' NE2' ' HB1' ' A' ' 38' ' ' ALA . 1.7 pp0? -64.82 -44.92 88.32 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 122.742 1.258 . . . . 2.52 110.591 -174.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.4 ' HB1' ' NE2' ' A' ' 37' ' ' GLN . . . -64.98 -47.62 76.93 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 111.772 -2.467 . . . . 1.1899999999999999 110.752 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.9 178.01 48.64 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.923 -1.035 . . . . 0.44 112.139 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.427 ' HG ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -110.99 159.02 18.12 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.109 0.481 . . . . 1.1699999999999999 110.628 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.61 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 62.6 m -145.08 129.03 17.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.866 -0.606 . . . . 1.1499999999999999 111.378 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.31 120.83 22.1 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.441 0.638 . . . . 1.1200000000000001 110.057 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.83 0.49 57.55 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.215 -1.154 . . . . 0.44 110.215 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -75.84 125.31 28.84 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.925 -0.638 . . . . 1.3 109.842 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 35.1 p -81.03 131.16 35.29 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.778 0.799 . . . . 1.3200000000000001 110.023 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.605 HG13 ' HB3' ' A' ' 7' ' ' TYR . 12.2 pt -131.28 140.64 47.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.354 -1.293 . . . . 1.0700000000000001 109.259 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.91 150.29 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.964 0.411 . . . . 1.3 110.853 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.431 HG22 ' CD2' ' A' ' 22' ' ' PHE . 37.1 mm -114.71 93.18 32.36 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 114.91 -1.041 . . . . 1.03 109.172 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.493 ' HA ' HD23 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -59.67 134.23 56.37 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.862 2.375 . . . . 0.20000000000000001 113.029 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.36 -6.25 80.79 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.932 -1.031 . . . . 0.26000000000000001 112.266 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.67 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 32.6 tp -122.64 115.69 29.53 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-O 121.26 0.553 . . . . 1.27 111.398 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.626 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 53.5 Cg_endo -79.16 -177.41 3.87 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.668 2.912 . . . . 0.31 114.288 -172.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.501 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 14.1 t70 -77.42 134.43 66.42 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.015 -1.448 . . . . 0.48999999999999999 112.552 -170.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.4 -15.78 24.87 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.683 2.922 . . . . 0.48999999999999999 113.279 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -95.96 -9.36 31.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.43 0.633 . . . . 1.8 111.309 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.501 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 30.0 p -85.74 -18.47 32.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.053 0.93 . . . . 1.1299999999999999 108.713 173.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.57 HG23 ' H ' ' A' ' 59' ' ' TYR . 7.8 mm -63.99 125.43 87.95 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 113.638 -1.619 . . . . 1.24 109.755 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.74 -13.53 13.09 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.984 1.789 . . . . 0.47999999999999998 112.699 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.57 ' H ' HG23 ' A' ' 57' ' ' ILE . 58.7 m-85 -103.45 169.79 8.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.892 0.377 . . . . 0.94999999999999996 111.756 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -154.13 127.76 8.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.701 -0.851 . . . . 3.7400000000000002 108.701 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 71' ' ' THR . 93.6 mt -107.19 130.92 58.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.831 -0.622 . . . . 1.05 111.352 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.08 115.39 26.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.781 -0.768 . . . . 1.0800000000000001 110.882 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 69' ' ' THR . 48.2 t -95.89 116.28 37.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.641 0.734 . . . . 1.04 111.053 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 68' ' ' LYS . 51.9 m -94.61 105.18 17.13 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.016 -0.993 . . . . 0.83999999999999997 110.401 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.512 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.0 mm -53.59 -58.53 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 122.13 0.967 . . . . 1.0600000000000001 111.104 167.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.05 -8.68 6.36 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 112.941 -1.936 . . . . 0.16 113.049 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.436 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -126.73 -17.72 4.92 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.589 0.756 . . . . 1.02 112.359 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.507 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 57.55 57.52 4.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.473 0.579 . . . . 1.3 111.302 -173.346 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 57.3 p -138.88 160.93 38.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 112.899 0.703 . . . . 0.98999999999999999 112.899 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.446 ' C ' HD21 ' A' ' 70' ' ' LEU . 8.5 tt -129.07 113.44 15.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.538 -1.21 . . . . 1.1799999999999999 109.999 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.699 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 9.9 m -94.05 122.86 37.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.081 0.467 . . . . 1.04 111.135 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.8 tp -99.03 103.22 15.14 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.367 -0.833 . . . . 1.3200000000000001 109.455 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 19.5 m -105.18 159.83 15.55 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.406 -0.918 . . . . 1.05 110.594 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -128.11 127.88 43.85 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.993 -0.743 . . . . 1.1000000000000001 108.993 168.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.573 ' N ' HD23 ' A' ' 74' ' ' LEU . 6.3 m-80 53.98 44.44 29.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.792 -1.095 . . . . 1.97 110.78 -174.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 71.37 -4.31 1.87 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.57 -0.741 . . . . 2.5499999999999998 111.558 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -102.77 120.85 41.31 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.681 -0.69 . . . . 4.0199999999999996 110.119 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 62.9 t -57.98 133.31 22.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 122.296 1.046 . . . . 1.0600000000000001 112.527 -175.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.471 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 14.5 mtm -103.04 -43.43 5.5 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 113.32 -1.764 . . . . 1.47 109.329 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -159.41 171.43 19.76 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 113.297 -1.774 . . . . 1.98 110.014 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.1 m -149.1 123.68 9.77 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.091 -1.413 . . . . 1.0 109.748 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -113.61 146.42 35.42 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.694 -0.685 . . . . 1.3999999999999999 110.303 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.439 ' HB2' HG23 ' A' ' 134' ' ' ILE . 35.0 Cg_endo -72.59 142.2 35.84 Favored 'Trans proline' 0 CA--C 1.495 -1.438 0 C-N-CA 122.038 1.825 . . . . 0.23999999999999999 110.775 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.489 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.38 172.64 11.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.828 -0.624 . . . . 1.04 110.853 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.923 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.93 140.32 49.89 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 110.032 -0.359 . . . . 1.03 110.032 -176.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.458 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 9.6 m -122.91 126.19 73.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.508 0.67 . . . . 1.26 111.672 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -80.58 150.42 31.35 Favored Glycine 0 N--CA 1.423 -2.168 0 N-CA-C 109.544 -1.423 . . . . 0.20000000000000001 109.544 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -57.7 4.74 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.951 0.723 . . . . 3.48 112.951 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.493 ' H ' ' C ' ' A' ' 87' ' ' GLY . 1.0 OUTLIER -89.13 -18.72 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-O 121.546 0.689 . . . . 1.0700000000000001 110.081 178.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.8 mm? -88.96 -17.28 29.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.793 0.806 . . . . 1.02 109.115 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.1 p -66.39 -18.49 65.39 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.535 -1.212 . . . . 1.05 111.302 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.73 -42.11 92.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.774 -1.103 . . . . 2.0299999999999998 112.165 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.61 134.66 19.55 Favored Pre-proline 0 C--N 1.325 -0.497 0 C-N-CA 120.539 -0.465 . . . . 1.1499999999999999 110.889 -175.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.527 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 84.7 Cg_endo -87.55 -16.1 3.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.472 2.114 . . . . 1.04 112.437 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.7 t -107.97 -38.75 5.73 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.31 -0.626 . . . . 1.1299999999999999 109.31 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 45.16 31.93 3.27 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 124.785 1.303 . . . . 0.35999999999999999 113.799 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.502 ' HB3' HG21 ' A' ' 164' ' ' THR . 8.2 pt-20 -84.55 115.74 22.77 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 122.801 1.286 . . . . 1.0800000000000001 109.174 -173.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 13.2 m-85 -136.46 179.47 6.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 112.89 -1.959 . . . . 0.26000000000000001 111.305 -167.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -140.1 134.31 31.12 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.217 -0.447 . . . . 0.78000000000000003 110.445 -172.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.579 HD11 ' HB ' ' A' ' 161' ' ' THR . 93.0 mt -61.58 118.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.413 -0.812 . . . . 1.02 110.511 171.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.583 HD11 ' C ' ' A' ' 22' ' ' PHE . 24.1 pt -84.18 -44.54 18.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 112.816 0.673 . . . . 1.03 112.816 -176.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.542 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 54.5 m-80 -171.99 171.14 5.14 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.042 -1.836 . . . . 2.0299999999999998 106.042 -168.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.93 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 3.4 mtt180 -130.51 174.59 9.74 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.433 -0.907 . . . . 2.02 112.167 -174.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -149.64 100.78 3.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.628 -1.169 . . . . 0.83999999999999997 109.838 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.478 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 26.9 ttt85 -64.09 166.58 7.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.47 -0.786 . . . . 3.2799999999999998 110.446 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.478 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 18.6 m-80 -34.77 102.64 0.23 Allowed Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 125.296 1.438 . . . . 0.34999999999999998 113.315 -157.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.5 Cg_endo . . . . . 0 N--CA 1.459 -0.551 0 C-N-CA 123.107 2.538 . . . . 0.63 111.289 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.524 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.565 1.522 0 N-CA-C 117.57 2.433 . . . . 1.1699999999999999 117.57 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.651 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.4 OUTLIER -166.28 159.72 15.22 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.43 -0.794 . . . . 0.60999999999999999 110.289 -177.187 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -140.37 98.1 3.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.449 -0.945 . . . . 0.56999999999999995 108.449 167.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.553 HD13 ' CG2' ' A' ' 150' ' ' VAL . 2.6 mt -90.04 115.49 27.36 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.709 -0.62 . . . . 1.3600000000000001 109.524 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.406 ' O ' HG12 ' A' ' 101' ' ' ILE . 17.4 m -84.81 143.49 29.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.953 -0.567 . . . . 0.42999999999999999 111.609 -169.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.82 169.68 8.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.543 . . . . 1.02 111.374 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 t -63.77 -9.82 16.53 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.036 -0.984 . . . . 1.79 113.299 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.556 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 9.1 tptm -127.86 134.76 49.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.547 -0.461 . . . . 1.8100000000000001 110.564 171.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.481 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 29.9 mm-40 -33.68 -59.61 0.39 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.982 1.105 . . . . 1.76 113.982 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.475 ' CB ' HG12 ' A' ' 89' ' ' ILE . 64.5 m80 -87.64 -2.32 58.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.313 -0.555 . . . . 3.2000000000000002 111.703 -169.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.752 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -93.97 38.57 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.001 1.112 . . . . 0.83999999999999997 114.001 -171.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -113.67 145.08 18.35 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 117.089 -2.482 . . . . 0.96999999999999997 112.617 -154.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -98.98 115.32 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.891 0.853 . . . . 1.04 110.833 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.57 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 31.0 p80 -144.43 171.88 13.73 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.08 -0.964 . . . . 0.20999999999999999 109.886 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.36 -167.93 38.55 Favored Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.422 -0.894 . . . . 0.34999999999999998 111.723 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.5 t -154.86 170.34 21.89 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.013 -0.698 . . . . 1.1100000000000001 110.551 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -115.01 -5.32 12.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.982 0.896 . . . . 2.1899999999999999 108.639 175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -112.45 88.53 11.11 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 114.46 -1.246 . . . . 1.8400000000000001 108.307 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.27 -18.25 26.87 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.438 2.092 . . . . 0.39000000000000001 113.474 -170.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.03 -0.55 35.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.852 -0.613 . . . . 1.0800000000000001 111.389 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 78.9 p -90.86 -9.13 47.46 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.054 -0.721 . . . . 1.9399999999999999 109.054 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.439 HG23 ' HB2' ' A' ' 83' ' ' PRO . 37.3 mm -78.95 136.75 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.259 -0.882 . . . . 1.04 110.263 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.09 -0.04 75.04 Favored Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 110.366 -1.094 . . . . 0.16 110.366 -176.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -112.04 170.08 8.4 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 123.071 1.415 . . . . 3.0299999999999998 114.098 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.32 124.14 46.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 111.969 -2.378 . . . . 1.01 108.154 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.412 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -120.91 159.95 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.36 -0.978 . . . . 1.3400000000000001 108.36 -173.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.5 m -50.62 -59.35 4.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.508 0.558 . . . . 0.87 112.508 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -132.03 -45.1 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 118.633 -1.227 . . . . 2.5499999999999998 113.851 -174.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.36 133.19 0.2 Allowed Glycine 0 N--CA 1.466 0.692 0 N-CA-C 117.232 1.653 . . . . 0.19 117.232 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.57 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 1.9 p -70.95 165.4 23.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 112.471 -1.865 . . . . 0.20000000000000001 112.348 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.923 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 66.7 mt -60.15 98.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 122.449 1.118 . . . . 1.1299999999999999 112.056 -163.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.558 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 13.1 mtp180 -85.34 145.62 27.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.523 -1.672 . . . . 2.3300000000000001 110.493 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.489 ' HG2' HG21 ' A' ' 84' ' ' ILE . 18.3 mtp -125.03 -164.81 1.32 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.717 -0.846 . . . . 1.0900000000000001 108.717 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.596 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 89.2 m-70 -93.65 161.64 14.27 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.629 -0.508 . . . . 2.9900000000000002 109.629 170.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.611 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.3 m120 -60.43 -51.96 67.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 118.744 -0.646 . . . . 0.73999999999999999 109.726 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -64.18 -27.04 68.8 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 120.782 1.628 . . . . 2.6899999999999999 112.244 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.596 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 68.8 m-20 -77.45 -46.68 21.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.261 0.553 . . . . 0.68999999999999995 110.489 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.553 ' CG2' HD13 ' A' ' 116' ' ' LEU . 14.2 p -67.19 -22.8 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.222 -0.899 . . . . 1.02 111.754 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -84.27 -41.78 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 119.087 -0.482 . . . . 1.1699999999999999 110.071 171.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.453 ' O ' HG13 ' A' ' 156' ' ' ILE . 24.6 mt-10 -49.26 -66.16 0.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 119.23 0.923 . . . . 1.99 112.278 170.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 157' ' ' VAL . 9.3 mp -48.69 -35.02 13.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.612 0.72 . . . . 1.9099999999999999 111.125 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.546 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -66.38 -31.17 71.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.624 -1.171 . . . . 1.04 111.4 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.2 t -88.28 -31.86 18.78 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.581 -0.7 . . . . 0.88 112.696 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.1 mt -84.95 -61.21 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.457 0.646 . . . . 1.0 112.33 -171.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -90.55 145.38 32.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.012 -0.994 . . . . 1.0700000000000001 111.792 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.93 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 19.0 Cg_endo -95.12 178.32 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 124.901 3.734 . . . . 0.23999999999999999 111.752 174.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.542 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 80.0 m-20 -68.66 158.23 34.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.227 -0.989 . . . . 1.1000000000000001 108.966 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.12 -14.11 65.82 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.056 -1.069 . . . . 0.17999999999999999 111.869 -173.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' HD11 ' A' ' 100' ' ' ILE . 85.2 m -66.73 139.01 57.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.44 -0.578 . . . . 1.05 109.44 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -92.34 115.69 28.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 122.726 1.251 . . . . 4.1100000000000003 110.815 -172.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.4 t -106.11 108.42 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 112.21 -2.268 . . . . 1.02 109.122 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.502 HG21 ' HB3' ' A' ' 97' ' ' GLU . 3.8 m -97.08 108.57 21.33 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 112.859 0.689 . . . . 1.0700000000000001 112.859 -171.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.479 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -83.72 94.46 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 122.573 1.177 . . . . 1.05 110.327 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -104.9 142.38 34.86 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.234 -1.348 . . . . 1.0900000000000001 109.86 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.527 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 8.8 mmm180 . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.957 0.408 . . . . 2.4900000000000002 110.49 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.066 0.46 . . . . 1.3300000000000001 111.578 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.692 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.5 tt -91.58 129.97 37.47 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.283 -0.872 . . . . 1.0700000000000001 110.757 -174.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.77 162.03 13.33 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.3 1.048 . . . . 1.03 113.067 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.669 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 70.9 t80 -132.54 142.82 49.35 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.432 -1.713 . . . . 1.0800000000000001 108.057 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -113.97 113.22 24.52 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.05 -1.092 . . . . 0.93000000000000005 108.05 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.604 HG11 ' HB2' ' A' ' 13' ' ' ASP . 95.9 t -66.13 149.5 11.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.327 1.06 . . . . 1.1000000000000001 113.039 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -104.06 158.74 16.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.307 -1.769 . . . . 2.4399999999999999 108.479 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.48 109.26 0.85 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.731 0.301 . . . . 2.4300000000000002 111.235 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.66 10.2 50.78 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.807 -0.633 . . . . 0.51000000000000001 113.925 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.604 ' HB2' HG11 ' A' ' 9' ' ' VAL . 43.9 m-20 -55.45 169.14 0.32 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.371 0.586 . . . . 1.46 110.865 172.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.32 152.43 50.58 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.562 0.696 . . . . 1.1599999999999999 112.26 174.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -67.52 -29.76 69.25 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.184 -1.371 . . . . 1.47 109.901 -177.154 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.488 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 5.4 t30 -93.49 -24.99 17.8 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.879 -1.055 . . . . 1.78 110.669 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 t -69.22 -39.55 78.51 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.36 -0.607 . . . . 1.74 109.36 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.42 HG21 ' CE1' ' A' ' 22' ' ' PHE . 15.5 mt -72.93 -26.59 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.219 0.533 . . . . 1.04 109.688 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.599 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.25 -9.93 59.69 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.2 -0.312 . . . . 1.0600000000000001 110.987 175.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.61 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.99 -39.33 9.41 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.609 1.195 . . . . 0.97999999999999998 108.148 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 119' ' ' SER . 11.2 m-20 -63.66 -44.78 92.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.536 -2.12 . . . . 0.53000000000000003 112.041 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.55 ' C ' HD11 ' A' ' 101' ' ' ILE . 64.4 m-85 -97.96 4.97 49.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 118.57 -1.252 . . . . 0.20000000000000001 111.613 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.61 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.1 mpt_? 54.04 46.92 24.49 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.782 0.801 . . . . 2.46 109.947 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.599 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.0 pt -118.38 -165.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 114.45 -1.25 . . . . 1.04 109.902 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.02 142.2 41.77 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.06 -0.973 . . . . 1.3400000000000001 109.746 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.609 ' HB ' ' CD1' ' A' ' 15' ' ' LEU . 71.4 p -73.14 -33.19 65.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.166 -1.05 . . . . 1.0900000000000001 108.166 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.22 -27.45 67.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.2 -0.909 . . . . 1.0700000000000001 111.55 169.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -92.24 -28.32 17.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.914 -0.773 . . . . 1.04 108.914 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.633 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 21.3 tp -73.84 -26.95 60.85 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.328 -0.851 . . . . 1.8100000000000001 109.47 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 26' ' ' THR . 43.1 mt -78.54 -31.28 47.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.835 0.826 . . . . 1.6399999999999999 109.699 172.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 6.1 tt0 -63.98 -38.97 93.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.364 -1.289 . . . . 2.3300000000000001 110.154 173.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -85.08 -20.94 29.61 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 119.965 -0.694 . . . . 1.0600000000000001 111.591 176.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.589 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.1 m-80 -149.12 82.73 6.93 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-O 121.195 0.522 . . . . 0.23000000000000001 110.466 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.7 Cg_endo -56.93 -11.73 7.95 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.928 3.086 . . . . 0.52000000000000002 113.013 175.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -77.35 -19.86 55.67 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.223 -0.444 . . . . 1.6499999999999999 112.017 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.633 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 38.2 mt -77.03 -34.03 57.34 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.318 0.58 . . . . 1.25 112.137 -171.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -63.24 -46.01 88.89 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 122.768 1.27 . . . . 2.52 110.926 -170.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.43 86.58 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 112.067 -2.333 . . . . 1.1899999999999999 111.016 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.81 178.43 48.44 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 114.731 -1.122 . . . . 0.44 110.94 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.465 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -112.86 157.62 21.18 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.264 0.554 . . . . 1.1699999999999999 111.186 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.576 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 47.0 m -138.06 127.94 25.46 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.161 -0.927 . . . . 1.1499999999999999 110.299 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 120.56 21.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.348 0.594 . . . . 1.1200000000000001 109.669 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.6 -0.51 56.77 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.305 -1.118 . . . . 0.44 110.305 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.576 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.4 tt0 -74.86 125.28 28.49 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 114.892 -0.654 . . . . 1.3 109.518 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 43.0 m -86.25 132.6 33.95 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.603 0.716 . . . . 1.3200000000000001 109.877 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.574 HG13 ' HB3' ' A' ' 7' ' ' TYR . 12.1 pt -133.1 143.39 39.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.414 -1.266 . . . . 1.0700000000000001 109.327 -176.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.67 151.48 3.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.079 0.466 . . . . 1.3 110.96 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.8 mm -115.41 91.97 30.76 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.706 -1.133 . . . . 1.03 109.31 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HA ' HD23 ' A' ' 4' ' ' LEU . 2.1 Cg_endo -58.15 134.36 61.41 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.898 2.399 . . . . 0.20000000000000001 112.741 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.43 -5.91 77.74 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.766 -1.106 . . . . 0.26000000000000001 112.405 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.682 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 21.3 tp -129.21 120.29 20.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 121.048 0.451 . . . . 1.27 111.407 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.692 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_endo -80.91 -177.81 3.98 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.488 2.792 . . . . 0.31 114.166 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.539 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 13.6 t70 -74.49 134.11 76.62 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 114.265 -1.334 . . . . 0.48999999999999999 112.915 -168.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 160' ' ' GLY . 83.9 Cg_endo -76.91 -15.4 16.69 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 124.105 3.203 . . . . 0.48999999999999999 112.951 -175.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -95.38 -16.05 22.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.918 0.39 . . . . 1.8 111.131 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.539 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 22.2 p -79.04 -13.95 59.46 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.96 0.886 . . . . 1.1299999999999999 109.445 175.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.502 HG23 ' H ' ' A' ' 59' ' ' TYR . 14.6 mm -63.86 126.08 89.17 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 113.813 -1.539 . . . . 1.24 110.193 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.2 -15.04 11.71 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.342 2.028 . . . . 0.47999999999999998 112.895 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.502 ' H ' HG23 ' A' ' 57' ' ' ILE . 66.2 m-85 -100.08 174.02 6.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.894 0.378 . . . . 0.94999999999999996 110.794 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -157.08 132.88 9.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.064 -0.717 . . . . 3.7400000000000002 109.064 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' A' ' 71' ' ' THR . 89.5 mt -113.66 134.68 55.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.132 -0.486 . . . . 1.05 111.497 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.01 116.09 26.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.829 -0.748 . . . . 1.0800000000000001 111.018 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 69' ' ' THR . 90.6 t -96.46 113.96 32.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.669 0.747 . . . . 1.04 111.066 176.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 68' ' ' LYS . 49.6 m -91.52 108.48 19.92 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.071 -0.968 . . . . 0.83999999999999997 110.62 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.471 HD11 HG12 ' A' ' 86' ' ' VAL . 50.6 mm -54.97 -59.69 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 122.038 0.923 . . . . 1.0600000000000001 111.001 166.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.8 -13.86 6.78 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 112.846 -1.979 . . . . 0.16 113.071 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.441 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -125.02 -16.45 6.07 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 123.196 0.598 . . . . 1.02 112.491 -178.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER 56.27 55.53 6.6 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.747 0.703 . . . . 1.3 111.493 -174.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 41.9 p -138.25 162.02 35.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.805 0.669 . . . . 0.98999999999999999 112.805 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.405 HD21 ' C ' ' A' ' 70' ' ' LEU . 7.9 tt -129.89 113.06 14.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.893 -1.049 . . . . 1.1799999999999999 110.062 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.2 m -93.13 122.86 35.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.097 0.475 . . . . 1.04 111.228 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.1 tp -100.39 106.11 17.67 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.318 -0.855 . . . . 1.3200000000000001 109.764 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 89.1 p -107.68 161.29 15.01 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.185 -1.006 . . . . 1.05 110.735 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.585 HD11 ' ND2' ' A' ' 75' ' ' ASN . 1.1 tm? -128.46 129.38 46.03 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.781 -0.822 . . . . 1.1000000000000001 108.781 169.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.585 ' ND2' HD11 ' A' ' 74' ' ' LEU . 9.7 p30 46.98 46.13 15.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.345 -1.298 . . . . 1.97 111.181 -166.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 73.55 -8.53 1.35 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.84 -1.073 . . . . 2.5499999999999998 111.785 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -94.96 119.82 34.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.767 -0.651 . . . . 4.0199999999999996 109.776 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 68.4 t -58.38 133.43 23.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 122.392 1.092 . . . . 1.0600000000000001 112.33 -174.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 18.6 mtm -102.56 -43.51 5.6 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.165 -1.834 . . . . 1.47 109.26 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -160.23 173.11 16.22 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.311 -1.768 . . . . 1.98 110.408 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.4 m -149.86 124.53 9.77 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 113.999 -1.455 . . . . 1.0 109.604 173.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -116.42 146.28 37.07 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.821 -0.627 . . . . 1.3999999999999999 109.904 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.473 ' HB2' HG23 ' A' ' 134' ' ' ILE . 37.9 Cg_endo -72.07 142.86 39.11 Favored 'Trans proline' 0 CA--C 1.494 -1.477 0 C-N-CA 122.34 2.026 . . . . 0.23999999999999999 111.26 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.549 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.94 173.71 8.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.665 -0.698 . . . . 1.04 110.609 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.878 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.63 147.39 43.81 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.989 -0.375 . . . . 1.03 109.989 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.471 HG12 HD11 ' A' ' 65' ' ' ILE . 8.1 m -128.2 127.66 67.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.714 0.769 . . . . 1.26 111.933 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -84.15 153.68 29.54 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 109.9 -1.28 . . . . 0.20000000000000001 109.9 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -56.52 2.97 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.147 0.795 . . . . 3.48 113.147 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.545 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.1 tp -87.76 -22.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.479 0.657 . . . . 1.0700000000000001 110.503 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.497 HD23 HG21 ' A' ' 89' ' ' ILE . 3.7 mm? -87.49 -14.93 39.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.663 0.744 . . . . 1.02 109.314 -175.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.4 p -69.27 -17.47 63.75 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.72 -1.127 . . . . 1.05 111.278 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -67.6 -38.62 84.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.055 -0.975 . . . . 2.0299999999999998 112.313 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.445 HG23 HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -107.02 109.4 63.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 120.415 -0.514 . . . . 1.1499999999999999 111.171 -177.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.445 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 6.0 Cg_exo -73.79 -14.51 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.918 2.412 . . . . 1.04 113.381 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.445 HG23 HG23 ' A' ' 93' ' ' THR . 9.2 t -91.96 -42.92 9.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.308 -0.627 . . . . 1.1299999999999999 109.308 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.551 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 55.97 29.49 55.48 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.969 -1.469 . . . . 0.35999999999999999 114.134 168.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.41 111.03 19.08 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.842 0.83 . . . . 1.0800000000000001 109.396 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.66 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.0 m-85 -140.13 161.51 37.46 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.68 -1.6 . . . . 0.26000000000000001 111.914 -172.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.677 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 16.0 m-85 -129.89 137.74 50.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.935 0.398 . . . . 0.78000000000000003 110.719 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.571 HD13 ' HB ' ' A' ' 161' ' ' THR . 78.9 mt -60.52 121.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.476 -0.784 . . . . 1.02 110.971 172.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.55 HD11 ' C ' ' A' ' 22' ' ' PHE . 22.0 pt -88.23 -34.88 7.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 113.243 0.831 . . . . 1.03 113.243 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.472 ' ND2' HG13 ' A' ' 101' ' ' ILE . 9.8 p30 178.95 178.22 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.536 -1.283 . . . . 2.0299999999999998 107.536 -176.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.465 ' HG2' HD21 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -134.75 154.6 51.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.558 0.694 . . . . 2.02 112.536 -174.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.418 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 49.0 tt0 -127.05 100.82 6.28 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.782 -1.099 . . . . 0.83999999999999997 109.617 174.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.494 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 71.0 ttt180 -65.2 166.13 10.27 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.417 -0.811 . . . . 3.2799999999999998 110.341 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.453 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 19.7 m-80 -35.42 103.33 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 125.24 1.416 . . . . 0.34999999999999998 113.794 -155.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 8.4 Cg_endo . . . . . 0 N--CA 1.457 -0.628 0 C-N-CA 122.861 2.374 . . . . 0.63 111.458 172.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.529 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.566 1.568 0 N-CA-C 117.125 2.269 . . . . 1.1699999999999999 117.125 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.656 ' HE1' ' CE2' ' A' ' 114' ' ' TYR . 0.4 OUTLIER -165.31 157.38 15.21 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.328 -0.857 . . . . 0.60999999999999999 110.305 -176.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 16.9 t-105 -138.32 97.88 3.48 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.31 -0.996 . . . . 0.56999999999999995 108.31 167.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.536 HD13 ' CG2' ' A' ' 150' ' ' VAL . 2.6 mt -88.48 114.43 25.08 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.105 -0.702 . . . . 1.3600000000000001 109.105 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.404 ' C ' HG12 ' A' ' 101' ' ' ILE . 30.1 m -85.0 143.75 28.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.885 -0.598 . . . . 0.42999999999999999 111.29 -169.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.774 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.4 170.78 7.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 1.02 111.113 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.5 t -61.6 -13.14 19.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.264 -0.88 . . . . 1.79 112.7 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.673 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.5 tmtp? -127.11 134.01 50.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.288 -0.565 . . . . 1.8100000000000001 110.682 173.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.673 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 27.1 mt-30 -35.97 -56.91 0.71 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.559 -1.2 . . . . 1.76 114.166 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.545 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -97.59 12.38 33.73 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.458 -0.897 . . . . 3.2000000000000002 111.613 -172.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.774 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -97.63 37.28 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.01 0.744 . . . . 0.83999999999999997 113.01 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.495 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -115.56 143.26 18.03 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 117.112 -2.471 . . . . 0.96999999999999997 112.79 -152.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -94.38 115.22 32.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.818 0.818 . . . . 1.04 110.691 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.563 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 29.9 p80 -144.56 170.8 15.36 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.238 -0.892 . . . . 0.20999999999999999 109.579 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.45 -168.46 38.6 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 120.184 -1.008 . . . . 0.34999999999999998 112.073 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.8 t -155.89 173.75 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.216 -0.579 . . . . 1.1100000000000001 111.008 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -110.98 -6.16 14.72 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.619 -0.882 . . . . 2.1899999999999999 108.619 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.19 86.41 20.9 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 108.492 -0.929 . . . . 1.8400000000000001 108.492 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -74.23 -17.27 21.8 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.82 2.347 . . . . 0.39000000000000001 113.894 -168.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.456 ' O ' ' HE2' ' A' ' 136' ' ' LYS . . . -78.69 -6.01 54.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.085 -0.507 . . . . 1.0800000000000001 110.826 -177.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.9 t -88.71 -9.53 51.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.58 -0.896 . . . . 1.9399999999999999 108.58 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.473 HG23 ' HB2' ' A' ' 83' ' ' PRO . 39.7 mm -76.88 138.92 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.127 -0.942 . . . . 1.04 109.581 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.49 3.01 78.66 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.793 -0.923 . . . . 0.16 110.793 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 132' ' ' ALA . 25.2 mttm -113.89 172.33 7.05 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 123.039 1.4 . . . . 3.0299999999999998 113.755 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.07 126.33 50.2 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 111.895 -2.412 . . . . 1.01 108.006 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.42 160.23 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.025 -0.731 . . . . 1.3400000000000001 109.025 -173.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.5 m -47.71 -61.0 2.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.521 0.563 . . . . 0.87 112.521 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.415 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 46.7 pttt -132.65 -44.2 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.783 -1.167 . . . . 2.5499999999999998 113.623 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.08 132.51 0.2 Allowed Glycine 0 N--CA 1.466 0.665 0 N-CA-C 117.056 1.583 . . . . 0.19 117.056 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.563 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 4.0 p -71.09 165.42 23.56 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 112.164 -2.018 . . . . 0.20000000000000001 112.02 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.878 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 53.8 mt -59.64 98.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 122.518 1.152 . . . . 1.1299999999999999 112.114 -163.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.45 ' HB2' ' CD1' ' A' ' 134' ' ' ILE . 13.6 mtp180 -87.38 148.24 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.568 -1.651 . . . . 2.3300000000000001 110.217 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.549 ' HG2' HG21 ' A' ' 84' ' ' ILE . 13.4 mtp -127.99 -164.8 1.41 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.773 -0.825 . . . . 1.0900000000000001 108.773 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.699 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 2.8 t60 -94.79 158.74 15.36 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.896 -0.779 . . . . 2.9900000000000002 108.896 171.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.617 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.7 m120 -57.69 -53.26 60.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.397 -0.811 . . . . 0.73999999999999999 110.408 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -63.15 -27.06 69.11 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 121.244 1.838 . . . . 2.6899999999999999 112.427 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.699 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 4.6 m-20 -79.42 -44.48 21.31 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.147 0.499 . . . . 0.68999999999999995 110.814 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.545 HG12 HD13 ' A' ' 151' ' ' ILE . 14.3 p -67.31 -23.6 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.488 -0.778 . . . . 1.02 111.589 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.617 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.34 -42.0 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 119.01 -0.519 . . . . 1.1699999999999999 110.045 171.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 156' ' ' ILE . 25.3 mt-10 -47.52 -69.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.232 0.924 . . . . 1.99 112.365 170.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 157' ' ' VAL . 8.6 mp -46.31 -39.18 9.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.48 0.657 . . . . 1.9099999999999999 111.261 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.8 78.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.424 -1.262 . . . . 1.04 111.724 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.1 t -87.69 -30.62 20.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 118.702 0.683 . . . . 0.88 112.284 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.0 mt -83.98 -60.14 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.43 0.633 . . . . 1.0 112.154 -172.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.6 m -87.38 143.32 34.13 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.026 -0.988 . . . . 1.0700000000000001 112.129 178.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -89.74 172.9 3.77 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 124.128 3.219 . . . . 0.23999999999999999 111.111 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 68.8 m-20 -67.67 157.26 34.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 118.955 -1.098 . . . . 1.1000000000000001 109.037 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 54' ' ' PRO . . . 95.36 -16.28 61.58 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.183 -1.008 . . . . 0.17999999999999999 112.219 -172.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.571 ' HB ' HD13 ' A' ' 100' ' ' ILE . 98.5 m -63.98 139.71 58.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.12 0.486 . . . . 1.05 109.9 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.677 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -93.48 124.82 37.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.559 1.171 . . . . 4.1100000000000003 111.63 -170.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.56 107.21 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 112.168 -2.287 . . . . 1.02 109.104 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.455 HG23 ' ND2' ' A' ' 166' ' ' ASN . 8.6 m -95.33 107.16 19.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 112.837 0.68 . . . . 1.0700000000000001 112.837 -171.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.551 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -80.84 107.14 12.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 122.153 0.978 . . . . 1.05 109.898 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.455 ' ND2' HG23 ' A' ' 164' ' ' THR . 14.2 m-80 -110.27 128.06 55.32 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.278 -1.328 . . . . 1.0900000000000001 110.016 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.445 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 15.1 mmm-85 . . . . . 0 C--N 1.318 -0.777 0 CA-C-O 121.219 0.533 . . . . 2.4900000000000002 110.042 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.785 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 tp . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 121.102 0.477 . . . . 1.3300000000000001 111.07 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.626 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.9 tt -88.68 127.03 35.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.259 -0.882 . . . . 1.0700000000000001 110.728 -172.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.72 161.2 13.98 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.78 -1.1 . . . . 1.03 112.444 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.663 ' HD1' ' CD2' ' A' ' 7' ' ' TYR . 86.2 t80 -131.71 140.01 49.18 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.912 -1.495 . . . . 1.0800000000000001 107.939 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.41 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.3 tt0 -112.69 110.56 20.77 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.807 -1.183 . . . . 0.93000000000000005 107.807 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 44' ' ' GLN . 90.3 t -66.48 151.59 10.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 122.466 1.127 . . . . 1.1000000000000001 113.433 -167.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.558 ' HB3' ' HZ2' ' A' ' 10' ' ' LYS . 8.1 mtpm? -102.53 158.94 15.87 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 113.486 -1.688 . . . . 2.4399999999999999 108.997 173.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.525 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 2.2 tt0 -62.73 112.87 2.71 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.07 -0.514 . . . . 2.4300000000000002 112.087 -172.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.51 12.95 42.95 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.922 -0.656 . . . . 0.51000000000000001 113.768 173.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.656 ' CG ' HD12 ' A' ' 18' ' ' ILE . 2.4 t70 -50.4 168.26 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 112.524 0.564 . . . . 1.46 112.524 174.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.547 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -127.12 149.5 49.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.147 0.499 . . . . 1.1599999999999999 110.86 166.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -38.5 89.49 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.344 1.069 . . . . 1.47 108.405 -175.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.437 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 63.5 t30 -83.57 -19.25 35.92 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.324 -1.307 . . . . 1.78 110.98 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -68.38 -42.69 78.72 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.487 -0.485 . . . . 1.74 110.227 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.656 HD12 ' CG ' ' A' ' 13' ' ' ASP . 18.6 mt -72.81 -26.64 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.435 0.636 . . . . 1.04 109.887 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.573 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.68 -9.5 59.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.213 -0.449 . . . . 1.0600000000000001 110.792 175.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.609 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.18 -40.88 8.97 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.836 1.303 . . . . 0.97999999999999998 108.528 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.5 ' HB3' ' O ' ' A' ' 119' ' ' SER . 26.5 m-20 -61.94 -42.93 99.67 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.937 -2.392 . . . . 0.53000000000000003 111.979 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.565 ' C ' HD13 ' A' ' 101' ' ' ILE . 66.3 m-85 -100.22 4.79 44.52 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.639 -1.224 . . . . 0.20000000000000001 111.822 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.609 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.6 mpt_? 54.59 42.25 31.41 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.828 0.823 . . . . 2.46 109.681 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.573 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.4 pt -114.99 -164.6 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.513 -1.221 . . . . 1.04 109.129 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 22.0 t -110.76 157.35 19.87 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.357 1.075 . . . . 1.3400000000000001 110.154 168.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.586 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 62.5 p -80.11 -28.54 38.98 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 112.792 -2.004 . . . . 1.0900000000000001 107.243 176.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.44 77.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.421 -0.809 . . . . 1.0700000000000001 111.958 171.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -88.08 -29.22 20.8 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.88 -0.785 . . . . 1.04 108.88 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.586 HD21 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -71.9 -28.48 63.53 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.093 -0.958 . . . . 1.8100000000000001 109.279 174.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 26' ' ' THR . 35.7 mt -76.83 -29.95 56.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.685 0.755 . . . . 1.6399999999999999 110.611 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 27.8 tt0 -65.47 -39.89 92.5 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.621 -1.172 . . . . 2.3300000000000001 109.998 174.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.454 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -84.93 -19.87 31.54 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 120.26 -0.576 . . . . 1.0600000000000001 111.614 177.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.579 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 21.5 m-80 -148.76 82.46 7.28 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-O 121.457 0.646 . . . . 0.23000000000000001 110.586 -173.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 21.4 Cg_endo -58.88 -5.94 3.07 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 124.169 3.246 . . . . 0.52000000000000002 113.872 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -81.94 -23.35 36.2 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.173 -0.329 . . . . 1.6499999999999999 111.42 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.586 ' CD1' HD21 ' A' ' 29' ' ' LEU . 28.9 mt -70.34 -32.38 70.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.521 0.677 . . . . 1.25 112.149 -170.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -65.99 -48.7 70.36 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.681 1.229 . . . . 2.52 110.022 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.77 -46.31 87.79 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.043 -2.344 . . . . 1.1899999999999999 111.005 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.91 -178.69 47.61 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 114.79 -1.095 . . . . 0.44 111.153 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.11 156.94 24.3 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.244 0.545 . . . . 1.1699999999999999 111.181 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.532 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 37.1 m -139.94 128.94 23.53 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.159 -0.928 . . . . 1.1499999999999999 110.469 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.525 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -78.82 126.21 30.4 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.288 0.566 . . . . 1.1200000000000001 110.212 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.41 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 91.24 4.65 68.37 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.406 -1.078 . . . . 0.44 110.406 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.22 123.79 28.76 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.104 -0.548 . . . . 1.3 109.805 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 19.1 p -77.97 127.62 32.62 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.909 0.862 . . . . 1.3200000000000001 110.667 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.577 HG13 ' HB3' ' A' ' 7' ' ' TYR . 12.0 pt -129.21 143.28 41.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.247 -1.342 . . . . 1.0700000000000001 109.417 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.35 151.45 3.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.271 0.558 . . . . 1.3 111.074 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.49 HG22 ' CD2' ' A' ' 22' ' ' PHE . 38.9 mm -116.85 94.61 44.65 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.628 -1.169 . . . . 1.03 108.896 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.458 ' HA ' HD22 ' A' ' 4' ' ' LEU . 3.9 Cg_exo -61.5 136.03 60.78 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.599 2.199 . . . . 0.20000000000000001 112.539 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.4 -0.54 81.0 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.477 -0.783 . . . . 0.26000000000000001 112.317 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.785 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 25.2 tp -131.02 117.53 17.17 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 121.08 0.467 . . . . 1.27 111.241 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.626 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 32.1 Cg_endo -75.26 168.86 23.73 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.546 2.831 . . . . 0.31 113.543 -171.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.522 ' OD1' HG21 ' A' ' 56' ' ' THR . 11.5 t70 -73.8 129.44 85.09 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 114.252 -1.34 . . . . 0.48999999999999999 111.307 -175.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.641 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 66.4 Cg_endo -73.76 -15.52 24.01 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 123.752 2.968 . . . . 0.48999999999999999 112.711 -174.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -95.66 -3.65 45.77 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.389 -0.823 . . . . 1.8 109.574 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.522 HG21 ' OD1' ' A' ' 53' ' ' ASP . 8.6 p -93.56 -14.87 26.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.534 -1.284 . . . . 1.1299999999999999 107.534 171.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.445 HG23 ' H ' ' A' ' 59' ' ' TYR . 36.1 mt -84.72 130.14 54.21 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 113.311 -1.768 . . . . 1.24 110.915 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.71 -23.12 11.35 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.388 2.059 . . . . 0.47999999999999998 113.301 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' H ' HG23 ' A' ' 57' ' ' ILE . 66.4 m-85 -86.37 150.7 24.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.89 -0.324 . . . . 0.94999999999999996 111.322 -176.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -143.55 135.2 26.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.07 -0.715 . . . . 3.7400000000000002 109.07 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.6 mt -117.2 134.19 61.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 112.534 0.568 . . . . 1.05 112.534 -175.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.91 119.84 35.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.116 -0.634 . . . . 1.0800000000000001 111.357 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.494 HG23 HD13 ' A' ' 70' ' ' LEU . 90.8 t -102.89 115.43 44.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.858 0.837 . . . . 1.04 111.382 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 68' ' ' LYS . 20.5 m -94.67 100.28 12.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.44 -1.255 . . . . 0.83999999999999997 110.628 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.3 mm -50.04 -58.47 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 122.056 0.932 . . . . 1.0600000000000001 111.624 170.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.77 -9.82 2.93 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 112.896 -1.956 . . . . 0.16 113.477 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -126.08 -18.8 4.93 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.773 0.829 . . . . 1.02 112.173 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.583 ' HB2' ' HZ2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.33 56.99 4.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.396 0.544 . . . . 1.3 111.505 -173.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.0 p -138.15 159.77 41.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 113.011 0.745 . . . . 0.98999999999999999 113.011 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.672 HD23 ' SD ' ' A' ' 145' ' ' MET . 4.3 tp -126.3 117.53 23.22 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.782 -1.099 . . . . 1.1799999999999999 110.944 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 62.6 m -100.63 121.92 42.43 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.959 -0.696 . . . . 1.04 111.485 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.574 ' O ' ' HB2' ' A' ' 79' ' ' MET . 3.6 tp -101.74 106.72 17.77 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.243 -0.889 . . . . 1.3200000000000001 109.262 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 87.2 p -104.99 163.69 12.35 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.585 -0.846 . . . . 1.05 110.722 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.531 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.1 tm? -124.64 126.57 45.96 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.901 -0.778 . . . . 1.1000000000000001 108.901 168.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.531 ' N ' HD23 ' A' ' 74' ' ' LEU . 38.5 m-80 49.74 46.76 23.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.71 -1.132 . . . . 1.97 111.015 -171.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 71.75 -7.75 1.2 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.566 0.746 . . . . 2.5499999999999998 111.849 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -98.12 119.96 37.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.986 -0.552 . . . . 4.0199999999999996 110.0 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 50.5 t -56.62 131.53 20.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 122.287 1.041 . . . . 1.0600000000000001 113.314 -172.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.574 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 3.3 mmt -95.42 -46.78 6.55 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 112.989 -1.914 . . . . 1.47 107.941 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.3 mmtt -164.12 174.03 11.76 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.041 -1.89 . . . . 1.98 110.64 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 16.4 m -147.9 123.66 10.56 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.832 -1.531 . . . . 1.0 109.318 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -108.7 144.88 30.48 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.676 -0.693 . . . . 1.3999999999999999 109.204 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.465 ' HB2' HG23 ' A' ' 134' ' ' ILE . 38.5 Cg_endo -72.37 140.99 34.46 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 121.848 1.699 . . . . 0.23999999999999999 110.207 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.438 ' HB ' ' CG2' ' A' ' 143' ' ' ILE . 2.1 pp -139.44 171.42 14.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 120.442 -0.503 . . . . 1.04 111.291 -177.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.924 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -116.23 142.27 47.05 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.144 -0.48 . . . . 1.03 109.781 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.502 ' C ' HG21 ' A' ' 138' ' ' VAL . 12.9 m -126.08 113.96 36.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.675 0.75 . . . . 1.26 110.621 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -76.26 155.54 45.85 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 109.048 -1.621 . . . . 0.20000000000000001 109.048 175.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 139' ' ' SER . 64.9 mttp -54.74 4.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 114.135 1.161 . . . . 3.48 114.135 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.518 HG21 HD23 ' A' ' 90' ' ' LEU . 1.3 tp -89.66 -21.82 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 O-C-N 121.591 -0.693 . . . . 1.0700000000000001 110.479 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.518 HD23 HG21 ' A' ' 89' ' ' ILE . 3.8 mm? -86.64 -18.88 30.24 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.019 0.914 . . . . 1.02 108.633 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -69.37 -12.9 62.05 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.053 -1.431 . . . . 1.05 111.456 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.447 ' NE2' HD13 ' A' ' 89' ' ' ILE . 76.2 mt-30 -75.07 -36.59 61.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.579 -1.192 . . . . 2.0299999999999998 113.16 -177.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.74 132.5 26.0 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 119.779 -0.768 . . . . 1.1499999999999999 111.286 -175.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.515 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 96.9 Cg_endo -89.13 -6.14 5.56 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.858 2.372 . . . . 1.04 113.105 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.8 t -123.35 -42.46 2.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.057 0.456 . . . . 1.1299999999999999 110.48 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.462 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 53.48 34.0 48.33 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.622 -1.172 . . . . 0.35999999999999999 114.121 167.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.37 113.01 20.85 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.955 0.884 . . . . 1.0800000000000001 109.556 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.674 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 23.9 m-85 -137.38 -179.76 5.92 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.774 -1.557 . . . . 0.26000000000000001 111.526 -170.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 80.9 m-85 -143.49 141.11 30.63 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 116.364 -0.38 . . . . 0.78000000000000003 110.381 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.594 HD13 ' HB ' ' A' ' 161' ' ' THR . 75.6 mt -65.86 114.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 115.568 -0.742 . . . . 1.02 110.081 171.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.565 HD13 ' C ' ' A' ' 22' ' ' PHE . 16.6 pt -83.55 -44.13 18.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.627 0.603 . . . . 1.03 112.627 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.829 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 51.9 m-80 -169.32 172.98 6.88 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.382 -1.34 . . . . 2.0299999999999998 107.382 -170.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.611 HH21 ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -135.7 151.99 50.73 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.872 -0.731 . . . . 2.02 111.968 -178.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 49.7 tt0 -123.52 101.04 7.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.097 -0.956 . . . . 0.83999999999999997 109.719 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.505 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 67.4 ttt180 -64.55 165.74 9.59 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.907 0.861 . . . . 3.2799999999999998 110.656 176.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.505 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 20.7 m-80 -37.55 102.75 0.25 Allowed Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-N 113.048 -1.887 . . . . 0.34999999999999998 114.756 -147.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.0 Cg_endo . . . . . 0 C--N 1.348 0.552 0 C-N-CA 123.188 2.592 . . . . 0.63 111.641 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.509 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.507 0 N-CA-C 116.61 2.078 . . . . 1.1699999999999999 116.61 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -165.32 169.11 16.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.898 0.879 . . . . 0.60999999999999999 109.144 -178.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 11.6 t-105 -147.82 97.48 2.82 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.78 -1.193 . . . . 0.56999999999999995 107.78 165.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.522 HD13 ' CG2' ' A' ' 150' ' ' VAL . 2.1 mt -86.75 114.24 23.26 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.031 -0.729 . . . . 1.3600000000000001 109.031 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.471 ' O ' HG12 ' A' ' 101' ' ' ILE . 11.9 m -84.0 142.6 30.36 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.606 -0.725 . . . . 0.42999999999999999 110.724 -170.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.501 ' N ' HD21 ' A' ' 118' ' ' LEU . 1.9 mm? -108.08 163.12 13.43 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.891 -0.595 . . . . 1.02 111.856 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 12.3 t -58.89 -9.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.563 1.165 . . . . 1.79 112.632 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.674 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 18.7 tptt -125.29 128.89 48.95 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 119.92 -0.712 . . . . 1.8100000000000001 109.586 166.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.555 ' HA ' ' NH1' ' A' ' 23' ' ' ARG . 7.1 pt20 -52.9 -23.46 7.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.265 -1.334 . . . . 1.76 113.653 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.556 ' O ' ' HB3' ' A' ' 142' ' ' CYS . 41.4 m80 -96.85 -9.55 28.4 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.793 -0.763 . . . . 3.2000000000000002 112.63 -177.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.513 ' CG ' ' HB3' ' A' ' 120' ' ' LYS . 3.2 m-30 -91.1 -37.01 13.67 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.586 0.958 . . . . 0.83999999999999997 113.586 -169.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.435 ' HA2' HD21 ' A' ' 118' ' ' LEU . . . -4.14 128.95 0.01 OUTLIER Glycine 0 C--N 1.296 -1.655 0 N-CA-C 119.695 2.638 . . . . 0.96999999999999997 119.695 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -97.27 114.21 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 113.128 -1.536 . . . . 1.04 109.699 175.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.696 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 24.2 p80 -140.56 177.81 7.76 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 115.473 -0.785 . . . . 0.20999999999999999 109.937 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.73 -166.46 37.51 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.782 -0.723 . . . . 0.34999999999999998 111.578 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.3 t -158.91 175.78 13.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.907 0.853 . . . . 1.1100000000000001 110.61 177.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -115.16 -3.12 12.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.807 -0.812 . . . . 2.1899999999999999 108.807 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -118.14 87.87 30.47 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.254 -0.884 . . . . 1.8400000000000001 108.863 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -73.55 -17.52 23.45 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.298 1.999 . . . . 0.39000000000000001 113.405 -169.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.98 -1.03 42.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.867 -0.606 . . . . 1.0800000000000001 111.13 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.507 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 38.9 t -93.64 -4.38 50.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.819 -0.808 . . . . 1.9399999999999999 108.819 171.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.465 HG23 ' HB2' ' A' ' 83' ' ' PRO . 45.2 mm -82.76 137.06 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.496 -0.774 . . . . 1.04 110.497 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.73 5.36 68.81 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 109.953 -1.259 . . . . 0.16 109.953 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.507 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 90.4 mttt -113.24 168.08 10.02 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 123.173 1.463 . . . . 3.0299999999999998 114.1 -176.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -97.54 123.09 41.29 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 111.747 -2.478 . . . . 1.01 107.487 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.504 HG13 ' H ' ' A' ' 139' ' ' SER . 0.3 OUTLIER -100.59 -166.15 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.954 -0.387 . . . . 1.3400000000000001 109.954 -170.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.504 ' H ' HG13 ' A' ' 138' ' ' VAL . 67.6 m -84.98 -59.94 2.19 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 110.119 -0.326 . . . . 0.87 110.119 167.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 89' ' ' ILE . 10.9 ptmm? -133.51 -43.99 0.83 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.357 -0.937 . . . . 2.5499999999999998 112.572 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.34 134.09 0.18 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 117.047 1.579 . . . . 0.19 117.047 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.564 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 5.9 p -69.4 166.16 19.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 112.141 -2.029 . . . . 0.20000000000000001 112.174 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.924 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 49.2 mt -60.4 99.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.374 -1.284 . . . . 1.1299999999999999 111.77 -161.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.696 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 70.6 mtt180 -88.11 146.97 25.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.003 -1.453 . . . . 2.3300000000000001 110.28 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.672 ' SD ' HD23 ' A' ' 70' ' ' LEU . 1.8 mtm -130.79 -163.61 1.34 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.861 -0.792 . . . . 1.0900000000000001 108.861 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.549 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 87.6 m-70 -93.31 162.48 13.98 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.451 -0.5 . . . . 2.9900000000000002 109.828 170.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.686 ' O ' HD11 ' A' ' 151' ' ' ILE . 2.8 m120 -64.33 -47.42 79.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 118.784 -0.627 . . . . 0.73999999999999999 110.234 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -65.9 -25.36 67.12 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 120.884 1.675 . . . . 2.6899999999999999 112.688 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 71.0 m-20 -79.11 -46.82 17.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.192 0.52 . . . . 0.68999999999999995 110.914 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.555 HG12 HD13 ' A' ' 151' ' ' ILE . 14.8 p -66.24 -24.27 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.347 -0.842 . . . . 1.02 111.685 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.686 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.19 -40.82 17.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 118.941 -0.552 . . . . 1.1699999999999999 110.187 172.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.437 ' O ' HG13 ' A' ' 156' ' ' ILE . 14.0 mt-10 -47.73 -67.72 0.25 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.505 1.048 . . . . 1.99 112.54 170.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.551 HD12 ' CD2' ' A' ' 70' ' ' LEU . 95.8 mt -43.67 -40.52 4.21 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.748 0.785 . . . . 1.9099999999999999 111.417 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.43 -37.34 86.93 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.875 -1.511 . . . . 1.04 111.591 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.0 t -86.35 -30.64 22.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.76 0.709 . . . . 0.88 112.401 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.6 mt -82.66 -60.55 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.521 0.676 . . . . 1.0 111.633 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 153' ' ' LEU . 3.4 m -91.9 142.35 26.4 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.84 -1.073 . . . . 1.0700000000000001 112.558 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.611 ' HA ' HH21 ' A' ' 103' ' ' ARG . 62.6 Cg_endo -89.21 173.9 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.872 3.048 . . . . 0.23999999999999999 111.123 172.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.829 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -62.4 157.63 19.56 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.437 -0.949 . . . . 1.1000000000000001 108.437 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.641 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 99.65 -27.07 21.87 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.931 -1.128 . . . . 0.17999999999999999 112.73 -176.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.594 ' HB ' HD13 ' A' ' 100' ' ' ILE . 51.6 m -59.73 135.12 57.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.07 -0.715 . . . . 1.05 109.07 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.568 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 11.9 ptm180 -92.97 130.51 38.52 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.586 1.184 . . . . 4.1100000000000003 111.776 -168.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.7 t -108.96 107.12 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 112.323 -2.217 . . . . 1.02 108.918 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.483 HG23 ' ND2' ' A' ' 166' ' ' ASN . 25.5 m -94.25 106.73 18.7 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.152 -0.476 . . . . 1.0700000000000001 112.105 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.462 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -83.55 98.01 5.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 122.304 1.05 . . . . 1.05 109.957 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.483 ' ND2' HG23 ' A' ' 164' ' ' THR . 63.9 m-80 -102.47 130.73 49.36 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.044 -1.435 . . . . 1.0900000000000001 108.9 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.515 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 15.9 mmm180 . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 116.339 -0.391 . . . . 2.4900000000000002 109.96 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.517 -0.294 0 CA-C-O 121.681 0.753 . . . . 1.3300000000000001 112.432 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.66 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.1 tt -98.51 129.29 45.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.628 -1.169 . . . . 1.0700000000000001 110.61 -175.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.31 162.24 13.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.056 0.931 . . . . 1.03 112.974 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.645 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 82.1 t80 -130.17 140.99 50.7 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.023 -1.444 . . . . 1.0800000000000001 108.133 176.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.43 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 56.4 tt0 -113.32 113.4 25.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.107 -1.071 . . . . 0.93000000000000005 108.107 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' A' ' 41' ' ' THR . 94.7 t -68.39 150.36 10.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 122.651 1.215 . . . . 1.1000000000000001 113.463 -168.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -101.48 159.15 15.53 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.198 -1.819 . . . . 2.4399999999999999 108.623 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -63.8 103.02 0.52 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.944 0.402 . . . . 2.4300000000000002 111.883 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.59 11.0 31.96 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.782 -0.723 . . . . 0.51000000000000001 113.152 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.556 ' HB2' HG11 ' A' ' 9' ' ' VAL . 86.9 m-20 -52.74 166.8 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.851 0.357 . . . . 1.46 111.136 171.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.51 149.76 49.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.0 0.428 . . . . 1.1599999999999999 111.028 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.431 HD22 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.66 -39.75 91.7 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.448 -0.945 . . . . 1.47 108.448 -177.217 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.457 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 16.9 t-20 -82.35 -26.4 32.99 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.451 -1.249 . . . . 1.78 110.256 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -65.19 -41.98 94.02 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.217 -0.66 . . . . 1.74 109.217 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 22' ' ' PHE . 15.6 mt -74.18 -26.62 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.238 0.542 . . . . 1.04 109.65 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.83 -10.05 59.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.319 -0.401 . . . . 1.0600000000000001 110.831 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.646 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.75 -40.22 9.07 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 122.52 1.152 . . . . 0.97999999999999998 108.045 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 119' ' ' SER . 7.2 m-20 -63.01 -45.76 90.83 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 112.265 -2.243 . . . . 0.53000000000000003 112.082 173.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.547 ' C ' HD11 ' A' ' 101' ' ' ILE . 60.7 m-85 -96.09 5.29 51.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 118.596 -1.242 . . . . 0.20000000000000001 111.36 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.646 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.4 mpt_? 54.52 42.51 31.28 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.793 0.806 . . . . 2.46 109.92 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.587 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.5 pt -117.14 -165.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.678 -1.147 . . . . 1.04 109.887 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.49 143.47 40.78 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.117 -0.947 . . . . 1.3400000000000001 110.279 175.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.457 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 37.0 p -73.32 -31.14 63.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.824 -1.176 . . . . 1.0900000000000001 107.824 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.81 -33.01 71.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.336 -0.847 . . . . 1.0700000000000001 111.815 169.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -90.26 -27.92 19.15 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.795 0.807 . . . . 1.04 108.886 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.541 HD23 HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -72.93 -30.63 64.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.757 -1.11 . . . . 1.8100000000000001 109.168 174.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 36' ' ' LEU . 46.0 mt -76.71 -29.24 56.16 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.579 0.704 . . . . 1.6399999999999999 110.624 171.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.486 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 20.0 tt0 -63.78 -39.98 95.57 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.72 -1.127 . . . . 2.3300000000000001 109.787 172.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.478 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -84.48 -19.76 32.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 120.248 -0.581 . . . . 1.0600000000000001 111.693 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.602 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.2 m-80 -150.55 82.59 6.15 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 110.482 -172.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.6 Cg_endo -56.2 -16.52 17.48 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 123.807 3.005 . . . . 0.52000000000000002 113.609 176.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 m -71.37 -22.21 61.92 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.162 0.43 . . . . 1.6499999999999999 112.162 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.602 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 28.9 mt -69.59 -35.48 75.37 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 112.563 0.579 . . . . 1.25 112.563 -170.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -64.69 -46.62 81.6 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 122.818 1.294 . . . . 2.52 110.304 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.21 -48.97 77.45 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 111.845 -2.434 . . . . 1.1899999999999999 110.622 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.28 176.96 48.16 Favored Glycine 0 N--CA 1.428 -1.886 0 CA-C-N 114.595 -1.184 . . . . 0.44 111.341 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.47 157.49 19.53 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.452 0.644 . . . . 1.1699999999999999 110.91 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 49.0 m -138.33 128.11 25.2 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.134 -0.939 . . . . 1.1499999999999999 110.512 -176.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.12 118.8 19.23 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.546 0.689 . . . . 1.1200000000000001 109.992 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.43 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.61 0.33 55.43 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 110.2 -1.16 . . . . 0.44 110.2 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -75.74 124.06 26.63 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.835 -0.682 . . . . 1.3 109.797 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.649 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 51.4 p -83.84 128.68 34.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.577 -0.738 . . . . 1.3200000000000001 110.425 177.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.592 HG13 ' HB3' ' A' ' 7' ' ' TYR . 10.8 pt -129.42 142.8 43.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.432 -1.258 . . . . 1.0700000000000001 109.459 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.11 150.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.465 0.65 . . . . 1.3 111.268 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.401 HG22 ' CD2' ' A' ' 22' ' ' PHE . 38.4 mm -115.77 94.6 41.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.285 -1.325 . . . . 1.03 108.669 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.52 ' HA ' HD23 ' A' ' 4' ' ' LEU . 5.9 Cg_exo -60.91 137.06 69.84 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.646 2.231 . . . . 0.20000000000000001 112.76 -172.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.23 83.82 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.895 -1.048 . . . . 0.26000000000000001 112.432 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.648 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 37.5 tp -120.36 116.97 31.97 Favored Pre-proline 0 N--CA 1.449 -0.502 0 O-C-N 122.415 -0.462 . . . . 1.27 111.295 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.66 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 43.2 Cg_endo -77.18 -177.25 3.69 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.891 3.061 . . . . 0.31 114.205 -172.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.464 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 9.1 t70 -86.31 127.84 59.71 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.266 -1.334 . . . . 0.48999999999999999 111.836 -169.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.543 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.8 Cg_endo -75.8 -10.03 19.83 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.29 2.66 . . . . 0.48999999999999999 112.891 -176.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.406 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 20.3 m-30 -92.55 -15.86 26.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.831 -0.622 . . . . 1.8 110.271 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.464 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 27.1 p -84.62 -26.33 27.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.586 1.184 . . . . 1.1299999999999999 108.286 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.503 HG23 ' H ' ' A' ' 59' ' ' TYR . 27.0 mt -68.02 129.27 93.18 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 112.966 -1.924 . . . . 1.24 111.155 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.415 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 86.7 Cg_endo -78.76 -14.34 14.04 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.474 2.116 . . . . 0.47999999999999998 113.492 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.503 ' H ' HG23 ' A' ' 57' ' ' ILE . 45.1 m-85 -99.16 162.95 12.77 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.549 -0.46 . . . . 0.94999999999999996 111.622 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -151.37 139.49 20.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.026 -0.731 . . . . 3.7400000000000002 109.026 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 71' ' ' THR . 88.4 mt -120.81 136.74 56.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.276 0.473 . . . . 1.05 112.276 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.56 24.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.946 -0.702 . . . . 1.0800000000000001 110.902 171.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 69' ' ' THR . 90.6 t -91.19 108.87 20.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.566 0.698 . . . . 1.04 110.78 173.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 68' ' ' LYS . 75.3 m -85.43 107.32 17.34 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.088 -0.96 . . . . 0.83999999999999997 110.563 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.8 mm -53.98 -58.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 122.17 0.986 . . . . 1.0600000000000001 111.164 166.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.65 -13.55 8.1 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 112.926 -1.943 . . . . 0.16 113.337 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -126.02 -17.01 5.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.523 0.729 . . . . 1.02 112.267 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.494 ' HB2' ' HZ2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 57.5 56.87 4.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.287 0.494 . . . . 1.3 111.376 -173.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 44.8 p -138.79 167.22 22.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 113.037 0.755 . . . . 0.98999999999999999 113.037 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.7 tt -133.94 111.14 10.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.617 -1.174 . . . . 1.1799999999999999 109.855 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 63.8 m -92.95 122.43 35.31 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.177 0.513 . . . . 1.04 111.15 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.7 tp -98.77 107.53 19.99 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.042 -0.981 . . . . 1.3200000000000001 109.309 173.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 75.2 p -109.14 158.8 17.44 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.989 -1.084 . . . . 1.05 110.998 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.762 ' HB2' ' SD ' ' A' ' 79' ' ' MET . 1.2 tm? -128.21 126.4 40.89 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.092 -0.707 . . . . 1.1000000000000001 109.092 171.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.614 ' ND2' HD11 ' A' ' 74' ' ' LEU . 9.0 p30 43.76 52.99 6.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 113.952 -1.476 . . . . 1.97 112.146 -167.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 53.9 t30 75.46 -10.35 1.26 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.527 -0.76 . . . . 2.5499999999999998 111.623 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -100.58 120.7 40.42 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.141 0.496 . . . . 4.0199999999999996 110.126 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 45.4 t -55.82 132.72 19.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.249 1.024 . . . . 1.0600000000000001 112.32 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.762 ' SD ' ' HB2' ' A' ' 74' ' ' LEU . 97.4 mtp -97.06 -48.24 5.47 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 113.364 -1.744 . . . . 1.47 108.405 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -158.67 171.97 19.13 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.498 -2.137 . . . . 1.98 109.902 -174.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.0 m -148.63 122.2 9.17 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.064 -1.425 . . . . 1.0 109.656 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 1.594 ' HD1' ' CD2' ' A' ' 82' ' ' TYR . 24.6 m-85 -105.21 156.5 36.09 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 115.214 -0.903 . . . . 1.3999999999999999 109.729 -174.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 145' ' ' MET . 59.1 Cg_endo -84.93 142.98 9.15 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.046 1.831 . . . . 0.23999999999999999 111.439 169.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.537 HG23 ' CG ' ' A' ' 145' ' ' MET . 2.2 pp -138.14 174.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.701 -0.681 . . . . 1.04 110.863 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.905 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.8 140.72 49.5 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.304 -0.407 . . . . 1.03 109.972 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.485 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 7.7 m -125.74 125.37 68.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.547 0.689 . . . . 1.26 111.829 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.568 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -82.76 157.58 36.0 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 114.899 -1.046 . . . . 0.20000000000000001 110.631 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 139' ' ' SER . 74.7 mmtt -55.48 3.21 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.894 0.701 . . . . 3.48 112.894 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.541 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.1 tp -92.55 -20.19 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.522 0.677 . . . . 1.0700000000000001 110.28 -177.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.6 mm? -89.22 -18.16 27.63 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.707 0.765 . . . . 1.02 108.969 -176.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.1 p -66.61 -19.21 65.72 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.53 -1.214 . . . . 1.05 111.73 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -59.1 -42.01 89.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.885 -1.052 . . . . 2.0299999999999998 112.372 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.94 133.54 20.23 Favored Pre-proline 0 C--N 1.324 -0.525 0 C-N-CA 120.449 -0.5 . . . . 1.1499999999999999 111.497 -172.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 97.2 Cg_endo -90.59 -15.27 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.665 2.243 . . . . 1.04 112.755 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.9 t -102.43 -43.54 5.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.23 0.538 . . . . 1.1299999999999999 109.828 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.511 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 52.92 35.17 47.33 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.286 -1.325 . . . . 0.35999999999999999 113.622 167.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -82.91 111.93 19.24 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 122.039 0.923 . . . . 1.0800000000000001 109.478 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 26.1 m-85 -138.54 177.54 7.81 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.496 -1.684 . . . . 0.26000000000000001 111.42 -173.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.432 ' CG ' HD12 ' A' ' 5' ' ' LEU . 28.5 m-85 -141.99 138.0 31.58 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.316 -0.402 . . . . 0.78000000000000003 110.49 -174.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.563 HD13 ' HB ' ' A' ' 161' ' ' THR . 80.3 mt -61.92 121.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.577 -0.738 . . . . 1.02 110.284 170.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.547 HD11 ' C ' ' A' ' 22' ' ' PHE . 20.0 pt -88.63 -44.18 15.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 113.219 0.822 . . . . 1.03 113.219 -175.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.554 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 51.7 m-80 -170.95 170.35 6.34 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.044 -1.465 . . . . 2.0299999999999998 107.044 -168.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.735 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 26.5 mtt180 -126.15 159.06 33.93 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.713 -0.795 . . . . 2.02 111.929 -173.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 60.7 tt0 -133.31 99.97 4.7 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.554 -0.748 . . . . 0.83999999999999997 110.058 169.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.493 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 34.1 ttt85 -66.07 166.06 12.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.647 -0.706 . . . . 3.2799999999999998 110.146 173.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.45 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 17.0 m-80 -35.26 101.92 0.22 Allowed Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 125.093 1.357 . . . . 0.34999999999999998 113.255 -156.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.1 Cg_endo . . . . . 0 C--N 1.345 0.384 0 C-N-CA 123.205 2.603 . . . . 0.63 111.688 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.535 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.565 1.528 0 N-CA-C 117.398 2.37 . . . . 1.1699999999999999 117.398 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.655 ' HE1' ' CE2' ' A' ' 114' ' ' TYR . 0.6 OUTLIER -166.17 149.38 7.36 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.412 -0.805 . . . . 0.60999999999999999 110.087 -176.162 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 9.9 t-105 -130.18 98.95 4.88 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.959 -1.126 . . . . 0.56999999999999995 107.959 167.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' A' ' 103' ' ' ARG . 5.4 mt -91.51 114.46 26.99 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.08 -0.711 . . . . 1.3600000000000001 109.08 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.9 m -84.08 144.68 28.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.533 -0.758 . . . . 0.42999999999999999 111.341 -168.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.759 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.5 mm? -108.91 170.1 8.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.094 -0.503 . . . . 1.02 111.407 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.2 t -62.0 -12.14 17.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.918 -1.037 . . . . 1.79 112.779 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.604 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 5.5 tptp -126.73 132.59 51.08 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.58 -0.448 . . . . 1.8100000000000001 110.42 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.501 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 76.7 mt-30 -31.89 -60.86 0.25 Allowed 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.554 1.159 . . . . 1.76 113.94 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.541 ' HB3' HG12 ' A' ' 89' ' ' ILE . 1.7 t-160 -94.01 5.4 51.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.954 -0.698 . . . . 3.2000000000000002 111.597 -169.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.759 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -93.9 38.43 1.07 Allowed 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 113.88 1.067 . . . . 0.83999999999999997 113.88 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.92 143.57 18.12 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 116.9 -2.571 . . . . 0.96999999999999997 112.67 -154.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 2.1 mp -96.52 114.04 32.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.808 0.814 . . . . 1.04 110.596 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.753 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.8 p80 -140.17 171.73 13.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.082 -0.963 . . . . 0.20999999999999999 109.01 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.25 -170.31 39.49 Favored Glycine 0 C--N 1.315 -0.583 0 C-N-CA 119.891 -1.147 . . . . 0.34999999999999998 111.613 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.7 t -153.23 168.74 24.96 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.35 -0.5 . . . . 1.1100000000000001 110.332 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -112.05 2.94 17.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.18 -1.044 . . . . 2.1899999999999999 108.18 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.9 84.67 26.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.384 -1.28 . . . . 1.8400000000000001 107.935 169.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.79 -22.32 11.9 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.679 2.253 . . . . 0.39000000000000001 114.495 -167.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.29 -10.19 59.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.923 -0.581 . . . . 1.0800000000000001 110.749 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.571 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 45.5 m -91.5 1.28 57.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 1.9399999999999999 110.375 176.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 83' ' ' PRO . 47.5 mm -79.56 141.41 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.089 -0.505 . . . . 1.04 110.152 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.7 6.4 63.9 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.463 -1.055 . . . . 0.16 110.463 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.571 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 59.2 mttm -114.85 176.75 4.92 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 123.603 1.668 . . . . 3.0299999999999998 114.078 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.77 125.46 51.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 110.813 -2.903 . . . . 1.01 108.406 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.568 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -121.51 162.67 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.798 -1.186 . . . . 1.3400000000000001 107.798 -176.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.419 ' HA ' ' HG2' ' A' ' 88' ' ' LYS . 43.5 m -61.22 -50.95 71.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 118.845 0.748 . . . . 0.87 112.691 -178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -130.57 -45.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 117.889 -1.524 . . . . 2.5499999999999998 114.112 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.29 132.78 0.21 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 117.071 1.588 . . . . 0.19 117.071 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.505 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 3.4 p -72.28 165.41 24.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 112.544 -1.828 . . . . 0.20000000000000001 112.028 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.905 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 56.9 mt -60.41 98.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.535 -1.211 . . . . 1.1299999999999999 112.276 -162.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.753 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 64.2 mtt180 -87.32 150.85 23.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.006 -1.452 . . . . 2.3300000000000001 110.92 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -133.67 -163.65 1.39 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.081 -0.509 . . . . 1.0900000000000001 109.994 174.293 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.518 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 26.2 m80 -91.39 162.07 14.74 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.167 -0.613 . . . . 2.9900000000000002 109.937 172.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.704 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.4 m120 -61.71 -54.81 37.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 118.63 -0.7 . . . . 0.73999999999999999 110.125 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -63.56 -24.79 67.95 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 121.119 1.782 . . . . 2.6899999999999999 112.071 -174.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 45.2 m-20 -87.12 -45.36 10.77 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.547 -0.751 . . . . 0.68999999999999995 111.281 -173.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.538 HG12 HD13 ' A' ' 151' ' ' ILE . 11.1 p -59.44 -25.13 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 111.781 0.289 . . . . 1.02 111.781 170.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.704 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -80.26 -40.27 19.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 118.95 -0.548 . . . . 1.1699999999999999 109.876 171.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.2 mm-40 -44.66 -72.64 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.237 0.926 . . . . 1.99 112.094 168.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.442 ' O ' HG23 ' A' ' 157' ' ' VAL . 44.2 mt -46.61 -39.67 11.58 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.649 0.738 . . . . 1.9099999999999999 111.514 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.3 80.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.098 -1.41 . . . . 1.04 111.466 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 25.5 t -86.29 -34.05 20.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.791 -0.568 . . . . 0.88 112.219 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 152' ' ' GLU . 30.3 mt -79.84 -60.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.61 0.719 . . . . 1.0 111.37 -171.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -91.95 141.64 25.59 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.882 -1.054 . . . . 1.0700000000000001 112.4 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.735 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 53.2 Cg_endo -89.06 175.71 3.4 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 124.143 3.229 . . . . 0.23999999999999999 111.062 173.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 75.7 m-20 -66.46 159.49 27.02 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 119.274 -0.971 . . . . 1.1000000000000001 109.107 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.16 -19.87 52.61 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.231 -0.985 . . . . 0.17999999999999999 112.3 -174.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.563 ' HB ' HD13 ' A' ' 100' ' ' ILE . 67.7 m -64.15 137.85 58.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.419 -0.586 . . . . 1.05 109.419 -175.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -92.97 123.49 36.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.715 1.245 . . . . 4.1100000000000003 111.246 -169.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.82 111.39 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 112.221 -2.263 . . . . 1.02 109.613 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 63' ' ' VAL . 13.6 m -93.34 108.66 20.28 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.051 -0.522 . . . . 1.0700000000000001 112.188 -174.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.511 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -79.95 100.23 4.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 123.201 1.477 . . . . 1.05 108.362 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -113.47 123.92 51.17 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 112.287 -2.233 . . . . 1.0900000000000001 109.22 -164.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.514 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 9.1 mmm180 . . . . . 0 C--N 1.321 -0.652 0 C-N-CA 120.811 -0.356 . . . . 2.4900000000000002 111.379 -177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 121.179 0.514 . . . . 1.3300000000000001 110.821 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 2.9 tt -95.33 127.69 41.58 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.341 -0.845 . . . . 1.0700000000000001 110.33 -176.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.14 162.33 13.41 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.202 1.001 . . . . 1.03 113.473 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.645 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 84.0 t80 -130.67 141.1 50.4 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.441 -1.709 . . . . 1.0800000000000001 107.932 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -114.03 114.21 25.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.02 -1.104 . . . . 0.93000000000000005 108.02 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.601 HG11 ' HB2' ' A' ' 13' ' ' ASP . 95.7 t -68.35 150.47 10.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 122.338 1.066 . . . . 1.1000000000000001 113.194 -169.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -103.38 157.85 16.74 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.505 -1.68 . . . . 2.4399999999999999 108.042 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.425 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 2.3 mm-40 -58.64 110.17 0.94 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.104 0.478 . . . . 2.4300000000000002 111.548 -176.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.22 11.71 51.32 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.548 -0.751 . . . . 0.51000000000000001 114.004 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.601 ' HB2' HG11 ' A' ' 9' ' ' VAL . 30.7 m-20 -54.0 170.5 0.13 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 117.392 0.596 . . . . 1.46 111.222 171.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.6 154.58 47.7 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.449 -0.5 . . . . 1.1599999999999999 111.424 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.466 HD23 ' HB ' ' A' ' 26' ' ' THR . 4.6 tp -67.35 -38.04 84.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.853 0.835 . . . . 1.47 110.031 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.412 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 6.3 t30 -86.96 -23.22 25.17 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.434 -1.257 . . . . 1.78 110.13 -174.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -69.7 -37.64 76.65 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.802 -0.444 . . . . 1.74 109.802 172.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.404 HG21 ' CE1' ' A' ' 22' ' ' PHE . 15.0 mt -76.68 -28.71 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.188 0.518 . . . . 1.04 109.997 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.599 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.81 -9.51 59.08 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.122 -0.361 . . . . 1.0600000000000001 110.538 175.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.694 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -95.92 -40.54 9.25 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.279 1.038 . . . . 0.97999999999999998 108.449 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.439 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 1.4 m-20 -61.29 -44.11 97.76 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.849 -1.978 . . . . 0.53000000000000003 112.0 174.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.549 ' C ' HD11 ' A' ' 101' ' ' ILE . 59.0 m-85 -98.7 6.16 47.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.706 -1.198 . . . . 0.20000000000000001 111.436 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.694 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.21 43.81 30.04 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.916 0.865 . . . . 2.46 109.328 177.481 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.599 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 30.9 pt -116.96 -164.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.385 -1.279 . . . . 1.04 110.23 -178.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 144.28 38.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.997 -1.001 . . . . 1.3400000000000001 110.523 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.514 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 75.8 p -73.98 -32.23 63.34 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.619 -0.882 . . . . 1.0900000000000001 108.619 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.38 -27.66 67.6 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.26 -0.882 . . . . 1.0700000000000001 111.629 169.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.98 -28.52 17.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.289 -0.564 . . . . 1.04 109.538 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.473 ' HG ' ' CD1' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -72.36 -30.55 64.81 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.781 -0.645 . . . . 1.8100000000000001 109.432 173.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.527 HD22 ' HB2' ' A' ' 36' ' ' LEU . 41.4 mt -75.16 -30.14 60.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.872 0.844 . . . . 1.6399999999999999 109.721 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.471 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 47.2 tt0 -65.61 -39.83 91.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.112 -1.403 . . . . 2.3300000000000001 110.527 173.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -84.48 -20.45 31.68 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 120.06 -0.656 . . . . 1.0600000000000001 111.563 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.597 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 20.8 m-80 -148.94 82.66 7.07 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-O 121.206 0.527 . . . . 0.23000000000000001 110.625 -172.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.57 -12.4 8.47 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 123.971 3.114 . . . . 0.52000000000000002 113.667 175.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 m -72.53 -26.43 61.75 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.996 0.427 . . . . 1.6499999999999999 111.661 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.597 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 36.4 mt -70.71 -33.69 71.13 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.89 -0.595 . . . . 1.25 112.564 -167.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.45 ' NE2' ' HB1' ' A' ' 38' ' ' ALA . 1.8 pp0? -63.46 -44.4 94.56 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 122.979 1.371 . . . . 2.52 110.582 -174.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.45 ' HB1' ' NE2' ' A' ' 37' ' ' GLN . . . -65.68 -45.68 81.96 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 111.818 -2.446 . . . . 1.1899999999999999 110.985 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.66 179.0 48.84 Favored Glycine 0 N--CA 1.428 -1.898 0 CA-C-N 114.835 -1.075 . . . . 0.44 111.173 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.445 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -112.35 156.99 21.55 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.151 0.5 . . . . 1.1699999999999999 110.978 177.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.53 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 31.7 m -134.89 127.58 30.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.076 -0.965 . . . . 1.1499999999999999 110.243 -177.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 11' ' ' GLN . . . -75.99 122.83 24.78 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.261 0.553 . . . . 1.1200000000000001 110.114 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.76 1.17 61.93 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.543 -1.023 . . . . 0.44 110.543 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -79.96 123.85 28.17 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.271 -0.464 . . . . 1.3 110.177 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 31.0 p -76.8 126.67 31.38 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 122.175 0.988 . . . . 1.3200000000000001 110.349 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.575 HG13 ' HB3' ' A' ' 7' ' ' TYR . 8.8 pt -125.85 141.26 46.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 113.875 -1.511 . . . . 1.0700000000000001 108.878 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.85 151.18 3.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.357 0.598 . . . . 1.3 111.167 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.6 mm -115.36 93.4 35.93 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.385 -1.279 . . . . 1.03 108.794 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HA ' HD23 ' A' ' 4' ' ' LEU . 5.6 Cg_exo -61.64 136.26 61.6 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.719 2.279 . . . . 0.20000000000000001 112.726 -172.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.15 -6.0 82.77 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 114.725 -1.125 . . . . 0.26000000000000001 112.435 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.683 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 29.8 tp -122.94 116.24 28.95 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-O 121.192 0.52 . . . . 1.27 110.948 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.613 ' HD2' HD11 ' A' ' 51' ' ' LEU . 52.3 Cg_endo -78.19 -177.14 3.66 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.491 2.794 . . . . 0.31 114.119 -171.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.48 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 12.0 t70 -79.3 133.59 60.13 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 114.202 -1.363 . . . . 0.48999999999999999 112.454 -170.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.35 -16.01 24.89 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.577 2.851 . . . . 0.48999999999999999 113.115 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -96.66 1.74 51.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.159 0.504 . . . . 1.8 111.701 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.48 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 26.8 p -95.74 -16.04 22.22 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.395 -0.965 . . . . 1.1299999999999999 108.395 172.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.566 HG23 ' H ' ' A' ' 59' ' ' TYR . 9.1 mm -64.62 129.24 94.19 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 113.422 -1.717 . . . . 1.24 110.08 176.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.416 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 60.4 Cg_endo -78.65 -17.71 12.41 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.057 1.838 . . . . 0.47999999999999998 113.037 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.566 ' H ' HG23 ' A' ' 57' ' ' ILE . 60.4 m-85 -104.13 172.99 6.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.066 0.46 . . . . 0.94999999999999996 111.67 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -155.53 138.24 15.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.595 -0.729 . . . . 3.7400000000000002 109.397 173.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 71' ' ' THR . 82.9 mt -113.55 131.97 63.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.108 -0.496 . . . . 1.05 111.789 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.44 118.27 32.72 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.169 -0.612 . . . . 1.0800000000000001 111.13 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 59.0 t -98.1 120.91 48.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.538 0.685 . . . . 1.04 110.888 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 68' ' ' LYS . 45.2 m -98.31 104.34 16.36 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.909 -1.041 . . . . 0.83999999999999997 110.989 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.525 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 35.2 mm -50.89 -58.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 122.053 0.93 . . . . 1.0600000000000001 111.263 166.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.21 -11.18 3.17 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 112.774 -2.012 . . . . 0.16 113.462 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -127.5 -21.52 3.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.982 0.734 . . . . 1.02 112.982 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 60.24 57.2 3.0 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.989 0.813 . . . . 1.3 111.249 -170.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -137.64 161.94 35.13 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.951 0.723 . . . . 0.98999999999999999 112.951 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.466 ' C ' HD21 ' A' ' 70' ' ' LEU . 7.8 tt -130.46 113.58 14.47 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.54 -1.209 . . . . 1.1799999999999999 109.702 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 52.7 m -95.12 123.88 38.86 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.157 0.504 . . . . 1.04 111.317 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' MET . 11.6 tp -99.16 107.91 20.38 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.12 -0.946 . . . . 1.3200000000000001 109.197 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 90.0 p -107.73 160.72 15.5 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.233 -0.987 . . . . 1.05 110.804 177.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -126.46 124.75 40.82 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.707 0.765 . . . . 1.1000000000000001 109.221 170.254 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.588 ' N ' HD23 ' A' ' 74' ' ' LEU . 9.3 p30 37.83 59.21 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.531 -1.668 . . . . 1.97 111.899 -164.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 75.49 -13.73 0.84 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.883 -1.053 . . . . 2.5499999999999998 112.156 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -96.0 121.59 37.91 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.699 -0.482 . . . . 4.0199999999999996 109.699 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 46.5 t -58.49 129.82 21.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 122.318 1.056 . . . . 1.0600000000000001 112.517 -176.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 48.4 mmm -93.9 -49.92 5.58 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.161 -1.836 . . . . 1.47 107.881 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -159.73 172.06 18.4 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.779 -2.01 . . . . 1.98 109.634 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.4 m -149.34 125.09 10.48 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.418 -1.265 . . . . 1.0 109.592 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -116.31 150.42 45.32 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.555 -0.748 . . . . 1.3999999999999999 110.077 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HB2' HG23 ' A' ' 134' ' ' ILE . 53.9 Cg_endo -75.5 145.57 29.92 Favored 'Trans proline' 0 CA--C 1.494 -1.492 0 C-N-CA 122.188 1.926 . . . . 0.23999999999999999 110.957 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.532 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -141.22 173.25 9.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.689 -0.687 . . . . 1.04 110.782 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.894 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.65 142.99 46.59 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.438 -0.346 . . . . 1.03 110.176 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.465 HG21 ' HG3' ' A' ' 68' ' ' LYS . 13.0 m -126.28 128.27 71.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.417 0.627 . . . . 1.26 111.622 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -92.01 160.14 25.96 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.067 -0.97 . . . . 0.20000000000000001 110.714 173.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -55.62 2.88 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 113.539 0.94 . . . . 3.48 113.539 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.3 tp -91.15 -18.89 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 O-C-N 121.051 -1.031 . . . . 1.0700000000000001 109.793 -177.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.3 mm? -91.63 -22.31 20.35 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.898 0.856 . . . . 1.02 108.693 -177.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.2 p -67.29 -11.76 58.38 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.263 -1.335 . . . . 1.05 111.404 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -71.14 -42.11 69.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.61 -1.177 . . . . 2.0299999999999998 112.287 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -96.74 125.78 45.46 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.274 -0.571 . . . . 1.1499999999999999 110.659 -176.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.9 Cg_endo -75.19 -15.24 20.45 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.771 2.314 . . . . 1.04 112.837 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.9 t -115.65 -41.62 3.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.649 -0.25 . . . . 1.1299999999999999 110.381 -177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.463 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 47.43 42.72 19.33 Favored Glycine 0 C--O 1.225 -0.447 0 O-C-N 124.045 0.841 . . . . 0.35999999999999999 113.778 169.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.57 113.54 21.32 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.793 0.806 . . . . 1.0800000000000001 109.237 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.717 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 25.6 m-85 -136.53 178.32 7.16 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.137 -1.392 . . . . 0.26000000000000001 112.275 -171.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 1.641 ' HD2' ' CD1' ' A' ' 99' ' ' TYR . 32.5 m-85 -144.28 139.12 28.41 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.197 -0.456 . . . . 0.78000000000000003 110.703 -171.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.588 HD13 ' HB ' ' A' ' 161' ' ' THR . 75.6 mt -65.68 116.02 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 115.424 -0.807 . . . . 1.02 110.674 171.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.549 HD11 ' C ' ' A' ' 22' ' ' PHE . 20.6 pt -84.16 -44.09 17.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 112.901 0.704 . . . . 1.03 112.901 -175.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.822 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 44.9 m-80 -170.45 169.84 7.25 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.003 -1.48 . . . . 2.0299999999999998 107.003 -169.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.624 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 14.0 mtt180 -129.27 158.13 39.93 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.819 -0.752 . . . . 2.02 111.536 -175.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.408 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.9 tt0 -131.89 100.87 5.22 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.711 -0.677 . . . . 0.83999999999999997 109.969 169.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.509 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 20.7 ttt85 -62.86 166.0 6.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.339 -0.846 . . . . 3.2799999999999998 111.01 174.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.509 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 21.5 m-80 -35.01 103.03 0.23 Allowed Pre-proline 0 C--O 1.234 0.274 0 C-N-CA 125.361 1.464 . . . . 0.34999999999999998 113.717 -153.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 13.9 Cg_exo . . . . . 0 N--CA 1.458 -0.584 0 C-N-CA 123.594 2.863 . . . . 0.63 111.238 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.515 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.563 1.474 0 N-CA-C 117.055 2.243 . . . . 1.1699999999999999 117.055 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.651 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.3 OUTLIER -167.26 162.67 15.12 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.583 -0.698 . . . . 0.60999999999999999 109.925 -176.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 22.1 t-105 -142.52 98.61 3.33 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.176 -1.046 . . . . 0.56999999999999995 108.176 166.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.51 HD21 ' HG2' ' A' ' 103' ' ' ARG . 4.6 mt -91.3 113.74 26.09 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.101 -0.703 . . . . 1.3600000000000001 109.101 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 101' ' ' ILE . 23.5 m -83.82 143.81 29.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.86 -0.609 . . . . 0.42999999999999999 111.325 -169.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.3 167.99 9.63 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.921 -0.581 . . . . 1.02 111.407 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 t -58.87 -13.87 7.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.583 -1.19 . . . . 1.79 112.967 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.717 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 4.0 tmtm? -127.01 130.12 49.4 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.016 0.436 . . . . 1.8100000000000001 110.127 172.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.695 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.9 mt-30 -34.37 -55.02 0.53 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.097 -1.411 . . . . 1.76 114.151 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.495 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -99.91 11.93 38.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.958 -0.697 . . . . 3.2000000000000002 111.997 -173.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.768 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -96.48 37.65 1.26 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.755 0.65 . . . . 0.83999999999999997 112.755 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.522 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -114.45 142.68 17.7 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 117.379 -2.343 . . . . 0.96999999999999997 112.58 -151.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -94.63 114.44 31.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.743 0.783 . . . . 1.04 110.568 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.671 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.8 p80 -145.05 171.44 14.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.20999999999999999 109.75 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.83 -168.03 37.89 Favored Glycine 0 C--N 1.316 -0.537 0 C-N-CA 120.287 -0.958 . . . . 0.34999999999999998 111.892 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.2 t -156.69 172.7 18.13 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.2 -0.588 . . . . 1.1100000000000001 110.175 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -114.26 -0.1 14.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.952 -0.759 . . . . 2.1899999999999999 108.952 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -114.83 86.8 13.72 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 107.916 -1.142 . . . . 1.8400000000000001 107.916 169.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -73.47 -18.18 23.09 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.486 2.124 . . . . 0.39000000000000001 113.53 -169.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.98 -1.82 45.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.778 -0.647 . . . . 1.0800000000000001 110.67 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 41.1 t -91.03 -4.06 56.69 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.049 -0.722 . . . . 1.9399999999999999 109.049 171.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.453 HG23 ' HB2' ' A' ' 83' ' ' PRO . 37.0 mm -83.3 134.14 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.81 -0.632 . . . . 1.04 110.251 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.95 1.19 70.54 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.867 -1.293 . . . . 0.16 109.867 -174.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 3.3 tttt -110.82 161.53 15.71 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 122.859 1.314 . . . . 3.0299999999999998 113.46 -176.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.435 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -96.52 126.95 42.07 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 112.551 -2.113 . . . . 1.01 108.239 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.489 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 1.2 p -122.19 166.91 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.585 -1.265 . . . . 1.3400000000000001 107.585 -176.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.4 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 45.2 m -64.17 -52.17 60.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.823 0.738 . . . . 0.87 112.605 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -130.23 -45.46 1.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 118.067 -1.453 . . . . 2.5499999999999998 113.805 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.06 133.7 0.17 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 117.023 1.569 . . . . 0.19 117.023 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.579 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 3.0 p -74.67 165.6 24.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 112.573 -1.813 . . . . 0.20000000000000001 111.676 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.894 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 61.5 mt -59.59 99.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 122.378 1.085 . . . . 1.1299999999999999 112.239 -162.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.671 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 70.9 mtt180 -86.85 145.83 26.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.752 -1.567 . . . . 2.3300000000000001 110.494 -177.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.532 ' HG2' HG21 ' A' ' 84' ' ' ILE . 10.9 mtp -126.23 -165.51 1.45 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.011 -0.737 . . . . 1.0900000000000001 109.011 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -90.47 165.1 13.99 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.113 -0.699 . . . . 2.9900000000000002 109.113 169.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.66 ' O ' HD11 ' A' ' 151' ' ' ILE . 2.8 m120 -63.57 -48.99 75.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 118.258 -0.877 . . . . 0.73999999999999999 110.145 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -64.48 -29.27 70.31 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 121.58 1.991 . . . . 2.6899999999999999 111.903 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.444 ' CB ' ' HE3' ' A' ' 145' ' ' MET . 68.1 m-20 -76.68 -45.67 28.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.06 0.457 . . . . 0.68999999999999995 110.435 -175.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.553 HG12 HD13 ' A' ' 151' ' ' ILE . 14.4 p -67.02 -23.46 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.387 -0.824 . . . . 1.02 111.308 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.66 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -84.08 -42.52 17.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 119.05 -0.5 . . . . 1.1699999999999999 110.142 171.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 156' ' ' ILE . 29.9 mt-10 -48.22 -68.55 0.17 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 119.392 0.996 . . . . 1.99 112.305 171.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.495 ' O ' HG23 ' A' ' 157' ' ' VAL . 9.2 mp -47.09 -39.02 12.35 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.455 0.645 . . . . 1.9099999999999999 111.436 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.73 -32.62 74.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.579 -1.191 . . . . 1.04 111.606 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.1 t -87.34 -32.25 19.72 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.487 -0.758 . . . . 0.88 112.316 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 152' ' ' GLU . 36.9 mt -82.88 -60.11 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.528 0.68 . . . . 1.0 111.547 -172.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 153' ' ' LEU . 3.8 m -89.52 138.16 28.5 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.812 -1.086 . . . . 1.0700000000000001 112.28 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.624 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 43.3 Cg_endo -89.01 176.04 3.34 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 C-N-CA 124.194 3.263 . . . . 0.23999999999999999 111.525 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.822 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.8 m-20 -67.24 154.42 41.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.13 -1.063 . . . . 1.1000000000000001 108.13 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.97 -15.35 63.18 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.789 -1.196 . . . . 0.17999999999999999 112.565 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.588 ' HB ' HD13 ' A' ' 100' ' ' ILE . 88.3 m -65.8 136.88 56.78 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.091 -0.707 . . . . 1.05 109.091 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.475 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 1.1 ptm180 -93.3 127.31 38.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.55 1.166 . . . . 4.1100000000000003 111.51 -171.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.5 t -111.69 108.61 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 112.327 -2.215 . . . . 1.02 109.215 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.8 m -95.54 109.89 22.05 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.459 0.541 . . . . 1.0700000000000001 112.459 -172.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.463 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -83.69 96.08 4.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 122.504 1.145 . . . . 1.05 109.946 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -101.56 138.32 38.72 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.724 -1.58 . . . . 1.0900000000000001 108.663 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.525 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 5.2 mmt85 . . . . . 0 C--N 1.313 -0.983 0 N-CA-C 108.988 -0.745 . . . . 2.4900000000000002 108.988 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.515 -0.398 0 CA-C-O 121.661 0.743 . . . . 1.3300000000000001 112.097 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.615 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.2 tt -96.19 129.67 43.44 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.644 -1.162 . . . . 1.0700000000000001 110.219 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.81 162.04 13.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.207 -0.906 . . . . 1.03 112.663 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.636 ' HD1' ' CD2' ' A' ' 7' ' ' TYR . 74.0 t80 -131.2 145.38 51.91 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.956 -1.475 . . . . 1.0800000000000001 108.193 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -116.02 114.55 24.73 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.436 -0.95 . . . . 0.93000000000000005 108.436 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 13' ' ' ASP . 97.5 t -68.04 151.46 10.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 122.567 1.175 . . . . 1.1000000000000001 113.364 -171.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -103.96 159.87 15.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.256 -1.793 . . . . 2.4399999999999999 108.837 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.406 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -63.07 105.3 0.67 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.972 0.415 . . . . 2.4300000000000002 111.751 -176.396 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.35 10.93 32.67 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.933 -0.651 . . . . 0.51000000000000001 113.215 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.55 ' HB2' HG11 ' A' ' 9' ' ' VAL . 87.8 m-20 -55.93 171.09 0.26 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.709 0.254 . . . . 1.46 111.26 172.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.2 154.3 50.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.599 0.714 . . . . 1.1599999999999999 111.893 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.653 HD23 ' O ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -69.14 -28.73 66.7 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.346 -1.297 . . . . 1.47 109.995 -176.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.459 ' HA ' HG23 ' A' ' 26' ' ' THR . 0.2 OUTLIER -93.51 -26.12 17.3 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.025 -0.989 . . . . 1.78 110.788 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -66.06 -40.6 91.06 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.604 -0.438 . . . . 1.74 109.927 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 22' ' ' PHE . 14.6 mt -73.47 -27.1 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.185 -0.461 . . . . 1.04 109.928 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.612 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.39 -11.37 59.92 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.809 -0.356 . . . . 1.0600000000000001 111.147 176.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.625 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -93.51 -40.02 10.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.458 0.647 . . . . 0.97999999999999998 109.885 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.653 ' HB3' ' O ' ' A' ' 119' ' ' SER . 47.1 m-20 -63.46 -40.54 97.4 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.726 -1.125 . . . . 0.53000000000000003 112.054 174.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 119' ' ' SER . 51.4 m-85 -99.25 4.81 46.74 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 118.506 -1.278 . . . . 0.20000000000000001 111.44 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.625 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.7 mpt_? 54.83 44.6 28.15 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.711 0.767 . . . . 2.46 109.619 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.612 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 32.4 pt -117.46 -165.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.624 -1.171 . . . . 1.04 110.028 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.42 142.55 41.98 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.91 -1.041 . . . . 1.3400000000000001 110.125 175.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.614 ' HB ' ' CD1' ' A' ' 15' ' ' LEU . 78.8 p -73.57 -32.75 64.32 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.409 -0.96 . . . . 1.0900000000000001 108.409 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.59 -24.4 66.65 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.095 -0.957 . . . . 1.0700000000000001 111.636 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.31 -28.2 15.1 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.983 -0.747 . . . . 1.04 108.983 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.636 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 21.3 tp -74.23 -27.01 60.57 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.486 -0.779 . . . . 1.8100000000000001 109.503 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.48 HD21 ' HB2' ' A' ' 36' ' ' LEU . 72.6 mt -80.19 -26.81 39.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.698 0.761 . . . . 1.6399999999999999 110.117 172.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 7.1 tt0 -66.03 -41.18 91.26 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.573 -1.194 . . . . 2.3300000000000001 110.13 171.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.436 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -84.1 -21.67 31.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.115 -0.634 . . . . 1.0600000000000001 111.456 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.2 m-80 -148.27 78.49 9.41 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.532 0.682 . . . . 0.23000000000000001 110.328 -172.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 20.3 Cg_endo -58.36 -7.79 4.41 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 124.331 3.354 . . . . 0.52000000000000002 114.149 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.6 m -84.69 -17.89 37.01 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 111.815 0.302 . . . . 1.6499999999999999 111.815 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.636 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 41.8 mt -67.74 -34.49 76.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.513 0.673 . . . . 1.25 111.704 -173.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.414 ' HG3' ' H ' ' A' ' 38' ' ' ALA . 5.7 pt20 -65.05 -46.64 80.4 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.819 1.295 . . . . 2.52 110.36 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.414 ' H ' ' HG3' ' A' ' 37' ' ' GLN . . . -58.86 -47.66 84.12 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 111.771 -2.468 . . . . 1.1899999999999999 110.648 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.48 47.43 Favored Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 114.753 -1.112 . . . . 0.44 111.318 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.26 156.8 20.95 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.273 0.558 . . . . 1.1699999999999999 111.006 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 62.3 m -138.05 127.32 24.53 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.17 -0.923 . . . . 1.1499999999999999 110.576 -175.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 11' ' ' GLN . . . -77.7 118.06 19.71 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.511 0.672 . . . . 1.1200000000000001 109.943 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.67 1.76 52.86 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.195 -1.162 . . . . 0.44 110.195 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -77.95 123.7 27.11 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.633 -0.783 . . . . 1.3 109.715 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 46.2 p -82.18 128.04 33.76 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.434 -0.803 . . . . 1.3200000000000001 110.275 176.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.584 HG13 ' HB3' ' A' ' 7' ' ' TYR . 12.4 pt -127.7 141.72 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.186 -1.37 . . . . 1.0700000000000001 109.326 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.36 150.61 3.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.094 0.473 . . . . 1.3 110.898 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.4 mm -114.8 92.1 28.57 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.709 -1.132 . . . . 1.03 108.992 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -58.94 133.81 56.0 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.903 2.402 . . . . 0.20000000000000001 112.918 -174.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.07 -6.38 78.88 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.8 -1.091 . . . . 0.26000000000000001 112.339 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.652 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 30.0 tp -123.47 116.97 27.97 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 121.106 0.479 . . . . 1.27 111.213 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.615 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 43.7 Cg_endo -76.86 -177.28 3.68 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.605 2.87 . . . . 0.31 113.907 -172.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 12.1 t70 -83.54 129.56 59.53 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 114.483 -1.235 . . . . 0.48999999999999999 111.97 -168.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.558 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.2 Cg_endo -75.23 -17.49 19.01 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.333 2.689 . . . . 0.48999999999999999 112.411 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -93.96 -5.41 47.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.476 0.655 . . . . 1.8 110.404 -172.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.456 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 30.2 p -89.24 -20.84 23.65 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.6 1.19 . . . . 1.1299999999999999 107.993 173.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.452 HG23 ' H ' ' A' ' 59' ' ' TYR . 27.1 mt -74.05 130.02 83.61 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 112.906 -1.952 . . . . 1.24 111.232 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.82 -17.06 9.86 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.48 2.12 . . . . 0.47999999999999998 113.153 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' H ' HG23 ' A' ' 57' ' ' ILE . 70.0 m-85 -92.26 159.5 15.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.823 -0.351 . . . . 0.94999999999999996 111.661 -177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -147.2 134.44 20.58 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.883 -0.784 . . . . 3.7400000000000002 108.883 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.698 ' HA ' ' O ' ' A' ' 71' ' ' THR . 86.3 mt -113.68 131.89 64.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.948 -0.569 . . . . 1.05 111.676 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.32 30.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.937 -0.705 . . . . 1.0800000000000001 110.843 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 69' ' ' THR . 91.2 t -97.62 111.31 27.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.765 0.793 . . . . 1.04 111.117 175.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 68' ' ' LYS . 58.8 m -93.64 101.25 13.39 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.508 -1.223 . . . . 0.83999999999999997 110.702 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.6 mm -49.26 -57.89 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 122.067 0.937 . . . . 1.0600000000000001 111.306 170.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.22 -9.1 2.85 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 112.764 -2.016 . . . . 0.16 113.208 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.07 -22.53 3.76 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.532 0.733 . . . . 1.02 112.517 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 64' ' ' SER . 1.1 mppt? 60.61 58.44 2.45 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 118.067 0.394 . . . . 1.3 111.354 -170.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 63.0 p -137.68 160.83 38.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 113.09 0.774 . . . . 0.98999999999999999 113.09 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.425 ' C ' HD21 ' A' ' 70' ' ' LEU . 7.4 tt -128.18 107.95 10.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.672 -1.149 . . . . 1.1799999999999999 109.534 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.698 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 61.7 m -90.37 122.02 32.87 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.082 0.468 . . . . 1.04 110.837 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' MET . 17.1 tp -97.88 105.21 17.32 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.446 -0.797 . . . . 1.3200000000000001 109.273 173.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 96.9 p -105.65 160.47 15.18 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 118.829 -1.148 . . . . 1.05 110.318 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.5 tm? -126.1 125.45 42.57 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.705 -0.85 . . . . 1.1000000000000001 108.705 168.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.52 ' N ' HD23 ' A' ' 74' ' ' LEU . 24.4 m-80 50.54 50.06 19.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.435 -1.257 . . . . 1.97 111.008 -171.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 71.74 -10.18 0.87 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.571 0.749 . . . . 2.5499999999999998 111.816 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -98.79 120.42 39.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.021 -0.536 . . . . 4.0199999999999996 109.82 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 54.6 t -57.74 132.98 22.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 122.493 1.139 . . . . 1.0600000000000001 112.768 -174.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -102.01 -45.01 5.31 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 112.837 -1.983 . . . . 1.47 108.732 177.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -154.27 174.49 14.72 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 113.2 -1.818 . . . . 1.98 110.102 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -149.29 121.21 8.19 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.481 -1.69 . . . . 1.0 109.46 168.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 1.635 ' HD1' ' CD2' ' A' ' 82' ' ' TYR . 12.9 m-85 -101.19 151.28 37.67 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 115.142 -0.935 . . . . 1.3999999999999999 109.165 -175.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HB2' HG23 ' A' ' 134' ' ' ILE . 57.3 Cg_endo -81.2 140.51 12.36 Favored 'Trans proline' 0 CA--C 1.5 -1.212 0 C-N-CA 121.499 1.466 . . . . 0.23999999999999999 111.062 169.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.543 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -139.81 176.13 6.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.516 -0.765 . . . . 1.04 110.393 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.883 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -120.14 150.17 41.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.126 -0.324 . . . . 1.03 110.126 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.475 HG23 ' HG3' ' A' ' 68' ' ' LYS . 9.8 m -130.95 127.47 61.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.58 0.705 . . . . 1.26 112.107 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -85.67 156.16 29.98 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.044 -1.222 . . . . 0.20000000000000001 110.044 172.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -57.46 3.96 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.236 0.828 . . . . 3.48 113.236 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.521 HG12 ' CB ' ' A' ' 122' ' ' HIS . 1.1 tp -90.28 -19.49 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 O-C-N 121.638 -0.664 . . . . 1.0700000000000001 110.291 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.7 mm? -89.78 -18.13 26.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.765 0.793 . . . . 1.02 109.256 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.5 p -68.04 -14.36 62.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.427 -1.26 . . . . 1.05 111.362 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -71.52 -37.67 71.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.47 -1.241 . . . . 2.0299999999999998 112.862 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -105.8 115.89 60.76 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 120.055 -0.658 . . . . 1.1499999999999999 110.793 -177.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.564 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.8 Cg_endo -75.58 -11.69 20.43 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.792 2.328 . . . . 1.04 113.63 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.1 t -105.02 -43.56 5.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.185 0.516 . . . . 1.1299999999999999 110.107 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.545 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 53.54 33.48 47.81 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.257 -1.338 . . . . 0.35999999999999999 113.93 167.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.16 112.61 20.4 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.969 0.89 . . . . 1.0800000000000001 109.721 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.702 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 19.0 m-85 -138.05 176.81 8.37 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.764 -1.562 . . . . 0.26000000000000001 111.949 -170.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CG ' HD13 ' A' ' 5' ' ' LEU . 45.3 m-85 -139.33 144.08 38.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.257 0.551 . . . . 0.78000000000000003 110.452 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.537 HD13 ' HB ' ' A' ' 161' ' ' THR . 83.8 mt -68.84 116.89 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 115.613 -0.721 . . . . 1.02 110.557 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.533 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 30.4 pt -85.93 -35.81 9.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 112.877 0.695 . . . . 1.03 112.877 -175.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.753 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 11.0 p30 -178.53 -179.21 0.65 Allowed 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 107.695 -1.224 . . . . 2.0299999999999998 107.695 -176.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.625 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -140.38 159.6 41.83 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.16 -0.616 . . . . 2.02 112.599 -176.041 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.8 tt0 -128.37 100.07 5.66 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.9 -1.046 . . . . 0.83999999999999997 109.428 172.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.496 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 61.5 ttt180 -64.73 165.91 9.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.341 -0.845 . . . . 3.2799999999999998 110.663 176.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.496 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 23.3 m-80 -35.07 102.05 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 125.282 1.433 . . . . 0.34999999999999998 113.743 -152.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 16.3 Cg_exo . . . . . 0 N--CA 1.456 -0.69 0 C-N-CA 123.504 2.803 . . . . 0.63 111.469 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.517 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.566 1.582 0 N-CA-C 116.977 2.214 . . . . 1.1699999999999999 116.977 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.642 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.4 OUTLIER -166.54 162.88 16.96 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.684 -0.635 . . . . 0.60999999999999999 110.04 -176.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 18.0 t-105 -143.9 97.85 3.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.302 -0.999 . . . . 0.56999999999999995 108.302 167.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.51 HD13 ' CG2' ' A' ' 150' ' ' VAL . 2.1 mt -89.48 115.19 26.72 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.381 0.61 . . . . 1.3600000000000001 109.739 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.436 ' C ' HG12 ' A' ' 101' ' ' ILE . 24.3 m -86.01 144.3 27.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.956 -0.565 . . . . 0.42999999999999999 111.19 -171.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.1 mm? -109.29 168.14 9.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 1.02 110.46 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.653 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.1 m -65.11 -2.38 2.79 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.937 0.718 . . . . 1.79 112.937 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.757 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 5.0 tmtm? -128.8 136.37 50.42 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.941 -0.392 . . . . 1.8100000000000001 109.941 168.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.757 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 25.5 mm-40 -36.46 -58.03 0.73 Allowed 'General case' 0 C--N 1.312 -1.041 0 O-C-N 124.222 0.951 . . . . 1.76 113.458 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.521 ' CB ' HG12 ' A' ' 89' ' ' ILE . 56.2 m80 -89.92 0.78 56.88 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.451 -0.499 . . . . 3.2000000000000002 111.83 -167.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.795 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.1 m-30 -96.73 37.93 1.25 Allowed 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 113.419 0.896 . . . . 0.83999999999999997 113.419 -170.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.49 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -114.41 142.95 17.85 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 116.693 -2.67 . . . . 0.96999999999999997 112.642 -152.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -93.35 115.21 31.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.773 0.797 . . . . 1.04 110.661 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.567 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 31.5 p80 -142.05 170.57 15.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.451 -0.795 . . . . 0.20999999999999999 109.394 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -92.35 -167.27 39.61 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.375 -0.917 . . . . 0.34999999999999998 111.687 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.2 t -156.79 169.82 23.86 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 122.039 -0.683 . . . . 1.1100000000000001 110.346 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -114.68 -5.22 12.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.643 -0.873 . . . . 2.1899999999999999 108.643 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -116.04 87.33 18.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 114.832 -1.077 . . . . 1.8400000000000001 108.231 171.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -72.78 -21.21 21.79 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.131 2.554 . . . . 0.39000000000000001 114.484 -167.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -75.83 -2.58 30.69 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.147 0.499 . . . . 1.0800000000000001 111.116 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.459 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 15.9 m -91.91 -5.52 53.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.275 0.559 . . . . 1.9399999999999999 109.673 173.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 83' ' ' PRO . 37.8 mm -81.89 134.96 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.713 -0.676 . . . . 1.04 110.085 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.89 2.28 66.91 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.954 -1.259 . . . . 0.16 109.954 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.459 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 54.6 mttp -113.93 170.08 8.53 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.988 1.375 . . . . 3.0299999999999998 113.466 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.07 124.92 49.45 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.118 -2.31 . . . . 1.01 108.191 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.43 162.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.757 -0.831 . . . . 1.3400000000000001 108.757 -173.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -51.55 -60.17 3.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.389 0.514 . . . . 0.87 112.389 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.404 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 18.8 pttp -133.5 -44.36 0.83 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 118.357 -1.337 . . . . 2.5499999999999998 113.765 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.88 133.24 0.17 Allowed Glycine 0 N--CA 1.464 0.54 0 N-CA-C 117.014 1.565 . . . . 0.19 117.014 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.567 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 5.4 p -69.53 165.75 20.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 112.411 -1.894 . . . . 0.20000000000000001 112.202 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.883 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 45.9 mt -59.8 98.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.566 -1.197 . . . . 1.1299999999999999 112.047 -162.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.555 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 11.4 mtp180 -86.27 150.03 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.874 -1.512 . . . . 2.3300000000000001 110.25 -177.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.543 ' HG2' HG21 ' A' ' 84' ' ' ILE . 6.3 mtp -129.31 -165.79 1.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.973 -0.751 . . . . 1.0900000000000001 108.973 173.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.712 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 5.1 t60 -92.91 159.54 15.3 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.605 -0.887 . . . . 2.9900000000000002 108.605 170.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.653 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.6 m120 -57.9 -53.21 60.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.357 -0.83 . . . . 0.73999999999999999 110.365 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -63.56 -27.15 69.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 121.376 1.898 . . . . 2.6899999999999999 112.005 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.712 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.9 m-20 -75.67 -51.31 13.06 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.72 -0.673 . . . . 0.68999999999999995 110.63 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.555 HG12 HD13 ' A' ' 151' ' ' ILE . 14.7 p -62.94 -22.63 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 115.285 -0.87 . . . . 1.02 111.746 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.653 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.58 -39.95 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 118.911 -0.566 . . . . 1.1699999999999999 110.569 172.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -45.79 -72.34 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.219 0.918 . . . . 1.99 112.674 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.559 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.1 mm? -49.0 -35.05 14.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.768 0.794 . . . . 1.9099999999999999 111.325 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.532 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -63.94 -35.09 79.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.561 -1.2 . . . . 1.04 112.048 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.3 t -90.99 -29.01 17.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 119.03 0.832 . . . . 0.88 113.099 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.4 mt -83.19 -60.44 2.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.509 0.671 . . . . 1.0 111.772 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.4 m -86.76 141.83 34.04 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.955 -1.02 . . . . 1.0700000000000001 111.53 177.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.625 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 77.9 Cg_endo -85.19 172.64 8.34 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.992 3.128 . . . . 0.23999999999999999 111.351 175.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.753 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.4 m-20 -63.65 156.3 27.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.243 -1.021 . . . . 1.1000000000000001 108.243 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.77 -22.08 42.42 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 119.634 -1.27 . . . . 0.17999999999999999 112.951 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.537 ' HB ' HD13 ' A' ' 100' ' ' ILE . 48.9 m -60.78 135.48 57.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.077 -0.712 . . . . 1.05 109.077 -174.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.547 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -94.16 129.91 40.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.589 1.185 . . . . 4.1100000000000003 111.403 -167.42 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.3 t -110.95 110.57 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 112.373 -2.194 . . . . 1.02 109.571 -173.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 15.7 m -94.24 105.58 17.56 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.512 0.56 . . . . 1.0700000000000001 112.512 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.545 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -82.42 99.96 5.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-O 122.412 1.101 . . . . 1.05 110.005 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -107.47 130.91 54.78 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.04 -1.436 . . . . 1.0900000000000001 109.61 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.564 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 17.3 mmm180 . . . . . 0 C--N 1.322 -0.593 0 CA-C-O 120.967 0.413 . . . . 2.4900000000000002 111.184 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER . . . . . 0 CA--C 1.514 -0.426 0 CA-C-O 121.64 0.733 . . . . 1.3300000000000001 112.076 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.9 tt -95.42 130.42 42.23 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.525 -1.216 . . . . 1.0700000000000001 110.124 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.55 162.97 13.23 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.135 0.969 . . . . 1.03 113.21 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' A' ' 7' ' ' TYR . 84.8 t80 -130.44 140.95 50.54 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.791 -1.549 . . . . 1.0800000000000001 107.959 175.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -113.36 113.19 24.88 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.063 -1.088 . . . . 0.93000000000000005 108.063 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 41' ' ' THR . 93.6 t -67.11 150.99 10.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 122.38 1.086 . . . . 1.1000000000000001 112.999 -170.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -107.49 159.05 16.71 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 113.376 -1.738 . . . . 2.4399999999999999 108.21 171.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -58.66 110.0 0.91 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.964 0.411 . . . . 2.4300000000000002 111.94 -174.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.99 11.32 43.39 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.766 -0.652 . . . . 0.51000000000000001 113.7 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.565 ' HB2' HG11 ' A' ' 9' ' ' VAL . 86.9 m-20 -55.85 167.95 0.51 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.193 0.497 . . . . 1.46 111.177 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.59 152.56 48.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.036 0.446 . . . . 1.1599999999999999 111.746 176.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.521 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.39 -32.72 74.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.082 -0.963 . . . . 1.47 108.643 -178.046 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.448 ' HA ' HG23 ' A' ' 26' ' ' THR . 64.1 t30 -93.05 -22.21 19.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.789 -1.096 . . . . 1.78 111.114 -177.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.7 t -65.64 -45.85 81.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.206 -0.664 . . . . 1.74 109.206 171.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.421 HG21 ' CE1' ' A' ' 22' ' ' PHE . 17.3 mt -71.84 -26.61 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.881 -0.6 . . . . 1.04 110.056 -176.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.596 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.45 -10.17 59.75 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.833 -0.347 . . . . 1.0600000000000001 111.111 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.593 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.32 -39.1 9.38 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.502 1.144 . . . . 0.97999999999999998 108.057 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 119' ' ' SER . 6.2 m-20 -63.32 -44.38 95.08 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 112.402 -2.181 . . . . 0.53000000000000003 111.911 173.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.552 ' C ' HD11 ' A' ' 101' ' ' ILE . 55.3 m-85 -97.72 4.66 49.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 118.725 -1.19 . . . . 0.20000000000000001 111.658 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.593 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.4 mpt_? 54.68 43.28 30.4 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.866 0.841 . . . . 2.46 109.928 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.596 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.4 pt -116.39 -165.18 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 114.529 -1.214 . . . . 1.04 109.702 -178.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.1 142.34 41.7 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.023 -0.99 . . . . 1.3400000000000001 110.227 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.622 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 67.1 p -72.68 -32.82 66.1 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.916 -1.142 . . . . 1.0900000000000001 107.916 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.45 67.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.188 -0.915 . . . . 1.0700000000000001 111.745 169.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.98 -26.64 18.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.662 0.744 . . . . 1.04 108.997 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.543 HD12 HD13 ' A' ' 46' ' ' ILE . 19.2 tp -76.35 -20.45 57.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.282 -0.872 . . . . 1.8100000000000001 109.554 174.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 26' ' ' THR . 28.9 mt -83.91 -29.54 27.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.396 0.617 . . . . 1.6399999999999999 110.606 170.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.545 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -59.97 -61.25 2.75 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.945 -1.132 . . . . 2.3300000000000001 107.945 169.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.468 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -71.61 -17.39 62.28 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.514 0.673 . . . . 1.0600000000000001 110.415 -169.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.449 ' HB3' ' CD2' ' A' ' 36' ' ' LEU . 33.9 m-80 -150.69 85.26 5.28 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.189 -0.914 . . . . 0.23000000000000001 110.579 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.46 -9.18 6.43 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.964 2.443 . . . . 0.52000000000000002 112.952 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 m -69.79 -34.66 74.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.154 0.502 . . . . 1.6499999999999999 111.319 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.578 HD21 ' N ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -61.37 -51.37 69.07 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 122.209 1.004 . . . . 1.25 112.152 -169.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.403 ' HG3' ' H ' ' A' ' 38' ' ' ALA . 3.9 pt20 -56.32 -48.53 76.52 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 113.231 -1.804 . . . . 2.52 110.93 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.403 ' H ' ' HG3' ' A' ' 37' ' ' GLN . . . -54.5 -52.52 61.7 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 111.893 -2.412 . . . . 1.1899999999999999 109.938 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.88 168.0 37.93 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 114.439 -1.255 . . . . 0.44 112.164 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.03 158.25 16.28 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.266 0.555 . . . . 1.1699999999999999 110.501 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.598 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 39.6 m -145.72 129.19 16.94 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.262 -0.881 . . . . 1.1499999999999999 110.427 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.89 117.64 16.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.495 0.664 . . . . 1.1200000000000001 109.953 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.15 0.54 54.47 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 114.716 -1.129 . . . . 0.44 110.289 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.598 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.3 tt0 -75.24 125.38 28.84 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.856 -0.672 . . . . 1.3 110.338 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 56.3 p -83.54 131.46 34.99 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.831 0.824 . . . . 1.3200000000000001 110.322 175.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.577 HG13 ' HB3' ' A' ' 7' ' ' TYR . 10.0 pt -132.37 143.57 39.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.366 -1.288 . . . . 1.0700000000000001 109.306 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.61 151.73 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.16 0.505 . . . . 1.3 111.455 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.3 mm -116.45 92.89 38.4 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.628 -1.169 . . . . 1.03 109.404 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.529 ' HA ' HD23 ' A' ' 4' ' ' LEU . 4.0 Cg_exo -57.34 134.88 66.65 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.853 2.369 . . . . 0.20000000000000001 113.174 -175.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.01 -7.58 80.93 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.317 -1.311 . . . . 0.26000000000000001 112.532 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 33.6 tp -120.87 115.2 32.07 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-O 121.2 0.524 . . . . 1.27 111.184 -177.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.608 ' HD2' HD11 ' A' ' 51' ' ' LEU . 54.7 Cg_endo -78.09 -176.12 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 124.05 3.167 . . . . 0.31 114.402 -171.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.463 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 15.5 t70 -82.74 129.0 63.9 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 114.19 -1.368 . . . . 0.48999999999999999 112.045 -169.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.524 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 46.2 Cg_endo -72.92 -13.87 26.47 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 123.371 2.714 . . . . 0.48999999999999999 112.61 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.432 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 59.7 m-85 -96.26 -0.53 49.62 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.451 0.643 . . . . 1.8 111.398 -175.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 19.6 p -95.33 -20.4 19.18 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.751 -1.203 . . . . 1.1299999999999999 107.751 171.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.458 HG23 ' H ' ' A' ' 59' ' ' TYR . 19.1 mt -75.69 131.5 76.74 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 113.168 -1.833 . . . . 1.24 111.147 177.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.456 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 95.5 Cg_endo -82.72 -18.26 6.76 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.233 1.956 . . . . 0.47999999999999998 113.486 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' H ' HG23 ' A' ' 57' ' ' ILE . 61.6 m-85 -95.2 158.47 15.45 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.499 0.555 . . . . 0.94999999999999996 112.499 -175.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -146.64 128.83 15.68 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.322 -0.853 . . . . 3.7400000000000002 108.975 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 71' ' ' THR . 87.2 mt -110.32 135.95 47.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.225 -0.443 . . . . 1.05 111.701 -176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.09 119.04 33.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 119.955 -0.698 . . . . 1.0800000000000001 110.968 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.2 t -98.96 116.38 41.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.525 0.679 . . . . 1.04 110.869 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 68' ' ' LYS . 70.3 m -95.06 105.89 17.84 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.046 -0.979 . . . . 0.83999999999999997 110.352 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.7 mm -54.22 -58.92 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 122.079 0.942 . . . . 1.0600000000000001 111.2 167.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.68 -10.65 4.7 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 112.789 -2.005 . . . . 0.16 113.351 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -126.67 -18.74 4.7 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.453 0.701 . . . . 1.02 112.213 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.64 55.74 4.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.373 0.533 . . . . 1.3 111.421 -173.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.8 p -138.02 160.52 39.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.84 0.681 . . . . 0.98999999999999999 112.84 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.416 HD21 ' C ' ' A' ' 70' ' ' LEU . 8.7 tt -128.54 113.29 15.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.778 -1.101 . . . . 1.1799999999999999 110.178 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 41.3 m -93.95 122.66 36.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.273 0.559 . . . . 1.04 111.43 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 79' ' ' MET . 12.9 tp -97.55 103.27 15.19 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.862 -1.063 . . . . 1.3200000000000001 109.45 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 7.5 m -105.49 160.64 15.0 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.474 -0.89 . . . . 1.05 110.77 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.2 tm? -127.18 126.99 43.79 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.981 -0.748 . . . . 1.1000000000000001 108.981 169.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.523 ' N ' HD23 ' A' ' 74' ' ' LEU . 50.4 m-80 47.65 51.44 13.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.561 -1.199 . . . . 1.97 111.228 -171.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 t30 71.8 -12.24 0.68 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.57 -0.741 . . . . 2.5499999999999998 111.695 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.414 ' H ' ' C ' ' A' ' 75' ' ' ASN . 16.5 tpt180 -96.22 120.27 36.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.17 0.509 . . . . 4.0199999999999996 110.221 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 64.1 t -59.53 131.85 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 122.32 1.057 . . . . 1.0600000000000001 112.468 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 8.7 mtm -100.59 -46.01 5.33 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 113.246 -1.797 . . . . 1.47 108.903 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -156.35 173.03 17.47 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.518 -1.673 . . . . 1.98 110.037 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.7 m -149.4 124.6 10.13 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.354 -1.293 . . . . 1.0 109.848 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -111.2 153.11 44.12 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.871 -0.604 . . . . 1.3999999999999999 109.439 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HB2' HG23 ' A' ' 134' ' ' ILE . 60.4 Cg_endo -79.7 143.11 16.52 Favored 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 122.194 1.929 . . . . 0.23999999999999999 111.495 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.543 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.92 175.1 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.746 -0.661 . . . . 1.04 110.948 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.873 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.51 146.08 45.76 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.309 -0.405 . . . . 1.03 110.067 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.467 HG23 ' HG3' ' A' ' 68' ' ' LYS . 8.8 m -127.04 128.81 70.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.532 0.682 . . . . 1.26 111.784 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -87.31 154.66 26.46 Favored Glycine 0 N--CA 1.425 -2.039 0 N-CA-C 110.09 -1.204 . . . . 0.20000000000000001 110.09 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -56.18 2.93 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.266 0.839 . . . . 3.48 113.266 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -88.68 -19.92 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 O-C-N 121.587 -0.696 . . . . 1.0700000000000001 110.177 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.7 mm? -89.42 -18.28 27.1 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.715 0.769 . . . . 1.02 109.314 -176.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.5 p -65.99 -14.9 62.44 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.553 -1.203 . . . . 1.05 111.767 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -67.08 -39.06 86.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.051 -0.977 . . . . 2.0299999999999998 112.327 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.95 117.55 54.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.668 -0.413 . . . . 1.1499999999999999 111.222 -175.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.597 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 1.8 Cg_endo -77.63 -13.83 16.17 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.674 2.25 . . . . 1.04 113.083 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.1 t -103.67 -41.84 5.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.677 -0.49 . . . . 1.1299999999999999 109.677 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.545 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.46 39.59 22.38 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.419 -1.264 . . . . 0.35999999999999999 114.024 168.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -84.11 112.12 19.94 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.907 0.86 . . . . 1.0800000000000001 109.507 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.9 m-85 -138.78 174.72 10.23 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.003 -1.453 . . . . 0.26000000000000001 112.12 -171.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.657 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 86.6 m-85 -139.69 136.3 34.1 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.058 -0.519 . . . . 0.78000000000000003 110.732 -175.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.546 HD13 ' HB ' ' A' ' 161' ' ' THR . 86.7 mt -59.74 121.68 8.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.361 -0.836 . . . . 1.02 110.44 170.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.552 HD11 ' C ' ' A' ' 22' ' ' PHE . 19.1 pt -87.3 -44.6 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.83 0.678 . . . . 1.03 112.83 -176.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.561 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 44.1 m-80 -171.54 172.08 5.18 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.976 -1.49 . . . . 2.0299999999999998 106.976 -168.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.651 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 39.8 mtt180 -124.28 171.56 9.78 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.531 -0.867 . . . . 2.02 111.592 -173.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 52.6 tt0 -148.28 99.91 3.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.08 -0.964 . . . . 0.83999999999999997 109.758 170.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.478 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 48.4 ttp180 -66.18 166.17 12.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.284 -0.871 . . . . 3.2799999999999998 110.421 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.463 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 25.4 m-80 -35.66 103.03 0.24 Allowed Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 125.323 1.449 . . . . 0.34999999999999998 113.405 -157.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.9 Cg_endo . . . . . 0 C--N 1.346 0.4 0 C-N-CA 122.99 2.46 . . . . 0.63 111.756 173.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.524 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.569 1.682 0 N-CA-C 117.294 2.331 . . . . 1.1699999999999999 117.294 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.646 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.5 OUTLIER -166.02 151.37 8.63 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.272 -0.892 . . . . 0.60999999999999999 110.594 -176.073 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.5 t-105 -132.09 99.62 4.78 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.41 -0.959 . . . . 0.56999999999999995 108.41 168.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 103' ' ' ARG . 5.3 mt -93.92 114.27 26.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.624 0.726 . . . . 1.3600000000000001 109.358 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 m -83.9 144.22 29.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.593 -0.731 . . . . 0.42999999999999999 111.466 -168.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.774 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -108.53 170.66 7.88 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.821 -0.627 . . . . 1.02 111.243 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.493 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 2.9 t -62.38 -13.73 32.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.112 -0.949 . . . . 1.79 112.729 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.686 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 1.4 tmtp? -126.63 132.3 51.26 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 120.446 -0.501 . . . . 1.8100000000000001 110.594 173.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.686 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 55.3 mt-30 -34.2 -56.87 0.49 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.003 -1.453 . . . . 1.76 113.869 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.481 ' CB ' HG12 ' A' ' 89' ' ' ILE . 75.0 m-70 -92.22 2.01 56.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.154 0.502 . . . . 3.2000000000000002 111.556 -171.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.774 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -94.0 37.44 1.09 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.405 0.891 . . . . 0.83999999999999997 113.405 -172.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -115.05 143.27 18.06 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 117.016 -2.516 . . . . 0.96999999999999997 112.717 -152.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.12 114.64 33.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.722 0.772 . . . . 1.04 110.766 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.644 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.0 p80 -143.99 172.12 13.31 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.432 -0.804 . . . . 0.20999999999999999 109.663 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.75 -176.68 39.8 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.982 -1.104 . . . . 0.34999999999999998 111.66 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -147.0 168.13 22.28 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.387 -0.478 . . . . 1.1100000000000001 110.387 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -111.25 -0.7 16.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.126 -1.065 . . . . 2.1899999999999999 108.126 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -116.05 85.86 15.86 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 114.537 -1.21 . . . . 1.8400000000000001 108.385 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -72.85 -21.19 21.58 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.164 1.909 . . . . 0.39000000000000001 113.727 -169.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.23 -2.58 38.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.156 0.503 . . . . 1.0800000000000001 110.845 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 44.7 t -91.42 -3.2 56.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.308 -0.627 . . . . 1.9399999999999999 109.308 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.453 HG23 ' HB2' ' A' ' 83' ' ' PRO . 42.8 mm -80.88 139.37 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.932 -0.576 . . . . 1.04 110.133 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.46 1.37 74.83 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 110.159 -1.176 . . . . 0.16 110.159 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -111.65 167.86 10.01 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 123.24 1.495 . . . . 3.0299999999999998 114.414 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.21 48.52 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 111.541 -2.572 . . . . 1.01 107.697 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.464 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -124.66 160.58 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.954 -0.758 . . . . 1.3400000000000001 108.954 -174.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.5 m -49.36 -59.78 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.616 0.598 . . . . 0.87 112.616 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -132.62 -43.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 118.411 -1.316 . . . . 2.5499999999999998 113.744 -175.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.53 ' N ' ' HD3' ' A' ' 140' ' ' LYS . . . -32.24 133.55 0.19 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 117.236 1.654 . . . . 0.19 117.236 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.586 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 4.0 p -73.39 165.52 24.91 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 112.636 -1.782 . . . . 0.20000000000000001 111.843 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.873 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 53.3 mt -59.77 98.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 122.316 1.055 . . . . 1.1299999999999999 112.018 -162.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.644 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 74.6 mtt180 -85.07 147.69 26.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.777 -1.556 . . . . 2.3300000000000001 110.281 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.543 ' HG2' HG21 ' A' ' 84' ' ' ILE . 12.3 mtp -127.51 -166.31 1.59 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.401 -0.592 . . . . 1.0900000000000001 109.401 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.681 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 6.8 t60 -94.9 156.18 16.45 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.448 -0.945 . . . . 2.9900000000000002 108.448 172.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.639 ' O ' HD11 ' A' ' 151' ' ' ILE . 2.7 m120 -58.7 -50.03 75.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 118.339 -0.839 . . . . 0.73999999999999999 110.736 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -63.34 -26.16 68.63 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 121.26 1.845 . . . . 2.6899999999999999 112.462 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.681 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 16.8 m-20 -83.95 -39.92 19.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.937 0.399 . . . . 0.68999999999999995 111.25 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.543 HG12 HD13 ' A' ' 151' ' ' ILE . 14.6 p -70.07 -23.58 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.956 -0.565 . . . . 1.02 111.146 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.639 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.01 -39.8 16.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 118.966 -0.54 . . . . 1.1699999999999999 109.592 171.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -45.52 -71.36 0.08 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.139 0.881 . . . . 1.99 112.238 167.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 157' ' ' VAL . 8.2 mp -46.32 -38.13 8.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.521 0.677 . . . . 1.9099999999999999 111.262 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.37 83.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.372 -1.286 . . . . 1.04 111.629 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.1 t -87.94 -34.48 18.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.513 -0.742 . . . . 0.88 112.47 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.2 mt -80.38 -59.56 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.177 0.513 . . . . 1.0 111.451 -172.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 153' ' ' LEU . 2.6 m -92.39 141.51 24.93 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.448 -0.797 . . . . 1.0700000000000001 112.112 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.651 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 69.4 Cg_endo -89.02 173.6 4.02 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.767 2.978 . . . . 0.23999999999999999 111.144 173.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.561 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 73.6 m-20 -66.91 157.1 34.04 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.611 -0.836 . . . . 1.1000000000000001 109.16 177.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.35 -19.19 55.42 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.196 -1.002 . . . . 0.17999999999999999 112.666 -173.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.546 ' HB ' HD13 ' A' ' 100' ' ' ILE . 59.0 m -63.48 139.77 58.8 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.496 -0.557 . . . . 1.05 109.496 -176.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.657 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 3.5 ptm180 -92.52 120.43 32.98 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.787 1.28 . . . . 4.1100000000000003 111.112 -170.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.1 t -106.96 109.4 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 112.205 -2.271 . . . . 1.02 109.149 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.427 HG23 ' ND2' ' A' ' 166' ' ' ASN . 18.8 m -95.49 108.12 20.33 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.484 0.55 . . . . 1.0700000000000001 112.484 -172.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.545 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -81.78 101.52 6.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 122.35 1.072 . . . . 1.05 109.77 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.427 ' ND2' HG23 ' A' ' 164' ' ' THR . 61.0 m-80 -106.62 129.54 54.52 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.905 -1.498 . . . . 1.0900000000000001 109.027 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.597 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 18.0 mmm180 . . . . . 0 C--N 1.321 -0.67 0 CA-C-O 120.865 0.364 . . . . 2.4900000000000002 110.637 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.308 0.575 . . . . 1.3300000000000001 111.845 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.5 tt -92.21 127.64 37.76 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.999 -1.0 . . . . 1.0700000000000001 110.605 -172.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.82 162.19 13.38 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.188 0.994 . . . . 1.03 113.401 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.651 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 80.2 t80 -131.01 141.91 50.28 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.547 -1.66 . . . . 1.0800000000000001 107.884 175.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -113.23 115.32 28.02 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.218 -1.031 . . . . 0.93000000000000005 108.218 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' A' ' 13' ' ' ASP . 98.2 t -68.73 150.3 10.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.53 1.157 . . . . 1.1000000000000001 113.254 -170.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -102.36 158.56 16.11 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.335 -1.757 . . . . 2.4399999999999999 108.541 172.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.33 105.34 0.49 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.879 0.371 . . . . 2.4300000000000002 111.622 -177.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.96 12.24 30.29 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.62 -0.8 . . . . 0.51000000000000001 113.366 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.556 ' HB2' HG11 ' A' ' 9' ' ' VAL . 90.2 m-20 -56.23 170.6 0.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.872 0.368 . . . . 1.46 111.171 170.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.89 155.47 45.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.326 0.584 . . . . 1.1599999999999999 111.146 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.537 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.97 -34.25 77.68 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.334 -0.987 . . . . 1.47 108.334 178.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.509 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -88.38 -28.0 21.24 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.911 -1.04 . . . . 1.78 111.442 -175.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.0 p -68.88 -37.67 79.18 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 118.422 0.556 . . . . 1.74 110.181 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.429 HG21 ' CE1' ' A' ' 22' ' ' PHE . 14.5 mt -73.89 -27.12 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 121.254 0.549 . . . . 1.04 109.796 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.26 -9.79 59.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.355 -0.384 . . . . 1.0600000000000001 110.684 175.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.717 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.55 -41.19 8.68 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.024 -1.102 . . . . 0.97999999999999998 108.024 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.494 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 5.6 m-20 -63.59 -41.96 98.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 112.797 -2.001 . . . . 0.53000000000000003 112.5 173.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.507 ' C ' HD11 ' A' ' 101' ' ' ILE . 56.3 m-85 -98.84 6.22 46.97 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 118.655 -1.218 . . . . 0.20000000000000001 110.858 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.717 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.06 41.04 32.18 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.927 0.87 . . . . 2.46 109.606 176.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.606 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.3 pt -114.43 -165.9 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 114.263 -1.335 . . . . 1.04 109.976 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.81 142.65 40.78 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.106 -0.952 . . . . 1.3400000000000001 109.996 175.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.663 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 70.8 p -72.82 -29.9 63.62 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.702 -0.851 . . . . 1.0900000000000001 108.702 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.93 -25.01 67.7 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.68 -0.691 . . . . 1.0700000000000001 111.816 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.435 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.37 -28.65 14.85 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.854 -0.795 . . . . 1.04 108.854 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.508 HD12 HD13 ' A' ' 46' ' ' ILE . 20.9 tp -72.29 -27.65 62.6 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.127 -0.942 . . . . 1.8100000000000001 108.584 172.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.663 ' HB2' ' O ' ' A' ' 26' ' ' THR . 7.6 tp -77.42 -31.73 54.23 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.812 0.815 . . . . 1.6399999999999999 109.462 175.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.435 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 5.8 tt0 -66.05 -40.94 91.35 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.167 -1.378 . . . . 2.3300000000000001 110.336 173.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.476 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -82.01 -17.78 45.64 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.988 -0.685 . . . . 1.0600000000000001 111.518 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.588 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.0 m-80 -146.64 81.5 9.23 Favored Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-O 121.246 0.546 . . . . 0.23000000000000001 110.754 -173.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 14.8 Cg_endo -55.81 -11.78 5.78 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 124.098 3.199 . . . . 0.52000000000000002 113.401 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m -78.89 -17.52 55.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.801 0.334 . . . . 1.6499999999999999 111.834 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.588 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 58.1 mt -75.36 -31.8 60.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.333 0.587 . . . . 1.25 112.072 -171.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.408 ' NE2' ' HB1' ' A' ' 38' ' ' ALA . 1.7 pp0? -62.4 -45.53 92.7 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 122.755 1.264 . . . . 2.52 110.772 -172.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.408 ' HB1' ' NE2' ' A' ' 37' ' ' GLN . . . -63.41 -48.53 77.45 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 111.893 -2.412 . . . . 1.1899999999999999 110.749 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.13 -179.57 48.74 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 114.78 -1.1 . . . . 0.44 111.255 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.439 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -109.88 156.37 20.49 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.135 0.493 . . . . 1.1699999999999999 110.789 178.414 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 31.3 m -137.26 129.76 29.9 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.348 -0.842 . . . . 1.1499999999999999 110.491 -175.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.11 123.36 26.28 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.403 0.62 . . . . 1.1200000000000001 110.235 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.53 0.18 62.93 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.272 -1.131 . . . . 0.44 110.272 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.611 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.1 tt0 -74.05 124.12 25.66 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.644 -0.778 . . . . 1.3 109.87 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 53.9 p -82.39 128.92 34.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.804 0.811 . . . . 1.3200000000000001 109.876 176.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.596 HG13 ' HB3' ' A' ' 7' ' ' TYR . 7.6 pt -128.55 141.38 46.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.57 -1.195 . . . . 1.0700000000000001 109.428 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.39 151.69 3.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.128 0.489 . . . . 1.3 111.048 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.6 mm -114.99 91.98 28.92 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.638 -1.164 . . . . 1.03 109.05 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.476 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 1.7 Cg_endo -59.59 134.39 57.67 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.738 2.292 . . . . 0.20000000000000001 112.778 -174.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.62 -6.74 80.14 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.893 -1.048 . . . . 0.26000000000000001 112.156 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.761 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.5 tp -124.74 116.13 26.47 Favored Pre-proline 0 N--CA 1.446 -0.63 0 CA-C-O 121.404 0.621 . . . . 1.27 111.504 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.619 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 59.0 Cg_endo -79.71 -176.09 3.06 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.14 3.227 . . . . 0.31 114.208 -172.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.46 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 17.7 t70 -81.14 130.5 62.62 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 114.225 -1.352 . . . . 0.48999999999999999 112.879 -169.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 40.1 Cg_endo -73.0 -14.98 26.28 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.852 3.035 . . . . 0.48999999999999999 113.134 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 80.2 m-85 -96.13 -8.6 32.83 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.902 -0.59 . . . . 1.8 111.427 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.46 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 24.7 p -86.49 -20.39 28.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.784 -1.191 . . . . 1.1299999999999999 107.784 172.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.525 HG23 ' H ' ' A' ' 59' ' ' TYR . 24.6 mt -76.73 129.13 80.07 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 112.912 -1.949 . . . . 1.24 111.036 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.38 -13.05 12.49 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.538 2.159 . . . . 0.47999999999999998 113.63 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.525 ' H ' HG23 ' A' ' 57' ' ' ILE . 62.7 m-85 -96.11 164.61 12.61 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.498 -0.481 . . . . 0.94999999999999996 111.786 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -154.09 130.65 10.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.852 -0.796 . . . . 3.7400000000000002 108.852 177.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 71' ' ' THR . 72.8 mt -112.06 136.75 47.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.155 -0.475 . . . . 1.05 111.607 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.25 116.84 27.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.926 -0.71 . . . . 1.0800000000000001 111.223 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.8 t -96.04 113.6 30.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.565 0.698 . . . . 1.04 110.777 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 68' ' ' LYS . 22.2 m -90.89 104.0 16.64 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.943 -1.026 . . . . 0.83999999999999997 110.45 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.479 HG22 HH11 ' A' ' 167' ' ' ARG . 50.5 mm -53.44 -58.54 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 122.262 1.03 . . . . 1.0600000000000001 111.208 168.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.16 -10.13 3.62 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 112.699 -2.046 . . . . 0.16 113.521 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -126.88 -18.02 4.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.596 0.758 . . . . 1.02 112.17 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 59.07 54.53 4.9 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.219 0.463 . . . . 1.3 111.078 -172.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 64' ' ' SER . 41.6 p -136.85 167.71 20.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 112.707 0.632 . . . . 0.98999999999999999 112.707 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.451 ' CD2' HD22 ' A' ' 153' ' ' LEU . 8.0 tt -135.84 112.76 10.28 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.729 -1.123 . . . . 1.1799999999999999 110.0 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 22.1 m -93.07 123.31 36.24 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.157 0.504 . . . . 1.04 110.781 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 79' ' ' MET . 16.1 tp -99.95 106.51 18.32 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.298 -0.864 . . . . 1.3200000000000001 109.125 172.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 83.4 p -105.44 161.46 14.31 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 119.234 -0.986 . . . . 1.05 110.498 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.585 HD11 ' ND2' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -125.61 125.33 42.98 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.657 -0.868 . . . . 1.1000000000000001 108.657 168.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.585 ' ND2' HD11 ' A' ' 74' ' ' LEU . 9.2 p30 41.98 53.03 4.27 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.769 -1.56 . . . . 1.97 112.126 -165.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 46.8 m-80 75.24 -9.53 1.38 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.02 -0.991 . . . . 2.5499999999999998 112.226 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HD2' ' C ' ' A' ' 77' ' ' ARG . 7.7 tmm_? -97.16 121.84 39.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.037 0.446 . . . . 4.0199999999999996 109.903 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 55.7 t -58.4 131.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 122.39 1.091 . . . . 1.0600000000000001 112.806 -175.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.526 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -100.91 -45.84 5.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 113.116 -1.856 . . . . 1.47 109.112 178.419 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -159.95 173.19 16.28 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.039 -1.892 . . . . 1.98 110.214 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -149.67 123.45 9.27 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.172 -1.376 . . . . 1.0 109.458 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -112.86 148.64 39.79 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.897 -0.592 . . . . 1.3999999999999999 109.734 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.433 ' HB2' HG23 ' A' ' 134' ' ' ILE . 32.7 Cg_endo -74.5 142.71 29.91 Favored 'Trans proline' 0 CA--C 1.498 -1.32 0 C-N-CA 122.231 1.954 . . . . 0.23999999999999999 110.938 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.516 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.67 172.77 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-N 115.777 -0.647 . . . . 1.04 110.761 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.929 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.16 137.6 52.87 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.762 0.315 . . . . 1.03 110.188 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.457 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 10.7 m -120.88 127.75 75.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.6 0.714 . . . . 1.26 111.776 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.19 151.48 28.52 Favored Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 110.067 -1.213 . . . . 0.20000000000000001 110.067 171.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.47 4.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.262 0.838 . . . . 3.48 113.262 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.534 HG12 ' CB ' ' A' ' 122' ' ' HIS . 1.1 tp -90.81 -19.12 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.385 0.612 . . . . 1.0700000000000001 110.158 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.7 mm? -86.89 -17.47 33.19 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.687 -0.857 . . . . 1.02 108.687 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.1 p -69.38 -16.1 63.45 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.369 -1.287 . . . . 1.05 111.345 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -69.95 -37.76 75.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.859 -1.064 . . . . 2.0299999999999998 112.845 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.517 HG21 HG21 ' A' ' 95' ' ' THR . 1.5 m -107.33 127.51 27.75 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 119.746 -0.782 . . . . 1.1499999999999999 111.161 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -89.41 -14.19 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.727 2.284 . . . . 1.04 113.172 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.517 HG21 HG21 ' A' ' 93' ' ' THR . 6.3 t -90.33 -44.52 9.63 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.584 0.707 . . . . 1.1299999999999999 109.417 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.546 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 61.58 18.46 56.19 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 114.066 -1.425 . . . . 0.35999999999999999 113.979 168.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.4 111.33 19.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 122.206 1.003 . . . . 1.0800000000000001 109.593 -175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.66 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 26.6 m-85 -138.42 177.51 7.83 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.359 -1.746 . . . . 0.26000000000000001 111.279 -171.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.426 ' CG ' HD12 ' A' ' 5' ' ' LEU . 39.8 m-85 -140.98 137.38 33.0 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.135 0.493 . . . . 0.78000000000000003 110.765 -173.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.543 HD13 ' HB ' ' A' ' 161' ' ' THR . 78.8 mt -63.01 114.62 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-N 115.185 -0.916 . . . . 1.02 110.268 170.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.564 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.4 pt -83.33 -45.43 18.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 113.367 0.877 . . . . 1.03 113.367 -175.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -168.75 165.88 11.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.0 -1.482 . . . . 2.0299999999999998 107.0 -169.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.652 ' NH1' ' HA ' ' A' ' 154' ' ' ALA . 51.9 mtt-85 -132.1 155.68 47.68 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.902 -0.719 . . . . 2.02 112.408 -168.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.507 ' NE2' ' HB3' ' A' ' 107' ' ' PRO . 51.6 tt0 -137.62 102.27 4.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.359 0.599 . . . . 0.83999999999999997 110.808 176.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.473 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 46.8 ttp180 -62.76 166.18 5.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.952 -1.022 . . . . 3.2799999999999998 111.279 174.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.774 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 28.7 m-80 -35.93 101.31 0.21 Allowed Pre-proline 0 C--O 1.232 0.158 0 C-N-CA 125.802 1.641 . . . . 0.34999999999999998 113.122 -159.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.507 ' HB3' ' NE2' ' A' ' 104' ' ' GLN . 24.1 Cg_endo . . . . . 0 C--N 1.344 0.327 0 C-N-CA 123.499 2.799 . . . . 0.63 113.604 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.774 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . . . . . . . . 0 N--CA 1.44 -0.94 0 CA-C-O 120.813 0.34 . . . . 1.1699999999999999 110.18 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.657 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.7 OUTLIER -162.99 154.28 17.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.457 -0.338 . . . . 0.60999999999999999 110.169 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -132.09 104.68 6.94 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.687 -1.227 . . . . 0.56999999999999995 107.687 165.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.651 HD23 ' NH1' ' A' ' 103' ' ' ARG . 5.0 mt -100.11 114.83 28.48 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.57 -0.706 . . . . 1.3600000000000001 109.859 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 101' ' ' ILE . 43.6 m -81.81 143.28 31.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.817 -0.629 . . . . 0.42999999999999999 110.901 -170.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.558 ' N ' HD21 ' A' ' 118' ' ' LEU . 1.4 mm? -108.02 164.88 11.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.535 -0.757 . . . . 1.02 110.416 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.1 p -65.13 -5.18 6.05 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.985 0.803 . . . . 1.79 112.72 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.695 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 4.2 tmtm? -127.41 129.42 47.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.111 0.958 . . . . 1.8100000000000001 109.849 166.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.695 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.0 mt-30 -37.2 -47.75 0.81 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 112.249 -2.25 . . . . 1.76 113.903 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.534 ' CB ' HG12 ' A' ' 89' ' ' ILE . 58.0 m80 -96.33 3.23 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.849 -0.614 . . . . 3.2000000000000002 111.915 -170.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.564 ' CD1' ' HB3' ' A' ' 120' ' ' LYS . 2.5 m-30 -92.99 -35.48 13.26 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.807 0.813 . . . . 0.83999999999999997 111.946 -173.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.465 ' HA2' HD21 ' A' ' 118' ' ' LEU . . . -10.46 131.01 0.01 OUTLIER Glycine 0 C--N 1.298 -1.58 0 N-CA-C 119.392 2.517 . . . . 0.96999999999999997 119.392 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.656 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -100.54 117.5 45.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 112.449 -1.876 . . . . 1.04 110.366 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.755 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 33.6 p80 -145.83 -176.79 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.318 0.488 . . . . 0.20999999999999999 112.318 -175.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.94 -167.72 37.63 Favored Glycine 0 C--O 1.22 -0.759 0 C-N-CA 121.22 -0.514 . . . . 0.34999999999999998 111.86 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.2 t -160.76 166.51 28.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 117.796 0.798 . . . . 1.1100000000000001 110.704 -176.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -116.53 0.19 12.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.831 0.824 . . . . 2.1899999999999999 109.288 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -126.03 89.21 52.82 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.39 -1.277 . . . . 1.8400000000000001 108.819 170.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -72.19 -20.75 24.4 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.753 2.302 . . . . 0.39000000000000001 114.008 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.96 -5.48 48.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.21 -0.45 . . . . 1.0800000000000001 111.008 -175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -91.29 -2.48 57.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.08 -0.509 . . . . 1.9399999999999999 110.016 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.433 HG23 ' HB2' ' A' ' 83' ' ' PRO . 38.8 mm -78.55 137.61 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-N 115.872 -0.604 . . . . 1.04 109.934 176.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.7 3.16 68.91 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.151 -1.18 . . . . 0.16 110.151 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.41 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 21.3 mtpt -113.74 169.07 9.25 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 123.223 1.487 . . . . 3.0299999999999998 114.395 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.16 126.59 46.44 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 111.509 -2.587 . . . . 1.01 107.946 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.417 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -123.47 159.44 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.541 -0.911 . . . . 1.3400000000000001 108.541 -174.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.1 m -48.08 -59.87 3.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.763 0.653 . . . . 0.87 112.763 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -132.13 -44.46 0.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 118.446 -1.302 . . . . 2.5499999999999998 114.033 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.69 133.92 0.21 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 117.464 1.746 . . . . 0.19 117.464 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.544 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 3.0 p -70.78 165.41 23.17 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 112.734 -1.733 . . . . 0.20000000000000001 111.956 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.929 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.8 mt -60.87 99.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.386 -1.279 . . . . 1.1299999999999999 112.154 -162.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.755 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 42.7 mtt180 -86.48 143.32 27.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.317 -1.311 . . . . 2.3300000000000001 110.161 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.516 ' HG2' HG21 ' A' ' 84' ' ' ILE . 20.8 mtp -118.97 -168.98 1.65 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.851 -0.796 . . . . 1.0900000000000001 108.851 173.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.53 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 81.8 m-70 -83.77 155.67 22.93 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.747 -0.835 . . . . 2.9900000000000002 108.747 167.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.686 ' O ' HD12 ' A' ' 151' ' ' ILE . 9.2 m120 -65.02 -44.16 90.09 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 118.283 -0.865 . . . . 0.73999999999999999 110.999 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -66.06 -25.46 67.04 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 121.902 2.137 . . . . 2.6899999999999999 112.068 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.53 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 37.8 m-20 -86.79 -35.4 19.15 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.235 -0.438 . . . . 0.68999999999999995 111.188 -174.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 147' ' ' ASN . 11.8 p -67.98 -21.91 27.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 1.02 110.747 172.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.686 HD12 ' O ' ' A' ' 147' ' ' ASN . 1.6 mp -83.08 -40.97 16.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.667 -0.494 . . . . 1.1699999999999999 109.667 170.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -47.14 -70.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.203 0.91 . . . . 1.99 112.428 168.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.475 HD23 ' SD ' ' A' ' 145' ' ' MET . 7.3 mp -49.86 -30.75 10.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.594 0.711 . . . . 1.9099999999999999 111.529 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.652 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -67.5 -41.22 84.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.805 -1.089 . . . . 1.04 111.528 176.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.0 t -85.13 -37.66 19.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.789 0.663 . . . . 0.88 112.789 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.58 -60.23 2.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.613 0.721 . . . . 1.0 111.377 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.609 HG21 HH22 ' A' ' 103' ' ' ARG . 3.8 m -92.06 145.81 31.58 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.0 -1.0 . . . . 1.0700000000000001 112.126 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.444 ' C ' HH21 ' A' ' 103' ' ' ARG . 50.4 Cg_endo -89.86 172.62 3.76 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 124.466 3.444 . . . . 0.23999999999999999 111.175 173.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -66.4 161.65 22.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 118.689 -1.204 . . . . 1.1000000000000001 109.897 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.51 -17.11 59.86 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.561 -0.828 . . . . 0.17999999999999999 111.825 -172.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.543 ' HB ' HD13 ' A' ' 100' ' ' ILE . 67.2 m -67.45 139.44 57.07 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.457 -0.571 . . . . 1.05 109.457 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.2 117.89 30.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.571 1.176 . . . . 4.1100000000000003 111.022 -168.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.2 t -104.03 109.66 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 112.316 -2.22 . . . . 1.02 109.358 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.495 HG23 ' ND2' ' A' ' 166' ' ' ASN . 32.6 m -95.71 107.68 19.92 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.727 0.64 . . . . 1.0700000000000001 112.727 -172.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.546 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mp -80.54 108.77 14.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 122.039 0.923 . . . . 1.05 109.855 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.495 ' ND2' HG23 ' A' ' 164' ' ' THR . 38.6 m-80 -110.97 124.46 52.18 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.489 -1.232 . . . . 1.0900000000000001 109.796 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.479 HH11 HG22 ' A' ' 65' ' ' ILE . 15.6 mmm180 . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 121.244 0.545 . . . . 2.4900000000000002 110.192 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 tp . . . . . 0 CA--C 1.517 -0.32 0 CA-C-O 121.296 0.57 . . . . 1.3300000000000001 111.555 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.685 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.7 tt -95.54 126.74 41.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.049 -0.978 . . . . 1.0700000000000001 110.258 -175.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.07 161.47 13.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.055 0.931 . . . . 1.03 112.632 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.649 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 90.6 t80 -130.74 139.8 50.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.935 -1.484 . . . . 1.0800000000000001 107.83 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -112.66 112.8 24.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.131 -1.063 . . . . 0.93000000000000005 108.131 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.582 HG11 ' HB2' ' A' ' 13' ' ' ASP . 98.4 t -67.09 149.46 11.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 122.395 1.093 . . . . 1.1000000000000001 113.169 -169.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -103.24 158.85 16.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 113.369 -1.741 . . . . 2.4399999999999999 108.718 174.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -62.85 104.26 0.53 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.198 0.523 . . . . 2.4300000000000002 112.308 -173.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.29 11.29 36.73 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.848 -0.692 . . . . 0.51000000000000001 113.356 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.582 ' HB2' HG11 ' A' ' 9' ' ' VAL . 83.9 m-20 -53.58 170.67 0.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.978 0.389 . . . . 1.46 111.307 172.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.452 ' HG1' ' CB ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -129.3 153.21 48.05 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.296 0.569 . . . . 1.1599999999999999 111.558 176.169 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.493 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.38 -35.03 79.72 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.33 -0.989 . . . . 1.47 108.33 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.46 ' HA ' HG23 ' A' ' 26' ' ' THR . 65.0 t30 -88.96 -25.89 21.81 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.916 -1.038 . . . . 1.78 111.438 -176.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.452 ' CB ' ' HG1' ' A' ' 14' ' ' THR . 90.3 p -68.17 -36.9 80.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.902 -0.719 . . . . 1.74 109.674 174.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.1 mt -75.62 -28.19 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.164 0.507 . . . . 1.04 110.023 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.59 -10.05 59.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.539 -0.301 . . . . 1.0600000000000001 110.872 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.592 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.71 -39.49 9.45 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.607 1.194 . . . . 0.97999999999999998 108.38 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 119' ' ' SER . 10.0 m-20 -62.19 -45.79 91.81 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.453 -2.158 . . . . 0.53000000000000003 111.856 172.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.568 ' C ' HD11 ' A' ' 101' ' ' ILE . 63.2 m-85 -97.2 5.12 50.66 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.681 -1.208 . . . . 0.20000000000000001 111.602 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.5 mpt_? 54.15 43.29 30.87 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.776 0.798 . . . . 2.46 109.891 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.583 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.0 pt -116.19 -165.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.535 -1.211 . . . . 1.04 109.771 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.87 143.02 38.62 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.177 -0.919 . . . . 1.3400000000000001 109.992 174.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.596 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 69.4 p -71.75 -32.19 67.44 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.759 -1.2 . . . . 1.0900000000000001 107.759 177.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.98 -32.2 70.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.277 -0.874 . . . . 1.0700000000000001 112.008 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -90.5 -25.94 20.02 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.657 0.741 . . . . 1.04 109.112 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.633 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 17.2 tp -75.55 -26.19 57.77 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.999 -1.001 . . . . 1.8100000000000001 109.361 173.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 26' ' ' THR . 30.7 mt -77.49 -31.71 53.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.792 0.806 . . . . 1.6399999999999999 109.67 171.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 45.0 tt0 -64.05 -41.13 97.49 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.282 -1.326 . . . . 2.3300000000000001 110.034 174.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.436 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -84.18 -20.64 32.04 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 120.118 -0.633 . . . . 1.0600000000000001 111.633 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.578 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 27.0 m-80 -147.11 80.69 9.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.46 0.648 . . . . 0.23000000000000001 110.64 -172.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 23.7 Cg_endo -58.97 -5.79 3.02 Favored 'Trans proline' 0 C--N 1.326 -0.644 0 C-N-CA 124.372 3.382 . . . . 0.52000000000000002 114.145 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 t -84.7 -23.31 29.41 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.215 -0.303 . . . . 1.6499999999999999 111.025 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.633 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 52.4 mt -67.01 -35.36 79.76 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.841 0.829 . . . . 1.25 111.632 -172.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -65.33 -46.72 79.17 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 114.239 -1.346 . . . . 2.52 110.298 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.55 -50.86 71.73 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 111.905 -2.407 . . . . 1.1899999999999999 110.282 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.56 177.95 48.55 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 114.742 -1.117 . . . . 0.44 111.656 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -109.59 157.63 18.84 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.349 0.595 . . . . 1.1699999999999999 111.235 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.606 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 82.6 m -140.35 128.64 22.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.141 -0.936 . . . . 1.1499999999999999 110.601 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 11' ' ' GLN . . . -76.16 120.07 20.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.449 0.642 . . . . 1.1200000000000001 110.234 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.26 0.05 57.09 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.181 -1.168 . . . . 0.44 110.181 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.606 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.8 tt0 -74.31 123.7 25.07 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.758 -0.721 . . . . 1.3 109.599 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 34.4 p -85.37 125.93 33.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.646 0.736 . . . . 1.3200000000000001 110.596 177.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.582 HG13 ' HB3' ' A' ' 7' ' ' TYR . 9.6 pt -125.63 143.59 38.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.393 -1.276 . . . . 1.0700000000000001 109.554 -176.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.24 150.99 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-O 121.113 0.482 . . . . 1.3 111.124 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.416 HG22 ' CD2' ' A' ' 22' ' ' PHE . 38.7 mm -115.86 92.87 35.98 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.643 -1.162 . . . . 1.03 109.147 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.507 ' HA ' HD23 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -58.16 135.41 68.19 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.847 2.365 . . . . 0.20000000000000001 112.819 -175.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.19 -6.0 81.26 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 114.992 -1.004 . . . . 0.26000000000000001 112.515 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.642 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 25.6 tp -126.74 119.87 22.82 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-O 120.972 0.415 . . . . 1.27 111.395 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.685 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 58.9 Cg_endo -80.89 178.69 6.66 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.438 2.759 . . . . 0.31 113.923 -172.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.521 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 12.9 t70 -75.17 131.8 77.73 Favored Pre-proline 0 N--CA 1.443 -0.819 0 CA-C-N 114.255 -1.339 . . . . 0.48999999999999999 111.646 -173.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HB2' ' HB3' ' A' ' 162' ' ' ARG . 60.5 Cg_endo -74.13 -16.73 22.42 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.415 2.743 . . . . 0.48999999999999999 113.02 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -96.53 -2.68 44.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.35 0.595 . . . . 1.8 111.169 -176.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.521 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 17.2 p -93.37 -14.54 26.72 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.493 -0.928 . . . . 1.1299999999999999 108.493 173.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.621 HG23 ' H ' ' A' ' 59' ' ' TYR . 7.9 mm -64.05 129.21 93.82 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 113.633 -1.621 . . . . 1.24 109.873 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 51.4 Cg_endo -73.08 -19.12 23.28 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.017 1.811 . . . . 0.47999999999999998 112.852 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.621 ' H ' HG23 ' A' ' 57' ' ' ILE . 41.0 m-85 -107.36 161.67 14.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.871 0.367 . . . . 0.94999999999999996 111.548 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -145.8 140.32 27.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.761 -0.829 . . . . 3.7400000000000002 108.761 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.684 ' HA ' ' O ' ' A' ' 71' ' ' THR . 88.1 mt -119.3 133.02 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.306 -0.407 . . . . 1.05 112.083 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.53 116.54 27.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.963 -0.695 . . . . 1.0800000000000001 111.014 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 69' ' ' THR . 85.5 t -95.12 115.68 34.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.684 0.754 . . . . 1.04 110.703 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.527 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 44.1 m -89.66 109.81 20.75 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.119 -0.946 . . . . 0.83999999999999997 110.85 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.471 ' CG1' ' HA ' ' A' ' 167' ' ' ARG . 23.3 mm -55.5 -60.21 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.186 0.993 . . . . 1.0600000000000001 110.844 164.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.83 -13.63 6.55 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 112.722 -2.036 . . . . 0.16 113.52 -175.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -126.66 -16.92 5.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 118.659 -0.686 . . . . 1.02 112.515 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.595 ' HZ1' ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 57.21 54.62 6.61 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.202 0.91 . . . . 1.3 111.527 -174.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 40.9 p -138.05 164.91 27.91 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.816 0.673 . . . . 0.98999999999999999 112.816 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.4 HD21 ' C ' ' A' ' 70' ' ' LEU . 7.7 tt -132.67 113.14 12.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.023 -0.989 . . . . 1.1799999999999999 110.093 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 38.4 m -92.89 123.69 36.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.992 0.425 . . . . 1.04 111.219 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 79' ' ' MET . 12.7 tp -98.59 106.61 18.91 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.498 -0.774 . . . . 1.3200000000000001 108.948 170.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 78.5 p -106.93 160.02 15.83 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 119.28 -0.968 . . . . 1.05 110.85 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.56 HD11 ' ND2' ' A' ' 75' ' ' ASN . 1.1 tm? -127.16 126.44 42.87 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.211 -0.663 . . . . 1.1000000000000001 109.211 171.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.56 ' ND2' HD11 ' A' ' 74' ' ' LEU . 7.8 p30 39.13 56.17 2.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 113.991 -1.459 . . . . 1.97 111.998 -166.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.3 m-80 74.76 -8.97 1.42 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.144 -0.935 . . . . 2.5499999999999998 112.429 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -101.57 119.45 38.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.012 0.434 . . . . 4.0199999999999996 110.296 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 50.8 t -55.04 131.64 18.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 122.444 1.116 . . . . 1.0600000000000001 112.54 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.524 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 67.8 mmm -96.81 -47.82 5.71 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 113.315 -1.766 . . . . 1.47 108.28 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -161.08 172.44 16.81 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 112.703 -2.044 . . . . 1.98 110.169 -176.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -149.5 125.42 10.57 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 113.973 -1.467 . . . . 1.0 109.532 173.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -117.28 150.54 46.52 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.087 -0.506 . . . . 1.3999999999999999 110.565 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HB2' HG23 ' A' ' 134' ' ' ILE . 37.5 Cg_endo -73.73 142.71 32.58 Favored 'Trans proline' 0 CA--C 1.495 -1.473 0 C-N-CA 122.351 2.034 . . . . 0.23999999999999999 111.201 176.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.538 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.72 173.34 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.452 -0.795 . . . . 1.04 110.433 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.908 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.61 143.74 45.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.927 -0.309 . . . . 1.03 110.167 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.458 HG23 ' HG3' ' A' ' 68' ' ' LYS . 11.4 m -125.99 125.83 68.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.583 0.706 . . . . 1.26 111.354 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -85.28 155.65 29.97 Favored Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 109.58 -1.408 . . . . 0.20000000000000001 109.58 171.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -57.6 4.9 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.224 0.824 . . . . 3.48 113.224 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.1 tp -87.02 -20.02 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 121.437 -0.789 . . . . 1.0700000000000001 109.684 178.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.6 mm? -89.44 -20.99 23.24 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.634 -0.876 . . . . 1.02 108.634 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.7 p -66.49 -16.75 64.36 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.512 -1.222 . . . . 1.05 110.938 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -72.19 -32.64 66.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.472 -1.24 . . . . 2.0299999999999998 112.966 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -108.54 120.41 46.48 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.008 -0.677 . . . . 1.1499999999999999 110.359 178.061 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.431 ' HA ' ' NE ' ' A' ' 167' ' ' ARG . 4.2 Cg_exo -70.37 -23.59 27.82 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.803 2.336 . . . . 1.04 112.881 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -99.23 -41.36 7.52 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.514 -0.55 . . . . 1.1299999999999999 109.514 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.531 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 51.44 21.06 5.91 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.514 -1.221 . . . . 0.35999999999999999 114.336 169.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 164' ' ' THR . 12.8 pt-20 -85.05 116.99 23.75 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 122.608 1.194 . . . . 1.0800000000000001 110.05 -172.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 13.0 m-85 -137.92 -171.83 3.1 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.362 -1.744 . . . . 0.26000000000000001 111.442 -166.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.497 ' CG ' HD12 ' A' ' 5' ' ' LEU . 28.6 m-85 -143.84 137.92 28.3 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.76 0.314 . . . . 0.78000000000000003 110.776 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.597 HD13 ' HB ' ' A' ' 161' ' ' THR . 76.3 mt -65.21 119.07 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.745 -0.661 . . . . 1.02 110.529 170.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.568 HD11 ' C ' ' A' ' 22' ' ' PHE . 23.3 pt -88.14 -32.85 6.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.028 0.751 . . . . 1.03 113.028 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.591 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 11.9 p30 179.27 179.3 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.846 -1.168 . . . . 2.0299999999999998 107.846 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.595 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 22.9 mtt180 -127.63 160.62 31.06 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.675 -0.81 . . . . 2.02 111.877 -175.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.48 HE21 ' HB3' ' A' ' 107' ' ' PRO . 54.7 tt0 -135.7 98.96 4.05 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.112 -0.949 . . . . 0.83999999999999997 109.665 171.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.482 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 40.4 ttp180 -65.74 164.98 13.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.427 -0.806 . . . . 3.2799999999999998 110.555 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.751 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 30.0 m-80 -36.05 101.28 0.21 Allowed Pre-proline 0 N--CA 1.461 0.098 0 C-N-CA 125.141 1.377 . . . . 0.34999999999999998 112.334 -158.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.48 ' HB3' HE21 ' A' ' 104' ' ' GLN . 15.7 Cg_endo . . . . . 0 N--CA 1.464 -0.255 0 C-N-CA 123.027 2.484 . . . . 0.63 113.1 176.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.751 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . . . . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 109.565 -0.531 . . . . 1.1699999999999999 109.565 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.482 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 1.5 m-85 -161.27 152.26 18.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.911 -0.586 . . . . 0.60999999999999999 110.109 -176.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 6.2 t-105 -129.48 99.15 5.08 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.019 -1.474 . . . . 0.56999999999999995 107.019 164.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.482 HD21 ' HG2' ' A' ' 103' ' ' ARG . 5.9 mt -90.71 114.03 26.26 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.234 -1.025 . . . . 1.3600000000000001 108.234 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.417 ' C ' HG12 ' A' ' 101' ' ' ILE . 19.4 m -83.68 143.88 29.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.772 -0.649 . . . . 0.42999999999999999 111.023 -166.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.767 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 3.1 mm? -108.88 165.1 11.82 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.102 -0.499 . . . . 1.02 111.445 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.5 t -60.36 -10.96 5.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.632 -1.167 . . . . 1.79 112.609 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.731 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.8 tmtm? -127.31 132.13 50.34 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.504 -0.478 . . . . 1.8100000000000001 109.885 171.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.731 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 21.5 mt-30 -35.25 -59.12 0.53 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 114.278 1.214 . . . . 1.76 114.278 -178.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.538 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -97.09 12.95 30.81 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.581 -0.848 . . . . 3.2000000000000002 111.852 -171.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.767 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.2 m-30 -98.67 38.46 1.36 Allowed 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 112.077 0.399 . . . . 0.83999999999999997 112.077 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.47 ' HA2' ' CD2' ' A' ' 118' ' ' LEU . . . -116.6 143.22 17.97 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 117.165 -2.445 . . . . 0.96999999999999997 112.523 -151.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -96.43 116.04 37.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 123.954 0.901 . . . . 1.04 110.934 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.636 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 31.2 p80 -146.65 -178.17 6.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.873 -0.603 . . . . 0.20999999999999999 112.16 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.23 -167.62 37.18 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 111.733 -0.547 . . . . 0.34999999999999998 111.733 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.6 t -162.73 167.97 22.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.878 0.839 . . . . 1.1100000000000001 110.391 -175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -113.29 -8.51 13.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.646 -0.872 . . . . 2.1899999999999999 108.646 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -120.32 88.11 41.47 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 114.874 -1.057 . . . . 1.8400000000000001 108.856 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -71.91 -21.81 24.08 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.979 2.453 . . . . 0.39000000000000001 114.294 -167.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.57 -1.93 29.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.0 0.428 . . . . 1.0800000000000001 111.253 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 20.1 m -90.26 -5.77 55.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.021 -0.536 . . . . 1.9399999999999999 109.964 172.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 83' ' ' PRO . 34.3 mm -77.44 131.3 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.181 -0.463 . . . . 1.04 110.486 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.01 3.51 60.47 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.235 -1.146 . . . . 0.16 110.235 -175.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.442 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 56.9 mttt -114.81 168.72 9.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 122.982 1.373 . . . . 3.0299999999999998 114.207 -176.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.17 127.24 45.11 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 112.011 -2.359 . . . . 1.01 107.759 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.456 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -123.6 160.79 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.5 -0.926 . . . . 1.3400000000000001 108.5 -175.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.7 m -49.1 -59.83 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.639 0.607 . . . . 0.87 112.639 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.74 -44.86 0.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 118.464 -1.295 . . . . 2.5499999999999998 114.131 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.24 134.36 0.17 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 117.193 1.637 . . . . 0.19 117.193 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.489 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 2.4 p -72.25 165.55 24.21 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 112.735 -1.732 . . . . 0.20000000000000001 112.002 -178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.908 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 46.4 mt -60.55 96.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 122.384 1.087 . . . . 1.1299999999999999 112.208 -162.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.636 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 68.0 mtt180 -83.63 147.23 27.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.889 -1.505 . . . . 2.3300000000000001 109.726 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.538 ' HG2' HG21 ' A' ' 84' ' ' ILE . 12.0 mtp -123.8 -169.9 2.03 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.407 -0.96 . . . . 1.0900000000000001 108.407 171.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.441 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 41.1 m80 -82.37 161.74 22.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.944 -0.762 . . . . 2.9900000000000002 108.944 168.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.624 ' HB3' ' HB3' ' A' ' 113' ' ' ALA . 13.4 m120 -66.94 -41.65 86.62 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 118.232 -0.89 . . . . 0.73999999999999999 110.805 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -69.66 -29.05 66.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 121.301 1.864 . . . . 2.6899999999999999 112.021 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 64.3 m-20 -76.31 -45.23 33.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.379 0.609 . . . . 0.68999999999999995 109.822 -174.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 147' ' ' ASN . 7.6 p -64.16 -25.04 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 114.819 -1.082 . . . . 1.02 111.562 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.542 HD13 ' O ' ' A' ' 147' ' ' ASN . 19.4 mt -83.41 -43.31 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 118.893 -0.575 . . . . 1.1699999999999999 111.538 174.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 156' ' ' ILE . 20.3 mt-10 -46.41 -70.39 0.1 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.529 1.058 . . . . 1.99 112.644 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.2 mt -45.79 -39.69 8.66 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.698 0.761 . . . . 1.9099999999999999 111.556 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.461 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . . . -61.22 -32.29 72.07 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.114 -1.403 . . . . 1.04 111.951 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.1 t -87.84 -30.81 19.91 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.511 -0.743 . . . . 0.88 112.198 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 152' ' ' GLU . 38.0 mt -82.91 -59.42 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.547 0.689 . . . . 1.0 111.747 -172.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 153' ' ' LEU . 5.4 m -88.39 139.81 30.14 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.73 -1.123 . . . . 1.0700000000000001 112.373 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.595 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 48.1 Cg_endo -88.87 173.89 4.06 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.324 3.349 . . . . 0.23999999999999999 111.118 174.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.591 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 60.9 m-20 -67.05 156.8 35.13 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 119.214 -0.994 . . . . 1.1000000000000001 108.687 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 54' ' ' PRO . . . 97.02 -20.85 49.18 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.833 -1.175 . . . . 0.17999999999999999 111.921 -173.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.597 ' HB ' HD13 ' A' ' 100' ' ' ILE . 85.8 m -59.82 128.9 39.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.724 -0.843 . . . . 1.05 108.724 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -93.32 123.45 36.62 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 122.809 1.29 . . . . 4.1100000000000003 110.833 -167.612 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.18 112.13 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 112.365 -2.198 . . . . 1.02 110.023 -171.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 97' ' ' GLU . 16.2 m -95.69 115.12 26.97 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.798 -0.761 . . . . 1.0700000000000001 112.202 -175.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.531 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mp -84.19 93.14 3.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.87 1.319 . . . . 1.05 109.421 172.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -93.0 125.32 37.53 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.262 -1.79 . . . . 1.0900000000000001 108.139 -175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.471 ' HA ' ' CG1' ' A' ' 65' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.613 0 C-N-CA 120.291 -0.563 . . . . 2.4900000000000002 110.697 -177.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.516 -0.339 0 CA-C-O 121.307 0.575 . . . . 1.3300000000000001 111.379 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.1 tt -95.94 128.68 43.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.091 -0.959 . . . . 1.0700000000000001 110.432 -175.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 161.29 13.85 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.084 0.945 . . . . 1.03 112.932 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.667 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 72.7 t80 -130.01 141.79 50.7 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.726 -1.579 . . . . 1.0800000000000001 108.071 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -114.01 112.2 22.88 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.863 -1.162 . . . . 0.93000000000000005 107.863 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.592 ' HB ' ' O ' ' A' ' 41' ' ' THR . 92.3 t -65.11 149.81 11.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 122.476 1.131 . . . . 1.1000000000000001 112.806 -170.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' HB3' ' HZ1' ' A' ' 10' ' ' LYS . 6.4 mtpm? -106.05 159.59 15.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.235 -1.802 . . . . 2.4399999999999999 108.6 173.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 108.02 0.99 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.071 0.462 . . . . 2.4300000000000002 111.949 -175.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.4 10.89 37.52 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.534 -0.757 . . . . 0.51000000000000001 113.283 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.547 ' HB2' HG11 ' A' ' 9' ' ' VAL . 91.5 m-20 -58.08 168.65 0.95 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.864 0.332 . . . . 1.46 110.765 172.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.66 153.61 49.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.577 0.703 . . . . 1.1599999999999999 112.011 174.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -68.2 -31.08 70.35 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.463 -1.244 . . . . 1.47 109.75 -176.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.431 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 65.3 t30 -93.34 -20.67 20.14 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.854 -1.066 . . . . 1.78 110.544 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.6 t -68.49 -43.22 77.35 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.152 -0.684 . . . . 1.74 109.152 171.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.426 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 17.2 mt -72.47 -25.84 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 121.354 0.597 . . . . 1.04 109.916 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.4 -9.91 59.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.401 -0.363 . . . . 1.0600000000000001 111.035 175.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.592 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.27 -38.87 9.51 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.677 1.227 . . . . 0.97999999999999998 107.982 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.6 m-20 -62.93 -49.16 75.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.255 -2.248 . . . . 0.53000000000000003 111.562 172.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.618 ' C ' HD11 ' A' ' 101' ' ' ILE . 63.5 m-85 -94.5 5.52 51.58 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.605 -1.238 . . . . 0.20000000000000001 111.527 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.0 mpt_? 53.4 44.51 29.92 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.661 0.744 . . . . 2.46 109.873 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.0 pt -116.2 -164.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 114.63 -1.168 . . . . 1.04 109.855 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.64 141.7 41.82 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.088 -0.96 . . . . 1.3400000000000001 110.137 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.548 ' HB ' ' CD1' ' A' ' 15' ' ' LEU . 67.0 p -72.67 -33.64 66.68 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.201 -1.037 . . . . 1.0900000000000001 108.201 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.46 68.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.981 -1.009 . . . . 1.0700000000000001 111.788 169.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -89.11 -27.88 20.45 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.955 -0.757 . . . . 1.04 108.955 -177.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.64 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.8 tp -74.76 -28.38 60.73 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.028 -0.987 . . . . 1.8100000000000001 109.461 175.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 26' ' ' THR . 55.9 mt -77.85 -30.47 51.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.785 0.802 . . . . 1.6399999999999999 109.86 172.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 39.4 tt0 -63.86 -41.47 97.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.29 -1.323 . . . . 2.3300000000000001 109.976 172.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.444 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -83.16 -22.08 33.38 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 121.91 -0.494 . . . . 1.0600000000000001 111.455 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.618 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 19.8 m-80 -150.11 98.34 3.33 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-O 121.26 0.553 . . . . 0.23000000000000001 109.75 -171.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 12.9 Cg_exo -79.67 -9.97 14.5 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.475 3.45 . . . . 0.52000000000000002 111.903 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -76.08 -25.78 55.84 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.852 -1.067 . . . . 1.6499999999999999 111.802 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.64 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 44.0 mt -65.04 -39.07 92.81 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.557 0.694 . . . . 1.25 112.103 -171.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -64.01 -46.27 85.24 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 122.917 1.342 . . . . 2.52 110.447 -173.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.98 83.62 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 111.808 -2.451 . . . . 1.1899999999999999 110.59 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.49 173.21 45.62 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 114.829 -1.078 . . . . 0.44 111.815 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -108.8 157.81 18.24 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.343 0.592 . . . . 1.1699999999999999 110.877 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.601 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 47.2 m -140.51 127.22 20.37 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.43 -0.804 . . . . 1.1499999999999999 110.912 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.71 118.85 18.14 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.291 0.567 . . . . 1.1200000000000001 109.931 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.48 -1.13 55.73 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.33 -1.108 . . . . 0.44 110.33 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.601 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -75.29 123.69 25.78 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.394 -0.595 . . . . 1.3 109.394 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 68.1 p -83.94 132.28 34.78 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.827 0.823 . . . . 1.3200000000000001 110.14 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.567 HG13 ' HB3' ' A' ' 7' ' ' TYR . 11.7 pt -132.11 142.83 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.235 -1.348 . . . . 1.0700000000000001 109.273 -177.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.39 150.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.17 0.51 . . . . 1.3 111.055 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.6 mm -114.36 91.72 25.09 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.694 -1.139 . . . . 1.03 109.056 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.52 ' HA ' HD23 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -58.41 135.93 71.04 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.907 2.405 . . . . 0.20000000000000001 112.756 -174.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.47 -5.95 82.42 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.889 -1.05 . . . . 0.26000000000000001 112.269 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.656 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.0 tp -125.41 116.95 25.12 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-O 121.207 0.527 . . . . 1.27 111.395 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.606 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 55.4 Cg_endo -79.25 -177.31 3.8 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.698 2.932 . . . . 0.31 114.075 -172.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.48 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 11.7 t70 -82.98 130.29 58.14 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.433 -1.258 . . . . 0.48999999999999999 112.089 -170.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.628 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 69.5 Cg_endo -75.23 -16.14 19.88 Favored 'Trans proline' 0 CA--C 1.52 -0.211 0 C-N-CA 123.49 2.793 . . . . 0.48999999999999999 112.867 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -95.3 0.3 53.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.752 0.787 . . . . 1.8 110.198 -172.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.48 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 20.2 p -96.97 -19.66 18.63 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 122.508 1.146 . . . . 1.1299999999999999 108.095 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.521 HG23 ' H ' ' A' ' 59' ' ' TYR . 20.5 mt -74.98 133.38 75.81 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 113.198 -1.819 . . . . 1.24 111.296 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.76 -15.5 12.05 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.561 2.174 . . . . 0.47999999999999998 113.742 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.521 ' H ' HG23 ' A' ' 57' ' ' ILE . 51.3 m-85 -100.81 158.34 16.04 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.542 -0.463 . . . . 0.94999999999999996 112.059 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -146.0 133.08 20.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.594 -0.891 . . . . 3.7400000000000002 108.594 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.9 mt -113.66 134.36 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.343 -0.39 . . . . 1.05 111.937 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.54 118.94 32.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.831 -0.748 . . . . 1.0800000000000001 111.473 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.8 t -96.99 116.01 38.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.825 0.822 . . . . 1.04 111.107 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 68' ' ' LYS . 27.7 m -95.68 103.12 14.99 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.754 -1.112 . . . . 0.83999999999999997 110.579 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.512 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.8 mm -51.02 -58.44 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.968 0.889 . . . . 1.0600000000000001 111.548 169.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.43 -12.51 4.6 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 112.782 -2.008 . . . . 0.16 113.208 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.31 -19.83 4.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.403 0.681 . . . . 1.02 112.554 -177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.83 57.99 3.42 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.552 0.615 . . . . 1.3 111.154 -172.225 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -138.57 163.76 31.2 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 112.969 0.729 . . . . 0.98999999999999999 112.969 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.5 tt -131.29 112.92 13.2 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.527 -1.215 . . . . 1.1799999999999999 110.041 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.647 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 23.4 m -92.06 122.95 35.04 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.243 0.544 . . . . 1.04 111.245 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.0 tp -99.43 103.29 15.06 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.1 -0.955 . . . . 1.3200000000000001 109.338 171.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 94.5 p -105.57 161.48 14.33 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.047 -1.061 . . . . 1.05 110.518 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.577 HD11 ' ND2' ' A' ' 75' ' ' ASN . 1.1 tm? -127.55 128.63 45.94 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.498 -0.927 . . . . 1.1000000000000001 108.498 169.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.577 ' ND2' HD11 ' A' ' 74' ' ' LEU . 8.4 p30 45.93 51.29 10.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.097 1.359 . . . . 1.97 111.48 -167.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 79.4 m-20 72.05 -13.62 0.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.587 -0.733 . . . . 2.5499999999999998 111.936 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 75' ' ' ASN . 20.1 tpt180 -96.67 119.07 34.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.309 0.576 . . . . 4.0199999999999996 109.934 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 69.9 t -57.91 132.49 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.313 1.054 . . . . 1.0600000000000001 112.852 -172.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 12.9 mtm -102.28 -45.66 5.05 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 112.994 -1.912 . . . . 1.47 108.85 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.19 171.41 20.22 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.088 -1.869 . . . . 1.98 110.085 -176.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.0 m -149.24 123.73 9.71 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.136 -1.393 . . . . 1.0 109.743 172.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -107.45 151.49 40.96 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.333 -0.849 . . . . 1.3999999999999999 109.291 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HB2' HG23 ' A' ' 134' ' ' ILE . 55.9 Cg_endo -78.9 144.32 18.97 Favored 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 121.871 1.714 . . . . 0.23999999999999999 111.059 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.544 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -141.01 173.33 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.777 -0.647 . . . . 1.04 111.098 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.892 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.23 145.17 45.2 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.342 -0.39 . . . . 1.03 110.299 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.47 HG23 ' HG3' ' A' ' 68' ' ' LYS . 7.1 m -127.97 131.26 69.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.132 0.491 . . . . 1.26 111.773 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -91.6 157.04 24.32 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 109.755 -1.338 . . . . 0.20000000000000001 109.755 171.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.891 ' HG3' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -57.5 8.1 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 114.449 1.278 . . . . 3.48 114.449 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 89' ' ' ILE . 1.0 OUTLIER -97.03 -13.0 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.641 0.734 . . . . 1.0700000000000001 110.339 -177.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.3 mm? -92.67 -15.17 27.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.692 -0.685 . . . . 1.02 109.342 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.1 p -69.06 -21.9 64.05 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.889 -1.05 . . . . 1.05 111.797 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 6.8 mp0 -56.74 -44.3 81.55 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.44 1.496 . . . . 2.0299999999999998 112.332 -176.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.49 117.05 58.02 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.799 -0.637 . . . . 1.1499999999999999 111.36 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 5.9 Cg_exo -73.1 -16.64 25.28 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.73 2.287 . . . . 1.04 113.132 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.1 t -104.0 -41.58 5.82 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.711 -0.477 . . . . 1.1299999999999999 109.711 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.516 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.26 40.19 21.79 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.343 -1.299 . . . . 0.35999999999999999 113.81 168.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -84.08 113.42 21.02 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.026 0.917 . . . . 1.0800000000000001 109.624 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.685 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.8 m-85 -136.73 178.08 7.35 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 113.604 -1.635 . . . . 0.26000000000000001 111.566 -171.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 66.0 m-85 -142.06 136.57 30.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.067 0.461 . . . . 0.78000000000000003 110.902 -172.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.573 HD13 ' HB ' ' A' ' 161' ' ' THR . 80.3 mt -62.46 117.56 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.223 -0.899 . . . . 1.02 110.916 171.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.618 HD11 ' C ' ' A' ' 22' ' ' PHE . 16.3 pt -87.52 -34.36 7.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 113.138 0.792 . . . . 1.03 113.138 -175.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.508 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 12.7 p30 -178.57 179.58 0.74 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.666 -1.235 . . . . 2.0299999999999998 107.666 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.663 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -135.65 163.14 30.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.622 0.725 . . . . 2.02 112.423 -177.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 53.7 tt0 -133.07 101.05 5.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.466 -1.243 . . . . 0.83999999999999997 109.819 172.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.51 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 13.6 ttt180 -63.77 166.27 7.37 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.665 -0.698 . . . . 3.2799999999999998 110.356 174.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.51 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 16.3 m-80 -36.74 101.28 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 113.869 -1.514 . . . . 0.34999999999999998 114.079 -151.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo . . . . . 0 N--CA 1.455 -0.77 0 C-N-CA 123.588 2.858 . . . . 0.63 110.723 169.933 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.51 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.514 0 N-CA-C 116.663 2.097 . . . . 1.1699999999999999 116.663 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 1.641 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.3 OUTLIER -165.56 166.37 18.24 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.465 0.706 . . . . 0.60999999999999999 109.717 -177.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 21.8 t-105 -146.68 98.73 3.1 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.96 -1.126 . . . . 0.56999999999999995 107.96 166.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.507 HD21 ' HG2' ' A' ' 103' ' ' ARG . 1.5 mt -89.39 114.12 25.53 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.337 0.589 . . . . 1.3600000000000001 109.503 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 101' ' ' ILE . 49.9 m -82.98 143.63 30.53 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.991 -0.549 . . . . 0.42999999999999999 111.017 -172.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.771 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -109.36 167.59 10.01 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.139 -0.482 . . . . 1.02 111.696 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.2 t -59.71 -12.86 7.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.686 -1.143 . . . . 1.79 113.175 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.685 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 3.3 tptp -126.87 133.22 50.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.45 -0.5 . . . . 1.8100000000000001 111.075 173.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.449 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 76.9 mt-30 -31.31 -57.41 0.25 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.02 1.118 . . . . 1.76 114.02 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.536 ' CB ' HG12 ' A' ' 89' ' ' ILE . 87.9 m-70 -95.7 3.15 54.15 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.231 -0.588 . . . . 3.2000000000000002 111.902 -170.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.771 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -95.14 38.19 1.14 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.661 0.985 . . . . 0.83999999999999997 113.661 -172.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.567 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -112.65 143.15 17.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 117.319 -2.372 . . . . 0.96999999999999997 112.565 -153.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -98.94 115.15 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.868 0.842 . . . . 1.04 110.801 -176.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.621 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 28.8 p80 -144.28 171.82 13.78 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-N 115.166 -0.925 . . . . 0.20999999999999999 109.789 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.02 -166.64 38.57 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 120.799 -0.715 . . . . 0.34999999999999998 111.73 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.1 t -156.98 169.16 25.45 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.266 -0.549 . . . . 1.1100000000000001 110.486 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -111.39 0.11 16.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.682 -0.859 . . . . 2.1899999999999999 108.682 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -118.07 86.22 25.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.755 -1.111 . . . . 1.8400000000000001 108.199 171.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -72.5 -19.92 24.31 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.77 2.313 . . . . 0.39000000000000001 114.175 -166.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.1 -4.01 42.21 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.034 0.445 . . . . 1.0800000000000001 110.839 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.0 t -85.71 -13.11 49.45 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.906 -0.776 . . . . 1.9399999999999999 108.906 172.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.429 HG23 ' HB2' ' A' ' 83' ' ' PRO . 28.6 mm -77.54 134.71 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 115.257 -0.883 . . . . 1.04 110.413 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.8 -1.38 71.23 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.217 -1.153 . . . . 0.16 110.217 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' ALA . 48.4 mttt -112.1 172.3 6.99 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 123.012 1.387 . . . . 3.0299999999999998 113.887 -177.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.32 127.72 45.36 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 112.189 -2.278 . . . . 1.01 108.046 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.495 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 1.4 p -118.57 167.91 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.054 -1.462 . . . . 1.3400000000000001 107.054 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.891 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 45.2 m -64.48 -59.68 4.04 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 119.731 -0.788 . . . . 0.87 111.949 177.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -127.34 -44.14 1.58 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 117.207 -1.797 . . . . 2.5499999999999998 113.9 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -33.39 132.56 0.31 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.67 1.428 . . . . 0.19 116.67 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.621 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 4.2 p -68.75 166.36 17.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.41 -1.895 . . . . 0.20000000000000001 112.141 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.892 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 66.9 mt -59.07 99.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 122.569 1.176 . . . . 1.1299999999999999 111.991 -163.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.616 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 50.3 mtt180 -86.09 147.1 26.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.371 -1.74 . . . . 2.3300000000000001 110.389 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.544 ' HG2' HG21 ' A' ' 84' ' ' ILE . 13.0 mtp -128.12 -166.21 1.59 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.29 -0.633 . . . . 1.0900000000000001 109.29 175.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.59 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 5.5 t60 -95.55 156.38 16.35 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.909 -0.775 . . . . 2.9900000000000002 108.909 171.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.608 ' O ' HD11 ' A' ' 151' ' ' ILE . 2.1 m120 -57.1 -52.69 64.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 118.422 -0.799 . . . . 0.73999999999999999 110.293 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.87 -25.82 68.48 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 121.154 1.797 . . . . 2.6899999999999999 112.522 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.59 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 7.5 m-20 -84.67 -41.38 16.35 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.303 -0.408 . . . . 0.68999999999999995 111.186 -175.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.543 HG12 HD13 ' A' ' 151' ' ' ILE . 13.3 p -67.94 -23.75 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.016 -0.538 . . . . 1.02 111.143 175.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.608 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.24 -39.67 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 119.042 -0.504 . . . . 1.1699999999999999 109.739 171.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.0 mm-40 -45.86 -72.06 0.06 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.171 0.896 . . . . 1.99 112.366 168.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 157' ' ' VAL . 44.8 mt -47.27 -38.46 12.5 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.675 0.75 . . . . 1.9099999999999999 111.495 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.35 79.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.126 -1.397 . . . . 1.04 111.664 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.9 t -88.44 -33.0 18.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 118.58 0.627 . . . . 0.88 112.416 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 152' ' ' GLU . 30.4 mt -81.24 -59.63 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.551 0.691 . . . . 1.0 111.193 -172.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 153' ' ' LEU . 2.8 m -92.58 140.12 23.86 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.845 -1.071 . . . . 1.0700000000000001 112.227 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.663 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 57.3 Cg_endo -89.86 177.14 2.64 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.114 3.209 . . . . 0.23999999999999999 111.122 173.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.508 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 12.7 m120 -67.07 157.8 32.64 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 119.658 -0.817 . . . . 1.1000000000000001 109.525 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 99.39 -25.58 27.69 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.211 -0.995 . . . . 0.17999999999999999 112.289 -173.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.573 ' HB ' HD13 ' A' ' 100' ' ' ILE . 36.1 m -61.41 138.31 58.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.383 -0.599 . . . . 1.05 109.383 -173.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.521 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 9.8 ptm180 -92.81 127.71 38.41 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.964 1.364 . . . . 4.1100000000000003 111.369 -170.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.3 t -109.58 108.34 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 111.915 -2.402 . . . . 1.02 109.008 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.6 m -94.76 107.05 19.06 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.524 0.564 . . . . 1.0700000000000001 112.524 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.516 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -82.86 100.75 6.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 122.29 1.043 . . . . 1.05 109.992 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -110.17 133.31 53.35 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.229 -1.35 . . . . 1.0900000000000001 109.832 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.512 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.6 mmm180 . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 116.465 -0.334 . . . . 2.4900000000000002 110.829 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 121.453 0.644 . . . . 1.3300000000000001 111.745 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.616 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.4 tt -94.63 130.87 40.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.857 -1.065 . . . . 1.0700000000000001 110.142 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.75 162.25 13.51 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.129 0.966 . . . . 1.03 113.171 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.652 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 84.7 t80 -129.57 139.98 51.34 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.469 -1.696 . . . . 1.0800000000000001 107.902 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.454 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.1 tt0 -112.93 110.89 21.25 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.242 -1.021 . . . . 0.93000000000000005 108.242 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.585 HG11 ' HB2' ' A' ' 13' ' ' ASP . 92.7 t -66.05 149.45 11.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 122.564 1.173 . . . . 1.1000000000000001 113.578 -167.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -98.93 159.97 14.59 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.211 -1.813 . . . . 2.4399999999999999 109.799 172.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.444 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 1.4 mm-40 -62.43 105.37 0.61 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.886 -1.052 . . . . 2.4300000000000002 111.432 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.94 11.66 49.05 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.485 -0.779 . . . . 0.51000000000000001 113.542 175.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.585 ' HB2' HG11 ' A' ' 9' ' ' VAL . 59.3 m-20 -52.38 169.52 0.08 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 117.423 0.611 . . . . 1.46 111.362 171.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.84 154.69 44.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.475 0.655 . . . . 1.1599999999999999 111.271 175.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.518 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.97 -33.23 75.34 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.394 -0.965 . . . . 1.47 108.394 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.441 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 17.8 t-20 -88.62 -25.12 22.6 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.883 -1.053 . . . . 1.78 111.391 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.4 p -68.76 -38.56 80.18 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 119.72 -0.792 . . . . 1.74 109.601 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 mt -75.47 -26.89 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.219 0.533 . . . . 1.04 109.75 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.91 -9.86 59.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.326 -0.397 . . . . 1.0600000000000001 110.646 174.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.716 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.44 -41.37 8.63 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.274 -1.01 . . . . 0.97999999999999998 108.274 176.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.465 ' OD1' ' HA ' ' A' ' 120' ' ' LYS . 1.5 m-20 -61.68 -39.45 91.47 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.015 -1.902 . . . . 0.53000000000000003 112.073 174.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' O ' HD11 ' A' ' 101' ' ' ILE . 68.4 m-85 -103.32 5.9 37.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 118.566 -1.254 . . . . 0.20000000000000001 111.487 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.716 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER 54.74 41.5 31.88 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.972 0.891 . . . . 2.46 109.559 176.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.8 pt -114.42 -165.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.208 -1.36 . . . . 1.04 110.024 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 142.62 41.07 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.241 -0.891 . . . . 1.3400000000000001 110.21 174.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.529 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 72.3 p -71.97 -34.01 68.61 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.007 -1.108 . . . . 1.0900000000000001 108.007 178.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.27 69.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.42 -0.809 . . . . 1.0700000000000001 111.816 170.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.37 -26.26 18.99 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.689 0.757 . . . . 1.04 109.093 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.656 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.1 tp -75.19 -26.29 58.89 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.09 -0.959 . . . . 1.8100000000000001 109.261 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 26' ' ' THR . 33.6 mt -77.86 -29.89 50.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.765 0.793 . . . . 1.6399999999999999 109.828 171.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 40.8 tt0 -64.49 -43.28 94.63 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.413 -1.267 . . . . 2.3300000000000001 109.95 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.442 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -83.18 -20.35 34.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.105 -0.638 . . . . 1.0600000000000001 111.495 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.3 m-80 -148.16 81.05 8.34 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.509 0.671 . . . . 0.23000000000000001 110.442 -172.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.4 Cg_endo -57.71 -10.93 8.09 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 124.077 3.185 . . . . 0.52000000000000002 114.057 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.5 t -80.67 -22.12 40.72 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.053 -0.404 . . . . 1.6499999999999999 111.249 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.656 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 38.1 mt -66.41 -35.67 80.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.526 0.679 . . . . 1.25 111.883 -171.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -65.51 -47.92 74.31 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 122.871 1.32 . . . . 2.52 110.167 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.51 82.56 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 111.934 -2.394 . . . . 1.1899999999999999 110.594 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.17 -179.53 48.19 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.857 -1.065 . . . . 0.44 111.541 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.01 158.22 23.44 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.212 0.529 . . . . 1.1699999999999999 110.791 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 29.4 m -139.05 128.11 23.81 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.493 -0.776 . . . . 1.1499999999999999 110.406 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' A' ' 11' ' ' GLN . . . -75.27 118.89 18.67 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.566 0.698 . . . . 1.1200000000000001 109.772 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.39 0.74 55.65 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.374 -1.09 . . . . 0.44 110.374 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.2 OUTLIER -76.42 124.16 27.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.985 -0.607 . . . . 1.3 109.469 179.366 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 24.4 p -84.45 126.17 33.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.967 0.889 . . . . 1.3200000000000001 110.752 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.56 HG13 ' HB3' ' A' ' 7' ' ' TYR . 10.6 pt -126.94 144.38 37.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.133 -1.394 . . . . 1.0700000000000001 109.377 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.68 151.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.125 0.488 . . . . 1.3 111.164 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.416 HG22 ' CD2' ' A' ' 22' ' ' PHE . 39.3 mm -116.35 91.69 33.93 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.885 -1.052 . . . . 1.03 109.425 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.501 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . 2.6 Cg_endo -56.93 133.7 59.67 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.834 2.356 . . . . 0.20000000000000001 112.551 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.18 -5.79 78.4 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.701 -1.136 . . . . 0.26000000000000001 112.569 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.66 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 25.6 tp -125.71 115.56 24.73 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.949 0.404 . . . . 1.27 111.452 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.641 ' HD2' HD13 ' A' ' 51' ' ' LEU . 36.4 Cg_endo -76.79 -177.82 4.07 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.565 2.844 . . . . 0.31 114.331 -172.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD2' ' HB2' ' A' ' 55' ' ' TYR . 16.1 t70 -78.31 133.05 64.67 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 113.94 -1.482 . . . . 0.48999999999999999 112.139 -170.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.47 -9.36 18.72 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.314 2.676 . . . . 0.48999999999999999 112.717 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.508 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 16.4 m-30 -93.9 -8.28 40.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.119 0.485 . . . . 1.8 110.52 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.492 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 19.0 p -88.72 -17.67 29.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.065 0.936 . . . . 1.1299999999999999 108.674 174.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.556 HG23 ' H ' ' A' ' 59' ' ' TYR . 9.6 mm -64.72 126.14 90.28 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 113.838 -1.528 . . . . 1.24 109.989 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.71 -13.48 10.62 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.999 1.799 . . . . 0.47999999999999998 112.608 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.556 ' H ' HG23 ' A' ' 57' ' ' ILE . 67.0 m-85 -103.68 170.56 7.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.281 0.562 . . . . 0.94999999999999996 111.825 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -153.81 134.07 13.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.117 -0.947 . . . . 3.7400000000000002 108.536 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 71' ' ' THR . 93.1 mt -111.54 130.34 65.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.342 -0.39 . . . . 1.05 111.322 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.87 115.48 28.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.937 -0.705 . . . . 1.0800000000000001 110.847 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 47.8 t -96.64 114.04 32.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.79 0.805 . . . . 1.04 110.571 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 68' ' ' LYS . 27.1 m -94.76 100.35 12.27 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.49 -1.232 . . . . 0.83999999999999997 110.359 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.0 mm -50.47 -57.32 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 122.028 0.918 . . . . 1.0600000000000001 111.13 170.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.34 -11.53 3.63 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 112.787 -2.006 . . . . 0.16 113.131 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -126.49 -17.53 5.07 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.436 0.694 . . . . 1.02 112.595 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.547 ' HB2' ' HZ2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 57.97 54.25 6.18 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.505 0.593 . . . . 1.3 111.488 -173.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.6 p -136.7 163.48 30.48 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.798 0.666 . . . . 0.98999999999999999 112.798 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.417 ' C ' HD21 ' A' ' 70' ' ' LEU . 7.5 tt -128.13 111.52 13.56 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.595 -1.184 . . . . 1.1799999999999999 109.549 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.635 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 31.2 m -93.41 121.77 35.15 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.261 0.553 . . . . 1.04 110.962 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 79' ' ' MET . 16.0 tp -96.79 104.96 17.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.179 -0.918 . . . . 1.3200000000000001 109.078 172.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 97.9 p -106.8 159.23 16.39 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.981 -1.088 . . . . 1.05 110.368 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.6 HD23 ' N ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -123.73 125.51 44.88 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.561 -0.903 . . . . 1.1000000000000001 108.561 170.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.6 ' N ' HD23 ' A' ' 74' ' ' LEU . 9.4 p30 41.06 54.83 3.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.713 -1.585 . . . . 1.97 111.58 -164.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 6.7 m-20 74.7 -13.62 0.8 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.008 -0.996 . . . . 2.5499999999999998 112.146 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -95.28 120.39 35.43 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.231 0.539 . . . . 4.0199999999999996 110.025 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 58.9 t -56.93 131.04 20.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 122.357 1.075 . . . . 1.0600000000000001 113.002 -173.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.518 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 2.8 mmm -97.99 -46.88 5.74 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.947 -1.933 . . . . 1.47 108.854 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.8 mmtt -160.56 173.99 14.7 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.046 -1.888 . . . . 1.98 110.037 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.8 m -149.6 123.7 9.46 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.224 -1.353 . . . . 1.0 109.699 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -114.94 145.06 33.21 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.6 -0.727 . . . . 1.3999999999999999 109.959 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HB2' HG23 ' A' ' 134' ' ' ILE . 37.3 Cg_endo -72.42 142.28 36.63 Favored 'Trans proline' 0 CA--C 1.496 -1.418 0 C-N-CA 122.259 1.973 . . . . 0.23999999999999999 111.173 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.527 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.32 172.56 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 115.517 -0.765 . . . . 1.04 110.959 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.917 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.04 139.66 50.88 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.237 -0.438 . . . . 1.03 109.88 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.463 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 10.9 m -121.74 126.87 75.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.713 0.768 . . . . 1.26 111.541 -177.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -82.18 150.63 29.1 Favored Glycine 0 N--CA 1.419 -2.452 0 N-CA-C 109.186 -1.566 . . . . 0.20000000000000001 109.186 171.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -57.19 4.39 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.809 0.67 . . . . 3.48 112.809 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.502 ' H ' ' C ' ' A' ' 87' ' ' GLY . 1.1 tp -87.46 -19.04 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.481 0.658 . . . . 1.0700000000000001 110.077 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.7 mm? -88.84 -16.36 32.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.694 0.759 . . . . 1.02 109.228 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.5 p -69.23 -18.51 63.9 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.565 -1.198 . . . . 1.05 111.194 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.25 -40.17 93.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.536 -1.211 . . . . 2.0299999999999998 112.704 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.67 131.26 29.75 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 119.799 -0.76 . . . . 1.1499999999999999 110.956 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.466 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 83.8 Cg_endo -86.97 -1.86 8.04 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.43 2.087 . . . . 1.04 112.314 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.3 t -119.62 -41.48 2.69 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.418 -0.586 . . . . 1.1299999999999999 109.418 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 165' ' ' ILE . . . 54.87 16.86 8.28 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 114.716 -1.129 . . . . 0.35999999999999999 114.413 169.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.526 ' HB3' HG21 ' A' ' 164' ' ' THR . 10.6 pt-20 -84.42 116.7 23.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.495 1.14 . . . . 1.0800000000000001 109.816 -173.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.589 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 11.3 m-85 -137.58 -174.78 3.86 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.278 -1.783 . . . . 0.26000000000000001 111.436 -166.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 162' ' ' ARG . 39.2 m-85 -142.18 137.95 31.19 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 120.945 0.402 . . . . 0.78000000000000003 110.991 -173.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.604 HD13 ' HB ' ' A' ' 161' ' ' THR . 80.2 mt -65.04 125.04 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.542 -0.753 . . . . 1.02 110.308 169.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.569 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 21.9 pt -91.45 -42.13 13.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 113.024 0.75 . . . . 1.03 113.024 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.508 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 57.6 m-80 -170.13 173.0 6.08 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.009 -1.478 . . . . 2.0299999999999998 107.009 -170.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.582 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 40.7 mtt180 -125.8 167.9 14.56 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.696 -0.802 . . . . 2.02 111.739 -175.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -145.44 100.76 3.5 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.148 -0.933 . . . . 0.83999999999999997 110.019 171.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.495 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 25.9 ttp180 -66.02 166.31 11.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.302 -0.863 . . . . 3.2799999999999998 110.735 175.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 33.8 m-80 -36.37 101.51 0.22 Allowed Pre-proline 0 C--O 1.233 0.207 0 C-N-CA 124.942 1.297 . . . . 0.34999999999999998 113.104 -156.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.4 Cg_endo . . . . . 0 C--N 1.347 0.47 0 C-N-CA 123.453 2.768 . . . . 0.63 112.601 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.607 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . . . . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 121.157 0.503 . . . . 1.1699999999999999 110.111 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.444 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -157.37 157.51 34.2 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.66 0.384 . . . . 0.60999999999999999 110.079 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -136.52 100.22 4.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.973 -1.121 . . . . 0.56999999999999995 107.973 165.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 103' ' ' ARG . 5.0 mt -93.52 114.18 26.49 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.64 -0.874 . . . . 1.3600000000000001 108.64 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.2 m -84.25 144.45 28.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.675 -0.693 . . . . 0.42999999999999999 111.213 -165.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -109.54 169.46 8.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 1.02 111.394 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.0 t -63.97 -12.21 35.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.848 -1.069 . . . . 1.79 112.787 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.732 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 3.9 tmtm? -127.65 132.31 49.74 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.158 0.98 . . . . 1.8100000000000001 109.704 171.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.732 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.0 mt-30 -37.57 -47.23 0.91 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.524 -2.126 . . . . 1.76 114.211 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.472 ' CB ' HG12 ' A' ' 89' ' ' ILE . 37.2 m80 -97.9 2.22 48.92 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.366 0.603 . . . . 3.2000000000000002 111.024 -171.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.795 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.6 m-85 -99.38 37.35 1.58 Allowed 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.495 0.924 . . . . 0.83999999999999997 113.495 -171.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.509 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -117.03 142.27 17.31 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 116.874 -2.584 . . . . 0.96999999999999997 112.668 -152.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -95.64 116.12 36.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 123.966 0.906 . . . . 1.04 110.868 -175.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.716 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 26.7 p80 -146.36 -179.01 6.45 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.186 -0.461 . . . . 0.20999999999999999 111.822 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.39 -167.98 37.05 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 111.19 -0.764 . . . . 0.34999999999999998 111.19 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.4 t -156.95 172.29 18.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 117.912 0.856 . . . . 1.1100000000000001 110.911 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -115.42 -2.43 12.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.528 -0.916 . . . . 2.1899999999999999 108.528 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -124.86 89.17 52.93 Favored Pre-proline 0 C--O 1.235 0.333 0 CA-C-N 114.426 -1.261 . . . . 1.8400000000000001 108.858 171.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -74.32 -21.04 17.95 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.627 2.218 . . . . 0.39000000000000001 114.113 -169.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.02 -3.65 40.14 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.034 0.445 . . . . 1.0800000000000001 111.337 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.9 m -91.13 -2.33 57.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.125 0.488 . . . . 1.9399999999999999 109.812 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.431 HG23 ' HB2' ' A' ' 83' ' ' PRO . 33.5 mm -77.23 136.34 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.919 -0.582 . . . . 1.04 110.026 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.59 2.12 65.57 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.314 -1.114 . . . . 0.16 110.314 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 30.2 mttm -114.87 169.96 8.69 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 123.315 1.531 . . . . 3.0299999999999998 114.635 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.4 126.51 48.18 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.67 -2.514 . . . . 1.01 108.203 176.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.77 161.23 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.446 -0.946 . . . . 1.3400000000000001 108.446 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.0 m -49.8 -60.1 3.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.794 0.664 . . . . 0.87 112.794 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -132.61 -44.46 0.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.36 -1.336 . . . . 2.5499999999999998 113.984 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.49 133.65 0.2 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 117.19 1.636 . . . . 0.19 117.19 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.544 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 2.4 p -71.22 165.6 23.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 112.545 -1.827 . . . . 0.20000000000000001 112.026 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.917 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 56.0 mt -60.01 96.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 122.538 1.161 . . . . 1.1299999999999999 111.783 -162.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.716 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 80.5 mtt180 -84.93 141.76 30.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.681 -1.6 . . . . 2.3300000000000001 109.399 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.527 ' HG2' HG21 ' A' ' 84' ' ' ILE . 24.4 mtp -118.6 179.22 4.19 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.477 0.656 . . . . 1.0900000000000001 109.857 175.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.569 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 9.5 t-80 -81.45 145.83 30.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.882 -1.155 . . . . 2.9900000000000002 107.882 168.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.673 ' O ' HD12 ' A' ' 151' ' ' ILE . 6.9 m120 -66.17 -40.47 90.52 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 114.883 -1.053 . . . . 0.73999999999999999 112.566 -166.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -67.54 -23.83 65.48 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 121.801 2.091 . . . . 2.6899999999999999 112.241 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 12.2 m-20 -85.19 -38.23 19.22 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.216 -0.447 . . . . 0.68999999999999995 110.851 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 147' ' ' ASN . 12.2 p -67.55 -21.98 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.852 -0.613 . . . . 1.02 111.176 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.19 -43.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 118.948 -0.549 . . . . 1.1699999999999999 109.923 171.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 156' ' ' ILE . 23.5 mt-10 -46.81 -70.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 119.385 0.993 . . . . 1.99 112.761 170.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 157' ' ' VAL . 27.3 mt -47.07 -38.62 11.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.631 0.729 . . . . 1.9099999999999999 111.658 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.65 -31.96 71.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.079 -1.419 . . . . 1.04 111.712 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.7 t -88.34 -31.77 18.75 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.481 -0.762 . . . . 0.88 112.324 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 152' ' ' GLU . 24.2 mt -82.31 -60.84 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.534 0.683 . . . . 1.0 111.828 -171.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 153' ' ' LEU . 8.7 m -88.35 139.46 30.16 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 114.783 -1.099 . . . . 1.0700000000000001 112.342 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.582 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 42.4 Cg_endo -88.54 174.55 4.13 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 124.37 3.38 . . . . 0.23999999999999999 111.119 176.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.508 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 54.0 m-20 -68.18 156.93 36.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.905 -1.118 . . . . 1.1000000000000001 108.219 175.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.78 -16.07 61.9 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.772 -1.204 . . . . 0.17999999999999999 111.928 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.604 ' HB ' HD13 ' A' ' 100' ' ' ILE . 95.2 m -64.91 135.29 55.54 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.203 -0.666 . . . . 1.05 109.203 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 99' ' ' TYR . 1.7 ptt180 -92.82 122.42 35.19 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.685 1.231 . . . . 4.1100000000000003 111.078 -170.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 39.8 t -110.14 109.56 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 112.204 -2.271 . . . . 1.02 109.475 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.526 HG21 ' HB3' ' A' ' 97' ' ' GLU . 6.9 m -97.35 110.28 22.86 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.082 0.771 . . . . 1.0700000000000001 113.082 -172.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.48 ' O ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -83.17 102.16 8.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.11 0.957 . . . . 1.05 109.792 176.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -109.22 129.84 55.5 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.979 -1.009 . . . . 1.0900000000000001 110.037 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 9.9 mmm180 . . . . . 0 C--N 1.321 -0.652 0 CA-C-O 121.362 0.601 . . . . 2.4900000000000002 109.432 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.765 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 tp . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.189 0.519 . . . . 1.3300000000000001 111.186 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.9 tt -94.28 126.42 39.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.521 -0.763 . . . . 1.0700000000000001 110.615 -174.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.71 161.62 13.8 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.051 0.929 . . . . 1.03 113.064 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.657 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 78.7 t80 -131.29 141.48 49.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.808 -1.542 . . . . 1.0800000000000001 108.058 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.5 tt0 -113.27 111.04 21.37 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.055 -1.091 . . . . 0.93000000000000005 108.055 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' ' 13' ' ' ASP . 94.3 t -66.52 150.49 10.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 122.155 0.978 . . . . 1.1000000000000001 113.032 -168.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -104.14 158.85 16.15 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.869 -1.514 . . . . 2.4399999999999999 108.658 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 1.1 tt0 -61.54 101.62 0.19 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.974 0.416 . . . . 2.4300000000000002 112.09 -175.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.79 11.97 27.27 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.754 -0.736 . . . . 0.51000000000000001 113.237 174.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.609 ' HB2' HG11 ' A' ' 9' ' ' VAL . 35.7 m-20 -55.54 170.48 0.25 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.912 0.356 . . . . 1.46 111.348 171.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.7 155.11 49.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.459 0.647 . . . . 1.1599999999999999 111.893 174.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -69.21 -29.71 67.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.526 -1.216 . . . . 1.47 109.897 -177.255 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.442 ' HA ' HG23 ' A' ' 26' ' ' THR . 65.9 t30 -93.79 -23.26 18.23 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.927 -1.033 . . . . 1.78 111.164 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.3 m -70.0 -39.84 75.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.553 -0.459 . . . . 1.74 109.886 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.428 HG21 ' CE1' ' A' ' 22' ' ' PHE . 15.2 mt -73.2 -27.4 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.112 0.482 . . . . 1.04 109.977 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.619 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.76 -10.42 59.77 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.811 -0.356 . . . . 1.0600000000000001 110.928 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.534 ' O ' ' HD3' ' A' ' 23' ' ' ARG . . . -97.16 -40.3 8.87 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 122.214 1.007 . . . . 0.97999999999999998 108.404 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.45 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 4.4 m-20 -61.44 -43.43 98.88 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.227 -1.806 . . . . 0.53000000000000003 111.867 173.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.607 ' C ' HD11 ' A' ' 101' ' ' ILE . 67.8 m-85 -98.01 8.19 45.14 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.574 -1.25 . . . . 0.20000000000000001 111.571 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.534 ' HD3' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER 52.08 40.65 28.95 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.613 0.721 . . . . 2.46 110.215 177.439 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.619 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.6 pt -113.63 -164.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 114.511 -1.222 . . . . 1.04 109.28 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -109.9 157.17 19.52 Favored 'General case' 0 CA--C 1.491 -1.318 0 CA-C-O 122.375 1.083 . . . . 1.3400000000000001 110.168 169.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.562 ' HB ' ' CD1' ' A' ' 15' ' ' LEU . 75.7 p -80.68 -31.12 36.4 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 112.914 -1.948 . . . . 1.0900000000000001 107.553 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 -30.72 71.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.098 -0.956 . . . . 1.0700000000000001 111.76 172.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -89.95 -26.87 20.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.728 -0.842 . . . . 1.04 108.728 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.588 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 20.0 tp -74.14 -28.18 61.2 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.355 -0.839 . . . . 1.8100000000000001 109.789 175.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' ' 36' ' ' LEU . 48.3 mt -77.79 -29.31 50.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.959 0.885 . . . . 1.6399999999999999 109.919 172.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 53.9 tt0 -67.9 -39.65 83.59 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.082 -1.417 . . . . 2.3300000000000001 110.572 174.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.433 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -84.67 -19.94 32.06 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.075 -0.65 . . . . 1.0600000000000001 111.409 176.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.571 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 26.8 m-80 -147.05 80.64 9.34 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-O 121.217 0.532 . . . . 0.23000000000000001 110.351 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.15 -11.2 7.36 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 123.889 3.059 . . . . 0.52000000000000002 113.305 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 m -74.05 -25.72 60.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.848 0.356 . . . . 1.6499999999999999 111.53 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.588 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 40.6 mt -70.91 -32.46 69.4 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.353 0.596 . . . . 1.25 112.462 -168.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -63.59 -44.64 93.43 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 123.057 1.408 . . . . 2.52 110.395 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.37 79.19 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 111.722 -2.49 . . . . 1.1899999999999999 110.693 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.41 178.33 48.65 Favored Glycine 0 N--CA 1.425 -2.094 0 CA-C-N 115.117 -0.947 . . . . 0.44 111.929 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.41 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -110.67 158.05 19.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.225 0.536 . . . . 1.1699999999999999 110.569 178.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.542 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 74.4 m -140.91 127.55 20.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.355 -0.839 . . . . 1.1499999999999999 110.301 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 11' ' ' GLN . . . -75.07 122.71 23.96 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.364 0.602 . . . . 1.1200000000000001 110.028 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.67 3.02 61.18 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 110.533 -1.027 . . . . 0.44 110.533 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.542 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.52 123.12 28.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.626 -0.509 . . . . 1.3 109.626 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 17.0 p -77.78 126.36 30.74 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.852 0.834 . . . . 1.3200000000000001 110.657 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.563 HG13 ' HB3' ' A' ' 7' ' ' TYR . 9.1 pt -126.13 144.07 37.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.138 -1.392 . . . . 1.0700000000000001 109.198 -178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.15 151.44 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.347 0.594 . . . . 1.3 111.191 -179.023 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.82 93.38 41.23 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.554 -1.203 . . . . 1.03 109.227 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.522 ' HA ' HD23 ' A' ' 4' ' ' LEU . 3.1 Cg_exo -56.12 133.91 60.97 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.488 2.125 . . . . 0.20000000000000001 112.535 -176.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.77 -6.88 79.76 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 114.412 -1.267 . . . . 0.26000000000000001 112.363 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.765 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER -112.98 118.49 44.41 Favored Pre-proline 0 C--O 1.217 -0.637 0 CA-C-N 116.98 0.39 . . . . 1.27 111.186 178.172 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.498 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 37.0 Cg_endo -80.0 -176.8 3.41 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.083 2.522 . . . . 0.31 112.65 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.471 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 9.7 t70 -86.72 127.37 60.49 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-N 115.363 -0.835 . . . . 0.48999999999999999 112.044 -168.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.567 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.1 Cg_endo -75.65 -10.39 20.17 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 123.626 2.884 . . . . 0.48999999999999999 112.934 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -94.08 -13.92 26.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.549 0.69 . . . . 1.8 110.186 -176.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 23.7 p -87.32 -21.23 25.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.507 1.146 . . . . 1.1299999999999999 108.176 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.478 HG23 ' H ' ' A' ' 59' ' ' TYR . 35.8 mt -73.89 129.08 85.58 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.124 -1.853 . . . . 1.24 111.018 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.06 -16.22 14.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.424 2.083 . . . . 0.47999999999999998 113.416 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.478 ' H ' HG23 ' A' ' 57' ' ' ILE . 62.9 m-85 -94.66 160.12 14.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.582 -0.447 . . . . 0.94999999999999996 111.591 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -150.99 132.03 14.31 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.902 -0.777 . . . . 3.7400000000000002 108.902 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 71' ' ' THR . 80.2 mt -112.49 136.38 48.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.233 -0.44 . . . . 1.05 111.889 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.77 117.39 29.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 119.957 -0.697 . . . . 1.0800000000000001 110.924 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.2 t -97.33 112.88 30.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.775 0.797 . . . . 1.04 110.53 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 68' ' ' LYS . 49.6 m -93.6 100.75 12.95 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.717 -1.129 . . . . 0.83999999999999997 110.546 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.8 mm -50.79 -58.77 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.894 0.854 . . . . 1.0600000000000001 111.443 170.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.92 -8.21 2.09 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 112.922 -1.945 . . . . 0.16 113.245 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 65' ' ' ILE . . . -127.46 -19.17 4.27 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.697 0.799 . . . . 1.02 112.267 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 59.24 54.51 4.77 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.335 0.516 . . . . 1.3 111.293 -172.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.6 p -137.29 166.2 24.34 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 112.787 0.662 . . . . 0.98999999999999999 112.787 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.9 tt -136.26 112.22 9.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.861 -1.063 . . . . 1.1799999999999999 110.197 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 86.6 m -93.24 124.3 37.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.146 0.498 . . . . 1.04 110.879 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.9 tp -99.78 107.3 19.31 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.173 -0.921 . . . . 1.3200000000000001 109.25 172.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 88.8 p -105.42 161.4 14.35 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.013 -1.075 . . . . 1.05 110.546 176.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -125.99 126.69 44.72 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.575 -0.898 . . . . 1.1000000000000001 108.575 167.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.551 ' N ' HD23 ' A' ' 74' ' ' LEU . 29.1 m-80 51.15 48.61 22.73 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.607 -1.179 . . . . 1.97 111.067 -172.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.0 t30 71.71 -5.89 1.56 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.339 0.656 . . . . 2.5499999999999998 111.414 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -104.94 120.64 41.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.125 0.488 . . . . 4.0199999999999996 110.582 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 54.7 t -55.23 132.85 18.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 122.361 1.077 . . . . 1.0600000000000001 113.399 -174.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.496 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 6.9 mmm -100.85 -44.43 5.77 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.229 -1.805 . . . . 1.47 109.275 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -159.37 173.43 16.26 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 113.189 -1.823 . . . . 1.98 110.156 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.0 m -149.3 123.08 9.27 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.986 -1.461 . . . . 1.0 109.391 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -108.85 156.6 38.72 Favored Pre-proline 0 C--N 1.312 -1.04 0 N-CA-C 109.386 -0.598 . . . . 1.3999999999999999 109.386 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.425 ' HB2' HG23 ' A' ' 134' ' ' ILE . 50.7 Cg_endo -80.69 144.2 15.41 Favored 'Trans proline' 0 CA--C 1.497 -1.372 0 C-N-CA 121.975 1.783 . . . . 0.23999999999999999 110.83 170.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.526 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -140.08 172.75 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.614 -0.721 . . . . 1.04 110.551 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.826 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.05 137.69 52.73 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.846 0.355 . . . . 1.03 110.321 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.461 HG21 ' HG3' ' A' ' 68' ' ' LYS . 13.2 m -121.11 130.16 74.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.678 -0.692 . . . . 1.26 111.527 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -88.91 154.26 24.46 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.988 -1.245 . . . . 0.20000000000000001 109.988 171.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -57.08 4.55 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 113.133 0.79 . . . . 3.48 113.133 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 89' ' ' ILE . 1.0 OUTLIER -88.78 -18.97 7.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.78 0.8 . . . . 1.0700000000000001 110.074 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.511 ' HG ' HD13 ' A' ' 143' ' ' ILE . 3.5 mm? -88.66 -18.53 27.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.791 0.805 . . . . 1.02 108.909 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.8 p -68.51 -15.05 63.41 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.376 -1.284 . . . . 1.05 111.658 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -69.6 -42.26 74.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.918 -1.037 . . . . 2.0299999999999998 112.127 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.72 111.94 62.7 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 1.1499999999999999 111.108 -175.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 1.9 Cg_endo -77.43 -11.87 17.19 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.831 2.354 . . . . 1.04 113.126 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.2 t -98.88 -43.58 6.68 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.468 -0.567 . . . . 1.1299999999999999 109.468 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.526 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 54.44 27.21 40.19 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.255 -1.339 . . . . 0.35999999999999999 114.228 168.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -84.59 111.86 19.91 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.988 0.899 . . . . 1.0800000000000001 109.363 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.681 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 22.4 m-85 -138.46 -176.9 4.62 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.66 -1.609 . . . . 0.26000000000000001 111.661 -170.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -143.96 144.12 31.55 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.974 0.416 . . . . 0.78000000000000003 110.552 -173.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.565 HD13 ' HB ' ' A' ' 161' ' ' THR . 82.3 mt -68.75 113.01 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.336 -0.847 . . . . 1.02 109.995 168.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.607 HD11 ' C ' ' A' ' 22' ' ' PHE . 18.7 pt -80.65 -43.54 21.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.569 -0.741 . . . . 1.03 112.552 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.815 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 52.1 m-80 -169.12 169.47 9.38 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.007 -1.479 . . . . 2.0299999999999998 107.007 -170.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.433 ' HB3' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -134.76 157.59 46.34 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.99 -0.684 . . . . 2.02 112.396 -177.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.508 ' NE2' ' HB3' ' A' ' 107' ' ' PRO . 29.8 tt0 -130.86 100.92 5.43 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.723 -1.126 . . . . 0.83999999999999997 109.85 174.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.466 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 52.0 ttt180 -61.45 165.31 4.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.35 -0.841 . . . . 3.2799999999999998 110.137 173.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.759 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 29.9 m-80 -34.99 100.91 0.2 Allowed Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 125.12 1.368 . . . . 0.34999999999999998 112.657 -156.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.508 ' HB3' ' NE2' ' A' ' 104' ' ' GLN . 19.7 Cg_endo . . . . . 0 N--CA 1.463 -0.308 0 C-N-CA 123.25 2.633 . . . . 0.63 112.827 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.759 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . . . . . . . . 0 N--CA 1.439 -0.985 0 N-CA-C 110.221 -0.288 . . . . 1.1699999999999999 110.221 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.466 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -161.06 157.24 25.8 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.57 0.348 . . . . 0.60999999999999999 110.206 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -135.68 99.05 4.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.129 -1.063 . . . . 0.56999999999999995 108.129 165.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 103' ' ' ARG . 2.7 mt -89.69 113.52 25.02 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.692 -0.855 . . . . 1.3600000000000001 108.692 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.477 ' O ' HG12 ' A' ' 101' ' ' ILE . 11.0 m -82.02 142.63 32.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.718 -0.674 . . . . 0.42999999999999999 110.153 -171.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.565 ' N ' HD21 ' A' ' 118' ' ' LEU . 1.3 mm? -108.14 163.81 12.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.282 -0.417 . . . . 1.02 111.725 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.3 t -57.6 -14.01 4.72 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 124.621 1.201 . . . . 1.79 112.546 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.681 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 5.9 tmtm? -125.94 130.33 51.06 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.266 -0.574 . . . . 1.8100000000000001 109.458 169.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.629 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 54.0 mt-30 -33.69 -60.29 0.37 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 125.438 1.711 . . . . 1.76 113.19 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.47 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -92.08 13.79 17.85 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.01 -0.676 . . . . 3.2000000000000002 112.412 -169.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.953 ' O ' HG12 ' A' ' 143' ' ' ILE . 2.5 m-30 -92.68 -35.13 13.66 Favored 'General case' 0 C--O 1.202 -1.441 0 CA-C-O 121.896 0.855 . . . . 0.83999999999999997 111.392 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.426 ' HA2' HD21 ' A' ' 118' ' ' LEU . . . -10.3 129.46 0.01 OUTLIER Glycine 0 C--N 1.286 -2.197 0 N-CA-C 119.414 2.526 . . . . 0.96999999999999997 119.414 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -98.43 116.52 41.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 112.538 -1.831 . . . . 1.04 110.149 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.631 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.2 p80 -144.13 -175.82 4.76 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 112.762 0.653 . . . . 0.20999999999999999 112.762 -174.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.17 -166.73 36.98 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 111.651 -0.579 . . . . 0.34999999999999998 111.651 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.8 t -160.92 165.6 29.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 117.99 0.895 . . . . 1.1100000000000001 110.826 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -114.42 -2.04 13.34 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.806 -1.183 . . . . 2.1899999999999999 107.806 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -123.73 96.47 43.07 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 114.187 -1.369 . . . . 1.8400000000000001 108.157 170.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -74.54 -20.32 18.14 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.238 1.958 . . . . 0.39000000000000001 112.767 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.53 -0.16 40.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.414 0.626 . . . . 1.0800000000000001 110.674 -176.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 43.0 t -91.94 -5.17 53.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.928 -0.767 . . . . 1.9399999999999999 108.928 170.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 30.6 mm -84.56 133.66 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.768 -0.651 . . . . 1.04 110.498 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.1 1.45 69.84 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.804 -1.319 . . . . 0.16 109.804 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' A' ' 137' ' ' ALA . 0.1 OUTLIER -113.69 161.79 17.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.913 1.34 . . . . 3.0299999999999998 114.067 -176.023 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -95.85 129.04 43.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 112.244 -2.253 . . . . 1.01 108.305 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 139' ' ' SER . 0.2 OUTLIER -126.02 165.07 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.618 -0.882 . . . . 1.3400000000000001 108.618 -175.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 66.0 m -50.02 -60.09 3.27 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.706 0.632 . . . . 0.87 112.706 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.461 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -133.87 -43.2 0.81 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 118.414 -1.314 . . . . 2.5499999999999998 113.802 -175.427 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.7 134.09 0.14 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 117.645 1.818 . . . . 0.19 117.645 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' CYS . . . . . 0.56 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 4.9 p -71.29 166.47 21.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 112.493 -1.853 . . . . 0.20000000000000001 112.037 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.953 HG12 ' O ' ' A' ' 123' ' ' TYR . 9.3 mm -58.9 101.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 115.118 -0.946 . . . . 1.1299999999999999 111.622 -162.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.631 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 28.6 mtp85 -88.17 141.13 28.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.178 -0.919 . . . . 2.3300000000000001 109.279 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.526 ' HG2' HG21 ' A' ' 84' ' ' ILE . 13.2 mtp -120.01 -168.49 1.62 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.959 -0.756 . . . . 1.0900000000000001 108.959 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . 0.404 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 7.5 t-160 -88.89 155.52 19.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.414 -0.958 . . . . 2.9900000000000002 108.414 170.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.851 ' O ' HD12 ' A' ' 151' ' ' ILE . 7.9 m120 -73.38 -18.27 61.18 Favored 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 112.745 0.646 . . . . 0.73999999999999999 112.745 -172.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -82.02 -27.56 33.01 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 120.551 1.523 . . . . 2.6899999999999999 112.831 164.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 67.1 m-20 -82.57 -38.64 23.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.992 0.425 . . . . 0.68999999999999995 111.001 -173.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.51 HG12 HD11 ' A' ' 151' ' ' ILE . 12.2 p -67.22 -21.65 28.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 1.02 111.13 174.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 147' ' ' ASN . 1.6 mp -84.6 -40.86 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 119.029 -0.51 . . . . 1.1699999999999999 110.203 172.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 156' ' ' ILE . 4.4 mm-40 -44.7 -72.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.105 0.866 . . . . 1.99 112.203 168.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.559 ' O ' HG23 ' A' ' 157' ' ' VAL . 41.6 mt -46.32 -39.12 9.67 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.669 0.747 . . . . 1.9099999999999999 111.644 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.454 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . . . -62.4 -37.66 86.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.159 -1.382 . . . . 1.04 111.764 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 34.6 t -86.79 -33.16 19.99 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.581 0.586 . . . . 0.88 112.581 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 152' ' ' GLU . 24.6 mt -81.24 -59.39 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.659 0.742 . . . . 1.0 111.367 -172.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 153' ' ' LEU . 3.0 m -89.57 141.89 29.01 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.743 -1.117 . . . . 1.0700000000000001 111.899 177.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -89.4 175.27 3.34 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.099 3.199 . . . . 0.23999999999999999 110.911 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.815 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.5 m-20 -65.38 158.63 26.07 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.831 -0.803 . . . . 1.1000000000000001 108.831 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 95.04 -17.9 58.41 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.108 -1.044 . . . . 0.17999999999999999 112.569 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.565 ' HB ' HD13 ' A' ' 100' ' ' ILE . 80.6 m -63.95 137.33 57.96 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.299 -0.63 . . . . 1.05 109.299 -175.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.15 119.82 32.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 122.673 1.225 . . . . 4.1100000000000003 111.137 -168.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.5 t -104.42 110.86 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 112.4 -2.182 . . . . 1.02 109.398 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.455 HG23 ' ND2' ' A' ' 166' ' ' ASN . 21.0 m -96.3 108.21 20.68 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 112.757 0.651 . . . . 1.0700000000000001 112.757 -173.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.526 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -81.28 106.64 12.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 122.198 0.999 . . . . 1.05 109.905 177.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.455 ' ND2' HG23 ' A' ' 164' ' ' THR . 64.1 m-80 -112.36 123.65 50.76 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.42 -1.264 . . . . 1.0900000000000001 109.806 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.517 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 17.7 mmm180 . . . . . 0 C--N 1.318 -0.762 0 N-CA-C 109.707 -0.479 . . . . 2.4900000000000002 109.707 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.717 -0.553 . . . . 3.3399999999999999 111.717 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -112.86 155.23 25.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.826 0.346 . . . . 4.9199999999999999 110.248 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -91.59 102.32 14.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.979 -0.555 . . . . 3.1000000000000001 110.147 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -109.21 174.7 5.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.58 0.705 . . . . 1.3300000000000001 112.661 -172.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.9 tt -98.99 129.05 45.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.581 -1.19 . . . . 1.0700000000000001 110.466 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.32 162.18 13.45 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.076 0.941 . . . . 1.03 113.347 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 82.6 t80 -131.96 141.5 49.32 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.676 -1.602 . . . . 1.0800000000000001 107.973 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.9 tt0 -114.64 115.23 26.79 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.198 -1.038 . . . . 0.93000000000000005 108.198 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.577 HG11 ' HB2' ' A' ' 13' ' ' ASP . 99.5 t -67.01 148.84 11.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 122.482 1.134 . . . . 1.1000000000000001 113.125 -172.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -103.1 158.84 16.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.171 -1.831 . . . . 2.4399999999999999 108.12 171.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -60.98 106.26 0.57 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 120.808 0.337 . . . . 2.4300000000000002 111.754 -175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.35 11.67 38.18 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.689 -0.767 . . . . 0.51000000000000001 113.553 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.577 ' HB2' HG11 ' A' ' 9' ' ' VAL . 65.3 m-20 -53.15 165.14 0.35 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.169 0.485 . . . . 1.46 111.646 172.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.1 147.69 47.72 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.43 0.633 . . . . 1.1599999999999999 111.171 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.4 HD22 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.89 -40.69 87.84 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.901 -1.045 . . . . 1.47 108.446 -176.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -84.28 -18.08 37.58 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.576 -1.193 . . . . 1.78 110.266 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.9 t -71.66 -43.31 66.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.151 -0.685 . . . . 1.74 109.151 170.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.405 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 15.0 mt -72.19 -27.66 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.37 0.605 . . . . 1.04 109.502 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.573 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.07 -9.04 59.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.161 -0.472 . . . . 1.0600000000000001 110.942 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.678 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.52 -40.79 8.48 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 122.631 1.205 . . . . 0.97999999999999998 107.965 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.1 m-20 -62.2 -45.8 91.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 112.417 -2.174 . . . . 0.53000000000000003 111.883 174.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.545 ' C ' HD11 ' A' ' 101' ' ' ILE . 60.6 m-85 -96.23 5.63 50.59 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 118.624 -1.23 . . . . 0.20000000000000001 111.213 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.7 mpt_? 54.2 45.86 26.5 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.648 0.737 . . . . 2.46 109.772 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.573 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 37.1 pt -120.53 -165.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.671 -1.149 . . . . 1.04 110.206 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.91 142.94 40.55 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.998 -1.001 . . . . 1.3400000000000001 110.252 174.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.523 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 68.4 p -71.4 -33.38 69.43 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.914 -1.143 . . . . 1.0900000000000001 107.914 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.01 68.08 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.443 -0.799 . . . . 1.0700000000000001 111.954 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.63 -27.73 16.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.717 0.77 . . . . 1.04 109.198 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.553 HD21 ' CD1' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -74.83 -29.75 61.16 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.707 -1.133 . . . . 1.8100000000000001 109.357 174.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 26' ' ' THR . 48.2 mt -76.6 -33.02 58.44 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.83 0.824 . . . . 1.6399999999999999 110.117 171.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 5.2 tt0 -61.49 -39.21 90.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.356 -1.293 . . . . 2.3300000000000001 109.522 172.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.572 ' HB3' HG11 ' A' ' 47' ' ' VAL . . . -86.47 -19.31 29.76 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.337 -0.545 . . . . 1.0600000000000001 112.217 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.588 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 26.4 m-80 -149.61 81.32 7.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.359 0.6 . . . . 0.23000000000000001 110.448 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.1 Cg_endo -56.63 -14.74 13.97 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 124.328 3.352 . . . . 0.52000000000000002 114.054 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -73.69 -23.92 59.88 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.16 -0.337 . . . . 1.6499999999999999 111.766 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.588 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 29.0 mt -67.91 -37.14 81.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.346 0.593 . . . . 1.25 112.199 -170.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -63.43 -44.14 95.44 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 123.01 1.386 . . . . 2.52 110.764 -173.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.3 -47.71 81.13 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 111.722 -2.49 . . . . 1.1899999999999999 110.705 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.57 48.44 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.887 -1.051 . . . . 0.44 111.488 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.94 157.83 20.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.424 0.631 . . . . 1.1699999999999999 111.217 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 58.1 m -139.09 128.9 24.84 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.118 -0.946 . . . . 1.1499999999999999 110.193 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.96 120.44 21.3 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.035 -0.666 . . . . 1.1200000000000001 109.916 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 97.73 2.44 58.53 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 110.365 -1.094 . . . . 0.44 110.365 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.3 OUTLIER -78.15 124.53 28.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.228 -0.656 . . . . 1.3 109.228 178.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.607 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 37.4 p -81.48 124.12 29.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.956 0.884 . . . . 1.3200000000000001 110.842 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.519 HG22 HD23 ' A' ' 36' ' ' LEU . 1.4 pp -129.87 132.8 65.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 113.933 -1.485 . . . . 1.0700000000000001 108.974 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.572 HG11 ' HB3' ' A' ' 32' ' ' ALA . 14.7 p -93.79 163.65 2.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 114.857 -1.065 . . . . 1.3 111.025 -169.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.493 ' H ' HG23 ' A' ' 47' ' ' VAL . 39.3 mm -121.24 102.48 43.13 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 114.698 -1.137 . . . . 1.03 109.894 -173.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HA ' HD23 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -66.27 135.85 41.56 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.928 1.752 . . . . 0.20000000000000001 112.341 -175.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.45 -5.94 80.52 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.065 -0.97 . . . . 0.26000000000000001 112.42 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 36.1 tp -122.72 116.1 29.28 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-O 121.218 0.532 . . . . 1.27 111.408 -177.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 53.5 Cg_endo -78.12 -176.91 3.5 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.918 3.079 . . . . 0.31 114.362 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.481 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 8.9 t70 -84.96 128.02 62.16 Favored Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-N 114.302 -1.317 . . . . 0.48999999999999999 111.975 -169.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 37.4 Cg_endo -69.94 -18.19 36.3 Favored 'Trans proline' 0 CA--C 1.519 -0.248 0 C-N-CA 123.619 2.879 . . . . 0.48999999999999999 112.69 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.408 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 69.3 m-85 -96.09 2.36 53.17 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.529 0.681 . . . . 1.8 111.451 -173.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.481 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 18.5 p -98.45 -20.58 17.03 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.897 -1.149 . . . . 1.1299999999999999 107.897 171.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.534 HG23 ' H ' ' A' ' 59' ' ' TYR . 19.4 mt -73.17 133.02 81.66 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 113.254 -1.794 . . . . 1.24 111.335 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 92.4 Cg_endo -79.33 -15.86 12.42 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.381 2.054 . . . . 0.47999999999999998 113.883 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' H ' HG23 ' A' ' 57' ' ' ILE . 50.7 m-85 -104.09 164.04 11.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.023 0.749 . . . . 0.94999999999999996 113.023 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -147.67 139.48 24.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.982 -1.008 . . . . 3.7400000000000002 108.795 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 71' ' ' THR . 79.2 mt -116.09 132.27 66.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.316 -0.402 . . . . 1.05 111.718 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.23 116.57 27.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.897 -0.721 . . . . 1.0800000000000001 111.122 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 65.0 t -98.57 112.99 32.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.647 0.737 . . . . 1.04 111.163 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 68' ' ' LYS . 53.3 m -95.74 100.87 12.53 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.893 -1.049 . . . . 0.83999999999999997 110.748 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.53 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.1 mm -48.93 -58.76 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.987 0.899 . . . . 1.0600000000000001 111.788 171.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.58 -9.38 3.44 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 112.925 -1.943 . . . . 0.16 113.055 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.57 -19.57 4.55 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.581 0.752 . . . . 1.02 112.087 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.548 ' HB2' ' HZ2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.68 55.93 4.47 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.27 0.486 . . . . 1.3 111.236 -173.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.7 p -137.24 159.67 41.26 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 112.861 0.689 . . . . 0.98999999999999999 112.861 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.401 HD21 ' C ' ' A' ' 70' ' ' LEU . 8.7 tt -126.77 112.58 15.56 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.559 -1.2 . . . . 1.1799999999999999 110.004 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.672 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 29.6 m -93.62 122.4 36.04 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.226 0.536 . . . . 1.04 111.288 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.5 tp -98.0 103.74 15.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.003 -0.998 . . . . 1.3200000000000001 109.464 172.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 82.2 p -105.75 161.11 14.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 119.086 -1.045 . . . . 1.05 110.612 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.581 HD11 ' ND2' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -127.08 128.23 45.93 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.541 -0.911 . . . . 1.1000000000000001 108.541 170.285 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.581 ' ND2' HD11 ' A' ' 74' ' ' LEU . 7.9 p30 43.8 51.15 6.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.303 -1.317 . . . . 1.97 111.892 -166.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.7 t30 74.76 -13.19 0.85 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.1 -0.954 . . . . 2.5499999999999998 111.382 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -95.76 121.37 37.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.92 -0.582 . . . . 4.0199999999999996 109.888 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 78.0 t -59.55 132.48 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 122.362 1.077 . . . . 1.0600000000000001 112.499 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 18.3 mtm -100.55 -46.91 5.05 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 113.022 -1.899 . . . . 1.47 108.805 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -155.56 172.97 17.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.42 -1.718 . . . . 1.98 110.019 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 78.6 m -148.75 123.02 9.58 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.082 -1.417 . . . . 1.0 109.783 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -108.01 145.34 31.22 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.487 -0.779 . . . . 1.3999999999999999 109.274 -176.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.455 ' HB2' HG23 ' A' ' 134' ' ' ILE . 42.7 Cg_endo -74.94 141.96 27.47 Favored 'Trans proline' 0 CA--C 1.499 -1.238 0 C-N-CA 122.031 1.82 . . . . 0.23999999999999999 111.285 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.537 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.44 175.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.92 -0.582 . . . . 1.04 111.051 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.869 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.13 147.32 44.31 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.306 -0.406 . . . . 1.03 110.15 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.472 HG23 ' HG3' ' A' ' 68' ' ' LYS . 11.4 m -129.64 128.44 65.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.47 0.653 . . . . 1.26 112.004 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -89.06 157.9 27.53 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 110.624 -0.99 . . . . 0.20000000000000001 110.624 173.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -56.37 2.68 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.309 0.855 . . . . 3.48 113.309 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.538 HG21 ' CD2' ' A' ' 90' ' ' LEU . 1.3 tp -89.9 -20.52 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 121.83 0.824 . . . . 1.0700000000000001 110.149 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.538 ' CD2' HG21 ' A' ' 89' ' ' ILE . 3.7 mm? -90.85 -19.53 23.29 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.442 -0.799 . . . . 1.02 109.211 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -66.74 -16.51 64.29 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.419 -1.264 . . . . 1.05 111.715 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -64.64 -42.32 95.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.841 -1.072 . . . . 2.0299999999999998 112.343 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.31 119.42 56.39 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.574 -0.45 . . . . 1.1499999999999999 110.966 -175.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 1.1 Cg_endo -78.8 -1.92 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.839 2.359 . . . . 1.04 113.239 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.0 t -119.73 -42.46 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.838 0.351 . . . . 1.1299999999999999 110.408 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.469 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.68 38.87 22.84 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.717 -1.129 . . . . 0.35999999999999999 114.063 168.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.443 ' HG2' HG21 ' A' ' 164' ' ' THR . 45.9 mt-10 -83.86 113.02 20.65 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.969 0.89 . . . . 1.0800000000000001 109.606 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 23.6 m-85 -137.61 176.15 8.97 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.909 -1.496 . . . . 0.26000000000000001 111.914 -170.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.595 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 82.7 m-85 -140.95 136.9 32.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.243 -0.435 . . . . 0.78000000000000003 110.603 -173.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.553 HD13 ' HB ' ' A' ' 161' ' ' THR . 81.6 mt -61.24 117.56 2.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.23 -0.895 . . . . 1.02 110.816 172.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.545 HD11 ' C ' ' A' ' 22' ' ' PHE . 20.8 pt -84.5 -35.43 10.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 112.766 0.654 . . . . 1.03 112.766 -176.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.481 ' ND2' HG13 ' A' ' 101' ' ' ILE . 9.3 p30 178.82 179.18 0.41 Allowed 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.32 -1.363 . . . . 2.0299999999999998 107.32 -176.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.462 ' HG2' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.16 155.58 49.4 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.873 -0.731 . . . . 2.02 112.303 -174.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -128.21 100.69 5.94 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.048 -0.978 . . . . 0.83999999999999997 109.872 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.505 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 71.2 ttt180 -62.77 166.31 5.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.162 -0.926 . . . . 3.2799999999999998 110.693 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.465 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 18.1 m-80 -34.75 102.97 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 125.189 1.395 . . . . 0.34999999999999998 113.195 -155.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.8 Cg_endo -60.2 -39.64 66.81 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.045 2.496 . . . . 0.63 111.695 174.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.32 -37.63 2.9 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.295 -0.722 . . . . 0.67000000000000004 111.295 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -79.62 -176.31 48.94 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.225 -0.487 . . . . 0.77000000000000002 112.813 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 112' ' ' GLY . 27.9 Cg_endo -59.69 5.16 0.12 Allowed 'Trans proline' 0 N--CA 1.485 1.012 1 C-N-CA 125.454 4.103 . . . . 1.1499999999999999 115.801 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.414 ' H ' ' C ' ' A' ' 109' ' ' GLY . 7.4 m-85 -70.37 10.13 0.51 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.295 0.479 . . . . 1.5900000000000001 112.295 -174.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.703 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 75.84 64.34 2.26 Favored Glycine 0 CA--C 1.501 -0.832 0 C-N-CA 119.649 -1.263 . . . . 1.6899999999999999 115.211 171.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.507 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 39.31 -2.2 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 117.177 2.288 . . . . 1.1699999999999999 117.177 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.642 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.4 OUTLIER -165.4 158.41 16.02 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.204 -0.935 . . . . 0.60999999999999999 110.297 -175.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -138.54 98.1 3.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.241 -1.022 . . . . 0.56999999999999995 108.241 167.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.536 HD13 ' CG2' ' A' ' 150' ' ' VAL . 2.4 mt -89.02 114.27 25.46 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.033 -0.728 . . . . 1.3600000000000001 109.033 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.41 ' C ' HG12 ' A' ' 101' ' ' ILE . 20.0 m -85.24 143.58 28.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.808 -0.633 . . . . 0.42999999999999999 111.424 -169.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.771 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.9 mm? -108.3 166.4 10.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.893 -0.594 . . . . 1.02 111.7 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.0 t -60.52 -13.27 12.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.793 -1.094 . . . . 1.79 112.816 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.666 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 4.9 tptm -126.27 130.27 50.54 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 120.492 -0.483 . . . . 1.8100000000000001 110.138 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 52.9 mt-30 -34.44 -57.61 0.5 Allowed 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.548 1.155 . . . . 1.76 113.994 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.519 ' CB ' HG12 ' A' ' 89' ' ' ILE . 32.5 m-70 -88.91 -1.78 58.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.317 0.58 . . . . 3.2000000000000002 111.635 -171.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.771 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -91.31 38.16 0.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.523 0.934 . . . . 0.83999999999999997 113.523 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -112.97 145.08 18.19 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 117.222 -2.418 . . . . 0.96999999999999997 112.783 -152.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.497 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -98.69 116.32 41.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 123.739 0.816 . . . . 1.04 110.833 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.628 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 27.5 p80 -145.62 171.15 15.12 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.229 -0.896 . . . . 0.20999999999999999 109.585 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.703 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.1 -168.62 39.19 Favored Glycine 0 C--N 1.316 -0.563 0 C-N-CA 120.107 -1.044 . . . . 0.34999999999999998 111.51 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.493 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 15.0 t -153.23 175.0 13.55 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.962 -0.728 . . . . 1.1100000000000001 110.27 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -116.79 0.41 12.52 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.61 -0.885 . . . . 2.1899999999999999 108.61 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -118.9 86.75 31.74 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 114.928 -1.033 . . . . 1.8400000000000001 108.476 172.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -72.72 -17.52 25.91 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.293 1.996 . . . . 0.39000000000000001 113.283 -169.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.37 -1.1 35.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.968 -0.56 . . . . 1.0800000000000001 111.094 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 98.1 p -91.57 -6.8 51.78 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.983 -0.747 . . . . 1.9399999999999999 108.983 170.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.455 HG23 ' HB2' ' A' ' 83' ' ' PRO . 44.2 mm -80.49 136.42 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.54 -0.755 . . . . 1.04 110.217 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.61 80.14 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.906 -1.277 . . . . 0.16 109.906 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 5.7 tttt -111.67 161.64 16.05 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 122.952 1.358 . . . . 3.0299999999999998 113.743 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.426 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -97.44 124.27 41.58 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 112.193 -2.276 . . . . 1.01 107.659 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.435 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -120.74 160.86 21.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.894 -0.78 . . . . 1.3400000000000001 108.894 -173.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.9 m -51.5 -58.76 5.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.688 0.625 . . . . 0.87 112.688 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.488 ' HB2' ' HZ2' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -132.56 -43.32 0.92 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 118.329 -1.348 . . . . 2.5499999999999998 113.555 -176.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.447 ' N ' ' HD3' ' A' ' 140' ' ' LYS . . . -31.5 133.23 0.14 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 116.958 1.543 . . . . 0.19 116.958 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.544 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 2.7 p -74.5 164.84 26.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.489 -1.855 . . . . 0.20000000000000001 111.571 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.869 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.0 mt -59.9 98.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 122.48 1.133 . . . . 1.1299999999999999 112.111 -162.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.628 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 79.9 mtt180 -84.33 151.66 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.601 -1.636 . . . . 2.3300000000000001 110.537 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.537 ' HG2' HG21 ' A' ' 84' ' ' ILE . 14.7 mtp -130.94 -166.57 1.71 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.799 -0.637 . . . . 1.0900000000000001 109.333 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.64 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 15.8 t-80 -97.81 152.89 18.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.825 -0.806 . . . . 2.9900000000000002 108.825 172.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.599 ' O ' HD11 ' A' ' 151' ' ' ILE . 2.3 m120 -56.17 -53.39 57.63 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 118.247 -0.882 . . . . 0.73999999999999999 110.629 -175.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -64.66 -24.18 67.5 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 121.6 2.0 . . . . 2.6899999999999999 112.04 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.64 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 4.6 m-20 -81.59 -43.36 18.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.661 -0.7 . . . . 0.68999999999999995 110.818 -176.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.536 ' CG2' HD13 ' A' ' 116' ' ' LEU . 14.6 p -68.58 -23.03 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.731 -0.668 . . . . 1.02 111.297 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.599 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.68 -37.9 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 119.062 -0.494 . . . . 1.1699999999999999 110.091 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 156' ' ' ILE . 9.3 mm-40 -45.09 -72.71 0.05 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.279 0.945 . . . . 1.99 112.022 167.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.482 ' O ' HG23 ' A' ' 157' ' ' VAL . 52.4 mt -46.81 -40.42 13.73 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 123.85 0.719 . . . . 1.9099999999999999 111.479 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.73 -37.07 80.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.119 -1.4 . . . . 1.04 111.758 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.0 t -88.16 -31.94 18.88 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.51 -0.744 . . . . 0.88 112.506 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.2 mt -81.07 -59.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.561 0.695 . . . . 1.0 111.561 -172.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 153' ' ' LEU . 3.1 m -89.38 142.96 30.11 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.871 -1.059 . . . . 1.0700000000000001 112.097 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -90.72 175.03 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 124.015 3.143 . . . . 0.23999999999999999 110.939 172.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.425 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 37.1 m-20 -65.99 157.86 29.74 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.655 -0.818 . . . . 1.1000000000000001 109.078 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.35 -18.53 57.31 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.119 -1.038 . . . . 0.17999999999999999 112.423 -174.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.553 ' HB ' HD13 ' A' ' 100' ' ' ILE . 78.2 m -65.12 138.89 58.58 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.035 -0.728 . . . . 1.05 109.035 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.595 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 11.3 ptm180 -92.44 127.25 37.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.741 1.258 . . . . 4.1100000000000003 111.211 -170.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.4 t -109.02 107.45 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 112.088 -2.324 . . . . 1.02 108.631 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.443 HG21 ' HG2' ' A' ' 97' ' ' GLU . 13.8 m -94.35 104.72 16.7 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.49 0.552 . . . . 1.0700000000000001 112.49 -171.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.469 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -83.36 96.47 4.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 122.342 1.068 . . . . 1.05 109.955 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -107.6 132.49 53.23 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.009 -1.451 . . . . 1.0900000000000001 109.215 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.53 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 19.2 mmm180 -65.68 -30.77 71.5 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.2 -0.667 . . . . 2.4900000000000002 109.2 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.59 -93.88 0.93 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.055 -0.975 . . . . 1.97 112.414 173.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--N 1.322 -0.62 0 N-CA-C 109.804 -0.443 . . . . 4.3300000000000001 109.804 178.751 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.908 -0.477 . . . . 3.3399999999999999 111.908 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -153.35 152.78 31.48 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.71 -0.478 . . . . 4.9199999999999999 109.71 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -97.57 114.9 26.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.923 0.392 . . . . 3.1000000000000001 110.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp -101.85 175.37 5.57 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.75 -0.659 . . . . 1.3300000000000001 111.392 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.0 tt -92.12 130.08 37.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.284 -0.871 . . . . 1.0700000000000001 110.445 -175.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.33 162.14 13.33 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.36 1.076 . . . . 1.03 113.239 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 72.0 t80 -131.96 142.25 49.56 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.294 -1.776 . . . . 1.0800000000000001 107.89 175.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.453 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 33.8 tt0 -113.25 112.71 24.2 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.091 -1.078 . . . . 0.93000000000000005 108.091 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' A' ' 41' ' ' THR . 96.1 t -66.67 151.35 10.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.364 1.078 . . . . 1.1000000000000001 112.74 -170.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -106.58 158.21 17.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.431 -1.713 . . . . 2.4399999999999999 108.372 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.23 107.68 0.51 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.782 0.325 . . . . 2.4300000000000002 111.819 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.77 46.23 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.857 -0.687 . . . . 0.51000000000000001 113.895 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.574 ' HB2' HG11 ' A' ' 9' ' ' VAL . 68.9 m-20 -54.46 170.16 0.16 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 117.181 0.49 . . . . 1.46 111.391 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.4 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -129.23 152.07 49.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.086 0.469 . . . . 1.1599999999999999 111.603 176.136 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.51 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -66.03 -36.37 83.07 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.044 -0.98 . . . . 1.47 108.574 -177.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.466 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 4.5 t30 -87.62 -26.04 23.26 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.764 -1.107 . . . . 1.78 110.552 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.4 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 13.0 t -66.05 -40.92 91.33 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.515 -0.55 . . . . 1.74 109.515 174.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.46 HG21 ' CE1' ' A' ' 22' ' ' PHE . 13.8 mt -73.86 -28.15 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.116 0.484 . . . . 1.04 109.783 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.608 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.43 -11.37 59.91 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.699 -0.4 . . . . 1.0600000000000001 110.896 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.709 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -93.12 -40.98 10.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.406 0.622 . . . . 0.97999999999999998 109.784 174.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.63 ' HB3' ' O ' ' A' ' 119' ' ' SER . 23.0 m-20 -63.42 -42.87 98.73 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.485 -1.234 . . . . 0.53000000000000003 111.922 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.539 ' C ' HD11 ' A' ' 101' ' ' ILE . 47.8 m-85 -96.33 4.85 51.99 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 118.597 -1.241 . . . . 0.20000000000000001 111.112 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.709 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER 54.51 40.77 32.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.961 0.886 . . . . 2.46 109.418 176.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.608 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.6 pt -114.3 -165.52 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.102 -1.408 . . . . 1.04 109.86 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.48 142.91 41.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.205 -0.907 . . . . 1.3400000000000001 110.212 175.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.521 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 71.4 p -73.21 -32.72 64.95 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.057 -1.09 . . . . 1.0900000000000001 108.057 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.7 -27.06 67.6 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.182 -0.917 . . . . 1.0700000000000001 111.796 170.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.95 -27.28 16.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.972 -0.751 . . . . 1.04 108.972 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.64 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 17.8 tp -74.71 -26.2 59.65 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.298 -0.865 . . . . 1.8100000000000001 109.331 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 26' ' ' THR . 35.9 mt -77.31 -29.98 53.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.695 0.759 . . . . 1.6399999999999999 110.076 171.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 4.7 tt0 -65.14 -41.63 94.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.393 -1.276 . . . . 2.3300000000000001 110.103 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -84.27 -20.67 31.8 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.937 -0.705 . . . . 1.0600000000000001 111.594 177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.61 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.8 m-80 -147.15 80.67 9.25 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 121.615 0.721 . . . . 0.23000000000000001 110.693 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.8 Cg_endo -56.79 -14.89 14.87 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 C-N-CA 124.099 3.199 . . . . 0.52000000000000002 114.199 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.2 t -79.59 -20.9 45.79 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.809 -0.356 . . . . 1.6499999999999999 111.115 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.64 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 67.6 mt -65.31 -39.19 92.18 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.542 0.687 . . . . 1.25 111.826 -172.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -64.05 -44.59 91.98 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 122.88 1.324 . . . . 2.52 110.251 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.05 -50.15 74.43 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 111.795 -2.457 . . . . 1.1899999999999999 110.439 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.23 175.16 46.97 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 114.779 -1.101 . . . . 0.44 111.74 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -107.9 155.99 19.67 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.229 0.538 . . . . 1.1699999999999999 110.876 178.178 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 34.5 m -139.46 128.64 23.9 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.218 -0.901 . . . . 1.1499999999999999 110.513 -175.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 119.99 20.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.634 0.731 . . . . 1.1200000000000001 110.396 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.453 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 98.13 0.73 58.44 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 114.738 -1.119 . . . . 0.44 110.325 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.2 tt0 -74.8 123.41 24.95 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.672 -0.764 . . . . 1.3 109.654 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 54.8 p -82.34 128.49 34.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.776 0.798 . . . . 1.3200000000000001 110.067 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.593 HG13 ' HB3' ' A' ' 7' ' ' TYR . 9.0 pt -128.52 142.35 44.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.306 -1.316 . . . . 1.0700000000000001 109.477 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.465 HG13 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.77 151.27 3.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.208 0.527 . . . . 1.3 111.019 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.1 mm -115.13 92.71 32.46 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 114.842 -1.072 . . . . 1.03 109.439 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HA ' HD23 ' A' ' 4' ' ' LEU . 2.4 Cg_endo -58.46 134.89 64.13 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.812 2.341 . . . . 0.20000000000000001 112.693 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.03 -4.06 81.09 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 114.948 -1.023 . . . . 0.26000000000000001 112.405 -176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.68 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.7 tp -129.28 117.97 19.07 Favored Pre-proline 0 N--CA 1.446 -0.638 0 CA-C-O 121.223 0.535 . . . . 1.27 111.341 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.662 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 55.5 Cg_endo -79.23 -177.96 4.27 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.585 2.857 . . . . 0.31 114.155 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.494 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 12.4 t0 -80.72 126.64 77.55 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.513 -1.222 . . . . 0.48999999999999999 111.542 -171.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.596 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 60.5 Cg_endo -73.22 -16.73 24.92 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.204 2.603 . . . . 0.48999999999999999 112.459 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -89.22 -10.33 47.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.842 -0.617 . . . . 1.8 110.438 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.494 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 25.1 p -88.15 -23.35 23.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.535 1.159 . . . . 1.1299999999999999 108.427 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.475 HG23 ' H ' ' A' ' 59' ' ' TYR . 15.3 mt -72.94 129.51 86.42 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 112.973 -1.922 . . . . 1.24 111.354 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.69 -19.73 14.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.336 2.024 . . . . 0.47999999999999998 113.386 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.475 ' H ' HG23 ' A' ' 57' ' ' ILE . 60.5 m-85 -91.91 158.68 16.16 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.546 -0.462 . . . . 0.94999999999999996 111.558 -176.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -148.77 129.87 14.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.026 -0.731 . . . . 3.7400000000000002 109.026 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.5 mt -111.38 130.96 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.946 -0.57 . . . . 1.05 111.609 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.96 119.88 38.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.001 -0.68 . . . . 1.0800000000000001 111.028 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.85 116.42 41.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.446 0.641 . . . . 1.04 110.833 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 68' ' ' LYS . 69.0 m -95.81 104.27 16.2 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.011 -0.995 . . . . 0.83999999999999997 110.8 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.9 mm -51.64 -59.38 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.937 0.875 . . . . 1.0600000000000001 111.59 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.82 -11.94 4.72 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 113.051 -1.886 . . . . 0.16 113.18 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.18 -18.87 4.87 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.369 0.668 . . . . 1.02 112.444 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HB2' ' HZ2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.89 54.97 4.79 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.522 0.601 . . . . 1.3 111.26 -173.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.5 p -136.77 160.99 37.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.811 0.671 . . . . 0.98999999999999999 112.811 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.424 ' C ' HD21 ' A' ' 70' ' ' LEU . 8.1 tt -129.04 113.51 15.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.765 -1.107 . . . . 1.1799999999999999 110.044 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.702 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.4 m -93.77 123.67 37.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.976 0.417 . . . . 1.04 111.337 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.8 tp -98.78 104.92 17.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.58 -0.737 . . . . 1.3200000000000001 109.434 171.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.6 m -104.96 159.61 15.67 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.541 -0.863 . . . . 1.05 110.519 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -127.88 127.26 43.09 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.903 -0.777 . . . . 1.1000000000000001 108.903 168.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.539 ' N ' HD23 ' A' ' 74' ' ' LEU . 46.4 m-80 48.21 50.36 16.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.584 -1.189 . . . . 1.97 111.076 -171.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 71.9 -10.03 0.91 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.755 0.822 . . . . 2.5499999999999998 111.662 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 75' ' ' ASN . 15.3 tpt180 -96.43 120.52 36.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.067 -0.515 . . . . 4.0199999999999996 109.893 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 55.8 t -59.31 131.58 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-O 122.295 1.045 . . . . 1.0600000000000001 112.017 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 5.4 mtm -103.08 -43.85 5.37 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.342 -1.754 . . . . 1.47 109.368 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -157.94 170.69 21.75 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.264 -1.789 . . . . 1.98 110.209 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 83.5 m -149.38 128.03 12.41 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.129 -1.396 . . . . 1.0 109.517 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -115.94 147.46 39.22 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 116.243 -0.435 . . . . 1.3999999999999999 110.729 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.42 ' HB2' HG23 ' A' ' 134' ' ' ILE . 36.8 Cg_endo -71.86 144.33 43.16 Favored 'Trans proline' 0 CA--C 1.491 -1.645 0 C-N-CA 122.333 2.022 . . . . 0.23999999999999999 110.284 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.519 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.3 pp -139.34 166.33 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-N 115.902 -0.59 . . . . 1.04 110.797 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.792 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -112.85 128.17 56.38 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.732 -0.84 . . . . 1.03 108.732 -176.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.7 p -124.15 130.93 73.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 114.076 -1.42 . . . . 1.26 111.168 -162.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -96.03 151.05 19.82 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.277 -1.329 . . . . 0.20000000000000001 111.896 -175.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 139' ' ' SER . 45.7 mmtm -57.71 2.7 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.525 -0.838 . . . . 3.48 113.145 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.581 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.6 tp -89.79 -19.65 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.725 0.774 . . . . 1.0700000000000001 110.27 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.538 ' CD2' HG21 ' A' ' 89' ' ' ILE . 3.8 mm? -88.4 -11.56 45.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.396 -0.82 . . . . 1.02 109.431 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -70.11 -16.53 63.13 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.952 -1.022 . . . . 1.05 111.55 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -71.83 -27.33 62.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.8 -1.091 . . . . 2.0299999999999998 112.972 -172.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.8 130.7 22.64 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 119.976 -0.69 . . . . 1.1499999999999999 110.771 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.459 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 89.9 Cg_endo -88.48 -2.24 6.74 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.707 2.271 . . . . 1.04 112.357 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 t -122.99 -41.83 2.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.884 -0.598 . . . . 1.1299999999999999 109.634 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.443 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 47.16 42.79 17.47 Favored Glycine 0 N--CA 1.45 -0.377 0 O-C-N 123.832 0.708 . . . . 0.35999999999999999 113.89 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.84 112.64 20.72 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.729 0.776 . . . . 1.0800000000000001 109.484 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.742 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 25.2 m-85 -137.06 177.76 7.61 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.158 -1.383 . . . . 0.26000000000000001 111.985 -170.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.45 ' CG ' HD13 ' A' ' 5' ' ' LEU . 21.2 m-85 -140.4 143.05 35.46 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.78000000000000003 110.521 -174.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.565 HD13 ' HB ' ' A' ' 161' ' ' THR . 76.6 mt -66.98 113.72 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 115.488 -0.778 . . . . 1.02 110.132 169.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.559 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 26.0 pt -84.33 -34.25 9.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 112.967 0.728 . . . . 1.03 112.967 -175.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.486 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 10.0 p30 179.97 177.79 0.63 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.488 -1.301 . . . . 2.0299999999999998 107.488 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.439 ' HG2' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.11 153.81 50.44 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.177 -0.609 . . . . 2.02 111.959 -175.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -125.38 100.97 6.74 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.097 -0.956 . . . . 0.83999999999999997 109.655 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.473 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 34.1 ttp180 -60.85 166.33 3.46 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.151 -0.931 . . . . 3.2799999999999998 110.59 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.462 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 20.6 m-80 -34.86 102.33 0.22 Allowed Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 124.997 1.319 . . . . 0.34999999999999998 113.33 -155.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 8.6 Cg_endo -58.36 -39.3 85.36 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.075 2.517 . . . . 0.63 111.365 174.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.95 -41.15 2.07 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 110.807 -0.917 . . . . 0.67000000000000004 110.807 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.4 -176.99 36.82 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 121.055 -0.593 . . . . 0.77000000000000002 112.46 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.6 5.36 0.2 Allowed 'Trans proline' 0 N--CA 1.481 0.743 1 C-N-CA 125.322 4.015 . . . . 1.1499999999999999 115.635 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -70.24 8.73 0.71 Allowed 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.363 0.505 . . . . 1.5900000000000001 112.363 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.697 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 80.8 64.03 1.85 Allowed Glycine 0 CA--C 1.498 -1.001 0 C-N-CA 119.729 -1.224 . . . . 1.6899999999999999 115.456 169.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.514 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 37.75 0.31 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 117.216 2.302 . . . . 1.1699999999999999 117.216 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.53 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.3 OUTLIER -165.69 164.76 18.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.426 -0.796 . . . . 0.60999999999999999 109.929 -177.1 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -145.09 96.72 2.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.054 -1.091 . . . . 0.56999999999999995 108.054 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.522 HD13 ' CG2' ' A' ' 150' ' ' VAL . 2.0 mt -87.28 114.12 23.6 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.24 -0.652 . . . . 1.3600000000000001 109.24 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.423 ' C ' HG12 ' A' ' 101' ' ' ILE . 27.1 m -83.48 143.89 29.93 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.684 -0.689 . . . . 0.42999999999999999 111.044 -170.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.78 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -108.99 165.26 11.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.032 -0.531 . . . . 1.02 110.789 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.63 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 8.8 m -64.73 -1.8 2.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.171 0.804 . . . . 1.79 113.171 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.743 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 3.6 tmtm? -129.71 132.19 46.56 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.958 -0.386 . . . . 1.8100000000000001 109.958 167.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.743 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 55.5 mt-30 -33.27 -57.97 0.4 Allowed 'General case' 0 C--N 1.309 -1.17 0 O-C-N 124.692 1.245 . . . . 1.76 114.324 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.581 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -94.51 5.04 53.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.315 0.578 . . . . 3.2000000000000002 111.423 -170.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.78 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -94.8 37.42 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.504 0.927 . . . . 0.83999999999999997 113.504 -174.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -113.23 144.2 18.02 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 116.963 -2.542 . . . . 0.96999999999999997 112.749 -152.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.79 115.13 35.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.895 0.855 . . . . 1.04 110.644 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.725 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.9 p80 -144.96 173.48 11.84 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.262 -0.881 . . . . 0.20999999999999999 109.648 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.697 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.26 -168.03 38.73 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.252 -0.975 . . . . 0.34999999999999998 111.57 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.46 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 12.2 t -155.01 172.06 18.73 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.942 -0.74 . . . . 1.1100000000000001 110.756 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -114.08 -2.06 13.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.961 0.886 . . . . 2.1899999999999999 108.652 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -115.92 86.55 16.65 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 114.754 -1.112 . . . . 1.8400000000000001 108.09 170.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -73.3 -19.47 22.3 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.225 1.95 . . . . 0.39000000000000001 113.191 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.27 -2.72 42.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.788 -0.642 . . . . 1.0800000000000001 110.869 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 33.4 t -90.25 -6.79 54.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.275 -0.639 . . . . 1.9399999999999999 109.275 171.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.42 HG23 ' HB2' ' A' ' 83' ' ' PRO . 38.2 mm -78.6 132.48 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.855 -0.611 . . . . 1.04 111.209 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.61 1.84 63.65 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.109 -1.196 . . . . 0.16 110.109 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.503 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 23.9 mttp -112.44 169.96 8.51 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 122.798 1.285 . . . . 3.0299999999999998 114.047 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.17 126.56 44.98 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.317 -2.22 . . . . 1.01 108.248 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.56 158.66 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.473 -0.936 . . . . 1.3400000000000001 108.473 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 49.4 m -51.46 -59.29 4.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.286 0.476 . . . . 0.87 112.286 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -131.17 -44.59 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.628 -1.229 . . . . 2.5499999999999998 113.813 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.29 133.58 0.19 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 116.999 1.56 . . . . 0.19 116.999 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.584 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 1.8 p -73.23 166.06 23.86 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.519 -1.84 . . . . 0.20000000000000001 112.13 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.792 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 44.7 mt -59.75 96.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 122.406 1.098 . . . . 1.1299999999999999 112.027 -163.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.725 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 79.1 mtt180 -86.08 146.75 26.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.53 -1.668 . . . . 2.3300000000000001 110.724 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.519 ' HG2' HG21 ' A' ' 84' ' ' ILE . 13.1 mtp -126.45 -164.82 1.37 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.901 -0.777 . . . . 1.0900000000000001 108.901 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -91.53 162.9 14.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.575 -0.528 . . . . 2.9900000000000002 109.575 169.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.65 ' O ' HD11 ' A' ' 151' ' ' ILE . 2.2 m120 -62.03 -49.92 74.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 118.537 -0.745 . . . . 0.73999999999999999 110.007 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -63.81 -28.27 69.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 121.021 1.737 . . . . 2.6899999999999999 112.106 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.424 ' CB ' ' HE3' ' A' ' 145' ' ' MET . 58.4 m-20 -78.1 -46.46 20.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.157 0.503 . . . . 0.68999999999999995 110.401 -176.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.557 HG12 HD13 ' A' ' 151' ' ' ILE . 13.4 p -67.11 -23.21 30.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.248 -0.887 . . . . 1.02 111.62 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.65 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -84.27 -42.63 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 118.764 -0.636 . . . . 1.1699999999999999 110.409 172.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.471 ' O ' HG13 ' A' ' 156' ' ' ILE . 24.9 mt-10 -47.98 -68.69 0.16 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 119.514 1.052 . . . . 1.99 112.467 171.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 157' ' ' VAL . 27.4 mt -47.6 -39.89 17.96 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.638 0.732 . . . . 1.9099999999999999 111.463 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.33 72.09 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.156 -1.384 . . . . 1.04 111.57 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 24.6 t -88.37 -32.07 18.57 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.573 -0.704 . . . . 0.88 112.523 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.8 mt -82.01 -59.93 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.673 0.749 . . . . 1.0 111.506 -172.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.9 m -90.42 143.79 29.85 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 114.739 -1.119 . . . . 1.0700000000000001 111.918 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -90.98 175.21 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 124.174 3.249 . . . . 0.23999999999999999 111.136 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 73.4 m-20 -66.8 157.24 33.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 119.668 -0.813 . . . . 1.1000000000000001 109.196 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.16 -24.29 32.46 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.042 -1.075 . . . . 0.17999999999999999 112.154 -172.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.565 ' HB ' HD13 ' A' ' 100' ' ' ILE . 84.6 m -60.35 132.07 52.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.675 -0.861 . . . . 1.05 108.675 -176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.541 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -93.59 128.98 39.99 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 122.581 1.182 . . . . 4.1100000000000003 111.012 -166.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.24 110.77 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 112.337 -2.21 . . . . 1.02 109.706 -173.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.407 HG23 ' ND2' ' A' ' 166' ' ' ASN . 24.5 m -94.79 108.89 20.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.045 -0.525 . . . . 1.0700000000000001 112.172 -173.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 165' ' ' ILE . 2.3 mp -82.51 100.68 6.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 122.51 1.148 . . . . 1.05 109.687 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.407 ' ND2' HG23 ' A' ' 164' ' ' THR . 60.7 m-80 -104.33 129.92 52.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 113.688 -1.597 . . . . 1.0900000000000001 108.749 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.486 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 16.1 mmm180 -69.29 -24.4 63.95 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.995 0.426 . . . . 2.4900000000000002 110.029 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.55 -136.91 39.28 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.317 -0.856 . . . . 1.97 113.472 169.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 109.892 -0.411 . . . . 4.3300000000000001 109.892 179.32 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.911 -0.476 . . . . 3.3399999999999999 111.911 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -146.88 144.63 29.42 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.99 -0.374 . . . . 4.9199999999999999 109.99 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -99.64 105.85 17.74 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.174 -0.466 . . . . 3.1000000000000001 110.833 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.753 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp -112.58 174.9 5.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.52 -0.763 . . . . 1.3300000000000001 111.307 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.3 tt -94.54 127.52 40.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.222 -0.899 . . . . 1.0700000000000001 110.437 -174.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 162.64 13.33 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.265 1.031 . . . . 1.03 113.347 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.65 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 87.4 t80 -130.82 140.77 50.29 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.622 -1.626 . . . . 1.0800000000000001 107.876 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -114.03 113.46 24.8 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.353 -0.98 . . . . 0.93000000000000005 108.353 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.565 ' HB ' ' O ' ' A' ' 41' ' ' THR . 96.7 t -67.88 150.89 10.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.553 1.168 . . . . 1.1000000000000001 113.325 -168.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -105.43 158.58 16.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.096 -1.866 . . . . 2.4399999999999999 108.211 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -63.42 104.69 0.65 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.416 0.524 . . . . 2.4300000000000002 112.416 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.87 10.7 27.91 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.885 -0.674 . . . . 0.51000000000000001 113.203 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.532 ' HB2' HG11 ' A' ' 9' ' ' VAL . 82.1 m-20 -54.94 167.53 0.38 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.871 0.367 . . . . 1.46 111.172 172.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.78 153.1 46.03 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.485 0.66 . . . . 1.1599999999999999 111.419 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.546 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -66.26 -34.88 79.0 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.466 -0.939 . . . . 1.47 108.466 -179.211 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.453 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 32.6 t-20 -88.8 -25.87 22.0 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.878 -1.056 . . . . 1.78 111.098 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p -66.99 -41.02 87.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 119.866 -0.734 . . . . 1.74 109.402 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.8 mt -72.82 -26.63 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.285 0.564 . . . . 1.04 109.747 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.594 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.34 -9.94 59.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.374 -0.375 . . . . 1.0600000000000001 111.199 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.633 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.43 -39.08 9.76 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.683 1.23 . . . . 0.97999999999999998 107.911 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.766 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 7.8 m-20 -63.96 -46.42 84.72 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.097 -2.319 . . . . 0.53000000000000003 112.239 173.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.568 ' C ' HD11 ' A' ' 101' ' ' ILE . 58.5 m-85 -95.92 5.91 50.12 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 118.58 -1.248 . . . . 0.20000000000000001 111.183 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.633 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 6.0 mpt_? 54.06 43.12 31.2 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.82 0.819 . . . . 2.46 109.69 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.594 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.1 pt -116.78 -165.78 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 114.521 -1.218 . . . . 1.04 110.121 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.49 142.57 40.34 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.912 -1.04 . . . . 1.3400000000000001 110.067 175.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.55 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 66.9 p -73.11 -31.62 64.44 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.089 -1.078 . . . . 1.0900000000000001 108.089 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 -29.79 69.99 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.314 -0.857 . . . . 1.0700000000000001 111.64 169.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.75 -26.83 18.4 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.991 -0.744 . . . . 1.04 108.991 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.602 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.5 tp -74.9 -27.28 60.16 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.198 -0.91 . . . . 1.8100000000000001 109.528 173.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 26' ' ' THR . 32.3 mt -76.98 -30.84 56.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.745 0.784 . . . . 1.6399999999999999 109.822 171.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 27.6 tt0 -62.92 -43.32 99.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.374 -1.284 . . . . 2.3300000000000001 109.867 173.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -83.62 -20.08 34.33 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.072 -0.651 . . . . 1.0600000000000001 111.716 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.594 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 30.0 m-80 -146.62 81.76 9.11 Favored Pre-proline 0 N--CA 1.449 -0.485 0 CA-C-O 121.578 0.704 . . . . 0.23000000000000001 110.932 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -58.24 -9.94 7.45 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 124.26 3.306 . . . . 0.52000000000000002 113.971 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 t -79.16 -24.92 42.95 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.175 -0.328 . . . . 1.6499999999999999 110.83 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.602 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 45.0 mt -67.11 -35.46 79.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.425 0.631 . . . . 1.25 111.913 -170.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.479 ' NE2' ' HB1' ' A' ' 38' ' ' ALA . 1.6 pp0? -63.02 -46.05 89.42 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 122.96 1.362 . . . . 2.52 110.147 -174.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.479 ' HB1' ' NE2' ' A' ' 37' ' ' GLN . . . -64.9 -47.42 77.86 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 111.554 -2.566 . . . . 1.1899999999999999 110.749 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.33 177.86 48.49 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.246 -0.888 . . . . 0.44 111.858 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.99 157.77 22.04 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.322 0.582 . . . . 1.1699999999999999 110.786 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.579 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 43.2 m -141.6 130.07 22.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.252 -0.886 . . . . 1.1499999999999999 110.336 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.43 120.37 20.78 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 119.956 -0.698 . . . . 1.1200000000000001 109.518 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.66 1.38 57.6 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.331 -1.108 . . . . 0.44 110.331 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.579 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -75.9 126.19 30.54 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.14 -0.689 . . . . 1.3 109.14 177.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 16.1 m -88.87 127.58 35.64 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.789 0.804 . . . . 1.3200000000000001 109.987 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.579 HG13 ' HB3' ' A' ' 7' ' ' TYR . 7.5 pt -127.07 142.72 42.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.246 -1.343 . . . . 1.0700000000000001 109.565 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.18 153.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.073 0.463 . . . . 1.3 111.141 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.2 mm -116.93 92.5 39.07 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.836 -1.075 . . . . 1.03 109.152 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.458 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . 2.1 Cg_endo -58.47 136.15 72.38 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.953 2.436 . . . . 0.20000000000000001 112.723 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.49 -6.02 83.48 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.116 -0.947 . . . . 0.26000000000000001 112.19 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.753 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.1 tp -123.91 114.03 28.24 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-O 121.35 0.595 . . . . 1.27 111.232 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.606 ' HD2' HD11 ' A' ' 51' ' ' LEU . 50.0 Cg_endo -78.11 -176.88 3.48 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.713 2.942 . . . . 0.31 113.965 -171.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.46 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 14.8 t70 -80.46 129.7 67.98 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 114.656 -1.156 . . . . 0.48999999999999999 112.007 -171.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.591 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.4 Cg_endo -76.5 -13.58 18.32 Favored 'Trans proline' 0 CA--C 1.518 -0.295 0 C-N-CA 123.632 2.888 . . . . 0.48999999999999999 112.881 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.442 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 18.1 m-30 -93.48 -9.59 37.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.663 -0.699 . . . . 1.8 110.037 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.46 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 29.5 p -87.96 -25.52 23.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.61 1.195 . . . . 1.1299999999999999 108.183 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.503 HG23 ' H ' ' A' ' 59' ' ' TYR . 33.4 mt -67.79 129.18 93.41 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 112.988 -1.914 . . . . 1.24 111.553 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.25 -19.64 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.571 2.181 . . . . 0.47999999999999998 113.557 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.503 ' H ' HG23 ' A' ' 57' ' ' ILE . 58.6 m-85 -98.17 163.31 12.79 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.29 -0.564 . . . . 0.94999999999999996 112.134 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -150.91 131.69 14.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.188 -0.915 . . . . 3.7400000000000002 108.858 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 71' ' ' THR . 96.9 mt -112.9 131.75 63.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.384 -0.371 . . . . 1.05 111.844 -176.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.39 117.62 31.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 120.044 -0.663 . . . . 1.0800000000000001 110.975 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 64.4 t -95.82 119.72 44.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.62 0.724 . . . . 1.04 110.681 175.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.469 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 38.5 m -96.66 107.63 20.11 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.004 -0.998 . . . . 0.83999999999999997 110.689 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.537 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 38.6 mm -54.01 -59.33 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 122.187 0.994 . . . . 1.0600000000000001 111.074 165.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.7 -12.77 7.01 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 112.72 -2.036 . . . . 0.16 113.379 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.469 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -126.34 -17.27 5.21 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.161 0.584 . . . . 1.02 112.548 -178.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.5 ' HD2' ' CG2' ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.41 55.52 5.7 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.703 0.683 . . . . 1.3 111.419 -174.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 45.8 p -137.59 163.7 30.56 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 113.09 0.774 . . . . 0.98999999999999999 113.09 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 81' ' ' THR . 8.0 tt -127.78 115.42 18.63 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.51 -1.223 . . . . 1.1799999999999999 109.443 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 48.0 m -95.53 119.63 34.37 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.304 0.573 . . . . 1.04 111.313 177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 79' ' ' MET . 0.5 OUTLIER -92.32 103.83 16.24 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.726 -1.212 . . . . 1.3200000000000001 107.726 174.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.6 m -106.8 158.32 17.08 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 118.924 -1.111 . . . . 1.05 111.371 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -127.96 124.63 37.76 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.462 0.648 . . . . 1.1000000000000001 109.622 170.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.587 ' N ' HD23 ' A' ' 74' ' ' LEU . 8.7 p30 30.97 68.07 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 113.918 -1.492 . . . . 1.97 112.804 -166.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 72.09 -9.41 1.0 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.034 -0.984 . . . . 2.5499999999999998 112.887 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -107.58 120.3 41.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.148 0.499 . . . . 4.0199999999999996 110.776 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 41.9 t -55.64 131.91 19.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.618 1.199 . . . . 1.0600000000000001 112.862 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.615 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 22.4 mmm -97.56 -46.86 5.87 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 112.816 -1.993 . . . . 1.47 108.538 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.643 ' HG2' ' CZ ' ' A' ' 82' ' ' TYR . 2.3 tptm -157.39 174.41 15.45 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.277 -1.783 . . . . 1.98 110.5 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 55.3 m -150.2 123.93 9.19 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.498 -1.683 . . . . 1.0 109.575 168.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.643 ' CZ ' ' HG2' ' A' ' 80' ' ' LYS . 29.9 m-85 -115.46 152.18 46.79 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.996 -0.547 . . . . 1.3999999999999999 110.163 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.47 ' HB2' HG23 ' A' ' 134' ' ' ILE . 55.2 Cg_endo -76.06 144.03 26.46 Favored 'Trans proline' 0 CA--C 1.496 -1.414 0 C-N-CA 122.003 1.802 . . . . 0.23999999999999999 110.981 176.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.561 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -141.31 172.62 10.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.685 -0.689 . . . . 1.04 110.496 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.948 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -116.87 140.41 49.48 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.852 -0.339 . . . . 1.03 110.215 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.5 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 12.9 m -124.02 126.08 71.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.618 0.723 . . . . 1.26 111.702 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.77 157.03 29.42 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 114.954 -1.021 . . . . 0.20000000000000001 110.621 173.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 139' ' ' SER . 27.6 mtpp -57.13 3.6 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.013 0.745 . . . . 3.48 113.013 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.524 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.1 tp -89.12 -20.72 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 O-C-N 121.467 -0.771 . . . . 1.0700000000000001 109.821 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.469 HD23 HG22 ' A' ' 89' ' ' ILE . 3.3 mm? -88.78 -21.62 23.69 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.545 -0.909 . . . . 1.02 108.545 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.2 p -69.17 -13.32 62.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.209 -1.36 . . . . 1.05 111.297 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -66.51 -42.95 86.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.103 -0.953 . . . . 2.0299999999999998 112.225 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.41 134.12 22.99 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.378 -0.529 . . . . 1.1499999999999999 110.49 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.536 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 93.9 Cg_endo -86.44 -6.58 8.01 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.452 2.101 . . . . 1.04 112.307 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -123.92 -38.71 2.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.55 . . . . 1.1299999999999999 110.317 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.437 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 44.98 46.22 9.42 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 124.165 0.915 . . . . 0.35999999999999999 114.131 171.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.73 112.91 20.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.741 0.781 . . . . 1.0800000000000001 109.874 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 17.5 m-85 -137.7 174.21 10.83 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.355 -1.293 . . . . 0.26000000000000001 112.86 -170.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.648 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 37.4 m-85 -141.99 137.31 31.08 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.589 -0.732 . . . . 0.78000000000000003 110.527 -175.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.552 HD13 ' HB ' ' A' ' 161' ' ' THR . 84.9 mt -61.33 123.88 14.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.779 -0.646 . . . . 1.02 110.444 171.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.568 HD11 ' C ' ' A' ' 22' ' ' PHE . 17.7 pt -87.44 -43.75 15.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 112.637 0.606 . . . . 1.03 112.637 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.509 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 55.3 m-80 -172.1 176.09 3.57 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 106.72 -1.585 . . . . 2.0299999999999998 106.72 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HB3' HD21 ' A' ' 116' ' ' LEU . 5.2 mtt180 -133.01 155.96 48.21 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.878 -0.729 . . . . 2.02 112.122 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -129.31 99.86 5.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.218 -0.901 . . . . 0.83999999999999997 109.538 172.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.476 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 20.7 ttt180 -66.33 166.26 12.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.427 -0.806 . . . . 3.2799999999999998 110.504 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.476 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 23.5 m-80 -35.27 104.9 0.27 Allowed Pre-proline 0 C--O 1.234 0.247 0 C-N-CA 125.198 1.399 . . . . 0.34999999999999998 113.605 -156.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.8 Cg_endo -60.28 -41.4 50.81 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.847 2.365 . . . . 0.63 111.215 170.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.88 -40.25 2.13 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.938 -0.865 . . . . 0.67000000000000004 110.938 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.69 -176.15 36.19 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 121.21 -0.519 . . . . 0.77000000000000002 112.745 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 112' ' ' GLY . 27.9 Cg_endo -59.52 2.42 0.28 Allowed 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 125.231 3.954 . . . . 1.1499999999999999 115.762 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.84 16.08 0.07 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.483 0.549 . . . . 1.5900000000000001 112.483 -175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.723 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 70.8 63.91 3.01 Favored Glycine 0 CA--C 1.499 -0.951 0 C-N-CA 120.212 -0.994 . . . . 1.6899999999999999 115.362 168.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.529 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 39.38 -3.9 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 117.392 2.367 . . . . 1.1699999999999999 117.392 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.653 ' HE1' ' CE2' ' A' ' 114' ' ' TYR . 0.4 OUTLIER -166.01 154.14 10.76 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.243 -0.91 . . . . 0.60999999999999999 110.549 -175.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 10.4 t-105 -134.23 98.59 4.15 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.064 -1.087 . . . . 0.56999999999999995 108.064 167.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 103' ' ' ARG . 4.5 mt -89.6 114.11 25.64 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.017 -0.735 . . . . 1.3600000000000001 109.017 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.7 m -84.46 144.27 28.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.76 -0.654 . . . . 0.42999999999999999 111.385 -167.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.767 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.5 mm? -108.84 171.61 7.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.975 -0.557 . . . . 1.02 110.625 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.605 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.5 OUTLIER -63.14 -13.84 41.56 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.93 0.715 . . . . 1.79 112.93 -179.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.766 ' HD3' ' OD1' ' A' ' 21' ' ' ASP . 5.3 tppp? -126.3 132.29 51.68 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.094 0.473 . . . . 1.8100000000000001 110.828 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.485 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 56.3 mt-30 -33.29 -57.42 0.41 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.907 -1.497 . . . . 1.76 114.308 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.524 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -99.74 12.13 37.42 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.569 -0.852 . . . . 3.2000000000000002 111.547 -172.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.767 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.1 m-85 -96.33 37.5 1.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.857 0.688 . . . . 0.83999999999999997 112.857 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -117.04 144.2 18.32 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 117.328 -2.367 . . . . 0.96999999999999997 112.649 -152.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -95.57 114.53 32.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.754 0.788 . . . . 1.04 110.778 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.563 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 27.5 p80 -143.34 171.97 13.39 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.389 -0.823 . . . . 0.20999999999999999 109.372 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.723 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.98 -169.4 38.08 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 119.847 -1.168 . . . . 0.34999999999999998 112.067 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.549 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 15.0 t -154.13 172.64 17.22 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.472 -0.428 . . . . 1.1100000000000001 110.009 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -113.0 -2.52 14.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.442 -0.947 . . . . 2.1899999999999999 108.442 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -115.71 88.17 19.76 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.004 -0.998 . . . . 1.8400000000000001 108.532 170.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -72.74 -16.87 26.37 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.248 1.965 . . . . 0.39000000000000001 112.779 -171.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.41 -0.61 33.58 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.546 -0.752 . . . . 1.0800000000000001 111.215 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.0 p -93.42 -6.45 47.04 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.134 -0.691 . . . . 1.9399999999999999 109.134 169.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.47 HG23 ' HB2' ' A' ' 83' ' ' PRO . 42.5 mm -81.18 130.78 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.255 -0.884 . . . . 1.04 110.627 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.73 2.58 59.76 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 109.944 -1.263 . . . . 0.16 109.944 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.421 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 23.3 mttp -114.81 170.57 8.23 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 123.146 1.45 . . . . 3.0299999999999998 114.431 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.421 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -101.91 127.66 48.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 111.887 -2.415 . . . . 1.01 108.006 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.411 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -123.23 162.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.643 -0.873 . . . . 1.3400000000000001 108.643 -176.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 58.7 m -52.18 -59.38 4.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.471 0.545 . . . . 0.87 112.471 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.93 -45.57 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 118.766 -1.174 . . . . 2.5499999999999998 113.726 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.83 133.54 0.16 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 116.955 1.542 . . . . 0.19 116.955 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.563 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 4.2 p -73.85 166.65 22.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 112.606 -1.797 . . . . 0.20000000000000001 112.066 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.948 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 54.0 mt -59.87 97.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 122.468 1.127 . . . . 1.1299999999999999 112.034 -163.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.546 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 34.3 mtt180 -84.12 152.98 24.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.694 -1.594 . . . . 2.3300000000000001 110.054 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.561 ' HG2' HG21 ' A' ' 84' ' ' ILE . 11.1 mtp -133.26 -165.88 1.68 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.545 -0.539 . . . . 1.0900000000000001 109.545 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.621 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 24.8 t-80 -97.54 151.3 20.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.569 -0.741 . . . . 2.9900000000000002 109.181 173.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.623 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.3 m120 -55.35 -53.52 55.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 118.132 -0.937 . . . . 0.73999999999999999 111.043 -174.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.452 ' HZ3' ' CG ' ' A' ' 149' ' ' ASP . 15.2 pttp -62.28 -28.23 69.57 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 121.592 1.996 . . . . 2.6899999999999999 111.827 -175.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.621 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 3.5 m-20 -78.23 -44.36 25.8 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.773 -0.649 . . . . 0.68999999999999995 110.903 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.534 HG12 HD13 ' A' ' 151' ' ' ILE . 14.2 p -67.27 -21.78 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.598 -0.728 . . . . 1.02 111.342 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.623 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.86 -42.37 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 119.124 -0.465 . . . . 1.1699999999999999 110.069 171.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.424 ' O ' HG13 ' A' ' 156' ' ' ILE . 31.2 mt-10 -46.84 -71.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.904 0.774 . . . . 1.99 112.87 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 149' ' ' ASP . 11.5 mt -43.54 -43.85 5.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.702 0.763 . . . . 1.9099999999999999 110.61 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.19 -37.35 74.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.701 -1.591 . . . . 1.04 111.722 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.3 t -85.94 -32.28 21.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.678 0.672 . . . . 0.88 112.032 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 152' ' ' GLU . 52.0 mt -81.13 -59.87 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.561 0.696 . . . . 1.0 111.408 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 153' ' ' LEU . 3.6 m -88.61 144.77 33.99 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 114.76 -1.109 . . . . 1.0700000000000001 111.728 175.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -91.63 177.21 1.89 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 124.09 3.193 . . . . 0.23999999999999999 111.266 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 61.0 m-20 -67.13 159.46 28.84 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.532 -0.867 . . . . 1.1000000000000001 109.339 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 94.84 -19.63 52.95 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.213 -0.994 . . . . 0.17999999999999999 112.125 -174.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.552 ' HB ' HD13 ' A' ' 100' ' ' ILE . 87.0 m -60.62 137.72 58.14 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.472 -0.566 . . . . 1.05 109.472 -175.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.472 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 1.9 ptt180 -92.05 116.4 28.9 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.769 1.271 . . . . 4.1100000000000003 110.51 -168.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.5 t -107.42 107.05 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 112.056 -2.338 . . . . 1.02 109.158 -175.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.0 m -94.74 109.92 21.82 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.038 -0.528 . . . . 1.0700000000000001 112.148 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.459 HD13 ' N ' ' A' ' 165' ' ' ILE . 2.4 mp -82.65 95.07 3.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 122.47 1.129 . . . . 1.05 109.694 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -101.58 136.57 41.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.607 -1.633 . . . . 1.0900000000000001 108.879 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.537 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 5.8 mmt85 -70.74 -33.29 70.66 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.446 -0.576 . . . . 2.4900000000000002 109.446 176.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 67.01 -97.76 0.38 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.327 -0.851 . . . . 1.97 112.399 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.5 m . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 109.651 -0.5 . . . . 4.3300000000000001 109.651 177.638 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.878 -0.489 . . . . 3.3399999999999999 111.878 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -107.37 156.63 18.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.892 0.377 . . . . 4.9199999999999999 110.664 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -88.48 98.04 11.41 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.913 -0.773 . . . . 3.1000000000000001 108.913 172.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 tp -114.06 174.15 6.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.027 -0.533 . . . . 1.3300000000000001 110.988 -176.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.2 tt -95.47 126.26 40.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.529 -0.76 . . . . 1.0700000000000001 110.338 -174.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.68 161.68 13.93 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.787 -1.097 . . . . 1.03 112.511 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.657 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 80.8 t80 -129.34 140.98 51.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.152 -1.386 . . . . 1.0800000000000001 107.987 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -112.92 112.74 24.43 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.936 -1.135 . . . . 0.93000000000000005 107.936 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' A' ' 13' ' ' ASP . 99.6 t -65.37 148.16 12.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 122.556 1.17 . . . . 1.1000000000000001 112.372 -170.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -106.29 158.16 17.07 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.287 -1.779 . . . . 2.4399999999999999 108.184 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -59.65 111.96 1.63 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.952 0.406 . . . . 2.4300000000000002 111.786 -173.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.53 54.13 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.744 -0.662 . . . . 0.51000000000000001 113.827 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.556 ' HB2' HG11 ' A' ' 9' ' ' VAL . 91.8 m-20 -55.61 168.2 0.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.198 0.499 . . . . 1.46 111.255 172.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.82 151.85 47.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.858 0.361 . . . . 1.1599999999999999 110.95 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -40.53 97.24 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.097 -1.075 . . . . 1.47 108.097 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.439 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 64.4 t30 -84.21 -22.65 30.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.353 -1.294 . . . . 1.78 110.434 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -65.09 -45.3 85.81 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.958 -0.756 . . . . 1.74 108.958 171.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.427 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 15.4 mt -72.52 -27.06 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.201 0.524 . . . . 1.04 109.84 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.617 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.27 -10.56 59.76 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.481 -0.327 . . . . 1.0600000000000001 110.912 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.639 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.5 -39.63 9.06 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 122.669 1.223 . . . . 0.97999999999999998 108.092 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 119' ' ' SER . 8.8 m-20 -62.46 -46.01 90.46 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 112.293 -2.23 . . . . 0.53000000000000003 111.904 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.629 ' C ' HD11 ' A' ' 101' ' ' ILE . 55.3 m-85 -95.83 5.68 50.72 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 118.81 -1.156 . . . . 0.20000000000000001 111.551 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.639 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.1 mpt_? 54.13 43.33 30.83 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.758 0.79 . . . . 2.46 109.838 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.617 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.5 pt -118.34 -165.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 114.442 -1.254 . . . . 1.04 109.799 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.7 142.73 42.22 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.156 -0.929 . . . . 1.3400000000000001 110.429 174.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.566 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 82.3 p -71.01 -33.34 70.29 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.198 -1.038 . . . . 1.0900000000000001 108.198 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.91 69.27 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.373 -0.831 . . . . 1.0700000000000001 112.008 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.42 -27.76 16.53 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.914 -0.773 . . . . 1.04 108.914 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.557 HD21 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -73.95 -28.86 61.7 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.956 -1.02 . . . . 1.8100000000000001 109.113 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 26' ' ' THR . 40.5 mt -76.1 -31.66 58.81 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.659 0.742 . . . . 1.6399999999999999 110.071 171.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 5.5 tt0 -63.78 -37.57 87.85 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.335 -1.302 . . . . 2.3300000000000001 110.084 174.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.46 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -85.97 -20.35 29.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 120.001 -0.68 . . . . 1.0600000000000001 111.679 176.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.592 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.7 m-80 -149.78 83.08 6.41 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-O 121.194 0.521 . . . . 0.23000000000000001 110.751 -172.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.2 Cg_endo -56.26 -15.46 14.75 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 123.927 3.085 . . . . 0.52000000000000002 113.834 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -73.2 -25.12 60.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.684 0.278 . . . . 1.6499999999999999 111.31 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 29.7 mt -67.88 -39.84 83.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.324 0.583 . . . . 1.25 112.397 -170.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -63.6 -44.79 92.96 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.933 1.349 . . . . 2.52 110.275 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.16 82.63 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 111.691 -2.504 . . . . 1.1899999999999999 110.614 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.06 176.55 48.01 Favored Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 115.048 -0.978 . . . . 0.44 111.951 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.03 157.69 19.05 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.163 0.506 . . . . 1.1699999999999999 110.791 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.569 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 49.9 m -141.39 127.93 20.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.33 -0.85 . . . . 1.1499999999999999 110.222 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 11' ' ' GLN . . . -76.45 117.21 17.87 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.492 0.663 . . . . 1.1200000000000001 109.986 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.66 -0.12 49.26 Favored Glycine 0 N--CA 1.429 -1.818 0 CA-C-N 114.775 -1.102 . . . . 0.44 110.389 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.569 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -75.14 124.69 27.47 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.921 -0.639 . . . . 1.3 109.63 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 61.8 p -85.67 131.79 34.27 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 122.099 0.952 . . . . 1.3200000000000001 110.448 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.576 HG13 ' HB3' ' A' ' 7' ' ' TYR . 10.2 pt -132.3 143.78 38.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.157 -1.383 . . . . 1.0700000000000001 109.521 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.24 151.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.2 0.524 . . . . 1.3 111.224 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.3 mm -116.74 93.37 40.89 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 114.614 -1.175 . . . . 1.03 108.948 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 2.3 Cg_endo -60.12 136.89 71.95 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.705 2.27 . . . . 0.20000000000000001 112.881 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.12 -6.23 83.79 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.114 -0.948 . . . . 0.26000000000000001 112.269 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.735 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 28.9 tp -121.46 114.53 31.6 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.287 0.565 . . . . 1.27 111.077 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.613 ' HD2' HD11 ' A' ' 51' ' ' LEU . 53.8 Cg_endo -78.67 -177.07 3.63 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.702 2.935 . . . . 0.31 114.135 -171.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.479 ' OD1' ' HB2' ' A' ' 55' ' ' TYR . 12.0 t70 -82.81 131.96 52.88 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 114.028 -1.442 . . . . 0.48999999999999999 112.317 -169.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 57.1 Cg_endo -73.98 -14.69 23.71 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 123.571 2.847 . . . . 0.48999999999999999 112.89 -177.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.479 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 22.0 m-85 -89.61 -15.47 32.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.082 -0.508 . . . . 1.8 110.73 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 20.8 p -83.22 -20.71 34.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 122.481 1.134 . . . . 1.1299999999999999 108.147 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.503 HG23 ' H ' ' A' ' 59' ' ' TYR . 26.4 mt -76.34 135.45 69.3 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 113.06 -1.882 . . . . 1.24 110.99 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.495 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 30.5 Cg_endo -84.7 -17.26 5.14 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 122.361 2.041 . . . . 0.47999999999999998 112.863 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.503 ' H ' HG23 ' A' ' 57' ' ' ILE . 42.9 m-85 -100.6 155.83 17.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.91 0.386 . . . . 0.94999999999999996 111.541 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -144.98 135.05 23.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.555 -0.748 . . . . 3.7400000000000002 109.102 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.64 ' HA ' ' O ' ' A' ' 71' ' ' THR . 84.1 mt -114.19 134.88 55.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.25 -0.432 . . . . 1.05 111.891 -175.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.05 118.88 33.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 119.89 -0.724 . . . . 1.0800000000000001 111.124 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.5 t -98.3 113.9 34.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.748 0.785 . . . . 1.04 111.166 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 68' ' ' LYS . 40.2 m -92.29 105.35 17.57 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.783 -1.099 . . . . 0.83999999999999997 110.336 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.7 mm -53.14 -58.73 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 122.055 0.931 . . . . 1.0600000000000001 111.314 168.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.01 -11.2 4.31 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 112.701 -2.045 . . . . 0.16 113.082 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -126.23 -16.53 5.45 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.653 0.781 . . . . 1.02 112.19 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.511 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 57.01 54.94 6.48 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.412 0.551 . . . . 1.3 111.28 -174.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.3 p -137.0 165.65 25.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.928 0.714 . . . . 0.98999999999999999 112.928 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.9 tt -132.8 111.66 11.29 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.68 -1.146 . . . . 1.1799999999999999 109.822 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.9 m -93.31 123.25 36.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.924 0.392 . . . . 1.04 111.101 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.575 ' O ' ' HB2' ' A' ' 79' ' ' MET . 11.6 tp -98.97 107.29 19.68 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.322 -0.854 . . . . 1.3200000000000001 108.791 172.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 88.3 p -105.37 161.89 13.92 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.324 -0.95 . . . . 1.05 110.591 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.599 HD11 ' ND2' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -126.31 126.33 43.76 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.522 -0.918 . . . . 1.1000000000000001 108.522 169.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.599 ' ND2' HD11 ' A' ' 74' ' ' LEU . 9.8 p30 43.0 48.1 5.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.021 -1.445 . . . . 1.97 111.647 -165.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.8 t30 78.15 -13.89 0.91 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.794 -1.094 . . . . 2.5499999999999998 111.591 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -92.51 122.78 35.28 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.193 -0.669 . . . . 4.0199999999999996 109.193 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 53.6 t -56.66 132.52 20.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.37 1.081 . . . . 1.0600000000000001 112.834 -173.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.575 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 57.2 mmm -96.91 -47.63 5.75 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.096 -1.865 . . . . 1.47 107.838 175.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -163.3 174.05 12.53 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 112.871 -1.968 . . . . 1.98 110.358 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.3 m -148.47 124.57 10.74 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.029 -1.441 . . . . 1.0 109.395 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -111.59 151.02 43.05 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 109.56 -0.533 . . . . 1.3999999999999999 109.56 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HB2' HG23 ' A' ' 134' ' ' ILE . 44.3 Cg_endo -76.63 140.82 21.5 Favored 'Trans proline' 0 CA--C 1.499 -1.247 0 C-N-CA 122.103 1.869 . . . . 0.23999999999999999 111.235 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.548 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.33 173.07 12.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.495 -0.775 . . . . 1.04 110.584 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.907 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.94 144.3 45.61 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 110.13 -0.322 . . . . 1.03 110.13 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.455 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 9.0 m -126.39 126.71 69.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.676 0.75 . . . . 1.26 111.801 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.28 152.41 29.41 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 109.771 -1.332 . . . . 0.20000000000000001 109.771 171.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 88' ' ' LYS . 31.9 mmtp -57.27 4.63 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.06 0.763 . . . . 3.48 113.06 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.484 ' H ' ' C ' ' A' ' 87' ' ' GLY . 1.1 tp -89.57 -19.65 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.504 0.669 . . . . 1.0700000000000001 110.235 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.7 mm? -88.09 -16.73 32.73 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.749 0.785 . . . . 1.02 109.097 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.9 p -68.95 -16.43 63.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.396 -1.274 . . . . 1.05 111.352 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -62.03 -42.06 98.76 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 114.945 -1.025 . . . . 2.0299999999999998 111.788 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.33 116.75 56.08 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 1.1499999999999999 110.644 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 6.0 Cg_exo -72.62 -21.25 22.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.604 2.202 . . . . 1.04 112.842 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -99.88 -40.44 7.69 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.529 -0.545 . . . . 1.1299999999999999 109.529 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.521 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 45.42 48.09 11.58 Favored Glycine 0 N--CA 1.446 -0.639 0 O-C-N 124.393 1.058 . . . . 0.35999999999999999 113.557 171.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -82.75 110.98 18.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.738 0.78 . . . . 1.0800000000000001 109.172 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.726 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 21.5 m-85 -139.53 169.29 18.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.01 -1.45 . . . . 0.26000000000000001 112.49 -171.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.669 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 43.6 m-85 -139.11 139.06 37.56 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.863 -0.608 . . . . 0.78000000000000003 110.377 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.561 HD13 ' HB ' ' A' ' 161' ' ' THR . 80.9 mt -61.63 118.93 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 115.412 -0.813 . . . . 1.02 110.492 172.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.629 HD11 ' C ' ' A' ' 22' ' ' PHE . 21.4 pt -85.28 -32.76 7.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 113.198 0.814 . . . . 1.03 113.198 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.589 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 10.4 p30 177.99 176.05 0.47 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.613 -1.254 . . . . 2.0299999999999998 107.613 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.698 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 19.6 mtt180 -125.2 161.25 27.29 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.509 -0.876 . . . . 2.02 111.914 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 107' ' ' PRO . 52.0 tt0 -135.99 100.17 4.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.216 -0.902 . . . . 0.83999999999999997 109.832 170.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.485 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 24.8 ttp180 -67.5 165.48 16.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.378 -0.828 . . . . 3.2799999999999998 110.843 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.737 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 34.5 m-80 -36.1 101.08 0.21 Allowed Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 125.32 1.448 . . . . 0.34999999999999998 112.706 -156.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 18.1 Cg_endo -64.52 -51.24 2.01 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.985 2.456 . . . . 0.63 112.392 175.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.74 -31.3 5.24 Favored Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 110.963 -0.855 . . . . 0.67000000000000004 110.963 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.13 -173.38 3.03 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.579 -0.811 . . . . 0.77000000000000002 112.306 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -52.15 -22.75 15.8 Favored 'Trans proline' 0 N--CA 1.478 0.591 0 C-N-CA 124.679 3.586 . . . . 1.1499999999999999 113.494 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -63.84 -37.4 87.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.056 0.931 . . . . 1.5900000000000001 108.868 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.564 ' O ' ' HB1' ' A' ' 113' ' ' ALA . . . 55.93 29.89 56.06 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 117.367 1.707 . . . . 1.6899999999999999 117.367 158.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.737 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . . . 173.92 -54.23 0.01 OUTLIER 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 118.653 1.226 . . . . 1.1699999999999999 110.518 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.485 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.8 OUTLIER -162.09 157.3 23.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.786 0.327 . . . . 0.60999999999999999 110.424 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -135.39 99.84 4.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.627 -1.249 . . . . 0.56999999999999995 107.627 164.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 103' ' ' ARG . 5.7 mt -92.18 113.95 26.36 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.579 -0.897 . . . . 1.3600000000000001 108.579 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.423 ' C ' HG12 ' A' ' 101' ' ' ILE . 13.2 m -83.55 144.88 29.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.775 -0.648 . . . . 0.42999999999999999 111.561 -166.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.728 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.9 mm? -110.28 166.53 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 1.02 110.936 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.596 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -62.65 -8.2 6.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.028 0.751 . . . . 1.79 113.028 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.76 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.9 tmtm? -126.84 133.01 50.84 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.362 1.077 . . . . 1.8100000000000001 109.833 172.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.76 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 52.9 mt-30 -39.08 -46.39 1.4 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 112.439 -2.164 . . . . 1.76 114.227 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.471 ' CB ' HG12 ' A' ' 89' ' ' ILE . 79.6 m-70 -97.38 -0.67 45.95 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.212 -0.595 . . . . 3.2000000000000002 111.51 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.728 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -97.21 38.19 1.27 Allowed 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.365 1.246 . . . . 0.83999999999999997 114.365 -169.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.454 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -117.19 146.0 18.73 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 116.457 -2.783 . . . . 0.96999999999999997 113.111 -153.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.73 116.58 39.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 124.053 0.941 . . . . 1.04 111.004 -176.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.558 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 29.5 p80 -146.23 -177.05 5.41 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 112.593 0.59 . . . . 0.20999999999999999 112.593 -176.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.98 -167.19 37.4 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.436 -0.666 . . . . 0.34999999999999998 111.436 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.6 t -161.68 164.05 29.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 117.727 0.764 . . . . 1.1100000000000001 110.589 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -115.18 -3.79 12.51 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.118 -1.067 . . . . 2.1899999999999999 108.118 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -121.74 91.43 48.62 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 114.148 -1.387 . . . . 1.8400000000000001 108.673 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.66 -22.27 18.2 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.346 2.031 . . . . 0.39000000000000001 113.769 -172.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.24 2.26 25.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.103 0.477 . . . . 1.0800000000000001 111.163 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.456 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 43.6 t -95.07 -4.89 45.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 1.9399999999999999 109.364 170.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 31.8 mm -78.76 138.17 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 115.899 -0.591 . . . . 1.04 110.106 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.56 1.81 80.19 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.119 -1.192 . . . . 0.16 110.119 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 91.8 mttt -113.36 167.94 10.15 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 123.161 1.457 . . . . 3.0299999999999998 114.253 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.1 126.63 46.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 111.699 -2.501 . . . . 1.01 107.961 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.417 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -125.24 161.95 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.909 -0.774 . . . . 1.3400000000000001 108.909 -174.418 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.7 m -49.72 -60.35 2.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.114 0.783 . . . . 0.87 113.114 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -133.52 -43.99 0.83 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 118.533 -1.267 . . . . 2.5499999999999998 113.619 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.42 133.49 0.2 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 117.055 1.582 . . . . 0.19 117.055 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.558 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 2.9 p -70.05 165.19 22.41 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 112.575 -1.813 . . . . 0.20000000000000001 112.419 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.907 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 49.4 mt -60.61 97.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 114.494 -1.23 . . . . 1.1299999999999999 112.077 -163.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.493 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 10.4 mtp180 -83.97 144.06 29.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.702 -1.59 . . . . 2.3300000000000001 109.501 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.548 ' HG2' HG21 ' A' ' 84' ' ' ILE . 14.9 mtp -121.38 -169.0 1.78 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.188 -0.671 . . . . 1.0900000000000001 109.188 173.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.606 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 1.5 t60 -89.85 153.91 20.28 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.158 -1.053 . . . . 2.9900000000000002 108.158 170.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.886 ' O ' HD12 ' A' ' 151' ' ' ILE . 9.2 m120 -72.45 -20.29 61.42 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 118.474 -0.774 . . . . 0.73999999999999999 113.069 -171.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -81.61 -28.75 33.58 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 121.364 1.893 . . . . 2.6899999999999999 112.734 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.606 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 5.0 m-20 -77.62 -41.21 39.34 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.186 0.517 . . . . 0.68999999999999995 110.63 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.507 HG12 HD11 ' A' ' 151' ' ' ILE . 12.5 p -66.34 -19.69 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.245 -0.889 . . . . 1.02 111.349 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.886 HD12 ' O ' ' A' ' 147' ' ' ASN . 1.6 mp -86.26 -42.98 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 118.801 -0.618 . . . . 1.1699999999999999 110.727 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.433 ' O ' HG13 ' A' ' 156' ' ' ILE . 16.2 mt-10 -45.12 -70.87 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.369 0.986 . . . . 1.99 112.578 170.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.514 ' O ' HG23 ' A' ' 157' ' ' VAL . 48.0 mt -46.07 -39.9 9.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.627 0.727 . . . . 1.9099999999999999 111.53 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.26 -36.07 79.0 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.01 -1.45 . . . . 1.04 111.775 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.3 t -86.97 -31.11 20.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 118.811 0.732 . . . . 0.88 112.501 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.1 mt -82.49 -60.35 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.652 0.739 . . . . 1.0 111.756 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -88.38 141.93 31.02 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.837 -1.074 . . . . 1.0700000000000001 112.252 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.698 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 56.9 Cg_endo -89.28 175.38 3.37 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 124.024 3.149 . . . . 0.23999999999999999 110.997 174.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.589 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 75.3 m-20 -65.53 156.04 33.81 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 119.371 -0.931 . . . . 1.1000000000000001 108.972 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 97.91 -19.78 53.21 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.008 -1.091 . . . . 0.17999999999999999 112.358 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.561 ' HB ' HD13 ' A' ' 100' ' ' ILE . 50.5 m -64.1 137.4 57.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.902 -0.777 . . . . 1.05 108.902 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.518 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 20.0 ttt180 -92.15 127.6 37.68 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 122.52 1.152 . . . . 4.1100000000000003 110.745 -169.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.31 107.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 112.374 -2.193 . . . . 1.02 109.086 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.1 m -93.92 107.91 19.77 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.377 0.51 . . . . 1.0700000000000001 112.377 -172.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.521 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.04 99.63 5.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 122.171 0.986 . . . . 1.05 109.955 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -110.77 133.38 53.39 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.391 -1.277 . . . . 1.0900000000000001 109.879 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.557 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 19.5 mmm180 -70.1 -22.01 63.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.239 -0.437 . . . . 2.4900000000000002 110.394 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 159.52 -75.24 0.2 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.916 -0.584 . . . . 1.97 112.285 173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 C--N 1.322 -0.621 0 N-CA-C 110.732 -0.099 . . . . 4.3300000000000001 110.732 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 111.627 -0.589 . . . . 3.3399999999999999 111.627 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -89.28 162.79 15.67 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.178 0.513 . . . . 4.9199999999999999 110.714 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -103.18 98.16 8.13 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.463 -0.79 . . . . 3.1000000000000001 109.404 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 mp -119.89 174.48 6.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.664 -0.698 . . . . 1.3300000000000001 111.643 -175.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.0 tt -98.18 128.67 44.79 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.904 -1.043 . . . . 1.0700000000000001 110.392 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.19 162.96 13.3 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.209 1.004 . . . . 1.03 113.075 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.639 ' HD1' ' CD2' ' A' ' 7' ' ' TYR . 86.9 t80 -130.32 139.36 50.7 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.768 -1.56 . . . . 1.0800000000000001 107.753 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -112.39 113.14 25.18 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.013 -1.106 . . . . 0.93000000000000005 108.013 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' A' ' 13' ' ' ASP . 94.9 t -67.23 148.15 12.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 122.528 1.156 . . . . 1.1000000000000001 113.283 -169.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -102.35 158.6 16.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 113.312 -1.767 . . . . 2.4399999999999999 108.367 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.61 104.22 0.4 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.059 0.457 . . . . 2.4300000000000002 112.068 -174.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.83 10.96 36.11 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.718 -0.674 . . . . 0.51000000000000001 113.502 174.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.617 ' HB2' HG11 ' A' ' 9' ' ' VAL . 29.8 m-20 -53.06 169.3 0.1 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.137 0.494 . . . . 1.46 111.671 173.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.35 150.47 50.7 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.105 0.479 . . . . 1.1599999999999999 111.95 177.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.515 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.56 -36.45 83.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.055 -0.975 . . . . 1.47 108.808 -177.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.42 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 2.7 t-20 -87.75 -24.5 23.79 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.812 -1.086 . . . . 1.78 110.855 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.0 m -70.1 -38.1 75.55 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.322 -0.551 . . . . 1.74 110.176 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 mt -74.67 -28.39 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.43 -0.581 . . . . 1.04 109.43 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.66 -9.54 59.43 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.281 -0.418 . . . . 1.0600000000000001 110.81 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.667 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.64 -40.8 8.83 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.38 1.086 . . . . 0.97999999999999998 108.116 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 119' ' ' SER . 7.5 m-20 -62.39 -44.41 96.52 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.462 -2.154 . . . . 0.53000000000000003 112.19 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.486 ' O ' HD11 ' A' ' 101' ' ' ILE . 53.0 m-85 -96.98 6.39 48.72 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 118.627 -1.229 . . . . 0.20000000000000001 111.03 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.667 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER 54.3 41.44 31.98 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.916 0.865 . . . . 2.46 109.25 176.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.62 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.1 pt -113.87 -165.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.442 -1.254 . . . . 1.04 110.214 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.06 142.61 41.28 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.206 -0.906 . . . . 1.3400000000000001 110.225 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.48 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 60.3 p -72.97 -33.29 65.77 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.804 -1.184 . . . . 1.0900000000000001 107.804 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.04 -27.2 66.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.34 -0.845 . . . . 1.0700000000000001 111.824 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.495 ' HA ' ' HB2' ' A' ' 31' ' ' GLN . . . -95.21 -25.3 16.43 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.649 0.737 . . . . 1.04 109.636 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.593 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 17.5 tp -75.23 -27.43 59.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.241 -0.89 . . . . 1.8100000000000001 109.054 173.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 36' ' ' LEU . 35.3 mt -78.04 -26.69 48.51 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.36 0.6 . . . . 1.6399999999999999 110.372 172.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.495 ' HB2' ' HA ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -59.81 -61.56 2.52 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 108.129 -1.063 . . . . 2.3300000000000001 108.129 169.471 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.465 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -71.29 -18.57 62.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.491 -0.777 . . . . 1.0600000000000001 110.86 -170.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.568 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 28.5 m-80 -147.61 80.65 8.93 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-N 115.642 -0.708 . . . . 0.23000000000000001 110.385 -174.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.5 -4.41 2.49 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 123.787 2.991 . . . . 0.52000000000000002 113.145 174.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 p -79.96 -25.75 40.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.052 0.453 . . . . 1.6499999999999999 111.542 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.593 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 33.6 mt -70.81 -33.66 70.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.733 -0.667 . . . . 1.25 112.387 -170.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.425 ' H ' ' HG3' ' A' ' 37' ' ' GLN . 1.7 pp0? -63.56 -44.72 93.3 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.822 1.296 . . . . 2.52 110.76 -172.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.416 ' HB1' ' NE2' ' A' ' 37' ' ' GLN . . . -64.19 -49.12 73.28 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 111.795 -2.457 . . . . 1.1899999999999999 110.404 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.6 176.23 47.87 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 114.683 -1.144 . . . . 0.44 111.405 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -109.51 157.99 18.44 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.37 0.605 . . . . 1.1699999999999999 110.626 179.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.606 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 53.2 m -138.39 128.8 26.1 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.317 -0.856 . . . . 1.1499999999999999 110.192 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.25 119.74 19.79 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 119.996 -0.682 . . . . 1.1200000000000001 109.535 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.44 1.51 56.67 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.254 -1.138 . . . . 0.44 110.254 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.606 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -76.65 123.6 26.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.918 -0.641 . . . . 1.3 109.824 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 29.8 p -84.32 125.93 32.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.491 -0.777 . . . . 1.3200000000000001 110.771 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.594 HG13 ' HB3' ' A' ' 7' ' ' TYR . 8.9 pt -126.3 143.23 40.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 114.241 -1.345 . . . . 1.0700000000000001 109.443 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.64 152.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 121.164 0.507 . . . . 1.3 111.185 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.9 mm -116.28 92.03 34.75 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.648 -1.16 . . . . 1.03 109.268 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 1.9 Cg_endo -57.98 135.06 66.38 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.811 2.341 . . . . 0.20000000000000001 112.71 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.98 -5.77 83.06 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.067 -0.97 . . . . 0.26000000000000001 112.279 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.707 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 27.7 tp -122.54 113.37 30.61 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 121.253 0.549 . . . . 1.27 110.978 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.623 ' HD2' HD11 ' A' ' 51' ' ' LEU . 48.6 Cg_endo -78.05 -176.22 3.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.77 2.98 . . . . 0.31 114.295 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.531 ' OD2' ' HB2' ' A' ' 55' ' ' TYR . 22.5 t70 -79.9 129.76 69.4 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 113.967 -1.47 . . . . 0.48999999999999999 112.648 -169.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 41.1 Cg_endo -73.06 -14.01 26.11 Favored 'Trans proline' 0 C--N 1.34 0.118 0 C-N-CA 123.396 2.731 . . . . 0.48999999999999999 112.687 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.531 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 75.5 m-85 -92.58 -10.28 38.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.971 -0.558 . . . . 1.8 111.332 -174.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 30.0 p -85.46 -24.69 27.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.586 1.184 . . . . 1.1299999999999999 108.153 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.528 HG23 ' H ' ' A' ' 59' ' ' TYR . 15.9 mt -72.53 136.34 80.98 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.82 -1.991 . . . . 1.24 111.246 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.518 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 36.8 Cg_endo -86.38 -16.49 3.94 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.459 2.106 . . . . 0.47999999999999998 113.319 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.528 ' H ' HG23 ' A' ' 57' ' ' ILE . 56.0 m-85 -98.43 158.15 15.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.199 0.444 . . . . 0.94999999999999996 112.199 -174.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.579 ' CD2' ' HE ' ' A' ' 162' ' ' ARG . 40.5 m80 -147.01 132.44 18.61 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.67 -0.695 . . . . 3.7400000000000002 109.15 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.703 ' HA ' ' O ' ' A' ' 71' ' ' THR . 76.1 mt -114.99 135.93 53.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.261 -0.427 . . . . 1.05 111.914 -176.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.79 117.6 28.63 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.11 -0.636 . . . . 1.0800000000000001 111.249 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 69' ' ' THR . 88.9 t -96.77 117.93 42.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.511 0.672 . . . . 1.04 111.168 175.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.46 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 65.1 m -92.84 109.56 21.0 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.253 -0.885 . . . . 0.83999999999999997 111.262 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 36.2 mm -54.48 -59.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 122.255 1.026 . . . . 1.0600000000000001 111.081 165.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.13 -12.75 6.0 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 112.783 -2.008 . . . . 0.16 113.362 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.46 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -126.94 -18.62 4.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.866 0.691 . . . . 1.02 112.866 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HB2' ' HZ2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.96 56.3 4.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.811 0.732 . . . . 1.3 111.438 -172.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 46.8 p -137.89 164.6 28.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.897 0.703 . . . . 0.98999999999999999 112.897 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.436 ' C ' HD21 ' A' ' 70' ' ' LEU . 7.4 tt -133.13 110.67 10.34 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.713 -1.131 . . . . 1.1799999999999999 109.81 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 53.1 m -93.42 121.77 35.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.288 0.566 . . . . 1.04 111.188 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.1 tp -96.5 107.37 19.77 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.909 -1.041 . . . . 1.3200000000000001 109.054 173.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 4.3 m -107.61 158.11 17.52 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.453 -0.899 . . . . 1.05 110.645 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.574 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -126.19 126.15 43.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.826 -0.805 . . . . 1.1000000000000001 108.826 170.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.574 ' N ' HD23 ' A' ' 74' ' ' LEU . 8.9 p30 41.48 54.81 3.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.04 -1.436 . . . . 1.97 111.539 -165.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.5 t30 73.86 -14.98 0.61 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.173 -0.921 . . . . 2.5499999999999998 111.709 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -91.84 118.99 31.23 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.81 -0.441 . . . . 4.0199999999999996 109.81 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.0 t -58.05 130.32 21.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 122.479 1.133 . . . . 1.0600000000000001 112.412 -175.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.53 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 64.0 mmm -96.27 -48.68 5.52 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.014 -1.903 . . . . 1.47 108.214 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 14.3 mmmt -160.72 174.06 14.49 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 112.669 -2.06 . . . . 1.98 109.477 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.3 m -148.58 124.49 10.62 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.602 -1.181 . . . . 1.0 109.072 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 1.622 ' HD1' ' CD2' ' A' ' 82' ' ' TYR . 12.9 m-85 -106.01 147.21 34.39 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.118 -0.946 . . . . 1.3999999999999999 109.588 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.44 ' HB2' HG23 ' A' ' 134' ' ' ILE . 37.4 Cg_endo -75.12 140.61 25.33 Favored 'Trans proline' 0 CA--C 1.498 -1.305 0 C-N-CA 121.445 1.43 . . . . 0.23999999999999999 110.24 168.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.524 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -141.06 174.68 6.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.764 -0.653 . . . . 1.04 110.554 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.889 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.16 143.55 47.16 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.793 0.33 . . . . 1.03 110.424 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.461 HG23 ' HG3' ' A' ' 68' ' ' LYS . 8.7 m -125.64 126.21 69.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.525 0.678 . . . . 1.26 111.779 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.03 154.41 31.91 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.609 -1.396 . . . . 0.20000000000000001 109.609 171.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -55.79 0.18 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.042 0.756 . . . . 3.48 113.042 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.549 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.2 tp -85.04 -19.11 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 O-C-N 121.353 -0.842 . . . . 1.0700000000000001 110.068 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.427 HD23 HG22 ' A' ' 89' ' ' ILE . 3.5 mm? -87.17 -17.25 33.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.766 -0.827 . . . . 1.02 108.766 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.6 p -70.41 -15.66 62.86 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.461 -1.245 . . . . 1.05 111.23 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.17 -43.21 98.9 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.477 -0.783 . . . . 2.0299999999999998 111.594 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.07 132.95 27.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.477 -0.489 . . . . 1.1499999999999999 110.72 -174.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.48 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 84.3 Cg_endo -88.7 4.3 5.51 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.73 2.286 . . . . 1.04 111.66 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -128.39 -41.51 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.161 -0.681 . . . . 1.1299999999999999 109.161 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.604 ' O ' ' HB ' ' A' ' 165' ' ' ILE . . . 53.13 16.92 4.86 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 124.595 1.184 . . . . 0.35999999999999999 114.377 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.642 ' CB ' HG21 ' A' ' 164' ' ' THR . 12.9 pt-20 -86.3 119.64 26.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.331 1.062 . . . . 1.0800000000000001 110.223 -171.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.66 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 9.3 m-85 -138.67 -170.56 2.87 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.679 -1.601 . . . . 0.26000000000000001 111.764 -163.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.596 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 85.7 m-85 -142.9 139.2 30.68 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.237 0.541 . . . . 0.78000000000000003 110.938 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.541 HD13 ' HB ' ' A' ' 161' ' ' THR . 85.5 mt -63.74 123.4 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.463 -0.79 . . . . 1.02 110.39 168.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.544 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.8 pt -89.64 -43.9 14.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 113.621 0.971 . . . . 1.03 113.621 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.601 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 49.1 m-80 -171.22 174.14 4.69 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.047 -1.464 . . . . 2.0299999999999998 107.047 -169.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.648 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 40.3 mtt180 -127.1 169.47 13.38 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.252 -0.979 . . . . 2.02 111.961 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 55.0 tt0 -147.13 99.8 3.21 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.075 -0.966 . . . . 0.83999999999999997 109.629 170.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.499 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 46.5 ttt180 -65.74 166.11 11.52 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.205 -0.907 . . . . 3.2799999999999998 110.826 175.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.47 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 19.3 m-80 -35.41 102.74 0.23 Allowed Pre-proline 0 C--O 1.232 0.168 0 C-N-CA 125.269 1.428 . . . . 0.34999999999999998 113.305 -157.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.4 Cg_endo -61.26 -36.03 81.84 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.153 2.568 . . . . 0.63 111.78 173.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.89 -33.82 4.89 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.151 -0.779 . . . . 0.67000000000000004 111.151 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -79.39 -176.88 49.45 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.199 -0.5 . . . . 0.77000000000000002 112.614 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 112' ' ' GLY . 30.2 Cg_endo -61.47 6.16 0.16 Allowed 'Trans proline' 0 N--CA 1.482 0.848 0 C-N-CA 125.024 3.816 . . . . 1.1499999999999999 115.515 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.417 ' H ' ' C ' ' A' ' 109' ' ' GLY . 9.7 m-85 -71.26 13.25 0.24 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 112.273 0.472 . . . . 1.5900000000000001 112.273 -174.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.719 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 73.67 64.04 2.57 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.912 -1.137 . . . . 1.6899999999999999 115.316 170.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.485 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 38.96 -3.48 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 117.482 2.401 . . . . 1.1699999999999999 117.482 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.652 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.3 OUTLIER -165.83 154.78 11.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.417 -0.802 . . . . 0.60999999999999999 110.449 -176.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.405 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.3 t-105 -135.25 99.28 4.2 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.115 -1.069 . . . . 0.56999999999999995 108.115 168.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 103' ' ' ARG . 4.9 mt -93.15 114.69 27.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.584 0.707 . . . . 1.3600000000000001 109.245 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.423 ' C ' HG12 ' A' ' 101' ' ' ILE . 19.6 m -83.54 144.23 29.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.666 -0.697 . . . . 0.42999999999999999 111.502 -167.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.517 ' N ' HD21 ' A' ' 118' ' ' LEU . 1.7 mm? -108.72 165.04 11.85 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.454 -0.794 . . . . 1.02 110.791 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.465 ' OG ' ' HD2' ' A' ' 98' ' ' PHE . 3.7 p -68.16 -4.58 14.3 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 124.008 0.817 . . . . 1.79 112.546 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.677 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 4.3 tmtm? -126.66 128.33 46.56 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 120.213 -0.595 . . . . 1.8100000000000001 109.581 166.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.677 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 52.9 mt-30 -33.19 -58.28 0.39 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.431 -1.713 . . . . 1.76 113.847 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.549 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -96.67 13.18 29.2 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.964 -0.694 . . . . 3.2000000000000002 112.17 -170.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.569 ' CG ' ' HB3' ' A' ' 120' ' ' LYS . 2.8 m-30 -90.38 -34.29 15.72 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-O 121.923 0.868 . . . . 0.83999999999999997 111.081 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.451 ' HA2' HD21 ' A' ' 118' ' ' LEU . . . -6.87 128.71 0.01 OUTLIER Glycine 0 C--N 1.297 -1.601 0 N-CA-C 119.262 2.465 . . . . 0.96999999999999997 119.262 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -99.96 115.67 41.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 112.822 -1.689 . . . . 1.04 109.815 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.696 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.0 p80 -143.27 175.16 10.11 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.501 -0.772 . . . . 0.20999999999999999 109.653 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.719 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.58 -168.81 38.52 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 120.016 -1.088 . . . . 0.34999999999999998 111.991 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.576 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 13.0 t -156.03 168.04 28.53 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.89 -0.771 . . . . 1.1100000000000001 110.367 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -110.33 -9.21 14.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.507 -0.923 . . . . 2.1899999999999999 108.507 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -111.21 88.33 8.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 114.816 -1.084 . . . . 1.8400000000000001 108.356 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -72.89 -19.64 23.27 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.754 2.303 . . . . 0.39000000000000001 113.326 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.6 -2.07 33.94 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.03 -0.532 . . . . 1.0800000000000001 111.002 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.5 m -91.97 -4.16 54.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.544 -0.539 . . . . 1.9399999999999999 109.544 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 83' ' ' PRO . 43.5 mm -82.31 131.4 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.845 -0.616 . . . . 1.04 110.401 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.7 1.4 65.87 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.811 -1.316 . . . . 0.16 109.811 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 137' ' ' ALA . 2.0 tttm -114.29 163.27 15.5 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 122.759 1.266 . . . . 3.0299999999999998 113.388 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -94.54 126.9 40.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 112.424 -2.171 . . . . 1.01 107.889 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.429 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -121.64 159.25 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 108.6 -0.889 . . . . 1.3400000000000001 108.6 -175.176 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 m -49.34 -59.35 3.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.406 0.521 . . . . 0.87 112.406 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.419 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 21.0 pttm -132.36 -45.96 0.91 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.506 -1.278 . . . . 2.5499999999999998 114.186 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.34 134.01 0.18 Allowed Glycine 0 N--CA 1.468 0.815 0 N-CA-C 117.648 1.819 . . . . 0.19 117.648 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.587 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 2.1 p -69.77 165.5 21.28 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 112.601 -1.8 . . . . 0.20000000000000001 111.916 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.889 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 57.8 mt -60.37 99.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 114.711 -1.131 . . . . 1.1299999999999999 112.008 -162.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.696 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 60.8 mtt180 -87.69 148.97 24.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.988 -1.46 . . . . 2.3300000000000001 110.685 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.524 ' HG2' HG21 ' A' ' 84' ' ' ILE . 17.5 mtp -126.34 -165.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.217 -0.661 . . . . 1.0900000000000001 109.217 173.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.617 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 12.8 t-80 -93.77 153.39 18.33 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.068 -0.715 . . . . 2.9900000000000002 109.068 172.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.625 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.2 m120 -57.41 -54.8 42.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 118.188 -0.911 . . . . 0.73999999999999999 110.907 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -65.22 -21.97 66.82 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 121.543 1.974 . . . . 2.6899999999999999 112.149 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.617 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.9 m-20 -80.9 -45.79 16.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.096 -0.956 . . . . 0.68999999999999995 111.169 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.526 HG12 HD13 ' A' ' 151' ' ' ILE . 14.9 p -65.8 -20.73 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.554 -0.748 . . . . 1.02 111.052 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.625 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.26 -41.0 16.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 119.006 -0.521 . . . . 1.1699999999999999 109.889 170.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.406 ' O ' HG13 ' A' ' 156' ' ' ILE . 28.7 mt-10 -45.92 -70.73 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.164 0.893 . . . . 1.99 112.339 168.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.464 HD23 ' SD ' ' A' ' 145' ' ' MET . 9.4 mp -46.18 -38.56 8.48 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.49 0.662 . . . . 1.9099999999999999 111.486 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.75 -33.52 76.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.376 -1.284 . . . . 1.04 111.598 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -88.79 -31.68 18.25 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.487 -0.758 . . . . 0.88 112.711 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 152' ' ' GLU . 35.2 mt -83.38 -60.1 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.451 0.643 . . . . 1.0 111.679 -172.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 153' ' ' LEU . 3.1 m -91.26 139.99 25.6 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 114.969 -1.014 . . . . 1.0700000000000001 112.158 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.648 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 61.2 Cg_endo -89.09 174.4 3.74 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 123.899 3.066 . . . . 0.23999999999999999 111.286 174.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.601 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 58.5 m-20 -67.75 156.07 37.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.423 -0.911 . . . . 1.1000000000000001 108.876 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.69 -20.53 50.02 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.246 -0.978 . . . . 0.17999999999999999 112.523 -172.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.541 ' HB ' HD13 ' A' ' 100' ' ' ILE . 53.2 m -63.75 137.74 58.19 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.006 -0.739 . . . . 1.05 109.006 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.596 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 18.8 ptt180 -92.48 120.6 33.12 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.944 1.354 . . . . 4.1100000000000003 111.22 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.6 t -102.78 106.48 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 111.951 -2.386 . . . . 1.02 108.875 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.642 HG21 ' CB ' ' A' ' 97' ' ' GLU . 1.8 m -93.74 104.59 16.68 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.257 -0.577 . . . . 1.0700000000000001 112.327 -170.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 2.4 mp -81.45 93.29 2.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 122.509 1.147 . . . . 1.05 109.552 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -103.31 139.15 39.12 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.865 -1.516 . . . . 1.0900000000000001 109.432 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.482 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 6.5 mmt85 -72.14 -14.95 61.96 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.057 -0.52 . . . . 2.4900000000000002 111.115 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.23 22.47 27.17 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 121.137 -0.554 . . . . 1.97 112.064 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 109.225 -0.657 . . . . 4.3300000000000001 109.225 -178.753 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.817 -0.513 . . . . 3.3399999999999999 111.817 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -98.06 125.73 43.17 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.874 -0.417 . . . . 4.9199999999999999 109.874 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 3' ' ' LYS . 28.9 mmmt -128.92 99.44 5.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.886 -0.597 . . . . 3.1000000000000001 111.191 -175.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -105.58 175.05 5.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.488 0.661 . . . . 1.3300000000000001 111.969 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.646 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.2 tt -99.09 131.82 44.86 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.717 -1.129 . . . . 1.0700000000000001 110.238 -175.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.7 162.37 13.47 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 122.218 1.008 . . . . 1.03 113.201 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' A' ' 7' ' ' TYR . 80.8 t80 -130.72 144.86 51.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.723 -1.581 . . . . 1.0800000000000001 107.859 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -115.85 113.53 23.48 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 108.483 -0.932 . . . . 0.93000000000000005 108.483 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.576 ' HB ' ' O ' ' A' ' 41' ' ' THR . 86.0 t -66.39 152.32 9.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 122.735 1.255 . . . . 1.1000000000000001 113.27 -171.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.0 mtmm -108.68 159.35 16.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.036 -1.893 . . . . 2.4399999999999999 108.54 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.452 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 2.2 mm-40 -62.13 113.8 3.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.041 0.448 . . . . 2.4300000000000002 112.044 -174.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.38 10.76 56.73 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.582 -0.735 . . . . 0.51000000000000001 113.669 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.514 ' HB2' HG11 ' A' ' 9' ' ' VAL . 86.3 m-20 -56.2 169.38 0.41 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.109 0.454 . . . . 1.46 111.161 173.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.81 156.69 43.19 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.432 -0.507 . . . . 1.1599999999999999 110.916 173.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.477 HD13 HD22 ' A' ' 29' ' ' LEU . 3.0 tp -66.07 -36.36 83.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.986 0.898 . . . . 1.47 109.539 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 5.1 t30 -85.87 -24.98 26.46 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.342 -1.299 . . . . 1.78 110.248 -176.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.6 t -65.88 -42.11 90.71 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.127 -0.694 . . . . 1.74 109.127 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 14.8 mt -74.69 -27.01 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.171 0.51 . . . . 1.04 109.908 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.32 -9.98 59.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.532 -0.304 . . . . 1.0600000000000001 110.679 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.61 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.73 -38.62 9.83 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.642 1.21 . . . . 0.97999999999999998 108.155 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.3 m-20 -62.28 -45.55 92.76 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.277 -2.238 . . . . 0.53000000000000003 111.689 172.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.578 ' C ' HD11 ' A' ' 101' ' ' ILE . 58.8 m-85 -98.62 4.8 48.06 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 118.685 -1.206 . . . . 0.20000000000000001 111.667 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.61 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.0 mpt_? 54.78 42.84 30.86 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.689 0.757 . . . . 2.46 109.738 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.6 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.7 pt -115.41 -165.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.548 -1.205 . . . . 1.04 109.883 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.39 142.82 39.8 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.123 -0.944 . . . . 1.3400000000000001 110.118 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.457 ' HB ' HD23 ' A' ' 15' ' ' LEU . 70.6 p -73.23 -31.95 64.44 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.364 -0.976 . . . . 1.0900000000000001 108.364 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.67 68.16 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.049 -0.978 . . . . 1.0700000000000001 111.512 169.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -92.89 -27.66 16.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.359 0.599 . . . . 1.04 109.461 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.634 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 15.2 tp -74.79 -26.64 59.89 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.662 -0.699 . . . . 1.8100000000000001 109.299 174.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.493 HD21 ' HB2' ' A' ' 36' ' ' LEU . 42.8 mt -77.62 -30.51 52.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.62 0.724 . . . . 1.6399999999999999 109.772 171.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 22.6 tt0 -63.74 -43.16 97.3 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.326 -1.306 . . . . 2.3300000000000001 110.002 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.428 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -83.47 -21.35 32.88 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.357 -0.537 . . . . 1.0600000000000001 111.715 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.557 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.1 m-80 -145.96 82.74 9.07 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-O 121.571 0.7 . . . . 0.23000000000000001 110.642 -171.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.84 -6.13 3.19 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 123.803 3.002 . . . . 0.52000000000000002 113.675 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.9 t -80.17 -25.78 39.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.651 0.263 . . . . 1.6499999999999999 111.297 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.634 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 32.0 mt -70.11 -35.1 73.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.57 0.7 . . . . 1.25 112.158 -170.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.35 -46.98 78.08 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 122.847 1.308 . . . . 2.52 110.296 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.67 -49.74 74.17 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 111.982 -2.372 . . . . 1.1899999999999999 110.479 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.26 179.36 48.89 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 114.715 -1.129 . . . . 0.44 111.332 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 157.09 19.76 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.39 0.614 . . . . 1.1699999999999999 110.895 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.576 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 39.7 m -143.31 126.26 16.27 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.231 -0.895 . . . . 1.1499999999999999 110.706 -176.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' CB ' ' HG2' ' A' ' 11' ' ' GLN . . . -75.86 116.62 16.75 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.561 0.696 . . . . 1.1200000000000001 109.735 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.34 -0.85 40.26 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.192 -1.163 . . . . 0.44 110.192 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.543 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.4 tt0 -75.51 123.82 26.11 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.961 -0.62 . . . . 1.3 109.733 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 58.8 p -80.89 133.13 35.51 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.589 -0.732 . . . . 1.3200000000000001 109.864 176.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.594 HG13 ' HB3' ' A' ' 7' ' ' TYR . 11.7 pt -134.28 141.61 43.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.498 -1.228 . . . . 1.0700000000000001 109.22 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.68 152.22 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.173 0.511 . . . . 1.3 110.713 -179.392 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.413 HG22 ' CD2' ' A' ' 22' ' ' PHE . 38.0 mm -115.89 92.5 34.78 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.97 -1.014 . . . . 1.03 109.412 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.519 ' HA ' HD23 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -57.41 132.69 52.32 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.727 2.285 . . . . 0.20000000000000001 112.598 -175.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.65 -2.27 80.01 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 114.825 -1.079 . . . . 0.26000000000000001 112.527 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.632 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 34.0 tp -125.4 114.94 25.5 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-O 121.314 0.578 . . . . 1.27 111.139 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.646 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 57.6 Cg_endo -79.79 -177.64 3.98 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.716 2.944 . . . . 0.31 114.577 -171.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.492 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 11.7 t70 -80.52 130.97 62.79 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 114.055 -1.429 . . . . 0.48999999999999999 111.602 -173.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.513 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 44.1 Cg_endo -71.29 -20.01 28.48 Favored 'Trans proline' 0 CA--C 1.519 -0.263 0 C-N-CA 123.381 2.72 . . . . 0.48999999999999999 113.121 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -96.79 -0.89 47.33 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.418 0.628 . . . . 1.8 111.88 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.492 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 29.5 p -89.31 -15.58 33.13 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.228 -1.397 . . . . 1.1299999999999999 107.228 169.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.507 HG23 ' H ' ' A' ' 59' ' ' TYR . 18.2 mt -82.53 134.36 48.1 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 112.5 -2.136 . . . . 1.24 110.317 175.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -84.1 -16.95 5.93 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.282 1.988 . . . . 0.47999999999999998 113.239 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.507 ' H ' HG23 ' A' ' 57' ' ' ILE . 61.2 m-85 -93.93 155.15 17.31 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.751 -0.38 . . . . 0.94999999999999996 111.859 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -146.33 131.72 18.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.77 -0.826 . . . . 3.7400000000000002 108.77 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 71' ' ' THR . 91.1 mt -114.95 133.98 59.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.072 0.397 . . . . 1.05 112.072 -175.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.1 121.55 42.48 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.17 -0.612 . . . . 1.0800000000000001 110.903 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.43 114.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.884 0.85 . . . . 1.04 111.444 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 68' ' ' LYS . 46.9 m -95.02 102.29 14.09 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.606 -1.179 . . . . 0.83999999999999997 110.743 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.9 mm -50.99 -57.74 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 122.25 1.024 . . . . 1.0600000000000001 111.536 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.25 -10.13 5.08 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 112.788 -2.005 . . . . 0.16 113.414 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.57 -18.54 4.79 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.51 0.724 . . . . 1.02 112.318 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.509 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.26 56.27 4.58 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.325 0.511 . . . . 1.3 111.003 -173.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.7 p -137.31 161.73 35.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 112.719 0.636 . . . . 0.98999999999999999 112.719 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.409 ' C ' HD21 ' A' ' 70' ' ' LEU . 7.5 tt -130.54 110.74 11.65 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.659 -1.155 . . . . 1.1799999999999999 109.928 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 36.2 m -92.12 123.47 35.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.022 0.439 . . . . 1.04 111.126 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.3 tp -98.88 104.32 16.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.413 -0.812 . . . . 1.3200000000000001 109.481 172.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 19.4 m -105.22 160.18 15.29 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.324 -0.95 . . . . 1.05 110.814 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.603 HD11 ' ND2' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -125.85 127.4 46.01 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.476 -0.935 . . . . 1.1000000000000001 108.476 169.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.603 ' ND2' HD11 ' A' ' 74' ' ' LEU . 8.6 p30 44.64 50.65 8.4 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.075 1.35 . . . . 1.97 111.419 -166.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 52.3 m-80 72.84 -11.83 0.82 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.892 -1.049 . . . . 2.5499999999999998 112.041 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -94.56 120.68 35.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.249 0.547 . . . . 4.0199999999999996 110.009 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 57.5 t -57.67 132.54 22.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 122.38 1.086 . . . . 1.0600000000000001 112.869 -173.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 6.9 mtm -103.46 -42.86 5.56 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 112.995 -1.911 . . . . 1.47 109.447 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -158.53 172.81 17.64 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 113.215 -1.811 . . . . 1.98 109.84 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.3 m -148.65 123.23 9.78 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.228 -1.351 . . . . 1.0 109.41 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 1.61 ' HD1' ' CD2' ' A' ' 82' ' ' TYR . 25.1 m-85 -103.93 148.55 36.03 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.312 -0.858 . . . . 1.3999999999999999 109.453 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.439 ' HB2' HG23 ' A' ' 134' ' ' ILE . 46.5 Cg_endo -77.58 141.06 19.45 Favored 'Trans proline' 0 CA--C 1.5 -1.209 0 C-N-CA 121.497 1.465 . . . . 0.23999999999999999 110.488 169.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.528 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -139.9 173.25 11.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.934 -0.575 . . . . 1.04 110.907 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.903 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.83 143.34 47.01 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.227 -0.442 . . . . 1.03 110.436 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.48 HG23 ' HG3' ' A' ' 68' ' ' LYS . 7.5 m -126.58 126.04 68.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.451 0.643 . . . . 1.26 112.057 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -89.16 157.17 26.77 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.71 -1.356 . . . . 0.20000000000000001 109.71 173.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.549 ' HG3' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -57.05 6.61 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 114.582 1.327 . . . . 3.48 114.582 -177.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.597 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.2 tp -96.88 -14.08 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.525 0.679 . . . . 1.0700000000000001 110.565 -177.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.509 HD23 HG21 ' A' ' 89' ' ' ILE . 3.3 mm? -91.2 -18.09 25.0 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.146 -0.687 . . . . 1.02 109.146 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.3 p -67.09 -24.52 65.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.777 -1.101 . . . . 1.05 112.132 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.479 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 8.7 mp0 -56.26 -44.35 79.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.118 1.367 . . . . 2.0299999999999998 111.61 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.45 119.7 58.17 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.471 -0.786 . . . . 1.1499999999999999 111.635 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.608 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 1.9 Cg_endo -77.36 -19.64 13.12 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.874 2.383 . . . . 1.04 113.068 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 t -105.48 -40.52 5.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.358 -0.608 . . . . 1.1299999999999999 109.358 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.419 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 43.69 45.89 7.23 Favored Glycine 0 C--N 1.338 0.682 0 O-C-N 124.565 1.165 . . . . 0.35999999999999999 113.903 170.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -83.59 113.09 20.59 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.901 0.858 . . . . 1.0800000000000001 109.723 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 15.9 m-85 -137.32 175.85 9.24 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.065 -1.425 . . . . 0.26000000000000001 112.484 -170.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.662 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 79.9 m-85 -142.85 133.07 24.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.78000000000000003 110.896 -174.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.561 HD11 ' HB ' ' A' ' 161' ' ' THR . 82.6 mt -58.02 121.85 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.576 -0.738 . . . . 1.02 110.84 172.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.578 HD11 ' C ' ' A' ' 22' ' ' PHE . 22.7 pt -86.8 -35.25 8.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 113.157 0.799 . . . . 1.03 113.157 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.543 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 11.6 p30 179.97 174.03 0.91 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.932 -1.136 . . . . 2.0299999999999998 107.932 -176.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.569 ' CB ' HD11 ' A' ' 116' ' ' LEU . 6.7 mtt180 -122.21 161.66 22.82 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.112 -0.635 . . . . 2.02 111.503 -170.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -143.84 102.41 3.9 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.222 0.534 . . . . 0.83999999999999997 110.898 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.502 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 63.7 ttt180 -65.95 166.89 10.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.38 -0.827 . . . . 3.2799999999999998 110.63 173.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.47 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 24.6 m-80 -35.49 104.52 0.26 Allowed Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 125.529 1.532 . . . . 0.34999999999999998 113.806 -160.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.3 Cg_endo -61.9 -35.58 77.14 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.785 2.324 . . . . 0.63 111.745 171.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.97 -35.59 3.88 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.398 -0.681 . . . . 0.67000000000000004 111.398 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.97 -175.89 42.78 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.229 -0.485 . . . . 0.77000000000000002 112.437 176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.515 ' C ' ' H ' ' A' ' 112' ' ' GLY . 25.8 Cg_endo -59.05 -0.34 0.57 Allowed 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 124.91 3.74 . . . . 1.1499999999999999 115.035 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -69.21 30.88 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.967 0.728 . . . . 1.5900000000000001 112.967 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.785 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 58.65 64.9 3.89 Favored Glycine 0 C--O 1.217 -0.927 0 N-CA-C 116.202 1.241 . . . . 1.6899999999999999 116.202 161.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.56 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 38.34 -8.18 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 117.97 2.582 . . . . 1.1699999999999999 117.97 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.622 ' CE2' ' HB3' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -163.29 151.77 13.97 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.085 0.857 . . . . 0.60999999999999999 110.117 -176.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -135.16 98.3 3.95 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.227 -1.027 . . . . 0.56999999999999995 108.227 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.569 HD11 ' CB ' ' A' ' 103' ' ' ARG . 0.6 OUTLIER -85.79 118.56 25.37 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 121.097 -1.002 . . . . 1.3600000000000001 109.877 174.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.42 ' C ' HG12 ' A' ' 101' ' ' ILE . 36.9 m -83.45 145.63 28.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.638 -0.71 . . . . 0.42999999999999999 111.411 -170.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -109.73 170.5 8.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 1.02 110.797 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.539 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -62.87 -13.11 30.02 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.936 0.717 . . . . 1.79 112.936 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.591 ' HB3' ' CG ' ' A' ' 123' ' ' TYR . 5.2 tptp -126.06 130.9 52.05 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.52 -0.472 . . . . 1.8100000000000001 110.756 175.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.413 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 67.6 mt-30 -30.97 -58.99 0.22 Allowed 'General case' 0 C--N 1.317 -0.827 0 O-C-N 124.733 1.271 . . . . 1.76 114.054 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.597 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -96.08 8.19 44.42 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.551 -0.86 . . . . 3.2000000000000002 111.706 -171.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.745 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.3 m-85 -94.88 37.48 1.14 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.877 1.065 . . . . 0.83999999999999997 113.877 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.553 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -114.57 143.74 18.13 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 116.865 -2.588 . . . . 0.96999999999999997 112.665 -153.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -97.09 112.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.937 0.875 . . . . 1.04 110.451 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.75 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.0 p80 -142.64 172.21 13.0 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.078 -0.964 . . . . 0.20999999999999999 109.592 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.785 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.7 -179.92 38.87 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 119.969 -1.11 . . . . 0.34999999999999998 111.791 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.544 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 11.5 t -142.89 170.96 14.73 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.79 -0.448 . . . . 1.1100000000000001 109.79 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -114.48 -4.75 12.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.9 0.857 . . . . 2.1899999999999999 108.705 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -112.26 87.91 9.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.563 -1.198 . . . . 1.8400000000000001 108.178 168.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -73.4 -19.69 21.77 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.744 2.296 . . . . 0.39000000000000001 113.601 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.97 0.19 28.52 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.227 0.537 . . . . 1.0800000000000001 111.112 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 52.6 m -94.51 -1.49 53.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 1.9399999999999999 109.628 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.439 HG23 ' HB2' ' A' ' 83' ' ' PRO . 44.0 mm -82.83 137.82 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.98 -0.555 . . . . 1.04 110.5 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.89 0.82 77.54 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.922 -1.271 . . . . 0.16 109.922 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -111.68 167.42 10.36 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 122.932 1.349 . . . . 3.0299999999999998 113.73 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.457 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -96.27 120.06 35.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.174 -2.285 . . . . 1.01 107.442 173.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.35 160.47 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.508 -0.923 . . . . 1.3400000000000001 108.508 -172.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.549 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.1 m -52.55 -60.93 2.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 111.974 0.361 . . . . 0.87 111.974 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -131.62 -46.57 0.97 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.09 -1.444 . . . . 2.5499999999999998 113.78 -172.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.48 133.69 0.2 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 117.758 1.863 . . . . 0.19 117.758 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.62 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 6.3 p -68.56 166.02 17.93 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 112.291 -1.954 . . . . 0.20000000000000001 111.756 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.903 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 59.5 mt -59.48 98.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 122.596 1.189 . . . . 1.1299999999999999 112.114 -163.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.75 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 75.5 mtt180 -87.06 147.76 25.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.461 -1.7 . . . . 2.3300000000000001 110.7 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.528 ' HG2' HG21 ' A' ' 84' ' ' ILE . 12.7 mtp -125.29 -165.5 1.41 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.295 -0.632 . . . . 1.0900000000000001 109.295 173.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.661 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 25.4 t-80 -95.86 153.99 17.46 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.538 -0.755 . . . . 2.9900000000000002 108.997 173.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.614 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.5 m120 -57.11 -54.4 47.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.193 -0.908 . . . . 0.73999999999999999 110.856 -174.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.489 ' HB3' ' HZ1' ' A' ' 148' ' ' LYS . 0.8 OUTLIER -63.93 -23.81 67.49 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 121.516 1.962 . . . . 2.6899999999999999 111.823 -175.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.661 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.3 m-20 -78.5 -46.72 18.95 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.01 -0.996 . . . . 0.68999999999999995 110.725 -176.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.52 HG12 HD13 ' A' ' 151' ' ' ILE . 13.7 p -67.97 -24.15 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.094 -0.957 . . . . 1.02 111.663 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.614 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -78.71 -39.41 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.483 -0.562 . . . . 1.1699999999999999 109.483 171.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 156' ' ' ILE . 22.7 mt-10 -46.54 -72.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.901 0.773 . . . . 1.99 112.261 168.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.417 HD23 ' CE1' ' A' ' 82' ' ' TYR . 43.4 mt -49.79 -40.31 41.16 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.751 0.786 . . . . 1.9099999999999999 111.532 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.622 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . . . -56.14 -39.97 73.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.968 -1.469 . . . . 1.04 111.415 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.2 t -87.86 -33.65 18.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.542 0.942 . . . . 0.88 113.542 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 152' ' ' GLU . 43.7 mt -80.57 -60.2 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.617 0.723 . . . . 1.0 112.034 -170.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.9 m -86.61 145.69 39.91 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.793 -1.094 . . . . 1.0700000000000001 112.049 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.515 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 63.8 Cg_endo -90.72 173.0 3.13 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.875 3.05 . . . . 0.23999999999999999 110.91 172.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.543 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 22.0 m-20 -64.87 158.23 25.72 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.744 -0.782 . . . . 1.1000000000000001 109.134 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 97.41 -19.63 53.95 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.079 -1.058 . . . . 0.17999999999999999 112.529 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.561 ' HB ' HD11 ' A' ' 100' ' ' ILE . 59.1 m -62.76 136.81 58.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.15 -0.685 . . . . 1.05 109.15 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.662 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -92.61 122.7 35.28 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.771 1.272 . . . . 4.1100000000000003 111.18 -169.272 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.13 108.63 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 112.25 -2.25 . . . . 1.02 109.159 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.3 m -94.23 107.7 19.62 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.521 0.563 . . . . 1.0700000000000001 112.521 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 165' ' ' ILE . 2.6 mp -86.14 97.41 5.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.991 0.9 . . . . 1.05 110.253 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -110.98 135.52 51.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.853 -1.067 . . . . 1.0900000000000001 111.203 -173.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.608 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 14.8 mmm-85 -78.3 64.84 3.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.474 0.654 . . . . 2.4900000000000002 109.701 172.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.28 158.67 25.99 Favored Glycine 0 N--CA 1.433 -1.553 0 CA-C-N 115.124 -0.944 . . . . 1.97 111.404 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.836 0.318 . . . . 4.3300000000000001 110.356 -179.68 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 111.686 -0.565 . . . . 3.3399999999999999 111.686 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -78.3 161.92 26.88 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.222 0.534 . . . . 4.9199999999999999 110.883 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -108.61 105.19 14.69 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.4 -0.818 . . . . 3.1000000000000001 110.699 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.517 ' CD1' ' HA ' ' A' ' 49' ' ' PRO . 20.3 mt -96.01 174.84 6.73 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.569 -0.741 . . . . 1.3300000000000001 110.872 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.8 tt -88.81 129.18 35.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.505 -0.77 . . . . 1.0700000000000001 109.756 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.14 161.11 14.11 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.138 -0.937 . . . . 1.03 112.944 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.645 ' HE2' ' CE1' ' A' ' 7' ' ' TYR . 86.2 t80 -129.6 140.66 51.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.715 -1.584 . . . . 1.0800000000000001 107.781 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.401 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 63.3 tt0 -114.23 111.79 22.09 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.907 -1.145 . . . . 0.93000000000000005 107.907 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.588 HG11 ' HB2' ' A' ' 13' ' ' ASP . 97.7 t -66.2 151.2 10.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.353 1.073 . . . . 1.1000000000000001 112.697 -169.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -108.02 158.07 17.7 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.554 -1.657 . . . . 2.4399999999999999 108.325 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.62 107.34 0.38 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.183 0.516 . . . . 2.4300000000000002 112.092 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.77 11.79 39.49 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.686 -0.688 . . . . 0.51000000000000001 113.57 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.588 ' HB2' HG11 ' A' ' 9' ' ' VAL . 70.9 m-20 -55.97 167.63 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.953 0.376 . . . . 1.46 110.961 172.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -128.19 152.96 47.42 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.914 0.388 . . . . 1.1599999999999999 111.176 174.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.415 HD22 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -64.38 -38.86 92.52 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.103 -1.073 . . . . 1.47 108.103 -177.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.437 ' HA ' HG23 ' A' ' 26' ' ' THR . 65.3 t30 -86.44 -22.04 26.74 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.512 -1.222 . . . . 1.78 110.715 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.424 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 17.4 t -67.98 -40.12 83.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.177 -0.675 . . . . 1.74 109.177 171.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.2 mt -75.32 -27.78 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.146 0.498 . . . . 1.04 109.937 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.54 -10.01 59.72 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.517 -0.31 . . . . 1.0600000000000001 110.795 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.697 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.09 -40.27 9.31 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 107.929 -1.137 . . . . 0.97999999999999998 107.929 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.435 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 3.0 m-20 -62.19 -42.77 99.59 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.544 -2.116 . . . . 0.53000000000000003 112.303 173.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.53 ' CE2' ' HB3' ' A' ' 119' ' ' SER . 57.5 m-85 -99.42 6.73 45.93 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 118.876 -1.13 . . . . 0.20000000000000001 111.129 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.697 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.76 41.06 32.2 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.765 0.793 . . . . 2.46 109.541 176.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.583 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.8 pt -116.8 -165.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.287 -1.324 . . . . 1.04 110.215 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.52 143.88 40.19 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.99 -1.005 . . . . 1.3400000000000001 110.244 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.511 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 44.3 p -72.18 -31.76 66.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.037 -1.097 . . . . 1.0900000000000001 108.037 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -31.09 69.98 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.703 -0.68 . . . . 1.0700000000000001 111.659 171.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.32 -28.27 17.85 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.641 0.734 . . . . 1.04 109.029 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.537 ' HG ' ' CD1' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -73.67 -28.04 61.55 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.046 -0.979 . . . . 1.8100000000000001 109.404 174.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 26' ' ' THR . 42.5 mt -76.63 -30.99 57.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.836 0.827 . . . . 1.6399999999999999 109.991 170.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 43.3 tt0 -65.61 -33.75 76.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.19 -1.368 . . . . 2.3300000000000001 110.095 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.448 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -88.57 -22.74 23.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 119.849 -0.74 . . . . 1.0600000000000001 111.805 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.6 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 19.1 m-80 -147.85 82.7 7.76 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.41 0.624 . . . . 0.23000000000000001 110.517 -171.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.26 -15.93 16.07 Favored 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 124.124 3.216 . . . . 0.52000000000000002 114.03 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 t -74.72 -22.65 58.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.75 0.31 . . . . 1.6499999999999999 111.391 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.6 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 35.6 mt -69.45 -36.11 76.31 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.568 0.581 . . . . 1.25 112.568 -169.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -64.07 -45.17 89.93 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 122.917 1.342 . . . . 2.52 110.135 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.64 -49.04 79.12 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 111.796 -2.456 . . . . 1.1899999999999999 110.712 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.87 -179.85 48.11 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 114.932 -1.031 . . . . 0.44 111.693 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.43 158.97 22.69 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.204 0.526 . . . . 1.1699999999999999 110.66 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.528 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 60.4 m -139.35 127.89 23.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.542 -0.754 . . . . 1.1499999999999999 110.385 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.49 121.51 21.61 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.576 0.703 . . . . 1.1200000000000001 110.313 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.401 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.7 3.56 60.89 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 114.733 -1.121 . . . . 0.44 110.468 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.528 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -80.22 124.93 29.24 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.202 -0.499 . . . . 1.3 109.91 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.8 m -77.7 130.35 36.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.152 -0.931 . . . . 1.3200000000000001 109.781 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.563 HG13 ' HB3' ' A' ' 7' ' ' TYR . 6.7 pt -132.01 143.63 39.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.671 -1.15 . . . . 1.0700000000000001 109.085 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -90.69 153.74 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.311 0.576 . . . . 1.3 111.612 -178.168 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.5 mm -118.24 93.6 45.3 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.597 -1.183 . . . . 1.03 109.03 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HA ' ' CD1' ' A' ' 4' ' ' LEU . 2.5 Cg_endo -59.05 137.39 79.28 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.775 2.316 . . . . 0.20000000000000001 112.745 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.46 -6.24 83.8 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.906 -1.043 . . . . 0.26000000000000001 112.387 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.597 HD11 ' HD2' ' A' ' 52' ' ' PRO . 26.9 tp -122.73 118.05 28.57 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.904 0.383 . . . . 1.27 110.721 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.61 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 57.9 Cg_endo -80.3 -176.68 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.649 2.9 . . . . 0.31 114.037 -172.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.463 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 13.3 t70 -80.69 132.25 58.48 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.726 -1.124 . . . . 0.48999999999999999 111.629 -171.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.577 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.8 Cg_endo -76.28 -16.13 17.63 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 123.395 2.73 . . . . 0.48999999999999999 112.694 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -95.58 -1.04 51.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.706 0.765 . . . . 1.8 110.135 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 27.1 p -94.66 -16.98 22.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.657 1.217 . . . . 1.1299999999999999 107.822 173.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.485 HG23 ' H ' ' A' ' 59' ' ' TYR . 25.6 mt -78.64 128.73 76.35 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 112.947 -1.933 . . . . 1.24 111.132 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 97.8 Cg_endo -76.75 -17.23 15.99 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.444 2.096 . . . . 0.47999999999999998 113.194 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.485 ' H ' HG23 ' A' ' 57' ' ' ILE . 61.4 m-85 -94.74 164.91 12.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.392 -0.523 . . . . 0.94999999999999996 112.153 -176.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -152.68 128.01 9.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.533 -0.914 . . . . 3.7400000000000002 108.533 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.687 ' HA ' ' O ' ' A' ' 71' ' ' THR . 95.4 mt -110.02 132.67 57.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.135 -0.484 . . . . 1.05 111.759 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.21 117.01 28.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.004 -0.678 . . . . 1.0800000000000001 111.09 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.84 112.85 31.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.814 0.816 . . . . 1.04 111.273 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 68' ' ' LYS . 16.5 m -93.23 102.73 15.02 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.682 -1.145 . . . . 0.83999999999999997 110.543 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.503 HG22 HH11 ' A' ' 167' ' ' ARG . 50.5 mm -52.15 -58.49 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 122.04 0.924 . . . . 1.0600000000000001 111.213 169.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.22 -11.39 3.34 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 112.955 -1.93 . . . . 0.16 113.244 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -126.72 -18.6 4.71 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.572 0.749 . . . . 1.02 112.455 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER 57.77 56.39 4.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.555 0.616 . . . . 1.3 111.431 -172.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.5 p -137.66 161.49 36.34 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 112.669 0.618 . . . . 0.98999999999999999 112.669 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.408 HD21 ' C ' ' A' ' 70' ' ' LEU . 8.5 tt -131.49 113.4 13.64 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.704 -1.135 . . . . 1.1799999999999999 110.122 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.687 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 66.7 m -94.23 122.95 37.3 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.324 0.583 . . . . 1.04 111.542 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 79' ' ' MET . 15.5 tp -97.56 103.2 15.12 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.906 -1.043 . . . . 1.3200000000000001 109.369 172.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.2 m -105.47 159.93 15.54 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.475 -0.89 . . . . 1.05 110.579 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.2 tm? -126.73 128.37 46.55 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.853 -0.795 . . . . 1.1000000000000001 108.853 169.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.556 ' N ' HD23 ' A' ' 74' ' ' LEU . 6.6 p30 43.61 49.01 6.53 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.128 1.371 . . . . 1.97 111.574 -167.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 84.2 m-20 75.85 -11.99 1.05 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.127 -0.942 . . . . 2.5499999999999998 112.317 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -96.99 120.82 38.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.207 0.527 . . . . 4.0199999999999996 110.095 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 55.1 t -56.15 132.44 20.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 122.316 1.055 . . . . 1.0600000000000001 112.998 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 7.9 mtm -102.59 -43.83 5.51 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.074 -1.875 . . . . 1.47 109.285 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.6 mmtt -157.92 172.15 18.98 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 113.107 -1.861 . . . . 1.98 109.874 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.0 m -149.8 122.28 8.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.417 -1.265 . . . . 1.0 109.808 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -109.71 145.82 32.77 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 115.454 -0.794 . . . . 1.3999999999999999 109.637 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.457 ' HB2' HG23 ' A' ' 134' ' ' ILE . 41.7 Cg_endo -74.61 142.12 28.78 Favored 'Trans proline' 0 CA--C 1.499 -1.26 0 C-N-CA 121.902 1.734 . . . . 0.23999999999999999 110.903 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.532 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.01 175.71 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.922 -0.581 . . . . 1.04 110.717 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.868 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -120.76 148.55 43.82 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.418 -0.355 . . . . 1.03 110.092 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.468 HG12 HD11 ' A' ' 65' ' ' ILE . 9.6 m -128.75 129.76 68.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.481 0.658 . . . . 1.26 111.899 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.6 154.6 27.23 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.21 -1.156 . . . . 0.20000000000000001 110.21 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -56.27 3.08 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.321 0.86 . . . . 3.48 113.321 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.571 HG12 ' CB ' ' A' ' 122' ' ' HIS . 1.3 tp -89.17 -19.96 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 121.534 0.683 . . . . 1.0700000000000001 110.417 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.491 ' CD2' HG21 ' A' ' 89' ' ' ILE . 3.8 mm? -89.72 -18.25 26.73 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.716 0.77 . . . . 1.02 109.288 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.9 p -66.81 -14.47 62.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.385 -1.279 . . . . 1.05 111.649 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.3 -39.56 89.41 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.74 -1.118 . . . . 2.0299999999999998 111.973 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.51 130.97 22.17 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.571 -0.452 . . . . 1.1499999999999999 111.028 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.671 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 87.0 Cg_endo -90.1 -13.87 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.7 2.267 . . . . 1.04 112.73 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.0 t -104.92 -41.0 5.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.758 -0.656 . . . . 1.1299999999999999 109.25 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.535 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 44.87 46.04 9.21 Favored Glycine 0 N--CA 1.446 -0.644 0 O-C-N 124.404 1.065 . . . . 0.35999999999999999 113.692 171.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.79 111.37 19.13 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.891 0.853 . . . . 1.0800000000000001 109.557 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.706 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 21.4 m-85 -139.41 171.94 13.53 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.89 -1.505 . . . . 0.26000000000000001 112.366 -171.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 162' ' ' ARG . 28.2 m-85 -140.99 136.15 31.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.739 -0.664 . . . . 0.78000000000000003 110.131 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.534 HD11 ' HB ' ' A' ' 161' ' ' THR . 80.1 mt -58.62 123.23 10.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.421 -0.809 . . . . 1.02 110.55 172.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.547 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.8 pt -88.05 -44.08 15.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 113.014 0.746 . . . . 1.03 113.014 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.464 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 56.2 m-80 -171.69 169.54 5.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 106.783 -1.562 . . . . 2.0299999999999998 106.783 -169.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.481 ' HB3' HD21 ' A' ' 116' ' ' LEU . 5.6 mtt180 -128.17 163.45 24.65 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.773 -0.771 . . . . 2.02 112.198 -173.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.4 tt0 -136.85 99.91 4.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.921 -1.036 . . . . 0.83999999999999997 109.713 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.494 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 30.8 ttp180 -67.05 166.52 13.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.24 -0.891 . . . . 3.2799999999999998 111.006 176.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.494 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 29.1 m-80 -36.44 102.23 0.23 Allowed Pre-proline 0 CA--C 1.518 -0.28 0 C-N-CA 125.439 1.496 . . . . 0.34999999999999998 113.951 -152.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -54.69 -51.68 9.85 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.513 2.809 . . . . 0.63 111.528 170.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.73 -31.83 5.95 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.279 -1.128 . . . . 0.67000000000000004 110.279 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.91 -174.81 37.54 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 114.48 -0.86 . . . . 0.77000000000000002 112.477 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -57.64 -10.03 6.45 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 124.879 3.719 . . . . 1.1499999999999999 114.766 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -63.45 -3.56 2.15 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.434 1.272 . . . . 1.5900000000000001 114.434 -172.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.655 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 90.11 64.53 1.23 Allowed Glycine 0 CA--C 1.497 -1.032 0 C-N-CA 119.053 -1.546 . . . . 1.6899999999999999 115.182 167.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.516 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 38.89 -1.97 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 116.915 2.191 . . . . 1.1699999999999999 116.915 -175.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.659 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.3 OUTLIER -166.06 161.35 17.2 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.385 -0.822 . . . . 0.60999999999999999 110.028 -177.007 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 12.6 t-105 -141.83 98.93 3.43 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.25 -1.018 . . . . 0.56999999999999995 108.25 166.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' A' ' 103' ' ' ARG . 4.4 mt -91.95 114.49 27.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.521 0.677 . . . . 1.3600000000000001 109.414 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 26.0 m -84.23 144.55 28.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.986 -0.552 . . . . 0.42999999999999999 111.368 -169.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.759 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -108.35 172.14 7.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.903 -0.59 . . . . 1.02 110.568 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.53 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -64.49 -11.14 30.77 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.894 0.701 . . . . 1.79 112.894 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.726 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.3 tmtp? -126.51 130.61 50.94 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 120.626 -0.43 . . . . 1.8100000000000001 110.405 174.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.726 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.2 mt-30 -34.77 -54.88 0.57 Allowed 'General case' 0 C--N 1.311 -1.074 0 O-C-N 124.953 1.408 . . . . 1.76 113.555 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.571 ' CB ' HG12 ' A' ' 89' ' ' ILE . 46.8 m80 -91.19 -1.49 57.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.867 -0.606 . . . . 3.2000000000000002 111.216 -169.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.759 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -94.29 37.88 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.534 0.938 . . . . 0.83999999999999997 113.534 -171.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.23 144.41 18.42 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 117.026 -2.511 . . . . 0.96999999999999997 112.601 -153.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.78 114.89 34.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 123.775 0.83 . . . . 1.04 110.763 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.558 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 26.8 p80 -143.53 175.97 9.54 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.4 -0.818 . . . . 0.20999999999999999 109.721 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.655 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.65 -166.98 37.8 Favored Glycine 0 C--N 1.314 -0.672 0 C-N-CA 120.49 -0.862 . . . . 0.34999999999999998 111.816 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.526 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 14.3 t -157.24 171.4 20.49 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.063 -0.669 . . . . 1.1100000000000001 110.627 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -115.12 -2.16 12.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.286 -1.005 . . . . 2.1899999999999999 108.286 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -113.19 85.78 8.75 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.506 -1.224 . . . . 1.8400000000000001 108.669 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -74.25 -19.07 20.2 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.363 2.042 . . . . 0.39000000000000001 113.102 -170.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.51 -2.29 49.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.733 -0.667 . . . . 1.0800000000000001 110.35 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.2 t -89.33 -6.33 56.77 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.042 -0.725 . . . . 1.9399999999999999 109.042 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.457 HG23 ' HB2' ' A' ' 83' ' ' PRO . 39.6 mm -81.82 137.11 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.485 -0.78 . . . . 1.04 110.392 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.91 2.19 69.5 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.172 -1.171 . . . . 0.16 110.172 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -115.12 171.77 7.47 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 123.178 1.466 . . . . 3.0299999999999998 114.0 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.51 126.73 50.84 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 111.613 -2.54 . . . . 1.01 107.736 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.402 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -122.5 159.73 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 108.662 -0.866 . . . . 1.3400000000000001 108.662 -174.467 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.9 m -49.5 -60.01 3.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.699 0.629 . . . . 0.87 112.699 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -132.74 -44.79 0.88 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.614 -1.234 . . . . 2.5499999999999998 113.549 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.46 133.19 0.21 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 117.077 1.591 . . . . 0.19 117.077 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.558 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 1.8 p -70.59 165.72 22.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.353 -1.923 . . . . 0.20000000000000001 111.808 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.868 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 57.6 mt -59.7 98.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 122.393 1.092 . . . . 1.1299999999999999 112.002 -163.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -85.06 148.52 26.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.515 -1.675 . . . . 2.3300000000000001 109.937 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.532 ' HG2' HG21 ' A' ' 84' ' ' ILE . 14.8 mtp -127.52 -165.9 1.54 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.33 -0.619 . . . . 1.0900000000000001 109.33 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.72 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 10.5 t-160 -95.96 154.49 17.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.523 -0.917 . . . . 2.9900000000000002 108.523 172.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.613 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.9 m120 -58.2 -51.1 71.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 118.388 -0.815 . . . . 0.73999999999999999 110.641 -176.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -64.42 -22.64 67.02 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 121.223 1.829 . . . . 2.6899999999999999 112.516 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.72 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 13.3 m-20 -85.3 -42.46 14.59 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.036 -0.529 . . . . 0.68999999999999995 111.263 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.548 HG12 HD13 ' A' ' 151' ' ' ILE . 14.7 p -67.78 -23.03 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.913 -0.585 . . . . 1.02 111.193 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.613 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.78 -40.66 16.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 118.846 -0.597 . . . . 1.1699999999999999 110.02 171.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.8 mm-40 -44.59 -72.57 0.06 Allowed 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 119.426 1.012 . . . . 1.99 112.293 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 157' ' ' VAL . 49.7 mt -47.42 -40.08 17.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.686 0.755 . . . . 1.9099999999999999 111.269 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.05 77.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.098 -1.41 . . . . 1.04 111.785 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.3 t -89.01 -31.78 17.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.56 -0.713 . . . . 0.88 112.694 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 152' ' ' GLU . 28.5 mt -82.0 -60.53 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.612 0.72 . . . . 1.0 111.339 -172.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 153' ' ' LEU . 3.3 m -89.19 140.74 28.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.786 -1.097 . . . . 1.0700000000000001 111.907 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -88.17 173.84 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.969 3.113 . . . . 0.23999999999999999 111.062 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.464 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 77.4 m-20 -65.41 155.76 34.41 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 119.723 -0.791 . . . . 1.1000000000000001 109.187 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.6 -20.02 52.07 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.125 -1.036 . . . . 0.17999999999999999 112.494 -173.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.534 ' HB ' HD11 ' A' ' 100' ' ' ILE . 91.2 m -63.21 138.03 58.41 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 117.419 0.61 . . . . 1.05 109.476 -174.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.566 ' HB3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -93.03 123.31 36.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.784 1.278 . . . . 4.1100000000000003 111.002 -169.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.95 108.56 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 111.94 -2.391 . . . . 1.02 109.022 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.405 HG23 ' ND2' ' A' ' 166' ' ' ASN . 8.8 m -94.43 108.05 19.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.069 -0.514 . . . . 1.0700000000000001 112.307 -171.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.535 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.19 101.15 7.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.152 0.977 . . . . 1.05 109.963 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.405 ' ND2' HG23 ' A' ' 164' ' ' THR . 66.5 m-80 -108.43 128.36 54.71 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.389 -1.278 . . . . 1.0900000000000001 109.794 -175.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.671 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 18.3 mmm180 -69.5 -20.77 63.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.838 0.351 . . . . 2.4900000000000002 111.008 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.39 15.87 54.35 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.984 -0.627 . . . . 1.97 112.202 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.326 -0.426 0 N-CA-C 110.768 -0.086 . . . . 4.3300000000000001 110.768 -177.806 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 112.105 -0.398 . . . . 3.3399999999999999 112.105 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -124.44 171.66 9.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.368 0.604 . . . . 4.9199999999999999 110.975 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -122.78 101.95 7.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.957 -1.019 . . . . 3.1000000000000001 108.668 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp -101.06 173.85 6.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.701 0.762 . . . . 1.3300000000000001 112.824 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.0 tt -102.54 133.04 48.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.5 -1.227 . . . . 1.0700000000000001 110.265 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.39 162.96 12.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.41 1.1 . . . . 1.03 113.839 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.652 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 87.8 t80 -129.14 140.29 51.6 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.243 -1.799 . . . . 1.0800000000000001 107.596 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.417 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.9 tt0 -112.89 112.64 24.26 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.185 -1.042 . . . . 0.93000000000000005 108.185 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 41' ' ' THR . 92.7 t -65.7 149.67 11.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 122.264 1.031 . . . . 1.1000000000000001 112.679 -171.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -106.27 159.48 16.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.768 -1.56 . . . . 2.4399999999999999 108.487 171.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -61.41 106.06 0.59 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.213 0.53 . . . . 2.4300000000000002 112.379 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.7 11.2 35.84 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.518 -0.765 . . . . 0.51000000000000001 113.395 172.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.522 ' HB2' HG11 ' A' ' 9' ' ' VAL . 84.1 m-20 -53.69 167.62 0.23 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.829 0.347 . . . . 1.46 111.006 172.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -125.95 150.86 47.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.229 0.538 . . . . 1.1599999999999999 111.145 175.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.502 HD22 HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.95 -38.14 89.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.16 -1.052 . . . . 1.47 108.16 -178.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.521 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -84.69 -25.9 28.09 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.37 -1.286 . . . . 1.78 110.532 -177.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.442 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 30.7 t -64.62 -43.25 94.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.396 -0.594 . . . . 1.74 109.396 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.7 mt -72.8 -26.69 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.15 0.5 . . . . 1.04 109.692 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.561 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.73 -11.18 59.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.251 -0.431 . . . . 1.0600000000000001 110.531 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.673 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -90.9 -41.94 10.87 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.595 0.712 . . . . 0.97999999999999998 109.77 171.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.723 ' HB3' ' O ' ' A' ' 119' ' ' SER . 83.6 m-20 -61.65 -44.65 96.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.247 -1.342 . . . . 0.53000000000000003 111.473 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 119' ' ' SER . 54.3 m-85 -99.47 6.63 45.88 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.69 -1.204 . . . . 0.20000000000000001 111.471 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.673 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER 53.87 43.26 31.18 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.71 0.767 . . . . 2.46 109.616 177.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.561 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 36.2 pt -115.75 -165.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.773 -1.103 . . . . 1.04 110.35 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.71 142.87 40.29 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.916 -1.038 . . . . 1.3400000000000001 109.801 174.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.562 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 68.2 p -72.95 -30.88 64.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.626 -0.879 . . . . 1.0900000000000001 108.626 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.05 -27.06 69.15 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.494 -0.776 . . . . 1.0700000000000001 111.625 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.614 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -94.31 -27.11 16.28 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.573 0.701 . . . . 1.04 109.148 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.518 HD12 HD13 ' A' ' 46' ' ' ILE . 17.8 tp -73.55 -28.43 61.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.153 -0.93 . . . . 1.8100000000000001 108.636 172.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 26' ' ' THR . 7.7 tp -78.52 -28.79 46.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.582 0.706 . . . . 1.6399999999999999 109.769 175.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.614 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -58.48 -60.48 3.74 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.472 -1.307 . . . . 2.3300000000000001 107.472 167.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.466 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -71.57 -17.41 62.3 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 120.313 -0.555 . . . . 1.0600000000000001 110.973 -169.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.567 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.7 m-80 -146.99 81.04 9.19 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 115.729 -0.669 . . . . 0.23000000000000001 110.532 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.87 -10.32 5.41 Favored 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 124.065 3.177 . . . . 0.52000000000000002 113.411 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -78.62 -19.91 51.59 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.841 0.312 . . . . 1.6499999999999999 111.841 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.567 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 63.1 mt -70.63 -34.49 72.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.312 0.577 . . . . 1.25 112.205 -171.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.461 ' HB3' HD12 ' A' ' 30' ' ' LEU . 3.8 pt20 -64.4 -47.21 80.07 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 122.805 1.288 . . . . 2.52 110.539 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.59 -49.67 75.65 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 111.729 -2.487 . . . . 1.1899999999999999 110.242 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.38 178.93 48.65 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 114.775 -1.102 . . . . 0.44 111.912 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 157.35 19.43 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.392 0.615 . . . . 1.1699999999999999 110.619 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 44' ' ' GLN . 83.5 m -143.62 130.89 20.83 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.169 -0.923 . . . . 1.1499999999999999 110.062 -176.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.75 120.08 20.64 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.526 0.679 . . . . 1.1200000000000001 110.221 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 101.35 0.97 53.82 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.709 -1.356 . . . . 0.44 109.709 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 47.4 tt0 -72.74 123.62 23.68 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.148 -1.026 . . . . 1.3 109.915 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 15.7 p -84.11 127.28 33.81 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 122.019 0.914 . . . . 1.3200000000000001 110.068 175.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.605 HG13 ' HB3' ' A' ' 7' ' ' TYR . 10.9 pt -127.33 140.72 48.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.178 -1.374 . . . . 1.0700000000000001 109.033 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.15 150.7 3.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 120.995 0.426 . . . . 1.3 110.885 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.2 mm -114.83 92.9 31.84 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.731 -1.122 . . . . 1.03 108.845 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HA ' HD23 ' A' ' 4' ' ' LEU . 1.8 Cg_endo -58.65 132.96 51.13 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.69 2.26 . . . . 0.20000000000000001 112.835 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.05 -5.79 72.3 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 114.703 -1.135 . . . . 0.26000000000000001 111.983 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.643 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 38.7 tp -123.82 115.67 27.89 Favored Pre-proline 0 N--CA 1.448 -0.569 0 CA-C-O 121.222 0.534 . . . . 1.27 111.75 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.638 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 61.1 Cg_endo -81.57 -176.74 3.22 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 124.204 3.27 . . . . 0.31 114.808 -172.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.473 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 12.6 t70 -81.04 128.96 69.3 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 113.968 -1.469 . . . . 0.48999999999999999 112.269 -170.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 52.3 Cg_endo -73.87 -14.36 24.03 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.629 2.886 . . . . 0.48999999999999999 113.139 -177.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.84 -5.6 37.92 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.891 -0.595 . . . . 1.8 111.402 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 28.0 p -89.15 -21.87 23.11 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.49 -1.3 . . . . 1.1299999999999999 107.49 171.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.487 HG23 ' H ' ' A' ' 59' ' ' TYR . 21.2 mt -75.23 128.04 85.32 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 112.847 -1.979 . . . . 1.24 111.119 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.4 -18.29 15.93 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.473 2.115 . . . . 0.47999999999999998 113.216 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.487 ' H ' HG23 ' A' ' 57' ' ' ILE . 56.4 m-85 -94.82 161.48 14.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.297 -0.561 . . . . 0.94999999999999996 111.628 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -151.15 124.65 8.95 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.655 -0.869 . . . . 3.7400000000000002 108.655 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.713 ' HA ' ' O ' ' A' ' 71' ' ' THR . 97.5 mt -106.44 131.38 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.867 -0.606 . . . . 1.05 111.391 -176.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.66 117.28 29.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.834 -0.746 . . . . 1.0800000000000001 111.341 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 69' ' ' THR . 60.0 t -97.5 117.04 41.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.573 0.702 . . . . 1.04 111.207 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 68' ' ' LYS . 19.3 m -95.31 106.2 18.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.974 -1.012 . . . . 0.83999999999999997 110.61 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.6 mm -54.46 -58.65 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 122.202 1.001 . . . . 1.0600000000000001 111.099 167.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.95 -7.86 3.94 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 112.836 -1.984 . . . . 0.16 113.292 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -127.96 -19.4 4.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.399 0.679 . . . . 1.02 112.671 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.504 ' HD2' ' CG2' ' A' ' 86' ' ' VAL . 0.0 OUTLIER 58.5 56.37 4.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.669 0.668 . . . . 1.3 111.624 -171.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 42.4 p -137.62 162.23 34.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.009 0.744 . . . . 0.98999999999999999 113.009 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.416 ' C ' HD21 ' A' ' 70' ' ' LEU . 8.5 tt -130.16 113.83 14.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.632 -1.167 . . . . 1.1799999999999999 110.023 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.713 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 22.0 m -94.81 122.97 37.98 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.172 0.511 . . . . 1.04 111.391 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 79' ' ' MET . 15.3 tp -98.35 104.39 16.42 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.416 -0.811 . . . . 1.3200000000000001 109.628 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 7.7 m -105.22 159.98 15.45 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.531 -0.867 . . . . 1.05 110.78 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.58 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.1 tm? -128.92 128.55 44.01 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.856 -0.794 . . . . 1.1000000000000001 108.856 169.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.58 ' N ' HD23 ' A' ' 74' ' ' LEU . 8.9 p30 46.54 48.64 14.01 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.132 1.373 . . . . 1.97 111.287 -166.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.9 t30 72.93 -9.45 1.11 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.038 -0.983 . . . . 2.5499999999999998 111.333 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.418 ' H ' ' C ' ' A' ' 75' ' ' ASN . 11.2 tpp180 -96.3 120.7 37.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.737 -0.665 . . . . 4.0199999999999996 109.764 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 69.7 t -58.3 132.25 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-O 122.311 1.053 . . . . 1.0600000000000001 112.606 -174.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 12.1 mtm -101.18 -45.5 5.35 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.206 -1.816 . . . . 1.47 109.151 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.488 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 13.7 mmmt -157.75 171.15 20.83 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.423 -1.717 . . . . 1.98 109.571 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -148.74 123.33 9.79 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.677 -1.147 . . . . 1.0 109.848 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -111.11 148.29 38.38 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.743 -0.662 . . . . 1.3999999999999999 109.995 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.444 ' HB2' HG23 ' A' ' 134' ' ' ILE . 48.1 Cg_endo -75.43 142.71 26.91 Favored 'Trans proline' 0 CA--C 1.498 -1.295 0 C-N-CA 122.113 1.875 . . . . 0.23999999999999999 110.848 175.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.527 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.6 175.0 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.718 -0.674 . . . . 1.04 110.754 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.875 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.17 146.39 45.2 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.311 -0.404 . . . . 1.03 110.153 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.504 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 7.5 m -127.23 130.18 70.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.558 0.694 . . . . 1.26 111.625 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.4 153.38 26.27 Favored Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 110.012 -1.235 . . . . 0.20000000000000001 110.012 172.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -56.12 3.3 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.238 0.829 . . . . 3.48 113.238 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.506 HG21 HD23 ' A' ' 90' ' ' LEU . 1.8 tp -91.48 -18.55 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 121.555 0.693 . . . . 1.0700000000000001 110.46 -178.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.506 HD23 HG21 ' A' ' 89' ' ' ILE . 3.8 mm? -88.86 -18.19 28.12 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.757 -0.656 . . . . 1.02 109.398 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.8 p -65.56 -19.4 65.91 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.627 -1.17 . . . . 1.05 111.778 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -57.64 -42.47 83.47 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.14 -0.936 . . . . 2.0299999999999998 111.941 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.37 120.9 48.03 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-O 120.867 0.365 . . . . 1.1499999999999999 111.582 -174.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.505 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 2.2 Cg_endo -76.84 -16.18 16.41 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.794 2.329 . . . . 1.04 113.262 177.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 t -106.58 -41.25 5.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.491 -0.559 . . . . 1.1299999999999999 109.491 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.46 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 46.6 48.6 17.12 Favored Glycine 0 N--CA 1.446 -0.636 0 O-C-N 124.374 1.047 . . . . 0.35999999999999999 113.585 170.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.01 111.83 19.22 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.808 0.813 . . . . 1.0800000000000001 109.728 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -137.7 169.44 17.78 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.141 -1.391 . . . . 0.26000000000000001 112.326 -172.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.658 ' HE1' ' CE2' ' A' ' 99' ' ' TYR . 19.3 m-85 -141.25 134.84 30.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.656 -0.702 . . . . 0.78000000000000003 110.241 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.521 HD11 ' HB ' ' A' ' 161' ' ' THR . 81.1 mt -58.62 117.83 2.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.507 -0.77 . . . . 1.02 110.695 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.538 HD11 ' C ' ' A' ' 22' ' ' PHE . 22.4 pt -82.87 -43.56 18.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 112.604 0.594 . . . . 1.03 112.604 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.554 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 52.9 m-80 -170.7 168.97 7.27 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.787 -1.56 . . . . 2.0299999999999998 106.787 -170.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.436 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 0.2 OUTLIER -133.95 152.97 52.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.207 -0.597 . . . . 2.02 111.944 -175.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -128.46 103.0 6.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.45 -0.796 . . . . 0.83999999999999997 110.161 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.475 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 38.0 ttt180 -62.92 166.85 5.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.334 -0.848 . . . . 3.2799999999999998 110.411 173.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.475 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 19.9 m-80 -35.32 103.51 0.24 Allowed Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 125.097 1.359 . . . . 0.34999999999999998 113.373 -156.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.8 Cg_endo -60.93 -32.19 92.26 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.026 2.484 . . . . 0.63 111.084 172.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.49 -39.16 2.93 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.94 -0.864 . . . . 0.67000000000000004 110.94 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -73.74 -177.2 34.95 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 121.082 -0.58 . . . . 0.77000000000000002 112.542 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.64 7.73 0.11 Allowed 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 125.117 3.878 . . . . 1.1499999999999999 115.436 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.439 ' H ' ' C ' ' A' ' 109' ' ' GLY . 12.6 m-85 -73.08 13.83 0.36 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 112.244 0.461 . . . . 1.5900000000000001 112.244 -174.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.732 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 75.32 63.64 2.46 Favored Glycine 0 CA--C 1.5 -0.87 0 C-N-CA 119.737 -1.221 . . . . 1.6899999999999999 115.298 170.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.537 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 38.76 -2.68 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 117.334 2.346 . . . . 1.1699999999999999 117.334 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.524 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.5 OUTLIER -164.63 160.79 20.44 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.426 -0.796 . . . . 0.60999999999999999 110.372 -175.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -141.62 98.67 3.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.693 -0.854 . . . . 0.56999999999999995 108.693 168.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.516 HD13 ' CG2' ' A' ' 150' ' ' VAL . 2.4 mt -90.69 114.49 26.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.342 0.591 . . . . 1.3600000000000001 109.428 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.432 ' C ' HG12 ' A' ' 101' ' ' ILE . 14.5 m -84.8 144.83 28.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.014 -0.539 . . . . 0.42999999999999999 111.384 -170.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.773 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -109.58 168.98 9.0 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.32 -0.4 . . . . 1.02 111.145 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.723 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -60.68 -10.87 5.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.074 0.768 . . . . 1.79 113.074 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' HG2' ' CE1' ' A' ' 123' ' ' TYR . 14.8 tppt? -127.38 131.38 50.34 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.642 0.734 . . . . 1.8100000000000001 110.185 171.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.495 ' NE2' ' HB2' ' A' ' 20' ' ' ALA . 8.5 pt20 -47.44 -31.61 4.3 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.323 -1.762 . . . . 1.76 114.872 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.481 ' H ' ' HG3' ' A' ' 120' ' ' LYS . 60.5 m80 -97.37 -8.48 29.46 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.692 -0.803 . . . . 3.2000000000000002 112.312 -177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.773 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.4 m-30 -94.82 40.07 1.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.185 1.18 . . . . 0.83999999999999997 114.185 -168.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.466 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -112.0 145.17 17.85 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 116.376 -2.821 . . . . 0.96999999999999997 112.509 -153.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.32 115.99 37.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.787 0.803 . . . . 1.04 110.762 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.654 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 30.3 p80 -145.12 172.2 13.43 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.344 -0.844 . . . . 0.20999999999999999 109.462 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.732 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.28 -168.2 38.76 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 120.157 -1.021 . . . . 0.34999999999999998 111.724 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.504 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 8.7 t -154.6 171.45 19.45 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.908 -0.76 . . . . 1.1100000000000001 111.325 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -113.48 -11.44 13.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.564 -0.902 . . . . 2.1899999999999999 108.564 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -107.45 86.97 3.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.216 -1.031 . . . . 1.8400000000000001 108.216 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.37 -18.6 29.75 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.355 2.037 . . . . 0.39000000000000001 112.906 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.46 -0.12 40.28 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.402 -0.817 . . . . 1.0800000000000001 111.077 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.464 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 98.2 p -91.59 -6.58 52.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.022 -0.733 . . . . 1.9399999999999999 109.022 171.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.444 HG23 ' HB2' ' A' ' 83' ' ' PRO . 40.5 mm -78.82 135.69 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.399 -0.819 . . . . 1.04 110.141 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.18 0.71 70.48 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.366 -1.093 . . . . 0.16 110.366 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.464 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 50.3 mttm -115.02 176.31 5.12 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 123.629 1.68 . . . . 3.0299999999999998 114.088 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -105.61 129.31 53.88 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.655 -2.975 . . . . 1.01 108.157 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -125.22 158.85 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.95 -0.759 . . . . 1.3400000000000001 108.95 -175.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 67.9 m -47.45 -59.61 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.712 0.634 . . . . 0.87 112.712 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -131.44 -44.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.014 -1.075 . . . . 2.5499999999999998 113.304 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.27 132.7 0.21 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 117.082 1.593 . . . . 0.19 117.082 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.654 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 1.9 p -71.5 165.15 24.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.359 -1.921 . . . . 0.20000000000000001 111.874 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.875 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 60.6 mt -59.83 98.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 114.841 -1.072 . . . . 1.1299999999999999 111.857 -163.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.635 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 74.8 mtt180 -84.52 149.58 25.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.676 -1.602 . . . . 2.3300000000000001 110.33 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.527 ' HG2' HG21 ' A' ' 84' ' ' ILE . 15.9 mtp -129.29 -165.4 1.51 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.002 -0.74 . . . . 1.0900000000000001 109.002 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.632 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 3.5 t-160 -96.28 157.36 15.93 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.59 -0.893 . . . . 2.9900000000000002 108.59 171.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.63 ' O ' HD11 ' A' ' 151' ' ' ILE . 3.7 m120 -59.03 -51.07 71.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 118.285 -0.864 . . . . 0.73999999999999999 110.549 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -64.42 -27.09 68.76 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 121.562 1.983 . . . . 2.6899999999999999 112.491 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.632 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 5.8 m-20 -79.03 -43.23 24.68 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.048 0.452 . . . . 0.68999999999999995 110.658 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.527 HG12 HD13 ' A' ' 151' ' ' ILE . 14.4 p -69.08 -23.85 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.645 -0.707 . . . . 1.02 111.539 177.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.63 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.06 -42.09 18.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 119.126 -0.464 . . . . 1.1699999999999999 109.954 171.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.461 ' O ' HG13 ' A' ' 156' ' ' ILE . 22.5 mt-10 -46.79 -69.42 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 119.058 0.845 . . . . 1.99 112.407 170.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 157' ' ' VAL . 37.0 mt -47.71 -40.2 19.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.509 0.671 . . . . 1.9099999999999999 111.517 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.68 -35.6 76.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.21 -1.359 . . . . 1.04 111.41 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.8 t -87.29 -29.77 21.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.603 0.638 . . . . 0.88 112.521 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.6 mt -84.87 -60.38 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.471 0.653 . . . . 1.0 112.025 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.1 m -90.51 143.01 28.6 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 114.994 -1.003 . . . . 1.0700000000000001 112.161 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.436 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 44.0 Cg_endo -91.91 176.1 1.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 124.273 3.315 . . . . 0.23999999999999999 111.378 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 77.0 m-20 -66.92 157.94 31.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.554 -0.859 . . . . 1.1000000000000001 109.454 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 95.85 -16.64 60.79 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.238 -0.982 . . . . 0.17999999999999999 112.02 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.521 ' HB ' HD11 ' A' ' 100' ' ' ILE . 91.5 m -66.38 139.0 57.98 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.199 -0.667 . . . . 1.05 109.199 -175.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.479 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 2.2 ptt180 -92.69 117.72 30.29 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.665 1.221 . . . . 4.1100000000000003 110.932 -169.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.77 107.2 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 111.992 -2.367 . . . . 1.02 108.806 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.473 HG23 ' ND2' ' A' ' 166' ' ' ASN . 6.4 m -95.24 109.48 21.59 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.609 0.596 . . . . 1.0700000000000001 112.609 -170.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.46 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.48 100.58 7.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 122.215 1.007 . . . . 1.05 110.062 178.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.473 ' ND2' HG23 ' A' ' 164' ' ' THR . 57.5 m-80 -109.44 134.64 51.61 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.234 -1.348 . . . . 1.0900000000000001 109.795 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.532 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.7 mmm180 -73.26 -27.91 61.84 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.867 -0.42 . . . . 2.4900000000000002 109.867 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 156.52 65.25 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.836 -0.62 . . . . 1.97 112.066 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 C--N 1.323 -0.584 0 N-CA-C 110.611 -0.144 . . . . 4.3300000000000001 110.611 -178.591 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.896 -0.482 . . . . 3.3399999999999999 111.896 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -152.37 140.79 20.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.131 -0.322 . . . . 4.9199999999999999 110.131 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -116.91 133.04 56.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.126 -0.488 . . . . 3.1000000000000001 110.577 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -105.25 174.66 5.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.33 0.586 . . . . 1.3300000000000001 111.851 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.626 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.8 tt -99.69 129.53 45.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.018 -0.992 . . . . 1.0700000000000001 110.32 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.39 162.2 13.59 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.02 0.914 . . . . 1.03 112.88 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 7' ' ' TYR . 80.9 t80 -130.38 143.84 51.02 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.106 -1.406 . . . . 1.0800000000000001 108.122 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -114.74 114.53 25.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.464 -0.939 . . . . 0.93000000000000005 108.464 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 41' ' ' THR . 95.2 t -67.97 151.44 10.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 122.383 1.087 . . . . 1.1000000000000001 113.611 -171.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -106.55 158.47 16.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.359 -1.746 . . . . 2.4399999999999999 108.392 172.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -61.89 115.42 4.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.058 0.456 . . . . 2.4300000000000002 111.799 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.33 12.86 47.15 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.976 -0.63 . . . . 0.51000000000000001 113.255 173.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.427 ' OD1' ' HG ' ' A' ' 40' ' ' LEU . 1.8 p-10 -50.63 170.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.019 0.914 . . . . 1.46 111.864 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.8 150.02 52.17 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.186 -0.915 . . . . 1.1599999999999999 110.959 169.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.492 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -64.66 -34.27 77.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.519 -1.219 . . . . 1.47 108.242 -178.204 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.52 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 4.2 t30 -85.02 -27.74 26.2 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.621 -1.172 . . . . 1.78 111.192 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.9 t -65.32 -42.31 93.11 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.307 -0.557 . . . . 1.74 109.921 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.6 mt -74.4 -25.93 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 121.381 0.61 . . . . 1.04 109.822 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.613 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.93 -9.94 59.66 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.269 -0.423 . . . . 1.0600000000000001 110.793 174.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.627 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.45 -40.14 9.23 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.399 1.095 . . . . 0.97999999999999998 108.079 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -61.84 -40.89 96.91 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 112.885 -1.962 . . . . 0.53000000000000003 111.897 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.583 ' C ' HD11 ' A' ' 101' ' ' ILE . 65.5 m-85 -101.46 5.51 42.03 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 118.611 -1.235 . . . . 0.20000000000000001 111.872 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.627 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.9 mpt_? 54.53 40.43 31.82 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.828 0.823 . . . . 2.46 109.553 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.613 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.0 pt -112.99 -165.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.486 -1.234 . . . . 1.04 109.957 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.32 142.26 42.2 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.086 -0.961 . . . . 1.3400000000000001 110.106 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.642 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 43.4 p -72.95 -30.7 64.06 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.383 -0.969 . . . . 1.0900000000000001 108.383 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.3 -24.25 67.59 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.559 -0.746 . . . . 1.0700000000000001 111.872 170.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.35 -29.2 14.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.993 -0.743 . . . . 1.04 108.993 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.494 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 21.7 tp -71.9 -28.49 63.53 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.96 -1.018 . . . . 1.8100000000000001 108.414 172.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' A' ' 26' ' ' THR . 8.2 tp -76.75 -31.73 57.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.939 0.876 . . . . 1.6399999999999999 109.575 175.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 44.6 tt0 -65.9 -43.23 88.81 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.112 -1.404 . . . . 2.3300000000000001 110.603 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -80.35 -17.98 50.41 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.193 -0.603 . . . . 1.0600000000000001 111.42 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.572 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 38.7 m-80 -144.21 81.59 11.37 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-O 121.554 0.692 . . . . 0.23000000000000001 110.641 -173.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.6 Cg_endo -56.57 -10.07 4.64 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 124.124 3.216 . . . . 0.52000000000000002 113.829 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.5 m -79.0 -24.84 43.44 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 122.097 -0.377 . . . . 1.6499999999999999 111.409 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.572 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 61.5 mt -67.12 -33.38 75.34 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.553 0.692 . . . . 1.25 111.92 -170.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.4 ' NE2' ' HB1' ' A' ' 38' ' ' ALA . 1.7 pp0? -64.82 -44.92 88.32 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 122.742 1.258 . . . . 2.52 110.591 -174.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.4 ' HB1' ' NE2' ' A' ' 37' ' ' GLN . . . -64.98 -47.62 76.93 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 111.772 -2.467 . . . . 1.1899999999999999 110.752 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.9 178.01 48.64 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.923 -1.035 . . . . 0.44 112.139 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.427 ' HG ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -110.99 159.02 18.12 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.109 0.481 . . . . 1.1699999999999999 110.628 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.61 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 62.6 m -145.08 129.03 17.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.866 -0.606 . . . . 1.1499999999999999 111.378 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.31 120.83 22.1 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.441 0.638 . . . . 1.1200000000000001 110.057 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.83 0.49 57.55 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.215 -1.154 . . . . 0.44 110.215 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -75.84 125.31 28.84 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.925 -0.638 . . . . 1.3 109.842 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 35.1 p -81.03 131.16 35.29 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.778 0.799 . . . . 1.3200000000000001 110.023 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.605 HG13 ' HB3' ' A' ' 7' ' ' TYR . 12.2 pt -131.28 140.64 47.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.354 -1.293 . . . . 1.0700000000000001 109.259 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.91 150.29 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.964 0.411 . . . . 1.3 110.853 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.431 HG22 ' CD2' ' A' ' 22' ' ' PHE . 37.1 mm -114.71 93.18 32.36 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 114.91 -1.041 . . . . 1.03 109.172 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.493 ' HA ' HD23 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -59.67 134.23 56.37 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.862 2.375 . . . . 0.20000000000000001 113.029 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.36 -6.25 80.79 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.932 -1.031 . . . . 0.26000000000000001 112.266 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.67 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 32.6 tp -122.64 115.69 29.53 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-O 121.26 0.553 . . . . 1.27 111.398 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.626 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 53.5 Cg_endo -79.16 -177.41 3.87 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.668 2.912 . . . . 0.31 114.288 -172.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.501 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 14.1 t70 -77.42 134.43 66.42 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.015 -1.448 . . . . 0.48999999999999999 112.552 -170.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.4 -15.78 24.87 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.683 2.922 . . . . 0.48999999999999999 113.279 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -95.96 -9.36 31.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.43 0.633 . . . . 1.8 111.309 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.501 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 30.0 p -85.74 -18.47 32.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.053 0.93 . . . . 1.1299999999999999 108.713 173.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.57 HG23 ' H ' ' A' ' 59' ' ' TYR . 7.8 mm -63.99 125.43 87.95 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 113.638 -1.619 . . . . 1.24 109.755 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.74 -13.53 13.09 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.984 1.789 . . . . 0.47999999999999998 112.699 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.57 ' H ' HG23 ' A' ' 57' ' ' ILE . 58.7 m-85 -103.45 169.79 8.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.892 0.377 . . . . 0.94999999999999996 111.756 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -154.13 127.76 8.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.701 -0.851 . . . . 3.7400000000000002 108.701 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 71' ' ' THR . 93.6 mt -107.19 130.92 58.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.831 -0.622 . . . . 1.05 111.352 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.08 115.39 26.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.781 -0.768 . . . . 1.0800000000000001 110.882 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 69' ' ' THR . 48.2 t -95.89 116.28 37.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.641 0.734 . . . . 1.04 111.053 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 68' ' ' LYS . 51.9 m -94.61 105.18 17.13 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.016 -0.993 . . . . 0.83999999999999997 110.401 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.512 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.0 mm -53.59 -58.53 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 122.13 0.967 . . . . 1.0600000000000001 111.104 167.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 169' ' ' SER . . . -59.05 -8.68 6.36 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 112.941 -1.936 . . . . 0.16 113.049 -175.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.436 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -126.73 -17.72 4.92 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.589 0.756 . . . . 1.02 112.359 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.507 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 57.55 57.52 4.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.473 0.579 . . . . 1.3 111.302 -173.346 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 57.3 p -138.88 160.93 38.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 112.899 0.703 . . . . 0.98999999999999999 112.899 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.446 ' C ' HD21 ' A' ' 70' ' ' LEU . 8.5 tt -129.07 113.44 15.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.538 -1.21 . . . . 1.1799999999999999 109.999 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.699 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 9.9 m -94.05 122.86 37.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.081 0.467 . . . . 1.04 111.135 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.8 tp -99.03 103.22 15.14 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.367 -0.833 . . . . 1.3200000000000001 109.455 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 19.5 m -105.18 159.83 15.55 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.406 -0.918 . . . . 1.05 110.594 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -128.11 127.88 43.85 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.993 -0.743 . . . . 1.1000000000000001 108.993 168.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.573 ' N ' HD23 ' A' ' 74' ' ' LEU . 6.3 m-80 53.98 44.44 29.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.792 -1.095 . . . . 1.97 110.78 -174.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 71.37 -4.31 1.87 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.57 -0.741 . . . . 2.5499999999999998 111.558 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -102.77 120.85 41.31 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.681 -0.69 . . . . 4.0199999999999996 110.119 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 62.9 t -57.98 133.31 22.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 122.296 1.046 . . . . 1.0600000000000001 112.527 -175.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.471 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 14.5 mtm -103.04 -43.43 5.5 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 113.32 -1.764 . . . . 1.47 109.329 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -159.41 171.43 19.76 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 113.297 -1.774 . . . . 1.98 110.014 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.1 m -149.1 123.68 9.77 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.091 -1.413 . . . . 1.0 109.748 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -113.61 146.42 35.42 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.694 -0.685 . . . . 1.3999999999999999 110.303 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.439 ' HB2' HG23 ' A' ' 134' ' ' ILE . 35.0 Cg_endo -72.59 142.2 35.84 Favored 'Trans proline' 0 CA--C 1.495 -1.438 0 C-N-CA 122.038 1.825 . . . . 0.23999999999999999 110.775 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.489 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.38 172.64 11.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.828 -0.624 . . . . 1.04 110.853 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.923 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.93 140.32 49.89 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 110.032 -0.359 . . . . 1.03 110.032 -176.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.458 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 9.6 m -122.91 126.19 73.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.508 0.67 . . . . 1.26 111.672 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -80.58 150.42 31.35 Favored Glycine 0 N--CA 1.423 -2.168 0 N-CA-C 109.544 -1.423 . . . . 0.20000000000000001 109.544 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -57.7 4.74 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.951 0.723 . . . . 3.48 112.951 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.493 ' H ' ' C ' ' A' ' 87' ' ' GLY . 1.0 OUTLIER -89.13 -18.72 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-O 121.546 0.689 . . . . 1.0700000000000001 110.081 178.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.8 mm? -88.96 -17.28 29.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.793 0.806 . . . . 1.02 109.115 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.1 p -66.39 -18.49 65.39 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.535 -1.212 . . . . 1.05 111.302 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.73 -42.11 92.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.774 -1.103 . . . . 2.0299999999999998 112.165 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.61 134.66 19.55 Favored Pre-proline 0 C--N 1.325 -0.497 0 C-N-CA 120.539 -0.465 . . . . 1.1499999999999999 110.889 -175.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.527 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 84.7 Cg_endo -87.55 -16.1 3.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.472 2.114 . . . . 1.04 112.437 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.7 t -107.97 -38.75 5.73 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.31 -0.626 . . . . 1.1299999999999999 109.31 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 45.16 31.93 3.27 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 124.785 1.303 . . . . 0.35999999999999999 113.799 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.502 ' HB3' HG21 ' A' ' 164' ' ' THR . 8.2 pt-20 -84.55 115.74 22.77 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 122.801 1.286 . . . . 1.0800000000000001 109.174 -173.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 13.2 m-85 -136.46 179.47 6.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 112.89 -1.959 . . . . 0.26000000000000001 111.305 -167.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -140.1 134.31 31.12 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.217 -0.447 . . . . 0.78000000000000003 110.445 -172.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.579 HD11 ' HB ' ' A' ' 161' ' ' THR . 93.0 mt -61.58 118.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.413 -0.812 . . . . 1.02 110.511 171.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.583 HD11 ' C ' ' A' ' 22' ' ' PHE . 24.1 pt -84.18 -44.54 18.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 112.816 0.673 . . . . 1.03 112.816 -176.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.542 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 54.5 m-80 -171.99 171.14 5.14 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.042 -1.836 . . . . 2.0299999999999998 106.042 -168.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.93 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 3.4 mtt180 -130.51 174.59 9.74 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.433 -0.907 . . . . 2.02 112.167 -174.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -149.64 100.78 3.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.628 -1.169 . . . . 0.83999999999999997 109.838 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.478 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 26.9 ttt85 -64.09 166.58 7.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.47 -0.786 . . . . 3.2799999999999998 110.446 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.478 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 18.6 m-80 -34.77 102.64 0.23 Allowed Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 125.296 1.438 . . . . 0.34999999999999998 113.315 -157.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.5 Cg_endo -60.41 -32.27 93.69 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.107 2.538 . . . . 0.63 111.289 174.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.23 -37.19 3.58 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 111.099 -0.8 . . . . 0.67000000000000004 111.099 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -77.75 -176.91 46.31 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.163 -0.519 . . . . 0.77000000000000002 112.742 178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 112' ' ' GLY . 29.7 Cg_endo -61.3 7.76 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 125.281 3.988 . . . . 1.1499999999999999 115.631 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 109' ' ' GLY . 7.1 m-85 -72.1 12.86 0.36 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 111.973 0.36 . . . . 1.5900000000000001 111.973 -175.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.684 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 75.46 64.03 2.36 Favored Glycine 0 CA--C 1.499 -0.912 0 C-N-CA 119.647 -1.263 . . . . 1.6899999999999999 114.971 170.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.524 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 37.48 0.23 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 117.57 2.433 . . . . 1.1699999999999999 117.57 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.651 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.4 OUTLIER -166.28 159.72 15.22 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.43 -0.794 . . . . 0.60999999999999999 110.289 -177.187 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -140.37 98.1 3.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.449 -0.945 . . . . 0.56999999999999995 108.449 167.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.553 HD13 ' CG2' ' A' ' 150' ' ' VAL . 2.6 mt -90.04 115.49 27.36 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.709 -0.62 . . . . 1.3600000000000001 109.524 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.406 ' O ' HG12 ' A' ' 101' ' ' ILE . 17.4 m -84.81 143.49 29.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.953 -0.567 . . . . 0.42999999999999999 111.609 -169.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.82 169.68 8.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.543 . . . . 1.02 111.374 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 t -63.77 -9.82 16.53 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.036 -0.984 . . . . 1.79 113.299 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.556 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 9.1 tptm -127.86 134.76 49.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.547 -0.461 . . . . 1.8100000000000001 110.564 171.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.481 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 29.9 mm-40 -33.68 -59.61 0.39 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.982 1.105 . . . . 1.76 113.982 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.475 ' CB ' HG12 ' A' ' 89' ' ' ILE . 64.5 m80 -87.64 -2.32 58.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.313 -0.555 . . . . 3.2000000000000002 111.703 -169.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.752 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -93.97 38.57 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.001 1.112 . . . . 0.83999999999999997 114.001 -171.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -113.67 145.08 18.35 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 117.089 -2.482 . . . . 0.96999999999999997 112.617 -154.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -98.98 115.32 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.891 0.853 . . . . 1.04 110.833 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.57 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 31.0 p80 -144.43 171.88 13.73 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.08 -0.964 . . . . 0.20999999999999999 109.886 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.684 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.36 -167.93 38.55 Favored Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.422 -0.894 . . . . 0.34999999999999998 111.723 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.534 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 12.5 t -154.86 170.34 21.89 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.013 -0.698 . . . . 1.1100000000000001 110.551 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -115.01 -5.32 12.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.982 0.896 . . . . 2.1899999999999999 108.639 175.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -112.45 88.53 11.11 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 114.46 -1.246 . . . . 1.8400000000000001 108.307 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.27 -18.25 26.87 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.438 2.092 . . . . 0.39000000000000001 113.474 -170.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.03 -0.55 35.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.852 -0.613 . . . . 1.0800000000000001 111.389 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 78.9 p -90.86 -9.13 47.46 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.054 -0.721 . . . . 1.9399999999999999 109.054 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.439 HG23 ' HB2' ' A' ' 83' ' ' PRO . 37.3 mm -78.95 136.75 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.259 -0.882 . . . . 1.04 110.263 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.09 -0.04 75.04 Favored Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 110.366 -1.094 . . . . 0.16 110.366 -176.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -112.04 170.08 8.4 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 123.071 1.415 . . . . 3.0299999999999998 114.098 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.32 124.14 46.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 111.969 -2.378 . . . . 1.01 108.154 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.412 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -120.91 159.95 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.36 -0.978 . . . . 1.3400000000000001 108.36 -173.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.5 m -50.62 -59.35 4.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.508 0.558 . . . . 0.87 112.508 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -132.03 -45.1 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 118.633 -1.227 . . . . 2.5499999999999998 113.851 -174.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.36 133.19 0.2 Allowed Glycine 0 N--CA 1.466 0.692 0 N-CA-C 117.232 1.653 . . . . 0.19 117.232 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.57 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 1.9 p -70.95 165.4 23.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 112.471 -1.865 . . . . 0.20000000000000001 112.348 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.923 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 66.7 mt -60.15 98.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 122.449 1.118 . . . . 1.1299999999999999 112.056 -163.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.558 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 13.1 mtp180 -85.34 145.62 27.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.523 -1.672 . . . . 2.3300000000000001 110.493 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.489 ' HG2' HG21 ' A' ' 84' ' ' ILE . 18.3 mtp -125.03 -164.81 1.32 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.717 -0.846 . . . . 1.0900000000000001 108.717 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.596 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 89.2 m-70 -93.65 161.64 14.27 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.629 -0.508 . . . . 2.9900000000000002 109.629 170.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.611 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.3 m120 -60.43 -51.96 67.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 118.744 -0.646 . . . . 0.73999999999999999 109.726 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -64.18 -27.04 68.8 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 120.782 1.628 . . . . 2.6899999999999999 112.244 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.596 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 68.8 m-20 -77.45 -46.68 21.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.261 0.553 . . . . 0.68999999999999995 110.489 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.553 ' CG2' HD13 ' A' ' 116' ' ' LEU . 14.2 p -67.19 -22.8 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.222 -0.899 . . . . 1.02 111.754 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -84.27 -41.78 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 119.087 -0.482 . . . . 1.1699999999999999 110.071 171.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.453 ' O ' HG13 ' A' ' 156' ' ' ILE . 24.6 mt-10 -49.26 -66.16 0.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 119.23 0.923 . . . . 1.99 112.278 170.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 157' ' ' VAL . 9.3 mp -48.69 -35.02 13.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.612 0.72 . . . . 1.9099999999999999 111.125 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.546 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -66.38 -31.17 71.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.624 -1.171 . . . . 1.04 111.4 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.2 t -88.28 -31.86 18.78 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.581 -0.7 . . . . 0.88 112.696 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.1 mt -84.95 -61.21 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.457 0.646 . . . . 1.0 112.33 -171.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -90.55 145.38 32.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.012 -0.994 . . . . 1.0700000000000001 111.792 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.93 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 19.0 Cg_endo -95.12 178.32 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 124.901 3.734 . . . . 0.23999999999999999 111.752 174.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.542 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 80.0 m-20 -68.66 158.23 34.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.227 -0.989 . . . . 1.1000000000000001 108.966 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.12 -14.11 65.82 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.056 -1.069 . . . . 0.17999999999999999 111.869 -173.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' HD11 ' A' ' 100' ' ' ILE . 85.2 m -66.73 139.01 57.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.44 -0.578 . . . . 1.05 109.44 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -92.34 115.69 28.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 122.726 1.251 . . . . 4.1100000000000003 110.815 -172.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.4 t -106.11 108.42 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 112.21 -2.268 . . . . 1.02 109.122 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.502 HG21 ' HB3' ' A' ' 97' ' ' GLU . 3.8 m -97.08 108.57 21.33 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 112.859 0.689 . . . . 1.0700000000000001 112.859 -171.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.479 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -83.72 94.46 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 122.573 1.177 . . . . 1.05 110.327 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.402 ' C ' ' H ' ' A' ' 168' ' ' GLY . 79.5 m-20 -104.9 142.38 34.86 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.234 -1.348 . . . . 1.0900000000000001 109.86 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.527 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 8.8 mmm180 -80.74 15.73 1.64 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.957 0.408 . . . . 2.4900000000000002 110.49 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 166' ' ' ASN . . . -58.93 131.88 52.27 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.402 -0.817 . . . . 1.97 112.611 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.46 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 13.0 m . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 110.237 -0.282 . . . . 4.3300000000000001 110.237 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 112.165 -0.374 . . . . 3.3399999999999999 112.165 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -120.01 165.56 14.52 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.859 -0.423 . . . . 4.9199999999999999 109.859 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -110.57 98.99 8.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.977 0.418 . . . . 3.1000000000000001 110.106 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 tp -94.48 175.09 6.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.648 -0.706 . . . . 1.3300000000000001 111.578 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.692 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.5 tt -91.58 129.97 37.47 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.283 -0.872 . . . . 1.0700000000000001 110.757 -174.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.77 162.03 13.33 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.3 1.048 . . . . 1.03 113.067 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.669 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 70.9 t80 -132.54 142.82 49.35 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.432 -1.713 . . . . 1.0800000000000001 108.057 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -113.97 113.22 24.52 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.05 -1.092 . . . . 0.93000000000000005 108.05 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.604 HG11 ' HB2' ' A' ' 13' ' ' ASP . 95.9 t -66.13 149.5 11.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.327 1.06 . . . . 1.1000000000000001 113.039 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -104.06 158.74 16.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.307 -1.769 . . . . 2.4399999999999999 108.479 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.48 109.26 0.85 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.731 0.301 . . . . 2.4300000000000002 111.235 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.66 10.2 50.78 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.807 -0.633 . . . . 0.51000000000000001 113.925 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.604 ' HB2' HG11 ' A' ' 9' ' ' VAL . 43.9 m-20 -55.45 169.14 0.32 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.371 0.586 . . . . 1.46 110.865 172.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.32 152.43 50.58 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.562 0.696 . . . . 1.1599999999999999 112.26 174.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -67.52 -29.76 69.25 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.184 -1.371 . . . . 1.47 109.901 -177.154 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.488 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 5.4 t30 -93.49 -24.99 17.8 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.879 -1.055 . . . . 1.78 110.669 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 t -69.22 -39.55 78.51 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.36 -0.607 . . . . 1.74 109.36 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.42 HG21 ' CE1' ' A' ' 22' ' ' PHE . 15.5 mt -72.93 -26.59 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.219 0.533 . . . . 1.04 109.688 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.599 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.25 -9.93 59.69 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.2 -0.312 . . . . 1.0600000000000001 110.987 175.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.61 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.99 -39.33 9.41 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.609 1.195 . . . . 0.97999999999999998 108.148 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 119' ' ' SER . 11.2 m-20 -63.66 -44.78 92.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.536 -2.12 . . . . 0.53000000000000003 112.041 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.55 ' C ' HD11 ' A' ' 101' ' ' ILE . 64.4 m-85 -97.96 4.97 49.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 118.57 -1.252 . . . . 0.20000000000000001 111.613 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.61 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.1 mpt_? 54.04 46.92 24.49 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.782 0.801 . . . . 2.46 109.947 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.599 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.0 pt -118.38 -165.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 114.45 -1.25 . . . . 1.04 109.902 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.02 142.2 41.77 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.06 -0.973 . . . . 1.3400000000000001 109.746 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.609 ' HB ' ' CD1' ' A' ' 15' ' ' LEU . 71.4 p -73.14 -33.19 65.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.166 -1.05 . . . . 1.0900000000000001 108.166 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.22 -27.45 67.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.2 -0.909 . . . . 1.0700000000000001 111.55 169.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -92.24 -28.32 17.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.914 -0.773 . . . . 1.04 108.914 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.633 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 21.3 tp -73.84 -26.95 60.85 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.328 -0.851 . . . . 1.8100000000000001 109.47 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 26' ' ' THR . 43.1 mt -78.54 -31.28 47.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.835 0.826 . . . . 1.6399999999999999 109.699 172.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 6.1 tt0 -63.98 -38.97 93.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.364 -1.289 . . . . 2.3300000000000001 110.154 173.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.445 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -85.08 -20.94 29.61 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 119.965 -0.694 . . . . 1.0600000000000001 111.591 176.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.589 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.1 m-80 -149.12 82.73 6.93 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-O 121.195 0.522 . . . . 0.23000000000000001 110.466 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.7 Cg_endo -56.93 -11.73 7.95 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.928 3.086 . . . . 0.52000000000000002 113.013 175.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -77.35 -19.86 55.67 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.223 -0.444 . . . . 1.6499999999999999 112.017 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.633 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 38.2 mt -77.03 -34.03 57.34 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.318 0.58 . . . . 1.25 112.137 -171.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -63.24 -46.01 88.89 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 122.768 1.27 . . . . 2.52 110.926 -170.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.43 86.58 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 112.067 -2.333 . . . . 1.1899999999999999 111.016 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.81 178.43 48.44 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 114.731 -1.122 . . . . 0.44 110.94 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.465 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -112.86 157.62 21.18 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.264 0.554 . . . . 1.1699999999999999 111.186 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.576 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 47.0 m -138.06 127.94 25.46 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.161 -0.927 . . . . 1.1499999999999999 110.299 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 120.56 21.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.348 0.594 . . . . 1.1200000000000001 109.669 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.6 -0.51 56.77 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.305 -1.118 . . . . 0.44 110.305 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.576 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.4 tt0 -74.86 125.28 28.49 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 114.892 -0.654 . . . . 1.3 109.518 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 43.0 m -86.25 132.6 33.95 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.603 0.716 . . . . 1.3200000000000001 109.877 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.574 HG13 ' HB3' ' A' ' 7' ' ' TYR . 12.1 pt -133.1 143.39 39.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.414 -1.266 . . . . 1.0700000000000001 109.327 -176.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.67 151.48 3.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.079 0.466 . . . . 1.3 110.96 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.8 mm -115.41 91.97 30.76 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.706 -1.133 . . . . 1.03 109.31 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HA ' HD23 ' A' ' 4' ' ' LEU . 2.1 Cg_endo -58.15 134.36 61.41 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.898 2.399 . . . . 0.20000000000000001 112.741 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.43 -5.91 77.74 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.766 -1.106 . . . . 0.26000000000000001 112.405 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.682 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 21.3 tp -129.21 120.29 20.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 121.048 0.451 . . . . 1.27 111.407 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.692 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_endo -80.91 -177.81 3.98 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.488 2.792 . . . . 0.31 114.166 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.539 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 13.6 t70 -74.49 134.11 76.62 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 114.265 -1.334 . . . . 0.48999999999999999 112.915 -168.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 160' ' ' GLY . 83.9 Cg_endo -76.91 -15.4 16.69 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 124.105 3.203 . . . . 0.48999999999999999 112.951 -175.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -95.38 -16.05 22.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.918 0.39 . . . . 1.8 111.131 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.539 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 22.2 p -79.04 -13.95 59.46 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.96 0.886 . . . . 1.1299999999999999 109.445 175.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.502 HG23 ' H ' ' A' ' 59' ' ' TYR . 14.6 mm -63.86 126.08 89.17 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 113.813 -1.539 . . . . 1.24 110.193 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.2 -15.04 11.71 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.342 2.028 . . . . 0.47999999999999998 112.895 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.502 ' H ' HG23 ' A' ' 57' ' ' ILE . 66.2 m-85 -100.08 174.02 6.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.894 0.378 . . . . 0.94999999999999996 110.794 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -157.08 132.88 9.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.064 -0.717 . . . . 3.7400000000000002 109.064 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.69 ' HA ' ' O ' ' A' ' 71' ' ' THR . 89.5 mt -113.66 134.68 55.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.132 -0.486 . . . . 1.05 111.497 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.01 116.09 26.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.829 -0.748 . . . . 1.0800000000000001 111.018 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 69' ' ' THR . 90.6 t -96.46 113.96 32.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.669 0.747 . . . . 1.04 111.066 176.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 68' ' ' LYS . 49.6 m -91.52 108.48 19.92 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.071 -0.968 . . . . 0.83999999999999997 110.62 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.471 HD11 HG12 ' A' ' 86' ' ' VAL . 50.6 mm -54.97 -59.69 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 122.038 0.923 . . . . 1.0600000000000001 111.001 166.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.8 -13.86 6.78 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 112.846 -1.979 . . . . 0.16 113.071 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.441 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -125.02 -16.45 6.07 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 123.196 0.598 . . . . 1.02 112.491 -178.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER 56.27 55.53 6.6 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.747 0.703 . . . . 1.3 111.493 -174.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 41.9 p -138.25 162.02 35.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.805 0.669 . . . . 0.98999999999999999 112.805 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.405 HD21 ' C ' ' A' ' 70' ' ' LEU . 7.9 tt -129.89 113.06 14.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.893 -1.049 . . . . 1.1799999999999999 110.062 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.69 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.2 m -93.13 122.86 35.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.097 0.475 . . . . 1.04 111.228 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.1 tp -100.39 106.11 17.67 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.318 -0.855 . . . . 1.3200000000000001 109.764 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 89.1 p -107.68 161.29 15.01 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.185 -1.006 . . . . 1.05 110.735 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.585 HD11 ' ND2' ' A' ' 75' ' ' ASN . 1.1 tm? -128.46 129.38 46.03 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.781 -0.822 . . . . 1.1000000000000001 108.781 169.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.585 ' ND2' HD11 ' A' ' 74' ' ' LEU . 9.7 p30 46.98 46.13 15.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.345 -1.298 . . . . 1.97 111.181 -166.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 73.55 -8.53 1.35 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.84 -1.073 . . . . 2.5499999999999998 111.785 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -94.96 119.82 34.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.767 -0.651 . . . . 4.0199999999999996 109.776 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 68.4 t -58.38 133.43 23.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 122.392 1.092 . . . . 1.0600000000000001 112.33 -174.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 18.6 mtm -102.56 -43.51 5.6 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.165 -1.834 . . . . 1.47 109.26 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -160.23 173.11 16.22 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.311 -1.768 . . . . 1.98 110.408 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.4 m -149.86 124.53 9.77 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 113.999 -1.455 . . . . 1.0 109.604 173.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -116.42 146.28 37.07 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.821 -0.627 . . . . 1.3999999999999999 109.904 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.473 ' HB2' HG23 ' A' ' 134' ' ' ILE . 37.9 Cg_endo -72.07 142.86 39.11 Favored 'Trans proline' 0 CA--C 1.494 -1.477 0 C-N-CA 122.34 2.026 . . . . 0.23999999999999999 111.26 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.549 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.94 173.71 8.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.665 -0.698 . . . . 1.04 110.609 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.878 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.63 147.39 43.81 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.989 -0.375 . . . . 1.03 109.989 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.471 HG12 HD11 ' A' ' 65' ' ' ILE . 8.1 m -128.2 127.66 67.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.714 0.769 . . . . 1.26 111.933 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -84.15 153.68 29.54 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 109.9 -1.28 . . . . 0.20000000000000001 109.9 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -56.52 2.97 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.147 0.795 . . . . 3.48 113.147 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.545 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.1 tp -87.76 -22.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.479 0.657 . . . . 1.0700000000000001 110.503 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.497 HD23 HG21 ' A' ' 89' ' ' ILE . 3.7 mm? -87.49 -14.93 39.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.663 0.744 . . . . 1.02 109.314 -175.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.4 p -69.27 -17.47 63.75 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.72 -1.127 . . . . 1.05 111.278 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -67.6 -38.62 84.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.055 -0.975 . . . . 2.0299999999999998 112.313 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.445 HG23 HG23 ' A' ' 95' ' ' THR . 0.2 OUTLIER -107.02 109.4 63.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 120.415 -0.514 . . . . 1.1499999999999999 111.171 -177.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.445 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 6.0 Cg_exo -73.79 -14.51 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.918 2.412 . . . . 1.04 113.381 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.445 HG23 HG23 ' A' ' 93' ' ' THR . 9.2 t -91.96 -42.92 9.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.308 -0.627 . . . . 1.1299999999999999 109.308 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.551 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 55.97 29.49 55.48 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.969 -1.469 . . . . 0.35999999999999999 114.134 168.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.41 111.03 19.08 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.842 0.83 . . . . 1.0800000000000001 109.396 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.66 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.0 m-85 -140.13 161.51 37.46 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.68 -1.6 . . . . 0.26000000000000001 111.914 -172.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.677 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 16.0 m-85 -129.89 137.74 50.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.935 0.398 . . . . 0.78000000000000003 110.719 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.571 HD13 ' HB ' ' A' ' 161' ' ' THR . 78.9 mt -60.52 121.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.476 -0.784 . . . . 1.02 110.971 172.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.55 HD11 ' C ' ' A' ' 22' ' ' PHE . 22.0 pt -88.23 -34.88 7.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 113.243 0.831 . . . . 1.03 113.243 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.472 ' ND2' HG13 ' A' ' 101' ' ' ILE . 9.8 p30 178.95 178.22 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.536 -1.283 . . . . 2.0299999999999998 107.536 -176.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.465 ' HG2' HD21 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -134.75 154.6 51.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.558 0.694 . . . . 2.02 112.536 -174.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.418 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 49.0 tt0 -127.05 100.82 6.28 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.782 -1.099 . . . . 0.83999999999999997 109.617 174.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.494 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 71.0 ttt180 -65.2 166.13 10.27 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.417 -0.811 . . . . 3.2799999999999998 110.341 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.453 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 19.7 m-80 -35.42 103.33 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 125.24 1.416 . . . . 0.34999999999999998 113.794 -155.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 8.4 Cg_endo -58.98 -39.38 81.33 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.861 2.374 . . . . 0.63 111.458 172.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.97 -31.7 5.59 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.763 -0.935 . . . . 0.67000000000000004 110.763 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -81.99 -176.5 51.23 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 114.72 -0.74 . . . . 0.77000000000000002 112.949 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 112' ' ' GLY . 30.4 Cg_endo -61.29 6.05 0.15 Allowed 'Trans proline' 0 N--CA 1.482 0.807 1 C-N-CA 125.41 4.073 . . . . 1.1499999999999999 115.596 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.409 ' H ' ' C ' ' A' ' 109' ' ' GLY . 10.1 m-85 -72.39 10.95 0.68 Allowed 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 111.846 0.313 . . . . 1.5900000000000001 111.846 -176.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.72 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 75.38 64.16 2.34 Favored Glycine 0 CA--C 1.497 -1.047 0 C-N-CA 119.688 -1.244 . . . . 1.6899999999999999 115.212 170.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.529 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 38.37 -1.44 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.125 2.269 . . . . 1.1699999999999999 117.125 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.656 ' HE1' ' CE2' ' A' ' 114' ' ' TYR . 0.4 OUTLIER -165.31 157.38 15.21 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.328 -0.857 . . . . 0.60999999999999999 110.305 -176.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 16.9 t-105 -138.32 97.88 3.48 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.31 -0.996 . . . . 0.56999999999999995 108.31 167.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.536 HD13 ' CG2' ' A' ' 150' ' ' VAL . 2.6 mt -88.48 114.43 25.08 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.105 -0.702 . . . . 1.3600000000000001 109.105 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.404 ' C ' HG12 ' A' ' 101' ' ' ILE . 30.1 m -85.0 143.75 28.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.885 -0.598 . . . . 0.42999999999999999 111.29 -169.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.774 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.4 170.78 7.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 1.02 111.113 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.5 t -61.6 -13.14 19.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.264 -0.88 . . . . 1.79 112.7 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.673 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.5 tmtp? -127.11 134.01 50.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.288 -0.565 . . . . 1.8100000000000001 110.682 173.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.673 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 27.1 mt-30 -35.97 -56.91 0.71 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.559 -1.2 . . . . 1.76 114.166 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.545 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -97.59 12.38 33.73 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.458 -0.897 . . . . 3.2000000000000002 111.613 -172.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.774 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -97.63 37.28 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.01 0.744 . . . . 0.83999999999999997 113.01 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.495 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -115.56 143.26 18.03 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 117.112 -2.471 . . . . 0.96999999999999997 112.79 -152.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -94.38 115.22 32.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.818 0.818 . . . . 1.04 110.691 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.563 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 29.9 p80 -144.56 170.8 15.36 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.238 -0.892 . . . . 0.20999999999999999 109.579 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.72 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.45 -168.46 38.6 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 120.184 -1.008 . . . . 0.34999999999999998 112.073 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.471 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 13.8 t -155.89 173.75 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.216 -0.579 . . . . 1.1100000000000001 111.008 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -110.98 -6.16 14.72 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.619 -0.882 . . . . 2.1899999999999999 108.619 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.19 86.41 20.9 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 108.492 -0.929 . . . . 1.8400000000000001 108.492 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -74.23 -17.27 21.8 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.82 2.347 . . . . 0.39000000000000001 113.894 -168.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.456 ' O ' ' HE2' ' A' ' 136' ' ' LYS . . . -78.69 -6.01 54.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.085 -0.507 . . . . 1.0800000000000001 110.826 -177.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.9 t -88.71 -9.53 51.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.58 -0.896 . . . . 1.9399999999999999 108.58 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.473 HG23 ' HB2' ' A' ' 83' ' ' PRO . 39.7 mm -76.88 138.92 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.127 -0.942 . . . . 1.04 109.581 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.49 3.01 78.66 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.793 -0.923 . . . . 0.16 110.793 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 132' ' ' ALA . 25.2 mttm -113.89 172.33 7.05 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 123.039 1.4 . . . . 3.0299999999999998 113.755 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.07 126.33 50.2 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 111.895 -2.412 . . . . 1.01 108.006 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.42 160.23 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.025 -0.731 . . . . 1.3400000000000001 109.025 -173.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.5 m -47.71 -61.0 2.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.521 0.563 . . . . 0.87 112.521 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.415 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 46.7 pttt -132.65 -44.2 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.783 -1.167 . . . . 2.5499999999999998 113.623 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.08 132.51 0.2 Allowed Glycine 0 N--CA 1.466 0.665 0 N-CA-C 117.056 1.583 . . . . 0.19 117.056 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.563 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 4.0 p -71.09 165.42 23.56 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 112.164 -2.018 . . . . 0.20000000000000001 112.02 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.878 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 53.8 mt -59.64 98.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 122.518 1.152 . . . . 1.1299999999999999 112.114 -163.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.45 ' HB2' ' CD1' ' A' ' 134' ' ' ILE . 13.6 mtp180 -87.38 148.24 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.568 -1.651 . . . . 2.3300000000000001 110.217 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.549 ' HG2' HG21 ' A' ' 84' ' ' ILE . 13.4 mtp -127.99 -164.8 1.41 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.773 -0.825 . . . . 1.0900000000000001 108.773 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.699 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 2.8 t60 -94.79 158.74 15.36 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.896 -0.779 . . . . 2.9900000000000002 108.896 171.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.617 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.7 m120 -57.69 -53.26 60.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.397 -0.811 . . . . 0.73999999999999999 110.408 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -63.15 -27.06 69.11 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 121.244 1.838 . . . . 2.6899999999999999 112.427 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.699 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 4.6 m-20 -79.42 -44.48 21.31 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.147 0.499 . . . . 0.68999999999999995 110.814 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.545 HG12 HD13 ' A' ' 151' ' ' ILE . 14.3 p -67.31 -23.6 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.488 -0.778 . . . . 1.02 111.589 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.617 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.34 -42.0 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 119.01 -0.519 . . . . 1.1699999999999999 110.045 171.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 156' ' ' ILE . 25.3 mt-10 -47.52 -69.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.232 0.924 . . . . 1.99 112.365 170.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 157' ' ' VAL . 8.6 mp -46.31 -39.18 9.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.48 0.657 . . . . 1.9099999999999999 111.261 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.8 78.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.424 -1.262 . . . . 1.04 111.724 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.1 t -87.69 -30.62 20.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 118.702 0.683 . . . . 0.88 112.284 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.0 mt -83.98 -60.14 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.43 0.633 . . . . 1.0 112.154 -172.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.6 m -87.38 143.32 34.13 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.026 -0.988 . . . . 1.0700000000000001 112.129 178.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -89.74 172.9 3.77 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 124.128 3.219 . . . . 0.23999999999999999 111.111 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 68.8 m-20 -67.67 157.26 34.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 118.955 -1.098 . . . . 1.1000000000000001 109.037 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 54' ' ' PRO . . . 95.36 -16.28 61.58 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.183 -1.008 . . . . 0.17999999999999999 112.219 -172.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.571 ' HB ' HD13 ' A' ' 100' ' ' ILE . 98.5 m -63.98 139.71 58.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.12 0.486 . . . . 1.05 109.9 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.677 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -93.48 124.82 37.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.559 1.171 . . . . 4.1100000000000003 111.63 -170.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.56 107.21 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 112.168 -2.287 . . . . 1.02 109.104 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.455 HG23 ' ND2' ' A' ' 166' ' ' ASN . 8.6 m -95.33 107.16 19.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 112.837 0.68 . . . . 1.0700000000000001 112.837 -171.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.551 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -80.84 107.14 12.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 122.153 0.978 . . . . 1.05 109.898 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.455 ' ND2' HG23 ' A' ' 164' ' ' THR . 14.2 m-80 -110.27 128.06 55.32 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.278 -1.328 . . . . 1.0900000000000001 110.016 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.445 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 15.1 mmm-85 -71.62 -15.71 62.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.219 0.533 . . . . 2.4900000000000002 110.042 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.04 17.49 22.64 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.244 -0.889 . . . . 1.97 111.788 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--N 1.323 -0.554 0 N-CA-C 110.228 -0.286 . . . . 4.3300000000000001 110.228 -179.744 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 112.064 -0.414 . . . . 3.3399999999999999 112.064 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 3' ' ' LYS . 72.7 ttt180 -149.84 158.34 44.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.869 -0.419 . . . . 4.9199999999999999 109.869 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.405 ' N ' ' HG2' ' A' ' 2' ' ' ARG . 7.3 mmpt? -85.26 152.3 23.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.192 0.52 . . . . 3.1000000000000001 110.511 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.785 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 tp -117.85 171.89 7.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.973 -1.012 . . . . 1.3300000000000001 111.07 -172.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.626 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.9 tt -88.68 127.03 35.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.259 -0.882 . . . . 1.0700000000000001 110.728 -172.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.72 161.2 13.98 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.78 -1.1 . . . . 1.03 112.444 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.663 ' HD1' ' CD2' ' A' ' 7' ' ' TYR . 86.2 t80 -131.71 140.01 49.18 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.912 -1.495 . . . . 1.0800000000000001 107.939 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.41 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.3 tt0 -112.69 110.56 20.77 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.807 -1.183 . . . . 0.93000000000000005 107.807 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 44' ' ' GLN . 90.3 t -66.48 151.59 10.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 122.466 1.127 . . . . 1.1000000000000001 113.433 -167.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.558 ' HB3' ' HZ2' ' A' ' 10' ' ' LYS . 8.1 mtpm? -102.53 158.94 15.87 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 113.486 -1.688 . . . . 2.4399999999999999 108.997 173.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.525 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 2.2 tt0 -62.73 112.87 2.71 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.07 -0.514 . . . . 2.4300000000000002 112.087 -172.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.51 12.95 42.95 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.922 -0.656 . . . . 0.51000000000000001 113.768 173.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.656 ' CG ' HD12 ' A' ' 18' ' ' ILE . 2.4 t70 -50.4 168.26 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 112.524 0.564 . . . . 1.46 112.524 174.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.547 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -127.12 149.5 49.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.147 0.499 . . . . 1.1599999999999999 110.86 166.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -38.5 89.49 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.344 1.069 . . . . 1.47 108.405 -175.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.437 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 63.5 t30 -83.57 -19.25 35.92 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.324 -1.307 . . . . 1.78 110.98 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -68.38 -42.69 78.72 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.487 -0.485 . . . . 1.74 110.227 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.656 HD12 ' CG ' ' A' ' 13' ' ' ASP . 18.6 mt -72.81 -26.64 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.435 0.636 . . . . 1.04 109.887 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.573 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.68 -9.5 59.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.213 -0.449 . . . . 1.0600000000000001 110.792 175.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.609 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.18 -40.88 8.97 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.836 1.303 . . . . 0.97999999999999998 108.528 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.5 ' HB3' ' O ' ' A' ' 119' ' ' SER . 26.5 m-20 -61.94 -42.93 99.67 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.937 -2.392 . . . . 0.53000000000000003 111.979 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.565 ' C ' HD13 ' A' ' 101' ' ' ILE . 66.3 m-85 -100.22 4.79 44.52 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.639 -1.224 . . . . 0.20000000000000001 111.822 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.609 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.6 mpt_? 54.59 42.25 31.41 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.828 0.823 . . . . 2.46 109.681 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.573 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.4 pt -114.99 -164.6 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.513 -1.221 . . . . 1.04 109.129 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 22.0 t -110.76 157.35 19.87 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.357 1.075 . . . . 1.3400000000000001 110.154 168.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.586 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 62.5 p -80.11 -28.54 38.98 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 112.792 -2.004 . . . . 1.0900000000000001 107.243 176.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.44 77.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.421 -0.809 . . . . 1.0700000000000001 111.958 171.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -88.08 -29.22 20.8 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.88 -0.785 . . . . 1.04 108.88 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.586 HD21 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -71.9 -28.48 63.53 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.093 -0.958 . . . . 1.8100000000000001 109.279 174.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 26' ' ' THR . 35.7 mt -76.83 -29.95 56.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.685 0.755 . . . . 1.6399999999999999 110.611 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 27.8 tt0 -65.47 -39.89 92.5 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.621 -1.172 . . . . 2.3300000000000001 109.998 174.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.454 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -84.93 -19.87 31.54 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 120.26 -0.576 . . . . 1.0600000000000001 111.614 177.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.579 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 21.5 m-80 -148.76 82.46 7.28 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-O 121.457 0.646 . . . . 0.23000000000000001 110.586 -173.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 21.4 Cg_endo -58.88 -5.94 3.07 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 124.169 3.246 . . . . 0.52000000000000002 113.872 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -81.94 -23.35 36.2 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.173 -0.329 . . . . 1.6499999999999999 111.42 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.586 ' CD1' HD21 ' A' ' 29' ' ' LEU . 28.9 mt -70.34 -32.38 70.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.521 0.677 . . . . 1.25 112.149 -170.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -65.99 -48.7 70.36 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.681 1.229 . . . . 2.52 110.022 -176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.77 -46.31 87.79 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.043 -2.344 . . . . 1.1899999999999999 111.005 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.91 -178.69 47.61 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 114.79 -1.095 . . . . 0.44 111.153 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.11 156.94 24.3 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.244 0.545 . . . . 1.1699999999999999 111.181 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.532 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 37.1 m -139.94 128.94 23.53 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.159 -0.928 . . . . 1.1499999999999999 110.469 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.525 ' HB1' ' HA ' ' A' ' 11' ' ' GLN . . . -78.82 126.21 30.4 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.288 0.566 . . . . 1.1200000000000001 110.212 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.41 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 91.24 4.65 68.37 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.406 -1.078 . . . . 0.44 110.406 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.22 123.79 28.76 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.104 -0.548 . . . . 1.3 109.805 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 19.1 p -77.97 127.62 32.62 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.909 0.862 . . . . 1.3200000000000001 110.667 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.577 HG13 ' HB3' ' A' ' 7' ' ' TYR . 12.0 pt -129.21 143.28 41.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.247 -1.342 . . . . 1.0700000000000001 109.417 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.35 151.45 3.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.271 0.558 . . . . 1.3 111.074 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.49 HG22 ' CD2' ' A' ' 22' ' ' PHE . 38.9 mm -116.85 94.61 44.65 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.628 -1.169 . . . . 1.03 108.896 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.458 ' HA ' HD22 ' A' ' 4' ' ' LEU . 3.9 Cg_exo -61.5 136.03 60.78 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.599 2.199 . . . . 0.20000000000000001 112.539 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.4 -0.54 81.0 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.477 -0.783 . . . . 0.26000000000000001 112.317 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.785 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 25.2 tp -131.02 117.53 17.17 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 121.08 0.467 . . . . 1.27 111.241 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.626 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 32.1 Cg_endo -75.26 168.86 23.73 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.546 2.831 . . . . 0.31 113.543 -171.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.522 ' OD1' HG21 ' A' ' 56' ' ' THR . 11.5 t70 -73.8 129.44 85.09 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 114.252 -1.34 . . . . 0.48999999999999999 111.307 -175.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.641 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 66.4 Cg_endo -73.76 -15.52 24.01 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 123.752 2.968 . . . . 0.48999999999999999 112.711 -174.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -95.66 -3.65 45.77 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.389 -0.823 . . . . 1.8 109.574 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.522 HG21 ' OD1' ' A' ' 53' ' ' ASP . 8.6 p -93.56 -14.87 26.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.534 -1.284 . . . . 1.1299999999999999 107.534 171.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.445 HG23 ' H ' ' A' ' 59' ' ' TYR . 36.1 mt -84.72 130.14 54.21 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 113.311 -1.768 . . . . 1.24 110.915 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.71 -23.12 11.35 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.388 2.059 . . . . 0.47999999999999998 113.301 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' H ' HG23 ' A' ' 57' ' ' ILE . 66.4 m-85 -86.37 150.7 24.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.89 -0.324 . . . . 0.94999999999999996 111.322 -176.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -143.55 135.2 26.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.07 -0.715 . . . . 3.7400000000000002 109.07 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.6 mt -117.2 134.19 61.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 112.534 0.568 . . . . 1.05 112.534 -175.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.91 119.84 35.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.116 -0.634 . . . . 1.0800000000000001 111.357 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.494 HG23 HD13 ' A' ' 70' ' ' LEU . 90.8 t -102.89 115.43 44.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.858 0.837 . . . . 1.04 111.382 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 68' ' ' LYS . 20.5 m -94.67 100.28 12.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.44 -1.255 . . . . 0.83999999999999997 110.628 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.3 mm -50.04 -58.47 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 122.056 0.932 . . . . 1.0600000000000001 111.624 170.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.77 -9.82 2.93 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 112.896 -1.956 . . . . 0.16 113.477 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -126.08 -18.8 4.93 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.773 0.829 . . . . 1.02 112.173 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.583 ' HB2' ' HZ2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.33 56.99 4.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.396 0.544 . . . . 1.3 111.505 -173.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.0 p -138.15 159.77 41.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 113.011 0.745 . . . . 0.98999999999999999 113.011 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.672 HD23 ' SD ' ' A' ' 145' ' ' MET . 4.3 tp -126.3 117.53 23.22 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.782 -1.099 . . . . 1.1799999999999999 110.944 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 62.6 m -100.63 121.92 42.43 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.959 -0.696 . . . . 1.04 111.485 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.574 ' O ' ' HB2' ' A' ' 79' ' ' MET . 3.6 tp -101.74 106.72 17.77 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.243 -0.889 . . . . 1.3200000000000001 109.262 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 87.2 p -104.99 163.69 12.35 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.585 -0.846 . . . . 1.05 110.722 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.531 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.1 tm? -124.64 126.57 45.96 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.901 -0.778 . . . . 1.1000000000000001 108.901 168.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.531 ' N ' HD23 ' A' ' 74' ' ' LEU . 38.5 m-80 49.74 46.76 23.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.71 -1.132 . . . . 1.97 111.015 -171.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 71.75 -7.75 1.2 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.566 0.746 . . . . 2.5499999999999998 111.849 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -98.12 119.96 37.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.986 -0.552 . . . . 4.0199999999999996 110.0 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 50.5 t -56.62 131.53 20.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 122.287 1.041 . . . . 1.0600000000000001 113.314 -172.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.574 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 3.3 mmt -95.42 -46.78 6.55 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 112.989 -1.914 . . . . 1.47 107.941 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.3 mmtt -164.12 174.03 11.76 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.041 -1.89 . . . . 1.98 110.64 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 16.4 m -147.9 123.66 10.56 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.832 -1.531 . . . . 1.0 109.318 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -108.7 144.88 30.48 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.676 -0.693 . . . . 1.3999999999999999 109.204 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.465 ' HB2' HG23 ' A' ' 134' ' ' ILE . 38.5 Cg_endo -72.37 140.99 34.46 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 121.848 1.699 . . . . 0.23999999999999999 110.207 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.438 ' HB ' ' CG2' ' A' ' 143' ' ' ILE . 2.1 pp -139.44 171.42 14.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 120.442 -0.503 . . . . 1.04 111.291 -177.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.924 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -116.23 142.27 47.05 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.144 -0.48 . . . . 1.03 109.781 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.502 ' C ' HG21 ' A' ' 138' ' ' VAL . 12.9 m -126.08 113.96 36.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.675 0.75 . . . . 1.26 110.621 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -76.26 155.54 45.85 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 109.048 -1.621 . . . . 0.20000000000000001 109.048 175.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 139' ' ' SER . 64.9 mttp -54.74 4.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 114.135 1.161 . . . . 3.48 114.135 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.518 HG21 HD23 ' A' ' 90' ' ' LEU . 1.3 tp -89.66 -21.82 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 O-C-N 121.591 -0.693 . . . . 1.0700000000000001 110.479 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.518 HD23 HG21 ' A' ' 89' ' ' ILE . 3.8 mm? -86.64 -18.88 30.24 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.019 0.914 . . . . 1.02 108.633 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -69.37 -12.9 62.05 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.053 -1.431 . . . . 1.05 111.456 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.447 ' NE2' HD13 ' A' ' 89' ' ' ILE . 76.2 mt-30 -75.07 -36.59 61.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.579 -1.192 . . . . 2.0299999999999998 113.16 -177.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.74 132.5 26.0 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 119.779 -0.768 . . . . 1.1499999999999999 111.286 -175.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.515 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 96.9 Cg_endo -89.13 -6.14 5.56 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.858 2.372 . . . . 1.04 113.105 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.8 t -123.35 -42.46 2.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.057 0.456 . . . . 1.1299999999999999 110.48 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.462 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 53.48 34.0 48.33 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.622 -1.172 . . . . 0.35999999999999999 114.121 167.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.37 113.01 20.85 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.955 0.884 . . . . 1.0800000000000001 109.556 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.674 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 23.9 m-85 -137.38 -179.76 5.92 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.774 -1.557 . . . . 0.26000000000000001 111.526 -170.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 80.9 m-85 -143.49 141.11 30.63 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 116.364 -0.38 . . . . 0.78000000000000003 110.381 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.594 HD13 ' HB ' ' A' ' 161' ' ' THR . 75.6 mt -65.86 114.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 115.568 -0.742 . . . . 1.02 110.081 171.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.565 HD13 ' C ' ' A' ' 22' ' ' PHE . 16.6 pt -83.55 -44.13 18.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.627 0.603 . . . . 1.03 112.627 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.829 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 51.9 m-80 -169.32 172.98 6.88 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.382 -1.34 . . . . 2.0299999999999998 107.382 -170.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.611 HH21 ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -135.7 151.99 50.73 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.872 -0.731 . . . . 2.02 111.968 -178.353 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 49.7 tt0 -123.52 101.04 7.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.097 -0.956 . . . . 0.83999999999999997 109.719 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.505 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 67.4 ttt180 -64.55 165.74 9.59 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.907 0.861 . . . . 3.2799999999999998 110.656 176.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.505 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 20.7 m-80 -37.55 102.75 0.25 Allowed Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-N 113.048 -1.887 . . . . 0.34999999999999998 114.756 -147.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.0 Cg_endo -58.33 -43.11 49.3 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.188 2.592 . . . . 0.63 111.641 170.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.03 -36.57 4.27 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.554 -1.018 . . . . 0.67000000000000004 110.554 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -71.91 -174.72 22.73 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.748 -0.726 . . . . 0.77000000000000002 112.557 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.486 ' O ' ' HA ' ' A' ' 128' ' ' THR . 19.1 Cg_endo -55.21 -6.17 0.74 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.845 3.697 . . . . 1.1499999999999999 115.081 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -67.69 -12.43 60.47 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.991 0.737 . . . . 1.5900000000000001 112.991 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.645 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 95.93 64.45 0.95 Allowed Glycine 0 CA--C 1.495 -1.177 0 C-N-CA 119.036 -1.554 . . . . 1.6899999999999999 114.929 168.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.509 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 37.57 1.56 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 116.61 2.078 . . . . 1.1699999999999999 116.61 -174.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.582 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.3 OUTLIER -165.32 169.11 16.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.898 0.879 . . . . 0.60999999999999999 109.144 -178.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 11.6 t-105 -147.82 97.48 2.82 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.78 -1.193 . . . . 0.56999999999999995 107.78 165.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.522 HD13 ' CG2' ' A' ' 150' ' ' VAL . 2.1 mt -86.75 114.24 23.26 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.031 -0.729 . . . . 1.3600000000000001 109.031 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.471 ' O ' HG12 ' A' ' 101' ' ' ILE . 11.9 m -84.0 142.6 30.36 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.606 -0.725 . . . . 0.42999999999999999 110.724 -170.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.501 ' N ' HD21 ' A' ' 118' ' ' LEU . 1.9 mm? -108.08 163.12 13.43 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.891 -0.595 . . . . 1.02 111.856 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.5 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 12.3 t -58.89 -9.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.563 1.165 . . . . 1.79 112.632 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.674 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 18.7 tptt -125.29 128.89 48.95 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 119.92 -0.712 . . . . 1.8100000000000001 109.586 166.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.555 ' HA ' ' NH1' ' A' ' 23' ' ' ARG . 7.1 pt20 -52.9 -23.46 7.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.265 -1.334 . . . . 1.76 113.653 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.556 ' O ' ' HB3' ' A' ' 142' ' ' CYS . 41.4 m80 -96.85 -9.55 28.4 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.793 -0.763 . . . . 3.2000000000000002 112.63 -177.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.513 ' CG ' ' HB3' ' A' ' 120' ' ' LYS . 3.2 m-30 -91.1 -37.01 13.67 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.586 0.958 . . . . 0.83999999999999997 113.586 -169.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.435 ' HA2' HD21 ' A' ' 118' ' ' LEU . . . -4.14 128.95 0.01 OUTLIER Glycine 0 C--N 1.296 -1.655 0 N-CA-C 119.695 2.638 . . . . 0.96999999999999997 119.695 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -97.27 114.21 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 113.128 -1.536 . . . . 1.04 109.699 175.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.696 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 24.2 p80 -140.56 177.81 7.76 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 115.473 -0.785 . . . . 0.20999999999999999 109.937 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.645 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.73 -166.46 37.51 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.782 -0.723 . . . . 0.34999999999999998 111.578 176.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 110' ' ' PRO . 11.3 t -158.91 175.78 13.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.907 0.853 . . . . 1.1100000000000001 110.61 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -115.16 -3.12 12.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.807 -0.812 . . . . 2.1899999999999999 108.807 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -118.14 87.87 30.47 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.254 -0.884 . . . . 1.8400000000000001 108.863 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -73.55 -17.52 23.45 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.298 1.999 . . . . 0.39000000000000001 113.405 -169.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.98 -1.03 42.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.867 -0.606 . . . . 1.0800000000000001 111.13 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.507 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 38.9 t -93.64 -4.38 50.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.819 -0.808 . . . . 1.9399999999999999 108.819 171.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.465 HG23 ' HB2' ' A' ' 83' ' ' PRO . 45.2 mm -82.76 137.06 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.496 -0.774 . . . . 1.04 110.497 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.73 5.36 68.81 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 109.953 -1.259 . . . . 0.16 109.953 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.507 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 90.4 mttt -113.24 168.08 10.02 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 123.173 1.463 . . . . 3.0299999999999998 114.1 -176.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -97.54 123.09 41.29 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 111.747 -2.478 . . . . 1.01 107.487 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.504 HG13 ' H ' ' A' ' 139' ' ' SER . 0.3 OUTLIER -100.59 -166.15 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.954 -0.387 . . . . 1.3400000000000001 109.954 -170.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.504 ' H ' HG13 ' A' ' 138' ' ' VAL . 67.6 m -84.98 -59.94 2.19 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 110.119 -0.326 . . . . 0.87 110.119 167.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 89' ' ' ILE . 10.9 ptmm? -133.51 -43.99 0.83 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.357 -0.937 . . . . 2.5499999999999998 112.572 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.34 134.09 0.18 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 117.047 1.579 . . . . 0.19 117.047 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.564 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 5.9 p -69.4 166.16 19.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 112.141 -2.029 . . . . 0.20000000000000001 112.174 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.924 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 49.2 mt -60.4 99.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.374 -1.284 . . . . 1.1299999999999999 111.77 -161.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.696 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 70.6 mtt180 -88.11 146.97 25.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.003 -1.453 . . . . 2.3300000000000001 110.28 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.672 ' SD ' HD23 ' A' ' 70' ' ' LEU . 1.8 mtm -130.79 -163.61 1.34 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.861 -0.792 . . . . 1.0900000000000001 108.861 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.549 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 87.6 m-70 -93.31 162.48 13.98 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.451 -0.5 . . . . 2.9900000000000002 109.828 170.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.686 ' O ' HD11 ' A' ' 151' ' ' ILE . 2.8 m120 -64.33 -47.42 79.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 118.784 -0.627 . . . . 0.73999999999999999 110.234 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -65.9 -25.36 67.12 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 120.884 1.675 . . . . 2.6899999999999999 112.688 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 71.0 m-20 -79.11 -46.82 17.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.192 0.52 . . . . 0.68999999999999995 110.914 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.555 HG12 HD13 ' A' ' 151' ' ' ILE . 14.8 p -66.24 -24.27 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.347 -0.842 . . . . 1.02 111.685 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.686 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.19 -40.82 17.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 118.941 -0.552 . . . . 1.1699999999999999 110.187 172.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.437 ' O ' HG13 ' A' ' 156' ' ' ILE . 14.0 mt-10 -47.73 -67.72 0.25 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.505 1.048 . . . . 1.99 112.54 170.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.551 HD12 ' CD2' ' A' ' 70' ' ' LEU . 95.8 mt -43.67 -40.52 4.21 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.748 0.785 . . . . 1.9099999999999999 111.417 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.43 -37.34 86.93 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.875 -1.511 . . . . 1.04 111.591 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.0 t -86.35 -30.64 22.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.76 0.709 . . . . 0.88 112.401 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.6 mt -82.66 -60.55 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.521 0.676 . . . . 1.0 111.633 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 153' ' ' LEU . 3.4 m -91.9 142.35 26.4 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.84 -1.073 . . . . 1.0700000000000001 112.558 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.611 ' HA ' HH21 ' A' ' 103' ' ' ARG . 62.6 Cg_endo -89.21 173.9 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.872 3.048 . . . . 0.23999999999999999 111.123 172.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.829 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -62.4 157.63 19.56 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.437 -0.949 . . . . 1.1000000000000001 108.437 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.641 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 99.65 -27.07 21.87 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.931 -1.128 . . . . 0.17999999999999999 112.73 -176.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.594 ' HB ' HD13 ' A' ' 100' ' ' ILE . 51.6 m -59.73 135.12 57.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.07 -0.715 . . . . 1.05 109.07 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.568 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 11.9 ptm180 -92.97 130.51 38.52 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.586 1.184 . . . . 4.1100000000000003 111.776 -168.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.7 t -108.96 107.12 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 112.323 -2.217 . . . . 1.02 108.918 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.483 HG23 ' ND2' ' A' ' 166' ' ' ASN . 25.5 m -94.25 106.73 18.7 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.152 -0.476 . . . . 1.0700000000000001 112.105 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.462 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -83.55 98.01 5.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 122.304 1.05 . . . . 1.05 109.957 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.483 ' ND2' HG23 ' A' ' 164' ' ' THR . 63.9 m-80 -102.47 130.73 49.36 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.044 -1.435 . . . . 1.0900000000000001 108.9 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.515 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 15.9 mmm180 -67.47 -31.0 70.86 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.339 -0.391 . . . . 2.4900000000000002 109.96 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.63 -104.25 0.54 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.297 -0.865 . . . . 1.97 112.629 175.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--N 1.32 -0.691 0 N-CA-C 109.976 -0.379 . . . . 4.3300000000000001 109.976 179.302 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.768 -0.533 . . . . 3.3399999999999999 111.768 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -102.43 176.37 5.2 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.318 -0.623 . . . . 4.9199999999999999 109.318 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -86.82 105.05 16.75 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.335 -0.617 . . . . 3.1000000000000001 109.335 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -106.92 174.88 5.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.681 0.753 . . . . 1.3300000000000001 112.432 -172.228 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.66 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.1 tt -98.51 129.29 45.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.628 -1.169 . . . . 1.0700000000000001 110.61 -175.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.31 162.24 13.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.056 0.931 . . . . 1.03 112.974 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.645 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 82.1 t80 -130.17 140.99 50.7 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.023 -1.444 . . . . 1.0800000000000001 108.133 176.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.43 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 56.4 tt0 -113.32 113.4 25.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.107 -1.071 . . . . 0.93000000000000005 108.107 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' A' ' 41' ' ' THR . 94.7 t -68.39 150.36 10.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 122.651 1.215 . . . . 1.1000000000000001 113.463 -168.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -101.48 159.15 15.53 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.198 -1.819 . . . . 2.4399999999999999 108.623 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -63.8 103.02 0.52 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.944 0.402 . . . . 2.4300000000000002 111.883 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.59 11.0 31.96 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.782 -0.723 . . . . 0.51000000000000001 113.152 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.556 ' HB2' HG11 ' A' ' 9' ' ' VAL . 86.9 m-20 -52.74 166.8 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.851 0.357 . . . . 1.46 111.136 171.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.51 149.76 49.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.0 0.428 . . . . 1.1599999999999999 111.028 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.431 HD22 HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.66 -39.75 91.7 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.448 -0.945 . . . . 1.47 108.448 -177.217 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.457 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 16.9 t-20 -82.35 -26.4 32.99 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.451 -1.249 . . . . 1.78 110.256 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -65.19 -41.98 94.02 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.217 -0.66 . . . . 1.74 109.217 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.414 HG21 ' CE1' ' A' ' 22' ' ' PHE . 15.6 mt -74.18 -26.62 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.238 0.542 . . . . 1.04 109.65 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.83 -10.05 59.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.319 -0.401 . . . . 1.0600000000000001 110.831 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.646 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.75 -40.22 9.07 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 122.52 1.152 . . . . 0.97999999999999998 108.045 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 119' ' ' SER . 7.2 m-20 -63.01 -45.76 90.83 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 112.265 -2.243 . . . . 0.53000000000000003 112.082 173.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.547 ' C ' HD11 ' A' ' 101' ' ' ILE . 60.7 m-85 -96.09 5.29 51.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 118.596 -1.242 . . . . 0.20000000000000001 111.36 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.646 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.4 mpt_? 54.52 42.51 31.28 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.793 0.806 . . . . 2.46 109.92 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.587 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.5 pt -117.14 -165.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.678 -1.147 . . . . 1.04 109.887 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.49 143.47 40.78 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.117 -0.947 . . . . 1.3400000000000001 110.279 175.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.457 ' CG2' ' HA ' ' A' ' 16' ' ' ASN . 37.0 p -73.32 -31.14 63.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.824 -1.176 . . . . 1.0900000000000001 107.824 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.81 -33.01 71.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.336 -0.847 . . . . 1.0700000000000001 111.815 169.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -90.26 -27.92 19.15 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.795 0.807 . . . . 1.04 108.886 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.541 HD23 HD12 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -72.93 -30.63 64.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.757 -1.11 . . . . 1.8100000000000001 109.168 174.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 36' ' ' LEU . 46.0 mt -76.71 -29.24 56.16 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.579 0.704 . . . . 1.6399999999999999 110.624 171.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.486 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 20.0 tt0 -63.78 -39.98 95.57 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.72 -1.127 . . . . 2.3300000000000001 109.787 172.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.478 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -84.48 -19.76 32.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 120.248 -0.581 . . . . 1.0600000000000001 111.693 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.602 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.2 m-80 -150.55 82.59 6.15 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 110.482 -172.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.6 Cg_endo -56.2 -16.52 17.48 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 123.807 3.005 . . . . 0.52000000000000002 113.609 176.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 m -71.37 -22.21 61.92 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.162 0.43 . . . . 1.6499999999999999 112.162 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.602 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 28.9 mt -69.59 -35.48 75.37 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 112.563 0.579 . . . . 1.25 112.563 -170.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -64.69 -46.62 81.6 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 122.818 1.294 . . . . 2.52 110.304 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.21 -48.97 77.45 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 111.845 -2.434 . . . . 1.1899999999999999 110.622 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.28 176.96 48.16 Favored Glycine 0 N--CA 1.428 -1.886 0 CA-C-N 114.595 -1.184 . . . . 0.44 111.341 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.47 157.49 19.53 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.452 0.644 . . . . 1.1699999999999999 110.91 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 49.0 m -138.33 128.11 25.2 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.134 -0.939 . . . . 1.1499999999999999 110.512 -176.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.12 118.8 19.23 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.546 0.689 . . . . 1.1200000000000001 109.992 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.43 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.61 0.33 55.43 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 110.2 -1.16 . . . . 0.44 110.2 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -75.74 124.06 26.63 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.835 -0.682 . . . . 1.3 109.797 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.649 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 51.4 p -83.84 128.68 34.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.577 -0.738 . . . . 1.3200000000000001 110.425 177.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.592 HG13 ' HB3' ' A' ' 7' ' ' TYR . 10.8 pt -129.42 142.8 43.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.432 -1.258 . . . . 1.0700000000000001 109.459 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.11 150.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.465 0.65 . . . . 1.3 111.268 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.401 HG22 ' CD2' ' A' ' 22' ' ' PHE . 38.4 mm -115.77 94.6 41.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.285 -1.325 . . . . 1.03 108.669 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.52 ' HA ' HD23 ' A' ' 4' ' ' LEU . 5.9 Cg_exo -60.91 137.06 69.84 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.646 2.231 . . . . 0.20000000000000001 112.76 -172.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.23 83.82 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.895 -1.048 . . . . 0.26000000000000001 112.432 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.648 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 37.5 tp -120.36 116.97 31.97 Favored Pre-proline 0 N--CA 1.449 -0.502 0 O-C-N 122.415 -0.462 . . . . 1.27 111.295 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.66 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 43.2 Cg_endo -77.18 -177.25 3.69 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.891 3.061 . . . . 0.31 114.205 -172.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.464 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 9.1 t70 -86.31 127.84 59.71 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.266 -1.334 . . . . 0.48999999999999999 111.836 -169.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.543 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.8 Cg_endo -75.8 -10.03 19.83 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.29 2.66 . . . . 0.48999999999999999 112.891 -176.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.406 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 20.3 m-30 -92.55 -15.86 26.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.831 -0.622 . . . . 1.8 110.271 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.464 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 27.1 p -84.62 -26.33 27.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.586 1.184 . . . . 1.1299999999999999 108.286 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.503 HG23 ' H ' ' A' ' 59' ' ' TYR . 27.0 mt -68.02 129.27 93.18 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 112.966 -1.924 . . . . 1.24 111.155 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.415 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 86.7 Cg_endo -78.76 -14.34 14.04 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.474 2.116 . . . . 0.47999999999999998 113.492 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.503 ' H ' HG23 ' A' ' 57' ' ' ILE . 45.1 m-85 -99.16 162.95 12.77 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.549 -0.46 . . . . 0.94999999999999996 111.622 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -151.37 139.49 20.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.026 -0.731 . . . . 3.7400000000000002 109.026 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 71' ' ' THR . 88.4 mt -120.81 136.74 56.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.276 0.473 . . . . 1.05 112.276 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.56 24.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.946 -0.702 . . . . 1.0800000000000001 110.902 171.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 69' ' ' THR . 90.6 t -91.19 108.87 20.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.566 0.698 . . . . 1.04 110.78 173.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 68' ' ' LYS . 75.3 m -85.43 107.32 17.34 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.088 -0.96 . . . . 0.83999999999999997 110.563 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.8 mm -53.98 -58.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 122.17 0.986 . . . . 1.0600000000000001 111.164 166.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.65 -13.55 8.1 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 112.926 -1.943 . . . . 0.16 113.337 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -126.02 -17.01 5.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.523 0.729 . . . . 1.02 112.267 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.494 ' HB2' ' HZ2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 57.5 56.87 4.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.287 0.494 . . . . 1.3 111.376 -173.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 44.8 p -138.79 167.22 22.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 113.037 0.755 . . . . 0.98999999999999999 113.037 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.7 tt -133.94 111.14 10.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.617 -1.174 . . . . 1.1799999999999999 109.855 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 63.8 m -92.95 122.43 35.31 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.177 0.513 . . . . 1.04 111.15 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.7 tp -98.77 107.53 19.99 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.042 -0.981 . . . . 1.3200000000000001 109.309 173.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 75.2 p -109.14 158.8 17.44 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.989 -1.084 . . . . 1.05 110.998 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.762 ' HB2' ' SD ' ' A' ' 79' ' ' MET . 1.2 tm? -128.21 126.4 40.89 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.092 -0.707 . . . . 1.1000000000000001 109.092 171.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.614 ' ND2' HD11 ' A' ' 74' ' ' LEU . 9.0 p30 43.76 52.99 6.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 113.952 -1.476 . . . . 1.97 112.146 -167.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 53.9 t30 75.46 -10.35 1.26 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.527 -0.76 . . . . 2.5499999999999998 111.623 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -100.58 120.7 40.42 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.141 0.496 . . . . 4.0199999999999996 110.126 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 45.4 t -55.82 132.72 19.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.249 1.024 . . . . 1.0600000000000001 112.32 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.762 ' SD ' ' HB2' ' A' ' 74' ' ' LEU . 97.4 mtp -97.06 -48.24 5.47 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 113.364 -1.744 . . . . 1.47 108.405 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -158.67 171.97 19.13 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.498 -2.137 . . . . 1.98 109.902 -174.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.0 m -148.63 122.2 9.17 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.064 -1.425 . . . . 1.0 109.656 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 1.594 ' HD1' ' CD2' ' A' ' 82' ' ' TYR . 24.6 m-85 -105.21 156.5 36.09 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 115.214 -0.903 . . . . 1.3999999999999999 109.729 -174.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.481 ' O ' ' HG2' ' A' ' 145' ' ' MET . 59.1 Cg_endo -84.93 142.98 9.15 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.046 1.831 . . . . 0.23999999999999999 111.439 169.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.537 HG23 ' CG ' ' A' ' 145' ' ' MET . 2.2 pp -138.14 174.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.701 -0.681 . . . . 1.04 110.863 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.905 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.8 140.72 49.5 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.304 -0.407 . . . . 1.03 109.972 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.485 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 7.7 m -125.74 125.37 68.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.547 0.689 . . . . 1.26 111.829 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.568 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -82.76 157.58 36.0 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 114.899 -1.046 . . . . 0.20000000000000001 110.631 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 139' ' ' SER . 74.7 mmtt -55.48 3.21 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.894 0.701 . . . . 3.48 112.894 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.541 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.1 tp -92.55 -20.19 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.522 0.677 . . . . 1.0700000000000001 110.28 -177.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.6 mm? -89.22 -18.16 27.63 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.707 0.765 . . . . 1.02 108.969 -176.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.1 p -66.61 -19.21 65.72 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.53 -1.214 . . . . 1.05 111.73 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -59.1 -42.01 89.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.885 -1.052 . . . . 2.0299999999999998 112.372 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.94 133.54 20.23 Favored Pre-proline 0 C--N 1.324 -0.525 0 C-N-CA 120.449 -0.5 . . . . 1.1499999999999999 111.497 -172.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 97.2 Cg_endo -90.59 -15.27 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.665 2.243 . . . . 1.04 112.755 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.9 t -102.43 -43.54 5.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.23 0.538 . . . . 1.1299999999999999 109.828 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.511 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 52.92 35.17 47.33 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.286 -1.325 . . . . 0.35999999999999999 113.622 167.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -82.91 111.93 19.24 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 122.039 0.923 . . . . 1.0800000000000001 109.478 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.604 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 26.1 m-85 -138.54 177.54 7.81 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.496 -1.684 . . . . 0.26000000000000001 111.42 -173.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.432 ' CG ' HD12 ' A' ' 5' ' ' LEU . 28.5 m-85 -141.99 138.0 31.58 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.316 -0.402 . . . . 0.78000000000000003 110.49 -174.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.563 HD13 ' HB ' ' A' ' 161' ' ' THR . 80.3 mt -61.92 121.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.577 -0.738 . . . . 1.02 110.284 170.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.547 HD11 ' C ' ' A' ' 22' ' ' PHE . 20.0 pt -88.63 -44.18 15.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 113.219 0.822 . . . . 1.03 113.219 -175.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.554 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 51.7 m-80 -170.95 170.35 6.34 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.044 -1.465 . . . . 2.0299999999999998 107.044 -168.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.735 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 26.5 mtt180 -126.15 159.06 33.93 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.713 -0.795 . . . . 2.02 111.929 -173.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 60.7 tt0 -133.31 99.97 4.7 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.554 -0.748 . . . . 0.83999999999999997 110.058 169.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.493 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 34.1 ttt85 -66.07 166.06 12.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.647 -0.706 . . . . 3.2799999999999998 110.146 173.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.45 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 17.0 m-80 -35.26 101.92 0.22 Allowed Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 125.093 1.357 . . . . 0.34999999999999998 113.255 -156.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.1 Cg_endo -63.24 -28.29 72.68 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.205 2.603 . . . . 0.63 111.688 174.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.3 -36.09 4.14 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.266 -0.734 . . . . 0.67000000000000004 111.266 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -79.32 -176.22 48.42 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.211 -0.494 . . . . 0.77000000000000002 112.703 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 112' ' ' GLY . 30.4 Cg_endo -61.75 8.06 0.11 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 125.15 3.9 . . . . 1.1499999999999999 115.429 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.446 ' H ' ' C ' ' A' ' 109' ' ' GLY . 9.1 m-85 -72.0 14.72 0.19 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 112.229 0.455 . . . . 1.5900000000000001 112.229 -174.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.743 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 72.2 63.19 3.03 Favored Glycine 0 CA--C 1.496 -1.149 0 C-N-CA 120.123 -1.037 . . . . 1.6899999999999999 114.894 170.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.535 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 38.21 -2.78 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 117.398 2.37 . . . . 1.1699999999999999 117.398 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.655 ' HE1' ' CE2' ' A' ' 114' ' ' TYR . 0.6 OUTLIER -166.17 149.38 7.36 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.412 -0.805 . . . . 0.60999999999999999 110.087 -176.162 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 9.9 t-105 -130.18 98.95 4.88 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.959 -1.126 . . . . 0.56999999999999995 107.959 167.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.499 HD21 ' HB3' ' A' ' 103' ' ' ARG . 5.4 mt -91.51 114.46 26.99 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.08 -0.711 . . . . 1.3600000000000001 109.08 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.9 m -84.08 144.68 28.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.533 -0.758 . . . . 0.42999999999999999 111.341 -168.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.759 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.5 mm? -108.91 170.1 8.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.094 -0.503 . . . . 1.02 111.407 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.2 t -62.0 -12.14 17.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.918 -1.037 . . . . 1.79 112.779 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.604 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 5.5 tptp -126.73 132.59 51.08 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.58 -0.448 . . . . 1.8100000000000001 110.42 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.501 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 76.7 mt-30 -31.89 -60.86 0.25 Allowed 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.554 1.159 . . . . 1.76 113.94 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.541 ' HB3' HG12 ' A' ' 89' ' ' ILE . 1.7 t-160 -94.01 5.4 51.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.954 -0.698 . . . . 3.2000000000000002 111.597 -169.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.759 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -93.9 38.43 1.07 Allowed 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 113.88 1.067 . . . . 0.83999999999999997 113.88 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.92 143.57 18.12 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 116.9 -2.571 . . . . 0.96999999999999997 112.67 -154.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 2.1 mp -96.52 114.04 32.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.808 0.814 . . . . 1.04 110.596 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.753 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.8 p80 -140.17 171.73 13.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.082 -0.963 . . . . 0.20999999999999999 109.01 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.743 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.25 -170.31 39.49 Favored Glycine 0 C--N 1.315 -0.583 0 C-N-CA 119.891 -1.147 . . . . 0.34999999999999998 111.613 177.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.54 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 13.7 t -153.23 168.74 24.96 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.35 -0.5 . . . . 1.1100000000000001 110.332 177.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -112.05 2.94 17.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.18 -1.044 . . . . 2.1899999999999999 108.18 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.9 84.67 26.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.384 -1.28 . . . . 1.8400000000000001 107.935 169.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.79 -22.32 11.9 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.679 2.253 . . . . 0.39000000000000001 114.495 -167.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.29 -10.19 59.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.923 -0.581 . . . . 1.0800000000000001 110.749 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.571 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 45.5 m -91.5 1.28 57.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 1.9399999999999999 110.375 176.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 83' ' ' PRO . 47.5 mm -79.56 141.41 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.089 -0.505 . . . . 1.04 110.152 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.7 6.4 63.9 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.463 -1.055 . . . . 0.16 110.463 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.571 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 59.2 mttm -114.85 176.75 4.92 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 123.603 1.668 . . . . 3.0299999999999998 114.078 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.77 125.46 51.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 110.813 -2.903 . . . . 1.01 108.406 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.568 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -121.51 162.67 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.798 -1.186 . . . . 1.3400000000000001 107.798 -176.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.419 ' HA ' ' HG2' ' A' ' 88' ' ' LYS . 43.5 m -61.22 -50.95 71.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 118.845 0.748 . . . . 0.87 112.691 -178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -130.57 -45.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 117.889 -1.524 . . . . 2.5499999999999998 114.112 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.29 132.78 0.21 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 117.071 1.588 . . . . 0.19 117.071 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.505 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 3.4 p -72.28 165.41 24.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 112.544 -1.828 . . . . 0.20000000000000001 112.028 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.905 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 56.9 mt -60.41 98.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.535 -1.211 . . . . 1.1299999999999999 112.276 -162.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.753 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 64.2 mtt180 -87.32 150.85 23.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.006 -1.452 . . . . 2.3300000000000001 110.92 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -133.67 -163.65 1.39 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.081 -0.509 . . . . 1.0900000000000001 109.994 174.293 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.518 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 26.2 m80 -91.39 162.07 14.74 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.167 -0.613 . . . . 2.9900000000000002 109.937 172.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.704 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.4 m120 -61.71 -54.81 37.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 118.63 -0.7 . . . . 0.73999999999999999 110.125 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -63.56 -24.79 67.95 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 121.119 1.782 . . . . 2.6899999999999999 112.071 -174.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 45.2 m-20 -87.12 -45.36 10.77 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.547 -0.751 . . . . 0.68999999999999995 111.281 -173.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.538 HG12 HD13 ' A' ' 151' ' ' ILE . 11.1 p -59.44 -25.13 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 111.781 0.289 . . . . 1.02 111.781 170.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.704 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -80.26 -40.27 19.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 118.95 -0.548 . . . . 1.1699999999999999 109.876 171.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.2 mm-40 -44.66 -72.64 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.237 0.926 . . . . 1.99 112.094 168.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.442 ' O ' HG23 ' A' ' 157' ' ' VAL . 44.2 mt -46.61 -39.67 11.58 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.649 0.738 . . . . 1.9099999999999999 111.514 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.3 80.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.098 -1.41 . . . . 1.04 111.466 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 25.5 t -86.29 -34.05 20.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.791 -0.568 . . . . 0.88 112.219 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 152' ' ' GLU . 30.3 mt -79.84 -60.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.61 0.719 . . . . 1.0 111.37 -171.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -91.95 141.64 25.59 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.882 -1.054 . . . . 1.0700000000000001 112.4 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.735 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 53.2 Cg_endo -89.06 175.71 3.4 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 124.143 3.229 . . . . 0.23999999999999999 111.062 173.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 75.7 m-20 -66.46 159.49 27.02 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 119.274 -0.971 . . . . 1.1000000000000001 109.107 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.16 -19.87 52.61 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.231 -0.985 . . . . 0.17999999999999999 112.3 -174.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.563 ' HB ' HD13 ' A' ' 100' ' ' ILE . 67.7 m -64.15 137.85 58.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.419 -0.586 . . . . 1.05 109.419 -175.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -92.97 123.49 36.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.715 1.245 . . . . 4.1100000000000003 111.246 -169.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.82 111.39 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 112.221 -2.263 . . . . 1.02 109.613 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 63' ' ' VAL . 13.6 m -93.34 108.66 20.28 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.051 -0.522 . . . . 1.0700000000000001 112.188 -174.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.511 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -79.95 100.23 4.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 123.201 1.477 . . . . 1.05 108.362 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -113.47 123.92 51.17 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 112.287 -2.233 . . . . 1.0900000000000001 109.22 -164.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.514 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 9.1 mmm180 -76.09 -0.21 21.09 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.811 -0.356 . . . . 2.4900000000000002 111.379 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.95 33.41 6.65 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.9 -0.667 . . . . 1.97 112.235 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 C--N 1.322 -0.61 0 N-CA-C 110.004 -0.369 . . . . 4.3300000000000001 110.004 178.044 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 112.255 -0.338 . . . . 3.3399999999999999 112.255 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -79.3 131.72 36.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.16 0.505 . . . . 4.9199999999999999 110.232 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 70.8 mmtt -90.31 97.93 11.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.546 -0.752 . . . . 3.1000000000000001 111.834 -174.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.683 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -116.04 175.22 5.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.384 -0.825 . . . . 1.3300000000000001 110.821 175.285 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 2.9 tt -95.33 127.69 41.58 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.341 -0.845 . . . . 1.0700000000000001 110.33 -176.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.14 162.33 13.41 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.202 1.001 . . . . 1.03 113.473 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.645 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 84.0 t80 -130.67 141.1 50.4 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.441 -1.709 . . . . 1.0800000000000001 107.932 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -114.03 114.21 25.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.02 -1.104 . . . . 0.93000000000000005 108.02 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.601 HG11 ' HB2' ' A' ' 13' ' ' ASP . 95.7 t -68.35 150.47 10.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 122.338 1.066 . . . . 1.1000000000000001 113.194 -169.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -103.38 157.85 16.74 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.505 -1.68 . . . . 2.4399999999999999 108.042 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.425 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 2.3 mm-40 -58.64 110.17 0.94 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.104 0.478 . . . . 2.4300000000000002 111.548 -176.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.22 11.71 51.32 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.548 -0.751 . . . . 0.51000000000000001 114.004 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.601 ' HB2' HG11 ' A' ' 9' ' ' VAL . 30.7 m-20 -54.0 170.5 0.13 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 117.392 0.596 . . . . 1.46 111.222 171.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.6 154.58 47.7 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.449 -0.5 . . . . 1.1599999999999999 111.424 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.466 HD23 ' HB ' ' A' ' 26' ' ' THR . 4.6 tp -67.35 -38.04 84.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.853 0.835 . . . . 1.47 110.031 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.412 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 6.3 t30 -86.96 -23.22 25.17 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.434 -1.257 . . . . 1.78 110.13 -174.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -69.7 -37.64 76.65 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.802 -0.444 . . . . 1.74 109.802 172.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.404 HG21 ' CE1' ' A' ' 22' ' ' PHE . 15.0 mt -76.68 -28.71 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.188 0.518 . . . . 1.04 109.997 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.599 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.81 -9.51 59.08 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.122 -0.361 . . . . 1.0600000000000001 110.538 175.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.694 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -95.92 -40.54 9.25 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.279 1.038 . . . . 0.97999999999999998 108.449 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 1.4 m-20 -61.29 -44.11 97.76 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.849 -1.978 . . . . 0.53000000000000003 112.0 174.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.549 ' C ' HD11 ' A' ' 101' ' ' ILE . 59.0 m-85 -98.7 6.16 47.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.706 -1.198 . . . . 0.20000000000000001 111.436 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.694 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.21 43.81 30.04 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.916 0.865 . . . . 2.46 109.328 177.481 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.599 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 30.9 pt -116.96 -164.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.385 -1.279 . . . . 1.04 110.23 -178.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 144.28 38.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.997 -1.001 . . . . 1.3400000000000001 110.523 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.514 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 75.8 p -73.98 -32.23 63.34 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.619 -0.882 . . . . 1.0900000000000001 108.619 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.38 -27.66 67.6 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.26 -0.882 . . . . 1.0700000000000001 111.629 169.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.98 -28.52 17.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.289 -0.564 . . . . 1.04 109.538 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.473 ' HG ' ' CD1' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -72.36 -30.55 64.81 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.781 -0.645 . . . . 1.8100000000000001 109.432 173.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.527 HD22 ' HB2' ' A' ' 36' ' ' LEU . 41.4 mt -75.16 -30.14 60.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.872 0.844 . . . . 1.6399999999999999 109.721 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.471 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 47.2 tt0 -65.61 -39.83 91.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.112 -1.403 . . . . 2.3300000000000001 110.527 173.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.473 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -84.48 -20.45 31.68 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 120.06 -0.656 . . . . 1.0600000000000001 111.563 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.597 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 20.8 m-80 -148.94 82.66 7.07 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-O 121.206 0.527 . . . . 0.23000000000000001 110.625 -172.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.57 -12.4 8.47 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 123.971 3.114 . . . . 0.52000000000000002 113.667 175.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 m -72.53 -26.43 61.75 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.996 0.427 . . . . 1.6499999999999999 111.661 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.597 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 36.4 mt -70.71 -33.69 71.13 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.89 -0.595 . . . . 1.25 112.564 -167.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.45 ' NE2' ' HB1' ' A' ' 38' ' ' ALA . 1.8 pp0? -63.46 -44.4 94.56 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 122.979 1.371 . . . . 2.52 110.582 -174.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.45 ' HB1' ' NE2' ' A' ' 37' ' ' GLN . . . -65.68 -45.68 81.96 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 111.818 -2.446 . . . . 1.1899999999999999 110.985 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.66 179.0 48.84 Favored Glycine 0 N--CA 1.428 -1.898 0 CA-C-N 114.835 -1.075 . . . . 0.44 111.173 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.445 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -112.35 156.99 21.55 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.151 0.5 . . . . 1.1699999999999999 110.978 177.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.53 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 31.7 m -134.89 127.58 30.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.076 -0.965 . . . . 1.1499999999999999 110.243 -177.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 11' ' ' GLN . . . -75.99 122.83 24.78 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.261 0.553 . . . . 1.1200000000000001 110.114 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.76 1.17 61.93 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.543 -1.023 . . . . 0.44 110.543 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.53 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -79.96 123.85 28.17 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.271 -0.464 . . . . 1.3 110.177 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 31.0 p -76.8 126.67 31.38 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 122.175 0.988 . . . . 1.3200000000000001 110.349 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.575 HG13 ' HB3' ' A' ' 7' ' ' TYR . 8.8 pt -125.85 141.26 46.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 113.875 -1.511 . . . . 1.0700000000000001 108.878 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.85 151.18 3.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.357 0.598 . . . . 1.3 111.167 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.6 mm -115.36 93.4 35.93 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.385 -1.279 . . . . 1.03 108.794 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.48 ' HA ' HD23 ' A' ' 4' ' ' LEU . 5.6 Cg_exo -61.64 136.26 61.6 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.719 2.279 . . . . 0.20000000000000001 112.726 -172.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.15 -6.0 82.77 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 114.725 -1.125 . . . . 0.26000000000000001 112.435 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.683 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 29.8 tp -122.94 116.24 28.95 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-O 121.192 0.52 . . . . 1.27 110.948 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.613 ' HD2' HD11 ' A' ' 51' ' ' LEU . 52.3 Cg_endo -78.19 -177.14 3.66 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.491 2.794 . . . . 0.31 114.119 -171.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.48 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 12.0 t70 -79.3 133.59 60.13 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 114.202 -1.363 . . . . 0.48999999999999999 112.454 -170.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.35 -16.01 24.89 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.577 2.851 . . . . 0.48999999999999999 113.115 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -96.66 1.74 51.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.159 0.504 . . . . 1.8 111.701 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.48 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 26.8 p -95.74 -16.04 22.22 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.395 -0.965 . . . . 1.1299999999999999 108.395 172.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.566 HG23 ' H ' ' A' ' 59' ' ' TYR . 9.1 mm -64.62 129.24 94.19 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 113.422 -1.717 . . . . 1.24 110.08 176.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.416 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 60.4 Cg_endo -78.65 -17.71 12.41 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.057 1.838 . . . . 0.47999999999999998 113.037 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.566 ' H ' HG23 ' A' ' 57' ' ' ILE . 60.4 m-85 -104.13 172.99 6.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.066 0.46 . . . . 0.94999999999999996 111.67 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -155.53 138.24 15.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.595 -0.729 . . . . 3.7400000000000002 109.397 173.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 71' ' ' THR . 82.9 mt -113.55 131.97 63.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.108 -0.496 . . . . 1.05 111.789 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.44 118.27 32.72 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.169 -0.612 . . . . 1.0800000000000001 111.13 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 59.0 t -98.1 120.91 48.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.538 0.685 . . . . 1.04 110.888 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 68' ' ' LYS . 45.2 m -98.31 104.34 16.36 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.909 -1.041 . . . . 0.83999999999999997 110.989 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.525 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 35.2 mm -50.89 -58.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 122.053 0.93 . . . . 1.0600000000000001 111.263 166.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.21 -11.18 3.17 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 112.774 -2.012 . . . . 0.16 113.462 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -127.5 -21.52 3.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.982 0.734 . . . . 1.02 112.982 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 60.24 57.2 3.0 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.989 0.813 . . . . 1.3 111.249 -170.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -137.64 161.94 35.13 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.951 0.723 . . . . 0.98999999999999999 112.951 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.466 ' C ' HD21 ' A' ' 70' ' ' LEU . 7.8 tt -130.46 113.58 14.47 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.54 -1.209 . . . . 1.1799999999999999 109.702 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.694 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 52.7 m -95.12 123.88 38.86 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.157 0.504 . . . . 1.04 111.317 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' MET . 11.6 tp -99.16 107.91 20.38 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.12 -0.946 . . . . 1.3200000000000001 109.197 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 90.0 p -107.73 160.72 15.5 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.233 -0.987 . . . . 1.05 110.804 177.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -126.46 124.75 40.82 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.707 0.765 . . . . 1.1000000000000001 109.221 170.254 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.588 ' N ' HD23 ' A' ' 74' ' ' LEU . 9.3 p30 37.83 59.21 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.531 -1.668 . . . . 1.97 111.899 -164.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 75.49 -13.73 0.84 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.883 -1.053 . . . . 2.5499999999999998 112.156 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -96.0 121.59 37.91 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.699 -0.482 . . . . 4.0199999999999996 109.699 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 46.5 t -58.49 129.82 21.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 122.318 1.056 . . . . 1.0600000000000001 112.517 -176.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 48.4 mmm -93.9 -49.92 5.58 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.161 -1.836 . . . . 1.47 107.881 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -159.73 172.06 18.4 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.779 -2.01 . . . . 1.98 109.634 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.4 m -149.34 125.09 10.48 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.418 -1.265 . . . . 1.0 109.592 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -116.31 150.42 45.32 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.555 -0.748 . . . . 1.3999999999999999 110.077 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HB2' HG23 ' A' ' 134' ' ' ILE . 53.9 Cg_endo -75.5 145.57 29.92 Favored 'Trans proline' 0 CA--C 1.494 -1.492 0 C-N-CA 122.188 1.926 . . . . 0.23999999999999999 110.957 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.532 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -141.22 173.25 9.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.689 -0.687 . . . . 1.04 110.782 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.894 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.65 142.99 46.59 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.438 -0.346 . . . . 1.03 110.176 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.465 HG21 ' HG3' ' A' ' 68' ' ' LYS . 13.0 m -126.28 128.27 71.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.417 0.627 . . . . 1.26 111.622 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -92.01 160.14 25.96 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.067 -0.97 . . . . 0.20000000000000001 110.714 173.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -55.62 2.88 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 113.539 0.94 . . . . 3.48 113.539 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.3 tp -91.15 -18.89 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 O-C-N 121.051 -1.031 . . . . 1.0700000000000001 109.793 -177.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.3 mm? -91.63 -22.31 20.35 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.898 0.856 . . . . 1.02 108.693 -177.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.2 p -67.29 -11.76 58.38 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.263 -1.335 . . . . 1.05 111.404 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -71.14 -42.11 69.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.61 -1.177 . . . . 2.0299999999999998 112.287 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -96.74 125.78 45.46 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.274 -0.571 . . . . 1.1499999999999999 110.659 -176.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.9 Cg_endo -75.19 -15.24 20.45 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.771 2.314 . . . . 1.04 112.837 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.9 t -115.65 -41.62 3.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.649 -0.25 . . . . 1.1299999999999999 110.381 -177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.463 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 47.43 42.72 19.33 Favored Glycine 0 C--O 1.225 -0.447 0 O-C-N 124.045 0.841 . . . . 0.35999999999999999 113.778 169.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.57 113.54 21.32 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.793 0.806 . . . . 1.0800000000000001 109.237 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.717 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 25.6 m-85 -136.53 178.32 7.16 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.137 -1.392 . . . . 0.26000000000000001 112.275 -171.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 1.641 ' HD2' ' CD1' ' A' ' 99' ' ' TYR . 32.5 m-85 -144.28 139.12 28.41 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.197 -0.456 . . . . 0.78000000000000003 110.703 -171.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.588 HD13 ' HB ' ' A' ' 161' ' ' THR . 75.6 mt -65.68 116.02 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 115.424 -0.807 . . . . 1.02 110.674 171.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.549 HD11 ' C ' ' A' ' 22' ' ' PHE . 20.6 pt -84.16 -44.09 17.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 112.901 0.704 . . . . 1.03 112.901 -175.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.822 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 44.9 m-80 -170.45 169.84 7.25 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.003 -1.48 . . . . 2.0299999999999998 107.003 -169.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.624 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 14.0 mtt180 -129.27 158.13 39.93 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.819 -0.752 . . . . 2.02 111.536 -175.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.408 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.9 tt0 -131.89 100.87 5.22 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.711 -0.677 . . . . 0.83999999999999997 109.969 169.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.509 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 20.7 ttt85 -62.86 166.0 6.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.339 -0.846 . . . . 3.2799999999999998 111.01 174.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.509 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 21.5 m-80 -35.01 103.03 0.23 Allowed Pre-proline 0 C--O 1.234 0.274 0 C-N-CA 125.361 1.464 . . . . 0.34999999999999998 113.717 -153.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 13.9 Cg_exo -52.41 -49.6 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.594 2.863 . . . . 0.63 111.238 170.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.33 -33.74 4.71 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 110.44 -1.064 . . . . 0.67000000000000004 110.44 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.79 -177.93 45.68 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.811 -0.695 . . . . 0.77000000000000002 112.431 175.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.06 -0.75 0.99 Allowed 'Trans proline' 0 N--CA 1.479 0.675 0 C-N-CA 125.056 3.837 . . . . 1.1499999999999999 115.365 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -71.43 7.06 1.49 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 112.919 0.711 . . . . 1.5900000000000001 112.919 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.67 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 88.03 63.47 1.38 Allowed Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 119.502 -1.332 . . . . 1.6899999999999999 115.673 165.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.515 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 37.16 0.66 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 117.055 2.243 . . . . 1.1699999999999999 117.055 -177.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.651 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.3 OUTLIER -167.26 162.67 15.12 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.583 -0.698 . . . . 0.60999999999999999 109.925 -176.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.408 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 22.1 t-105 -142.52 98.61 3.33 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.176 -1.046 . . . . 0.56999999999999995 108.176 166.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.51 HD21 ' HG2' ' A' ' 103' ' ' ARG . 4.6 mt -91.3 113.74 26.09 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.101 -0.703 . . . . 1.3600000000000001 109.101 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 101' ' ' ILE . 23.5 m -83.82 143.81 29.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.86 -0.609 . . . . 0.42999999999999999 111.325 -169.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.3 167.99 9.63 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.921 -0.581 . . . . 1.02 111.407 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 t -58.87 -13.87 7.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.583 -1.19 . . . . 1.79 112.967 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.717 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 4.0 tmtm? -127.01 130.12 49.4 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.016 0.436 . . . . 1.8100000000000001 110.127 172.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.695 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.9 mt-30 -34.37 -55.02 0.53 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.097 -1.411 . . . . 1.76 114.151 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.495 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -99.91 11.93 38.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.958 -0.697 . . . . 3.2000000000000002 111.997 -173.381 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.768 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -96.48 37.65 1.26 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.755 0.65 . . . . 0.83999999999999997 112.755 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.522 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -114.45 142.68 17.7 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 117.379 -2.343 . . . . 0.96999999999999997 112.58 -151.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -94.63 114.44 31.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.743 0.783 . . . . 1.04 110.568 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.671 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.8 p80 -145.05 171.44 14.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.20999999999999999 109.75 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.67 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.83 -168.03 37.89 Favored Glycine 0 C--N 1.316 -0.537 0 C-N-CA 120.287 -0.958 . . . . 0.34999999999999998 111.892 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.427 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 14.2 t -156.69 172.7 18.13 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.2 -0.588 . . . . 1.1100000000000001 110.175 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -114.26 -0.1 14.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.952 -0.759 . . . . 2.1899999999999999 108.952 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -114.83 86.8 13.72 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 107.916 -1.142 . . . . 1.8400000000000001 107.916 169.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -73.47 -18.18 23.09 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.486 2.124 . . . . 0.39000000000000001 113.53 -169.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.98 -1.82 45.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.778 -0.647 . . . . 1.0800000000000001 110.67 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 41.1 t -91.03 -4.06 56.69 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.049 -0.722 . . . . 1.9399999999999999 109.049 171.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.453 HG23 ' HB2' ' A' ' 83' ' ' PRO . 37.0 mm -83.3 134.14 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.81 -0.632 . . . . 1.04 110.251 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.95 1.19 70.54 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.867 -1.293 . . . . 0.16 109.867 -174.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 3.3 tttt -110.82 161.53 15.71 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 122.859 1.314 . . . . 3.0299999999999998 113.46 -176.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.435 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -96.52 126.95 42.07 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 112.551 -2.113 . . . . 1.01 108.239 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.489 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 1.2 p -122.19 166.91 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.585 -1.265 . . . . 1.3400000000000001 107.585 -176.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.4 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 45.2 m -64.17 -52.17 60.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.823 0.738 . . . . 0.87 112.605 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -130.23 -45.46 1.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 118.067 -1.453 . . . . 2.5499999999999998 113.805 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.06 133.7 0.17 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 117.023 1.569 . . . . 0.19 117.023 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.579 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 3.0 p -74.67 165.6 24.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 112.573 -1.813 . . . . 0.20000000000000001 111.676 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.894 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 61.5 mt -59.59 99.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 122.378 1.085 . . . . 1.1299999999999999 112.239 -162.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.671 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 70.9 mtt180 -86.85 145.83 26.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.752 -1.567 . . . . 2.3300000000000001 110.494 -177.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.532 ' HG2' HG21 ' A' ' 84' ' ' ILE . 10.9 mtp -126.23 -165.51 1.45 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.011 -0.737 . . . . 1.0900000000000001 109.011 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -90.47 165.1 13.99 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.113 -0.699 . . . . 2.9900000000000002 109.113 169.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.66 ' O ' HD11 ' A' ' 151' ' ' ILE . 2.8 m120 -63.57 -48.99 75.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 118.258 -0.877 . . . . 0.73999999999999999 110.145 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -64.48 -29.27 70.31 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 121.58 1.991 . . . . 2.6899999999999999 111.903 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' CB ' ' HE3' ' A' ' 145' ' ' MET . 68.1 m-20 -76.68 -45.67 28.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.06 0.457 . . . . 0.68999999999999995 110.435 -175.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.553 HG12 HD13 ' A' ' 151' ' ' ILE . 14.4 p -67.02 -23.46 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.387 -0.824 . . . . 1.02 111.308 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.66 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -84.08 -42.52 17.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 119.05 -0.5 . . . . 1.1699999999999999 110.142 171.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 156' ' ' ILE . 29.9 mt-10 -48.22 -68.55 0.17 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 119.392 0.996 . . . . 1.99 112.305 171.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.495 ' O ' HG23 ' A' ' 157' ' ' VAL . 9.2 mp -47.09 -39.02 12.35 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.455 0.645 . . . . 1.9099999999999999 111.436 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.73 -32.62 74.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.579 -1.191 . . . . 1.04 111.606 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.1 t -87.34 -32.25 19.72 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.487 -0.758 . . . . 0.88 112.316 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 152' ' ' GLU . 36.9 mt -82.88 -60.11 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.528 0.68 . . . . 1.0 111.547 -172.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 153' ' ' LEU . 3.8 m -89.52 138.16 28.5 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.812 -1.086 . . . . 1.0700000000000001 112.28 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.624 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 43.3 Cg_endo -89.01 176.04 3.34 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 C-N-CA 124.194 3.263 . . . . 0.23999999999999999 111.525 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.822 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.8 m-20 -67.24 154.42 41.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.13 -1.063 . . . . 1.1000000000000001 108.13 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.97 -15.35 63.18 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.789 -1.196 . . . . 0.17999999999999999 112.565 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.588 ' HB ' HD13 ' A' ' 100' ' ' ILE . 88.3 m -65.8 136.88 56.78 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.091 -0.707 . . . . 1.05 109.091 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.475 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 1.1 ptm180 -93.3 127.31 38.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.55 1.166 . . . . 4.1100000000000003 111.51 -171.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.5 t -111.69 108.61 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 112.327 -2.215 . . . . 1.02 109.215 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.8 m -95.54 109.89 22.05 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.459 0.541 . . . . 1.0700000000000001 112.459 -172.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.463 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -83.69 96.08 4.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 122.504 1.145 . . . . 1.05 109.946 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -101.56 138.32 38.72 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.724 -1.58 . . . . 1.0900000000000001 108.663 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.525 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 5.2 mmt85 -73.97 -24.51 59.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.988 -0.745 . . . . 2.4900000000000002 108.988 175.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.26 -48.04 3.72 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.154 -0.93 . . . . 1.97 112.226 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.323 -0.583 0 N-CA-C 109.623 -0.51 . . . . 4.3300000000000001 109.623 175.515 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.867 -0.493 . . . . 3.3399999999999999 111.867 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -108.41 147.67 31.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.003 0.43 . . . . 4.9199999999999999 110.222 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -86.57 109.34 19.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.618 -0.719 . . . . 3.1000000000000001 109.826 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -105.9 174.45 5.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.661 0.743 . . . . 1.3300000000000001 112.097 -177.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.615 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.2 tt -96.19 129.67 43.44 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.644 -1.162 . . . . 1.0700000000000001 110.219 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.81 162.04 13.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.207 -0.906 . . . . 1.03 112.663 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.636 ' HD1' ' CD2' ' A' ' 7' ' ' TYR . 74.0 t80 -131.2 145.38 51.91 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.956 -1.475 . . . . 1.0800000000000001 108.193 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -116.02 114.55 24.73 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.436 -0.95 . . . . 0.93000000000000005 108.436 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 13' ' ' ASP . 97.5 t -68.04 151.46 10.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 122.567 1.175 . . . . 1.1000000000000001 113.364 -171.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -103.96 159.87 15.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.256 -1.793 . . . . 2.4399999999999999 108.837 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.406 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -63.07 105.3 0.67 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.972 0.415 . . . . 2.4300000000000002 111.751 -176.396 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.35 10.93 32.67 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.933 -0.651 . . . . 0.51000000000000001 113.215 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.55 ' HB2' HG11 ' A' ' 9' ' ' VAL . 87.8 m-20 -55.93 171.09 0.26 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.709 0.254 . . . . 1.46 111.26 172.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.2 154.3 50.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.599 0.714 . . . . 1.1599999999999999 111.893 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.653 HD23 ' O ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -69.14 -28.73 66.7 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.346 -1.297 . . . . 1.47 109.995 -176.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.459 ' HA ' HG23 ' A' ' 26' ' ' THR . 0.2 OUTLIER -93.51 -26.12 17.3 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.025 -0.989 . . . . 1.78 110.788 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -66.06 -40.6 91.06 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.604 -0.438 . . . . 1.74 109.927 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.418 HG21 ' CE1' ' A' ' 22' ' ' PHE . 14.6 mt -73.47 -27.1 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.185 -0.461 . . . . 1.04 109.928 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.612 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.39 -11.37 59.92 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.809 -0.356 . . . . 1.0600000000000001 111.147 176.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.625 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -93.51 -40.02 10.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.458 0.647 . . . . 0.97999999999999998 109.885 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.653 ' HB3' ' O ' ' A' ' 119' ' ' SER . 47.1 m-20 -63.46 -40.54 97.4 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.726 -1.125 . . . . 0.53000000000000003 112.054 174.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 119' ' ' SER . 51.4 m-85 -99.25 4.81 46.74 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 118.506 -1.278 . . . . 0.20000000000000001 111.44 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.625 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.7 mpt_? 54.83 44.6 28.15 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.711 0.767 . . . . 2.46 109.619 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.612 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 32.4 pt -117.46 -165.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.624 -1.171 . . . . 1.04 110.028 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.42 142.55 41.98 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.91 -1.041 . . . . 1.3400000000000001 110.125 175.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.614 ' HB ' ' CD1' ' A' ' 15' ' ' LEU . 78.8 p -73.57 -32.75 64.32 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.409 -0.96 . . . . 1.0900000000000001 108.409 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.59 -24.4 66.65 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.095 -0.957 . . . . 1.0700000000000001 111.636 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.31 -28.2 15.1 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.983 -0.747 . . . . 1.04 108.983 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.636 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 21.3 tp -74.23 -27.01 60.57 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.486 -0.779 . . . . 1.8100000000000001 109.503 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.48 HD21 ' HB2' ' A' ' 36' ' ' LEU . 72.6 mt -80.19 -26.81 39.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.698 0.761 . . . . 1.6399999999999999 110.117 172.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 7.1 tt0 -66.03 -41.18 91.26 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.573 -1.194 . . . . 2.3300000000000001 110.13 171.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.436 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -84.1 -21.67 31.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.115 -0.634 . . . . 1.0600000000000001 111.456 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.2 m-80 -148.27 78.49 9.41 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.532 0.682 . . . . 0.23000000000000001 110.328 -172.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 20.3 Cg_endo -58.36 -7.79 4.41 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 124.331 3.354 . . . . 0.52000000000000002 114.149 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.6 m -84.69 -17.89 37.01 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 111.815 0.302 . . . . 1.6499999999999999 111.815 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.636 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 41.8 mt -67.74 -34.49 76.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.513 0.673 . . . . 1.25 111.704 -173.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.414 ' HG3' ' H ' ' A' ' 38' ' ' ALA . 5.7 pt20 -65.05 -46.64 80.4 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.819 1.295 . . . . 2.52 110.36 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.414 ' H ' ' HG3' ' A' ' 37' ' ' GLN . . . -58.86 -47.66 84.12 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 111.771 -2.468 . . . . 1.1899999999999999 110.648 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.48 47.43 Favored Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 114.753 -1.112 . . . . 0.44 111.318 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.26 156.8 20.95 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.273 0.558 . . . . 1.1699999999999999 111.006 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 62.3 m -138.05 127.32 24.53 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.17 -0.923 . . . . 1.1499999999999999 110.576 -175.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 11' ' ' GLN . . . -77.7 118.06 19.71 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.511 0.672 . . . . 1.1200000000000001 109.943 -178.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.67 1.76 52.86 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.195 -1.162 . . . . 0.44 110.195 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -77.95 123.7 27.11 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.633 -0.783 . . . . 1.3 109.715 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 46.2 p -82.18 128.04 33.76 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.434 -0.803 . . . . 1.3200000000000001 110.275 176.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.584 HG13 ' HB3' ' A' ' 7' ' ' TYR . 12.4 pt -127.7 141.72 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.186 -1.37 . . . . 1.0700000000000001 109.326 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.36 150.61 3.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.094 0.473 . . . . 1.3 110.898 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.4 mm -114.8 92.1 28.57 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.709 -1.132 . . . . 1.03 108.992 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.515 ' HA ' HD23 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -58.94 133.81 56.0 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.903 2.402 . . . . 0.20000000000000001 112.918 -174.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.07 -6.38 78.88 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.8 -1.091 . . . . 0.26000000000000001 112.339 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.652 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 30.0 tp -123.47 116.97 27.97 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 121.106 0.479 . . . . 1.27 111.213 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.615 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 43.7 Cg_endo -76.86 -177.28 3.68 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.605 2.87 . . . . 0.31 113.907 -172.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 12.1 t70 -83.54 129.56 59.53 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 114.483 -1.235 . . . . 0.48999999999999999 111.97 -168.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.558 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.2 Cg_endo -75.23 -17.49 19.01 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.333 2.689 . . . . 0.48999999999999999 112.411 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -93.96 -5.41 47.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.476 0.655 . . . . 1.8 110.404 -172.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.456 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 30.2 p -89.24 -20.84 23.65 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.6 1.19 . . . . 1.1299999999999999 107.993 173.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.452 HG23 ' H ' ' A' ' 59' ' ' TYR . 27.1 mt -74.05 130.02 83.61 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 112.906 -1.952 . . . . 1.24 111.232 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.82 -17.06 9.86 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.48 2.12 . . . . 0.47999999999999998 113.153 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' H ' HG23 ' A' ' 57' ' ' ILE . 70.0 m-85 -92.26 159.5 15.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.823 -0.351 . . . . 0.94999999999999996 111.661 -177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -147.2 134.44 20.58 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.883 -0.784 . . . . 3.7400000000000002 108.883 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.698 ' HA ' ' O ' ' A' ' 71' ' ' THR . 86.3 mt -113.68 131.89 64.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.948 -0.569 . . . . 1.05 111.676 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.32 30.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.937 -0.705 . . . . 1.0800000000000001 110.843 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 69' ' ' THR . 91.2 t -97.62 111.31 27.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.765 0.793 . . . . 1.04 111.117 175.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 68' ' ' LYS . 58.8 m -93.64 101.25 13.39 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.508 -1.223 . . . . 0.83999999999999997 110.702 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.6 mm -49.26 -57.89 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 122.067 0.937 . . . . 1.0600000000000001 111.306 170.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.22 -9.1 2.85 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 112.764 -2.016 . . . . 0.16 113.208 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.07 -22.53 3.76 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.532 0.733 . . . . 1.02 112.517 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 64' ' ' SER . 1.1 mppt? 60.61 58.44 2.45 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 118.067 0.394 . . . . 1.3 111.354 -170.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 63.0 p -137.68 160.83 38.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 113.09 0.774 . . . . 0.98999999999999999 113.09 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.425 ' C ' HD21 ' A' ' 70' ' ' LEU . 7.4 tt -128.18 107.95 10.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.672 -1.149 . . . . 1.1799999999999999 109.534 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.698 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 61.7 m -90.37 122.02 32.87 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.082 0.468 . . . . 1.04 110.837 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 79' ' ' MET . 17.1 tp -97.88 105.21 17.32 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.446 -0.797 . . . . 1.3200000000000001 109.273 173.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 96.9 p -105.65 160.47 15.18 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 118.829 -1.148 . . . . 1.05 110.318 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.5 tm? -126.1 125.45 42.57 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.705 -0.85 . . . . 1.1000000000000001 108.705 168.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.52 ' N ' HD23 ' A' ' 74' ' ' LEU . 24.4 m-80 50.54 50.06 19.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.435 -1.257 . . . . 1.97 111.008 -171.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 71.74 -10.18 0.87 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.571 0.749 . . . . 2.5499999999999998 111.816 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -98.79 120.42 39.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.021 -0.536 . . . . 4.0199999999999996 109.82 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 54.6 t -57.74 132.98 22.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 122.493 1.139 . . . . 1.0600000000000001 112.768 -174.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -102.01 -45.01 5.31 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 112.837 -1.983 . . . . 1.47 108.732 177.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -154.27 174.49 14.72 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 113.2 -1.818 . . . . 1.98 110.102 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -149.29 121.21 8.19 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.481 -1.69 . . . . 1.0 109.46 168.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 1.635 ' HD1' ' CD2' ' A' ' 82' ' ' TYR . 12.9 m-85 -101.19 151.28 37.67 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 115.142 -0.935 . . . . 1.3999999999999999 109.165 -175.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HB2' HG23 ' A' ' 134' ' ' ILE . 57.3 Cg_endo -81.2 140.51 12.36 Favored 'Trans proline' 0 CA--C 1.5 -1.212 0 C-N-CA 121.499 1.466 . . . . 0.23999999999999999 111.062 169.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.543 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -139.81 176.13 6.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.516 -0.765 . . . . 1.04 110.393 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.883 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -120.14 150.17 41.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.126 -0.324 . . . . 1.03 110.126 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.475 HG23 ' HG3' ' A' ' 68' ' ' LYS . 9.8 m -130.95 127.47 61.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.58 0.705 . . . . 1.26 112.107 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -85.67 156.16 29.98 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.044 -1.222 . . . . 0.20000000000000001 110.044 172.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -57.46 3.96 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.236 0.828 . . . . 3.48 113.236 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.521 HG12 ' CB ' ' A' ' 122' ' ' HIS . 1.1 tp -90.28 -19.49 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 O-C-N 121.638 -0.664 . . . . 1.0700000000000001 110.291 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.7 mm? -89.78 -18.13 26.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.765 0.793 . . . . 1.02 109.256 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.5 p -68.04 -14.36 62.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.427 -1.26 . . . . 1.05 111.362 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -71.52 -37.67 71.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.47 -1.241 . . . . 2.0299999999999998 112.862 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -105.8 115.89 60.76 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 120.055 -0.658 . . . . 1.1499999999999999 110.793 -177.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.564 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.8 Cg_endo -75.58 -11.69 20.43 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.792 2.328 . . . . 1.04 113.63 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.1 t -105.02 -43.56 5.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.185 0.516 . . . . 1.1299999999999999 110.107 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.545 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 53.54 33.48 47.81 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.257 -1.338 . . . . 0.35999999999999999 113.93 167.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.16 112.61 20.4 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.969 0.89 . . . . 1.0800000000000001 109.721 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.702 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 19.0 m-85 -138.05 176.81 8.37 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.764 -1.562 . . . . 0.26000000000000001 111.949 -170.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CG ' HD13 ' A' ' 5' ' ' LEU . 45.3 m-85 -139.33 144.08 38.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.257 0.551 . . . . 0.78000000000000003 110.452 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.537 HD13 ' HB ' ' A' ' 161' ' ' THR . 83.8 mt -68.84 116.89 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 115.613 -0.721 . . . . 1.02 110.557 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.533 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 30.4 pt -85.93 -35.81 9.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 112.877 0.695 . . . . 1.03 112.877 -175.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.753 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 11.0 p30 -178.53 -179.21 0.65 Allowed 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 107.695 -1.224 . . . . 2.0299999999999998 107.695 -176.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.625 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -140.38 159.6 41.83 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.16 -0.616 . . . . 2.02 112.599 -176.041 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.8 tt0 -128.37 100.07 5.66 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.9 -1.046 . . . . 0.83999999999999997 109.428 172.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.496 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 61.5 ttt180 -64.73 165.91 9.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.341 -0.845 . . . . 3.2799999999999998 110.663 176.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.496 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 23.3 m-80 -35.07 102.05 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 125.282 1.433 . . . . 0.34999999999999998 113.743 -152.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 16.3 Cg_exo -53.84 -51.53 10.55 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.504 2.803 . . . . 0.63 111.469 169.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.26 -33.84 4.53 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.152 -1.179 . . . . 0.67000000000000004 110.152 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.49 -175.16 33.57 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.636 -0.782 . . . . 0.77000000000000002 112.745 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.69 -8.47 7.46 Favored 'Trans proline' 0 N--CA 1.479 0.675 0 C-N-CA 124.877 3.718 . . . . 1.1499999999999999 114.844 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -63.99 -0.11 1.04 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.08 1.141 . . . . 1.5900000000000001 114.08 -172.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.657 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 89.18 63.32 1.32 Allowed Glycine 0 CA--C 1.494 -1.277 0 C-N-CA 119.287 -1.435 . . . . 1.6899999999999999 114.884 166.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.517 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 37.68 0.77 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 116.977 2.214 . . . . 1.1699999999999999 116.977 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.642 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.4 OUTLIER -166.54 162.88 16.96 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.684 -0.635 . . . . 0.60999999999999999 110.04 -176.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 18.0 t-105 -143.9 97.85 3.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.302 -0.999 . . . . 0.56999999999999995 108.302 167.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.51 HD13 ' CG2' ' A' ' 150' ' ' VAL . 2.1 mt -89.48 115.19 26.72 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.381 0.61 . . . . 1.3600000000000001 109.739 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.436 ' C ' HG12 ' A' ' 101' ' ' ILE . 24.3 m -86.01 144.3 27.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.956 -0.565 . . . . 0.42999999999999999 111.19 -171.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.1 mm? -109.29 168.14 9.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 1.02 110.46 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.653 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.1 m -65.11 -2.38 2.79 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.937 0.718 . . . . 1.79 112.937 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.757 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 5.0 tmtm? -128.8 136.37 50.42 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.941 -0.392 . . . . 1.8100000000000001 109.941 168.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.757 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 25.5 mm-40 -36.46 -58.03 0.73 Allowed 'General case' 0 C--N 1.312 -1.041 0 O-C-N 124.222 0.951 . . . . 1.76 113.458 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.521 ' CB ' HG12 ' A' ' 89' ' ' ILE . 56.2 m80 -89.92 0.78 56.88 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.451 -0.499 . . . . 3.2000000000000002 111.83 -167.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.795 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.1 m-30 -96.73 37.93 1.25 Allowed 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 113.419 0.896 . . . . 0.83999999999999997 113.419 -170.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.49 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -114.41 142.95 17.85 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 116.693 -2.67 . . . . 0.96999999999999997 112.642 -152.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -93.35 115.21 31.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.773 0.797 . . . . 1.04 110.661 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.567 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 31.5 p80 -142.05 170.57 15.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.451 -0.795 . . . . 0.20999999999999999 109.394 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.657 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -92.35 -167.27 39.61 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.375 -0.917 . . . . 0.34999999999999998 111.687 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.479 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 9.2 t -156.79 169.82 23.86 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 122.039 -0.683 . . . . 1.1100000000000001 110.346 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -114.68 -5.22 12.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.643 -0.873 . . . . 2.1899999999999999 108.643 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -116.04 87.33 18.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 114.832 -1.077 . . . . 1.8400000000000001 108.231 171.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -72.78 -21.21 21.79 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.131 2.554 . . . . 0.39000000000000001 114.484 -167.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -75.83 -2.58 30.69 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.147 0.499 . . . . 1.0800000000000001 111.116 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.459 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 15.9 m -91.91 -5.52 53.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.275 0.559 . . . . 1.9399999999999999 109.673 173.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.451 HG23 ' HB2' ' A' ' 83' ' ' PRO . 37.8 mm -81.89 134.96 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.713 -0.676 . . . . 1.04 110.085 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.89 2.28 66.91 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.954 -1.259 . . . . 0.16 109.954 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.459 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 54.6 mttp -113.93 170.08 8.53 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.988 1.375 . . . . 3.0299999999999998 113.466 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.07 124.92 49.45 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.118 -2.31 . . . . 1.01 108.191 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.43 162.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.757 -0.831 . . . . 1.3400000000000001 108.757 -173.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -51.55 -60.17 3.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.389 0.514 . . . . 0.87 112.389 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.404 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 18.8 pttp -133.5 -44.36 0.83 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 118.357 -1.337 . . . . 2.5499999999999998 113.765 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.88 133.24 0.17 Allowed Glycine 0 N--CA 1.464 0.54 0 N-CA-C 117.014 1.565 . . . . 0.19 117.014 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.567 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 5.4 p -69.53 165.75 20.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 112.411 -1.894 . . . . 0.20000000000000001 112.202 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.883 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 45.9 mt -59.8 98.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.566 -1.197 . . . . 1.1299999999999999 112.047 -162.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.555 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 11.4 mtp180 -86.27 150.03 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.874 -1.512 . . . . 2.3300000000000001 110.25 -177.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.543 ' HG2' HG21 ' A' ' 84' ' ' ILE . 6.3 mtp -129.31 -165.79 1.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.973 -0.751 . . . . 1.0900000000000001 108.973 173.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.712 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 5.1 t60 -92.91 159.54 15.3 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.605 -0.887 . . . . 2.9900000000000002 108.605 170.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.653 ' O ' HD11 ' A' ' 151' ' ' ILE . 1.6 m120 -57.9 -53.21 60.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.357 -0.83 . . . . 0.73999999999999999 110.365 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -63.56 -27.15 69.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 121.376 1.898 . . . . 2.6899999999999999 112.005 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.712 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.9 m-20 -75.67 -51.31 13.06 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.72 -0.673 . . . . 0.68999999999999995 110.63 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.555 HG12 HD13 ' A' ' 151' ' ' ILE . 14.7 p -62.94 -22.63 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 115.285 -0.87 . . . . 1.02 111.746 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.653 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.58 -39.95 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 118.911 -0.566 . . . . 1.1699999999999999 110.569 172.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -45.79 -72.34 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.219 0.918 . . . . 1.99 112.674 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.559 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.1 mm? -49.0 -35.05 14.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.768 0.794 . . . . 1.9099999999999999 111.325 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.532 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -63.94 -35.09 79.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.561 -1.2 . . . . 1.04 112.048 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.3 t -90.99 -29.01 17.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 119.03 0.832 . . . . 0.88 113.099 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.4 mt -83.19 -60.44 2.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.509 0.671 . . . . 1.0 111.772 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 153' ' ' LEU . 4.4 m -86.76 141.83 34.04 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.955 -1.02 . . . . 1.0700000000000001 111.53 177.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.625 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 77.9 Cg_endo -85.19 172.64 8.34 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.992 3.128 . . . . 0.23999999999999999 111.351 175.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.753 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.4 m-20 -63.65 156.3 27.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.243 -1.021 . . . . 1.1000000000000001 108.243 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.77 -22.08 42.42 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 119.634 -1.27 . . . . 0.17999999999999999 112.951 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.537 ' HB ' HD13 ' A' ' 100' ' ' ILE . 48.9 m -60.78 135.48 57.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.077 -0.712 . . . . 1.05 109.077 -174.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.547 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -94.16 129.91 40.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.589 1.185 . . . . 4.1100000000000003 111.403 -167.42 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.3 t -110.95 110.57 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 112.373 -2.194 . . . . 1.02 109.571 -173.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 15.7 m -94.24 105.58 17.56 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.512 0.56 . . . . 1.0700000000000001 112.512 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.545 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -82.42 99.96 5.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-O 122.412 1.101 . . . . 1.05 110.005 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -107.47 130.91 54.78 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.04 -1.436 . . . . 1.0900000000000001 109.61 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.564 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 17.3 mmm180 -72.62 -7.74 51.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.967 0.413 . . . . 2.4900000000000002 111.184 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.98 8.14 69.55 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.804 -0.712 . . . . 1.97 112.033 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 C--N 1.321 -0.663 0 N-CA-C 109.552 -0.536 . . . . 4.3300000000000001 109.552 177.622 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 111.697 -0.561 . . . . 3.3399999999999999 111.697 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -117.04 133.02 56.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.009 0.433 . . . . 4.9199999999999999 110.232 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -90.83 119.06 30.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.696 -0.684 . . . . 3.1000000000000001 110.637 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -113.89 175.12 5.6 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.64 0.733 . . . . 1.3300000000000001 112.076 -175.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.9 tt -95.42 130.42 42.23 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.525 -1.216 . . . . 1.0700000000000001 110.124 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.55 162.97 13.23 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.135 0.969 . . . . 1.03 113.21 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' A' ' 7' ' ' TYR . 84.8 t80 -130.44 140.95 50.54 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.791 -1.549 . . . . 1.0800000000000001 107.959 175.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -113.36 113.19 24.88 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.063 -1.088 . . . . 0.93000000000000005 108.063 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 41' ' ' THR . 93.6 t -67.11 150.99 10.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 122.38 1.086 . . . . 1.1000000000000001 112.999 -170.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -107.49 159.05 16.71 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 113.376 -1.738 . . . . 2.4399999999999999 108.21 171.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -58.66 110.0 0.91 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.964 0.411 . . . . 2.4300000000000002 111.94 -174.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.99 11.32 43.39 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.766 -0.652 . . . . 0.51000000000000001 113.7 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.565 ' HB2' HG11 ' A' ' 9' ' ' VAL . 86.9 m-20 -55.85 167.95 0.51 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.193 0.497 . . . . 1.46 111.177 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.59 152.56 48.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.036 0.446 . . . . 1.1599999999999999 111.746 176.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.521 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.39 -32.72 74.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.082 -0.963 . . . . 1.47 108.643 -178.046 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.448 ' HA ' HG23 ' A' ' 26' ' ' THR . 64.1 t30 -93.05 -22.21 19.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.789 -1.096 . . . . 1.78 111.114 -177.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.7 t -65.64 -45.85 81.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.206 -0.664 . . . . 1.74 109.206 171.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.421 HG21 ' CE1' ' A' ' 22' ' ' PHE . 17.3 mt -71.84 -26.61 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.881 -0.6 . . . . 1.04 110.056 -176.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.596 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.45 -10.17 59.75 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.833 -0.347 . . . . 1.0600000000000001 111.111 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.593 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.32 -39.1 9.38 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.502 1.144 . . . . 0.97999999999999998 108.057 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 119' ' ' SER . 6.2 m-20 -63.32 -44.38 95.08 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 112.402 -2.181 . . . . 0.53000000000000003 111.911 173.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.552 ' C ' HD11 ' A' ' 101' ' ' ILE . 55.3 m-85 -97.72 4.66 49.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 118.725 -1.19 . . . . 0.20000000000000001 111.658 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.593 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.4 mpt_? 54.68 43.28 30.4 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.866 0.841 . . . . 2.46 109.928 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.596 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.4 pt -116.39 -165.18 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 114.529 -1.214 . . . . 1.04 109.702 -178.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.1 142.34 41.7 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.023 -0.99 . . . . 1.3400000000000001 110.227 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.622 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 67.1 p -72.68 -32.82 66.1 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.916 -1.142 . . . . 1.0900000000000001 107.916 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.45 67.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.188 -0.915 . . . . 1.0700000000000001 111.745 169.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.98 -26.64 18.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.662 0.744 . . . . 1.04 108.997 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.543 HD12 HD13 ' A' ' 46' ' ' ILE . 19.2 tp -76.35 -20.45 57.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.282 -0.872 . . . . 1.8100000000000001 109.554 174.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 26' ' ' THR . 28.9 mt -83.91 -29.54 27.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.396 0.617 . . . . 1.6399999999999999 110.606 170.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.545 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -59.97 -61.25 2.75 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.945 -1.132 . . . . 2.3300000000000001 107.945 169.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.468 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -71.61 -17.39 62.28 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.514 0.673 . . . . 1.0600000000000001 110.415 -169.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.449 ' HB3' ' CD2' ' A' ' 36' ' ' LEU . 33.9 m-80 -150.69 85.26 5.28 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.189 -0.914 . . . . 0.23000000000000001 110.579 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.46 -9.18 6.43 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.964 2.443 . . . . 0.52000000000000002 112.952 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 m -69.79 -34.66 74.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.154 0.502 . . . . 1.6499999999999999 111.319 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.578 HD21 ' N ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -61.37 -51.37 69.07 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 122.209 1.004 . . . . 1.25 112.152 -169.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.403 ' HG3' ' H ' ' A' ' 38' ' ' ALA . 3.9 pt20 -56.32 -48.53 76.52 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 113.231 -1.804 . . . . 2.52 110.93 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.403 ' H ' ' HG3' ' A' ' 37' ' ' GLN . . . -54.5 -52.52 61.7 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 111.893 -2.412 . . . . 1.1899999999999999 109.938 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.88 168.0 37.93 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 114.439 -1.255 . . . . 0.44 112.164 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.03 158.25 16.28 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.266 0.555 . . . . 1.1699999999999999 110.501 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.598 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 39.6 m -145.72 129.19 16.94 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.262 -0.881 . . . . 1.1499999999999999 110.427 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.89 117.64 16.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.495 0.664 . . . . 1.1200000000000001 109.953 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.15 0.54 54.47 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 114.716 -1.129 . . . . 0.44 110.289 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.598 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.3 tt0 -75.24 125.38 28.84 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.856 -0.672 . . . . 1.3 110.338 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 56.3 p -83.54 131.46 34.99 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.831 0.824 . . . . 1.3200000000000001 110.322 175.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.577 HG13 ' HB3' ' A' ' 7' ' ' TYR . 10.0 pt -132.37 143.57 39.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.366 -1.288 . . . . 1.0700000000000001 109.306 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.61 151.73 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.16 0.505 . . . . 1.3 111.455 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.3 mm -116.45 92.89 38.4 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.628 -1.169 . . . . 1.03 109.404 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.529 ' HA ' HD23 ' A' ' 4' ' ' LEU . 4.0 Cg_exo -57.34 134.88 66.65 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.853 2.369 . . . . 0.20000000000000001 113.174 -175.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.01 -7.58 80.93 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.317 -1.311 . . . . 0.26000000000000001 112.532 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.61 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 33.6 tp -120.87 115.2 32.07 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-O 121.2 0.524 . . . . 1.27 111.184 -177.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.608 ' HD2' HD11 ' A' ' 51' ' ' LEU . 54.7 Cg_endo -78.09 -176.12 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 124.05 3.167 . . . . 0.31 114.402 -171.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.463 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 15.5 t70 -82.74 129.0 63.9 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 114.19 -1.368 . . . . 0.48999999999999999 112.045 -169.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.524 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 46.2 Cg_endo -72.92 -13.87 26.47 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 123.371 2.714 . . . . 0.48999999999999999 112.61 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.432 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 59.7 m-85 -96.26 -0.53 49.62 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.451 0.643 . . . . 1.8 111.398 -175.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 19.6 p -95.33 -20.4 19.18 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.751 -1.203 . . . . 1.1299999999999999 107.751 171.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.458 HG23 ' H ' ' A' ' 59' ' ' TYR . 19.1 mt -75.69 131.5 76.74 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 113.168 -1.833 . . . . 1.24 111.147 177.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.456 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 95.5 Cg_endo -82.72 -18.26 6.76 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.233 1.956 . . . . 0.47999999999999998 113.486 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' H ' HG23 ' A' ' 57' ' ' ILE . 61.6 m-85 -95.2 158.47 15.45 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.499 0.555 . . . . 0.94999999999999996 112.499 -175.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -146.64 128.83 15.68 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.322 -0.853 . . . . 3.7400000000000002 108.975 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 71' ' ' THR . 87.2 mt -110.32 135.95 47.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.225 -0.443 . . . . 1.05 111.701 -176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.09 119.04 33.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 119.955 -0.698 . . . . 1.0800000000000001 110.968 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.2 t -98.96 116.38 41.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.525 0.679 . . . . 1.04 110.869 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 68' ' ' LYS . 70.3 m -95.06 105.89 17.84 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.046 -0.979 . . . . 0.83999999999999997 110.352 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.7 mm -54.22 -58.92 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 122.079 0.942 . . . . 1.0600000000000001 111.2 167.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.68 -10.65 4.7 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 112.789 -2.005 . . . . 0.16 113.351 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.427 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -126.67 -18.74 4.7 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.453 0.701 . . . . 1.02 112.213 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.64 55.74 4.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.373 0.533 . . . . 1.3 111.421 -173.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.8 p -138.02 160.52 39.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.84 0.681 . . . . 0.98999999999999999 112.84 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.416 HD21 ' C ' ' A' ' 70' ' ' LEU . 8.7 tt -128.54 113.29 15.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.778 -1.101 . . . . 1.1799999999999999 110.178 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 41.3 m -93.95 122.66 36.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.273 0.559 . . . . 1.04 111.43 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 79' ' ' MET . 12.9 tp -97.55 103.27 15.19 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.862 -1.063 . . . . 1.3200000000000001 109.45 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 7.5 m -105.49 160.64 15.0 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.474 -0.89 . . . . 1.05 110.77 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.2 tm? -127.18 126.99 43.79 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.981 -0.748 . . . . 1.1000000000000001 108.981 169.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.523 ' N ' HD23 ' A' ' 74' ' ' LEU . 50.4 m-80 47.65 51.44 13.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.561 -1.199 . . . . 1.97 111.228 -171.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 t30 71.8 -12.24 0.68 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.57 -0.741 . . . . 2.5499999999999998 111.695 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.414 ' H ' ' C ' ' A' ' 75' ' ' ASN . 16.5 tpt180 -96.22 120.27 36.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.17 0.509 . . . . 4.0199999999999996 110.221 -178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 64.1 t -59.53 131.85 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 122.32 1.057 . . . . 1.0600000000000001 112.468 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 8.7 mtm -100.59 -46.01 5.33 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 113.246 -1.797 . . . . 1.47 108.903 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -156.35 173.03 17.47 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.518 -1.673 . . . . 1.98 110.037 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.7 m -149.4 124.6 10.13 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.354 -1.293 . . . . 1.0 109.848 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -111.2 153.11 44.12 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.871 -0.604 . . . . 1.3999999999999999 109.439 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HB2' HG23 ' A' ' 134' ' ' ILE . 60.4 Cg_endo -79.7 143.11 16.52 Favored 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 122.194 1.929 . . . . 0.23999999999999999 111.495 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.543 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.92 175.1 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.746 -0.661 . . . . 1.04 110.948 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.873 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.51 146.08 45.76 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.309 -0.405 . . . . 1.03 110.067 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.467 HG23 ' HG3' ' A' ' 68' ' ' LYS . 8.8 m -127.04 128.81 70.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.532 0.682 . . . . 1.26 111.784 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -87.31 154.66 26.46 Favored Glycine 0 N--CA 1.425 -2.039 0 N-CA-C 110.09 -1.204 . . . . 0.20000000000000001 110.09 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -56.18 2.93 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.266 0.839 . . . . 3.48 113.266 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 89' ' ' ILE . 0.9 OUTLIER -88.68 -19.92 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 O-C-N 121.587 -0.696 . . . . 1.0700000000000001 110.177 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.7 mm? -89.42 -18.28 27.1 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.715 0.769 . . . . 1.02 109.314 -176.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.5 p -65.99 -14.9 62.44 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.553 -1.203 . . . . 1.05 111.767 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -67.08 -39.06 86.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.051 -0.977 . . . . 2.0299999999999998 112.327 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.95 117.55 54.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.668 -0.413 . . . . 1.1499999999999999 111.222 -175.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.597 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 1.8 Cg_endo -77.63 -13.83 16.17 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.674 2.25 . . . . 1.04 113.083 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.1 t -103.67 -41.84 5.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.677 -0.49 . . . . 1.1299999999999999 109.677 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.545 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.46 39.59 22.38 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.419 -1.264 . . . . 0.35999999999999999 114.024 168.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -84.11 112.12 19.94 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.907 0.86 . . . . 1.0800000000000001 109.507 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.9 m-85 -138.78 174.72 10.23 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.003 -1.453 . . . . 0.26000000000000001 112.12 -171.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.657 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 86.6 m-85 -139.69 136.3 34.1 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.058 -0.519 . . . . 0.78000000000000003 110.732 -175.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.546 HD13 ' HB ' ' A' ' 161' ' ' THR . 86.7 mt -59.74 121.68 8.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.361 -0.836 . . . . 1.02 110.44 170.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.552 HD11 ' C ' ' A' ' 22' ' ' PHE . 19.1 pt -87.3 -44.6 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.83 0.678 . . . . 1.03 112.83 -176.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.561 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 44.1 m-80 -171.54 172.08 5.18 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.976 -1.49 . . . . 2.0299999999999998 106.976 -168.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.651 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 39.8 mtt180 -124.28 171.56 9.78 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.531 -0.867 . . . . 2.02 111.592 -173.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 52.6 tt0 -148.28 99.91 3.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.08 -0.964 . . . . 0.83999999999999997 109.758 170.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.478 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 48.4 ttp180 -66.18 166.17 12.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.284 -0.871 . . . . 3.2799999999999998 110.421 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.463 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 25.4 m-80 -35.66 103.03 0.24 Allowed Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 125.323 1.449 . . . . 0.34999999999999998 113.405 -157.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.9 Cg_endo -61.36 -31.44 88.75 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.99 2.46 . . . . 0.63 111.756 173.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.14 -34.15 5.34 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.746 -0.942 . . . . 0.67000000000000004 110.746 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.08 -177.16 45.21 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.969 -0.615 . . . . 0.77000000000000002 112.437 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 112' ' ' GLY . 30.8 Cg_endo -62.1 6.23 0.18 Allowed 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 125.002 3.802 . . . . 1.1499999999999999 115.662 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -73.29 21.64 0.08 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.506 0.558 . . . . 1.5900000000000001 112.506 -175.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.753 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 68.31 63.69 3.46 Favored Glycine 0 CA--C 1.499 -0.914 0 N-CA-C 115.568 0.987 . . . . 1.6899999999999999 115.568 168.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.524 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 38.61 -4.48 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 117.294 2.331 . . . . 1.1699999999999999 117.294 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.646 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.5 OUTLIER -166.02 151.37 8.63 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.272 -0.892 . . . . 0.60999999999999999 110.594 -176.073 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.5 t-105 -132.09 99.62 4.78 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.41 -0.959 . . . . 0.56999999999999995 108.41 168.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 103' ' ' ARG . 5.3 mt -93.92 114.27 26.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.624 0.726 . . . . 1.3600000000000001 109.358 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 m -83.9 144.22 29.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.593 -0.731 . . . . 0.42999999999999999 111.466 -168.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.774 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -108.53 170.66 7.88 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.821 -0.627 . . . . 1.02 111.243 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.493 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 2.9 t -62.38 -13.73 32.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.112 -0.949 . . . . 1.79 112.729 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.686 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 1.4 tmtp? -126.63 132.3 51.26 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 120.446 -0.501 . . . . 1.8100000000000001 110.594 173.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.686 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 55.3 mt-30 -34.2 -56.87 0.49 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.003 -1.453 . . . . 1.76 113.869 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.481 ' CB ' HG12 ' A' ' 89' ' ' ILE . 75.0 m-70 -92.22 2.01 56.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.154 0.502 . . . . 3.2000000000000002 111.556 -171.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.774 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -94.0 37.44 1.09 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.405 0.891 . . . . 0.83999999999999997 113.405 -172.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -115.05 143.27 18.06 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 117.016 -2.516 . . . . 0.96999999999999997 112.717 -152.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.12 114.64 33.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.722 0.772 . . . . 1.04 110.766 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.644 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.0 p80 -143.99 172.12 13.31 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.432 -0.804 . . . . 0.20999999999999999 109.663 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.753 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.75 -176.68 39.8 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.982 -1.104 . . . . 0.34999999999999998 111.66 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.515 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 15.0 t -147.0 168.13 22.28 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.387 -0.478 . . . . 1.1100000000000001 110.387 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -111.25 -0.7 16.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.126 -1.065 . . . . 2.1899999999999999 108.126 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -116.05 85.86 15.86 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 114.537 -1.21 . . . . 1.8400000000000001 108.385 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -72.85 -21.19 21.58 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.164 1.909 . . . . 0.39000000000000001 113.727 -169.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.23 -2.58 38.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.156 0.503 . . . . 1.0800000000000001 110.845 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 44.7 t -91.42 -3.2 56.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.308 -0.627 . . . . 1.9399999999999999 109.308 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.453 HG23 ' HB2' ' A' ' 83' ' ' PRO . 42.8 mm -80.88 139.37 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.932 -0.576 . . . . 1.04 110.133 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.46 1.37 74.83 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 110.159 -1.176 . . . . 0.16 110.159 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -111.65 167.86 10.01 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 123.24 1.495 . . . . 3.0299999999999998 114.414 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.21 48.52 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 111.541 -2.572 . . . . 1.01 107.697 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.464 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -124.66 160.58 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.954 -0.758 . . . . 1.3400000000000001 108.954 -174.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.5 m -49.36 -59.78 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.616 0.598 . . . . 0.87 112.616 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -132.62 -43.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 118.411 -1.316 . . . . 2.5499999999999998 113.744 -175.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.53 ' N ' ' HD3' ' A' ' 140' ' ' LYS . . . -32.24 133.55 0.19 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 117.236 1.654 . . . . 0.19 117.236 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.586 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 4.0 p -73.39 165.52 24.91 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 112.636 -1.782 . . . . 0.20000000000000001 111.843 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.873 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 53.3 mt -59.77 98.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 122.316 1.055 . . . . 1.1299999999999999 112.018 -162.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.644 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 74.6 mtt180 -85.07 147.69 26.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.777 -1.556 . . . . 2.3300000000000001 110.281 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.543 ' HG2' HG21 ' A' ' 84' ' ' ILE . 12.3 mtp -127.51 -166.31 1.59 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.401 -0.592 . . . . 1.0900000000000001 109.401 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.681 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 6.8 t60 -94.9 156.18 16.45 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.448 -0.945 . . . . 2.9900000000000002 108.448 172.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.639 ' O ' HD11 ' A' ' 151' ' ' ILE . 2.7 m120 -58.7 -50.03 75.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 118.339 -0.839 . . . . 0.73999999999999999 110.736 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -63.34 -26.16 68.63 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 121.26 1.845 . . . . 2.6899999999999999 112.462 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.681 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 16.8 m-20 -83.95 -39.92 19.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.937 0.399 . . . . 0.68999999999999995 111.25 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.543 HG12 HD13 ' A' ' 151' ' ' ILE . 14.6 p -70.07 -23.58 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.956 -0.565 . . . . 1.02 111.146 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.639 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.01 -39.8 16.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 118.966 -0.54 . . . . 1.1699999999999999 109.592 171.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -45.52 -71.36 0.08 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.139 0.881 . . . . 1.99 112.238 167.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 157' ' ' VAL . 8.2 mp -46.32 -38.13 8.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.521 0.677 . . . . 1.9099999999999999 111.262 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.37 83.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.372 -1.286 . . . . 1.04 111.629 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.1 t -87.94 -34.48 18.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.513 -0.742 . . . . 0.88 112.47 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.2 mt -80.38 -59.56 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.177 0.513 . . . . 1.0 111.451 -172.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 153' ' ' LEU . 2.6 m -92.39 141.51 24.93 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.448 -0.797 . . . . 1.0700000000000001 112.112 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.651 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 69.4 Cg_endo -89.02 173.6 4.02 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.767 2.978 . . . . 0.23999999999999999 111.144 173.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.561 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 73.6 m-20 -66.91 157.1 34.04 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.611 -0.836 . . . . 1.1000000000000001 109.16 177.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.35 -19.19 55.42 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.196 -1.002 . . . . 0.17999999999999999 112.666 -173.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.546 ' HB ' HD13 ' A' ' 100' ' ' ILE . 59.0 m -63.48 139.77 58.8 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.496 -0.557 . . . . 1.05 109.496 -176.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.657 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 3.5 ptm180 -92.52 120.43 32.98 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.787 1.28 . . . . 4.1100000000000003 111.112 -170.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.1 t -106.96 109.4 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 112.205 -2.271 . . . . 1.02 109.149 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.427 HG23 ' ND2' ' A' ' 166' ' ' ASN . 18.8 m -95.49 108.12 20.33 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.484 0.55 . . . . 1.0700000000000001 112.484 -172.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.545 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -81.78 101.52 6.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 122.35 1.072 . . . . 1.05 109.77 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.427 ' ND2' HG23 ' A' ' 164' ' ' THR . 61.0 m-80 -106.62 129.54 54.52 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.905 -1.498 . . . . 1.0900000000000001 109.027 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.597 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 18.0 mmm180 -69.7 -19.62 63.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.865 0.364 . . . . 2.4900000000000002 110.637 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 161.18 -80.93 0.14 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 121.16 -0.543 . . . . 1.97 111.776 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.32 -0.695 0 N-CA-C 110.251 -0.278 . . . . 4.3300000000000001 110.251 179.412 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.848 0 N-CA-C 112.211 -0.355 . . . . 3.3399999999999999 112.211 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -83.62 161.72 21.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.433 0.635 . . . . 4.9199999999999999 110.943 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -86.67 99.1 11.51 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.167 -0.924 . . . . 3.1000000000000001 108.667 172.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp -104.39 174.33 5.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.308 0.575 . . . . 1.3300000000000001 111.845 -175.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.5 tt -92.21 127.64 37.76 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.999 -1.0 . . . . 1.0700000000000001 110.605 -172.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.82 162.19 13.38 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.188 0.994 . . . . 1.03 113.401 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.651 ' HE1' ' CE2' ' A' ' 7' ' ' TYR . 80.2 t80 -131.01 141.91 50.28 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.547 -1.66 . . . . 1.0800000000000001 107.884 175.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -113.23 115.32 28.02 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.218 -1.031 . . . . 0.93000000000000005 108.218 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' A' ' 13' ' ' ASP . 98.2 t -68.73 150.3 10.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.53 1.157 . . . . 1.1000000000000001 113.254 -170.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -102.36 158.56 16.11 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.335 -1.757 . . . . 2.4399999999999999 108.541 172.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.33 105.34 0.49 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.879 0.371 . . . . 2.4300000000000002 111.622 -177.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.96 12.24 30.29 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.62 -0.8 . . . . 0.51000000000000001 113.366 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.556 ' HB2' HG11 ' A' ' 9' ' ' VAL . 90.2 m-20 -56.23 170.6 0.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.872 0.368 . . . . 1.46 111.171 170.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.89 155.47 45.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.326 0.584 . . . . 1.1599999999999999 111.146 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.537 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.97 -34.25 77.68 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.334 -0.987 . . . . 1.47 108.334 178.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.509 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -88.38 -28.0 21.24 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.911 -1.04 . . . . 1.78 111.442 -175.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.0 p -68.88 -37.67 79.18 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 118.422 0.556 . . . . 1.74 110.181 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.429 HG21 ' CE1' ' A' ' 22' ' ' PHE . 14.5 mt -73.89 -27.12 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 121.254 0.549 . . . . 1.04 109.796 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.606 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.26 -9.79 59.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.355 -0.384 . . . . 1.0600000000000001 110.684 175.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.717 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.55 -41.19 8.68 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.024 -1.102 . . . . 0.97999999999999998 108.024 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.494 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 5.6 m-20 -63.59 -41.96 98.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 112.797 -2.001 . . . . 0.53000000000000003 112.5 173.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.507 ' C ' HD11 ' A' ' 101' ' ' ILE . 56.3 m-85 -98.84 6.22 46.97 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 118.655 -1.218 . . . . 0.20000000000000001 110.858 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.717 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.06 41.04 32.18 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.927 0.87 . . . . 2.46 109.606 176.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.606 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.3 pt -114.43 -165.9 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 114.263 -1.335 . . . . 1.04 109.976 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.81 142.65 40.78 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.106 -0.952 . . . . 1.3400000000000001 109.996 175.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.663 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 70.8 p -72.82 -29.9 63.62 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.702 -0.851 . . . . 1.0900000000000001 108.702 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.93 -25.01 67.7 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.68 -0.691 . . . . 1.0700000000000001 111.816 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.435 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.37 -28.65 14.85 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.854 -0.795 . . . . 1.04 108.854 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.508 HD12 HD13 ' A' ' 46' ' ' ILE . 20.9 tp -72.29 -27.65 62.6 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.127 -0.942 . . . . 1.8100000000000001 108.584 172.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.663 ' HB2' ' O ' ' A' ' 26' ' ' THR . 7.6 tp -77.42 -31.73 54.23 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.812 0.815 . . . . 1.6399999999999999 109.462 175.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.435 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 5.8 tt0 -66.05 -40.94 91.35 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.167 -1.378 . . . . 2.3300000000000001 110.336 173.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -82.01 -17.78 45.64 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.988 -0.685 . . . . 1.0600000000000001 111.518 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.588 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.0 m-80 -146.64 81.5 9.23 Favored Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-O 121.246 0.546 . . . . 0.23000000000000001 110.754 -173.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 14.8 Cg_endo -55.81 -11.78 5.78 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 124.098 3.199 . . . . 0.52000000000000002 113.401 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m -78.89 -17.52 55.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.801 0.334 . . . . 1.6499999999999999 111.834 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.588 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 58.1 mt -75.36 -31.8 60.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.333 0.587 . . . . 1.25 112.072 -171.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.408 ' NE2' ' HB1' ' A' ' 38' ' ' ALA . 1.7 pp0? -62.4 -45.53 92.7 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 122.755 1.264 . . . . 2.52 110.772 -172.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.408 ' HB1' ' NE2' ' A' ' 37' ' ' GLN . . . -63.41 -48.53 77.45 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 111.893 -2.412 . . . . 1.1899999999999999 110.749 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.13 -179.57 48.74 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 114.78 -1.1 . . . . 0.44 111.255 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.439 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -109.88 156.37 20.49 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.135 0.493 . . . . 1.1699999999999999 110.789 178.414 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 31.3 m -137.26 129.76 29.9 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.348 -0.842 . . . . 1.1499999999999999 110.491 -175.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.11 123.36 26.28 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.403 0.62 . . . . 1.1200000000000001 110.235 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.53 0.18 62.93 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.272 -1.131 . . . . 0.44 110.272 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.611 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.1 tt0 -74.05 124.12 25.66 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.644 -0.778 . . . . 1.3 109.87 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 53.9 p -82.39 128.92 34.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.804 0.811 . . . . 1.3200000000000001 109.876 176.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.596 HG13 ' HB3' ' A' ' 7' ' ' TYR . 7.6 pt -128.55 141.38 46.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.57 -1.195 . . . . 1.0700000000000001 109.428 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.39 151.69 3.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.128 0.489 . . . . 1.3 111.048 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.6 mm -114.99 91.98 28.92 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.638 -1.164 . . . . 1.03 109.05 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.476 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 1.7 Cg_endo -59.59 134.39 57.67 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.738 2.292 . . . . 0.20000000000000001 112.778 -174.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.62 -6.74 80.14 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.893 -1.048 . . . . 0.26000000000000001 112.156 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.761 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.5 tp -124.74 116.13 26.47 Favored Pre-proline 0 N--CA 1.446 -0.63 0 CA-C-O 121.404 0.621 . . . . 1.27 111.504 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.619 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 59.0 Cg_endo -79.71 -176.09 3.06 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.14 3.227 . . . . 0.31 114.208 -172.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.46 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 17.7 t70 -81.14 130.5 62.62 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 114.225 -1.352 . . . . 0.48999999999999999 112.879 -169.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 40.1 Cg_endo -73.0 -14.98 26.28 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.852 3.035 . . . . 0.48999999999999999 113.134 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 80.2 m-85 -96.13 -8.6 32.83 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.902 -0.59 . . . . 1.8 111.427 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.46 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 24.7 p -86.49 -20.39 28.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.784 -1.191 . . . . 1.1299999999999999 107.784 172.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.525 HG23 ' H ' ' A' ' 59' ' ' TYR . 24.6 mt -76.73 129.13 80.07 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 112.912 -1.949 . . . . 1.24 111.036 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.38 -13.05 12.49 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.538 2.159 . . . . 0.47999999999999998 113.63 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.525 ' H ' HG23 ' A' ' 57' ' ' ILE . 62.7 m-85 -96.11 164.61 12.61 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.498 -0.481 . . . . 0.94999999999999996 111.786 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -154.09 130.65 10.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.852 -0.796 . . . . 3.7400000000000002 108.852 177.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 71' ' ' THR . 72.8 mt -112.06 136.75 47.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.155 -0.475 . . . . 1.05 111.607 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.25 116.84 27.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.926 -0.71 . . . . 1.0800000000000001 111.223 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.8 t -96.04 113.6 30.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.565 0.698 . . . . 1.04 110.777 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 68' ' ' LYS . 22.2 m -90.89 104.0 16.64 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.943 -1.026 . . . . 0.83999999999999997 110.45 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.479 HG22 HH11 ' A' ' 167' ' ' ARG . 50.5 mm -53.44 -58.54 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 122.262 1.03 . . . . 1.0600000000000001 111.208 168.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.16 -10.13 3.62 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 112.699 -2.046 . . . . 0.16 113.521 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -126.88 -18.02 4.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.596 0.758 . . . . 1.02 112.17 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 59.07 54.53 4.9 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.219 0.463 . . . . 1.3 111.078 -172.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 64' ' ' SER . 41.6 p -136.85 167.71 20.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 112.707 0.632 . . . . 0.98999999999999999 112.707 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.451 ' CD2' HD22 ' A' ' 153' ' ' LEU . 8.0 tt -135.84 112.76 10.28 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.729 -1.123 . . . . 1.1799999999999999 110.0 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 22.1 m -93.07 123.31 36.24 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.157 0.504 . . . . 1.04 110.781 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' ' HB2' ' A' ' 79' ' ' MET . 16.1 tp -99.95 106.51 18.32 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.298 -0.864 . . . . 1.3200000000000001 109.125 172.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 83.4 p -105.44 161.46 14.31 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 119.234 -0.986 . . . . 1.05 110.498 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.585 HD11 ' ND2' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -125.61 125.33 42.98 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.657 -0.868 . . . . 1.1000000000000001 108.657 168.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.585 ' ND2' HD11 ' A' ' 74' ' ' LEU . 9.2 p30 41.98 53.03 4.27 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.769 -1.56 . . . . 1.97 112.126 -165.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 46.8 m-80 75.24 -9.53 1.38 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.02 -0.991 . . . . 2.5499999999999998 112.226 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HD2' ' C ' ' A' ' 77' ' ' ARG . 7.7 tmm_? -97.16 121.84 39.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.037 0.446 . . . . 4.0199999999999996 109.903 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 55.7 t -58.4 131.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 122.39 1.091 . . . . 1.0600000000000001 112.806 -175.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.526 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -100.91 -45.84 5.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 113.116 -1.856 . . . . 1.47 109.112 178.419 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -159.95 173.19 16.28 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.039 -1.892 . . . . 1.98 110.214 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -149.67 123.45 9.27 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.172 -1.376 . . . . 1.0 109.458 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -112.86 148.64 39.79 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.897 -0.592 . . . . 1.3999999999999999 109.734 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.433 ' HB2' HG23 ' A' ' 134' ' ' ILE . 32.7 Cg_endo -74.5 142.71 29.91 Favored 'Trans proline' 0 CA--C 1.498 -1.32 0 C-N-CA 122.231 1.954 . . . . 0.23999999999999999 110.938 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.516 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.67 172.77 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-N 115.777 -0.647 . . . . 1.04 110.761 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.929 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.16 137.6 52.87 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.762 0.315 . . . . 1.03 110.188 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.457 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 10.7 m -120.88 127.75 75.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.6 0.714 . . . . 1.26 111.776 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.19 151.48 28.52 Favored Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 110.067 -1.213 . . . . 0.20000000000000001 110.067 171.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.47 4.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.262 0.838 . . . . 3.48 113.262 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.534 HG12 ' CB ' ' A' ' 122' ' ' HIS . 1.1 tp -90.81 -19.12 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.385 0.612 . . . . 1.0700000000000001 110.158 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.7 mm? -86.89 -17.47 33.19 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.687 -0.857 . . . . 1.02 108.687 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.1 p -69.38 -16.1 63.45 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.369 -1.287 . . . . 1.05 111.345 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -69.95 -37.76 75.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.859 -1.064 . . . . 2.0299999999999998 112.845 -175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.517 HG21 HG21 ' A' ' 95' ' ' THR . 1.5 m -107.33 127.51 27.75 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 119.746 -0.782 . . . . 1.1499999999999999 111.161 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -89.41 -14.19 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.727 2.284 . . . . 1.04 113.172 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.517 HG21 HG21 ' A' ' 93' ' ' THR . 6.3 t -90.33 -44.52 9.63 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.584 0.707 . . . . 1.1299999999999999 109.417 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.546 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 61.58 18.46 56.19 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 114.066 -1.425 . . . . 0.35999999999999999 113.979 168.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.4 111.33 19.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 122.206 1.003 . . . . 1.0800000000000001 109.593 -175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.66 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 26.6 m-85 -138.42 177.51 7.83 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.359 -1.746 . . . . 0.26000000000000001 111.279 -171.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.426 ' CG ' HD12 ' A' ' 5' ' ' LEU . 39.8 m-85 -140.98 137.38 33.0 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.135 0.493 . . . . 0.78000000000000003 110.765 -173.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.543 HD13 ' HB ' ' A' ' 161' ' ' THR . 78.8 mt -63.01 114.62 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-N 115.185 -0.916 . . . . 1.02 110.268 170.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.564 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.4 pt -83.33 -45.43 18.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 113.367 0.877 . . . . 1.03 113.367 -175.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -168.75 165.88 11.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.0 -1.482 . . . . 2.0299999999999998 107.0 -169.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.652 ' NH1' ' HA ' ' A' ' 154' ' ' ALA . 51.9 mtt-85 -132.1 155.68 47.68 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.902 -0.719 . . . . 2.02 112.408 -168.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.507 ' NE2' ' HB3' ' A' ' 107' ' ' PRO . 51.6 tt0 -137.62 102.27 4.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.359 0.599 . . . . 0.83999999999999997 110.808 176.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.473 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 46.8 ttp180 -62.76 166.18 5.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.952 -1.022 . . . . 3.2799999999999998 111.279 174.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.774 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 28.7 m-80 -35.93 101.31 0.21 Allowed Pre-proline 0 C--O 1.232 0.158 0 C-N-CA 125.802 1.641 . . . . 0.34999999999999998 113.122 -159.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.507 ' HB3' ' NE2' ' A' ' 104' ' ' GLN . 24.1 Cg_endo -69.43 -49.6 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.499 2.799 . . . . 0.63 113.604 176.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.32 -33.06 4.3 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.67000000000000004 111.54 -175.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.2 -172.61 2.76 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.956 -0.622 . . . . 0.77000000000000002 112.589 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.497 ' O ' ' HA ' ' A' ' 128' ' ' THR . 35.9 Cg_endo -56.65 -14.21 12.74 Favored 'Trans proline' 0 N--CA 1.475 0.441 0 C-N-CA 124.207 3.271 . . . . 1.1499999999999999 113.13 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' A' ' 115' ' ' TRP . 5.8 m-30 -65.82 -37.9 87.47 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 107.573 -1.269 . . . . 1.5900000000000001 107.573 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.542 ' O ' ' HB1' ' A' ' 113' ' ' ALA . . . 58.99 23.69 57.35 Favored Glycine 0 CA--C 1.491 -1.444 0 CA-C-N 113.21 -1.814 . . . . 1.6899999999999999 117.177 160.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.774 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . . . 173.35 -48.37 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 118.341 1.071 . . . . 1.1699999999999999 110.18 -177.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.657 ' HD1' ' CD2' ' A' ' 114' ' ' TYR . 0.7 OUTLIER -162.99 154.28 17.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.457 -0.338 . . . . 0.60999999999999999 110.169 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 111' ' ' PHE . 7.6 t-105 -132.09 104.68 6.94 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.687 -1.227 . . . . 0.56999999999999995 107.687 165.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.651 HD23 ' NH1' ' A' ' 103' ' ' ARG . 5.0 mt -100.11 114.83 28.48 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.57 -0.706 . . . . 1.3600000000000001 109.859 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 101' ' ' ILE . 43.6 m -81.81 143.28 31.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.817 -0.629 . . . . 0.42999999999999999 110.901 -170.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.558 ' N ' HD21 ' A' ' 118' ' ' LEU . 1.4 mm? -108.02 164.88 11.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.535 -0.757 . . . . 1.02 110.416 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.1 p -65.13 -5.18 6.05 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.985 0.803 . . . . 1.79 112.72 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.695 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 4.2 tmtm? -127.41 129.42 47.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.111 0.958 . . . . 1.8100000000000001 109.849 166.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.695 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.0 mt-30 -37.2 -47.75 0.81 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 112.249 -2.25 . . . . 1.76 113.903 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.534 ' CB ' HG12 ' A' ' 89' ' ' ILE . 58.0 m80 -96.33 3.23 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.849 -0.614 . . . . 3.2000000000000002 111.915 -170.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.564 ' CD1' ' HB3' ' A' ' 120' ' ' LYS . 2.5 m-30 -92.99 -35.48 13.26 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.807 0.813 . . . . 0.83999999999999997 111.946 -173.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.465 ' HA2' HD21 ' A' ' 118' ' ' LEU . . . -10.46 131.01 0.01 OUTLIER Glycine 0 C--N 1.298 -1.58 0 N-CA-C 119.392 2.517 . . . . 0.96999999999999997 119.392 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.656 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -100.54 117.5 45.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 112.449 -1.876 . . . . 1.04 110.366 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.755 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 33.6 p80 -145.83 -176.79 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.318 0.488 . . . . 0.20999999999999999 112.318 -175.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.94 -167.72 37.63 Favored Glycine 0 C--O 1.22 -0.759 0 C-N-CA 121.22 -0.514 . . . . 0.34999999999999998 111.86 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 110' ' ' PRO . 9.2 t -160.76 166.51 28.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 117.796 0.798 . . . . 1.1100000000000001 110.704 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -116.53 0.19 12.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.831 0.824 . . . . 2.1899999999999999 109.288 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -126.03 89.21 52.82 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.39 -1.277 . . . . 1.8400000000000001 108.819 170.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -72.19 -20.75 24.4 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.753 2.302 . . . . 0.39000000000000001 114.008 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.96 -5.48 48.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.21 -0.45 . . . . 1.0800000000000001 111.008 -175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -91.29 -2.48 57.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.08 -0.509 . . . . 1.9399999999999999 110.016 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.433 HG23 ' HB2' ' A' ' 83' ' ' PRO . 38.8 mm -78.55 137.61 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-N 115.872 -0.604 . . . . 1.04 109.934 176.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.7 3.16 68.91 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.151 -1.18 . . . . 0.16 110.151 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.41 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 21.3 mtpt -113.74 169.07 9.25 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 123.223 1.487 . . . . 3.0299999999999998 114.395 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.16 126.59 46.44 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 111.509 -2.587 . . . . 1.01 107.946 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.417 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -123.47 159.44 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.541 -0.911 . . . . 1.3400000000000001 108.541 -174.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.1 m -48.08 -59.87 3.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.763 0.653 . . . . 0.87 112.763 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -132.13 -44.46 0.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 118.446 -1.302 . . . . 2.5499999999999998 114.033 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.69 133.92 0.21 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 117.464 1.746 . . . . 0.19 117.464 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.544 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 3.0 p -70.78 165.41 23.17 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 112.734 -1.733 . . . . 0.20000000000000001 111.956 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.929 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.8 mt -60.87 99.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.386 -1.279 . . . . 1.1299999999999999 112.154 -162.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.755 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 42.7 mtt180 -86.48 143.32 27.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.317 -1.311 . . . . 2.3300000000000001 110.161 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.516 ' HG2' HG21 ' A' ' 84' ' ' ILE . 20.8 mtp -118.97 -168.98 1.65 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.851 -0.796 . . . . 1.0900000000000001 108.851 173.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.53 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 81.8 m-70 -83.77 155.67 22.93 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.747 -0.835 . . . . 2.9900000000000002 108.747 167.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.686 ' O ' HD12 ' A' ' 151' ' ' ILE . 9.2 m120 -65.02 -44.16 90.09 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 118.283 -0.865 . . . . 0.73999999999999999 110.999 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -66.06 -25.46 67.04 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 121.902 2.137 . . . . 2.6899999999999999 112.068 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.53 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 37.8 m-20 -86.79 -35.4 19.15 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.235 -0.438 . . . . 0.68999999999999995 111.188 -174.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 147' ' ' ASN . 11.8 p -67.98 -21.91 27.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 1.02 110.747 172.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.686 HD12 ' O ' ' A' ' 147' ' ' ASN . 1.6 mp -83.08 -40.97 16.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.667 -0.494 . . . . 1.1699999999999999 109.667 170.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -47.14 -70.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.203 0.91 . . . . 1.99 112.428 168.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.475 HD23 ' SD ' ' A' ' 145' ' ' MET . 7.3 mp -49.86 -30.75 10.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.594 0.711 . . . . 1.9099999999999999 111.529 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.652 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -67.5 -41.22 84.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.805 -1.089 . . . . 1.04 111.528 176.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.0 t -85.13 -37.66 19.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.789 0.663 . . . . 0.88 112.789 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.58 -60.23 2.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.613 0.721 . . . . 1.0 111.377 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.609 HG21 HH22 ' A' ' 103' ' ' ARG . 3.8 m -92.06 145.81 31.58 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.0 -1.0 . . . . 1.0700000000000001 112.126 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.444 ' C ' HH21 ' A' ' 103' ' ' ARG . 50.4 Cg_endo -89.86 172.62 3.76 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 124.466 3.444 . . . . 0.23999999999999999 111.175 173.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -66.4 161.65 22.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 118.689 -1.204 . . . . 1.1000000000000001 109.897 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.51 -17.11 59.86 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.561 -0.828 . . . . 0.17999999999999999 111.825 -172.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.543 ' HB ' HD13 ' A' ' 100' ' ' ILE . 67.2 m -67.45 139.44 57.07 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.457 -0.571 . . . . 1.05 109.457 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.2 117.89 30.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.571 1.176 . . . . 4.1100000000000003 111.022 -168.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.2 t -104.03 109.66 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 112.316 -2.22 . . . . 1.02 109.358 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.495 HG23 ' ND2' ' A' ' 166' ' ' ASN . 32.6 m -95.71 107.68 19.92 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.727 0.64 . . . . 1.0700000000000001 112.727 -172.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.546 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mp -80.54 108.77 14.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 122.039 0.923 . . . . 1.05 109.855 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.495 ' ND2' HG23 ' A' ' 164' ' ' THR . 38.6 m-80 -110.97 124.46 52.18 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.489 -1.232 . . . . 1.0900000000000001 109.796 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.479 HH11 HG22 ' A' ' 65' ' ' ILE . 15.6 mmm180 -70.28 -19.23 63.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.244 0.545 . . . . 2.4900000000000002 110.192 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.89 173.69 21.32 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.434 -0.803 . . . . 1.97 112.504 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 C--N 1.331 -0.206 0 O-C-N 123.999 0.47 . . . . 4.3300000000000001 110.95 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.992 -0.443 . . . . 3.3399999999999999 111.992 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -145.48 144.87 30.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.983 0.42 . . . . 4.9199999999999999 110.515 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.8 106.77 16.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.098 -0.501 . . . . 3.1000000000000001 109.884 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 tp -101.4 172.53 6.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.296 0.57 . . . . 1.3300000000000001 111.555 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.685 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.7 tt -95.54 126.74 41.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.049 -0.978 . . . . 1.0700000000000001 110.258 -175.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.07 161.47 13.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.055 0.931 . . . . 1.03 112.632 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.649 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 90.6 t80 -130.74 139.8 50.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.935 -1.484 . . . . 1.0800000000000001 107.83 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -112.66 112.8 24.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.131 -1.063 . . . . 0.93000000000000005 108.131 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.582 HG11 ' HB2' ' A' ' 13' ' ' ASP . 98.4 t -67.09 149.46 11.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 122.395 1.093 . . . . 1.1000000000000001 113.169 -169.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -103.24 158.85 16.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 113.369 -1.741 . . . . 2.4399999999999999 108.718 174.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -62.85 104.26 0.53 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.198 0.523 . . . . 2.4300000000000002 112.308 -173.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.29 11.29 36.73 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.848 -0.692 . . . . 0.51000000000000001 113.356 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.582 ' HB2' HG11 ' A' ' 9' ' ' VAL . 83.9 m-20 -53.58 170.67 0.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.978 0.389 . . . . 1.46 111.307 172.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.452 ' HG1' ' CB ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -129.3 153.21 48.05 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.296 0.569 . . . . 1.1599999999999999 111.558 176.169 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.493 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.38 -35.03 79.72 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.33 -0.989 . . . . 1.47 108.33 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.46 ' HA ' HG23 ' A' ' 26' ' ' THR . 65.0 t30 -88.96 -25.89 21.81 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.916 -1.038 . . . . 1.78 111.438 -176.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.452 ' CB ' ' HG1' ' A' ' 14' ' ' THR . 90.3 p -68.17 -36.9 80.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.902 -0.719 . . . . 1.74 109.674 174.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.1 mt -75.62 -28.19 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.164 0.507 . . . . 1.04 110.023 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.583 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.59 -10.05 59.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.539 -0.301 . . . . 1.0600000000000001 110.872 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.592 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.71 -39.49 9.45 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.607 1.194 . . . . 0.97999999999999998 108.38 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 119' ' ' SER . 10.0 m-20 -62.19 -45.79 91.81 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.453 -2.158 . . . . 0.53000000000000003 111.856 172.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.568 ' C ' HD11 ' A' ' 101' ' ' ILE . 63.2 m-85 -97.2 5.12 50.66 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.681 -1.208 . . . . 0.20000000000000001 111.602 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.5 mpt_? 54.15 43.29 30.87 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.776 0.798 . . . . 2.46 109.891 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.583 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.0 pt -116.19 -165.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.535 -1.211 . . . . 1.04 109.771 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.87 143.02 38.62 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.177 -0.919 . . . . 1.3400000000000001 109.992 174.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.596 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 69.4 p -71.75 -32.19 67.44 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.759 -1.2 . . . . 1.0900000000000001 107.759 177.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.98 -32.2 70.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.277 -0.874 . . . . 1.0700000000000001 112.008 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -90.5 -25.94 20.02 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.657 0.741 . . . . 1.04 109.112 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.633 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 17.2 tp -75.55 -26.19 57.77 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.999 -1.001 . . . . 1.8100000000000001 109.361 173.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 26' ' ' THR . 30.7 mt -77.49 -31.71 53.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.792 0.806 . . . . 1.6399999999999999 109.67 171.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 45.0 tt0 -64.05 -41.13 97.49 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.282 -1.326 . . . . 2.3300000000000001 110.034 174.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.436 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -84.18 -20.64 32.04 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 120.118 -0.633 . . . . 1.0600000000000001 111.633 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.578 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 27.0 m-80 -147.11 80.69 9.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.46 0.648 . . . . 0.23000000000000001 110.64 -172.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 23.7 Cg_endo -58.97 -5.79 3.02 Favored 'Trans proline' 0 C--N 1.326 -0.644 0 C-N-CA 124.372 3.382 . . . . 0.52000000000000002 114.145 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 t -84.7 -23.31 29.41 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.215 -0.303 . . . . 1.6499999999999999 111.025 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.633 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 52.4 mt -67.01 -35.36 79.76 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.841 0.829 . . . . 1.25 111.632 -172.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -65.33 -46.72 79.17 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 114.239 -1.346 . . . . 2.52 110.298 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.55 -50.86 71.73 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 111.905 -2.407 . . . . 1.1899999999999999 110.282 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.56 177.95 48.55 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 114.742 -1.117 . . . . 0.44 111.656 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -109.59 157.63 18.84 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.349 0.595 . . . . 1.1699999999999999 111.235 179.229 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.606 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 82.6 m -140.35 128.64 22.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.141 -0.936 . . . . 1.1499999999999999 110.601 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 11' ' ' GLN . . . -76.16 120.07 20.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.449 0.642 . . . . 1.1200000000000001 110.234 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.26 0.05 57.09 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.181 -1.168 . . . . 0.44 110.181 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.606 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.8 tt0 -74.31 123.7 25.07 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.758 -0.721 . . . . 1.3 109.599 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 34.4 p -85.37 125.93 33.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.646 0.736 . . . . 1.3200000000000001 110.596 177.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.582 HG13 ' HB3' ' A' ' 7' ' ' TYR . 9.6 pt -125.63 143.59 38.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.393 -1.276 . . . . 1.0700000000000001 109.554 -176.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.24 150.99 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-O 121.113 0.482 . . . . 1.3 111.124 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.416 HG22 ' CD2' ' A' ' 22' ' ' PHE . 38.7 mm -115.86 92.87 35.98 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.643 -1.162 . . . . 1.03 109.147 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.507 ' HA ' HD23 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -58.16 135.41 68.19 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.847 2.365 . . . . 0.20000000000000001 112.819 -175.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.19 -6.0 81.26 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 114.992 -1.004 . . . . 0.26000000000000001 112.515 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.642 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 25.6 tp -126.74 119.87 22.82 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-O 120.972 0.415 . . . . 1.27 111.395 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.685 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 58.9 Cg_endo -80.89 178.69 6.66 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.438 2.759 . . . . 0.31 113.923 -172.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.521 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 12.9 t70 -75.17 131.8 77.73 Favored Pre-proline 0 N--CA 1.443 -0.819 0 CA-C-N 114.255 -1.339 . . . . 0.48999999999999999 111.646 -173.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HB2' ' HB3' ' A' ' 162' ' ' ARG . 60.5 Cg_endo -74.13 -16.73 22.42 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.415 2.743 . . . . 0.48999999999999999 113.02 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -96.53 -2.68 44.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.35 0.595 . . . . 1.8 111.169 -176.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.521 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 17.2 p -93.37 -14.54 26.72 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.493 -0.928 . . . . 1.1299999999999999 108.493 173.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.621 HG23 ' H ' ' A' ' 59' ' ' TYR . 7.9 mm -64.05 129.21 93.82 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 113.633 -1.621 . . . . 1.24 109.873 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 51.4 Cg_endo -73.08 -19.12 23.28 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.017 1.811 . . . . 0.47999999999999998 112.852 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.621 ' H ' HG23 ' A' ' 57' ' ' ILE . 41.0 m-85 -107.36 161.67 14.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.871 0.367 . . . . 0.94999999999999996 111.548 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -145.8 140.32 27.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.761 -0.829 . . . . 3.7400000000000002 108.761 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.684 ' HA ' ' O ' ' A' ' 71' ' ' THR . 88.1 mt -119.3 133.02 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.306 -0.407 . . . . 1.05 112.083 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.53 116.54 27.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.963 -0.695 . . . . 1.0800000000000001 111.014 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 69' ' ' THR . 85.5 t -95.12 115.68 34.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.684 0.754 . . . . 1.04 110.703 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.527 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 44.1 m -89.66 109.81 20.75 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.119 -0.946 . . . . 0.83999999999999997 110.85 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.471 ' CG1' ' HA ' ' A' ' 167' ' ' ARG . 23.3 mm -55.5 -60.21 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.186 0.993 . . . . 1.0600000000000001 110.844 164.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.83 -13.63 6.55 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 112.722 -2.036 . . . . 0.16 113.52 -175.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 64' ' ' SER . . . -126.66 -16.92 5.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 118.659 -0.686 . . . . 1.02 112.515 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.595 ' HZ1' ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 57.21 54.62 6.61 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.202 0.91 . . . . 1.3 111.527 -174.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 40.9 p -138.05 164.91 27.91 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.816 0.673 . . . . 0.98999999999999999 112.816 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.4 HD21 ' C ' ' A' ' 70' ' ' LEU . 7.7 tt -132.67 113.14 12.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.023 -0.989 . . . . 1.1799999999999999 110.093 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 38.4 m -92.89 123.69 36.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.992 0.425 . . . . 1.04 111.219 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 79' ' ' MET . 12.7 tp -98.59 106.61 18.91 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.498 -0.774 . . . . 1.3200000000000001 108.948 170.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 78.5 p -106.93 160.02 15.83 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 119.28 -0.968 . . . . 1.05 110.85 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.56 HD11 ' ND2' ' A' ' 75' ' ' ASN . 1.1 tm? -127.16 126.44 42.87 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.211 -0.663 . . . . 1.1000000000000001 109.211 171.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.56 ' ND2' HD11 ' A' ' 74' ' ' LEU . 7.8 p30 39.13 56.17 2.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 113.991 -1.459 . . . . 1.97 111.998 -166.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.3 m-80 74.76 -8.97 1.42 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.144 -0.935 . . . . 2.5499999999999998 112.429 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -101.57 119.45 38.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.012 0.434 . . . . 4.0199999999999996 110.296 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 50.8 t -55.04 131.64 18.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 122.444 1.116 . . . . 1.0600000000000001 112.54 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.524 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 67.8 mmm -96.81 -47.82 5.71 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 113.315 -1.766 . . . . 1.47 108.28 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -161.08 172.44 16.81 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 112.703 -2.044 . . . . 1.98 110.169 -176.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -149.5 125.42 10.57 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 113.973 -1.467 . . . . 1.0 109.532 173.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -117.28 150.54 46.52 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.087 -0.506 . . . . 1.3999999999999999 110.565 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HB2' HG23 ' A' ' 134' ' ' ILE . 37.5 Cg_endo -73.73 142.71 32.58 Favored 'Trans proline' 0 CA--C 1.495 -1.473 0 C-N-CA 122.351 2.034 . . . . 0.23999999999999999 111.201 176.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.538 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.72 173.34 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.452 -0.795 . . . . 1.04 110.433 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.908 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.61 143.74 45.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.927 -0.309 . . . . 1.03 110.167 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.458 HG23 ' HG3' ' A' ' 68' ' ' LYS . 11.4 m -125.99 125.83 68.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.583 0.706 . . . . 1.26 111.354 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -85.28 155.65 29.97 Favored Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 109.58 -1.408 . . . . 0.20000000000000001 109.58 171.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -57.6 4.9 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.224 0.824 . . . . 3.48 113.224 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 122' ' ' HIS . 1.1 tp -87.02 -20.02 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 121.437 -0.789 . . . . 1.0700000000000001 109.684 178.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.6 mm? -89.44 -20.99 23.24 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.634 -0.876 . . . . 1.02 108.634 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.7 p -66.49 -16.75 64.36 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.512 -1.222 . . . . 1.05 110.938 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -72.19 -32.64 66.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.472 -1.24 . . . . 2.0299999999999998 112.966 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -108.54 120.41 46.48 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.008 -0.677 . . . . 1.1499999999999999 110.359 178.061 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.431 ' HA ' ' NE ' ' A' ' 167' ' ' ARG . 4.2 Cg_exo -70.37 -23.59 27.82 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.803 2.336 . . . . 1.04 112.881 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -99.23 -41.36 7.52 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.514 -0.55 . . . . 1.1299999999999999 109.514 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.531 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 51.44 21.06 5.91 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.514 -1.221 . . . . 0.35999999999999999 114.336 169.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 164' ' ' THR . 12.8 pt-20 -85.05 116.99 23.75 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 122.608 1.194 . . . . 1.0800000000000001 110.05 -172.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 13.0 m-85 -137.92 -171.83 3.1 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.362 -1.744 . . . . 0.26000000000000001 111.442 -166.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.497 ' CG ' HD12 ' A' ' 5' ' ' LEU . 28.6 m-85 -143.84 137.92 28.3 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.76 0.314 . . . . 0.78000000000000003 110.776 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.597 HD13 ' HB ' ' A' ' 161' ' ' THR . 76.3 mt -65.21 119.07 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.745 -0.661 . . . . 1.02 110.529 170.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.568 HD11 ' C ' ' A' ' 22' ' ' PHE . 23.3 pt -88.14 -32.85 6.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.028 0.751 . . . . 1.03 113.028 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.591 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 11.9 p30 179.27 179.3 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.846 -1.168 . . . . 2.0299999999999998 107.846 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.595 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 22.9 mtt180 -127.63 160.62 31.06 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.675 -0.81 . . . . 2.02 111.877 -175.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.48 HE21 ' HB3' ' A' ' 107' ' ' PRO . 54.7 tt0 -135.7 98.96 4.05 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.112 -0.949 . . . . 0.83999999999999997 109.665 171.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.482 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 40.4 ttp180 -65.74 164.98 13.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.427 -0.806 . . . . 3.2799999999999998 110.555 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.751 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 30.0 m-80 -36.05 101.28 0.21 Allowed Pre-proline 0 N--CA 1.461 0.098 0 C-N-CA 125.141 1.377 . . . . 0.34999999999999998 112.334 -158.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.48 ' HB3' HE21 ' A' ' 104' ' ' GLN . 15.7 Cg_endo -64.5 -49.07 3.65 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.027 2.484 . . . . 0.63 113.1 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.8 -33.31 3.95 Favored Glycine 0 CA--C 1.506 -0.507 0 N-CA-C 110.851 -0.9 . . . . 0.67000000000000004 110.851 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.02 -173.29 3.69 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 114.771 -0.714 . . . . 0.77000000000000002 112.412 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -55.82 -15.71 13.76 Favored 'Trans proline' 0 C--O 1.222 -0.296 0 C-N-CA 124.062 3.175 . . . . 1.1499999999999999 113.151 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -64.38 -41.4 96.7 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.36 -0.978 . . . . 1.5900000000000001 108.36 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 60.06 28.48 66.46 Favored Glycine 0 CA--C 1.495 -1.168 0 N-CA-C 116.905 1.522 . . . . 1.6899999999999999 116.905 160.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.751 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . . . 175.85 -60.36 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 118.311 1.056 . . . . 1.1699999999999999 109.565 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.482 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 1.5 m-85 -161.27 152.26 18.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.911 -0.586 . . . . 0.60999999999999999 110.109 -176.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 6.2 t-105 -129.48 99.15 5.08 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.019 -1.474 . . . . 0.56999999999999995 107.019 164.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.482 HD21 ' HG2' ' A' ' 103' ' ' ARG . 5.9 mt -90.71 114.03 26.26 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.234 -1.025 . . . . 1.3600000000000001 108.234 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.417 ' C ' HG12 ' A' ' 101' ' ' ILE . 19.4 m -83.68 143.88 29.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.772 -0.649 . . . . 0.42999999999999999 111.023 -166.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.767 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 3.1 mm? -108.88 165.1 11.82 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.102 -0.499 . . . . 1.02 111.445 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.5 t -60.36 -10.96 5.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.632 -1.167 . . . . 1.79 112.609 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.731 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.8 tmtm? -127.31 132.13 50.34 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.504 -0.478 . . . . 1.8100000000000001 109.885 171.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.731 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 21.5 mt-30 -35.25 -59.12 0.53 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 114.278 1.214 . . . . 1.76 114.278 -178.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.538 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -97.09 12.95 30.81 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.581 -0.848 . . . . 3.2000000000000002 111.852 -171.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.767 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.2 m-30 -98.67 38.46 1.36 Allowed 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 112.077 0.399 . . . . 0.83999999999999997 112.077 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.47 ' HA2' ' CD2' ' A' ' 118' ' ' LEU . . . -116.6 143.22 17.97 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 117.165 -2.445 . . . . 0.96999999999999997 112.523 -151.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -96.43 116.04 37.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 123.954 0.901 . . . . 1.04 110.934 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.636 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 31.2 p80 -146.65 -178.17 6.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.873 -0.603 . . . . 0.20999999999999999 112.16 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.23 -167.62 37.18 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 111.733 -0.547 . . . . 0.34999999999999998 111.733 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.6 t -162.73 167.97 22.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.878 0.839 . . . . 1.1100000000000001 110.391 -175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -113.29 -8.51 13.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.646 -0.872 . . . . 2.1899999999999999 108.646 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -120.32 88.11 41.47 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 114.874 -1.057 . . . . 1.8400000000000001 108.856 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -71.91 -21.81 24.08 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.979 2.453 . . . . 0.39000000000000001 114.294 -167.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.57 -1.93 29.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.0 0.428 . . . . 1.0800000000000001 111.253 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 20.1 m -90.26 -5.77 55.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.021 -0.536 . . . . 1.9399999999999999 109.964 172.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 83' ' ' PRO . 34.3 mm -77.44 131.3 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.181 -0.463 . . . . 1.04 110.486 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.01 3.51 60.47 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.235 -1.146 . . . . 0.16 110.235 -175.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.442 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 56.9 mttt -114.81 168.72 9.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 122.982 1.373 . . . . 3.0299999999999998 114.207 -176.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.17 127.24 45.11 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 112.011 -2.359 . . . . 1.01 107.759 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.456 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -123.6 160.79 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.5 -0.926 . . . . 1.3400000000000001 108.5 -175.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.7 m -49.1 -59.83 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.639 0.607 . . . . 0.87 112.639 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.74 -44.86 0.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 118.464 -1.295 . . . . 2.5499999999999998 114.131 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.24 134.36 0.17 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 117.193 1.637 . . . . 0.19 117.193 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.489 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 2.4 p -72.25 165.55 24.21 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 112.735 -1.732 . . . . 0.20000000000000001 112.002 -178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.908 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 46.4 mt -60.55 96.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 122.384 1.087 . . . . 1.1299999999999999 112.208 -162.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.636 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 68.0 mtt180 -83.63 147.23 27.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.889 -1.505 . . . . 2.3300000000000001 109.726 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.538 ' HG2' HG21 ' A' ' 84' ' ' ILE . 12.0 mtp -123.8 -169.9 2.03 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.407 -0.96 . . . . 1.0900000000000001 108.407 171.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.441 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 41.1 m80 -82.37 161.74 22.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.944 -0.762 . . . . 2.9900000000000002 108.944 168.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.624 ' HB3' ' HB3' ' A' ' 113' ' ' ALA . 13.4 m120 -66.94 -41.65 86.62 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 118.232 -0.89 . . . . 0.73999999999999999 110.805 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -69.66 -29.05 66.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 121.301 1.864 . . . . 2.6899999999999999 112.021 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 64.3 m-20 -76.31 -45.23 33.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.379 0.609 . . . . 0.68999999999999995 109.822 -174.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 147' ' ' ASN . 7.6 p -64.16 -25.04 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 114.819 -1.082 . . . . 1.02 111.562 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.542 HD13 ' O ' ' A' ' 147' ' ' ASN . 19.4 mt -83.41 -43.31 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 118.893 -0.575 . . . . 1.1699999999999999 111.538 174.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 156' ' ' ILE . 20.3 mt-10 -46.41 -70.39 0.1 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.529 1.058 . . . . 1.99 112.644 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.2 mt -45.79 -39.69 8.66 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.698 0.761 . . . . 1.9099999999999999 111.556 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.461 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . . . -61.22 -32.29 72.07 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.114 -1.403 . . . . 1.04 111.951 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.1 t -87.84 -30.81 19.91 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.511 -0.743 . . . . 0.88 112.198 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 152' ' ' GLU . 38.0 mt -82.91 -59.42 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.547 0.689 . . . . 1.0 111.747 -172.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 153' ' ' LEU . 5.4 m -88.39 139.81 30.14 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.73 -1.123 . . . . 1.0700000000000001 112.373 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.595 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 48.1 Cg_endo -88.87 173.89 4.06 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.324 3.349 . . . . 0.23999999999999999 111.118 174.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.591 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 60.9 m-20 -67.05 156.8 35.13 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 119.214 -0.994 . . . . 1.1000000000000001 108.687 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 54' ' ' PRO . . . 97.02 -20.85 49.18 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.833 -1.175 . . . . 0.17999999999999999 111.921 -173.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.597 ' HB ' HD13 ' A' ' 100' ' ' ILE . 85.8 m -59.82 128.9 39.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.724 -0.843 . . . . 1.05 108.724 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.468 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -93.32 123.45 36.62 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 122.809 1.29 . . . . 4.1100000000000003 110.833 -167.612 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.18 112.13 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 112.365 -2.198 . . . . 1.02 110.023 -171.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 97' ' ' GLU . 16.2 m -95.69 115.12 26.97 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.798 -0.761 . . . . 1.0700000000000001 112.202 -175.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.531 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mp -84.19 93.14 3.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.87 1.319 . . . . 1.05 109.421 172.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -93.0 125.32 37.53 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.262 -1.79 . . . . 1.0900000000000001 108.139 -175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.471 ' HA ' ' CG1' ' A' ' 65' ' ' ILE . 0.7 OUTLIER -68.99 -28.33 66.5 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.291 -0.563 . . . . 2.4900000000000002 110.697 -177.391 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 166.63 91.47 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.458 -0.877 . . . . 1.97 112.889 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 61.5 m . . . . . 0 C--N 1.322 -0.59 0 N-CA-C 110.071 -0.344 . . . . 4.3300000000000001 110.071 176.921 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.849 0 N-CA-C 112.276 -0.33 . . . . 3.3399999999999999 112.276 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -74.63 145.37 43.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.977 -0.379 . . . . 4.9199999999999999 109.977 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 3' ' ' LYS . 10.7 mtpp -87.74 123.56 32.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.873 -0.603 . . . . 3.1000000000000001 111.149 -172.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -105.76 174.07 6.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.847 -0.615 . . . . 1.3300000000000001 111.379 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.1 tt -95.94 128.68 43.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.091 -0.959 . . . . 1.0700000000000001 110.432 -175.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 161.29 13.85 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.084 0.945 . . . . 1.03 112.932 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.667 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 72.7 t80 -130.01 141.79 50.7 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.726 -1.579 . . . . 1.0800000000000001 108.071 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -114.01 112.2 22.88 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.863 -1.162 . . . . 0.93000000000000005 107.863 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.592 ' HB ' ' O ' ' A' ' 41' ' ' THR . 92.3 t -65.11 149.81 11.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 122.476 1.131 . . . . 1.1000000000000001 112.806 -170.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' HB3' ' HZ1' ' A' ' 10' ' ' LYS . 6.4 mtpm? -106.05 159.59 15.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.235 -1.802 . . . . 2.4399999999999999 108.6 173.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 108.02 0.99 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.071 0.462 . . . . 2.4300000000000002 111.949 -175.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.4 10.89 37.52 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.534 -0.757 . . . . 0.51000000000000001 113.283 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.547 ' HB2' HG11 ' A' ' 9' ' ' VAL . 91.5 m-20 -58.08 168.65 0.95 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.864 0.332 . . . . 1.46 110.765 172.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.66 153.61 49.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.577 0.703 . . . . 1.1599999999999999 112.011 174.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -68.2 -31.08 70.35 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.463 -1.244 . . . . 1.47 109.75 -176.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.431 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 65.3 t30 -93.34 -20.67 20.14 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.854 -1.066 . . . . 1.78 110.544 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.6 t -68.49 -43.22 77.35 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.152 -0.684 . . . . 1.74 109.152 171.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.426 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 17.2 mt -72.47 -25.84 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 121.354 0.597 . . . . 1.04 109.916 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.4 -9.91 59.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.401 -0.363 . . . . 1.0600000000000001 111.035 175.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.592 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.27 -38.87 9.51 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.677 1.227 . . . . 0.97999999999999998 107.982 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.6 m-20 -62.93 -49.16 75.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.255 -2.248 . . . . 0.53000000000000003 111.562 172.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.618 ' C ' HD11 ' A' ' 101' ' ' ILE . 63.5 m-85 -94.5 5.52 51.58 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.605 -1.238 . . . . 0.20000000000000001 111.527 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.0 mpt_? 53.4 44.51 29.92 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.661 0.744 . . . . 2.46 109.873 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.0 pt -116.2 -164.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 114.63 -1.168 . . . . 1.04 109.855 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.64 141.7 41.82 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.088 -0.96 . . . . 1.3400000000000001 110.137 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.548 ' HB ' ' CD1' ' A' ' 15' ' ' LEU . 67.0 p -72.67 -33.64 66.68 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.201 -1.037 . . . . 1.0900000000000001 108.201 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.46 68.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.981 -1.009 . . . . 1.0700000000000001 111.788 169.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -89.11 -27.88 20.45 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.955 -0.757 . . . . 1.04 108.955 -177.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.64 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.8 tp -74.76 -28.38 60.73 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.028 -0.987 . . . . 1.8100000000000001 109.461 175.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 26' ' ' THR . 55.9 mt -77.85 -30.47 51.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.785 0.802 . . . . 1.6399999999999999 109.86 172.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 39.4 tt0 -63.86 -41.47 97.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.29 -1.323 . . . . 2.3300000000000001 109.976 172.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.444 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -83.16 -22.08 33.38 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 121.91 -0.494 . . . . 1.0600000000000001 111.455 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.618 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 19.8 m-80 -150.11 98.34 3.33 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-O 121.26 0.553 . . . . 0.23000000000000001 109.75 -171.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 12.9 Cg_exo -79.67 -9.97 14.5 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.475 3.45 . . . . 0.52000000000000002 111.903 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -76.08 -25.78 55.84 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.852 -1.067 . . . . 1.6499999999999999 111.802 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.64 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 44.0 mt -65.04 -39.07 92.81 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.557 0.694 . . . . 1.25 112.103 -171.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -64.01 -46.27 85.24 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 122.917 1.342 . . . . 2.52 110.447 -173.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.98 83.62 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 111.808 -2.451 . . . . 1.1899999999999999 110.59 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.49 173.21 45.62 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 114.829 -1.078 . . . . 0.44 111.815 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.418 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -108.8 157.81 18.24 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.343 0.592 . . . . 1.1699999999999999 110.877 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.601 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 47.2 m -140.51 127.22 20.37 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.43 -0.804 . . . . 1.1499999999999999 110.912 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.71 118.85 18.14 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.291 0.567 . . . . 1.1200000000000001 109.931 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.48 -1.13 55.73 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.33 -1.108 . . . . 0.44 110.33 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.601 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -75.29 123.69 25.78 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.394 -0.595 . . . . 1.3 109.394 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 68.1 p -83.94 132.28 34.78 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.827 0.823 . . . . 1.3200000000000001 110.14 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.567 HG13 ' HB3' ' A' ' 7' ' ' TYR . 11.7 pt -132.11 142.83 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.235 -1.348 . . . . 1.0700000000000001 109.273 -177.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.39 150.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.17 0.51 . . . . 1.3 111.055 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.6 mm -114.36 91.72 25.09 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.694 -1.139 . . . . 1.03 109.056 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.52 ' HA ' HD23 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -58.41 135.93 71.04 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.907 2.405 . . . . 0.20000000000000001 112.756 -174.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.47 -5.95 82.42 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.889 -1.05 . . . . 0.26000000000000001 112.269 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.656 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.0 tp -125.41 116.95 25.12 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-O 121.207 0.527 . . . . 1.27 111.395 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.606 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 55.4 Cg_endo -79.25 -177.31 3.8 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.698 2.932 . . . . 0.31 114.075 -172.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.48 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 11.7 t70 -82.98 130.29 58.14 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.433 -1.258 . . . . 0.48999999999999999 112.089 -170.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.628 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 69.5 Cg_endo -75.23 -16.14 19.88 Favored 'Trans proline' 0 CA--C 1.52 -0.211 0 C-N-CA 123.49 2.793 . . . . 0.48999999999999999 112.867 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -95.3 0.3 53.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.752 0.787 . . . . 1.8 110.198 -172.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.48 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 20.2 p -96.97 -19.66 18.63 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 122.508 1.146 . . . . 1.1299999999999999 108.095 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.521 HG23 ' H ' ' A' ' 59' ' ' TYR . 20.5 mt -74.98 133.38 75.81 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 113.198 -1.819 . . . . 1.24 111.296 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.76 -15.5 12.05 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.561 2.174 . . . . 0.47999999999999998 113.742 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.521 ' H ' HG23 ' A' ' 57' ' ' ILE . 51.3 m-85 -100.81 158.34 16.04 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.542 -0.463 . . . . 0.94999999999999996 112.059 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -146.0 133.08 20.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.594 -0.891 . . . . 3.7400000000000002 108.594 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.9 mt -113.66 134.36 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.343 -0.39 . . . . 1.05 111.937 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.54 118.94 32.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.831 -0.748 . . . . 1.0800000000000001 111.473 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.8 t -96.99 116.01 38.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.825 0.822 . . . . 1.04 111.107 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 68' ' ' LYS . 27.7 m -95.68 103.12 14.99 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.754 -1.112 . . . . 0.83999999999999997 110.579 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.512 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.8 mm -51.02 -58.44 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.968 0.889 . . . . 1.0600000000000001 111.548 169.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.43 -12.51 4.6 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 112.782 -2.008 . . . . 0.16 113.208 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.31 -19.83 4.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.403 0.681 . . . . 1.02 112.554 -177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.83 57.99 3.42 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.552 0.615 . . . . 1.3 111.154 -172.225 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -138.57 163.76 31.2 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 112.969 0.729 . . . . 0.98999999999999999 112.969 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.5 tt -131.29 112.92 13.2 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.527 -1.215 . . . . 1.1799999999999999 110.041 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.647 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 23.4 m -92.06 122.95 35.04 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.243 0.544 . . . . 1.04 111.245 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.0 tp -99.43 103.29 15.06 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.1 -0.955 . . . . 1.3200000000000001 109.338 171.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 94.5 p -105.57 161.48 14.33 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.047 -1.061 . . . . 1.05 110.518 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.577 HD11 ' ND2' ' A' ' 75' ' ' ASN . 1.1 tm? -127.55 128.63 45.94 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.498 -0.927 . . . . 1.1000000000000001 108.498 169.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.577 ' ND2' HD11 ' A' ' 74' ' ' LEU . 8.4 p30 45.93 51.29 10.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.097 1.359 . . . . 1.97 111.48 -167.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 79.4 m-20 72.05 -13.62 0.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.587 -0.733 . . . . 2.5499999999999998 111.936 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 75' ' ' ASN . 20.1 tpt180 -96.67 119.07 34.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.309 0.576 . . . . 4.0199999999999996 109.934 -175.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 69.9 t -57.91 132.49 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.313 1.054 . . . . 1.0600000000000001 112.852 -172.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 12.9 mtm -102.28 -45.66 5.05 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 112.994 -1.912 . . . . 1.47 108.85 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.19 171.41 20.22 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.088 -1.869 . . . . 1.98 110.085 -176.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.0 m -149.24 123.73 9.71 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.136 -1.393 . . . . 1.0 109.743 172.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -107.45 151.49 40.96 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.333 -0.849 . . . . 1.3999999999999999 109.291 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HB2' HG23 ' A' ' 134' ' ' ILE . 55.9 Cg_endo -78.9 144.32 18.97 Favored 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 121.871 1.714 . . . . 0.23999999999999999 111.059 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.544 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -141.01 173.33 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.777 -0.647 . . . . 1.04 111.098 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.892 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.23 145.17 45.2 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.342 -0.39 . . . . 1.03 110.299 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.47 HG23 ' HG3' ' A' ' 68' ' ' LYS . 7.1 m -127.97 131.26 69.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.132 0.491 . . . . 1.26 111.773 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -91.6 157.04 24.32 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 109.755 -1.338 . . . . 0.20000000000000001 109.755 171.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.891 ' HG3' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -57.5 8.1 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 114.449 1.278 . . . . 3.48 114.449 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 89' ' ' ILE . 1.0 OUTLIER -97.03 -13.0 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.641 0.734 . . . . 1.0700000000000001 110.339 -177.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.3 mm? -92.67 -15.17 27.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.692 -0.685 . . . . 1.02 109.342 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.1 p -69.06 -21.9 64.05 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.889 -1.05 . . . . 1.05 111.797 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 6.8 mp0 -56.74 -44.3 81.55 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.44 1.496 . . . . 2.0299999999999998 112.332 -176.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.49 117.05 58.02 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.799 -0.637 . . . . 1.1499999999999999 111.36 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 5.9 Cg_exo -73.1 -16.64 25.28 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.73 2.287 . . . . 1.04 113.132 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.1 t -104.0 -41.58 5.82 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.711 -0.477 . . . . 1.1299999999999999 109.711 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.516 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.26 40.19 21.79 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.343 -1.299 . . . . 0.35999999999999999 113.81 168.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -84.08 113.42 21.02 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.026 0.917 . . . . 1.0800000000000001 109.624 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.685 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.8 m-85 -136.73 178.08 7.35 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 113.604 -1.635 . . . . 0.26000000000000001 111.566 -171.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 66.0 m-85 -142.06 136.57 30.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.067 0.461 . . . . 0.78000000000000003 110.902 -172.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.573 HD13 ' HB ' ' A' ' 161' ' ' THR . 80.3 mt -62.46 117.56 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.223 -0.899 . . . . 1.02 110.916 171.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.618 HD11 ' C ' ' A' ' 22' ' ' PHE . 16.3 pt -87.52 -34.36 7.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 113.138 0.792 . . . . 1.03 113.138 -175.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.508 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 12.7 p30 -178.57 179.58 0.74 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.666 -1.235 . . . . 2.0299999999999998 107.666 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.663 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -135.65 163.14 30.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.622 0.725 . . . . 2.02 112.423 -177.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 53.7 tt0 -133.07 101.05 5.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.466 -1.243 . . . . 0.83999999999999997 109.819 172.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.51 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 13.6 ttt180 -63.77 166.27 7.37 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.665 -0.698 . . . . 3.2799999999999998 110.356 174.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.51 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 16.3 m-80 -36.74 101.28 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 113.869 -1.514 . . . . 0.34999999999999998 114.079 -151.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -54.73 -50.9 11.74 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.588 2.858 . . . . 0.63 110.723 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.18 -34.71 4.46 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.156 -1.177 . . . . 0.67000000000000004 110.156 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.4 -175.21 25.98 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 114.509 -0.846 . . . . 0.77000000000000002 112.83 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.528 ' O ' ' HA ' ' A' ' 128' ' ' THR . 35.7 Cg_endo -58.3 -9.01 5.83 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 125.009 3.806 . . . . 1.1499999999999999 114.463 -177.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -65.55 -3.68 4.89 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.689 0.996 . . . . 1.5900000000000001 113.689 -172.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.693 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 92.29 64.63 1.12 Allowed Glycine 0 CA--C 1.493 -1.304 0 C-N-CA 118.95 -1.595 . . . . 1.6899999999999999 115.272 165.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.51 ' CB ' HD12 ' A' ' 151' ' ' ILE . . . 38.41 0.95 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 116.663 2.097 . . . . 1.1699999999999999 116.663 -175.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 1.641 ' HD2' ' CD1' ' A' ' 114' ' ' TYR . 0.3 OUTLIER -165.56 166.37 18.24 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.465 0.706 . . . . 0.60999999999999999 109.717 -177.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 21.8 t-105 -146.68 98.73 3.1 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.96 -1.126 . . . . 0.56999999999999995 107.96 166.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.507 HD21 ' HG2' ' A' ' 103' ' ' ARG . 1.5 mt -89.39 114.12 25.53 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.337 0.589 . . . . 1.3600000000000001 109.503 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 101' ' ' ILE . 49.9 m -82.98 143.63 30.53 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.991 -0.549 . . . . 0.42999999999999999 111.017 -172.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.771 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -109.36 167.59 10.01 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.139 -0.482 . . . . 1.02 111.696 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.2 t -59.71 -12.86 7.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.686 -1.143 . . . . 1.79 113.175 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.685 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 3.3 tptp -126.87 133.22 50.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.45 -0.5 . . . . 1.8100000000000001 111.075 173.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.449 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 76.9 mt-30 -31.31 -57.41 0.25 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.02 1.118 . . . . 1.76 114.02 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.536 ' CB ' HG12 ' A' ' 89' ' ' ILE . 87.9 m-70 -95.7 3.15 54.15 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.231 -0.588 . . . . 3.2000000000000002 111.902 -170.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.771 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -95.14 38.19 1.14 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.661 0.985 . . . . 0.83999999999999997 113.661 -172.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.567 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -112.65 143.15 17.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 117.319 -2.372 . . . . 0.96999999999999997 112.565 -153.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -98.94 115.15 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.868 0.842 . . . . 1.04 110.801 -176.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.621 ' CD2' ' HG ' ' A' ' 142' ' ' CYS . 28.8 p80 -144.28 171.82 13.78 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-N 115.166 -0.925 . . . . 0.20999999999999999 109.789 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.693 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.02 -166.64 38.57 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 120.799 -0.715 . . . . 0.34999999999999998 111.73 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 110' ' ' PRO . 13.1 t -156.98 169.16 25.45 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.266 -0.549 . . . . 1.1100000000000001 110.486 176.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -111.39 0.11 16.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.682 -0.859 . . . . 2.1899999999999999 108.682 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -118.07 86.22 25.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.755 -1.111 . . . . 1.8400000000000001 108.199 171.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -72.5 -19.92 24.31 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.77 2.313 . . . . 0.39000000000000001 114.175 -166.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.1 -4.01 42.21 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.034 0.445 . . . . 1.0800000000000001 110.839 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.0 t -85.71 -13.11 49.45 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.906 -0.776 . . . . 1.9399999999999999 108.906 172.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.429 HG23 ' HB2' ' A' ' 83' ' ' PRO . 28.6 mm -77.54 134.71 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 115.257 -0.883 . . . . 1.04 110.413 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.8 -1.38 71.23 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.217 -1.153 . . . . 0.16 110.217 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' ALA . 48.4 mttt -112.1 172.3 6.99 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 123.012 1.387 . . . . 3.0299999999999998 113.887 -177.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.32 127.72 45.36 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 112.189 -2.278 . . . . 1.01 108.046 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.495 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 1.4 p -118.57 167.91 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.054 -1.462 . . . . 1.3400000000000001 107.054 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.891 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 45.2 m -64.48 -59.68 4.04 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 119.731 -0.788 . . . . 0.87 111.949 177.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -127.34 -44.14 1.58 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 117.207 -1.797 . . . . 2.5499999999999998 113.9 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -33.39 132.56 0.31 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.67 1.428 . . . . 0.19 116.67 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.621 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 4.2 p -68.75 166.36 17.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.41 -1.895 . . . . 0.20000000000000001 112.141 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.892 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 66.9 mt -59.07 99.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 122.569 1.176 . . . . 1.1299999999999999 111.991 -163.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.616 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 50.3 mtt180 -86.09 147.1 26.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.371 -1.74 . . . . 2.3300000000000001 110.389 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.544 ' HG2' HG21 ' A' ' 84' ' ' ILE . 13.0 mtp -128.12 -166.21 1.59 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.29 -0.633 . . . . 1.0900000000000001 109.29 175.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.59 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 5.5 t60 -95.55 156.38 16.35 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.909 -0.775 . . . . 2.9900000000000002 108.909 171.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.608 ' O ' HD11 ' A' ' 151' ' ' ILE . 2.1 m120 -57.1 -52.69 64.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 118.422 -0.799 . . . . 0.73999999999999999 110.293 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.87 -25.82 68.48 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 121.154 1.797 . . . . 2.6899999999999999 112.522 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.59 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 7.5 m-20 -84.67 -41.38 16.35 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.303 -0.408 . . . . 0.68999999999999995 111.186 -175.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.543 HG12 HD13 ' A' ' 151' ' ' ILE . 13.3 p -67.94 -23.75 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.016 -0.538 . . . . 1.02 111.143 175.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.608 HD11 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.24 -39.67 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 119.042 -0.504 . . . . 1.1699999999999999 109.739 171.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.0 mm-40 -45.86 -72.06 0.06 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.171 0.896 . . . . 1.99 112.366 168.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 157' ' ' VAL . 44.8 mt -47.27 -38.46 12.5 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.675 0.75 . . . . 1.9099999999999999 111.495 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.35 79.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.126 -1.397 . . . . 1.04 111.664 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.9 t -88.44 -33.0 18.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 118.58 0.627 . . . . 0.88 112.416 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 152' ' ' GLU . 30.4 mt -81.24 -59.63 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.551 0.691 . . . . 1.0 111.193 -172.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 153' ' ' LEU . 2.8 m -92.58 140.12 23.86 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.845 -1.071 . . . . 1.0700000000000001 112.227 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.663 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 57.3 Cg_endo -89.86 177.14 2.64 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.114 3.209 . . . . 0.23999999999999999 111.122 173.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.508 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 12.7 m120 -67.07 157.8 32.64 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 119.658 -0.817 . . . . 1.1000000000000001 109.525 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 99.39 -25.58 27.69 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.211 -0.995 . . . . 0.17999999999999999 112.289 -173.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.573 ' HB ' HD13 ' A' ' 100' ' ' ILE . 36.1 m -61.41 138.31 58.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.383 -0.599 . . . . 1.05 109.383 -173.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.521 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 9.8 ptm180 -92.81 127.71 38.41 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.964 1.364 . . . . 4.1100000000000003 111.369 -170.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.3 t -109.58 108.34 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 111.915 -2.402 . . . . 1.02 109.008 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.6 m -94.76 107.05 19.06 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.524 0.564 . . . . 1.0700000000000001 112.524 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.516 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -82.86 100.75 6.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 122.29 1.043 . . . . 1.05 109.992 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -110.17 133.31 53.35 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.229 -1.35 . . . . 1.0900000000000001 109.832 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.512 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.6 mmm180 -70.68 -18.75 62.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.465 -0.334 . . . . 2.4900000000000002 110.829 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.44 -144.21 18.98 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.938 -0.574 . . . . 1.97 112.101 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 110.281 -0.266 . . . . 4.3300000000000001 110.281 178.572 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.157 -0.377 . . . . 3.3399999999999999 112.157 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -102.93 169.67 8.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.048 0.451 . . . . 4.9199999999999999 111.065 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -87.2 98.96 11.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.253 -0.885 . . . . 3.1000000000000001 108.895 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 mp -105.34 175.21 5.57 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.453 0.644 . . . . 1.3300000000000001 111.745 -175.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.616 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.4 tt -94.63 130.87 40.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.857 -1.065 . . . . 1.0700000000000001 110.142 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.75 162.25 13.51 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.129 0.966 . . . . 1.03 113.171 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.652 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 84.7 t80 -129.57 139.98 51.34 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.469 -1.696 . . . . 1.0800000000000001 107.902 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.454 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.1 tt0 -112.93 110.89 21.25 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.242 -1.021 . . . . 0.93000000000000005 108.242 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.585 HG11 ' HB2' ' A' ' 13' ' ' ASP . 92.7 t -66.05 149.45 11.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 122.564 1.173 . . . . 1.1000000000000001 113.578 -167.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -98.93 159.97 14.59 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.211 -1.813 . . . . 2.4399999999999999 109.799 172.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.444 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 1.4 mm-40 -62.43 105.37 0.61 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.886 -1.052 . . . . 2.4300000000000002 111.432 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.94 11.66 49.05 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.485 -0.779 . . . . 0.51000000000000001 113.542 175.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.585 ' HB2' HG11 ' A' ' 9' ' ' VAL . 59.3 m-20 -52.38 169.52 0.08 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 117.423 0.611 . . . . 1.46 111.362 171.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.84 154.69 44.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.475 0.655 . . . . 1.1599999999999999 111.271 175.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.518 ' O ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -65.97 -33.23 75.34 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.394 -0.965 . . . . 1.47 108.394 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.441 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 17.8 t-20 -88.62 -25.12 22.6 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.883 -1.053 . . . . 1.78 111.391 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.4 p -68.76 -38.56 80.18 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 119.72 -0.792 . . . . 1.74 109.601 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 mt -75.47 -26.89 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.219 0.533 . . . . 1.04 109.75 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.91 -9.86 59.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.326 -0.397 . . . . 1.0600000000000001 110.646 174.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.716 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.44 -41.37 8.63 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.274 -1.01 . . . . 0.97999999999999998 108.274 176.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.465 ' OD1' ' HA ' ' A' ' 120' ' ' LYS . 1.5 m-20 -61.68 -39.45 91.47 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.015 -1.902 . . . . 0.53000000000000003 112.073 174.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' O ' HD11 ' A' ' 101' ' ' ILE . 68.4 m-85 -103.32 5.9 37.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 118.566 -1.254 . . . . 0.20000000000000001 111.487 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.716 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER 54.74 41.5 31.88 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.972 0.891 . . . . 2.46 109.559 176.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.8 pt -114.42 -165.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.208 -1.36 . . . . 1.04 110.024 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 142.62 41.07 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.241 -0.891 . . . . 1.3400000000000001 110.21 174.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.529 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 72.3 p -71.97 -34.01 68.61 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.007 -1.108 . . . . 1.0900000000000001 108.007 178.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.27 69.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.42 -0.809 . . . . 1.0700000000000001 111.816 170.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.37 -26.26 18.99 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.689 0.757 . . . . 1.04 109.093 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.656 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.1 tp -75.19 -26.29 58.89 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.09 -0.959 . . . . 1.8100000000000001 109.261 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 26' ' ' THR . 33.6 mt -77.86 -29.89 50.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.765 0.793 . . . . 1.6399999999999999 109.828 171.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 40.8 tt0 -64.49 -43.28 94.63 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.413 -1.267 . . . . 2.3300000000000001 109.95 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.442 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -83.18 -20.35 34.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.105 -0.638 . . . . 1.0600000000000001 111.495 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.3 m-80 -148.16 81.05 8.34 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.509 0.671 . . . . 0.23000000000000001 110.442 -172.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.4 Cg_endo -57.71 -10.93 8.09 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 124.077 3.185 . . . . 0.52000000000000002 114.057 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.5 t -80.67 -22.12 40.72 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.053 -0.404 . . . . 1.6499999999999999 111.249 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.656 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 38.1 mt -66.41 -35.67 80.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.526 0.679 . . . . 1.25 111.883 -171.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -65.51 -47.92 74.31 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 122.871 1.32 . . . . 2.52 110.167 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.51 82.56 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 111.934 -2.394 . . . . 1.1899999999999999 110.594 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.17 -179.53 48.19 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.857 -1.065 . . . . 0.44 111.541 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.01 158.22 23.44 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.212 0.529 . . . . 1.1699999999999999 110.791 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.589 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 29.4 m -139.05 128.11 23.81 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.493 -0.776 . . . . 1.1499999999999999 110.406 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' A' ' 11' ' ' GLN . . . -75.27 118.89 18.67 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.566 0.698 . . . . 1.1200000000000001 109.772 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.39 0.74 55.65 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.374 -1.09 . . . . 0.44 110.374 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.2 OUTLIER -76.42 124.16 27.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.985 -0.607 . . . . 1.3 109.469 179.366 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 24.4 p -84.45 126.17 33.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.967 0.889 . . . . 1.3200000000000001 110.752 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.56 HG13 ' HB3' ' A' ' 7' ' ' TYR . 10.6 pt -126.94 144.38 37.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.133 -1.394 . . . . 1.0700000000000001 109.377 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.68 151.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.125 0.488 . . . . 1.3 111.164 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.416 HG22 ' CD2' ' A' ' 22' ' ' PHE . 39.3 mm -116.35 91.69 33.93 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.885 -1.052 . . . . 1.03 109.425 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.501 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . 2.6 Cg_endo -56.93 133.7 59.67 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.834 2.356 . . . . 0.20000000000000001 112.551 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.18 -5.79 78.4 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.701 -1.136 . . . . 0.26000000000000001 112.569 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.66 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 25.6 tp -125.71 115.56 24.73 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.949 0.404 . . . . 1.27 111.452 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.641 ' HD2' HD13 ' A' ' 51' ' ' LEU . 36.4 Cg_endo -76.79 -177.82 4.07 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.565 2.844 . . . . 0.31 114.331 -172.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' OD2' ' HB2' ' A' ' 55' ' ' TYR . 16.1 t70 -78.31 133.05 64.67 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 113.94 -1.482 . . . . 0.48999999999999999 112.139 -170.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.47 -9.36 18.72 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.314 2.676 . . . . 0.48999999999999999 112.717 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.508 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 16.4 m-30 -93.9 -8.28 40.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.119 0.485 . . . . 1.8 110.52 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.492 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 19.0 p -88.72 -17.67 29.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.065 0.936 . . . . 1.1299999999999999 108.674 174.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.556 HG23 ' H ' ' A' ' 59' ' ' TYR . 9.6 mm -64.72 126.14 90.28 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 113.838 -1.528 . . . . 1.24 109.989 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.71 -13.48 10.62 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.999 1.799 . . . . 0.47999999999999998 112.608 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.556 ' H ' HG23 ' A' ' 57' ' ' ILE . 67.0 m-85 -103.68 170.56 7.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.281 0.562 . . . . 0.94999999999999996 111.825 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -153.81 134.07 13.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.117 -0.947 . . . . 3.7400000000000002 108.536 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 71' ' ' THR . 93.1 mt -111.54 130.34 65.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.342 -0.39 . . . . 1.05 111.322 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.87 115.48 28.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.937 -0.705 . . . . 1.0800000000000001 110.847 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 47.8 t -96.64 114.04 32.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.79 0.805 . . . . 1.04 110.571 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 68' ' ' LYS . 27.1 m -94.76 100.35 12.27 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.49 -1.232 . . . . 0.83999999999999997 110.359 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.0 mm -50.47 -57.32 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 122.028 0.918 . . . . 1.0600000000000001 111.13 170.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.34 -11.53 3.63 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 112.787 -2.006 . . . . 0.16 113.131 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 64' ' ' SER . . . -126.49 -17.53 5.07 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.436 0.694 . . . . 1.02 112.595 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.547 ' HB2' ' HZ2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 57.97 54.25 6.18 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.505 0.593 . . . . 1.3 111.488 -173.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.6 p -136.7 163.48 30.48 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.798 0.666 . . . . 0.98999999999999999 112.798 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.417 ' C ' HD21 ' A' ' 70' ' ' LEU . 7.5 tt -128.13 111.52 13.56 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.595 -1.184 . . . . 1.1799999999999999 109.549 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.635 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 31.2 m -93.41 121.77 35.15 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.261 0.553 . . . . 1.04 110.962 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 79' ' ' MET . 16.0 tp -96.79 104.96 17.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.179 -0.918 . . . . 1.3200000000000001 109.078 172.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 97.9 p -106.8 159.23 16.39 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.981 -1.088 . . . . 1.05 110.368 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.6 HD23 ' N ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -123.73 125.51 44.88 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.561 -0.903 . . . . 1.1000000000000001 108.561 170.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.6 ' N ' HD23 ' A' ' 74' ' ' LEU . 9.4 p30 41.06 54.83 3.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.713 -1.585 . . . . 1.97 111.58 -164.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 6.7 m-20 74.7 -13.62 0.8 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.008 -0.996 . . . . 2.5499999999999998 112.146 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -95.28 120.39 35.43 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.231 0.539 . . . . 4.0199999999999996 110.025 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 58.9 t -56.93 131.04 20.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 122.357 1.075 . . . . 1.0600000000000001 113.002 -173.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.518 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 2.8 mmm -97.99 -46.88 5.74 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.947 -1.933 . . . . 1.47 108.854 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.8 mmtt -160.56 173.99 14.7 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.046 -1.888 . . . . 1.98 110.037 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.8 m -149.6 123.7 9.46 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.224 -1.353 . . . . 1.0 109.699 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -114.94 145.06 33.21 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.6 -0.727 . . . . 1.3999999999999999 109.959 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HB2' HG23 ' A' ' 134' ' ' ILE . 37.3 Cg_endo -72.42 142.28 36.63 Favored 'Trans proline' 0 CA--C 1.496 -1.418 0 C-N-CA 122.259 1.973 . . . . 0.23999999999999999 111.173 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.527 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.32 172.56 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 115.517 -0.765 . . . . 1.04 110.959 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.917 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.04 139.66 50.88 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.237 -0.438 . . . . 1.03 109.88 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.463 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 10.9 m -121.74 126.87 75.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.713 0.768 . . . . 1.26 111.541 -177.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -82.18 150.63 29.1 Favored Glycine 0 N--CA 1.419 -2.452 0 N-CA-C 109.186 -1.566 . . . . 0.20000000000000001 109.186 171.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -57.19 4.39 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.809 0.67 . . . . 3.48 112.809 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.502 ' H ' ' C ' ' A' ' 87' ' ' GLY . 1.1 tp -87.46 -19.04 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.481 0.658 . . . . 1.0700000000000001 110.077 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.488 HD13 ' HA ' ' A' ' 123' ' ' TYR . 3.7 mm? -88.84 -16.36 32.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.694 0.759 . . . . 1.02 109.228 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.5 p -69.23 -18.51 63.9 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.565 -1.198 . . . . 1.05 111.194 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.25 -40.17 93.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.536 -1.211 . . . . 2.0299999999999998 112.704 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.67 131.26 29.75 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 119.799 -0.76 . . . . 1.1499999999999999 110.956 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.466 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 83.8 Cg_endo -86.97 -1.86 8.04 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.43 2.087 . . . . 1.04 112.314 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.3 t -119.62 -41.48 2.69 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.418 -0.586 . . . . 1.1299999999999999 109.418 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 165' ' ' ILE . . . 54.87 16.86 8.28 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 114.716 -1.129 . . . . 0.35999999999999999 114.413 169.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.526 ' HB3' HG21 ' A' ' 164' ' ' THR . 10.6 pt-20 -84.42 116.7 23.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.495 1.14 . . . . 1.0800000000000001 109.816 -173.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.589 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 11.3 m-85 -137.58 -174.78 3.86 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.278 -1.783 . . . . 0.26000000000000001 111.436 -166.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 162' ' ' ARG . 39.2 m-85 -142.18 137.95 31.19 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 120.945 0.402 . . . . 0.78000000000000003 110.991 -173.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.604 HD13 ' HB ' ' A' ' 161' ' ' THR . 80.2 mt -65.04 125.04 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.542 -0.753 . . . . 1.02 110.308 169.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.569 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 21.9 pt -91.45 -42.13 13.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 113.024 0.75 . . . . 1.03 113.024 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.508 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 57.6 m-80 -170.13 173.0 6.08 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.009 -1.478 . . . . 2.0299999999999998 107.009 -170.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.582 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 40.7 mtt180 -125.8 167.9 14.56 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.696 -0.802 . . . . 2.02 111.739 -175.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -145.44 100.76 3.5 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.148 -0.933 . . . . 0.83999999999999997 110.019 171.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.495 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 25.9 ttp180 -66.02 166.31 11.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.302 -0.863 . . . . 3.2799999999999998 110.735 175.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 33.8 m-80 -36.37 101.51 0.22 Allowed Pre-proline 0 C--O 1.233 0.207 0 C-N-CA 124.942 1.297 . . . . 0.34999999999999998 113.104 -156.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.4 Cg_endo -63.41 -44.55 14.2 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.453 2.768 . . . . 0.63 112.601 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.58 -33.95 5.26 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.87 -0.892 . . . . 0.67000000000000004 110.87 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.75 -174.46 25.84 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.735 -0.733 . . . . 0.77000000000000002 112.592 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -56.09 -5.73 1.05 Allowed 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 125.064 3.842 . . . . 1.1499999999999999 114.461 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.427 ' HB2' ' CG ' ' A' ' 107' ' ' PRO . 5.2 m-85 -70.4 -16.19 62.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.506 1.146 . . . . 1.5900000000000001 108.366 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.586 ' O ' ' HB1' ' A' ' 113' ' ' ALA . . . 84.13 -12.75 53.14 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 118.465 2.146 . . . . 1.6899999999999999 118.465 152.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.607 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . . . 166.36 -36.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 119.629 1.715 . . . . 1.1699999999999999 110.111 -175.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.444 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -157.37 157.51 34.2 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.66 0.384 . . . . 0.60999999999999999 110.079 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -136.52 100.22 4.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.973 -1.121 . . . . 0.56999999999999995 107.973 165.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 103' ' ' ARG . 5.0 mt -93.52 114.18 26.49 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.64 -0.874 . . . . 1.3600000000000001 108.64 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.2 m -84.25 144.45 28.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.675 -0.693 . . . . 0.42999999999999999 111.213 -165.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -109.54 169.46 8.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 1.02 111.394 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.0 t -63.97 -12.21 35.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.848 -1.069 . . . . 1.79 112.787 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.732 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 3.9 tmtm? -127.65 132.31 49.74 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.158 0.98 . . . . 1.8100000000000001 109.704 171.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.732 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.0 mt-30 -37.57 -47.23 0.91 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.524 -2.126 . . . . 1.76 114.211 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.472 ' CB ' HG12 ' A' ' 89' ' ' ILE . 37.2 m80 -97.9 2.22 48.92 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.366 0.603 . . . . 3.2000000000000002 111.024 -171.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.795 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.6 m-85 -99.38 37.35 1.58 Allowed 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.495 0.924 . . . . 0.83999999999999997 113.495 -171.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.509 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -117.03 142.27 17.31 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 116.874 -2.584 . . . . 0.96999999999999997 112.668 -152.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -95.64 116.12 36.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 123.966 0.906 . . . . 1.04 110.868 -175.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.716 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 26.7 p80 -146.36 -179.01 6.45 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.186 -0.461 . . . . 0.20999999999999999 111.822 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.39 -167.98 37.05 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 111.19 -0.764 . . . . 0.34999999999999998 111.19 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.4 t -156.95 172.29 18.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 117.912 0.856 . . . . 1.1100000000000001 110.911 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -115.42 -2.43 12.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.528 -0.916 . . . . 2.1899999999999999 108.528 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -124.86 89.17 52.93 Favored Pre-proline 0 C--O 1.235 0.333 0 CA-C-N 114.426 -1.261 . . . . 1.8400000000000001 108.858 171.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -74.32 -21.04 17.95 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.627 2.218 . . . . 0.39000000000000001 114.113 -169.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.02 -3.65 40.14 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.034 0.445 . . . . 1.0800000000000001 111.337 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.9 m -91.13 -2.33 57.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.125 0.488 . . . . 1.9399999999999999 109.812 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.431 HG23 ' HB2' ' A' ' 83' ' ' PRO . 33.5 mm -77.23 136.34 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.919 -0.582 . . . . 1.04 110.026 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.59 2.12 65.57 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.314 -1.114 . . . . 0.16 110.314 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 30.2 mttm -114.87 169.96 8.69 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 123.315 1.531 . . . . 3.0299999999999998 114.635 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.4 126.51 48.18 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.67 -2.514 . . . . 1.01 108.203 176.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.77 161.23 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.446 -0.946 . . . . 1.3400000000000001 108.446 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.0 m -49.8 -60.1 3.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.794 0.664 . . . . 0.87 112.794 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -132.61 -44.46 0.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.36 -1.336 . . . . 2.5499999999999998 113.984 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.49 133.65 0.2 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 117.19 1.636 . . . . 0.19 117.19 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.544 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 2.4 p -71.22 165.6 23.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 112.545 -1.827 . . . . 0.20000000000000001 112.026 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.917 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 56.0 mt -60.01 96.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 122.538 1.161 . . . . 1.1299999999999999 111.783 -162.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.716 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 80.5 mtt180 -84.93 141.76 30.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.681 -1.6 . . . . 2.3300000000000001 109.399 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.527 ' HG2' HG21 ' A' ' 84' ' ' ILE . 24.4 mtp -118.6 179.22 4.19 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.477 0.656 . . . . 1.0900000000000001 109.857 175.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.569 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 9.5 t-80 -81.45 145.83 30.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.882 -1.155 . . . . 2.9900000000000002 107.882 168.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.673 ' O ' HD12 ' A' ' 151' ' ' ILE . 6.9 m120 -66.17 -40.47 90.52 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 114.883 -1.053 . . . . 0.73999999999999999 112.566 -166.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -67.54 -23.83 65.48 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 121.801 2.091 . . . . 2.6899999999999999 112.241 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 12.2 m-20 -85.19 -38.23 19.22 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.216 -0.447 . . . . 0.68999999999999995 110.851 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 147' ' ' ASN . 12.2 p -67.55 -21.98 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.852 -0.613 . . . . 1.02 111.176 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.19 -43.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 118.948 -0.549 . . . . 1.1699999999999999 109.923 171.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 156' ' ' ILE . 23.5 mt-10 -46.81 -70.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 119.385 0.993 . . . . 1.99 112.761 170.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 157' ' ' VAL . 27.3 mt -47.07 -38.62 11.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.631 0.729 . . . . 1.9099999999999999 111.658 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.65 -31.96 71.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.079 -1.419 . . . . 1.04 111.712 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.7 t -88.34 -31.77 18.75 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.481 -0.762 . . . . 0.88 112.324 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 152' ' ' GLU . 24.2 mt -82.31 -60.84 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.534 0.683 . . . . 1.0 111.828 -171.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 153' ' ' LEU . 8.7 m -88.35 139.46 30.16 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 114.783 -1.099 . . . . 1.0700000000000001 112.342 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.582 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 42.4 Cg_endo -88.54 174.55 4.13 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 124.37 3.38 . . . . 0.23999999999999999 111.119 176.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.508 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 54.0 m-20 -68.18 156.93 36.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.905 -1.118 . . . . 1.1000000000000001 108.219 175.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.78 -16.07 61.9 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.772 -1.204 . . . . 0.17999999999999999 111.928 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.604 ' HB ' HD13 ' A' ' 100' ' ' ILE . 95.2 m -64.91 135.29 55.54 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.203 -0.666 . . . . 1.05 109.203 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 99' ' ' TYR . 1.7 ptt180 -92.82 122.42 35.19 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.685 1.231 . . . . 4.1100000000000003 111.078 -170.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 39.8 t -110.14 109.56 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 112.204 -2.271 . . . . 1.02 109.475 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.526 HG21 ' HB3' ' A' ' 97' ' ' GLU . 6.9 m -97.35 110.28 22.86 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.082 0.771 . . . . 1.0700000000000001 113.082 -172.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.48 ' O ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -83.17 102.16 8.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.11 0.957 . . . . 1.05 109.792 176.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -109.22 129.84 55.5 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.979 -1.009 . . . . 1.0900000000000001 110.037 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 9.9 mmm180 -77.7 -23.17 49.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.362 0.601 . . . . 2.4900000000000002 109.432 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 153.6 -177.89 30.88 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.925 -1.034 . . . . 1.97 111.572 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--N 1.321 -0.64 0 N-CA-C 110.114 -0.328 . . . . 4.3300000000000001 110.114 178.931 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 111.768 -0.533 . . . . 3.3399999999999999 111.768 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -99.59 140.37 33.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.063 0.459 . . . . 4.9199999999999999 110.671 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 6.1 mmpt? -91.36 100.88 13.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.777 -0.647 . . . . 3.1000000000000001 110.671 -177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.765 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 tp -107.47 174.43 5.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.891 -0.595 . . . . 1.3300000000000001 111.186 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.9 tt -94.28 126.42 39.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.521 -0.763 . . . . 1.0700000000000001 110.615 -174.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.71 161.62 13.8 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.051 0.929 . . . . 1.03 113.064 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.657 ' HD2' ' CD1' ' A' ' 7' ' ' TYR . 78.7 t80 -131.29 141.48 49.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.808 -1.542 . . . . 1.0800000000000001 108.058 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.5 tt0 -113.27 111.04 21.37 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.055 -1.091 . . . . 0.93000000000000005 108.055 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.609 HG11 ' HB2' ' A' ' 13' ' ' ASP . 94.3 t -66.52 150.49 10.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 122.155 0.978 . . . . 1.1000000000000001 113.032 -168.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -104.14 158.85 16.15 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.869 -1.514 . . . . 2.4399999999999999 108.658 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 1.1 tt0 -61.54 101.62 0.19 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.974 0.416 . . . . 2.4300000000000002 112.09 -175.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.79 11.97 27.27 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.754 -0.736 . . . . 0.51000000000000001 113.237 174.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.609 ' HB2' HG11 ' A' ' 9' ' ' VAL . 35.7 m-20 -55.54 170.48 0.25 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.912 0.356 . . . . 1.46 111.348 171.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.7 155.11 49.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.459 0.647 . . . . 1.1599999999999999 111.893 174.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -69.21 -29.71 67.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.526 -1.216 . . . . 1.47 109.897 -177.255 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.442 ' HA ' HG23 ' A' ' 26' ' ' THR . 65.9 t30 -93.79 -23.26 18.23 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.927 -1.033 . . . . 1.78 111.164 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.3 m -70.0 -39.84 75.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.553 -0.459 . . . . 1.74 109.886 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.428 HG21 ' CE1' ' A' ' 22' ' ' PHE . 15.2 mt -73.2 -27.4 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.112 0.482 . . . . 1.04 109.977 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.619 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.76 -10.42 59.77 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.811 -0.356 . . . . 1.0600000000000001 110.928 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.534 ' O ' ' HD3' ' A' ' 23' ' ' ARG . . . -97.16 -40.3 8.87 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 122.214 1.007 . . . . 0.97999999999999998 108.404 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.45 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 4.4 m-20 -61.44 -43.43 98.88 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.227 -1.806 . . . . 0.53000000000000003 111.867 173.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.607 ' C ' HD11 ' A' ' 101' ' ' ILE . 67.8 m-85 -98.01 8.19 45.14 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.574 -1.25 . . . . 0.20000000000000001 111.571 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.534 ' HD3' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER 52.08 40.65 28.95 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.613 0.721 . . . . 2.46 110.215 177.439 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.619 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.6 pt -113.63 -164.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 114.511 -1.222 . . . . 1.04 109.28 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -109.9 157.17 19.52 Favored 'General case' 0 CA--C 1.491 -1.318 0 CA-C-O 122.375 1.083 . . . . 1.3400000000000001 110.168 169.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.562 ' HB ' ' CD1' ' A' ' 15' ' ' LEU . 75.7 p -80.68 -31.12 36.4 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 112.914 -1.948 . . . . 1.0900000000000001 107.553 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 -30.72 71.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.098 -0.956 . . . . 1.0700000000000001 111.76 172.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -89.95 -26.87 20.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.728 -0.842 . . . . 1.04 108.728 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.588 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 20.0 tp -74.14 -28.18 61.2 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.355 -0.839 . . . . 1.8100000000000001 109.789 175.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' ' 36' ' ' LEU . 48.3 mt -77.79 -29.31 50.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.959 0.885 . . . . 1.6399999999999999 109.919 172.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 53.9 tt0 -67.9 -39.65 83.59 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.082 -1.417 . . . . 2.3300000000000001 110.572 174.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.433 ' HB3' ' HG3' ' A' ' 49' ' ' PRO . . . -84.67 -19.94 32.06 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.075 -0.65 . . . . 1.0600000000000001 111.409 176.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.571 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 26.8 m-80 -147.05 80.64 9.34 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-O 121.217 0.532 . . . . 0.23000000000000001 110.351 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.15 -11.2 7.36 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 123.889 3.059 . . . . 0.52000000000000002 113.305 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 m -74.05 -25.72 60.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.848 0.356 . . . . 1.6499999999999999 111.53 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.588 ' CD1' ' HG ' ' A' ' 29' ' ' LEU . 40.6 mt -70.91 -32.46 69.4 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.353 0.596 . . . . 1.25 112.462 -168.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -63.59 -44.64 93.43 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 123.057 1.408 . . . . 2.52 110.395 -175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.37 79.19 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 111.722 -2.49 . . . . 1.1899999999999999 110.693 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.41 178.33 48.65 Favored Glycine 0 N--CA 1.425 -2.094 0 CA-C-N 115.117 -0.947 . . . . 0.44 111.929 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.41 HD22 ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -110.67 158.05 19.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.225 0.536 . . . . 1.1699999999999999 110.569 178.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.542 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 74.4 m -140.91 127.55 20.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.355 -0.839 . . . . 1.1499999999999999 110.301 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 11' ' ' GLN . . . -75.07 122.71 23.96 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.364 0.602 . . . . 1.1200000000000001 110.028 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.67 3.02 61.18 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 110.533 -1.027 . . . . 0.44 110.533 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.542 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.52 123.12 28.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.626 -0.509 . . . . 1.3 109.626 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 17.0 p -77.78 126.36 30.74 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.852 0.834 . . . . 1.3200000000000001 110.657 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.563 HG13 ' HB3' ' A' ' 7' ' ' TYR . 9.1 pt -126.13 144.07 37.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.138 -1.392 . . . . 1.0700000000000001 109.198 -178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.15 151.44 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.347 0.594 . . . . 1.3 111.191 -179.023 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.82 93.38 41.23 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.554 -1.203 . . . . 1.03 109.227 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.522 ' HA ' HD23 ' A' ' 4' ' ' LEU . 3.1 Cg_exo -56.12 133.91 60.97 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.488 2.125 . . . . 0.20000000000000001 112.535 -176.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.77 -6.88 79.76 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 114.412 -1.267 . . . . 0.26000000000000001 112.363 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.765 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER -112.98 118.49 44.41 Favored Pre-proline 0 C--O 1.217 -0.637 0 CA-C-N 116.98 0.39 . . . . 1.27 111.186 178.172 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.498 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 37.0 Cg_endo -80.0 -176.8 3.41 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.083 2.522 . . . . 0.31 112.65 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.471 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 9.7 t70 -86.72 127.37 60.49 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-N 115.363 -0.835 . . . . 0.48999999999999999 112.044 -168.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.567 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.1 Cg_endo -75.65 -10.39 20.17 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 123.626 2.884 . . . . 0.48999999999999999 112.934 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -94.08 -13.92 26.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.549 0.69 . . . . 1.8 110.186 -176.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.471 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 23.7 p -87.32 -21.23 25.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.507 1.146 . . . . 1.1299999999999999 108.176 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.478 HG23 ' H ' ' A' ' 59' ' ' TYR . 35.8 mt -73.89 129.08 85.58 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.124 -1.853 . . . . 1.24 111.018 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.06 -16.22 14.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.424 2.083 . . . . 0.47999999999999998 113.416 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.478 ' H ' HG23 ' A' ' 57' ' ' ILE . 62.9 m-85 -94.66 160.12 14.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.582 -0.447 . . . . 0.94999999999999996 111.591 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -150.99 132.03 14.31 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.902 -0.777 . . . . 3.7400000000000002 108.902 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 71' ' ' THR . 80.2 mt -112.49 136.38 48.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.233 -0.44 . . . . 1.05 111.889 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.77 117.39 29.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 119.957 -0.697 . . . . 1.0800000000000001 110.924 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.2 t -97.33 112.88 30.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.775 0.797 . . . . 1.04 110.53 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 68' ' ' LYS . 49.6 m -93.6 100.75 12.95 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.717 -1.129 . . . . 0.83999999999999997 110.546 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.488 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.8 mm -50.79 -58.77 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.894 0.854 . . . . 1.0600000000000001 111.443 170.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.92 -8.21 2.09 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 112.922 -1.945 . . . . 0.16 113.245 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.4 ' H ' ' C ' ' A' ' 65' ' ' ILE . . . -127.46 -19.17 4.27 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.697 0.799 . . . . 1.02 112.267 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 59.24 54.51 4.77 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.335 0.516 . . . . 1.3 111.293 -172.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.6 p -137.29 166.2 24.34 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 112.787 0.662 . . . . 0.98999999999999999 112.787 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.9 tt -136.26 112.22 9.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.861 -1.063 . . . . 1.1799999999999999 110.197 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 86.6 m -93.24 124.3 37.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.146 0.498 . . . . 1.04 110.879 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.9 tp -99.78 107.3 19.31 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.173 -0.921 . . . . 1.3200000000000001 109.25 172.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 88.8 p -105.42 161.4 14.35 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.013 -1.075 . . . . 1.05 110.546 176.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -125.99 126.69 44.72 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.575 -0.898 . . . . 1.1000000000000001 108.575 167.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.551 ' N ' HD23 ' A' ' 74' ' ' LEU . 29.1 m-80 51.15 48.61 22.73 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.607 -1.179 . . . . 1.97 111.067 -172.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.0 t30 71.71 -5.89 1.56 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.339 0.656 . . . . 2.5499999999999998 111.414 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -104.94 120.64 41.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.125 0.488 . . . . 4.0199999999999996 110.582 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 54.7 t -55.23 132.85 18.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 122.361 1.077 . . . . 1.0600000000000001 113.399 -174.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.496 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 6.9 mmm -100.85 -44.43 5.77 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.229 -1.805 . . . . 1.47 109.275 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -159.37 173.43 16.26 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 113.189 -1.823 . . . . 1.98 110.156 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.0 m -149.3 123.08 9.27 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.986 -1.461 . . . . 1.0 109.391 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -108.85 156.6 38.72 Favored Pre-proline 0 C--N 1.312 -1.04 0 N-CA-C 109.386 -0.598 . . . . 1.3999999999999999 109.386 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.425 ' HB2' HG23 ' A' ' 134' ' ' ILE . 50.7 Cg_endo -80.69 144.2 15.41 Favored 'Trans proline' 0 CA--C 1.497 -1.372 0 C-N-CA 121.975 1.783 . . . . 0.23999999999999999 110.83 170.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.526 HG21 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -140.08 172.75 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.614 -0.721 . . . . 1.04 110.551 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.826 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.05 137.69 52.73 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.846 0.355 . . . . 1.03 110.321 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.461 HG21 ' HG3' ' A' ' 68' ' ' LYS . 13.2 m -121.11 130.16 74.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.678 -0.692 . . . . 1.26 111.527 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -88.91 154.26 24.46 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.988 -1.245 . . . . 0.20000000000000001 109.988 171.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -57.08 4.55 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 113.133 0.79 . . . . 3.48 113.133 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 89' ' ' ILE . 1.0 OUTLIER -88.78 -18.97 7.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.78 0.8 . . . . 1.0700000000000001 110.074 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.511 ' HG ' HD13 ' A' ' 143' ' ' ILE . 3.5 mm? -88.66 -18.53 27.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.791 0.805 . . . . 1.02 108.909 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.8 p -68.51 -15.05 63.41 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.376 -1.284 . . . . 1.05 111.658 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -69.6 -42.26 74.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.918 -1.037 . . . . 2.0299999999999998 112.127 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.72 111.94 62.7 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 1.1499999999999999 111.108 -175.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.517 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 1.9 Cg_endo -77.43 -11.87 17.19 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.831 2.354 . . . . 1.04 113.126 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.2 t -98.88 -43.58 6.68 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.468 -0.567 . . . . 1.1299999999999999 109.468 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.526 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 54.44 27.21 40.19 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.255 -1.339 . . . . 0.35999999999999999 114.228 168.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -84.59 111.86 19.91 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.988 0.899 . . . . 1.0800000000000001 109.363 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.681 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 22.4 m-85 -138.46 -176.9 4.62 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.66 -1.609 . . . . 0.26000000000000001 111.661 -170.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -143.96 144.12 31.55 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.974 0.416 . . . . 0.78000000000000003 110.552 -173.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.565 HD13 ' HB ' ' A' ' 161' ' ' THR . 82.3 mt -68.75 113.01 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.336 -0.847 . . . . 1.02 109.995 168.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.607 HD11 ' C ' ' A' ' 22' ' ' PHE . 18.7 pt -80.65 -43.54 21.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.569 -0.741 . . . . 1.03 112.552 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.815 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 52.1 m-80 -169.12 169.47 9.38 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.007 -1.479 . . . . 2.0299999999999998 107.007 -170.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.433 ' HB3' ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -134.76 157.59 46.34 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.99 -0.684 . . . . 2.02 112.396 -177.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.508 ' NE2' ' HB3' ' A' ' 107' ' ' PRO . 29.8 tt0 -130.86 100.92 5.43 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.723 -1.126 . . . . 0.83999999999999997 109.85 174.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.466 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 52.0 ttt180 -61.45 165.31 4.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.35 -0.841 . . . . 3.2799999999999998 110.137 173.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.759 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 29.9 m-80 -34.99 100.91 0.2 Allowed Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 125.12 1.368 . . . . 0.34999999999999998 112.657 -156.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.508 ' HB3' ' NE2' ' A' ' 104' ' ' GLN . 19.7 Cg_endo -67.04 -50.89 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.25 2.633 . . . . 0.63 112.827 176.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.56 -32.88 4.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.793 -0.718 . . . . 0.67000000000000004 111.336 -175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.06 -173.77 3.14 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.179 -0.51 . . . . 0.77000000000000002 112.512 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.42 ' O ' ' HA ' ' A' ' 128' ' ' THR . 36.2 Cg_endo -57.06 -11.57 7.89 Favored 'Trans proline' 0 N--CA 1.478 0.595 0 C-N-CA 124.307 3.338 . . . . 1.1499999999999999 113.071 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.428 ' CD2' ' HB2' ' A' ' 115' ' ' TRP . 6.2 m-30 -67.36 -37.99 84.06 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.802 -1.184 . . . . 1.5900000000000001 107.802 174.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.555 ' O ' ' HB1' ' A' ' 113' ' ' ALA . . . 54.2 29.65 45.68 Favored Glycine 0 CA--C 1.492 -1.405 0 CA-C-N 113.256 -1.793 . . . . 1.6899999999999999 117.232 161.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.759 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . . . 173.27 -51.19 0.01 OUTLIER 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.32 1.06 . . . . 1.1699999999999999 110.221 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.466 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -161.06 157.24 25.8 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.57 0.348 . . . . 0.60999999999999999 110.206 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.428 ' HB2' ' CD2' ' A' ' 111' ' ' PHE . 8.6 t-105 -135.68 99.05 4.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.129 -1.063 . . . . 0.56999999999999995 108.129 165.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 103' ' ' ARG . 2.7 mt -89.69 113.52 25.02 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.692 -0.855 . . . . 1.3600000000000001 108.692 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.477 ' O ' HG12 ' A' ' 101' ' ' ILE . 11.0 m -82.02 142.63 32.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.718 -0.674 . . . . 0.42999999999999999 110.153 -171.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.565 ' N ' HD21 ' A' ' 118' ' ' LEU . 1.3 mm? -108.14 163.81 12.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.282 -0.417 . . . . 1.02 111.725 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.3 t -57.6 -14.01 4.72 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 124.621 1.201 . . . . 1.79 112.546 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.681 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 5.9 tmtm? -125.94 130.33 51.06 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.266 -0.574 . . . . 1.8100000000000001 109.458 169.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.629 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 54.0 mt-30 -33.69 -60.29 0.37 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 125.438 1.711 . . . . 1.76 113.19 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.47 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -92.08 13.79 17.85 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.01 -0.676 . . . . 3.2000000000000002 112.412 -169.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.953 ' O ' HG12 ' A' ' 143' ' ' ILE . 2.5 m-30 -92.68 -35.13 13.66 Favored 'General case' 0 C--O 1.202 -1.441 0 CA-C-O 121.896 0.855 . . . . 0.83999999999999997 111.392 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.426 ' HA2' HD21 ' A' ' 118' ' ' LEU . . . -10.3 129.46 0.01 OUTLIER Glycine 0 C--N 1.286 -2.197 0 N-CA-C 119.414 2.526 . . . . 0.96999999999999997 119.414 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -98.43 116.52 41.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 112.538 -1.831 . . . . 1.04 110.149 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.631 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.2 p80 -144.13 -175.82 4.76 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 112.762 0.653 . . . . 0.20999999999999999 112.762 -174.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.17 -166.73 36.98 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 111.651 -0.579 . . . . 0.34999999999999998 111.651 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 110' ' ' PRO . 13.8 t -160.92 165.6 29.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 117.99 0.895 . . . . 1.1100000000000001 110.826 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -114.42 -2.04 13.34 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.806 -1.183 . . . . 2.1899999999999999 107.806 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -123.73 96.47 43.07 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 114.187 -1.369 . . . . 1.8400000000000001 108.157 170.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -74.54 -20.32 18.14 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.238 1.958 . . . . 0.39000000000000001 112.767 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.53 -0.16 40.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.414 0.626 . . . . 1.0800000000000001 110.674 -176.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 43.0 t -91.94 -5.17 53.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.928 -0.767 . . . . 1.9399999999999999 108.928 170.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 30.6 mm -84.56 133.66 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.768 -0.651 . . . . 1.04 110.498 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.1 1.45 69.84 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.804 -1.319 . . . . 0.16 109.804 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.404 ' HG3' ' N ' ' A' ' 137' ' ' ALA . 0.1 OUTLIER -113.69 161.79 17.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.913 1.34 . . . . 3.0299999999999998 114.067 -176.023 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -95.85 129.04 43.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 112.244 -2.253 . . . . 1.01 108.305 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 139' ' ' SER . 0.2 OUTLIER -126.02 165.07 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.618 -0.882 . . . . 1.3400000000000001 108.618 -175.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 66.0 m -50.02 -60.09 3.27 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.706 0.632 . . . . 0.87 112.706 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.461 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -133.87 -43.2 0.81 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 118.414 -1.314 . . . . 2.5499999999999998 113.802 -175.427 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.7 134.09 0.14 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 117.645 1.818 . . . . 0.19 117.645 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' CYS . . . . . 0.56 ' HG ' ' CD2' ' A' ' 126' ' ' HIS . 4.9 p -71.29 166.47 21.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 112.493 -1.853 . . . . 0.20000000000000001 112.037 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.953 HG12 ' O ' ' A' ' 123' ' ' TYR . 9.3 mm -58.9 101.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 115.118 -0.946 . . . . 1.1299999999999999 111.622 -162.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.631 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 28.6 mtp85 -88.17 141.13 28.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.178 -0.919 . . . . 2.3300000000000001 109.279 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.526 ' HG2' HG21 ' A' ' 84' ' ' ILE . 13.2 mtp -120.01 -168.49 1.62 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.959 -0.756 . . . . 1.0900000000000001 108.959 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.404 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 7.5 t-160 -88.89 155.52 19.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.414 -0.958 . . . . 2.9900000000000002 108.414 170.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.851 ' O ' HD12 ' A' ' 151' ' ' ILE . 7.9 m120 -73.38 -18.27 61.18 Favored 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 112.745 0.646 . . . . 0.73999999999999999 112.745 -172.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -82.02 -27.56 33.01 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 120.551 1.523 . . . . 2.6899999999999999 112.831 164.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 67.1 m-20 -82.57 -38.64 23.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.992 0.425 . . . . 0.68999999999999995 111.001 -173.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.51 HG12 HD11 ' A' ' 151' ' ' ILE . 12.2 p -67.22 -21.65 28.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 1.02 111.13 174.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 147' ' ' ASN . 1.6 mp -84.6 -40.86 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 119.029 -0.51 . . . . 1.1699999999999999 110.203 172.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 156' ' ' ILE . 4.4 mm-40 -44.7 -72.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.105 0.866 . . . . 1.99 112.203 168.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.559 ' O ' HG23 ' A' ' 157' ' ' VAL . 41.6 mt -46.32 -39.12 9.67 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.669 0.747 . . . . 1.9099999999999999 111.644 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.454 ' HB3' ' CE2' ' A' ' 114' ' ' TYR . . . -62.4 -37.66 86.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.159 -1.382 . . . . 1.04 111.764 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 34.6 t -86.79 -33.16 19.99 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.581 0.586 . . . . 0.88 112.581 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 152' ' ' GLU . 24.6 mt -81.24 -59.39 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.659 0.742 . . . . 1.0 111.367 -172.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 153' ' ' LEU . 3.0 m -89.57 141.89 29.01 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.743 -1.117 . . . . 1.0700000000000001 111.899 177.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -89.4 175.27 3.34 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.099 3.199 . . . . 0.23999999999999999 110.911 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.815 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.5 m-20 -65.38 158.63 26.07 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.831 -0.803 . . . . 1.1000000000000001 108.831 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 95.04 -17.9 58.41 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.108 -1.044 . . . . 0.17999999999999999 112.569 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.565 ' HB ' HD13 ' A' ' 100' ' ' ILE . 80.6 m -63.95 137.33 57.96 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.299 -0.63 . . . . 1.05 109.299 -175.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.15 119.82 32.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 122.673 1.225 . . . . 4.1100000000000003 111.137 -168.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.5 t -104.42 110.86 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 112.4 -2.182 . . . . 1.02 109.398 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.455 HG23 ' ND2' ' A' ' 166' ' ' ASN . 21.0 m -96.3 108.21 20.68 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 112.757 0.651 . . . . 1.0700000000000001 112.757 -173.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.526 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -81.28 106.64 12.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 122.198 0.999 . . . . 1.05 109.905 177.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.455 ' ND2' HG23 ' A' ' 164' ' ' THR . 64.1 m-80 -112.36 123.65 50.76 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.42 -1.264 . . . . 1.0900000000000001 109.806 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.517 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 17.7 mmm180 -68.48 -31.7 71.17 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.707 -0.479 . . . . 2.4900000000000002 109.707 175.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 162.32 57.11 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.651 -0.704 . . . . 1.97 112.418 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 110.213 -0.292 . . . . 4.3300000000000001 110.213 179.514 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.654 HD21 ' HA ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.58 0.705 . . . . 0.65 112.661 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.9 tt -98.99 129.05 45.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.581 -1.19 . . . . 0.28 110.466 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.32 162.18 13.45 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.076 0.941 . . . . 0.31 113.347 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 45' ' ' SER . 82.6 t80 -131.96 141.5 49.32 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.676 -1.602 . . . . 0.44 107.973 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.9 tt0 -114.64 115.23 26.79 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.198 -1.038 . . . . 0.76 108.198 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 13' ' ' ASP . 99.5 t -67.01 148.84 11.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 122.482 1.134 . . . . 0.39 113.125 -172.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -103.1 158.84 16.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.171 -1.831 . . . . 2.01 108.12 171.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -60.98 106.26 0.57 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 120.808 0.337 . . . . 1.83 111.754 -175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.35 11.67 38.18 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.689 -0.767 . . . . 0.48 113.553 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB2' HG13 ' A' ' 9' ' ' VAL . 65.3 m-20 -53.15 165.14 0.35 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.169 0.485 . . . . 1.46 111.646 172.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.1 147.69 47.72 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.43 0.633 . . . . 0.41 111.171 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.534 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.89 -40.69 87.84 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.901 -1.045 . . . . 0.86 108.446 -176.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -84.28 -18.08 37.58 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.576 -1.193 . . . . 1.15 110.266 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.9 t -71.66 -43.31 66.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.151 -0.685 . . . . 1.21 109.151 170.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.423 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.0 mt -72.19 -27.66 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.37 0.605 . . . . 0.21 109.502 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.07 -9.04 59.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.161 -0.472 . . . . 0.16 110.942 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.69 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.52 -40.79 8.48 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 122.631 1.205 . . . . 0.21 107.965 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.1 m-20 -62.2 -45.8 91.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 112.417 -2.174 . . . . 0.53 111.883 174.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.586 ' HA ' HG21 ' A' ' 101' ' ' ILE . 60.6 m-85 -96.23 5.63 50.59 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 118.624 -1.23 . . . . 0.18 111.213 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.69 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.7 mpt_? 54.2 45.86 26.5 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.648 0.737 . . . . 1.78 109.772 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.616 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 37.1 pt -120.53 -165.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.671 -1.149 . . . . 0.19 110.206 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.91 142.94 40.55 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.998 -1.001 . . . . 0.95 110.252 174.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.534 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 68.4 p -71.4 -33.38 69.43 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.914 -1.143 . . . . 0.25 107.914 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.01 68.08 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.443 -0.799 . . . . 0.2 111.954 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.539 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.63 -27.73 16.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.717 0.77 . . . . 0.17 109.198 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.576 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -74.83 -29.75 61.16 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.707 -1.133 . . . . 1.16 109.357 174.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.551 HD23 ' HB2' ' A' ' 36' ' ' LEU . 48.2 mt -76.6 -33.02 58.44 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.83 0.824 . . . . 1.05 110.117 171.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 36.9 tt0 -61.49 -39.21 90.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.356 -1.293 . . . . 1.81 109.522 172.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.632 ' HB1' HG13 ' A' ' 47' ' ' VAL . . . -86.47 -19.31 29.76 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.337 -0.545 . . . . 0.2 112.217 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.633 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 26.4 m-80 -149.61 81.32 7.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.359 0.6 . . . . 0.23 110.448 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.417 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 18.1 Cg_endo -56.63 -14.74 13.97 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 124.328 3.352 . . . . 0.36 114.054 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -73.69 -23.92 59.88 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.16 -0.337 . . . . 1.38 111.766 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.899 HD21 HG21 ' A' ' 46' ' ' ILE . 29.0 mt -67.91 -37.14 81.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.346 0.593 . . . . 0.49 112.199 -170.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 1.6 pp0? -63.43 -44.14 95.44 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 123.01 1.386 . . . . 1.95 110.764 -173.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.3 -47.71 81.13 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 111.722 -2.49 . . . . 0.49 110.705 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.57 48.44 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.887 -1.051 . . . . 0.42 111.488 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.94 157.83 20.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.424 0.631 . . . . 0.41 111.217 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.623 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 58.1 m -139.09 128.9 24.84 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.118 -0.946 . . . . 0.42 110.193 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.96 120.44 21.3 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.035 -0.666 . . . . 0.47 109.916 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 97.73 2.44 58.53 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 110.365 -1.094 . . . . 0.41 110.365 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.623 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.3 OUTLIER -78.15 124.53 28.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.228 -0.656 . . . . 1.3 109.228 178.655 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 37.4 p -81.48 124.12 29.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.956 0.884 . . . . 0.85 110.842 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.899 HG21 HD21 ' A' ' 36' ' ' LEU . 1.4 pp -129.87 132.8 65.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 113.933 -1.485 . . . . 0.25 108.974 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.632 HG13 ' HB1' ' A' ' 32' ' ' ALA . 14.7 p -93.79 163.65 2.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 114.857 -1.065 . . . . 0.67 111.025 -169.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.481 HG13 ' CE2' ' A' ' 22' ' ' PHE . 39.3 mm -121.24 102.48 43.13 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 114.698 -1.137 . . . . 0.16 109.894 -173.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.654 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -66.27 135.85 41.56 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.928 1.752 . . . . 0.18 112.341 -175.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.45 -5.94 80.52 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.065 -0.97 . . . . 0.26 112.42 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.701 HD12 ' HD2' ' A' ' 52' ' ' PRO . 36.1 tp -122.72 116.1 29.28 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-O 121.218 0.532 . . . . 0.61 111.408 -177.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.701 ' HD2' HD12 ' A' ' 51' ' ' LEU . 53.5 Cg_endo -78.12 -176.91 3.5 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.918 3.079 . . . . 0.28 114.362 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.613 ' HB3' HG23 ' A' ' 56' ' ' THR . 8.9 t70 -84.96 128.02 62.16 Favored Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-N 114.302 -1.317 . . . . 0.49 111.975 -169.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 37.4 Cg_endo -69.94 -18.19 36.3 Favored 'Trans proline' 0 CA--C 1.519 -0.248 0 C-N-CA 123.619 2.879 . . . . 0.46 112.69 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.411 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 69.3 m-85 -96.09 2.36 53.17 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.529 0.681 . . . . 1.38 111.451 -173.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 53' ' ' ASP . 18.5 p -98.45 -20.58 17.03 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.897 -1.149 . . . . 0.46 107.897 171.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 59' ' ' TYR . 19.4 mt -73.17 133.02 81.66 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 113.254 -1.794 . . . . 0.7 111.335 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.42 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 92.4 Cg_endo -79.33 -15.86 12.42 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.381 2.054 . . . . 0.39 113.883 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.604 ' H ' HG22 ' A' ' 57' ' ' ILE . 50.7 m-85 -104.09 164.04 11.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.023 0.749 . . . . 0.24 113.023 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -147.67 139.48 24.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.982 -1.008 . . . . 2.89 108.795 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.671 ' HA ' ' O ' ' A' ' 71' ' ' THR . 79.2 mt -116.09 132.27 66.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.316 -0.402 . . . . 0.16 111.718 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.23 116.57 27.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.897 -0.721 . . . . 0.16 111.122 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 65.0 t -98.57 112.99 32.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.647 0.737 . . . . 0.19 111.163 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 68' ' ' LYS . 53.3 m -95.74 100.87 12.53 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.893 -1.049 . . . . 0.2 110.748 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.58 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.1 mm -48.93 -58.76 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.987 0.899 . . . . 0.23 111.788 171.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.58 -9.38 3.44 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 112.925 -1.943 . . . . 0.16 113.055 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.57 -19.57 4.55 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.581 0.752 . . . . 0.15 112.087 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.519 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.68 55.93 4.47 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.27 0.486 . . . . 0.69 111.236 -173.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.7 p -137.24 159.67 41.26 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 112.861 0.689 . . . . 0.13 112.861 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.503 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.7 tt -126.77 112.58 15.56 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.559 -1.2 . . . . 0.4 110.004 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.671 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 29.6 m -93.62 122.4 36.04 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.226 0.536 . . . . 0.16 111.288 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.5 tp -98.0 103.74 15.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.003 -0.998 . . . . 0.59 109.464 172.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 82.2 p -105.75 161.11 14.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 119.086 -1.045 . . . . 1.05 110.612 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.607 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -127.08 128.23 45.93 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.541 -0.911 . . . . 0.26 108.541 170.285 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.607 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.7 p-10 43.8 51.15 6.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.303 -1.317 . . . . 1.84 111.892 -166.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.7 t30 74.76 -13.19 0.85 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.1 -0.954 . . . . 1.89 111.382 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -95.76 121.37 37.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.92 -0.582 . . . . 3.44 109.888 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 78.0 t -59.55 132.48 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 122.362 1.077 . . . . 0.24 112.499 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 18.3 mtm -100.55 -46.91 5.05 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 113.022 -1.899 . . . . 0.81 108.805 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -155.56 172.97 17.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.42 -1.718 . . . . 1.46 110.019 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 78.6 m -148.75 123.02 9.58 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.082 -1.417 . . . . 0.17 109.783 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -108.01 145.34 31.22 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.487 -0.779 . . . . 1.05 109.274 -176.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.435 ' HB2' HG22 ' A' ' 134' ' ' ILE . 42.7 Cg_endo -74.94 141.96 27.47 Favored 'Trans proline' 0 CA--C 1.499 -1.238 0 C-N-CA 122.031 1.82 . . . . 0.2 111.285 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.668 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.44 175.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.92 -0.582 . . . . 0.13 111.051 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.876 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.13 147.32 44.31 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.306 -0.406 . . . . 0.26 110.15 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.519 HG22 ' HG3' ' A' ' 68' ' ' LYS . 11.4 m -129.64 128.44 65.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.47 0.653 . . . . 0.56 112.004 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -89.06 157.9 27.53 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 110.624 -0.99 . . . . 0.17 110.624 173.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -56.37 2.68 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.309 0.855 . . . . 3.05 113.309 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.927 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -89.9 -20.52 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 121.83 0.824 . . . . 0.23 110.149 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.927 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -90.85 -19.53 23.29 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.442 -0.799 . . . . 0.18 109.211 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -66.74 -16.51 64.29 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.419 -1.264 . . . . 0.33 111.715 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -64.64 -42.32 95.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.841 -1.072 . . . . 1.52 112.343 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.31 119.42 56.39 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.574 -0.45 . . . . 0.43 110.966 -175.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.445 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 1.1 Cg_endo -78.8 -1.92 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.839 2.359 . . . . 0.73 113.239 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 96' ' ' GLY . 11.0 t -119.73 -42.46 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.838 0.351 . . . . 0.48 110.408 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.68 38.87 22.84 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.717 -1.129 . . . . 0.33 114.063 168.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.485 ' HG2' HG23 ' A' ' 164' ' ' THR . 45.9 mt-10 -83.86 113.02 20.65 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.969 0.89 . . . . 0.84 109.606 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.683 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 23.6 m-85 -137.61 176.15 8.97 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.909 -1.496 . . . . 0.22 111.914 -170.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 82.7 m-85 -140.95 136.9 32.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.243 -0.435 . . . . 0.54 110.603 -173.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.579 HD12 ' HB ' ' A' ' 161' ' ' THR . 81.6 mt -61.24 117.56 2.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.23 -0.895 . . . . 0.17 110.816 172.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.586 HG21 ' HA ' ' A' ' 22' ' ' PHE . 20.8 pt -84.5 -35.43 10.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 112.766 0.654 . . . . 0.21 112.766 -176.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.416 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 1.7 p-10 178.82 179.18 0.41 Allowed 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.32 -1.363 . . . . 2.03 107.32 -176.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.16 155.58 49.4 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.873 -0.731 . . . . 1.52 112.303 -174.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -128.21 100.69 5.94 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.048 -0.978 . . . . 0.59 109.872 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.496 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 71.2 ttt180 -62.77 166.31 5.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.162 -0.926 . . . . 2.82 110.693 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.512 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 18.1 m-80 -34.75 102.97 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 125.189 1.395 . . . . 0.35 113.195 -155.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.512 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.8 Cg_endo . . . . . 0 N--CA 1.457 -0.627 0 C-N-CA 123.045 2.496 . . . . 0.48 111.695 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.527 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.502 0 N-CA-C 117.177 2.288 . . . . 0.48 117.177 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.496 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -165.4 158.41 16.02 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.204 -0.935 . . . . 0.28 110.297 -175.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -138.54 98.1 3.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.241 -1.022 . . . . 0.49 108.241 167.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 103' ' ' ARG . 2.4 mt -89.02 114.27 25.46 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.033 -0.728 . . . . 0.66 109.033 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.418 ' C ' HG12 ' A' ' 101' ' ' ILE . 20.0 m -85.24 143.58 28.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.808 -0.633 . . . . 0.19 111.424 -169.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.794 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.9 mm? -108.3 166.4 10.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.13 111.7 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.0 t -60.52 -13.27 12.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.793 -1.094 . . . . 1.17 112.816 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.683 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 4.9 tptm -126.27 130.27 50.54 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 120.492 -0.483 . . . . 1.22 110.138 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 52.9 mt-30 -34.44 -57.61 0.5 Allowed 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.548 1.155 . . . . 1.51 113.994 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.534 ' CB ' HG12 ' A' ' 89' ' ' ILE . 32.5 m-70 -88.91 -1.78 58.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.317 0.58 . . . . 2.53 111.635 -171.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.794 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -91.31 38.16 0.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.523 0.934 . . . . 0.84 113.523 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.62 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -112.97 145.08 18.19 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 117.222 -2.418 . . . . 0.32 112.783 -152.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.528 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -98.69 116.32 41.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 123.739 0.816 . . . . 0.18 110.833 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.637 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 27.5 p80 -145.62 171.15 15.12 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.229 -0.896 . . . . 0.21 109.585 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.1 -168.62 39.19 Favored Glycine 0 C--N 1.316 -0.563 0 C-N-CA 120.107 -1.044 . . . . 0.27 111.51 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -153.23 175.0 13.55 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.962 -0.728 . . . . 0.41 110.27 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -116.79 0.41 12.52 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.61 -0.885 . . . . 1.99 108.61 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -118.9 86.75 31.74 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 114.928 -1.033 . . . . 1.36 108.476 172.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -72.72 -17.52 25.91 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.293 1.996 . . . . 0.35 113.283 -169.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.37 -1.1 35.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.968 -0.56 . . . . 0.33 111.094 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.476 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 98.1 p -91.57 -6.8 51.78 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.983 -0.747 . . . . 1.35 108.983 170.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 44.2 mm -80.49 136.42 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.54 -0.755 . . . . 0.21 110.217 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.61 80.14 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.906 -1.277 . . . . 0.15 109.906 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 5.7 tttt -111.67 161.64 16.05 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 122.952 1.358 . . . . 2.5 113.743 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -97.44 124.27 41.58 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 112.193 -2.276 . . . . 0.17 107.659 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.442 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -120.74 160.86 21.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.894 -0.78 . . . . 0.66 108.894 -173.106 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.9 m -51.5 -58.76 5.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.688 0.625 . . . . 0.43 112.688 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -132.56 -43.32 0.92 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 118.329 -1.348 . . . . 2.02 113.555 -176.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.453 ' N ' ' HD3' ' A' ' 140' ' ' LYS . . . -31.5 133.23 0.14 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 116.958 1.543 . . . . 0.18 116.958 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.7 p -74.5 164.84 26.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.489 -1.855 . . . . 0.16 111.571 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.876 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.0 mt -59.9 98.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 122.48 1.133 . . . . 0.4 112.111 -162.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.637 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 79.9 mtt180 -84.33 151.66 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.601 -1.636 . . . . 1.87 110.537 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.668 ' HG2' HG22 ' A' ' 84' ' ' ILE . 14.7 mtp -130.94 -166.57 1.71 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.799 -0.637 . . . . 0.79 109.333 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.643 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 15.8 t-80 -97.81 152.89 18.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.825 -0.806 . . . . 2.32 108.825 172.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.616 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.3 m120 -56.17 -53.39 57.63 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 118.247 -0.882 . . . . 0.68 110.629 -175.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -64.66 -24.18 67.5 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 121.6 2.0 . . . . 2.18 112.04 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.643 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 4.6 m-20 -81.59 -43.36 18.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.661 -0.7 . . . . 0.69 110.818 -176.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.637 HG13 HD12 ' A' ' 151' ' ' ILE . 14.6 p -68.58 -23.03 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.731 -0.668 . . . . 0.11 111.297 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.637 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.68 -37.9 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 119.062 -0.494 . . . . 0.38 110.091 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 156' ' ' ILE . 9.3 mm-40 -45.09 -72.71 0.05 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.279 0.945 . . . . 1.99 112.022 167.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 157' ' ' VAL . 52.4 mt -46.81 -40.42 13.73 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 123.85 0.719 . . . . 1.27 111.479 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.73 -37.07 80.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.119 -1.4 . . . . 0.18 111.758 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.0 t -88.16 -31.94 18.88 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.51 -0.744 . . . . 0.21 112.506 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.2 mt -81.07 -59.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.561 0.695 . . . . 0.16 111.561 -172.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.1 m -89.38 142.96 30.11 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.871 -1.059 . . . . 0.16 112.097 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -90.72 175.03 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 124.015 3.143 . . . . 0.2 110.939 172.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.416 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 37.1 m-20 -65.99 157.86 29.74 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.655 -0.818 . . . . 1.1 109.078 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.35 -18.53 57.31 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.119 -1.038 . . . . 0.18 112.423 -174.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' HD12 ' A' ' 100' ' ' ILE . 78.2 m -65.12 138.89 58.58 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.035 -0.728 . . . . 0.14 109.035 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.622 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 11.3 ptm180 -92.44 127.25 37.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.741 1.258 . . . . 3.63 111.211 -170.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.4 t -109.02 107.45 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 112.088 -2.324 . . . . 0.14 108.631 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.485 HG23 ' HG2' ' A' ' 97' ' ' GLU . 13.8 m -94.35 104.72 16.7 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.49 0.552 . . . . 0.21 112.49 -171.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.478 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -83.36 96.47 4.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 122.342 1.068 . . . . 0.24 109.955 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -107.6 132.49 53.23 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.009 -1.451 . . . . 1.09 109.215 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.58 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 19.2 mmm180 . . . . . 0 C--N 1.317 -0.809 0 N-CA-C 109.2 -0.667 . . . . 2.08 109.2 174.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.289 0.566 . . . . 0.65 111.392 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.667 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.0 tt -92.12 130.08 37.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.284 -0.871 . . . . 0.28 110.445 -175.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.33 162.14 13.33 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.36 1.076 . . . . 0.31 113.239 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.64 ' O ' ' HA ' ' A' ' 45' ' ' SER . 72.0 t80 -131.96 142.25 49.56 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.294 -1.776 . . . . 0.44 107.89 175.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.491 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 33.8 tt0 -113.25 112.71 24.2 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.091 -1.078 . . . . 0.76 108.091 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.632 HG13 ' HB2' ' A' ' 13' ' ' ASP . 96.1 t -66.67 151.35 10.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.364 1.078 . . . . 0.39 112.74 -170.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -106.58 158.21 17.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.431 -1.713 . . . . 2.01 108.372 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.23 107.68 0.51 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.782 0.325 . . . . 1.83 111.819 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.77 46.23 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.857 -0.687 . . . . 0.48 113.895 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.632 ' HB2' HG13 ' A' ' 9' ' ' VAL . 68.9 m-20 -54.46 170.16 0.16 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 117.181 0.49 . . . . 1.46 111.391 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -129.23 152.07 49.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.086 0.469 . . . . 0.41 111.603 176.136 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.597 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.03 -36.37 83.07 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.044 -0.98 . . . . 0.86 108.574 -177.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 4.5 t30 -87.62 -26.04 23.26 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.764 -1.107 . . . . 1.15 110.552 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.423 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 13.0 t -66.05 -40.92 91.33 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.515 -0.55 . . . . 1.21 109.515 174.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.477 HG23 ' CE1' ' A' ' 22' ' ' PHE . 13.8 mt -73.86 -28.15 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.116 0.484 . . . . 0.21 109.783 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.644 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.43 -11.37 59.91 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.699 -0.4 . . . . 0.16 110.896 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.723 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -93.12 -40.98 10.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.406 0.622 . . . . 0.21 109.784 174.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.643 ' HB3' ' O ' ' A' ' 119' ' ' SER . 23.0 m-20 -63.42 -42.87 98.73 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.485 -1.234 . . . . 0.53 111.922 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.532 ' HA ' HG21 ' A' ' 101' ' ' ILE . 47.8 m-85 -96.33 4.85 51.99 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 118.597 -1.241 . . . . 0.18 111.112 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.723 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER 54.51 40.77 32.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.961 0.886 . . . . 1.78 109.418 176.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.644 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.6 pt -114.3 -165.52 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.102 -1.408 . . . . 0.19 109.86 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.48 142.91 41.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.205 -0.907 . . . . 0.95 110.212 175.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.537 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 71.4 p -73.21 -32.72 64.95 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.057 -1.09 . . . . 0.25 108.057 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.7 -27.06 67.6 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.182 -0.917 . . . . 0.2 111.796 170.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.95 -27.28 16.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.972 -0.751 . . . . 0.17 108.972 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.653 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 17.8 tp -74.71 -26.2 59.65 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.298 -0.865 . . . . 1.16 109.331 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 26' ' ' THR . 35.9 mt -77.31 -29.98 53.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.695 0.759 . . . . 1.05 110.076 171.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.479 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 34.4 tt0 -65.14 -41.63 94.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.393 -1.276 . . . . 1.81 110.103 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.27 -20.67 31.8 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.937 -0.705 . . . . 0.2 111.594 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.65 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.8 m-80 -147.15 80.67 9.25 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 121.615 0.721 . . . . 0.23 110.693 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.8 Cg_endo -56.79 -14.89 14.87 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 C-N-CA 124.099 3.199 . . . . 0.36 114.199 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.2 t -79.59 -20.9 45.79 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.809 -0.356 . . . . 1.38 111.115 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.825 HD21 HG21 ' A' ' 46' ' ' ILE . 67.6 mt -65.31 -39.19 92.18 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.542 0.687 . . . . 0.49 111.826 -172.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 5.9 pt20 -64.05 -44.59 91.98 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 122.88 1.324 . . . . 1.95 110.251 -174.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.05 -50.15 74.43 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 111.795 -2.457 . . . . 0.49 110.439 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.23 175.16 46.97 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 114.779 -1.101 . . . . 0.42 111.74 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -107.9 155.99 19.67 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.229 0.538 . . . . 0.41 110.876 178.178 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.644 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 34.5 m -139.46 128.64 23.9 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.218 -0.901 . . . . 0.42 110.513 -175.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 119.99 20.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.634 0.731 . . . . 0.47 110.396 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.491 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 98.13 0.73 58.44 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 114.738 -1.119 . . . . 0.41 110.325 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.644 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.2 tt0 -74.8 123.41 24.95 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.672 -0.764 . . . . 1.3 109.654 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 54.8 p -82.34 128.49 34.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.776 0.798 . . . . 0.85 110.067 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.825 HG21 HD21 ' A' ' 36' ' ' LEU . 9.0 pt -128.52 142.35 44.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.306 -1.316 . . . . 0.25 109.477 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.77 151.27 3.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.208 0.527 . . . . 0.67 111.019 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.1 mm -115.13 92.71 32.46 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 114.842 -1.072 . . . . 0.16 109.439 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.673 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.4 Cg_endo -58.46 134.89 64.13 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.812 2.341 . . . . 0.18 112.693 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.03 -4.06 81.09 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 114.948 -1.023 . . . . 0.26 112.405 -176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.696 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.7 tp -129.28 117.97 19.07 Favored Pre-proline 0 N--CA 1.446 -0.638 0 CA-C-O 121.223 0.535 . . . . 0.61 111.341 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.685 ' HD2' HD12 ' A' ' 51' ' ' LEU . 55.5 Cg_endo -79.23 -177.96 4.27 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.585 2.857 . . . . 0.28 114.155 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.613 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.4 t0 -80.72 126.64 77.55 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.513 -1.222 . . . . 0.49 111.542 -171.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 60.5 Cg_endo -73.22 -16.73 24.92 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.204 2.603 . . . . 0.46 112.459 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -89.22 -10.33 47.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.842 -0.617 . . . . 1.38 110.438 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 53' ' ' ASP . 25.1 p -88.15 -23.35 23.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.535 1.159 . . . . 0.46 108.427 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 59' ' ' TYR . 15.3 mt -72.94 129.51 86.42 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 112.973 -1.922 . . . . 0.7 111.354 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.69 -19.73 14.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.336 2.024 . . . . 0.39 113.386 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.512 ' H ' HG22 ' A' ' 57' ' ' ILE . 60.5 m-85 -91.91 158.68 16.16 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.546 -0.462 . . . . 0.24 111.558 -176.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -148.77 129.87 14.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.026 -0.731 . . . . 2.89 109.026 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.5 mt -111.38 130.96 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.946 -0.57 . . . . 0.16 111.609 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.96 119.88 38.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.001 -0.68 . . . . 0.16 111.028 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.85 116.42 41.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.446 0.641 . . . . 0.19 110.833 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 68' ' ' LYS . 69.0 m -95.81 104.27 16.2 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.011 -0.995 . . . . 0.2 110.8 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.534 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.9 mm -51.64 -59.38 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.937 0.875 . . . . 0.23 111.59 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.82 -11.94 4.72 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 113.051 -1.886 . . . . 0.16 113.18 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.18 -18.87 4.87 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.369 0.668 . . . . 0.15 112.444 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HG2' ' C ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER 58.89 54.97 4.79 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.522 0.601 . . . . 0.69 111.26 -173.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.5 p -136.77 160.99 37.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.811 0.671 . . . . 0.13 112.811 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 70' ' ' LEU . 8.1 tt -129.04 113.51 15.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.765 -1.107 . . . . 0.4 110.044 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.699 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.4 m -93.77 123.67 37.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.976 0.417 . . . . 0.16 111.337 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.8 tp -98.78 104.92 17.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.58 -0.737 . . . . 0.59 109.434 171.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.6 m -104.96 159.61 15.67 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.541 -0.863 . . . . 1.05 110.519 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -127.88 127.26 43.09 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.903 -0.777 . . . . 0.26 108.903 168.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.558 ' N ' HD22 ' A' ' 74' ' ' LEU . 15.5 m120 48.21 50.36 16.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.584 -1.189 . . . . 1.84 111.076 -171.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 71.9 -10.03 0.91 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.755 0.822 . . . . 1.89 111.662 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -96.43 120.52 36.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.067 -0.515 . . . . 3.44 109.893 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 55.8 t -59.31 131.58 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-O 122.295 1.045 . . . . 0.24 112.017 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 5.4 mtm -103.08 -43.85 5.37 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.342 -1.754 . . . . 0.81 109.368 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -157.94 170.69 21.75 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.264 -1.789 . . . . 1.46 110.209 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 83.5 m -149.38 128.03 12.41 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.129 -1.396 . . . . 0.17 109.517 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -115.94 147.46 39.22 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 116.243 -0.435 . . . . 1.05 110.729 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HB2' HG22 ' A' ' 134' ' ' ILE . 36.8 Cg_endo -71.86 144.33 43.16 Favored 'Trans proline' 0 CA--C 1.491 -1.645 0 C-N-CA 122.333 2.022 . . . . 0.2 110.284 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.595 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.3 pp -139.34 166.33 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-N 115.902 -0.59 . . . . 0.13 110.797 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.819 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -112.85 128.17 56.38 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.732 -0.84 . . . . 0.26 108.732 -176.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.413 HG12 ' HD2' ' A' ' 68' ' ' LYS . 1.7 p -124.15 130.93 73.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 114.076 -1.42 . . . . 0.56 111.168 -162.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -96.03 151.05 19.82 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.277 -1.329 . . . . 0.17 111.896 -175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 139' ' ' SER . 45.7 mmtm -57.71 2.7 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.525 -0.838 . . . . 3.05 113.145 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.882 HG23 HD22 ' A' ' 90' ' ' LEU . 1.6 tp -89.79 -19.65 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.725 0.774 . . . . 0.23 110.27 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.882 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -88.4 -11.56 45.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.396 -0.82 . . . . 0.18 109.431 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -70.11 -16.53 63.13 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.952 -1.022 . . . . 0.33 111.55 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -71.83 -27.33 62.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.8 -1.091 . . . . 1.52 112.972 -172.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.8 130.7 22.64 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 119.976 -0.69 . . . . 0.43 110.771 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.46 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 89.9 Cg_endo -88.48 -2.24 6.74 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.707 2.271 . . . . 0.73 112.357 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 96' ' ' GLY . 13.6 t -122.99 -41.83 2.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.884 -0.598 . . . . 0.48 109.634 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 47.16 42.79 17.47 Favored Glycine 0 N--CA 1.45 -0.377 0 O-C-N 123.832 0.708 . . . . 0.33 113.89 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.84 112.64 20.72 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.729 0.776 . . . . 0.84 109.484 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.756 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 25.2 m-85 -137.06 177.76 7.61 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.158 -1.383 . . . . 0.22 111.985 -170.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.491 ' CG ' HD11 ' A' ' 5' ' ' LEU . 21.2 m-85 -140.4 143.05 35.46 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.54 110.521 -174.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.599 HD12 ' HB ' ' A' ' 161' ' ' THR . 76.6 mt -66.98 113.72 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 115.488 -0.778 . . . . 0.17 110.132 169.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.559 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 26.0 pt -84.33 -34.25 9.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 112.967 0.728 . . . . 0.21 112.967 -175.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.501 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 2.0 p-10 179.97 177.79 0.63 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.488 -1.301 . . . . 2.03 107.488 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.456 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.11 153.81 50.44 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.177 -0.609 . . . . 1.52 111.959 -175.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -125.38 100.97 6.74 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.097 -0.956 . . . . 0.59 109.655 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.491 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 34.1 ttp180 -60.85 166.33 3.46 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.151 -0.931 . . . . 2.82 110.59 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.491 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 20.6 m-80 -34.86 102.33 0.22 Allowed Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 124.997 1.319 . . . . 0.35 113.33 -155.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 8.6 Cg_endo . . . . . 0 N--CA 1.457 -0.656 0 C-N-CA 123.075 2.517 . . . . 0.48 111.365 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.515 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.493 0 N-CA-C 117.216 2.302 . . . . 0.48 117.216 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.465 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -165.69 164.76 18.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.426 -0.796 . . . . 0.28 109.929 -177.1 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -145.09 96.72 2.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.054 -1.091 . . . . 0.49 108.054 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.528 HD12 HG23 ' A' ' 150' ' ' VAL . 2.0 mt -87.28 114.12 23.6 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.24 -0.652 . . . . 0.66 109.24 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 101' ' ' ILE . 27.1 m -83.48 143.89 29.93 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.684 -0.689 . . . . 0.19 111.044 -170.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.797 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -108.99 165.26 11.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.032 -0.531 . . . . 0.13 110.789 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.643 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 8.8 m -64.73 -1.8 2.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.171 0.804 . . . . 1.17 113.171 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.757 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 3.6 tmtm? -129.71 132.19 46.56 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.958 -0.386 . . . . 1.22 109.958 167.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.757 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 55.5 mt-30 -33.27 -57.97 0.4 Allowed 'General case' 0 C--N 1.309 -1.17 0 O-C-N 124.692 1.245 . . . . 1.51 114.324 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.621 ' HB3' HG12 ' A' ' 89' ' ' ILE . 1.4 t-80 -94.51 5.04 53.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.315 0.578 . . . . 2.53 111.423 -170.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.797 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -94.8 37.42 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.504 0.927 . . . . 0.84 113.504 -174.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.598 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -113.23 144.2 18.02 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 116.963 -2.542 . . . . 0.32 112.749 -152.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.518 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -96.79 115.13 35.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.895 0.855 . . . . 0.18 110.644 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.734 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.9 p80 -144.96 173.48 11.84 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.262 -0.881 . . . . 0.21 109.648 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.26 -168.03 38.73 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.252 -0.975 . . . . 0.27 111.57 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.2 t -155.01 172.06 18.73 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.942 -0.74 . . . . 0.41 110.756 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -114.08 -2.06 13.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.961 0.886 . . . . 1.99 108.652 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -115.92 86.55 16.65 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 114.754 -1.112 . . . . 1.36 108.09 170.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -73.3 -19.47 22.3 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.225 1.95 . . . . 0.35 113.191 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.27 -2.72 42.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.788 -0.642 . . . . 0.33 110.869 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 33.4 t -90.25 -6.79 54.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.275 -0.639 . . . . 1.35 109.275 171.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.421 HG22 ' HB2' ' A' ' 83' ' ' PRO . 38.2 mm -78.6 132.48 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.855 -0.611 . . . . 0.21 111.209 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.61 1.84 63.65 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.109 -1.196 . . . . 0.15 110.109 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.522 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 23.9 mttp -112.44 169.96 8.51 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 122.798 1.285 . . . . 2.5 114.047 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.17 126.56 44.98 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.317 -2.22 . . . . 0.17 108.248 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.56 158.66 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.473 -0.936 . . . . 0.66 108.473 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 49.4 m -51.46 -59.29 4.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.286 0.476 . . . . 0.43 112.286 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -131.17 -44.59 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.628 -1.229 . . . . 2.02 113.813 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.29 133.58 0.19 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 116.999 1.56 . . . . 0.18 116.999 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.8 p -73.23 166.06 23.86 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.519 -1.84 . . . . 0.16 112.13 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.819 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 44.7 mt -59.75 96.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 122.406 1.098 . . . . 0.4 112.027 -163.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.734 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 79.1 mtt180 -86.08 146.75 26.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.53 -1.668 . . . . 1.87 110.724 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.595 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.1 mtp -126.45 -164.82 1.37 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.901 -0.777 . . . . 0.79 108.901 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.467 ' O ' HG12 ' A' ' 150' ' ' VAL . 41.5 m80 -91.53 162.9 14.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.575 -0.528 . . . . 2.32 109.575 169.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.644 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.2 m120 -62.03 -49.92 74.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 118.537 -0.745 . . . . 0.68 110.007 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -63.81 -28.27 69.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 121.021 1.737 . . . . 2.18 112.106 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -78.1 -46.46 20.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.157 0.503 . . . . 0.69 110.401 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.675 HG13 HD12 ' A' ' 151' ' ' ILE . 13.4 p -67.11 -23.21 30.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.248 -0.887 . . . . 0.11 111.62 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.675 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -84.27 -42.63 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 118.764 -0.636 . . . . 0.38 110.409 172.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 156' ' ' ILE . 24.9 mt-10 -47.98 -68.69 0.16 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 119.514 1.052 . . . . 1.99 112.467 171.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.506 ' O ' HG22 ' A' ' 157' ' ' VAL . 27.4 mt -47.6 -39.89 17.96 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.638 0.732 . . . . 1.27 111.463 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.33 72.09 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.156 -1.384 . . . . 0.18 111.57 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 24.6 t -88.37 -32.07 18.57 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.573 -0.704 . . . . 0.21 112.523 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.8 mt -82.01 -59.93 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.673 0.749 . . . . 0.16 111.506 -172.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.9 m -90.42 143.79 29.85 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 114.739 -1.119 . . . . 0.16 111.918 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -90.98 175.21 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 124.174 3.249 . . . . 0.2 111.136 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 73.4 m-20 -66.8 157.24 33.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 119.668 -0.813 . . . . 1.1 109.196 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.16 -24.29 32.46 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.042 -1.075 . . . . 0.18 112.154 -172.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.599 ' HB ' HD12 ' A' ' 100' ' ' ILE . 84.6 m -60.35 132.07 52.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.675 -0.861 . . . . 0.14 108.675 -176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.634 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -93.59 128.98 39.99 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 122.581 1.182 . . . . 3.63 111.012 -166.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.24 110.77 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 112.337 -2.21 . . . . 0.14 109.706 -173.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -94.79 108.89 20.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.045 -0.525 . . . . 0.21 112.172 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.457 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -82.51 100.68 6.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 122.51 1.148 . . . . 0.24 109.687 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -104.33 129.92 52.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 113.688 -1.597 . . . . 1.09 108.749 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.534 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 16.1 mmm180 . . . . . 0 C--N 1.321 -0.674 0 CA-C-O 120.995 0.426 . . . . 2.08 110.029 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 121.247 0.546 . . . . 0.65 111.307 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.3 tt -94.54 127.52 40.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.222 -0.899 . . . . 0.28 110.437 -174.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 162.64 13.33 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.265 1.031 . . . . 0.31 113.347 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.608 ' HB3' HG13 ' A' ' 46' ' ' ILE . 87.4 t80 -130.82 140.77 50.29 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.622 -1.626 . . . . 0.44 107.876 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.424 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 58.7 tt0 -114.03 113.46 24.8 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.353 -0.98 . . . . 0.76 108.353 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.599 HG13 ' HB2' ' A' ' 13' ' ' ASP . 96.7 t -67.88 150.89 10.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.553 1.168 . . . . 0.39 113.325 -168.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -105.43 158.58 16.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.096 -1.866 . . . . 2.01 108.211 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -63.42 104.69 0.65 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.416 0.524 . . . . 1.83 112.416 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.87 10.7 27.91 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.885 -0.674 . . . . 0.48 113.203 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.599 ' HB2' HG13 ' A' ' 9' ' ' VAL . 82.1 m-20 -54.94 167.53 0.38 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.871 0.367 . . . . 1.46 111.172 172.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.78 153.1 46.03 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.485 0.66 . . . . 0.41 111.419 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.588 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.26 -34.88 79.0 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.466 -0.939 . . . . 0.86 108.466 -179.211 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.451 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 32.6 t-20 -88.8 -25.87 22.0 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.878 -1.056 . . . . 1.15 111.098 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p -66.99 -41.02 87.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 119.866 -0.734 . . . . 1.21 109.402 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.412 HG23 ' CE1' ' A' ' 22' ' ' PHE . 16.8 mt -72.82 -26.63 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.285 0.564 . . . . 0.21 109.747 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.628 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.34 -9.94 59.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.374 -0.375 . . . . 0.16 111.199 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.646 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.43 -39.08 9.76 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.683 1.23 . . . . 0.21 107.911 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.777 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 7.8 m-20 -63.96 -46.42 84.72 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.097 -2.319 . . . . 0.53 112.239 173.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 58.5 m-85 -95.92 5.91 50.12 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 118.58 -1.248 . . . . 0.18 111.183 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.646 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 6.0 mpt_? 54.06 43.12 31.2 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.82 0.819 . . . . 1.78 109.69 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.628 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.1 pt -116.78 -165.78 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 114.521 -1.218 . . . . 0.19 110.121 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.49 142.57 40.34 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.912 -1.04 . . . . 0.95 110.067 175.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.563 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 66.9 p -73.11 -31.62 64.44 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.089 -1.078 . . . . 0.25 108.089 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 -29.79 69.99 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.314 -0.857 . . . . 0.2 111.64 169.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.75 -26.83 18.4 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.991 -0.744 . . . . 0.17 108.991 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.616 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.5 tp -74.9 -27.28 60.16 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.198 -0.91 . . . . 1.16 109.528 173.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 26' ' ' THR . 32.3 mt -76.98 -30.84 56.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.745 0.784 . . . . 1.05 109.822 171.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 27.6 tt0 -62.92 -43.32 99.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.374 -1.284 . . . . 1.81 109.867 173.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.62 -20.08 34.33 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.072 -0.651 . . . . 0.2 111.716 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.638 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 30.0 m-80 -146.62 81.76 9.11 Favored Pre-proline 0 N--CA 1.449 -0.485 0 CA-C-O 121.578 0.704 . . . . 0.23 110.932 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 20.4 Cg_endo -58.24 -9.94 7.45 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 124.26 3.306 . . . . 0.36 113.971 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 t -79.16 -24.92 42.95 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.175 -0.328 . . . . 1.38 110.83 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.829 HD21 HG21 ' A' ' 46' ' ' ILE . 45.0 mt -67.11 -35.46 79.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.425 0.631 . . . . 0.49 111.913 -170.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.428 ' NE2' ' HB2' ' A' ' 38' ' ' ALA . 1.6 pp0? -63.02 -46.05 89.42 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 122.96 1.362 . . . . 1.95 110.147 -174.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.428 ' HB2' ' NE2' ' A' ' 37' ' ' GLN . . . -64.9 -47.42 77.86 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 111.554 -2.566 . . . . 0.49 110.749 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.33 177.86 48.49 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.246 -0.888 . . . . 0.42 111.858 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.99 157.77 22.04 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.322 0.582 . . . . 0.41 110.786 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 43.2 m -141.6 130.07 22.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.252 -0.886 . . . . 0.42 110.336 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.43 120.37 20.78 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 119.956 -0.698 . . . . 0.47 109.518 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.424 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 98.66 1.38 57.6 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.331 -1.108 . . . . 0.41 110.331 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.603 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -75.9 126.19 30.54 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.14 -0.689 . . . . 1.3 109.14 177.514 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 16.1 m -88.87 127.58 35.64 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.789 0.804 . . . . 0.85 109.987 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.829 HG21 HD21 ' A' ' 36' ' ' LEU . 7.5 pt -127.07 142.72 42.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.246 -1.343 . . . . 0.25 109.565 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.18 153.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.073 0.463 . . . . 0.67 111.141 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.2 mm -116.93 92.5 39.07 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.836 -1.075 . . . . 0.16 109.152 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.1 Cg_endo -58.47 136.15 72.38 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.953 2.436 . . . . 0.18 112.723 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.49 -6.02 83.48 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.116 -0.947 . . . . 0.26 112.19 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.768 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.1 tp -123.91 114.03 28.24 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-O 121.35 0.595 . . . . 0.61 111.232 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.683 ' HD2' HD12 ' A' ' 51' ' ' LEU . 50.0 Cg_endo -78.11 -176.88 3.48 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.713 2.942 . . . . 0.28 113.965 -171.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.557 ' HB3' HG23 ' A' ' 56' ' ' THR . 14.8 t70 -80.46 129.7 67.98 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 114.656 -1.156 . . . . 0.49 112.007 -171.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.588 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.4 Cg_endo -76.5 -13.58 18.32 Favored 'Trans proline' 0 CA--C 1.518 -0.295 0 C-N-CA 123.632 2.888 . . . . 0.46 112.881 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.443 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 18.1 m-30 -93.48 -9.59 37.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.663 -0.699 . . . . 1.38 110.037 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.557 HG23 ' HB3' ' A' ' 53' ' ' ASP . 29.5 p -87.96 -25.52 23.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.61 1.195 . . . . 0.46 108.183 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.55 HG22 ' H ' ' A' ' 59' ' ' TYR . 33.4 mt -67.79 129.18 93.41 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 112.988 -1.914 . . . . 0.7 111.553 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.25 -19.64 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.571 2.181 . . . . 0.39 113.557 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.55 ' H ' HG22 ' A' ' 57' ' ' ILE . 58.6 m-85 -98.17 163.31 12.79 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.29 -0.564 . . . . 0.24 112.134 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -150.91 131.69 14.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.188 -0.915 . . . . 2.89 108.858 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.689 ' HA ' ' O ' ' A' ' 71' ' ' THR . 96.9 mt -112.9 131.75 63.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.384 -0.371 . . . . 0.16 111.844 -176.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.39 117.62 31.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 120.044 -0.663 . . . . 0.16 110.975 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.453 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 64.4 t -95.82 119.72 44.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.62 0.724 . . . . 0.19 110.681 175.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.473 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 38.5 m -96.66 107.63 20.11 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.004 -0.998 . . . . 0.2 110.689 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.583 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 38.6 mm -54.01 -59.33 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 122.187 0.994 . . . . 0.23 111.074 165.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.7 -12.77 7.01 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 112.72 -2.036 . . . . 0.16 113.379 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.34 -17.27 5.21 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.161 0.584 . . . . 0.15 112.548 -178.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.548 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.41 55.52 5.7 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.703 0.683 . . . . 0.69 111.419 -174.052 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.8 p -137.59 163.7 30.56 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 113.09 0.774 . . . . 0.13 113.09 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 81' ' ' THR . 8.0 tt -127.78 115.42 18.63 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.51 -1.223 . . . . 0.4 109.443 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.689 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 48.0 m -95.53 119.63 34.37 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.304 0.573 . . . . 0.16 111.313 177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 79' ' ' MET . 0.5 OUTLIER -92.32 103.83 16.24 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.726 -1.212 . . . . 0.59 107.726 174.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.6 m -106.8 158.32 17.08 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 118.924 -1.111 . . . . 1.05 111.371 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.606 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -127.96 124.63 37.76 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.462 0.648 . . . . 0.26 109.622 170.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.606 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.4 p-10 30.97 68.07 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 113.918 -1.492 . . . . 1.84 112.804 -166.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 72.09 -9.41 1.0 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.034 -0.984 . . . . 1.89 112.887 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -107.58 120.3 41.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.148 0.499 . . . . 3.44 110.776 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 41.9 t -55.64 131.91 19.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.618 1.199 . . . . 0.24 112.862 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.614 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 22.4 mmm -97.56 -46.86 5.87 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 112.816 -1.993 . . . . 0.81 108.538 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.673 ' HG2' ' CZ ' ' A' ' 82' ' ' TYR . 2.3 tptm -157.39 174.41 15.45 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.277 -1.783 . . . . 1.46 110.5 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 55.3 m -150.2 123.93 9.19 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.498 -1.683 . . . . 0.17 109.575 168.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.673 ' CZ ' ' HG2' ' A' ' 80' ' ' LYS . 29.9 m-85 -115.46 152.18 46.79 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.996 -0.547 . . . . 1.05 110.163 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HB2' HG22 ' A' ' 134' ' ' ILE . 55.2 Cg_endo -76.06 144.03 26.46 Favored 'Trans proline' 0 CA--C 1.496 -1.414 0 C-N-CA 122.003 1.802 . . . . 0.2 110.981 176.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.668 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -141.31 172.62 10.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.685 -0.689 . . . . 0.13 110.496 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.953 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -116.87 140.41 49.48 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.852 -0.339 . . . . 0.26 110.215 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 68' ' ' LYS . 12.9 m -124.02 126.08 71.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.618 0.723 . . . . 0.56 111.702 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.77 157.03 29.42 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 114.954 -1.021 . . . . 0.17 110.621 173.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 139' ' ' SER . 27.6 mtpp -57.13 3.6 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.013 0.745 . . . . 3.05 113.013 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.927 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -89.12 -20.72 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 O-C-N 121.467 -0.771 . . . . 0.23 109.821 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.927 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -88.78 -21.62 23.69 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.545 -0.909 . . . . 0.18 108.545 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.2 p -69.17 -13.32 62.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.209 -1.36 . . . . 0.33 111.297 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -66.51 -42.95 86.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.103 -0.953 . . . . 1.52 112.225 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.41 134.12 22.99 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.378 -0.529 . . . . 0.43 110.49 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.574 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 93.9 Cg_endo -86.44 -6.58 8.01 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.452 2.101 . . . . 0.73 112.307 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -123.92 -38.71 2.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.55 . . . . 0.48 110.317 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.442 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 44.98 46.22 9.42 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 124.165 0.915 . . . . 0.33 114.131 171.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.73 112.91 20.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.741 0.781 . . . . 0.84 109.874 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 17.5 m-85 -137.7 174.21 10.83 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.355 -1.293 . . . . 0.22 112.86 -170.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.479 ' CE2' ' HB3' ' A' ' 162' ' ' ARG . 37.4 m-85 -141.99 137.31 31.08 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.589 -0.732 . . . . 0.54 110.527 -175.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.576 HD12 ' HB ' ' A' ' 161' ' ' THR . 84.9 mt -61.33 123.88 14.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.779 -0.646 . . . . 0.17 110.444 171.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 17.7 pt -87.44 -43.75 15.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 112.637 0.606 . . . . 0.21 112.637 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 55.3 m-80 -172.1 176.09 3.57 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 106.72 -1.585 . . . . 2.03 106.72 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.607 ' HB3' HD23 ' A' ' 116' ' ' LEU . 5.2 mtt180 -133.01 155.96 48.21 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.878 -0.729 . . . . 1.52 112.122 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 7.3 tt0 -129.31 99.86 5.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.218 -0.901 . . . . 0.59 109.538 172.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.483 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 20.7 ttt180 -66.33 166.26 12.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.427 -0.806 . . . . 2.82 110.504 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.513 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 23.5 m-80 -35.27 104.9 0.27 Allowed Pre-proline 0 C--O 1.234 0.247 0 C-N-CA 125.198 1.399 . . . . 0.35 113.605 -156.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.8 Cg_endo . . . . . 0 N--CA 1.459 -0.534 0 C-N-CA 122.847 2.365 . . . . 0.48 111.215 170.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.566 1.575 0 N-CA-C 117.392 2.367 . . . . 0.48 117.392 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.4 OUTLIER -166.01 154.14 10.76 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.243 -0.91 . . . . 0.28 110.549 -175.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.405 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.4 t-105 -134.23 98.59 4.15 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.064 -1.087 . . . . 0.49 108.064 167.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 103' ' ' ARG . 4.5 mt -89.6 114.11 25.64 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.017 -0.735 . . . . 0.66 109.017 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.7 m -84.46 144.27 28.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.76 -0.654 . . . . 0.19 111.385 -167.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.789 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.5 mm? -108.84 171.61 7.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.13 110.625 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.63 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.5 OUTLIER -63.14 -13.84 41.56 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.93 0.715 . . . . 1.17 112.93 -179.309 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.777 ' HD3' ' OD1' ' A' ' 21' ' ' ASP . 5.3 tppp? -126.3 132.29 51.68 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.094 0.473 . . . . 1.22 110.828 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.512 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 56.3 mt-30 -33.29 -57.42 0.41 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.907 -1.497 . . . . 1.51 114.308 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.567 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -99.74 12.13 37.42 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.569 -0.852 . . . . 2.53 111.547 -172.493 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.789 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.1 m-85 -96.33 37.5 1.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.857 0.688 . . . . 0.84 112.857 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.678 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -117.04 144.2 18.32 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 117.328 -2.367 . . . . 0.32 112.649 -152.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -95.57 114.53 32.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.754 0.788 . . . . 0.18 110.778 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.558 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 27.5 p80 -143.34 171.97 13.39 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.389 -0.823 . . . . 0.21 109.372 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.98 -169.4 38.08 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 119.847 -1.168 . . . . 0.27 112.067 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -154.13 172.64 17.22 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.472 -0.428 . . . . 0.41 110.009 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -113.0 -2.52 14.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.442 -0.947 . . . . 1.99 108.442 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -115.71 88.17 19.76 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.004 -0.998 . . . . 1.36 108.532 170.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.419 ' HA ' HG12 ' A' ' 134' ' ' ILE . 21.5 Cg_endo -72.74 -16.87 26.37 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.248 1.965 . . . . 0.35 112.779 -171.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.41 -0.61 33.58 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.546 -0.752 . . . . 0.33 111.215 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.0 p -93.42 -6.45 47.04 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.134 -0.691 . . . . 1.35 109.134 169.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' A' ' 83' ' ' PRO . 42.5 mm -81.18 130.78 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.255 -0.884 . . . . 0.21 110.627 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.73 2.58 59.76 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 109.944 -1.263 . . . . 0.15 109.944 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.434 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 23.3 mttp -114.81 170.57 8.23 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 123.146 1.45 . . . . 2.5 114.431 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.43 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -101.91 127.66 48.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 111.887 -2.415 . . . . 0.17 108.006 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.418 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -123.23 162.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.643 -0.873 . . . . 0.66 108.643 -176.066 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 58.7 m -52.18 -59.38 4.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.471 0.545 . . . . 0.43 112.471 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.93 -45.57 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 118.766 -1.174 . . . . 2.02 113.726 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.83 133.54 0.16 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 116.955 1.542 . . . . 0.18 116.955 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.546 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.2 p -73.85 166.65 22.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 112.606 -1.797 . . . . 0.16 112.066 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.953 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 54.0 mt -59.87 97.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 122.468 1.127 . . . . 0.4 112.034 -163.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.558 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 34.3 mtt180 -84.12 152.98 24.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.694 -1.594 . . . . 1.87 110.054 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.668 ' HG2' HG22 ' A' ' 84' ' ' ILE . 11.1 mtp -133.26 -165.88 1.68 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.545 -0.539 . . . . 0.79 109.545 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.619 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 24.8 t-80 -97.54 151.3 20.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.569 -0.741 . . . . 2.32 109.181 173.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.633 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.3 m120 -55.35 -53.52 55.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 118.132 -0.937 . . . . 0.68 111.043 -174.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -62.28 -28.23 69.57 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 121.592 1.996 . . . . 2.18 111.827 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.619 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 3.5 m-20 -78.23 -44.36 25.8 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.773 -0.649 . . . . 0.69 110.903 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.606 HG13 HD12 ' A' ' 151' ' ' ILE . 14.2 p -67.27 -21.78 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.598 -0.728 . . . . 0.11 111.342 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.633 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.86 -42.37 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 119.124 -0.465 . . . . 0.38 110.069 171.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.412 ' O ' HG13 ' A' ' 156' ' ' ILE . 31.2 mt-10 -46.84 -71.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.904 0.774 . . . . 1.99 112.87 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.558 ' O ' HG22 ' A' ' 157' ' ' VAL . 11.5 mt -43.54 -43.85 5.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.702 0.763 . . . . 1.27 110.61 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.19 -37.35 74.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.701 -1.591 . . . . 0.18 111.722 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.3 t -85.94 -32.28 21.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.678 0.672 . . . . 0.21 112.032 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 152' ' ' GLU . 52.0 mt -81.13 -59.87 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.561 0.696 . . . . 0.16 111.408 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.6 m -88.61 144.77 33.99 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 114.76 -1.109 . . . . 0.16 111.728 175.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -91.63 177.21 1.89 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 124.09 3.193 . . . . 0.2 111.266 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.506 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 61.0 m-20 -67.13 159.46 28.84 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.532 -0.867 . . . . 1.1 109.339 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.588 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 94.84 -19.63 52.95 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.213 -0.994 . . . . 0.18 112.125 -174.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.576 ' HB ' HD12 ' A' ' 100' ' ' ILE . 87.0 m -60.62 137.72 58.14 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.472 -0.566 . . . . 0.14 109.472 -175.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.479 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 1.9 ptt180 -92.05 116.4 28.9 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.769 1.271 . . . . 3.63 110.51 -168.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.5 t -107.42 107.05 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 112.056 -2.338 . . . . 0.14 109.158 -175.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.0 m -94.74 109.92 21.82 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.038 -0.528 . . . . 0.21 112.148 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 2.4 mp -82.65 95.07 3.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 122.47 1.129 . . . . 0.24 109.694 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -101.58 136.57 41.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.607 -1.633 . . . . 1.09 108.879 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.583 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 5.8 mmt85 . . . . . 0 C--N 1.317 -0.84 0 N-CA-C 109.446 -0.576 . . . . 2.08 109.446 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.192 0.52 . . . . 0.65 110.988 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.615 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.2 tt -95.47 126.26 40.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.529 -0.76 . . . . 0.28 110.338 -174.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.68 161.68 13.93 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.787 -1.097 . . . . 0.31 112.511 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.646 ' O ' ' HA ' ' A' ' 45' ' ' SER . 80.8 t80 -129.34 140.98 51.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.152 -1.386 . . . . 0.44 107.987 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -112.92 112.74 24.43 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.936 -1.135 . . . . 0.76 107.936 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 13' ' ' ASP . 99.6 t -65.37 148.16 12.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 122.556 1.17 . . . . 0.39 112.372 -170.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -106.29 158.16 17.07 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.287 -1.779 . . . . 2.01 108.184 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -59.65 111.96 1.63 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.952 0.406 . . . . 1.83 111.786 -173.18 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.53 54.13 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.744 -0.662 . . . . 0.48 113.827 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.592 ' HB2' HG13 ' A' ' 9' ' ' VAL . 91.8 m-20 -55.61 168.2 0.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.198 0.499 . . . . 1.46 111.255 172.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.82 151.85 47.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.858 0.361 . . . . 0.41 110.95 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.528 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.56 -40.53 97.24 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.097 -1.075 . . . . 0.86 108.097 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.436 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 64.4 t30 -84.21 -22.65 30.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.353 -1.294 . . . . 1.15 110.434 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -65.09 -45.3 85.81 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.958 -0.756 . . . . 1.21 108.958 171.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.435 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 15.4 mt -72.52 -27.06 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.201 0.524 . . . . 0.21 109.84 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.655 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.27 -10.56 59.76 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.481 -0.327 . . . . 0.16 110.912 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.652 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.5 -39.63 9.06 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 122.669 1.223 . . . . 0.21 108.092 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.623 ' HB3' ' O ' ' A' ' 119' ' ' SER . 8.8 m-20 -62.46 -46.01 90.46 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 112.293 -2.23 . . . . 0.53 111.904 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.607 ' HA ' HG21 ' A' ' 101' ' ' ILE . 55.3 m-85 -95.83 5.68 50.72 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 118.81 -1.156 . . . . 0.18 111.551 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.652 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.1 mpt_? 54.13 43.33 30.83 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.758 0.79 . . . . 1.78 109.838 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.5 pt -118.34 -165.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 114.442 -1.254 . . . . 0.19 109.799 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.7 142.73 42.22 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.156 -0.929 . . . . 0.95 110.429 174.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.581 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 82.3 p -71.01 -33.34 70.29 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.198 -1.038 . . . . 0.25 108.198 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.91 69.27 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.373 -0.831 . . . . 0.2 112.008 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.42 -27.76 16.53 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.914 -0.773 . . . . 0.17 108.914 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.607 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -73.95 -28.86 61.7 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.956 -1.02 . . . . 1.16 109.113 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 26' ' ' THR . 40.5 mt -76.1 -31.66 58.81 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.659 0.742 . . . . 1.05 110.071 171.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 39.4 tt0 -63.78 -37.57 87.85 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.335 -1.302 . . . . 1.81 110.084 174.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.442 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -85.97 -20.35 29.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 120.001 -0.68 . . . . 0.2 111.679 176.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.635 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.7 m-80 -149.78 83.08 6.41 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-O 121.194 0.521 . . . . 0.23 110.751 -172.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.2 Cg_endo -56.26 -15.46 14.75 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 123.927 3.085 . . . . 0.36 113.834 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -73.2 -25.12 60.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.684 0.278 . . . . 1.38 111.31 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.891 HD21 HG21 ' A' ' 46' ' ' ILE . 29.7 mt -67.88 -39.84 83.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.324 0.583 . . . . 0.49 112.397 -170.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -63.6 -44.79 92.96 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.933 1.349 . . . . 1.95 110.275 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.16 82.63 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 111.691 -2.504 . . . . 0.49 110.614 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.06 176.55 48.01 Favored Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 115.048 -0.978 . . . . 0.42 111.951 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.03 157.69 19.05 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.163 0.506 . . . . 0.41 110.791 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.594 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 49.9 m -141.39 127.93 20.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.33 -0.85 . . . . 0.42 110.222 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -76.45 117.21 17.87 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.492 0.663 . . . . 0.47 109.986 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.66 -0.12 49.26 Favored Glycine 0 N--CA 1.429 -1.818 0 CA-C-N 114.775 -1.102 . . . . 0.41 110.389 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.594 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -75.14 124.69 27.47 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.921 -0.639 . . . . 1.3 109.63 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 61.8 p -85.67 131.79 34.27 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 122.099 0.952 . . . . 0.85 110.448 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.891 HG21 HD21 ' A' ' 36' ' ' LEU . 10.2 pt -132.3 143.78 38.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.157 -1.383 . . . . 0.25 109.521 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.24 151.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.2 0.524 . . . . 0.67 111.224 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.3 mm -116.74 93.37 40.89 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 114.614 -1.175 . . . . 0.16 108.948 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.3 Cg_endo -60.12 136.89 71.95 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.705 2.27 . . . . 0.18 112.881 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.12 -6.23 83.79 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.114 -0.948 . . . . 0.26 112.269 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.75 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 28.9 tp -121.46 114.53 31.6 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.287 0.565 . . . . 0.61 111.077 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.688 ' HD2' HD12 ' A' ' 51' ' ' LEU . 53.8 Cg_endo -78.67 -177.07 3.63 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.702 2.935 . . . . 0.28 114.135 -171.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.613 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.0 t70 -82.81 131.96 52.88 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 114.028 -1.442 . . . . 0.49 112.317 -169.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 57.1 Cg_endo -73.98 -14.69 23.71 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 123.571 2.847 . . . . 0.46 112.89 -177.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.465 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 22.0 m-85 -89.61 -15.47 32.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.082 -0.508 . . . . 1.38 110.73 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 53' ' ' ASP . 20.8 p -83.22 -20.71 34.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 122.481 1.134 . . . . 0.46 108.147 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.563 HG22 ' H ' ' A' ' 59' ' ' TYR . 26.4 mt -76.34 135.45 69.3 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 113.06 -1.882 . . . . 0.7 110.99 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.519 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 30.5 Cg_endo -84.7 -17.26 5.14 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 122.361 2.041 . . . . 0.39 112.863 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.563 ' H ' HG22 ' A' ' 57' ' ' ILE . 42.9 m-85 -100.6 155.83 17.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.91 0.386 . . . . 0.24 111.541 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -144.98 135.05 23.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.555 -0.748 . . . . 2.89 109.102 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 71' ' ' THR . 84.1 mt -114.19 134.88 55.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.25 -0.432 . . . . 0.16 111.891 -175.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.05 118.88 33.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 119.89 -0.724 . . . . 0.16 111.124 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.5 t -98.3 113.9 34.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.748 0.785 . . . . 0.19 111.166 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 40.2 m -92.29 105.35 17.57 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.783 -1.099 . . . . 0.2 110.336 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.7 mm -53.14 -58.73 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 122.055 0.931 . . . . 0.23 111.314 168.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.01 -11.2 4.31 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 112.701 -2.045 . . . . 0.16 113.082 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.23 -16.53 5.45 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.653 0.781 . . . . 0.15 112.19 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.509 ' NZ ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 57.01 54.94 6.48 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.412 0.551 . . . . 0.69 111.28 -174.566 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.3 p -137.0 165.65 25.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.928 0.714 . . . . 0.13 112.928 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.9 tt -132.8 111.66 11.29 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.68 -1.146 . . . . 0.4 109.822 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.638 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.9 m -93.31 123.25 36.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.924 0.392 . . . . 0.16 111.101 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 79' ' ' MET . 11.6 tp -98.97 107.29 19.68 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.322 -0.854 . . . . 0.59 108.791 172.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 88.3 p -105.37 161.89 13.92 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.324 -0.95 . . . . 1.05 110.591 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -126.31 126.33 43.76 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.522 -0.918 . . . . 0.26 108.522 169.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.604 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.7 p-10 43.0 48.1 5.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.021 -1.445 . . . . 1.84 111.647 -165.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.8 t30 78.15 -13.89 0.91 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.794 -1.094 . . . . 1.89 111.591 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -92.51 122.78 35.28 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.193 -0.669 . . . . 3.44 109.193 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 53.6 t -56.66 132.52 20.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.37 1.081 . . . . 0.24 112.834 -173.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 57.2 mmm -96.91 -47.63 5.75 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.096 -1.865 . . . . 0.81 107.838 175.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -163.3 174.05 12.53 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 112.871 -1.968 . . . . 1.46 110.358 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.3 m -148.47 124.57 10.74 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.029 -1.441 . . . . 0.17 109.395 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -111.59 151.02 43.05 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 109.56 -0.533 . . . . 1.05 109.56 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HB2' HG22 ' A' ' 134' ' ' ILE . 44.3 Cg_endo -76.63 140.82 21.5 Favored 'Trans proline' 0 CA--C 1.499 -1.247 0 C-N-CA 122.103 1.869 . . . . 0.2 111.235 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.667 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.33 173.07 12.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.495 -0.775 . . . . 0.13 110.584 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.913 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.94 144.3 45.61 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 110.13 -0.322 . . . . 0.26 110.13 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 65' ' ' ILE . 9.0 m -126.39 126.71 69.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.676 0.75 . . . . 0.56 111.801 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.28 152.41 29.41 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 109.771 -1.332 . . . . 0.17 109.771 171.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -57.27 4.63 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.06 0.763 . . . . 3.05 113.06 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.938 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -89.57 -19.65 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.504 0.669 . . . . 0.23 110.235 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.938 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -88.09 -16.73 32.73 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.749 0.785 . . . . 0.18 109.097 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.9 p -68.95 -16.43 63.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.396 -1.274 . . . . 0.33 111.352 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.03 -42.06 98.76 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 114.945 -1.025 . . . . 1.52 111.788 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -108.33 116.75 56.08 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 0.43 110.644 -176.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 6.0 Cg_exo -72.62 -21.25 22.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.604 2.202 . . . . 0.73 112.842 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -99.88 -40.44 7.69 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.529 -0.545 . . . . 0.48 109.529 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.535 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 45.42 48.09 11.58 Favored Glycine 0 N--CA 1.446 -0.639 0 O-C-N 124.393 1.058 . . . . 0.33 113.557 171.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -82.75 110.98 18.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.738 0.78 . . . . 0.84 109.172 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 21.5 m-85 -139.53 169.29 18.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.01 -1.45 . . . . 0.22 112.49 -171.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' A' ' 162' ' ' ARG . 43.6 m-85 -139.11 139.06 37.56 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.863 -0.608 . . . . 0.54 110.377 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.583 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.9 mt -61.63 118.93 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 115.412 -0.813 . . . . 0.17 110.492 172.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.607 HG21 ' HA ' ' A' ' 22' ' ' PHE . 21.4 pt -85.28 -32.76 7.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 113.198 0.814 . . . . 0.21 113.198 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.571 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 2.0 p-10 177.99 176.05 0.47 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.613 -1.254 . . . . 2.03 107.613 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.703 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 19.6 mtt180 -125.2 161.25 27.29 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.509 -0.876 . . . . 1.52 111.914 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -135.99 100.17 4.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.216 -0.902 . . . . 0.59 109.832 170.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.471 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 24.8 ttp180 -67.5 165.48 16.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.378 -0.828 . . . . 2.82 110.843 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.748 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 34.5 m-80 -36.1 101.08 0.21 Allowed Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 125.32 1.448 . . . . 0.35 112.706 -156.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 18.1 Cg_endo . . . . . 0 C--N 1.343 0.245 0 C-N-CA 122.985 2.456 . . . . 0.48 112.392 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 N--CA 1.439 -0.998 0 CA-C-O 120.71 0.291 . . . . 0.48 110.518 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.471 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.8 OUTLIER -162.09 157.3 23.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.786 0.327 . . . . 0.28 110.424 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -135.39 99.84 4.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.627 -1.249 . . . . 0.49 107.627 164.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.7 mt -92.18 113.95 26.36 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.579 -0.897 . . . . 0.66 108.579 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.455 ' HB3' HD11 ' A' ' 101' ' ' ILE . 13.2 m -83.55 144.88 29.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.775 -0.648 . . . . 0.19 111.561 -166.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.9 mm? -110.28 166.53 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.13 110.936 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.623 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -62.65 -8.2 6.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.028 0.751 . . . . 1.17 113.028 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.773 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.9 tmtm? -126.84 133.01 50.84 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.362 1.077 . . . . 1.22 109.833 172.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.773 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 52.9 mt-30 -39.08 -46.39 1.4 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 112.439 -2.164 . . . . 1.51 114.227 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.483 ' CB ' HG12 ' A' ' 89' ' ' ILE . 79.6 m-70 -97.38 -0.67 45.95 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.212 -0.595 . . . . 2.53 111.51 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.746 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -97.21 38.19 1.27 Allowed 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.365 1.246 . . . . 0.84 114.365 -169.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.684 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -117.19 146.0 18.73 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 116.457 -2.783 . . . . 0.32 113.111 -153.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.73 116.58 39.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 124.053 0.941 . . . . 0.18 111.004 -176.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.5 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.5 p80 -146.23 -177.05 5.41 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 112.593 0.59 . . . . 0.21 112.593 -176.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.98 -167.19 37.4 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.436 -0.666 . . . . 0.27 111.436 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.6 t -161.68 164.05 29.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 117.727 0.764 . . . . 0.41 110.589 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -115.18 -3.79 12.51 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.118 -1.067 . . . . 1.99 108.118 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -121.74 91.43 48.62 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 114.148 -1.387 . . . . 1.36 108.673 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.66 -22.27 18.2 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.346 2.031 . . . . 0.35 113.769 -172.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.24 2.26 25.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.103 0.477 . . . . 0.33 111.163 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.471 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 43.6 t -95.07 -4.89 45.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 1.35 109.364 170.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 31.8 mm -78.76 138.17 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 115.899 -0.591 . . . . 0.21 110.106 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.56 1.81 80.19 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.119 -1.192 . . . . 0.15 110.119 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.471 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 91.8 mttt -113.36 167.94 10.15 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 123.161 1.457 . . . . 2.5 114.253 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.1 126.63 46.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 111.699 -2.501 . . . . 0.17 107.961 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.417 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -125.24 161.95 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.909 -0.774 . . . . 0.66 108.909 -174.418 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.7 m -49.72 -60.35 2.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.114 0.783 . . . . 0.43 113.114 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -133.52 -43.99 0.83 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 118.533 -1.267 . . . . 2.02 113.619 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.42 133.49 0.2 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 117.055 1.582 . . . . 0.18 117.055 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.535 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 2.9 p -70.05 165.19 22.41 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 112.575 -1.813 . . . . 0.16 112.419 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.913 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 49.4 mt -60.61 97.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 114.494 -1.23 . . . . 0.4 112.077 -163.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.5 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 10.4 mtp180 -83.97 144.06 29.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.702 -1.59 . . . . 1.87 109.501 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.667 ' HG2' HG22 ' A' ' 84' ' ' ILE . 14.9 mtp -121.38 -169.0 1.78 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.188 -0.671 . . . . 0.79 109.188 173.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.622 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 1.5 t60 -89.85 153.91 20.28 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.158 -1.053 . . . . 2.32 108.158 170.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.877 ' O ' HD13 ' A' ' 151' ' ' ILE . 11.7 m-80 -72.45 -20.29 61.42 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 118.474 -0.774 . . . . 0.68 113.069 -171.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -81.61 -28.75 33.58 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 121.364 1.893 . . . . 2.18 112.734 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.622 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 5.0 m-20 -77.62 -41.21 39.34 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.186 0.517 . . . . 0.69 110.63 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.61 HG13 HD12 ' A' ' 151' ' ' ILE . 12.5 p -66.34 -19.69 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.245 -0.889 . . . . 0.11 111.349 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.888 HD11 ' HB1' ' A' ' 113' ' ' ALA . 1.6 mp -86.26 -42.98 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 118.801 -0.618 . . . . 0.38 110.727 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.424 ' O ' HG13 ' A' ' 156' ' ' ILE . 16.2 mt-10 -45.12 -70.87 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.369 0.986 . . . . 1.99 112.578 170.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.554 ' O ' HG22 ' A' ' 157' ' ' VAL . 48.0 mt -46.07 -39.9 9.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.627 0.727 . . . . 1.27 111.53 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.26 -36.07 79.0 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.01 -1.45 . . . . 0.18 111.775 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.3 t -86.97 -31.11 20.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 118.811 0.732 . . . . 0.21 112.501 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.1 mt -82.49 -60.35 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.652 0.739 . . . . 0.16 111.756 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -88.38 141.93 31.02 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.837 -1.074 . . . . 0.16 112.252 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.703 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 56.9 Cg_endo -89.28 175.38 3.37 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 124.024 3.149 . . . . 0.2 110.997 174.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.571 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 75.3 m-20 -65.53 156.04 33.81 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 119.371 -0.931 . . . . 1.1 108.972 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 97.91 -19.78 53.21 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.008 -1.091 . . . . 0.18 112.358 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.583 ' HB ' HD12 ' A' ' 100' ' ' ILE . 50.5 m -64.1 137.4 57.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.902 -0.777 . . . . 0.14 108.902 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.523 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 20.0 ttt180 -92.15 127.6 37.68 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 122.52 1.152 . . . . 3.63 110.745 -169.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.31 107.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 112.374 -2.193 . . . . 0.14 109.086 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.1 m -93.92 107.91 19.77 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.377 0.51 . . . . 0.21 112.377 -172.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.535 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.04 99.63 5.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 122.171 0.986 . . . . 0.24 109.955 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -110.77 133.38 53.39 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.391 -1.277 . . . . 1.09 109.879 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.575 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 19.5 mmm180 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 116.239 -0.437 . . . . 2.08 110.394 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.408 0.623 . . . . 0.65 111.643 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.0 tt -98.18 128.67 44.79 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.904 -1.043 . . . . 0.28 110.392 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.19 162.96 13.3 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.209 1.004 . . . . 0.31 113.075 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.631 ' HB3' HG13 ' A' ' 46' ' ' ILE . 86.9 t80 -130.32 139.36 50.7 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.768 -1.56 . . . . 0.44 107.753 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.436 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 58.7 tt0 -112.39 113.14 25.18 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.013 -1.106 . . . . 0.76 108.013 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.673 HG13 ' HB2' ' A' ' 13' ' ' ASP . 94.9 t -67.23 148.15 12.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 122.528 1.156 . . . . 0.39 113.283 -169.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -102.35 158.6 16.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 113.312 -1.767 . . . . 2.01 108.367 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.61 104.22 0.4 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.059 0.457 . . . . 1.83 112.068 -174.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.83 10.96 36.11 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.718 -0.674 . . . . 0.48 113.502 174.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.673 ' HB2' HG13 ' A' ' 9' ' ' VAL . 29.8 m-20 -53.06 169.3 0.1 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.137 0.494 . . . . 1.46 111.671 173.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.35 150.47 50.7 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.105 0.479 . . . . 0.41 111.95 177.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.635 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.56 -36.45 83.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.055 -0.975 . . . . 0.86 108.808 -177.185 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.426 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 65.4 t30 -87.75 -24.5 23.79 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.812 -1.086 . . . . 1.15 110.855 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.0 m -70.1 -38.1 75.55 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.322 -0.551 . . . . 1.21 110.176 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 mt -74.67 -28.39 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.43 -0.581 . . . . 0.21 109.43 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.662 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.66 -9.54 59.43 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.281 -0.418 . . . . 0.16 110.81 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.677 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.64 -40.8 8.83 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.38 1.086 . . . . 0.21 108.116 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 119' ' ' SER . 7.5 m-20 -62.39 -44.41 96.52 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.462 -2.154 . . . . 0.53 112.19 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HA ' HG21 ' A' ' 101' ' ' ILE . 53.0 m-85 -96.98 6.39 48.72 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 118.627 -1.229 . . . . 0.18 111.03 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.677 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER 54.3 41.44 31.98 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.916 0.865 . . . . 1.78 109.25 176.773 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.662 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.1 pt -113.87 -165.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.442 -1.254 . . . . 0.19 110.214 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.06 142.61 41.28 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.206 -0.906 . . . . 0.95 110.225 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.49 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 60.3 p -72.97 -33.29 65.77 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.804 -1.184 . . . . 0.25 107.804 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.04 -27.2 66.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.34 -0.845 . . . . 0.2 111.824 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HA ' ' HB2' ' A' ' 31' ' ' GLN . . . -95.21 -25.3 16.43 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.649 0.737 . . . . 0.17 109.636 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.635 HD23 HD23 ' A' ' 15' ' ' LEU . 17.5 tp -75.23 -27.43 59.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.241 -0.89 . . . . 1.16 109.054 173.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.521 HD23 ' HB2' ' A' ' 36' ' ' LEU . 35.3 mt -78.04 -26.69 48.51 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.36 0.6 . . . . 1.05 110.372 172.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.479 ' HB2' ' HA ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -59.81 -61.56 2.52 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 108.129 -1.063 . . . . 1.81 108.129 169.471 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -71.29 -18.57 62.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.491 -0.777 . . . . 0.2 110.86 -170.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.614 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 28.5 m-80 -147.61 80.65 8.93 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-N 115.642 -0.708 . . . . 0.23 110.385 -174.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 24.6 Cg_endo -59.5 -4.41 2.49 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 123.787 2.991 . . . . 0.36 113.145 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 p -79.96 -25.75 40.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.052 0.453 . . . . 1.38 111.542 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.861 HD21 HG21 ' A' ' 46' ' ' ILE . 33.6 mt -70.81 -33.66 70.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.733 -0.667 . . . . 0.49 112.387 -170.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.429 ' H ' ' HG3' ' A' ' 37' ' ' GLN . 1.7 pp0? -63.56 -44.72 93.3 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.822 1.296 . . . . 1.95 110.76 -172.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.19 -49.12 73.28 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 111.795 -2.457 . . . . 0.49 110.404 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.6 176.23 47.87 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 114.683 -1.144 . . . . 0.42 111.405 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.51 157.99 18.44 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.37 0.605 . . . . 0.41 110.626 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 53.2 m -138.39 128.8 26.1 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.317 -0.856 . . . . 0.42 110.192 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.25 119.74 19.79 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 119.996 -0.682 . . . . 0.47 109.535 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.436 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 99.44 1.51 56.67 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.254 -1.138 . . . . 0.41 110.254 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.63 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -76.65 123.6 26.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.918 -0.641 . . . . 1.3 109.824 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 29.8 p -84.32 125.93 32.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.491 -0.777 . . . . 0.85 110.771 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.861 HG21 HD21 ' A' ' 36' ' ' LEU . 8.9 pt -126.3 143.23 40.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 114.241 -1.345 . . . . 0.25 109.443 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.64 152.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 121.164 0.507 . . . . 0.67 111.185 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.9 mm -116.28 92.03 34.75 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.648 -1.16 . . . . 0.16 109.268 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.557 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -57.98 135.06 66.38 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.811 2.341 . . . . 0.18 112.71 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.98 -5.77 83.06 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.067 -0.97 . . . . 0.26 112.279 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.72 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 27.7 tp -122.54 113.37 30.61 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 121.253 0.549 . . . . 0.61 110.978 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.675 ' HD2' HD12 ' A' ' 51' ' ' LEU . 48.6 Cg_endo -78.05 -176.22 3.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.77 2.98 . . . . 0.28 114.295 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.571 ' HB3' HG23 ' A' ' 56' ' ' THR . 22.5 t70 -79.9 129.76 69.4 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 113.967 -1.47 . . . . 0.49 112.648 -169.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 41.1 Cg_endo -73.06 -14.01 26.11 Favored 'Trans proline' 0 C--N 1.34 0.118 0 C-N-CA 123.396 2.731 . . . . 0.46 112.687 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.539 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 75.5 m-85 -92.58 -10.28 38.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.971 -0.558 . . . . 1.38 111.332 -174.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.571 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.0 p -85.46 -24.69 27.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.586 1.184 . . . . 0.46 108.153 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 59' ' ' TYR . 15.9 mt -72.53 136.34 80.98 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.82 -1.991 . . . . 0.7 111.246 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.539 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 36.8 Cg_endo -86.38 -16.49 3.94 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.459 2.106 . . . . 0.39 113.319 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.594 ' H ' HG22 ' A' ' 57' ' ' ILE . 56.0 m-85 -98.43 158.15 15.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.199 0.444 . . . . 0.24 112.199 -174.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -147.01 132.44 18.61 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.67 -0.695 . . . . 2.89 109.15 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.703 ' HA ' ' O ' ' A' ' 71' ' ' THR . 76.1 mt -114.99 135.93 53.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.261 -0.427 . . . . 0.16 111.914 -176.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.79 117.6 28.63 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.11 -0.636 . . . . 0.16 111.249 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 69' ' ' THR . 88.9 t -96.77 117.93 42.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.511 0.672 . . . . 0.19 111.168 175.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 65.1 m -92.84 109.56 21.0 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.253 -0.885 . . . . 0.2 111.262 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 36.2 mm -54.48 -59.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 122.255 1.026 . . . . 0.23 111.081 165.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.13 -12.75 6.0 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 112.783 -2.008 . . . . 0.16 113.362 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.469 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.94 -18.62 4.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.866 0.691 . . . . 0.15 112.866 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.96 56.3 4.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.811 0.732 . . . . 0.69 111.438 -172.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 46.8 p -137.89 164.6 28.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.897 0.703 . . . . 0.13 112.897 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.445 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.4 tt -133.13 110.67 10.34 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.713 -1.131 . . . . 0.4 109.81 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 53.1 m -93.42 121.77 35.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.288 0.566 . . . . 0.16 111.188 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.1 tp -96.5 107.37 19.77 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.909 -1.041 . . . . 0.59 109.054 173.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 4.3 m -107.61 158.11 17.52 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.453 -0.899 . . . . 1.05 110.645 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -126.19 126.15 43.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.826 -0.805 . . . . 0.26 108.826 170.277 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.592 ' N ' HD22 ' A' ' 74' ' ' LEU . 3.0 p-10 41.48 54.81 3.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.04 -1.436 . . . . 1.84 111.539 -165.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.5 t30 73.86 -14.98 0.61 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.173 -0.921 . . . . 1.89 111.709 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -91.84 118.99 31.23 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.81 -0.441 . . . . 3.44 109.81 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.0 t -58.05 130.32 21.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 122.479 1.133 . . . . 0.24 112.412 -175.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.518 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 64.0 mmm -96.27 -48.68 5.52 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.014 -1.903 . . . . 0.81 108.214 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 14.3 mmmt -160.72 174.06 14.49 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 112.669 -2.06 . . . . 1.46 109.477 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.3 m -148.58 124.49 10.62 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.602 -1.181 . . . . 0.17 109.072 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 149' ' ' ASP . 12.9 m-85 -106.01 147.21 34.39 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.118 -0.946 . . . . 1.05 109.588 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.435 ' HB2' HG22 ' A' ' 134' ' ' ILE . 37.4 Cg_endo -75.12 140.61 25.33 Favored 'Trans proline' 0 CA--C 1.498 -1.305 0 C-N-CA 121.445 1.43 . . . . 0.2 110.24 168.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.633 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -141.06 174.68 6.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.764 -0.653 . . . . 0.13 110.554 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.893 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.16 143.55 47.16 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.793 0.33 . . . . 0.26 110.424 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.508 HG22 ' HG3' ' A' ' 68' ' ' LYS . 8.7 m -125.64 126.21 69.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.525 0.678 . . . . 0.56 111.779 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.03 154.41 31.91 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.609 -1.396 . . . . 0.17 109.609 171.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -55.79 0.18 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.042 0.756 . . . . 3.05 113.042 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.876 HG23 HD22 ' A' ' 90' ' ' LEU . 1.2 tp -85.04 -19.11 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 O-C-N 121.353 -0.842 . . . . 0.23 110.068 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.876 HD22 HG23 ' A' ' 89' ' ' ILE . 3.5 mm? -87.17 -17.25 33.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.766 -0.827 . . . . 0.18 108.766 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.6 p -70.41 -15.66 62.86 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.461 -1.245 . . . . 0.33 111.23 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.17 -43.21 98.9 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.477 -0.783 . . . . 1.52 111.594 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.07 132.95 27.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.477 -0.489 . . . . 0.43 110.72 -174.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 84.3 Cg_endo -88.7 4.3 5.51 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.73 2.286 . . . . 0.73 111.66 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -128.39 -41.51 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.161 -0.681 . . . . 0.48 109.161 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 165' ' ' ILE . . . 53.13 16.92 4.86 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 124.595 1.184 . . . . 0.33 114.377 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.674 ' CB ' HG23 ' A' ' 164' ' ' THR . 12.9 pt-20 -86.3 119.64 26.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.331 1.062 . . . . 0.84 110.223 -171.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.667 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 9.3 m-85 -138.67 -170.56 2.87 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.679 -1.601 . . . . 0.22 111.764 -163.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.626 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 85.7 m-85 -142.9 139.2 30.68 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.237 0.541 . . . . 0.54 110.938 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.568 HD12 ' HB ' ' A' ' 161' ' ' THR . 85.5 mt -63.74 123.4 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.463 -0.79 . . . . 0.17 110.39 168.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.546 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.8 pt -89.64 -43.9 14.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 113.621 0.971 . . . . 0.21 113.621 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.591 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 49.1 m-80 -171.22 174.14 4.69 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.047 -1.464 . . . . 2.03 107.047 -169.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.655 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 40.3 mtt180 -127.1 169.47 13.38 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.252 -0.979 . . . . 1.52 111.961 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 55.0 tt0 -147.13 99.8 3.21 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.075 -0.966 . . . . 0.59 109.629 170.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.517 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 46.5 ttt180 -65.74 166.11 11.52 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.205 -0.907 . . . . 2.82 110.826 175.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.517 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 19.3 m-80 -35.41 102.74 0.23 Allowed Pre-proline 0 C--O 1.232 0.168 0 C-N-CA 125.269 1.428 . . . . 0.35 113.305 -157.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.4 Cg_endo . . . . . 0 C--N 1.345 0.372 0 C-N-CA 123.153 2.568 . . . . 0.48 111.78 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.513 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.565 1.554 0 N-CA-C 117.482 2.401 . . . . 0.48 117.482 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.494 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -165.83 154.78 11.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.417 -0.802 . . . . 0.28 110.449 -176.502 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.3 t-105 -135.25 99.28 4.2 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.115 -1.069 . . . . 0.49 108.115 168.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.516 HD12 HG23 ' A' ' 150' ' ' VAL . 4.9 mt -93.15 114.69 27.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.584 0.707 . . . . 0.66 109.245 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.436 ' C ' HG12 ' A' ' 101' ' ' ILE . 19.6 m -83.54 144.23 29.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.666 -0.697 . . . . 0.19 111.502 -167.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.714 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.7 mm? -108.72 165.04 11.85 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.454 -0.794 . . . . 0.13 110.791 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.468 ' OG ' ' HD2' ' A' ' 98' ' ' PHE . 3.7 p -68.16 -4.58 14.3 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 124.008 0.817 . . . . 1.17 112.546 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.689 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 4.3 tmtm? -126.66 128.33 46.56 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 120.213 -0.595 . . . . 1.22 109.581 166.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.689 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 52.9 mt-30 -33.19 -58.28 0.39 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.431 -1.713 . . . . 1.51 113.847 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.588 ' HB3' HG12 ' A' ' 89' ' ' ILE . 1.1 t-80 -96.67 13.18 29.2 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.964 -0.694 . . . . 2.53 112.17 -170.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.587 ' HA ' HD11 ' A' ' 90' ' ' LEU . 2.8 m-30 -90.38 -34.29 15.72 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-O 121.923 0.868 . . . . 0.84 111.081 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.714 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -6.87 128.71 0.01 OUTLIER Glycine 0 C--N 1.297 -1.601 0 N-CA-C 119.262 2.465 . . . . 0.32 119.262 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.642 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -99.96 115.67 41.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 112.822 -1.689 . . . . 0.18 109.815 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.691 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.0 p80 -143.27 175.16 10.11 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.501 -0.772 . . . . 0.21 109.653 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.58 -168.81 38.52 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 120.016 -1.088 . . . . 0.27 111.991 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.0 t -156.03 168.04 28.53 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.89 -0.771 . . . . 0.41 110.367 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -110.33 -9.21 14.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.507 -0.923 . . . . 1.99 108.507 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -111.21 88.33 8.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 114.816 -1.084 . . . . 1.36 108.356 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -72.89 -19.64 23.27 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.754 2.303 . . . . 0.35 113.326 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.6 -2.07 33.94 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.03 -0.532 . . . . 0.33 111.002 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.5 m -91.97 -4.16 54.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.544 -0.539 . . . . 1.35 109.544 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 43.5 mm -82.31 131.4 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.845 -0.616 . . . . 0.21 110.401 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.7 1.4 65.87 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.811 -1.316 . . . . 0.15 109.811 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 137' ' ' ALA . 2.0 tttm -114.29 163.27 15.5 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 122.759 1.266 . . . . 2.5 113.388 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -94.54 126.9 40.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 112.424 -2.171 . . . . 0.17 107.889 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.432 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -121.64 159.25 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 108.6 -0.889 . . . . 0.66 108.6 -175.176 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 m -49.34 -59.35 3.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.406 0.521 . . . . 0.43 112.406 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.434 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 21.0 pttm -132.36 -45.96 0.91 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.506 -1.278 . . . . 2.02 114.186 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.34 134.01 0.18 Allowed Glycine 0 N--CA 1.468 0.815 0 N-CA-C 117.648 1.819 . . . . 0.18 117.648 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 2.1 p -69.77 165.5 21.28 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 112.601 -1.8 . . . . 0.16 111.916 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.893 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 57.8 mt -60.37 99.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 114.711 -1.131 . . . . 0.4 112.008 -162.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.691 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 60.8 mtt180 -87.69 148.97 24.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.988 -1.46 . . . . 1.87 110.685 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.633 ' HG2' HG22 ' A' ' 84' ' ' ILE . 17.5 mtp -126.34 -165.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.217 -0.661 . . . . 0.79 109.217 173.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.615 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 12.8 t-80 -93.77 153.39 18.33 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.068 -0.715 . . . . 2.32 109.068 172.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.657 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.2 m120 -57.41 -54.8 42.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 118.188 -0.911 . . . . 0.68 110.907 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -65.22 -21.97 66.82 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 121.543 1.974 . . . . 2.18 112.149 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.615 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.9 m-20 -80.9 -45.79 16.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.096 -0.956 . . . . 0.69 111.169 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.591 HG13 HD12 ' A' ' 151' ' ' ILE . 14.9 p -65.8 -20.73 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.554 -0.748 . . . . 0.11 111.052 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.657 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.26 -41.0 16.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 119.006 -0.521 . . . . 0.38 109.889 170.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -45.92 -70.73 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.164 0.893 . . . . 1.99 112.339 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.479 HD22 ' SD ' ' A' ' 145' ' ' MET . 9.4 mp -46.18 -38.56 8.48 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.49 0.662 . . . . 1.27 111.486 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.75 -33.52 76.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.376 -1.284 . . . . 0.18 111.598 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -88.79 -31.68 18.25 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.487 -0.758 . . . . 0.21 112.711 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.2 mt -83.38 -60.1 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.451 0.643 . . . . 0.16 111.679 -172.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.1 m -91.26 139.99 25.6 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 114.969 -1.014 . . . . 0.16 112.158 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.655 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 61.2 Cg_endo -89.09 174.4 3.74 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 123.899 3.066 . . . . 0.2 111.286 174.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.591 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 58.5 m-20 -67.75 156.07 37.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.423 -0.911 . . . . 1.1 108.876 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.69 -20.53 50.02 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.246 -0.978 . . . . 0.18 112.523 -172.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.568 ' HB ' HD12 ' A' ' 100' ' ' ILE . 53.2 m -63.75 137.74 58.19 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.006 -0.739 . . . . 0.14 109.006 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.626 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 18.8 ptt180 -92.48 120.6 33.12 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.944 1.354 . . . . 3.63 111.22 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.6 t -102.78 106.48 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 111.951 -2.386 . . . . 0.14 108.875 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.674 HG23 ' CB ' ' A' ' 97' ' ' GLU . 1.8 m -93.74 104.59 16.68 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.257 -0.577 . . . . 0.21 112.327 -170.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 2.4 mp -81.45 93.29 2.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 122.509 1.147 . . . . 0.24 109.552 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -103.31 139.15 39.12 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.865 -1.516 . . . . 1.09 109.432 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.535 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 6.5 mmt85 . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 116.057 -0.52 . . . . 2.08 111.115 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.653 HD21 ' HA ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.488 0.661 . . . . 0.65 111.969 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.655 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.2 tt -99.09 131.82 44.86 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.717 -1.129 . . . . 0.28 110.238 -175.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.7 162.37 13.47 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 122.218 1.008 . . . . 0.31 113.201 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.631 ' HB3' HG13 ' A' ' 46' ' ' ILE . 80.8 t80 -130.72 144.86 51.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.723 -1.581 . . . . 0.44 107.859 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.425 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 61.5 tt0 -115.85 113.53 23.48 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 108.483 -0.932 . . . . 0.76 108.483 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.596 ' HB ' ' O ' ' A' ' 41' ' ' THR . 86.0 t -66.39 152.32 9.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 122.735 1.255 . . . . 0.39 113.27 -171.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.0 mtmm -108.68 159.35 16.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.036 -1.893 . . . . 2.01 108.54 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.453 ' OE1' ' HA ' ' A' ' 11' ' ' GLN . 2.2 mm-40 -62.13 113.8 3.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.041 0.448 . . . . 1.83 112.044 -174.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.38 10.76 56.73 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.582 -0.735 . . . . 0.48 113.669 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.545 ' HB2' HG13 ' A' ' 9' ' ' VAL . 86.3 m-20 -56.2 169.38 0.41 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.109 0.454 . . . . 1.46 111.161 173.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.43 ' HB ' ' H ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -128.81 156.69 43.19 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.432 -0.507 . . . . 0.41 110.916 173.491 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.61 HD12 HD23 ' A' ' 29' ' ' LEU . 3.0 tp -66.07 -36.36 83.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.986 0.898 . . . . 0.86 109.539 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.461 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 5.1 t30 -85.87 -24.98 26.46 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.342 -1.299 . . . . 1.15 110.248 -176.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.43 ' H ' ' HB ' ' A' ' 14' ' ' THR . 39.6 t -65.88 -42.11 90.71 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.127 -0.694 . . . . 1.21 109.127 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 14.8 mt -74.69 -27.01 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.171 0.51 . . . . 0.21 109.908 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.636 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.32 -9.98 59.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.532 -0.304 . . . . 0.16 110.679 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.621 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.73 -38.62 9.83 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.642 1.21 . . . . 0.21 108.155 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.3 m-20 -62.28 -45.55 92.76 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.277 -2.238 . . . . 0.53 111.689 172.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.556 ' HA ' HG21 ' A' ' 101' ' ' ILE . 58.8 m-85 -98.62 4.8 48.06 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 118.685 -1.206 . . . . 0.18 111.667 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.621 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.0 mpt_? 54.78 42.84 30.86 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.689 0.757 . . . . 1.78 109.738 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.636 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.7 pt -115.41 -165.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.548 -1.205 . . . . 0.19 109.883 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.39 142.82 39.8 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.123 -0.944 . . . . 0.95 110.118 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.597 ' HB ' HD21 ' A' ' 15' ' ' LEU . 70.6 p -73.23 -31.95 64.44 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.364 -0.976 . . . . 0.25 108.364 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.67 68.16 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.049 -0.978 . . . . 0.2 111.512 169.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -92.89 -27.66 16.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.359 0.599 . . . . 0.17 109.461 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.647 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 15.2 tp -74.79 -26.64 59.89 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.662 -0.699 . . . . 1.16 109.299 174.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 36' ' ' LEU . 42.8 mt -77.62 -30.51 52.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.62 0.724 . . . . 1.05 109.772 171.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 22.6 tt0 -63.74 -43.16 97.3 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.326 -1.306 . . . . 1.81 110.002 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.47 -21.35 32.88 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.357 -0.537 . . . . 0.2 111.715 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.601 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.1 m-80 -145.96 82.74 9.07 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-O 121.571 0.7 . . . . 0.23 110.642 -171.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.84 -6.13 3.19 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 123.803 3.002 . . . . 0.36 113.675 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.9 t -80.17 -25.78 39.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.651 0.263 . . . . 1.38 111.297 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.812 HD21 HG21 ' A' ' 46' ' ' ILE . 32.0 mt -70.11 -35.1 73.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.57 0.7 . . . . 0.49 112.158 -170.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 37' ' ' GLN . 2.8 pt20 -65.35 -46.98 78.08 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 122.847 1.308 . . . . 1.95 110.296 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.67 -49.74 74.17 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 111.982 -2.372 . . . . 0.49 110.479 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.26 179.36 48.89 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 114.715 -1.129 . . . . 0.42 111.332 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 157.09 19.76 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.39 0.614 . . . . 0.41 110.895 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.596 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 39.7 m -143.31 126.26 16.27 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.231 -0.895 . . . . 0.42 110.706 -176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' CB ' ' HG2' ' A' ' 11' ' ' GLN . . . -75.86 116.62 16.75 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.561 0.696 . . . . 0.47 109.735 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 105.34 -0.85 40.26 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.192 -1.163 . . . . 0.41 110.192 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.568 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.4 tt0 -75.51 123.82 26.11 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.961 -0.62 . . . . 1.3 109.733 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 58.8 p -80.89 133.13 35.51 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.589 -0.732 . . . . 0.85 109.864 176.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.812 HG21 HD21 ' A' ' 36' ' ' LEU . 11.7 pt -134.28 141.61 43.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.498 -1.228 . . . . 0.25 109.22 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.434 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.68 152.22 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.173 0.511 . . . . 0.67 110.713 -179.392 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.413 HG13 ' CE2' ' A' ' 22' ' ' PHE . 38.0 mm -115.89 92.5 34.78 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.97 -1.014 . . . . 0.16 109.412 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.653 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -57.41 132.69 52.32 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.727 2.285 . . . . 0.18 112.598 -175.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.65 -2.27 80.01 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 114.825 -1.079 . . . . 0.26 112.527 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.695 HD12 ' HD2' ' A' ' 52' ' ' PRO . 34.0 tp -125.4 114.94 25.5 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-O 121.314 0.578 . . . . 0.61 111.139 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.695 ' HD2' HD12 ' A' ' 51' ' ' LEU . 57.6 Cg_endo -79.79 -177.64 3.98 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.716 2.944 . . . . 0.28 114.577 -171.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.58 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.7 t70 -80.52 130.97 62.79 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 114.055 -1.429 . . . . 0.49 111.602 -173.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 44.1 Cg_endo -71.29 -20.01 28.48 Favored 'Trans proline' 0 CA--C 1.519 -0.263 0 C-N-CA 123.381 2.72 . . . . 0.46 113.121 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -96.79 -0.89 47.33 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.418 0.628 . . . . 1.38 111.88 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.58 HG23 ' HB3' ' A' ' 53' ' ' ASP . 29.5 p -89.31 -15.58 33.13 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.228 -1.397 . . . . 0.46 107.228 169.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 59' ' ' TYR . 18.2 mt -82.53 134.36 48.1 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 112.5 -2.136 . . . . 0.7 110.317 175.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -84.1 -16.95 5.93 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.282 1.988 . . . . 0.39 113.239 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.567 ' H ' HG22 ' A' ' 57' ' ' ILE . 61.2 m-85 -93.93 155.15 17.31 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.751 -0.38 . . . . 0.24 111.859 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -146.33 131.72 18.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.77 -0.826 . . . . 2.89 108.77 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 71' ' ' THR . 91.1 mt -114.95 133.98 59.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.072 0.397 . . . . 0.16 112.072 -175.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.1 121.55 42.48 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.17 -0.612 . . . . 0.16 110.903 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.43 114.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.884 0.85 . . . . 0.19 111.444 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 68' ' ' LYS . 46.9 m -95.02 102.29 14.09 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.606 -1.179 . . . . 0.2 110.743 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.9 mm -50.99 -57.74 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 122.25 1.024 . . . . 0.23 111.536 169.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.25 -10.13 5.08 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 112.788 -2.005 . . . . 0.16 113.414 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.57 -18.54 4.79 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.51 0.724 . . . . 0.15 112.318 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.534 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.26 56.27 4.58 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.325 0.511 . . . . 0.69 111.003 -173.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.7 p -137.31 161.73 35.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 112.719 0.636 . . . . 0.13 112.719 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.456 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.5 tt -130.54 110.74 11.65 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.659 -1.155 . . . . 0.4 109.928 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.604 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 36.2 m -92.12 123.47 35.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.022 0.439 . . . . 0.16 111.126 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.3 tp -98.88 104.32 16.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.413 -0.812 . . . . 0.59 109.481 172.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 19.4 m -105.22 160.18 15.29 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.324 -0.95 . . . . 1.05 110.814 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -125.85 127.4 46.01 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.476 -0.935 . . . . 0.26 108.476 169.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.605 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.9 p-10 44.64 50.65 8.4 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.075 1.35 . . . . 1.84 111.419 -166.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 72.84 -11.83 0.82 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.892 -1.049 . . . . 1.89 112.041 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -94.56 120.68 35.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.249 0.547 . . . . 3.44 110.009 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 57.5 t -57.67 132.54 22.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 122.38 1.086 . . . . 0.24 112.869 -173.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 6.9 mtm -103.46 -42.86 5.56 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 112.995 -1.911 . . . . 0.81 109.447 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -158.53 172.81 17.64 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 113.215 -1.811 . . . . 1.46 109.84 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.3 m -148.65 123.23 9.78 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.228 -1.351 . . . . 0.17 109.41 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.521 ' HD2' ' OD2' ' A' ' 149' ' ' ASP . 25.1 m-85 -103.93 148.55 36.03 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.312 -0.858 . . . . 1.05 109.453 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.435 ' HB2' HG22 ' A' ' 134' ' ' ILE . 46.5 Cg_endo -77.58 141.06 19.45 Favored 'Trans proline' 0 CA--C 1.5 -1.209 0 C-N-CA 121.497 1.465 . . . . 0.2 110.488 169.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.627 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -139.9 173.25 11.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.934 -0.575 . . . . 0.13 110.907 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.9 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.83 143.34 47.01 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.227 -0.442 . . . . 0.26 110.436 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.534 HG22 ' HG3' ' A' ' 68' ' ' LYS . 7.5 m -126.58 126.04 68.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.451 0.643 . . . . 0.56 112.057 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -89.16 157.17 26.77 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.71 -1.356 . . . . 0.17 109.71 173.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -57.05 6.61 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 114.582 1.327 . . . . 3.05 114.582 -177.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.839 HG23 HD22 ' A' ' 90' ' ' LEU . 1.2 tp -96.88 -14.08 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.525 0.679 . . . . 0.23 110.565 -177.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.839 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -91.2 -18.09 25.0 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.146 -0.687 . . . . 0.18 109.146 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.3 p -67.09 -24.52 65.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.777 -1.101 . . . . 0.33 112.132 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.479 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 8.7 mp0 -56.26 -44.35 79.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.118 1.367 . . . . 1.52 111.61 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -100.45 119.7 58.17 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.471 -0.786 . . . . 0.43 111.635 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.599 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 1.9 Cg_endo -77.36 -19.64 13.12 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.874 2.383 . . . . 0.73 113.068 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 t -105.48 -40.52 5.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.358 -0.608 . . . . 0.48 109.358 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 43.69 45.89 7.23 Favored Glycine 0 C--N 1.338 0.682 0 O-C-N 124.565 1.165 . . . . 0.33 113.903 170.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -83.59 113.09 20.59 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.901 0.858 . . . . 0.84 109.723 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 15.9 m-85 -137.32 175.85 9.24 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.065 -1.425 . . . . 0.22 112.484 -170.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.69 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 79.9 m-85 -142.85 133.07 24.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.54 110.896 -174.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.579 HD12 ' HB ' ' A' ' 161' ' ' THR . 82.6 mt -58.02 121.85 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.576 -0.738 . . . . 0.17 110.84 172.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.556 HG21 ' HA ' ' A' ' 22' ' ' PHE . 22.7 pt -86.8 -35.25 8.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 113.157 0.799 . . . . 0.21 113.157 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.536 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 1.4 p-10 179.97 174.03 0.91 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.932 -1.136 . . . . 2.03 107.932 -176.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.662 ' CB ' HD12 ' A' ' 116' ' ' LEU . 6.7 mtt180 -122.21 161.66 22.82 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.112 -0.635 . . . . 1.52 111.503 -170.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -143.84 102.41 3.9 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.222 0.534 . . . . 0.59 110.898 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 63.7 ttt180 -65.95 166.89 10.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.38 -0.827 . . . . 2.82 110.63 173.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.497 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 24.6 m-80 -35.49 104.52 0.26 Allowed Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 125.529 1.532 . . . . 0.35 113.806 -160.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.3 Cg_endo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.785 2.324 . . . . 0.48 111.745 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.597 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.569 1.675 0 N-CA-C 117.97 2.582 . . . . 0.48 117.97 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.599 ' CE2' ' HB1' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -163.29 151.77 13.97 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.085 0.857 . . . . 0.28 110.117 -176.317 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -135.16 98.3 3.95 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.227 -1.027 . . . . 0.49 108.227 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.662 HD12 ' CB ' ' A' ' 103' ' ' ARG . 0.6 OUTLIER -85.79 118.56 25.37 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 121.097 -1.002 . . . . 0.66 109.877 174.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.523 ' HB3' HD11 ' A' ' 101' ' ' ILE . 36.9 m -83.45 145.63 28.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.638 -0.71 . . . . 0.19 111.411 -170.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.764 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -109.73 170.5 8.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.13 110.797 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.567 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -62.87 -13.11 30.02 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.936 0.717 . . . . 1.17 112.936 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.602 ' HB3' ' CG ' ' A' ' 123' ' ' TYR . 5.2 tptp -126.06 130.9 52.05 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.52 -0.472 . . . . 1.22 110.756 175.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.452 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 67.6 mt-30 -30.97 -58.99 0.22 Allowed 'General case' 0 C--N 1.317 -0.827 0 O-C-N 124.733 1.271 . . . . 1.51 114.054 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.643 ' HB3' HG12 ' A' ' 89' ' ' ILE . 1.3 t-80 -96.08 8.19 44.42 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.551 -0.86 . . . . 2.53 111.706 -171.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.764 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.3 m-85 -94.88 37.48 1.14 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.877 1.065 . . . . 0.84 113.877 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -114.57 143.74 18.13 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 116.865 -2.588 . . . . 0.32 112.665 -153.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -97.09 112.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.937 0.875 . . . . 0.18 110.451 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.756 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.0 p80 -142.64 172.21 13.0 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.078 -0.964 . . . . 0.21 109.592 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.7 -179.92 38.87 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 119.969 -1.11 . . . . 0.27 111.791 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.5 t -142.89 170.96 14.73 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.79 -0.448 . . . . 0.41 109.79 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -114.48 -4.75 12.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.9 0.857 . . . . 1.99 108.705 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -112.26 87.91 9.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.563 -1.198 . . . . 1.36 108.178 168.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -73.4 -19.69 21.77 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.744 2.296 . . . . 0.35 113.601 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.97 0.19 28.52 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.227 0.537 . . . . 0.33 111.112 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 52.6 m -94.51 -1.49 53.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 1.35 109.628 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 44.0 mm -82.83 137.82 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.98 -0.555 . . . . 0.21 110.5 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.89 0.82 77.54 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.922 -1.271 . . . . 0.15 109.922 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -111.68 167.42 10.36 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 122.932 1.349 . . . . 2.5 113.73 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.468 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -96.27 120.06 35.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.174 -2.285 . . . . 0.17 107.442 173.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.35 160.47 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.508 -0.923 . . . . 0.66 108.508 -172.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.588 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.1 m -52.55 -60.93 2.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 111.974 0.361 . . . . 0.43 111.974 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -131.62 -46.57 0.97 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.09 -1.444 . . . . 2.02 113.78 -172.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.48 133.69 0.2 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 117.758 1.863 . . . . 0.18 117.758 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.608 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 6.3 p -68.56 166.02 17.93 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 112.291 -1.954 . . . . 0.16 111.756 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.9 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 59.5 mt -59.48 98.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 122.596 1.189 . . . . 0.4 112.114 -163.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.756 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 75.5 mtt180 -87.06 147.76 25.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.461 -1.7 . . . . 1.87 110.7 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.627 ' HG2' HG22 ' A' ' 84' ' ' ILE . 12.7 mtp -125.29 -165.5 1.41 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.295 -0.632 . . . . 0.79 109.295 173.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.657 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 25.4 t-80 -95.86 153.99 17.46 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.538 -0.755 . . . . 2.32 108.997 173.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.646 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.5 m120 -57.11 -54.4 47.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.193 -0.908 . . . . 0.68 110.856 -174.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.411 ' HG2' ' ND1' ' A' ' 146' ' ' HIS . 0.8 OUTLIER -63.93 -23.81 67.49 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 121.516 1.962 . . . . 2.18 111.823 -175.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.657 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.3 m-20 -78.5 -46.72 18.95 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.01 -0.996 . . . . 0.69 110.725 -176.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.583 HG13 HD12 ' A' ' 151' ' ' ILE . 13.7 p -67.97 -24.15 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.094 -0.957 . . . . 0.11 111.663 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.646 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -78.71 -39.41 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.483 -0.562 . . . . 0.38 109.483 171.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 156' ' ' ILE . 22.7 mt-10 -46.54 -72.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.901 0.773 . . . . 1.99 112.261 168.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.508 HD21 ' CE1' ' A' ' 82' ' ' TYR . 43.4 mt -49.79 -40.31 41.16 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.751 0.786 . . . . 1.27 111.532 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.599 ' HB1' ' CE2' ' A' ' 114' ' ' TYR . . . -56.14 -39.97 73.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.968 -1.469 . . . . 0.18 111.415 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.2 t -87.86 -33.65 18.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.542 0.942 . . . . 0.21 113.542 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 152' ' ' GLU . 43.7 mt -80.57 -60.2 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.617 0.723 . . . . 0.16 112.034 -170.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.9 m -86.61 145.69 39.91 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.793 -1.094 . . . . 0.16 112.049 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.493 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 63.8 Cg_endo -90.72 173.0 3.13 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.875 3.05 . . . . 0.2 110.91 172.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.536 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 22.0 m-20 -64.87 158.23 25.72 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.744 -0.782 . . . . 1.1 109.134 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 97.41 -19.63 53.95 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.079 -1.058 . . . . 0.18 112.529 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' HD12 ' A' ' 100' ' ' ILE . 59.1 m -62.76 136.81 58.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.15 -0.685 . . . . 0.14 109.15 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.69 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -92.61 122.7 35.28 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.771 1.272 . . . . 3.63 111.18 -169.272 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.13 108.63 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 112.25 -2.25 . . . . 0.14 109.159 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.3 m -94.23 107.7 19.62 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.521 0.563 . . . . 0.21 112.521 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.428 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -86.14 97.41 5.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.991 0.9 . . . . 0.24 110.253 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -110.98 135.52 51.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.853 -1.067 . . . . 1.09 111.203 -173.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.599 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 14.8 mmm-85 . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.474 0.654 . . . . 2.08 109.701 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.576 HD13 ' HA ' ' A' ' 49' ' ' PRO . 20.3 mt . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.047 0.451 . . . . 0.65 110.872 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.8 tt -88.81 129.18 35.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.505 -0.77 . . . . 0.28 109.756 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.14 161.11 14.11 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.138 -0.937 . . . . 0.31 112.944 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.6 ' HB3' HG13 ' A' ' 46' ' ' ILE . 86.2 t80 -129.6 140.66 51.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.715 -1.584 . . . . 0.44 107.781 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.438 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 63.3 tt0 -114.23 111.79 22.09 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.907 -1.145 . . . . 0.76 107.907 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.653 HG13 ' HB2' ' A' ' 13' ' ' ASP . 97.7 t -66.2 151.2 10.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.353 1.073 . . . . 0.39 112.697 -169.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -108.02 158.07 17.7 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.554 -1.657 . . . . 2.01 108.325 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.62 107.34 0.38 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.183 0.516 . . . . 1.83 112.092 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.77 11.79 39.49 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.686 -0.688 . . . . 0.48 113.57 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.653 ' HB2' HG13 ' A' ' 9' ' ' VAL . 70.9 m-20 -55.97 167.63 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.953 0.376 . . . . 1.46 110.961 172.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -128.19 152.96 47.42 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.914 0.388 . . . . 0.41 111.176 174.654 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.526 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -64.38 -38.86 92.52 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.103 -1.073 . . . . 0.86 108.103 -177.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.409 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 65.3 t30 -86.44 -22.04 26.74 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.512 -1.222 . . . . 1.15 110.715 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.446 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 17.4 t -67.98 -40.12 83.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.177 -0.675 . . . . 1.21 109.177 171.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.2 mt -75.32 -27.78 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.146 0.498 . . . . 0.21 109.937 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.54 -10.01 59.72 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.517 -0.31 . . . . 0.16 110.795 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.707 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.09 -40.27 9.31 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 107.929 -1.137 . . . . 0.21 107.929 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 3.0 m-20 -62.19 -42.77 99.59 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.544 -2.116 . . . . 0.53 112.303 173.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 119' ' ' SER . 57.5 m-85 -99.42 6.73 45.93 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 118.876 -1.13 . . . . 0.18 111.129 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.707 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.76 41.06 32.2 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.765 0.793 . . . . 1.78 109.541 176.432 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.62 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.8 pt -116.8 -165.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.287 -1.324 . . . . 0.19 110.215 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.52 143.88 40.19 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.99 -1.005 . . . . 0.95 110.244 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.526 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 44.3 p -72.18 -31.76 66.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.037 -1.097 . . . . 0.25 108.037 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -31.09 69.98 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.703 -0.68 . . . . 0.2 111.659 171.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.32 -28.27 17.85 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.641 0.734 . . . . 0.17 109.029 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.568 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -73.67 -28.04 61.55 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.046 -0.979 . . . . 1.16 109.404 174.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 36' ' ' LEU . 42.5 mt -76.63 -30.99 57.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.836 0.827 . . . . 1.05 109.991 170.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 43.3 tt0 -65.61 -33.75 76.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.19 -1.368 . . . . 1.81 110.095 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -88.57 -22.74 23.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 119.849 -0.74 . . . . 0.2 111.805 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.643 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 19.1 m-80 -147.85 82.7 7.76 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.41 0.624 . . . . 0.23 110.517 -171.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.26 -15.93 16.07 Favored 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 124.124 3.216 . . . . 0.36 114.03 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 t -74.72 -22.65 58.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.75 0.31 . . . . 1.38 111.391 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.71 HD21 HG21 ' A' ' 46' ' ' ILE . 35.6 mt -69.45 -36.11 76.31 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.568 0.581 . . . . 0.49 112.568 -169.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 5.4 pt20 -64.07 -45.17 89.93 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 122.917 1.342 . . . . 1.95 110.135 -175.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.64 -49.04 79.12 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 111.796 -2.456 . . . . 0.49 110.712 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.87 -179.85 48.11 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 114.932 -1.031 . . . . 0.42 111.693 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.43 158.97 22.69 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.204 0.526 . . . . 0.41 110.66 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.546 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 60.4 m -139.35 127.89 23.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.542 -0.754 . . . . 0.42 110.385 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.49 121.51 21.61 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.576 0.703 . . . . 0.47 110.313 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.7 3.56 60.89 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 114.733 -1.121 . . . . 0.41 110.468 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.546 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -80.22 124.93 29.24 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.202 -0.499 . . . . 1.3 109.91 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.8 m -77.7 130.35 36.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.152 -0.931 . . . . 0.85 109.781 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.71 HG21 HD21 ' A' ' 36' ' ' LEU . 6.7 pt -132.01 143.63 39.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.671 -1.15 . . . . 0.25 109.085 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -90.69 153.74 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.311 0.576 . . . . 0.67 111.612 -178.168 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.5 mm -118.24 93.6 45.3 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.597 -1.183 . . . . 0.16 109.03 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.576 ' HA ' HD13 ' A' ' 4' ' ' LEU . 2.5 Cg_endo -59.05 137.39 79.28 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.775 2.316 . . . . 0.18 112.745 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.46 -6.24 83.8 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.906 -1.043 . . . . 0.26 112.387 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.743 HD12 ' HD2' ' A' ' 52' ' ' PRO . 26.9 tp -122.73 118.05 28.57 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.904 0.383 . . . . 0.61 110.721 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.743 ' HD2' HD12 ' A' ' 51' ' ' LEU . 57.9 Cg_endo -80.3 -176.68 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.649 2.9 . . . . 0.28 114.037 -172.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.538 ' HB3' HG23 ' A' ' 56' ' ' THR . 13.3 t70 -80.69 132.25 58.48 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.726 -1.124 . . . . 0.49 111.629 -171.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.577 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.8 Cg_endo -76.28 -16.13 17.63 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 123.395 2.73 . . . . 0.46 112.694 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -95.58 -1.04 51.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.706 0.765 . . . . 1.38 110.135 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 53' ' ' ASP . 27.1 p -94.66 -16.98 22.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.657 1.217 . . . . 0.46 107.822 173.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 59' ' ' TYR . 25.6 mt -78.64 128.73 76.35 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 112.947 -1.933 . . . . 0.7 111.132 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.417 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 97.8 Cg_endo -76.75 -17.23 15.99 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.444 2.096 . . . . 0.39 113.194 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.533 ' H ' HG22 ' A' ' 57' ' ' ILE . 61.4 m-85 -94.74 164.91 12.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.392 -0.523 . . . . 0.24 112.153 -176.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -152.68 128.01 9.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.533 -0.914 . . . . 2.89 108.533 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 71' ' ' THR . 95.4 mt -110.02 132.67 57.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.135 -0.484 . . . . 0.16 111.759 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.21 117.01 28.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.004 -0.678 . . . . 0.16 111.09 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.84 112.85 31.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.814 0.816 . . . . 0.19 111.273 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 16.5 m -93.23 102.73 15.02 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.682 -1.145 . . . . 0.2 110.543 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.546 HD13 HG11 ' A' ' 86' ' ' VAL . 50.5 mm -52.15 -58.49 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 122.04 0.924 . . . . 0.23 111.213 169.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.22 -11.39 3.34 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 112.955 -1.93 . . . . 0.16 113.244 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.72 -18.6 4.71 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.572 0.749 . . . . 0.15 112.455 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER 57.77 56.39 4.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.555 0.616 . . . . 0.69 111.431 -172.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.5 p -137.66 161.49 36.34 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 112.669 0.618 . . . . 0.13 112.669 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -131.49 113.4 13.64 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.704 -1.135 . . . . 0.4 110.122 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 66.7 m -94.23 122.95 37.3 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.324 0.583 . . . . 0.16 111.542 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 79' ' ' MET . 15.5 tp -97.56 103.2 15.12 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.906 -1.043 . . . . 0.59 109.369 172.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.2 m -105.47 159.93 15.54 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.475 -0.89 . . . . 1.05 110.579 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.579 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.2 tm? -126.73 128.37 46.55 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.853 -0.795 . . . . 0.26 108.853 169.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.579 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.2 p-10 43.61 49.01 6.53 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.128 1.371 . . . . 1.84 111.574 -167.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 84.2 m-20 75.85 -11.99 1.05 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.127 -0.942 . . . . 1.89 112.317 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -96.99 120.82 38.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.207 0.527 . . . . 3.44 110.095 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.494 HG22 ' CG2' ' A' ' 71' ' ' THR . 55.1 t -56.15 132.44 20.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 122.316 1.055 . . . . 0.24 112.998 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 7.9 mtm -102.59 -43.83 5.51 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.074 -1.875 . . . . 0.81 109.285 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.6 mmtt -157.92 172.15 18.98 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 113.107 -1.861 . . . . 1.46 109.874 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.0 m -149.8 122.28 8.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.417 -1.265 . . . . 0.17 109.808 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -109.71 145.82 32.77 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 115.454 -0.794 . . . . 1.05 109.637 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.446 ' HB2' HG22 ' A' ' 134' ' ' ILE . 41.7 Cg_endo -74.61 142.12 28.78 Favored 'Trans proline' 0 CA--C 1.499 -1.26 0 C-N-CA 121.902 1.734 . . . . 0.2 110.903 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.663 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.01 175.71 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.922 -0.581 . . . . 0.13 110.717 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.879 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -120.76 148.55 43.82 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.418 -0.355 . . . . 0.26 110.092 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.546 HG11 HD13 ' A' ' 65' ' ' ILE . 9.6 m -128.75 129.76 68.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.481 0.658 . . . . 0.56 111.899 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.6 154.6 27.23 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.21 -1.156 . . . . 0.17 110.21 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -56.27 3.08 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.321 0.86 . . . . 3.05 113.321 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.917 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -89.17 -19.96 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 121.534 0.683 . . . . 0.23 110.417 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.917 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -89.72 -18.25 26.73 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.716 0.77 . . . . 0.18 109.288 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.9 p -66.81 -14.47 62.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.385 -1.279 . . . . 0.33 111.649 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -66.3 -39.56 89.41 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.74 -1.118 . . . . 1.52 111.973 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.51 130.97 22.17 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.571 -0.452 . . . . 0.43 111.028 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.658 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 87.0 Cg_endo -90.1 -13.87 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.7 2.267 . . . . 0.73 112.73 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.0 t -104.92 -41.0 5.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.758 -0.656 . . . . 0.48 109.25 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.553 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 44.87 46.04 9.21 Favored Glycine 0 N--CA 1.446 -0.644 0 O-C-N 124.404 1.065 . . . . 0.33 113.692 171.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.79 111.37 19.13 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.891 0.853 . . . . 0.84 109.557 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.719 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 21.4 m-85 -139.41 171.94 13.53 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.89 -1.505 . . . . 0.22 112.366 -171.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.58 ' CD1' ' HB3' ' A' ' 162' ' ' ARG . 28.2 m-85 -140.99 136.15 31.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.739 -0.664 . . . . 0.54 110.131 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.55 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.1 mt -58.62 123.23 10.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.421 -0.809 . . . . 0.17 110.55 172.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.55 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.8 pt -88.05 -44.08 15.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 113.014 0.746 . . . . 0.21 113.014 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.462 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 56.2 m-80 -171.69 169.54 5.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 106.783 -1.562 . . . . 2.03 106.783 -169.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.596 ' HB3' HD23 ' A' ' 116' ' ' LEU . 5.6 mtt180 -128.17 163.45 24.65 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.773 -0.771 . . . . 1.52 112.198 -173.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.4 tt0 -136.85 99.91 4.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.921 -1.036 . . . . 0.59 109.713 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.475 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 30.8 ttp180 -67.05 166.52 13.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.24 -0.891 . . . . 2.82 111.006 176.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.475 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 29.1 m-80 -36.44 102.23 0.23 Allowed Pre-proline 0 CA--C 1.518 -0.28 0 C-N-CA 125.439 1.496 . . . . 0.35 113.951 -152.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 14.5 Cg_exo . . . . . 0 N--CA 1.457 -0.648 0 C-N-CA 123.513 2.809 . . . . 0.48 111.528 170.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.533 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.489 0 N-CA-C 116.915 2.191 . . . . 0.48 116.915 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.44 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -166.06 161.35 17.2 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.385 -0.822 . . . . 0.28 110.028 -177.007 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 12.6 t-105 -141.83 98.93 3.43 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.25 -1.018 . . . . 0.49 108.25 166.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 103' ' ' ARG . 4.4 mt -91.95 114.49 27.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.521 0.677 . . . . 0.66 109.414 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.425 ' HB3' HD11 ' A' ' 101' ' ' ILE . 26.0 m -84.23 144.55 28.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.986 -0.552 . . . . 0.19 111.368 -169.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -108.35 172.14 7.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.903 -0.59 . . . . 0.13 110.568 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.533 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -64.49 -11.14 30.77 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.894 0.701 . . . . 1.17 112.894 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.735 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.3 tmtp? -126.51 130.61 50.94 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 120.626 -0.43 . . . . 1.22 110.405 174.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.735 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.2 mt-30 -34.77 -54.88 0.57 Allowed 'General case' 0 C--N 1.311 -1.074 0 O-C-N 124.953 1.408 . . . . 1.51 113.555 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.59 ' CB ' HG12 ' A' ' 89' ' ' ILE . 46.8 m80 -91.19 -1.49 57.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.867 -0.606 . . . . 2.53 111.216 -169.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.777 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -94.29 37.88 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.534 0.938 . . . . 0.84 113.534 -171.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.644 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.23 144.41 18.42 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 117.026 -2.511 . . . . 0.32 112.601 -153.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.507 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -96.78 114.89 34.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 123.775 0.83 . . . . 0.18 110.763 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.445 ' O ' ' N ' ' A' ' 145' ' ' MET . 26.8 p80 -143.53 175.97 9.54 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.4 -0.818 . . . . 0.21 109.721 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.65 -166.98 37.8 Favored Glycine 0 C--N 1.314 -0.672 0 C-N-CA 120.49 -0.862 . . . . 0.27 111.816 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 t -157.24 171.4 20.49 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.063 -0.669 . . . . 0.41 110.627 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -115.12 -2.16 12.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.286 -1.005 . . . . 1.99 108.286 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -113.19 85.78 8.75 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.506 -1.224 . . . . 1.36 108.669 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -74.25 -19.07 20.2 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.363 2.042 . . . . 0.35 113.102 -170.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.51 -2.29 49.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.733 -0.667 . . . . 0.33 110.35 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.2 t -89.33 -6.33 56.77 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.042 -0.725 . . . . 1.35 109.042 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' ' 83' ' ' PRO . 39.6 mm -81.82 137.11 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.485 -0.78 . . . . 0.21 110.392 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.91 2.19 69.5 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.172 -1.171 . . . . 0.15 110.172 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.41 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 42.9 mttt -115.12 171.77 7.47 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 123.178 1.466 . . . . 2.5 114.0 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.51 126.73 50.84 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 111.613 -2.54 . . . . 0.17 107.736 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.407 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -122.5 159.73 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 108.662 -0.866 . . . . 0.66 108.662 -174.467 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.9 m -49.5 -60.01 3.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.699 0.629 . . . . 0.43 112.699 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -132.74 -44.79 0.88 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.614 -1.234 . . . . 2.02 113.549 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.46 133.19 0.21 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 117.077 1.591 . . . . 0.18 117.077 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.457 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.8 p -70.59 165.72 22.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.353 -1.923 . . . . 0.16 111.808 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.879 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 57.6 mt -59.7 98.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 122.393 1.092 . . . . 0.4 112.002 -163.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 134' ' ' ILE . 9.8 mtp180 -85.06 148.52 26.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.515 -1.675 . . . . 1.87 109.937 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.663 ' HG2' HG22 ' A' ' 84' ' ' ILE . 14.8 mtp -127.52 -165.9 1.54 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.33 -0.619 . . . . 0.79 109.33 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.735 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 10.5 t-160 -95.96 154.49 17.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.523 -0.917 . . . . 2.32 108.523 172.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.9 m120 -58.2 -51.1 71.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 118.388 -0.815 . . . . 0.68 110.641 -176.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -64.42 -22.64 67.02 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 121.223 1.829 . . . . 2.18 112.516 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.735 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 13.3 m-20 -85.3 -42.46 14.59 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.036 -0.529 . . . . 0.69 111.263 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.637 HG13 HD12 ' A' ' 151' ' ' ILE . 14.7 p -67.78 -23.03 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.913 -0.585 . . . . 0.11 111.193 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.637 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.78 -40.66 16.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 118.846 -0.597 . . . . 0.38 110.02 171.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.8 mm-40 -44.59 -72.57 0.06 Allowed 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 119.426 1.012 . . . . 1.99 112.293 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.529 ' O ' HG22 ' A' ' 157' ' ' VAL . 49.7 mt -47.42 -40.08 17.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.686 0.755 . . . . 1.27 111.269 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.05 77.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.098 -1.41 . . . . 0.18 111.785 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.3 t -89.01 -31.78 17.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.56 -0.713 . . . . 0.21 112.694 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 152' ' ' GLU . 28.5 mt -82.0 -60.53 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.612 0.72 . . . . 0.16 111.339 -172.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.3 m -89.19 140.74 28.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.786 -1.097 . . . . 0.16 111.907 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -88.17 173.84 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.969 3.113 . . . . 0.2 111.062 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.462 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 77.4 m-20 -65.41 155.76 34.41 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 119.723 -0.791 . . . . 1.1 109.187 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.6 -20.02 52.07 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.125 -1.036 . . . . 0.18 112.494 -173.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.55 ' HB ' HD12 ' A' ' 100' ' ' ILE . 91.2 m -63.21 138.03 58.41 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 117.419 0.61 . . . . 0.14 109.476 -174.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.58 ' HB3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -93.03 123.31 36.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.784 1.278 . . . . 3.63 111.002 -169.208 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.95 108.56 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 111.94 -2.391 . . . . 0.14 109.022 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.8 m -94.43 108.05 19.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.069 -0.514 . . . . 0.21 112.307 -171.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.553 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.19 101.15 7.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.152 0.977 . . . . 0.24 109.963 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -108.43 128.36 54.71 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.389 -1.278 . . . . 1.09 109.794 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.658 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 18.3 mmm180 . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 120.838 0.351 . . . . 2.08 111.008 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp . . . . . 0 CA--C 1.52 -0.201 0 CA-C-O 121.701 0.762 . . . . 0.65 112.824 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.646 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.0 tt -102.54 133.04 48.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.5 -1.227 . . . . 0.28 110.265 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.39 162.96 12.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.41 1.1 . . . . 0.31 113.839 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.644 ' HB3' HG13 ' A' ' 46' ' ' ILE . 87.8 t80 -129.14 140.29 51.6 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.243 -1.799 . . . . 0.44 107.596 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.442 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.9 tt0 -112.89 112.64 24.26 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.185 -1.042 . . . . 0.76 108.185 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.605 HG13 ' HB2' ' A' ' 13' ' ' ASP . 92.7 t -65.7 149.67 11.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 122.264 1.031 . . . . 0.39 112.679 -171.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -106.27 159.48 16.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.768 -1.56 . . . . 2.01 108.487 171.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -61.41 106.06 0.59 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.213 0.53 . . . . 1.83 112.379 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.7 11.2 35.84 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.518 -0.765 . . . . 0.48 113.395 172.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.605 ' HB2' HG13 ' A' ' 9' ' ' VAL . 84.1 m-20 -53.69 167.62 0.23 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.829 0.347 . . . . 1.46 111.006 172.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -125.95 150.86 47.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.229 0.538 . . . . 0.41 111.145 175.181 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.66 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.95 -38.14 89.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.16 -1.052 . . . . 0.86 108.16 -178.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.52 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -84.69 -25.9 28.09 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.37 -1.286 . . . . 1.15 110.532 -177.116 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.466 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 30.7 t -64.62 -43.25 94.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.396 -0.594 . . . . 1.21 109.396 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.7 mt -72.8 -26.69 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.15 0.5 . . . . 0.21 109.692 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.73 -11.18 59.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.251 -0.431 . . . . 0.16 110.531 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.691 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -90.9 -41.94 10.87 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.595 0.712 . . . . 0.21 109.77 171.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.749 ' HB3' ' O ' ' A' ' 119' ' ' SER . 83.6 m-20 -61.65 -44.65 96.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.247 -1.342 . . . . 0.53 111.473 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.594 ' CE2' ' HB3' ' A' ' 119' ' ' SER . 54.3 m-85 -99.47 6.63 45.88 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.69 -1.204 . . . . 0.18 111.471 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.691 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER 53.87 43.26 31.18 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.71 0.767 . . . . 1.78 109.616 177.386 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 36.2 pt -115.75 -165.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.773 -1.103 . . . . 0.19 110.35 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.71 142.87 40.29 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.916 -1.038 . . . . 0.95 109.801 174.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.574 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 68.2 p -72.95 -30.88 64.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.626 -0.879 . . . . 0.25 108.626 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.05 -27.06 69.15 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.494 -0.776 . . . . 0.2 111.625 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.618 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -94.31 -27.11 16.28 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.573 0.701 . . . . 0.17 109.148 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.66 HD23 HD23 ' A' ' 15' ' ' LEU . 17.8 tp -73.55 -28.43 61.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.153 -0.93 . . . . 1.16 108.636 172.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 26' ' ' THR . 7.7 tp -78.52 -28.79 46.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.582 0.706 . . . . 1.05 109.769 175.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.618 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -58.48 -60.48 3.74 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.472 -1.307 . . . . 1.81 107.472 167.62 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.439 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -71.57 -17.41 62.3 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 120.313 -0.555 . . . . 0.2 110.973 -169.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.61 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.7 m-80 -146.99 81.04 9.19 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 115.729 -0.669 . . . . 0.23 110.532 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.87 -10.32 5.41 Favored 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 124.065 3.177 . . . . 0.36 113.411 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -78.62 -19.91 51.59 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.841 0.312 . . . . 1.38 111.841 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.704 HD21 HG21 ' A' ' 46' ' ' ILE . 63.1 mt -70.63 -34.49 72.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.312 0.577 . . . . 0.49 112.205 -171.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.438 ' CB ' HD11 ' A' ' 30' ' ' LEU . 3.8 pt20 -64.4 -47.21 80.07 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 122.805 1.288 . . . . 1.95 110.539 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.59 -49.67 75.65 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 111.729 -2.487 . . . . 0.49 110.242 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.38 178.93 48.65 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 114.775 -1.102 . . . . 0.42 111.912 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 157.35 19.43 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.392 0.615 . . . . 0.41 110.619 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.616 ' HB ' ' HB2' ' A' ' 44' ' ' GLN . 83.5 m -143.62 130.89 20.83 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.169 -0.923 . . . . 0.42 110.062 -176.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.75 120.08 20.64 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.526 0.679 . . . . 0.47 110.221 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.442 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 101.35 0.97 53.82 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.709 -1.356 . . . . 0.41 109.709 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.616 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 47.4 tt0 -72.74 123.62 23.68 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.148 -1.026 . . . . 1.3 109.915 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 15.7 p -84.11 127.28 33.81 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 122.019 0.914 . . . . 0.85 110.068 175.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.704 HG21 HD21 ' A' ' 36' ' ' LEU . 10.9 pt -127.33 140.72 48.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.178 -1.374 . . . . 0.25 109.033 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.15 150.7 3.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 120.995 0.426 . . . . 0.67 110.885 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.2 mm -114.83 92.9 31.84 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.731 -1.122 . . . . 0.16 108.845 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.652 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.8 Cg_endo -58.65 132.96 51.13 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.69 2.26 . . . . 0.18 112.835 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.05 -5.79 72.3 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 114.703 -1.135 . . . . 0.26 111.983 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.658 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 38.7 tp -123.82 115.67 27.89 Favored Pre-proline 0 N--CA 1.448 -0.569 0 CA-C-O 121.222 0.534 . . . . 0.61 111.75 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.653 ' HD2' HD12 ' A' ' 51' ' ' LEU . 61.1 Cg_endo -81.57 -176.74 3.22 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 124.204 3.27 . . . . 0.28 114.808 -172.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.562 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.6 t70 -81.04 128.96 69.3 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 113.968 -1.469 . . . . 0.49 112.269 -170.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 52.3 Cg_endo -73.87 -14.36 24.03 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.629 2.886 . . . . 0.46 113.139 -177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.84 -5.6 37.92 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.891 -0.595 . . . . 1.38 111.402 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.562 HG23 ' HB3' ' A' ' 53' ' ' ASP . 28.0 p -89.15 -21.87 23.11 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.49 -1.3 . . . . 0.46 107.49 171.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 59' ' ' TYR . 21.2 mt -75.23 128.04 85.32 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 112.847 -1.979 . . . . 0.7 111.119 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.4 -18.29 15.93 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.473 2.115 . . . . 0.39 113.216 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.531 ' H ' HG22 ' A' ' 57' ' ' ILE . 56.4 m-85 -94.82 161.48 14.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.297 -0.561 . . . . 0.24 111.628 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -151.15 124.65 8.95 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.655 -0.869 . . . . 2.89 108.655 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 71' ' ' THR . 97.5 mt -106.44 131.38 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.867 -0.606 . . . . 0.16 111.391 -176.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.66 117.28 29.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.834 -0.746 . . . . 0.16 111.341 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 69' ' ' THR . 60.0 t -97.5 117.04 41.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.573 0.702 . . . . 0.19 111.207 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 19.3 m -95.31 106.2 18.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.974 -1.012 . . . . 0.2 110.61 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.584 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.6 mm -54.46 -58.65 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 122.202 1.001 . . . . 0.23 111.099 167.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.95 -7.86 3.94 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 112.836 -1.984 . . . . 0.16 113.292 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -127.96 -19.4 4.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.399 0.679 . . . . 0.15 112.671 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.518 ' HD2' ' CG2' ' A' ' 86' ' ' VAL . 0.0 OUTLIER 58.5 56.37 4.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.669 0.668 . . . . 0.69 111.624 -171.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 42.4 p -137.62 162.23 34.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.009 0.744 . . . . 0.13 113.009 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.466 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -130.16 113.83 14.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.632 -1.167 . . . . 0.4 110.023 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.708 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 22.0 m -94.81 122.97 37.98 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.172 0.511 . . . . 0.16 111.391 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 79' ' ' MET . 15.3 tp -98.35 104.39 16.42 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.416 -0.811 . . . . 0.59 109.628 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 7.7 m -105.22 159.98 15.45 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.531 -0.867 . . . . 1.05 110.78 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.615 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.1 tm? -128.92 128.55 44.01 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.856 -0.794 . . . . 0.26 108.856 169.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.615 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.6 p-10 46.54 48.64 14.01 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.132 1.373 . . . . 1.84 111.287 -166.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.9 t30 72.93 -9.45 1.11 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.038 -0.983 . . . . 1.89 111.333 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -96.3 120.7 37.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.737 -0.665 . . . . 3.44 109.764 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 69.7 t -58.3 132.25 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-O 122.311 1.053 . . . . 0.24 112.606 -174.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 12.1 mtm -101.18 -45.5 5.35 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.206 -1.816 . . . . 0.81 109.151 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 13.7 mmmt -157.75 171.15 20.83 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.423 -1.717 . . . . 1.46 109.571 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -148.74 123.33 9.79 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.677 -1.147 . . . . 0.17 109.848 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -111.11 148.29 38.38 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.743 -0.662 . . . . 1.05 109.995 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.445 ' HB2' HG22 ' A' ' 134' ' ' ILE . 48.1 Cg_endo -75.43 142.71 26.91 Favored 'Trans proline' 0 CA--C 1.498 -1.295 0 C-N-CA 122.113 1.875 . . . . 0.2 110.848 175.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.643 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.6 175.0 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.718 -0.674 . . . . 0.13 110.754 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.89 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.17 146.39 45.2 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.311 -0.404 . . . . 0.26 110.153 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.518 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 7.5 m -127.23 130.18 70.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.558 0.694 . . . . 0.56 111.625 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.4 153.38 26.27 Favored Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 110.012 -1.235 . . . . 0.17 110.012 172.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -56.12 3.3 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.238 0.829 . . . . 3.05 113.238 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.868 HG23 HD22 ' A' ' 90' ' ' LEU . 1.8 tp -91.48 -18.55 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 121.555 0.693 . . . . 0.23 110.46 -178.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.868 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -88.86 -18.19 28.12 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.757 -0.656 . . . . 0.18 109.398 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.8 p -65.56 -19.4 65.91 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.627 -1.17 . . . . 0.33 111.778 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -57.64 -42.47 83.47 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.14 -0.936 . . . . 1.52 111.941 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.37 120.9 48.03 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-O 120.867 0.365 . . . . 0.43 111.582 -174.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 2.2 Cg_endo -76.84 -16.18 16.41 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.794 2.329 . . . . 0.73 113.262 177.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 t -106.58 -41.25 5.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.491 -0.559 . . . . 0.48 109.491 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.472 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 46.6 48.6 17.12 Favored Glycine 0 N--CA 1.446 -0.636 0 O-C-N 124.374 1.047 . . . . 0.33 113.585 170.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.01 111.83 19.22 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.808 0.813 . . . . 0.84 109.728 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -137.7 169.44 17.78 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.141 -1.391 . . . . 0.22 112.326 -172.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.502 ' CG ' HD11 ' A' ' 5' ' ' LEU . 19.3 m-85 -141.25 134.84 30.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.656 -0.702 . . . . 0.54 110.241 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.555 HD12 ' HB ' ' A' ' 161' ' ' THR . 81.1 mt -58.62 117.83 2.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.507 -0.77 . . . . 0.17 110.695 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.53 HG21 ' HA ' ' A' ' 22' ' ' PHE . 22.4 pt -82.87 -43.56 18.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 112.604 0.594 . . . . 0.21 112.604 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.564 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 52.9 m-80 -170.7 168.97 7.27 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.787 -1.56 . . . . 2.03 106.787 -170.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.576 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -133.95 152.97 52.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.207 -0.597 . . . . 1.52 111.944 -175.114 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 50.7 tt0 -128.46 103.0 6.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.45 -0.796 . . . . 0.59 110.161 175.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.461 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 38.0 ttt180 -62.92 166.85 5.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.334 -0.848 . . . . 2.82 110.411 173.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.497 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 19.9 m-80 -35.32 103.51 0.24 Allowed Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 125.097 1.359 . . . . 0.35 113.373 -156.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.497 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.8 Cg_endo . . . . . 0 C--N 1.347 0.457 0 C-N-CA 123.026 2.484 . . . . 0.48 111.084 172.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.558 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.563 1.47 0 N-CA-C 117.334 2.346 . . . . 0.48 117.334 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.465 ' CD1' HG13 ' A' ' 151' ' ' ILE . 0.5 OUTLIER -164.63 160.79 20.44 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.426 -0.796 . . . . 0.28 110.372 -175.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 24.4 t-105 -141.62 98.67 3.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.693 -0.854 . . . . 0.49 108.693 168.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 103' ' ' ARG . 2.4 mt -90.69 114.49 26.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.342 0.591 . . . . 0.66 109.428 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.44 ' C ' HG12 ' A' ' 101' ' ' ILE . 14.5 m -84.8 144.83 28.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.014 -0.539 . . . . 0.19 111.384 -170.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.781 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -109.58 168.98 9.0 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.32 -0.4 . . . . 0.13 111.145 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.749 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -60.68 -10.87 5.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.074 0.768 . . . . 1.17 113.074 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.548 ' HG3' ' H ' ' A' ' 122' ' ' HIS . 14.8 tppt? -127.38 131.38 50.34 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.642 0.734 . . . . 1.22 110.185 171.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.467 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 8.5 pt20 -47.44 -31.61 4.3 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.323 -1.762 . . . . 1.51 114.872 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.548 ' H ' ' HG3' ' A' ' 120' ' ' LYS . 60.5 m80 -97.37 -8.48 29.46 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.692 -0.803 . . . . 2.53 112.312 -177.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.781 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.4 m-30 -94.82 40.07 1.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.185 1.18 . . . . 0.84 114.185 -168.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.694 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -112.0 145.17 17.85 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 116.376 -2.821 . . . . 0.32 112.509 -153.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.32 115.99 37.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.787 0.803 . . . . 0.18 110.762 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.643 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.3 p80 -145.12 172.2 13.43 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.344 -0.844 . . . . 0.21 109.462 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.28 -168.2 38.76 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 120.157 -1.021 . . . . 0.27 111.724 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.7 t -154.6 171.45 19.45 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.908 -0.76 . . . . 0.41 111.325 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -113.48 -11.44 13.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.564 -0.902 . . . . 1.99 108.564 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -107.45 86.97 3.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.216 -1.031 . . . . 1.36 108.216 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.37 -18.6 29.75 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.355 2.037 . . . . 0.35 112.906 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.46 -0.12 40.28 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.402 -0.817 . . . . 0.33 111.077 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.473 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 98.2 p -91.59 -6.58 52.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.022 -0.733 . . . . 1.35 109.022 171.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 83' ' ' PRO . 40.5 mm -78.82 135.69 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.399 -0.819 . . . . 0.21 110.141 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.18 0.71 70.48 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.366 -1.093 . . . . 0.15 110.366 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 50.3 mttm -115.02 176.31 5.12 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 123.629 1.68 . . . . 2.5 114.088 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -105.61 129.31 53.88 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.655 -2.975 . . . . 0.17 108.157 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.469 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -125.22 158.85 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.95 -0.759 . . . . 0.66 108.95 -175.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 67.9 m -47.45 -59.61 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.712 0.634 . . . . 0.43 112.712 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -131.44 -44.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.014 -1.075 . . . . 2.02 113.304 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.27 132.7 0.21 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 117.082 1.593 . . . . 0.18 117.082 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.489 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.9 p -71.5 165.15 24.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.359 -1.921 . . . . 0.16 111.874 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.89 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 60.6 mt -59.83 98.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 114.841 -1.072 . . . . 0.4 111.857 -163.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.643 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 74.8 mtt180 -84.52 149.58 25.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.676 -1.602 . . . . 1.87 110.33 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.643 ' HG2' HG22 ' A' ' 84' ' ' ILE . 15.9 mtp -129.29 -165.4 1.51 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.002 -0.74 . . . . 0.79 109.002 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.645 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 3.5 t-160 -96.28 157.36 15.93 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.59 -0.893 . . . . 2.32 108.59 171.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.644 ' O ' HD13 ' A' ' 151' ' ' ILE . 3.7 m120 -59.03 -51.07 71.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 118.285 -0.864 . . . . 0.68 110.549 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -64.42 -27.09 68.76 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 121.562 1.983 . . . . 2.18 112.491 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.645 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 5.8 m-20 -79.03 -43.23 24.68 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.048 0.452 . . . . 0.69 110.658 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.638 HG13 HD12 ' A' ' 151' ' ' ILE . 14.4 p -69.08 -23.85 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.645 -0.707 . . . . 0.11 111.539 177.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.06 -42.09 18.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 119.126 -0.464 . . . . 0.38 109.954 171.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 156' ' ' ILE . 22.5 mt-10 -46.79 -69.42 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 119.058 0.845 . . . . 1.99 112.407 170.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 157' ' ' VAL . 37.0 mt -47.71 -40.2 19.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.509 0.671 . . . . 1.27 111.517 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.68 -35.6 76.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.21 -1.359 . . . . 0.18 111.41 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.8 t -87.29 -29.77 21.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.603 0.638 . . . . 0.21 112.521 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.6 mt -84.87 -60.38 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.471 0.653 . . . . 0.16 112.025 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.1 m -90.51 143.01 28.6 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 114.994 -1.003 . . . . 0.16 112.161 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.424 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 44.0 Cg_endo -91.91 176.1 1.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 124.273 3.315 . . . . 0.2 111.378 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 77.0 m-20 -66.92 157.94 31.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.554 -0.859 . . . . 1.1 109.454 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 95.85 -16.64 60.79 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.238 -0.982 . . . . 0.18 112.02 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.555 ' HB ' HD12 ' A' ' 100' ' ' ILE . 91.5 m -66.38 139.0 57.98 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.199 -0.667 . . . . 0.14 109.199 -175.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.492 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 2.2 ptt180 -92.69 117.72 30.29 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.665 1.221 . . . . 3.63 110.932 -169.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.77 107.2 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 111.992 -2.367 . . . . 0.14 108.806 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.4 m -95.24 109.48 21.59 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.609 0.596 . . . . 0.21 112.609 -170.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.472 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.48 100.58 7.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 122.215 1.007 . . . . 0.24 110.062 178.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -109.44 134.64 51.61 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.234 -1.348 . . . . 1.09 109.795 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.584 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.7 mmm180 . . . . . 0 C--N 1.32 -0.699 0 N-CA-C 109.867 -0.42 . . . . 2.08 109.867 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 121.33 0.586 . . . . 0.65 111.851 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.8 tt -99.69 129.53 45.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.018 -0.992 . . . . 0.28 110.32 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.39 162.2 13.59 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.02 0.914 . . . . 0.31 112.88 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.652 ' HB3' HG13 ' A' ' 46' ' ' ILE . 80.9 t80 -130.38 143.84 51.02 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.106 -1.406 . . . . 0.44 108.122 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -114.74 114.53 25.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.464 -0.939 . . . . 0.76 108.464 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 41' ' ' THR . 95.2 t -67.97 151.44 10.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 122.383 1.087 . . . . 0.39 113.611 -171.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -106.55 158.47 16.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.359 -1.746 . . . . 2.01 108.392 172.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -61.89 115.42 4.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.058 0.456 . . . . 1.83 111.799 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.33 12.86 47.15 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.976 -0.63 . . . . 0.48 113.255 173.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' HB3' HG13 ' A' ' 9' ' ' VAL . 1.8 p-10 -50.63 170.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.019 0.914 . . . . 1.46 111.864 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.8 150.02 52.17 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.186 -0.915 . . . . 0.41 110.959 169.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.646 HD13 ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -64.66 -34.27 77.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.519 -1.219 . . . . 0.86 108.242 -178.204 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.523 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 4.2 t30 -85.02 -27.74 26.2 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.621 -1.172 . . . . 1.15 111.192 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.9 t -65.32 -42.31 93.11 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.307 -0.557 . . . . 1.21 109.921 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.6 mt -74.4 -25.93 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 121.381 0.61 . . . . 0.21 109.822 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.655 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.93 -9.94 59.66 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.269 -0.423 . . . . 0.16 110.793 174.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.645 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.45 -40.14 9.23 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.399 1.095 . . . . 0.21 108.079 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -61.84 -40.89 96.91 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 112.885 -1.962 . . . . 0.53 111.897 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.563 ' HA ' HG21 ' A' ' 101' ' ' ILE . 65.5 m-85 -101.46 5.51 42.03 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 118.611 -1.235 . . . . 0.18 111.872 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.9 mpt_? 54.53 40.43 31.82 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.828 0.823 . . . . 1.78 109.553 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.0 pt -112.99 -165.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.486 -1.234 . . . . 0.19 109.957 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.32 142.26 42.2 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.086 -0.961 . . . . 0.95 110.106 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.652 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 43.4 p -72.95 -30.7 64.06 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.383 -0.969 . . . . 0.25 108.383 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.3 -24.25 67.59 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.559 -0.746 . . . . 0.2 111.872 170.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.35 -29.2 14.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.993 -0.743 . . . . 0.17 108.993 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.594 HD23 HD23 ' A' ' 15' ' ' LEU . 21.7 tp -71.9 -28.49 63.53 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.96 -1.018 . . . . 1.16 108.414 172.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.652 ' HB2' ' O ' ' A' ' 26' ' ' THR . 8.2 tp -76.75 -31.73 57.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.939 0.876 . . . . 1.05 109.575 175.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 44.6 tt0 -65.9 -43.23 88.81 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.112 -1.404 . . . . 1.81 110.603 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.422 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -80.35 -17.98 50.41 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.193 -0.603 . . . . 0.2 111.42 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.615 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 38.7 m-80 -144.21 81.59 11.37 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-O 121.554 0.692 . . . . 0.23 110.641 -173.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.6 Cg_endo -56.57 -10.07 4.64 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 124.124 3.216 . . . . 0.36 113.829 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.5 m -79.0 -24.84 43.44 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 122.097 -0.377 . . . . 1.38 111.409 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.615 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 61.5 mt -67.12 -33.38 75.34 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.553 0.692 . . . . 0.49 111.92 -170.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.524 ' HB3' HD11 ' A' ' 30' ' ' LEU . 1.7 pp0? -64.82 -44.92 88.32 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 122.742 1.258 . . . . 1.95 110.591 -174.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.98 -47.62 76.93 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 111.772 -2.467 . . . . 0.49 110.752 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.9 178.01 48.64 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.923 -1.035 . . . . 0.42 112.139 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' HG ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -110.99 159.02 18.12 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.109 0.481 . . . . 0.41 110.628 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 62.6 m -145.08 129.03 17.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.866 -0.606 . . . . 0.42 111.378 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.31 120.83 22.1 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.441 0.638 . . . . 0.47 110.057 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.83 0.49 57.55 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.215 -1.154 . . . . 0.41 110.215 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.631 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -75.84 125.31 28.84 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.925 -0.638 . . . . 1.3 109.842 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 35.1 p -81.03 131.16 35.29 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.778 0.799 . . . . 0.85 110.023 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.652 HG13 ' HB3' ' A' ' 7' ' ' TYR . 12.2 pt -131.28 140.64 47.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.354 -1.293 . . . . 0.25 109.259 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.91 150.29 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.964 0.411 . . . . 0.67 110.853 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.416 HG21 ' CD2' ' A' ' 22' ' ' PHE . 37.1 mm -114.71 93.18 32.36 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 114.91 -1.041 . . . . 0.16 109.172 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.638 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -59.67 134.23 56.37 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.862 2.375 . . . . 0.18 113.029 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.36 -6.25 80.79 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.932 -1.031 . . . . 0.26 112.266 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.707 HD12 ' HD2' ' A' ' 52' ' ' PRO . 32.6 tp -122.64 115.69 29.53 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-O 121.26 0.553 . . . . 0.61 111.398 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.707 ' HD2' HD12 ' A' ' 51' ' ' LEU . 53.5 Cg_endo -79.16 -177.41 3.87 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.668 2.912 . . . . 0.28 114.288 -172.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.599 ' HB3' HG23 ' A' ' 56' ' ' THR . 14.1 t70 -77.42 134.43 66.42 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.015 -1.448 . . . . 0.49 112.552 -170.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.4 -15.78 24.87 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.683 2.922 . . . . 0.46 113.279 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -95.96 -9.36 31.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.43 0.633 . . . . 1.38 111.309 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.599 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.0 p -85.74 -18.47 32.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.053 0.93 . . . . 0.46 108.713 173.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 59' ' ' TYR . 7.8 mm -63.99 125.43 87.95 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 113.638 -1.619 . . . . 0.7 109.755 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.74 -13.53 13.09 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.984 1.789 . . . . 0.39 112.699 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.654 ' H ' HG22 ' A' ' 57' ' ' ILE . 58.7 m-85 -103.45 169.79 8.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.892 0.377 . . . . 0.24 111.756 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -154.13 127.76 8.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.701 -0.851 . . . . 2.89 108.701 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 71' ' ' THR . 93.6 mt -107.19 130.92 58.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.831 -0.622 . . . . 0.16 111.352 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.08 115.39 26.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.781 -0.768 . . . . 0.16 110.882 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 48.2 t -95.89 116.28 37.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.641 0.734 . . . . 0.19 111.053 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 68' ' ' LYS . 51.9 m -94.61 105.18 17.13 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.016 -0.993 . . . . 0.2 110.401 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.557 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.0 mm -53.59 -58.53 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 122.13 0.967 . . . . 0.23 111.104 167.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.05 -8.68 6.36 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 112.941 -1.936 . . . . 0.16 113.049 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.73 -17.72 4.92 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.589 0.756 . . . . 0.15 112.359 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.512 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.55 57.52 4.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.473 0.579 . . . . 0.69 111.302 -173.346 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 57.3 p -138.88 160.93 38.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 112.899 0.703 . . . . 0.13 112.899 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.465 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -129.07 113.44 15.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.538 -1.21 . . . . 0.4 109.999 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 9.9 m -94.05 122.86 37.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.081 0.467 . . . . 0.16 111.135 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.8 tp -99.03 103.22 15.14 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.367 -0.833 . . . . 0.59 109.455 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 19.5 m -105.18 159.83 15.55 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.406 -0.918 . . . . 1.05 110.594 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -128.11 127.88 43.85 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.993 -0.743 . . . . 0.26 108.993 168.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.582 ' N ' HD22 ' A' ' 74' ' ' LEU . 6.3 m-80 53.98 44.44 29.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.792 -1.095 . . . . 1.84 110.78 -174.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 71.37 -4.31 1.87 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.57 -0.741 . . . . 1.89 111.558 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -102.77 120.85 41.31 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.681 -0.69 . . . . 3.44 110.119 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 62.9 t -57.98 133.31 22.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 122.296 1.046 . . . . 0.24 112.527 -175.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 14.5 mtm -103.04 -43.43 5.5 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 113.32 -1.764 . . . . 0.81 109.329 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -159.41 171.43 19.76 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 113.297 -1.774 . . . . 1.46 110.014 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.1 m -149.1 123.68 9.77 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.091 -1.413 . . . . 0.17 109.748 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -113.61 146.42 35.42 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.694 -0.685 . . . . 1.05 110.303 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.434 ' HB2' HG22 ' A' ' 134' ' ' ILE . 35.0 Cg_endo -72.59 142.2 35.84 Favored 'Trans proline' 0 CA--C 1.495 -1.438 0 C-N-CA 122.038 1.825 . . . . 0.2 110.775 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.583 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.38 172.64 11.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.828 -0.624 . . . . 0.13 110.853 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.928 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.93 140.32 49.89 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 110.032 -0.359 . . . . 0.26 110.032 -176.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.512 HG22 ' HG3' ' A' ' 68' ' ' LYS . 9.6 m -122.91 126.19 73.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.508 0.67 . . . . 0.56 111.672 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -80.58 150.42 31.35 Favored Glycine 0 N--CA 1.423 -2.168 0 N-CA-C 109.544 -1.423 . . . . 0.17 109.544 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -57.7 4.74 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.951 0.723 . . . . 3.05 112.951 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.922 HG23 HD22 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -89.13 -18.72 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-O 121.546 0.689 . . . . 0.23 110.081 178.497 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.922 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -88.96 -17.28 29.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.793 0.806 . . . . 0.18 109.115 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.1 p -66.39 -18.49 65.39 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.535 -1.212 . . . . 0.33 111.302 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.73 -42.11 92.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.774 -1.103 . . . . 1.52 112.165 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.61 134.66 19.55 Favored Pre-proline 0 C--N 1.325 -0.497 0 C-N-CA 120.539 -0.465 . . . . 0.43 110.889 -175.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.523 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 84.7 Cg_endo -87.55 -16.1 3.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.472 2.114 . . . . 0.73 112.437 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.7 t -107.97 -38.75 5.73 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.31 -0.626 . . . . 0.48 109.31 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 45.16 31.93 3.27 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 124.785 1.303 . . . . 0.33 113.799 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB3' HG23 ' A' ' 164' ' ' THR . 8.2 pt-20 -84.55 115.74 22.77 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 122.801 1.286 . . . . 0.84 109.174 -173.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 13.2 m-85 -136.46 179.47 6.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 112.89 -1.959 . . . . 0.22 111.305 -167.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 45.7 m-85 -140.1 134.31 31.12 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.217 -0.447 . . . . 0.54 110.445 -172.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.609 HD12 ' HB ' ' A' ' 161' ' ' THR . 93.0 mt -61.58 118.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.413 -0.812 . . . . 0.17 110.511 171.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.563 HG21 ' HA ' ' A' ' 22' ' ' PHE . 24.1 pt -84.18 -44.54 18.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 112.816 0.673 . . . . 0.21 112.816 -176.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.535 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 54.5 m-80 -171.99 171.14 5.14 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.042 -1.836 . . . . 2.03 106.042 -168.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.942 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 3.4 mtt180 -130.51 174.59 9.74 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.433 -0.907 . . . . 1.52 112.167 -174.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -149.64 100.78 3.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.628 -1.169 . . . . 0.59 109.838 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.501 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 26.9 ttt85 -64.09 166.58 7.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.47 -0.786 . . . . 2.82 110.446 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.501 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 18.6 m-80 -34.77 102.64 0.23 Allowed Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 125.296 1.438 . . . . 0.35 113.315 -157.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.5 Cg_endo . . . . . 0 N--CA 1.459 -0.551 0 C-N-CA 123.107 2.538 . . . . 0.48 111.289 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.565 1.522 0 N-CA-C 117.57 2.433 . . . . 0.48 117.57 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.471 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -166.28 159.72 15.22 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.43 -0.794 . . . . 0.28 110.289 -177.187 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -140.37 98.1 3.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.449 -0.945 . . . . 0.49 108.449 167.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.57 HD12 HG23 ' A' ' 150' ' ' VAL . 2.6 mt -90.04 115.49 27.36 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.709 -0.62 . . . . 0.66 109.524 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 101' ' ' ILE . 17.4 m -84.81 143.49 29.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.953 -0.567 . . . . 0.19 111.609 -169.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.77 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.82 169.68 8.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.543 . . . . 0.13 111.374 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 t -63.77 -9.82 16.53 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.036 -0.984 . . . . 1.17 113.299 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.578 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 9.1 tptm -127.86 134.76 49.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.547 -0.461 . . . . 1.22 110.564 171.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.517 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 29.9 mm-40 -33.68 -59.61 0.39 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.982 1.105 . . . . 1.51 113.982 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.489 ' CB ' HG12 ' A' ' 89' ' ' ILE . 64.5 m80 -87.64 -2.32 58.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.313 -0.555 . . . . 2.53 111.703 -169.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.77 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -93.97 38.57 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.001 1.112 . . . . 0.84 114.001 -171.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.603 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -113.67 145.08 18.35 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 117.089 -2.482 . . . . 0.32 112.617 -154.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.518 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -98.98 115.32 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.891 0.853 . . . . 0.18 110.833 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.561 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 31.0 p80 -144.43 171.88 13.73 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.08 -0.964 . . . . 0.21 109.886 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.36 -167.93 38.55 Favored Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.422 -0.894 . . . . 0.27 111.723 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.5 t -154.86 170.34 21.89 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.013 -0.698 . . . . 0.41 110.551 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -115.01 -5.32 12.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.982 0.896 . . . . 1.99 108.639 175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -112.45 88.53 11.11 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 114.46 -1.246 . . . . 1.36 108.307 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.27 -18.25 26.87 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.438 2.092 . . . . 0.35 113.474 -170.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.03 -0.55 35.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.852 -0.613 . . . . 0.33 111.389 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 78.9 p -90.86 -9.13 47.46 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.054 -0.721 . . . . 1.35 109.054 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 83' ' ' PRO . 37.3 mm -78.95 136.75 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.259 -0.882 . . . . 0.21 110.263 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.09 -0.04 75.04 Favored Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 110.366 -1.094 . . . . 0.15 110.366 -176.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -112.04 170.08 8.4 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 123.071 1.415 . . . . 2.5 114.098 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.32 124.14 46.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 111.969 -2.378 . . . . 0.17 108.154 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.415 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -120.91 159.95 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.36 -0.978 . . . . 0.66 108.36 -173.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.5 m -50.62 -59.35 4.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.508 0.558 . . . . 0.43 112.508 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -132.03 -45.1 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 118.633 -1.227 . . . . 2.02 113.851 -174.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.36 133.19 0.2 Allowed Glycine 0 N--CA 1.466 0.692 0 N-CA-C 117.232 1.653 . . . . 0.18 117.232 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.442 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.9 p -70.95 165.4 23.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 112.471 -1.865 . . . . 0.16 112.348 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.928 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 66.7 mt -60.15 98.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 122.449 1.118 . . . . 0.4 112.056 -163.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.561 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 13.1 mtp180 -85.34 145.62 27.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.523 -1.672 . . . . 1.87 110.493 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.583 ' HG2' HG22 ' A' ' 84' ' ' ILE . 18.3 mtp -125.03 -164.81 1.32 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.717 -0.846 . . . . 0.79 108.717 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.593 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 89.2 m-70 -93.65 161.64 14.27 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.629 -0.508 . . . . 2.32 109.629 170.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.3 m120 -60.43 -51.96 67.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 118.744 -0.646 . . . . 0.68 109.726 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -64.18 -27.04 68.8 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 120.782 1.628 . . . . 2.18 112.244 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.593 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 68.8 m-20 -77.45 -46.68 21.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.261 0.553 . . . . 0.69 110.489 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.641 HG13 HD12 ' A' ' 151' ' ' ILE . 14.2 p -67.19 -22.8 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.222 -0.899 . . . . 0.11 111.754 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.641 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -84.27 -41.78 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 119.087 -0.482 . . . . 0.38 110.071 171.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 156' ' ' ILE . 24.6 mt-10 -49.26 -66.16 0.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 119.23 0.923 . . . . 1.99 112.278 170.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.47 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.3 mp -48.69 -35.02 13.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.612 0.72 . . . . 1.27 111.125 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.516 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -66.38 -31.17 71.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.624 -1.171 . . . . 0.18 111.4 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.2 t -88.28 -31.86 18.78 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.581 -0.7 . . . . 0.21 112.696 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.1 mt -84.95 -61.21 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.457 0.646 . . . . 0.16 112.33 -171.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -90.55 145.38 32.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.012 -0.994 . . . . 0.16 111.792 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.942 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 19.0 Cg_endo -95.12 178.32 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 124.901 3.734 . . . . 0.2 111.752 174.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 80.0 m-20 -68.66 158.23 34.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.227 -0.989 . . . . 1.1 108.966 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.12 -14.11 65.82 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.056 -1.069 . . . . 0.18 111.869 -173.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.609 ' HB ' HD12 ' A' ' 100' ' ' ILE . 85.2 m -66.73 139.01 57.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.44 -0.578 . . . . 0.14 109.44 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 2.0 ptt180 -92.34 115.69 28.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 122.726 1.251 . . . . 3.63 110.815 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.4 t -106.11 108.42 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 112.21 -2.268 . . . . 0.14 109.122 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.539 HG23 ' HB3' ' A' ' 97' ' ' GLU . 3.8 m -97.08 108.57 21.33 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 112.859 0.689 . . . . 0.21 112.859 -171.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.486 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -83.72 94.46 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 122.573 1.177 . . . . 0.24 110.327 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.406 ' O ' HG12 ' A' ' 65' ' ' ILE . 79.5 m-20 -104.9 142.38 34.86 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.234 -1.348 . . . . 1.09 109.86 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.557 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.8 mmm180 . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.957 0.408 . . . . 2.08 110.49 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.066 0.46 . . . . 0.65 111.578 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.699 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.5 tt -91.58 129.97 37.47 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.283 -0.872 . . . . 0.28 110.757 -174.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.77 162.03 13.33 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.3 1.048 . . . . 0.31 113.067 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 45' ' ' SER . 70.9 t80 -132.54 142.82 49.35 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.432 -1.713 . . . . 0.44 108.057 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.426 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 34.0 tt0 -113.97 113.22 24.52 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.05 -1.092 . . . . 0.76 108.05 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.651 HG13 ' HB2' ' A' ' 13' ' ' ASP . 95.9 t -66.13 149.5 11.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.327 1.06 . . . . 0.39 113.039 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -104.06 158.74 16.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.307 -1.769 . . . . 2.01 108.479 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.48 109.26 0.85 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.731 0.301 . . . . 1.83 111.235 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.66 10.2 50.78 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.807 -0.633 . . . . 0.48 113.925 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.651 ' HB2' HG13 ' A' ' 9' ' ' VAL . 43.9 m-20 -55.45 169.14 0.32 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.371 0.586 . . . . 1.46 110.865 172.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.32 152.43 50.58 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.562 0.696 . . . . 0.41 112.26 174.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.675 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -67.52 -29.76 69.25 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.184 -1.371 . . . . 0.86 109.901 -177.154 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.497 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 5.4 t30 -93.49 -24.99 17.8 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.879 -1.055 . . . . 1.15 110.669 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 t -69.22 -39.55 78.51 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.36 -0.607 . . . . 1.21 109.36 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.434 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.5 mt -72.93 -26.59 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.219 0.533 . . . . 0.21 109.688 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.25 -9.93 59.69 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.2 -0.312 . . . . 0.16 110.987 175.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.622 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.99 -39.33 9.41 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.609 1.195 . . . . 0.21 108.148 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 119' ' ' SER . 11.2 m-20 -63.66 -44.78 92.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.536 -2.12 . . . . 0.53 112.041 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.556 ' HA ' HG21 ' A' ' 101' ' ' ILE . 64.4 m-85 -97.96 4.97 49.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 118.57 -1.252 . . . . 0.18 111.613 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.622 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.1 mpt_? 54.04 46.92 24.49 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.782 0.801 . . . . 1.78 109.947 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.64 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.0 pt -118.38 -165.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 114.45 -1.25 . . . . 0.19 109.902 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.02 142.2 41.77 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.06 -0.973 . . . . 0.95 109.746 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.675 ' HB ' HD11 ' A' ' 15' ' ' LEU . 71.4 p -73.14 -33.19 65.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.166 -1.05 . . . . 0.25 108.166 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.22 -27.45 67.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.2 -0.909 . . . . 0.2 111.55 169.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -92.24 -28.32 17.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.914 -0.773 . . . . 0.17 108.914 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.646 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 21.3 tp -73.84 -26.95 60.85 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.328 -0.851 . . . . 1.16 109.47 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 26' ' ' THR . 43.1 mt -78.54 -31.28 47.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.835 0.826 . . . . 1.05 109.699 172.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 43.3 tt0 -63.98 -38.97 93.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.364 -1.289 . . . . 1.81 110.154 173.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -85.08 -20.94 29.61 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 119.965 -0.694 . . . . 0.2 111.591 176.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.632 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.1 m-80 -149.12 82.73 6.93 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-O 121.195 0.522 . . . . 0.23 110.466 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.7 Cg_endo -56.93 -11.73 7.95 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.928 3.086 . . . . 0.36 113.013 175.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -77.35 -19.86 55.67 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.223 -0.444 . . . . 1.38 112.017 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.876 HD21 HG21 ' A' ' 46' ' ' ILE . 38.2 mt -77.03 -34.03 57.34 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.318 0.58 . . . . 0.49 112.137 -171.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.421 ' H ' ' HG3' ' A' ' 37' ' ' GLN . 1.7 pp0? -63.24 -46.01 88.89 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 122.768 1.27 . . . . 1.95 110.926 -170.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.43 86.58 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 112.067 -2.333 . . . . 0.49 111.016 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.81 178.43 48.44 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 114.731 -1.122 . . . . 0.42 110.94 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.86 157.62 21.18 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.264 0.554 . . . . 0.41 111.186 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 47.0 m -138.06 127.94 25.46 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.161 -0.927 . . . . 0.42 110.299 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 120.56 21.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.348 0.594 . . . . 0.47 109.669 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.426 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 99.6 -0.51 56.77 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.305 -1.118 . . . . 0.41 110.305 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.4 tt0 -74.86 125.28 28.49 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 114.892 -0.654 . . . . 1.3 109.518 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 43.0 m -86.25 132.6 33.95 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.603 0.716 . . . . 0.85 109.877 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.876 HG21 HD21 ' A' ' 36' ' ' LEU . 12.1 pt -133.1 143.39 39.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.414 -1.266 . . . . 0.25 109.327 -176.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.468 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.67 151.48 3.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.079 0.466 . . . . 0.67 110.96 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.8 mm -115.41 91.97 30.76 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.706 -1.133 . . . . 0.16 109.31 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.623 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.1 Cg_endo -58.15 134.36 61.41 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.898 2.399 . . . . 0.18 112.741 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.43 -5.91 77.74 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.766 -1.106 . . . . 0.26 112.405 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.696 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 21.3 tp -129.21 120.29 20.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 121.048 0.451 . . . . 0.61 111.407 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.699 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_endo -80.91 -177.81 3.98 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.488 2.792 . . . . 0.28 114.166 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.58 ' HB3' HG23 ' A' ' 56' ' ' THR . 13.6 t70 -74.49 134.11 76.62 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 114.265 -1.334 . . . . 0.49 112.915 -168.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.91 -15.4 16.69 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 124.105 3.203 . . . . 0.46 112.951 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -95.38 -16.05 22.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.918 0.39 . . . . 1.38 111.131 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.58 HG23 ' HB3' ' A' ' 53' ' ' ASP . 22.2 p -79.04 -13.95 59.46 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.96 0.886 . . . . 0.46 109.445 175.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.568 HG22 ' H ' ' A' ' 59' ' ' TYR . 14.6 mm -63.86 126.08 89.17 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 113.813 -1.539 . . . . 0.7 110.193 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.2 -15.04 11.71 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.342 2.028 . . . . 0.39 112.895 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.568 ' H ' HG22 ' A' ' 57' ' ' ILE . 66.2 m-85 -100.08 174.02 6.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.894 0.378 . . . . 0.24 110.794 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -157.08 132.88 9.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.064 -0.717 . . . . 2.89 109.064 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.688 ' HA ' ' O ' ' A' ' 71' ' ' THR . 89.5 mt -113.66 134.68 55.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.132 -0.486 . . . . 0.16 111.497 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.01 116.09 26.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.829 -0.748 . . . . 0.16 111.018 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.6 t -96.46 113.96 32.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.669 0.747 . . . . 0.19 111.066 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 68' ' ' LYS . 49.6 m -91.52 108.48 19.92 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.071 -0.968 . . . . 0.2 110.62 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.56 HD13 HG11 ' A' ' 86' ' ' VAL . 50.6 mm -54.97 -59.69 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 122.038 0.923 . . . . 0.23 111.001 166.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.8 -13.86 6.78 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 112.846 -1.979 . . . . 0.16 113.071 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -125.02 -16.45 6.07 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 123.196 0.598 . . . . 0.15 112.491 -178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER 56.27 55.53 6.6 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.747 0.703 . . . . 0.69 111.493 -174.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.9 p -138.25 162.02 35.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.805 0.669 . . . . 0.13 112.805 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.485 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.9 tt -129.89 113.06 14.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.893 -1.049 . . . . 0.4 110.062 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.688 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.2 m -93.13 122.86 35.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.097 0.475 . . . . 0.16 111.228 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.417 HD21 ' HE3' ' A' ' 79' ' ' MET . 14.1 tp -100.39 106.11 17.67 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.318 -0.855 . . . . 0.59 109.764 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 89.1 p -107.68 161.29 15.01 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.185 -1.006 . . . . 1.05 110.735 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.625 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.1 tm? -128.46 129.38 46.03 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.781 -0.822 . . . . 0.26 108.781 169.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.625 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.5 p-10 46.98 46.13 15.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.345 -1.298 . . . . 1.84 111.181 -166.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 73.55 -8.53 1.35 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.84 -1.073 . . . . 1.89 111.785 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -94.96 119.82 34.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.767 -0.651 . . . . 3.44 109.776 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 68.4 t -58.38 133.43 23.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 122.392 1.092 . . . . 0.24 112.33 -174.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.417 ' HE3' HD21 ' A' ' 72' ' ' LEU . 18.6 mtm -102.56 -43.51 5.6 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.165 -1.834 . . . . 0.81 109.26 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -160.23 173.11 16.22 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.311 -1.768 . . . . 1.46 110.408 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.4 m -149.86 124.53 9.77 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 113.999 -1.455 . . . . 0.17 109.604 173.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -116.42 146.28 37.07 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.821 -0.627 . . . . 1.05 109.904 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.456 ' HB2' HG22 ' A' ' 134' ' ' ILE . 37.9 Cg_endo -72.07 142.86 39.11 Favored 'Trans proline' 0 CA--C 1.494 -1.477 0 C-N-CA 122.34 2.026 . . . . 0.2 111.26 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.665 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.94 173.71 8.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.665 -0.698 . . . . 0.13 110.609 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.887 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.63 147.39 43.81 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.989 -0.375 . . . . 0.26 109.989 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.56 HG11 HD13 ' A' ' 65' ' ' ILE . 8.1 m -128.2 127.66 67.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.714 0.769 . . . . 0.56 111.933 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -84.15 153.68 29.54 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 109.9 -1.28 . . . . 0.17 109.9 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -56.52 2.97 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.147 0.795 . . . . 3.05 113.147 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.94 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -87.76 -22.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.479 0.657 . . . . 0.23 110.503 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.94 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -87.49 -14.93 39.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.663 0.744 . . . . 0.18 109.314 -175.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.4 p -69.27 -17.47 63.75 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.72 -1.127 . . . . 0.33 111.278 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -67.6 -38.62 84.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.055 -0.975 . . . . 1.52 112.313 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 95' ' ' THR . 0.2 OUTLIER -107.02 109.4 63.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 120.415 -0.514 . . . . 0.43 111.171 -177.502 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.421 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 6.0 Cg_exo -73.79 -14.51 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.918 2.412 . . . . 0.73 113.381 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 93' ' ' THR . 9.2 t -91.96 -42.92 9.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.308 -0.627 . . . . 0.48 109.308 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.574 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 55.97 29.49 55.48 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.969 -1.469 . . . . 0.33 114.134 168.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.41 111.03 19.08 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.842 0.83 . . . . 0.84 109.396 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.675 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.0 m-85 -140.13 161.51 37.46 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.68 -1.6 . . . . 0.22 111.914 -172.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.691 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 16.0 m-85 -129.89 137.74 50.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.935 0.398 . . . . 0.54 110.719 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.619 HD12 ' HB ' ' A' ' 161' ' ' THR . 78.9 mt -60.52 121.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.476 -0.784 . . . . 0.17 110.971 172.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.556 HG21 ' HA ' ' A' ' 22' ' ' PHE . 22.0 pt -88.23 -34.88 7.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 113.243 0.831 . . . . 0.21 113.243 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.478 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 1.8 p-10 178.95 178.22 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.536 -1.283 . . . . 2.03 107.536 -176.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.513 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -134.75 154.6 51.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.558 0.694 . . . . 1.52 112.536 -174.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 49.0 tt0 -127.05 100.82 6.28 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.782 -1.099 . . . . 0.59 109.617 174.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.487 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 71.0 ttt180 -65.2 166.13 10.27 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.417 -0.811 . . . . 2.82 110.341 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.5 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 19.7 m-80 -35.42 103.33 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 125.24 1.416 . . . . 0.35 113.794 -155.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 8.4 Cg_endo . . . . . 0 N--CA 1.457 -0.628 0 C-N-CA 122.861 2.374 . . . . 0.48 111.458 172.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.566 1.568 0 N-CA-C 117.125 2.269 . . . . 0.48 117.125 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.487 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -165.31 157.38 15.21 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.328 -0.857 . . . . 0.28 110.305 -176.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 16.9 t-105 -138.32 97.88 3.48 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.31 -0.996 . . . . 0.49 108.31 167.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.524 HD12 HG23 ' A' ' 150' ' ' VAL . 2.6 mt -88.48 114.43 25.08 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.105 -0.702 . . . . 0.66 109.105 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.435 ' HB3' HD11 ' A' ' 101' ' ' ILE . 30.1 m -85.0 143.75 28.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.885 -0.598 . . . . 0.19 111.29 -169.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.79 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.4 170.78 7.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.13 111.113 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.5 t -61.6 -13.14 19.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.264 -0.88 . . . . 1.17 112.7 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.678 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.5 tmtp? -127.11 134.01 50.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.288 -0.565 . . . . 1.22 110.682 173.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.678 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 27.1 mt-30 -35.97 -56.91 0.71 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.559 -1.2 . . . . 1.51 114.166 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.588 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.9 OUTLIER -97.59 12.38 33.73 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.458 -0.897 . . . . 2.53 111.613 -172.614 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.79 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -97.63 37.28 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.01 0.744 . . . . 0.84 113.01 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.651 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.56 143.26 18.03 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 117.112 -2.471 . . . . 0.32 112.79 -152.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -94.38 115.22 32.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.818 0.818 . . . . 0.18 110.691 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 145' ' ' MET . 29.9 p80 -144.56 170.8 15.36 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.238 -0.892 . . . . 0.21 109.579 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.45 -168.46 38.6 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 120.184 -1.008 . . . . 0.27 112.073 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.8 t -155.89 173.75 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.216 -0.579 . . . . 0.41 111.008 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -110.98 -6.16 14.72 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.619 -0.882 . . . . 1.99 108.619 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -117.19 86.41 20.9 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 108.492 -0.929 . . . . 1.36 108.492 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.435 ' HA ' HG12 ' A' ' 134' ' ' ILE . 32.0 Cg_endo -74.23 -17.27 21.8 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.82 2.347 . . . . 0.35 113.894 -168.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.465 ' O ' ' HE2' ' A' ' 136' ' ' LYS . . . -78.69 -6.01 54.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.085 -0.507 . . . . 0.33 110.826 -177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.9 t -88.71 -9.53 51.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.58 -0.896 . . . . 1.35 108.58 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 39.7 mm -76.88 138.92 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.127 -0.942 . . . . 0.21 109.581 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.49 3.01 78.66 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.793 -0.923 . . . . 0.15 110.793 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 132' ' ' ALA . 25.2 mttm -113.89 172.33 7.05 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 123.039 1.4 . . . . 2.5 113.755 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.07 126.33 50.2 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 111.895 -2.412 . . . . 0.17 108.006 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.42 160.23 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.025 -0.731 . . . . 0.66 109.025 -173.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.5 m -47.71 -61.0 2.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.521 0.563 . . . . 0.43 112.521 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.429 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 46.7 pttt -132.65 -44.2 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.783 -1.167 . . . . 2.02 113.623 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.08 132.51 0.2 Allowed Glycine 0 N--CA 1.466 0.665 0 N-CA-C 117.056 1.583 . . . . 0.18 117.056 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.577 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.0 p -71.09 165.42 23.56 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 112.164 -2.018 . . . . 0.16 112.02 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.887 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 53.8 mt -59.64 98.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 122.518 1.152 . . . . 0.4 112.114 -163.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.47 ' HB2' ' CD1' ' A' ' 134' ' ' ILE . 13.6 mtp180 -87.38 148.24 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.568 -1.651 . . . . 1.87 110.217 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.665 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.4 mtp -127.99 -164.8 1.41 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.773 -0.825 . . . . 0.79 108.773 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.713 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 29.6 t-80 -94.79 158.74 15.36 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.896 -0.779 . . . . 2.32 108.896 171.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.7 m120 -57.69 -53.26 60.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.397 -0.811 . . . . 0.68 110.408 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -63.15 -27.06 69.11 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 121.244 1.838 . . . . 2.18 112.427 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.713 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 4.6 m-20 -79.42 -44.48 21.31 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.147 0.499 . . . . 0.69 110.814 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.634 HG13 HD12 ' A' ' 151' ' ' ILE . 14.3 p -67.31 -23.6 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.488 -0.778 . . . . 0.11 111.589 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.634 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.34 -42.0 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 119.01 -0.519 . . . . 0.38 110.045 171.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 156' ' ' ILE . 25.3 mt-10 -47.52 -69.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.232 0.924 . . . . 1.99 112.365 170.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.572 ' O ' HG22 ' A' ' 157' ' ' VAL . 8.6 mp -46.31 -39.18 9.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.48 0.657 . . . . 1.27 111.261 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.8 78.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.424 -1.262 . . . . 0.18 111.724 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.1 t -87.69 -30.62 20.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 118.702 0.683 . . . . 0.21 112.284 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.0 mt -83.98 -60.14 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.43 0.633 . . . . 0.16 112.154 -172.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.6 m -87.38 143.32 34.13 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.026 -0.988 . . . . 0.16 112.129 178.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -89.74 172.9 3.77 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 124.128 3.219 . . . . 0.2 111.111 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.478 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 68.8 m-20 -67.67 157.26 34.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 118.955 -1.098 . . . . 1.1 109.037 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.36 -16.28 61.58 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.183 -1.008 . . . . 0.18 112.219 -172.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.619 ' HB ' HD12 ' A' ' 100' ' ' ILE . 98.5 m -63.98 139.71 58.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.12 0.486 . . . . 0.14 109.9 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.691 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -93.48 124.82 37.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.559 1.171 . . . . 3.63 111.63 -170.422 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.56 107.21 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 112.168 -2.287 . . . . 0.14 109.104 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.6 m -95.33 107.16 19.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 112.837 0.68 . . . . 0.21 112.837 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.574 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -80.84 107.14 12.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 122.153 0.978 . . . . 0.24 109.898 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -110.27 128.06 55.32 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.278 -1.328 . . . . 1.09 110.016 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.469 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 15.1 mmm-85 . . . . . 0 C--N 1.318 -0.777 0 CA-C-O 121.219 0.533 . . . . 2.08 110.042 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.798 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 tp . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 121.102 0.477 . . . . 0.65 111.07 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.9 tt -88.68 127.03 35.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.259 -0.882 . . . . 0.28 110.728 -172.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.72 161.2 13.98 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.78 -1.1 . . . . 0.31 112.444 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 45' ' ' SER . 86.2 t80 -131.71 140.01 49.18 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.912 -1.495 . . . . 0.44 107.939 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.454 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.3 tt0 -112.69 110.56 20.77 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.807 -1.183 . . . . 0.76 107.807 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 44' ' ' GLN . 90.3 t -66.48 151.59 10.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 122.466 1.127 . . . . 0.39 113.433 -167.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 10' ' ' LYS . 8.1 mtpm? -102.53 158.94 15.87 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 113.486 -1.688 . . . . 2.01 108.997 173.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.604 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 2.2 tt0 -62.73 112.87 2.71 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.07 -0.514 . . . . 1.83 112.087 -172.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.51 12.95 42.95 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.922 -0.656 . . . . 0.48 113.768 173.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.575 ' CG ' HD11 ' A' ' 18' ' ' ILE . 2.4 t70 -50.4 168.26 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 112.524 0.564 . . . . 1.46 112.524 174.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.547 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -127.12 149.5 49.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.147 0.499 . . . . 0.41 110.86 166.523 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -62.24 -38.5 89.49 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.344 1.069 . . . . 0.86 108.405 -175.383 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.439 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 63.5 t30 -83.57 -19.25 35.92 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.324 -1.307 . . . . 1.15 110.98 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -68.38 -42.69 78.72 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.487 -0.485 . . . . 1.21 110.227 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.575 HD11 ' CG ' ' A' ' 13' ' ' ASP . 18.6 mt -72.81 -26.64 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.435 0.636 . . . . 0.21 109.887 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.68 -9.5 59.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.213 -0.449 . . . . 0.16 110.792 175.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.626 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.18 -40.88 8.97 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.836 1.303 . . . . 0.21 108.528 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.529 ' HB3' ' O ' ' A' ' 119' ' ' SER . 26.5 m-20 -61.94 -42.93 99.67 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.937 -2.392 . . . . 0.53 111.979 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.594 ' HA ' HG21 ' A' ' 101' ' ' ILE . 66.3 m-85 -100.22 4.79 44.52 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.639 -1.224 . . . . 0.18 111.822 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.626 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.6 mpt_? 54.59 42.25 31.41 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.828 0.823 . . . . 1.78 109.681 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.616 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.4 pt -114.99 -164.6 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.513 -1.221 . . . . 0.19 109.129 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 22.0 t -110.76 157.35 19.87 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.357 1.075 . . . . 0.95 110.154 168.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.601 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 62.5 p -80.11 -28.54 38.98 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 112.792 -2.004 . . . . 0.25 107.243 176.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.44 77.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.421 -0.809 . . . . 0.2 111.958 171.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -88.08 -29.22 20.8 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.88 -0.785 . . . . 0.17 108.88 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.637 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -71.9 -28.48 63.53 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.093 -0.958 . . . . 1.16 109.279 174.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 26' ' ' THR . 35.7 mt -76.83 -29.95 56.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.685 0.755 . . . . 1.05 110.611 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 27.8 tt0 -65.47 -39.89 92.5 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.621 -1.172 . . . . 1.81 109.998 174.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.443 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.93 -19.87 31.54 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 120.26 -0.576 . . . . 0.2 111.614 177.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.624 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 21.5 m-80 -148.76 82.46 7.28 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-O 121.457 0.646 . . . . 0.23 110.586 -173.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 21.4 Cg_endo -58.88 -5.94 3.07 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 124.169 3.246 . . . . 0.36 113.872 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -81.94 -23.35 36.2 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.173 -0.329 . . . . 1.38 111.42 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.68 HD21 HG21 ' A' ' 46' ' ' ILE . 28.9 mt -70.34 -32.38 70.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.521 0.677 . . . . 0.49 112.149 -170.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 3.4 pt20 -65.99 -48.7 70.36 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.681 1.229 . . . . 1.95 110.022 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.77 -46.31 87.79 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.043 -2.344 . . . . 0.49 111.005 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.91 -178.69 47.61 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 114.79 -1.095 . . . . 0.42 111.153 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.11 156.94 24.3 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.244 0.545 . . . . 0.41 111.181 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.546 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 37.1 m -139.94 128.94 23.53 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.159 -0.928 . . . . 0.42 110.469 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.604 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -78.82 126.21 30.4 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.288 0.566 . . . . 0.47 110.212 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 91.24 4.65 68.37 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.406 -1.078 . . . . 0.41 110.406 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.546 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.22 123.79 28.76 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.104 -0.548 . . . . 1.3 109.805 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 19.1 p -77.97 127.62 32.62 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.909 0.862 . . . . 0.85 110.667 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.68 HG21 HD21 ' A' ' 36' ' ' LEU . 12.0 pt -129.21 143.28 41.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.247 -1.342 . . . . 0.25 109.417 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.35 151.45 3.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.271 0.558 . . . . 0.67 111.074 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.472 HG21 ' CD2' ' A' ' 22' ' ' PHE . 38.9 mm -116.85 94.61 44.65 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.628 -1.169 . . . . 0.16 108.896 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.554 ' HA ' HD21 ' A' ' 4' ' ' LEU . 3.9 Cg_exo -61.5 136.03 60.78 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.599 2.199 . . . . 0.18 112.539 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.4 -0.54 81.0 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.477 -0.783 . . . . 0.26 112.317 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.798 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 25.2 tp -131.02 117.53 17.17 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 121.08 0.467 . . . . 0.61 111.241 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.7 ' HD2' HD12 ' A' ' 51' ' ' LEU . 32.1 Cg_endo -75.26 168.86 23.73 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.546 2.831 . . . . 0.28 113.543 -171.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.502 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 11.5 t70 -73.8 129.44 85.09 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 114.252 -1.34 . . . . 0.49 111.307 -175.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.639 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 66.4 Cg_endo -73.76 -15.52 24.01 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 123.752 2.968 . . . . 0.46 112.711 -174.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -95.66 -3.65 45.77 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.389 -0.823 . . . . 1.38 109.574 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 8.6 p -93.56 -14.87 26.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.534 -1.284 . . . . 0.46 107.534 171.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.486 HG22 ' H ' ' A' ' 59' ' ' TYR . 36.1 mt -84.72 130.14 54.21 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 113.311 -1.768 . . . . 0.7 110.915 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.71 -23.12 11.35 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.388 2.059 . . . . 0.39 113.301 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.486 ' H ' HG22 ' A' ' 57' ' ' ILE . 66.4 m-85 -86.37 150.7 24.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.89 -0.324 . . . . 0.24 111.322 -176.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -143.55 135.2 26.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.07 -0.715 . . . . 2.89 109.07 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.6 mt -117.2 134.19 61.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 112.534 0.568 . . . . 0.16 112.534 -175.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.91 119.84 35.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.116 -0.634 . . . . 0.16 111.357 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.72 HG22 HD12 ' A' ' 70' ' ' LEU . 90.8 t -102.89 115.43 44.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.858 0.837 . . . . 0.19 111.382 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 68' ' ' LYS . 20.5 m -94.67 100.28 12.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.44 -1.255 . . . . 0.2 110.628 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.3 mm -50.04 -58.47 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 122.056 0.932 . . . . 0.23 111.624 170.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.77 -9.82 2.93 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 112.896 -1.956 . . . . 0.16 113.477 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.08 -18.8 4.93 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.773 0.829 . . . . 0.15 112.173 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.33 56.99 4.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.396 0.544 . . . . 0.69 111.505 -173.387 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.0 p -138.15 159.77 41.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 113.011 0.745 . . . . 0.13 113.011 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.726 HD22 ' SD ' ' A' ' 145' ' ' MET . 4.3 tp -126.3 117.53 23.22 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.782 -1.099 . . . . 0.4 110.944 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 62.6 m -100.63 121.92 42.43 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.959 -0.696 . . . . 0.16 111.485 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 79' ' ' MET . 3.6 tp -101.74 106.72 17.77 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.243 -0.889 . . . . 0.59 109.262 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 87.2 p -104.99 163.69 12.35 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.585 -0.846 . . . . 1.05 110.722 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.1 tm? -124.64 126.57 45.96 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.901 -0.778 . . . . 0.26 108.901 168.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.548 ' N ' HD22 ' A' ' 74' ' ' LEU . 12.4 m120 49.74 46.76 23.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.71 -1.132 . . . . 1.84 111.015 -171.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 71.75 -7.75 1.2 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.566 0.746 . . . . 1.89 111.849 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -98.12 119.96 37.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.986 -0.552 . . . . 3.44 110.0 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 50.5 t -56.62 131.53 20.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 122.287 1.041 . . . . 0.24 113.314 -172.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.579 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 3.3 mmt -95.42 -46.78 6.55 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 112.989 -1.914 . . . . 0.81 107.941 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.3 mmtt -164.12 174.03 11.76 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.041 -1.89 . . . . 1.46 110.64 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 16.4 m -147.9 123.66 10.56 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.832 -1.531 . . . . 0.17 109.318 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -108.7 144.88 30.48 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.676 -0.693 . . . . 1.05 109.204 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HB2' HG22 ' A' ' 134' ' ' ILE . 38.5 Cg_endo -72.37 140.99 34.46 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 121.848 1.699 . . . . 0.2 110.207 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.47 HG21 ' HB2' ' A' ' 70' ' ' LEU . 2.1 pp -139.44 171.42 14.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 120.442 -0.503 . . . . 0.13 111.291 -177.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.92 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -116.23 142.27 47.05 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.144 -0.48 . . . . 0.26 109.781 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.521 HG22 ' HG3' ' A' ' 68' ' ' LYS . 12.9 m -126.08 113.96 36.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.675 0.75 . . . . 0.56 110.621 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -76.26 155.54 45.85 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 109.048 -1.621 . . . . 0.17 109.048 175.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 139' ' ' SER . 64.9 mttp -54.74 4.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 114.135 1.161 . . . . 3.05 114.135 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.845 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -89.66 -21.82 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 O-C-N 121.591 -0.693 . . . . 0.23 110.479 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.845 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -86.64 -18.88 30.24 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.019 0.914 . . . . 0.18 108.633 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -69.37 -12.9 62.05 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.053 -1.431 . . . . 0.33 111.456 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -75.07 -36.59 61.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.579 -1.192 . . . . 1.52 113.16 -177.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.74 132.5 26.0 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 119.779 -0.768 . . . . 0.43 111.286 -175.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 96.9 Cg_endo -89.13 -6.14 5.56 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.858 2.372 . . . . 0.73 113.105 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 96' ' ' GLY . 8.8 t -123.35 -42.46 2.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.057 0.456 . . . . 0.48 110.48 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 53.48 34.0 48.33 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.622 -1.172 . . . . 0.33 114.121 167.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.443 ' HG2' HG23 ' A' ' 164' ' ' THR . 44.8 mt-10 -84.37 113.01 20.85 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.955 0.884 . . . . 0.84 109.556 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.687 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 23.9 m-85 -137.38 -179.76 5.92 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.774 -1.557 . . . . 0.22 111.526 -170.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 80.9 m-85 -143.49 141.11 30.63 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 116.364 -0.38 . . . . 0.54 110.381 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.624 HD12 ' HB ' ' A' ' 161' ' ' THR . 75.6 mt -65.86 114.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 115.568 -0.742 . . . . 0.17 110.081 171.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.594 HG21 ' HA ' ' A' ' 22' ' ' PHE . 16.6 pt -83.55 -44.13 18.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.627 0.603 . . . . 0.21 112.627 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.868 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 51.9 m-80 -169.32 172.98 6.88 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.382 -1.34 . . . . 2.03 107.382 -170.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.653 HH21 ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -135.7 151.99 50.73 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.872 -0.731 . . . . 1.52 111.968 -178.353 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 49.7 tt0 -123.52 101.04 7.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.097 -0.956 . . . . 0.59 109.719 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.501 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 67.4 ttt180 -64.55 165.74 9.59 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.907 0.861 . . . . 2.82 110.656 176.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.501 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 20.7 m-80 -37.55 102.75 0.25 Allowed Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-N 113.048 -1.887 . . . . 0.35 114.756 -147.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.0 Cg_endo . . . . . 0 C--N 1.348 0.552 0 C-N-CA 123.188 2.592 . . . . 0.48 111.641 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.506 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.507 0 N-CA-C 116.61 2.078 . . . . 0.48 116.61 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -165.32 169.11 16.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.898 0.879 . . . . 0.28 109.144 -178.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 11.6 t-105 -147.82 97.48 2.82 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.78 -1.193 . . . . 0.49 107.78 165.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.579 HD12 HG23 ' A' ' 150' ' ' VAL . 2.1 mt -86.75 114.24 23.26 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.031 -0.729 . . . . 0.66 109.031 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.492 ' O ' HG12 ' A' ' 101' ' ' ILE . 11.9 m -84.0 142.6 30.36 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.606 -0.725 . . . . 0.19 110.724 -170.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.672 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.9 mm? -108.08 163.12 13.43 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.13 111.856 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.529 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 12.3 t -58.89 -9.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.563 1.165 . . . . 1.17 112.632 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.687 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 18.7 tptt -125.29 128.89 48.95 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 119.92 -0.712 . . . . 1.22 109.586 166.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.549 ' HA ' ' NH1' ' A' ' 23' ' ' ARG . 7.1 pt20 -52.9 -23.46 7.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.265 -1.334 . . . . 1.51 113.653 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.578 ' O ' ' HB3' ' A' ' 142' ' ' CYS . 41.4 m80 -96.85 -9.55 28.4 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.793 -0.763 . . . . 2.53 112.63 -177.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.532 ' CG ' ' HB3' ' A' ' 120' ' ' LYS . 3.2 m-30 -91.1 -37.01 13.67 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.586 0.958 . . . . 0.84 113.586 -169.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.672 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -4.14 128.95 0.01 OUTLIER Glycine 0 C--N 1.296 -1.655 0 N-CA-C 119.695 2.638 . . . . 0.32 119.695 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -97.27 114.21 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 113.128 -1.536 . . . . 0.18 109.699 175.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.701 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 24.2 p80 -140.56 177.81 7.76 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 115.473 -0.785 . . . . 0.21 109.937 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.73 -166.46 37.51 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.782 -0.723 . . . . 0.27 111.578 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.3 t -158.91 175.78 13.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.907 0.853 . . . . 0.41 110.61 177.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -115.16 -3.12 12.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.807 -0.812 . . . . 1.99 108.807 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -118.14 87.87 30.47 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.254 -0.884 . . . . 1.36 108.863 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.413 ' HA ' HG12 ' A' ' 134' ' ' ILE . 28.8 Cg_endo -73.55 -17.52 23.45 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.298 1.999 . . . . 0.35 113.405 -169.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.98 -1.03 42.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.867 -0.606 . . . . 0.33 111.13 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.524 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 38.9 t -93.64 -4.38 50.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.819 -0.808 . . . . 1.35 108.819 171.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 83' ' ' PRO . 45.2 mm -82.76 137.06 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.496 -0.774 . . . . 0.21 110.497 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.73 5.36 68.81 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 109.953 -1.259 . . . . 0.15 109.953 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 90.4 mttt -113.24 168.08 10.02 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 123.173 1.463 . . . . 2.5 114.1 -176.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -97.54 123.09 41.29 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 111.747 -2.478 . . . . 0.17 107.487 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.504 HG23 ' C ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -100.59 -166.15 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.954 -0.387 . . . . 0.66 109.954 -170.612 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.497 ' H ' HG12 ' A' ' 138' ' ' VAL . 67.6 m -84.98 -59.94 2.19 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 110.119 -0.326 . . . . 0.43 110.119 167.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -133.51 -43.99 0.83 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.357 -0.937 . . . . 2.02 112.572 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.34 134.09 0.18 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 117.047 1.579 . . . . 0.18 117.047 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 5.9 p -69.4 166.16 19.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 112.141 -2.029 . . . . 0.16 112.174 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.92 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 49.2 mt -60.4 99.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.374 -1.284 . . . . 0.4 111.77 -161.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.701 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 70.6 mtt180 -88.11 146.97 25.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.003 -1.453 . . . . 1.87 110.28 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.726 ' SD ' HD22 ' A' ' 70' ' ' LEU . 1.8 mtm -130.79 -163.61 1.34 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.861 -0.792 . . . . 0.79 108.861 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.546 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 87.6 m-70 -93.31 162.48 13.98 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.451 -0.5 . . . . 2.32 109.828 170.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.679 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.8 m120 -64.33 -47.42 79.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 118.784 -0.627 . . . . 0.68 110.234 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -65.9 -25.36 67.12 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 120.884 1.675 . . . . 2.18 112.688 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.546 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 71.0 m-20 -79.11 -46.82 17.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.192 0.52 . . . . 0.69 110.914 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.659 HG13 HD12 ' A' ' 151' ' ' ILE . 14.8 p -66.24 -24.27 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.347 -0.842 . . . . 0.11 111.685 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.679 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.19 -40.82 17.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 118.941 -0.552 . . . . 0.38 110.187 172.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.427 ' O ' HG13 ' A' ' 156' ' ' ILE . 14.0 mt-10 -47.73 -67.72 0.25 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.505 1.048 . . . . 1.99 112.54 170.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.577 HD11 ' CD2' ' A' ' 70' ' ' LEU . 95.8 mt -43.67 -40.52 4.21 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.748 0.785 . . . . 1.27 111.417 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.43 -37.34 86.93 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.875 -1.511 . . . . 0.18 111.591 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.0 t -86.35 -30.64 22.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.76 0.709 . . . . 0.21 112.401 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.6 mt -82.66 -60.55 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.521 0.676 . . . . 0.16 111.633 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.4 m -91.9 142.35 26.4 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.84 -1.073 . . . . 0.16 112.558 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.653 ' HA ' HH21 ' A' ' 103' ' ' ARG . 62.6 Cg_endo -89.21 173.9 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.872 3.048 . . . . 0.2 111.123 172.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.868 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -62.4 157.63 19.56 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.437 -0.949 . . . . 1.1 108.437 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 99.65 -27.07 21.87 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.931 -1.128 . . . . 0.18 112.73 -176.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.624 ' HB ' HD12 ' A' ' 100' ' ' ILE . 51.6 m -59.73 135.12 57.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.07 -0.715 . . . . 0.14 109.07 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.585 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 11.9 ptm180 -92.97 130.51 38.52 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.586 1.184 . . . . 3.63 111.776 -168.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.7 t -108.96 107.12 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 112.323 -2.217 . . . . 0.14 108.918 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 97' ' ' GLU . 25.5 m -94.25 106.73 18.7 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.152 -0.476 . . . . 0.21 112.105 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.479 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -83.55 98.01 5.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 122.304 1.05 . . . . 0.24 109.957 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -102.47 130.73 49.36 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.044 -1.435 . . . . 1.09 108.9 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.532 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 15.9 mmm180 . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 116.339 -0.391 . . . . 2.08 109.96 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.517 -0.294 0 CA-C-O 121.681 0.753 . . . . 0.65 112.432 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.1 tt -98.51 129.29 45.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.628 -1.169 . . . . 0.28 110.61 -175.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.31 162.24 13.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.056 0.931 . . . . 0.31 112.974 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.652 ' O ' ' HA ' ' A' ' 45' ' ' SER . 82.1 t80 -130.17 140.99 50.7 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.023 -1.444 . . . . 0.44 108.133 176.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.464 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 56.4 tt0 -113.32 113.4 25.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.107 -1.071 . . . . 0.76 108.107 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.614 HG13 ' HB2' ' A' ' 13' ' ' ASP . 94.7 t -68.39 150.36 10.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 122.651 1.215 . . . . 0.39 113.463 -168.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.414 ' O ' HG12 ' A' ' 9' ' ' VAL . 44.1 mtpt -101.48 159.15 15.53 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.198 -1.819 . . . . 2.01 108.623 172.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -63.8 103.02 0.52 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.944 0.402 . . . . 1.83 111.883 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.59 11.0 31.96 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.782 -0.723 . . . . 0.48 113.152 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.614 ' HB2' HG13 ' A' ' 9' ' ' VAL . 86.9 m-20 -52.74 166.8 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.851 0.357 . . . . 1.46 111.136 171.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.51 149.76 49.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.0 0.428 . . . . 0.41 111.028 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.565 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.66 -39.75 91.7 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.448 -0.945 . . . . 0.86 108.448 -177.217 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.467 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 4.7 t30 -82.35 -26.4 32.99 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.451 -1.249 . . . . 1.15 110.256 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -65.19 -41.98 94.02 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.217 -0.66 . . . . 1.21 109.217 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.443 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.6 mt -74.18 -26.62 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.238 0.542 . . . . 0.21 109.65 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.627 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.83 -10.05 59.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.319 -0.401 . . . . 0.16 110.831 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.66 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.75 -40.22 9.07 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 122.52 1.152 . . . . 0.21 108.045 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 119' ' ' SER . 7.2 m-20 -63.01 -45.76 90.83 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 112.265 -2.243 . . . . 0.53 112.082 173.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 60.7 m-85 -96.09 5.29 51.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 118.596 -1.242 . . . . 0.18 111.36 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.66 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.4 mpt_? 54.52 42.51 31.28 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.793 0.806 . . . . 1.78 109.92 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.627 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.5 pt -117.14 -165.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.678 -1.147 . . . . 0.19 109.887 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.49 143.47 40.78 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.117 -0.947 . . . . 0.95 110.279 175.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.471 ' HB ' HD13 ' A' ' 15' ' ' LEU . 37.0 p -73.32 -31.14 63.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.824 -1.176 . . . . 0.25 107.824 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.81 -33.01 71.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.336 -0.847 . . . . 0.2 111.815 169.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -90.26 -27.92 19.15 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.795 0.807 . . . . 0.17 108.886 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -72.93 -30.63 64.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.757 -1.11 . . . . 1.16 109.168 174.654 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 36' ' ' LEU . 46.0 mt -76.71 -29.24 56.16 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.579 0.704 . . . . 1.05 110.624 171.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 20.0 tt0 -63.78 -39.98 95.57 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.72 -1.127 . . . . 1.81 109.787 172.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.48 -19.76 32.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 120.248 -0.581 . . . . 0.2 111.693 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.648 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.2 m-80 -150.55 82.59 6.15 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.139 0.495 . . . . 0.23 110.482 -172.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.6 Cg_endo -56.2 -16.52 17.48 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 123.807 3.005 . . . . 0.36 113.609 176.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 m -71.37 -22.21 61.92 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.162 0.43 . . . . 1.38 112.162 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.782 HD21 HG21 ' A' ' 46' ' ' ILE . 28.9 mt -69.59 -35.48 75.37 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 112.563 0.579 . . . . 0.49 112.563 -170.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -64.69 -46.62 81.6 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 122.818 1.294 . . . . 1.95 110.304 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.21 -48.97 77.45 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 111.845 -2.434 . . . . 0.49 110.622 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.28 176.96 48.16 Favored Glycine 0 N--CA 1.428 -1.886 0 CA-C-N 114.595 -1.184 . . . . 0.42 111.341 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.47 157.49 19.53 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.452 0.644 . . . . 0.41 110.91 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.645 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 49.0 m -138.33 128.11 25.2 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.134 -0.939 . . . . 0.42 110.512 -176.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.12 118.8 19.23 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.546 0.689 . . . . 0.47 109.992 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.61 0.33 55.43 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 110.2 -1.16 . . . . 0.41 110.2 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.645 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -75.74 124.06 26.63 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.835 -0.682 . . . . 1.3 109.797 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 51.4 p -83.84 128.68 34.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.577 -0.738 . . . . 0.85 110.425 177.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.782 HG21 HD21 ' A' ' 36' ' ' LEU . 10.8 pt -129.42 142.8 43.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.432 -1.258 . . . . 0.25 109.459 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.11 150.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.465 0.65 . . . . 0.67 111.268 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.4 mm -115.77 94.6 41.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.285 -1.325 . . . . 0.16 108.669 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.654 ' HA ' HD21 ' A' ' 4' ' ' LEU . 5.9 Cg_exo -60.91 137.06 69.84 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.646 2.231 . . . . 0.18 112.76 -172.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.23 83.82 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.895 -1.048 . . . . 0.26 112.432 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.725 HD12 ' HD2' ' A' ' 52' ' ' PRO . 37.5 tp -120.36 116.97 31.97 Favored Pre-proline 0 N--CA 1.449 -0.502 0 O-C-N 122.415 -0.462 . . . . 0.61 111.295 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.725 ' HD2' HD12 ' A' ' 51' ' ' LEU . 43.2 Cg_endo -77.18 -177.25 3.69 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.891 3.061 . . . . 0.28 114.205 -172.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.603 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.1 t70 -86.31 127.84 59.71 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.266 -1.334 . . . . 0.49 111.836 -169.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.54 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.8 Cg_endo -75.8 -10.03 19.83 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.29 2.66 . . . . 0.46 112.891 -176.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -92.55 -15.86 26.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.831 -0.622 . . . . 1.38 110.271 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.603 HG23 ' HB3' ' A' ' 53' ' ' ASP . 27.1 p -84.62 -26.33 27.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.586 1.184 . . . . 0.46 108.286 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.559 HG22 ' H ' ' A' ' 59' ' ' TYR . 27.0 mt -68.02 129.27 93.18 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 112.966 -1.924 . . . . 0.7 111.155 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.419 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 86.7 Cg_endo -78.76 -14.34 14.04 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.474 2.116 . . . . 0.39 113.492 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.559 ' H ' HG22 ' A' ' 57' ' ' ILE . 45.1 m-85 -99.16 162.95 12.77 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.549 -0.46 . . . . 0.24 111.622 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -151.37 139.49 20.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.026 -0.731 . . . . 2.89 109.026 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.654 ' HA ' ' O ' ' A' ' 71' ' ' THR . 88.4 mt -120.81 136.74 56.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.276 0.473 . . . . 0.16 112.276 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.56 24.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.946 -0.702 . . . . 0.16 110.902 171.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' THR . 90.6 t -91.19 108.87 20.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.566 0.698 . . . . 0.19 110.78 173.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 68' ' ' LYS . 75.3 m -85.43 107.32 17.34 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.088 -0.96 . . . . 0.2 110.563 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.8 mm -53.98 -58.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 122.17 0.986 . . . . 0.23 111.164 166.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.65 -13.55 8.1 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 112.926 -1.943 . . . . 0.16 113.337 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.02 -17.01 5.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.523 0.729 . . . . 0.15 112.267 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.498 ' HD2' ' CG2' ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.5 56.87 4.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.287 0.494 . . . . 0.69 111.376 -173.522 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 44.8 p -138.79 167.22 22.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 113.037 0.755 . . . . 0.13 113.037 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 70' ' ' LEU . 7.7 tt -133.94 111.14 10.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.617 -1.174 . . . . 0.4 109.855 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.654 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 63.8 m -92.95 122.43 35.31 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.177 0.513 . . . . 0.16 111.15 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.7 tp -98.77 107.53 19.99 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.042 -0.981 . . . . 0.59 109.309 173.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 75.2 p -109.14 158.8 17.44 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.989 -1.084 . . . . 1.05 110.998 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.784 ' HB2' ' SD ' ' A' ' 79' ' ' MET . 1.2 tm? -128.21 126.4 40.89 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.092 -0.707 . . . . 0.26 109.092 171.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.62 ' OD1' HD13 ' A' ' 74' ' ' LEU . 2.6 p-10 43.76 52.99 6.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 113.952 -1.476 . . . . 1.84 112.146 -167.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 53.9 t30 75.46 -10.35 1.26 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.527 -0.76 . . . . 1.89 111.623 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -100.58 120.7 40.42 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.141 0.496 . . . . 3.44 110.126 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 45.4 t -55.82 132.72 19.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.249 1.024 . . . . 0.24 112.32 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.784 ' SD ' ' HB2' ' A' ' 74' ' ' LEU . 97.4 mtp -97.06 -48.24 5.47 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 113.364 -1.744 . . . . 0.81 108.405 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -158.67 171.97 19.13 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.498 -2.137 . . . . 1.46 109.902 -174.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.0 m -148.63 122.2 9.17 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.064 -1.425 . . . . 0.17 109.656 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.614 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 24.6 m-85 -105.21 156.5 36.09 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 115.214 -0.903 . . . . 1.05 109.729 -174.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.491 ' O ' ' HG2' ' A' ' 145' ' ' MET . 59.1 Cg_endo -84.93 142.98 9.15 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.046 1.831 . . . . 0.2 111.439 169.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.547 HG22 ' CG ' ' A' ' 145' ' ' MET . 2.2 pp -138.14 174.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.701 -0.681 . . . . 0.13 110.863 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.905 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.8 140.72 49.5 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.304 -0.407 . . . . 0.26 109.972 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.498 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 7.7 m -125.74 125.37 68.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.547 0.689 . . . . 0.56 111.829 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -82.76 157.58 36.0 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 114.899 -1.046 . . . . 0.17 110.631 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 139' ' ' SER . 74.7 mmtt -55.48 3.21 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.894 0.701 . . . . 3.05 112.894 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.954 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -92.55 -20.19 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.522 0.677 . . . . 0.23 110.28 -177.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.954 HD22 HG23 ' A' ' 89' ' ' ILE . 3.6 mm? -89.22 -18.16 27.63 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.707 0.765 . . . . 0.18 108.969 -176.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.1 p -66.61 -19.21 65.72 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.53 -1.214 . . . . 0.33 111.73 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -59.1 -42.01 89.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.885 -1.052 . . . . 1.52 112.372 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.94 133.54 20.23 Favored Pre-proline 0 C--N 1.324 -0.525 0 C-N-CA 120.449 -0.5 . . . . 0.43 111.497 -172.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 97.2 Cg_endo -90.59 -15.27 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.665 2.243 . . . . 0.73 112.755 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.416 HG23 ' N ' ' A' ' 96' ' ' GLY . 7.9 t -102.43 -43.54 5.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.23 0.538 . . . . 0.48 109.828 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.536 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 52.92 35.17 47.33 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.286 -1.325 . . . . 0.33 113.622 167.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -82.91 111.93 19.24 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 122.039 0.923 . . . . 0.84 109.478 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.621 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 26.1 m-85 -138.54 177.54 7.81 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.496 -1.684 . . . . 0.22 111.42 -173.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.469 ' CG ' HD11 ' A' ' 5' ' ' LEU . 28.5 m-85 -141.99 138.0 31.58 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.316 -0.402 . . . . 0.54 110.49 -174.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.586 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.3 mt -61.92 121.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.577 -0.738 . . . . 0.17 110.284 170.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 20.0 pt -88.63 -44.18 15.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 113.219 0.822 . . . . 0.21 113.219 -175.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.55 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 51.7 m-80 -170.95 170.35 6.34 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.044 -1.465 . . . . 2.03 107.044 -168.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.742 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 26.5 mtt180 -126.15 159.06 33.93 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.713 -0.795 . . . . 1.52 111.929 -173.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 60.7 tt0 -133.31 99.97 4.7 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.554 -0.748 . . . . 0.59 110.058 169.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 34.1 ttt85 -66.07 166.06 12.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.647 -0.706 . . . . 2.82 110.146 173.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.497 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 17.0 m-80 -35.26 101.92 0.22 Allowed Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 125.093 1.357 . . . . 0.35 113.255 -156.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.497 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.1 Cg_endo . . . . . 0 C--N 1.345 0.384 0 C-N-CA 123.205 2.603 . . . . 0.48 111.688 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.523 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.565 1.528 0 N-CA-C 117.398 2.37 . . . . 0.48 117.398 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.482 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -166.17 149.38 7.36 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.412 -0.805 . . . . 0.28 110.087 -176.162 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 9.9 t-105 -130.18 98.95 4.88 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.959 -1.126 . . . . 0.49 107.959 167.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.4 mt -91.51 114.46 26.99 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.08 -0.711 . . . . 0.66 109.08 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 101' ' ' ILE . 16.9 m -84.08 144.68 28.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.533 -0.758 . . . . 0.19 111.341 -168.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.778 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.5 mm? -108.91 170.1 8.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.13 111.407 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.2 t -62.0 -12.14 17.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.918 -1.037 . . . . 1.17 112.779 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.621 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 5.5 tptp -126.73 132.59 51.08 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.58 -0.448 . . . . 1.22 110.42 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.532 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 76.7 mt-30 -31.89 -60.86 0.25 Allowed 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.554 1.159 . . . . 1.51 113.94 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.582 ' HB3' HG12 ' A' ' 89' ' ' ILE . 1.7 t-160 -94.01 5.4 51.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.954 -0.698 . . . . 2.53 111.597 -169.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.778 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -93.9 38.43 1.07 Allowed 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 113.88 1.067 . . . . 0.84 113.88 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.644 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.92 143.57 18.12 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 116.9 -2.571 . . . . 0.32 112.67 -154.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 2.1 mp -96.52 114.04 32.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.808 0.814 . . . . 0.18 110.596 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.757 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.8 p80 -140.17 171.73 13.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.082 -0.963 . . . . 0.21 109.01 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.25 -170.31 39.49 Favored Glycine 0 C--N 1.315 -0.583 0 C-N-CA 119.891 -1.147 . . . . 0.27 111.613 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.7 t -153.23 168.74 24.96 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.35 -0.5 . . . . 0.41 110.332 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -112.05 2.94 17.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.18 -1.044 . . . . 1.99 108.18 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.9 84.67 26.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.384 -1.28 . . . . 1.36 107.935 169.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.79 -22.32 11.9 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.679 2.253 . . . . 0.35 114.495 -167.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.29 -10.19 59.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.923 -0.581 . . . . 0.33 110.749 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.593 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 45.5 m -91.5 1.28 57.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 1.35 110.375 176.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.409 HG22 ' HB2' ' A' ' 83' ' ' PRO . 47.5 mm -79.56 141.41 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.089 -0.505 . . . . 0.21 110.152 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.7 6.4 63.9 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.463 -1.055 . . . . 0.15 110.463 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.593 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 59.2 mttm -114.85 176.75 4.92 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 123.603 1.668 . . . . 2.5 114.078 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.77 125.46 51.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 110.813 -2.903 . . . . 0.17 108.406 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.575 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -121.51 162.67 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.798 -1.186 . . . . 0.66 107.798 -176.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.452 ' HA ' ' HG2' ' A' ' 88' ' ' LYS . 43.5 m -61.22 -50.95 71.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 118.845 0.748 . . . . 0.43 112.691 -178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -130.57 -45.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 117.889 -1.524 . . . . 2.02 114.112 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.29 132.78 0.21 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 117.071 1.588 . . . . 0.18 117.071 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.418 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 3.4 p -72.28 165.41 24.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 112.544 -1.828 . . . . 0.16 112.028 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.905 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 56.9 mt -60.41 98.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.535 -1.211 . . . . 0.4 112.276 -162.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.757 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 64.2 mtt180 -87.32 150.85 23.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.006 -1.452 . . . . 1.87 110.92 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.614 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -133.67 -163.65 1.39 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.081 -0.509 . . . . 0.79 109.994 174.293 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.518 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 26.2 m80 -91.39 162.07 14.74 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.167 -0.613 . . . . 2.32 109.937 172.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.688 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.4 m120 -61.71 -54.81 37.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 118.63 -0.7 . . . . 0.68 110.125 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -63.56 -24.79 67.95 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 121.119 1.782 . . . . 2.18 112.071 -174.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 45.2 m-20 -87.12 -45.36 10.77 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.547 -0.751 . . . . 0.69 111.281 -173.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.617 HG13 HD12 ' A' ' 151' ' ' ILE . 11.1 p -59.44 -25.13 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 111.781 0.289 . . . . 0.11 111.781 170.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.688 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -80.26 -40.27 19.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 118.95 -0.548 . . . . 0.38 109.876 171.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.477 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.2 mm-40 -44.66 -72.64 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.237 0.926 . . . . 1.99 112.094 168.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 157' ' ' VAL . 44.2 mt -46.61 -39.67 11.58 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.649 0.738 . . . . 1.27 111.514 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.3 80.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.098 -1.41 . . . . 0.18 111.466 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 25.5 t -86.29 -34.05 20.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.791 -0.568 . . . . 0.21 112.219 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 152' ' ' GLU . 30.3 mt -79.84 -60.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.61 0.719 . . . . 0.16 111.37 -171.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -91.95 141.64 25.59 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.882 -1.054 . . . . 0.16 112.4 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.742 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 53.2 Cg_endo -89.06 175.71 3.4 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 124.143 3.229 . . . . 0.2 111.062 173.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 75.7 m-20 -66.46 159.49 27.02 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 119.274 -0.971 . . . . 1.1 109.107 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.16 -19.87 52.61 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.231 -0.985 . . . . 0.18 112.3 -174.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.586 ' HB ' HD12 ' A' ' 100' ' ' ILE . 67.7 m -64.15 137.85 58.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.419 -0.586 . . . . 0.14 109.419 -175.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -92.97 123.49 36.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.715 1.245 . . . . 3.63 111.246 -169.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.82 111.39 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 112.221 -2.263 . . . . 0.14 109.613 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 63' ' ' VAL . 13.6 m -93.34 108.66 20.28 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.051 -0.522 . . . . 0.21 112.188 -174.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.536 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -79.95 100.23 4.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 123.201 1.477 . . . . 0.24 108.362 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -113.47 123.92 51.17 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 112.287 -2.233 . . . . 1.09 109.22 -164.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.504 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 9.1 mmm180 . . . . . 0 C--N 1.321 -0.652 0 C-N-CA 120.811 -0.356 . . . . 2.08 111.379 -177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 121.179 0.514 . . . . 0.65 110.821 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.616 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 2.9 tt -95.33 127.69 41.58 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.341 -0.845 . . . . 0.28 110.33 -176.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.14 162.33 13.41 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.202 1.001 . . . . 0.31 113.473 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 45' ' ' SER . 84.0 t80 -130.67 141.1 50.4 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.441 -1.709 . . . . 0.44 107.932 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.411 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 56.7 tt0 -114.03 114.21 25.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.02 -1.104 . . . . 0.76 108.02 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.686 HG13 ' HB2' ' A' ' 13' ' ' ASP . 95.7 t -68.35 150.47 10.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 122.338 1.066 . . . . 0.39 113.194 -169.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -103.38 157.85 16.74 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.505 -1.68 . . . . 2.01 108.042 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 2.3 mm-40 -58.64 110.17 0.94 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.104 0.478 . . . . 1.83 111.548 -176.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.22 11.71 51.32 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.548 -0.751 . . . . 0.48 114.004 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.686 ' HB2' HG13 ' A' ' 9' ' ' VAL . 30.7 m-20 -54.0 170.5 0.13 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 117.392 0.596 . . . . 1.46 111.222 171.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.6 154.58 47.7 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.449 -0.5 . . . . 0.41 111.424 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 26' ' ' THR . 4.6 tp -67.35 -38.04 84.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.853 0.835 . . . . 0.86 110.031 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 6.3 t30 -86.96 -23.22 25.17 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.434 -1.257 . . . . 1.15 110.13 -174.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -69.7 -37.64 76.65 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.802 -0.444 . . . . 1.21 109.802 172.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.43 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.0 mt -76.68 -28.71 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.188 0.518 . . . . 0.21 109.997 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.637 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.81 -9.51 59.08 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.122 -0.361 . . . . 0.16 110.538 175.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.708 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -95.92 -40.54 9.25 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.279 1.038 . . . . 0.21 108.449 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.445 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 1.4 m-20 -61.29 -44.11 97.76 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.849 -1.978 . . . . 0.53 112.0 174.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.497 ' HA ' HG21 ' A' ' 101' ' ' ILE . 59.0 m-85 -98.7 6.16 47.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.706 -1.198 . . . . 0.18 111.436 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.708 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.21 43.81 30.04 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.916 0.865 . . . . 1.78 109.328 177.481 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.637 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 30.9 pt -116.96 -164.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.385 -1.279 . . . . 0.19 110.23 -178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 144.28 38.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.997 -1.001 . . . . 0.95 110.523 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.594 ' HB ' HD21 ' A' ' 15' ' ' LEU . 75.8 p -73.98 -32.23 63.34 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.619 -0.882 . . . . 0.25 108.619 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.38 -27.66 67.6 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.26 -0.882 . . . . 0.2 111.629 169.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.98 -28.52 17.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.289 -0.564 . . . . 0.17 109.538 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.552 HD21 HD12 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -72.36 -30.55 64.81 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.781 -0.645 . . . . 1.16 109.432 173.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 36' ' ' LEU . 41.4 mt -75.16 -30.14 60.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.872 0.844 . . . . 1.05 109.721 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 47.2 tt0 -65.61 -39.83 91.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.112 -1.403 . . . . 1.81 110.527 173.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.48 -20.45 31.68 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 120.06 -0.656 . . . . 0.2 111.563 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.64 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 20.8 m-80 -148.94 82.66 7.07 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-O 121.206 0.527 . . . . 0.23 110.625 -172.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.57 -12.4 8.47 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 123.971 3.114 . . . . 0.36 113.667 175.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 m -72.53 -26.43 61.75 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.996 0.427 . . . . 1.38 111.661 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.64 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 36.4 mt -70.71 -33.69 71.13 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.89 -0.595 . . . . 0.49 112.564 -167.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.421 ' H ' ' HG3' ' A' ' 37' ' ' GLN . 1.8 pp0? -63.46 -44.4 94.56 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 122.979 1.371 . . . . 1.95 110.582 -174.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.68 81.96 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 111.818 -2.446 . . . . 0.49 110.985 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.66 179.0 48.84 Favored Glycine 0 N--CA 1.428 -1.898 0 CA-C-N 114.835 -1.075 . . . . 0.42 111.173 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.35 156.99 21.55 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.151 0.5 . . . . 0.41 110.978 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.547 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 31.7 m -134.89 127.58 30.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.076 -0.965 . . . . 0.42 110.243 -177.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -75.99 122.83 24.78 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.261 0.553 . . . . 0.47 110.114 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.411 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.76 1.17 61.93 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.543 -1.023 . . . . 0.41 110.543 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.547 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -79.96 123.85 28.17 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.271 -0.464 . . . . 1.3 110.177 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 31.0 p -76.8 126.67 31.38 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 122.175 0.988 . . . . 0.85 110.349 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.608 HG21 HD21 ' A' ' 36' ' ' LEU . 8.8 pt -125.85 141.26 46.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 113.875 -1.511 . . . . 0.25 108.878 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.85 151.18 3.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.357 0.598 . . . . 0.67 111.167 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.6 mm -115.36 93.4 35.93 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.385 -1.279 . . . . 0.16 108.794 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.579 ' HA ' HD21 ' A' ' 4' ' ' LEU . 5.6 Cg_exo -61.64 136.26 61.6 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.719 2.279 . . . . 0.18 112.726 -172.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.15 -6.0 82.77 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 114.725 -1.125 . . . . 0.26 112.435 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.701 HD12 ' HD2' ' A' ' 52' ' ' PRO . 29.8 tp -122.94 116.24 28.95 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-O 121.192 0.52 . . . . 0.61 110.948 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.701 ' HD2' HD12 ' A' ' 51' ' ' LEU . 52.3 Cg_endo -78.19 -177.14 3.66 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.491 2.794 . . . . 0.28 114.119 -171.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.624 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.0 t70 -79.3 133.59 60.13 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 114.202 -1.363 . . . . 0.49 112.454 -170.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.35 -16.01 24.89 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.577 2.851 . . . . 0.46 113.115 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -96.66 1.74 51.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.159 0.504 . . . . 1.38 111.701 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.624 HG23 ' HB3' ' A' ' 53' ' ' ASP . 26.8 p -95.74 -16.04 22.22 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.395 -0.965 . . . . 0.46 108.395 172.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.676 HG22 ' H ' ' A' ' 59' ' ' TYR . 9.1 mm -64.62 129.24 94.19 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 113.422 -1.717 . . . . 0.7 110.08 176.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.435 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 60.4 Cg_endo -78.65 -17.71 12.41 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.057 1.838 . . . . 0.39 113.037 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.676 ' H ' HG22 ' A' ' 57' ' ' ILE . 60.4 m-85 -104.13 172.99 6.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.066 0.46 . . . . 0.24 111.67 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -155.53 138.24 15.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.595 -0.729 . . . . 2.89 109.397 173.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 71' ' ' THR . 82.9 mt -113.55 131.97 63.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.108 -0.496 . . . . 0.16 111.789 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.44 118.27 32.72 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.169 -0.612 . . . . 0.16 111.13 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 59.0 t -98.1 120.91 48.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.538 0.685 . . . . 0.19 110.888 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 45.2 m -98.31 104.34 16.36 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.909 -1.041 . . . . 0.2 110.989 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.561 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 35.2 mm -50.89 -58.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 122.053 0.93 . . . . 0.23 111.263 166.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.21 -11.18 3.17 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 112.774 -2.012 . . . . 0.16 113.462 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -127.5 -21.52 3.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.982 0.734 . . . . 0.15 112.982 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.529 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 60.24 57.2 3.0 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.989 0.813 . . . . 0.69 111.249 -170.536 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -137.64 161.94 35.13 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.951 0.723 . . . . 0.13 112.951 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.478 ' CD2' HD21 ' A' ' 153' ' ' LEU . 7.8 tt -130.46 113.58 14.47 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.54 -1.209 . . . . 0.4 109.702 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 52.7 m -95.12 123.88 38.86 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.157 0.504 . . . . 0.16 111.317 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 79' ' ' MET . 11.6 tp -99.16 107.91 20.38 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.12 -0.946 . . . . 0.59 109.197 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 90.0 p -107.73 160.72 15.5 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.233 -0.987 . . . . 1.05 110.804 177.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.613 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -126.46 124.75 40.82 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.707 0.765 . . . . 0.26 109.221 170.254 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.613 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.9 p-10 37.83 59.21 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.531 -1.668 . . . . 1.84 111.899 -164.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 75.49 -13.73 0.84 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.883 -1.053 . . . . 1.89 112.156 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -96.0 121.59 37.91 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.699 -0.482 . . . . 3.44 109.699 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 46.5 t -58.49 129.82 21.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 122.318 1.056 . . . . 0.24 112.517 -176.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 48.4 mmm -93.9 -49.92 5.58 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.161 -1.836 . . . . 0.81 107.881 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -159.73 172.06 18.4 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.779 -2.01 . . . . 1.46 109.634 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.4 m -149.34 125.09 10.48 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.418 -1.265 . . . . 0.17 109.592 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -116.31 150.42 45.32 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.555 -0.748 . . . . 1.05 110.077 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.433 ' HB2' HG22 ' A' ' 134' ' ' ILE . 53.9 Cg_endo -75.5 145.57 29.92 Favored 'Trans proline' 0 CA--C 1.494 -1.492 0 C-N-CA 122.188 1.926 . . . . 0.2 110.957 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.636 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -141.22 173.25 9.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.689 -0.687 . . . . 0.13 110.782 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.898 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.65 142.99 46.59 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.438 -0.346 . . . . 0.26 110.176 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 68' ' ' LYS . 13.0 m -126.28 128.27 71.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.417 0.627 . . . . 0.56 111.622 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -92.01 160.14 25.96 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.067 -0.97 . . . . 0.17 110.714 173.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -55.62 2.88 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 113.539 0.94 . . . . 3.05 113.539 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.91 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -91.15 -18.89 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 O-C-N 121.051 -1.031 . . . . 0.23 109.793 -177.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.91 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -91.63 -22.31 20.35 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.898 0.856 . . . . 0.18 108.693 -177.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.2 p -67.29 -11.76 58.38 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.263 -1.335 . . . . 0.33 111.404 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -71.14 -42.11 69.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.61 -1.177 . . . . 1.52 112.287 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -96.74 125.78 45.46 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.274 -0.571 . . . . 0.43 110.659 -176.501 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.551 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.9 Cg_endo -75.19 -15.24 20.45 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.771 2.314 . . . . 0.73 112.837 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 96' ' ' GLY . 14.9 t -115.65 -41.62 3.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.649 -0.25 . . . . 0.48 110.381 -177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.475 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 47.43 42.72 19.33 Favored Glycine 0 C--O 1.225 -0.447 0 O-C-N 124.045 0.841 . . . . 0.33 113.778 169.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.57 113.54 21.32 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.793 0.806 . . . . 0.84 109.237 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.733 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 25.6 m-85 -136.53 178.32 7.16 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.137 -1.392 . . . . 0.22 112.275 -171.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.486 ' CD2' ' HB3' ' A' ' 162' ' ' ARG . 32.5 m-85 -144.28 139.12 28.41 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.197 -0.456 . . . . 0.54 110.703 -171.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.634 HD12 ' HB ' ' A' ' 161' ' ' THR . 75.6 mt -65.68 116.02 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 115.424 -0.807 . . . . 0.17 110.674 171.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.523 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 20.6 pt -84.16 -44.09 17.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 112.901 0.704 . . . . 0.21 112.901 -175.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.84 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 44.9 m-80 -170.45 169.84 7.25 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.003 -1.48 . . . . 2.03 107.003 -169.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.656 HH21 ' HA ' ' A' ' 158' ' ' PRO . 14.0 mtt180 -129.27 158.13 39.93 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.819 -0.752 . . . . 1.52 111.536 -175.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.9 tt0 -131.89 100.87 5.22 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.711 -0.677 . . . . 0.59 109.969 169.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.492 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 20.7 ttt85 -62.86 166.0 6.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.339 -0.846 . . . . 2.82 111.01 174.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.492 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 21.5 m-80 -35.01 103.03 0.23 Allowed Pre-proline 0 C--O 1.234 0.274 0 C-N-CA 125.361 1.464 . . . . 0.35 113.717 -153.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 13.9 Cg_exo . . . . . 0 N--CA 1.458 -0.584 0 C-N-CA 123.594 2.863 . . . . 0.48 111.238 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.524 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.563 1.474 0 N-CA-C 117.055 2.243 . . . . 0.48 117.055 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.479 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -167.26 162.67 15.12 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.583 -0.698 . . . . 0.28 109.925 -176.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 22.1 t-105 -142.52 98.61 3.33 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.176 -1.046 . . . . 0.49 108.176 166.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.6 HD12 HG23 ' A' ' 150' ' ' VAL . 4.6 mt -91.3 113.74 26.09 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.101 -0.703 . . . . 0.66 109.101 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 101' ' ' ILE . 23.5 m -83.82 143.81 29.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.86 -0.609 . . . . 0.19 111.325 -169.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.791 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.3 167.99 9.63 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.921 -0.581 . . . . 0.13 111.407 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 t -58.87 -13.87 7.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.583 -1.19 . . . . 1.17 112.967 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.733 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 4.0 tmtm? -127.01 130.12 49.4 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.016 0.436 . . . . 1.22 110.127 172.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.712 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.9 mt-30 -34.37 -55.02 0.53 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.097 -1.411 . . . . 1.51 114.151 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.529 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -99.91 11.93 38.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.958 -0.697 . . . . 2.53 111.997 -173.381 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.791 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -96.48 37.65 1.26 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.755 0.65 . . . . 0.84 112.755 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.612 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -114.45 142.68 17.7 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 117.379 -2.343 . . . . 0.32 112.58 -151.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.529 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -94.63 114.44 31.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.743 0.783 . . . . 0.18 110.568 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.679 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.8 p80 -145.05 171.44 14.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.21 109.75 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.83 -168.03 37.89 Favored Glycine 0 C--N 1.316 -0.537 0 C-N-CA 120.287 -0.958 . . . . 0.27 111.892 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.2 t -156.69 172.7 18.13 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.2 -0.588 . . . . 0.41 110.175 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -114.26 -0.1 14.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.952 -0.759 . . . . 1.99 108.952 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -114.83 86.8 13.72 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 107.916 -1.142 . . . . 1.36 107.916 169.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -73.47 -18.18 23.09 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.486 2.124 . . . . 0.35 113.53 -169.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.98 -1.82 45.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.778 -0.647 . . . . 0.33 110.67 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 41.1 t -91.03 -4.06 56.69 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.049 -0.722 . . . . 1.35 109.049 171.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.433 HG22 ' HB2' ' A' ' 83' ' ' PRO . 37.0 mm -83.3 134.14 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.81 -0.632 . . . . 0.21 110.251 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.95 1.19 70.54 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.867 -1.293 . . . . 0.15 109.867 -174.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 3.3 tttt -110.82 161.53 15.71 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 122.859 1.314 . . . . 2.5 113.46 -176.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.445 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -96.52 126.95 42.07 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 112.551 -2.113 . . . . 0.17 108.239 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.495 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 1.2 p -122.19 166.91 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.585 -1.265 . . . . 0.66 107.585 -176.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.4 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 45.2 m -64.17 -52.17 60.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.823 0.738 . . . . 0.43 112.605 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -130.23 -45.46 1.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 118.067 -1.453 . . . . 2.02 113.805 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.06 133.7 0.17 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 117.023 1.569 . . . . 0.18 117.023 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.598 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 3.0 p -74.67 165.6 24.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 112.573 -1.813 . . . . 0.16 111.676 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.898 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 61.5 mt -59.59 99.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 122.378 1.085 . . . . 0.4 112.239 -162.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.679 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 70.9 mtt180 -86.85 145.83 26.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.752 -1.567 . . . . 1.87 110.494 -177.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.636 ' HG2' HG22 ' A' ' 84' ' ' ILE . 10.9 mtp -126.23 -165.51 1.45 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.011 -0.737 . . . . 0.79 109.011 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.472 ' O ' HG12 ' A' ' 150' ' ' VAL . 40.0 m80 -90.47 165.1 13.99 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.113 -0.699 . . . . 2.32 109.113 169.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.663 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.8 m120 -63.57 -48.99 75.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 118.258 -0.877 . . . . 0.68 110.145 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -64.48 -29.27 70.31 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 121.58 1.991 . . . . 2.18 111.903 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.541 ' HB3' ' HE2' ' A' ' 145' ' ' MET . 68.1 m-20 -76.68 -45.67 28.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.06 0.457 . . . . 0.69 110.435 -175.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.657 HG13 HD12 ' A' ' 151' ' ' ILE . 14.4 p -67.02 -23.46 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.387 -0.824 . . . . 0.11 111.308 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.663 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -84.08 -42.52 17.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 119.05 -0.5 . . . . 0.38 110.142 171.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.478 ' O ' HG13 ' A' ' 156' ' ' ILE . 29.9 mt-10 -48.22 -68.55 0.17 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 119.392 0.996 . . . . 1.99 112.305 171.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.2 mp -47.09 -39.02 12.35 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.455 0.645 . . . . 1.27 111.436 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.73 -32.62 74.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.579 -1.191 . . . . 0.18 111.606 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.1 t -87.34 -32.25 19.72 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.487 -0.758 . . . . 0.21 112.316 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 152' ' ' GLU . 36.9 mt -82.88 -60.11 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.528 0.68 . . . . 0.16 111.547 -172.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.8 m -89.52 138.16 28.5 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.812 -1.086 . . . . 0.16 112.28 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.656 ' HA ' HH21 ' A' ' 103' ' ' ARG . 43.3 Cg_endo -89.01 176.04 3.34 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 C-N-CA 124.194 3.263 . . . . 0.2 111.525 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.84 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.8 m-20 -67.24 154.42 41.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.13 -1.063 . . . . 1.1 108.13 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.97 -15.35 63.18 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.789 -1.196 . . . . 0.18 112.565 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.634 ' HB ' HD12 ' A' ' 100' ' ' ILE . 88.3 m -65.8 136.88 56.78 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.091 -0.707 . . . . 0.14 109.091 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.486 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 1.1 ptm180 -93.3 127.31 38.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.55 1.166 . . . . 3.63 111.51 -171.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.5 t -111.69 108.61 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 112.327 -2.215 . . . . 0.14 109.215 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.8 m -95.54 109.89 22.05 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.459 0.541 . . . . 0.21 112.459 -172.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.475 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -83.69 96.08 4.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 122.504 1.145 . . . . 0.24 109.946 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -101.56 138.32 38.72 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.724 -1.58 . . . . 1.09 108.663 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.561 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 5.2 mmt85 . . . . . 0 C--N 1.313 -0.983 0 N-CA-C 108.988 -0.745 . . . . 2.08 108.988 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.515 -0.398 0 CA-C-O 121.661 0.743 . . . . 0.65 112.097 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.62 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.2 tt -96.19 129.67 43.44 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.644 -1.162 . . . . 0.28 110.219 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.81 162.04 13.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.207 -0.906 . . . . 0.31 112.663 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 45' ' ' SER . 74.0 t80 -131.2 145.38 51.91 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.956 -1.475 . . . . 0.44 108.193 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.425 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 59.0 tt0 -116.02 114.55 24.73 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.436 -0.95 . . . . 0.76 108.436 177.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 13' ' ' ASP . 97.5 t -68.04 151.46 10.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 122.567 1.175 . . . . 0.39 113.364 -171.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -103.96 159.87 15.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.256 -1.793 . . . . 2.01 108.837 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -63.07 105.3 0.67 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.972 0.415 . . . . 1.83 111.751 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.35 10.93 32.67 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.933 -0.651 . . . . 0.48 113.215 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.598 ' HB2' HG13 ' A' ' 9' ' ' VAL . 87.8 m-20 -55.93 171.09 0.26 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.709 0.254 . . . . 1.46 111.26 172.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.2 154.3 50.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.599 0.714 . . . . 0.41 111.893 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.708 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -69.14 -28.73 66.7 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.346 -1.297 . . . . 0.86 109.995 -176.349 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.459 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -93.51 -26.12 17.3 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.025 -0.989 . . . . 1.15 110.788 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -66.06 -40.6 91.06 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.604 -0.438 . . . . 1.21 109.927 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.431 HG23 ' CE1' ' A' ' 22' ' ' PHE . 14.6 mt -73.47 -27.1 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.185 -0.461 . . . . 0.21 109.928 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.651 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.39 -11.37 59.92 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.809 -0.356 . . . . 0.16 111.147 176.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.644 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -93.51 -40.02 10.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.458 0.647 . . . . 0.21 109.885 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.67 ' HB3' ' O ' ' A' ' 119' ' ' SER . 47.1 m-20 -63.46 -40.54 97.4 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.726 -1.125 . . . . 0.53 112.054 174.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 51.4 m-85 -99.25 4.81 46.74 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 118.506 -1.278 . . . . 0.18 111.44 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.644 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.7 mpt_? 54.83 44.6 28.15 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.711 0.767 . . . . 1.78 109.619 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.651 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 32.4 pt -117.46 -165.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.624 -1.171 . . . . 0.19 110.028 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.42 142.55 41.98 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.91 -1.041 . . . . 0.95 110.125 175.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.708 ' HB ' HD11 ' A' ' 15' ' ' LEU . 78.8 p -73.57 -32.75 64.32 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.409 -0.96 . . . . 0.25 108.409 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.59 -24.4 66.65 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.095 -0.957 . . . . 0.2 111.636 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.461 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.31 -28.2 15.1 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.983 -0.747 . . . . 0.17 108.983 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.646 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 21.3 tp -74.23 -27.01 60.57 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.486 -0.779 . . . . 1.16 109.503 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 36' ' ' LEU . 72.6 mt -80.19 -26.81 39.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.698 0.761 . . . . 1.05 110.117 172.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.461 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 47.8 tt0 -66.03 -41.18 91.26 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.573 -1.194 . . . . 1.81 110.13 171.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.1 -21.67 31.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.115 -0.634 . . . . 0.2 111.456 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.656 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.2 m-80 -148.27 78.49 9.41 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.532 0.682 . . . . 0.23 110.328 -172.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 20.3 Cg_endo -58.36 -7.79 4.41 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 124.331 3.354 . . . . 0.36 114.149 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.6 m -84.69 -17.89 37.01 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 111.815 0.302 . . . . 1.38 111.815 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.742 HD21 HG21 ' A' ' 46' ' ' ILE . 41.8 mt -67.74 -34.49 76.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.513 0.673 . . . . 0.49 111.704 -173.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.422 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 5.7 pt20 -65.05 -46.64 80.4 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.819 1.295 . . . . 1.95 110.36 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' A' ' 37' ' ' GLN . . . -58.86 -47.66 84.12 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 111.771 -2.468 . . . . 0.49 110.648 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.48 47.43 Favored Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 114.753 -1.112 . . . . 0.42 111.318 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.26 156.8 20.95 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.273 0.558 . . . . 0.41 111.006 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 62.3 m -138.05 127.32 24.53 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.17 -0.923 . . . . 0.42 110.576 -175.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.7 118.06 19.71 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.511 0.672 . . . . 0.47 109.943 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 101.67 1.76 52.86 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.195 -1.162 . . . . 0.41 110.195 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -77.95 123.7 27.11 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.633 -0.783 . . . . 1.3 109.715 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 46.2 p -82.18 128.04 33.76 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.434 -0.803 . . . . 0.85 110.275 176.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.742 HG21 HD21 ' A' ' 36' ' ' LEU . 12.4 pt -127.7 141.72 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.186 -1.37 . . . . 0.25 109.326 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.36 150.61 3.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.094 0.473 . . . . 0.67 110.898 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.4 mm -114.8 92.1 28.57 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.709 -1.132 . . . . 0.16 108.992 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.635 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -58.94 133.81 56.0 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.903 2.402 . . . . 0.18 112.918 -174.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.07 -6.38 78.88 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.8 -1.091 . . . . 0.26 112.339 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.727 HD12 ' HD2' ' A' ' 52' ' ' PRO . 30.0 tp -123.47 116.97 27.97 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 121.106 0.479 . . . . 0.61 111.213 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.727 ' HD2' HD12 ' A' ' 51' ' ' LEU . 43.7 Cg_endo -76.86 -177.28 3.68 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.605 2.87 . . . . 0.28 113.907 -172.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.508 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.1 t70 -83.54 129.56 59.53 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 114.483 -1.235 . . . . 0.49 111.97 -168.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.557 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.2 Cg_endo -75.23 -17.49 19.01 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.333 2.689 . . . . 0.46 112.411 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -93.96 -5.41 47.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.476 0.655 . . . . 1.38 110.404 -172.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.2 p -89.24 -20.84 23.65 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.6 1.19 . . . . 0.46 107.993 173.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.497 HG22 ' H ' ' A' ' 59' ' ' TYR . 27.1 mt -74.05 130.02 83.61 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 112.906 -1.952 . . . . 0.7 111.232 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.82 -17.06 9.86 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.48 2.12 . . . . 0.39 113.153 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.497 ' H ' HG22 ' A' ' 57' ' ' ILE . 70.0 m-85 -92.26 159.5 15.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.823 -0.351 . . . . 0.24 111.661 -177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -147.2 134.44 20.58 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.883 -0.784 . . . . 2.89 108.883 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' A' ' 71' ' ' THR . 86.3 mt -113.68 131.89 64.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.948 -0.569 . . . . 0.16 111.676 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.32 30.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.937 -0.705 . . . . 0.16 110.843 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 69' ' ' THR . 91.2 t -97.62 111.31 27.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.765 0.793 . . . . 0.19 111.117 175.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 68' ' ' LYS . 58.8 m -93.64 101.25 13.39 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.508 -1.223 . . . . 0.2 110.702 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.52 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.6 mm -49.26 -57.89 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 122.067 0.937 . . . . 0.23 111.306 170.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.22 -9.1 2.85 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 112.764 -2.016 . . . . 0.16 113.208 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.07 -22.53 3.76 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.532 0.733 . . . . 0.15 112.517 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HG3' HG22 ' A' ' 86' ' ' VAL . 1.1 mppt? 60.61 58.44 2.45 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 118.067 0.394 . . . . 0.69 111.354 -170.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 63.0 p -137.68 160.83 38.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 113.09 0.774 . . . . 0.13 113.09 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.435 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.4 tt -128.18 107.95 10.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.672 -1.149 . . . . 0.4 109.534 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.7 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 61.7 m -90.37 122.02 32.87 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.082 0.468 . . . . 0.16 110.837 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 79' ' ' MET . 17.1 tp -97.88 105.21 17.32 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.446 -0.797 . . . . 0.59 109.273 173.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 96.9 p -105.65 160.47 15.18 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 118.829 -1.148 . . . . 1.05 110.318 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.5 tm? -126.1 125.45 42.57 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.705 -0.85 . . . . 0.26 108.705 168.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.538 ' N ' HD22 ' A' ' 74' ' ' LEU . 7.7 m120 50.54 50.06 19.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.435 -1.257 . . . . 1.84 111.008 -171.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 71.74 -10.18 0.87 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.571 0.749 . . . . 1.89 111.816 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -98.79 120.42 39.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.021 -0.536 . . . . 3.44 109.82 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 54.6 t -57.74 132.98 22.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 122.493 1.139 . . . . 0.24 112.768 -174.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -102.01 -45.01 5.31 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 112.837 -1.983 . . . . 0.81 108.732 177.391 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -154.27 174.49 14.72 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 113.2 -1.818 . . . . 1.46 110.102 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 27.9 m -149.29 121.21 8.19 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.481 -1.69 . . . . 0.17 109.46 168.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.503 ' HD2' ' OD2' ' A' ' 149' ' ' ASP . 12.9 m-85 -101.19 151.28 37.67 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 115.142 -0.935 . . . . 1.05 109.165 -175.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HB2' HG22 ' A' ' 134' ' ' ILE . 57.3 Cg_endo -81.2 140.51 12.36 Favored 'Trans proline' 0 CA--C 1.5 -1.212 0 C-N-CA 121.499 1.466 . . . . 0.2 111.062 169.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.674 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -139.81 176.13 6.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.516 -0.765 . . . . 0.13 110.393 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.878 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -120.14 150.17 41.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.126 -0.324 . . . . 0.26 110.126 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.513 HG11 HD13 ' A' ' 65' ' ' ILE . 9.8 m -130.95 127.47 61.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.58 0.705 . . . . 0.56 112.107 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -85.67 156.16 29.98 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.044 -1.222 . . . . 0.17 110.044 172.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -57.46 3.96 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.236 0.828 . . . . 3.05 113.236 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.947 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -90.28 -19.49 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 O-C-N 121.638 -0.664 . . . . 0.23 110.291 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.947 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -89.78 -18.13 26.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.765 0.793 . . . . 0.18 109.256 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.5 p -68.04 -14.36 62.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.427 -1.26 . . . . 0.33 111.362 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -71.52 -37.67 71.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.47 -1.241 . . . . 1.52 112.862 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -105.8 115.89 60.76 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 120.055 -0.658 . . . . 0.43 110.793 -177.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.558 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.8 Cg_endo -75.58 -11.69 20.43 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.792 2.328 . . . . 0.73 113.63 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.439 HG23 ' N ' ' A' ' 96' ' ' GLY . 10.1 t -105.02 -43.56 5.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.185 0.516 . . . . 0.48 110.107 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.557 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 53.54 33.48 47.81 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.257 -1.338 . . . . 0.33 113.93 167.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.16 112.61 20.4 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.969 0.89 . . . . 0.84 109.721 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.715 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 19.0 m-85 -138.05 176.81 8.37 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.764 -1.562 . . . . 0.22 111.949 -170.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.455 ' CG ' HD11 ' A' ' 5' ' ' LEU . 45.3 m-85 -139.33 144.08 38.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.257 0.551 . . . . 0.54 110.452 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.564 HD12 ' HB ' ' A' ' 161' ' ' THR . 83.8 mt -68.84 116.89 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 115.613 -0.721 . . . . 0.17 110.557 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 30.4 pt -85.93 -35.81 9.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 112.877 0.695 . . . . 0.21 112.877 -175.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.782 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 11.0 p30 -178.53 -179.21 0.65 Allowed 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 107.695 -1.224 . . . . 2.03 107.695 -176.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.674 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -140.38 159.6 41.83 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.16 -0.616 . . . . 1.52 112.599 -176.041 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.8 tt0 -128.37 100.07 5.66 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.9 -1.046 . . . . 0.59 109.428 172.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.518 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 61.5 ttt180 -64.73 165.91 9.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.341 -0.845 . . . . 2.82 110.663 176.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.518 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 23.3 m-80 -35.07 102.05 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 125.282 1.433 . . . . 0.35 113.743 -152.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 16.3 Cg_exo . . . . . 0 N--CA 1.456 -0.69 0 C-N-CA 123.504 2.803 . . . . 0.48 111.469 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.514 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.566 1.582 0 N-CA-C 116.977 2.214 . . . . 0.48 116.977 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.49 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -166.54 162.88 16.96 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.684 -0.635 . . . . 0.28 110.04 -176.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 18.0 t-105 -143.9 97.85 3.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.302 -0.999 . . . . 0.49 108.302 167.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.468 HD12 HG23 ' A' ' 150' ' ' VAL . 2.1 mt -89.48 115.19 26.72 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.381 0.61 . . . . 0.66 109.739 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.449 ' C ' HG12 ' A' ' 101' ' ' ILE . 24.3 m -86.01 144.3 27.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.956 -0.565 . . . . 0.19 111.19 -171.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.807 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.1 mm? -109.29 168.14 9.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.13 110.46 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.67 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.1 m -65.11 -2.38 2.79 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.937 0.718 . . . . 1.17 112.937 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.773 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 5.0 tmtm? -128.8 136.37 50.42 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.941 -0.392 . . . . 1.22 109.941 168.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.773 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 25.5 mm-40 -36.46 -58.03 0.73 Allowed 'General case' 0 C--N 1.312 -1.041 0 O-C-N 124.222 0.951 . . . . 1.51 113.458 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.538 ' CB ' HG12 ' A' ' 89' ' ' ILE . 56.2 m80 -89.92 0.78 56.88 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.451 -0.499 . . . . 2.53 111.83 -167.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.807 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.1 m-30 -96.73 37.93 1.25 Allowed 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 113.419 0.896 . . . . 0.84 113.419 -170.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.699 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -114.41 142.95 17.85 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 116.693 -2.67 . . . . 0.32 112.642 -152.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -93.35 115.21 31.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.773 0.797 . . . . 0.18 110.661 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.555 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 31.5 p80 -142.05 170.57 15.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.451 -0.795 . . . . 0.21 109.394 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -92.35 -167.27 39.61 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.375 -0.917 . . . . 0.27 111.687 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.2 t -156.79 169.82 23.86 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 122.039 -0.683 . . . . 0.41 110.346 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -114.68 -5.22 12.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.643 -0.873 . . . . 1.99 108.643 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -116.04 87.33 18.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 114.832 -1.077 . . . . 1.36 108.231 171.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -72.78 -21.21 21.79 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.131 2.554 . . . . 0.35 114.484 -167.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -75.83 -2.58 30.69 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.147 0.499 . . . . 0.33 111.116 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.483 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 15.9 m -91.91 -5.52 53.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.275 0.559 . . . . 1.35 109.673 173.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 83' ' ' PRO . 37.8 mm -81.89 134.96 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.21 110.085 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.89 2.28 66.91 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.954 -1.259 . . . . 0.15 109.954 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 54.6 mttp -113.93 170.08 8.53 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.988 1.375 . . . . 2.5 113.466 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.07 124.92 49.45 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.118 -2.31 . . . . 0.17 108.191 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.43 162.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.757 -0.831 . . . . 0.66 108.757 -173.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -51.55 -60.17 3.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.389 0.514 . . . . 0.43 112.389 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.416 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 18.8 pttp -133.5 -44.36 0.83 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 118.357 -1.337 . . . . 2.02 113.765 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.88 133.24 0.17 Allowed Glycine 0 N--CA 1.464 0.54 0 N-CA-C 117.014 1.565 . . . . 0.18 117.014 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.547 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 5.4 p -69.53 165.75 20.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 112.411 -1.894 . . . . 0.16 112.202 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.878 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 45.9 mt -59.8 98.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.566 -1.197 . . . . 0.4 112.047 -162.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.555 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 11.4 mtp180 -86.27 150.03 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.874 -1.512 . . . . 1.87 110.25 -177.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.674 ' HG2' HG22 ' A' ' 84' ' ' ILE . 6.3 mtp -129.31 -165.79 1.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.973 -0.751 . . . . 0.79 108.973 173.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.724 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 5.1 t60 -92.91 159.54 15.3 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.605 -0.887 . . . . 2.32 108.605 170.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.645 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.6 m120 -57.9 -53.21 60.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.357 -0.83 . . . . 0.68 110.365 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -63.56 -27.15 69.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 121.376 1.898 . . . . 2.18 112.005 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.724 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.9 m-20 -75.67 -51.31 13.06 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.72 -0.673 . . . . 0.69 110.63 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.648 HG13 HD12 ' A' ' 151' ' ' ILE . 14.7 p -62.94 -22.63 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 115.285 -0.87 . . . . 0.11 111.746 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.648 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.58 -39.95 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 118.911 -0.566 . . . . 0.38 110.569 172.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -45.79 -72.34 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.219 0.918 . . . . 1.99 112.674 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.587 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.1 mm? -49.0 -35.05 14.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.768 0.794 . . . . 1.27 111.325 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.508 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -63.94 -35.09 79.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.561 -1.2 . . . . 0.18 112.048 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.3 t -90.99 -29.01 17.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 119.03 0.832 . . . . 0.21 113.099 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.4 mt -83.19 -60.44 2.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.509 0.671 . . . . 0.16 111.772 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.4 m -86.76 141.83 34.04 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.955 -1.02 . . . . 0.16 111.53 177.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.674 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 77.9 Cg_endo -85.19 172.64 8.34 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.992 3.128 . . . . 0.2 111.351 175.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.782 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.4 m-20 -63.65 156.3 27.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.243 -1.021 . . . . 1.1 108.243 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.77 -22.08 42.42 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 119.634 -1.27 . . . . 0.18 112.951 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.564 ' HB ' HD12 ' A' ' 100' ' ' ILE . 48.9 m -60.78 135.48 57.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.077 -0.712 . . . . 0.14 109.077 -174.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.637 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -94.16 129.91 40.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.589 1.185 . . . . 3.63 111.403 -167.42 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.3 t -110.95 110.57 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 112.373 -2.194 . . . . 0.14 109.571 -173.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 15.7 m -94.24 105.58 17.56 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.512 0.56 . . . . 0.21 112.512 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.557 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -82.42 99.96 5.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-O 122.412 1.101 . . . . 0.24 110.005 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -107.47 130.91 54.78 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.04 -1.436 . . . . 1.09 109.61 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.558 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 17.3 mmm180 . . . . . 0 C--N 1.322 -0.593 0 CA-C-O 120.967 0.413 . . . . 2.08 111.184 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.692 HD21 ' HA ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER . . . . . 0 CA--C 1.514 -0.426 0 CA-C-O 121.64 0.733 . . . . 0.65 112.076 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.9 tt -95.42 130.42 42.23 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.525 -1.216 . . . . 0.28 110.124 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.55 162.97 13.23 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.135 0.969 . . . . 0.31 113.21 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 45' ' ' SER . 84.8 t80 -130.44 140.95 50.54 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.791 -1.549 . . . . 0.44 107.959 175.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.403 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.8 tt0 -113.36 113.19 24.88 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.063 -1.088 . . . . 0.76 108.063 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' A' ' 13' ' ' ASP . 93.6 t -67.11 150.99 10.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 122.38 1.086 . . . . 0.39 112.999 -170.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -107.49 159.05 16.71 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 113.376 -1.738 . . . . 2.01 108.21 171.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -58.66 110.0 0.91 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.964 0.411 . . . . 1.83 111.94 -174.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.99 11.32 43.39 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.766 -0.652 . . . . 0.48 113.7 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.643 ' HB2' HG13 ' A' ' 9' ' ' VAL . 86.9 m-20 -55.85 167.95 0.51 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.193 0.497 . . . . 1.46 111.177 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.59 152.56 48.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.036 0.446 . . . . 0.41 111.746 176.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.56 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.39 -32.72 74.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.082 -0.963 . . . . 0.86 108.643 -178.046 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.433 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 64.1 t30 -93.05 -22.21 19.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.789 -1.096 . . . . 1.15 111.114 -177.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.7 t -65.64 -45.85 81.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.206 -0.664 . . . . 1.21 109.206 171.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.436 HG23 ' CE1' ' A' ' 22' ' ' PHE . 17.3 mt -71.84 -26.61 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.881 -0.6 . . . . 0.21 110.056 -176.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.638 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.45 -10.17 59.75 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.833 -0.347 . . . . 0.16 111.111 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.607 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.32 -39.1 9.38 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.502 1.144 . . . . 0.21 108.057 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 119' ' ' SER . 6.2 m-20 -63.32 -44.38 95.08 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 112.402 -2.181 . . . . 0.53 111.911 173.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.569 ' HA ' HG21 ' A' ' 101' ' ' ILE . 55.3 m-85 -97.72 4.66 49.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 118.725 -1.19 . . . . 0.18 111.658 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.4 mpt_? 54.68 43.28 30.4 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.866 0.841 . . . . 1.78 109.928 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.638 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.4 pt -116.39 -165.18 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 114.529 -1.214 . . . . 0.19 109.702 -178.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.1 142.34 41.7 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.023 -0.99 . . . . 0.95 110.227 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.633 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 67.1 p -72.68 -32.82 66.1 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.916 -1.142 . . . . 0.25 107.916 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.45 67.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.188 -0.915 . . . . 0.2 111.745 169.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.98 -26.64 18.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.662 0.744 . . . . 0.17 108.997 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.635 HD11 HD12 ' A' ' 46' ' ' ILE . 19.2 tp -76.35 -20.45 57.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.282 -0.872 . . . . 1.16 109.554 174.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 26' ' ' THR . 28.9 mt -83.91 -29.54 27.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.396 0.617 . . . . 1.05 110.606 170.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -59.97 -61.25 2.75 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.945 -1.132 . . . . 1.81 107.945 169.617 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -71.61 -17.39 62.28 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.514 0.673 . . . . 0.2 110.415 -169.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.659 ' HB3' HD23 ' A' ' 36' ' ' LEU . 33.9 m-80 -150.69 85.26 5.28 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.189 -0.914 . . . . 0.23 110.579 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.46 -9.18 6.43 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.964 2.443 . . . . 0.36 112.952 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 m -69.79 -34.66 74.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.154 0.502 . . . . 1.38 111.319 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -61.37 -51.37 69.07 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 122.209 1.004 . . . . 0.49 112.152 -169.099 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 38' ' ' ALA . 4.2 pt20 -56.32 -48.53 76.52 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 113.231 -1.804 . . . . 1.95 110.93 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.43 ' H ' ' HG3' ' A' ' 37' ' ' GLN . . . -54.5 -52.52 61.7 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 111.893 -2.412 . . . . 0.49 109.938 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.88 168.0 37.93 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 114.439 -1.255 . . . . 0.42 112.164 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.03 158.25 16.28 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.266 0.555 . . . . 0.41 110.501 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 39.6 m -145.72 129.19 16.94 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.262 -0.881 . . . . 0.42 110.427 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.89 117.64 16.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.495 0.664 . . . . 0.47 109.953 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 101.15 0.54 54.47 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 114.716 -1.129 . . . . 0.41 110.289 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.3 tt0 -75.24 125.38 28.84 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.856 -0.672 . . . . 1.3 110.338 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 56.3 p -83.54 131.46 34.99 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.831 0.824 . . . . 0.85 110.322 175.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.635 HD12 HD11 ' A' ' 29' ' ' LEU . 10.0 pt -132.37 143.57 39.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.366 -1.288 . . . . 0.25 109.306 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.61 151.73 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.16 0.505 . . . . 0.67 111.455 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.3 mm -116.45 92.89 38.4 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.628 -1.169 . . . . 0.16 109.404 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.692 ' HA ' HD21 ' A' ' 4' ' ' LEU . 4.0 Cg_exo -57.34 134.88 66.65 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.853 2.369 . . . . 0.18 113.174 -175.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.01 -7.58 80.93 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.317 -1.311 . . . . 0.26 112.532 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.718 HD12 ' HD2' ' A' ' 52' ' ' PRO . 33.6 tp -120.87 115.2 32.07 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-O 121.2 0.524 . . . . 0.61 111.184 -177.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.718 ' HD2' HD12 ' A' ' 51' ' ' LEU . 54.7 Cg_endo -78.09 -176.12 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 124.05 3.167 . . . . 0.28 114.402 -171.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.594 ' HB3' HG23 ' A' ' 56' ' ' THR . 15.5 t70 -82.74 129.0 63.9 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 114.19 -1.368 . . . . 0.49 112.045 -169.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 46.2 Cg_endo -72.92 -13.87 26.47 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 123.371 2.714 . . . . 0.46 112.61 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.444 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 59.7 m-85 -96.26 -0.53 49.62 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.451 0.643 . . . . 1.38 111.398 -175.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.594 HG23 ' HB3' ' A' ' 53' ' ' ASP . 19.6 p -95.33 -20.4 19.18 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.751 -1.203 . . . . 0.46 107.751 171.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 59' ' ' TYR . 19.1 mt -75.69 131.5 76.74 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 113.168 -1.833 . . . . 0.7 111.147 177.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 95.5 Cg_endo -82.72 -18.26 6.76 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.233 1.956 . . . . 0.39 113.486 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' H ' HG22 ' A' ' 57' ' ' ILE . 61.6 m-85 -95.2 158.47 15.45 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.499 0.555 . . . . 0.24 112.499 -175.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -146.64 128.83 15.68 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.322 -0.853 . . . . 2.89 108.975 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.655 ' HA ' ' O ' ' A' ' 71' ' ' THR . 87.2 mt -110.32 135.95 47.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.225 -0.443 . . . . 0.16 111.701 -176.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.09 119.04 33.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 119.955 -0.698 . . . . 0.16 110.968 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.2 t -98.96 116.38 41.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.525 0.679 . . . . 0.19 110.869 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 68' ' ' LYS . 70.3 m -95.06 105.89 17.84 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.046 -0.979 . . . . 0.2 110.352 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.7 mm -54.22 -58.92 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 122.079 0.942 . . . . 0.23 111.2 167.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.68 -10.65 4.7 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 112.789 -2.005 . . . . 0.16 113.351 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.426 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.67 -18.74 4.7 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.453 0.701 . . . . 0.15 112.213 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.506 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.64 55.74 4.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.373 0.533 . . . . 0.69 111.421 -173.751 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.8 p -138.02 160.52 39.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.84 0.681 . . . . 0.13 112.84 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.503 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.7 tt -128.54 113.29 15.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.778 -1.101 . . . . 0.4 110.178 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.655 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 41.3 m -93.95 122.66 36.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.273 0.559 . . . . 0.16 111.43 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 79' ' ' MET . 12.9 tp -97.55 103.27 15.19 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.862 -1.063 . . . . 0.59 109.45 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 7.5 m -105.49 160.64 15.0 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.474 -0.89 . . . . 1.05 110.77 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.2 tm? -127.18 126.99 43.79 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.981 -0.748 . . . . 0.26 108.981 169.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.54 ' N ' HD22 ' A' ' 74' ' ' LEU . 16.7 m120 47.65 51.44 13.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.561 -1.199 . . . . 1.84 111.228 -171.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 t30 71.8 -12.24 0.68 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.57 -0.741 . . . . 1.89 111.695 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -96.22 120.27 36.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.17 0.509 . . . . 3.44 110.221 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 64.1 t -59.53 131.85 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 122.32 1.057 . . . . 0.24 112.468 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 8.7 mtm -100.59 -46.01 5.33 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 113.246 -1.797 . . . . 0.81 108.903 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -156.35 173.03 17.47 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.518 -1.673 . . . . 1.46 110.037 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.7 m -149.4 124.6 10.13 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.354 -1.293 . . . . 0.17 109.848 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -111.2 153.11 44.12 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.871 -0.604 . . . . 1.05 109.439 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.443 ' HB2' HG22 ' A' ' 134' ' ' ILE . 60.4 Cg_endo -79.7 143.11 16.52 Favored 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 122.194 1.929 . . . . 0.2 111.495 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.682 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.92 175.1 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.746 -0.661 . . . . 0.13 110.948 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.887 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.51 146.08 45.76 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.309 -0.405 . . . . 0.26 110.067 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.533 HG11 HD13 ' A' ' 65' ' ' ILE . 8.8 m -127.04 128.81 70.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.532 0.682 . . . . 0.56 111.784 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -87.31 154.66 26.46 Favored Glycine 0 N--CA 1.425 -2.039 0 N-CA-C 110.09 -1.204 . . . . 0.17 110.09 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -56.18 2.93 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.266 0.839 . . . . 3.05 113.266 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.953 HG23 HD22 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -88.68 -19.92 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 O-C-N 121.587 -0.696 . . . . 0.23 110.177 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.953 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -89.42 -18.28 27.1 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.715 0.769 . . . . 0.18 109.314 -176.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.5 p -65.99 -14.9 62.44 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.553 -1.203 . . . . 0.33 111.767 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -67.08 -39.06 86.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.051 -0.977 . . . . 1.52 112.327 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -107.95 117.55 54.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.668 -0.413 . . . . 0.43 111.222 -175.388 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.598 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 1.8 Cg_endo -77.63 -13.83 16.17 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.674 2.25 . . . . 0.73 113.083 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.1 t -103.67 -41.84 5.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.677 -0.49 . . . . 0.48 109.677 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.567 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.46 39.59 22.38 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.419 -1.264 . . . . 0.33 114.024 168.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -84.11 112.12 19.94 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.907 0.86 . . . . 0.84 109.507 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.9 m-85 -138.78 174.72 10.23 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.003 -1.453 . . . . 0.22 112.12 -171.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.687 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 86.6 m-85 -139.69 136.3 34.1 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.058 -0.519 . . . . 0.54 110.732 -175.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.571 HD12 ' HB ' ' A' ' 161' ' ' THR . 86.7 mt -59.74 121.68 8.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.361 -0.836 . . . . 0.17 110.44 170.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.569 HG21 ' HA ' ' A' ' 22' ' ' PHE . 19.1 pt -87.3 -44.6 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.83 0.678 . . . . 0.21 112.83 -176.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.569 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 44.1 m-80 -171.54 172.08 5.18 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.976 -1.49 . . . . 2.03 106.976 -168.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.655 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 39.8 mtt180 -124.28 171.56 9.78 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.531 -0.867 . . . . 1.52 111.592 -173.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 7.8 tt0 -148.28 99.91 3.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.08 -0.964 . . . . 0.59 109.758 170.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.467 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 48.4 ttp180 -66.18 166.17 12.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.284 -0.871 . . . . 2.82 110.421 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.51 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 25.4 m-80 -35.66 103.03 0.24 Allowed Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 125.323 1.449 . . . . 0.35 113.405 -157.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.51 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.9 Cg_endo . . . . . 0 C--N 1.346 0.4 0 C-N-CA 122.99 2.46 . . . . 0.48 111.756 173.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.542 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.569 1.682 0 N-CA-C 117.294 2.331 . . . . 0.48 117.294 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.467 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.5 OUTLIER -166.02 151.37 8.63 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.272 -0.892 . . . . 0.28 110.594 -176.073 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.5 t-105 -132.09 99.62 4.78 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.41 -0.959 . . . . 0.49 108.41 168.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.547 HD12 HG23 ' A' ' 150' ' ' VAL . 5.3 mt -93.92 114.27 26.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.624 0.726 . . . . 0.66 109.358 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.413 ' HB3' HD11 ' A' ' 101' ' ' ILE . 19.5 m -83.9 144.22 29.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.593 -0.731 . . . . 0.19 111.466 -168.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -108.53 170.66 7.88 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.821 -0.627 . . . . 0.13 111.243 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 2.9 t -62.38 -13.73 32.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.112 -0.949 . . . . 1.17 112.729 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.688 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 1.4 tmtp? -126.63 132.3 51.26 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 120.446 -0.501 . . . . 1.22 110.594 173.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.688 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 55.3 mt-30 -34.2 -56.87 0.49 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.003 -1.453 . . . . 1.51 113.869 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.497 ' HB2' HG12 ' A' ' 89' ' ' ILE . 75.0 m-70 -92.22 2.01 56.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.154 0.502 . . . . 2.53 111.556 -171.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.793 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -94.0 37.44 1.09 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.405 0.891 . . . . 0.84 113.405 -172.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.604 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.05 143.27 18.06 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 117.016 -2.516 . . . . 0.32 112.717 -152.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.52 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -96.12 114.64 33.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.722 0.772 . . . . 0.18 110.766 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.648 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.0 p80 -143.99 172.12 13.31 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.432 -0.804 . . . . 0.21 109.663 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.75 -176.68 39.8 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.982 -1.104 . . . . 0.27 111.66 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -147.0 168.13 22.28 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.387 -0.478 . . . . 0.41 110.387 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -111.25 -0.7 16.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.126 -1.065 . . . . 1.99 108.126 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -116.05 85.86 15.86 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 114.537 -1.21 . . . . 1.36 108.385 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -72.85 -21.19 21.58 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.164 1.909 . . . . 0.35 113.727 -169.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.23 -2.58 38.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.156 0.503 . . . . 0.33 110.845 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 44.7 t -91.42 -3.2 56.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.308 -0.627 . . . . 1.35 109.308 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 83' ' ' PRO . 42.8 mm -80.88 139.37 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.932 -0.576 . . . . 0.21 110.133 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.46 1.37 74.83 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 110.159 -1.176 . . . . 0.15 110.159 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -111.65 167.86 10.01 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 123.24 1.495 . . . . 2.5 114.414 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.21 48.52 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 111.541 -2.572 . . . . 0.17 107.697 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.469 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -124.66 160.58 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.954 -0.758 . . . . 0.66 108.954 -174.246 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.5 m -49.36 -59.78 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.616 0.598 . . . . 0.43 112.616 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.533 ' HD3' ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -132.62 -43.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 118.411 -1.316 . . . . 2.02 113.744 -175.04 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.533 ' N ' ' HD3' ' A' ' 140' ' ' LYS . . . -32.24 133.55 0.19 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 117.236 1.654 . . . . 0.18 117.236 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.504 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.0 p -73.39 165.52 24.91 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 112.636 -1.782 . . . . 0.16 111.843 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.887 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 53.3 mt -59.77 98.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 122.316 1.055 . . . . 0.4 112.018 -162.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.648 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 74.6 mtt180 -85.07 147.69 26.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.777 -1.556 . . . . 1.87 110.281 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.682 ' HG2' HG22 ' A' ' 84' ' ' ILE . 12.3 mtp -127.51 -166.31 1.59 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.401 -0.592 . . . . 0.79 109.401 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.696 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 46.7 t-80 -94.9 156.18 16.45 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.448 -0.945 . . . . 2.32 108.448 172.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.653 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.7 m120 -58.7 -50.03 75.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 118.339 -0.839 . . . . 0.68 110.736 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -63.34 -26.16 68.63 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 121.26 1.845 . . . . 2.18 112.462 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.696 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 16.8 m-20 -83.95 -39.92 19.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.937 0.399 . . . . 0.69 111.25 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.619 HG13 HD12 ' A' ' 151' ' ' ILE . 14.6 p -70.07 -23.58 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.956 -0.565 . . . . 0.11 111.146 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.653 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.01 -39.8 16.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 118.966 -0.54 . . . . 0.38 109.592 171.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -45.52 -71.36 0.08 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.139 0.881 . . . . 1.99 112.238 167.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 157' ' ' VAL . 8.2 mp -46.32 -38.13 8.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.521 0.677 . . . . 1.27 111.262 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.37 83.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.372 -1.286 . . . . 0.18 111.629 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.1 t -87.94 -34.48 18.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.513 -0.742 . . . . 0.21 112.47 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.2 mt -80.38 -59.56 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.177 0.513 . . . . 0.16 111.451 -172.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 153' ' ' LEU . 2.6 m -92.39 141.51 24.93 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.448 -0.797 . . . . 0.16 112.112 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.655 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 69.4 Cg_endo -89.02 173.6 4.02 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.767 2.978 . . . . 0.2 111.144 173.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.569 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 73.6 m-20 -66.91 157.1 34.04 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.611 -0.836 . . . . 1.1 109.16 177.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.35 -19.19 55.42 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.196 -1.002 . . . . 0.18 112.666 -173.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.571 ' HB ' HD12 ' A' ' 100' ' ' ILE . 59.0 m -63.48 139.77 58.8 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.496 -0.557 . . . . 0.14 109.496 -176.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.687 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 3.5 ptm180 -92.52 120.43 32.98 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.787 1.28 . . . . 3.63 111.112 -170.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.1 t -106.96 109.4 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 112.205 -2.271 . . . . 0.14 109.149 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.8 m -95.49 108.12 20.33 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.484 0.55 . . . . 0.21 112.484 -172.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.567 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -81.78 101.52 6.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 122.35 1.072 . . . . 0.24 109.77 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -106.62 129.54 54.52 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.905 -1.498 . . . . 1.09 109.027 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.598 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 18.0 mmm180 . . . . . 0 C--N 1.321 -0.67 0 CA-C-O 120.865 0.364 . . . . 2.08 110.637 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.308 0.575 . . . . 0.65 111.845 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.5 tt -92.21 127.64 37.76 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.999 -1.0 . . . . 0.28 110.605 -172.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.82 162.19 13.38 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.188 0.994 . . . . 0.31 113.401 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.633 ' HB3' HG13 ' A' ' 46' ' ' ILE . 80.2 t80 -131.01 141.91 50.28 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.547 -1.66 . . . . 0.44 107.884 175.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 36.2 tt0 -113.23 115.32 28.02 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.218 -1.031 . . . . 0.76 108.218 177.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 13' ' ' ASP . 98.2 t -68.73 150.3 10.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.53 1.157 . . . . 0.39 113.254 -170.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.409 ' O ' HG12 ' A' ' 9' ' ' VAL . 43.8 mtpt -102.36 158.56 16.11 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.335 -1.757 . . . . 2.01 108.541 172.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.33 105.34 0.49 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.879 0.371 . . . . 1.83 111.622 -177.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.96 12.24 30.29 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.62 -0.8 . . . . 0.48 113.366 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.611 ' HB2' HG13 ' A' ' 9' ' ' VAL . 90.2 m-20 -56.23 170.6 0.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.872 0.368 . . . . 1.46 111.171 170.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.89 155.47 45.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.326 0.584 . . . . 0.41 111.146 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.598 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.97 -34.25 77.68 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.334 -0.987 . . . . 0.86 108.334 178.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.508 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -88.38 -28.0 21.24 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.911 -1.04 . . . . 1.15 111.442 -175.335 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.0 p -68.88 -37.67 79.18 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 118.422 0.556 . . . . 1.21 110.181 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.447 HG23 ' CE1' ' A' ' 22' ' ' PHE . 14.5 mt -73.89 -27.12 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 121.254 0.549 . . . . 0.21 109.796 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.645 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.26 -9.79 59.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.355 -0.384 . . . . 0.16 110.684 175.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.728 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.55 -41.19 8.68 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.024 -1.102 . . . . 0.21 108.024 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 5.6 m-20 -63.59 -41.96 98.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 112.797 -2.001 . . . . 0.53 112.5 173.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 24' ' ' ILE . 56.3 m-85 -98.84 6.22 46.97 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 118.655 -1.218 . . . . 0.18 110.858 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.728 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.06 41.04 32.18 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.927 0.87 . . . . 1.78 109.606 176.116 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.645 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.3 pt -114.43 -165.9 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 114.263 -1.335 . . . . 0.19 109.976 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.81 142.65 40.78 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.106 -0.952 . . . . 0.95 109.996 175.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.672 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 70.8 p -72.82 -29.9 63.62 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.702 -0.851 . . . . 0.25 108.702 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.93 -25.01 67.7 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.68 -0.691 . . . . 0.2 111.816 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.37 -28.65 14.85 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.854 -0.795 . . . . 0.17 108.854 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.598 HD23 HD23 ' A' ' 15' ' ' LEU . 20.9 tp -72.29 -27.65 62.6 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.127 -0.942 . . . . 1.16 108.584 172.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.672 ' HB2' ' O ' ' A' ' 26' ' ' THR . 7.6 tp -77.42 -31.73 54.23 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.812 0.815 . . . . 1.05 109.462 175.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 42.0 tt0 -66.05 -40.94 91.35 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.167 -1.378 . . . . 1.81 110.336 173.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -82.01 -17.78 45.64 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.988 -0.685 . . . . 0.2 111.518 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.634 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.0 m-80 -146.64 81.5 9.23 Favored Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-O 121.246 0.546 . . . . 0.23 110.754 -173.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.8 Cg_endo -55.81 -11.78 5.78 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 124.098 3.199 . . . . 0.36 113.401 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m -78.89 -17.52 55.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.801 0.334 . . . . 1.38 111.834 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.634 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 58.1 mt -75.36 -31.8 60.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.333 0.587 . . . . 0.49 112.072 -171.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.44 ' HB3' HD11 ' A' ' 30' ' ' LEU . 1.7 pp0? -62.4 -45.53 92.7 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 122.755 1.264 . . . . 1.95 110.772 -172.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.41 -48.53 77.45 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 111.893 -2.412 . . . . 0.49 110.749 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.13 -179.57 48.74 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 114.78 -1.1 . . . . 0.42 111.255 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.88 156.37 20.49 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.135 0.493 . . . . 0.41 110.789 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 31.3 m -137.26 129.76 29.9 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.348 -0.842 . . . . 0.42 110.491 -175.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.11 123.36 26.28 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.403 0.62 . . . . 0.47 110.235 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.53 0.18 62.93 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.272 -1.131 . . . . 0.41 110.272 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.634 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.1 tt0 -74.05 124.12 25.66 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.644 -0.778 . . . . 1.3 109.87 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 53.9 p -82.39 128.92 34.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.804 0.811 . . . . 0.85 109.876 176.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.633 HG13 ' HB3' ' A' ' 7' ' ' TYR . 7.6 pt -128.55 141.38 46.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.57 -1.195 . . . . 0.25 109.428 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.39 151.69 3.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.128 0.489 . . . . 0.67 111.048 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.6 mm -114.99 91.98 28.92 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.638 -1.164 . . . . 0.16 109.05 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.496 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . 1.7 Cg_endo -59.59 134.39 57.67 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.738 2.292 . . . . 0.18 112.778 -174.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.62 -6.74 80.14 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.893 -1.048 . . . . 0.26 112.156 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.772 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.5 tp -124.74 116.13 26.47 Favored Pre-proline 0 N--CA 1.446 -0.63 0 CA-C-O 121.404 0.621 . . . . 0.61 111.504 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.658 ' HD2' HD12 ' A' ' 51' ' ' LEU . 59.0 Cg_endo -79.71 -176.09 3.06 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.14 3.227 . . . . 0.28 114.208 -172.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.556 ' HB3' HG23 ' A' ' 56' ' ' THR . 17.7 t70 -81.14 130.5 62.62 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 114.225 -1.352 . . . . 0.49 112.879 -169.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.45 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 40.1 Cg_endo -73.0 -14.98 26.28 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.852 3.035 . . . . 0.46 113.134 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 80.2 m-85 -96.13 -8.6 32.83 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.902 -0.59 . . . . 1.38 111.427 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.556 HG23 ' HB3' ' A' ' 53' ' ' ASP . 24.7 p -86.49 -20.39 28.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.784 -1.191 . . . . 0.46 107.784 172.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 59' ' ' TYR . 24.6 mt -76.73 129.13 80.07 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 112.912 -1.949 . . . . 0.7 111.036 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.38 -13.05 12.49 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.538 2.159 . . . . 0.39 113.63 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.565 ' H ' HG22 ' A' ' 57' ' ' ILE . 62.7 m-85 -96.11 164.61 12.61 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.498 -0.481 . . . . 0.24 111.786 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -154.09 130.65 10.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.852 -0.796 . . . . 2.89 108.852 177.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 71' ' ' THR . 72.8 mt -112.06 136.75 47.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.155 -0.475 . . . . 0.16 111.607 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.25 116.84 27.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.926 -0.71 . . . . 0.16 111.223 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.8 t -96.04 113.6 30.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.565 0.698 . . . . 0.19 110.777 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 22.2 m -90.89 104.0 16.64 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.943 -1.026 . . . . 0.2 110.45 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.5 mm -53.44 -58.54 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 122.262 1.03 . . . . 0.23 111.208 168.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.16 -10.13 3.62 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 112.699 -2.046 . . . . 0.16 113.521 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.88 -18.02 4.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.596 0.758 . . . . 0.15 112.17 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.511 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 59.07 54.53 4.9 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.219 0.463 . . . . 0.69 111.078 -172.78 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 64' ' ' SER . 41.6 p -136.85 167.71 20.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 112.707 0.632 . . . . 0.13 112.707 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.465 HD21 HD21 ' A' ' 153' ' ' LEU . 8.0 tt -135.84 112.76 10.28 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.729 -1.123 . . . . 0.4 110.0 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 22.1 m -93.07 123.31 36.24 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.157 0.504 . . . . 0.16 110.781 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 79' ' ' MET . 16.1 tp -99.95 106.51 18.32 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.298 -0.864 . . . . 0.59 109.125 172.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 83.4 p -105.44 161.46 14.31 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 119.234 -0.986 . . . . 1.05 110.498 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -125.61 125.33 42.98 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.657 -0.868 . . . . 0.26 108.657 168.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.598 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.8 p-10 41.98 53.03 4.27 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.769 -1.56 . . . . 1.84 112.126 -165.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 46.8 m-80 75.24 -9.53 1.38 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.02 -0.991 . . . . 1.89 112.226 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -97.16 121.84 39.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.037 0.446 . . . . 3.44 109.903 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 55.7 t -58.4 131.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 122.39 1.091 . . . . 0.24 112.806 -175.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.523 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -100.91 -45.84 5.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 113.116 -1.856 . . . . 0.81 109.112 178.419 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -159.95 173.19 16.28 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.039 -1.892 . . . . 1.46 110.214 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -149.67 123.45 9.27 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.172 -1.376 . . . . 0.17 109.458 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -112.86 148.64 39.79 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.897 -0.592 . . . . 1.05 109.734 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.42 ' HB2' HG22 ' A' ' 134' ' ' ILE . 32.7 Cg_endo -74.5 142.71 29.91 Favored 'Trans proline' 0 CA--C 1.498 -1.32 0 C-N-CA 122.231 1.954 . . . . 0.2 110.938 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.622 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.67 172.77 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-N 115.777 -0.647 . . . . 0.13 110.761 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.94 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.16 137.6 52.87 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.762 0.315 . . . . 0.26 110.188 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.511 HG22 ' HG3' ' A' ' 68' ' ' LYS . 10.7 m -120.88 127.75 75.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.6 0.714 . . . . 0.56 111.776 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.501 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.19 151.48 28.52 Favored Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 110.067 -1.213 . . . . 0.17 110.067 171.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.47 4.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.262 0.838 . . . . 3.05 113.262 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.875 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -90.81 -19.12 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.385 0.612 . . . . 0.23 110.158 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.875 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -86.89 -17.47 33.19 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.687 -0.857 . . . . 0.18 108.687 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.1 p -69.38 -16.1 63.45 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.369 -1.287 . . . . 0.33 111.345 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.405 ' OE1' HD12 ' A' ' 89' ' ' ILE . 24.8 mt-30 -69.95 -37.76 75.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.859 -1.064 . . . . 1.52 112.845 -175.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 95' ' ' THR . 1.5 m -107.33 127.51 27.75 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 119.746 -0.782 . . . . 0.43 111.161 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -89.41 -14.19 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.727 2.284 . . . . 0.73 113.172 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 93' ' ' THR . 6.3 t -90.33 -44.52 9.63 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.584 0.707 . . . . 0.48 109.417 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.576 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 61.58 18.46 56.19 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 114.066 -1.425 . . . . 0.33 113.979 168.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.4 111.33 19.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 122.206 1.003 . . . . 0.84 109.593 -175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.669 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 26.6 m-85 -138.42 177.51 7.83 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.359 -1.746 . . . . 0.22 111.279 -171.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.457 ' CG ' HD11 ' A' ' 5' ' ' LEU . 39.8 m-85 -140.98 137.38 33.0 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.135 0.493 . . . . 0.54 110.765 -173.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.575 HD12 ' HB ' ' A' ' 161' ' ' THR . 78.8 mt -63.01 114.62 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-N 115.185 -0.916 . . . . 0.17 110.268 170.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.565 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.4 pt -83.33 -45.43 18.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 113.367 0.877 . . . . 0.21 113.367 -175.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -168.75 165.88 11.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.0 -1.482 . . . . 2.03 107.0 -169.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.701 ' HB3' HD23 ' A' ' 116' ' ' LEU . 51.9 mtt-85 -132.1 155.68 47.68 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.902 -0.719 . . . . 1.52 112.408 -168.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -137.62 102.27 4.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.359 0.599 . . . . 0.59 110.808 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.467 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 46.8 ttp180 -62.76 166.18 5.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.952 -1.022 . . . . 2.82 111.279 174.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.786 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 28.7 m-80 -35.93 101.31 0.21 Allowed Pre-proline 0 C--O 1.232 0.158 0 C-N-CA 125.802 1.641 . . . . 0.35 113.122 -159.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.487 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 24.1 Cg_endo . . . . . 0 C--N 1.344 0.327 0 C-N-CA 123.499 2.799 . . . . 0.48 113.604 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.865 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 N--CA 1.44 -0.94 0 CA-C-O 120.813 0.34 . . . . 0.48 110.18 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.461 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.7 OUTLIER -162.99 154.28 17.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.457 -0.338 . . . . 0.28 110.169 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -132.09 104.68 6.94 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.687 -1.227 . . . . 0.49 107.687 165.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.701 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.0 mt -100.11 114.83 28.48 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.57 -0.706 . . . . 0.66 109.859 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.459 ' HB3' HD11 ' A' ' 101' ' ' ILE . 43.6 m -81.81 143.28 31.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.817 -0.629 . . . . 0.19 110.901 -170.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.728 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.4 mm? -108.02 164.88 11.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.535 -0.757 . . . . 0.13 110.416 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.1 p -65.13 -5.18 6.05 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.985 0.803 . . . . 1.17 112.72 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.707 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 4.2 tmtm? -127.41 129.42 47.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.111 0.958 . . . . 1.22 109.849 166.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.707 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.0 mt-30 -37.2 -47.75 0.81 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 112.249 -2.25 . . . . 1.51 113.903 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.549 ' CB ' HG12 ' A' ' 89' ' ' ILE . 58.0 m80 -96.33 3.23 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.849 -0.614 . . . . 2.53 111.915 -170.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.578 ' HA ' HD11 ' A' ' 90' ' ' LEU . 2.5 m-30 -92.99 -35.48 13.26 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.807 0.813 . . . . 0.84 111.946 -173.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.728 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -10.46 131.01 0.01 OUTLIER Glycine 0 C--N 1.298 -1.58 0 N-CA-C 119.392 2.517 . . . . 0.32 119.392 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -100.54 117.5 45.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 112.449 -1.876 . . . . 0.18 110.366 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.76 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 33.6 p80 -145.83 -176.79 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.318 0.488 . . . . 0.21 112.318 -175.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.94 -167.72 37.63 Favored Glycine 0 C--O 1.22 -0.759 0 C-N-CA 121.22 -0.514 . . . . 0.27 111.86 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.2 t -160.76 166.51 28.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 117.796 0.798 . . . . 0.41 110.704 -176.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -116.53 0.19 12.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.831 0.824 . . . . 1.99 109.288 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -126.03 89.21 52.82 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.39 -1.277 . . . . 1.36 108.819 170.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -72.19 -20.75 24.4 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.753 2.302 . . . . 0.35 114.008 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.96 -5.48 48.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.21 -0.45 . . . . 0.33 111.008 -175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -91.29 -2.48 57.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.08 -0.509 . . . . 1.35 110.016 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 83' ' ' PRO . 38.8 mm -78.55 137.61 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-N 115.872 -0.604 . . . . 0.21 109.934 176.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.7 3.16 68.91 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.151 -1.18 . . . . 0.15 110.151 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.426 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 21.3 mtpt -113.74 169.07 9.25 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 123.223 1.487 . . . . 2.5 114.395 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.16 126.59 46.44 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 111.509 -2.587 . . . . 0.17 107.946 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.42 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -123.47 159.44 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.541 -0.911 . . . . 0.66 108.541 -174.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.1 m -48.08 -59.87 3.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.763 0.653 . . . . 0.43 112.763 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -132.13 -44.46 0.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 118.446 -1.302 . . . . 2.02 114.033 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.69 133.92 0.21 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 117.464 1.746 . . . . 0.18 117.464 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 3.0 p -70.78 165.41 23.17 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 112.734 -1.733 . . . . 0.16 111.956 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.94 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.8 mt -60.87 99.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.386 -1.279 . . . . 0.4 112.154 -162.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.76 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 42.7 mtt180 -86.48 143.32 27.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.317 -1.311 . . . . 1.87 110.161 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.622 ' HG2' HG22 ' A' ' 84' ' ' ILE . 20.8 mtp -118.97 -168.98 1.65 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.851 -0.796 . . . . 0.79 108.851 173.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.543 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 75.3 m80 -83.77 155.67 22.93 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.747 -0.835 . . . . 2.32 108.747 167.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.797 ' O ' HD13 ' A' ' 151' ' ' ILE . 12.7 m-80 -65.02 -44.16 90.09 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 118.283 -0.865 . . . . 0.68 110.999 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -66.06 -25.46 67.04 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 121.902 2.137 . . . . 2.18 112.068 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 37.8 m-20 -86.79 -35.4 19.15 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.235 -0.438 . . . . 0.69 111.188 -174.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.59 HG13 HD12 ' A' ' 151' ' ' ILE . 11.8 p -67.98 -21.91 27.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 0.11 110.747 172.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.865 HD11 ' HB1' ' A' ' 113' ' ' ALA . 1.6 mp -83.08 -40.97 16.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.667 -0.494 . . . . 0.38 109.667 170.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -47.14 -70.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.203 0.91 . . . . 1.99 112.428 168.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.489 HD22 ' SD ' ' A' ' 145' ' ' MET . 7.3 mp -49.86 -30.75 10.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.594 0.711 . . . . 1.27 111.529 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.673 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -67.5 -41.22 84.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.805 -1.089 . . . . 0.18 111.528 176.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.0 t -85.13 -37.66 19.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.789 0.663 . . . . 0.21 112.789 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.58 -60.23 2.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.613 0.721 . . . . 0.16 111.377 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.643 HG23 HH22 ' A' ' 103' ' ' ARG . 3.8 m -92.06 145.81 31.58 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.0 -1.0 . . . . 0.16 112.126 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.457 ' C ' HH21 ' A' ' 103' ' ' ARG . 50.4 Cg_endo -89.86 172.62 3.76 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 124.466 3.444 . . . . 0.2 111.175 173.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -66.4 161.65 22.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 118.689 -1.204 . . . . 1.1 109.897 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.51 -17.11 59.86 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.561 -0.828 . . . . 0.18 111.825 -172.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.575 ' HB ' HD12 ' A' ' 100' ' ' ILE . 67.2 m -67.45 139.44 57.07 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.457 -0.571 . . . . 0.14 109.457 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.2 117.89 30.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.571 1.176 . . . . 3.63 111.022 -168.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.2 t -104.03 109.66 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 112.316 -2.22 . . . . 0.14 109.358 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 32.6 m -95.71 107.68 19.92 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.727 0.64 . . . . 0.21 112.727 -172.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.576 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mp -80.54 108.77 14.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 122.039 0.923 . . . . 0.24 109.855 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -110.97 124.46 52.18 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.489 -1.232 . . . . 1.09 109.796 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.519 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 15.6 mmm180 . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 121.244 0.545 . . . . 2.08 110.192 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.656 HD21 ' HA ' ' A' ' 49' ' ' PRO . 1.1 tp . . . . . 0 CA--C 1.517 -0.32 0 CA-C-O 121.296 0.57 . . . . 0.65 111.555 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.7 tt -95.54 126.74 41.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.049 -0.978 . . . . 0.28 110.258 -175.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.07 161.47 13.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.055 0.931 . . . . 0.31 112.632 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 45' ' ' SER . 90.6 t80 -130.74 139.8 50.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.935 -1.484 . . . . 0.44 107.83 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.4 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.8 tt0 -112.66 112.8 24.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.131 -1.063 . . . . 0.76 108.131 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 13' ' ' ASP . 98.4 t -67.09 149.46 11.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 122.395 1.093 . . . . 0.39 113.169 -169.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HE2' ' OH ' ' A' ' 7' ' ' TYR . 42.2 mtmt -103.24 158.85 16.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 113.369 -1.741 . . . . 2.01 108.718 174.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.456 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -62.85 104.26 0.53 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.198 0.523 . . . . 1.83 112.308 -173.163 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.29 11.29 36.73 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.848 -0.692 . . . . 0.48 113.356 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB2' HG13 ' A' ' 9' ' ' VAL . 83.9 m-20 -53.58 170.67 0.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.978 0.389 . . . . 1.46 111.307 172.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.3 153.21 48.05 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.296 0.569 . . . . 0.41 111.558 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.598 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.38 -35.03 79.72 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.33 -0.989 . . . . 0.86 108.33 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.442 ' HA ' HG22 ' A' ' 26' ' ' THR . 65.0 t30 -88.96 -25.89 21.81 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.916 -1.038 . . . . 1.15 111.438 -176.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.3 p -68.17 -36.9 80.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.902 -0.719 . . . . 1.21 109.674 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.409 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.1 mt -75.62 -28.19 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.164 0.507 . . . . 0.21 110.023 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.59 -10.05 59.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.539 -0.301 . . . . 0.16 110.872 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.607 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.71 -39.49 9.45 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.607 1.194 . . . . 0.21 108.38 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 119' ' ' SER . 10.0 m-20 -62.19 -45.79 91.81 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.453 -2.158 . . . . 0.53 111.856 172.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 63.2 m-85 -97.2 5.12 50.66 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.681 -1.208 . . . . 0.18 111.602 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.5 mpt_? 54.15 43.29 30.87 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.776 0.798 . . . . 1.78 109.891 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.62 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.0 pt -116.19 -165.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.535 -1.211 . . . . 0.19 109.771 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.87 143.02 38.62 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.177 -0.919 . . . . 0.95 109.992 174.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.608 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 69.4 p -71.75 -32.19 67.44 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.759 -1.2 . . . . 0.25 107.759 177.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.98 -32.2 70.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.277 -0.874 . . . . 0.2 112.008 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -90.5 -25.94 20.02 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.657 0.741 . . . . 0.17 109.112 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.647 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 17.2 tp -75.55 -26.19 57.77 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.999 -1.001 . . . . 1.16 109.361 173.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 26' ' ' THR . 30.7 mt -77.49 -31.71 53.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.792 0.806 . . . . 1.05 109.67 171.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 45.0 tt0 -64.05 -41.13 97.49 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.282 -1.326 . . . . 1.81 110.034 174.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.18 -20.64 32.04 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 120.118 -0.633 . . . . 0.2 111.633 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.624 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 27.0 m-80 -147.11 80.69 9.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.46 0.648 . . . . 0.23 110.64 -172.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 23.7 Cg_endo -58.97 -5.79 3.02 Favored 'Trans proline' 0 C--N 1.326 -0.644 0 C-N-CA 124.372 3.382 . . . . 0.36 114.145 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 t -84.7 -23.31 29.41 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.215 -0.303 . . . . 1.38 111.025 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.852 HD21 HG21 ' A' ' 46' ' ' ILE . 52.4 mt -67.01 -35.36 79.76 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.841 0.829 . . . . 0.49 111.632 -172.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.452 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 3.3 pt20 -65.33 -46.72 79.17 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 114.239 -1.346 . . . . 1.95 110.298 -174.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.55 -50.86 71.73 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 111.905 -2.407 . . . . 0.49 110.282 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.56 177.95 48.55 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 114.742 -1.117 . . . . 0.42 111.656 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.59 157.63 18.84 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.349 0.595 . . . . 0.41 111.235 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 82.6 m -140.35 128.64 22.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.141 -0.936 . . . . 0.42 110.601 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -76.16 120.07 20.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.449 0.642 . . . . 0.47 110.234 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 99.26 0.05 57.09 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.181 -1.168 . . . . 0.41 110.181 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.63 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.8 tt0 -74.31 123.7 25.07 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.758 -0.721 . . . . 1.3 109.599 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 34.4 p -85.37 125.93 33.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.646 0.736 . . . . 0.85 110.596 177.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.852 HG21 HD21 ' A' ' 36' ' ' LEU . 9.6 pt -125.63 143.59 38.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.393 -1.276 . . . . 0.25 109.554 -176.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.4 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.24 150.99 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-O 121.113 0.482 . . . . 0.67 111.124 -179.218 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.7 mm -115.86 92.87 35.98 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.643 -1.162 . . . . 0.16 109.147 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.656 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -58.16 135.41 68.19 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.847 2.365 . . . . 0.18 112.819 -175.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.19 -6.0 81.26 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 114.992 -1.004 . . . . 0.26 112.515 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.698 HD12 ' HD2' ' A' ' 52' ' ' PRO . 25.6 tp -126.74 119.87 22.82 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-O 120.972 0.415 . . . . 0.61 111.395 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.698 ' HD2' HD12 ' A' ' 51' ' ' LEU . 58.9 Cg_endo -80.89 178.69 6.66 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.438 2.759 . . . . 0.28 113.923 -172.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.588 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.9 t70 -75.17 131.8 77.73 Favored Pre-proline 0 N--CA 1.443 -0.819 0 CA-C-N 114.255 -1.339 . . . . 0.49 111.646 -173.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 162' ' ' ARG . 60.5 Cg_endo -74.13 -16.73 22.42 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.415 2.743 . . . . 0.46 113.02 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -96.53 -2.68 44.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.35 0.595 . . . . 1.38 111.169 -176.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.588 HG23 ' HB3' ' A' ' 53' ' ' ASP . 17.2 p -93.37 -14.54 26.72 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.493 -0.928 . . . . 0.46 108.493 173.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.703 HG22 ' H ' ' A' ' 59' ' ' TYR . 7.9 mm -64.05 129.21 93.82 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 113.633 -1.621 . . . . 0.7 109.873 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 51.4 Cg_endo -73.08 -19.12 23.28 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.017 1.811 . . . . 0.39 112.852 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.703 ' H ' HG22 ' A' ' 57' ' ' ILE . 41.0 m-85 -107.36 161.67 14.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.871 0.367 . . . . 0.24 111.548 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -145.8 140.32 27.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.761 -0.829 . . . . 2.89 108.761 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 71' ' ' THR . 88.1 mt -119.3 133.02 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.306 -0.407 . . . . 0.16 112.083 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.53 116.54 27.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.963 -0.695 . . . . 0.16 111.014 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 69' ' ' THR . 85.5 t -95.12 115.68 34.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.684 0.754 . . . . 0.19 110.703 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.537 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 44.1 m -89.66 109.81 20.75 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.119 -0.946 . . . . 0.2 110.85 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 167' ' ' ARG . 23.3 mm -55.5 -60.21 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.186 0.993 . . . . 0.23 110.844 164.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.83 -13.63 6.55 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 112.722 -2.036 . . . . 0.16 113.52 -175.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.537 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.66 -16.92 5.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 118.659 -0.686 . . . . 0.15 112.515 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 57.21 54.62 6.61 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.202 0.91 . . . . 0.69 111.527 -174.039 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 40.9 p -138.05 164.91 27.91 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.816 0.673 . . . . 0.13 112.816 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.7 tt -132.67 113.14 12.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.023 -0.989 . . . . 0.4 110.093 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 38.4 m -92.89 123.69 36.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.992 0.425 . . . . 0.16 111.219 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' MET . 12.7 tp -98.59 106.61 18.91 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.498 -0.774 . . . . 0.59 108.948 170.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 78.5 p -106.93 160.02 15.83 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 119.28 -0.968 . . . . 1.05 110.85 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.1 tm? -127.16 126.44 42.87 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.211 -0.663 . . . . 0.26 109.211 171.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.574 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.8 p-10 39.13 56.17 2.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 113.991 -1.459 . . . . 1.84 111.998 -166.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.3 m-80 74.76 -8.97 1.42 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.144 -0.935 . . . . 1.89 112.429 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -101.57 119.45 38.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.012 0.434 . . . . 3.44 110.296 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 50.8 t -55.04 131.64 18.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 122.444 1.116 . . . . 0.24 112.54 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 67.8 mmm -96.81 -47.82 5.71 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 113.315 -1.766 . . . . 0.81 108.28 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -161.08 172.44 16.81 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 112.703 -2.044 . . . . 1.46 110.169 -176.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -149.5 125.42 10.57 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 113.973 -1.467 . . . . 0.17 109.532 173.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -117.28 150.54 46.52 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.087 -0.506 . . . . 1.05 110.565 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.73 142.71 32.58 Favored 'Trans proline' 0 CA--C 1.495 -1.473 0 C-N-CA 122.351 2.034 . . . . 0.2 111.201 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.643 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.72 173.34 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.452 -0.795 . . . . 0.13 110.433 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.918 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.61 143.74 45.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.927 -0.309 . . . . 0.26 110.167 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.516 HG22 ' HG3' ' A' ' 68' ' ' LYS . 11.4 m -125.99 125.83 68.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.583 0.706 . . . . 0.56 111.354 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -85.28 155.65 29.97 Favored Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 109.58 -1.408 . . . . 0.17 109.58 171.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -57.6 4.9 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.224 0.824 . . . . 3.05 113.224 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.915 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -87.02 -20.02 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 121.437 -0.789 . . . . 0.23 109.684 178.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.915 HD22 HG23 ' A' ' 89' ' ' ILE . 3.6 mm? -89.44 -20.99 23.24 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.634 -0.876 . . . . 0.18 108.634 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.7 p -66.49 -16.75 64.36 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.512 -1.222 . . . . 0.33 110.938 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -72.19 -32.64 66.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.472 -1.24 . . . . 1.52 112.966 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -108.54 120.41 46.48 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.008 -0.677 . . . . 0.43 110.359 178.061 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 93' ' ' THR . 4.2 Cg_exo -70.37 -23.59 27.82 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.803 2.336 . . . . 0.73 112.881 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -99.23 -41.36 7.52 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.514 -0.55 . . . . 0.48 109.514 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.541 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 51.44 21.06 5.91 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.514 -1.221 . . . . 0.33 114.336 169.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 164' ' ' THR . 12.8 pt-20 -85.05 116.99 23.75 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 122.608 1.194 . . . . 0.84 110.05 -172.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.728 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 13.0 m-85 -137.92 -171.83 3.1 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.362 -1.744 . . . . 0.22 111.442 -166.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CG ' HD11 ' A' ' 5' ' ' LEU . 28.6 m-85 -143.84 137.92 28.3 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.76 0.314 . . . . 0.54 110.776 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.733 HD12 ' HB ' ' A' ' 161' ' ' THR . 76.3 mt -65.21 119.07 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.745 -0.661 . . . . 0.17 110.529 170.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 23.3 pt -88.14 -32.85 6.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.028 0.751 . . . . 0.21 113.028 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.568 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 1.8 p-10 179.27 179.3 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.846 -1.168 . . . . 2.03 107.846 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.594 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 22.9 mtt180 -127.63 160.62 31.06 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.675 -0.81 . . . . 1.52 111.877 -175.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.453 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 7.6 tt0 -135.7 98.96 4.05 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.112 -0.949 . . . . 0.59 109.665 171.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.47 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 40.4 ttp180 -65.74 164.98 13.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.427 -0.806 . . . . 2.82 110.555 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.753 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 30.0 m-80 -36.05 101.28 0.21 Allowed Pre-proline 0 N--CA 1.461 0.098 0 C-N-CA 125.141 1.377 . . . . 0.35 112.334 -158.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo . . . . . 0 N--CA 1.464 -0.255 0 C-N-CA 123.027 2.484 . . . . 0.48 113.1 176.632 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.753 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . . . . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 109.565 -0.531 . . . . 0.48 109.565 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.47 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 1.5 m-85 -161.27 152.26 18.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.911 -0.586 . . . . 0.28 110.109 -176.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 6.2 t-105 -129.48 99.15 5.08 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.019 -1.474 . . . . 0.49 107.019 164.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.9 mt -90.71 114.03 26.26 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.234 -1.025 . . . . 0.66 108.234 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.454 ' HB3' HD11 ' A' ' 101' ' ' ILE . 19.4 m -83.68 143.88 29.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.772 -0.649 . . . . 0.19 111.023 -166.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 3.1 mm? -108.88 165.1 11.82 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.102 -0.499 . . . . 0.13 111.445 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.5 t -60.36 -10.96 5.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.632 -1.167 . . . . 1.17 112.609 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.746 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.8 tmtm? -127.31 132.13 50.34 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.504 -0.478 . . . . 1.22 109.885 171.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.746 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 21.5 mt-30 -35.25 -59.12 0.53 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 114.278 1.214 . . . . 1.51 114.278 -178.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.582 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -97.09 12.95 30.81 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.581 -0.848 . . . . 2.53 111.852 -171.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.784 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.2 m-30 -98.67 38.46 1.36 Allowed 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 112.077 0.399 . . . . 0.84 112.077 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.751 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -116.6 143.22 17.97 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 117.165 -2.445 . . . . 0.32 112.523 -151.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -96.43 116.04 37.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 123.954 0.901 . . . . 0.18 110.934 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.639 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 31.2 p80 -146.65 -178.17 6.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.873 -0.603 . . . . 0.21 112.16 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.23 -167.62 37.18 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 111.733 -0.547 . . . . 0.27 111.733 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.6 t -162.73 167.97 22.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.878 0.839 . . . . 0.41 110.391 -175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -113.29 -8.51 13.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.646 -0.872 . . . . 1.99 108.646 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -120.32 88.11 41.47 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 114.874 -1.057 . . . . 1.36 108.856 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -71.91 -21.81 24.08 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.979 2.453 . . . . 0.35 114.294 -167.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.57 -1.93 29.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.0 0.428 . . . . 0.33 111.253 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 20.1 m -90.26 -5.77 55.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.021 -0.536 . . . . 1.35 109.964 172.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 34.3 mm -77.44 131.3 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.181 -0.463 . . . . 0.21 110.486 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.01 3.51 60.47 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.235 -1.146 . . . . 0.15 110.235 -175.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.459 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 56.9 mttt -114.81 168.72 9.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 122.982 1.373 . . . . 2.5 114.207 -176.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.17 127.24 45.11 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 112.011 -2.359 . . . . 0.17 107.759 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -123.6 160.79 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.5 -0.926 . . . . 0.66 108.5 -175.59 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.7 m -49.1 -59.83 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.639 0.607 . . . . 0.43 112.639 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.74 -44.86 0.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 118.464 -1.295 . . . . 2.02 114.131 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.24 134.36 0.17 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 117.193 1.637 . . . . 0.18 117.193 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.534 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 2.4 p -72.25 165.55 24.21 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 112.735 -1.732 . . . . 0.16 112.002 -178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.918 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 46.4 mt -60.55 96.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 122.384 1.087 . . . . 0.4 112.208 -162.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.639 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 68.0 mtt180 -83.63 147.23 27.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.889 -1.505 . . . . 1.87 109.726 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.643 ' HG2' HG22 ' A' ' 84' ' ' ILE . 12.0 mtp -123.8 -169.9 2.03 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.407 -0.96 . . . . 0.79 108.407 171.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.434 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 41.1 m80 -82.37 161.74 22.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.944 -0.762 . . . . 2.32 108.944 168.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.627 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . 25.2 m-80 -66.94 -41.65 86.62 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 118.232 -0.89 . . . . 0.68 110.805 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -69.66 -29.05 66.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 121.301 1.864 . . . . 2.18 112.021 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 64.3 m-20 -76.31 -45.23 33.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.379 0.609 . . . . 0.69 109.822 -174.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.16 -25.04 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 114.819 -1.082 . . . . 0.11 111.562 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 147' ' ' ASN . 19.4 mt -83.41 -43.31 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 118.893 -0.575 . . . . 0.38 111.538 174.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.424 ' O ' HG13 ' A' ' 156' ' ' ILE . 20.3 mt-10 -46.41 -70.39 0.1 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.529 1.058 . . . . 1.99 112.644 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.564 ' O ' HG22 ' A' ' 157' ' ' VAL . 26.2 mt -45.79 -39.69 8.66 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.698 0.761 . . . . 1.27 111.556 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.442 ' HB1' ' CE2' ' A' ' 114' ' ' TYR . . . -61.22 -32.29 72.07 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.114 -1.403 . . . . 0.18 111.951 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.1 t -87.84 -30.81 19.91 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.511 -0.743 . . . . 0.21 112.198 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 152' ' ' GLU . 38.0 mt -82.91 -59.42 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.547 0.689 . . . . 0.16 111.747 -172.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 153' ' ' LEU . 5.4 m -88.39 139.81 30.14 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.73 -1.123 . . . . 0.16 112.373 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.594 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 48.1 Cg_endo -88.87 173.89 4.06 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.324 3.349 . . . . 0.2 111.118 174.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.568 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 60.9 m-20 -67.05 156.8 35.13 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 119.214 -0.994 . . . . 1.1 108.687 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.02 -20.85 49.18 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.833 -1.175 . . . . 0.18 111.921 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.733 ' HB ' HD12 ' A' ' 100' ' ' ILE . 85.8 m -59.82 128.9 39.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.724 -0.843 . . . . 0.14 108.724 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -93.32 123.45 36.62 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 122.809 1.29 . . . . 3.63 110.833 -167.612 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.18 112.13 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 112.365 -2.198 . . . . 0.14 110.023 -171.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 97' ' ' GLU . 16.2 m -95.69 115.12 26.97 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.798 -0.761 . . . . 0.21 112.202 -175.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.541 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mp -84.19 93.14 3.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.87 1.319 . . . . 0.24 109.421 172.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -93.0 125.32 37.53 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.262 -1.79 . . . . 1.09 108.139 -175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.48 ' HA ' HG13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.613 0 C-N-CA 120.291 -0.563 . . . . 2.08 110.697 -177.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.516 -0.339 0 CA-C-O 121.307 0.575 . . . . 0.65 111.379 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.1 tt -95.94 128.68 43.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.091 -0.959 . . . . 0.28 110.432 -175.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 161.29 13.85 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.084 0.945 . . . . 0.31 112.932 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' A' ' 45' ' ' SER . 72.7 t80 -130.01 141.79 50.7 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.726 -1.579 . . . . 0.44 108.071 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 34.9 tt0 -114.01 112.2 22.88 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.863 -1.162 . . . . 0.76 107.863 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' ' 41' ' ' THR . 92.3 t -65.11 149.81 11.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 122.476 1.131 . . . . 0.39 112.806 -170.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -106.05 159.59 15.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.235 -1.802 . . . . 2.01 108.6 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 108.02 0.99 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.071 0.462 . . . . 1.83 111.949 -175.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.4 10.89 37.52 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.534 -0.757 . . . . 0.48 113.283 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.605 ' HB2' HG13 ' A' ' 9' ' ' VAL . 91.5 m-20 -58.08 168.65 0.95 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.864 0.332 . . . . 1.46 110.765 172.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.66 153.61 49.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.577 0.703 . . . . 0.41 112.011 174.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.734 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -68.2 -31.08 70.35 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.463 -1.244 . . . . 0.86 109.75 -176.619 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.442 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 65.3 t30 -93.34 -20.67 20.14 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.854 -1.066 . . . . 1.15 110.544 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.6 t -68.49 -43.22 77.35 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.152 -0.684 . . . . 1.21 109.152 171.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 17.2 mt -72.47 -25.84 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 121.354 0.597 . . . . 0.21 109.916 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.643 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.4 -9.91 59.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.401 -0.363 . . . . 0.16 111.035 175.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.606 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.27 -38.87 9.51 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.677 1.227 . . . . 0.21 107.982 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.6 m-20 -62.93 -49.16 75.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.255 -2.248 . . . . 0.53 111.562 172.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.569 ' HA ' HG21 ' A' ' 101' ' ' ILE . 63.5 m-85 -94.5 5.52 51.58 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.605 -1.238 . . . . 0.18 111.527 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.0 mpt_? 53.4 44.51 29.92 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.661 0.744 . . . . 1.78 109.873 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.643 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.0 pt -116.2 -164.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 114.63 -1.168 . . . . 0.19 109.855 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.64 141.7 41.82 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.088 -0.96 . . . . 0.95 110.137 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.734 ' HB ' HD11 ' A' ' 15' ' ' LEU . 67.0 p -72.67 -33.64 66.68 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.201 -1.037 . . . . 0.25 108.201 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.46 68.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.981 -1.009 . . . . 0.2 111.788 169.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -89.11 -27.88 20.45 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.955 -0.757 . . . . 0.17 108.955 -177.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.654 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.8 tp -74.76 -28.38 60.73 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.028 -0.987 . . . . 1.16 109.461 175.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 26' ' ' THR . 55.9 mt -77.85 -30.47 51.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.785 0.802 . . . . 1.05 109.86 172.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 39.4 tt0 -63.86 -41.47 97.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.29 -1.323 . . . . 1.81 109.976 172.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.16 -22.08 33.38 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 121.91 -0.494 . . . . 0.2 111.455 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.658 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 19.8 m-80 -150.11 98.34 3.33 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-O 121.26 0.553 . . . . 0.23 109.75 -171.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 12.9 Cg_exo -79.67 -9.97 14.5 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.475 3.45 . . . . 0.36 111.903 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -76.08 -25.78 55.84 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.852 -1.067 . . . . 1.38 111.802 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.863 HD21 HG21 ' A' ' 46' ' ' ILE . 44.0 mt -65.04 -39.07 92.81 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.557 0.694 . . . . 0.49 112.103 -171.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 3.5 pt20 -64.01 -46.27 85.24 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 122.917 1.342 . . . . 1.95 110.447 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.98 83.62 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 111.808 -2.451 . . . . 0.49 110.59 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.49 173.21 45.62 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 114.829 -1.078 . . . . 0.42 111.815 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.8 157.81 18.24 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.343 0.592 . . . . 0.41 110.877 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.625 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 47.2 m -140.51 127.22 20.37 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.43 -0.804 . . . . 0.42 110.912 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.71 118.85 18.14 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.291 0.567 . . . . 0.47 109.931 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.419 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.48 -1.13 55.73 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.33 -1.108 . . . . 0.41 110.33 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -75.29 123.69 25.78 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.394 -0.595 . . . . 1.3 109.394 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 68.1 p -83.94 132.28 34.78 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.827 0.823 . . . . 0.85 110.14 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.863 HG21 HD21 ' A' ' 36' ' ' LEU . 11.7 pt -132.11 142.83 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.235 -1.348 . . . . 0.25 109.273 -177.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.39 150.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.17 0.51 . . . . 0.67 111.055 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.6 mm -114.36 91.72 25.09 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.694 -1.139 . . . . 0.16 109.056 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.641 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -58.41 135.93 71.04 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.907 2.405 . . . . 0.18 112.756 -174.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.47 -5.95 82.42 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.889 -1.05 . . . . 0.26 112.269 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.694 HD12 ' HD2' ' A' ' 52' ' ' PRO . 31.0 tp -125.41 116.95 25.12 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-O 121.207 0.527 . . . . 0.61 111.395 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.694 ' HD2' HD12 ' A' ' 51' ' ' LEU . 55.4 Cg_endo -79.25 -177.31 3.8 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.698 2.932 . . . . 0.28 114.075 -172.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.7 t70 -82.98 130.29 58.14 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.433 -1.258 . . . . 0.49 112.089 -170.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.629 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 69.5 Cg_endo -75.23 -16.14 19.88 Favored 'Trans proline' 0 CA--C 1.52 -0.211 0 C-N-CA 123.49 2.793 . . . . 0.46 112.867 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -95.3 0.3 53.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.752 0.787 . . . . 1.38 110.198 -172.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 53' ' ' ASP . 20.2 p -96.97 -19.66 18.63 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 122.508 1.146 . . . . 0.46 108.095 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 59' ' ' TYR . 20.5 mt -74.98 133.38 75.81 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 113.198 -1.819 . . . . 0.7 111.296 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.76 -15.5 12.05 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.561 2.174 . . . . 0.39 113.742 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.581 ' H ' HG22 ' A' ' 57' ' ' ILE . 51.3 m-85 -100.81 158.34 16.04 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.542 -0.463 . . . . 0.24 112.059 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -146.0 133.08 20.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.594 -0.891 . . . . 2.89 108.594 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.645 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.9 mt -113.66 134.36 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.343 -0.39 . . . . 0.16 111.937 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.54 118.94 32.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.831 -0.748 . . . . 0.16 111.473 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.8 t -96.99 116.01 38.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.825 0.822 . . . . 0.19 111.107 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 68' ' ' LYS . 27.7 m -95.68 103.12 14.99 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.754 -1.112 . . . . 0.2 110.579 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.8 mm -51.02 -58.44 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.968 0.889 . . . . 0.23 111.548 169.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.43 -12.51 4.6 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 112.782 -2.008 . . . . 0.16 113.208 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.31 -19.83 4.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.403 0.681 . . . . 0.15 112.554 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.512 ' NZ ' ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.83 57.99 3.42 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.552 0.615 . . . . 0.69 111.154 -172.225 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -138.57 163.76 31.2 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 112.969 0.729 . . . . 0.13 112.969 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.452 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -131.29 112.92 13.2 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.527 -1.215 . . . . 0.4 110.041 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.645 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 23.4 m -92.06 122.95 35.04 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.243 0.544 . . . . 0.16 111.245 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.0 tp -99.43 103.29 15.06 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.1 -0.955 . . . . 0.59 109.338 171.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 94.5 p -105.57 161.48 14.33 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.047 -1.061 . . . . 1.05 110.518 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.603 HD13 ' OD1' ' A' ' 75' ' ' ASN . 1.1 tm? -127.55 128.63 45.94 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.498 -0.927 . . . . 0.26 108.498 169.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.603 ' OD1' HD13 ' A' ' 74' ' ' LEU . 2.6 p-10 45.93 51.29 10.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.097 1.359 . . . . 1.84 111.48 -167.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 79.4 m-20 72.05 -13.62 0.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.587 -0.733 . . . . 1.89 111.936 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -96.67 119.07 34.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.309 0.576 . . . . 3.44 109.934 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 69.9 t -57.91 132.49 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.313 1.054 . . . . 0.24 112.852 -172.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 12.9 mtm -102.28 -45.66 5.05 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 112.994 -1.912 . . . . 0.81 108.85 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.19 171.41 20.22 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.088 -1.869 . . . . 1.46 110.085 -176.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.0 m -149.24 123.73 9.71 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.136 -1.393 . . . . 0.17 109.743 172.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -107.45 151.49 40.96 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.333 -0.849 . . . . 1.05 109.291 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HB2' HG22 ' A' ' 134' ' ' ILE . 55.9 Cg_endo -78.9 144.32 18.97 Favored 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 121.871 1.714 . . . . 0.2 111.059 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.656 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -141.01 173.33 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.777 -0.647 . . . . 0.13 111.098 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.895 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.23 145.17 45.2 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.342 -0.39 . . . . 0.26 110.299 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.496 HG22 ' HG3' ' A' ' 68' ' ' LYS . 7.1 m -127.97 131.26 69.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.132 0.491 . . . . 0.56 111.773 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -91.6 157.04 24.32 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 109.755 -1.338 . . . . 0.17 109.755 171.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.897 ' HG3' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -57.5 8.1 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 114.449 1.278 . . . . 3.05 114.449 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.915 HG23 HD22 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -97.03 -13.0 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.641 0.734 . . . . 0.23 110.339 -177.136 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.915 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -92.67 -15.17 27.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.692 -0.685 . . . . 0.18 109.342 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.1 p -69.06 -21.9 64.05 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.889 -1.05 . . . . 0.33 111.797 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 6.8 mp0 -56.74 -44.3 81.55 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.44 1.496 . . . . 1.52 112.332 -176.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -106.49 117.05 58.02 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.799 -0.637 . . . . 0.43 111.36 -178.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.492 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 5.9 Cg_exo -73.1 -16.64 25.28 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.73 2.287 . . . . 0.73 113.132 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.411 HG23 ' N ' ' A' ' 96' ' ' GLY . 12.1 t -104.0 -41.58 5.82 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.711 -0.477 . . . . 0.48 109.711 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.534 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.26 40.19 21.79 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.343 -1.299 . . . . 0.33 113.81 168.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 164' ' ' THR . 49.0 mt-10 -84.08 113.42 21.02 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.026 0.917 . . . . 0.84 109.624 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.702 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.8 m-85 -136.73 178.08 7.35 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 113.604 -1.635 . . . . 0.22 111.566 -171.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 66.0 m-85 -142.06 136.57 30.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.067 0.461 . . . . 0.54 110.902 -172.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.597 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.3 mt -62.46 117.56 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.223 -0.899 . . . . 0.17 110.916 171.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.569 HG21 ' HA ' ' A' ' 22' ' ' PHE . 16.3 pt -87.52 -34.36 7.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 113.138 0.792 . . . . 0.21 113.138 -175.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.596 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 1.5 p-10 -178.57 179.58 0.74 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.666 -1.235 . . . . 2.03 107.666 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.657 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -135.65 163.14 30.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.622 0.725 . . . . 1.52 112.423 -177.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.445 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 53.7 tt0 -133.07 101.05 5.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.466 -1.243 . . . . 0.59 109.819 172.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.492 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 13.6 ttt180 -63.77 166.27 7.37 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.665 -0.698 . . . . 2.82 110.356 174.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.492 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 16.3 m-80 -36.74 101.28 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 113.869 -1.514 . . . . 0.35 114.079 -151.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 16.1 Cg_exo . . . . . 0 N--CA 1.455 -0.77 0 C-N-CA 123.588 2.858 . . . . 0.48 110.723 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.514 0 N-CA-C 116.663 2.097 . . . . 0.48 116.663 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.437 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -165.56 166.37 18.24 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.465 0.706 . . . . 0.28 109.717 -177.444 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 21.8 t-105 -146.68 98.73 3.1 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.96 -1.126 . . . . 0.49 107.96 166.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.626 HD23 ' HG2' ' A' ' 103' ' ' ARG . 1.5 mt -89.39 114.12 25.53 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.337 0.589 . . . . 0.66 109.503 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 101' ' ' ILE . 49.9 m -82.98 143.63 30.53 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.991 -0.549 . . . . 0.19 111.017 -172.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -109.36 167.59 10.01 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.13 111.696 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.538 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.2 t -59.71 -12.86 7.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.686 -1.143 . . . . 1.17 113.175 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.702 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 3.3 tptp -126.87 133.22 50.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.45 -0.5 . . . . 1.22 111.075 173.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.482 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 76.9 mt-30 -31.31 -57.41 0.25 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.02 1.118 . . . . 1.51 114.02 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.552 ' CB ' HG12 ' A' ' 89' ' ' ILE . 87.9 m-70 -95.7 3.15 54.15 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.231 -0.588 . . . . 2.53 111.902 -170.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.793 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -95.14 38.19 1.14 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.661 0.985 . . . . 0.84 113.661 -172.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.617 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -112.65 143.15 17.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 117.319 -2.372 . . . . 0.32 112.565 -153.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.544 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -98.94 115.15 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.868 0.842 . . . . 0.18 110.801 -176.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.628 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 28.8 p80 -144.28 171.82 13.78 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-N 115.166 -0.925 . . . . 0.21 109.789 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.02 -166.64 38.57 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 120.799 -0.715 . . . . 0.27 111.73 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.1 t -156.98 169.16 25.45 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.266 -0.549 . . . . 0.41 110.486 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -111.39 0.11 16.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.682 -0.859 . . . . 1.99 108.682 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -118.07 86.22 25.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.755 -1.111 . . . . 1.36 108.199 171.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -72.5 -19.92 24.31 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.77 2.313 . . . . 0.35 114.175 -166.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.1 -4.01 42.21 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.034 0.445 . . . . 0.33 110.839 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.0 t -85.71 -13.11 49.45 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.906 -0.776 . . . . 1.35 108.906 172.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 83' ' ' PRO . 28.6 mm -77.54 134.71 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 115.257 -0.883 . . . . 0.21 110.413 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.8 -1.38 71.23 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.217 -1.153 . . . . 0.15 110.217 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 85' ' ' ALA . 48.4 mttt -112.1 172.3 6.99 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 123.012 1.387 . . . . 2.5 113.887 -177.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.32 127.72 45.36 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 112.189 -2.278 . . . . 0.17 108.046 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.501 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 1.4 p -118.57 167.91 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.054 -1.462 . . . . 0.66 107.054 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.897 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 45.2 m -64.48 -59.68 4.04 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 119.731 -0.788 . . . . 0.43 111.949 177.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -127.34 -44.14 1.58 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 117.207 -1.797 . . . . 2.02 113.9 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -33.39 132.56 0.31 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.67 1.428 . . . . 0.18 116.67 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.617 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.2 p -68.75 166.36 17.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.41 -1.895 . . . . 0.16 112.141 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.895 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 66.9 mt -59.07 99.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 122.569 1.176 . . . . 0.4 111.991 -163.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.628 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 50.3 mtt180 -86.09 147.1 26.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.371 -1.74 . . . . 1.87 110.389 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.656 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.0 mtp -128.12 -166.21 1.59 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.29 -0.633 . . . . 0.79 109.29 175.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.602 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 5.5 t60 -95.55 156.38 16.35 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.909 -0.775 . . . . 2.32 108.909 171.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.613 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.1 m120 -57.1 -52.69 64.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 118.422 -0.799 . . . . 0.68 110.293 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.87 -25.82 68.48 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 121.154 1.797 . . . . 2.18 112.522 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.602 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 7.5 m-20 -84.67 -41.38 16.35 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.303 -0.408 . . . . 0.69 111.186 -175.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.649 HG13 HD12 ' A' ' 151' ' ' ILE . 13.3 p -67.94 -23.75 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.016 -0.538 . . . . 0.11 111.143 175.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.649 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.24 -39.67 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 119.042 -0.504 . . . . 0.38 109.739 171.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.0 mm-40 -45.86 -72.06 0.06 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.171 0.896 . . . . 1.99 112.366 168.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 157' ' ' VAL . 44.8 mt -47.27 -38.46 12.5 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.675 0.75 . . . . 1.27 111.495 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.35 79.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.126 -1.397 . . . . 0.18 111.664 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.9 t -88.44 -33.0 18.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 118.58 0.627 . . . . 0.21 112.416 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 152' ' ' GLU . 30.4 mt -81.24 -59.63 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.551 0.691 . . . . 0.16 111.193 -172.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 153' ' ' LEU . 2.8 m -92.58 140.12 23.86 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.845 -1.071 . . . . 0.16 112.227 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.657 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 57.3 Cg_endo -89.86 177.14 2.64 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.114 3.209 . . . . 0.2 111.122 173.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.596 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 71.1 m-20 -67.07 157.8 32.64 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 119.658 -0.817 . . . . 1.1 109.525 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 99.39 -25.58 27.69 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.211 -0.995 . . . . 0.18 112.289 -173.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.597 ' HB ' HD12 ' A' ' 100' ' ' ILE . 36.1 m -61.41 138.31 58.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.383 -0.599 . . . . 0.14 109.383 -173.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.538 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 9.8 ptm180 -92.81 127.71 38.41 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.964 1.364 . . . . 3.63 111.369 -170.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.3 t -109.58 108.34 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 111.915 -2.402 . . . . 0.14 109.008 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.438 HG23 ' HG2' ' A' ' 97' ' ' GLU . 30.6 m -94.76 107.05 19.06 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.524 0.564 . . . . 0.21 112.524 -171.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.534 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -82.86 100.75 6.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 122.29 1.043 . . . . 0.24 109.992 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -110.17 133.31 53.35 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.229 -1.35 . . . . 1.09 109.832 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.558 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.6 mmm180 . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 116.465 -0.334 . . . . 2.08 110.829 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 121.453 0.644 . . . . 0.65 111.745 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.621 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.4 tt -94.63 130.87 40.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.857 -1.065 . . . . 0.28 110.142 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.75 162.25 13.51 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.129 0.966 . . . . 0.31 113.171 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.624 ' O ' ' HA ' ' A' ' 45' ' ' SER . 84.7 t80 -129.57 139.98 51.34 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.469 -1.696 . . . . 0.44 107.902 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.486 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.1 tt0 -112.93 110.89 21.25 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.242 -1.021 . . . . 0.76 108.242 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 13' ' ' ASP . 92.7 t -66.05 149.45 11.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 122.564 1.173 . . . . 0.39 113.578 -167.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.409 ' O ' HG12 ' A' ' 9' ' ' VAL . 57.9 mttt -98.93 159.97 14.59 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.211 -1.813 . . . . 2.01 109.799 172.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.4 mm-40 -62.43 105.37 0.61 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.886 -1.052 . . . . 1.83 111.432 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.94 11.66 49.05 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.485 -0.779 . . . . 0.48 113.542 175.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.618 ' HB2' HG13 ' A' ' 9' ' ' VAL . 59.3 m-20 -52.38 169.52 0.08 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 117.423 0.611 . . . . 1.46 111.362 171.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.84 154.69 44.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.475 0.655 . . . . 0.41 111.271 175.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.539 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.97 -33.23 75.34 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.394 -0.965 . . . . 0.86 108.394 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 3.8 t30 -88.62 -25.12 22.6 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.883 -1.053 . . . . 1.15 111.391 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.4 p -68.76 -38.56 80.18 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 119.72 -0.792 . . . . 1.21 109.601 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 mt -75.47 -26.89 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.219 0.533 . . . . 0.21 109.75 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.643 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.91 -9.86 59.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.326 -0.397 . . . . 0.16 110.646 174.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.729 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.44 -41.37 8.63 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.274 -1.01 . . . . 0.21 108.274 176.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.463 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 1.5 m-20 -61.68 -39.45 91.47 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.015 -1.902 . . . . 0.53 112.073 174.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.469 ' O ' HD12 ' A' ' 101' ' ' ILE . 68.4 m-85 -103.32 5.9 37.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 118.566 -1.254 . . . . 0.18 111.487 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.729 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER 54.74 41.5 31.88 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.972 0.891 . . . . 1.78 109.559 176.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.643 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.8 pt -114.42 -165.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.208 -1.36 . . . . 0.19 110.024 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 142.62 41.07 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.241 -0.891 . . . . 0.95 110.21 174.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.544 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 72.3 p -71.97 -34.01 68.61 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.007 -1.108 . . . . 0.25 108.007 178.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.27 69.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.42 -0.809 . . . . 0.2 111.816 170.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.37 -26.26 18.99 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.689 0.757 . . . . 0.17 109.093 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.667 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.1 tp -75.19 -26.29 58.89 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.09 -0.959 . . . . 1.16 109.261 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 26' ' ' THR . 33.6 mt -77.86 -29.89 50.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.765 0.793 . . . . 1.05 109.828 171.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 40.8 tt0 -64.49 -43.28 94.63 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.413 -1.267 . . . . 1.81 109.95 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.18 -20.35 34.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.105 -0.638 . . . . 0.2 111.495 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.64 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.3 m-80 -148.16 81.05 8.34 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.509 0.671 . . . . 0.23 110.442 -172.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.4 Cg_endo -57.71 -10.93 8.09 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 124.077 3.185 . . . . 0.36 114.057 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.5 t -80.67 -22.12 40.72 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.053 -0.404 . . . . 1.38 111.249 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 46' ' ' ILE . 38.1 mt -66.41 -35.67 80.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.526 0.679 . . . . 0.49 111.883 -171.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 3.7 pt20 -65.51 -47.92 74.31 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 122.871 1.32 . . . . 1.95 110.167 -175.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.51 82.56 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 111.934 -2.394 . . . . 0.49 110.594 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.17 -179.53 48.19 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.857 -1.065 . . . . 0.42 111.541 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.01 158.22 23.44 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.212 0.529 . . . . 0.41 110.791 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.61 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 29.4 m -139.05 128.11 23.81 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.493 -0.776 . . . . 0.42 110.406 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -75.27 118.89 18.67 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.566 0.698 . . . . 0.47 109.772 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.486 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.39 0.74 55.65 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.374 -1.09 . . . . 0.41 110.374 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.2 OUTLIER -76.42 124.16 27.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.985 -0.607 . . . . 1.3 109.469 179.366 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 24.4 p -84.45 126.17 33.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.967 0.889 . . . . 0.85 110.752 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.859 HG21 HD21 ' A' ' 36' ' ' LEU . 10.6 pt -126.94 144.38 37.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.133 -1.394 . . . . 0.25 109.377 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.68 151.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.125 0.488 . . . . 0.67 111.164 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.3 mm -116.35 91.69 33.93 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.885 -1.052 . . . . 0.16 109.425 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.528 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.6 Cg_endo -56.93 133.7 59.67 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.834 2.356 . . . . 0.18 112.551 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.18 -5.79 78.4 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.701 -1.136 . . . . 0.26 112.569 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.688 HD12 ' HD2' ' A' ' 52' ' ' PRO . 25.6 tp -125.71 115.56 24.73 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.949 0.404 . . . . 0.61 111.452 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.688 ' HD2' HD12 ' A' ' 51' ' ' LEU . 36.4 Cg_endo -76.79 -177.82 4.07 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.565 2.844 . . . . 0.28 114.331 -172.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.67 ' HB3' HG23 ' A' ' 56' ' ' THR . 16.1 t70 -78.31 133.05 64.67 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 113.94 -1.482 . . . . 0.49 112.139 -170.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.47 -9.36 18.72 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.314 2.676 . . . . 0.46 112.717 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.507 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 16.4 m-30 -93.9 -8.28 40.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.119 0.485 . . . . 1.38 110.52 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.67 HG23 ' HB3' ' A' ' 53' ' ' ASP . 19.0 p -88.72 -17.67 29.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.065 0.936 . . . . 0.46 108.674 174.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.655 HG22 ' H ' ' A' ' 59' ' ' TYR . 9.6 mm -64.72 126.14 90.28 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 113.838 -1.528 . . . . 0.7 109.989 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.71 -13.48 10.62 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.999 1.799 . . . . 0.39 112.608 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.655 ' H ' HG22 ' A' ' 57' ' ' ILE . 67.0 m-85 -103.68 170.56 7.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.281 0.562 . . . . 0.24 111.825 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -153.81 134.07 13.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.117 -0.947 . . . . 2.89 108.536 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 71' ' ' THR . 93.1 mt -111.54 130.34 65.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.342 -0.39 . . . . 0.16 111.322 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.87 115.48 28.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.937 -0.705 . . . . 0.16 110.847 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 47.8 t -96.64 114.04 32.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.79 0.805 . . . . 0.19 110.571 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 68' ' ' LYS . 27.1 m -94.76 100.35 12.27 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.49 -1.232 . . . . 0.2 110.359 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.0 mm -50.47 -57.32 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 122.028 0.918 . . . . 0.23 111.13 170.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.34 -11.53 3.63 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 112.787 -2.006 . . . . 0.16 113.131 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.49 -17.53 5.07 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.436 0.694 . . . . 0.15 112.595 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.498 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.97 54.25 6.18 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.505 0.593 . . . . 0.69 111.488 -173.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.6 p -136.7 163.48 30.48 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.798 0.666 . . . . 0.13 112.798 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.501 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.5 tt -128.13 111.52 13.56 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.595 -1.184 . . . . 0.4 109.549 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.631 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 31.2 m -93.41 121.77 35.15 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.261 0.553 . . . . 0.16 110.962 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' A' ' 79' ' ' MET . 16.0 tp -96.79 104.96 17.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.179 -0.918 . . . . 0.59 109.078 172.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 97.9 p -106.8 159.23 16.39 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.981 -1.088 . . . . 1.05 110.368 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.619 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -123.73 125.51 44.88 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.561 -0.903 . . . . 0.26 108.561 170.832 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.619 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.9 p-10 41.06 54.83 3.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.713 -1.585 . . . . 1.84 111.58 -164.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 6.7 m-20 74.7 -13.62 0.8 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.008 -0.996 . . . . 1.89 112.146 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -95.28 120.39 35.43 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.231 0.539 . . . . 3.44 110.025 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 58.9 t -56.93 131.04 20.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 122.357 1.075 . . . . 0.24 113.002 -173.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 2.8 mmm -97.99 -46.88 5.74 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.947 -1.933 . . . . 0.81 108.854 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.8 mmtt -160.56 173.99 14.7 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.046 -1.888 . . . . 1.46 110.037 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.8 m -149.6 123.7 9.46 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.224 -1.353 . . . . 0.17 109.699 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -114.94 145.06 33.21 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.6 -0.727 . . . . 1.05 109.959 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HB2' HG22 ' A' ' 134' ' ' ILE . 37.3 Cg_endo -72.42 142.28 36.63 Favored 'Trans proline' 0 CA--C 1.496 -1.418 0 C-N-CA 122.259 1.973 . . . . 0.2 111.173 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.661 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.32 172.56 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 115.517 -0.765 . . . . 0.13 110.959 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.929 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.04 139.66 50.88 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.237 -0.438 . . . . 0.26 109.88 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.498 HG22 ' HG3' ' A' ' 68' ' ' LYS . 10.9 m -121.74 126.87 75.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.713 0.768 . . . . 0.56 111.541 -177.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -82.18 150.63 29.1 Favored Glycine 0 N--CA 1.419 -2.452 0 N-CA-C 109.186 -1.566 . . . . 0.17 109.186 171.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -57.19 4.39 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.809 0.67 . . . . 3.05 112.809 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.944 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -87.46 -19.04 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.481 0.658 . . . . 0.23 110.077 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.944 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -88.84 -16.36 32.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.694 0.759 . . . . 0.18 109.228 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.5 p -69.23 -18.51 63.9 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.565 -1.198 . . . . 0.33 111.194 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.25 -40.17 93.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.536 -1.211 . . . . 1.52 112.704 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.67 131.26 29.75 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 119.799 -0.76 . . . . 0.43 110.956 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 83.8 Cg_endo -86.97 -1.86 8.04 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.43 2.087 . . . . 0.73 112.314 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.3 t -119.62 -41.48 2.69 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.418 -0.586 . . . . 0.48 109.418 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 165' ' ' ILE . . . 54.87 16.86 8.28 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 114.716 -1.129 . . . . 0.33 114.413 169.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.596 ' HB3' HG23 ' A' ' 164' ' ' THR . 10.6 pt-20 -84.42 116.7 23.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.495 1.14 . . . . 0.84 109.816 -173.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 11.3 m-85 -137.58 -174.78 3.86 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.278 -1.783 . . . . 0.22 111.436 -166.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 162' ' ' ARG . 39.2 m-85 -142.18 137.95 31.19 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 120.945 0.402 . . . . 0.54 110.991 -173.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.662 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.2 mt -65.04 125.04 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.542 -0.753 . . . . 0.17 110.308 169.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.57 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 21.9 pt -91.45 -42.13 13.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 113.024 0.75 . . . . 0.21 113.024 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 57.6 m-80 -170.13 173.0 6.08 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.009 -1.478 . . . . 2.03 107.009 -170.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.61 HH21 ' HA ' ' A' ' 158' ' ' PRO . 40.7 mtt180 -125.8 167.9 14.56 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.696 -0.802 . . . . 1.52 111.739 -175.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -145.44 100.76 3.5 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.148 -0.933 . . . . 0.59 110.019 171.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.469 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 25.9 ttp180 -66.02 166.31 11.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.302 -0.863 . . . . 2.82 110.735 175.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 33.8 m-80 -36.37 101.51 0.22 Allowed Pre-proline 0 C--O 1.233 0.207 0 C-N-CA 124.942 1.297 . . . . 0.35 113.104 -156.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.516 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.4 Cg_endo . . . . . 0 C--N 1.347 0.47 0 C-N-CA 123.453 2.768 . . . . 0.48 112.601 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.788 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 121.157 0.503 . . . . 0.48 110.111 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.429 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -157.37 157.51 34.2 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.66 0.384 . . . . 0.28 110.079 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -136.52 100.22 4.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.973 -1.121 . . . . 0.49 107.973 165.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.547 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.0 mt -93.52 114.18 26.49 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.64 -0.874 . . . . 0.66 108.64 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.406 ' C ' HG12 ' A' ' 101' ' ' ILE . 9.2 m -84.25 144.45 28.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.675 -0.693 . . . . 0.19 111.213 -165.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.815 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -109.54 169.46 8.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 0.13 111.394 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.0 t -63.97 -12.21 35.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.848 -1.069 . . . . 1.17 112.787 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.746 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 3.9 tmtm? -127.65 132.31 49.74 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.158 0.98 . . . . 1.22 109.704 171.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.746 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.0 mt-30 -37.57 -47.23 0.91 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.524 -2.126 . . . . 1.51 114.211 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.486 ' HB2' HG12 ' A' ' 89' ' ' ILE . 37.2 m80 -97.9 2.22 48.92 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.366 0.603 . . . . 2.53 111.024 -171.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.815 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.6 m-85 -99.38 37.35 1.58 Allowed 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.495 0.924 . . . . 0.84 113.495 -171.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.672 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -117.03 142.27 17.31 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 116.874 -2.584 . . . . 0.32 112.668 -152.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -95.64 116.12 36.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 123.966 0.906 . . . . 0.18 110.868 -175.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.724 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 26.7 p80 -146.36 -179.01 6.45 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.186 -0.461 . . . . 0.21 111.822 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.39 -167.98 37.05 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 111.19 -0.764 . . . . 0.27 111.19 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.4 t -156.95 172.29 18.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 117.912 0.856 . . . . 0.41 110.911 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -115.42 -2.43 12.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.528 -0.916 . . . . 1.99 108.528 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -124.86 89.17 52.93 Favored Pre-proline 0 C--O 1.235 0.333 0 CA-C-N 114.426 -1.261 . . . . 1.36 108.858 171.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -74.32 -21.04 17.95 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.627 2.218 . . . . 0.35 114.113 -169.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.02 -3.65 40.14 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.034 0.445 . . . . 0.33 111.337 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.9 m -91.13 -2.33 57.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.125 0.488 . . . . 1.35 109.812 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 83' ' ' PRO . 33.5 mm -77.23 136.34 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.21 110.026 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.59 2.12 65.57 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.314 -1.114 . . . . 0.15 110.314 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.428 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 30.2 mttm -114.87 169.96 8.69 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 123.315 1.531 . . . . 2.5 114.635 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.4 126.51 48.18 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.67 -2.514 . . . . 0.17 108.203 176.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.77 161.23 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.446 -0.946 . . . . 0.66 108.446 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.0 m -49.8 -60.1 3.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.794 0.664 . . . . 0.43 112.794 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -132.61 -44.46 0.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.36 -1.336 . . . . 2.02 113.984 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.49 133.65 0.2 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 117.19 1.636 . . . . 0.18 117.19 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.616 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 2.4 p -71.22 165.6 23.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 112.545 -1.827 . . . . 0.16 112.026 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.929 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 56.0 mt -60.01 96.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 122.538 1.161 . . . . 0.4 111.783 -162.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.724 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 80.5 mtt180 -84.93 141.76 30.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.681 -1.6 . . . . 1.87 109.399 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.661 ' HG2' HG22 ' A' ' 84' ' ' ILE . 24.4 mtp -118.6 179.22 4.19 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.477 0.656 . . . . 0.79 109.857 175.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.569 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 9.5 t-80 -81.45 145.83 30.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.882 -1.155 . . . . 2.32 107.882 168.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.789 ' O ' HD13 ' A' ' 151' ' ' ILE . 6.9 m120 -66.17 -40.47 90.52 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 114.883 -1.053 . . . . 0.68 112.566 -166.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -67.54 -23.83 65.48 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 121.801 2.091 . . . . 2.18 112.241 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 12.2 m-20 -85.19 -38.23 19.22 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.216 -0.447 . . . . 0.69 110.851 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.62 HG13 HD12 ' A' ' 151' ' ' ILE . 12.2 p -67.55 -21.98 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.852 -0.613 . . . . 0.11 111.176 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.789 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.19 -43.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 118.948 -0.549 . . . . 0.38 109.923 171.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 156' ' ' ILE . 23.5 mt-10 -46.81 -70.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 119.385 0.993 . . . . 1.99 112.761 170.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.473 ' O ' HG22 ' A' ' 157' ' ' VAL . 27.3 mt -47.07 -38.62 11.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.631 0.729 . . . . 1.27 111.658 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.65 -31.96 71.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.079 -1.419 . . . . 0.18 111.712 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.7 t -88.34 -31.77 18.75 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.481 -0.762 . . . . 0.21 112.324 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 152' ' ' GLU . 24.2 mt -82.31 -60.84 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.534 0.683 . . . . 0.16 111.828 -171.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 153' ' ' LEU . 8.7 m -88.35 139.46 30.16 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 114.783 -1.099 . . . . 0.16 112.342 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.61 ' HA ' HH21 ' A' ' 103' ' ' ARG . 42.4 Cg_endo -88.54 174.55 4.13 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 124.37 3.38 . . . . 0.2 111.119 176.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 54.0 m-20 -68.18 156.93 36.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.905 -1.118 . . . . 1.1 108.219 175.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.78 -16.07 61.9 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.772 -1.204 . . . . 0.18 111.928 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.662 ' HB ' HD12 ' A' ' 100' ' ' ILE . 95.2 m -64.91 135.29 55.54 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.203 -0.666 . . . . 0.14 109.203 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.443 ' HB3' ' CD1' ' A' ' 99' ' ' TYR . 1.7 ptt180 -92.82 122.42 35.19 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.685 1.231 . . . . 3.63 111.078 -170.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 39.8 t -110.14 109.56 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 112.204 -2.271 . . . . 0.14 109.475 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.596 HG23 ' HB3' ' A' ' 97' ' ' GLU . 6.9 m -97.35 110.28 22.86 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.082 0.771 . . . . 0.21 113.082 -172.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.488 HG12 HD12 ' A' ' 90' ' ' LEU . 2.3 mp -83.17 102.16 8.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.11 0.957 . . . . 0.24 109.792 176.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -109.22 129.84 55.5 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.979 -1.009 . . . . 1.09 110.037 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 9.9 mmm180 . . . . . 0 C--N 1.321 -0.652 0 CA-C-O 121.362 0.601 . . . . 2.08 109.432 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.771 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 tp . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.189 0.519 . . . . 0.65 111.186 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.9 tt -94.28 126.42 39.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.521 -0.763 . . . . 0.28 110.615 -174.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.71 161.62 13.8 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.051 0.929 . . . . 0.31 113.064 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.651 ' O ' ' HA ' ' A' ' 45' ' ' SER . 78.7 t80 -131.29 141.48 49.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.808 -1.542 . . . . 0.44 108.058 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.457 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.5 tt0 -113.27 111.04 21.37 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.055 -1.091 . . . . 0.76 108.055 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' A' ' 13' ' ' ASP . 94.3 t -66.52 150.49 10.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 122.155 0.978 . . . . 0.39 113.032 -168.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -104.14 158.85 16.15 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.869 -1.514 . . . . 2.01 108.658 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.427 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.1 tt0 -61.54 101.62 0.19 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.974 0.416 . . . . 1.83 112.09 -175.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.79 11.97 27.27 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.754 -0.736 . . . . 0.48 113.237 174.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.647 ' HB2' HG13 ' A' ' 9' ' ' VAL . 35.7 m-20 -55.54 170.48 0.25 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.912 0.356 . . . . 1.46 111.348 171.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.7 155.11 49.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.459 0.647 . . . . 0.41 111.893 174.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.754 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -69.21 -29.71 67.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.526 -1.216 . . . . 0.86 109.897 -177.255 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.441 ' HA ' HG22 ' A' ' 26' ' ' THR . 65.9 t30 -93.79 -23.26 18.23 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.927 -1.033 . . . . 1.15 111.164 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.3 m -70.0 -39.84 75.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.553 -0.459 . . . . 1.21 109.886 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.443 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.2 mt -73.2 -27.4 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.112 0.482 . . . . 0.21 109.977 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.654 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.76 -10.42 59.77 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.811 -0.356 . . . . 0.16 110.928 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.565 ' O ' ' HD3' ' A' ' 23' ' ' ARG . . . -97.16 -40.3 8.87 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 122.214 1.007 . . . . 0.21 108.404 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 4.4 m-20 -61.44 -43.43 98.88 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.227 -1.806 . . . . 0.53 111.867 173.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.568 ' C ' HD12 ' A' ' 101' ' ' ILE . 67.8 m-85 -98.01 8.19 45.14 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.574 -1.25 . . . . 0.18 111.571 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.565 ' HD3' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER 52.08 40.65 28.95 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.613 0.721 . . . . 1.78 110.215 177.439 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.654 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.6 pt -113.63 -164.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 114.511 -1.222 . . . . 0.19 109.28 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -109.9 157.17 19.52 Favored 'General case' 0 CA--C 1.491 -1.318 0 CA-C-O 122.375 1.083 . . . . 0.95 110.168 169.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.754 ' HB ' HD11 ' A' ' 15' ' ' LEU . 75.7 p -80.68 -31.12 36.4 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 112.914 -1.948 . . . . 0.25 107.553 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 -30.72 71.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.098 -0.956 . . . . 0.2 111.76 172.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.51 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -89.95 -26.87 20.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.728 -0.842 . . . . 0.17 108.728 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.6 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 20.0 tp -74.14 -28.18 61.2 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.355 -0.839 . . . . 1.16 109.789 175.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 36' ' ' LEU . 48.3 mt -77.79 -29.31 50.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.959 0.885 . . . . 1.05 109.919 172.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 53.9 tt0 -67.9 -39.65 83.59 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.082 -1.417 . . . . 1.81 110.572 174.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.67 -19.94 32.06 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.075 -0.65 . . . . 0.2 111.409 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 26.8 m-80 -147.05 80.64 9.34 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-O 121.217 0.532 . . . . 0.23 110.351 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.418 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 18.5 Cg_endo -57.15 -11.2 7.36 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 123.889 3.059 . . . . 0.36 113.305 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 m -74.05 -25.72 60.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.848 0.356 . . . . 1.38 111.53 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.663 HD21 HG21 ' A' ' 46' ' ' ILE . 40.6 mt -70.91 -32.46 69.4 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.353 0.596 . . . . 0.49 112.462 -168.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 1.7 pp0? -63.59 -44.64 93.43 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 123.057 1.408 . . . . 1.95 110.395 -175.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.37 79.19 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 111.722 -2.49 . . . . 0.49 110.693 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.41 178.33 48.65 Favored Glycine 0 N--CA 1.425 -2.094 0 CA-C-N 115.117 -0.947 . . . . 0.42 111.929 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.67 158.05 19.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.225 0.536 . . . . 0.41 110.569 178.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.556 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 74.4 m -140.91 127.55 20.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.355 -0.839 . . . . 0.42 110.301 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -75.07 122.71 23.96 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.364 0.602 . . . . 0.47 110.028 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.457 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.67 3.02 61.18 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 110.533 -1.027 . . . . 0.41 110.533 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.556 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.52 123.12 28.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.626 -0.509 . . . . 1.3 109.626 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 17.0 p -77.78 126.36 30.74 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.852 0.834 . . . . 0.85 110.657 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.663 HG21 HD21 ' A' ' 36' ' ' LEU . 9.1 pt -126.13 144.07 37.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.138 -1.392 . . . . 0.25 109.198 -178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.426 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.15 151.44 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.347 0.594 . . . . 0.67 111.191 -179.023 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.82 93.38 41.23 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.554 -1.203 . . . . 0.16 109.227 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.613 ' HA ' HD21 ' A' ' 4' ' ' LEU . 3.1 Cg_exo -56.12 133.91 60.97 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.488 2.125 . . . . 0.18 112.535 -176.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.77 -6.88 79.76 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 114.412 -1.267 . . . . 0.26 112.363 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.771 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER -112.98 118.49 44.41 Favored Pre-proline 0 C--O 1.217 -0.637 0 CA-C-N 116.98 0.39 . . . . 0.61 111.186 178.172 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.592 ' HD2' HD23 ' A' ' 51' ' ' LEU . 37.0 Cg_endo -80.0 -176.8 3.41 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.083 2.522 . . . . 0.28 112.65 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.552 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.7 t70 -86.72 127.37 60.49 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-N 115.363 -0.835 . . . . 0.49 112.044 -168.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.566 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.1 Cg_endo -75.65 -10.39 20.17 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 123.626 2.884 . . . . 0.46 112.934 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -94.08 -13.92 26.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.549 0.69 . . . . 1.38 110.186 -176.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.552 HG23 ' HB3' ' A' ' 53' ' ' ASP . 23.7 p -87.32 -21.23 25.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.507 1.146 . . . . 0.46 108.176 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 59' ' ' TYR . 35.8 mt -73.89 129.08 85.58 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.124 -1.853 . . . . 0.7 111.018 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.06 -16.22 14.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.424 2.083 . . . . 0.39 113.416 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.531 ' H ' HG22 ' A' ' 57' ' ' ILE . 62.9 m-85 -94.66 160.12 14.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.582 -0.447 . . . . 0.24 111.591 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -150.99 132.03 14.31 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.902 -0.777 . . . . 2.89 108.902 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 71' ' ' THR . 80.2 mt -112.49 136.38 48.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.233 -0.44 . . . . 0.16 111.889 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.77 117.39 29.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 119.957 -0.697 . . . . 0.16 110.924 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.2 t -97.33 112.88 30.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.775 0.797 . . . . 0.19 110.53 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 68' ' ' LYS . 49.6 m -93.6 100.75 12.95 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.717 -1.129 . . . . 0.2 110.546 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.8 mm -50.79 -58.77 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.894 0.854 . . . . 0.23 111.443 170.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.92 -8.21 2.09 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 112.922 -1.945 . . . . 0.16 113.245 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.46 -19.17 4.27 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.697 0.799 . . . . 0.15 112.267 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.554 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 59.24 54.51 4.77 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.335 0.516 . . . . 0.69 111.293 -172.648 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.6 p -137.29 166.2 24.34 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 112.787 0.662 . . . . 0.13 112.787 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.431 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.9 tt -136.26 112.22 9.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.861 -1.063 . . . . 0.4 110.197 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 86.6 m -93.24 124.3 37.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.146 0.498 . . . . 0.16 110.879 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.9 tp -99.78 107.3 19.31 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.173 -0.921 . . . . 0.59 109.25 172.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 88.8 p -105.42 161.4 14.35 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.013 -1.075 . . . . 1.05 110.546 176.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -125.99 126.69 44.72 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.575 -0.898 . . . . 0.26 108.575 167.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.566 ' N ' HD22 ' A' ' 74' ' ' LEU . 9.1 m120 51.15 48.61 22.73 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.607 -1.179 . . . . 1.84 111.067 -172.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.0 t30 71.71 -5.89 1.56 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.339 0.656 . . . . 1.89 111.414 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -104.94 120.64 41.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.125 0.488 . . . . 3.44 110.582 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 54.7 t -55.23 132.85 18.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 122.361 1.077 . . . . 0.24 113.399 -174.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 6.9 mmm -100.85 -44.43 5.77 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.229 -1.805 . . . . 0.81 109.275 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -159.37 173.43 16.26 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 113.189 -1.823 . . . . 1.46 110.156 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.0 m -149.3 123.08 9.27 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.986 -1.461 . . . . 0.17 109.391 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.459 ' HE2' HD21 ' A' ' 153' ' ' LEU . 19.0 m-85 -108.85 156.6 38.72 Favored Pre-proline 0 C--N 1.312 -1.04 0 N-CA-C 109.386 -0.598 . . . . 1.05 109.386 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HB2' HG22 ' A' ' 134' ' ' ILE . 50.7 Cg_endo -80.69 144.2 15.41 Favored 'Trans proline' 0 CA--C 1.497 -1.372 0 C-N-CA 121.975 1.783 . . . . 0.2 110.83 170.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.631 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -140.08 172.75 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.614 -0.721 . . . . 0.13 110.551 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.85 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.05 137.69 52.73 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.846 0.355 . . . . 0.26 110.321 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.554 HG22 ' HG3' ' A' ' 68' ' ' LYS . 13.2 m -121.11 130.16 74.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.678 -0.692 . . . . 0.56 111.527 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 140' ' ' LYS . . . -88.91 154.26 24.46 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.988 -1.245 . . . . 0.17 109.988 171.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -57.08 4.55 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 113.133 0.79 . . . . 3.05 113.133 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.936 HG23 HD22 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -88.78 -18.97 7.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.78 0.8 . . . . 0.23 110.074 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.936 HD22 HG23 ' A' ' 89' ' ' ILE . 3.5 mm? -88.66 -18.53 27.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.791 0.805 . . . . 0.18 108.909 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.8 p -68.51 -15.05 63.41 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.376 -1.284 . . . . 0.33 111.658 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -69.6 -42.26 74.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.918 -1.037 . . . . 1.52 112.127 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -99.72 111.94 62.7 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.43 111.108 -175.105 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.509 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 1.9 Cg_endo -77.43 -11.87 17.19 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.831 2.354 . . . . 0.73 113.126 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.425 HG23 ' N ' ' A' ' 96' ' ' GLY . 10.2 t -98.88 -43.58 6.68 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.468 -0.567 . . . . 0.48 109.468 176.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.55 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 54.44 27.21 40.19 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.255 -1.339 . . . . 0.33 114.228 168.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -84.59 111.86 19.91 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.988 0.899 . . . . 0.84 109.363 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.692 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 22.4 m-85 -138.46 -176.9 4.62 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.66 -1.609 . . . . 0.22 111.661 -170.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.401 ' CE1' ' HG3' ' A' ' 54' ' ' PRO . 46.5 m-85 -143.96 144.12 31.55 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.974 0.416 . . . . 0.54 110.552 -173.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.586 HD12 ' HB ' ' A' ' 161' ' ' THR . 82.3 mt -68.75 113.01 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.336 -0.847 . . . . 0.17 109.995 168.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.568 HD12 ' C ' ' A' ' 22' ' ' PHE . 18.7 pt -80.65 -43.54 21.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.569 -0.741 . . . . 0.21 112.552 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.824 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 52.1 m-80 -169.12 169.47 9.38 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.007 -1.479 . . . . 2.03 107.007 -170.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.608 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -134.76 157.59 46.34 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.99 -0.684 . . . . 1.52 112.396 -177.537 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -130.86 100.92 5.43 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.723 -1.126 . . . . 0.59 109.85 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.459 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 52.0 ttt180 -61.45 165.31 4.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.35 -0.841 . . . . 2.82 110.137 173.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.77 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 29.9 m-80 -34.99 100.91 0.2 Allowed Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 125.12 1.368 . . . . 0.35 112.657 -156.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.492 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 19.7 Cg_endo . . . . . 0 N--CA 1.463 -0.308 0 C-N-CA 123.25 2.633 . . . . 0.48 112.827 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.9 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 N--CA 1.439 -0.985 0 N-CA-C 110.221 -0.288 . . . . 0.48 110.221 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.454 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -161.06 157.24 25.8 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.57 0.348 . . . . 0.28 110.206 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -135.68 99.05 4.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.129 -1.063 . . . . 0.49 108.129 165.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.608 HD23 ' HB3' ' A' ' 103' ' ' ARG . 2.7 mt -89.69 113.52 25.02 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.692 -0.855 . . . . 0.66 108.692 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.497 ' O ' HG12 ' A' ' 101' ' ' ILE . 11.0 m -82.02 142.63 32.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.718 -0.674 . . . . 0.19 110.153 -171.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.722 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.3 mm? -108.14 163.81 12.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.282 -0.417 . . . . 0.13 111.725 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.3 t -57.6 -14.01 4.72 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 124.621 1.201 . . . . 1.17 112.546 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.692 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 5.9 tmtm? -125.94 130.33 51.06 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.266 -0.574 . . . . 1.22 109.458 169.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.64 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 54.0 mt-30 -33.69 -60.29 0.37 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 125.438 1.711 . . . . 1.51 113.19 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.503 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -92.08 13.79 17.85 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.01 -0.676 . . . . 2.53 112.412 -169.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.949 ' O ' HG12 ' A' ' 143' ' ' ILE . 2.5 m-30 -92.68 -35.13 13.66 Favored 'General case' 0 C--O 1.202 -1.441 0 CA-C-O 121.896 0.855 . . . . 0.84 111.392 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.722 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -10.3 129.46 0.01 OUTLIER Glycine 0 C--N 1.286 -2.197 0 N-CA-C 119.414 2.526 . . . . 0.32 119.414 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -98.43 116.52 41.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 112.538 -1.831 . . . . 0.18 110.149 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.633 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.2 p80 -144.13 -175.82 4.76 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 112.762 0.653 . . . . 0.21 112.762 -174.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.17 -166.73 36.98 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 111.651 -0.579 . . . . 0.27 111.651 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.8 t -160.92 165.6 29.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 117.99 0.895 . . . . 0.41 110.826 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.42 -2.04 13.34 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.806 -1.183 . . . . 1.99 107.806 175.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -123.73 96.47 43.07 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 114.187 -1.369 . . . . 1.36 108.157 170.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -74.54 -20.32 18.14 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.238 1.958 . . . . 0.35 112.767 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.53 -0.16 40.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.414 0.626 . . . . 0.33 110.674 -176.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 43.0 t -91.94 -5.17 53.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.928 -0.767 . . . . 1.35 108.928 170.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 30.6 mm -84.56 133.66 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.768 -0.651 . . . . 0.21 110.498 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.1 1.45 69.84 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.804 -1.319 . . . . 0.15 109.804 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 0.1 OUTLIER -113.69 161.79 17.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.913 1.34 . . . . 2.5 114.067 -176.023 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -95.85 129.04 43.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 112.244 -2.253 . . . . 0.17 108.305 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 139' ' ' SER . 0.2 OUTLIER -126.02 165.07 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.618 -0.882 . . . . 0.66 108.618 -175.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 66.0 m -50.02 -60.09 3.27 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.706 0.632 . . . . 0.43 112.706 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.47 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -133.87 -43.2 0.81 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 118.414 -1.314 . . . . 2.02 113.802 -175.427 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.7 134.09 0.14 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 117.645 1.818 . . . . 0.18 117.645 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 4.9 p -71.29 166.47 21.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 112.493 -1.853 . . . . 0.16 112.037 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.949 HG12 ' O ' ' A' ' 123' ' ' TYR . 9.3 mm -58.9 101.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 115.118 -0.946 . . . . 0.4 111.622 -162.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.633 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 28.6 mtp85 -88.17 141.13 28.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.178 -0.919 . . . . 1.87 109.279 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.631 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.2 mtp -120.01 -168.49 1.62 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.959 -0.756 . . . . 0.79 108.959 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' HIS . . . . . 0.424 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 7.5 t-160 -88.89 155.52 19.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.414 -0.958 . . . . 2.32 108.414 170.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.875 ' O ' HD13 ' A' ' 151' ' ' ILE . 7.2 m-80 -73.38 -18.27 61.18 Favored 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 112.745 0.646 . . . . 0.68 112.745 -172.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -82.02 -27.56 33.01 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 120.551 1.523 . . . . 2.18 112.831 164.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.424 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 67.1 m-20 -82.57 -38.64 23.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.992 0.425 . . . . 0.69 111.001 -173.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.659 HG13 HD12 ' A' ' 151' ' ' ILE . 12.2 p -67.22 -21.65 28.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.11 111.13 174.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.9 HD11 ' HB1' ' A' ' 113' ' ' ALA . 1.6 mp -84.6 -40.86 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 119.029 -0.51 . . . . 0.38 110.203 172.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 156' ' ' ILE . 4.4 mm-40 -44.7 -72.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.105 0.866 . . . . 1.99 112.203 168.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.587 ' O ' HG22 ' A' ' 157' ' ' VAL . 41.6 mt -46.32 -39.12 9.67 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.669 0.747 . . . . 1.27 111.644 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HB1' ' CE2' ' A' ' 114' ' ' TYR . . . -62.4 -37.66 86.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.159 -1.382 . . . . 0.18 111.764 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 34.6 t -86.79 -33.16 19.99 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.581 0.586 . . . . 0.21 112.581 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 152' ' ' GLU . 24.6 mt -81.24 -59.39 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.659 0.742 . . . . 0.16 111.367 -172.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.0 m -89.57 141.89 29.01 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.743 -1.117 . . . . 0.16 111.899 177.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -89.4 175.27 3.34 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.099 3.199 . . . . 0.2 110.911 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.824 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.5 m-20 -65.38 158.63 26.07 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.831 -0.803 . . . . 1.1 108.831 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 95.04 -17.9 58.41 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.108 -1.044 . . . . 0.18 112.569 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.586 ' HB ' HD12 ' A' ' 100' ' ' ILE . 80.6 m -63.95 137.33 57.96 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.299 -0.63 . . . . 0.14 109.299 -175.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.15 119.82 32.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 122.673 1.225 . . . . 3.63 111.137 -168.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.5 t -104.42 110.86 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 112.4 -2.182 . . . . 0.14 109.398 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.0 m -96.3 108.21 20.68 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 112.757 0.651 . . . . 0.21 112.757 -173.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.55 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -81.28 106.64 12.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 122.198 0.999 . . . . 0.24 109.905 177.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -112.36 123.65 50.76 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.42 -1.264 . . . . 1.09 109.806 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.543 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 17.7 mmm180 . . . . . 0 C--N 1.318 -0.762 0 N-CA-C 109.707 -0.479 . . . . 2.08 109.707 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.717 -0.553 . . . . 2.8 111.717 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -112.86 155.23 25.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.826 0.346 . . . . 4.44 110.248 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -91.59 102.32 14.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.979 -0.555 . . . . 2.46 110.147 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.654 HD21 ' HA ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -109.21 174.7 5.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.58 0.705 . . . . 0.65 112.661 -172.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.9 tt -98.99 129.05 45.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.581 -1.19 . . . . 0.28 110.466 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.32 162.18 13.45 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.076 0.941 . . . . 0.31 113.347 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 45' ' ' SER . 82.6 t80 -131.96 141.5 49.32 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.676 -1.602 . . . . 0.44 107.973 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.9 tt0 -114.64 115.23 26.79 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.198 -1.038 . . . . 0.76 108.198 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 13' ' ' ASP . 99.5 t -67.01 148.84 11.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 122.482 1.134 . . . . 0.39 113.125 -172.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -103.1 158.84 16.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.171 -1.831 . . . . 2.01 108.12 171.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -60.98 106.26 0.57 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 120.808 0.337 . . . . 1.83 111.754 -175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.35 11.67 38.18 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.689 -0.767 . . . . 0.48 113.553 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB2' HG13 ' A' ' 9' ' ' VAL . 65.3 m-20 -53.15 165.14 0.35 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.169 0.485 . . . . 1.46 111.646 172.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.1 147.69 47.72 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.43 0.633 . . . . 0.41 111.171 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.534 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.89 -40.69 87.84 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.901 -1.045 . . . . 0.86 108.446 -176.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -84.28 -18.08 37.58 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.576 -1.193 . . . . 1.15 110.266 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.9 t -71.66 -43.31 66.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.151 -0.685 . . . . 1.21 109.151 170.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.423 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.0 mt -72.19 -27.66 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.37 0.605 . . . . 0.21 109.502 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.07 -9.04 59.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.161 -0.472 . . . . 0.16 110.942 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.69 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.52 -40.79 8.48 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 122.631 1.205 . . . . 0.21 107.965 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.1 m-20 -62.2 -45.8 91.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 112.417 -2.174 . . . . 0.53 111.883 174.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.586 ' HA ' HG21 ' A' ' 101' ' ' ILE . 60.6 m-85 -96.23 5.63 50.59 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 118.624 -1.23 . . . . 0.18 111.213 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.69 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.7 mpt_? 54.2 45.86 26.5 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.648 0.737 . . . . 1.78 109.772 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.616 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 37.1 pt -120.53 -165.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.671 -1.149 . . . . 0.19 110.206 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.91 142.94 40.55 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.998 -1.001 . . . . 0.95 110.252 174.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.534 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 68.4 p -71.4 -33.38 69.43 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.914 -1.143 . . . . 0.25 107.914 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.01 68.08 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.443 -0.799 . . . . 0.2 111.954 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.539 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.63 -27.73 16.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.717 0.77 . . . . 0.17 109.198 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.576 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -74.83 -29.75 61.16 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.707 -1.133 . . . . 1.16 109.357 174.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.551 HD23 ' HB2' ' A' ' 36' ' ' LEU . 48.2 mt -76.6 -33.02 58.44 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.83 0.824 . . . . 1.05 110.117 171.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 36.9 tt0 -61.49 -39.21 90.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.356 -1.293 . . . . 1.81 109.522 172.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.632 ' HB1' HG13 ' A' ' 47' ' ' VAL . . . -86.47 -19.31 29.76 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.337 -0.545 . . . . 0.2 112.217 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.633 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 26.4 m-80 -149.61 81.32 7.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.359 0.6 . . . . 0.23 110.448 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.417 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 18.1 Cg_endo -56.63 -14.74 13.97 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 124.328 3.352 . . . . 0.36 114.054 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -73.69 -23.92 59.88 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.16 -0.337 . . . . 1.38 111.766 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.899 HD21 HG21 ' A' ' 46' ' ' ILE . 29.0 mt -67.91 -37.14 81.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.346 0.593 . . . . 0.49 112.199 -170.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 1.6 pp0? -63.43 -44.14 95.44 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 123.01 1.386 . . . . 1.95 110.764 -173.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.3 -47.71 81.13 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 111.722 -2.49 . . . . 0.49 110.705 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.57 48.44 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.887 -1.051 . . . . 0.42 111.488 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.94 157.83 20.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.424 0.631 . . . . 0.41 111.217 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.623 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 58.1 m -139.09 128.9 24.84 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.118 -0.946 . . . . 0.42 110.193 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.96 120.44 21.3 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.035 -0.666 . . . . 0.47 109.916 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 97.73 2.44 58.53 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 110.365 -1.094 . . . . 0.41 110.365 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.623 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.3 OUTLIER -78.15 124.53 28.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.228 -0.656 . . . . 1.3 109.228 178.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 37.4 p -81.48 124.12 29.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.956 0.884 . . . . 0.85 110.842 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.899 HG21 HD21 ' A' ' 36' ' ' LEU . 1.4 pp -129.87 132.8 65.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 113.933 -1.485 . . . . 0.25 108.974 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.632 HG13 ' HB1' ' A' ' 32' ' ' ALA . 14.7 p -93.79 163.65 2.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 114.857 -1.065 . . . . 0.67 111.025 -169.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.481 HG13 ' CE2' ' A' ' 22' ' ' PHE . 39.3 mm -121.24 102.48 43.13 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 114.698 -1.137 . . . . 0.16 109.894 -173.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.654 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -66.27 135.85 41.56 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.928 1.752 . . . . 0.18 112.341 -175.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.45 -5.94 80.52 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.065 -0.97 . . . . 0.26 112.42 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.701 HD12 ' HD2' ' A' ' 52' ' ' PRO . 36.1 tp -122.72 116.1 29.28 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-O 121.218 0.532 . . . . 0.61 111.408 -177.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.701 ' HD2' HD12 ' A' ' 51' ' ' LEU . 53.5 Cg_endo -78.12 -176.91 3.5 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.918 3.079 . . . . 0.28 114.362 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.613 ' HB3' HG23 ' A' ' 56' ' ' THR . 8.9 t70 -84.96 128.02 62.16 Favored Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-N 114.302 -1.317 . . . . 0.49 111.975 -169.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 37.4 Cg_endo -69.94 -18.19 36.3 Favored 'Trans proline' 0 CA--C 1.519 -0.248 0 C-N-CA 123.619 2.879 . . . . 0.46 112.69 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.411 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 69.3 m-85 -96.09 2.36 53.17 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.529 0.681 . . . . 1.38 111.451 -173.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 53' ' ' ASP . 18.5 p -98.45 -20.58 17.03 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.897 -1.149 . . . . 0.46 107.897 171.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 59' ' ' TYR . 19.4 mt -73.17 133.02 81.66 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 113.254 -1.794 . . . . 0.7 111.335 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.42 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 92.4 Cg_endo -79.33 -15.86 12.42 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.381 2.054 . . . . 0.39 113.883 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.604 ' H ' HG22 ' A' ' 57' ' ' ILE . 50.7 m-85 -104.09 164.04 11.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.023 0.749 . . . . 0.24 113.023 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -147.67 139.48 24.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.982 -1.008 . . . . 2.89 108.795 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.671 ' HA ' ' O ' ' A' ' 71' ' ' THR . 79.2 mt -116.09 132.27 66.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.316 -0.402 . . . . 0.16 111.718 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.23 116.57 27.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.897 -0.721 . . . . 0.16 111.122 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 65.0 t -98.57 112.99 32.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.647 0.737 . . . . 0.19 111.163 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 68' ' ' LYS . 53.3 m -95.74 100.87 12.53 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.893 -1.049 . . . . 0.2 110.748 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.58 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.1 mm -48.93 -58.76 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.987 0.899 . . . . 0.23 111.788 171.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.58 -9.38 3.44 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 112.925 -1.943 . . . . 0.16 113.055 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.57 -19.57 4.55 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.581 0.752 . . . . 0.15 112.087 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.519 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.68 55.93 4.47 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.27 0.486 . . . . 0.69 111.236 -173.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.7 p -137.24 159.67 41.26 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 112.861 0.689 . . . . 0.13 112.861 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.503 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.7 tt -126.77 112.58 15.56 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.559 -1.2 . . . . 0.4 110.004 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.671 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 29.6 m -93.62 122.4 36.04 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.226 0.536 . . . . 0.16 111.288 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.5 tp -98.0 103.74 15.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.003 -0.998 . . . . 0.59 109.464 172.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 82.2 p -105.75 161.11 14.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 119.086 -1.045 . . . . 1.05 110.612 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.607 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -127.08 128.23 45.93 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.541 -0.911 . . . . 0.26 108.541 170.285 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.607 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.7 p-10 43.8 51.15 6.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.303 -1.317 . . . . 1.84 111.892 -166.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.7 t30 74.76 -13.19 0.85 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.1 -0.954 . . . . 1.89 111.382 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -95.76 121.37 37.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.92 -0.582 . . . . 3.44 109.888 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 78.0 t -59.55 132.48 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 122.362 1.077 . . . . 0.24 112.499 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 18.3 mtm -100.55 -46.91 5.05 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 113.022 -1.899 . . . . 0.81 108.805 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -155.56 172.97 17.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.42 -1.718 . . . . 1.46 110.019 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 78.6 m -148.75 123.02 9.58 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.082 -1.417 . . . . 0.17 109.783 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -108.01 145.34 31.22 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.487 -0.779 . . . . 1.05 109.274 -176.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.435 ' HB2' HG22 ' A' ' 134' ' ' ILE . 42.7 Cg_endo -74.94 141.96 27.47 Favored 'Trans proline' 0 CA--C 1.499 -1.238 0 C-N-CA 122.031 1.82 . . . . 0.2 111.285 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.668 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.44 175.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.92 -0.582 . . . . 0.13 111.051 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.876 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.13 147.32 44.31 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.306 -0.406 . . . . 0.26 110.15 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.519 HG22 ' HG3' ' A' ' 68' ' ' LYS . 11.4 m -129.64 128.44 65.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.47 0.653 . . . . 0.56 112.004 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -89.06 157.9 27.53 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 110.624 -0.99 . . . . 0.17 110.624 173.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -56.37 2.68 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.309 0.855 . . . . 3.05 113.309 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.927 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -89.9 -20.52 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 121.83 0.824 . . . . 0.23 110.149 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.927 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -90.85 -19.53 23.29 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.442 -0.799 . . . . 0.18 109.211 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -66.74 -16.51 64.29 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.419 -1.264 . . . . 0.33 111.715 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -64.64 -42.32 95.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.841 -1.072 . . . . 1.52 112.343 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.31 119.42 56.39 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.574 -0.45 . . . . 0.43 110.966 -175.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.445 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 1.1 Cg_endo -78.8 -1.92 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.839 2.359 . . . . 0.73 113.239 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 96' ' ' GLY . 11.0 t -119.73 -42.46 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.838 0.351 . . . . 0.48 110.408 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.68 38.87 22.84 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.717 -1.129 . . . . 0.33 114.063 168.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.485 ' HG2' HG23 ' A' ' 164' ' ' THR . 45.9 mt-10 -83.86 113.02 20.65 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.969 0.89 . . . . 0.84 109.606 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.683 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 23.6 m-85 -137.61 176.15 8.97 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.909 -1.496 . . . . 0.22 111.914 -170.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 82.7 m-85 -140.95 136.9 32.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.243 -0.435 . . . . 0.54 110.603 -173.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.579 HD12 ' HB ' ' A' ' 161' ' ' THR . 81.6 mt -61.24 117.56 2.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.23 -0.895 . . . . 0.17 110.816 172.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.586 HG21 ' HA ' ' A' ' 22' ' ' PHE . 20.8 pt -84.5 -35.43 10.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 112.766 0.654 . . . . 0.21 112.766 -176.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.416 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 1.7 p-10 178.82 179.18 0.41 Allowed 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.32 -1.363 . . . . 2.03 107.32 -176.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.16 155.58 49.4 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.873 -0.731 . . . . 1.52 112.303 -174.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -128.21 100.69 5.94 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.048 -0.978 . . . . 0.59 109.872 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.496 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 71.2 ttt180 -62.77 166.31 5.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.162 -0.926 . . . . 2.82 110.693 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.512 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 18.1 m-80 -34.75 102.97 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 125.189 1.395 . . . . 0.35 113.195 -155.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.512 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.8 Cg_endo -60.2 -39.64 66.81 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.045 2.496 . . . . 0.48 111.695 174.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.32 -37.63 2.9 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.295 -0.722 . . . . 0.67 111.295 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.62 -176.31 48.94 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.225 -0.487 . . . . 0.62 112.813 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.69 5.16 0.12 Allowed 'Trans proline' 0 N--CA 1.485 1.012 1 C-N-CA 125.454 4.103 . . . . 0.94 115.801 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -70.37 10.13 0.51 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.295 0.479 . . . . 1.23 112.295 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.728 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 75.84 64.34 2.26 Favored Glycine 0 CA--C 1.501 -0.832 0 C-N-CA 119.649 -1.263 . . . . 1.69 115.211 171.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.527 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 39.31 -2.2 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 117.177 2.288 . . . . 0.48 117.177 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.496 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -165.4 158.41 16.02 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.204 -0.935 . . . . 0.28 110.297 -175.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -138.54 98.1 3.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.241 -1.022 . . . . 0.49 108.241 167.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 103' ' ' ARG . 2.4 mt -89.02 114.27 25.46 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.033 -0.728 . . . . 0.66 109.033 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.418 ' C ' HG12 ' A' ' 101' ' ' ILE . 20.0 m -85.24 143.58 28.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.808 -0.633 . . . . 0.19 111.424 -169.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.794 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.9 mm? -108.3 166.4 10.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.13 111.7 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.0 t -60.52 -13.27 12.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.793 -1.094 . . . . 1.17 112.816 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.683 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 4.9 tptm -126.27 130.27 50.54 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 120.492 -0.483 . . . . 1.22 110.138 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 52.9 mt-30 -34.44 -57.61 0.5 Allowed 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.548 1.155 . . . . 1.51 113.994 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.534 ' CB ' HG12 ' A' ' 89' ' ' ILE . 32.5 m-70 -88.91 -1.78 58.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.317 0.58 . . . . 2.53 111.635 -171.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.794 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -91.31 38.16 0.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.523 0.934 . . . . 0.84 113.523 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.62 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -112.97 145.08 18.19 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 117.222 -2.418 . . . . 0.32 112.783 -152.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.528 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -98.69 116.32 41.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 123.739 0.816 . . . . 0.18 110.833 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.637 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 27.5 p80 -145.62 171.15 15.12 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.229 -0.896 . . . . 0.21 109.585 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.728 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.1 -168.62 39.19 Favored Glycine 0 C--N 1.316 -0.563 0 C-N-CA 120.107 -1.044 . . . . 0.27 111.51 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.513 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 15.0 t -153.23 175.0 13.55 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.962 -0.728 . . . . 0.41 110.27 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -116.79 0.41 12.52 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.61 -0.885 . . . . 1.99 108.61 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -118.9 86.75 31.74 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 114.928 -1.033 . . . . 1.36 108.476 172.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -72.72 -17.52 25.91 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.293 1.996 . . . . 0.35 113.283 -169.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.37 -1.1 35.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.968 -0.56 . . . . 0.33 111.094 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.476 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 98.1 p -91.57 -6.8 51.78 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.983 -0.747 . . . . 1.35 108.983 170.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 44.2 mm -80.49 136.42 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.54 -0.755 . . . . 0.21 110.217 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.61 80.14 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.906 -1.277 . . . . 0.15 109.906 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 5.7 tttt -111.67 161.64 16.05 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 122.952 1.358 . . . . 2.5 113.743 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -97.44 124.27 41.58 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 112.193 -2.276 . . . . 0.17 107.659 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.442 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -120.74 160.86 21.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.894 -0.78 . . . . 0.66 108.894 -173.106 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.9 m -51.5 -58.76 5.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.688 0.625 . . . . 0.43 112.688 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -132.56 -43.32 0.92 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 118.329 -1.348 . . . . 2.02 113.555 -176.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.453 ' N ' ' HD3' ' A' ' 140' ' ' LYS . . . -31.5 133.23 0.14 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 116.958 1.543 . . . . 0.18 116.958 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.7 p -74.5 164.84 26.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.489 -1.855 . . . . 0.16 111.571 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.876 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.0 mt -59.9 98.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 122.48 1.133 . . . . 0.4 112.111 -162.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.637 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 79.9 mtt180 -84.33 151.66 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.601 -1.636 . . . . 1.87 110.537 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.668 ' HG2' HG22 ' A' ' 84' ' ' ILE . 14.7 mtp -130.94 -166.57 1.71 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.799 -0.637 . . . . 0.79 109.333 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.643 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 15.8 t-80 -97.81 152.89 18.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.825 -0.806 . . . . 2.32 108.825 172.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.616 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.3 m-80 -56.17 -53.39 57.63 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 118.247 -0.882 . . . . 0.68 110.629 -175.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -64.66 -24.18 67.5 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 121.6 2.0 . . . . 2.18 112.04 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.643 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 4.6 m-20 -81.59 -43.36 18.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.661 -0.7 . . . . 0.69 110.818 -176.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.637 HG13 HD12 ' A' ' 151' ' ' ILE . 14.6 p -68.58 -23.03 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.731 -0.668 . . . . 0.11 111.297 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.637 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.68 -37.9 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 119.062 -0.494 . . . . 0.38 110.091 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 156' ' ' ILE . 9.3 mm-40 -45.09 -72.71 0.05 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.279 0.945 . . . . 1.99 112.022 167.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 157' ' ' VAL . 52.4 mt -46.81 -40.42 13.73 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 123.85 0.719 . . . . 1.27 111.479 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.73 -37.07 80.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.119 -1.4 . . . . 0.18 111.758 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.0 t -88.16 -31.94 18.88 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.51 -0.744 . . . . 0.21 112.506 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.2 mt -81.07 -59.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.561 0.695 . . . . 0.16 111.561 -172.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.1 m -89.38 142.96 30.11 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.871 -1.059 . . . . 0.16 112.097 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -90.72 175.03 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 124.015 3.143 . . . . 0.2 110.939 172.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.416 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 37.1 m-20 -65.99 157.86 29.74 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.655 -0.818 . . . . 1.1 109.078 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.35 -18.53 57.31 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.119 -1.038 . . . . 0.18 112.423 -174.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' HD12 ' A' ' 100' ' ' ILE . 78.2 m -65.12 138.89 58.58 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.035 -0.728 . . . . 0.14 109.035 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.622 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 11.3 ptm180 -92.44 127.25 37.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.741 1.258 . . . . 3.63 111.211 -170.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.4 t -109.02 107.45 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 112.088 -2.324 . . . . 0.14 108.631 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.485 HG23 ' HG2' ' A' ' 97' ' ' GLU . 13.8 m -94.35 104.72 16.7 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.49 0.552 . . . . 0.21 112.49 -171.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.478 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -83.36 96.47 4.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 122.342 1.068 . . . . 0.24 109.955 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -107.6 132.49 53.23 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.009 -1.451 . . . . 1.09 109.215 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.58 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 19.2 mmm180 -65.68 -30.77 71.5 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.2 -0.667 . . . . 2.08 109.2 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.59 -93.88 0.93 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.055 -0.975 . . . . 1.97 112.414 173.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--N 1.322 -0.62 0 N-CA-C 109.804 -0.443 . . . . 3.91 109.804 178.751 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.908 -0.477 . . . . 2.8 111.908 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -153.35 152.78 31.48 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.71 -0.478 . . . . 4.44 109.71 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -97.57 114.9 26.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.923 0.392 . . . . 2.46 110.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp -101.85 175.37 5.57 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.75 -0.659 . . . . 0.65 111.392 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.667 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.0 tt -92.12 130.08 37.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.284 -0.871 . . . . 0.28 110.445 -175.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.33 162.14 13.33 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.36 1.076 . . . . 0.31 113.239 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.64 ' O ' ' HA ' ' A' ' 45' ' ' SER . 72.0 t80 -131.96 142.25 49.56 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.294 -1.776 . . . . 0.44 107.89 175.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.491 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 33.8 tt0 -113.25 112.71 24.2 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.091 -1.078 . . . . 0.76 108.091 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.632 HG13 ' HB2' ' A' ' 13' ' ' ASP . 96.1 t -66.67 151.35 10.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.364 1.078 . . . . 0.39 112.74 -170.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -106.58 158.21 17.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.431 -1.713 . . . . 2.01 108.372 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.23 107.68 0.51 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.782 0.325 . . . . 1.83 111.819 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.77 46.23 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.857 -0.687 . . . . 0.48 113.895 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.632 ' HB2' HG13 ' A' ' 9' ' ' VAL . 68.9 m-20 -54.46 170.16 0.16 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 117.181 0.49 . . . . 1.46 111.391 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -129.23 152.07 49.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.086 0.469 . . . . 0.41 111.603 176.136 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.597 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.03 -36.37 83.07 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.044 -0.98 . . . . 0.86 108.574 -177.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 4.5 t30 -87.62 -26.04 23.26 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.764 -1.107 . . . . 1.15 110.552 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.423 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 13.0 t -66.05 -40.92 91.33 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.515 -0.55 . . . . 1.21 109.515 174.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.477 HG23 ' CE1' ' A' ' 22' ' ' PHE . 13.8 mt -73.86 -28.15 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.116 0.484 . . . . 0.21 109.783 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.644 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.43 -11.37 59.91 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.699 -0.4 . . . . 0.16 110.896 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.723 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -93.12 -40.98 10.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.406 0.622 . . . . 0.21 109.784 174.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.643 ' HB3' ' O ' ' A' ' 119' ' ' SER . 23.0 m-20 -63.42 -42.87 98.73 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.485 -1.234 . . . . 0.53 111.922 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.532 ' HA ' HG21 ' A' ' 101' ' ' ILE . 47.8 m-85 -96.33 4.85 51.99 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 118.597 -1.241 . . . . 0.18 111.112 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.723 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER 54.51 40.77 32.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.961 0.886 . . . . 1.78 109.418 176.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.644 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.6 pt -114.3 -165.52 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.102 -1.408 . . . . 0.19 109.86 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.48 142.91 41.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.205 -0.907 . . . . 0.95 110.212 175.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.537 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 71.4 p -73.21 -32.72 64.95 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.057 -1.09 . . . . 0.25 108.057 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.7 -27.06 67.6 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.182 -0.917 . . . . 0.2 111.796 170.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.95 -27.28 16.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.972 -0.751 . . . . 0.17 108.972 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.653 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 17.8 tp -74.71 -26.2 59.65 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.298 -0.865 . . . . 1.16 109.331 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 26' ' ' THR . 35.9 mt -77.31 -29.98 53.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.695 0.759 . . . . 1.05 110.076 171.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.479 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 34.4 tt0 -65.14 -41.63 94.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.393 -1.276 . . . . 1.81 110.103 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.27 -20.67 31.8 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.937 -0.705 . . . . 0.2 111.594 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.65 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.8 m-80 -147.15 80.67 9.25 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 121.615 0.721 . . . . 0.23 110.693 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.8 Cg_endo -56.79 -14.89 14.87 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 C-N-CA 124.099 3.199 . . . . 0.36 114.199 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.2 t -79.59 -20.9 45.79 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.809 -0.356 . . . . 1.38 111.115 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.825 HD21 HG21 ' A' ' 46' ' ' ILE . 67.6 mt -65.31 -39.19 92.18 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.542 0.687 . . . . 0.49 111.826 -172.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 5.9 pt20 -64.05 -44.59 91.98 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 122.88 1.324 . . . . 1.95 110.251 -174.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.05 -50.15 74.43 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 111.795 -2.457 . . . . 0.49 110.439 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.23 175.16 46.97 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 114.779 -1.101 . . . . 0.42 111.74 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -107.9 155.99 19.67 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.229 0.538 . . . . 0.41 110.876 178.178 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.644 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 34.5 m -139.46 128.64 23.9 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.218 -0.901 . . . . 0.42 110.513 -175.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 119.99 20.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.634 0.731 . . . . 0.47 110.396 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.491 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 98.13 0.73 58.44 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 114.738 -1.119 . . . . 0.41 110.325 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.644 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.2 tt0 -74.8 123.41 24.95 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.672 -0.764 . . . . 1.3 109.654 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 54.8 p -82.34 128.49 34.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.776 0.798 . . . . 0.85 110.067 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.825 HG21 HD21 ' A' ' 36' ' ' LEU . 9.0 pt -128.52 142.35 44.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.306 -1.316 . . . . 0.25 109.477 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.77 151.27 3.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.208 0.527 . . . . 0.67 111.019 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.1 mm -115.13 92.71 32.46 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 114.842 -1.072 . . . . 0.16 109.439 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.673 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.4 Cg_endo -58.46 134.89 64.13 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.812 2.341 . . . . 0.18 112.693 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.03 -4.06 81.09 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 114.948 -1.023 . . . . 0.26 112.405 -176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.696 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.7 tp -129.28 117.97 19.07 Favored Pre-proline 0 N--CA 1.446 -0.638 0 CA-C-O 121.223 0.535 . . . . 0.61 111.341 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.685 ' HD2' HD12 ' A' ' 51' ' ' LEU . 55.5 Cg_endo -79.23 -177.96 4.27 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.585 2.857 . . . . 0.28 114.155 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.613 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.4 t0 -80.72 126.64 77.55 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.513 -1.222 . . . . 0.49 111.542 -171.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 60.5 Cg_endo -73.22 -16.73 24.92 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.204 2.603 . . . . 0.46 112.459 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -89.22 -10.33 47.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.842 -0.617 . . . . 1.38 110.438 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 53' ' ' ASP . 25.1 p -88.15 -23.35 23.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.535 1.159 . . . . 0.46 108.427 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 59' ' ' TYR . 15.3 mt -72.94 129.51 86.42 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 112.973 -1.922 . . . . 0.7 111.354 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.69 -19.73 14.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.336 2.024 . . . . 0.39 113.386 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.512 ' H ' HG22 ' A' ' 57' ' ' ILE . 60.5 m-85 -91.91 158.68 16.16 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.546 -0.462 . . . . 0.24 111.558 -176.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -148.77 129.87 14.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.026 -0.731 . . . . 2.89 109.026 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.5 mt -111.38 130.96 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.946 -0.57 . . . . 0.16 111.609 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.96 119.88 38.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.001 -0.68 . . . . 0.16 111.028 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.85 116.42 41.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.446 0.641 . . . . 0.19 110.833 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 68' ' ' LYS . 69.0 m -95.81 104.27 16.2 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.011 -0.995 . . . . 0.2 110.8 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.534 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.9 mm -51.64 -59.38 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.937 0.875 . . . . 0.23 111.59 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.82 -11.94 4.72 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 113.051 -1.886 . . . . 0.16 113.18 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.18 -18.87 4.87 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.369 0.668 . . . . 0.15 112.444 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HG2' ' C ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER 58.89 54.97 4.79 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.522 0.601 . . . . 0.69 111.26 -173.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.5 p -136.77 160.99 37.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.811 0.671 . . . . 0.13 112.811 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 70' ' ' LEU . 8.1 tt -129.04 113.51 15.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.765 -1.107 . . . . 0.4 110.044 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.699 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.4 m -93.77 123.67 37.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.976 0.417 . . . . 0.16 111.337 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.8 tp -98.78 104.92 17.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.58 -0.737 . . . . 0.59 109.434 171.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.6 m -104.96 159.61 15.67 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.541 -0.863 . . . . 1.05 110.519 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -127.88 127.26 43.09 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.903 -0.777 . . . . 0.26 108.903 168.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.558 ' N ' HD22 ' A' ' 74' ' ' LEU . 15.5 m120 48.21 50.36 16.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.584 -1.189 . . . . 1.84 111.076 -171.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 71.9 -10.03 0.91 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.755 0.822 . . . . 1.89 111.662 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -96.43 120.52 36.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.067 -0.515 . . . . 3.44 109.893 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 55.8 t -59.31 131.58 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-O 122.295 1.045 . . . . 0.24 112.017 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 5.4 mtm -103.08 -43.85 5.37 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.342 -1.754 . . . . 0.81 109.368 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -157.94 170.69 21.75 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.264 -1.789 . . . . 1.46 110.209 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 83.5 m -149.38 128.03 12.41 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.129 -1.396 . . . . 0.17 109.517 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -115.94 147.46 39.22 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 116.243 -0.435 . . . . 1.05 110.729 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HB2' HG22 ' A' ' 134' ' ' ILE . 36.8 Cg_endo -71.86 144.33 43.16 Favored 'Trans proline' 0 CA--C 1.491 -1.645 0 C-N-CA 122.333 2.022 . . . . 0.2 110.284 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.595 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.3 pp -139.34 166.33 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-N 115.902 -0.59 . . . . 0.13 110.797 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.819 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -112.85 128.17 56.38 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.732 -0.84 . . . . 0.26 108.732 -176.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.413 HG12 ' HD2' ' A' ' 68' ' ' LYS . 1.7 p -124.15 130.93 73.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 114.076 -1.42 . . . . 0.56 111.168 -162.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -96.03 151.05 19.82 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.277 -1.329 . . . . 0.17 111.896 -175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 139' ' ' SER . 45.7 mmtm -57.71 2.7 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.525 -0.838 . . . . 3.05 113.145 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.882 HG23 HD22 ' A' ' 90' ' ' LEU . 1.6 tp -89.79 -19.65 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.725 0.774 . . . . 0.23 110.27 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.882 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -88.4 -11.56 45.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.396 -0.82 . . . . 0.18 109.431 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -70.11 -16.53 63.13 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.952 -1.022 . . . . 0.33 111.55 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -71.83 -27.33 62.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.8 -1.091 . . . . 1.52 112.972 -172.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.8 130.7 22.64 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 119.976 -0.69 . . . . 0.43 110.771 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.46 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 89.9 Cg_endo -88.48 -2.24 6.74 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.707 2.271 . . . . 0.73 112.357 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 96' ' ' GLY . 13.6 t -122.99 -41.83 2.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.884 -0.598 . . . . 0.48 109.634 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 47.16 42.79 17.47 Favored Glycine 0 N--CA 1.45 -0.377 0 O-C-N 123.832 0.708 . . . . 0.33 113.89 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.84 112.64 20.72 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.729 0.776 . . . . 0.84 109.484 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.756 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 25.2 m-85 -137.06 177.76 7.61 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.158 -1.383 . . . . 0.22 111.985 -170.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.491 ' CG ' HD11 ' A' ' 5' ' ' LEU . 21.2 m-85 -140.4 143.05 35.46 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.54 110.521 -174.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.599 HD12 ' HB ' ' A' ' 161' ' ' THR . 76.6 mt -66.98 113.72 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 115.488 -0.778 . . . . 0.17 110.132 169.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.559 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 26.0 pt -84.33 -34.25 9.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 112.967 0.728 . . . . 0.21 112.967 -175.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.501 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 2.0 p-10 179.97 177.79 0.63 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.488 -1.301 . . . . 2.03 107.488 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.456 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.11 153.81 50.44 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.177 -0.609 . . . . 1.52 111.959 -175.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -125.38 100.97 6.74 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.097 -0.956 . . . . 0.59 109.655 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.491 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 34.1 ttp180 -60.85 166.33 3.46 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.151 -0.931 . . . . 2.82 110.59 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.491 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 20.6 m-80 -34.86 102.33 0.22 Allowed Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 124.997 1.319 . . . . 0.35 113.33 -155.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 8.6 Cg_endo -58.36 -39.3 85.36 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.075 2.517 . . . . 0.48 111.365 174.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.95 -41.15 2.07 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 110.807 -0.917 . . . . 0.67 110.807 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.4 -176.99 36.82 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 121.055 -0.593 . . . . 0.62 112.46 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.6 5.36 0.2 Allowed 'Trans proline' 0 N--CA 1.481 0.743 1 C-N-CA 125.322 4.015 . . . . 0.94 115.635 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -70.24 8.73 0.71 Allowed 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.363 0.505 . . . . 1.23 112.363 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.724 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 80.8 64.03 1.85 Allowed Glycine 0 CA--C 1.498 -1.001 0 C-N-CA 119.729 -1.224 . . . . 1.69 115.456 169.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.515 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 37.75 0.31 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 117.216 2.302 . . . . 0.48 117.216 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.477 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.3 OUTLIER -165.69 164.76 18.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.426 -0.796 . . . . 0.28 109.929 -177.1 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -145.09 96.72 2.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.054 -1.091 . . . . 0.49 108.054 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.528 HD12 HG23 ' A' ' 150' ' ' VAL . 2.0 mt -87.28 114.12 23.6 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.24 -0.652 . . . . 0.66 109.24 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 101' ' ' ILE . 27.1 m -83.48 143.89 29.93 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.684 -0.689 . . . . 0.19 111.044 -170.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.797 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -108.99 165.26 11.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.032 -0.531 . . . . 0.13 110.789 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.643 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 8.8 m -64.73 -1.8 2.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.171 0.804 . . . . 1.17 113.171 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.757 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 3.6 tmtm? -129.71 132.19 46.56 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.958 -0.386 . . . . 1.22 109.958 167.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.757 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 55.5 mt-30 -33.27 -57.97 0.4 Allowed 'General case' 0 C--N 1.309 -1.17 0 O-C-N 124.692 1.245 . . . . 1.51 114.324 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.621 ' HB3' HG12 ' A' ' 89' ' ' ILE . 1.4 t-80 -94.51 5.04 53.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.315 0.578 . . . . 2.53 111.423 -170.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.797 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -94.8 37.42 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.504 0.927 . . . . 0.84 113.504 -174.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.598 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -113.23 144.2 18.02 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 116.963 -2.542 . . . . 0.32 112.749 -152.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.518 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -96.79 115.13 35.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.895 0.855 . . . . 0.18 110.644 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.734 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.9 p80 -144.96 173.48 11.84 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.262 -0.881 . . . . 0.21 109.648 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.724 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.26 -168.03 38.73 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.252 -0.975 . . . . 0.27 111.57 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.48 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 12.2 t -155.01 172.06 18.73 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.942 -0.74 . . . . 0.41 110.756 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -114.08 -2.06 13.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.961 0.886 . . . . 1.99 108.652 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -115.92 86.55 16.65 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 114.754 -1.112 . . . . 1.36 108.09 170.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -73.3 -19.47 22.3 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.225 1.95 . . . . 0.35 113.191 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.27 -2.72 42.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.788 -0.642 . . . . 0.33 110.869 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 33.4 t -90.25 -6.79 54.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.275 -0.639 . . . . 1.35 109.275 171.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.421 HG22 ' HB2' ' A' ' 83' ' ' PRO . 38.2 mm -78.6 132.48 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.855 -0.611 . . . . 0.21 111.209 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.61 1.84 63.65 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.109 -1.196 . . . . 0.15 110.109 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.522 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 23.9 mttp -112.44 169.96 8.51 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 122.798 1.285 . . . . 2.5 114.047 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.17 126.56 44.98 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.317 -2.22 . . . . 0.17 108.248 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.56 158.66 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.473 -0.936 . . . . 0.66 108.473 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 49.4 m -51.46 -59.29 4.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.286 0.476 . . . . 0.43 112.286 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -131.17 -44.59 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.628 -1.229 . . . . 2.02 113.813 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.29 133.58 0.19 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 116.999 1.56 . . . . 0.18 116.999 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.8 p -73.23 166.06 23.86 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.519 -1.84 . . . . 0.16 112.13 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.819 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 44.7 mt -59.75 96.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 122.406 1.098 . . . . 0.4 112.027 -163.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.734 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 79.1 mtt180 -86.08 146.75 26.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.53 -1.668 . . . . 1.87 110.724 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.595 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.1 mtp -126.45 -164.82 1.37 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.901 -0.777 . . . . 0.79 108.901 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.467 ' O ' HG12 ' A' ' 150' ' ' VAL . 41.5 m80 -91.53 162.9 14.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.575 -0.528 . . . . 2.32 109.575 169.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.644 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.2 m120 -62.03 -49.92 74.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 118.537 -0.745 . . . . 0.68 110.007 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -63.81 -28.27 69.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 121.021 1.737 . . . . 2.18 112.106 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -78.1 -46.46 20.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.157 0.503 . . . . 0.69 110.401 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.675 HG13 HD12 ' A' ' 151' ' ' ILE . 13.4 p -67.11 -23.21 30.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.248 -0.887 . . . . 0.11 111.62 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.675 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -84.27 -42.63 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 118.764 -0.636 . . . . 0.38 110.409 172.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 156' ' ' ILE . 24.9 mt-10 -47.98 -68.69 0.16 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 119.514 1.052 . . . . 1.99 112.467 171.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.506 ' O ' HG22 ' A' ' 157' ' ' VAL . 27.4 mt -47.6 -39.89 17.96 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.638 0.732 . . . . 1.27 111.463 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.33 72.09 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.156 -1.384 . . . . 0.18 111.57 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 24.6 t -88.37 -32.07 18.57 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.573 -0.704 . . . . 0.21 112.523 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.8 mt -82.01 -59.93 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.673 0.749 . . . . 0.16 111.506 -172.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.9 m -90.42 143.79 29.85 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 114.739 -1.119 . . . . 0.16 111.918 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -90.98 175.21 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 124.174 3.249 . . . . 0.2 111.136 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 73.4 m-20 -66.8 157.24 33.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 119.668 -0.813 . . . . 1.1 109.196 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.16 -24.29 32.46 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.042 -1.075 . . . . 0.18 112.154 -172.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.599 ' HB ' HD12 ' A' ' 100' ' ' ILE . 84.6 m -60.35 132.07 52.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.675 -0.861 . . . . 0.14 108.675 -176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.634 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -93.59 128.98 39.99 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 122.581 1.182 . . . . 3.63 111.012 -166.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.24 110.77 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 112.337 -2.21 . . . . 0.14 109.706 -173.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -94.79 108.89 20.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.045 -0.525 . . . . 0.21 112.172 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.457 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -82.51 100.68 6.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 122.51 1.148 . . . . 0.24 109.687 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -104.33 129.92 52.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 113.688 -1.597 . . . . 1.09 108.749 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.534 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 16.1 mmm180 -69.29 -24.4 63.95 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.995 0.426 . . . . 2.08 110.029 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.55 -136.91 39.28 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.317 -0.856 . . . . 1.97 113.472 169.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 109.892 -0.411 . . . . 3.91 109.892 179.32 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.911 -0.476 . . . . 2.8 111.911 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -146.88 144.63 29.42 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.99 -0.374 . . . . 4.44 109.99 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -99.64 105.85 17.74 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.174 -0.466 . . . . 2.46 110.833 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp -112.58 174.9 5.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.52 -0.763 . . . . 0.65 111.307 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.3 tt -94.54 127.52 40.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.222 -0.899 . . . . 0.28 110.437 -174.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 162.64 13.33 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.265 1.031 . . . . 0.31 113.347 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.608 ' HB3' HG13 ' A' ' 46' ' ' ILE . 87.4 t80 -130.82 140.77 50.29 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.622 -1.626 . . . . 0.44 107.876 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.424 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 58.7 tt0 -114.03 113.46 24.8 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.353 -0.98 . . . . 0.76 108.353 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.599 HG13 ' HB2' ' A' ' 13' ' ' ASP . 96.7 t -67.88 150.89 10.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.553 1.168 . . . . 0.39 113.325 -168.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -105.43 158.58 16.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.096 -1.866 . . . . 2.01 108.211 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -63.42 104.69 0.65 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.416 0.524 . . . . 1.83 112.416 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.87 10.7 27.91 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.885 -0.674 . . . . 0.48 113.203 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.599 ' HB2' HG13 ' A' ' 9' ' ' VAL . 82.1 m-20 -54.94 167.53 0.38 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.871 0.367 . . . . 1.46 111.172 172.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.78 153.1 46.03 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.485 0.66 . . . . 0.41 111.419 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.588 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.26 -34.88 79.0 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.466 -0.939 . . . . 0.86 108.466 -179.211 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.451 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 32.6 t-20 -88.8 -25.87 22.0 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.878 -1.056 . . . . 1.15 111.098 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p -66.99 -41.02 87.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 119.866 -0.734 . . . . 1.21 109.402 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.412 HG23 ' CE1' ' A' ' 22' ' ' PHE . 16.8 mt -72.82 -26.63 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.285 0.564 . . . . 0.21 109.747 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.628 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.34 -9.94 59.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.374 -0.375 . . . . 0.16 111.199 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.646 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.43 -39.08 9.76 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.683 1.23 . . . . 0.21 107.911 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.777 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 7.8 m-20 -63.96 -46.42 84.72 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.097 -2.319 . . . . 0.53 112.239 173.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 58.5 m-85 -95.92 5.91 50.12 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 118.58 -1.248 . . . . 0.18 111.183 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.646 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 6.0 mpt_? 54.06 43.12 31.2 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.82 0.819 . . . . 1.78 109.69 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.628 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.1 pt -116.78 -165.78 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 114.521 -1.218 . . . . 0.19 110.121 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.49 142.57 40.34 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.912 -1.04 . . . . 0.95 110.067 175.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.563 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 66.9 p -73.11 -31.62 64.44 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.089 -1.078 . . . . 0.25 108.089 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 -29.79 69.99 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.314 -0.857 . . . . 0.2 111.64 169.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.75 -26.83 18.4 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.991 -0.744 . . . . 0.17 108.991 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.616 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.5 tp -74.9 -27.28 60.16 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.198 -0.91 . . . . 1.16 109.528 173.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 26' ' ' THR . 32.3 mt -76.98 -30.84 56.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.745 0.784 . . . . 1.05 109.822 171.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 27.6 tt0 -62.92 -43.32 99.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.374 -1.284 . . . . 1.81 109.867 173.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.62 -20.08 34.33 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.072 -0.651 . . . . 0.2 111.716 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.638 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 30.0 m-80 -146.62 81.76 9.11 Favored Pre-proline 0 N--CA 1.449 -0.485 0 CA-C-O 121.578 0.704 . . . . 0.23 110.932 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 20.4 Cg_endo -58.24 -9.94 7.45 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 124.26 3.306 . . . . 0.36 113.971 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 t -79.16 -24.92 42.95 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.175 -0.328 . . . . 1.38 110.83 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.829 HD21 HG21 ' A' ' 46' ' ' ILE . 45.0 mt -67.11 -35.46 79.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.425 0.631 . . . . 0.49 111.913 -170.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.428 ' NE2' ' HB2' ' A' ' 38' ' ' ALA . 1.6 pp0? -63.02 -46.05 89.42 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 122.96 1.362 . . . . 1.95 110.147 -174.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.428 ' HB2' ' NE2' ' A' ' 37' ' ' GLN . . . -64.9 -47.42 77.86 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 111.554 -2.566 . . . . 0.49 110.749 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.33 177.86 48.49 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.246 -0.888 . . . . 0.42 111.858 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.99 157.77 22.04 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.322 0.582 . . . . 0.41 110.786 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 43.2 m -141.6 130.07 22.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.252 -0.886 . . . . 0.42 110.336 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.43 120.37 20.78 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 119.956 -0.698 . . . . 0.47 109.518 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.424 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 98.66 1.38 57.6 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.331 -1.108 . . . . 0.41 110.331 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.603 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -75.9 126.19 30.54 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.14 -0.689 . . . . 1.3 109.14 177.514 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 16.1 m -88.87 127.58 35.64 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.789 0.804 . . . . 0.85 109.987 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.829 HG21 HD21 ' A' ' 36' ' ' LEU . 7.5 pt -127.07 142.72 42.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.246 -1.343 . . . . 0.25 109.565 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.18 153.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.073 0.463 . . . . 0.67 111.141 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.2 mm -116.93 92.5 39.07 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.836 -1.075 . . . . 0.16 109.152 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.1 Cg_endo -58.47 136.15 72.38 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.953 2.436 . . . . 0.18 112.723 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.49 -6.02 83.48 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.116 -0.947 . . . . 0.26 112.19 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.768 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.1 tp -123.91 114.03 28.24 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-O 121.35 0.595 . . . . 0.61 111.232 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.683 ' HD2' HD12 ' A' ' 51' ' ' LEU . 50.0 Cg_endo -78.11 -176.88 3.48 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.713 2.942 . . . . 0.28 113.965 -171.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.557 ' HB3' HG23 ' A' ' 56' ' ' THR . 14.8 t70 -80.46 129.7 67.98 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 114.656 -1.156 . . . . 0.49 112.007 -171.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.588 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.4 Cg_endo -76.5 -13.58 18.32 Favored 'Trans proline' 0 CA--C 1.518 -0.295 0 C-N-CA 123.632 2.888 . . . . 0.46 112.881 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.443 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 18.1 m-30 -93.48 -9.59 37.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.663 -0.699 . . . . 1.38 110.037 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.557 HG23 ' HB3' ' A' ' 53' ' ' ASP . 29.5 p -87.96 -25.52 23.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.61 1.195 . . . . 0.46 108.183 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.55 HG22 ' H ' ' A' ' 59' ' ' TYR . 33.4 mt -67.79 129.18 93.41 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 112.988 -1.914 . . . . 0.7 111.553 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.25 -19.64 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.571 2.181 . . . . 0.39 113.557 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.55 ' H ' HG22 ' A' ' 57' ' ' ILE . 58.6 m-85 -98.17 163.31 12.79 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.29 -0.564 . . . . 0.24 112.134 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -150.91 131.69 14.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.188 -0.915 . . . . 2.89 108.858 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.689 ' HA ' ' O ' ' A' ' 71' ' ' THR . 96.9 mt -112.9 131.75 63.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.384 -0.371 . . . . 0.16 111.844 -176.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.39 117.62 31.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 120.044 -0.663 . . . . 0.16 110.975 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.453 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 64.4 t -95.82 119.72 44.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.62 0.724 . . . . 0.19 110.681 175.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.473 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 38.5 m -96.66 107.63 20.11 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.004 -0.998 . . . . 0.2 110.689 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.583 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 38.6 mm -54.01 -59.33 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 122.187 0.994 . . . . 0.23 111.074 165.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.7 -12.77 7.01 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 112.72 -2.036 . . . . 0.16 113.379 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.34 -17.27 5.21 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.161 0.584 . . . . 0.15 112.548 -178.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.548 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.41 55.52 5.7 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.703 0.683 . . . . 0.69 111.419 -174.052 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.8 p -137.59 163.7 30.56 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 113.09 0.774 . . . . 0.13 113.09 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 81' ' ' THR . 8.0 tt -127.78 115.42 18.63 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.51 -1.223 . . . . 0.4 109.443 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.689 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 48.0 m -95.53 119.63 34.37 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.304 0.573 . . . . 0.16 111.313 177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 79' ' ' MET . 0.5 OUTLIER -92.32 103.83 16.24 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.726 -1.212 . . . . 0.59 107.726 174.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.6 m -106.8 158.32 17.08 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 118.924 -1.111 . . . . 1.05 111.371 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.606 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -127.96 124.63 37.76 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.462 0.648 . . . . 0.26 109.622 170.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.606 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.4 p-10 30.97 68.07 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 113.918 -1.492 . . . . 1.84 112.804 -166.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 72.09 -9.41 1.0 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.034 -0.984 . . . . 1.89 112.887 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -107.58 120.3 41.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.148 0.499 . . . . 3.44 110.776 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 41.9 t -55.64 131.91 19.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.618 1.199 . . . . 0.24 112.862 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.614 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 22.4 mmm -97.56 -46.86 5.87 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 112.816 -1.993 . . . . 0.81 108.538 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.673 ' HG2' ' CZ ' ' A' ' 82' ' ' TYR . 2.3 tptm -157.39 174.41 15.45 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.277 -1.783 . . . . 1.46 110.5 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 55.3 m -150.2 123.93 9.19 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.498 -1.683 . . . . 0.17 109.575 168.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.673 ' CZ ' ' HG2' ' A' ' 80' ' ' LYS . 29.9 m-85 -115.46 152.18 46.79 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.996 -0.547 . . . . 1.05 110.163 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HB2' HG22 ' A' ' 134' ' ' ILE . 55.2 Cg_endo -76.06 144.03 26.46 Favored 'Trans proline' 0 CA--C 1.496 -1.414 0 C-N-CA 122.003 1.802 . . . . 0.2 110.981 176.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.668 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -141.31 172.62 10.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.685 -0.689 . . . . 0.13 110.496 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.953 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -116.87 140.41 49.48 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.852 -0.339 . . . . 0.26 110.215 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 68' ' ' LYS . 12.9 m -124.02 126.08 71.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.618 0.723 . . . . 0.56 111.702 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.77 157.03 29.42 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 114.954 -1.021 . . . . 0.17 110.621 173.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 139' ' ' SER . 27.6 mtpp -57.13 3.6 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.013 0.745 . . . . 3.05 113.013 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.927 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -89.12 -20.72 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 O-C-N 121.467 -0.771 . . . . 0.23 109.821 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.927 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -88.78 -21.62 23.69 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.545 -0.909 . . . . 0.18 108.545 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.2 p -69.17 -13.32 62.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.209 -1.36 . . . . 0.33 111.297 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -66.51 -42.95 86.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.103 -0.953 . . . . 1.52 112.225 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.41 134.12 22.99 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.378 -0.529 . . . . 0.43 110.49 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.574 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 93.9 Cg_endo -86.44 -6.58 8.01 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.452 2.101 . . . . 0.73 112.307 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -123.92 -38.71 2.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.55 . . . . 0.48 110.317 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.442 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 44.98 46.22 9.42 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 124.165 0.915 . . . . 0.33 114.131 171.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.73 112.91 20.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.741 0.781 . . . . 0.84 109.874 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 17.5 m-85 -137.7 174.21 10.83 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.355 -1.293 . . . . 0.22 112.86 -170.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.479 ' CE2' ' HB3' ' A' ' 162' ' ' ARG . 37.4 m-85 -141.99 137.31 31.08 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.589 -0.732 . . . . 0.54 110.527 -175.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.576 HD12 ' HB ' ' A' ' 161' ' ' THR . 84.9 mt -61.33 123.88 14.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.779 -0.646 . . . . 0.17 110.444 171.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 17.7 pt -87.44 -43.75 15.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 112.637 0.606 . . . . 0.21 112.637 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 55.3 m-80 -172.1 176.09 3.57 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 106.72 -1.585 . . . . 2.03 106.72 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.607 ' HB3' HD23 ' A' ' 116' ' ' LEU . 5.2 mtt180 -133.01 155.96 48.21 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.878 -0.729 . . . . 1.52 112.122 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 7.3 tt0 -129.31 99.86 5.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.218 -0.901 . . . . 0.59 109.538 172.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.483 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 20.7 ttt180 -66.33 166.26 12.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.427 -0.806 . . . . 2.82 110.504 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.513 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 23.5 m-80 -35.27 104.9 0.27 Allowed Pre-proline 0 C--O 1.234 0.247 0 C-N-CA 125.198 1.399 . . . . 0.35 113.605 -156.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.8 Cg_endo -60.28 -41.4 50.81 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.847 2.365 . . . . 0.48 111.215 170.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.88 -40.25 2.13 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.938 -0.865 . . . . 0.67 110.938 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.69 -176.15 36.19 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 121.21 -0.519 . . . . 0.62 112.745 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.52 2.42 0.28 Allowed 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 125.231 3.954 . . . . 0.94 115.762 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.84 16.08 0.07 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.483 0.549 . . . . 1.23 112.483 -175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.747 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 70.8 63.91 3.01 Favored Glycine 0 CA--C 1.499 -0.951 0 C-N-CA 120.212 -0.994 . . . . 1.69 115.362 168.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 39.38 -3.9 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 117.392 2.367 . . . . 0.48 117.392 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.476 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -166.01 154.14 10.76 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.243 -0.91 . . . . 0.28 110.549 -175.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.405 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.4 t-105 -134.23 98.59 4.15 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.064 -1.087 . . . . 0.49 108.064 167.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 103' ' ' ARG . 4.5 mt -89.6 114.11 25.64 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.017 -0.735 . . . . 0.66 109.017 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.7 m -84.46 144.27 28.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.76 -0.654 . . . . 0.19 111.385 -167.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.789 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.5 mm? -108.84 171.61 7.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.13 110.625 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.63 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.5 OUTLIER -63.14 -13.84 41.56 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.93 0.715 . . . . 1.17 112.93 -179.309 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.777 ' HD3' ' OD1' ' A' ' 21' ' ' ASP . 5.3 tppp? -126.3 132.29 51.68 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.094 0.473 . . . . 1.22 110.828 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.512 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 56.3 mt-30 -33.29 -57.42 0.41 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.907 -1.497 . . . . 1.51 114.308 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.567 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -99.74 12.13 37.42 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.569 -0.852 . . . . 2.53 111.547 -172.493 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.789 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.1 m-85 -96.33 37.5 1.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.857 0.688 . . . . 0.84 112.857 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.678 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -117.04 144.2 18.32 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 117.328 -2.367 . . . . 0.32 112.649 -152.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -95.57 114.53 32.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.754 0.788 . . . . 0.18 110.778 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.558 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 27.5 p80 -143.34 171.97 13.39 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.389 -0.823 . . . . 0.21 109.372 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.747 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.98 -169.4 38.08 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 119.847 -1.168 . . . . 0.27 112.067 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.569 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 15.0 t -154.13 172.64 17.22 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.472 -0.428 . . . . 0.41 110.009 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -113.0 -2.52 14.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.442 -0.947 . . . . 1.99 108.442 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -115.71 88.17 19.76 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.004 -0.998 . . . . 1.36 108.532 170.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.419 ' HA ' HG12 ' A' ' 134' ' ' ILE . 21.5 Cg_endo -72.74 -16.87 26.37 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.248 1.965 . . . . 0.35 112.779 -171.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.41 -0.61 33.58 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.546 -0.752 . . . . 0.33 111.215 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.0 p -93.42 -6.45 47.04 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.134 -0.691 . . . . 1.35 109.134 169.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' A' ' 83' ' ' PRO . 42.5 mm -81.18 130.78 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.255 -0.884 . . . . 0.21 110.627 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.73 2.58 59.76 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 109.944 -1.263 . . . . 0.15 109.944 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.434 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 23.3 mttp -114.81 170.57 8.23 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 123.146 1.45 . . . . 2.5 114.431 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.43 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -101.91 127.66 48.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 111.887 -2.415 . . . . 0.17 108.006 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.418 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -123.23 162.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.643 -0.873 . . . . 0.66 108.643 -176.066 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 58.7 m -52.18 -59.38 4.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.471 0.545 . . . . 0.43 112.471 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.93 -45.57 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 118.766 -1.174 . . . . 2.02 113.726 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.83 133.54 0.16 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 116.955 1.542 . . . . 0.18 116.955 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.546 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.2 p -73.85 166.65 22.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 112.606 -1.797 . . . . 0.16 112.066 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.953 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 54.0 mt -59.87 97.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 122.468 1.127 . . . . 0.4 112.034 -163.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.558 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 34.3 mtt180 -84.12 152.98 24.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.694 -1.594 . . . . 1.87 110.054 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.668 ' HG2' HG22 ' A' ' 84' ' ' ILE . 11.1 mtp -133.26 -165.88 1.68 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.545 -0.539 . . . . 0.79 109.545 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.619 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 24.8 t-80 -97.54 151.3 20.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.569 -0.741 . . . . 2.32 109.181 173.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.633 ' O ' HD13 ' A' ' 151' ' ' ILE . 0.7 OUTLIER -55.35 -53.52 55.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 118.132 -0.937 . . . . 0.68 111.043 -174.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -62.28 -28.23 69.57 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 121.592 1.996 . . . . 2.18 111.827 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.619 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 3.5 m-20 -78.23 -44.36 25.8 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.773 -0.649 . . . . 0.69 110.903 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.606 HG13 HD12 ' A' ' 151' ' ' ILE . 14.2 p -67.27 -21.78 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.598 -0.728 . . . . 0.11 111.342 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.633 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.86 -42.37 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 119.124 -0.465 . . . . 0.38 110.069 171.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.412 ' O ' HG13 ' A' ' 156' ' ' ILE . 31.2 mt-10 -46.84 -71.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.904 0.774 . . . . 1.99 112.87 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.558 ' O ' HG22 ' A' ' 157' ' ' VAL . 11.5 mt -43.54 -43.85 5.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.702 0.763 . . . . 1.27 110.61 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.19 -37.35 74.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.701 -1.591 . . . . 0.18 111.722 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.3 t -85.94 -32.28 21.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.678 0.672 . . . . 0.21 112.032 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 152' ' ' GLU . 52.0 mt -81.13 -59.87 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.561 0.696 . . . . 0.16 111.408 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.6 m -88.61 144.77 33.99 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 114.76 -1.109 . . . . 0.16 111.728 175.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -91.63 177.21 1.89 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 124.09 3.193 . . . . 0.2 111.266 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.506 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 61.0 m-20 -67.13 159.46 28.84 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.532 -0.867 . . . . 1.1 109.339 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.588 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 94.84 -19.63 52.95 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.213 -0.994 . . . . 0.18 112.125 -174.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.576 ' HB ' HD12 ' A' ' 100' ' ' ILE . 87.0 m -60.62 137.72 58.14 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.472 -0.566 . . . . 0.14 109.472 -175.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.479 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 1.9 ptt180 -92.05 116.4 28.9 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.769 1.271 . . . . 3.63 110.51 -168.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.5 t -107.42 107.05 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 112.056 -2.338 . . . . 0.14 109.158 -175.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.0 m -94.74 109.92 21.82 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.038 -0.528 . . . . 0.21 112.148 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 2.4 mp -82.65 95.07 3.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 122.47 1.129 . . . . 0.24 109.694 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -101.58 136.57 41.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.607 -1.633 . . . . 1.09 108.879 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.583 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 5.8 mmt85 -70.74 -33.29 70.66 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.446 -0.576 . . . . 2.08 109.446 176.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 67.01 -97.76 0.38 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.327 -0.851 . . . . 1.97 112.399 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.5 m . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 109.651 -0.5 . . . . 3.91 109.651 177.638 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.878 -0.489 . . . . 2.8 111.878 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -107.37 156.63 18.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.892 0.377 . . . . 4.44 110.664 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -88.48 98.04 11.41 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.913 -0.773 . . . . 2.46 108.913 172.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 tp -114.06 174.15 6.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.027 -0.533 . . . . 0.65 110.988 -176.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.615 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.2 tt -95.47 126.26 40.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.529 -0.76 . . . . 0.28 110.338 -174.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.68 161.68 13.93 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.787 -1.097 . . . . 0.31 112.511 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.646 ' O ' ' HA ' ' A' ' 45' ' ' SER . 80.8 t80 -129.34 140.98 51.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.152 -1.386 . . . . 0.44 107.987 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -112.92 112.74 24.43 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.936 -1.135 . . . . 0.76 107.936 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 13' ' ' ASP . 99.6 t -65.37 148.16 12.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 122.556 1.17 . . . . 0.39 112.372 -170.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -106.29 158.16 17.07 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.287 -1.779 . . . . 2.01 108.184 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -59.65 111.96 1.63 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.952 0.406 . . . . 1.83 111.786 -173.18 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.53 54.13 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.744 -0.662 . . . . 0.48 113.827 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.592 ' HB2' HG13 ' A' ' 9' ' ' VAL . 91.8 m-20 -55.61 168.2 0.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.198 0.499 . . . . 1.46 111.255 172.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.82 151.85 47.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.858 0.361 . . . . 0.41 110.95 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.528 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.56 -40.53 97.24 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.097 -1.075 . . . . 0.86 108.097 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.436 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 64.4 t30 -84.21 -22.65 30.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.353 -1.294 . . . . 1.15 110.434 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -65.09 -45.3 85.81 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.958 -0.756 . . . . 1.21 108.958 171.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.435 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 15.4 mt -72.52 -27.06 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.201 0.524 . . . . 0.21 109.84 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.655 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.27 -10.56 59.76 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.481 -0.327 . . . . 0.16 110.912 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.652 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.5 -39.63 9.06 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 122.669 1.223 . . . . 0.21 108.092 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.623 ' HB3' ' O ' ' A' ' 119' ' ' SER . 8.8 m-20 -62.46 -46.01 90.46 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 112.293 -2.23 . . . . 0.53 111.904 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.607 ' HA ' HG21 ' A' ' 101' ' ' ILE . 55.3 m-85 -95.83 5.68 50.72 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 118.81 -1.156 . . . . 0.18 111.551 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.652 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.1 mpt_? 54.13 43.33 30.83 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.758 0.79 . . . . 1.78 109.838 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.5 pt -118.34 -165.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 114.442 -1.254 . . . . 0.19 109.799 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.7 142.73 42.22 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.156 -0.929 . . . . 0.95 110.429 174.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.581 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 82.3 p -71.01 -33.34 70.29 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.198 -1.038 . . . . 0.25 108.198 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.91 69.27 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.373 -0.831 . . . . 0.2 112.008 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.42 -27.76 16.53 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.914 -0.773 . . . . 0.17 108.914 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.607 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -73.95 -28.86 61.7 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.956 -1.02 . . . . 1.16 109.113 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 26' ' ' THR . 40.5 mt -76.1 -31.66 58.81 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.659 0.742 . . . . 1.05 110.071 171.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 39.4 tt0 -63.78 -37.57 87.85 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.335 -1.302 . . . . 1.81 110.084 174.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.442 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -85.97 -20.35 29.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 120.001 -0.68 . . . . 0.2 111.679 176.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.635 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.7 m-80 -149.78 83.08 6.41 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-O 121.194 0.521 . . . . 0.23 110.751 -172.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.2 Cg_endo -56.26 -15.46 14.75 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 123.927 3.085 . . . . 0.36 113.834 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -73.2 -25.12 60.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.684 0.278 . . . . 1.38 111.31 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.891 HD21 HG21 ' A' ' 46' ' ' ILE . 29.7 mt -67.88 -39.84 83.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.324 0.583 . . . . 0.49 112.397 -170.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -63.6 -44.79 92.96 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.933 1.349 . . . . 1.95 110.275 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.16 82.63 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 111.691 -2.504 . . . . 0.49 110.614 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.06 176.55 48.01 Favored Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 115.048 -0.978 . . . . 0.42 111.951 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.03 157.69 19.05 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.163 0.506 . . . . 0.41 110.791 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.594 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 49.9 m -141.39 127.93 20.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.33 -0.85 . . . . 0.42 110.222 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -76.45 117.21 17.87 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.492 0.663 . . . . 0.47 109.986 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.66 -0.12 49.26 Favored Glycine 0 N--CA 1.429 -1.818 0 CA-C-N 114.775 -1.102 . . . . 0.41 110.389 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.594 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -75.14 124.69 27.47 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.921 -0.639 . . . . 1.3 109.63 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 61.8 p -85.67 131.79 34.27 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 122.099 0.952 . . . . 0.85 110.448 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.891 HG21 HD21 ' A' ' 36' ' ' LEU . 10.2 pt -132.3 143.78 38.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.157 -1.383 . . . . 0.25 109.521 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.24 151.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.2 0.524 . . . . 0.67 111.224 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.3 mm -116.74 93.37 40.89 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 114.614 -1.175 . . . . 0.16 108.948 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.3 Cg_endo -60.12 136.89 71.95 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.705 2.27 . . . . 0.18 112.881 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.12 -6.23 83.79 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.114 -0.948 . . . . 0.26 112.269 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.75 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 28.9 tp -121.46 114.53 31.6 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.287 0.565 . . . . 0.61 111.077 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.688 ' HD2' HD12 ' A' ' 51' ' ' LEU . 53.8 Cg_endo -78.67 -177.07 3.63 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.702 2.935 . . . . 0.28 114.135 -171.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.613 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.0 t70 -82.81 131.96 52.88 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 114.028 -1.442 . . . . 0.49 112.317 -169.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 57.1 Cg_endo -73.98 -14.69 23.71 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 123.571 2.847 . . . . 0.46 112.89 -177.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.465 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 22.0 m-85 -89.61 -15.47 32.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.082 -0.508 . . . . 1.38 110.73 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 53' ' ' ASP . 20.8 p -83.22 -20.71 34.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 122.481 1.134 . . . . 0.46 108.147 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.563 HG22 ' H ' ' A' ' 59' ' ' TYR . 26.4 mt -76.34 135.45 69.3 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 113.06 -1.882 . . . . 0.7 110.99 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.519 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 30.5 Cg_endo -84.7 -17.26 5.14 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 122.361 2.041 . . . . 0.39 112.863 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.563 ' H ' HG22 ' A' ' 57' ' ' ILE . 42.9 m-85 -100.6 155.83 17.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.91 0.386 . . . . 0.24 111.541 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -144.98 135.05 23.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.555 -0.748 . . . . 2.89 109.102 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 71' ' ' THR . 84.1 mt -114.19 134.88 55.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.25 -0.432 . . . . 0.16 111.891 -175.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.05 118.88 33.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 119.89 -0.724 . . . . 0.16 111.124 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.5 t -98.3 113.9 34.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.748 0.785 . . . . 0.19 111.166 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 40.2 m -92.29 105.35 17.57 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.783 -1.099 . . . . 0.2 110.336 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.7 mm -53.14 -58.73 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 122.055 0.931 . . . . 0.23 111.314 168.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.01 -11.2 4.31 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 112.701 -2.045 . . . . 0.16 113.082 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.23 -16.53 5.45 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.653 0.781 . . . . 0.15 112.19 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.509 ' NZ ' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 57.01 54.94 6.48 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.412 0.551 . . . . 0.69 111.28 -174.566 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.3 p -137.0 165.65 25.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.928 0.714 . . . . 0.13 112.928 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.9 tt -132.8 111.66 11.29 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.68 -1.146 . . . . 0.4 109.822 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.638 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.9 m -93.31 123.25 36.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.924 0.392 . . . . 0.16 111.101 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 79' ' ' MET . 11.6 tp -98.97 107.29 19.68 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.322 -0.854 . . . . 0.59 108.791 172.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 88.3 p -105.37 161.89 13.92 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.324 -0.95 . . . . 1.05 110.591 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -126.31 126.33 43.76 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.522 -0.918 . . . . 0.26 108.522 169.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.604 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.7 p-10 43.0 48.1 5.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.021 -1.445 . . . . 1.84 111.647 -165.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.8 t30 78.15 -13.89 0.91 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.794 -1.094 . . . . 1.89 111.591 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -92.51 122.78 35.28 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.193 -0.669 . . . . 3.44 109.193 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 53.6 t -56.66 132.52 20.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.37 1.081 . . . . 0.24 112.834 -173.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 57.2 mmm -96.91 -47.63 5.75 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.096 -1.865 . . . . 0.81 107.838 175.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -163.3 174.05 12.53 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 112.871 -1.968 . . . . 1.46 110.358 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.3 m -148.47 124.57 10.74 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.029 -1.441 . . . . 0.17 109.395 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -111.59 151.02 43.05 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 109.56 -0.533 . . . . 1.05 109.56 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HB2' HG22 ' A' ' 134' ' ' ILE . 44.3 Cg_endo -76.63 140.82 21.5 Favored 'Trans proline' 0 CA--C 1.499 -1.247 0 C-N-CA 122.103 1.869 . . . . 0.2 111.235 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.667 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.33 173.07 12.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.495 -0.775 . . . . 0.13 110.584 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.913 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.94 144.3 45.61 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 110.13 -0.322 . . . . 0.26 110.13 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 65' ' ' ILE . 9.0 m -126.39 126.71 69.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.676 0.75 . . . . 0.56 111.801 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.28 152.41 29.41 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 109.771 -1.332 . . . . 0.17 109.771 171.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -57.27 4.63 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.06 0.763 . . . . 3.05 113.06 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.938 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -89.57 -19.65 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.504 0.669 . . . . 0.23 110.235 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.938 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -88.09 -16.73 32.73 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.749 0.785 . . . . 0.18 109.097 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.9 p -68.95 -16.43 63.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.396 -1.274 . . . . 0.33 111.352 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.03 -42.06 98.76 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 114.945 -1.025 . . . . 1.52 111.788 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -108.33 116.75 56.08 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 0.43 110.644 -176.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 6.0 Cg_exo -72.62 -21.25 22.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.604 2.202 . . . . 0.73 112.842 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -99.88 -40.44 7.69 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.529 -0.545 . . . . 0.48 109.529 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.535 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 45.42 48.09 11.58 Favored Glycine 0 N--CA 1.446 -0.639 0 O-C-N 124.393 1.058 . . . . 0.33 113.557 171.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -82.75 110.98 18.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.738 0.78 . . . . 0.84 109.172 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 21.5 m-85 -139.53 169.29 18.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.01 -1.45 . . . . 0.22 112.49 -171.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' A' ' 162' ' ' ARG . 43.6 m-85 -139.11 139.06 37.56 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.863 -0.608 . . . . 0.54 110.377 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.583 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.9 mt -61.63 118.93 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 115.412 -0.813 . . . . 0.17 110.492 172.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.607 HG21 ' HA ' ' A' ' 22' ' ' PHE . 21.4 pt -85.28 -32.76 7.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 113.198 0.814 . . . . 0.21 113.198 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.571 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 2.0 p-10 177.99 176.05 0.47 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.613 -1.254 . . . . 2.03 107.613 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.703 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 19.6 mtt180 -125.2 161.25 27.29 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.509 -0.876 . . . . 1.52 111.914 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -135.99 100.17 4.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.216 -0.902 . . . . 0.59 109.832 170.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.471 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 24.8 ttp180 -67.5 165.48 16.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.378 -0.828 . . . . 2.82 110.843 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.748 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 34.5 m-80 -36.1 101.08 0.21 Allowed Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 125.32 1.448 . . . . 0.35 112.706 -156.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 18.1 Cg_endo -64.52 -51.24 2.01 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.985 2.456 . . . . 0.48 112.392 175.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.74 -31.3 5.24 Favored Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 110.963 -0.855 . . . . 0.67 110.963 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.13 -173.38 3.03 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.579 -0.811 . . . . 0.62 112.306 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -52.15 -22.75 15.8 Favored 'Trans proline' 0 N--CA 1.478 0.591 0 C-N-CA 124.679 3.586 . . . . 0.94 113.494 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -63.84 -37.4 87.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.056 0.931 . . . . 1.23 108.868 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 113' ' ' ALA . . . 55.93 29.89 56.06 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 117.367 1.707 . . . . 1.69 117.367 158.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 173.92 -54.23 0.01 OUTLIER 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 118.653 1.226 . . . . 0.48 110.518 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.471 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.8 OUTLIER -162.09 157.3 23.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.786 0.327 . . . . 0.28 110.424 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -135.39 99.84 4.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.627 -1.249 . . . . 0.49 107.627 164.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.7 mt -92.18 113.95 26.36 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.579 -0.897 . . . . 0.66 108.579 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.455 ' HB3' HD11 ' A' ' 101' ' ' ILE . 13.2 m -83.55 144.88 29.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.775 -0.648 . . . . 0.19 111.561 -166.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.9 mm? -110.28 166.53 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.13 110.936 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.623 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -62.65 -8.2 6.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.028 0.751 . . . . 1.17 113.028 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.773 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.9 tmtm? -126.84 133.01 50.84 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.362 1.077 . . . . 1.22 109.833 172.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.773 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 52.9 mt-30 -39.08 -46.39 1.4 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 112.439 -2.164 . . . . 1.51 114.227 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.483 ' CB ' HG12 ' A' ' 89' ' ' ILE . 79.6 m-70 -97.38 -0.67 45.95 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.212 -0.595 . . . . 2.53 111.51 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.746 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -97.21 38.19 1.27 Allowed 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.365 1.246 . . . . 0.84 114.365 -169.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.684 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -117.19 146.0 18.73 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 116.457 -2.783 . . . . 0.32 113.111 -153.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.73 116.58 39.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 124.053 0.941 . . . . 0.18 111.004 -176.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.5 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.5 p80 -146.23 -177.05 5.41 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 112.593 0.59 . . . . 0.21 112.593 -176.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.98 -167.19 37.4 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.436 -0.666 . . . . 0.27 111.436 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.6 t -161.68 164.05 29.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 117.727 0.764 . . . . 0.41 110.589 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -115.18 -3.79 12.51 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.118 -1.067 . . . . 1.99 108.118 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -121.74 91.43 48.62 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 114.148 -1.387 . . . . 1.36 108.673 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.66 -22.27 18.2 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.346 2.031 . . . . 0.35 113.769 -172.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.24 2.26 25.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.103 0.477 . . . . 0.33 111.163 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.471 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 43.6 t -95.07 -4.89 45.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 1.35 109.364 170.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 31.8 mm -78.76 138.17 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 115.899 -0.591 . . . . 0.21 110.106 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.56 1.81 80.19 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.119 -1.192 . . . . 0.15 110.119 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.471 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 91.8 mttt -113.36 167.94 10.15 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 123.161 1.457 . . . . 2.5 114.253 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.1 126.63 46.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 111.699 -2.501 . . . . 0.17 107.961 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.417 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -125.24 161.95 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.909 -0.774 . . . . 0.66 108.909 -174.418 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.7 m -49.72 -60.35 2.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.114 0.783 . . . . 0.43 113.114 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -133.52 -43.99 0.83 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 118.533 -1.267 . . . . 2.02 113.619 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.42 133.49 0.2 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 117.055 1.582 . . . . 0.18 117.055 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.535 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 2.9 p -70.05 165.19 22.41 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 112.575 -1.813 . . . . 0.16 112.419 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.913 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 49.4 mt -60.61 97.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 114.494 -1.23 . . . . 0.4 112.077 -163.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.5 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 10.4 mtp180 -83.97 144.06 29.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.702 -1.59 . . . . 1.87 109.501 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.667 ' HG2' HG22 ' A' ' 84' ' ' ILE . 14.9 mtp -121.38 -169.0 1.78 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.188 -0.671 . . . . 0.79 109.188 173.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.622 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 1.5 t60 -89.85 153.91 20.28 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.158 -1.053 . . . . 2.32 108.158 170.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.877 ' O ' HD13 ' A' ' 151' ' ' ILE . 11.7 m-80 -72.45 -20.29 61.42 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 118.474 -0.774 . . . . 0.68 113.069 -171.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -81.61 -28.75 33.58 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 121.364 1.893 . . . . 2.18 112.734 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.622 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 5.0 m-20 -77.62 -41.21 39.34 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.186 0.517 . . . . 0.69 110.63 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.61 HG13 HD12 ' A' ' 151' ' ' ILE . 12.5 p -66.34 -19.69 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.245 -0.889 . . . . 0.11 111.349 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.888 HD11 ' HB1' ' A' ' 113' ' ' ALA . 1.6 mp -86.26 -42.98 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 118.801 -0.618 . . . . 0.38 110.727 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.424 ' O ' HG13 ' A' ' 156' ' ' ILE . 16.2 mt-10 -45.12 -70.87 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.369 0.986 . . . . 1.99 112.578 170.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.554 ' O ' HG22 ' A' ' 157' ' ' VAL . 48.0 mt -46.07 -39.9 9.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.627 0.727 . . . . 1.27 111.53 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.26 -36.07 79.0 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.01 -1.45 . . . . 0.18 111.775 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.3 t -86.97 -31.11 20.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 118.811 0.732 . . . . 0.21 112.501 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.1 mt -82.49 -60.35 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.652 0.739 . . . . 0.16 111.756 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -88.38 141.93 31.02 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.837 -1.074 . . . . 0.16 112.252 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.703 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 56.9 Cg_endo -89.28 175.38 3.37 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 124.024 3.149 . . . . 0.2 110.997 174.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.571 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 75.3 m-20 -65.53 156.04 33.81 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 119.371 -0.931 . . . . 1.1 108.972 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 97.91 -19.78 53.21 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.008 -1.091 . . . . 0.18 112.358 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.583 ' HB ' HD12 ' A' ' 100' ' ' ILE . 50.5 m -64.1 137.4 57.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.902 -0.777 . . . . 0.14 108.902 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.523 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 20.0 ttt180 -92.15 127.6 37.68 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 122.52 1.152 . . . . 3.63 110.745 -169.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.31 107.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 112.374 -2.193 . . . . 0.14 109.086 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.1 m -93.92 107.91 19.77 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.377 0.51 . . . . 0.21 112.377 -172.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.535 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.04 99.63 5.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 122.171 0.986 . . . . 0.24 109.955 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -110.77 133.38 53.39 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.391 -1.277 . . . . 1.09 109.879 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.575 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 19.5 mmm180 -70.1 -22.01 63.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.239 -0.437 . . . . 2.08 110.394 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 159.52 -75.24 0.2 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.916 -0.584 . . . . 1.97 112.285 173.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 C--N 1.322 -0.621 0 N-CA-C 110.732 -0.099 . . . . 3.91 110.732 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 111.627 -0.589 . . . . 2.8 111.627 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -89.28 162.79 15.67 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.178 0.513 . . . . 4.44 110.714 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -103.18 98.16 8.13 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.463 -0.79 . . . . 2.46 109.404 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 mp -119.89 174.48 6.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.664 -0.698 . . . . 0.65 111.643 -175.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.0 tt -98.18 128.67 44.79 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.904 -1.043 . . . . 0.28 110.392 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.19 162.96 13.3 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.209 1.004 . . . . 0.31 113.075 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.631 ' HB3' HG13 ' A' ' 46' ' ' ILE . 86.9 t80 -130.32 139.36 50.7 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.768 -1.56 . . . . 0.44 107.753 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.436 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 58.7 tt0 -112.39 113.14 25.18 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.013 -1.106 . . . . 0.76 108.013 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.673 HG13 ' HB2' ' A' ' 13' ' ' ASP . 94.9 t -67.23 148.15 12.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 122.528 1.156 . . . . 0.39 113.283 -169.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -102.35 158.6 16.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 113.312 -1.767 . . . . 2.01 108.367 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.61 104.22 0.4 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.059 0.457 . . . . 1.83 112.068 -174.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.83 10.96 36.11 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.718 -0.674 . . . . 0.48 113.502 174.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.673 ' HB2' HG13 ' A' ' 9' ' ' VAL . 29.8 m-20 -53.06 169.3 0.1 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.137 0.494 . . . . 1.46 111.671 173.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.35 150.47 50.7 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.105 0.479 . . . . 0.41 111.95 177.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.635 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.56 -36.45 83.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.055 -0.975 . . . . 0.86 108.808 -177.185 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.426 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 65.4 t30 -87.75 -24.5 23.79 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.812 -1.086 . . . . 1.15 110.855 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.0 m -70.1 -38.1 75.55 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.322 -0.551 . . . . 1.21 110.176 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 mt -74.67 -28.39 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.43 -0.581 . . . . 0.21 109.43 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.662 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.66 -9.54 59.43 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.281 -0.418 . . . . 0.16 110.81 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.677 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.64 -40.8 8.83 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.38 1.086 . . . . 0.21 108.116 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 119' ' ' SER . 7.5 m-20 -62.39 -44.41 96.52 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.462 -2.154 . . . . 0.53 112.19 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HA ' HG21 ' A' ' 101' ' ' ILE . 53.0 m-85 -96.98 6.39 48.72 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 118.627 -1.229 . . . . 0.18 111.03 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.677 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER 54.3 41.44 31.98 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.916 0.865 . . . . 1.78 109.25 176.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.662 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.1 pt -113.87 -165.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.442 -1.254 . . . . 0.19 110.214 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.06 142.61 41.28 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.206 -0.906 . . . . 0.95 110.225 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.49 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 60.3 p -72.97 -33.29 65.77 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.804 -1.184 . . . . 0.25 107.804 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.04 -27.2 66.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.34 -0.845 . . . . 0.2 111.824 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HA ' ' HB2' ' A' ' 31' ' ' GLN . . . -95.21 -25.3 16.43 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.649 0.737 . . . . 0.17 109.636 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.635 HD23 HD23 ' A' ' 15' ' ' LEU . 17.5 tp -75.23 -27.43 59.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.241 -0.89 . . . . 1.16 109.054 173.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.521 HD23 ' HB2' ' A' ' 36' ' ' LEU . 35.3 mt -78.04 -26.69 48.51 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.36 0.6 . . . . 1.05 110.372 172.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.479 ' HB2' ' HA ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -59.81 -61.56 2.52 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 108.129 -1.063 . . . . 1.81 108.129 169.471 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -71.29 -18.57 62.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.491 -0.777 . . . . 0.2 110.86 -170.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.614 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 28.5 m-80 -147.61 80.65 8.93 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-N 115.642 -0.708 . . . . 0.23 110.385 -174.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 24.6 Cg_endo -59.5 -4.41 2.49 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 123.787 2.991 . . . . 0.36 113.145 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 p -79.96 -25.75 40.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.052 0.453 . . . . 1.38 111.542 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.861 HD21 HG21 ' A' ' 46' ' ' ILE . 33.6 mt -70.81 -33.66 70.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.733 -0.667 . . . . 0.49 112.387 -170.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.429 ' H ' ' HG3' ' A' ' 37' ' ' GLN . 1.7 pp0? -63.56 -44.72 93.3 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.822 1.296 . . . . 1.95 110.76 -172.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.19 -49.12 73.28 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 111.795 -2.457 . . . . 0.49 110.404 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.6 176.23 47.87 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 114.683 -1.144 . . . . 0.42 111.405 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.51 157.99 18.44 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.37 0.605 . . . . 0.41 110.626 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 53.2 m -138.39 128.8 26.1 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.317 -0.856 . . . . 0.42 110.192 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.25 119.74 19.79 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 119.996 -0.682 . . . . 0.47 109.535 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.436 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 99.44 1.51 56.67 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.254 -1.138 . . . . 0.41 110.254 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.63 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -76.65 123.6 26.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.918 -0.641 . . . . 1.3 109.824 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 29.8 p -84.32 125.93 32.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.491 -0.777 . . . . 0.85 110.771 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.861 HG21 HD21 ' A' ' 36' ' ' LEU . 8.9 pt -126.3 143.23 40.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 114.241 -1.345 . . . . 0.25 109.443 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.64 152.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 121.164 0.507 . . . . 0.67 111.185 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.9 mm -116.28 92.03 34.75 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.648 -1.16 . . . . 0.16 109.268 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.557 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -57.98 135.06 66.38 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.811 2.341 . . . . 0.18 112.71 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.98 -5.77 83.06 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.067 -0.97 . . . . 0.26 112.279 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.72 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 27.7 tp -122.54 113.37 30.61 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 121.253 0.549 . . . . 0.61 110.978 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.675 ' HD2' HD12 ' A' ' 51' ' ' LEU . 48.6 Cg_endo -78.05 -176.22 3.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.77 2.98 . . . . 0.28 114.295 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.571 ' HB3' HG23 ' A' ' 56' ' ' THR . 22.5 t70 -79.9 129.76 69.4 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 113.967 -1.47 . . . . 0.49 112.648 -169.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 41.1 Cg_endo -73.06 -14.01 26.11 Favored 'Trans proline' 0 C--N 1.34 0.118 0 C-N-CA 123.396 2.731 . . . . 0.46 112.687 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.539 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 75.5 m-85 -92.58 -10.28 38.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.971 -0.558 . . . . 1.38 111.332 -174.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.571 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.0 p -85.46 -24.69 27.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.586 1.184 . . . . 0.46 108.153 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 59' ' ' TYR . 15.9 mt -72.53 136.34 80.98 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.82 -1.991 . . . . 0.7 111.246 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.539 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 36.8 Cg_endo -86.38 -16.49 3.94 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.459 2.106 . . . . 0.39 113.319 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.594 ' H ' HG22 ' A' ' 57' ' ' ILE . 56.0 m-85 -98.43 158.15 15.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.199 0.444 . . . . 0.24 112.199 -174.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -147.01 132.44 18.61 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.67 -0.695 . . . . 2.89 109.15 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.703 ' HA ' ' O ' ' A' ' 71' ' ' THR . 76.1 mt -114.99 135.93 53.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.261 -0.427 . . . . 0.16 111.914 -176.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.79 117.6 28.63 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.11 -0.636 . . . . 0.16 111.249 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 69' ' ' THR . 88.9 t -96.77 117.93 42.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.511 0.672 . . . . 0.19 111.168 175.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 65.1 m -92.84 109.56 21.0 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.253 -0.885 . . . . 0.2 111.262 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 36.2 mm -54.48 -59.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 122.255 1.026 . . . . 0.23 111.081 165.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.13 -12.75 6.0 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 112.783 -2.008 . . . . 0.16 113.362 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.469 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.94 -18.62 4.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.866 0.691 . . . . 0.15 112.866 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.96 56.3 4.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.811 0.732 . . . . 0.69 111.438 -172.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 46.8 p -137.89 164.6 28.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.897 0.703 . . . . 0.13 112.897 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.445 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.4 tt -133.13 110.67 10.34 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.713 -1.131 . . . . 0.4 109.81 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 53.1 m -93.42 121.77 35.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.288 0.566 . . . . 0.16 111.188 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.1 tp -96.5 107.37 19.77 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.909 -1.041 . . . . 0.59 109.054 173.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 4.3 m -107.61 158.11 17.52 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.453 -0.899 . . . . 1.05 110.645 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.592 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -126.19 126.15 43.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.826 -0.805 . . . . 0.26 108.826 170.277 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.592 ' N ' HD22 ' A' ' 74' ' ' LEU . 3.0 p-10 41.48 54.81 3.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.04 -1.436 . . . . 1.84 111.539 -165.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.5 t30 73.86 -14.98 0.61 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.173 -0.921 . . . . 1.89 111.709 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -91.84 118.99 31.23 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.81 -0.441 . . . . 3.44 109.81 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.0 t -58.05 130.32 21.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 122.479 1.133 . . . . 0.24 112.412 -175.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.518 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 64.0 mmm -96.27 -48.68 5.52 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.014 -1.903 . . . . 0.81 108.214 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 14.3 mmmt -160.72 174.06 14.49 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 112.669 -2.06 . . . . 1.46 109.477 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.3 m -148.58 124.49 10.62 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.602 -1.181 . . . . 0.17 109.072 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 149' ' ' ASP . 12.9 m-85 -106.01 147.21 34.39 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.118 -0.946 . . . . 1.05 109.588 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.435 ' HB2' HG22 ' A' ' 134' ' ' ILE . 37.4 Cg_endo -75.12 140.61 25.33 Favored 'Trans proline' 0 CA--C 1.498 -1.305 0 C-N-CA 121.445 1.43 . . . . 0.2 110.24 168.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.633 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -141.06 174.68 6.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.764 -0.653 . . . . 0.13 110.554 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.893 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.16 143.55 47.16 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.793 0.33 . . . . 0.26 110.424 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.508 HG22 ' HG3' ' A' ' 68' ' ' LYS . 8.7 m -125.64 126.21 69.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.525 0.678 . . . . 0.56 111.779 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.03 154.41 31.91 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.609 -1.396 . . . . 0.17 109.609 171.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -55.79 0.18 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.042 0.756 . . . . 3.05 113.042 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.876 HG23 HD22 ' A' ' 90' ' ' LEU . 1.2 tp -85.04 -19.11 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 O-C-N 121.353 -0.842 . . . . 0.23 110.068 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.876 HD22 HG23 ' A' ' 89' ' ' ILE . 3.5 mm? -87.17 -17.25 33.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.766 -0.827 . . . . 0.18 108.766 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.6 p -70.41 -15.66 62.86 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.461 -1.245 . . . . 0.33 111.23 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.17 -43.21 98.9 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.477 -0.783 . . . . 1.52 111.594 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.07 132.95 27.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.477 -0.489 . . . . 0.43 110.72 -174.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 84.3 Cg_endo -88.7 4.3 5.51 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.73 2.286 . . . . 0.73 111.66 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -128.39 -41.51 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.161 -0.681 . . . . 0.48 109.161 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 165' ' ' ILE . . . 53.13 16.92 4.86 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 124.595 1.184 . . . . 0.33 114.377 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.674 ' CB ' HG23 ' A' ' 164' ' ' THR . 12.9 pt-20 -86.3 119.64 26.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.331 1.062 . . . . 0.84 110.223 -171.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.667 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 9.3 m-85 -138.67 -170.56 2.87 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.679 -1.601 . . . . 0.22 111.764 -163.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.626 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 85.7 m-85 -142.9 139.2 30.68 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.237 0.541 . . . . 0.54 110.938 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.568 HD12 ' HB ' ' A' ' 161' ' ' THR . 85.5 mt -63.74 123.4 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.463 -0.79 . . . . 0.17 110.39 168.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.546 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.8 pt -89.64 -43.9 14.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 113.621 0.971 . . . . 0.21 113.621 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.591 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 49.1 m-80 -171.22 174.14 4.69 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.047 -1.464 . . . . 2.03 107.047 -169.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.655 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 40.3 mtt180 -127.1 169.47 13.38 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.252 -0.979 . . . . 1.52 111.961 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 55.0 tt0 -147.13 99.8 3.21 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.075 -0.966 . . . . 0.59 109.629 170.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.517 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 46.5 ttt180 -65.74 166.11 11.52 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.205 -0.907 . . . . 2.82 110.826 175.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.517 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 19.3 m-80 -35.41 102.74 0.23 Allowed Pre-proline 0 C--O 1.232 0.168 0 C-N-CA 125.269 1.428 . . . . 0.35 113.305 -157.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.4 Cg_endo -61.26 -36.03 81.84 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.153 2.568 . . . . 0.48 111.78 173.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.89 -33.82 4.89 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.151 -0.779 . . . . 0.67 111.151 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.39 -176.88 49.45 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.199 -0.5 . . . . 0.62 112.614 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.47 6.16 0.16 Allowed 'Trans proline' 0 N--CA 1.482 0.848 0 C-N-CA 125.024 3.816 . . . . 0.94 115.515 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -71.26 13.25 0.24 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 112.273 0.472 . . . . 1.23 112.273 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.746 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 73.67 64.04 2.57 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.912 -1.137 . . . . 1.69 115.316 170.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.513 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.96 -3.48 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 117.482 2.401 . . . . 0.48 117.482 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.494 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -165.83 154.78 11.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.417 -0.802 . . . . 0.28 110.449 -176.502 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.3 t-105 -135.25 99.28 4.2 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.115 -1.069 . . . . 0.49 108.115 168.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.516 HD12 HG23 ' A' ' 150' ' ' VAL . 4.9 mt -93.15 114.69 27.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.584 0.707 . . . . 0.66 109.245 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.436 ' C ' HG12 ' A' ' 101' ' ' ILE . 19.6 m -83.54 144.23 29.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.666 -0.697 . . . . 0.19 111.502 -167.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.714 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.7 mm? -108.72 165.04 11.85 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.454 -0.794 . . . . 0.13 110.791 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.468 ' OG ' ' HD2' ' A' ' 98' ' ' PHE . 3.7 p -68.16 -4.58 14.3 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 124.008 0.817 . . . . 1.17 112.546 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.689 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 4.3 tmtm? -126.66 128.33 46.56 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 120.213 -0.595 . . . . 1.22 109.581 166.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.689 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 52.9 mt-30 -33.19 -58.28 0.39 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.431 -1.713 . . . . 1.51 113.847 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.588 ' HB3' HG12 ' A' ' 89' ' ' ILE . 1.1 t-80 -96.67 13.18 29.2 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.964 -0.694 . . . . 2.53 112.17 -170.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.587 ' HA ' HD11 ' A' ' 90' ' ' LEU . 2.8 m-30 -90.38 -34.29 15.72 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-O 121.923 0.868 . . . . 0.84 111.081 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.714 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -6.87 128.71 0.01 OUTLIER Glycine 0 C--N 1.297 -1.601 0 N-CA-C 119.262 2.465 . . . . 0.32 119.262 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.642 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -99.96 115.67 41.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 112.822 -1.689 . . . . 0.18 109.815 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.691 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.0 p80 -143.27 175.16 10.11 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.501 -0.772 . . . . 0.21 109.653 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.746 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.58 -168.81 38.52 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 120.016 -1.088 . . . . 0.27 111.991 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.597 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 13.0 t -156.03 168.04 28.53 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.89 -0.771 . . . . 0.41 110.367 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -110.33 -9.21 14.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.507 -0.923 . . . . 1.99 108.507 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -111.21 88.33 8.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 114.816 -1.084 . . . . 1.36 108.356 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -72.89 -19.64 23.27 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.754 2.303 . . . . 0.35 113.326 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.6 -2.07 33.94 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.03 -0.532 . . . . 0.33 111.002 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.5 m -91.97 -4.16 54.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.544 -0.539 . . . . 1.35 109.544 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 43.5 mm -82.31 131.4 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.845 -0.616 . . . . 0.21 110.401 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.7 1.4 65.87 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.811 -1.316 . . . . 0.15 109.811 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 137' ' ' ALA . 2.0 tttm -114.29 163.27 15.5 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 122.759 1.266 . . . . 2.5 113.388 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -94.54 126.9 40.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 112.424 -2.171 . . . . 0.17 107.889 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.432 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -121.64 159.25 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 108.6 -0.889 . . . . 0.66 108.6 -175.176 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 m -49.34 -59.35 3.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.406 0.521 . . . . 0.43 112.406 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.434 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 21.0 pttm -132.36 -45.96 0.91 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.506 -1.278 . . . . 2.02 114.186 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.34 134.01 0.18 Allowed Glycine 0 N--CA 1.468 0.815 0 N-CA-C 117.648 1.819 . . . . 0.18 117.648 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 2.1 p -69.77 165.5 21.28 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 112.601 -1.8 . . . . 0.16 111.916 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.893 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 57.8 mt -60.37 99.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 114.711 -1.131 . . . . 0.4 112.008 -162.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.691 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 60.8 mtt180 -87.69 148.97 24.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.988 -1.46 . . . . 1.87 110.685 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.633 ' HG2' HG22 ' A' ' 84' ' ' ILE . 17.5 mtp -126.34 -165.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.217 -0.661 . . . . 0.79 109.217 173.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.615 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 12.8 t-80 -93.77 153.39 18.33 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.068 -0.715 . . . . 2.32 109.068 172.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.657 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.2 m120 -57.41 -54.8 42.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 118.188 -0.911 . . . . 0.68 110.907 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -65.22 -21.97 66.82 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 121.543 1.974 . . . . 2.18 112.149 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.615 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.9 m-20 -80.9 -45.79 16.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.096 -0.956 . . . . 0.69 111.169 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.591 HG13 HD12 ' A' ' 151' ' ' ILE . 14.9 p -65.8 -20.73 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.554 -0.748 . . . . 0.11 111.052 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.657 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.26 -41.0 16.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 119.006 -0.521 . . . . 0.38 109.889 170.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -45.92 -70.73 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.164 0.893 . . . . 1.99 112.339 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.479 HD22 ' SD ' ' A' ' 145' ' ' MET . 9.4 mp -46.18 -38.56 8.48 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.49 0.662 . . . . 1.27 111.486 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.75 -33.52 76.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.376 -1.284 . . . . 0.18 111.598 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -88.79 -31.68 18.25 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.487 -0.758 . . . . 0.21 112.711 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.2 mt -83.38 -60.1 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.451 0.643 . . . . 0.16 111.679 -172.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.1 m -91.26 139.99 25.6 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 114.969 -1.014 . . . . 0.16 112.158 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.655 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 61.2 Cg_endo -89.09 174.4 3.74 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 123.899 3.066 . . . . 0.2 111.286 174.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.591 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 58.5 m-20 -67.75 156.07 37.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.423 -0.911 . . . . 1.1 108.876 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.69 -20.53 50.02 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.246 -0.978 . . . . 0.18 112.523 -172.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.568 ' HB ' HD12 ' A' ' 100' ' ' ILE . 53.2 m -63.75 137.74 58.19 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.006 -0.739 . . . . 0.14 109.006 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.626 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 18.8 ptt180 -92.48 120.6 33.12 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.944 1.354 . . . . 3.63 111.22 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.6 t -102.78 106.48 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 111.951 -2.386 . . . . 0.14 108.875 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.674 HG23 ' CB ' ' A' ' 97' ' ' GLU . 1.8 m -93.74 104.59 16.68 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.257 -0.577 . . . . 0.21 112.327 -170.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 2.4 mp -81.45 93.29 2.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 122.509 1.147 . . . . 0.24 109.552 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -103.31 139.15 39.12 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.865 -1.516 . . . . 1.09 109.432 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.535 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 6.5 mmt85 -72.14 -14.95 61.96 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.057 -0.52 . . . . 2.08 111.115 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.23 22.47 27.17 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 121.137 -0.554 . . . . 1.97 112.064 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 109.225 -0.657 . . . . 3.91 109.225 -178.753 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.817 -0.513 . . . . 2.8 111.817 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -98.06 125.73 43.17 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.874 -0.417 . . . . 4.44 109.874 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 3' ' ' LYS . 28.9 mmmt -128.92 99.44 5.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.886 -0.597 . . . . 2.46 111.191 -175.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.653 HD21 ' HA ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -105.58 175.05 5.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.488 0.661 . . . . 0.65 111.969 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.655 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.2 tt -99.09 131.82 44.86 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.717 -1.129 . . . . 0.28 110.238 -175.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.7 162.37 13.47 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 122.218 1.008 . . . . 0.31 113.201 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.631 ' HB3' HG13 ' A' ' 46' ' ' ILE . 80.8 t80 -130.72 144.86 51.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.723 -1.581 . . . . 0.44 107.859 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.425 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 61.5 tt0 -115.85 113.53 23.48 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 108.483 -0.932 . . . . 0.76 108.483 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.596 ' HB ' ' O ' ' A' ' 41' ' ' THR . 86.0 t -66.39 152.32 9.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 122.735 1.255 . . . . 0.39 113.27 -171.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.0 mtmm -108.68 159.35 16.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.036 -1.893 . . . . 2.01 108.54 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.453 ' OE1' ' HA ' ' A' ' 11' ' ' GLN . 2.2 mm-40 -62.13 113.8 3.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.041 0.448 . . . . 1.83 112.044 -174.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.38 10.76 56.73 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.582 -0.735 . . . . 0.48 113.669 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.545 ' HB2' HG13 ' A' ' 9' ' ' VAL . 86.3 m-20 -56.2 169.38 0.41 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.109 0.454 . . . . 1.46 111.161 173.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.43 ' HB ' ' H ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -128.81 156.69 43.19 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.432 -0.507 . . . . 0.41 110.916 173.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.61 HD12 HD23 ' A' ' 29' ' ' LEU . 3.0 tp -66.07 -36.36 83.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.986 0.898 . . . . 0.86 109.539 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.461 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 5.1 t30 -85.87 -24.98 26.46 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.342 -1.299 . . . . 1.15 110.248 -176.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.43 ' H ' ' HB ' ' A' ' 14' ' ' THR . 39.6 t -65.88 -42.11 90.71 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.127 -0.694 . . . . 1.21 109.127 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 14.8 mt -74.69 -27.01 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.171 0.51 . . . . 0.21 109.908 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.636 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.32 -9.98 59.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.532 -0.304 . . . . 0.16 110.679 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.621 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.73 -38.62 9.83 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.642 1.21 . . . . 0.21 108.155 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.3 m-20 -62.28 -45.55 92.76 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.277 -2.238 . . . . 0.53 111.689 172.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.556 ' HA ' HG21 ' A' ' 101' ' ' ILE . 58.8 m-85 -98.62 4.8 48.06 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 118.685 -1.206 . . . . 0.18 111.667 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.621 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.0 mpt_? 54.78 42.84 30.86 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.689 0.757 . . . . 1.78 109.738 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.636 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.7 pt -115.41 -165.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.548 -1.205 . . . . 0.19 109.883 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.39 142.82 39.8 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.123 -0.944 . . . . 0.95 110.118 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.597 ' HB ' HD21 ' A' ' 15' ' ' LEU . 70.6 p -73.23 -31.95 64.44 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.364 -0.976 . . . . 0.25 108.364 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.67 68.16 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.049 -0.978 . . . . 0.2 111.512 169.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -92.89 -27.66 16.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.359 0.599 . . . . 0.17 109.461 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.647 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 15.2 tp -74.79 -26.64 59.89 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.662 -0.699 . . . . 1.16 109.299 174.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 36' ' ' LEU . 42.8 mt -77.62 -30.51 52.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.62 0.724 . . . . 1.05 109.772 171.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 22.6 tt0 -63.74 -43.16 97.3 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.326 -1.306 . . . . 1.81 110.002 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.47 -21.35 32.88 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.357 -0.537 . . . . 0.2 111.715 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.601 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.1 m-80 -145.96 82.74 9.07 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-O 121.571 0.7 . . . . 0.23 110.642 -171.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.84 -6.13 3.19 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 123.803 3.002 . . . . 0.36 113.675 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.9 t -80.17 -25.78 39.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.651 0.263 . . . . 1.38 111.297 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.812 HD21 HG21 ' A' ' 46' ' ' ILE . 32.0 mt -70.11 -35.1 73.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.57 0.7 . . . . 0.49 112.158 -170.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 37' ' ' GLN . 2.8 pt20 -65.35 -46.98 78.08 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 122.847 1.308 . . . . 1.95 110.296 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.67 -49.74 74.17 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 111.982 -2.372 . . . . 0.49 110.479 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.26 179.36 48.89 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 114.715 -1.129 . . . . 0.42 111.332 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 157.09 19.76 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.39 0.614 . . . . 0.41 110.895 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.596 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 39.7 m -143.31 126.26 16.27 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.231 -0.895 . . . . 0.42 110.706 -176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' CB ' ' HG2' ' A' ' 11' ' ' GLN . . . -75.86 116.62 16.75 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.561 0.696 . . . . 0.47 109.735 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 105.34 -0.85 40.26 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.192 -1.163 . . . . 0.41 110.192 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.568 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.4 tt0 -75.51 123.82 26.11 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.961 -0.62 . . . . 1.3 109.733 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 58.8 p -80.89 133.13 35.51 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.589 -0.732 . . . . 0.85 109.864 176.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.812 HG21 HD21 ' A' ' 36' ' ' LEU . 11.7 pt -134.28 141.61 43.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.498 -1.228 . . . . 0.25 109.22 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.434 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.68 152.22 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.173 0.511 . . . . 0.67 110.713 -179.392 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.413 HG13 ' CE2' ' A' ' 22' ' ' PHE . 38.0 mm -115.89 92.5 34.78 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.97 -1.014 . . . . 0.16 109.412 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.653 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -57.41 132.69 52.32 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.727 2.285 . . . . 0.18 112.598 -175.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.65 -2.27 80.01 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 114.825 -1.079 . . . . 0.26 112.527 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.695 HD12 ' HD2' ' A' ' 52' ' ' PRO . 34.0 tp -125.4 114.94 25.5 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-O 121.314 0.578 . . . . 0.61 111.139 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.695 ' HD2' HD12 ' A' ' 51' ' ' LEU . 57.6 Cg_endo -79.79 -177.64 3.98 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.716 2.944 . . . . 0.28 114.577 -171.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.58 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.7 t70 -80.52 130.97 62.79 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 114.055 -1.429 . . . . 0.49 111.602 -173.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 44.1 Cg_endo -71.29 -20.01 28.48 Favored 'Trans proline' 0 CA--C 1.519 -0.263 0 C-N-CA 123.381 2.72 . . . . 0.46 113.121 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -96.79 -0.89 47.33 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.418 0.628 . . . . 1.38 111.88 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.58 HG23 ' HB3' ' A' ' 53' ' ' ASP . 29.5 p -89.31 -15.58 33.13 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.228 -1.397 . . . . 0.46 107.228 169.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 59' ' ' TYR . 18.2 mt -82.53 134.36 48.1 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 112.5 -2.136 . . . . 0.7 110.317 175.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -84.1 -16.95 5.93 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.282 1.988 . . . . 0.39 113.239 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.567 ' H ' HG22 ' A' ' 57' ' ' ILE . 61.2 m-85 -93.93 155.15 17.31 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.751 -0.38 . . . . 0.24 111.859 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -146.33 131.72 18.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.77 -0.826 . . . . 2.89 108.77 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 71' ' ' THR . 91.1 mt -114.95 133.98 59.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.072 0.397 . . . . 0.16 112.072 -175.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.1 121.55 42.48 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.17 -0.612 . . . . 0.16 110.903 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.43 114.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.884 0.85 . . . . 0.19 111.444 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 68' ' ' LYS . 46.9 m -95.02 102.29 14.09 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.606 -1.179 . . . . 0.2 110.743 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.9 mm -50.99 -57.74 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 122.25 1.024 . . . . 0.23 111.536 169.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.25 -10.13 5.08 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 112.788 -2.005 . . . . 0.16 113.414 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.57 -18.54 4.79 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.51 0.724 . . . . 0.15 112.318 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.534 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.26 56.27 4.58 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.325 0.511 . . . . 0.69 111.003 -173.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.7 p -137.31 161.73 35.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 112.719 0.636 . . . . 0.13 112.719 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.456 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.5 tt -130.54 110.74 11.65 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.659 -1.155 . . . . 0.4 109.928 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.604 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 36.2 m -92.12 123.47 35.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.022 0.439 . . . . 0.16 111.126 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.3 tp -98.88 104.32 16.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.413 -0.812 . . . . 0.59 109.481 172.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 19.4 m -105.22 160.18 15.29 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.324 -0.95 . . . . 1.05 110.814 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -125.85 127.4 46.01 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.476 -0.935 . . . . 0.26 108.476 169.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.605 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.9 p-10 44.64 50.65 8.4 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.075 1.35 . . . . 1.84 111.419 -166.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 72.84 -11.83 0.82 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.892 -1.049 . . . . 1.89 112.041 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -94.56 120.68 35.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.249 0.547 . . . . 3.44 110.009 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 57.5 t -57.67 132.54 22.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 122.38 1.086 . . . . 0.24 112.869 -173.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 6.9 mtm -103.46 -42.86 5.56 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 112.995 -1.911 . . . . 0.81 109.447 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -158.53 172.81 17.64 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 113.215 -1.811 . . . . 1.46 109.84 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.3 m -148.65 123.23 9.78 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.228 -1.351 . . . . 0.17 109.41 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.521 ' HD2' ' OD2' ' A' ' 149' ' ' ASP . 25.1 m-85 -103.93 148.55 36.03 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.312 -0.858 . . . . 1.05 109.453 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.435 ' HB2' HG22 ' A' ' 134' ' ' ILE . 46.5 Cg_endo -77.58 141.06 19.45 Favored 'Trans proline' 0 CA--C 1.5 -1.209 0 C-N-CA 121.497 1.465 . . . . 0.2 110.488 169.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.627 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -139.9 173.25 11.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.934 -0.575 . . . . 0.13 110.907 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.9 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.83 143.34 47.01 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.227 -0.442 . . . . 0.26 110.436 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG22 ' HG3' ' A' ' 68' ' ' LYS . 7.5 m -126.58 126.04 68.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.451 0.643 . . . . 0.56 112.057 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -89.16 157.17 26.77 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.71 -1.356 . . . . 0.17 109.71 173.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -57.05 6.61 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 114.582 1.327 . . . . 3.05 114.582 -177.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.839 HG23 HD22 ' A' ' 90' ' ' LEU . 1.2 tp -96.88 -14.08 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.525 0.679 . . . . 0.23 110.565 -177.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.839 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -91.2 -18.09 25.0 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.146 -0.687 . . . . 0.18 109.146 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.3 p -67.09 -24.52 65.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.777 -1.101 . . . . 0.33 112.132 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.479 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 8.7 mp0 -56.26 -44.35 79.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.118 1.367 . . . . 1.52 111.61 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -100.45 119.7 58.17 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.471 -0.786 . . . . 0.43 111.635 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.599 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 1.9 Cg_endo -77.36 -19.64 13.12 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.874 2.383 . . . . 0.73 113.068 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 t -105.48 -40.52 5.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.358 -0.608 . . . . 0.48 109.358 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 43.69 45.89 7.23 Favored Glycine 0 C--N 1.338 0.682 0 O-C-N 124.565 1.165 . . . . 0.33 113.903 170.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -83.59 113.09 20.59 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.901 0.858 . . . . 0.84 109.723 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 15.9 m-85 -137.32 175.85 9.24 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.065 -1.425 . . . . 0.22 112.484 -170.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.69 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 79.9 m-85 -142.85 133.07 24.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.54 110.896 -174.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.579 HD12 ' HB ' ' A' ' 161' ' ' THR . 82.6 mt -58.02 121.85 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.576 -0.738 . . . . 0.17 110.84 172.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.556 HG21 ' HA ' ' A' ' 22' ' ' PHE . 22.7 pt -86.8 -35.25 8.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 113.157 0.799 . . . . 0.21 113.157 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.536 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 1.4 p-10 179.97 174.03 0.91 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.932 -1.136 . . . . 2.03 107.932 -176.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.662 ' CB ' HD12 ' A' ' 116' ' ' LEU . 6.7 mtt180 -122.21 161.66 22.82 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.112 -0.635 . . . . 1.52 111.503 -170.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -143.84 102.41 3.9 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.222 0.534 . . . . 0.59 110.898 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 63.7 ttt180 -65.95 166.89 10.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.38 -0.827 . . . . 2.82 110.63 173.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.497 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 24.6 m-80 -35.49 104.52 0.26 Allowed Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 125.529 1.532 . . . . 0.35 113.806 -160.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.3 Cg_endo -61.9 -35.58 77.14 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.785 2.324 . . . . 0.48 111.745 171.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.97 -35.59 3.88 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.398 -0.681 . . . . 0.67 111.398 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.97 -175.89 42.78 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.229 -0.485 . . . . 0.62 112.437 176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 112' ' ' GLY . 25.8 Cg_endo -59.05 -0.34 0.57 Allowed 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 124.91 3.74 . . . . 0.94 115.035 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -69.21 30.88 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.967 0.728 . . . . 1.23 112.967 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.81 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 58.65 64.9 3.89 Favored Glycine 0 C--O 1.217 -0.927 0 N-CA-C 116.202 1.241 . . . . 1.69 116.202 161.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.597 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.34 -8.18 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 117.97 2.582 . . . . 0.48 117.97 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.599 ' CE2' ' HB1' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -163.29 151.77 13.97 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.085 0.857 . . . . 0.28 110.117 -176.317 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -135.16 98.3 3.95 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.227 -1.027 . . . . 0.49 108.227 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.662 HD12 ' CB ' ' A' ' 103' ' ' ARG . 0.6 OUTLIER -85.79 118.56 25.37 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 121.097 -1.002 . . . . 0.66 109.877 174.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.523 ' HB3' HD11 ' A' ' 101' ' ' ILE . 36.9 m -83.45 145.63 28.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.638 -0.71 . . . . 0.19 111.411 -170.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.764 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -109.73 170.5 8.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.13 110.797 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.567 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -62.87 -13.11 30.02 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.936 0.717 . . . . 1.17 112.936 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.602 ' HB3' ' CG ' ' A' ' 123' ' ' TYR . 5.2 tptp -126.06 130.9 52.05 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.52 -0.472 . . . . 1.22 110.756 175.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.452 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 67.6 mt-30 -30.97 -58.99 0.22 Allowed 'General case' 0 C--N 1.317 -0.827 0 O-C-N 124.733 1.271 . . . . 1.51 114.054 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.643 ' HB3' HG12 ' A' ' 89' ' ' ILE . 1.3 t-80 -96.08 8.19 44.42 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.551 -0.86 . . . . 2.53 111.706 -171.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.764 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.3 m-85 -94.88 37.48 1.14 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.877 1.065 . . . . 0.84 113.877 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -114.57 143.74 18.13 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 116.865 -2.588 . . . . 0.32 112.665 -153.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -97.09 112.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.937 0.875 . . . . 0.18 110.451 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.756 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.0 p80 -142.64 172.21 13.0 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.078 -0.964 . . . . 0.21 109.592 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.81 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.7 -179.92 38.87 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 119.969 -1.11 . . . . 0.27 111.791 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.565 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 11.5 t -142.89 170.96 14.73 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.79 -0.448 . . . . 0.41 109.79 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -114.48 -4.75 12.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.9 0.857 . . . . 1.99 108.705 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -112.26 87.91 9.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.563 -1.198 . . . . 1.36 108.178 168.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -73.4 -19.69 21.77 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.744 2.296 . . . . 0.35 113.601 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.97 0.19 28.52 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.227 0.537 . . . . 0.33 111.112 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 52.6 m -94.51 -1.49 53.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 1.35 109.628 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 44.0 mm -82.83 137.82 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.98 -0.555 . . . . 0.21 110.5 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.89 0.82 77.54 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.922 -1.271 . . . . 0.15 109.922 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -111.68 167.42 10.36 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 122.932 1.349 . . . . 2.5 113.73 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.468 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -96.27 120.06 35.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.174 -2.285 . . . . 0.17 107.442 173.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.35 160.47 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.508 -0.923 . . . . 0.66 108.508 -172.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.588 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.1 m -52.55 -60.93 2.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 111.974 0.361 . . . . 0.43 111.974 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -131.62 -46.57 0.97 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.09 -1.444 . . . . 2.02 113.78 -172.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.48 133.69 0.2 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 117.758 1.863 . . . . 0.18 117.758 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.608 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 6.3 p -68.56 166.02 17.93 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 112.291 -1.954 . . . . 0.16 111.756 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.9 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 59.5 mt -59.48 98.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 122.596 1.189 . . . . 0.4 112.114 -163.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.756 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 75.5 mtt180 -87.06 147.76 25.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.461 -1.7 . . . . 1.87 110.7 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.627 ' HG2' HG22 ' A' ' 84' ' ' ILE . 12.7 mtp -125.29 -165.5 1.41 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.295 -0.632 . . . . 0.79 109.295 173.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.657 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 25.4 t-80 -95.86 153.99 17.46 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.538 -0.755 . . . . 2.32 108.997 173.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.646 ' O ' HD13 ' A' ' 151' ' ' ILE . 0.9 OUTLIER -57.11 -54.4 47.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.193 -0.908 . . . . 0.68 110.856 -174.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.411 ' HG2' ' ND1' ' A' ' 146' ' ' HIS . 0.8 OUTLIER -63.93 -23.81 67.49 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 121.516 1.962 . . . . 2.18 111.823 -175.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.657 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.3 m-20 -78.5 -46.72 18.95 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.01 -0.996 . . . . 0.69 110.725 -176.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.583 HG13 HD12 ' A' ' 151' ' ' ILE . 13.7 p -67.97 -24.15 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.094 -0.957 . . . . 0.11 111.663 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.646 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -78.71 -39.41 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.483 -0.562 . . . . 0.38 109.483 171.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 156' ' ' ILE . 22.7 mt-10 -46.54 -72.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.901 0.773 . . . . 1.99 112.261 168.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.508 HD21 ' CE1' ' A' ' 82' ' ' TYR . 43.4 mt -49.79 -40.31 41.16 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.751 0.786 . . . . 1.27 111.532 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.599 ' HB1' ' CE2' ' A' ' 114' ' ' TYR . . . -56.14 -39.97 73.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.968 -1.469 . . . . 0.18 111.415 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.2 t -87.86 -33.65 18.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.542 0.942 . . . . 0.21 113.542 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 152' ' ' GLU . 43.7 mt -80.57 -60.2 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.617 0.723 . . . . 0.16 112.034 -170.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.9 m -86.61 145.69 39.91 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.793 -1.094 . . . . 0.16 112.049 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.493 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 63.8 Cg_endo -90.72 173.0 3.13 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.875 3.05 . . . . 0.2 110.91 172.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.536 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 22.0 m-20 -64.87 158.23 25.72 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.744 -0.782 . . . . 1.1 109.134 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 97.41 -19.63 53.95 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.079 -1.058 . . . . 0.18 112.529 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' HD12 ' A' ' 100' ' ' ILE . 59.1 m -62.76 136.81 58.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.15 -0.685 . . . . 0.14 109.15 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.69 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -92.61 122.7 35.28 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.771 1.272 . . . . 3.63 111.18 -169.272 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.13 108.63 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 112.25 -2.25 . . . . 0.14 109.159 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.3 m -94.23 107.7 19.62 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.521 0.563 . . . . 0.21 112.521 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.428 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -86.14 97.41 5.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.991 0.9 . . . . 0.24 110.253 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -110.98 135.52 51.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.853 -1.067 . . . . 1.09 111.203 -173.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.599 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 14.8 mmm-85 -78.3 64.84 3.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.474 0.654 . . . . 2.08 109.701 172.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.28 158.67 25.99 Favored Glycine 0 N--CA 1.433 -1.553 0 CA-C-N 115.124 -0.944 . . . . 1.97 111.404 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.836 0.318 . . . . 3.91 110.356 -179.68 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 111.686 -0.565 . . . . 2.8 111.686 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -78.3 161.92 26.88 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.222 0.534 . . . . 4.44 110.883 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -108.61 105.19 14.69 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.4 -0.818 . . . . 2.46 110.699 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.576 HD13 ' HA ' ' A' ' 49' ' ' PRO . 20.3 mt -96.01 174.84 6.73 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.569 -0.741 . . . . 0.65 110.872 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.8 tt -88.81 129.18 35.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.505 -0.77 . . . . 0.28 109.756 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.14 161.11 14.11 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.138 -0.937 . . . . 0.31 112.944 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.6 ' HB3' HG13 ' A' ' 46' ' ' ILE . 86.2 t80 -129.6 140.66 51.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.715 -1.584 . . . . 0.44 107.781 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.438 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 63.3 tt0 -114.23 111.79 22.09 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.907 -1.145 . . . . 0.76 107.907 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.653 HG13 ' HB2' ' A' ' 13' ' ' ASP . 97.7 t -66.2 151.2 10.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.353 1.073 . . . . 0.39 112.697 -169.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -108.02 158.07 17.7 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.554 -1.657 . . . . 2.01 108.325 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.62 107.34 0.38 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.183 0.516 . . . . 1.83 112.092 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.77 11.79 39.49 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.686 -0.688 . . . . 0.48 113.57 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.653 ' HB2' HG13 ' A' ' 9' ' ' VAL . 70.9 m-20 -55.97 167.63 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.953 0.376 . . . . 1.46 110.961 172.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -128.19 152.96 47.42 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.914 0.388 . . . . 0.41 111.176 174.654 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.526 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -64.38 -38.86 92.52 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.103 -1.073 . . . . 0.86 108.103 -177.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.409 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 65.3 t30 -86.44 -22.04 26.74 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.512 -1.222 . . . . 1.15 110.715 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.446 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 17.4 t -67.98 -40.12 83.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.177 -0.675 . . . . 1.21 109.177 171.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.2 mt -75.32 -27.78 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.146 0.498 . . . . 0.21 109.937 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.54 -10.01 59.72 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.517 -0.31 . . . . 0.16 110.795 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.707 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.09 -40.27 9.31 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 107.929 -1.137 . . . . 0.21 107.929 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 3.0 m-20 -62.19 -42.77 99.59 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.544 -2.116 . . . . 0.53 112.303 173.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 119' ' ' SER . 57.5 m-85 -99.42 6.73 45.93 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 118.876 -1.13 . . . . 0.18 111.129 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.707 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.76 41.06 32.2 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.765 0.793 . . . . 1.78 109.541 176.432 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.62 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.8 pt -116.8 -165.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.287 -1.324 . . . . 0.19 110.215 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.52 143.88 40.19 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.99 -1.005 . . . . 0.95 110.244 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.526 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 44.3 p -72.18 -31.76 66.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.037 -1.097 . . . . 0.25 108.037 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -31.09 69.98 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.703 -0.68 . . . . 0.2 111.659 171.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.32 -28.27 17.85 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.641 0.734 . . . . 0.17 109.029 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.568 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -73.67 -28.04 61.55 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.046 -0.979 . . . . 1.16 109.404 174.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 36' ' ' LEU . 42.5 mt -76.63 -30.99 57.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.836 0.827 . . . . 1.05 109.991 170.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 43.3 tt0 -65.61 -33.75 76.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.19 -1.368 . . . . 1.81 110.095 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -88.57 -22.74 23.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 119.849 -0.74 . . . . 0.2 111.805 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.643 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 19.1 m-80 -147.85 82.7 7.76 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.41 0.624 . . . . 0.23 110.517 -171.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.26 -15.93 16.07 Favored 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 124.124 3.216 . . . . 0.36 114.03 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 t -74.72 -22.65 58.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.75 0.31 . . . . 1.38 111.391 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.71 HD21 HG21 ' A' ' 46' ' ' ILE . 35.6 mt -69.45 -36.11 76.31 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.568 0.581 . . . . 0.49 112.568 -169.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 5.4 pt20 -64.07 -45.17 89.93 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 122.917 1.342 . . . . 1.95 110.135 -175.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.64 -49.04 79.12 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 111.796 -2.456 . . . . 0.49 110.712 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.87 -179.85 48.11 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 114.932 -1.031 . . . . 0.42 111.693 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.43 158.97 22.69 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.204 0.526 . . . . 0.41 110.66 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.546 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 60.4 m -139.35 127.89 23.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.542 -0.754 . . . . 0.42 110.385 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.49 121.51 21.61 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.576 0.703 . . . . 0.47 110.313 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.7 3.56 60.89 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 114.733 -1.121 . . . . 0.41 110.468 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.546 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -80.22 124.93 29.24 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.202 -0.499 . . . . 1.3 109.91 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.8 m -77.7 130.35 36.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.152 -0.931 . . . . 0.85 109.781 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.71 HG21 HD21 ' A' ' 36' ' ' LEU . 6.7 pt -132.01 143.63 39.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.671 -1.15 . . . . 0.25 109.085 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -90.69 153.74 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.311 0.576 . . . . 0.67 111.612 -178.168 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.5 mm -118.24 93.6 45.3 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.597 -1.183 . . . . 0.16 109.03 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.576 ' HA ' HD13 ' A' ' 4' ' ' LEU . 2.5 Cg_endo -59.05 137.39 79.28 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.775 2.316 . . . . 0.18 112.745 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.46 -6.24 83.8 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.906 -1.043 . . . . 0.26 112.387 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.743 HD12 ' HD2' ' A' ' 52' ' ' PRO . 26.9 tp -122.73 118.05 28.57 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.904 0.383 . . . . 0.61 110.721 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.743 ' HD2' HD12 ' A' ' 51' ' ' LEU . 57.9 Cg_endo -80.3 -176.68 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.649 2.9 . . . . 0.28 114.037 -172.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.538 ' HB3' HG23 ' A' ' 56' ' ' THR . 13.3 t70 -80.69 132.25 58.48 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.726 -1.124 . . . . 0.49 111.629 -171.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.577 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.8 Cg_endo -76.28 -16.13 17.63 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 123.395 2.73 . . . . 0.46 112.694 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -95.58 -1.04 51.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.706 0.765 . . . . 1.38 110.135 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 53' ' ' ASP . 27.1 p -94.66 -16.98 22.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.657 1.217 . . . . 0.46 107.822 173.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 59' ' ' TYR . 25.6 mt -78.64 128.73 76.35 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 112.947 -1.933 . . . . 0.7 111.132 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.417 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 97.8 Cg_endo -76.75 -17.23 15.99 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.444 2.096 . . . . 0.39 113.194 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.533 ' H ' HG22 ' A' ' 57' ' ' ILE . 61.4 m-85 -94.74 164.91 12.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.392 -0.523 . . . . 0.24 112.153 -176.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -152.68 128.01 9.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.533 -0.914 . . . . 2.89 108.533 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 71' ' ' THR . 95.4 mt -110.02 132.67 57.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.135 -0.484 . . . . 0.16 111.759 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.21 117.01 28.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.004 -0.678 . . . . 0.16 111.09 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.84 112.85 31.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.814 0.816 . . . . 0.19 111.273 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 16.5 m -93.23 102.73 15.02 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.682 -1.145 . . . . 0.2 110.543 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.546 HD13 HG11 ' A' ' 86' ' ' VAL . 50.5 mm -52.15 -58.49 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 122.04 0.924 . . . . 0.23 111.213 169.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.22 -11.39 3.34 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 112.955 -1.93 . . . . 0.16 113.244 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.72 -18.6 4.71 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.572 0.749 . . . . 0.15 112.455 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER 57.77 56.39 4.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.555 0.616 . . . . 0.69 111.431 -172.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.5 p -137.66 161.49 36.34 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 112.669 0.618 . . . . 0.13 112.669 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -131.49 113.4 13.64 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.704 -1.135 . . . . 0.4 110.122 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 66.7 m -94.23 122.95 37.3 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.324 0.583 . . . . 0.16 111.542 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 79' ' ' MET . 15.5 tp -97.56 103.2 15.12 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.906 -1.043 . . . . 0.59 109.369 172.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.2 m -105.47 159.93 15.54 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.475 -0.89 . . . . 1.05 110.579 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.579 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.2 tm? -126.73 128.37 46.55 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.853 -0.795 . . . . 0.26 108.853 169.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.579 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.2 p-10 43.61 49.01 6.53 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.128 1.371 . . . . 1.84 111.574 -167.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 84.2 m-20 75.85 -11.99 1.05 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.127 -0.942 . . . . 1.89 112.317 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -96.99 120.82 38.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.207 0.527 . . . . 3.44 110.095 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.494 HG22 ' CG2' ' A' ' 71' ' ' THR . 55.1 t -56.15 132.44 20.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 122.316 1.055 . . . . 0.24 112.998 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 7.9 mtm -102.59 -43.83 5.51 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.074 -1.875 . . . . 0.81 109.285 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.6 mmtt -157.92 172.15 18.98 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 113.107 -1.861 . . . . 1.46 109.874 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.0 m -149.8 122.28 8.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.417 -1.265 . . . . 0.17 109.808 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -109.71 145.82 32.77 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 115.454 -0.794 . . . . 1.05 109.637 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.446 ' HB2' HG22 ' A' ' 134' ' ' ILE . 41.7 Cg_endo -74.61 142.12 28.78 Favored 'Trans proline' 0 CA--C 1.499 -1.26 0 C-N-CA 121.902 1.734 . . . . 0.2 110.903 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.663 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.01 175.71 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.922 -0.581 . . . . 0.13 110.717 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.879 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -120.76 148.55 43.82 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.418 -0.355 . . . . 0.26 110.092 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG11 HD13 ' A' ' 65' ' ' ILE . 9.6 m -128.75 129.76 68.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.481 0.658 . . . . 0.56 111.899 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.6 154.6 27.23 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.21 -1.156 . . . . 0.17 110.21 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -56.27 3.08 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.321 0.86 . . . . 3.05 113.321 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.917 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -89.17 -19.96 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 121.534 0.683 . . . . 0.23 110.417 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.917 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -89.72 -18.25 26.73 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.716 0.77 . . . . 0.18 109.288 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.9 p -66.81 -14.47 62.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.385 -1.279 . . . . 0.33 111.649 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -66.3 -39.56 89.41 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.74 -1.118 . . . . 1.52 111.973 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.51 130.97 22.17 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.571 -0.452 . . . . 0.43 111.028 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.658 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 87.0 Cg_endo -90.1 -13.87 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.7 2.267 . . . . 0.73 112.73 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.0 t -104.92 -41.0 5.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.758 -0.656 . . . . 0.48 109.25 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.553 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 44.87 46.04 9.21 Favored Glycine 0 N--CA 1.446 -0.644 0 O-C-N 124.404 1.065 . . . . 0.33 113.692 171.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.79 111.37 19.13 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.891 0.853 . . . . 0.84 109.557 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.719 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 21.4 m-85 -139.41 171.94 13.53 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.89 -1.505 . . . . 0.22 112.366 -171.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.58 ' CD1' ' HB3' ' A' ' 162' ' ' ARG . 28.2 m-85 -140.99 136.15 31.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.739 -0.664 . . . . 0.54 110.131 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.55 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.1 mt -58.62 123.23 10.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.421 -0.809 . . . . 0.17 110.55 172.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.55 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.8 pt -88.05 -44.08 15.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 113.014 0.746 . . . . 0.21 113.014 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.462 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 56.2 m-80 -171.69 169.54 5.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 106.783 -1.562 . . . . 2.03 106.783 -169.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.596 ' HB3' HD23 ' A' ' 116' ' ' LEU . 5.6 mtt180 -128.17 163.45 24.65 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.773 -0.771 . . . . 1.52 112.198 -173.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.4 tt0 -136.85 99.91 4.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.921 -1.036 . . . . 0.59 109.713 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.475 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 30.8 ttp180 -67.05 166.52 13.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.24 -0.891 . . . . 2.82 111.006 176.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.475 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 29.1 m-80 -36.44 102.23 0.23 Allowed Pre-proline 0 CA--C 1.518 -0.28 0 C-N-CA 125.439 1.496 . . . . 0.35 113.951 -152.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 14.5 Cg_exo -54.69 -51.68 9.85 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.513 2.809 . . . . 0.48 111.528 170.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.73 -31.83 5.95 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.279 -1.128 . . . . 0.67 110.279 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.91 -174.81 37.54 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 114.48 -0.86 . . . . 0.62 112.477 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -57.64 -10.03 6.45 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 124.879 3.719 . . . . 0.94 114.766 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -63.45 -3.56 2.15 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.434 1.272 . . . . 1.23 114.434 -172.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.682 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 90.11 64.53 1.23 Allowed Glycine 0 CA--C 1.497 -1.032 0 C-N-CA 119.053 -1.546 . . . . 1.69 115.182 167.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.533 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.89 -1.97 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 116.915 2.191 . . . . 0.48 116.915 -175.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.507 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.3 OUTLIER -166.06 161.35 17.2 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.385 -0.822 . . . . 0.28 110.028 -177.007 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 12.6 t-105 -141.83 98.93 3.43 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.25 -1.018 . . . . 0.49 108.25 166.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 103' ' ' ARG . 4.4 mt -91.95 114.49 27.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.521 0.677 . . . . 0.66 109.414 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.425 ' HB3' HD11 ' A' ' 101' ' ' ILE . 26.0 m -84.23 144.55 28.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.986 -0.552 . . . . 0.19 111.368 -169.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -108.35 172.14 7.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.903 -0.59 . . . . 0.13 110.568 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.533 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -64.49 -11.14 30.77 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.894 0.701 . . . . 1.17 112.894 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.735 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.3 tmtp? -126.51 130.61 50.94 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 120.626 -0.43 . . . . 1.22 110.405 174.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.735 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.2 mt-30 -34.77 -54.88 0.57 Allowed 'General case' 0 C--N 1.311 -1.074 0 O-C-N 124.953 1.408 . . . . 1.51 113.555 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.59 ' CB ' HG12 ' A' ' 89' ' ' ILE . 46.8 m80 -91.19 -1.49 57.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.867 -0.606 . . . . 2.53 111.216 -169.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.777 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -94.29 37.88 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.534 0.938 . . . . 0.84 113.534 -171.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.644 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.23 144.41 18.42 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 117.026 -2.511 . . . . 0.32 112.601 -153.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.507 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -96.78 114.89 34.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 123.775 0.83 . . . . 0.18 110.763 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.445 ' O ' ' N ' ' A' ' 145' ' ' MET . 26.8 p80 -143.53 175.97 9.54 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.4 -0.818 . . . . 0.21 109.721 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.682 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.65 -166.98 37.8 Favored Glycine 0 C--N 1.314 -0.672 0 C-N-CA 120.49 -0.862 . . . . 0.27 111.816 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.546 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 14.3 t -157.24 171.4 20.49 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.063 -0.669 . . . . 0.41 110.627 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -115.12 -2.16 12.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.286 -1.005 . . . . 1.99 108.286 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -113.19 85.78 8.75 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.506 -1.224 . . . . 1.36 108.669 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -74.25 -19.07 20.2 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.363 2.042 . . . . 0.35 113.102 -170.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.51 -2.29 49.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.733 -0.667 . . . . 0.33 110.35 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.2 t -89.33 -6.33 56.77 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.042 -0.725 . . . . 1.35 109.042 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' ' 83' ' ' PRO . 39.6 mm -81.82 137.11 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.485 -0.78 . . . . 0.21 110.392 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.91 2.19 69.5 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.172 -1.171 . . . . 0.15 110.172 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.41 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 42.9 mttt -115.12 171.77 7.47 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 123.178 1.466 . . . . 2.5 114.0 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.51 126.73 50.84 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 111.613 -2.54 . . . . 0.17 107.736 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.407 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -122.5 159.73 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 108.662 -0.866 . . . . 0.66 108.662 -174.467 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.9 m -49.5 -60.01 3.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.699 0.629 . . . . 0.43 112.699 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -132.74 -44.79 0.88 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.614 -1.234 . . . . 2.02 113.549 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.46 133.19 0.21 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 117.077 1.591 . . . . 0.18 117.077 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.457 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.8 p -70.59 165.72 22.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.353 -1.923 . . . . 0.16 111.808 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.879 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 57.6 mt -59.7 98.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 122.393 1.092 . . . . 0.4 112.002 -163.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 134' ' ' ILE . 9.8 mtp180 -85.06 148.52 26.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.515 -1.675 . . . . 1.87 109.937 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.663 ' HG2' HG22 ' A' ' 84' ' ' ILE . 14.8 mtp -127.52 -165.9 1.54 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.33 -0.619 . . . . 0.79 109.33 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.735 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 10.5 t-160 -95.96 154.49 17.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.523 -0.917 . . . . 2.32 108.523 172.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.0 OUTLIER -58.2 -51.1 71.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 118.388 -0.815 . . . . 0.68 110.641 -176.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -64.42 -22.64 67.02 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 121.223 1.829 . . . . 2.18 112.516 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.735 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 13.3 m-20 -85.3 -42.46 14.59 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.036 -0.529 . . . . 0.69 111.263 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.637 HG13 HD12 ' A' ' 151' ' ' ILE . 14.7 p -67.78 -23.03 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.913 -0.585 . . . . 0.11 111.193 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.637 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.78 -40.66 16.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 118.846 -0.597 . . . . 0.38 110.02 171.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.8 mm-40 -44.59 -72.57 0.06 Allowed 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 119.426 1.012 . . . . 1.99 112.293 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.529 ' O ' HG22 ' A' ' 157' ' ' VAL . 49.7 mt -47.42 -40.08 17.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.686 0.755 . . . . 1.27 111.269 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.05 77.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.098 -1.41 . . . . 0.18 111.785 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.3 t -89.01 -31.78 17.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.56 -0.713 . . . . 0.21 112.694 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 152' ' ' GLU . 28.5 mt -82.0 -60.53 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.612 0.72 . . . . 0.16 111.339 -172.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.3 m -89.19 140.74 28.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.786 -1.097 . . . . 0.16 111.907 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -88.17 173.84 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.969 3.113 . . . . 0.2 111.062 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.462 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 77.4 m-20 -65.41 155.76 34.41 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 119.723 -0.791 . . . . 1.1 109.187 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.6 -20.02 52.07 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.125 -1.036 . . . . 0.18 112.494 -173.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.55 ' HB ' HD12 ' A' ' 100' ' ' ILE . 91.2 m -63.21 138.03 58.41 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 117.419 0.61 . . . . 0.14 109.476 -174.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.58 ' HB3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -93.03 123.31 36.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.784 1.278 . . . . 3.63 111.002 -169.208 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.95 108.56 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 111.94 -2.391 . . . . 0.14 109.022 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.8 m -94.43 108.05 19.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.069 -0.514 . . . . 0.21 112.307 -171.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.553 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.19 101.15 7.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.152 0.977 . . . . 0.24 109.963 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -108.43 128.36 54.71 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.389 -1.278 . . . . 1.09 109.794 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.658 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 18.3 mmm180 -69.5 -20.77 63.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.838 0.351 . . . . 2.08 111.008 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.39 15.87 54.35 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.984 -0.627 . . . . 1.97 112.202 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.326 -0.426 0 N-CA-C 110.768 -0.086 . . . . 3.91 110.768 -177.806 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 112.105 -0.398 . . . . 2.8 112.105 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -124.44 171.66 9.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.368 0.604 . . . . 4.44 110.975 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -122.78 101.95 7.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.957 -1.019 . . . . 2.46 108.668 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp -101.06 173.85 6.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.701 0.762 . . . . 0.65 112.824 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.646 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.0 tt -102.54 133.04 48.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.5 -1.227 . . . . 0.28 110.265 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.39 162.96 12.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.41 1.1 . . . . 0.31 113.839 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.644 ' HB3' HG13 ' A' ' 46' ' ' ILE . 87.8 t80 -129.14 140.29 51.6 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.243 -1.799 . . . . 0.44 107.596 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.442 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.9 tt0 -112.89 112.64 24.26 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.185 -1.042 . . . . 0.76 108.185 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.605 HG13 ' HB2' ' A' ' 13' ' ' ASP . 92.7 t -65.7 149.67 11.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 122.264 1.031 . . . . 0.39 112.679 -171.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -106.27 159.48 16.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.768 -1.56 . . . . 2.01 108.487 171.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -61.41 106.06 0.59 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.213 0.53 . . . . 1.83 112.379 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.7 11.2 35.84 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.518 -0.765 . . . . 0.48 113.395 172.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.605 ' HB2' HG13 ' A' ' 9' ' ' VAL . 84.1 m-20 -53.69 167.62 0.23 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.829 0.347 . . . . 1.46 111.006 172.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -125.95 150.86 47.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.229 0.538 . . . . 0.41 111.145 175.181 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.66 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.95 -38.14 89.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.16 -1.052 . . . . 0.86 108.16 -178.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.52 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -84.69 -25.9 28.09 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.37 -1.286 . . . . 1.15 110.532 -177.116 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.466 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 30.7 t -64.62 -43.25 94.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.396 -0.594 . . . . 1.21 109.396 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.7 mt -72.8 -26.69 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.15 0.5 . . . . 0.21 109.692 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.73 -11.18 59.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.251 -0.431 . . . . 0.16 110.531 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.691 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -90.9 -41.94 10.87 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.595 0.712 . . . . 0.21 109.77 171.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.749 ' HB3' ' O ' ' A' ' 119' ' ' SER . 83.6 m-20 -61.65 -44.65 96.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.247 -1.342 . . . . 0.53 111.473 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.594 ' CE2' ' HB3' ' A' ' 119' ' ' SER . 54.3 m-85 -99.47 6.63 45.88 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.69 -1.204 . . . . 0.18 111.471 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.691 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER 53.87 43.26 31.18 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.71 0.767 . . . . 1.78 109.616 177.386 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 36.2 pt -115.75 -165.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.773 -1.103 . . . . 0.19 110.35 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.71 142.87 40.29 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.916 -1.038 . . . . 0.95 109.801 174.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.574 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 68.2 p -72.95 -30.88 64.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.626 -0.879 . . . . 0.25 108.626 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.05 -27.06 69.15 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.494 -0.776 . . . . 0.2 111.625 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.618 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -94.31 -27.11 16.28 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.573 0.701 . . . . 0.17 109.148 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.66 HD23 HD23 ' A' ' 15' ' ' LEU . 17.8 tp -73.55 -28.43 61.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.153 -0.93 . . . . 1.16 108.636 172.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 26' ' ' THR . 7.7 tp -78.52 -28.79 46.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.582 0.706 . . . . 1.05 109.769 175.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.618 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -58.48 -60.48 3.74 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.472 -1.307 . . . . 1.81 107.472 167.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.439 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -71.57 -17.41 62.3 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 120.313 -0.555 . . . . 0.2 110.973 -169.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.61 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.7 m-80 -146.99 81.04 9.19 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 115.729 -0.669 . . . . 0.23 110.532 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.87 -10.32 5.41 Favored 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 124.065 3.177 . . . . 0.36 113.411 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -78.62 -19.91 51.59 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.841 0.312 . . . . 1.38 111.841 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.704 HD21 HG21 ' A' ' 46' ' ' ILE . 63.1 mt -70.63 -34.49 72.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.312 0.577 . . . . 0.49 112.205 -171.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.438 ' CB ' HD11 ' A' ' 30' ' ' LEU . 3.8 pt20 -64.4 -47.21 80.07 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 122.805 1.288 . . . . 1.95 110.539 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.59 -49.67 75.65 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 111.729 -2.487 . . . . 0.49 110.242 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.38 178.93 48.65 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 114.775 -1.102 . . . . 0.42 111.912 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 157.35 19.43 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.392 0.615 . . . . 0.41 110.619 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.616 ' HB ' ' HB2' ' A' ' 44' ' ' GLN . 83.5 m -143.62 130.89 20.83 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.169 -0.923 . . . . 0.42 110.062 -176.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.75 120.08 20.64 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.526 0.679 . . . . 0.47 110.221 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.442 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 101.35 0.97 53.82 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.709 -1.356 . . . . 0.41 109.709 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.616 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 47.4 tt0 -72.74 123.62 23.68 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.148 -1.026 . . . . 1.3 109.915 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 15.7 p -84.11 127.28 33.81 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 122.019 0.914 . . . . 0.85 110.068 175.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.704 HG21 HD21 ' A' ' 36' ' ' LEU . 10.9 pt -127.33 140.72 48.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.178 -1.374 . . . . 0.25 109.033 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.15 150.7 3.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 120.995 0.426 . . . . 0.67 110.885 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.2 mm -114.83 92.9 31.84 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.731 -1.122 . . . . 0.16 108.845 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.652 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.8 Cg_endo -58.65 132.96 51.13 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.69 2.26 . . . . 0.18 112.835 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.05 -5.79 72.3 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 114.703 -1.135 . . . . 0.26 111.983 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.658 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 38.7 tp -123.82 115.67 27.89 Favored Pre-proline 0 N--CA 1.448 -0.569 0 CA-C-O 121.222 0.534 . . . . 0.61 111.75 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.653 ' HD2' HD12 ' A' ' 51' ' ' LEU . 61.1 Cg_endo -81.57 -176.74 3.22 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 124.204 3.27 . . . . 0.28 114.808 -172.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.562 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.6 t70 -81.04 128.96 69.3 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 113.968 -1.469 . . . . 0.49 112.269 -170.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 52.3 Cg_endo -73.87 -14.36 24.03 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.629 2.886 . . . . 0.46 113.139 -177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.84 -5.6 37.92 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.891 -0.595 . . . . 1.38 111.402 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.562 HG23 ' HB3' ' A' ' 53' ' ' ASP . 28.0 p -89.15 -21.87 23.11 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.49 -1.3 . . . . 0.46 107.49 171.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 59' ' ' TYR . 21.2 mt -75.23 128.04 85.32 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 112.847 -1.979 . . . . 0.7 111.119 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.4 -18.29 15.93 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.473 2.115 . . . . 0.39 113.216 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.531 ' H ' HG22 ' A' ' 57' ' ' ILE . 56.4 m-85 -94.82 161.48 14.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.297 -0.561 . . . . 0.24 111.628 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -151.15 124.65 8.95 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.655 -0.869 . . . . 2.89 108.655 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 71' ' ' THR . 97.5 mt -106.44 131.38 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.867 -0.606 . . . . 0.16 111.391 -176.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.66 117.28 29.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.834 -0.746 . . . . 0.16 111.341 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 69' ' ' THR . 60.0 t -97.5 117.04 41.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.573 0.702 . . . . 0.19 111.207 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 19.3 m -95.31 106.2 18.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.974 -1.012 . . . . 0.2 110.61 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.584 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.6 mm -54.46 -58.65 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 122.202 1.001 . . . . 0.23 111.099 167.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.95 -7.86 3.94 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 112.836 -1.984 . . . . 0.16 113.292 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -127.96 -19.4 4.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.399 0.679 . . . . 0.15 112.671 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.518 ' HD2' ' CG2' ' A' ' 86' ' ' VAL . 0.0 OUTLIER 58.5 56.37 4.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.669 0.668 . . . . 0.69 111.624 -171.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 42.4 p -137.62 162.23 34.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.009 0.744 . . . . 0.13 113.009 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.466 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -130.16 113.83 14.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.632 -1.167 . . . . 0.4 110.023 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.708 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 22.0 m -94.81 122.97 37.98 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.172 0.511 . . . . 0.16 111.391 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 79' ' ' MET . 15.3 tp -98.35 104.39 16.42 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.416 -0.811 . . . . 0.59 109.628 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 7.7 m -105.22 159.98 15.45 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.531 -0.867 . . . . 1.05 110.78 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.615 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.1 tm? -128.92 128.55 44.01 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.856 -0.794 . . . . 0.26 108.856 169.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.615 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.6 p-10 46.54 48.64 14.01 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.132 1.373 . . . . 1.84 111.287 -166.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.9 t30 72.93 -9.45 1.11 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.038 -0.983 . . . . 1.89 111.333 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -96.3 120.7 37.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.737 -0.665 . . . . 3.44 109.764 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 69.7 t -58.3 132.25 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-O 122.311 1.053 . . . . 0.24 112.606 -174.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 12.1 mtm -101.18 -45.5 5.35 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.206 -1.816 . . . . 0.81 109.151 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 13.7 mmmt -157.75 171.15 20.83 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.423 -1.717 . . . . 1.46 109.571 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -148.74 123.33 9.79 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.677 -1.147 . . . . 0.17 109.848 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -111.11 148.29 38.38 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.743 -0.662 . . . . 1.05 109.995 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.445 ' HB2' HG22 ' A' ' 134' ' ' ILE . 48.1 Cg_endo -75.43 142.71 26.91 Favored 'Trans proline' 0 CA--C 1.498 -1.295 0 C-N-CA 122.113 1.875 . . . . 0.2 110.848 175.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.643 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.6 175.0 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.718 -0.674 . . . . 0.13 110.754 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.89 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.17 146.39 45.2 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.311 -0.404 . . . . 0.26 110.153 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.518 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 7.5 m -127.23 130.18 70.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.558 0.694 . . . . 0.56 111.625 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.4 153.38 26.27 Favored Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 110.012 -1.235 . . . . 0.17 110.012 172.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -56.12 3.3 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.238 0.829 . . . . 3.05 113.238 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.868 HG23 HD22 ' A' ' 90' ' ' LEU . 1.8 tp -91.48 -18.55 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 121.555 0.693 . . . . 0.23 110.46 -178.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.868 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -88.86 -18.19 28.12 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.757 -0.656 . . . . 0.18 109.398 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.8 p -65.56 -19.4 65.91 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.627 -1.17 . . . . 0.33 111.778 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -57.64 -42.47 83.47 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.14 -0.936 . . . . 1.52 111.941 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.37 120.9 48.03 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-O 120.867 0.365 . . . . 0.43 111.582 -174.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 2.2 Cg_endo -76.84 -16.18 16.41 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.794 2.329 . . . . 0.73 113.262 177.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 t -106.58 -41.25 5.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.491 -0.559 . . . . 0.48 109.491 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.472 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 46.6 48.6 17.12 Favored Glycine 0 N--CA 1.446 -0.636 0 O-C-N 124.374 1.047 . . . . 0.33 113.585 170.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.01 111.83 19.22 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.808 0.813 . . . . 0.84 109.728 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -137.7 169.44 17.78 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.141 -1.391 . . . . 0.22 112.326 -172.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.502 ' CG ' HD11 ' A' ' 5' ' ' LEU . 19.3 m-85 -141.25 134.84 30.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.656 -0.702 . . . . 0.54 110.241 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.555 HD12 ' HB ' ' A' ' 161' ' ' THR . 81.1 mt -58.62 117.83 2.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.507 -0.77 . . . . 0.17 110.695 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.53 HG21 ' HA ' ' A' ' 22' ' ' PHE . 22.4 pt -82.87 -43.56 18.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 112.604 0.594 . . . . 0.21 112.604 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.564 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 52.9 m-80 -170.7 168.97 7.27 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.787 -1.56 . . . . 2.03 106.787 -170.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.576 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -133.95 152.97 52.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.207 -0.597 . . . . 1.52 111.944 -175.114 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 50.7 tt0 -128.46 103.0 6.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.45 -0.796 . . . . 0.59 110.161 175.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.461 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 38.0 ttt180 -62.92 166.85 5.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.334 -0.848 . . . . 2.82 110.411 173.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.497 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 19.9 m-80 -35.32 103.51 0.24 Allowed Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 125.097 1.359 . . . . 0.35 113.373 -156.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.497 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.8 Cg_endo -60.93 -32.19 92.26 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.026 2.484 . . . . 0.48 111.084 172.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.49 -39.16 2.93 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.94 -0.864 . . . . 0.67 110.94 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -73.74 -177.2 34.95 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 121.082 -0.58 . . . . 0.62 112.542 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.64 7.73 0.11 Allowed 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 125.117 3.878 . . . . 0.94 115.436 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' A' ' 109' ' ' GLY . 12.6 m-85 -73.08 13.83 0.36 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 112.244 0.461 . . . . 1.23 112.244 -174.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.759 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 75.32 63.64 2.46 Favored Glycine 0 CA--C 1.5 -0.87 0 C-N-CA 119.737 -1.221 . . . . 1.69 115.298 170.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.558 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.76 -2.68 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 117.334 2.346 . . . . 0.48 117.334 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.5 OUTLIER -164.63 160.79 20.44 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.426 -0.796 . . . . 0.28 110.372 -175.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 24.4 t-105 -141.62 98.67 3.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.693 -0.854 . . . . 0.49 108.693 168.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 103' ' ' ARG . 2.4 mt -90.69 114.49 26.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.342 0.591 . . . . 0.66 109.428 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.44 ' C ' HG12 ' A' ' 101' ' ' ILE . 14.5 m -84.8 144.83 28.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.014 -0.539 . . . . 0.19 111.384 -170.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.781 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -109.58 168.98 9.0 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.32 -0.4 . . . . 0.13 111.145 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.749 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -60.68 -10.87 5.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.074 0.768 . . . . 1.17 113.074 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.548 ' HG3' ' H ' ' A' ' 122' ' ' HIS . 14.8 tppt? -127.38 131.38 50.34 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.642 0.734 . . . . 1.22 110.185 171.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.467 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 8.5 pt20 -47.44 -31.61 4.3 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.323 -1.762 . . . . 1.51 114.872 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.548 ' H ' ' HG3' ' A' ' 120' ' ' LYS . 60.5 m80 -97.37 -8.48 29.46 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.692 -0.803 . . . . 2.53 112.312 -177.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.781 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.4 m-30 -94.82 40.07 1.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.185 1.18 . . . . 0.84 114.185 -168.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.694 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -112.0 145.17 17.85 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 116.376 -2.821 . . . . 0.32 112.509 -153.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.32 115.99 37.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.787 0.803 . . . . 0.18 110.762 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.643 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.3 p80 -145.12 172.2 13.43 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.344 -0.844 . . . . 0.21 109.462 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.759 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.28 -168.2 38.76 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 120.157 -1.021 . . . . 0.27 111.724 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.524 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 8.7 t -154.6 171.45 19.45 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.908 -0.76 . . . . 0.41 111.325 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -113.48 -11.44 13.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.564 -0.902 . . . . 1.99 108.564 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -107.45 86.97 3.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.216 -1.031 . . . . 1.36 108.216 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.37 -18.6 29.75 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.355 2.037 . . . . 0.35 112.906 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.46 -0.12 40.28 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.402 -0.817 . . . . 0.33 111.077 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.473 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 98.2 p -91.59 -6.58 52.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.022 -0.733 . . . . 1.35 109.022 171.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 83' ' ' PRO . 40.5 mm -78.82 135.69 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.399 -0.819 . . . . 0.21 110.141 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.18 0.71 70.48 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.366 -1.093 . . . . 0.15 110.366 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 50.3 mttm -115.02 176.31 5.12 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 123.629 1.68 . . . . 2.5 114.088 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -105.61 129.31 53.88 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.655 -2.975 . . . . 0.17 108.157 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.469 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -125.22 158.85 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.95 -0.759 . . . . 0.66 108.95 -175.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 67.9 m -47.45 -59.61 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.712 0.634 . . . . 0.43 112.712 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -131.44 -44.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.014 -1.075 . . . . 2.02 113.304 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.27 132.7 0.21 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 117.082 1.593 . . . . 0.18 117.082 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.489 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.9 p -71.5 165.15 24.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.359 -1.921 . . . . 0.16 111.874 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.89 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 60.6 mt -59.83 98.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 114.841 -1.072 . . . . 0.4 111.857 -163.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.643 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 74.8 mtt180 -84.52 149.58 25.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.676 -1.602 . . . . 1.87 110.33 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.643 ' HG2' HG22 ' A' ' 84' ' ' ILE . 15.9 mtp -129.29 -165.4 1.51 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.002 -0.74 . . . . 0.79 109.002 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.645 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 3.5 t-160 -96.28 157.36 15.93 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.59 -0.893 . . . . 2.32 108.59 171.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.644 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.9 m-80 -59.03 -51.07 71.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 118.285 -0.864 . . . . 0.68 110.549 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -64.42 -27.09 68.76 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 121.562 1.983 . . . . 2.18 112.491 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.645 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 5.8 m-20 -79.03 -43.23 24.68 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.048 0.452 . . . . 0.69 110.658 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.638 HG13 HD12 ' A' ' 151' ' ' ILE . 14.4 p -69.08 -23.85 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.645 -0.707 . . . . 0.11 111.539 177.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.06 -42.09 18.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 119.126 -0.464 . . . . 0.38 109.954 171.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 156' ' ' ILE . 22.5 mt-10 -46.79 -69.42 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 119.058 0.845 . . . . 1.99 112.407 170.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 157' ' ' VAL . 37.0 mt -47.71 -40.2 19.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.509 0.671 . . . . 1.27 111.517 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.68 -35.6 76.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.21 -1.359 . . . . 0.18 111.41 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.8 t -87.29 -29.77 21.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.603 0.638 . . . . 0.21 112.521 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.6 mt -84.87 -60.38 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.471 0.653 . . . . 0.16 112.025 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.1 m -90.51 143.01 28.6 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 114.994 -1.003 . . . . 0.16 112.161 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.424 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 44.0 Cg_endo -91.91 176.1 1.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 124.273 3.315 . . . . 0.2 111.378 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 77.0 m-20 -66.92 157.94 31.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.554 -0.859 . . . . 1.1 109.454 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 95.85 -16.64 60.79 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.238 -0.982 . . . . 0.18 112.02 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.555 ' HB ' HD12 ' A' ' 100' ' ' ILE . 91.5 m -66.38 139.0 57.98 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.199 -0.667 . . . . 0.14 109.199 -175.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.492 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 2.2 ptt180 -92.69 117.72 30.29 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.665 1.221 . . . . 3.63 110.932 -169.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.77 107.2 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 111.992 -2.367 . . . . 0.14 108.806 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.4 m -95.24 109.48 21.59 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.609 0.596 . . . . 0.21 112.609 -170.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.472 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.48 100.58 7.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 122.215 1.007 . . . . 0.24 110.062 178.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -109.44 134.64 51.61 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.234 -1.348 . . . . 1.09 109.795 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.584 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.7 mmm180 -73.26 -27.91 61.84 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.867 -0.42 . . . . 2.08 109.867 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 156.52 65.25 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.836 -0.62 . . . . 1.97 112.066 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 C--N 1.323 -0.584 0 N-CA-C 110.611 -0.144 . . . . 3.91 110.611 -178.591 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.896 -0.482 . . . . 2.8 111.896 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -152.37 140.79 20.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.131 -0.322 . . . . 4.44 110.131 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -116.91 133.04 56.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.126 -0.488 . . . . 2.46 110.577 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -105.25 174.66 5.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.33 0.586 . . . . 0.65 111.851 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.8 tt -99.69 129.53 45.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.018 -0.992 . . . . 0.28 110.32 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.39 162.2 13.59 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.02 0.914 . . . . 0.31 112.88 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.652 ' HB3' HG13 ' A' ' 46' ' ' ILE . 80.9 t80 -130.38 143.84 51.02 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.106 -1.406 . . . . 0.44 108.122 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -114.74 114.53 25.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.464 -0.939 . . . . 0.76 108.464 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 41' ' ' THR . 95.2 t -67.97 151.44 10.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 122.383 1.087 . . . . 0.39 113.611 -171.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -106.55 158.47 16.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.359 -1.746 . . . . 2.01 108.392 172.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -61.89 115.42 4.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.058 0.456 . . . . 1.83 111.799 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.33 12.86 47.15 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.976 -0.63 . . . . 0.48 113.255 173.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' HB3' HG13 ' A' ' 9' ' ' VAL . 1.8 p-10 -50.63 170.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.019 0.914 . . . . 1.46 111.864 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.8 150.02 52.17 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.186 -0.915 . . . . 0.41 110.959 169.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.646 HD13 ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -64.66 -34.27 77.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.519 -1.219 . . . . 0.86 108.242 -178.204 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.523 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 4.2 t30 -85.02 -27.74 26.2 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.621 -1.172 . . . . 1.15 111.192 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.9 t -65.32 -42.31 93.11 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.307 -0.557 . . . . 1.21 109.921 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.6 mt -74.4 -25.93 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 121.381 0.61 . . . . 0.21 109.822 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.655 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.93 -9.94 59.66 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.269 -0.423 . . . . 0.16 110.793 174.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.645 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.45 -40.14 9.23 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.399 1.095 . . . . 0.21 108.079 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -61.84 -40.89 96.91 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 112.885 -1.962 . . . . 0.53 111.897 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.563 ' HA ' HG21 ' A' ' 101' ' ' ILE . 65.5 m-85 -101.46 5.51 42.03 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 118.611 -1.235 . . . . 0.18 111.872 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.9 mpt_? 54.53 40.43 31.82 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.828 0.823 . . . . 1.78 109.553 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.0 pt -112.99 -165.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.486 -1.234 . . . . 0.19 109.957 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.32 142.26 42.2 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.086 -0.961 . . . . 0.95 110.106 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.652 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 43.4 p -72.95 -30.7 64.06 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.383 -0.969 . . . . 0.25 108.383 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.3 -24.25 67.59 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.559 -0.746 . . . . 0.2 111.872 170.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.35 -29.2 14.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.993 -0.743 . . . . 0.17 108.993 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.594 HD23 HD23 ' A' ' 15' ' ' LEU . 21.7 tp -71.9 -28.49 63.53 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.96 -1.018 . . . . 1.16 108.414 172.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.652 ' HB2' ' O ' ' A' ' 26' ' ' THR . 8.2 tp -76.75 -31.73 57.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.939 0.876 . . . . 1.05 109.575 175.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 44.6 tt0 -65.9 -43.23 88.81 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.112 -1.404 . . . . 1.81 110.603 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.422 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -80.35 -17.98 50.41 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.193 -0.603 . . . . 0.2 111.42 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.615 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 38.7 m-80 -144.21 81.59 11.37 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-O 121.554 0.692 . . . . 0.23 110.641 -173.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.6 Cg_endo -56.57 -10.07 4.64 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 124.124 3.216 . . . . 0.36 113.829 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.5 m -79.0 -24.84 43.44 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 122.097 -0.377 . . . . 1.38 111.409 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.615 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 61.5 mt -67.12 -33.38 75.34 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.553 0.692 . . . . 0.49 111.92 -170.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.524 ' HB3' HD11 ' A' ' 30' ' ' LEU . 1.7 pp0? -64.82 -44.92 88.32 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 122.742 1.258 . . . . 1.95 110.591 -174.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.98 -47.62 76.93 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 111.772 -2.467 . . . . 0.49 110.752 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.9 178.01 48.64 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.923 -1.035 . . . . 0.42 112.139 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' HG ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -110.99 159.02 18.12 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.109 0.481 . . . . 0.41 110.628 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 62.6 m -145.08 129.03 17.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.866 -0.606 . . . . 0.42 111.378 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.31 120.83 22.1 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.441 0.638 . . . . 0.47 110.057 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.83 0.49 57.55 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.215 -1.154 . . . . 0.41 110.215 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.631 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -75.84 125.31 28.84 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.925 -0.638 . . . . 1.3 109.842 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 35.1 p -81.03 131.16 35.29 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.778 0.799 . . . . 0.85 110.023 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.652 HG13 ' HB3' ' A' ' 7' ' ' TYR . 12.2 pt -131.28 140.64 47.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.354 -1.293 . . . . 0.25 109.259 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.91 150.29 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.964 0.411 . . . . 0.67 110.853 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.416 HG21 ' CD2' ' A' ' 22' ' ' PHE . 37.1 mm -114.71 93.18 32.36 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 114.91 -1.041 . . . . 0.16 109.172 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.638 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -59.67 134.23 56.37 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.862 2.375 . . . . 0.18 113.029 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.36 -6.25 80.79 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.932 -1.031 . . . . 0.26 112.266 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.707 HD12 ' HD2' ' A' ' 52' ' ' PRO . 32.6 tp -122.64 115.69 29.53 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-O 121.26 0.553 . . . . 0.61 111.398 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.707 ' HD2' HD12 ' A' ' 51' ' ' LEU . 53.5 Cg_endo -79.16 -177.41 3.87 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.668 2.912 . . . . 0.28 114.288 -172.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.599 ' HB3' HG23 ' A' ' 56' ' ' THR . 14.1 t70 -77.42 134.43 66.42 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.015 -1.448 . . . . 0.49 112.552 -170.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.4 -15.78 24.87 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.683 2.922 . . . . 0.46 113.279 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -95.96 -9.36 31.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.43 0.633 . . . . 1.38 111.309 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.599 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.0 p -85.74 -18.47 32.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.053 0.93 . . . . 0.46 108.713 173.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 59' ' ' TYR . 7.8 mm -63.99 125.43 87.95 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 113.638 -1.619 . . . . 0.7 109.755 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.74 -13.53 13.09 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.984 1.789 . . . . 0.39 112.699 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.654 ' H ' HG22 ' A' ' 57' ' ' ILE . 58.7 m-85 -103.45 169.79 8.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.892 0.377 . . . . 0.24 111.756 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -154.13 127.76 8.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.701 -0.851 . . . . 2.89 108.701 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 71' ' ' THR . 93.6 mt -107.19 130.92 58.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.831 -0.622 . . . . 0.16 111.352 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.08 115.39 26.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.781 -0.768 . . . . 0.16 110.882 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 48.2 t -95.89 116.28 37.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.641 0.734 . . . . 0.19 111.053 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 68' ' ' LYS . 51.9 m -94.61 105.18 17.13 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.016 -0.993 . . . . 0.2 110.401 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.557 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.0 mm -53.59 -58.53 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 122.13 0.967 . . . . 0.23 111.104 167.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 169' ' ' SER . . . -59.05 -8.68 6.36 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 112.941 -1.936 . . . . 0.16 113.049 -175.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.73 -17.72 4.92 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.589 0.756 . . . . 0.15 112.359 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.512 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.55 57.52 4.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.473 0.579 . . . . 0.69 111.302 -173.346 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 57.3 p -138.88 160.93 38.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 112.899 0.703 . . . . 0.13 112.899 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.465 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -129.07 113.44 15.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.538 -1.21 . . . . 0.4 109.999 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 9.9 m -94.05 122.86 37.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.081 0.467 . . . . 0.16 111.135 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.8 tp -99.03 103.22 15.14 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.367 -0.833 . . . . 0.59 109.455 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 19.5 m -105.18 159.83 15.55 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.406 -0.918 . . . . 1.05 110.594 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -128.11 127.88 43.85 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.993 -0.743 . . . . 0.26 108.993 168.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.582 ' N ' HD22 ' A' ' 74' ' ' LEU . 6.3 m-80 53.98 44.44 29.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.792 -1.095 . . . . 1.84 110.78 -174.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 71.37 -4.31 1.87 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.57 -0.741 . . . . 1.89 111.558 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -102.77 120.85 41.31 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.681 -0.69 . . . . 3.44 110.119 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 62.9 t -57.98 133.31 22.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 122.296 1.046 . . . . 0.24 112.527 -175.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 14.5 mtm -103.04 -43.43 5.5 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 113.32 -1.764 . . . . 0.81 109.329 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -159.41 171.43 19.76 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 113.297 -1.774 . . . . 1.46 110.014 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.1 m -149.1 123.68 9.77 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.091 -1.413 . . . . 0.17 109.748 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -113.61 146.42 35.42 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.694 -0.685 . . . . 1.05 110.303 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.434 ' HB2' HG22 ' A' ' 134' ' ' ILE . 35.0 Cg_endo -72.59 142.2 35.84 Favored 'Trans proline' 0 CA--C 1.495 -1.438 0 C-N-CA 122.038 1.825 . . . . 0.2 110.775 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.583 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.38 172.64 11.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.828 -0.624 . . . . 0.13 110.853 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.928 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.93 140.32 49.89 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 110.032 -0.359 . . . . 0.26 110.032 -176.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.512 HG22 ' HG3' ' A' ' 68' ' ' LYS . 9.6 m -122.91 126.19 73.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.508 0.67 . . . . 0.56 111.672 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -80.58 150.42 31.35 Favored Glycine 0 N--CA 1.423 -2.168 0 N-CA-C 109.544 -1.423 . . . . 0.17 109.544 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -57.7 4.74 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.951 0.723 . . . . 3.05 112.951 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.922 HG23 HD22 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -89.13 -18.72 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-O 121.546 0.689 . . . . 0.23 110.081 178.497 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.922 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -88.96 -17.28 29.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.793 0.806 . . . . 0.18 109.115 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.1 p -66.39 -18.49 65.39 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.535 -1.212 . . . . 0.33 111.302 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.73 -42.11 92.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.774 -1.103 . . . . 1.52 112.165 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.61 134.66 19.55 Favored Pre-proline 0 C--N 1.325 -0.497 0 C-N-CA 120.539 -0.465 . . . . 0.43 110.889 -175.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.523 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 84.7 Cg_endo -87.55 -16.1 3.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.472 2.114 . . . . 0.73 112.437 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.7 t -107.97 -38.75 5.73 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.31 -0.626 . . . . 0.48 109.31 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 45.16 31.93 3.27 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 124.785 1.303 . . . . 0.33 113.799 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB3' HG23 ' A' ' 164' ' ' THR . 8.2 pt-20 -84.55 115.74 22.77 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 122.801 1.286 . . . . 0.84 109.174 -173.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 13.2 m-85 -136.46 179.47 6.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 112.89 -1.959 . . . . 0.22 111.305 -167.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 45.7 m-85 -140.1 134.31 31.12 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.217 -0.447 . . . . 0.54 110.445 -172.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.609 HD12 ' HB ' ' A' ' 161' ' ' THR . 93.0 mt -61.58 118.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.413 -0.812 . . . . 0.17 110.511 171.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.563 HG21 ' HA ' ' A' ' 22' ' ' PHE . 24.1 pt -84.18 -44.54 18.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 112.816 0.673 . . . . 0.21 112.816 -176.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.535 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 54.5 m-80 -171.99 171.14 5.14 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.042 -1.836 . . . . 2.03 106.042 -168.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.942 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 3.4 mtt180 -130.51 174.59 9.74 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.433 -0.907 . . . . 1.52 112.167 -174.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -149.64 100.78 3.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.628 -1.169 . . . . 0.59 109.838 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.501 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 26.9 ttt85 -64.09 166.58 7.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.47 -0.786 . . . . 2.82 110.446 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.501 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 18.6 m-80 -34.77 102.64 0.23 Allowed Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 125.296 1.438 . . . . 0.35 113.315 -157.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.5 Cg_endo -60.41 -32.27 93.69 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.107 2.538 . . . . 0.48 111.289 174.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.23 -37.19 3.58 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 111.099 -0.8 . . . . 0.67 111.099 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.75 -176.91 46.31 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.163 -0.519 . . . . 0.62 112.742 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.3 7.76 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 125.281 3.988 . . . . 0.94 115.631 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -72.1 12.86 0.36 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 111.973 0.36 . . . . 1.23 111.973 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.71 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 75.46 64.03 2.36 Favored Glycine 0 CA--C 1.499 -0.912 0 C-N-CA 119.647 -1.263 . . . . 1.69 114.971 170.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 37.48 0.23 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 117.57 2.433 . . . . 0.48 117.57 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -166.28 159.72 15.22 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.43 -0.794 . . . . 0.28 110.289 -177.187 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -140.37 98.1 3.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.449 -0.945 . . . . 0.49 108.449 167.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.57 HD12 HG23 ' A' ' 150' ' ' VAL . 2.6 mt -90.04 115.49 27.36 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.709 -0.62 . . . . 0.66 109.524 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 101' ' ' ILE . 17.4 m -84.81 143.49 29.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.953 -0.567 . . . . 0.19 111.609 -169.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.77 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.82 169.68 8.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.543 . . . . 0.13 111.374 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 t -63.77 -9.82 16.53 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.036 -0.984 . . . . 1.17 113.299 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.578 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 9.1 tptm -127.86 134.76 49.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.547 -0.461 . . . . 1.22 110.564 171.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.517 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 29.9 mm-40 -33.68 -59.61 0.39 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.982 1.105 . . . . 1.51 113.982 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.489 ' CB ' HG12 ' A' ' 89' ' ' ILE . 64.5 m80 -87.64 -2.32 58.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.313 -0.555 . . . . 2.53 111.703 -169.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.77 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -93.97 38.57 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.001 1.112 . . . . 0.84 114.001 -171.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.603 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -113.67 145.08 18.35 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 117.089 -2.482 . . . . 0.32 112.617 -154.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.518 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -98.98 115.32 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.891 0.853 . . . . 0.18 110.833 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.561 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 31.0 p80 -144.43 171.88 13.73 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.08 -0.964 . . . . 0.21 109.886 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.71 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.36 -167.93 38.55 Favored Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.422 -0.894 . . . . 0.27 111.723 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.554 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 12.5 t -154.86 170.34 21.89 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.013 -0.698 . . . . 0.41 110.551 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -115.01 -5.32 12.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.982 0.896 . . . . 1.99 108.639 175.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -112.45 88.53 11.11 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 114.46 -1.246 . . . . 1.36 108.307 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.27 -18.25 26.87 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.438 2.092 . . . . 0.35 113.474 -170.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.03 -0.55 35.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.852 -0.613 . . . . 0.33 111.389 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 78.9 p -90.86 -9.13 47.46 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.054 -0.721 . . . . 1.35 109.054 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 83' ' ' PRO . 37.3 mm -78.95 136.75 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.259 -0.882 . . . . 0.21 110.263 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.09 -0.04 75.04 Favored Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 110.366 -1.094 . . . . 0.15 110.366 -176.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -112.04 170.08 8.4 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 123.071 1.415 . . . . 2.5 114.098 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.32 124.14 46.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 111.969 -2.378 . . . . 0.17 108.154 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.415 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -120.91 159.95 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.36 -0.978 . . . . 0.66 108.36 -173.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.5 m -50.62 -59.35 4.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.508 0.558 . . . . 0.43 112.508 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -132.03 -45.1 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 118.633 -1.227 . . . . 2.02 113.851 -174.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.36 133.19 0.2 Allowed Glycine 0 N--CA 1.466 0.692 0 N-CA-C 117.232 1.653 . . . . 0.18 117.232 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.442 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.9 p -70.95 165.4 23.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 112.471 -1.865 . . . . 0.16 112.348 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.928 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 66.7 mt -60.15 98.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 122.449 1.118 . . . . 0.4 112.056 -163.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.561 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 13.1 mtp180 -85.34 145.62 27.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.523 -1.672 . . . . 1.87 110.493 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.583 ' HG2' HG22 ' A' ' 84' ' ' ILE . 18.3 mtp -125.03 -164.81 1.32 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.717 -0.846 . . . . 0.79 108.717 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.593 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 89.2 m-70 -93.65 161.64 14.27 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.629 -0.508 . . . . 2.32 109.629 170.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -60.43 -51.96 67.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 118.744 -0.646 . . . . 0.68 109.726 178.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -64.18 -27.04 68.8 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 120.782 1.628 . . . . 2.18 112.244 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.593 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 68.8 m-20 -77.45 -46.68 21.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.261 0.553 . . . . 0.69 110.489 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.641 HG13 HD12 ' A' ' 151' ' ' ILE . 14.2 p -67.19 -22.8 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.222 -0.899 . . . . 0.11 111.754 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.641 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -84.27 -41.78 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 119.087 -0.482 . . . . 0.38 110.071 171.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 156' ' ' ILE . 24.6 mt-10 -49.26 -66.16 0.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 119.23 0.923 . . . . 1.99 112.278 170.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.47 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.3 mp -48.69 -35.02 13.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.612 0.72 . . . . 1.27 111.125 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.516 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -66.38 -31.17 71.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.624 -1.171 . . . . 0.18 111.4 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.2 t -88.28 -31.86 18.78 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.581 -0.7 . . . . 0.21 112.696 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.1 mt -84.95 -61.21 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.457 0.646 . . . . 0.16 112.33 -171.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -90.55 145.38 32.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.012 -0.994 . . . . 0.16 111.792 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.942 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 19.0 Cg_endo -95.12 178.32 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 124.901 3.734 . . . . 0.2 111.752 174.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 80.0 m-20 -68.66 158.23 34.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.227 -0.989 . . . . 1.1 108.966 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.12 -14.11 65.82 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.056 -1.069 . . . . 0.18 111.869 -173.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.609 ' HB ' HD12 ' A' ' 100' ' ' ILE . 85.2 m -66.73 139.01 57.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.44 -0.578 . . . . 0.14 109.44 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 2.0 ptt180 -92.34 115.69 28.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 122.726 1.251 . . . . 3.63 110.815 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.4 t -106.11 108.42 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 112.21 -2.268 . . . . 0.14 109.122 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.539 HG23 ' HB3' ' A' ' 97' ' ' GLU . 3.8 m -97.08 108.57 21.33 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 112.859 0.689 . . . . 0.21 112.859 -171.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.486 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -83.72 94.46 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 122.573 1.177 . . . . 0.24 110.327 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.406 ' O ' HG12 ' A' ' 65' ' ' ILE . 79.5 m-20 -104.9 142.38 34.86 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.234 -1.348 . . . . 1.09 109.86 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.557 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.8 mmm180 -80.74 15.73 1.64 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.957 0.408 . . . . 2.08 110.49 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.93 131.88 52.27 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.402 -0.817 . . . . 1.97 112.611 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.458 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 13.0 m . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 110.237 -0.282 . . . . 3.91 110.237 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 112.165 -0.374 . . . . 2.8 112.165 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -120.01 165.56 14.52 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.859 -0.423 . . . . 4.44 109.859 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -110.57 98.99 8.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.977 0.418 . . . . 2.46 110.106 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 tp -94.48 175.09 6.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.648 -0.706 . . . . 0.65 111.578 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.699 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.5 tt -91.58 129.97 37.47 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.283 -0.872 . . . . 0.28 110.757 -174.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.77 162.03 13.33 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.3 1.048 . . . . 0.31 113.067 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 45' ' ' SER . 70.9 t80 -132.54 142.82 49.35 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.432 -1.713 . . . . 0.44 108.057 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.426 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 34.0 tt0 -113.97 113.22 24.52 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.05 -1.092 . . . . 0.76 108.05 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.651 HG13 ' HB2' ' A' ' 13' ' ' ASP . 95.9 t -66.13 149.5 11.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.327 1.06 . . . . 0.39 113.039 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -104.06 158.74 16.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.307 -1.769 . . . . 2.01 108.479 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.48 109.26 0.85 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.731 0.301 . . . . 1.83 111.235 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.66 10.2 50.78 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.807 -0.633 . . . . 0.48 113.925 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.651 ' HB2' HG13 ' A' ' 9' ' ' VAL . 43.9 m-20 -55.45 169.14 0.32 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.371 0.586 . . . . 1.46 110.865 172.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.32 152.43 50.58 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.562 0.696 . . . . 0.41 112.26 174.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.675 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -67.52 -29.76 69.25 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.184 -1.371 . . . . 0.86 109.901 -177.154 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.497 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 5.4 t30 -93.49 -24.99 17.8 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.879 -1.055 . . . . 1.15 110.669 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 t -69.22 -39.55 78.51 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.36 -0.607 . . . . 1.21 109.36 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.434 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.5 mt -72.93 -26.59 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.219 0.533 . . . . 0.21 109.688 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.25 -9.93 59.69 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.2 -0.312 . . . . 0.16 110.987 175.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.622 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.99 -39.33 9.41 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.609 1.195 . . . . 0.21 108.148 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 119' ' ' SER . 11.2 m-20 -63.66 -44.78 92.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.536 -2.12 . . . . 0.53 112.041 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.556 ' HA ' HG21 ' A' ' 101' ' ' ILE . 64.4 m-85 -97.96 4.97 49.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 118.57 -1.252 . . . . 0.18 111.613 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.622 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.1 mpt_? 54.04 46.92 24.49 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.782 0.801 . . . . 1.78 109.947 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.64 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.0 pt -118.38 -165.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 114.45 -1.25 . . . . 0.19 109.902 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.02 142.2 41.77 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.06 -0.973 . . . . 0.95 109.746 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.675 ' HB ' HD11 ' A' ' 15' ' ' LEU . 71.4 p -73.14 -33.19 65.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.166 -1.05 . . . . 0.25 108.166 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.22 -27.45 67.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.2 -0.909 . . . . 0.2 111.55 169.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -92.24 -28.32 17.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.914 -0.773 . . . . 0.17 108.914 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.646 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 21.3 tp -73.84 -26.95 60.85 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.328 -0.851 . . . . 1.16 109.47 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 26' ' ' THR . 43.1 mt -78.54 -31.28 47.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.835 0.826 . . . . 1.05 109.699 172.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 43.3 tt0 -63.98 -38.97 93.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.364 -1.289 . . . . 1.81 110.154 173.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -85.08 -20.94 29.61 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 119.965 -0.694 . . . . 0.2 111.591 176.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.632 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.1 m-80 -149.12 82.73 6.93 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-O 121.195 0.522 . . . . 0.23 110.466 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.7 Cg_endo -56.93 -11.73 7.95 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.928 3.086 . . . . 0.36 113.013 175.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -77.35 -19.86 55.67 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.223 -0.444 . . . . 1.38 112.017 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.876 HD21 HG21 ' A' ' 46' ' ' ILE . 38.2 mt -77.03 -34.03 57.34 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.318 0.58 . . . . 0.49 112.137 -171.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.421 ' H ' ' HG3' ' A' ' 37' ' ' GLN . 1.7 pp0? -63.24 -46.01 88.89 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 122.768 1.27 . . . . 1.95 110.926 -170.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.43 86.58 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 112.067 -2.333 . . . . 0.49 111.016 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.81 178.43 48.44 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 114.731 -1.122 . . . . 0.42 110.94 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.86 157.62 21.18 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.264 0.554 . . . . 0.41 111.186 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 47.0 m -138.06 127.94 25.46 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.161 -0.927 . . . . 0.42 110.299 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 120.56 21.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.348 0.594 . . . . 0.47 109.669 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.426 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 99.6 -0.51 56.77 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.305 -1.118 . . . . 0.41 110.305 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.4 tt0 -74.86 125.28 28.49 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 114.892 -0.654 . . . . 1.3 109.518 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 43.0 m -86.25 132.6 33.95 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.603 0.716 . . . . 0.85 109.877 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.876 HG21 HD21 ' A' ' 36' ' ' LEU . 12.1 pt -133.1 143.39 39.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.414 -1.266 . . . . 0.25 109.327 -176.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.468 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.67 151.48 3.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.079 0.466 . . . . 0.67 110.96 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.8 mm -115.41 91.97 30.76 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.706 -1.133 . . . . 0.16 109.31 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.623 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.1 Cg_endo -58.15 134.36 61.41 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.898 2.399 . . . . 0.18 112.741 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.43 -5.91 77.74 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.766 -1.106 . . . . 0.26 112.405 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.696 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 21.3 tp -129.21 120.29 20.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 121.048 0.451 . . . . 0.61 111.407 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.699 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_endo -80.91 -177.81 3.98 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.488 2.792 . . . . 0.28 114.166 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.58 ' HB3' HG23 ' A' ' 56' ' ' THR . 13.6 t70 -74.49 134.11 76.62 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 114.265 -1.334 . . . . 0.49 112.915 -168.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.91 -15.4 16.69 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 124.105 3.203 . . . . 0.46 112.951 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -95.38 -16.05 22.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.918 0.39 . . . . 1.38 111.131 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.58 HG23 ' HB3' ' A' ' 53' ' ' ASP . 22.2 p -79.04 -13.95 59.46 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.96 0.886 . . . . 0.46 109.445 175.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.568 HG22 ' H ' ' A' ' 59' ' ' TYR . 14.6 mm -63.86 126.08 89.17 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 113.813 -1.539 . . . . 0.7 110.193 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.2 -15.04 11.71 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.342 2.028 . . . . 0.39 112.895 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.568 ' H ' HG22 ' A' ' 57' ' ' ILE . 66.2 m-85 -100.08 174.02 6.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.894 0.378 . . . . 0.24 110.794 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -157.08 132.88 9.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.064 -0.717 . . . . 2.89 109.064 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.688 ' HA ' ' O ' ' A' ' 71' ' ' THR . 89.5 mt -113.66 134.68 55.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.132 -0.486 . . . . 0.16 111.497 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.01 116.09 26.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.829 -0.748 . . . . 0.16 111.018 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.6 t -96.46 113.96 32.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.669 0.747 . . . . 0.19 111.066 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 68' ' ' LYS . 49.6 m -91.52 108.48 19.92 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.071 -0.968 . . . . 0.2 110.62 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.56 HD13 HG11 ' A' ' 86' ' ' VAL . 50.6 mm -54.97 -59.69 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 122.038 0.923 . . . . 0.23 111.001 166.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.8 -13.86 6.78 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 112.846 -1.979 . . . . 0.16 113.071 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -125.02 -16.45 6.07 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 123.196 0.598 . . . . 0.15 112.491 -178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER 56.27 55.53 6.6 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.747 0.703 . . . . 0.69 111.493 -174.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.9 p -138.25 162.02 35.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.805 0.669 . . . . 0.13 112.805 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.485 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.9 tt -129.89 113.06 14.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.893 -1.049 . . . . 0.4 110.062 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.688 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.2 m -93.13 122.86 35.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.097 0.475 . . . . 0.16 111.228 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.417 HD21 ' HE3' ' A' ' 79' ' ' MET . 14.1 tp -100.39 106.11 17.67 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.318 -0.855 . . . . 0.59 109.764 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 89.1 p -107.68 161.29 15.01 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.185 -1.006 . . . . 1.05 110.735 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.625 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.1 tm? -128.46 129.38 46.03 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.781 -0.822 . . . . 0.26 108.781 169.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.625 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.5 p-10 46.98 46.13 15.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.345 -1.298 . . . . 1.84 111.181 -166.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 73.55 -8.53 1.35 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.84 -1.073 . . . . 1.89 111.785 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -94.96 119.82 34.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.767 -0.651 . . . . 3.44 109.776 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 68.4 t -58.38 133.43 23.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 122.392 1.092 . . . . 0.24 112.33 -174.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.417 ' HE3' HD21 ' A' ' 72' ' ' LEU . 18.6 mtm -102.56 -43.51 5.6 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.165 -1.834 . . . . 0.81 109.26 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -160.23 173.11 16.22 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.311 -1.768 . . . . 1.46 110.408 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.4 m -149.86 124.53 9.77 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 113.999 -1.455 . . . . 0.17 109.604 173.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -116.42 146.28 37.07 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.821 -0.627 . . . . 1.05 109.904 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.456 ' HB2' HG22 ' A' ' 134' ' ' ILE . 37.9 Cg_endo -72.07 142.86 39.11 Favored 'Trans proline' 0 CA--C 1.494 -1.477 0 C-N-CA 122.34 2.026 . . . . 0.2 111.26 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.665 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.94 173.71 8.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.665 -0.698 . . . . 0.13 110.609 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.887 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.63 147.39 43.81 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.989 -0.375 . . . . 0.26 109.989 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.56 HG11 HD13 ' A' ' 65' ' ' ILE . 8.1 m -128.2 127.66 67.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.714 0.769 . . . . 0.56 111.933 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -84.15 153.68 29.54 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 109.9 -1.28 . . . . 0.17 109.9 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -56.52 2.97 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.147 0.795 . . . . 3.05 113.147 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.94 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -87.76 -22.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.479 0.657 . . . . 0.23 110.503 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.94 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -87.49 -14.93 39.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.663 0.744 . . . . 0.18 109.314 -175.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.4 p -69.27 -17.47 63.75 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.72 -1.127 . . . . 0.33 111.278 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -67.6 -38.62 84.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.055 -0.975 . . . . 1.52 112.313 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 95' ' ' THR . 0.2 OUTLIER -107.02 109.4 63.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 120.415 -0.514 . . . . 0.43 111.171 -177.502 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.421 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 6.0 Cg_exo -73.79 -14.51 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.918 2.412 . . . . 0.73 113.381 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 93' ' ' THR . 9.2 t -91.96 -42.92 9.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.308 -0.627 . . . . 0.48 109.308 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.574 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 55.97 29.49 55.48 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.969 -1.469 . . . . 0.33 114.134 168.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.41 111.03 19.08 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.842 0.83 . . . . 0.84 109.396 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.675 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.0 m-85 -140.13 161.51 37.46 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.68 -1.6 . . . . 0.22 111.914 -172.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.691 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 16.0 m-85 -129.89 137.74 50.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.935 0.398 . . . . 0.54 110.719 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.619 HD12 ' HB ' ' A' ' 161' ' ' THR . 78.9 mt -60.52 121.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.476 -0.784 . . . . 0.17 110.971 172.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.556 HG21 ' HA ' ' A' ' 22' ' ' PHE . 22.0 pt -88.23 -34.88 7.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 113.243 0.831 . . . . 0.21 113.243 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.478 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 1.8 p-10 178.95 178.22 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.536 -1.283 . . . . 2.03 107.536 -176.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.513 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -134.75 154.6 51.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.558 0.694 . . . . 1.52 112.536 -174.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 49.0 tt0 -127.05 100.82 6.28 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.782 -1.099 . . . . 0.59 109.617 174.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.487 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 71.0 ttt180 -65.2 166.13 10.27 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.417 -0.811 . . . . 2.82 110.341 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.5 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 19.7 m-80 -35.42 103.33 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 125.24 1.416 . . . . 0.35 113.794 -155.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 8.4 Cg_endo -58.98 -39.38 81.33 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.861 2.374 . . . . 0.48 111.458 172.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.97 -31.7 5.59 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.763 -0.935 . . . . 0.67 110.763 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.99 -176.5 51.23 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 114.72 -0.74 . . . . 0.62 112.949 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.29 6.05 0.15 Allowed 'Trans proline' 0 N--CA 1.482 0.807 1 C-N-CA 125.41 4.073 . . . . 0.94 115.596 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -72.39 10.95 0.68 Allowed 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 111.846 0.313 . . . . 1.23 111.846 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.746 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 75.38 64.16 2.34 Favored Glycine 0 CA--C 1.497 -1.047 0 C-N-CA 119.688 -1.244 . . . . 1.69 115.212 170.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.37 -1.44 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.125 2.269 . . . . 0.48 117.125 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.487 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -165.31 157.38 15.21 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.328 -0.857 . . . . 0.28 110.305 -176.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 16.9 t-105 -138.32 97.88 3.48 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.31 -0.996 . . . . 0.49 108.31 167.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.524 HD12 HG23 ' A' ' 150' ' ' VAL . 2.6 mt -88.48 114.43 25.08 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.105 -0.702 . . . . 0.66 109.105 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.435 ' HB3' HD11 ' A' ' 101' ' ' ILE . 30.1 m -85.0 143.75 28.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.885 -0.598 . . . . 0.19 111.29 -169.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.79 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.4 170.78 7.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.13 111.113 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.5 t -61.6 -13.14 19.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.264 -0.88 . . . . 1.17 112.7 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.678 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.5 tmtp? -127.11 134.01 50.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.288 -0.565 . . . . 1.22 110.682 173.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.678 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 27.1 mt-30 -35.97 -56.91 0.71 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.559 -1.2 . . . . 1.51 114.166 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.588 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.9 OUTLIER -97.59 12.38 33.73 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.458 -0.897 . . . . 2.53 111.613 -172.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.79 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -97.63 37.28 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.01 0.744 . . . . 0.84 113.01 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.651 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.56 143.26 18.03 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 117.112 -2.471 . . . . 0.32 112.79 -152.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -94.38 115.22 32.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.818 0.818 . . . . 0.18 110.691 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 145' ' ' MET . 29.9 p80 -144.56 170.8 15.36 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.238 -0.892 . . . . 0.21 109.579 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.746 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.45 -168.46 38.6 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 120.184 -1.008 . . . . 0.27 112.073 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.49 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 13.8 t -155.89 173.75 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.216 -0.579 . . . . 0.41 111.008 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.98 -6.16 14.72 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.619 -0.882 . . . . 1.99 108.619 176.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -117.19 86.41 20.9 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 108.492 -0.929 . . . . 1.36 108.492 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.435 ' HA ' HG12 ' A' ' 134' ' ' ILE . 32.0 Cg_endo -74.23 -17.27 21.8 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.82 2.347 . . . . 0.35 113.894 -168.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.465 ' O ' ' HE2' ' A' ' 136' ' ' LYS . . . -78.69 -6.01 54.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.085 -0.507 . . . . 0.33 110.826 -177.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.9 t -88.71 -9.53 51.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.58 -0.896 . . . . 1.35 108.58 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 39.7 mm -76.88 138.92 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.127 -0.942 . . . . 0.21 109.581 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.49 3.01 78.66 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.793 -0.923 . . . . 0.15 110.793 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 132' ' ' ALA . 25.2 mttm -113.89 172.33 7.05 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 123.039 1.4 . . . . 2.5 113.755 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.07 126.33 50.2 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 111.895 -2.412 . . . . 0.17 108.006 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.42 160.23 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.025 -0.731 . . . . 0.66 109.025 -173.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.5 m -47.71 -61.0 2.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.521 0.563 . . . . 0.43 112.521 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 46.7 pttt -132.65 -44.2 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.783 -1.167 . . . . 2.02 113.623 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.08 132.51 0.2 Allowed Glycine 0 N--CA 1.466 0.665 0 N-CA-C 117.056 1.583 . . . . 0.18 117.056 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.577 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.0 p -71.09 165.42 23.56 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 112.164 -2.018 . . . . 0.16 112.02 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.887 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 53.8 mt -59.64 98.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 122.518 1.152 . . . . 0.4 112.114 -163.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.47 ' HB2' ' CD1' ' A' ' 134' ' ' ILE . 13.6 mtp180 -87.38 148.24 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.568 -1.651 . . . . 1.87 110.217 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.665 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.4 mtp -127.99 -164.8 1.41 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.773 -0.825 . . . . 0.79 108.773 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.713 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 29.6 t-80 -94.79 158.74 15.36 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.896 -0.779 . . . . 2.32 108.896 171.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 151' ' ' ILE . 0.9 OUTLIER -57.69 -53.26 60.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.397 -0.811 . . . . 0.68 110.408 -179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -63.15 -27.06 69.11 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 121.244 1.838 . . . . 2.18 112.427 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.713 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 4.6 m-20 -79.42 -44.48 21.31 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.147 0.499 . . . . 0.69 110.814 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.634 HG13 HD12 ' A' ' 151' ' ' ILE . 14.3 p -67.31 -23.6 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.488 -0.778 . . . . 0.11 111.589 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.634 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.34 -42.0 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 119.01 -0.519 . . . . 0.38 110.045 171.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 156' ' ' ILE . 25.3 mt-10 -47.52 -69.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.232 0.924 . . . . 1.99 112.365 170.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.572 ' O ' HG22 ' A' ' 157' ' ' VAL . 8.6 mp -46.31 -39.18 9.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.48 0.657 . . . . 1.27 111.261 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.8 78.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.424 -1.262 . . . . 0.18 111.724 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.1 t -87.69 -30.62 20.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 118.702 0.683 . . . . 0.21 112.284 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.0 mt -83.98 -60.14 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.43 0.633 . . . . 0.16 112.154 -172.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.6 m -87.38 143.32 34.13 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.026 -0.988 . . . . 0.16 112.129 178.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -89.74 172.9 3.77 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 124.128 3.219 . . . . 0.2 111.111 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.478 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 68.8 m-20 -67.67 157.26 34.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 118.955 -1.098 . . . . 1.1 109.037 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.36 -16.28 61.58 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.183 -1.008 . . . . 0.18 112.219 -172.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.619 ' HB ' HD12 ' A' ' 100' ' ' ILE . 98.5 m -63.98 139.71 58.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.12 0.486 . . . . 0.14 109.9 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.691 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -93.48 124.82 37.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.559 1.171 . . . . 3.63 111.63 -170.422 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.56 107.21 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 112.168 -2.287 . . . . 0.14 109.104 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.6 m -95.33 107.16 19.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 112.837 0.68 . . . . 0.21 112.837 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.574 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -80.84 107.14 12.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 122.153 0.978 . . . . 0.24 109.898 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -110.27 128.06 55.32 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.278 -1.328 . . . . 1.09 110.016 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.469 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 15.1 mmm-85 -71.62 -15.71 62.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.219 0.533 . . . . 2.08 110.042 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.04 17.49 22.64 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.244 -0.889 . . . . 1.97 111.788 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--N 1.323 -0.554 0 N-CA-C 110.228 -0.286 . . . . 3.91 110.228 -179.744 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 112.064 -0.414 . . . . 2.8 112.064 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.414 ' HG2' ' N ' ' A' ' 3' ' ' LYS . 72.7 ttt180 -149.84 158.34 44.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.869 -0.419 . . . . 4.44 109.869 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' N ' ' HG2' ' A' ' 2' ' ' ARG . 7.3 mmpt? -85.26 152.3 23.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.192 0.52 . . . . 2.46 110.511 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.798 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 tp -117.85 171.89 7.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.973 -1.012 . . . . 0.65 111.07 -172.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.9 tt -88.68 127.03 35.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.259 -0.882 . . . . 0.28 110.728 -172.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.72 161.2 13.98 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.78 -1.1 . . . . 0.31 112.444 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 45' ' ' SER . 86.2 t80 -131.71 140.01 49.18 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.912 -1.495 . . . . 0.44 107.939 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.454 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.3 tt0 -112.69 110.56 20.77 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.807 -1.183 . . . . 0.76 107.807 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 44' ' ' GLN . 90.3 t -66.48 151.59 10.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 122.466 1.127 . . . . 0.39 113.433 -167.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 10' ' ' LYS . 8.1 mtpm? -102.53 158.94 15.87 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 113.486 -1.688 . . . . 2.01 108.997 173.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.604 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 2.2 tt0 -62.73 112.87 2.71 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.07 -0.514 . . . . 1.83 112.087 -172.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.51 12.95 42.95 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.922 -0.656 . . . . 0.48 113.768 173.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.575 ' CG ' HD11 ' A' ' 18' ' ' ILE . 2.4 t70 -50.4 168.26 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 112.524 0.564 . . . . 1.46 112.524 174.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.547 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -127.12 149.5 49.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.147 0.499 . . . . 0.41 110.86 166.523 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -62.24 -38.5 89.49 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.344 1.069 . . . . 0.86 108.405 -175.383 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.439 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 63.5 t30 -83.57 -19.25 35.92 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.324 -1.307 . . . . 1.15 110.98 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -68.38 -42.69 78.72 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.487 -0.485 . . . . 1.21 110.227 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.575 HD11 ' CG ' ' A' ' 13' ' ' ASP . 18.6 mt -72.81 -26.64 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.435 0.636 . . . . 0.21 109.887 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.68 -9.5 59.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.213 -0.449 . . . . 0.16 110.792 175.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.626 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.18 -40.88 8.97 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.836 1.303 . . . . 0.21 108.528 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.529 ' HB3' ' O ' ' A' ' 119' ' ' SER . 26.5 m-20 -61.94 -42.93 99.67 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.937 -2.392 . . . . 0.53 111.979 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.594 ' HA ' HG21 ' A' ' 101' ' ' ILE . 66.3 m-85 -100.22 4.79 44.52 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.639 -1.224 . . . . 0.18 111.822 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.626 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.6 mpt_? 54.59 42.25 31.41 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.828 0.823 . . . . 1.78 109.681 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.616 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.4 pt -114.99 -164.6 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.513 -1.221 . . . . 0.19 109.129 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 22.0 t -110.76 157.35 19.87 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.357 1.075 . . . . 0.95 110.154 168.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.601 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 62.5 p -80.11 -28.54 38.98 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 112.792 -2.004 . . . . 0.25 107.243 176.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.44 77.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.421 -0.809 . . . . 0.2 111.958 171.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -88.08 -29.22 20.8 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.88 -0.785 . . . . 0.17 108.88 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.637 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -71.9 -28.48 63.53 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.093 -0.958 . . . . 1.16 109.279 174.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 26' ' ' THR . 35.7 mt -76.83 -29.95 56.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.685 0.755 . . . . 1.05 110.611 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 27.8 tt0 -65.47 -39.89 92.5 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.621 -1.172 . . . . 1.81 109.998 174.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.443 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.93 -19.87 31.54 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 120.26 -0.576 . . . . 0.2 111.614 177.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.624 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 21.5 m-80 -148.76 82.46 7.28 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-O 121.457 0.646 . . . . 0.23 110.586 -173.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 21.4 Cg_endo -58.88 -5.94 3.07 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 124.169 3.246 . . . . 0.36 113.872 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -81.94 -23.35 36.2 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.173 -0.329 . . . . 1.38 111.42 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.68 HD21 HG21 ' A' ' 46' ' ' ILE . 28.9 mt -70.34 -32.38 70.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.521 0.677 . . . . 0.49 112.149 -170.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 3.4 pt20 -65.99 -48.7 70.36 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.681 1.229 . . . . 1.95 110.022 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.77 -46.31 87.79 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.043 -2.344 . . . . 0.49 111.005 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.91 -178.69 47.61 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 114.79 -1.095 . . . . 0.42 111.153 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.11 156.94 24.3 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.244 0.545 . . . . 0.41 111.181 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.546 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 37.1 m -139.94 128.94 23.53 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.159 -0.928 . . . . 0.42 110.469 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.604 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -78.82 126.21 30.4 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.288 0.566 . . . . 0.47 110.212 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 91.24 4.65 68.37 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.406 -1.078 . . . . 0.41 110.406 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.546 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.22 123.79 28.76 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.104 -0.548 . . . . 1.3 109.805 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 19.1 p -77.97 127.62 32.62 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.909 0.862 . . . . 0.85 110.667 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.68 HG21 HD21 ' A' ' 36' ' ' LEU . 12.0 pt -129.21 143.28 41.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.247 -1.342 . . . . 0.25 109.417 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.35 151.45 3.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.271 0.558 . . . . 0.67 111.074 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.472 HG21 ' CD2' ' A' ' 22' ' ' PHE . 38.9 mm -116.85 94.61 44.65 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.628 -1.169 . . . . 0.16 108.896 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.554 ' HA ' HD21 ' A' ' 4' ' ' LEU . 3.9 Cg_exo -61.5 136.03 60.78 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.599 2.199 . . . . 0.18 112.539 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.4 -0.54 81.0 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.477 -0.783 . . . . 0.26 112.317 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.798 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 25.2 tp -131.02 117.53 17.17 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 121.08 0.467 . . . . 0.61 111.241 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.7 ' HD2' HD12 ' A' ' 51' ' ' LEU . 32.1 Cg_endo -75.26 168.86 23.73 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.546 2.831 . . . . 0.28 113.543 -171.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.502 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 11.5 t70 -73.8 129.44 85.09 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 114.252 -1.34 . . . . 0.49 111.307 -175.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.639 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 66.4 Cg_endo -73.76 -15.52 24.01 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 123.752 2.968 . . . . 0.46 112.711 -174.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -95.66 -3.65 45.77 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.389 -0.823 . . . . 1.38 109.574 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 8.6 p -93.56 -14.87 26.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.534 -1.284 . . . . 0.46 107.534 171.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.486 HG22 ' H ' ' A' ' 59' ' ' TYR . 36.1 mt -84.72 130.14 54.21 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 113.311 -1.768 . . . . 0.7 110.915 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.71 -23.12 11.35 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.388 2.059 . . . . 0.39 113.301 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.486 ' H ' HG22 ' A' ' 57' ' ' ILE . 66.4 m-85 -86.37 150.7 24.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.89 -0.324 . . . . 0.24 111.322 -176.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -143.55 135.2 26.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.07 -0.715 . . . . 2.89 109.07 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.6 mt -117.2 134.19 61.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 112.534 0.568 . . . . 0.16 112.534 -175.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.91 119.84 35.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.116 -0.634 . . . . 0.16 111.357 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.72 HG22 HD12 ' A' ' 70' ' ' LEU . 90.8 t -102.89 115.43 44.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.858 0.837 . . . . 0.19 111.382 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 68' ' ' LYS . 20.5 m -94.67 100.28 12.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.44 -1.255 . . . . 0.2 110.628 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.3 mm -50.04 -58.47 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 122.056 0.932 . . . . 0.23 111.624 170.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.77 -9.82 2.93 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 112.896 -1.956 . . . . 0.16 113.477 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.08 -18.8 4.93 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.773 0.829 . . . . 0.15 112.173 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.33 56.99 4.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.396 0.544 . . . . 0.69 111.505 -173.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.0 p -138.15 159.77 41.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 113.011 0.745 . . . . 0.13 113.011 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.726 HD22 ' SD ' ' A' ' 145' ' ' MET . 4.3 tp -126.3 117.53 23.22 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.782 -1.099 . . . . 0.4 110.944 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 62.6 m -100.63 121.92 42.43 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.959 -0.696 . . . . 0.16 111.485 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 79' ' ' MET . 3.6 tp -101.74 106.72 17.77 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.243 -0.889 . . . . 0.59 109.262 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 87.2 p -104.99 163.69 12.35 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.585 -0.846 . . . . 1.05 110.722 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.1 tm? -124.64 126.57 45.96 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.901 -0.778 . . . . 0.26 108.901 168.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.548 ' N ' HD22 ' A' ' 74' ' ' LEU . 12.4 m120 49.74 46.76 23.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.71 -1.132 . . . . 1.84 111.015 -171.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 71.75 -7.75 1.2 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.566 0.746 . . . . 1.89 111.849 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -98.12 119.96 37.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.986 -0.552 . . . . 3.44 110.0 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 50.5 t -56.62 131.53 20.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 122.287 1.041 . . . . 0.24 113.314 -172.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.579 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 3.3 mmt -95.42 -46.78 6.55 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 112.989 -1.914 . . . . 0.81 107.941 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.3 mmtt -164.12 174.03 11.76 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.041 -1.89 . . . . 1.46 110.64 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 16.4 m -147.9 123.66 10.56 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.832 -1.531 . . . . 0.17 109.318 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -108.7 144.88 30.48 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.676 -0.693 . . . . 1.05 109.204 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HB2' HG22 ' A' ' 134' ' ' ILE . 38.5 Cg_endo -72.37 140.99 34.46 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 121.848 1.699 . . . . 0.2 110.207 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.47 HG21 ' HB2' ' A' ' 70' ' ' LEU . 2.1 pp -139.44 171.42 14.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 120.442 -0.503 . . . . 0.13 111.291 -177.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.92 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -116.23 142.27 47.05 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.144 -0.48 . . . . 0.26 109.781 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.521 HG22 ' HG3' ' A' ' 68' ' ' LYS . 12.9 m -126.08 113.96 36.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.675 0.75 . . . . 0.56 110.621 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -76.26 155.54 45.85 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 109.048 -1.621 . . . . 0.17 109.048 175.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 139' ' ' SER . 64.9 mttp -54.74 4.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 114.135 1.161 . . . . 3.05 114.135 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.845 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -89.66 -21.82 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 O-C-N 121.591 -0.693 . . . . 0.23 110.479 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.845 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -86.64 -18.88 30.24 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.019 0.914 . . . . 0.18 108.633 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -69.37 -12.9 62.05 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.053 -1.431 . . . . 0.33 111.456 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -75.07 -36.59 61.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.579 -1.192 . . . . 1.52 113.16 -177.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.74 132.5 26.0 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 119.779 -0.768 . . . . 0.43 111.286 -175.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 96.9 Cg_endo -89.13 -6.14 5.56 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.858 2.372 . . . . 0.73 113.105 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 96' ' ' GLY . 8.8 t -123.35 -42.46 2.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.057 0.456 . . . . 0.48 110.48 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 53.48 34.0 48.33 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.622 -1.172 . . . . 0.33 114.121 167.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.443 ' HG2' HG23 ' A' ' 164' ' ' THR . 44.8 mt-10 -84.37 113.01 20.85 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.955 0.884 . . . . 0.84 109.556 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.687 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 23.9 m-85 -137.38 -179.76 5.92 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.774 -1.557 . . . . 0.22 111.526 -170.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 80.9 m-85 -143.49 141.11 30.63 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 116.364 -0.38 . . . . 0.54 110.381 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.624 HD12 ' HB ' ' A' ' 161' ' ' THR . 75.6 mt -65.86 114.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 115.568 -0.742 . . . . 0.17 110.081 171.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.594 HG21 ' HA ' ' A' ' 22' ' ' PHE . 16.6 pt -83.55 -44.13 18.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.627 0.603 . . . . 0.21 112.627 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.868 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 51.9 m-80 -169.32 172.98 6.88 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.382 -1.34 . . . . 2.03 107.382 -170.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.653 HH21 ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -135.7 151.99 50.73 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.872 -0.731 . . . . 1.52 111.968 -178.353 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 49.7 tt0 -123.52 101.04 7.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.097 -0.956 . . . . 0.59 109.719 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.501 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 67.4 ttt180 -64.55 165.74 9.59 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.907 0.861 . . . . 2.82 110.656 176.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.501 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 20.7 m-80 -37.55 102.75 0.25 Allowed Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-N 113.048 -1.887 . . . . 0.35 114.756 -147.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.0 Cg_endo -58.33 -43.11 49.3 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.188 2.592 . . . . 0.48 111.641 170.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.03 -36.57 4.27 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.554 -1.018 . . . . 0.67 110.554 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -71.91 -174.72 22.73 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.748 -0.726 . . . . 0.62 112.557 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.498 ' O ' ' HA ' ' A' ' 128' ' ' THR . 19.1 Cg_endo -55.21 -6.17 0.74 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.845 3.697 . . . . 0.94 115.081 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -67.69 -12.43 60.47 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.991 0.737 . . . . 1.23 112.991 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.672 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 95.93 64.45 0.95 Allowed Glycine 0 CA--C 1.495 -1.177 0 C-N-CA 119.036 -1.554 . . . . 1.69 114.929 168.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.506 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 37.57 1.56 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 116.61 2.078 . . . . 0.48 116.61 -174.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.53 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.3 OUTLIER -165.32 169.11 16.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.898 0.879 . . . . 0.28 109.144 -178.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 11.6 t-105 -147.82 97.48 2.82 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.78 -1.193 . . . . 0.49 107.78 165.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.579 HD12 HG23 ' A' ' 150' ' ' VAL . 2.1 mt -86.75 114.24 23.26 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.031 -0.729 . . . . 0.66 109.031 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.492 ' O ' HG12 ' A' ' 101' ' ' ILE . 11.9 m -84.0 142.6 30.36 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.606 -0.725 . . . . 0.19 110.724 -170.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.672 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.9 mm? -108.08 163.12 13.43 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.13 111.856 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.529 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 12.3 t -58.89 -9.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.563 1.165 . . . . 1.17 112.632 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.687 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 18.7 tptt -125.29 128.89 48.95 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 119.92 -0.712 . . . . 1.22 109.586 166.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.549 ' HA ' ' NH1' ' A' ' 23' ' ' ARG . 7.1 pt20 -52.9 -23.46 7.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.265 -1.334 . . . . 1.51 113.653 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.578 ' O ' ' HB3' ' A' ' 142' ' ' CYS . 41.4 m80 -96.85 -9.55 28.4 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.793 -0.763 . . . . 2.53 112.63 -177.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.532 ' CG ' ' HB3' ' A' ' 120' ' ' LYS . 3.2 m-30 -91.1 -37.01 13.67 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.586 0.958 . . . . 0.84 113.586 -169.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.672 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -4.14 128.95 0.01 OUTLIER Glycine 0 C--N 1.296 -1.655 0 N-CA-C 119.695 2.638 . . . . 0.32 119.695 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -97.27 114.21 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 113.128 -1.536 . . . . 0.18 109.699 175.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.701 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 24.2 p80 -140.56 177.81 7.76 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 115.473 -0.785 . . . . 0.21 109.937 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.672 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.73 -166.46 37.51 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.782 -0.723 . . . . 0.27 111.578 176.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 110' ' ' PRO . 11.3 t -158.91 175.78 13.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.907 0.853 . . . . 0.41 110.61 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -115.16 -3.12 12.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.807 -0.812 . . . . 1.99 108.807 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -118.14 87.87 30.47 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.254 -0.884 . . . . 1.36 108.863 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.413 ' HA ' HG12 ' A' ' 134' ' ' ILE . 28.8 Cg_endo -73.55 -17.52 23.45 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.298 1.999 . . . . 0.35 113.405 -169.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.98 -1.03 42.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.867 -0.606 . . . . 0.33 111.13 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.524 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 38.9 t -93.64 -4.38 50.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.819 -0.808 . . . . 1.35 108.819 171.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 83' ' ' PRO . 45.2 mm -82.76 137.06 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.496 -0.774 . . . . 0.21 110.497 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.73 5.36 68.81 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 109.953 -1.259 . . . . 0.15 109.953 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 90.4 mttt -113.24 168.08 10.02 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 123.173 1.463 . . . . 2.5 114.1 -176.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -97.54 123.09 41.29 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 111.747 -2.478 . . . . 0.17 107.487 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.504 HG23 ' C ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -100.59 -166.15 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.954 -0.387 . . . . 0.66 109.954 -170.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.497 ' H ' HG12 ' A' ' 138' ' ' VAL . 67.6 m -84.98 -59.94 2.19 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 110.119 -0.326 . . . . 0.43 110.119 167.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -133.51 -43.99 0.83 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.357 -0.937 . . . . 2.02 112.572 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.34 134.09 0.18 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 117.047 1.579 . . . . 0.18 117.047 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 5.9 p -69.4 166.16 19.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 112.141 -2.029 . . . . 0.16 112.174 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.92 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 49.2 mt -60.4 99.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.374 -1.284 . . . . 0.4 111.77 -161.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.701 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 70.6 mtt180 -88.11 146.97 25.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.003 -1.453 . . . . 1.87 110.28 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.726 ' SD ' HD22 ' A' ' 70' ' ' LEU . 1.8 mtm -130.79 -163.61 1.34 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.861 -0.792 . . . . 0.79 108.861 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.546 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 87.6 m-70 -93.31 162.48 13.98 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.451 -0.5 . . . . 2.32 109.828 170.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.679 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.7 m-80 -64.33 -47.42 79.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 118.784 -0.627 . . . . 0.68 110.234 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -65.9 -25.36 67.12 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 120.884 1.675 . . . . 2.18 112.688 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.546 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 71.0 m-20 -79.11 -46.82 17.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.192 0.52 . . . . 0.69 110.914 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.659 HG13 HD12 ' A' ' 151' ' ' ILE . 14.8 p -66.24 -24.27 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.347 -0.842 . . . . 0.11 111.685 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.679 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.19 -40.82 17.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 118.941 -0.552 . . . . 0.38 110.187 172.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.427 ' O ' HG13 ' A' ' 156' ' ' ILE . 14.0 mt-10 -47.73 -67.72 0.25 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.505 1.048 . . . . 1.99 112.54 170.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.577 HD11 ' CD2' ' A' ' 70' ' ' LEU . 95.8 mt -43.67 -40.52 4.21 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.748 0.785 . . . . 1.27 111.417 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.43 -37.34 86.93 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.875 -1.511 . . . . 0.18 111.591 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.0 t -86.35 -30.64 22.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.76 0.709 . . . . 0.21 112.401 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.6 mt -82.66 -60.55 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.521 0.676 . . . . 0.16 111.633 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.4 m -91.9 142.35 26.4 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.84 -1.073 . . . . 0.16 112.558 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.653 ' HA ' HH21 ' A' ' 103' ' ' ARG . 62.6 Cg_endo -89.21 173.9 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.872 3.048 . . . . 0.2 111.123 172.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.868 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -62.4 157.63 19.56 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.437 -0.949 . . . . 1.1 108.437 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 99.65 -27.07 21.87 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.931 -1.128 . . . . 0.18 112.73 -176.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.624 ' HB ' HD12 ' A' ' 100' ' ' ILE . 51.6 m -59.73 135.12 57.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.07 -0.715 . . . . 0.14 109.07 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.585 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 11.9 ptm180 -92.97 130.51 38.52 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.586 1.184 . . . . 3.63 111.776 -168.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.7 t -108.96 107.12 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 112.323 -2.217 . . . . 0.14 108.918 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 97' ' ' GLU . 25.5 m -94.25 106.73 18.7 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.152 -0.476 . . . . 0.21 112.105 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.479 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -83.55 98.01 5.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 122.304 1.05 . . . . 0.24 109.957 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -102.47 130.73 49.36 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.044 -1.435 . . . . 1.09 108.9 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.532 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 15.9 mmm180 -67.47 -31.0 70.86 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.339 -0.391 . . . . 2.08 109.96 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.63 -104.25 0.54 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.297 -0.865 . . . . 1.97 112.629 175.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--N 1.32 -0.691 0 N-CA-C 109.976 -0.379 . . . . 3.91 109.976 179.302 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.768 -0.533 . . . . 2.8 111.768 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -102.43 176.37 5.2 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.318 -0.623 . . . . 4.44 109.318 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -86.82 105.05 16.75 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.335 -0.617 . . . . 2.46 109.335 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -106.92 174.88 5.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.681 0.753 . . . . 0.65 112.432 -172.228 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.1 tt -98.51 129.29 45.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.628 -1.169 . . . . 0.28 110.61 -175.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.31 162.24 13.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.056 0.931 . . . . 0.31 112.974 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.652 ' O ' ' HA ' ' A' ' 45' ' ' SER . 82.1 t80 -130.17 140.99 50.7 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.023 -1.444 . . . . 0.44 108.133 176.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.464 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 56.4 tt0 -113.32 113.4 25.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.107 -1.071 . . . . 0.76 108.107 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.614 HG13 ' HB2' ' A' ' 13' ' ' ASP . 94.7 t -68.39 150.36 10.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 122.651 1.215 . . . . 0.39 113.463 -168.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.414 ' O ' HG12 ' A' ' 9' ' ' VAL . 44.1 mtpt -101.48 159.15 15.53 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.198 -1.819 . . . . 2.01 108.623 172.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -63.8 103.02 0.52 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.944 0.402 . . . . 1.83 111.883 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.59 11.0 31.96 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.782 -0.723 . . . . 0.48 113.152 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.614 ' HB2' HG13 ' A' ' 9' ' ' VAL . 86.9 m-20 -52.74 166.8 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.851 0.357 . . . . 1.46 111.136 171.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.51 149.76 49.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.0 0.428 . . . . 0.41 111.028 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.565 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.66 -39.75 91.7 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.448 -0.945 . . . . 0.86 108.448 -177.217 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 4.7 t30 -82.35 -26.4 32.99 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.451 -1.249 . . . . 1.15 110.256 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -65.19 -41.98 94.02 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.217 -0.66 . . . . 1.21 109.217 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.443 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.6 mt -74.18 -26.62 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.238 0.542 . . . . 0.21 109.65 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.627 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.83 -10.05 59.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.319 -0.401 . . . . 0.16 110.831 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.66 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.75 -40.22 9.07 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 122.52 1.152 . . . . 0.21 108.045 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 119' ' ' SER . 7.2 m-20 -63.01 -45.76 90.83 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 112.265 -2.243 . . . . 0.53 112.082 173.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 60.7 m-85 -96.09 5.29 51.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 118.596 -1.242 . . . . 0.18 111.36 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.66 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.4 mpt_? 54.52 42.51 31.28 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.793 0.806 . . . . 1.78 109.92 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.627 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.5 pt -117.14 -165.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.678 -1.147 . . . . 0.19 109.887 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.49 143.47 40.78 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.117 -0.947 . . . . 0.95 110.279 175.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.471 ' HB ' HD13 ' A' ' 15' ' ' LEU . 37.0 p -73.32 -31.14 63.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.824 -1.176 . . . . 0.25 107.824 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.81 -33.01 71.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.336 -0.847 . . . . 0.2 111.815 169.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -90.26 -27.92 19.15 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.795 0.807 . . . . 0.17 108.886 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -72.93 -30.63 64.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.757 -1.11 . . . . 1.16 109.168 174.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 36' ' ' LEU . 46.0 mt -76.71 -29.24 56.16 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.579 0.704 . . . . 1.05 110.624 171.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 20.0 tt0 -63.78 -39.98 95.57 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.72 -1.127 . . . . 1.81 109.787 172.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.48 -19.76 32.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 120.248 -0.581 . . . . 0.2 111.693 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.648 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.2 m-80 -150.55 82.59 6.15 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.139 0.495 . . . . 0.23 110.482 -172.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.6 Cg_endo -56.2 -16.52 17.48 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 123.807 3.005 . . . . 0.36 113.609 176.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 m -71.37 -22.21 61.92 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.162 0.43 . . . . 1.38 112.162 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.782 HD21 HG21 ' A' ' 46' ' ' ILE . 28.9 mt -69.59 -35.48 75.37 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 112.563 0.579 . . . . 0.49 112.563 -170.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -64.69 -46.62 81.6 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 122.818 1.294 . . . . 1.95 110.304 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.21 -48.97 77.45 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 111.845 -2.434 . . . . 0.49 110.622 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.28 176.96 48.16 Favored Glycine 0 N--CA 1.428 -1.886 0 CA-C-N 114.595 -1.184 . . . . 0.42 111.341 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.47 157.49 19.53 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.452 0.644 . . . . 0.41 110.91 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.645 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 49.0 m -138.33 128.11 25.2 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.134 -0.939 . . . . 0.42 110.512 -176.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.12 118.8 19.23 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.546 0.689 . . . . 0.47 109.992 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.61 0.33 55.43 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 110.2 -1.16 . . . . 0.41 110.2 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.645 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -75.74 124.06 26.63 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.835 -0.682 . . . . 1.3 109.797 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 51.4 p -83.84 128.68 34.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.577 -0.738 . . . . 0.85 110.425 177.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.782 HG21 HD21 ' A' ' 36' ' ' LEU . 10.8 pt -129.42 142.8 43.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.432 -1.258 . . . . 0.25 109.459 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.11 150.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.465 0.65 . . . . 0.67 111.268 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.4 mm -115.77 94.6 41.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.285 -1.325 . . . . 0.16 108.669 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.654 ' HA ' HD21 ' A' ' 4' ' ' LEU . 5.9 Cg_exo -60.91 137.06 69.84 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.646 2.231 . . . . 0.18 112.76 -172.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.23 83.82 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.895 -1.048 . . . . 0.26 112.432 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.725 HD12 ' HD2' ' A' ' 52' ' ' PRO . 37.5 tp -120.36 116.97 31.97 Favored Pre-proline 0 N--CA 1.449 -0.502 0 O-C-N 122.415 -0.462 . . . . 0.61 111.295 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.725 ' HD2' HD12 ' A' ' 51' ' ' LEU . 43.2 Cg_endo -77.18 -177.25 3.69 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.891 3.061 . . . . 0.28 114.205 -172.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.603 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.1 t70 -86.31 127.84 59.71 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.266 -1.334 . . . . 0.49 111.836 -169.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.54 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.8 Cg_endo -75.8 -10.03 19.83 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.29 2.66 . . . . 0.46 112.891 -176.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -92.55 -15.86 26.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.831 -0.622 . . . . 1.38 110.271 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.603 HG23 ' HB3' ' A' ' 53' ' ' ASP . 27.1 p -84.62 -26.33 27.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.586 1.184 . . . . 0.46 108.286 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.559 HG22 ' H ' ' A' ' 59' ' ' TYR . 27.0 mt -68.02 129.27 93.18 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 112.966 -1.924 . . . . 0.7 111.155 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.419 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 86.7 Cg_endo -78.76 -14.34 14.04 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.474 2.116 . . . . 0.39 113.492 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.559 ' H ' HG22 ' A' ' 57' ' ' ILE . 45.1 m-85 -99.16 162.95 12.77 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.549 -0.46 . . . . 0.24 111.622 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -151.37 139.49 20.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.026 -0.731 . . . . 2.89 109.026 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.654 ' HA ' ' O ' ' A' ' 71' ' ' THR . 88.4 mt -120.81 136.74 56.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.276 0.473 . . . . 0.16 112.276 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.56 24.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.946 -0.702 . . . . 0.16 110.902 171.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' THR . 90.6 t -91.19 108.87 20.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.566 0.698 . . . . 0.19 110.78 173.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 68' ' ' LYS . 75.3 m -85.43 107.32 17.34 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.088 -0.96 . . . . 0.2 110.563 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.8 mm -53.98 -58.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 122.17 0.986 . . . . 0.23 111.164 166.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.65 -13.55 8.1 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 112.926 -1.943 . . . . 0.16 113.337 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.02 -17.01 5.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.523 0.729 . . . . 0.15 112.267 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.498 ' HD2' ' CG2' ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.5 56.87 4.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.287 0.494 . . . . 0.69 111.376 -173.522 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 44.8 p -138.79 167.22 22.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 113.037 0.755 . . . . 0.13 113.037 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 70' ' ' LEU . 7.7 tt -133.94 111.14 10.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.617 -1.174 . . . . 0.4 109.855 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.654 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 63.8 m -92.95 122.43 35.31 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.177 0.513 . . . . 0.16 111.15 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.7 tp -98.77 107.53 19.99 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.042 -0.981 . . . . 0.59 109.309 173.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 75.2 p -109.14 158.8 17.44 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.989 -1.084 . . . . 1.05 110.998 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.784 ' HB2' ' SD ' ' A' ' 79' ' ' MET . 1.2 tm? -128.21 126.4 40.89 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.092 -0.707 . . . . 0.26 109.092 171.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.62 ' OD1' HD13 ' A' ' 74' ' ' LEU . 2.6 p-10 43.76 52.99 6.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 113.952 -1.476 . . . . 1.84 112.146 -167.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 53.9 t30 75.46 -10.35 1.26 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.527 -0.76 . . . . 1.89 111.623 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -100.58 120.7 40.42 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.141 0.496 . . . . 3.44 110.126 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 45.4 t -55.82 132.72 19.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.249 1.024 . . . . 0.24 112.32 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.784 ' SD ' ' HB2' ' A' ' 74' ' ' LEU . 97.4 mtp -97.06 -48.24 5.47 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 113.364 -1.744 . . . . 0.81 108.405 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -158.67 171.97 19.13 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.498 -2.137 . . . . 1.46 109.902 -174.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.0 m -148.63 122.2 9.17 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.064 -1.425 . . . . 0.17 109.656 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.614 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 24.6 m-85 -105.21 156.5 36.09 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 115.214 -0.903 . . . . 1.05 109.729 -174.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.491 ' O ' ' HG2' ' A' ' 145' ' ' MET . 59.1 Cg_endo -84.93 142.98 9.15 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.046 1.831 . . . . 0.2 111.439 169.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.547 HG22 ' CG ' ' A' ' 145' ' ' MET . 2.2 pp -138.14 174.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.701 -0.681 . . . . 0.13 110.863 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.905 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.8 140.72 49.5 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.304 -0.407 . . . . 0.26 109.972 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.498 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 7.7 m -125.74 125.37 68.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.547 0.689 . . . . 0.56 111.829 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -82.76 157.58 36.0 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 114.899 -1.046 . . . . 0.17 110.631 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 139' ' ' SER . 74.7 mmtt -55.48 3.21 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.894 0.701 . . . . 3.05 112.894 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.954 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -92.55 -20.19 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.522 0.677 . . . . 0.23 110.28 -177.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.954 HD22 HG23 ' A' ' 89' ' ' ILE . 3.6 mm? -89.22 -18.16 27.63 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.707 0.765 . . . . 0.18 108.969 -176.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.1 p -66.61 -19.21 65.72 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.53 -1.214 . . . . 0.33 111.73 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -59.1 -42.01 89.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.885 -1.052 . . . . 1.52 112.372 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.94 133.54 20.23 Favored Pre-proline 0 C--N 1.324 -0.525 0 C-N-CA 120.449 -0.5 . . . . 0.43 111.497 -172.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 97.2 Cg_endo -90.59 -15.27 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.665 2.243 . . . . 0.73 112.755 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.416 HG23 ' N ' ' A' ' 96' ' ' GLY . 7.9 t -102.43 -43.54 5.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.23 0.538 . . . . 0.48 109.828 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.536 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 52.92 35.17 47.33 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.286 -1.325 . . . . 0.33 113.622 167.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -82.91 111.93 19.24 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 122.039 0.923 . . . . 0.84 109.478 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.621 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 26.1 m-85 -138.54 177.54 7.81 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.496 -1.684 . . . . 0.22 111.42 -173.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.469 ' CG ' HD11 ' A' ' 5' ' ' LEU . 28.5 m-85 -141.99 138.0 31.58 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.316 -0.402 . . . . 0.54 110.49 -174.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.586 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.3 mt -61.92 121.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.577 -0.738 . . . . 0.17 110.284 170.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 20.0 pt -88.63 -44.18 15.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 113.219 0.822 . . . . 0.21 113.219 -175.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.55 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 51.7 m-80 -170.95 170.35 6.34 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.044 -1.465 . . . . 2.03 107.044 -168.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.742 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 26.5 mtt180 -126.15 159.06 33.93 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.713 -0.795 . . . . 1.52 111.929 -173.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 60.7 tt0 -133.31 99.97 4.7 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.554 -0.748 . . . . 0.59 110.058 169.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 34.1 ttt85 -66.07 166.06 12.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.647 -0.706 . . . . 2.82 110.146 173.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.497 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 17.0 m-80 -35.26 101.92 0.22 Allowed Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 125.093 1.357 . . . . 0.35 113.255 -156.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.497 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.1 Cg_endo -63.24 -28.29 72.68 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.205 2.603 . . . . 0.48 111.688 174.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.3 -36.09 4.14 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.266 -0.734 . . . . 0.67 111.266 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -79.32 -176.22 48.42 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.211 -0.494 . . . . 0.62 112.703 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.75 8.06 0.11 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 125.15 3.9 . . . . 0.94 115.429 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.404 ' H ' ' C ' ' A' ' 109' ' ' GLY . 9.1 m-85 -72.0 14.72 0.19 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 112.229 0.455 . . . . 1.23 112.229 -174.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.77 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 72.2 63.19 3.03 Favored Glycine 0 CA--C 1.496 -1.149 0 C-N-CA 120.123 -1.037 . . . . 1.69 114.894 170.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.523 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.21 -2.78 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 117.398 2.37 . . . . 0.48 117.398 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -166.17 149.38 7.36 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.412 -0.805 . . . . 0.28 110.087 -176.162 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 9.9 t-105 -130.18 98.95 4.88 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.959 -1.126 . . . . 0.49 107.959 167.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.4 mt -91.51 114.46 26.99 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.08 -0.711 . . . . 0.66 109.08 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 101' ' ' ILE . 16.9 m -84.08 144.68 28.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.533 -0.758 . . . . 0.19 111.341 -168.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.778 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.5 mm? -108.91 170.1 8.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.13 111.407 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.2 t -62.0 -12.14 17.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.918 -1.037 . . . . 1.17 112.779 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.621 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 5.5 tptp -126.73 132.59 51.08 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.58 -0.448 . . . . 1.22 110.42 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.532 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 76.7 mt-30 -31.89 -60.86 0.25 Allowed 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.554 1.159 . . . . 1.51 113.94 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.582 ' HB3' HG12 ' A' ' 89' ' ' ILE . 1.7 t-160 -94.01 5.4 51.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.954 -0.698 . . . . 2.53 111.597 -169.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.778 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -93.9 38.43 1.07 Allowed 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 113.88 1.067 . . . . 0.84 113.88 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.644 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.92 143.57 18.12 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 116.9 -2.571 . . . . 0.32 112.67 -154.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 2.1 mp -96.52 114.04 32.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.808 0.814 . . . . 0.18 110.596 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.757 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.8 p80 -140.17 171.73 13.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.082 -0.963 . . . . 0.21 109.01 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.77 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.25 -170.31 39.49 Favored Glycine 0 C--N 1.315 -0.583 0 C-N-CA 119.891 -1.147 . . . . 0.27 111.613 177.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.562 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 13.7 t -153.23 168.74 24.96 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.35 -0.5 . . . . 0.41 110.332 177.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -112.05 2.94 17.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.18 -1.044 . . . . 1.99 108.18 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.9 84.67 26.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.384 -1.28 . . . . 1.36 107.935 169.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.79 -22.32 11.9 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.679 2.253 . . . . 0.35 114.495 -167.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.29 -10.19 59.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.923 -0.581 . . . . 0.33 110.749 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.593 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 45.5 m -91.5 1.28 57.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 1.35 110.375 176.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.409 HG22 ' HB2' ' A' ' 83' ' ' PRO . 47.5 mm -79.56 141.41 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.089 -0.505 . . . . 0.21 110.152 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.7 6.4 63.9 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.463 -1.055 . . . . 0.15 110.463 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.593 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 59.2 mttm -114.85 176.75 4.92 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 123.603 1.668 . . . . 2.5 114.078 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.77 125.46 51.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 110.813 -2.903 . . . . 0.17 108.406 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.575 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -121.51 162.67 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.798 -1.186 . . . . 0.66 107.798 -176.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.452 ' HA ' ' HG2' ' A' ' 88' ' ' LYS . 43.5 m -61.22 -50.95 71.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 118.845 0.748 . . . . 0.43 112.691 -178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -130.57 -45.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 117.889 -1.524 . . . . 2.02 114.112 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.29 132.78 0.21 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 117.071 1.588 . . . . 0.18 117.071 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.418 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 3.4 p -72.28 165.41 24.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 112.544 -1.828 . . . . 0.16 112.028 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.905 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 56.9 mt -60.41 98.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.535 -1.211 . . . . 0.4 112.276 -162.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.757 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 64.2 mtt180 -87.32 150.85 23.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.006 -1.452 . . . . 1.87 110.92 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.614 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -133.67 -163.65 1.39 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.081 -0.509 . . . . 0.79 109.994 174.293 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.518 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 26.2 m80 -91.39 162.07 14.74 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.167 -0.613 . . . . 2.32 109.937 172.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.688 ' O ' HD13 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -61.71 -54.81 37.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 118.63 -0.7 . . . . 0.68 110.125 178.41 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -63.56 -24.79 67.95 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 121.119 1.782 . . . . 2.18 112.071 -174.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 45.2 m-20 -87.12 -45.36 10.77 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.547 -0.751 . . . . 0.69 111.281 -173.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.617 HG13 HD12 ' A' ' 151' ' ' ILE . 11.1 p -59.44 -25.13 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 111.781 0.289 . . . . 0.11 111.781 170.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.688 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -80.26 -40.27 19.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 118.95 -0.548 . . . . 0.38 109.876 171.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.477 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.2 mm-40 -44.66 -72.64 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.237 0.926 . . . . 1.99 112.094 168.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 157' ' ' VAL . 44.2 mt -46.61 -39.67 11.58 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.649 0.738 . . . . 1.27 111.514 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.3 80.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.098 -1.41 . . . . 0.18 111.466 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 25.5 t -86.29 -34.05 20.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.791 -0.568 . . . . 0.21 112.219 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 152' ' ' GLU . 30.3 mt -79.84 -60.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.61 0.719 . . . . 0.16 111.37 -171.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -91.95 141.64 25.59 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.882 -1.054 . . . . 0.16 112.4 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.742 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 53.2 Cg_endo -89.06 175.71 3.4 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 124.143 3.229 . . . . 0.2 111.062 173.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 75.7 m-20 -66.46 159.49 27.02 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 119.274 -0.971 . . . . 1.1 109.107 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.16 -19.87 52.61 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.231 -0.985 . . . . 0.18 112.3 -174.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.586 ' HB ' HD12 ' A' ' 100' ' ' ILE . 67.7 m -64.15 137.85 58.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.419 -0.586 . . . . 0.14 109.419 -175.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -92.97 123.49 36.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.715 1.245 . . . . 3.63 111.246 -169.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.82 111.39 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 112.221 -2.263 . . . . 0.14 109.613 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 63' ' ' VAL . 13.6 m -93.34 108.66 20.28 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.051 -0.522 . . . . 0.21 112.188 -174.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.536 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -79.95 100.23 4.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 123.201 1.477 . . . . 0.24 108.362 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -113.47 123.92 51.17 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 112.287 -2.233 . . . . 1.09 109.22 -164.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.504 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 9.1 mmm180 -76.09 -0.21 21.09 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.811 -0.356 . . . . 2.08 111.379 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.95 33.41 6.65 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.9 -0.667 . . . . 1.97 112.235 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 C--N 1.322 -0.61 0 N-CA-C 110.004 -0.369 . . . . 3.91 110.004 178.044 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 112.255 -0.338 . . . . 2.8 112.255 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -79.3 131.72 36.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.16 0.505 . . . . 4.44 110.232 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 70.8 mmtt -90.31 97.93 11.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.546 -0.752 . . . . 2.46 111.834 -174.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -116.04 175.22 5.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.384 -0.825 . . . . 0.65 110.821 175.285 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.616 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 2.9 tt -95.33 127.69 41.58 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.341 -0.845 . . . . 0.28 110.33 -176.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.14 162.33 13.41 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.202 1.001 . . . . 0.31 113.473 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 45' ' ' SER . 84.0 t80 -130.67 141.1 50.4 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.441 -1.709 . . . . 0.44 107.932 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.411 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 56.7 tt0 -114.03 114.21 25.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.02 -1.104 . . . . 0.76 108.02 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.686 HG13 ' HB2' ' A' ' 13' ' ' ASP . 95.7 t -68.35 150.47 10.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 122.338 1.066 . . . . 0.39 113.194 -169.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -103.38 157.85 16.74 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.505 -1.68 . . . . 2.01 108.042 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 2.3 mm-40 -58.64 110.17 0.94 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.104 0.478 . . . . 1.83 111.548 -176.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.22 11.71 51.32 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.548 -0.751 . . . . 0.48 114.004 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.686 ' HB2' HG13 ' A' ' 9' ' ' VAL . 30.7 m-20 -54.0 170.5 0.13 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 117.392 0.596 . . . . 1.46 111.222 171.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.6 154.58 47.7 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.449 -0.5 . . . . 0.41 111.424 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 26' ' ' THR . 4.6 tp -67.35 -38.04 84.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.853 0.835 . . . . 0.86 110.031 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 6.3 t30 -86.96 -23.22 25.17 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.434 -1.257 . . . . 1.15 110.13 -174.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -69.7 -37.64 76.65 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.802 -0.444 . . . . 1.21 109.802 172.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.43 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.0 mt -76.68 -28.71 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.188 0.518 . . . . 0.21 109.997 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.637 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.81 -9.51 59.08 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.122 -0.361 . . . . 0.16 110.538 175.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.708 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -95.92 -40.54 9.25 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.279 1.038 . . . . 0.21 108.449 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.445 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 1.4 m-20 -61.29 -44.11 97.76 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.849 -1.978 . . . . 0.53 112.0 174.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.497 ' HA ' HG21 ' A' ' 101' ' ' ILE . 59.0 m-85 -98.7 6.16 47.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.706 -1.198 . . . . 0.18 111.436 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.708 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.21 43.81 30.04 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.916 0.865 . . . . 1.78 109.328 177.481 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.637 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 30.9 pt -116.96 -164.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.385 -1.279 . . . . 0.19 110.23 -178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 144.28 38.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.997 -1.001 . . . . 0.95 110.523 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.594 ' HB ' HD21 ' A' ' 15' ' ' LEU . 75.8 p -73.98 -32.23 63.34 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.619 -0.882 . . . . 0.25 108.619 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.38 -27.66 67.6 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.26 -0.882 . . . . 0.2 111.629 169.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.98 -28.52 17.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.289 -0.564 . . . . 0.17 109.538 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.552 HD21 HD12 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -72.36 -30.55 64.81 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.781 -0.645 . . . . 1.16 109.432 173.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 36' ' ' LEU . 41.4 mt -75.16 -30.14 60.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.872 0.844 . . . . 1.05 109.721 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 47.2 tt0 -65.61 -39.83 91.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.112 -1.403 . . . . 1.81 110.527 173.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.48 -20.45 31.68 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 120.06 -0.656 . . . . 0.2 111.563 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.64 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 20.8 m-80 -148.94 82.66 7.07 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-O 121.206 0.527 . . . . 0.23 110.625 -172.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.57 -12.4 8.47 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 123.971 3.114 . . . . 0.36 113.667 175.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 m -72.53 -26.43 61.75 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.996 0.427 . . . . 1.38 111.661 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.64 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 36.4 mt -70.71 -33.69 71.13 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.89 -0.595 . . . . 0.49 112.564 -167.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.421 ' H ' ' HG3' ' A' ' 37' ' ' GLN . 1.8 pp0? -63.46 -44.4 94.56 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 122.979 1.371 . . . . 1.95 110.582 -174.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.68 81.96 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 111.818 -2.446 . . . . 0.49 110.985 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.66 179.0 48.84 Favored Glycine 0 N--CA 1.428 -1.898 0 CA-C-N 114.835 -1.075 . . . . 0.42 111.173 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.35 156.99 21.55 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.151 0.5 . . . . 0.41 110.978 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.547 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 31.7 m -134.89 127.58 30.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.076 -0.965 . . . . 0.42 110.243 -177.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -75.99 122.83 24.78 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.261 0.553 . . . . 0.47 110.114 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.411 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.76 1.17 61.93 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.543 -1.023 . . . . 0.41 110.543 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.547 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -79.96 123.85 28.17 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.271 -0.464 . . . . 1.3 110.177 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 31.0 p -76.8 126.67 31.38 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 122.175 0.988 . . . . 0.85 110.349 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.608 HG21 HD21 ' A' ' 36' ' ' LEU . 8.8 pt -125.85 141.26 46.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 113.875 -1.511 . . . . 0.25 108.878 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.85 151.18 3.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.357 0.598 . . . . 0.67 111.167 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.6 mm -115.36 93.4 35.93 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.385 -1.279 . . . . 0.16 108.794 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.579 ' HA ' HD21 ' A' ' 4' ' ' LEU . 5.6 Cg_exo -61.64 136.26 61.6 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.719 2.279 . . . . 0.18 112.726 -172.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.15 -6.0 82.77 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 114.725 -1.125 . . . . 0.26 112.435 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.701 HD12 ' HD2' ' A' ' 52' ' ' PRO . 29.8 tp -122.94 116.24 28.95 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-O 121.192 0.52 . . . . 0.61 110.948 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.701 ' HD2' HD12 ' A' ' 51' ' ' LEU . 52.3 Cg_endo -78.19 -177.14 3.66 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.491 2.794 . . . . 0.28 114.119 -171.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.624 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.0 t70 -79.3 133.59 60.13 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 114.202 -1.363 . . . . 0.49 112.454 -170.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.35 -16.01 24.89 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.577 2.851 . . . . 0.46 113.115 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -96.66 1.74 51.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.159 0.504 . . . . 1.38 111.701 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.624 HG23 ' HB3' ' A' ' 53' ' ' ASP . 26.8 p -95.74 -16.04 22.22 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.395 -0.965 . . . . 0.46 108.395 172.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.676 HG22 ' H ' ' A' ' 59' ' ' TYR . 9.1 mm -64.62 129.24 94.19 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 113.422 -1.717 . . . . 0.7 110.08 176.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.435 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 60.4 Cg_endo -78.65 -17.71 12.41 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.057 1.838 . . . . 0.39 113.037 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.676 ' H ' HG22 ' A' ' 57' ' ' ILE . 60.4 m-85 -104.13 172.99 6.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.066 0.46 . . . . 0.24 111.67 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -155.53 138.24 15.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.595 -0.729 . . . . 2.89 109.397 173.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 71' ' ' THR . 82.9 mt -113.55 131.97 63.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.108 -0.496 . . . . 0.16 111.789 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.44 118.27 32.72 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.169 -0.612 . . . . 0.16 111.13 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 59.0 t -98.1 120.91 48.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.538 0.685 . . . . 0.19 110.888 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 45.2 m -98.31 104.34 16.36 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.909 -1.041 . . . . 0.2 110.989 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.561 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 35.2 mm -50.89 -58.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 122.053 0.93 . . . . 0.23 111.263 166.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.21 -11.18 3.17 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 112.774 -2.012 . . . . 0.16 113.462 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -127.5 -21.52 3.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.982 0.734 . . . . 0.15 112.982 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 60.24 57.2 3.0 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.989 0.813 . . . . 0.69 111.249 -170.536 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -137.64 161.94 35.13 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.951 0.723 . . . . 0.13 112.951 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.478 ' CD2' HD21 ' A' ' 153' ' ' LEU . 7.8 tt -130.46 113.58 14.47 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.54 -1.209 . . . . 0.4 109.702 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 52.7 m -95.12 123.88 38.86 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.157 0.504 . . . . 0.16 111.317 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 79' ' ' MET . 11.6 tp -99.16 107.91 20.38 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.12 -0.946 . . . . 0.59 109.197 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 90.0 p -107.73 160.72 15.5 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.233 -0.987 . . . . 1.05 110.804 177.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.613 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -126.46 124.75 40.82 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.707 0.765 . . . . 0.26 109.221 170.254 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.613 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.9 p-10 37.83 59.21 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.531 -1.668 . . . . 1.84 111.899 -164.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 75.49 -13.73 0.84 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.883 -1.053 . . . . 1.89 112.156 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -96.0 121.59 37.91 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.699 -0.482 . . . . 3.44 109.699 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 46.5 t -58.49 129.82 21.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 122.318 1.056 . . . . 0.24 112.517 -176.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 48.4 mmm -93.9 -49.92 5.58 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.161 -1.836 . . . . 0.81 107.881 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -159.73 172.06 18.4 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.779 -2.01 . . . . 1.46 109.634 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.4 m -149.34 125.09 10.48 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.418 -1.265 . . . . 0.17 109.592 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -116.31 150.42 45.32 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.555 -0.748 . . . . 1.05 110.077 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.433 ' HB2' HG22 ' A' ' 134' ' ' ILE . 53.9 Cg_endo -75.5 145.57 29.92 Favored 'Trans proline' 0 CA--C 1.494 -1.492 0 C-N-CA 122.188 1.926 . . . . 0.2 110.957 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.636 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -141.22 173.25 9.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.689 -0.687 . . . . 0.13 110.782 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.898 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.65 142.99 46.59 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.438 -0.346 . . . . 0.26 110.176 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 68' ' ' LYS . 13.0 m -126.28 128.27 71.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.417 0.627 . . . . 0.56 111.622 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -92.01 160.14 25.96 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.067 -0.97 . . . . 0.17 110.714 173.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -55.62 2.88 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 113.539 0.94 . . . . 3.05 113.539 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.91 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -91.15 -18.89 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 O-C-N 121.051 -1.031 . . . . 0.23 109.793 -177.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.91 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -91.63 -22.31 20.35 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.898 0.856 . . . . 0.18 108.693 -177.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.2 p -67.29 -11.76 58.38 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.263 -1.335 . . . . 0.33 111.404 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -71.14 -42.11 69.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.61 -1.177 . . . . 1.52 112.287 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -96.74 125.78 45.46 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.274 -0.571 . . . . 0.43 110.659 -176.501 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.551 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.9 Cg_endo -75.19 -15.24 20.45 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.771 2.314 . . . . 0.73 112.837 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 96' ' ' GLY . 14.9 t -115.65 -41.62 3.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.649 -0.25 . . . . 0.48 110.381 -177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.475 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 47.43 42.72 19.33 Favored Glycine 0 C--O 1.225 -0.447 0 O-C-N 124.045 0.841 . . . . 0.33 113.778 169.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.57 113.54 21.32 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.793 0.806 . . . . 0.84 109.237 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.733 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 25.6 m-85 -136.53 178.32 7.16 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.137 -1.392 . . . . 0.22 112.275 -171.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.486 ' CD2' ' HB3' ' A' ' 162' ' ' ARG . 32.5 m-85 -144.28 139.12 28.41 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.197 -0.456 . . . . 0.54 110.703 -171.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.634 HD12 ' HB ' ' A' ' 161' ' ' THR . 75.6 mt -65.68 116.02 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 115.424 -0.807 . . . . 0.17 110.674 171.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.523 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 20.6 pt -84.16 -44.09 17.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 112.901 0.704 . . . . 0.21 112.901 -175.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.84 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 44.9 m-80 -170.45 169.84 7.25 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.003 -1.48 . . . . 2.03 107.003 -169.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.656 HH21 ' HA ' ' A' ' 158' ' ' PRO . 14.0 mtt180 -129.27 158.13 39.93 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.819 -0.752 . . . . 1.52 111.536 -175.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.9 tt0 -131.89 100.87 5.22 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.711 -0.677 . . . . 0.59 109.969 169.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.492 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 20.7 ttt85 -62.86 166.0 6.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.339 -0.846 . . . . 2.82 111.01 174.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.492 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 21.5 m-80 -35.01 103.03 0.23 Allowed Pre-proline 0 C--O 1.234 0.274 0 C-N-CA 125.361 1.464 . . . . 0.35 113.717 -153.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 13.9 Cg_exo -52.41 -49.6 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.594 2.863 . . . . 0.48 111.238 170.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.33 -33.74 4.71 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 110.44 -1.064 . . . . 0.67 110.44 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.79 -177.93 45.68 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.811 -0.695 . . . . 0.62 112.431 175.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.06 -0.75 0.99 Allowed 'Trans proline' 0 N--CA 1.479 0.675 0 C-N-CA 125.056 3.837 . . . . 0.94 115.365 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -71.43 7.06 1.49 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 112.919 0.711 . . . . 1.23 112.919 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.697 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 88.03 63.47 1.38 Allowed Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 119.502 -1.332 . . . . 1.69 115.673 165.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.524 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 37.16 0.66 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 117.055 2.243 . . . . 0.48 117.055 -177.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.495 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.3 OUTLIER -167.26 162.67 15.12 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.583 -0.698 . . . . 0.28 109.925 -176.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 22.1 t-105 -142.52 98.61 3.33 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.176 -1.046 . . . . 0.49 108.176 166.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.6 HD12 HG23 ' A' ' 150' ' ' VAL . 4.6 mt -91.3 113.74 26.09 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.101 -0.703 . . . . 0.66 109.101 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 101' ' ' ILE . 23.5 m -83.82 143.81 29.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.86 -0.609 . . . . 0.19 111.325 -169.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.791 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.3 167.99 9.63 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.921 -0.581 . . . . 0.13 111.407 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 t -58.87 -13.87 7.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.583 -1.19 . . . . 1.17 112.967 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.733 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 4.0 tmtm? -127.01 130.12 49.4 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.016 0.436 . . . . 1.22 110.127 172.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.712 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.9 mt-30 -34.37 -55.02 0.53 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.097 -1.411 . . . . 1.51 114.151 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.529 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -99.91 11.93 38.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.958 -0.697 . . . . 2.53 111.997 -173.381 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.791 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -96.48 37.65 1.26 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.755 0.65 . . . . 0.84 112.755 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.612 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -114.45 142.68 17.7 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 117.379 -2.343 . . . . 0.32 112.58 -151.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.529 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -94.63 114.44 31.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.743 0.783 . . . . 0.18 110.568 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.679 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.8 p80 -145.05 171.44 14.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.21 109.75 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.697 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.83 -168.03 37.89 Favored Glycine 0 C--N 1.316 -0.537 0 C-N-CA 120.287 -0.958 . . . . 0.27 111.892 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.445 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 14.2 t -156.69 172.7 18.13 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.2 -0.588 . . . . 0.41 110.175 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -114.26 -0.1 14.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.952 -0.759 . . . . 1.99 108.952 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -114.83 86.8 13.72 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 107.916 -1.142 . . . . 1.36 107.916 169.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -73.47 -18.18 23.09 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.486 2.124 . . . . 0.35 113.53 -169.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.98 -1.82 45.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.778 -0.647 . . . . 0.33 110.67 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 41.1 t -91.03 -4.06 56.69 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.049 -0.722 . . . . 1.35 109.049 171.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.433 HG22 ' HB2' ' A' ' 83' ' ' PRO . 37.0 mm -83.3 134.14 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.81 -0.632 . . . . 0.21 110.251 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.95 1.19 70.54 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.867 -1.293 . . . . 0.15 109.867 -174.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 3.3 tttt -110.82 161.53 15.71 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 122.859 1.314 . . . . 2.5 113.46 -176.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.445 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -96.52 126.95 42.07 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 112.551 -2.113 . . . . 0.17 108.239 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.495 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 1.2 p -122.19 166.91 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.585 -1.265 . . . . 0.66 107.585 -176.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.4 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 45.2 m -64.17 -52.17 60.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.823 0.738 . . . . 0.43 112.605 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -130.23 -45.46 1.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 118.067 -1.453 . . . . 2.02 113.805 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.06 133.7 0.17 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 117.023 1.569 . . . . 0.18 117.023 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.598 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 3.0 p -74.67 165.6 24.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 112.573 -1.813 . . . . 0.16 111.676 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.898 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 61.5 mt -59.59 99.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 122.378 1.085 . . . . 0.4 112.239 -162.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.679 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 70.9 mtt180 -86.85 145.83 26.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.752 -1.567 . . . . 1.87 110.494 -177.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.636 ' HG2' HG22 ' A' ' 84' ' ' ILE . 10.9 mtp -126.23 -165.51 1.45 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.011 -0.737 . . . . 0.79 109.011 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.472 ' O ' HG12 ' A' ' 150' ' ' VAL . 40.0 m80 -90.47 165.1 13.99 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.113 -0.699 . . . . 2.32 109.113 169.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.663 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.8 m120 -63.57 -48.99 75.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 118.258 -0.877 . . . . 0.68 110.145 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -64.48 -29.27 70.31 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 121.58 1.991 . . . . 2.18 111.903 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.541 ' HB3' ' HE2' ' A' ' 145' ' ' MET . 68.1 m-20 -76.68 -45.67 28.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.06 0.457 . . . . 0.69 110.435 -175.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.657 HG13 HD12 ' A' ' 151' ' ' ILE . 14.4 p -67.02 -23.46 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.387 -0.824 . . . . 0.11 111.308 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.663 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -84.08 -42.52 17.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 119.05 -0.5 . . . . 0.38 110.142 171.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.478 ' O ' HG13 ' A' ' 156' ' ' ILE . 29.9 mt-10 -48.22 -68.55 0.17 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 119.392 0.996 . . . . 1.99 112.305 171.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.2 mp -47.09 -39.02 12.35 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.455 0.645 . . . . 1.27 111.436 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.73 -32.62 74.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.579 -1.191 . . . . 0.18 111.606 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.1 t -87.34 -32.25 19.72 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.487 -0.758 . . . . 0.21 112.316 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 152' ' ' GLU . 36.9 mt -82.88 -60.11 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.528 0.68 . . . . 0.16 111.547 -172.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.8 m -89.52 138.16 28.5 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.812 -1.086 . . . . 0.16 112.28 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.656 ' HA ' HH21 ' A' ' 103' ' ' ARG . 43.3 Cg_endo -89.01 176.04 3.34 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 C-N-CA 124.194 3.263 . . . . 0.2 111.525 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.84 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.8 m-20 -67.24 154.42 41.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.13 -1.063 . . . . 1.1 108.13 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.97 -15.35 63.18 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.789 -1.196 . . . . 0.18 112.565 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.634 ' HB ' HD12 ' A' ' 100' ' ' ILE . 88.3 m -65.8 136.88 56.78 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.091 -0.707 . . . . 0.14 109.091 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.486 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 1.1 ptm180 -93.3 127.31 38.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.55 1.166 . . . . 3.63 111.51 -171.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.5 t -111.69 108.61 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 112.327 -2.215 . . . . 0.14 109.215 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.8 m -95.54 109.89 22.05 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.459 0.541 . . . . 0.21 112.459 -172.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.475 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -83.69 96.08 4.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 122.504 1.145 . . . . 0.24 109.946 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -101.56 138.32 38.72 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.724 -1.58 . . . . 1.09 108.663 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.561 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 5.2 mmt85 -73.97 -24.51 59.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.988 -0.745 . . . . 2.08 108.988 175.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.26 -48.04 3.72 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.154 -0.93 . . . . 1.97 112.226 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.323 -0.583 0 N-CA-C 109.623 -0.51 . . . . 3.91 109.623 175.515 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.867 -0.493 . . . . 2.8 111.867 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -108.41 147.67 31.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.003 0.43 . . . . 4.44 110.222 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -86.57 109.34 19.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.618 -0.719 . . . . 2.46 109.826 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -105.9 174.45 5.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.661 0.743 . . . . 0.65 112.097 -177.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.62 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.2 tt -96.19 129.67 43.44 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.644 -1.162 . . . . 0.28 110.219 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.81 162.04 13.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.207 -0.906 . . . . 0.31 112.663 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 45' ' ' SER . 74.0 t80 -131.2 145.38 51.91 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.956 -1.475 . . . . 0.44 108.193 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.425 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 59.0 tt0 -116.02 114.55 24.73 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.436 -0.95 . . . . 0.76 108.436 177.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 13' ' ' ASP . 97.5 t -68.04 151.46 10.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 122.567 1.175 . . . . 0.39 113.364 -171.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -103.96 159.87 15.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.256 -1.793 . . . . 2.01 108.837 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -63.07 105.3 0.67 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.972 0.415 . . . . 1.83 111.751 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.35 10.93 32.67 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.933 -0.651 . . . . 0.48 113.215 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.598 ' HB2' HG13 ' A' ' 9' ' ' VAL . 87.8 m-20 -55.93 171.09 0.26 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.709 0.254 . . . . 1.46 111.26 172.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.2 154.3 50.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.599 0.714 . . . . 0.41 111.893 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.708 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -69.14 -28.73 66.7 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.346 -1.297 . . . . 0.86 109.995 -176.349 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.459 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -93.51 -26.12 17.3 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.025 -0.989 . . . . 1.15 110.788 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -66.06 -40.6 91.06 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.604 -0.438 . . . . 1.21 109.927 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.431 HG23 ' CE1' ' A' ' 22' ' ' PHE . 14.6 mt -73.47 -27.1 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.185 -0.461 . . . . 0.21 109.928 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.651 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.39 -11.37 59.92 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.809 -0.356 . . . . 0.16 111.147 176.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.644 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -93.51 -40.02 10.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.458 0.647 . . . . 0.21 109.885 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.67 ' HB3' ' O ' ' A' ' 119' ' ' SER . 47.1 m-20 -63.46 -40.54 97.4 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.726 -1.125 . . . . 0.53 112.054 174.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 51.4 m-85 -99.25 4.81 46.74 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 118.506 -1.278 . . . . 0.18 111.44 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.644 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.7 mpt_? 54.83 44.6 28.15 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.711 0.767 . . . . 1.78 109.619 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.651 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 32.4 pt -117.46 -165.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.624 -1.171 . . . . 0.19 110.028 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.42 142.55 41.98 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.91 -1.041 . . . . 0.95 110.125 175.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.708 ' HB ' HD11 ' A' ' 15' ' ' LEU . 78.8 p -73.57 -32.75 64.32 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.409 -0.96 . . . . 0.25 108.409 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.59 -24.4 66.65 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.095 -0.957 . . . . 0.2 111.636 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.461 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.31 -28.2 15.1 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.983 -0.747 . . . . 0.17 108.983 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.646 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 21.3 tp -74.23 -27.01 60.57 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.486 -0.779 . . . . 1.16 109.503 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 36' ' ' LEU . 72.6 mt -80.19 -26.81 39.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.698 0.761 . . . . 1.05 110.117 172.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.461 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 47.8 tt0 -66.03 -41.18 91.26 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.573 -1.194 . . . . 1.81 110.13 171.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.1 -21.67 31.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.115 -0.634 . . . . 0.2 111.456 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.656 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.2 m-80 -148.27 78.49 9.41 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.532 0.682 . . . . 0.23 110.328 -172.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 20.3 Cg_endo -58.36 -7.79 4.41 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 124.331 3.354 . . . . 0.36 114.149 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.6 m -84.69 -17.89 37.01 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 111.815 0.302 . . . . 1.38 111.815 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.742 HD21 HG21 ' A' ' 46' ' ' ILE . 41.8 mt -67.74 -34.49 76.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.513 0.673 . . . . 0.49 111.704 -173.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.422 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 5.7 pt20 -65.05 -46.64 80.4 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.819 1.295 . . . . 1.95 110.36 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' A' ' 37' ' ' GLN . . . -58.86 -47.66 84.12 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 111.771 -2.468 . . . . 0.49 110.648 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.48 47.43 Favored Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 114.753 -1.112 . . . . 0.42 111.318 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.26 156.8 20.95 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.273 0.558 . . . . 0.41 111.006 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 62.3 m -138.05 127.32 24.53 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.17 -0.923 . . . . 0.42 110.576 -175.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.7 118.06 19.71 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.511 0.672 . . . . 0.47 109.943 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 101.67 1.76 52.86 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.195 -1.162 . . . . 0.41 110.195 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -77.95 123.7 27.11 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.633 -0.783 . . . . 1.3 109.715 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 46.2 p -82.18 128.04 33.76 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.434 -0.803 . . . . 0.85 110.275 176.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.742 HG21 HD21 ' A' ' 36' ' ' LEU . 12.4 pt -127.7 141.72 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.186 -1.37 . . . . 0.25 109.326 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.36 150.61 3.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.094 0.473 . . . . 0.67 110.898 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.4 mm -114.8 92.1 28.57 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.709 -1.132 . . . . 0.16 108.992 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.635 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -58.94 133.81 56.0 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.903 2.402 . . . . 0.18 112.918 -174.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.07 -6.38 78.88 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.8 -1.091 . . . . 0.26 112.339 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.727 HD12 ' HD2' ' A' ' 52' ' ' PRO . 30.0 tp -123.47 116.97 27.97 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 121.106 0.479 . . . . 0.61 111.213 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.727 ' HD2' HD12 ' A' ' 51' ' ' LEU . 43.7 Cg_endo -76.86 -177.28 3.68 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.605 2.87 . . . . 0.28 113.907 -172.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.1 t70 -83.54 129.56 59.53 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 114.483 -1.235 . . . . 0.49 111.97 -168.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.557 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.2 Cg_endo -75.23 -17.49 19.01 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.333 2.689 . . . . 0.46 112.411 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -93.96 -5.41 47.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.476 0.655 . . . . 1.38 110.404 -172.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.2 p -89.24 -20.84 23.65 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.6 1.19 . . . . 0.46 107.993 173.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.497 HG22 ' H ' ' A' ' 59' ' ' TYR . 27.1 mt -74.05 130.02 83.61 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 112.906 -1.952 . . . . 0.7 111.232 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.82 -17.06 9.86 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.48 2.12 . . . . 0.39 113.153 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.497 ' H ' HG22 ' A' ' 57' ' ' ILE . 70.0 m-85 -92.26 159.5 15.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.823 -0.351 . . . . 0.24 111.661 -177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -147.2 134.44 20.58 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.883 -0.784 . . . . 2.89 108.883 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' A' ' 71' ' ' THR . 86.3 mt -113.68 131.89 64.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.948 -0.569 . . . . 0.16 111.676 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.32 30.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.937 -0.705 . . . . 0.16 110.843 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 69' ' ' THR . 91.2 t -97.62 111.31 27.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.765 0.793 . . . . 0.19 111.117 175.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 68' ' ' LYS . 58.8 m -93.64 101.25 13.39 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.508 -1.223 . . . . 0.2 110.702 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.52 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.6 mm -49.26 -57.89 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 122.067 0.937 . . . . 0.23 111.306 170.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.22 -9.1 2.85 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 112.764 -2.016 . . . . 0.16 113.208 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.07 -22.53 3.76 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.532 0.733 . . . . 0.15 112.517 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HG3' HG22 ' A' ' 86' ' ' VAL . 1.1 mppt? 60.61 58.44 2.45 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 118.067 0.394 . . . . 0.69 111.354 -170.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 63.0 p -137.68 160.83 38.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 113.09 0.774 . . . . 0.13 113.09 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.435 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.4 tt -128.18 107.95 10.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.672 -1.149 . . . . 0.4 109.534 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.7 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 61.7 m -90.37 122.02 32.87 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.082 0.468 . . . . 0.16 110.837 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 79' ' ' MET . 17.1 tp -97.88 105.21 17.32 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.446 -0.797 . . . . 0.59 109.273 173.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 96.9 p -105.65 160.47 15.18 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 118.829 -1.148 . . . . 1.05 110.318 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.5 tm? -126.1 125.45 42.57 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.705 -0.85 . . . . 0.26 108.705 168.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.538 ' N ' HD22 ' A' ' 74' ' ' LEU . 7.7 m120 50.54 50.06 19.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.435 -1.257 . . . . 1.84 111.008 -171.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 71.74 -10.18 0.87 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.571 0.749 . . . . 1.89 111.816 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -98.79 120.42 39.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.021 -0.536 . . . . 3.44 109.82 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 54.6 t -57.74 132.98 22.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 122.493 1.139 . . . . 0.24 112.768 -174.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -102.01 -45.01 5.31 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 112.837 -1.983 . . . . 0.81 108.732 177.391 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -154.27 174.49 14.72 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 113.2 -1.818 . . . . 1.46 110.102 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 27.9 m -149.29 121.21 8.19 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.481 -1.69 . . . . 0.17 109.46 168.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.503 ' HD2' ' OD2' ' A' ' 149' ' ' ASP . 12.9 m-85 -101.19 151.28 37.67 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 115.142 -0.935 . . . . 1.05 109.165 -175.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HB2' HG22 ' A' ' 134' ' ' ILE . 57.3 Cg_endo -81.2 140.51 12.36 Favored 'Trans proline' 0 CA--C 1.5 -1.212 0 C-N-CA 121.499 1.466 . . . . 0.2 111.062 169.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.674 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -139.81 176.13 6.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.516 -0.765 . . . . 0.13 110.393 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.878 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -120.14 150.17 41.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.126 -0.324 . . . . 0.26 110.126 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.513 HG11 HD13 ' A' ' 65' ' ' ILE . 9.8 m -130.95 127.47 61.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.58 0.705 . . . . 0.56 112.107 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -85.67 156.16 29.98 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.044 -1.222 . . . . 0.17 110.044 172.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -57.46 3.96 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.236 0.828 . . . . 3.05 113.236 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.947 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -90.28 -19.49 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 O-C-N 121.638 -0.664 . . . . 0.23 110.291 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.947 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -89.78 -18.13 26.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.765 0.793 . . . . 0.18 109.256 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.5 p -68.04 -14.36 62.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.427 -1.26 . . . . 0.33 111.362 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -71.52 -37.67 71.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.47 -1.241 . . . . 1.52 112.862 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -105.8 115.89 60.76 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 120.055 -0.658 . . . . 0.43 110.793 -177.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.558 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.8 Cg_endo -75.58 -11.69 20.43 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.792 2.328 . . . . 0.73 113.63 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.439 HG23 ' N ' ' A' ' 96' ' ' GLY . 10.1 t -105.02 -43.56 5.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.185 0.516 . . . . 0.48 110.107 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.557 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 53.54 33.48 47.81 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.257 -1.338 . . . . 0.33 113.93 167.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.16 112.61 20.4 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.969 0.89 . . . . 0.84 109.721 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.715 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 19.0 m-85 -138.05 176.81 8.37 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.764 -1.562 . . . . 0.22 111.949 -170.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.455 ' CG ' HD11 ' A' ' 5' ' ' LEU . 45.3 m-85 -139.33 144.08 38.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.257 0.551 . . . . 0.54 110.452 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.564 HD12 ' HB ' ' A' ' 161' ' ' THR . 83.8 mt -68.84 116.89 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 115.613 -0.721 . . . . 0.17 110.557 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 30.4 pt -85.93 -35.81 9.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 112.877 0.695 . . . . 0.21 112.877 -175.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.782 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 11.0 p30 -178.53 -179.21 0.65 Allowed 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 107.695 -1.224 . . . . 2.03 107.695 -176.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.674 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -140.38 159.6 41.83 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.16 -0.616 . . . . 1.52 112.599 -176.041 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.8 tt0 -128.37 100.07 5.66 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.9 -1.046 . . . . 0.59 109.428 172.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.518 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 61.5 ttt180 -64.73 165.91 9.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.341 -0.845 . . . . 2.82 110.663 176.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.518 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 23.3 m-80 -35.07 102.05 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 125.282 1.433 . . . . 0.35 113.743 -152.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 16.3 Cg_exo -53.84 -51.53 10.55 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.504 2.803 . . . . 0.48 111.469 169.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.26 -33.84 4.53 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.152 -1.179 . . . . 0.67 110.152 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.49 -175.16 33.57 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.636 -0.782 . . . . 0.62 112.745 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.69 -8.47 7.46 Favored 'Trans proline' 0 N--CA 1.479 0.675 0 C-N-CA 124.877 3.718 . . . . 0.94 114.844 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -63.99 -0.11 1.04 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.08 1.141 . . . . 1.23 114.08 -172.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.684 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 89.18 63.32 1.32 Allowed Glycine 0 CA--C 1.494 -1.277 0 C-N-CA 119.287 -1.435 . . . . 1.69 114.884 166.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.514 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 37.68 0.77 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 116.977 2.214 . . . . 0.48 116.977 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.49 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -166.54 162.88 16.96 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.684 -0.635 . . . . 0.28 110.04 -176.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 18.0 t-105 -143.9 97.85 3.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.302 -0.999 . . . . 0.49 108.302 167.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.468 HD12 HG23 ' A' ' 150' ' ' VAL . 2.1 mt -89.48 115.19 26.72 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.381 0.61 . . . . 0.66 109.739 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.449 ' C ' HG12 ' A' ' 101' ' ' ILE . 24.3 m -86.01 144.3 27.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.956 -0.565 . . . . 0.19 111.19 -171.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.807 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.1 mm? -109.29 168.14 9.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.13 110.46 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.67 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.1 m -65.11 -2.38 2.79 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.937 0.718 . . . . 1.17 112.937 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.773 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 5.0 tmtm? -128.8 136.37 50.42 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.941 -0.392 . . . . 1.22 109.941 168.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.773 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 25.5 mm-40 -36.46 -58.03 0.73 Allowed 'General case' 0 C--N 1.312 -1.041 0 O-C-N 124.222 0.951 . . . . 1.51 113.458 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.538 ' CB ' HG12 ' A' ' 89' ' ' ILE . 56.2 m80 -89.92 0.78 56.88 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.451 -0.499 . . . . 2.53 111.83 -167.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.807 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.1 m-30 -96.73 37.93 1.25 Allowed 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 113.419 0.896 . . . . 0.84 113.419 -170.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.699 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -114.41 142.95 17.85 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 116.693 -2.67 . . . . 0.32 112.642 -152.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -93.35 115.21 31.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.773 0.797 . . . . 0.18 110.661 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.555 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 31.5 p80 -142.05 170.57 15.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.451 -0.795 . . . . 0.21 109.394 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.684 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -92.35 -167.27 39.61 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.375 -0.917 . . . . 0.27 111.687 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.501 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 9.2 t -156.79 169.82 23.86 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 122.039 -0.683 . . . . 0.41 110.346 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -114.68 -5.22 12.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.643 -0.873 . . . . 1.99 108.643 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -116.04 87.33 18.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 114.832 -1.077 . . . . 1.36 108.231 171.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -72.78 -21.21 21.79 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.131 2.554 . . . . 0.35 114.484 -167.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -75.83 -2.58 30.69 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.147 0.499 . . . . 0.33 111.116 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.483 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 15.9 m -91.91 -5.52 53.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.275 0.559 . . . . 1.35 109.673 173.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 83' ' ' PRO . 37.8 mm -81.89 134.96 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.21 110.085 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.89 2.28 66.91 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.954 -1.259 . . . . 0.15 109.954 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 54.6 mttp -113.93 170.08 8.53 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.988 1.375 . . . . 2.5 113.466 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.07 124.92 49.45 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.118 -2.31 . . . . 0.17 108.191 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.43 162.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.757 -0.831 . . . . 0.66 108.757 -173.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -51.55 -60.17 3.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.389 0.514 . . . . 0.43 112.389 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.416 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 18.8 pttp -133.5 -44.36 0.83 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 118.357 -1.337 . . . . 2.02 113.765 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.88 133.24 0.17 Allowed Glycine 0 N--CA 1.464 0.54 0 N-CA-C 117.014 1.565 . . . . 0.18 117.014 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.547 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 5.4 p -69.53 165.75 20.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 112.411 -1.894 . . . . 0.16 112.202 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.878 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 45.9 mt -59.8 98.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.566 -1.197 . . . . 0.4 112.047 -162.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.555 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 11.4 mtp180 -86.27 150.03 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.874 -1.512 . . . . 1.87 110.25 -177.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.674 ' HG2' HG22 ' A' ' 84' ' ' ILE . 6.3 mtp -129.31 -165.79 1.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.973 -0.751 . . . . 0.79 108.973 173.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.724 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 5.1 t60 -92.91 159.54 15.3 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.605 -0.887 . . . . 2.32 108.605 170.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.645 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.1 m-80 -57.9 -53.21 60.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.357 -0.83 . . . . 0.68 110.365 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -63.56 -27.15 69.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 121.376 1.898 . . . . 2.18 112.005 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.724 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.9 m-20 -75.67 -51.31 13.06 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.72 -0.673 . . . . 0.69 110.63 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.648 HG13 HD12 ' A' ' 151' ' ' ILE . 14.7 p -62.94 -22.63 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 115.285 -0.87 . . . . 0.11 111.746 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.648 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.58 -39.95 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 118.911 -0.566 . . . . 0.38 110.569 172.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -45.79 -72.34 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.219 0.918 . . . . 1.99 112.674 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.587 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.1 mm? -49.0 -35.05 14.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.768 0.794 . . . . 1.27 111.325 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.508 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -63.94 -35.09 79.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.561 -1.2 . . . . 0.18 112.048 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.3 t -90.99 -29.01 17.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 119.03 0.832 . . . . 0.21 113.099 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.4 mt -83.19 -60.44 2.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.509 0.671 . . . . 0.16 111.772 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.4 m -86.76 141.83 34.04 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.955 -1.02 . . . . 0.16 111.53 177.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.674 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 77.9 Cg_endo -85.19 172.64 8.34 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.992 3.128 . . . . 0.2 111.351 175.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.782 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.4 m-20 -63.65 156.3 27.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.243 -1.021 . . . . 1.1 108.243 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.77 -22.08 42.42 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 119.634 -1.27 . . . . 0.18 112.951 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.564 ' HB ' HD12 ' A' ' 100' ' ' ILE . 48.9 m -60.78 135.48 57.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.077 -0.712 . . . . 0.14 109.077 -174.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.637 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -94.16 129.91 40.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.589 1.185 . . . . 3.63 111.403 -167.42 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.3 t -110.95 110.57 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 112.373 -2.194 . . . . 0.14 109.571 -173.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 15.7 m -94.24 105.58 17.56 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.512 0.56 . . . . 0.21 112.512 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.557 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -82.42 99.96 5.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-O 122.412 1.101 . . . . 0.24 110.005 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -107.47 130.91 54.78 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.04 -1.436 . . . . 1.09 109.61 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.558 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 17.3 mmm180 -72.62 -7.74 51.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.967 0.413 . . . . 2.08 111.184 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.98 8.14 69.55 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.804 -0.712 . . . . 1.97 112.033 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 C--N 1.321 -0.663 0 N-CA-C 109.552 -0.536 . . . . 3.91 109.552 177.622 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 111.697 -0.561 . . . . 2.8 111.697 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -117.04 133.02 56.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.009 0.433 . . . . 4.44 110.232 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -90.83 119.06 30.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.696 -0.684 . . . . 2.46 110.637 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.692 HD21 ' HA ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -113.89 175.12 5.6 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.64 0.733 . . . . 0.65 112.076 -175.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.9 tt -95.42 130.42 42.23 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.525 -1.216 . . . . 0.28 110.124 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.55 162.97 13.23 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.135 0.969 . . . . 0.31 113.21 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 45' ' ' SER . 84.8 t80 -130.44 140.95 50.54 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.791 -1.549 . . . . 0.44 107.959 175.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.403 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.8 tt0 -113.36 113.19 24.88 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.063 -1.088 . . . . 0.76 108.063 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' A' ' 13' ' ' ASP . 93.6 t -67.11 150.99 10.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 122.38 1.086 . . . . 0.39 112.999 -170.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -107.49 159.05 16.71 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 113.376 -1.738 . . . . 2.01 108.21 171.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -58.66 110.0 0.91 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.964 0.411 . . . . 1.83 111.94 -174.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.99 11.32 43.39 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.766 -0.652 . . . . 0.48 113.7 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.643 ' HB2' HG13 ' A' ' 9' ' ' VAL . 86.9 m-20 -55.85 167.95 0.51 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.193 0.497 . . . . 1.46 111.177 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.59 152.56 48.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.036 0.446 . . . . 0.41 111.746 176.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.56 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.39 -32.72 74.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.082 -0.963 . . . . 0.86 108.643 -178.046 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 64.1 t30 -93.05 -22.21 19.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.789 -1.096 . . . . 1.15 111.114 -177.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.7 t -65.64 -45.85 81.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.206 -0.664 . . . . 1.21 109.206 171.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.436 HG23 ' CE1' ' A' ' 22' ' ' PHE . 17.3 mt -71.84 -26.61 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.881 -0.6 . . . . 0.21 110.056 -176.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.638 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.45 -10.17 59.75 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.833 -0.347 . . . . 0.16 111.111 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.607 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.32 -39.1 9.38 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.502 1.144 . . . . 0.21 108.057 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 119' ' ' SER . 6.2 m-20 -63.32 -44.38 95.08 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 112.402 -2.181 . . . . 0.53 111.911 173.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.569 ' HA ' HG21 ' A' ' 101' ' ' ILE . 55.3 m-85 -97.72 4.66 49.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 118.725 -1.19 . . . . 0.18 111.658 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.4 mpt_? 54.68 43.28 30.4 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.866 0.841 . . . . 1.78 109.928 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.638 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.4 pt -116.39 -165.18 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 114.529 -1.214 . . . . 0.19 109.702 -178.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.1 142.34 41.7 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.023 -0.99 . . . . 0.95 110.227 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.633 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 67.1 p -72.68 -32.82 66.1 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.916 -1.142 . . . . 0.25 107.916 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.45 67.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.188 -0.915 . . . . 0.2 111.745 169.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.98 -26.64 18.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.662 0.744 . . . . 0.17 108.997 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.635 HD11 HD12 ' A' ' 46' ' ' ILE . 19.2 tp -76.35 -20.45 57.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.282 -0.872 . . . . 1.16 109.554 174.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 26' ' ' THR . 28.9 mt -83.91 -29.54 27.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.396 0.617 . . . . 1.05 110.606 170.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -59.97 -61.25 2.75 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.945 -1.132 . . . . 1.81 107.945 169.617 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -71.61 -17.39 62.28 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.514 0.673 . . . . 0.2 110.415 -169.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.659 ' HB3' HD23 ' A' ' 36' ' ' LEU . 33.9 m-80 -150.69 85.26 5.28 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.189 -0.914 . . . . 0.23 110.579 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.46 -9.18 6.43 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.964 2.443 . . . . 0.36 112.952 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 m -69.79 -34.66 74.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.154 0.502 . . . . 1.38 111.319 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -61.37 -51.37 69.07 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 122.209 1.004 . . . . 0.49 112.152 -169.099 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 38' ' ' ALA . 4.2 pt20 -56.32 -48.53 76.52 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 113.231 -1.804 . . . . 1.95 110.93 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.43 ' H ' ' HG3' ' A' ' 37' ' ' GLN . . . -54.5 -52.52 61.7 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 111.893 -2.412 . . . . 0.49 109.938 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.88 168.0 37.93 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 114.439 -1.255 . . . . 0.42 112.164 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.03 158.25 16.28 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.266 0.555 . . . . 0.41 110.501 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 39.6 m -145.72 129.19 16.94 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.262 -0.881 . . . . 0.42 110.427 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.89 117.64 16.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.495 0.664 . . . . 0.47 109.953 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 101.15 0.54 54.47 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 114.716 -1.129 . . . . 0.41 110.289 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.3 tt0 -75.24 125.38 28.84 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.856 -0.672 . . . . 1.3 110.338 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 56.3 p -83.54 131.46 34.99 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.831 0.824 . . . . 0.85 110.322 175.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.635 HD12 HD11 ' A' ' 29' ' ' LEU . 10.0 pt -132.37 143.57 39.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.366 -1.288 . . . . 0.25 109.306 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.61 151.73 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.16 0.505 . . . . 0.67 111.455 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.3 mm -116.45 92.89 38.4 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.628 -1.169 . . . . 0.16 109.404 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.692 ' HA ' HD21 ' A' ' 4' ' ' LEU . 4.0 Cg_exo -57.34 134.88 66.65 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.853 2.369 . . . . 0.18 113.174 -175.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.01 -7.58 80.93 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.317 -1.311 . . . . 0.26 112.532 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.718 HD12 ' HD2' ' A' ' 52' ' ' PRO . 33.6 tp -120.87 115.2 32.07 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-O 121.2 0.524 . . . . 0.61 111.184 -177.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.718 ' HD2' HD12 ' A' ' 51' ' ' LEU . 54.7 Cg_endo -78.09 -176.12 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 124.05 3.167 . . . . 0.28 114.402 -171.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.594 ' HB3' HG23 ' A' ' 56' ' ' THR . 15.5 t70 -82.74 129.0 63.9 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 114.19 -1.368 . . . . 0.49 112.045 -169.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 46.2 Cg_endo -72.92 -13.87 26.47 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 123.371 2.714 . . . . 0.46 112.61 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.444 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 59.7 m-85 -96.26 -0.53 49.62 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.451 0.643 . . . . 1.38 111.398 -175.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.594 HG23 ' HB3' ' A' ' 53' ' ' ASP . 19.6 p -95.33 -20.4 19.18 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.751 -1.203 . . . . 0.46 107.751 171.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 59' ' ' TYR . 19.1 mt -75.69 131.5 76.74 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 113.168 -1.833 . . . . 0.7 111.147 177.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 95.5 Cg_endo -82.72 -18.26 6.76 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.233 1.956 . . . . 0.39 113.486 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' H ' HG22 ' A' ' 57' ' ' ILE . 61.6 m-85 -95.2 158.47 15.45 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.499 0.555 . . . . 0.24 112.499 -175.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -146.64 128.83 15.68 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.322 -0.853 . . . . 2.89 108.975 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.655 ' HA ' ' O ' ' A' ' 71' ' ' THR . 87.2 mt -110.32 135.95 47.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.225 -0.443 . . . . 0.16 111.701 -176.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.09 119.04 33.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 119.955 -0.698 . . . . 0.16 110.968 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.2 t -98.96 116.38 41.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.525 0.679 . . . . 0.19 110.869 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 68' ' ' LYS . 70.3 m -95.06 105.89 17.84 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.046 -0.979 . . . . 0.2 110.352 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.7 mm -54.22 -58.92 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 122.079 0.942 . . . . 0.23 111.2 167.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.68 -10.65 4.7 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 112.789 -2.005 . . . . 0.16 113.351 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.426 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.67 -18.74 4.7 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.453 0.701 . . . . 0.15 112.213 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.506 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.64 55.74 4.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.373 0.533 . . . . 0.69 111.421 -173.751 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.8 p -138.02 160.52 39.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.84 0.681 . . . . 0.13 112.84 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.503 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.7 tt -128.54 113.29 15.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.778 -1.101 . . . . 0.4 110.178 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.655 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 41.3 m -93.95 122.66 36.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.273 0.559 . . . . 0.16 111.43 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 79' ' ' MET . 12.9 tp -97.55 103.27 15.19 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.862 -1.063 . . . . 0.59 109.45 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 7.5 m -105.49 160.64 15.0 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.474 -0.89 . . . . 1.05 110.77 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.2 tm? -127.18 126.99 43.79 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.981 -0.748 . . . . 0.26 108.981 169.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.54 ' N ' HD22 ' A' ' 74' ' ' LEU . 16.7 m120 47.65 51.44 13.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.561 -1.199 . . . . 1.84 111.228 -171.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 t30 71.8 -12.24 0.68 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.57 -0.741 . . . . 1.89 111.695 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -96.22 120.27 36.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.17 0.509 . . . . 3.44 110.221 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 64.1 t -59.53 131.85 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 122.32 1.057 . . . . 0.24 112.468 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 8.7 mtm -100.59 -46.01 5.33 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 113.246 -1.797 . . . . 0.81 108.903 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -156.35 173.03 17.47 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.518 -1.673 . . . . 1.46 110.037 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.7 m -149.4 124.6 10.13 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.354 -1.293 . . . . 0.17 109.848 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -111.2 153.11 44.12 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.871 -0.604 . . . . 1.05 109.439 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.443 ' HB2' HG22 ' A' ' 134' ' ' ILE . 60.4 Cg_endo -79.7 143.11 16.52 Favored 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 122.194 1.929 . . . . 0.2 111.495 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.682 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.92 175.1 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.746 -0.661 . . . . 0.13 110.948 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.887 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.51 146.08 45.76 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.309 -0.405 . . . . 0.26 110.067 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.533 HG11 HD13 ' A' ' 65' ' ' ILE . 8.8 m -127.04 128.81 70.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.532 0.682 . . . . 0.56 111.784 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -87.31 154.66 26.46 Favored Glycine 0 N--CA 1.425 -2.039 0 N-CA-C 110.09 -1.204 . . . . 0.17 110.09 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -56.18 2.93 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.266 0.839 . . . . 3.05 113.266 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.953 HG23 HD22 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -88.68 -19.92 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 O-C-N 121.587 -0.696 . . . . 0.23 110.177 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.953 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -89.42 -18.28 27.1 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.715 0.769 . . . . 0.18 109.314 -176.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.5 p -65.99 -14.9 62.44 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.553 -1.203 . . . . 0.33 111.767 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -67.08 -39.06 86.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.051 -0.977 . . . . 1.52 112.327 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -107.95 117.55 54.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.668 -0.413 . . . . 0.43 111.222 -175.388 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.598 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 1.8 Cg_endo -77.63 -13.83 16.17 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.674 2.25 . . . . 0.73 113.083 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.1 t -103.67 -41.84 5.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.677 -0.49 . . . . 0.48 109.677 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.567 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.46 39.59 22.38 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.419 -1.264 . . . . 0.33 114.024 168.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -84.11 112.12 19.94 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.907 0.86 . . . . 0.84 109.507 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.9 m-85 -138.78 174.72 10.23 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.003 -1.453 . . . . 0.22 112.12 -171.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.687 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 86.6 m-85 -139.69 136.3 34.1 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.058 -0.519 . . . . 0.54 110.732 -175.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.571 HD12 ' HB ' ' A' ' 161' ' ' THR . 86.7 mt -59.74 121.68 8.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.361 -0.836 . . . . 0.17 110.44 170.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.569 HG21 ' HA ' ' A' ' 22' ' ' PHE . 19.1 pt -87.3 -44.6 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.83 0.678 . . . . 0.21 112.83 -176.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.569 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 44.1 m-80 -171.54 172.08 5.18 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.976 -1.49 . . . . 2.03 106.976 -168.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.655 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 39.8 mtt180 -124.28 171.56 9.78 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.531 -0.867 . . . . 1.52 111.592 -173.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 7.8 tt0 -148.28 99.91 3.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.08 -0.964 . . . . 0.59 109.758 170.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.467 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 48.4 ttp180 -66.18 166.17 12.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.284 -0.871 . . . . 2.82 110.421 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.51 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 25.4 m-80 -35.66 103.03 0.24 Allowed Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 125.323 1.449 . . . . 0.35 113.405 -157.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.51 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.9 Cg_endo -61.36 -31.44 88.75 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.99 2.46 . . . . 0.48 111.756 173.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.14 -34.15 5.34 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.746 -0.942 . . . . 0.67 110.746 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.08 -177.16 45.21 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.969 -0.615 . . . . 0.62 112.437 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 112' ' ' GLY . 30.8 Cg_endo -62.1 6.23 0.18 Allowed 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 125.002 3.802 . . . . 0.94 115.662 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -73.29 21.64 0.08 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.506 0.558 . . . . 1.23 112.506 -175.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.778 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 68.31 63.69 3.46 Favored Glycine 0 CA--C 1.499 -0.914 0 N-CA-C 115.568 0.987 . . . . 1.69 115.568 168.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.542 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.61 -4.48 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 117.294 2.331 . . . . 0.48 117.294 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.5 OUTLIER -166.02 151.37 8.63 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.272 -0.892 . . . . 0.28 110.594 -176.073 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.5 t-105 -132.09 99.62 4.78 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.41 -0.959 . . . . 0.49 108.41 168.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.547 HD12 HG23 ' A' ' 150' ' ' VAL . 5.3 mt -93.92 114.27 26.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.624 0.726 . . . . 0.66 109.358 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.413 ' HB3' HD11 ' A' ' 101' ' ' ILE . 19.5 m -83.9 144.22 29.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.593 -0.731 . . . . 0.19 111.466 -168.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -108.53 170.66 7.88 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.821 -0.627 . . . . 0.13 111.243 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 2.9 t -62.38 -13.73 32.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.112 -0.949 . . . . 1.17 112.729 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.688 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 1.4 tmtp? -126.63 132.3 51.26 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 120.446 -0.501 . . . . 1.22 110.594 173.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.688 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 55.3 mt-30 -34.2 -56.87 0.49 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.003 -1.453 . . . . 1.51 113.869 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.497 ' HB2' HG12 ' A' ' 89' ' ' ILE . 75.0 m-70 -92.22 2.01 56.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.154 0.502 . . . . 2.53 111.556 -171.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.793 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -94.0 37.44 1.09 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.405 0.891 . . . . 0.84 113.405 -172.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.604 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.05 143.27 18.06 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 117.016 -2.516 . . . . 0.32 112.717 -152.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.52 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -96.12 114.64 33.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.722 0.772 . . . . 0.18 110.766 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.648 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.0 p80 -143.99 172.12 13.31 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.432 -0.804 . . . . 0.21 109.663 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.778 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.75 -176.68 39.8 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.982 -1.104 . . . . 0.27 111.66 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.537 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 15.0 t -147.0 168.13 22.28 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.387 -0.478 . . . . 0.41 110.387 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -111.25 -0.7 16.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.126 -1.065 . . . . 1.99 108.126 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -116.05 85.86 15.86 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 114.537 -1.21 . . . . 1.36 108.385 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -72.85 -21.19 21.58 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.164 1.909 . . . . 0.35 113.727 -169.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.23 -2.58 38.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.156 0.503 . . . . 0.33 110.845 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 44.7 t -91.42 -3.2 56.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.308 -0.627 . . . . 1.35 109.308 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 83' ' ' PRO . 42.8 mm -80.88 139.37 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.932 -0.576 . . . . 0.21 110.133 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.46 1.37 74.83 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 110.159 -1.176 . . . . 0.15 110.159 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -111.65 167.86 10.01 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 123.24 1.495 . . . . 2.5 114.414 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.21 48.52 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 111.541 -2.572 . . . . 0.17 107.697 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.469 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -124.66 160.58 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.954 -0.758 . . . . 0.66 108.954 -174.246 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.5 m -49.36 -59.78 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.616 0.598 . . . . 0.43 112.616 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.533 ' HD3' ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -132.62 -43.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 118.411 -1.316 . . . . 2.02 113.744 -175.04 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.533 ' N ' ' HD3' ' A' ' 140' ' ' LYS . . . -32.24 133.55 0.19 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 117.236 1.654 . . . . 0.18 117.236 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.504 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.0 p -73.39 165.52 24.91 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 112.636 -1.782 . . . . 0.16 111.843 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.887 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 53.3 mt -59.77 98.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 122.316 1.055 . . . . 0.4 112.018 -162.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.648 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 74.6 mtt180 -85.07 147.69 26.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.777 -1.556 . . . . 1.87 110.281 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.682 ' HG2' HG22 ' A' ' 84' ' ' ILE . 12.3 mtp -127.51 -166.31 1.59 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.401 -0.592 . . . . 0.79 109.401 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.696 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 46.7 t-80 -94.9 156.18 16.45 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.448 -0.945 . . . . 2.32 108.448 172.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.653 ' O ' HD13 ' A' ' 151' ' ' ILE . 8.1 m-20 -58.7 -50.03 75.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 118.339 -0.839 . . . . 0.68 110.736 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -63.34 -26.16 68.63 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 121.26 1.845 . . . . 2.18 112.462 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.696 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 16.8 m-20 -83.95 -39.92 19.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.937 0.399 . . . . 0.69 111.25 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.619 HG13 HD12 ' A' ' 151' ' ' ILE . 14.6 p -70.07 -23.58 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.956 -0.565 . . . . 0.11 111.146 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.653 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.01 -39.8 16.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 118.966 -0.54 . . . . 0.38 109.592 171.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -45.52 -71.36 0.08 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.139 0.881 . . . . 1.99 112.238 167.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 157' ' ' VAL . 8.2 mp -46.32 -38.13 8.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.521 0.677 . . . . 1.27 111.262 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.37 83.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.372 -1.286 . . . . 0.18 111.629 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.1 t -87.94 -34.48 18.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.513 -0.742 . . . . 0.21 112.47 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.2 mt -80.38 -59.56 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.177 0.513 . . . . 0.16 111.451 -172.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 153' ' ' LEU . 2.6 m -92.39 141.51 24.93 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.448 -0.797 . . . . 0.16 112.112 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.655 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 69.4 Cg_endo -89.02 173.6 4.02 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.767 2.978 . . . . 0.2 111.144 173.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.569 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 73.6 m-20 -66.91 157.1 34.04 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.611 -0.836 . . . . 1.1 109.16 177.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.35 -19.19 55.42 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.196 -1.002 . . . . 0.18 112.666 -173.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.571 ' HB ' HD12 ' A' ' 100' ' ' ILE . 59.0 m -63.48 139.77 58.8 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.496 -0.557 . . . . 0.14 109.496 -176.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.687 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 3.5 ptm180 -92.52 120.43 32.98 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.787 1.28 . . . . 3.63 111.112 -170.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.1 t -106.96 109.4 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 112.205 -2.271 . . . . 0.14 109.149 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.8 m -95.49 108.12 20.33 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.484 0.55 . . . . 0.21 112.484 -172.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.567 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -81.78 101.52 6.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 122.35 1.072 . . . . 0.24 109.77 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -106.62 129.54 54.52 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.905 -1.498 . . . . 1.09 109.027 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.598 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 18.0 mmm180 -69.7 -19.62 63.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.865 0.364 . . . . 2.08 110.637 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 161.18 -80.93 0.14 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 121.16 -0.543 . . . . 1.97 111.776 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.32 -0.695 0 N-CA-C 110.251 -0.278 . . . . 3.91 110.251 179.412 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.848 0 N-CA-C 112.211 -0.355 . . . . 2.8 112.211 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -83.62 161.72 21.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.433 0.635 . . . . 4.44 110.943 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -86.67 99.1 11.51 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.167 -0.924 . . . . 2.46 108.667 172.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp -104.39 174.33 5.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.308 0.575 . . . . 0.65 111.845 -175.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.5 tt -92.21 127.64 37.76 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.999 -1.0 . . . . 0.28 110.605 -172.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.82 162.19 13.38 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.188 0.994 . . . . 0.31 113.401 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.633 ' HB3' HG13 ' A' ' 46' ' ' ILE . 80.2 t80 -131.01 141.91 50.28 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.547 -1.66 . . . . 0.44 107.884 175.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 36.2 tt0 -113.23 115.32 28.02 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.218 -1.031 . . . . 0.76 108.218 177.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 13' ' ' ASP . 98.2 t -68.73 150.3 10.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.53 1.157 . . . . 0.39 113.254 -170.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.409 ' O ' HG12 ' A' ' 9' ' ' VAL . 43.8 mtpt -102.36 158.56 16.11 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.335 -1.757 . . . . 2.01 108.541 172.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.33 105.34 0.49 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.879 0.371 . . . . 1.83 111.622 -177.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.96 12.24 30.29 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.62 -0.8 . . . . 0.48 113.366 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.611 ' HB2' HG13 ' A' ' 9' ' ' VAL . 90.2 m-20 -56.23 170.6 0.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.872 0.368 . . . . 1.46 111.171 170.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.89 155.47 45.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.326 0.584 . . . . 0.41 111.146 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.598 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.97 -34.25 77.68 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.334 -0.987 . . . . 0.86 108.334 178.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.508 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -88.38 -28.0 21.24 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.911 -1.04 . . . . 1.15 111.442 -175.335 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.0 p -68.88 -37.67 79.18 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 118.422 0.556 . . . . 1.21 110.181 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.447 HG23 ' CE1' ' A' ' 22' ' ' PHE . 14.5 mt -73.89 -27.12 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 121.254 0.549 . . . . 0.21 109.796 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.645 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.26 -9.79 59.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.355 -0.384 . . . . 0.16 110.684 175.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.728 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.55 -41.19 8.68 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.024 -1.102 . . . . 0.21 108.024 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 5.6 m-20 -63.59 -41.96 98.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 112.797 -2.001 . . . . 0.53 112.5 173.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 24' ' ' ILE . 56.3 m-85 -98.84 6.22 46.97 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 118.655 -1.218 . . . . 0.18 110.858 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.728 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.06 41.04 32.18 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.927 0.87 . . . . 1.78 109.606 176.116 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.645 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.3 pt -114.43 -165.9 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 114.263 -1.335 . . . . 0.19 109.976 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.81 142.65 40.78 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.106 -0.952 . . . . 0.95 109.996 175.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.672 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 70.8 p -72.82 -29.9 63.62 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.702 -0.851 . . . . 0.25 108.702 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.93 -25.01 67.7 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.68 -0.691 . . . . 0.2 111.816 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.37 -28.65 14.85 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.854 -0.795 . . . . 0.17 108.854 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.598 HD23 HD23 ' A' ' 15' ' ' LEU . 20.9 tp -72.29 -27.65 62.6 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.127 -0.942 . . . . 1.16 108.584 172.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.672 ' HB2' ' O ' ' A' ' 26' ' ' THR . 7.6 tp -77.42 -31.73 54.23 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.812 0.815 . . . . 1.05 109.462 175.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 42.0 tt0 -66.05 -40.94 91.35 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.167 -1.378 . . . . 1.81 110.336 173.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -82.01 -17.78 45.64 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.988 -0.685 . . . . 0.2 111.518 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.634 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.0 m-80 -146.64 81.5 9.23 Favored Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-O 121.246 0.546 . . . . 0.23 110.754 -173.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.8 Cg_endo -55.81 -11.78 5.78 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 124.098 3.199 . . . . 0.36 113.401 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m -78.89 -17.52 55.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.801 0.334 . . . . 1.38 111.834 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.634 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 58.1 mt -75.36 -31.8 60.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.333 0.587 . . . . 0.49 112.072 -171.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.44 ' HB3' HD11 ' A' ' 30' ' ' LEU . 1.7 pp0? -62.4 -45.53 92.7 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 122.755 1.264 . . . . 1.95 110.772 -172.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.41 -48.53 77.45 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 111.893 -2.412 . . . . 0.49 110.749 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.13 -179.57 48.74 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 114.78 -1.1 . . . . 0.42 111.255 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.88 156.37 20.49 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.135 0.493 . . . . 0.41 110.789 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 31.3 m -137.26 129.76 29.9 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.348 -0.842 . . . . 0.42 110.491 -175.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.11 123.36 26.28 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.403 0.62 . . . . 0.47 110.235 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.53 0.18 62.93 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.272 -1.131 . . . . 0.41 110.272 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.634 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.1 tt0 -74.05 124.12 25.66 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.644 -0.778 . . . . 1.3 109.87 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 53.9 p -82.39 128.92 34.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.804 0.811 . . . . 0.85 109.876 176.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.633 HG13 ' HB3' ' A' ' 7' ' ' TYR . 7.6 pt -128.55 141.38 46.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.57 -1.195 . . . . 0.25 109.428 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.39 151.69 3.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.128 0.489 . . . . 0.67 111.048 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.6 mm -114.99 91.98 28.92 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.638 -1.164 . . . . 0.16 109.05 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.496 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . 1.7 Cg_endo -59.59 134.39 57.67 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.738 2.292 . . . . 0.18 112.778 -174.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.62 -6.74 80.14 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.893 -1.048 . . . . 0.26 112.156 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.772 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.5 tp -124.74 116.13 26.47 Favored Pre-proline 0 N--CA 1.446 -0.63 0 CA-C-O 121.404 0.621 . . . . 0.61 111.504 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.658 ' HD2' HD12 ' A' ' 51' ' ' LEU . 59.0 Cg_endo -79.71 -176.09 3.06 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.14 3.227 . . . . 0.28 114.208 -172.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.556 ' HB3' HG23 ' A' ' 56' ' ' THR . 17.7 t70 -81.14 130.5 62.62 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 114.225 -1.352 . . . . 0.49 112.879 -169.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.45 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 40.1 Cg_endo -73.0 -14.98 26.28 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.852 3.035 . . . . 0.46 113.134 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 80.2 m-85 -96.13 -8.6 32.83 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.902 -0.59 . . . . 1.38 111.427 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.556 HG23 ' HB3' ' A' ' 53' ' ' ASP . 24.7 p -86.49 -20.39 28.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.784 -1.191 . . . . 0.46 107.784 172.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 59' ' ' TYR . 24.6 mt -76.73 129.13 80.07 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 112.912 -1.949 . . . . 0.7 111.036 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.38 -13.05 12.49 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.538 2.159 . . . . 0.39 113.63 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.565 ' H ' HG22 ' A' ' 57' ' ' ILE . 62.7 m-85 -96.11 164.61 12.61 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.498 -0.481 . . . . 0.24 111.786 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -154.09 130.65 10.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.852 -0.796 . . . . 2.89 108.852 177.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 71' ' ' THR . 72.8 mt -112.06 136.75 47.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.155 -0.475 . . . . 0.16 111.607 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.25 116.84 27.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.926 -0.71 . . . . 0.16 111.223 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.8 t -96.04 113.6 30.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.565 0.698 . . . . 0.19 110.777 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 22.2 m -90.89 104.0 16.64 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.943 -1.026 . . . . 0.2 110.45 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.5 mm -53.44 -58.54 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 122.262 1.03 . . . . 0.23 111.208 168.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.16 -10.13 3.62 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 112.699 -2.046 . . . . 0.16 113.521 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.88 -18.02 4.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.596 0.758 . . . . 0.15 112.17 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.511 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 59.07 54.53 4.9 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.219 0.463 . . . . 0.69 111.078 -172.78 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 64' ' ' SER . 41.6 p -136.85 167.71 20.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 112.707 0.632 . . . . 0.13 112.707 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.465 HD21 HD21 ' A' ' 153' ' ' LEU . 8.0 tt -135.84 112.76 10.28 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.729 -1.123 . . . . 0.4 110.0 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 22.1 m -93.07 123.31 36.24 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.157 0.504 . . . . 0.16 110.781 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 79' ' ' MET . 16.1 tp -99.95 106.51 18.32 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.298 -0.864 . . . . 0.59 109.125 172.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 83.4 p -105.44 161.46 14.31 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 119.234 -0.986 . . . . 1.05 110.498 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -125.61 125.33 42.98 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.657 -0.868 . . . . 0.26 108.657 168.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.598 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.8 p-10 41.98 53.03 4.27 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.769 -1.56 . . . . 1.84 112.126 -165.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 46.8 m-80 75.24 -9.53 1.38 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.02 -0.991 . . . . 1.89 112.226 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -97.16 121.84 39.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.037 0.446 . . . . 3.44 109.903 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 55.7 t -58.4 131.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 122.39 1.091 . . . . 0.24 112.806 -175.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.523 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -100.91 -45.84 5.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 113.116 -1.856 . . . . 0.81 109.112 178.419 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -159.95 173.19 16.28 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.039 -1.892 . . . . 1.46 110.214 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -149.67 123.45 9.27 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.172 -1.376 . . . . 0.17 109.458 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -112.86 148.64 39.79 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.897 -0.592 . . . . 1.05 109.734 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.42 ' HB2' HG22 ' A' ' 134' ' ' ILE . 32.7 Cg_endo -74.5 142.71 29.91 Favored 'Trans proline' 0 CA--C 1.498 -1.32 0 C-N-CA 122.231 1.954 . . . . 0.2 110.938 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.622 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.67 172.77 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-N 115.777 -0.647 . . . . 0.13 110.761 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.94 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.16 137.6 52.87 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.762 0.315 . . . . 0.26 110.188 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.511 HG22 ' HG3' ' A' ' 68' ' ' LYS . 10.7 m -120.88 127.75 75.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.6 0.714 . . . . 0.56 111.776 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.501 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.19 151.48 28.52 Favored Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 110.067 -1.213 . . . . 0.17 110.067 171.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.47 4.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.262 0.838 . . . . 3.05 113.262 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.875 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -90.81 -19.12 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.385 0.612 . . . . 0.23 110.158 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.875 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -86.89 -17.47 33.19 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.687 -0.857 . . . . 0.18 108.687 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.1 p -69.38 -16.1 63.45 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.369 -1.287 . . . . 0.33 111.345 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.405 ' OE1' HD12 ' A' ' 89' ' ' ILE . 24.8 mt-30 -69.95 -37.76 75.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.859 -1.064 . . . . 1.52 112.845 -175.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 95' ' ' THR . 1.5 m -107.33 127.51 27.75 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 119.746 -0.782 . . . . 0.43 111.161 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -89.41 -14.19 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.727 2.284 . . . . 0.73 113.172 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 93' ' ' THR . 6.3 t -90.33 -44.52 9.63 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.584 0.707 . . . . 0.48 109.417 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.576 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 61.58 18.46 56.19 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 114.066 -1.425 . . . . 0.33 113.979 168.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.4 111.33 19.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 122.206 1.003 . . . . 0.84 109.593 -175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.669 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 26.6 m-85 -138.42 177.51 7.83 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.359 -1.746 . . . . 0.22 111.279 -171.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.457 ' CG ' HD11 ' A' ' 5' ' ' LEU . 39.8 m-85 -140.98 137.38 33.0 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.135 0.493 . . . . 0.54 110.765 -173.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.575 HD12 ' HB ' ' A' ' 161' ' ' THR . 78.8 mt -63.01 114.62 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-N 115.185 -0.916 . . . . 0.17 110.268 170.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.565 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.4 pt -83.33 -45.43 18.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 113.367 0.877 . . . . 0.21 113.367 -175.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -168.75 165.88 11.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.0 -1.482 . . . . 2.03 107.0 -169.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.701 ' HB3' HD23 ' A' ' 116' ' ' LEU . 51.9 mtt-85 -132.1 155.68 47.68 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.902 -0.719 . . . . 1.52 112.408 -168.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -137.62 102.27 4.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.359 0.599 . . . . 0.59 110.808 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.467 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 46.8 ttp180 -62.76 166.18 5.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.952 -1.022 . . . . 2.82 111.279 174.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.786 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 28.7 m-80 -35.93 101.31 0.21 Allowed Pre-proline 0 C--O 1.232 0.158 0 C-N-CA 125.802 1.641 . . . . 0.35 113.122 -159.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.487 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 24.1 Cg_endo -69.43 -49.6 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.499 2.799 . . . . 0.48 113.604 176.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.32 -33.06 4.3 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.67 111.54 -175.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.2 -172.61 2.76 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.956 -0.622 . . . . 0.62 112.589 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 128' ' ' THR . 35.9 Cg_endo -56.65 -14.21 12.74 Favored 'Trans proline' 0 N--CA 1.475 0.441 0 C-N-CA 124.207 3.271 . . . . 0.94 113.13 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' CD2' ' HB2' ' A' ' 115' ' ' TRP . 5.8 m-30 -65.82 -37.9 87.47 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 107.573 -1.269 . . . . 1.23 107.573 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 113' ' ' ALA . . . 58.99 23.69 57.35 Favored Glycine 0 CA--C 1.491 -1.444 0 CA-C-N 113.21 -1.814 . . . . 1.69 117.177 160.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.865 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 173.35 -48.37 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 118.341 1.071 . . . . 0.48 110.18 -177.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.461 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.7 OUTLIER -162.99 154.28 17.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.457 -0.338 . . . . 0.28 110.169 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.438 ' HB2' ' CD2' ' A' ' 111' ' ' PHE . 7.6 t-105 -132.09 104.68 6.94 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.687 -1.227 . . . . 0.49 107.687 165.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.701 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.0 mt -100.11 114.83 28.48 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.57 -0.706 . . . . 0.66 109.859 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.459 ' HB3' HD11 ' A' ' 101' ' ' ILE . 43.6 m -81.81 143.28 31.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.817 -0.629 . . . . 0.19 110.901 -170.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.728 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.4 mm? -108.02 164.88 11.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.535 -0.757 . . . . 0.13 110.416 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.1 p -65.13 -5.18 6.05 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.985 0.803 . . . . 1.17 112.72 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.707 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 4.2 tmtm? -127.41 129.42 47.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.111 0.958 . . . . 1.22 109.849 166.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.707 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.0 mt-30 -37.2 -47.75 0.81 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 112.249 -2.25 . . . . 1.51 113.903 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.549 ' CB ' HG12 ' A' ' 89' ' ' ILE . 58.0 m80 -96.33 3.23 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.849 -0.614 . . . . 2.53 111.915 -170.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.578 ' HA ' HD11 ' A' ' 90' ' ' LEU . 2.5 m-30 -92.99 -35.48 13.26 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.807 0.813 . . . . 0.84 111.946 -173.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.728 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -10.46 131.01 0.01 OUTLIER Glycine 0 C--N 1.298 -1.58 0 N-CA-C 119.392 2.517 . . . . 0.32 119.392 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -100.54 117.5 45.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 112.449 -1.876 . . . . 0.18 110.366 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.76 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 33.6 p80 -145.83 -176.79 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.318 0.488 . . . . 0.21 112.318 -175.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.94 -167.72 37.63 Favored Glycine 0 C--O 1.22 -0.759 0 C-N-CA 121.22 -0.514 . . . . 0.27 111.86 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 110' ' ' PRO . 9.2 t -160.76 166.51 28.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 117.796 0.798 . . . . 0.41 110.704 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -116.53 0.19 12.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.831 0.824 . . . . 1.99 109.288 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -126.03 89.21 52.82 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.39 -1.277 . . . . 1.36 108.819 170.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -72.19 -20.75 24.4 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.753 2.302 . . . . 0.35 114.008 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.96 -5.48 48.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.21 -0.45 . . . . 0.33 111.008 -175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -91.29 -2.48 57.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.08 -0.509 . . . . 1.35 110.016 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 83' ' ' PRO . 38.8 mm -78.55 137.61 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-N 115.872 -0.604 . . . . 0.21 109.934 176.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.7 3.16 68.91 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.151 -1.18 . . . . 0.15 110.151 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.426 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 21.3 mtpt -113.74 169.07 9.25 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 123.223 1.487 . . . . 2.5 114.395 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.16 126.59 46.44 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 111.509 -2.587 . . . . 0.17 107.946 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.42 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -123.47 159.44 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.541 -0.911 . . . . 0.66 108.541 -174.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.1 m -48.08 -59.87 3.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.763 0.653 . . . . 0.43 112.763 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -132.13 -44.46 0.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 118.446 -1.302 . . . . 2.02 114.033 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.69 133.92 0.21 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 117.464 1.746 . . . . 0.18 117.464 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 3.0 p -70.78 165.41 23.17 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 112.734 -1.733 . . . . 0.16 111.956 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.94 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.8 mt -60.87 99.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.386 -1.279 . . . . 0.4 112.154 -162.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.76 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 42.7 mtt180 -86.48 143.32 27.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.317 -1.311 . . . . 1.87 110.161 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.622 ' HG2' HG22 ' A' ' 84' ' ' ILE . 20.8 mtp -118.97 -168.98 1.65 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.851 -0.796 . . . . 0.79 108.851 173.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.543 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 75.3 m80 -83.77 155.67 22.93 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.747 -0.835 . . . . 2.32 108.747 167.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.797 ' O ' HD13 ' A' ' 151' ' ' ILE . 12.7 m-80 -65.02 -44.16 90.09 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 118.283 -0.865 . . . . 0.68 110.999 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -66.06 -25.46 67.04 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 121.902 2.137 . . . . 2.18 112.068 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 37.8 m-20 -86.79 -35.4 19.15 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.235 -0.438 . . . . 0.69 111.188 -174.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.59 HG13 HD12 ' A' ' 151' ' ' ILE . 11.8 p -67.98 -21.91 27.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 0.11 110.747 172.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.865 HD11 ' HB1' ' A' ' 113' ' ' ALA . 1.6 mp -83.08 -40.97 16.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.667 -0.494 . . . . 0.38 109.667 170.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -47.14 -70.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.203 0.91 . . . . 1.99 112.428 168.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.489 HD22 ' SD ' ' A' ' 145' ' ' MET . 7.3 mp -49.86 -30.75 10.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.594 0.711 . . . . 1.27 111.529 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.673 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -67.5 -41.22 84.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.805 -1.089 . . . . 0.18 111.528 176.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.0 t -85.13 -37.66 19.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.789 0.663 . . . . 0.21 112.789 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.58 -60.23 2.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.613 0.721 . . . . 0.16 111.377 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.643 HG23 HH22 ' A' ' 103' ' ' ARG . 3.8 m -92.06 145.81 31.58 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.0 -1.0 . . . . 0.16 112.126 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.457 ' C ' HH21 ' A' ' 103' ' ' ARG . 50.4 Cg_endo -89.86 172.62 3.76 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 124.466 3.444 . . . . 0.2 111.175 173.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -66.4 161.65 22.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 118.689 -1.204 . . . . 1.1 109.897 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.51 -17.11 59.86 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.561 -0.828 . . . . 0.18 111.825 -172.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.575 ' HB ' HD12 ' A' ' 100' ' ' ILE . 67.2 m -67.45 139.44 57.07 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.457 -0.571 . . . . 0.14 109.457 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.2 117.89 30.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.571 1.176 . . . . 3.63 111.022 -168.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.2 t -104.03 109.66 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 112.316 -2.22 . . . . 0.14 109.358 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 32.6 m -95.71 107.68 19.92 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.727 0.64 . . . . 0.21 112.727 -172.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.576 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mp -80.54 108.77 14.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 122.039 0.923 . . . . 0.24 109.855 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -110.97 124.46 52.18 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.489 -1.232 . . . . 1.09 109.796 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.519 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 15.6 mmm180 -70.28 -19.23 63.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.244 0.545 . . . . 2.08 110.192 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.89 173.69 21.32 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.434 -0.803 . . . . 1.97 112.504 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 C--N 1.331 -0.206 0 O-C-N 123.999 0.47 . . . . 3.91 110.95 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.992 -0.443 . . . . 2.8 111.992 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -145.48 144.87 30.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.983 0.42 . . . . 4.44 110.515 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.8 106.77 16.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.098 -0.501 . . . . 2.46 109.884 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.656 HD21 ' HA ' ' A' ' 49' ' ' PRO . 1.1 tp -101.4 172.53 6.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.296 0.57 . . . . 0.65 111.555 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.7 tt -95.54 126.74 41.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.049 -0.978 . . . . 0.28 110.258 -175.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.07 161.47 13.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.055 0.931 . . . . 0.31 112.632 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 45' ' ' SER . 90.6 t80 -130.74 139.8 50.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.935 -1.484 . . . . 0.44 107.83 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.4 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.8 tt0 -112.66 112.8 24.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.131 -1.063 . . . . 0.76 108.131 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 13' ' ' ASP . 98.4 t -67.09 149.46 11.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 122.395 1.093 . . . . 0.39 113.169 -169.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HE2' ' OH ' ' A' ' 7' ' ' TYR . 42.2 mtmt -103.24 158.85 16.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 113.369 -1.741 . . . . 2.01 108.718 174.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.456 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -62.85 104.26 0.53 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.198 0.523 . . . . 1.83 112.308 -173.163 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.29 11.29 36.73 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.848 -0.692 . . . . 0.48 113.356 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB2' HG13 ' A' ' 9' ' ' VAL . 83.9 m-20 -53.58 170.67 0.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.978 0.389 . . . . 1.46 111.307 172.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.3 153.21 48.05 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.296 0.569 . . . . 0.41 111.558 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.598 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.38 -35.03 79.72 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.33 -0.989 . . . . 0.86 108.33 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.442 ' HA ' HG22 ' A' ' 26' ' ' THR . 65.0 t30 -88.96 -25.89 21.81 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.916 -1.038 . . . . 1.15 111.438 -176.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.3 p -68.17 -36.9 80.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.902 -0.719 . . . . 1.21 109.674 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.409 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.1 mt -75.62 -28.19 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.164 0.507 . . . . 0.21 110.023 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.59 -10.05 59.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.539 -0.301 . . . . 0.16 110.872 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.607 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.71 -39.49 9.45 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.607 1.194 . . . . 0.21 108.38 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 119' ' ' SER . 10.0 m-20 -62.19 -45.79 91.81 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.453 -2.158 . . . . 0.53 111.856 172.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 63.2 m-85 -97.2 5.12 50.66 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.681 -1.208 . . . . 0.18 111.602 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.5 mpt_? 54.15 43.29 30.87 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.776 0.798 . . . . 1.78 109.891 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.62 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.0 pt -116.19 -165.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.535 -1.211 . . . . 0.19 109.771 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.87 143.02 38.62 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.177 -0.919 . . . . 0.95 109.992 174.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.608 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 69.4 p -71.75 -32.19 67.44 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.759 -1.2 . . . . 0.25 107.759 177.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.98 -32.2 70.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.277 -0.874 . . . . 0.2 112.008 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -90.5 -25.94 20.02 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.657 0.741 . . . . 0.17 109.112 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.647 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 17.2 tp -75.55 -26.19 57.77 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.999 -1.001 . . . . 1.16 109.361 173.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 26' ' ' THR . 30.7 mt -77.49 -31.71 53.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.792 0.806 . . . . 1.05 109.67 171.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 45.0 tt0 -64.05 -41.13 97.49 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.282 -1.326 . . . . 1.81 110.034 174.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.18 -20.64 32.04 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 120.118 -0.633 . . . . 0.2 111.633 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.624 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 27.0 m-80 -147.11 80.69 9.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.46 0.648 . . . . 0.23 110.64 -172.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 23.7 Cg_endo -58.97 -5.79 3.02 Favored 'Trans proline' 0 C--N 1.326 -0.644 0 C-N-CA 124.372 3.382 . . . . 0.36 114.145 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 t -84.7 -23.31 29.41 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.215 -0.303 . . . . 1.38 111.025 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.852 HD21 HG21 ' A' ' 46' ' ' ILE . 52.4 mt -67.01 -35.36 79.76 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.841 0.829 . . . . 0.49 111.632 -172.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.452 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 3.3 pt20 -65.33 -46.72 79.17 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 114.239 -1.346 . . . . 1.95 110.298 -174.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.55 -50.86 71.73 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 111.905 -2.407 . . . . 0.49 110.282 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.56 177.95 48.55 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 114.742 -1.117 . . . . 0.42 111.656 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.59 157.63 18.84 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.349 0.595 . . . . 0.41 111.235 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 82.6 m -140.35 128.64 22.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.141 -0.936 . . . . 0.42 110.601 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -76.16 120.07 20.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.449 0.642 . . . . 0.47 110.234 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 99.26 0.05 57.09 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.181 -1.168 . . . . 0.41 110.181 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.63 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.8 tt0 -74.31 123.7 25.07 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.758 -0.721 . . . . 1.3 109.599 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 34.4 p -85.37 125.93 33.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.646 0.736 . . . . 0.85 110.596 177.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.852 HG21 HD21 ' A' ' 36' ' ' LEU . 9.6 pt -125.63 143.59 38.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.393 -1.276 . . . . 0.25 109.554 -176.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.4 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.24 150.99 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-O 121.113 0.482 . . . . 0.67 111.124 -179.218 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.7 mm -115.86 92.87 35.98 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.643 -1.162 . . . . 0.16 109.147 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.656 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -58.16 135.41 68.19 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.847 2.365 . . . . 0.18 112.819 -175.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.19 -6.0 81.26 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 114.992 -1.004 . . . . 0.26 112.515 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.698 HD12 ' HD2' ' A' ' 52' ' ' PRO . 25.6 tp -126.74 119.87 22.82 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-O 120.972 0.415 . . . . 0.61 111.395 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.698 ' HD2' HD12 ' A' ' 51' ' ' LEU . 58.9 Cg_endo -80.89 178.69 6.66 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.438 2.759 . . . . 0.28 113.923 -172.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.588 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.9 t70 -75.17 131.8 77.73 Favored Pre-proline 0 N--CA 1.443 -0.819 0 CA-C-N 114.255 -1.339 . . . . 0.49 111.646 -173.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 162' ' ' ARG . 60.5 Cg_endo -74.13 -16.73 22.42 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.415 2.743 . . . . 0.46 113.02 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -96.53 -2.68 44.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.35 0.595 . . . . 1.38 111.169 -176.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.588 HG23 ' HB3' ' A' ' 53' ' ' ASP . 17.2 p -93.37 -14.54 26.72 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.493 -0.928 . . . . 0.46 108.493 173.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.703 HG22 ' H ' ' A' ' 59' ' ' TYR . 7.9 mm -64.05 129.21 93.82 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 113.633 -1.621 . . . . 0.7 109.873 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 51.4 Cg_endo -73.08 -19.12 23.28 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.017 1.811 . . . . 0.39 112.852 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.703 ' H ' HG22 ' A' ' 57' ' ' ILE . 41.0 m-85 -107.36 161.67 14.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.871 0.367 . . . . 0.24 111.548 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -145.8 140.32 27.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.761 -0.829 . . . . 2.89 108.761 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 71' ' ' THR . 88.1 mt -119.3 133.02 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.306 -0.407 . . . . 0.16 112.083 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.53 116.54 27.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.963 -0.695 . . . . 0.16 111.014 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 69' ' ' THR . 85.5 t -95.12 115.68 34.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.684 0.754 . . . . 0.19 110.703 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.537 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 44.1 m -89.66 109.81 20.75 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.119 -0.946 . . . . 0.2 110.85 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 167' ' ' ARG . 23.3 mm -55.5 -60.21 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.186 0.993 . . . . 0.23 110.844 164.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.83 -13.63 6.55 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 112.722 -2.036 . . . . 0.16 113.52 -175.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.537 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.66 -16.92 5.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 118.659 -0.686 . . . . 0.15 112.515 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 57.21 54.62 6.61 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.202 0.91 . . . . 0.69 111.527 -174.039 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 40.9 p -138.05 164.91 27.91 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.816 0.673 . . . . 0.13 112.816 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.7 tt -132.67 113.14 12.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.023 -0.989 . . . . 0.4 110.093 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 38.4 m -92.89 123.69 36.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.992 0.425 . . . . 0.16 111.219 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' MET . 12.7 tp -98.59 106.61 18.91 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.498 -0.774 . . . . 0.59 108.948 170.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 78.5 p -106.93 160.02 15.83 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 119.28 -0.968 . . . . 1.05 110.85 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.1 tm? -127.16 126.44 42.87 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.211 -0.663 . . . . 0.26 109.211 171.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.574 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.8 p-10 39.13 56.17 2.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 113.991 -1.459 . . . . 1.84 111.998 -166.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.3 m-80 74.76 -8.97 1.42 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.144 -0.935 . . . . 1.89 112.429 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -101.57 119.45 38.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.012 0.434 . . . . 3.44 110.296 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 50.8 t -55.04 131.64 18.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 122.444 1.116 . . . . 0.24 112.54 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 67.8 mmm -96.81 -47.82 5.71 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 113.315 -1.766 . . . . 0.81 108.28 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -161.08 172.44 16.81 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 112.703 -2.044 . . . . 1.46 110.169 -176.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -149.5 125.42 10.57 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 113.973 -1.467 . . . . 0.17 109.532 173.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -117.28 150.54 46.52 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.087 -0.506 . . . . 1.05 110.565 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.73 142.71 32.58 Favored 'Trans proline' 0 CA--C 1.495 -1.473 0 C-N-CA 122.351 2.034 . . . . 0.2 111.201 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.643 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.72 173.34 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.452 -0.795 . . . . 0.13 110.433 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.918 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.61 143.74 45.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.927 -0.309 . . . . 0.26 110.167 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.516 HG22 ' HG3' ' A' ' 68' ' ' LYS . 11.4 m -125.99 125.83 68.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.583 0.706 . . . . 0.56 111.354 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -85.28 155.65 29.97 Favored Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 109.58 -1.408 . . . . 0.17 109.58 171.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -57.6 4.9 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.224 0.824 . . . . 3.05 113.224 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.915 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -87.02 -20.02 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 121.437 -0.789 . . . . 0.23 109.684 178.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.915 HD22 HG23 ' A' ' 89' ' ' ILE . 3.6 mm? -89.44 -20.99 23.24 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.634 -0.876 . . . . 0.18 108.634 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.7 p -66.49 -16.75 64.36 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.512 -1.222 . . . . 0.33 110.938 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -72.19 -32.64 66.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.472 -1.24 . . . . 1.52 112.966 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -108.54 120.41 46.48 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.008 -0.677 . . . . 0.43 110.359 178.061 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 93' ' ' THR . 4.2 Cg_exo -70.37 -23.59 27.82 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.803 2.336 . . . . 0.73 112.881 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -99.23 -41.36 7.52 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.514 -0.55 . . . . 0.48 109.514 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.541 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 51.44 21.06 5.91 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.514 -1.221 . . . . 0.33 114.336 169.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 164' ' ' THR . 12.8 pt-20 -85.05 116.99 23.75 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 122.608 1.194 . . . . 0.84 110.05 -172.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.728 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 13.0 m-85 -137.92 -171.83 3.1 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.362 -1.744 . . . . 0.22 111.442 -166.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CG ' HD11 ' A' ' 5' ' ' LEU . 28.6 m-85 -143.84 137.92 28.3 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.76 0.314 . . . . 0.54 110.776 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.733 HD12 ' HB ' ' A' ' 161' ' ' THR . 76.3 mt -65.21 119.07 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.745 -0.661 . . . . 0.17 110.529 170.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 23.3 pt -88.14 -32.85 6.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.028 0.751 . . . . 0.21 113.028 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.568 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 1.8 p-10 179.27 179.3 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.846 -1.168 . . . . 2.03 107.846 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.594 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 22.9 mtt180 -127.63 160.62 31.06 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.675 -0.81 . . . . 1.52 111.877 -175.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.453 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 7.6 tt0 -135.7 98.96 4.05 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.112 -0.949 . . . . 0.59 109.665 171.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.47 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 40.4 ttp180 -65.74 164.98 13.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.427 -0.806 . . . . 2.82 110.555 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.753 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 30.0 m-80 -36.05 101.28 0.21 Allowed Pre-proline 0 N--CA 1.461 0.098 0 C-N-CA 125.141 1.377 . . . . 0.35 112.334 -158.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -64.5 -49.07 3.65 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.027 2.484 . . . . 0.48 113.1 176.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.8 -33.31 3.95 Favored Glycine 0 CA--C 1.506 -0.507 0 N-CA-C 110.851 -0.9 . . . . 0.67 110.851 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.02 -173.29 3.69 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 114.771 -0.714 . . . . 0.62 112.412 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -55.82 -15.71 13.76 Favored 'Trans proline' 0 C--O 1.222 -0.296 0 C-N-CA 124.062 3.175 . . . . 0.94 113.151 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -64.38 -41.4 96.7 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.36 -0.978 . . . . 1.23 108.36 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 60.06 28.48 66.46 Favored Glycine 0 CA--C 1.495 -1.168 0 N-CA-C 116.905 1.522 . . . . 1.69 116.905 160.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.753 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . . . 175.85 -60.36 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 118.311 1.056 . . . . 0.48 109.565 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.47 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 1.5 m-85 -161.27 152.26 18.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.911 -0.586 . . . . 0.28 110.109 -176.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 6.2 t-105 -129.48 99.15 5.08 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.019 -1.474 . . . . 0.49 107.019 164.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.9 mt -90.71 114.03 26.26 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.234 -1.025 . . . . 0.66 108.234 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.454 ' HB3' HD11 ' A' ' 101' ' ' ILE . 19.4 m -83.68 143.88 29.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.772 -0.649 . . . . 0.19 111.023 -166.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 3.1 mm? -108.88 165.1 11.82 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.102 -0.499 . . . . 0.13 111.445 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.5 t -60.36 -10.96 5.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.632 -1.167 . . . . 1.17 112.609 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.746 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.8 tmtm? -127.31 132.13 50.34 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.504 -0.478 . . . . 1.22 109.885 171.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.746 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 21.5 mt-30 -35.25 -59.12 0.53 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 114.278 1.214 . . . . 1.51 114.278 -178.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.582 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -97.09 12.95 30.81 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.581 -0.848 . . . . 2.53 111.852 -171.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.784 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.2 m-30 -98.67 38.46 1.36 Allowed 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 112.077 0.399 . . . . 0.84 112.077 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.751 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -116.6 143.22 17.97 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 117.165 -2.445 . . . . 0.32 112.523 -151.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -96.43 116.04 37.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 123.954 0.901 . . . . 0.18 110.934 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.639 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 31.2 p80 -146.65 -178.17 6.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.873 -0.603 . . . . 0.21 112.16 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.23 -167.62 37.18 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 111.733 -0.547 . . . . 0.27 111.733 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.6 t -162.73 167.97 22.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.878 0.839 . . . . 0.41 110.391 -175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -113.29 -8.51 13.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.646 -0.872 . . . . 1.99 108.646 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -120.32 88.11 41.47 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 114.874 -1.057 . . . . 1.36 108.856 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -71.91 -21.81 24.08 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.979 2.453 . . . . 0.35 114.294 -167.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.57 -1.93 29.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.0 0.428 . . . . 0.33 111.253 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 20.1 m -90.26 -5.77 55.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.021 -0.536 . . . . 1.35 109.964 172.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 34.3 mm -77.44 131.3 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.181 -0.463 . . . . 0.21 110.486 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.01 3.51 60.47 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.235 -1.146 . . . . 0.15 110.235 -175.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.459 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 56.9 mttt -114.81 168.72 9.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 122.982 1.373 . . . . 2.5 114.207 -176.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.17 127.24 45.11 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 112.011 -2.359 . . . . 0.17 107.759 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -123.6 160.79 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.5 -0.926 . . . . 0.66 108.5 -175.59 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.7 m -49.1 -59.83 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.639 0.607 . . . . 0.43 112.639 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.74 -44.86 0.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 118.464 -1.295 . . . . 2.02 114.131 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.24 134.36 0.17 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 117.193 1.637 . . . . 0.18 117.193 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.534 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 2.4 p -72.25 165.55 24.21 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 112.735 -1.732 . . . . 0.16 112.002 -178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.918 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 46.4 mt -60.55 96.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 122.384 1.087 . . . . 0.4 112.208 -162.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.639 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 68.0 mtt180 -83.63 147.23 27.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.889 -1.505 . . . . 1.87 109.726 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.643 ' HG2' HG22 ' A' ' 84' ' ' ILE . 12.0 mtp -123.8 -169.9 2.03 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.407 -0.96 . . . . 0.79 108.407 171.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.434 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 41.1 m80 -82.37 161.74 22.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.944 -0.762 . . . . 2.32 108.944 168.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.627 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . 25.2 m-80 -66.94 -41.65 86.62 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 118.232 -0.89 . . . . 0.68 110.805 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -69.66 -29.05 66.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 121.301 1.864 . . . . 2.18 112.021 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 64.3 m-20 -76.31 -45.23 33.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.379 0.609 . . . . 0.69 109.822 -174.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.16 -25.04 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 114.819 -1.082 . . . . 0.11 111.562 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 147' ' ' ASN . 19.4 mt -83.41 -43.31 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 118.893 -0.575 . . . . 0.38 111.538 174.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.424 ' O ' HG13 ' A' ' 156' ' ' ILE . 20.3 mt-10 -46.41 -70.39 0.1 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.529 1.058 . . . . 1.99 112.644 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.564 ' O ' HG22 ' A' ' 157' ' ' VAL . 26.2 mt -45.79 -39.69 8.66 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.698 0.761 . . . . 1.27 111.556 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.442 ' HB1' ' CE2' ' A' ' 114' ' ' TYR . . . -61.22 -32.29 72.07 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.114 -1.403 . . . . 0.18 111.951 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.1 t -87.84 -30.81 19.91 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.511 -0.743 . . . . 0.21 112.198 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 152' ' ' GLU . 38.0 mt -82.91 -59.42 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.547 0.689 . . . . 0.16 111.747 -172.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 153' ' ' LEU . 5.4 m -88.39 139.81 30.14 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.73 -1.123 . . . . 0.16 112.373 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.594 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 48.1 Cg_endo -88.87 173.89 4.06 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.324 3.349 . . . . 0.2 111.118 174.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.568 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 60.9 m-20 -67.05 156.8 35.13 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 119.214 -0.994 . . . . 1.1 108.687 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.02 -20.85 49.18 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.833 -1.175 . . . . 0.18 111.921 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.733 ' HB ' HD12 ' A' ' 100' ' ' ILE . 85.8 m -59.82 128.9 39.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.724 -0.843 . . . . 0.14 108.724 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -93.32 123.45 36.62 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 122.809 1.29 . . . . 3.63 110.833 -167.612 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.18 112.13 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 112.365 -2.198 . . . . 0.14 110.023 -171.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 97' ' ' GLU . 16.2 m -95.69 115.12 26.97 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.798 -0.761 . . . . 0.21 112.202 -175.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.541 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mp -84.19 93.14 3.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.87 1.319 . . . . 0.24 109.421 172.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -93.0 125.32 37.53 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.262 -1.79 . . . . 1.09 108.139 -175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.48 ' HA ' HG13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -68.99 -28.33 66.5 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.291 -0.563 . . . . 2.08 110.697 -177.391 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 166.63 91.47 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.458 -0.877 . . . . 1.97 112.889 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 61.5 m . . . . . 0 C--N 1.322 -0.59 0 N-CA-C 110.071 -0.344 . . . . 3.91 110.071 176.921 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.849 0 N-CA-C 112.276 -0.33 . . . . 2.8 112.276 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -74.63 145.37 43.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.977 -0.379 . . . . 4.44 109.977 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -87.74 123.56 32.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.873 -0.603 . . . . 2.46 111.149 -172.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -105.76 174.07 6.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.847 -0.615 . . . . 0.65 111.379 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.1 tt -95.94 128.68 43.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.091 -0.959 . . . . 0.28 110.432 -175.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 161.29 13.85 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.084 0.945 . . . . 0.31 112.932 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' A' ' 45' ' ' SER . 72.7 t80 -130.01 141.79 50.7 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.726 -1.579 . . . . 0.44 108.071 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 34.9 tt0 -114.01 112.2 22.88 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.863 -1.162 . . . . 0.76 107.863 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' ' 41' ' ' THR . 92.3 t -65.11 149.81 11.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 122.476 1.131 . . . . 0.39 112.806 -170.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -106.05 159.59 15.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.235 -1.802 . . . . 2.01 108.6 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 108.02 0.99 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.071 0.462 . . . . 1.83 111.949 -175.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.4 10.89 37.52 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.534 -0.757 . . . . 0.48 113.283 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.605 ' HB2' HG13 ' A' ' 9' ' ' VAL . 91.5 m-20 -58.08 168.65 0.95 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.864 0.332 . . . . 1.46 110.765 172.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.66 153.61 49.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.577 0.703 . . . . 0.41 112.011 174.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.734 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -68.2 -31.08 70.35 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.463 -1.244 . . . . 0.86 109.75 -176.619 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.442 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 65.3 t30 -93.34 -20.67 20.14 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.854 -1.066 . . . . 1.15 110.544 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.6 t -68.49 -43.22 77.35 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.152 -0.684 . . . . 1.21 109.152 171.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 17.2 mt -72.47 -25.84 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 121.354 0.597 . . . . 0.21 109.916 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.643 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.4 -9.91 59.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.401 -0.363 . . . . 0.16 111.035 175.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.606 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.27 -38.87 9.51 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.677 1.227 . . . . 0.21 107.982 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.6 m-20 -62.93 -49.16 75.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.255 -2.248 . . . . 0.53 111.562 172.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.569 ' HA ' HG21 ' A' ' 101' ' ' ILE . 63.5 m-85 -94.5 5.52 51.58 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.605 -1.238 . . . . 0.18 111.527 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.0 mpt_? 53.4 44.51 29.92 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.661 0.744 . . . . 1.78 109.873 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.643 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.0 pt -116.2 -164.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 114.63 -1.168 . . . . 0.19 109.855 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.64 141.7 41.82 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.088 -0.96 . . . . 0.95 110.137 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.734 ' HB ' HD11 ' A' ' 15' ' ' LEU . 67.0 p -72.67 -33.64 66.68 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.201 -1.037 . . . . 0.25 108.201 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.46 68.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.981 -1.009 . . . . 0.2 111.788 169.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -89.11 -27.88 20.45 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.955 -0.757 . . . . 0.17 108.955 -177.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.654 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.8 tp -74.76 -28.38 60.73 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.028 -0.987 . . . . 1.16 109.461 175.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 26' ' ' THR . 55.9 mt -77.85 -30.47 51.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.785 0.802 . . . . 1.05 109.86 172.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 39.4 tt0 -63.86 -41.47 97.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.29 -1.323 . . . . 1.81 109.976 172.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.16 -22.08 33.38 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 121.91 -0.494 . . . . 0.2 111.455 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.658 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 19.8 m-80 -150.11 98.34 3.33 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-O 121.26 0.553 . . . . 0.23 109.75 -171.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 12.9 Cg_exo -79.67 -9.97 14.5 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.475 3.45 . . . . 0.36 111.903 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -76.08 -25.78 55.84 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.852 -1.067 . . . . 1.38 111.802 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.863 HD21 HG21 ' A' ' 46' ' ' ILE . 44.0 mt -65.04 -39.07 92.81 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.557 0.694 . . . . 0.49 112.103 -171.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 3.5 pt20 -64.01 -46.27 85.24 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 122.917 1.342 . . . . 1.95 110.447 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.98 83.62 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 111.808 -2.451 . . . . 0.49 110.59 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.49 173.21 45.62 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 114.829 -1.078 . . . . 0.42 111.815 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.8 157.81 18.24 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.343 0.592 . . . . 0.41 110.877 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.625 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 47.2 m -140.51 127.22 20.37 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.43 -0.804 . . . . 0.42 110.912 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.71 118.85 18.14 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.291 0.567 . . . . 0.47 109.931 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.419 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.48 -1.13 55.73 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.33 -1.108 . . . . 0.41 110.33 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -75.29 123.69 25.78 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.394 -0.595 . . . . 1.3 109.394 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 68.1 p -83.94 132.28 34.78 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.827 0.823 . . . . 0.85 110.14 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.863 HG21 HD21 ' A' ' 36' ' ' LEU . 11.7 pt -132.11 142.83 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.235 -1.348 . . . . 0.25 109.273 -177.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.39 150.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.17 0.51 . . . . 0.67 111.055 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.6 mm -114.36 91.72 25.09 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.694 -1.139 . . . . 0.16 109.056 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.641 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -58.41 135.93 71.04 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.907 2.405 . . . . 0.18 112.756 -174.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.47 -5.95 82.42 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.889 -1.05 . . . . 0.26 112.269 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.694 HD12 ' HD2' ' A' ' 52' ' ' PRO . 31.0 tp -125.41 116.95 25.12 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-O 121.207 0.527 . . . . 0.61 111.395 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.694 ' HD2' HD12 ' A' ' 51' ' ' LEU . 55.4 Cg_endo -79.25 -177.31 3.8 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.698 2.932 . . . . 0.28 114.075 -172.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.7 t70 -82.98 130.29 58.14 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.433 -1.258 . . . . 0.49 112.089 -170.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.629 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 69.5 Cg_endo -75.23 -16.14 19.88 Favored 'Trans proline' 0 CA--C 1.52 -0.211 0 C-N-CA 123.49 2.793 . . . . 0.46 112.867 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -95.3 0.3 53.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.752 0.787 . . . . 1.38 110.198 -172.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 53' ' ' ASP . 20.2 p -96.97 -19.66 18.63 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 122.508 1.146 . . . . 0.46 108.095 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 59' ' ' TYR . 20.5 mt -74.98 133.38 75.81 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 113.198 -1.819 . . . . 0.7 111.296 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.76 -15.5 12.05 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.561 2.174 . . . . 0.39 113.742 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.581 ' H ' HG22 ' A' ' 57' ' ' ILE . 51.3 m-85 -100.81 158.34 16.04 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.542 -0.463 . . . . 0.24 112.059 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -146.0 133.08 20.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.594 -0.891 . . . . 2.89 108.594 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.645 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.9 mt -113.66 134.36 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.343 -0.39 . . . . 0.16 111.937 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.54 118.94 32.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.831 -0.748 . . . . 0.16 111.473 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.8 t -96.99 116.01 38.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.825 0.822 . . . . 0.19 111.107 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 68' ' ' LYS . 27.7 m -95.68 103.12 14.99 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.754 -1.112 . . . . 0.2 110.579 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.8 mm -51.02 -58.44 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.968 0.889 . . . . 0.23 111.548 169.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.43 -12.51 4.6 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 112.782 -2.008 . . . . 0.16 113.208 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.31 -19.83 4.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.403 0.681 . . . . 0.15 112.554 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.512 ' NZ ' ' HB2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.83 57.99 3.42 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.552 0.615 . . . . 0.69 111.154 -172.225 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -138.57 163.76 31.2 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 112.969 0.729 . . . . 0.13 112.969 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.452 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -131.29 112.92 13.2 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.527 -1.215 . . . . 0.4 110.041 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.645 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 23.4 m -92.06 122.95 35.04 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.243 0.544 . . . . 0.16 111.245 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.0 tp -99.43 103.29 15.06 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.1 -0.955 . . . . 0.59 109.338 171.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 94.5 p -105.57 161.48 14.33 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.047 -1.061 . . . . 1.05 110.518 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.603 HD13 ' OD1' ' A' ' 75' ' ' ASN . 1.1 tm? -127.55 128.63 45.94 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.498 -0.927 . . . . 0.26 108.498 169.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.603 ' OD1' HD13 ' A' ' 74' ' ' LEU . 2.6 p-10 45.93 51.29 10.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.097 1.359 . . . . 1.84 111.48 -167.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 79.4 m-20 72.05 -13.62 0.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.587 -0.733 . . . . 1.89 111.936 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -96.67 119.07 34.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.309 0.576 . . . . 3.44 109.934 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 69.9 t -57.91 132.49 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.313 1.054 . . . . 0.24 112.852 -172.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 12.9 mtm -102.28 -45.66 5.05 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 112.994 -1.912 . . . . 0.81 108.85 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.19 171.41 20.22 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.088 -1.869 . . . . 1.46 110.085 -176.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.0 m -149.24 123.73 9.71 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.136 -1.393 . . . . 0.17 109.743 172.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -107.45 151.49 40.96 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.333 -0.849 . . . . 1.05 109.291 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HB2' HG22 ' A' ' 134' ' ' ILE . 55.9 Cg_endo -78.9 144.32 18.97 Favored 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 121.871 1.714 . . . . 0.2 111.059 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.656 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -141.01 173.33 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.777 -0.647 . . . . 0.13 111.098 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.895 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.23 145.17 45.2 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.342 -0.39 . . . . 0.26 110.299 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.496 HG22 ' HG3' ' A' ' 68' ' ' LYS . 7.1 m -127.97 131.26 69.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.132 0.491 . . . . 0.56 111.773 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -91.6 157.04 24.32 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 109.755 -1.338 . . . . 0.17 109.755 171.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.897 ' HG3' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -57.5 8.1 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 114.449 1.278 . . . . 3.05 114.449 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.915 HG23 HD22 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -97.03 -13.0 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.641 0.734 . . . . 0.23 110.339 -177.136 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.915 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -92.67 -15.17 27.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.692 -0.685 . . . . 0.18 109.342 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.1 p -69.06 -21.9 64.05 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.889 -1.05 . . . . 0.33 111.797 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 6.8 mp0 -56.74 -44.3 81.55 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.44 1.496 . . . . 1.52 112.332 -176.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -106.49 117.05 58.02 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.799 -0.637 . . . . 0.43 111.36 -178.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.492 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 5.9 Cg_exo -73.1 -16.64 25.28 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.73 2.287 . . . . 0.73 113.132 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.411 HG23 ' N ' ' A' ' 96' ' ' GLY . 12.1 t -104.0 -41.58 5.82 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.711 -0.477 . . . . 0.48 109.711 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.534 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.26 40.19 21.79 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.343 -1.299 . . . . 0.33 113.81 168.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 164' ' ' THR . 49.0 mt-10 -84.08 113.42 21.02 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.026 0.917 . . . . 0.84 109.624 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.702 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.8 m-85 -136.73 178.08 7.35 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 113.604 -1.635 . . . . 0.22 111.566 -171.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 66.0 m-85 -142.06 136.57 30.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.067 0.461 . . . . 0.54 110.902 -172.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.597 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.3 mt -62.46 117.56 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.223 -0.899 . . . . 0.17 110.916 171.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.569 HG21 ' HA ' ' A' ' 22' ' ' PHE . 16.3 pt -87.52 -34.36 7.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 113.138 0.792 . . . . 0.21 113.138 -175.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.596 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 1.5 p-10 -178.57 179.58 0.74 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.666 -1.235 . . . . 2.03 107.666 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.657 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -135.65 163.14 30.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.622 0.725 . . . . 1.52 112.423 -177.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.445 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 53.7 tt0 -133.07 101.05 5.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.466 -1.243 . . . . 0.59 109.819 172.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.492 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 13.6 ttt180 -63.77 166.27 7.37 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.665 -0.698 . . . . 2.82 110.356 174.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.492 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 16.3 m-80 -36.74 101.28 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 113.869 -1.514 . . . . 0.35 114.079 -151.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 16.1 Cg_exo -54.73 -50.9 11.74 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.588 2.858 . . . . 0.48 110.723 169.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.18 -34.71 4.46 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.156 -1.177 . . . . 0.67 110.156 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.4 -175.21 25.98 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 114.509 -0.846 . . . . 0.62 112.83 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.537 ' O ' ' HA ' ' A' ' 128' ' ' THR . 35.7 Cg_endo -58.3 -9.01 5.83 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 125.009 3.806 . . . . 0.94 114.463 -177.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -65.55 -3.68 4.89 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.689 0.996 . . . . 1.23 113.689 -172.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.718 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 92.29 64.63 1.12 Allowed Glycine 0 CA--C 1.493 -1.304 0 C-N-CA 118.95 -1.595 . . . . 1.69 115.272 165.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.41 0.95 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 116.663 2.097 . . . . 0.48 116.663 -175.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.51 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.3 OUTLIER -165.56 166.37 18.24 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.465 0.706 . . . . 0.28 109.717 -177.444 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 21.8 t-105 -146.68 98.73 3.1 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.96 -1.126 . . . . 0.49 107.96 166.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.626 HD23 ' HG2' ' A' ' 103' ' ' ARG . 1.5 mt -89.39 114.12 25.53 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.337 0.589 . . . . 0.66 109.503 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 101' ' ' ILE . 49.9 m -82.98 143.63 30.53 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.991 -0.549 . . . . 0.19 111.017 -172.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -109.36 167.59 10.01 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.13 111.696 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.538 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.2 t -59.71 -12.86 7.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.686 -1.143 . . . . 1.17 113.175 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.702 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 3.3 tptp -126.87 133.22 50.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.45 -0.5 . . . . 1.22 111.075 173.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.482 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 76.9 mt-30 -31.31 -57.41 0.25 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.02 1.118 . . . . 1.51 114.02 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.552 ' CB ' HG12 ' A' ' 89' ' ' ILE . 87.9 m-70 -95.7 3.15 54.15 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.231 -0.588 . . . . 2.53 111.902 -170.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.793 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -95.14 38.19 1.14 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.661 0.985 . . . . 0.84 113.661 -172.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.617 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -112.65 143.15 17.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 117.319 -2.372 . . . . 0.32 112.565 -153.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.544 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -98.94 115.15 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.868 0.842 . . . . 0.18 110.801 -176.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.628 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 28.8 p80 -144.28 171.82 13.78 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-N 115.166 -0.925 . . . . 0.21 109.789 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.718 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.02 -166.64 38.57 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 120.799 -0.715 . . . . 0.27 111.73 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 110' ' ' PRO . 13.1 t -156.98 169.16 25.45 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.266 -0.549 . . . . 0.41 110.486 176.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -111.39 0.11 16.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.682 -0.859 . . . . 1.99 108.682 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -118.07 86.22 25.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.755 -1.111 . . . . 1.36 108.199 171.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -72.5 -19.92 24.31 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.77 2.313 . . . . 0.35 114.175 -166.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.1 -4.01 42.21 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.034 0.445 . . . . 0.33 110.839 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.0 t -85.71 -13.11 49.45 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.906 -0.776 . . . . 1.35 108.906 172.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 83' ' ' PRO . 28.6 mm -77.54 134.71 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 115.257 -0.883 . . . . 0.21 110.413 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.8 -1.38 71.23 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.217 -1.153 . . . . 0.15 110.217 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 85' ' ' ALA . 48.4 mttt -112.1 172.3 6.99 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 123.012 1.387 . . . . 2.5 113.887 -177.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.32 127.72 45.36 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 112.189 -2.278 . . . . 0.17 108.046 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.501 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 1.4 p -118.57 167.91 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.054 -1.462 . . . . 0.66 107.054 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.897 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 45.2 m -64.48 -59.68 4.04 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 119.731 -0.788 . . . . 0.43 111.949 177.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -127.34 -44.14 1.58 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 117.207 -1.797 . . . . 2.02 113.9 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -33.39 132.56 0.31 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.67 1.428 . . . . 0.18 116.67 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.617 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.2 p -68.75 166.36 17.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.41 -1.895 . . . . 0.16 112.141 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.895 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 66.9 mt -59.07 99.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 122.569 1.176 . . . . 0.4 111.991 -163.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.628 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 50.3 mtt180 -86.09 147.1 26.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.371 -1.74 . . . . 1.87 110.389 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.656 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.0 mtp -128.12 -166.21 1.59 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.29 -0.633 . . . . 0.79 109.29 175.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.602 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 5.5 t60 -95.55 156.38 16.35 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.909 -0.775 . . . . 2.32 108.909 171.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.613 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.6 m-80 -57.1 -52.69 64.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 118.422 -0.799 . . . . 0.68 110.293 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.87 -25.82 68.48 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 121.154 1.797 . . . . 2.18 112.522 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.602 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 7.5 m-20 -84.67 -41.38 16.35 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.303 -0.408 . . . . 0.69 111.186 -175.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.649 HG13 HD12 ' A' ' 151' ' ' ILE . 13.3 p -67.94 -23.75 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.016 -0.538 . . . . 0.11 111.143 175.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.649 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.24 -39.67 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 119.042 -0.504 . . . . 0.38 109.739 171.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.0 mm-40 -45.86 -72.06 0.06 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.171 0.896 . . . . 1.99 112.366 168.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 157' ' ' VAL . 44.8 mt -47.27 -38.46 12.5 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.675 0.75 . . . . 1.27 111.495 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.35 79.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.126 -1.397 . . . . 0.18 111.664 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.9 t -88.44 -33.0 18.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 118.58 0.627 . . . . 0.21 112.416 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 152' ' ' GLU . 30.4 mt -81.24 -59.63 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.551 0.691 . . . . 0.16 111.193 -172.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 153' ' ' LEU . 2.8 m -92.58 140.12 23.86 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.845 -1.071 . . . . 0.16 112.227 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.657 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 57.3 Cg_endo -89.86 177.14 2.64 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.114 3.209 . . . . 0.2 111.122 173.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.596 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 71.1 m-20 -67.07 157.8 32.64 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 119.658 -0.817 . . . . 1.1 109.525 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 99.39 -25.58 27.69 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.211 -0.995 . . . . 0.18 112.289 -173.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.597 ' HB ' HD12 ' A' ' 100' ' ' ILE . 36.1 m -61.41 138.31 58.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.383 -0.599 . . . . 0.14 109.383 -173.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.538 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 9.8 ptm180 -92.81 127.71 38.41 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.964 1.364 . . . . 3.63 111.369 -170.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.3 t -109.58 108.34 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 111.915 -2.402 . . . . 0.14 109.008 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.438 HG23 ' HG2' ' A' ' 97' ' ' GLU . 30.6 m -94.76 107.05 19.06 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.524 0.564 . . . . 0.21 112.524 -171.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.534 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -82.86 100.75 6.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 122.29 1.043 . . . . 0.24 109.992 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -110.17 133.31 53.35 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.229 -1.35 . . . . 1.09 109.832 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.558 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.6 mmm180 -70.68 -18.75 62.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.465 -0.334 . . . . 2.08 110.829 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.44 -144.21 18.98 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.938 -0.574 . . . . 1.97 112.101 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 110.281 -0.266 . . . . 3.91 110.281 178.572 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.157 -0.377 . . . . 2.8 112.157 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -102.93 169.67 8.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.048 0.451 . . . . 4.44 111.065 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -87.2 98.96 11.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.253 -0.885 . . . . 2.46 108.895 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 mp -105.34 175.21 5.57 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.453 0.644 . . . . 0.65 111.745 -175.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.621 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.4 tt -94.63 130.87 40.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.857 -1.065 . . . . 0.28 110.142 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.75 162.25 13.51 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.129 0.966 . . . . 0.31 113.171 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.624 ' O ' ' HA ' ' A' ' 45' ' ' SER . 84.7 t80 -129.57 139.98 51.34 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.469 -1.696 . . . . 0.44 107.902 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.486 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.1 tt0 -112.93 110.89 21.25 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.242 -1.021 . . . . 0.76 108.242 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 13' ' ' ASP . 92.7 t -66.05 149.45 11.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 122.564 1.173 . . . . 0.39 113.578 -167.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.409 ' O ' HG12 ' A' ' 9' ' ' VAL . 57.9 mttt -98.93 159.97 14.59 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.211 -1.813 . . . . 2.01 109.799 172.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.4 mm-40 -62.43 105.37 0.61 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.886 -1.052 . . . . 1.83 111.432 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.94 11.66 49.05 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.485 -0.779 . . . . 0.48 113.542 175.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.618 ' HB2' HG13 ' A' ' 9' ' ' VAL . 59.3 m-20 -52.38 169.52 0.08 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 117.423 0.611 . . . . 1.46 111.362 171.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.84 154.69 44.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.475 0.655 . . . . 0.41 111.271 175.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.539 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.97 -33.23 75.34 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.394 -0.965 . . . . 0.86 108.394 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 3.8 t30 -88.62 -25.12 22.6 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.883 -1.053 . . . . 1.15 111.391 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.4 p -68.76 -38.56 80.18 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 119.72 -0.792 . . . . 1.21 109.601 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 mt -75.47 -26.89 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.219 0.533 . . . . 0.21 109.75 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.643 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.91 -9.86 59.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.326 -0.397 . . . . 0.16 110.646 174.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.729 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.44 -41.37 8.63 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.274 -1.01 . . . . 0.21 108.274 176.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.463 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 1.5 m-20 -61.68 -39.45 91.47 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.015 -1.902 . . . . 0.53 112.073 174.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.469 ' O ' HD12 ' A' ' 101' ' ' ILE . 68.4 m-85 -103.32 5.9 37.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 118.566 -1.254 . . . . 0.18 111.487 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.729 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER 54.74 41.5 31.88 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.972 0.891 . . . . 1.78 109.559 176.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.643 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.8 pt -114.42 -165.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.208 -1.36 . . . . 0.19 110.024 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 142.62 41.07 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.241 -0.891 . . . . 0.95 110.21 174.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.544 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 72.3 p -71.97 -34.01 68.61 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.007 -1.108 . . . . 0.25 108.007 178.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.27 69.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.42 -0.809 . . . . 0.2 111.816 170.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.37 -26.26 18.99 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.689 0.757 . . . . 0.17 109.093 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.667 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.1 tp -75.19 -26.29 58.89 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.09 -0.959 . . . . 1.16 109.261 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 26' ' ' THR . 33.6 mt -77.86 -29.89 50.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.765 0.793 . . . . 1.05 109.828 171.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 40.8 tt0 -64.49 -43.28 94.63 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.413 -1.267 . . . . 1.81 109.95 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.18 -20.35 34.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.105 -0.638 . . . . 0.2 111.495 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.64 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.3 m-80 -148.16 81.05 8.34 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.509 0.671 . . . . 0.23 110.442 -172.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.4 Cg_endo -57.71 -10.93 8.09 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 124.077 3.185 . . . . 0.36 114.057 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.5 t -80.67 -22.12 40.72 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.053 -0.404 . . . . 1.38 111.249 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 46' ' ' ILE . 38.1 mt -66.41 -35.67 80.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.526 0.679 . . . . 0.49 111.883 -171.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 3.7 pt20 -65.51 -47.92 74.31 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 122.871 1.32 . . . . 1.95 110.167 -175.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.51 82.56 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 111.934 -2.394 . . . . 0.49 110.594 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.17 -179.53 48.19 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.857 -1.065 . . . . 0.42 111.541 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.01 158.22 23.44 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.212 0.529 . . . . 0.41 110.791 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.61 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 29.4 m -139.05 128.11 23.81 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.493 -0.776 . . . . 0.42 110.406 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -75.27 118.89 18.67 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.566 0.698 . . . . 0.47 109.772 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.486 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.39 0.74 55.65 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.374 -1.09 . . . . 0.41 110.374 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.2 OUTLIER -76.42 124.16 27.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.985 -0.607 . . . . 1.3 109.469 179.366 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 24.4 p -84.45 126.17 33.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.967 0.889 . . . . 0.85 110.752 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.859 HG21 HD21 ' A' ' 36' ' ' LEU . 10.6 pt -126.94 144.38 37.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.133 -1.394 . . . . 0.25 109.377 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.68 151.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.125 0.488 . . . . 0.67 111.164 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.3 mm -116.35 91.69 33.93 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.885 -1.052 . . . . 0.16 109.425 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.528 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.6 Cg_endo -56.93 133.7 59.67 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.834 2.356 . . . . 0.18 112.551 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.18 -5.79 78.4 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.701 -1.136 . . . . 0.26 112.569 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.688 HD12 ' HD2' ' A' ' 52' ' ' PRO . 25.6 tp -125.71 115.56 24.73 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.949 0.404 . . . . 0.61 111.452 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.688 ' HD2' HD12 ' A' ' 51' ' ' LEU . 36.4 Cg_endo -76.79 -177.82 4.07 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.565 2.844 . . . . 0.28 114.331 -172.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.67 ' HB3' HG23 ' A' ' 56' ' ' THR . 16.1 t70 -78.31 133.05 64.67 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 113.94 -1.482 . . . . 0.49 112.139 -170.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.47 -9.36 18.72 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.314 2.676 . . . . 0.46 112.717 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.507 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 16.4 m-30 -93.9 -8.28 40.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.119 0.485 . . . . 1.38 110.52 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.67 HG23 ' HB3' ' A' ' 53' ' ' ASP . 19.0 p -88.72 -17.67 29.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.065 0.936 . . . . 0.46 108.674 174.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.655 HG22 ' H ' ' A' ' 59' ' ' TYR . 9.6 mm -64.72 126.14 90.28 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 113.838 -1.528 . . . . 0.7 109.989 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.71 -13.48 10.62 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.999 1.799 . . . . 0.39 112.608 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.655 ' H ' HG22 ' A' ' 57' ' ' ILE . 67.0 m-85 -103.68 170.56 7.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.281 0.562 . . . . 0.24 111.825 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -153.81 134.07 13.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.117 -0.947 . . . . 2.89 108.536 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 71' ' ' THR . 93.1 mt -111.54 130.34 65.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.342 -0.39 . . . . 0.16 111.322 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.87 115.48 28.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.937 -0.705 . . . . 0.16 110.847 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 47.8 t -96.64 114.04 32.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.79 0.805 . . . . 0.19 110.571 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 68' ' ' LYS . 27.1 m -94.76 100.35 12.27 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.49 -1.232 . . . . 0.2 110.359 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.0 mm -50.47 -57.32 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 122.028 0.918 . . . . 0.23 111.13 170.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.34 -11.53 3.63 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 112.787 -2.006 . . . . 0.16 113.131 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.49 -17.53 5.07 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.436 0.694 . . . . 0.15 112.595 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.498 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.97 54.25 6.18 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.505 0.593 . . . . 0.69 111.488 -173.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.6 p -136.7 163.48 30.48 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.798 0.666 . . . . 0.13 112.798 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.501 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.5 tt -128.13 111.52 13.56 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.595 -1.184 . . . . 0.4 109.549 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.631 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 31.2 m -93.41 121.77 35.15 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.261 0.553 . . . . 0.16 110.962 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' A' ' 79' ' ' MET . 16.0 tp -96.79 104.96 17.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.179 -0.918 . . . . 0.59 109.078 172.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 97.9 p -106.8 159.23 16.39 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.981 -1.088 . . . . 1.05 110.368 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.619 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -123.73 125.51 44.88 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.561 -0.903 . . . . 0.26 108.561 170.832 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.619 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.9 p-10 41.06 54.83 3.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.713 -1.585 . . . . 1.84 111.58 -164.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 6.7 m-20 74.7 -13.62 0.8 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.008 -0.996 . . . . 1.89 112.146 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -95.28 120.39 35.43 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.231 0.539 . . . . 3.44 110.025 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 58.9 t -56.93 131.04 20.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 122.357 1.075 . . . . 0.24 113.002 -173.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 2.8 mmm -97.99 -46.88 5.74 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.947 -1.933 . . . . 0.81 108.854 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.8 mmtt -160.56 173.99 14.7 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.046 -1.888 . . . . 1.46 110.037 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.8 m -149.6 123.7 9.46 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.224 -1.353 . . . . 0.17 109.699 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -114.94 145.06 33.21 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.6 -0.727 . . . . 1.05 109.959 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HB2' HG22 ' A' ' 134' ' ' ILE . 37.3 Cg_endo -72.42 142.28 36.63 Favored 'Trans proline' 0 CA--C 1.496 -1.418 0 C-N-CA 122.259 1.973 . . . . 0.2 111.173 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.661 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.32 172.56 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 115.517 -0.765 . . . . 0.13 110.959 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.929 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.04 139.66 50.88 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.237 -0.438 . . . . 0.26 109.88 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.498 HG22 ' HG3' ' A' ' 68' ' ' LYS . 10.9 m -121.74 126.87 75.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.713 0.768 . . . . 0.56 111.541 -177.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -82.18 150.63 29.1 Favored Glycine 0 N--CA 1.419 -2.452 0 N-CA-C 109.186 -1.566 . . . . 0.17 109.186 171.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -57.19 4.39 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.809 0.67 . . . . 3.05 112.809 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.944 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -87.46 -19.04 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.481 0.658 . . . . 0.23 110.077 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.944 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -88.84 -16.36 32.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.694 0.759 . . . . 0.18 109.228 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.5 p -69.23 -18.51 63.9 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.565 -1.198 . . . . 0.33 111.194 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.25 -40.17 93.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.536 -1.211 . . . . 1.52 112.704 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.67 131.26 29.75 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 119.799 -0.76 . . . . 0.43 110.956 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 83.8 Cg_endo -86.97 -1.86 8.04 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.43 2.087 . . . . 0.73 112.314 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.3 t -119.62 -41.48 2.69 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.418 -0.586 . . . . 0.48 109.418 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 165' ' ' ILE . . . 54.87 16.86 8.28 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 114.716 -1.129 . . . . 0.33 114.413 169.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.596 ' HB3' HG23 ' A' ' 164' ' ' THR . 10.6 pt-20 -84.42 116.7 23.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.495 1.14 . . . . 0.84 109.816 -173.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 11.3 m-85 -137.58 -174.78 3.86 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.278 -1.783 . . . . 0.22 111.436 -166.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 162' ' ' ARG . 39.2 m-85 -142.18 137.95 31.19 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 120.945 0.402 . . . . 0.54 110.991 -173.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.662 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.2 mt -65.04 125.04 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.542 -0.753 . . . . 0.17 110.308 169.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.57 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 21.9 pt -91.45 -42.13 13.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 113.024 0.75 . . . . 0.21 113.024 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 57.6 m-80 -170.13 173.0 6.08 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.009 -1.478 . . . . 2.03 107.009 -170.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.61 HH21 ' HA ' ' A' ' 158' ' ' PRO . 40.7 mtt180 -125.8 167.9 14.56 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.696 -0.802 . . . . 1.52 111.739 -175.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -145.44 100.76 3.5 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.148 -0.933 . . . . 0.59 110.019 171.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.469 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 25.9 ttp180 -66.02 166.31 11.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.302 -0.863 . . . . 2.82 110.735 175.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 33.8 m-80 -36.37 101.51 0.22 Allowed Pre-proline 0 C--O 1.233 0.207 0 C-N-CA 124.942 1.297 . . . . 0.35 113.104 -156.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.516 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.4 Cg_endo -63.41 -44.55 14.2 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.453 2.768 . . . . 0.48 112.601 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.58 -33.95 5.26 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.87 -0.892 . . . . 0.67 110.87 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.75 -174.46 25.84 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.735 -0.733 . . . . 0.62 112.592 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -56.09 -5.73 1.05 Allowed 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 125.064 3.842 . . . . 0.94 114.461 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.444 ' HB2' ' CG ' ' A' ' 107' ' ' PRO . 5.2 m-85 -70.4 -16.19 62.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.506 1.146 . . . . 1.23 108.366 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 113' ' ' ALA . . . 84.13 -12.75 53.14 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 118.465 2.146 . . . . 1.69 118.465 152.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.788 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 166.36 -36.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 119.629 1.715 . . . . 0.48 110.111 -175.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.429 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -157.37 157.51 34.2 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.66 0.384 . . . . 0.28 110.079 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -136.52 100.22 4.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.973 -1.121 . . . . 0.49 107.973 165.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.547 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.0 mt -93.52 114.18 26.49 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.64 -0.874 . . . . 0.66 108.64 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.406 ' C ' HG12 ' A' ' 101' ' ' ILE . 9.2 m -84.25 144.45 28.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.675 -0.693 . . . . 0.19 111.213 -165.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.815 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -109.54 169.46 8.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 0.13 111.394 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.0 t -63.97 -12.21 35.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.848 -1.069 . . . . 1.17 112.787 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.746 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 3.9 tmtm? -127.65 132.31 49.74 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.158 0.98 . . . . 1.22 109.704 171.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.746 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.0 mt-30 -37.57 -47.23 0.91 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.524 -2.126 . . . . 1.51 114.211 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.486 ' HB2' HG12 ' A' ' 89' ' ' ILE . 37.2 m80 -97.9 2.22 48.92 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.366 0.603 . . . . 2.53 111.024 -171.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.815 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.6 m-85 -99.38 37.35 1.58 Allowed 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.495 0.924 . . . . 0.84 113.495 -171.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.672 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -117.03 142.27 17.31 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 116.874 -2.584 . . . . 0.32 112.668 -152.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -95.64 116.12 36.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 123.966 0.906 . . . . 0.18 110.868 -175.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.724 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 26.7 p80 -146.36 -179.01 6.45 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.186 -0.461 . . . . 0.21 111.822 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.39 -167.98 37.05 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 111.19 -0.764 . . . . 0.27 111.19 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.4 t -156.95 172.29 18.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 117.912 0.856 . . . . 0.41 110.911 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -115.42 -2.43 12.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.528 -0.916 . . . . 1.99 108.528 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -124.86 89.17 52.93 Favored Pre-proline 0 C--O 1.235 0.333 0 CA-C-N 114.426 -1.261 . . . . 1.36 108.858 171.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -74.32 -21.04 17.95 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.627 2.218 . . . . 0.35 114.113 -169.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.02 -3.65 40.14 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.034 0.445 . . . . 0.33 111.337 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.9 m -91.13 -2.33 57.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.125 0.488 . . . . 1.35 109.812 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 83' ' ' PRO . 33.5 mm -77.23 136.34 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.21 110.026 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.59 2.12 65.57 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.314 -1.114 . . . . 0.15 110.314 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.428 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 30.2 mttm -114.87 169.96 8.69 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 123.315 1.531 . . . . 2.5 114.635 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.4 126.51 48.18 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.67 -2.514 . . . . 0.17 108.203 176.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.77 161.23 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.446 -0.946 . . . . 0.66 108.446 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.0 m -49.8 -60.1 3.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.794 0.664 . . . . 0.43 112.794 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -132.61 -44.46 0.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.36 -1.336 . . . . 2.02 113.984 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.49 133.65 0.2 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 117.19 1.636 . . . . 0.18 117.19 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.616 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 2.4 p -71.22 165.6 23.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 112.545 -1.827 . . . . 0.16 112.026 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.929 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 56.0 mt -60.01 96.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 122.538 1.161 . . . . 0.4 111.783 -162.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.724 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 80.5 mtt180 -84.93 141.76 30.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.681 -1.6 . . . . 1.87 109.399 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.661 ' HG2' HG22 ' A' ' 84' ' ' ILE . 24.4 mtp -118.6 179.22 4.19 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.477 0.656 . . . . 0.79 109.857 175.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.569 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 9.5 t-80 -81.45 145.83 30.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.882 -1.155 . . . . 2.32 107.882 168.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.789 ' O ' HD13 ' A' ' 151' ' ' ILE . 8.3 m-80 -66.17 -40.47 90.52 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 114.883 -1.053 . . . . 0.68 112.566 -166.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -67.54 -23.83 65.48 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 121.801 2.091 . . . . 2.18 112.241 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 12.2 m-20 -85.19 -38.23 19.22 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.216 -0.447 . . . . 0.69 110.851 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.62 HG13 HD12 ' A' ' 151' ' ' ILE . 12.2 p -67.55 -21.98 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.852 -0.613 . . . . 0.11 111.176 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.789 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.19 -43.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 118.948 -0.549 . . . . 0.38 109.923 171.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 156' ' ' ILE . 23.5 mt-10 -46.81 -70.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 119.385 0.993 . . . . 1.99 112.761 170.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.473 ' O ' HG22 ' A' ' 157' ' ' VAL . 27.3 mt -47.07 -38.62 11.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.631 0.729 . . . . 1.27 111.658 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.65 -31.96 71.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.079 -1.419 . . . . 0.18 111.712 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.7 t -88.34 -31.77 18.75 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.481 -0.762 . . . . 0.21 112.324 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 152' ' ' GLU . 24.2 mt -82.31 -60.84 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.534 0.683 . . . . 0.16 111.828 -171.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 153' ' ' LEU . 8.7 m -88.35 139.46 30.16 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 114.783 -1.099 . . . . 0.16 112.342 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.61 ' HA ' HH21 ' A' ' 103' ' ' ARG . 42.4 Cg_endo -88.54 174.55 4.13 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 124.37 3.38 . . . . 0.2 111.119 176.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 54.0 m-20 -68.18 156.93 36.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.905 -1.118 . . . . 1.1 108.219 175.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.78 -16.07 61.9 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.772 -1.204 . . . . 0.18 111.928 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.662 ' HB ' HD12 ' A' ' 100' ' ' ILE . 95.2 m -64.91 135.29 55.54 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.203 -0.666 . . . . 0.14 109.203 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.443 ' HB3' ' CD1' ' A' ' 99' ' ' TYR . 1.7 ptt180 -92.82 122.42 35.19 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.685 1.231 . . . . 3.63 111.078 -170.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 39.8 t -110.14 109.56 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 112.204 -2.271 . . . . 0.14 109.475 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.596 HG23 ' HB3' ' A' ' 97' ' ' GLU . 6.9 m -97.35 110.28 22.86 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.082 0.771 . . . . 0.21 113.082 -172.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.488 HG12 HD12 ' A' ' 90' ' ' LEU . 2.3 mp -83.17 102.16 8.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.11 0.957 . . . . 0.24 109.792 176.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -109.22 129.84 55.5 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.979 -1.009 . . . . 1.09 110.037 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 9.9 mmm180 -77.7 -23.17 49.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.362 0.601 . . . . 2.08 109.432 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 153.6 -177.89 30.88 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.925 -1.034 . . . . 1.97 111.572 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--N 1.321 -0.64 0 N-CA-C 110.114 -0.328 . . . . 3.91 110.114 178.931 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 111.768 -0.533 . . . . 2.8 111.768 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -99.59 140.37 33.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.063 0.459 . . . . 4.44 110.671 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 6.1 mmpt? -91.36 100.88 13.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.777 -0.647 . . . . 2.46 110.671 -177.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.771 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 tp -107.47 174.43 5.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.891 -0.595 . . . . 0.65 111.186 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.9 tt -94.28 126.42 39.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.521 -0.763 . . . . 0.28 110.615 -174.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.71 161.62 13.8 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.051 0.929 . . . . 0.31 113.064 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.651 ' O ' ' HA ' ' A' ' 45' ' ' SER . 78.7 t80 -131.29 141.48 49.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.808 -1.542 . . . . 0.44 108.058 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.457 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.5 tt0 -113.27 111.04 21.37 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.055 -1.091 . . . . 0.76 108.055 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' A' ' 13' ' ' ASP . 94.3 t -66.52 150.49 10.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 122.155 0.978 . . . . 0.39 113.032 -168.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -104.14 158.85 16.15 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.869 -1.514 . . . . 2.01 108.658 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.1 tt0 -61.54 101.62 0.19 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.974 0.416 . . . . 1.83 112.09 -175.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.79 11.97 27.27 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.754 -0.736 . . . . 0.48 113.237 174.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.647 ' HB2' HG13 ' A' ' 9' ' ' VAL . 35.7 m-20 -55.54 170.48 0.25 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.912 0.356 . . . . 1.46 111.348 171.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.7 155.11 49.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.459 0.647 . . . . 0.41 111.893 174.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.754 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -69.21 -29.71 67.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.526 -1.216 . . . . 0.86 109.897 -177.255 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.441 ' HA ' HG22 ' A' ' 26' ' ' THR . 65.9 t30 -93.79 -23.26 18.23 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.927 -1.033 . . . . 1.15 111.164 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.3 m -70.0 -39.84 75.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.553 -0.459 . . . . 1.21 109.886 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.443 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.2 mt -73.2 -27.4 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.112 0.482 . . . . 0.21 109.977 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.654 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.76 -10.42 59.77 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.811 -0.356 . . . . 0.16 110.928 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.565 ' O ' ' HD3' ' A' ' 23' ' ' ARG . . . -97.16 -40.3 8.87 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 122.214 1.007 . . . . 0.21 108.404 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 4.4 m-20 -61.44 -43.43 98.88 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.227 -1.806 . . . . 0.53 111.867 173.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.568 ' C ' HD12 ' A' ' 101' ' ' ILE . 67.8 m-85 -98.01 8.19 45.14 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.574 -1.25 . . . . 0.18 111.571 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.565 ' HD3' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER 52.08 40.65 28.95 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.613 0.721 . . . . 1.78 110.215 177.439 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.654 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.6 pt -113.63 -164.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 114.511 -1.222 . . . . 0.19 109.28 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -109.9 157.17 19.52 Favored 'General case' 0 CA--C 1.491 -1.318 0 CA-C-O 122.375 1.083 . . . . 0.95 110.168 169.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.754 ' HB ' HD11 ' A' ' 15' ' ' LEU . 75.7 p -80.68 -31.12 36.4 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 112.914 -1.948 . . . . 0.25 107.553 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 -30.72 71.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.098 -0.956 . . . . 0.2 111.76 172.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.51 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -89.95 -26.87 20.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.728 -0.842 . . . . 0.17 108.728 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.6 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 20.0 tp -74.14 -28.18 61.2 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.355 -0.839 . . . . 1.16 109.789 175.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 36' ' ' LEU . 48.3 mt -77.79 -29.31 50.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.959 0.885 . . . . 1.05 109.919 172.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 53.9 tt0 -67.9 -39.65 83.59 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.082 -1.417 . . . . 1.81 110.572 174.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.67 -19.94 32.06 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.075 -0.65 . . . . 0.2 111.409 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 26.8 m-80 -147.05 80.64 9.34 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-O 121.217 0.532 . . . . 0.23 110.351 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.418 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 18.5 Cg_endo -57.15 -11.2 7.36 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 123.889 3.059 . . . . 0.36 113.305 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 m -74.05 -25.72 60.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.848 0.356 . . . . 1.38 111.53 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.663 HD21 HG21 ' A' ' 46' ' ' ILE . 40.6 mt -70.91 -32.46 69.4 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.353 0.596 . . . . 0.49 112.462 -168.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 1.7 pp0? -63.59 -44.64 93.43 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 123.057 1.408 . . . . 1.95 110.395 -175.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.37 79.19 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 111.722 -2.49 . . . . 0.49 110.693 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.41 178.33 48.65 Favored Glycine 0 N--CA 1.425 -2.094 0 CA-C-N 115.117 -0.947 . . . . 0.42 111.929 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.67 158.05 19.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.225 0.536 . . . . 0.41 110.569 178.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.556 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 74.4 m -140.91 127.55 20.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.355 -0.839 . . . . 0.42 110.301 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -75.07 122.71 23.96 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.364 0.602 . . . . 0.47 110.028 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.457 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.67 3.02 61.18 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 110.533 -1.027 . . . . 0.41 110.533 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.556 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.52 123.12 28.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.626 -0.509 . . . . 1.3 109.626 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 17.0 p -77.78 126.36 30.74 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.852 0.834 . . . . 0.85 110.657 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.663 HG21 HD21 ' A' ' 36' ' ' LEU . 9.1 pt -126.13 144.07 37.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.138 -1.392 . . . . 0.25 109.198 -178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.426 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.15 151.44 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.347 0.594 . . . . 0.67 111.191 -179.023 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.82 93.38 41.23 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.554 -1.203 . . . . 0.16 109.227 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.613 ' HA ' HD21 ' A' ' 4' ' ' LEU . 3.1 Cg_exo -56.12 133.91 60.97 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.488 2.125 . . . . 0.18 112.535 -176.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.77 -6.88 79.76 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 114.412 -1.267 . . . . 0.26 112.363 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.771 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER -112.98 118.49 44.41 Favored Pre-proline 0 C--O 1.217 -0.637 0 CA-C-N 116.98 0.39 . . . . 0.61 111.186 178.172 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.592 ' HD2' HD23 ' A' ' 51' ' ' LEU . 37.0 Cg_endo -80.0 -176.8 3.41 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.083 2.522 . . . . 0.28 112.65 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.552 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.7 t70 -86.72 127.37 60.49 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-N 115.363 -0.835 . . . . 0.49 112.044 -168.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.566 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.1 Cg_endo -75.65 -10.39 20.17 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 123.626 2.884 . . . . 0.46 112.934 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -94.08 -13.92 26.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.549 0.69 . . . . 1.38 110.186 -176.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.552 HG23 ' HB3' ' A' ' 53' ' ' ASP . 23.7 p -87.32 -21.23 25.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.507 1.146 . . . . 0.46 108.176 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 59' ' ' TYR . 35.8 mt -73.89 129.08 85.58 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.124 -1.853 . . . . 0.7 111.018 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.06 -16.22 14.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.424 2.083 . . . . 0.39 113.416 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.531 ' H ' HG22 ' A' ' 57' ' ' ILE . 62.9 m-85 -94.66 160.12 14.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.582 -0.447 . . . . 0.24 111.591 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -150.99 132.03 14.31 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.902 -0.777 . . . . 2.89 108.902 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 71' ' ' THR . 80.2 mt -112.49 136.38 48.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.233 -0.44 . . . . 0.16 111.889 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.77 117.39 29.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 119.957 -0.697 . . . . 0.16 110.924 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.2 t -97.33 112.88 30.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.775 0.797 . . . . 0.19 110.53 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 68' ' ' LYS . 49.6 m -93.6 100.75 12.95 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.717 -1.129 . . . . 0.2 110.546 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.8 mm -50.79 -58.77 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.894 0.854 . . . . 0.23 111.443 170.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.92 -8.21 2.09 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 112.922 -1.945 . . . . 0.16 113.245 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.46 -19.17 4.27 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.697 0.799 . . . . 0.15 112.267 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.554 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 59.24 54.51 4.77 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.335 0.516 . . . . 0.69 111.293 -172.648 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.6 p -137.29 166.2 24.34 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 112.787 0.662 . . . . 0.13 112.787 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.431 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.9 tt -136.26 112.22 9.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.861 -1.063 . . . . 0.4 110.197 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 86.6 m -93.24 124.3 37.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.146 0.498 . . . . 0.16 110.879 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.9 tp -99.78 107.3 19.31 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.173 -0.921 . . . . 0.59 109.25 172.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 88.8 p -105.42 161.4 14.35 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.013 -1.075 . . . . 1.05 110.546 176.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -125.99 126.69 44.72 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.575 -0.898 . . . . 0.26 108.575 167.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.566 ' N ' HD22 ' A' ' 74' ' ' LEU . 9.1 m120 51.15 48.61 22.73 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.607 -1.179 . . . . 1.84 111.067 -172.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.0 t30 71.71 -5.89 1.56 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.339 0.656 . . . . 1.89 111.414 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -104.94 120.64 41.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.125 0.488 . . . . 3.44 110.582 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 54.7 t -55.23 132.85 18.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 122.361 1.077 . . . . 0.24 113.399 -174.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 6.9 mmm -100.85 -44.43 5.77 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.229 -1.805 . . . . 0.81 109.275 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -159.37 173.43 16.26 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 113.189 -1.823 . . . . 1.46 110.156 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.0 m -149.3 123.08 9.27 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.986 -1.461 . . . . 0.17 109.391 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.459 ' HE2' HD21 ' A' ' 153' ' ' LEU . 19.0 m-85 -108.85 156.6 38.72 Favored Pre-proline 0 C--N 1.312 -1.04 0 N-CA-C 109.386 -0.598 . . . . 1.05 109.386 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HB2' HG22 ' A' ' 134' ' ' ILE . 50.7 Cg_endo -80.69 144.2 15.41 Favored 'Trans proline' 0 CA--C 1.497 -1.372 0 C-N-CA 121.975 1.783 . . . . 0.2 110.83 170.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.631 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -140.08 172.75 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.614 -0.721 . . . . 0.13 110.551 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.85 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.05 137.69 52.73 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.846 0.355 . . . . 0.26 110.321 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.554 HG22 ' HG3' ' A' ' 68' ' ' LYS . 13.2 m -121.11 130.16 74.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.678 -0.692 . . . . 0.56 111.527 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 140' ' ' LYS . . . -88.91 154.26 24.46 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.988 -1.245 . . . . 0.17 109.988 171.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -57.08 4.55 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 113.133 0.79 . . . . 3.05 113.133 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.936 HG23 HD22 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -88.78 -18.97 7.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.78 0.8 . . . . 0.23 110.074 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.936 HD22 HG23 ' A' ' 89' ' ' ILE . 3.5 mm? -88.66 -18.53 27.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.791 0.805 . . . . 0.18 108.909 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.8 p -68.51 -15.05 63.41 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.376 -1.284 . . . . 0.33 111.658 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -69.6 -42.26 74.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.918 -1.037 . . . . 1.52 112.127 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -99.72 111.94 62.7 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.43 111.108 -175.105 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.509 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 1.9 Cg_endo -77.43 -11.87 17.19 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.831 2.354 . . . . 0.73 113.126 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.425 HG23 ' N ' ' A' ' 96' ' ' GLY . 10.2 t -98.88 -43.58 6.68 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.468 -0.567 . . . . 0.48 109.468 176.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.55 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 54.44 27.21 40.19 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.255 -1.339 . . . . 0.33 114.228 168.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -84.59 111.86 19.91 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.988 0.899 . . . . 0.84 109.363 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.692 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 22.4 m-85 -138.46 -176.9 4.62 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.66 -1.609 . . . . 0.22 111.661 -170.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.401 ' CE1' ' HG3' ' A' ' 54' ' ' PRO . 46.5 m-85 -143.96 144.12 31.55 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.974 0.416 . . . . 0.54 110.552 -173.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.586 HD12 ' HB ' ' A' ' 161' ' ' THR . 82.3 mt -68.75 113.01 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.336 -0.847 . . . . 0.17 109.995 168.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.568 HD12 ' C ' ' A' ' 22' ' ' PHE . 18.7 pt -80.65 -43.54 21.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.569 -0.741 . . . . 0.21 112.552 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.824 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 52.1 m-80 -169.12 169.47 9.38 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.007 -1.479 . . . . 2.03 107.007 -170.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.608 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -134.76 157.59 46.34 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.99 -0.684 . . . . 1.52 112.396 -177.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -130.86 100.92 5.43 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.723 -1.126 . . . . 0.59 109.85 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.459 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 52.0 ttt180 -61.45 165.31 4.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.35 -0.841 . . . . 2.82 110.137 173.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.77 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 29.9 m-80 -34.99 100.91 0.2 Allowed Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 125.12 1.368 . . . . 0.35 112.657 -156.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.492 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 19.7 Cg_endo -67.04 -50.89 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.25 2.633 . . . . 0.48 112.827 176.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.56 -32.88 4.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.793 -0.718 . . . . 0.67 111.336 -175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.06 -173.77 3.14 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.179 -0.51 . . . . 0.62 112.512 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.437 ' O ' ' HA ' ' A' ' 128' ' ' THR . 36.2 Cg_endo -57.06 -11.57 7.89 Favored 'Trans proline' 0 N--CA 1.478 0.595 0 C-N-CA 124.307 3.338 . . . . 0.94 113.071 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 115' ' ' TRP . 6.2 m-30 -67.36 -37.99 84.06 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.802 -1.184 . . . . 1.23 107.802 174.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 113' ' ' ALA . . . 54.2 29.65 45.68 Favored Glycine 0 CA--C 1.492 -1.405 0 CA-C-N 113.256 -1.793 . . . . 1.69 117.232 161.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.9 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 173.27 -51.19 0.01 OUTLIER 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.32 1.06 . . . . 0.48 110.221 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.454 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -161.06 157.24 25.8 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.57 0.348 . . . . 0.28 110.206 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.439 ' HB2' ' CD2' ' A' ' 111' ' ' PHE . 8.6 t-105 -135.68 99.05 4.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.129 -1.063 . . . . 0.49 108.129 165.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.608 HD23 ' HB3' ' A' ' 103' ' ' ARG . 2.7 mt -89.69 113.52 25.02 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.692 -0.855 . . . . 0.66 108.692 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.497 ' O ' HG12 ' A' ' 101' ' ' ILE . 11.0 m -82.02 142.63 32.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.718 -0.674 . . . . 0.19 110.153 -171.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.722 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.3 mm? -108.14 163.81 12.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.282 -0.417 . . . . 0.13 111.725 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.3 t -57.6 -14.01 4.72 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 124.621 1.201 . . . . 1.17 112.546 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.692 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 5.9 tmtm? -125.94 130.33 51.06 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.266 -0.574 . . . . 1.22 109.458 169.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.64 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 54.0 mt-30 -33.69 -60.29 0.37 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 125.438 1.711 . . . . 1.51 113.19 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.503 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -92.08 13.79 17.85 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.01 -0.676 . . . . 2.53 112.412 -169.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.949 ' O ' HG12 ' A' ' 143' ' ' ILE . 2.5 m-30 -92.68 -35.13 13.66 Favored 'General case' 0 C--O 1.202 -1.441 0 CA-C-O 121.896 0.855 . . . . 0.84 111.392 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.722 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -10.3 129.46 0.01 OUTLIER Glycine 0 C--N 1.286 -2.197 0 N-CA-C 119.414 2.526 . . . . 0.32 119.414 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -98.43 116.52 41.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 112.538 -1.831 . . . . 0.18 110.149 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.633 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.2 p80 -144.13 -175.82 4.76 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 112.762 0.653 . . . . 0.21 112.762 -174.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.17 -166.73 36.98 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 111.651 -0.579 . . . . 0.27 111.651 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 110' ' ' PRO . 13.8 t -160.92 165.6 29.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 117.99 0.895 . . . . 0.41 110.826 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.42 -2.04 13.34 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.806 -1.183 . . . . 1.99 107.806 175.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -123.73 96.47 43.07 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 114.187 -1.369 . . . . 1.36 108.157 170.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -74.54 -20.32 18.14 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.238 1.958 . . . . 0.35 112.767 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.53 -0.16 40.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.414 0.626 . . . . 0.33 110.674 -176.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 43.0 t -91.94 -5.17 53.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.928 -0.767 . . . . 1.35 108.928 170.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 30.6 mm -84.56 133.66 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.768 -0.651 . . . . 0.21 110.498 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.1 1.45 69.84 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.804 -1.319 . . . . 0.15 109.804 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 0.1 OUTLIER -113.69 161.79 17.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.913 1.34 . . . . 2.5 114.067 -176.023 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -95.85 129.04 43.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 112.244 -2.253 . . . . 0.17 108.305 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 139' ' ' SER . 0.2 OUTLIER -126.02 165.07 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.618 -0.882 . . . . 0.66 108.618 -175.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 66.0 m -50.02 -60.09 3.27 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.706 0.632 . . . . 0.43 112.706 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.47 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -133.87 -43.2 0.81 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 118.414 -1.314 . . . . 2.02 113.802 -175.427 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.7 134.09 0.14 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 117.645 1.818 . . . . 0.18 117.645 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 4.9 p -71.29 166.47 21.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 112.493 -1.853 . . . . 0.16 112.037 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.949 HG12 ' O ' ' A' ' 123' ' ' TYR . 9.3 mm -58.9 101.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 115.118 -0.946 . . . . 0.4 111.622 -162.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.633 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 28.6 mtp85 -88.17 141.13 28.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.178 -0.919 . . . . 1.87 109.279 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.631 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.2 mtp -120.01 -168.49 1.62 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.959 -0.756 . . . . 0.79 108.959 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.424 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 7.5 t-160 -88.89 155.52 19.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.414 -0.958 . . . . 2.32 108.414 170.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.875 ' O ' HD13 ' A' ' 151' ' ' ILE . 7.2 m-80 -73.38 -18.27 61.18 Favored 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 112.745 0.646 . . . . 0.68 112.745 -172.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -82.02 -27.56 33.01 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 120.551 1.523 . . . . 2.18 112.831 164.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.424 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 67.1 m-20 -82.57 -38.64 23.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.992 0.425 . . . . 0.69 111.001 -173.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.659 HG13 HD12 ' A' ' 151' ' ' ILE . 12.2 p -67.22 -21.65 28.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.11 111.13 174.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.9 HD11 ' HB1' ' A' ' 113' ' ' ALA . 1.6 mp -84.6 -40.86 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 119.029 -0.51 . . . . 0.38 110.203 172.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 156' ' ' ILE . 4.4 mm-40 -44.7 -72.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.105 0.866 . . . . 1.99 112.203 168.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.587 ' O ' HG22 ' A' ' 157' ' ' VAL . 41.6 mt -46.32 -39.12 9.67 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.669 0.747 . . . . 1.27 111.644 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HB1' ' CE2' ' A' ' 114' ' ' TYR . . . -62.4 -37.66 86.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.159 -1.382 . . . . 0.18 111.764 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 34.6 t -86.79 -33.16 19.99 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.581 0.586 . . . . 0.21 112.581 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 152' ' ' GLU . 24.6 mt -81.24 -59.39 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.659 0.742 . . . . 0.16 111.367 -172.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.0 m -89.57 141.89 29.01 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.743 -1.117 . . . . 0.16 111.899 177.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -89.4 175.27 3.34 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.099 3.199 . . . . 0.2 110.911 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.824 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.5 m-20 -65.38 158.63 26.07 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.831 -0.803 . . . . 1.1 108.831 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 95.04 -17.9 58.41 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.108 -1.044 . . . . 0.18 112.569 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.586 ' HB ' HD12 ' A' ' 100' ' ' ILE . 80.6 m -63.95 137.33 57.96 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.299 -0.63 . . . . 0.14 109.299 -175.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.15 119.82 32.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 122.673 1.225 . . . . 3.63 111.137 -168.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.5 t -104.42 110.86 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 112.4 -2.182 . . . . 0.14 109.398 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.0 m -96.3 108.21 20.68 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 112.757 0.651 . . . . 0.21 112.757 -173.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.55 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -81.28 106.64 12.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 122.198 0.999 . . . . 0.24 109.905 177.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -112.36 123.65 50.76 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.42 -1.264 . . . . 1.09 109.806 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.543 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 17.7 mmm180 -68.48 -31.7 71.17 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.707 -0.479 . . . . 2.08 109.707 175.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 162.32 57.11 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.651 -0.704 . . . . 1.97 112.418 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 110.213 -0.292 . . . . 3.91 110.213 179.514 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.654 HD21 ' HA ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER . . . . . 0 CA--C 1.519 -0.242 0 CA-C-O 121.58 0.705 . . . . 0.65000000000000002 112.661 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.9 tt -98.99 129.05 45.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.581 -1.19 . . . . 0.28000000000000003 110.466 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.32 162.18 13.45 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.076 0.941 . . . . 0.31 113.347 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 45' ' ' SER . 82.6 t80 -131.96 141.5 49.32 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.676 -1.602 . . . . 0.44 107.973 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.9 tt0 -114.64 115.23 26.79 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.198 -1.038 . . . . 0.76000000000000001 108.198 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 13' ' ' ASP . 99.5 t -67.01 148.84 11.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 122.482 1.134 . . . . 0.39000000000000001 113.125 -172.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -103.1 158.84 16.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.171 -1.831 . . . . 2.0099999999999998 108.12 171.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -60.98 106.26 0.57 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 120.808 0.337 . . . . 1.8300000000000001 111.754 -175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.35 11.67 38.18 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.689 -0.767 . . . . 0.47999999999999998 113.553 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB2' HG13 ' A' ' 9' ' ' VAL . 65.3 m-20 -53.15 165.14 0.35 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.169 0.485 . . . . 1.46 111.646 172.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.1 147.69 47.72 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.43 0.633 . . . . 0.40999999999999998 111.171 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.534 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.89 -40.69 87.84 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.901 -1.045 . . . . 0.85999999999999999 108.446 -176.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -84.28 -18.08 37.58 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.576 -1.193 . . . . 1.1499999999999999 110.266 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.9 t -71.66 -43.31 66.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.151 -0.685 . . . . 1.21 109.151 170.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.423 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.0 mt -72.19 -27.66 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.37 0.605 . . . . 0.20999999999999999 109.502 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.07 -9.04 59.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.161 -0.472 . . . . 0.16 110.942 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.69 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.52 -40.79 8.48 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 122.631 1.205 . . . . 0.20999999999999999 107.965 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.1 m-20 -62.2 -45.8 91.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 112.417 -2.174 . . . . 0.53000000000000003 111.883 174.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.586 ' HA ' HG21 ' A' ' 101' ' ' ILE . 60.6 m-85 -96.23 5.63 50.59 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 118.624 -1.23 . . . . 0.17999999999999999 111.213 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.69 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.7 mpt_? 54.2 45.86 26.5 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.648 0.737 . . . . 1.78 109.772 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.616 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 37.1 pt -120.53 -165.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.671 -1.149 . . . . 0.19 110.206 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.91 142.94 40.55 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.998 -1.001 . . . . 0.94999999999999996 110.252 174.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.534 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 68.4 p -71.4 -33.38 69.43 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.914 -1.143 . . . . 0.25 107.914 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.01 68.08 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.443 -0.799 . . . . 0.20000000000000001 111.954 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.539 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.63 -27.73 16.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.717 0.77 . . . . 0.17000000000000001 109.198 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.576 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -74.83 -29.75 61.16 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.707 -1.133 . . . . 1.1599999999999999 109.357 174.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.551 HD23 ' HB2' ' A' ' 36' ' ' LEU . 48.2 mt -76.6 -33.02 58.44 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.83 0.824 . . . . 1.05 110.117 171.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 5.2 tt0 -61.49 -39.21 90.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.356 -1.293 . . . . 1.8100000000000001 109.522 172.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.632 ' HB1' HG13 ' A' ' 47' ' ' VAL . . . -86.47 -19.31 29.76 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.337 -0.545 . . . . 0.20000000000000001 112.217 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.633 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 26.4 m-80 -149.61 81.32 7.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.359 0.6 . . . . 0.23000000000000001 110.448 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.417 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 18.1 Cg_endo -56.63 -14.74 13.97 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 124.328 3.352 . . . . 0.35999999999999999 114.054 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -73.69 -23.92 59.88 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.16 -0.337 . . . . 1.3799999999999999 111.766 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.899 HD21 HG21 ' A' ' 46' ' ' ILE . 29.0 mt -67.91 -37.14 81.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.346 0.593 . . . . 0.48999999999999999 112.199 -170.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 1.6 pp0? -63.43 -44.14 95.44 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 123.01 1.386 . . . . 1.95 110.764 -173.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.3 -47.71 81.13 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 111.722 -2.49 . . . . 0.48999999999999999 110.705 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.57 48.44 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.887 -1.051 . . . . 0.41999999999999998 111.488 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.94 157.83 20.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.424 0.631 . . . . 0.40999999999999998 111.217 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.623 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 58.1 m -139.09 128.9 24.84 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.118 -0.946 . . . . 0.41999999999999998 110.193 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.96 120.44 21.3 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.035 -0.666 . . . . 0.46999999999999997 109.916 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 97.73 2.44 58.53 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 110.365 -1.094 . . . . 0.40999999999999998 110.365 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.623 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.3 OUTLIER -78.15 124.53 28.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.228 -0.656 . . . . 1.3 109.228 178.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 37.4 p -81.48 124.12 29.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.956 0.884 . . . . 0.84999999999999998 110.842 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.899 HG21 HD21 ' A' ' 36' ' ' LEU . 1.4 pp -129.87 132.8 65.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 113.933 -1.485 . . . . 0.25 108.974 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.632 HG13 ' HB1' ' A' ' 32' ' ' ALA . 14.7 p -93.79 163.65 2.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 114.857 -1.065 . . . . 0.67000000000000004 111.025 -169.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.481 HG13 ' CE2' ' A' ' 22' ' ' PHE . 39.3 mm -121.24 102.48 43.13 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 114.698 -1.137 . . . . 0.16 109.894 -173.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.654 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -66.27 135.85 41.56 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.928 1.752 . . . . 0.17999999999999999 112.341 -175.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.45 -5.94 80.52 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.065 -0.97 . . . . 0.26000000000000001 112.42 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.701 HD12 ' HD2' ' A' ' 52' ' ' PRO . 36.1 tp -122.72 116.1 29.28 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-O 121.218 0.532 . . . . 0.60999999999999999 111.408 -177.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.701 ' HD2' HD12 ' A' ' 51' ' ' LEU . 53.5 Cg_endo -78.12 -176.91 3.5 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.918 3.079 . . . . 0.28000000000000003 114.362 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.613 ' HB3' HG23 ' A' ' 56' ' ' THR . 8.9 t70 -84.96 128.02 62.16 Favored Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-N 114.302 -1.317 . . . . 0.48999999999999999 111.975 -169.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 37.4 Cg_endo -69.94 -18.19 36.3 Favored 'Trans proline' 0 CA--C 1.519 -0.248 0 C-N-CA 123.619 2.879 . . . . 0.46000000000000002 112.69 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.411 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 69.3 m-85 -96.09 2.36 53.17 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.529 0.681 . . . . 1.3799999999999999 111.451 -173.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 53' ' ' ASP . 18.5 p -98.45 -20.58 17.03 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.897 -1.149 . . . . 0.46000000000000002 107.897 171.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 59' ' ' TYR . 19.4 mt -73.17 133.02 81.66 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 113.254 -1.794 . . . . 0.69999999999999996 111.335 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.42 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 92.4 Cg_endo -79.33 -15.86 12.42 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.381 2.054 . . . . 0.39000000000000001 113.883 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.604 ' H ' HG22 ' A' ' 57' ' ' ILE . 50.7 m-85 -104.09 164.04 11.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.023 0.749 . . . . 0.23999999999999999 113.023 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -147.67 139.48 24.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.982 -1.008 . . . . 2.8900000000000001 108.795 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.671 ' HA ' ' O ' ' A' ' 71' ' ' THR . 79.2 mt -116.09 132.27 66.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.316 -0.402 . . . . 0.16 111.718 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.23 116.57 27.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.897 -0.721 . . . . 0.16 111.122 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 65.0 t -98.57 112.99 32.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.647 0.737 . . . . 0.19 111.163 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 68' ' ' LYS . 53.3 m -95.74 100.87 12.53 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.893 -1.049 . . . . 0.20000000000000001 110.748 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.58 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.1 mm -48.93 -58.76 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.987 0.899 . . . . 0.23000000000000001 111.788 171.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.58 -9.38 3.44 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 112.925 -1.943 . . . . 0.16 113.055 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.57 -19.57 4.55 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.581 0.752 . . . . 0.14999999999999999 112.087 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.519 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.68 55.93 4.47 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.27 0.486 . . . . 0.68999999999999995 111.236 -173.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.7 p -137.24 159.67 41.26 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 112.861 0.689 . . . . 0.13 112.861 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.503 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.7 tt -126.77 112.58 15.56 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.559 -1.2 . . . . 0.40000000000000002 110.004 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.671 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 29.6 m -93.62 122.4 36.04 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.226 0.536 . . . . 0.16 111.288 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.5 tp -98.0 103.74 15.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.003 -0.998 . . . . 0.58999999999999997 109.464 172.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 82.2 p -105.75 161.11 14.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 119.086 -1.045 . . . . 1.05 110.612 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.77 HD13 HD22 ' A' ' 75' ' ' ASN . 0.9 OUTLIER -127.08 128.23 45.93 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.541 -0.911 . . . . 0.26000000000000001 108.541 170.285 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.77 HD22 HD13 ' A' ' 74' ' ' LEU . 7.9 p30 43.8 51.15 6.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.303 -1.317 . . . . 1.8400000000000001 111.892 -166.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.7 t30 74.76 -13.19 0.85 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.1 -0.954 . . . . 1.8899999999999999 111.382 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -95.76 121.37 37.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.92 -0.582 . . . . 3.4399999999999999 109.888 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 78.0 t -59.55 132.48 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 122.362 1.077 . . . . 0.23999999999999999 112.499 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 18.3 mtm -100.55 -46.91 5.05 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 113.022 -1.899 . . . . 0.81000000000000005 108.805 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -155.56 172.97 17.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.42 -1.718 . . . . 1.46 110.019 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 78.6 m -148.75 123.02 9.58 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.082 -1.417 . . . . 0.17000000000000001 109.783 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -108.01 145.34 31.22 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.487 -0.779 . . . . 1.05 109.274 -176.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.435 ' HB2' HG22 ' A' ' 134' ' ' ILE . 42.7 Cg_endo -74.94 141.96 27.47 Favored 'Trans proline' 0 CA--C 1.499 -1.238 0 C-N-CA 122.031 1.82 . . . . 0.20000000000000001 111.285 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.668 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.44 175.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.92 -0.582 . . . . 0.13 111.051 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.876 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.13 147.32 44.31 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.306 -0.406 . . . . 0.26000000000000001 110.15 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.519 HG22 ' HG3' ' A' ' 68' ' ' LYS . 11.4 m -129.64 128.44 65.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.47 0.653 . . . . 0.56000000000000005 112.004 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -89.06 157.9 27.53 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 110.624 -0.99 . . . . 0.17000000000000001 110.624 173.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -56.37 2.68 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.309 0.855 . . . . 3.0499999999999998 113.309 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.927 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -89.9 -20.52 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 121.83 0.824 . . . . 0.23000000000000001 110.149 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.927 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -90.85 -19.53 23.29 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.442 -0.799 . . . . 0.17999999999999999 109.211 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -66.74 -16.51 64.29 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.419 -1.264 . . . . 0.33000000000000002 111.715 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -64.64 -42.32 95.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.841 -1.072 . . . . 1.52 112.343 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.31 119.42 56.39 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.574 -0.45 . . . . 0.42999999999999999 110.966 -175.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.445 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 1.1 Cg_endo -78.8 -1.92 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.839 2.359 . . . . 0.72999999999999998 113.239 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 96' ' ' GLY . 11.0 t -119.73 -42.46 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.838 0.351 . . . . 0.47999999999999998 110.408 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.68 38.87 22.84 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.717 -1.129 . . . . 0.33000000000000002 114.063 168.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.485 ' HG2' HG23 ' A' ' 164' ' ' THR . 45.9 mt-10 -83.86 113.02 20.65 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.969 0.89 . . . . 0.83999999999999997 109.606 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.683 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 23.6 m-85 -137.61 176.15 8.97 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.909 -1.496 . . . . 0.22 111.914 -170.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 82.7 m-85 -140.95 136.9 32.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.243 -0.435 . . . . 0.54000000000000004 110.603 -173.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.579 HD12 ' HB ' ' A' ' 161' ' ' THR . 81.6 mt -61.24 117.56 2.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.23 -0.895 . . . . 0.17000000000000001 110.816 172.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.586 HG21 ' HA ' ' A' ' 22' ' ' PHE . 20.8 pt -84.5 -35.43 10.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 112.766 0.654 . . . . 0.20999999999999999 112.766 -176.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.477 ' ND2' HG13 ' A' ' 101' ' ' ILE . 9.3 p30 178.82 179.18 0.41 Allowed 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.32 -1.363 . . . . 2.0299999999999998 107.32 -176.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.16 155.58 49.4 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.873 -0.731 . . . . 1.52 112.303 -174.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -128.21 100.69 5.94 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.048 -0.978 . . . . 0.58999999999999997 109.872 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.496 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 71.2 ttt180 -62.77 166.31 5.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.162 -0.926 . . . . 2.8199999999999998 110.693 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.512 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 18.1 m-80 -34.75 102.97 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 125.189 1.395 . . . . 0.34999999999999998 113.195 -155.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.512 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.8 Cg_endo . . . . . 0 N--CA 1.457 -0.627 0 C-N-CA 123.045 2.496 . . . . 0.47999999999999998 111.695 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.527 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.502 0 N-CA-C 117.177 2.288 . . . . 0.47999999999999998 117.177 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.496 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -165.4 158.41 16.02 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.204 -0.935 . . . . 0.28000000000000003 110.297 -175.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -138.54 98.1 3.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.241 -1.022 . . . . 0.48999999999999999 108.241 167.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 103' ' ' ARG . 2.4 mt -89.02 114.27 25.46 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.033 -0.728 . . . . 0.66000000000000003 109.033 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.418 ' C ' HG12 ' A' ' 101' ' ' ILE . 20.0 m -85.24 143.58 28.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.808 -0.633 . . . . 0.19 111.424 -169.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.794 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.9 mm? -108.3 166.4 10.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.13 111.7 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.0 t -60.52 -13.27 12.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.793 -1.094 . . . . 1.1699999999999999 112.816 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.683 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 4.9 tptm -126.27 130.27 50.54 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 120.492 -0.483 . . . . 1.22 110.138 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 52.9 mt-30 -34.44 -57.61 0.5 Allowed 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.548 1.155 . . . . 1.51 113.994 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.534 ' CB ' HG12 ' A' ' 89' ' ' ILE . 32.5 m-70 -88.91 -1.78 58.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.317 0.58 . . . . 2.5299999999999998 111.635 -171.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.794 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -91.31 38.16 0.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.523 0.934 . . . . 0.83999999999999997 113.523 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.62 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -112.97 145.08 18.19 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 117.222 -2.418 . . . . 0.32000000000000001 112.783 -152.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.528 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -98.69 116.32 41.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 123.739 0.816 . . . . 0.17999999999999999 110.833 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.637 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 27.5 p80 -145.62 171.15 15.12 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.229 -0.896 . . . . 0.20999999999999999 109.585 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.1 -168.62 39.19 Favored Glycine 0 C--N 1.316 -0.563 0 C-N-CA 120.107 -1.044 . . . . 0.27000000000000002 111.51 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -153.23 175.0 13.55 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.962 -0.728 . . . . 0.40999999999999998 110.27 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -116.79 0.41 12.52 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.61 -0.885 . . . . 1.99 108.61 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -118.9 86.75 31.74 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 114.928 -1.033 . . . . 1.3600000000000001 108.476 172.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -72.72 -17.52 25.91 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.293 1.996 . . . . 0.34999999999999998 113.283 -169.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.37 -1.1 35.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.968 -0.56 . . . . 0.33000000000000002 111.094 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.476 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 98.1 p -91.57 -6.8 51.78 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.983 -0.747 . . . . 1.3500000000000001 108.983 170.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 44.2 mm -80.49 136.42 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.54 -0.755 . . . . 0.20999999999999999 110.217 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.61 80.14 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.906 -1.277 . . . . 0.14999999999999999 109.906 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 5.7 tttt -111.67 161.64 16.05 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 122.952 1.358 . . . . 2.5 113.743 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -97.44 124.27 41.58 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 112.193 -2.276 . . . . 0.17000000000000001 107.659 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.442 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -120.74 160.86 21.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.894 -0.78 . . . . 0.66000000000000003 108.894 -173.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.9 m -51.5 -58.76 5.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.688 0.625 . . . . 0.42999999999999999 112.688 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -132.56 -43.32 0.92 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 118.329 -1.348 . . . . 2.02 113.555 -176.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.453 ' N ' ' HD3' ' A' ' 140' ' ' LYS . . . -31.5 133.23 0.14 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 116.958 1.543 . . . . 0.17999999999999999 116.958 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.7 p -74.5 164.84 26.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.489 -1.855 . . . . 0.16 111.571 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.876 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.0 mt -59.9 98.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 122.48 1.133 . . . . 0.40000000000000002 112.111 -162.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.637 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 79.9 mtt180 -84.33 151.66 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.601 -1.636 . . . . 1.8700000000000001 110.537 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.668 ' HG2' HG22 ' A' ' 84' ' ' ILE . 14.7 mtp -130.94 -166.57 1.71 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.799 -0.637 . . . . 0.79000000000000004 109.333 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.643 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 15.8 t-80 -97.81 152.89 18.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.825 -0.806 . . . . 2.3199999999999998 108.825 172.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.616 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.3 m120 -56.17 -53.39 57.63 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 118.247 -0.882 . . . . 0.68000000000000005 110.629 -175.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -64.66 -24.18 67.5 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 121.6 2.0 . . . . 2.1800000000000002 112.04 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.643 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 4.6 m-20 -81.59 -43.36 18.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.661 -0.7 . . . . 0.68999999999999995 110.818 -176.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.637 HG13 HD12 ' A' ' 151' ' ' ILE . 14.6 p -68.58 -23.03 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.731 -0.668 . . . . 0.11 111.297 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.637 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.68 -37.9 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 119.062 -0.494 . . . . 0.38 110.091 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 156' ' ' ILE . 9.3 mm-40 -45.09 -72.71 0.05 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.279 0.945 . . . . 1.99 112.022 167.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 157' ' ' VAL . 52.4 mt -46.81 -40.42 13.73 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 123.85 0.719 . . . . 1.27 111.479 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.73 -37.07 80.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.119 -1.4 . . . . 0.17999999999999999 111.758 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.0 t -88.16 -31.94 18.88 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.51 -0.744 . . . . 0.20999999999999999 112.506 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.2 mt -81.07 -59.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.561 0.695 . . . . 0.16 111.561 -172.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.1 m -89.38 142.96 30.11 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.871 -1.059 . . . . 0.16 112.097 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -90.72 175.03 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 124.015 3.143 . . . . 0.20000000000000001 110.939 172.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.416 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 37.1 m-20 -65.99 157.86 29.74 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.655 -0.818 . . . . 1.1000000000000001 109.078 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.35 -18.53 57.31 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.119 -1.038 . . . . 0.17999999999999999 112.423 -174.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' HD12 ' A' ' 100' ' ' ILE . 78.2 m -65.12 138.89 58.58 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.035 -0.728 . . . . 0.14000000000000001 109.035 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.622 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 11.3 ptm180 -92.44 127.25 37.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.741 1.258 . . . . 3.6299999999999999 111.211 -170.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.4 t -109.02 107.45 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 112.088 -2.324 . . . . 0.14000000000000001 108.631 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.485 HG23 ' HG2' ' A' ' 97' ' ' GLU . 13.8 m -94.35 104.72 16.7 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.49 0.552 . . . . 0.20999999999999999 112.49 -171.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.478 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -83.36 96.47 4.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 122.342 1.068 . . . . 0.23999999999999999 109.955 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -107.6 132.49 53.23 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.009 -1.451 . . . . 1.0900000000000001 109.215 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.58 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 19.2 mmm180 . . . . . 0 C--N 1.317 -0.809 0 N-CA-C 109.2 -0.667 . . . . 2.0800000000000001 109.2 174.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.289 0.566 . . . . 0.65000000000000002 111.392 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.667 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.0 tt -92.12 130.08 37.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.284 -0.871 . . . . 0.28000000000000003 110.445 -175.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.33 162.14 13.33 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.36 1.076 . . . . 0.31 113.239 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.64 ' O ' ' HA ' ' A' ' 45' ' ' SER . 72.0 t80 -131.96 142.25 49.56 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.294 -1.776 . . . . 0.44 107.89 175.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.491 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 33.8 tt0 -113.25 112.71 24.2 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.091 -1.078 . . . . 0.76000000000000001 108.091 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.632 HG13 ' HB2' ' A' ' 13' ' ' ASP . 96.1 t -66.67 151.35 10.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.364 1.078 . . . . 0.39000000000000001 112.74 -170.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -106.58 158.21 17.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.431 -1.713 . . . . 2.0099999999999998 108.372 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.23 107.68 0.51 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.782 0.325 . . . . 1.8300000000000001 111.819 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.77 46.23 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.857 -0.687 . . . . 0.47999999999999998 113.895 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.632 ' HB2' HG13 ' A' ' 9' ' ' VAL . 68.9 m-20 -54.46 170.16 0.16 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 117.181 0.49 . . . . 1.46 111.391 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -129.23 152.07 49.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.086 0.469 . . . . 0.40999999999999998 111.603 176.136 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.597 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.03 -36.37 83.07 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.044 -0.98 . . . . 0.85999999999999999 108.574 -177.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 4.5 t30 -87.62 -26.04 23.26 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.764 -1.107 . . . . 1.1499999999999999 110.552 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.423 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 13.0 t -66.05 -40.92 91.33 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.515 -0.55 . . . . 1.21 109.515 174.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.477 HG23 ' CE1' ' A' ' 22' ' ' PHE . 13.8 mt -73.86 -28.15 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.116 0.484 . . . . 0.20999999999999999 109.783 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.644 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.43 -11.37 59.91 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.699 -0.4 . . . . 0.16 110.896 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.723 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -93.12 -40.98 10.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.406 0.622 . . . . 0.20999999999999999 109.784 174.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.643 ' HB3' ' O ' ' A' ' 119' ' ' SER . 23.0 m-20 -63.42 -42.87 98.73 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.485 -1.234 . . . . 0.53000000000000003 111.922 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.532 ' HA ' HG21 ' A' ' 101' ' ' ILE . 47.8 m-85 -96.33 4.85 51.99 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 118.597 -1.241 . . . . 0.17999999999999999 111.112 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.723 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER 54.51 40.77 32.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.961 0.886 . . . . 1.78 109.418 176.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.644 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.6 pt -114.3 -165.52 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.102 -1.408 . . . . 0.19 109.86 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.48 142.91 41.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.205 -0.907 . . . . 0.94999999999999996 110.212 175.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.537 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 71.4 p -73.21 -32.72 64.95 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.057 -1.09 . . . . 0.25 108.057 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.7 -27.06 67.6 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.182 -0.917 . . . . 0.20000000000000001 111.796 170.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.95 -27.28 16.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.972 -0.751 . . . . 0.17000000000000001 108.972 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.653 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 17.8 tp -74.71 -26.2 59.65 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.298 -0.865 . . . . 1.1599999999999999 109.331 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 26' ' ' THR . 35.9 mt -77.31 -29.98 53.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.695 0.759 . . . . 1.05 110.076 171.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.479 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 4.7 tt0 -65.14 -41.63 94.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.393 -1.276 . . . . 1.8100000000000001 110.103 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.27 -20.67 31.8 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.937 -0.705 . . . . 0.20000000000000001 111.594 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.65 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.8 m-80 -147.15 80.67 9.25 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 121.615 0.721 . . . . 0.23000000000000001 110.693 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.8 Cg_endo -56.79 -14.89 14.87 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 C-N-CA 124.099 3.199 . . . . 0.35999999999999999 114.199 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.2 t -79.59 -20.9 45.79 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.809 -0.356 . . . . 1.3799999999999999 111.115 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.825 HD21 HG21 ' A' ' 46' ' ' ILE . 67.6 mt -65.31 -39.19 92.18 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.542 0.687 . . . . 0.48999999999999999 111.826 -172.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 5.9 pt20 -64.05 -44.59 91.98 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 122.88 1.324 . . . . 1.95 110.251 -174.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.05 -50.15 74.43 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 111.795 -2.457 . . . . 0.48999999999999999 110.439 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.23 175.16 46.97 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 114.779 -1.101 . . . . 0.41999999999999998 111.74 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -107.9 155.99 19.67 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.229 0.538 . . . . 0.40999999999999998 110.876 178.178 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.644 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 34.5 m -139.46 128.64 23.9 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.218 -0.901 . . . . 0.41999999999999998 110.513 -175.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 119.99 20.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.634 0.731 . . . . 0.46999999999999997 110.396 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.491 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 98.13 0.73 58.44 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 114.738 -1.119 . . . . 0.40999999999999998 110.325 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.644 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.2 tt0 -74.8 123.41 24.95 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.672 -0.764 . . . . 1.3 109.654 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 54.8 p -82.34 128.49 34.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.776 0.798 . . . . 0.84999999999999998 110.067 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.825 HG21 HD21 ' A' ' 36' ' ' LEU . 9.0 pt -128.52 142.35 44.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.306 -1.316 . . . . 0.25 109.477 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.77 151.27 3.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.208 0.527 . . . . 0.67000000000000004 111.019 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.1 mm -115.13 92.71 32.46 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 114.842 -1.072 . . . . 0.16 109.439 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.673 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.4 Cg_endo -58.46 134.89 64.13 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.812 2.341 . . . . 0.17999999999999999 112.693 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.03 -4.06 81.09 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 114.948 -1.023 . . . . 0.26000000000000001 112.405 -176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.696 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.7 tp -129.28 117.97 19.07 Favored Pre-proline 0 N--CA 1.446 -0.638 0 CA-C-O 121.223 0.535 . . . . 0.60999999999999999 111.341 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.685 ' HD2' HD12 ' A' ' 51' ' ' LEU . 55.5 Cg_endo -79.23 -177.96 4.27 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.585 2.857 . . . . 0.28000000000000003 114.155 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.613 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.4 t0 -80.72 126.64 77.55 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.513 -1.222 . . . . 0.48999999999999999 111.542 -171.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 60.5 Cg_endo -73.22 -16.73 24.92 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.204 2.603 . . . . 0.46000000000000002 112.459 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -89.22 -10.33 47.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.842 -0.617 . . . . 1.3799999999999999 110.438 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 53' ' ' ASP . 25.1 p -88.15 -23.35 23.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.535 1.159 . . . . 0.46000000000000002 108.427 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 59' ' ' TYR . 15.3 mt -72.94 129.51 86.42 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 112.973 -1.922 . . . . 0.69999999999999996 111.354 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.69 -19.73 14.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.336 2.024 . . . . 0.39000000000000001 113.386 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.512 ' H ' HG22 ' A' ' 57' ' ' ILE . 60.5 m-85 -91.91 158.68 16.16 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.546 -0.462 . . . . 0.23999999999999999 111.558 -176.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -148.77 129.87 14.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.026 -0.731 . . . . 2.8900000000000001 109.026 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.5 mt -111.38 130.96 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.946 -0.57 . . . . 0.16 111.609 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.96 119.88 38.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.001 -0.68 . . . . 0.16 111.028 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.85 116.42 41.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.446 0.641 . . . . 0.19 110.833 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 68' ' ' LYS . 69.0 m -95.81 104.27 16.2 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.011 -0.995 . . . . 0.20000000000000001 110.8 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.534 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.9 mm -51.64 -59.38 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.937 0.875 . . . . 0.23000000000000001 111.59 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.82 -11.94 4.72 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 113.051 -1.886 . . . . 0.16 113.18 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.18 -18.87 4.87 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.369 0.668 . . . . 0.14999999999999999 112.444 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HG2' ' C ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER 58.89 54.97 4.79 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.522 0.601 . . . . 0.68999999999999995 111.26 -173.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.5 p -136.77 160.99 37.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.811 0.671 . . . . 0.13 112.811 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 70' ' ' LEU . 8.1 tt -129.04 113.51 15.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.765 -1.107 . . . . 0.40000000000000002 110.044 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.699 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.4 m -93.77 123.67 37.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.976 0.417 . . . . 0.16 111.337 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.8 tp -98.78 104.92 17.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.58 -0.737 . . . . 0.58999999999999997 109.434 171.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.6 m -104.96 159.61 15.67 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.541 -0.863 . . . . 1.05 110.519 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -127.88 127.26 43.09 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.903 -0.777 . . . . 0.26000000000000001 108.903 168.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.558 ' N ' HD22 ' A' ' 74' ' ' LEU . 46.4 m-80 48.21 50.36 16.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.584 -1.189 . . . . 1.8400000000000001 111.076 -171.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 71.9 -10.03 0.91 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.755 0.822 . . . . 1.8899999999999999 111.662 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -96.43 120.52 36.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.067 -0.515 . . . . 3.4399999999999999 109.893 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 55.8 t -59.31 131.58 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-O 122.295 1.045 . . . . 0.23999999999999999 112.017 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 5.4 mtm -103.08 -43.85 5.37 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.342 -1.754 . . . . 0.81000000000000005 109.368 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -157.94 170.69 21.75 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.264 -1.789 . . . . 1.46 110.209 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 83.5 m -149.38 128.03 12.41 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.129 -1.396 . . . . 0.17000000000000001 109.517 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -115.94 147.46 39.22 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 116.243 -0.435 . . . . 1.05 110.729 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HB2' HG22 ' A' ' 134' ' ' ILE . 36.8 Cg_endo -71.86 144.33 43.16 Favored 'Trans proline' 0 CA--C 1.491 -1.645 0 C-N-CA 122.333 2.022 . . . . 0.20000000000000001 110.284 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.595 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.3 pp -139.34 166.33 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-N 115.902 -0.59 . . . . 0.13 110.797 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.819 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -112.85 128.17 56.38 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.732 -0.84 . . . . 0.26000000000000001 108.732 -176.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.413 HG12 ' HD2' ' A' ' 68' ' ' LYS . 1.7 p -124.15 130.93 73.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 114.076 -1.42 . . . . 0.56000000000000005 111.168 -162.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -96.03 151.05 19.82 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.277 -1.329 . . . . 0.17000000000000001 111.896 -175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 139' ' ' SER . 45.7 mmtm -57.71 2.7 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.525 -0.838 . . . . 3.0499999999999998 113.145 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.882 HG23 HD22 ' A' ' 90' ' ' LEU . 1.6 tp -89.79 -19.65 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.725 0.774 . . . . 0.23000000000000001 110.27 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.882 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -88.4 -11.56 45.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.396 -0.82 . . . . 0.17999999999999999 109.431 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -70.11 -16.53 63.13 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.952 -1.022 . . . . 0.33000000000000002 111.55 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -71.83 -27.33 62.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.8 -1.091 . . . . 1.52 112.972 -172.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.8 130.7 22.64 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 119.976 -0.69 . . . . 0.42999999999999999 110.771 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.46 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 89.9 Cg_endo -88.48 -2.24 6.74 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.707 2.271 . . . . 0.72999999999999998 112.357 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 96' ' ' GLY . 13.6 t -122.99 -41.83 2.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.884 -0.598 . . . . 0.47999999999999998 109.634 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 47.16 42.79 17.47 Favored Glycine 0 N--CA 1.45 -0.377 0 O-C-N 123.832 0.708 . . . . 0.33000000000000002 113.89 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.84 112.64 20.72 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.729 0.776 . . . . 0.83999999999999997 109.484 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.756 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 25.2 m-85 -137.06 177.76 7.61 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.158 -1.383 . . . . 0.22 111.985 -170.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.491 ' CG ' HD11 ' A' ' 5' ' ' LEU . 21.2 m-85 -140.4 143.05 35.46 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.54000000000000004 110.521 -174.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.599 HD12 ' HB ' ' A' ' 161' ' ' THR . 76.6 mt -66.98 113.72 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 115.488 -0.778 . . . . 0.17000000000000001 110.132 169.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.559 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 26.0 pt -84.33 -34.25 9.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 112.967 0.728 . . . . 0.20999999999999999 112.967 -175.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.501 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 10.0 p30 179.97 177.79 0.63 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.488 -1.301 . . . . 2.0299999999999998 107.488 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.456 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.11 153.81 50.44 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.177 -0.609 . . . . 1.52 111.959 -175.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -125.38 100.97 6.74 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.097 -0.956 . . . . 0.58999999999999997 109.655 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.491 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 34.1 ttp180 -60.85 166.33 3.46 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.151 -0.931 . . . . 2.8199999999999998 110.59 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.491 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 20.6 m-80 -34.86 102.33 0.22 Allowed Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 124.997 1.319 . . . . 0.34999999999999998 113.33 -155.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 8.6 Cg_endo . . . . . 0 N--CA 1.457 -0.656 0 C-N-CA 123.075 2.517 . . . . 0.47999999999999998 111.365 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.515 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.493 0 N-CA-C 117.216 2.302 . . . . 0.47999999999999998 117.216 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.465 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -165.69 164.76 18.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.426 -0.796 . . . . 0.28000000000000003 109.929 -177.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -145.09 96.72 2.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.054 -1.091 . . . . 0.48999999999999999 108.054 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.528 HD12 HG23 ' A' ' 150' ' ' VAL . 2.0 mt -87.28 114.12 23.6 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.24 -0.652 . . . . 0.66000000000000003 109.24 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 101' ' ' ILE . 27.1 m -83.48 143.89 29.93 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.684 -0.689 . . . . 0.19 111.044 -170.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.797 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -108.99 165.26 11.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.032 -0.531 . . . . 0.13 110.789 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.643 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 8.8 m -64.73 -1.8 2.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.171 0.804 . . . . 1.1699999999999999 113.171 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.757 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 3.6 tmtm? -129.71 132.19 46.56 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.958 -0.386 . . . . 1.22 109.958 167.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.757 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 55.5 mt-30 -33.27 -57.97 0.4 Allowed 'General case' 0 C--N 1.309 -1.17 0 O-C-N 124.692 1.245 . . . . 1.51 114.324 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.621 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -94.51 5.04 53.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.315 0.578 . . . . 2.5299999999999998 111.423 -170.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.797 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -94.8 37.42 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.504 0.927 . . . . 0.83999999999999997 113.504 -174.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.598 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -113.23 144.2 18.02 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 116.963 -2.542 . . . . 0.32000000000000001 112.749 -152.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.518 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -96.79 115.13 35.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.895 0.855 . . . . 0.17999999999999999 110.644 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.734 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.9 p80 -144.96 173.48 11.84 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.262 -0.881 . . . . 0.20999999999999999 109.648 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.26 -168.03 38.73 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.252 -0.975 . . . . 0.27000000000000002 111.57 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.2 t -155.01 172.06 18.73 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.942 -0.74 . . . . 0.40999999999999998 110.756 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -114.08 -2.06 13.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.961 0.886 . . . . 1.99 108.652 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -115.92 86.55 16.65 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 114.754 -1.112 . . . . 1.3600000000000001 108.09 170.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -73.3 -19.47 22.3 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.225 1.95 . . . . 0.34999999999999998 113.191 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.27 -2.72 42.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.788 -0.642 . . . . 0.33000000000000002 110.869 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 33.4 t -90.25 -6.79 54.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.275 -0.639 . . . . 1.3500000000000001 109.275 171.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.421 HG22 ' HB2' ' A' ' 83' ' ' PRO . 38.2 mm -78.6 132.48 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.855 -0.611 . . . . 0.20999999999999999 111.209 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.61 1.84 63.65 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.109 -1.196 . . . . 0.14999999999999999 110.109 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.522 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 23.9 mttp -112.44 169.96 8.51 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 122.798 1.285 . . . . 2.5 114.047 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.17 126.56 44.98 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.317 -2.22 . . . . 0.17000000000000001 108.248 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.56 158.66 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.473 -0.936 . . . . 0.66000000000000003 108.473 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 49.4 m -51.46 -59.29 4.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.286 0.476 . . . . 0.42999999999999999 112.286 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -131.17 -44.59 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.628 -1.229 . . . . 2.02 113.813 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.29 133.58 0.19 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 116.999 1.56 . . . . 0.17999999999999999 116.999 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.8 p -73.23 166.06 23.86 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.519 -1.84 . . . . 0.16 112.13 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.819 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 44.7 mt -59.75 96.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 122.406 1.098 . . . . 0.40000000000000002 112.027 -163.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.734 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 79.1 mtt180 -86.08 146.75 26.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.53 -1.668 . . . . 1.8700000000000001 110.724 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.595 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.1 mtp -126.45 -164.82 1.37 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.901 -0.777 . . . . 0.79000000000000004 108.901 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.467 ' O ' HG12 ' A' ' 150' ' ' VAL . 41.5 m80 -91.53 162.9 14.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.575 -0.528 . . . . 2.3199999999999998 109.575 169.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.644 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.2 m120 -62.03 -49.92 74.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 118.537 -0.745 . . . . 0.68000000000000005 110.007 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -63.81 -28.27 69.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 121.021 1.737 . . . . 2.1800000000000002 112.106 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -78.1 -46.46 20.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.157 0.503 . . . . 0.68999999999999995 110.401 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.675 HG13 HD12 ' A' ' 151' ' ' ILE . 13.4 p -67.11 -23.21 30.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.248 -0.887 . . . . 0.11 111.62 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.675 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -84.27 -42.63 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 118.764 -0.636 . . . . 0.38 110.409 172.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 156' ' ' ILE . 24.9 mt-10 -47.98 -68.69 0.16 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 119.514 1.052 . . . . 1.99 112.467 171.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.506 ' O ' HG22 ' A' ' 157' ' ' VAL . 27.4 mt -47.6 -39.89 17.96 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.638 0.732 . . . . 1.27 111.463 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.33 72.09 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.156 -1.384 . . . . 0.17999999999999999 111.57 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 24.6 t -88.37 -32.07 18.57 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.573 -0.704 . . . . 0.20999999999999999 112.523 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.8 mt -82.01 -59.93 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.673 0.749 . . . . 0.16 111.506 -172.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.9 m -90.42 143.79 29.85 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 114.739 -1.119 . . . . 0.16 111.918 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -90.98 175.21 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 124.174 3.249 . . . . 0.20000000000000001 111.136 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 73.4 m-20 -66.8 157.24 33.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 119.668 -0.813 . . . . 1.1000000000000001 109.196 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.16 -24.29 32.46 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.042 -1.075 . . . . 0.17999999999999999 112.154 -172.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.599 ' HB ' HD12 ' A' ' 100' ' ' ILE . 84.6 m -60.35 132.07 52.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.675 -0.861 . . . . 0.14000000000000001 108.675 -176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.634 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -93.59 128.98 39.99 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 122.581 1.182 . . . . 3.6299999999999999 111.012 -166.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.24 110.77 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 112.337 -2.21 . . . . 0.14000000000000001 109.706 -173.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -94.79 108.89 20.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.045 -0.525 . . . . 0.20999999999999999 112.172 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.457 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -82.51 100.68 6.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 122.51 1.148 . . . . 0.23999999999999999 109.687 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -104.33 129.92 52.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 113.688 -1.597 . . . . 1.0900000000000001 108.749 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.534 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 16.1 mmm180 . . . . . 0 C--N 1.321 -0.674 0 CA-C-O 120.995 0.426 . . . . 2.0800000000000001 110.029 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 121.247 0.546 . . . . 0.65000000000000002 111.307 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.3 tt -94.54 127.52 40.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.222 -0.899 . . . . 0.28000000000000003 110.437 -174.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 162.64 13.33 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.265 1.031 . . . . 0.31 113.347 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.608 ' HB3' HG13 ' A' ' 46' ' ' ILE . 87.4 t80 -130.82 140.77 50.29 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.622 -1.626 . . . . 0.44 107.876 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.424 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 58.7 tt0 -114.03 113.46 24.8 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.353 -0.98 . . . . 0.76000000000000001 108.353 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.599 HG13 ' HB2' ' A' ' 13' ' ' ASP . 96.7 t -67.88 150.89 10.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.553 1.168 . . . . 0.39000000000000001 113.325 -168.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -105.43 158.58 16.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.096 -1.866 . . . . 2.0099999999999998 108.211 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -63.42 104.69 0.65 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.416 0.524 . . . . 1.8300000000000001 112.416 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.87 10.7 27.91 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.885 -0.674 . . . . 0.47999999999999998 113.203 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.599 ' HB2' HG13 ' A' ' 9' ' ' VAL . 82.1 m-20 -54.94 167.53 0.38 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.871 0.367 . . . . 1.46 111.172 172.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.78 153.1 46.03 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.485 0.66 . . . . 0.40999999999999998 111.419 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.588 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.26 -34.88 79.0 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.466 -0.939 . . . . 0.85999999999999999 108.466 -179.211 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.451 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 32.6 t-20 -88.8 -25.87 22.0 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.878 -1.056 . . . . 1.1499999999999999 111.098 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p -66.99 -41.02 87.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 119.866 -0.734 . . . . 1.21 109.402 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.412 HG23 ' CE1' ' A' ' 22' ' ' PHE . 16.8 mt -72.82 -26.63 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.285 0.564 . . . . 0.20999999999999999 109.747 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.628 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.34 -9.94 59.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.374 -0.375 . . . . 0.16 111.199 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.646 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.43 -39.08 9.76 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.683 1.23 . . . . 0.20999999999999999 107.911 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.777 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 7.8 m-20 -63.96 -46.42 84.72 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.097 -2.319 . . . . 0.53000000000000003 112.239 173.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 58.5 m-85 -95.92 5.91 50.12 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 118.58 -1.248 . . . . 0.17999999999999999 111.183 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.646 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 6.0 mpt_? 54.06 43.12 31.2 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.82 0.819 . . . . 1.78 109.69 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.628 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.1 pt -116.78 -165.78 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 114.521 -1.218 . . . . 0.19 110.121 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.49 142.57 40.34 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.912 -1.04 . . . . 0.94999999999999996 110.067 175.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.563 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 66.9 p -73.11 -31.62 64.44 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.089 -1.078 . . . . 0.25 108.089 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 -29.79 69.99 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.314 -0.857 . . . . 0.20000000000000001 111.64 169.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.75 -26.83 18.4 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.991 -0.744 . . . . 0.17000000000000001 108.991 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.616 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.5 tp -74.9 -27.28 60.16 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.198 -0.91 . . . . 1.1599999999999999 109.528 173.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 26' ' ' THR . 32.3 mt -76.98 -30.84 56.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.745 0.784 . . . . 1.05 109.822 171.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 27.6 tt0 -62.92 -43.32 99.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.374 -1.284 . . . . 1.8100000000000001 109.867 173.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.62 -20.08 34.33 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.072 -0.651 . . . . 0.20000000000000001 111.716 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.638 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 30.0 m-80 -146.62 81.76 9.11 Favored Pre-proline 0 N--CA 1.449 -0.485 0 CA-C-O 121.578 0.704 . . . . 0.23000000000000001 110.932 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 20.4 Cg_endo -58.24 -9.94 7.45 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 124.26 3.306 . . . . 0.35999999999999999 113.971 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 t -79.16 -24.92 42.95 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.175 -0.328 . . . . 1.3799999999999999 110.83 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.829 HD21 HG21 ' A' ' 46' ' ' ILE . 45.0 mt -67.11 -35.46 79.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.425 0.631 . . . . 0.48999999999999999 111.913 -170.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.428 ' NE2' ' HB2' ' A' ' 38' ' ' ALA . 1.6 pp0? -63.02 -46.05 89.42 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 122.96 1.362 . . . . 1.95 110.147 -174.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.428 ' HB2' ' NE2' ' A' ' 37' ' ' GLN . . . -64.9 -47.42 77.86 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 111.554 -2.566 . . . . 0.48999999999999999 110.749 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.33 177.86 48.49 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.246 -0.888 . . . . 0.41999999999999998 111.858 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.99 157.77 22.04 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.322 0.582 . . . . 0.40999999999999998 110.786 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 43.2 m -141.6 130.07 22.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.252 -0.886 . . . . 0.41999999999999998 110.336 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.43 120.37 20.78 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 119.956 -0.698 . . . . 0.46999999999999997 109.518 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.424 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 98.66 1.38 57.6 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.331 -1.108 . . . . 0.40999999999999998 110.331 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.603 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -75.9 126.19 30.54 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.14 -0.689 . . . . 1.3 109.14 177.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 16.1 m -88.87 127.58 35.64 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.789 0.804 . . . . 0.84999999999999998 109.987 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.829 HG21 HD21 ' A' ' 36' ' ' LEU . 7.5 pt -127.07 142.72 42.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.246 -1.343 . . . . 0.25 109.565 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.18 153.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.073 0.463 . . . . 0.67000000000000004 111.141 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.2 mm -116.93 92.5 39.07 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.836 -1.075 . . . . 0.16 109.152 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.1 Cg_endo -58.47 136.15 72.38 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.953 2.436 . . . . 0.17999999999999999 112.723 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.49 -6.02 83.48 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.116 -0.947 . . . . 0.26000000000000001 112.19 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.768 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.1 tp -123.91 114.03 28.24 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-O 121.35 0.595 . . . . 0.60999999999999999 111.232 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.683 ' HD2' HD12 ' A' ' 51' ' ' LEU . 50.0 Cg_endo -78.11 -176.88 3.48 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.713 2.942 . . . . 0.28000000000000003 113.965 -171.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.557 ' HB3' HG23 ' A' ' 56' ' ' THR . 14.8 t70 -80.46 129.7 67.98 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 114.656 -1.156 . . . . 0.48999999999999999 112.007 -171.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.588 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.4 Cg_endo -76.5 -13.58 18.32 Favored 'Trans proline' 0 CA--C 1.518 -0.295 0 C-N-CA 123.632 2.888 . . . . 0.46000000000000002 112.881 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.443 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 18.1 m-30 -93.48 -9.59 37.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.663 -0.699 . . . . 1.3799999999999999 110.037 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.557 HG23 ' HB3' ' A' ' 53' ' ' ASP . 29.5 p -87.96 -25.52 23.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.61 1.195 . . . . 0.46000000000000002 108.183 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.55 HG22 ' H ' ' A' ' 59' ' ' TYR . 33.4 mt -67.79 129.18 93.41 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 112.988 -1.914 . . . . 0.69999999999999996 111.553 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.25 -19.64 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.571 2.181 . . . . 0.39000000000000001 113.557 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.55 ' H ' HG22 ' A' ' 57' ' ' ILE . 58.6 m-85 -98.17 163.31 12.79 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.29 -0.564 . . . . 0.23999999999999999 112.134 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -150.91 131.69 14.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.188 -0.915 . . . . 2.8900000000000001 108.858 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.689 ' HA ' ' O ' ' A' ' 71' ' ' THR . 96.9 mt -112.9 131.75 63.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.384 -0.371 . . . . 0.16 111.844 -176.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.39 117.62 31.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 120.044 -0.663 . . . . 0.16 110.975 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.453 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 64.4 t -95.82 119.72 44.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.62 0.724 . . . . 0.19 110.681 175.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.473 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 38.5 m -96.66 107.63 20.11 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.004 -0.998 . . . . 0.20000000000000001 110.689 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.583 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 38.6 mm -54.01 -59.33 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 122.187 0.994 . . . . 0.23000000000000001 111.074 165.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.7 -12.77 7.01 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 112.72 -2.036 . . . . 0.16 113.379 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.34 -17.27 5.21 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.161 0.584 . . . . 0.14999999999999999 112.548 -178.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.548 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.41 55.52 5.7 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.703 0.683 . . . . 0.68999999999999995 111.419 -174.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.8 p -137.59 163.7 30.56 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 113.09 0.774 . . . . 0.13 113.09 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 81' ' ' THR . 8.0 tt -127.78 115.42 18.63 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.51 -1.223 . . . . 0.40000000000000002 109.443 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.689 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 48.0 m -95.53 119.63 34.37 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.304 0.573 . . . . 0.16 111.313 177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 79' ' ' MET . 0.5 OUTLIER -92.32 103.83 16.24 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.726 -1.212 . . . . 0.58999999999999997 107.726 174.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.6 m -106.8 158.32 17.08 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 118.924 -1.111 . . . . 1.05 111.371 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.606 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -127.96 124.63 37.76 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.462 0.648 . . . . 0.26000000000000001 109.622 170.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.606 ' N ' HD22 ' A' ' 74' ' ' LEU . 8.7 p30 30.97 68.07 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 113.918 -1.492 . . . . 1.8400000000000001 112.804 -166.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 72.09 -9.41 1.0 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.034 -0.984 . . . . 1.8899999999999999 112.887 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -107.58 120.3 41.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.148 0.499 . . . . 3.4399999999999999 110.776 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 41.9 t -55.64 131.91 19.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.618 1.199 . . . . 0.23999999999999999 112.862 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.614 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 22.4 mmm -97.56 -46.86 5.87 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 112.816 -1.993 . . . . 0.81000000000000005 108.538 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.673 ' HG2' ' CZ ' ' A' ' 82' ' ' TYR . 2.3 tptm -157.39 174.41 15.45 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.277 -1.783 . . . . 1.46 110.5 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 55.3 m -150.2 123.93 9.19 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.498 -1.683 . . . . 0.17000000000000001 109.575 168.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.673 ' CZ ' ' HG2' ' A' ' 80' ' ' LYS . 29.9 m-85 -115.46 152.18 46.79 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.996 -0.547 . . . . 1.05 110.163 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HB2' HG22 ' A' ' 134' ' ' ILE . 55.2 Cg_endo -76.06 144.03 26.46 Favored 'Trans proline' 0 CA--C 1.496 -1.414 0 C-N-CA 122.003 1.802 . . . . 0.20000000000000001 110.981 176.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.668 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -141.31 172.62 10.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.685 -0.689 . . . . 0.13 110.496 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.953 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -116.87 140.41 49.48 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.852 -0.339 . . . . 0.26000000000000001 110.215 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 68' ' ' LYS . 12.9 m -124.02 126.08 71.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.618 0.723 . . . . 0.56000000000000005 111.702 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.77 157.03 29.42 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 114.954 -1.021 . . . . 0.17000000000000001 110.621 173.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 139' ' ' SER . 27.6 mtpp -57.13 3.6 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.013 0.745 . . . . 3.0499999999999998 113.013 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.927 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -89.12 -20.72 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 O-C-N 121.467 -0.771 . . . . 0.23000000000000001 109.821 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.927 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -88.78 -21.62 23.69 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.545 -0.909 . . . . 0.17999999999999999 108.545 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.2 p -69.17 -13.32 62.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.209 -1.36 . . . . 0.33000000000000002 111.297 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -66.51 -42.95 86.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.103 -0.953 . . . . 1.52 112.225 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.41 134.12 22.99 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.378 -0.529 . . . . 0.42999999999999999 110.49 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.574 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 93.9 Cg_endo -86.44 -6.58 8.01 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.452 2.101 . . . . 0.72999999999999998 112.307 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -123.92 -38.71 2.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.55 . . . . 0.47999999999999998 110.317 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.442 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 44.98 46.22 9.42 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 124.165 0.915 . . . . 0.33000000000000002 114.131 171.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.73 112.91 20.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.741 0.781 . . . . 0.83999999999999997 109.874 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 17.5 m-85 -137.7 174.21 10.83 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.355 -1.293 . . . . 0.22 112.86 -170.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.479 ' CE2' ' HB3' ' A' ' 162' ' ' ARG . 37.4 m-85 -141.99 137.31 31.08 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.589 -0.732 . . . . 0.54000000000000004 110.527 -175.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.576 HD12 ' HB ' ' A' ' 161' ' ' THR . 84.9 mt -61.33 123.88 14.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.779 -0.646 . . . . 0.17000000000000001 110.444 171.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 17.7 pt -87.44 -43.75 15.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 112.637 0.606 . . . . 0.20999999999999999 112.637 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 55.3 m-80 -172.1 176.09 3.57 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 106.72 -1.585 . . . . 2.0299999999999998 106.72 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.607 ' HB3' HD23 ' A' ' 116' ' ' LEU . 5.2 mtt180 -133.01 155.96 48.21 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.878 -0.729 . . . . 1.52 112.122 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 49.3 tt0 -129.31 99.86 5.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.218 -0.901 . . . . 0.58999999999999997 109.538 172.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.483 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 20.7 ttt180 -66.33 166.26 12.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.427 -0.806 . . . . 2.8199999999999998 110.504 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.513 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 23.5 m-80 -35.27 104.9 0.27 Allowed Pre-proline 0 C--O 1.234 0.247 0 C-N-CA 125.198 1.399 . . . . 0.34999999999999998 113.605 -156.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.8 Cg_endo . . . . . 0 N--CA 1.459 -0.534 0 C-N-CA 122.847 2.365 . . . . 0.47999999999999998 111.215 170.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.566 1.575 0 N-CA-C 117.392 2.367 . . . . 0.47999999999999998 117.392 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.457 ' CD2' HG13 ' A' ' 151' ' ' ILE . 0.4 OUTLIER -166.01 154.14 10.76 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.243 -0.91 . . . . 0.28000000000000003 110.549 -175.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.405 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.4 t-105 -134.23 98.59 4.15 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.064 -1.087 . . . . 0.48999999999999999 108.064 167.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 103' ' ' ARG . 4.5 mt -89.6 114.11 25.64 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.017 -0.735 . . . . 0.66000000000000003 109.017 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.7 m -84.46 144.27 28.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.76 -0.654 . . . . 0.19 111.385 -167.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.789 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.5 mm? -108.84 171.61 7.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.13 110.625 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.63 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.5 OUTLIER -63.14 -13.84 41.56 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.93 0.715 . . . . 1.1699999999999999 112.93 -179.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.777 ' HD3' ' OD1' ' A' ' 21' ' ' ASP . 5.3 tppp? -126.3 132.29 51.68 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.094 0.473 . . . . 1.22 110.828 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.512 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 56.3 mt-30 -33.29 -57.42 0.41 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.907 -1.497 . . . . 1.51 114.308 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.567 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -99.74 12.13 37.42 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.569 -0.852 . . . . 2.5299999999999998 111.547 -172.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.789 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.1 m-85 -96.33 37.5 1.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.857 0.688 . . . . 0.83999999999999997 112.857 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.678 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -117.04 144.2 18.32 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 117.328 -2.367 . . . . 0.32000000000000001 112.649 -152.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -95.57 114.53 32.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.754 0.788 . . . . 0.17999999999999999 110.778 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.558 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 27.5 p80 -143.34 171.97 13.39 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.389 -0.823 . . . . 0.20999999999999999 109.372 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.98 -169.4 38.08 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 119.847 -1.168 . . . . 0.27000000000000002 112.067 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -154.13 172.64 17.22 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.472 -0.428 . . . . 0.40999999999999998 110.009 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -113.0 -2.52 14.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.442 -0.947 . . . . 1.99 108.442 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -115.71 88.17 19.76 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.004 -0.998 . . . . 1.3600000000000001 108.532 170.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.419 ' HA ' HG12 ' A' ' 134' ' ' ILE . 21.5 Cg_endo -72.74 -16.87 26.37 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.248 1.965 . . . . 0.34999999999999998 112.779 -171.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.41 -0.61 33.58 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.546 -0.752 . . . . 0.33000000000000002 111.215 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.0 p -93.42 -6.45 47.04 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.134 -0.691 . . . . 1.3500000000000001 109.134 169.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' A' ' 83' ' ' PRO . 42.5 mm -81.18 130.78 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.255 -0.884 . . . . 0.20999999999999999 110.627 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.73 2.58 59.76 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 109.944 -1.263 . . . . 0.14999999999999999 109.944 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.434 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 23.3 mttp -114.81 170.57 8.23 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 123.146 1.45 . . . . 2.5 114.431 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.43 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -101.91 127.66 48.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 111.887 -2.415 . . . . 0.17000000000000001 108.006 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.418 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -123.23 162.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.643 -0.873 . . . . 0.66000000000000003 108.643 -176.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 58.7 m -52.18 -59.38 4.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.471 0.545 . . . . 0.42999999999999999 112.471 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.93 -45.57 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 118.766 -1.174 . . . . 2.02 113.726 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.83 133.54 0.16 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 116.955 1.542 . . . . 0.17999999999999999 116.955 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.546 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.2 p -73.85 166.65 22.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 112.606 -1.797 . . . . 0.16 112.066 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.953 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 54.0 mt -59.87 97.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 122.468 1.127 . . . . 0.40000000000000002 112.034 -163.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.558 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 34.3 mtt180 -84.12 152.98 24.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.694 -1.594 . . . . 1.8700000000000001 110.054 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.668 ' HG2' HG22 ' A' ' 84' ' ' ILE . 11.1 mtp -133.26 -165.88 1.68 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.545 -0.539 . . . . 0.79000000000000004 109.545 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.619 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 24.8 t-80 -97.54 151.3 20.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.569 -0.741 . . . . 2.3199999999999998 109.181 173.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.633 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.3 m120 -55.35 -53.52 55.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 118.132 -0.937 . . . . 0.68000000000000005 111.043 -174.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -62.28 -28.23 69.57 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 121.592 1.996 . . . . 2.1800000000000002 111.827 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.619 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 3.5 m-20 -78.23 -44.36 25.8 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.773 -0.649 . . . . 0.68999999999999995 110.903 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.606 HG13 HD12 ' A' ' 151' ' ' ILE . 14.2 p -67.27 -21.78 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.598 -0.728 . . . . 0.11 111.342 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.633 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.86 -42.37 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 119.124 -0.465 . . . . 0.38 110.069 171.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.412 ' O ' HG13 ' A' ' 156' ' ' ILE . 31.2 mt-10 -46.84 -71.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.904 0.774 . . . . 1.99 112.87 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.558 ' O ' HG22 ' A' ' 157' ' ' VAL . 11.5 mt -43.54 -43.85 5.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.702 0.763 . . . . 1.27 110.61 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.19 -37.35 74.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.701 -1.591 . . . . 0.17999999999999999 111.722 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.3 t -85.94 -32.28 21.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.678 0.672 . . . . 0.20999999999999999 112.032 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 152' ' ' GLU . 52.0 mt -81.13 -59.87 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.561 0.696 . . . . 0.16 111.408 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.6 m -88.61 144.77 33.99 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 114.76 -1.109 . . . . 0.16 111.728 175.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -91.63 177.21 1.89 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 124.09 3.193 . . . . 0.20000000000000001 111.266 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.506 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 61.0 m-20 -67.13 159.46 28.84 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.532 -0.867 . . . . 1.1000000000000001 109.339 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.588 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 94.84 -19.63 52.95 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.213 -0.994 . . . . 0.17999999999999999 112.125 -174.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.576 ' HB ' HD12 ' A' ' 100' ' ' ILE . 87.0 m -60.62 137.72 58.14 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.472 -0.566 . . . . 0.14000000000000001 109.472 -175.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.479 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 1.9 ptt180 -92.05 116.4 28.9 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.769 1.271 . . . . 3.6299999999999999 110.51 -168.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.5 t -107.42 107.05 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 112.056 -2.338 . . . . 0.14000000000000001 109.158 -175.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.0 m -94.74 109.92 21.82 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.038 -0.528 . . . . 0.20999999999999999 112.148 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 2.4 mp -82.65 95.07 3.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 122.47 1.129 . . . . 0.23999999999999999 109.694 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -101.58 136.57 41.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.607 -1.633 . . . . 1.0900000000000001 108.879 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.583 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 5.8 mmt85 . . . . . 0 C--N 1.317 -0.84 0 N-CA-C 109.446 -0.576 . . . . 2.0800000000000001 109.446 176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.192 0.52 . . . . 0.65000000000000002 110.988 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.615 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.2 tt -95.47 126.26 40.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.529 -0.76 . . . . 0.28000000000000003 110.338 -174.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.68 161.68 13.93 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.787 -1.097 . . . . 0.31 112.511 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.646 ' O ' ' HA ' ' A' ' 45' ' ' SER . 80.8 t80 -129.34 140.98 51.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.152 -1.386 . . . . 0.44 107.987 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -112.92 112.74 24.43 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.936 -1.135 . . . . 0.76000000000000001 107.936 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 13' ' ' ASP . 99.6 t -65.37 148.16 12.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 122.556 1.17 . . . . 0.39000000000000001 112.372 -170.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -106.29 158.16 17.07 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.287 -1.779 . . . . 2.0099999999999998 108.184 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -59.65 111.96 1.63 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.952 0.406 . . . . 1.8300000000000001 111.786 -173.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.53 54.13 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.744 -0.662 . . . . 0.47999999999999998 113.827 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.592 ' HB2' HG13 ' A' ' 9' ' ' VAL . 91.8 m-20 -55.61 168.2 0.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.198 0.499 . . . . 1.46 111.255 172.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.82 151.85 47.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.858 0.361 . . . . 0.40999999999999998 110.95 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.528 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.56 -40.53 97.24 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.097 -1.075 . . . . 0.85999999999999999 108.097 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.436 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 64.4 t30 -84.21 -22.65 30.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.353 -1.294 . . . . 1.1499999999999999 110.434 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -65.09 -45.3 85.81 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.958 -0.756 . . . . 1.21 108.958 171.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.435 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 15.4 mt -72.52 -27.06 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.201 0.524 . . . . 0.20999999999999999 109.84 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.655 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.27 -10.56 59.76 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.481 -0.327 . . . . 0.16 110.912 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.652 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.5 -39.63 9.06 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 122.669 1.223 . . . . 0.20999999999999999 108.092 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.623 ' HB3' ' O ' ' A' ' 119' ' ' SER . 8.8 m-20 -62.46 -46.01 90.46 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 112.293 -2.23 . . . . 0.53000000000000003 111.904 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.607 ' HA ' HG21 ' A' ' 101' ' ' ILE . 55.3 m-85 -95.83 5.68 50.72 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 118.81 -1.156 . . . . 0.17999999999999999 111.551 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.652 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.1 mpt_? 54.13 43.33 30.83 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.758 0.79 . . . . 1.78 109.838 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.5 pt -118.34 -165.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 114.442 -1.254 . . . . 0.19 109.799 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.7 142.73 42.22 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.156 -0.929 . . . . 0.94999999999999996 110.429 174.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.581 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 82.3 p -71.01 -33.34 70.29 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.198 -1.038 . . . . 0.25 108.198 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.91 69.27 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.373 -0.831 . . . . 0.20000000000000001 112.008 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.42 -27.76 16.53 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.914 -0.773 . . . . 0.17000000000000001 108.914 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.607 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -73.95 -28.86 61.7 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.956 -1.02 . . . . 1.1599999999999999 109.113 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 26' ' ' THR . 40.5 mt -76.1 -31.66 58.81 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.659 0.742 . . . . 1.05 110.071 171.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 5.5 tt0 -63.78 -37.57 87.85 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.335 -1.302 . . . . 1.8100000000000001 110.084 174.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.442 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -85.97 -20.35 29.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 120.001 -0.68 . . . . 0.20000000000000001 111.679 176.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.635 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.7 m-80 -149.78 83.08 6.41 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-O 121.194 0.521 . . . . 0.23000000000000001 110.751 -172.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.2 Cg_endo -56.26 -15.46 14.75 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 123.927 3.085 . . . . 0.35999999999999999 113.834 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -73.2 -25.12 60.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.684 0.278 . . . . 1.3799999999999999 111.31 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.891 HD21 HG21 ' A' ' 46' ' ' ILE . 29.7 mt -67.88 -39.84 83.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.324 0.583 . . . . 0.48999999999999999 112.397 -170.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -63.6 -44.79 92.96 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.933 1.349 . . . . 1.95 110.275 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.16 82.63 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 111.691 -2.504 . . . . 0.48999999999999999 110.614 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.06 176.55 48.01 Favored Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 115.048 -0.978 . . . . 0.41999999999999998 111.951 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.03 157.69 19.05 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.163 0.506 . . . . 0.40999999999999998 110.791 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.594 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 49.9 m -141.39 127.93 20.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.33 -0.85 . . . . 0.41999999999999998 110.222 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -76.45 117.21 17.87 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.492 0.663 . . . . 0.46999999999999997 109.986 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.66 -0.12 49.26 Favored Glycine 0 N--CA 1.429 -1.818 0 CA-C-N 114.775 -1.102 . . . . 0.40999999999999998 110.389 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.594 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -75.14 124.69 27.47 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.921 -0.639 . . . . 1.3 109.63 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 61.8 p -85.67 131.79 34.27 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 122.099 0.952 . . . . 0.84999999999999998 110.448 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.891 HG21 HD21 ' A' ' 36' ' ' LEU . 10.2 pt -132.3 143.78 38.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.157 -1.383 . . . . 0.25 109.521 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.24 151.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.2 0.524 . . . . 0.67000000000000004 111.224 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.3 mm -116.74 93.37 40.89 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 114.614 -1.175 . . . . 0.16 108.948 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.3 Cg_endo -60.12 136.89 71.95 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.705 2.27 . . . . 0.17999999999999999 112.881 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.12 -6.23 83.79 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.114 -0.948 . . . . 0.26000000000000001 112.269 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.75 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 28.9 tp -121.46 114.53 31.6 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.287 0.565 . . . . 0.60999999999999999 111.077 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.688 ' HD2' HD12 ' A' ' 51' ' ' LEU . 53.8 Cg_endo -78.67 -177.07 3.63 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.702 2.935 . . . . 0.28000000000000003 114.135 -171.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.613 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.0 t70 -82.81 131.96 52.88 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 114.028 -1.442 . . . . 0.48999999999999999 112.317 -169.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 57.1 Cg_endo -73.98 -14.69 23.71 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 123.571 2.847 . . . . 0.46000000000000002 112.89 -177.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.465 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 22.0 m-85 -89.61 -15.47 32.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.082 -0.508 . . . . 1.3799999999999999 110.73 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 53' ' ' ASP . 20.8 p -83.22 -20.71 34.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 122.481 1.134 . . . . 0.46000000000000002 108.147 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.563 HG22 ' H ' ' A' ' 59' ' ' TYR . 26.4 mt -76.34 135.45 69.3 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 113.06 -1.882 . . . . 0.69999999999999996 110.99 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.519 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 30.5 Cg_endo -84.7 -17.26 5.14 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 122.361 2.041 . . . . 0.39000000000000001 112.863 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.563 ' H ' HG22 ' A' ' 57' ' ' ILE . 42.9 m-85 -100.6 155.83 17.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.91 0.386 . . . . 0.23999999999999999 111.541 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -144.98 135.05 23.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.555 -0.748 . . . . 2.8900000000000001 109.102 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 71' ' ' THR . 84.1 mt -114.19 134.88 55.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.25 -0.432 . . . . 0.16 111.891 -175.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.05 118.88 33.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 119.89 -0.724 . . . . 0.16 111.124 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.5 t -98.3 113.9 34.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.748 0.785 . . . . 0.19 111.166 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 40.2 m -92.29 105.35 17.57 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.783 -1.099 . . . . 0.20000000000000001 110.336 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.7 mm -53.14 -58.73 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 122.055 0.931 . . . . 0.23000000000000001 111.314 168.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.01 -11.2 4.31 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 112.701 -2.045 . . . . 0.16 113.082 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.23 -16.53 5.45 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.653 0.781 . . . . 0.14999999999999999 112.19 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.509 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 57.01 54.94 6.48 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.412 0.551 . . . . 0.68999999999999995 111.28 -174.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.3 p -137.0 165.65 25.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.928 0.714 . . . . 0.13 112.928 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.9 tt -132.8 111.66 11.29 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.68 -1.146 . . . . 0.40000000000000002 109.822 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.638 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.9 m -93.31 123.25 36.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.924 0.392 . . . . 0.16 111.101 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 79' ' ' MET . 11.6 tp -98.97 107.29 19.68 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.322 -0.854 . . . . 0.58999999999999997 108.791 172.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 88.3 p -105.37 161.89 13.92 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.324 -0.95 . . . . 1.05 110.591 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.749 HD13 ' ND2' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -126.31 126.33 43.76 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.522 -0.918 . . . . 0.26000000000000001 108.522 169.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.749 ' ND2' HD13 ' A' ' 74' ' ' LEU . 9.8 p30 43.0 48.1 5.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.021 -1.445 . . . . 1.8400000000000001 111.647 -165.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.8 t30 78.15 -13.89 0.91 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.794 -1.094 . . . . 1.8899999999999999 111.591 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -92.51 122.78 35.28 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.193 -0.669 . . . . 3.4399999999999999 109.193 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 53.6 t -56.66 132.52 20.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.37 1.081 . . . . 0.23999999999999999 112.834 -173.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 57.2 mmm -96.91 -47.63 5.75 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.096 -1.865 . . . . 0.81000000000000005 107.838 175.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -163.3 174.05 12.53 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 112.871 -1.968 . . . . 1.46 110.358 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.3 m -148.47 124.57 10.74 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.029 -1.441 . . . . 0.17000000000000001 109.395 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -111.59 151.02 43.05 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 109.56 -0.533 . . . . 1.05 109.56 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HB2' HG22 ' A' ' 134' ' ' ILE . 44.3 Cg_endo -76.63 140.82 21.5 Favored 'Trans proline' 0 CA--C 1.499 -1.247 0 C-N-CA 122.103 1.869 . . . . 0.20000000000000001 111.235 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.667 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.33 173.07 12.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.495 -0.775 . . . . 0.13 110.584 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.913 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.94 144.3 45.61 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 110.13 -0.322 . . . . 0.26000000000000001 110.13 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 65' ' ' ILE . 9.0 m -126.39 126.71 69.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.676 0.75 . . . . 0.56000000000000005 111.801 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.28 152.41 29.41 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 109.771 -1.332 . . . . 0.17000000000000001 109.771 171.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -57.27 4.63 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.06 0.763 . . . . 3.0499999999999998 113.06 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.938 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -89.57 -19.65 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.504 0.669 . . . . 0.23000000000000001 110.235 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.938 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -88.09 -16.73 32.73 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.749 0.785 . . . . 0.17999999999999999 109.097 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.9 p -68.95 -16.43 63.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.396 -1.274 . . . . 0.33000000000000002 111.352 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -62.03 -42.06 98.76 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 114.945 -1.025 . . . . 1.52 111.788 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -108.33 116.75 56.08 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 0.42999999999999999 110.644 -176.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 6.0 Cg_exo -72.62 -21.25 22.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.604 2.202 . . . . 0.72999999999999998 112.842 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -99.88 -40.44 7.69 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.529 -0.545 . . . . 0.47999999999999998 109.529 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.535 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 45.42 48.09 11.58 Favored Glycine 0 N--CA 1.446 -0.639 0 O-C-N 124.393 1.058 . . . . 0.33000000000000002 113.557 171.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -82.75 110.98 18.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.738 0.78 . . . . 0.83999999999999997 109.172 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 21.5 m-85 -139.53 169.29 18.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.01 -1.45 . . . . 0.22 112.49 -171.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' A' ' 162' ' ' ARG . 43.6 m-85 -139.11 139.06 37.56 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.863 -0.608 . . . . 0.54000000000000004 110.377 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.583 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.9 mt -61.63 118.93 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 115.412 -0.813 . . . . 0.17000000000000001 110.492 172.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.607 HG21 ' HA ' ' A' ' 22' ' ' PHE . 21.4 pt -85.28 -32.76 7.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 113.198 0.814 . . . . 0.20999999999999999 113.198 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.571 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 10.4 p30 177.99 176.05 0.47 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.613 -1.254 . . . . 2.0299999999999998 107.613 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.703 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 19.6 mtt180 -125.2 161.25 27.29 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.509 -0.876 . . . . 1.52 111.914 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.45 HE21 ' HB3' ' A' ' 107' ' ' PRO . 52.0 tt0 -135.99 100.17 4.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.216 -0.902 . . . . 0.58999999999999997 109.832 170.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.471 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 24.8 ttp180 -67.5 165.48 16.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.378 -0.828 . . . . 2.8199999999999998 110.843 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.748 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 34.5 m-80 -36.1 101.08 0.21 Allowed Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 125.32 1.448 . . . . 0.34999999999999998 112.706 -156.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 18.1 Cg_endo . . . . . 0 C--N 1.343 0.245 0 C-N-CA 122.985 2.456 . . . . 0.47999999999999998 112.392 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 N--CA 1.439 -0.998 0 CA-C-O 120.71 0.291 . . . . 0.47999999999999998 110.518 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.471 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.8 OUTLIER -162.09 157.3 23.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.786 0.327 . . . . 0.28000000000000003 110.424 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -135.39 99.84 4.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.627 -1.249 . . . . 0.48999999999999999 107.627 164.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.7 mt -92.18 113.95 26.36 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.579 -0.897 . . . . 0.66000000000000003 108.579 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.455 ' HB3' HD11 ' A' ' 101' ' ' ILE . 13.2 m -83.55 144.88 29.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.775 -0.648 . . . . 0.19 111.561 -166.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.9 mm? -110.28 166.53 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.13 110.936 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.623 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -62.65 -8.2 6.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.028 0.751 . . . . 1.1699999999999999 113.028 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.773 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.9 tmtm? -126.84 133.01 50.84 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.362 1.077 . . . . 1.22 109.833 172.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.773 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 52.9 mt-30 -39.08 -46.39 1.4 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 112.439 -2.164 . . . . 1.51 114.227 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.483 ' CB ' HG12 ' A' ' 89' ' ' ILE . 79.6 m-70 -97.38 -0.67 45.95 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.212 -0.595 . . . . 2.5299999999999998 111.51 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.746 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -97.21 38.19 1.27 Allowed 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.365 1.246 . . . . 0.83999999999999997 114.365 -169.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.684 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -117.19 146.0 18.73 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 116.457 -2.783 . . . . 0.32000000000000001 113.111 -153.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.73 116.58 39.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 124.053 0.941 . . . . 0.17999999999999999 111.004 -176.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.5 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.5 p80 -146.23 -177.05 5.41 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 112.593 0.59 . . . . 0.20999999999999999 112.593 -176.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.98 -167.19 37.4 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.436 -0.666 . . . . 0.27000000000000002 111.436 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.6 t -161.68 164.05 29.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 117.727 0.764 . . . . 0.40999999999999998 110.589 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -115.18 -3.79 12.51 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.118 -1.067 . . . . 1.99 108.118 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -121.74 91.43 48.62 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 114.148 -1.387 . . . . 1.3600000000000001 108.673 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.66 -22.27 18.2 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.346 2.031 . . . . 0.34999999999999998 113.769 -172.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.24 2.26 25.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.103 0.477 . . . . 0.33000000000000002 111.163 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.471 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 43.6 t -95.07 -4.89 45.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 1.3500000000000001 109.364 170.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 31.8 mm -78.76 138.17 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 115.899 -0.591 . . . . 0.20999999999999999 110.106 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.56 1.81 80.19 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.119 -1.192 . . . . 0.14999999999999999 110.119 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.471 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 91.8 mttt -113.36 167.94 10.15 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 123.161 1.457 . . . . 2.5 114.253 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.1 126.63 46.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 111.699 -2.501 . . . . 0.17000000000000001 107.961 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.417 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -125.24 161.95 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.909 -0.774 . . . . 0.66000000000000003 108.909 -174.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.7 m -49.72 -60.35 2.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.114 0.783 . . . . 0.42999999999999999 113.114 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -133.52 -43.99 0.83 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 118.533 -1.267 . . . . 2.02 113.619 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.42 133.49 0.2 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 117.055 1.582 . . . . 0.17999999999999999 117.055 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.535 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 2.9 p -70.05 165.19 22.41 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 112.575 -1.813 . . . . 0.16 112.419 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.913 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 49.4 mt -60.61 97.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 114.494 -1.23 . . . . 0.40000000000000002 112.077 -163.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.5 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 10.4 mtp180 -83.97 144.06 29.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.702 -1.59 . . . . 1.8700000000000001 109.501 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.667 ' HG2' HG22 ' A' ' 84' ' ' ILE . 14.9 mtp -121.38 -169.0 1.78 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.188 -0.671 . . . . 0.79000000000000004 109.188 173.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.622 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 1.5 t60 -89.85 153.91 20.28 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.158 -1.053 . . . . 2.3199999999999998 108.158 170.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.877 ' O ' HD13 ' A' ' 151' ' ' ILE . 9.2 m120 -72.45 -20.29 61.42 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 118.474 -0.774 . . . . 0.68000000000000005 113.069 -171.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -81.61 -28.75 33.58 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 121.364 1.893 . . . . 2.1800000000000002 112.734 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.622 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 5.0 m-20 -77.62 -41.21 39.34 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.186 0.517 . . . . 0.68999999999999995 110.63 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.61 HG13 HD12 ' A' ' 151' ' ' ILE . 12.5 p -66.34 -19.69 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.245 -0.889 . . . . 0.11 111.349 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.888 HD11 ' HB1' ' A' ' 113' ' ' ALA . 1.6 mp -86.26 -42.98 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 118.801 -0.618 . . . . 0.38 110.727 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.424 ' O ' HG13 ' A' ' 156' ' ' ILE . 16.2 mt-10 -45.12 -70.87 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.369 0.986 . . . . 1.99 112.578 170.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.554 ' O ' HG22 ' A' ' 157' ' ' VAL . 48.0 mt -46.07 -39.9 9.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.627 0.727 . . . . 1.27 111.53 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.26 -36.07 79.0 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.01 -1.45 . . . . 0.17999999999999999 111.775 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.3 t -86.97 -31.11 20.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 118.811 0.732 . . . . 0.20999999999999999 112.501 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.1 mt -82.49 -60.35 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.652 0.739 . . . . 0.16 111.756 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -88.38 141.93 31.02 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.837 -1.074 . . . . 0.16 112.252 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.703 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 56.9 Cg_endo -89.28 175.38 3.37 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 124.024 3.149 . . . . 0.20000000000000001 110.997 174.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.571 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 75.3 m-20 -65.53 156.04 33.81 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 119.371 -0.931 . . . . 1.1000000000000001 108.972 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 97.91 -19.78 53.21 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.008 -1.091 . . . . 0.17999999999999999 112.358 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.583 ' HB ' HD12 ' A' ' 100' ' ' ILE . 50.5 m -64.1 137.4 57.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.902 -0.777 . . . . 0.14000000000000001 108.902 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.523 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 20.0 ttt180 -92.15 127.6 37.68 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 122.52 1.152 . . . . 3.6299999999999999 110.745 -169.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.31 107.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 112.374 -2.193 . . . . 0.14000000000000001 109.086 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.1 m -93.92 107.91 19.77 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.377 0.51 . . . . 0.20999999999999999 112.377 -172.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.535 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.04 99.63 5.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 122.171 0.986 . . . . 0.23999999999999999 109.955 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -110.77 133.38 53.39 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.391 -1.277 . . . . 1.0900000000000001 109.879 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.575 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 19.5 mmm180 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 116.239 -0.437 . . . . 2.0800000000000001 110.394 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.408 0.623 . . . . 0.65000000000000002 111.643 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.0 tt -98.18 128.67 44.79 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.904 -1.043 . . . . 0.28000000000000003 110.392 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.19 162.96 13.3 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.209 1.004 . . . . 0.31 113.075 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.631 ' HB3' HG13 ' A' ' 46' ' ' ILE . 86.9 t80 -130.32 139.36 50.7 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.768 -1.56 . . . . 0.44 107.753 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.436 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 58.7 tt0 -112.39 113.14 25.18 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.013 -1.106 . . . . 0.76000000000000001 108.013 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.673 HG13 ' HB2' ' A' ' 13' ' ' ASP . 94.9 t -67.23 148.15 12.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 122.528 1.156 . . . . 0.39000000000000001 113.283 -169.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -102.35 158.6 16.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 113.312 -1.767 . . . . 2.0099999999999998 108.367 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.61 104.22 0.4 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.059 0.457 . . . . 1.8300000000000001 112.068 -174.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.83 10.96 36.11 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.718 -0.674 . . . . 0.47999999999999998 113.502 174.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.673 ' HB2' HG13 ' A' ' 9' ' ' VAL . 29.8 m-20 -53.06 169.3 0.1 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.137 0.494 . . . . 1.46 111.671 173.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.35 150.47 50.7 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.105 0.479 . . . . 0.40999999999999998 111.95 177.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.635 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.56 -36.45 83.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.055 -0.975 . . . . 0.85999999999999999 108.808 -177.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.426 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 2.7 t-20 -87.75 -24.5 23.79 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.812 -1.086 . . . . 1.1499999999999999 110.855 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.0 m -70.1 -38.1 75.55 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.322 -0.551 . . . . 1.21 110.176 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 mt -74.67 -28.39 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.43 -0.581 . . . . 0.20999999999999999 109.43 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.662 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.66 -9.54 59.43 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.281 -0.418 . . . . 0.16 110.81 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.677 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.64 -40.8 8.83 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.38 1.086 . . . . 0.20999999999999999 108.116 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 119' ' ' SER . 7.5 m-20 -62.39 -44.41 96.52 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.462 -2.154 . . . . 0.53000000000000003 112.19 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HA ' HG21 ' A' ' 101' ' ' ILE . 53.0 m-85 -96.98 6.39 48.72 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 118.627 -1.229 . . . . 0.17999999999999999 111.03 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.677 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER 54.3 41.44 31.98 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.916 0.865 . . . . 1.78 109.25 176.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.662 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.1 pt -113.87 -165.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.442 -1.254 . . . . 0.19 110.214 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.06 142.61 41.28 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.206 -0.906 . . . . 0.94999999999999996 110.225 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.49 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 60.3 p -72.97 -33.29 65.77 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.804 -1.184 . . . . 0.25 107.804 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.04 -27.2 66.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.34 -0.845 . . . . 0.20000000000000001 111.824 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HA ' ' HB2' ' A' ' 31' ' ' GLN . . . -95.21 -25.3 16.43 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.649 0.737 . . . . 0.17000000000000001 109.636 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.635 HD23 HD23 ' A' ' 15' ' ' LEU . 17.5 tp -75.23 -27.43 59.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.241 -0.89 . . . . 1.1599999999999999 109.054 173.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.521 HD23 ' HB2' ' A' ' 36' ' ' LEU . 35.3 mt -78.04 -26.69 48.51 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.36 0.6 . . . . 1.05 110.372 172.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.479 ' HB2' ' HA ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -59.81 -61.56 2.52 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 108.129 -1.063 . . . . 1.8100000000000001 108.129 169.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -71.29 -18.57 62.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.491 -0.777 . . . . 0.20000000000000001 110.86 -170.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.614 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 28.5 m-80 -147.61 80.65 8.93 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-N 115.642 -0.708 . . . . 0.23000000000000001 110.385 -174.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 24.6 Cg_endo -59.5 -4.41 2.49 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 123.787 2.991 . . . . 0.35999999999999999 113.145 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 p -79.96 -25.75 40.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.052 0.453 . . . . 1.3799999999999999 111.542 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.861 HD21 HG21 ' A' ' 46' ' ' ILE . 33.6 mt -70.81 -33.66 70.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.733 -0.667 . . . . 0.48999999999999999 112.387 -170.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 37' ' ' GLN . 1.7 pp0? -63.56 -44.72 93.3 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.822 1.296 . . . . 1.95 110.76 -172.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.19 -49.12 73.28 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 111.795 -2.457 . . . . 0.48999999999999999 110.404 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.6 176.23 47.87 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 114.683 -1.144 . . . . 0.41999999999999998 111.405 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.51 157.99 18.44 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.37 0.605 . . . . 0.40999999999999998 110.626 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 53.2 m -138.39 128.8 26.1 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.317 -0.856 . . . . 0.41999999999999998 110.192 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.25 119.74 19.79 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 119.996 -0.682 . . . . 0.46999999999999997 109.535 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.436 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 99.44 1.51 56.67 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.254 -1.138 . . . . 0.40999999999999998 110.254 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.63 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -76.65 123.6 26.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.918 -0.641 . . . . 1.3 109.824 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 29.8 p -84.32 125.93 32.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.491 -0.777 . . . . 0.84999999999999998 110.771 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.861 HG21 HD21 ' A' ' 36' ' ' LEU . 8.9 pt -126.3 143.23 40.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 114.241 -1.345 . . . . 0.25 109.443 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.64 152.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 121.164 0.507 . . . . 0.67000000000000004 111.185 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.9 mm -116.28 92.03 34.75 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.648 -1.16 . . . . 0.16 109.268 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.557 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -57.98 135.06 66.38 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.811 2.341 . . . . 0.17999999999999999 112.71 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.98 -5.77 83.06 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.067 -0.97 . . . . 0.26000000000000001 112.279 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.72 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 27.7 tp -122.54 113.37 30.61 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 121.253 0.549 . . . . 0.60999999999999999 110.978 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.675 ' HD2' HD12 ' A' ' 51' ' ' LEU . 48.6 Cg_endo -78.05 -176.22 3.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.77 2.98 . . . . 0.28000000000000003 114.295 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.571 ' HB3' HG23 ' A' ' 56' ' ' THR . 22.5 t70 -79.9 129.76 69.4 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 113.967 -1.47 . . . . 0.48999999999999999 112.648 -169.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 41.1 Cg_endo -73.06 -14.01 26.11 Favored 'Trans proline' 0 C--N 1.34 0.118 0 C-N-CA 123.396 2.731 . . . . 0.46000000000000002 112.687 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.539 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 75.5 m-85 -92.58 -10.28 38.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.971 -0.558 . . . . 1.3799999999999999 111.332 -174.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.571 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.0 p -85.46 -24.69 27.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.586 1.184 . . . . 0.46000000000000002 108.153 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 59' ' ' TYR . 15.9 mt -72.53 136.34 80.98 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.82 -1.991 . . . . 0.69999999999999996 111.246 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.539 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 36.8 Cg_endo -86.38 -16.49 3.94 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.459 2.106 . . . . 0.39000000000000001 113.319 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.594 ' H ' HG22 ' A' ' 57' ' ' ILE . 56.0 m-85 -98.43 158.15 15.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.199 0.444 . . . . 0.23999999999999999 112.199 -174.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.612 ' CD2' ' HE ' ' A' ' 162' ' ' ARG . 40.5 m80 -147.01 132.44 18.61 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.67 -0.695 . . . . 2.8900000000000001 109.15 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.703 ' HA ' ' O ' ' A' ' 71' ' ' THR . 76.1 mt -114.99 135.93 53.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.261 -0.427 . . . . 0.16 111.914 -176.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.79 117.6 28.63 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.11 -0.636 . . . . 0.16 111.249 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 69' ' ' THR . 88.9 t -96.77 117.93 42.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.511 0.672 . . . . 0.19 111.168 175.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 65.1 m -92.84 109.56 21.0 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.253 -0.885 . . . . 0.20000000000000001 111.262 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 36.2 mm -54.48 -59.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 122.255 1.026 . . . . 0.23000000000000001 111.081 165.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.13 -12.75 6.0 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 112.783 -2.008 . . . . 0.16 113.362 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.469 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.94 -18.62 4.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.866 0.691 . . . . 0.14999999999999999 112.866 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.96 56.3 4.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.811 0.732 . . . . 0.68999999999999995 111.438 -172.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 46.8 p -137.89 164.6 28.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.897 0.703 . . . . 0.13 112.897 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.445 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.4 tt -133.13 110.67 10.34 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.713 -1.131 . . . . 0.40000000000000002 109.81 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 53.1 m -93.42 121.77 35.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.288 0.566 . . . . 0.16 111.188 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.1 tp -96.5 107.37 19.77 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.909 -1.041 . . . . 0.58999999999999997 109.054 173.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 4.3 m -107.61 158.11 17.52 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.453 -0.899 . . . . 1.05 110.645 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.738 HD13 ' ND2' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -126.19 126.15 43.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.826 -0.805 . . . . 0.26000000000000001 108.826 170.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.738 ' ND2' HD13 ' A' ' 74' ' ' LEU . 8.9 p30 41.48 54.81 3.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.04 -1.436 . . . . 1.8400000000000001 111.539 -165.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.5 t30 73.86 -14.98 0.61 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.173 -0.921 . . . . 1.8899999999999999 111.709 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -91.84 118.99 31.23 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.81 -0.441 . . . . 3.4399999999999999 109.81 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.0 t -58.05 130.32 21.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 122.479 1.133 . . . . 0.23999999999999999 112.412 -175.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.518 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 64.0 mmm -96.27 -48.68 5.52 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.014 -1.903 . . . . 0.81000000000000005 108.214 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 14.3 mmmt -160.72 174.06 14.49 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 112.669 -2.06 . . . . 1.46 109.477 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.3 m -148.58 124.49 10.62 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.602 -1.181 . . . . 0.17000000000000001 109.072 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 149' ' ' ASP . 12.9 m-85 -106.01 147.21 34.39 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.118 -0.946 . . . . 1.05 109.588 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.435 ' HB2' HG22 ' A' ' 134' ' ' ILE . 37.4 Cg_endo -75.12 140.61 25.33 Favored 'Trans proline' 0 CA--C 1.498 -1.305 0 C-N-CA 121.445 1.43 . . . . 0.20000000000000001 110.24 168.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.633 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -141.06 174.68 6.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.764 -0.653 . . . . 0.13 110.554 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.893 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.16 143.55 47.16 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.793 0.33 . . . . 0.26000000000000001 110.424 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.508 HG22 ' HG3' ' A' ' 68' ' ' LYS . 8.7 m -125.64 126.21 69.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.525 0.678 . . . . 0.56000000000000005 111.779 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.03 154.41 31.91 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.609 -1.396 . . . . 0.17000000000000001 109.609 171.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -55.79 0.18 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.042 0.756 . . . . 3.0499999999999998 113.042 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.876 HG23 HD22 ' A' ' 90' ' ' LEU . 1.2 tp -85.04 -19.11 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 O-C-N 121.353 -0.842 . . . . 0.23000000000000001 110.068 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.876 HD22 HG23 ' A' ' 89' ' ' ILE . 3.5 mm? -87.17 -17.25 33.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.766 -0.827 . . . . 0.17999999999999999 108.766 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.6 p -70.41 -15.66 62.86 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.461 -1.245 . . . . 0.33000000000000002 111.23 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.17 -43.21 98.9 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.477 -0.783 . . . . 1.52 111.594 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.07 132.95 27.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.477 -0.489 . . . . 0.42999999999999999 110.72 -174.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 84.3 Cg_endo -88.7 4.3 5.51 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.73 2.286 . . . . 0.72999999999999998 111.66 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -128.39 -41.51 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.161 -0.681 . . . . 0.47999999999999998 109.161 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 165' ' ' ILE . . . 53.13 16.92 4.86 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 124.595 1.184 . . . . 0.33000000000000002 114.377 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.674 ' CB ' HG23 ' A' ' 164' ' ' THR . 12.9 pt-20 -86.3 119.64 26.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.331 1.062 . . . . 0.83999999999999997 110.223 -171.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.667 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 9.3 m-85 -138.67 -170.56 2.87 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.679 -1.601 . . . . 0.22 111.764 -163.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.626 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 85.7 m-85 -142.9 139.2 30.68 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.237 0.541 . . . . 0.54000000000000004 110.938 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.568 HD12 ' HB ' ' A' ' 161' ' ' THR . 85.5 mt -63.74 123.4 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.463 -0.79 . . . . 0.17000000000000001 110.39 168.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.546 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.8 pt -89.64 -43.9 14.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 113.621 0.971 . . . . 0.20999999999999999 113.621 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.591 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 49.1 m-80 -171.22 174.14 4.69 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.047 -1.464 . . . . 2.0299999999999998 107.047 -169.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.655 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 40.3 mtt180 -127.1 169.47 13.38 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.252 -0.979 . . . . 1.52 111.961 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 55.0 tt0 -147.13 99.8 3.21 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.075 -0.966 . . . . 0.58999999999999997 109.629 170.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.517 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 46.5 ttt180 -65.74 166.11 11.52 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.205 -0.907 . . . . 2.8199999999999998 110.826 175.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.517 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 19.3 m-80 -35.41 102.74 0.23 Allowed Pre-proline 0 C--O 1.232 0.168 0 C-N-CA 125.269 1.428 . . . . 0.34999999999999998 113.305 -157.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.4 Cg_endo . . . . . 0 C--N 1.345 0.372 0 C-N-CA 123.153 2.568 . . . . 0.47999999999999998 111.78 173.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.513 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.565 1.554 0 N-CA-C 117.482 2.401 . . . . 0.47999999999999998 117.482 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.494 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -165.83 154.78 11.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.417 -0.802 . . . . 0.28000000000000003 110.449 -176.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.3 t-105 -135.25 99.28 4.2 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.115 -1.069 . . . . 0.48999999999999999 108.115 168.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.516 HD12 HG23 ' A' ' 150' ' ' VAL . 4.9 mt -93.15 114.69 27.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.584 0.707 . . . . 0.66000000000000003 109.245 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.436 ' C ' HG12 ' A' ' 101' ' ' ILE . 19.6 m -83.54 144.23 29.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.666 -0.697 . . . . 0.19 111.502 -167.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.714 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.7 mm? -108.72 165.04 11.85 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.454 -0.794 . . . . 0.13 110.791 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.468 ' OG ' ' HD2' ' A' ' 98' ' ' PHE . 3.7 p -68.16 -4.58 14.3 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 124.008 0.817 . . . . 1.1699999999999999 112.546 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.689 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 4.3 tmtm? -126.66 128.33 46.56 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 120.213 -0.595 . . . . 1.22 109.581 166.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.689 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 52.9 mt-30 -33.19 -58.28 0.39 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.431 -1.713 . . . . 1.51 113.847 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.588 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -96.67 13.18 29.2 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.964 -0.694 . . . . 2.5299999999999998 112.17 -170.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.587 ' HA ' HD11 ' A' ' 90' ' ' LEU . 2.8 m-30 -90.38 -34.29 15.72 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-O 121.923 0.868 . . . . 0.83999999999999997 111.081 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.714 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -6.87 128.71 0.01 OUTLIER Glycine 0 C--N 1.297 -1.601 0 N-CA-C 119.262 2.465 . . . . 0.32000000000000001 119.262 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.642 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -99.96 115.67 41.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 112.822 -1.689 . . . . 0.17999999999999999 109.815 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.691 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.0 p80 -143.27 175.16 10.11 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.501 -0.772 . . . . 0.20999999999999999 109.653 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.58 -168.81 38.52 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 120.016 -1.088 . . . . 0.27000000000000002 111.991 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.0 t -156.03 168.04 28.53 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.89 -0.771 . . . . 0.40999999999999998 110.367 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -110.33 -9.21 14.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.507 -0.923 . . . . 1.99 108.507 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -111.21 88.33 8.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 114.816 -1.084 . . . . 1.3600000000000001 108.356 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -72.89 -19.64 23.27 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.754 2.303 . . . . 0.34999999999999998 113.326 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.6 -2.07 33.94 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.03 -0.532 . . . . 0.33000000000000002 111.002 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.5 m -91.97 -4.16 54.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.544 -0.539 . . . . 1.3500000000000001 109.544 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 43.5 mm -82.31 131.4 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.845 -0.616 . . . . 0.20999999999999999 110.401 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.7 1.4 65.87 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.811 -1.316 . . . . 0.14999999999999999 109.811 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 137' ' ' ALA . 2.0 tttm -114.29 163.27 15.5 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 122.759 1.266 . . . . 2.5 113.388 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -94.54 126.9 40.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 112.424 -2.171 . . . . 0.17000000000000001 107.889 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.432 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -121.64 159.25 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 108.6 -0.889 . . . . 0.66000000000000003 108.6 -175.176 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 m -49.34 -59.35 3.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.406 0.521 . . . . 0.42999999999999999 112.406 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.434 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 21.0 pttm -132.36 -45.96 0.91 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.506 -1.278 . . . . 2.02 114.186 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.34 134.01 0.18 Allowed Glycine 0 N--CA 1.468 0.815 0 N-CA-C 117.648 1.819 . . . . 0.17999999999999999 117.648 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 2.1 p -69.77 165.5 21.28 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 112.601 -1.8 . . . . 0.16 111.916 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.893 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 57.8 mt -60.37 99.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 114.711 -1.131 . . . . 0.40000000000000002 112.008 -162.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.691 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 60.8 mtt180 -87.69 148.97 24.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.988 -1.46 . . . . 1.8700000000000001 110.685 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.633 ' HG2' HG22 ' A' ' 84' ' ' ILE . 17.5 mtp -126.34 -165.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.217 -0.661 . . . . 0.79000000000000004 109.217 173.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.615 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 12.8 t-80 -93.77 153.39 18.33 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.068 -0.715 . . . . 2.3199999999999998 109.068 172.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.657 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.2 m120 -57.41 -54.8 42.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 118.188 -0.911 . . . . 0.68000000000000005 110.907 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -65.22 -21.97 66.82 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 121.543 1.974 . . . . 2.1800000000000002 112.149 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.615 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.9 m-20 -80.9 -45.79 16.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.096 -0.956 . . . . 0.68999999999999995 111.169 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.591 HG13 HD12 ' A' ' 151' ' ' ILE . 14.9 p -65.8 -20.73 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.554 -0.748 . . . . 0.11 111.052 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.657 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.26 -41.0 16.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 119.006 -0.521 . . . . 0.38 109.889 170.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -45.92 -70.73 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.164 0.893 . . . . 1.99 112.339 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.479 HD22 ' SD ' ' A' ' 145' ' ' MET . 9.4 mp -46.18 -38.56 8.48 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.49 0.662 . . . . 1.27 111.486 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.75 -33.52 76.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.376 -1.284 . . . . 0.17999999999999999 111.598 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -88.79 -31.68 18.25 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.487 -0.758 . . . . 0.20999999999999999 112.711 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.2 mt -83.38 -60.1 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.451 0.643 . . . . 0.16 111.679 -172.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.1 m -91.26 139.99 25.6 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 114.969 -1.014 . . . . 0.16 112.158 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.655 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 61.2 Cg_endo -89.09 174.4 3.74 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 123.899 3.066 . . . . 0.20000000000000001 111.286 174.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.591 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 58.5 m-20 -67.75 156.07 37.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.423 -0.911 . . . . 1.1000000000000001 108.876 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.69 -20.53 50.02 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.246 -0.978 . . . . 0.17999999999999999 112.523 -172.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.568 ' HB ' HD12 ' A' ' 100' ' ' ILE . 53.2 m -63.75 137.74 58.19 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.006 -0.739 . . . . 0.14000000000000001 109.006 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.626 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 18.8 ptt180 -92.48 120.6 33.12 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.944 1.354 . . . . 3.6299999999999999 111.22 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.6 t -102.78 106.48 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 111.951 -2.386 . . . . 0.14000000000000001 108.875 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.674 HG23 ' CB ' ' A' ' 97' ' ' GLU . 1.8 m -93.74 104.59 16.68 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.257 -0.577 . . . . 0.20999999999999999 112.327 -170.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 2.4 mp -81.45 93.29 2.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 122.509 1.147 . . . . 0.23999999999999999 109.552 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -103.31 139.15 39.12 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.865 -1.516 . . . . 1.0900000000000001 109.432 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.535 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 6.5 mmt85 . . . . . 0 C--N 1.316 -0.873 0 CA-C-N 116.057 -0.52 . . . . 2.0800000000000001 111.115 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.653 HD21 ' HA ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.488 0.661 . . . . 0.65000000000000002 111.969 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.655 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.2 tt -99.09 131.82 44.86 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.717 -1.129 . . . . 0.28000000000000003 110.238 -175.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.7 162.37 13.47 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 122.218 1.008 . . . . 0.31 113.201 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.631 ' HB3' HG13 ' A' ' 46' ' ' ILE . 80.8 t80 -130.72 144.86 51.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.723 -1.581 . . . . 0.44 107.859 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.425 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 61.5 tt0 -115.85 113.53 23.48 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 108.483 -0.932 . . . . 0.76000000000000001 108.483 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.596 ' HB ' ' O ' ' A' ' 41' ' ' THR . 86.0 t -66.39 152.32 9.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 122.735 1.255 . . . . 0.39000000000000001 113.27 -171.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.0 mtmm -108.68 159.35 16.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.036 -1.893 . . . . 2.0099999999999998 108.54 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.453 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 2.2 mm-40 -62.13 113.8 3.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.041 0.448 . . . . 1.8300000000000001 112.044 -174.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.38 10.76 56.73 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.582 -0.735 . . . . 0.47999999999999998 113.669 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.545 ' HB2' HG13 ' A' ' 9' ' ' VAL . 86.3 m-20 -56.2 169.38 0.41 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.109 0.454 . . . . 1.46 111.161 173.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.43 ' HB ' ' H ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -128.81 156.69 43.19 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.432 -0.507 . . . . 0.40999999999999998 110.916 173.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.61 HD12 HD23 ' A' ' 29' ' ' LEU . 3.0 tp -66.07 -36.36 83.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.986 0.898 . . . . 0.85999999999999999 109.539 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.461 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 5.1 t30 -85.87 -24.98 26.46 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.342 -1.299 . . . . 1.1499999999999999 110.248 -176.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.43 ' H ' ' HB ' ' A' ' 14' ' ' THR . 39.6 t -65.88 -42.11 90.71 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.127 -0.694 . . . . 1.21 109.127 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 14.8 mt -74.69 -27.01 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.171 0.51 . . . . 0.20999999999999999 109.908 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.636 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.32 -9.98 59.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.532 -0.304 . . . . 0.16 110.679 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.621 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.73 -38.62 9.83 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.642 1.21 . . . . 0.20999999999999999 108.155 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.3 m-20 -62.28 -45.55 92.76 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.277 -2.238 . . . . 0.53000000000000003 111.689 172.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.556 ' HA ' HG21 ' A' ' 101' ' ' ILE . 58.8 m-85 -98.62 4.8 48.06 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 118.685 -1.206 . . . . 0.17999999999999999 111.667 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.621 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.0 mpt_? 54.78 42.84 30.86 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.689 0.757 . . . . 1.78 109.738 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.636 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.7 pt -115.41 -165.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.548 -1.205 . . . . 0.19 109.883 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.39 142.82 39.8 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.123 -0.944 . . . . 0.94999999999999996 110.118 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.597 ' HB ' HD21 ' A' ' 15' ' ' LEU . 70.6 p -73.23 -31.95 64.44 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.364 -0.976 . . . . 0.25 108.364 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.67 68.16 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.049 -0.978 . . . . 0.20000000000000001 111.512 169.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -92.89 -27.66 16.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.359 0.599 . . . . 0.17000000000000001 109.461 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.647 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 15.2 tp -74.79 -26.64 59.89 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.662 -0.699 . . . . 1.1599999999999999 109.299 174.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 36' ' ' LEU . 42.8 mt -77.62 -30.51 52.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.62 0.724 . . . . 1.05 109.772 171.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 22.6 tt0 -63.74 -43.16 97.3 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.326 -1.306 . . . . 1.8100000000000001 110.002 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.47 -21.35 32.88 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.357 -0.537 . . . . 0.20000000000000001 111.715 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.601 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.1 m-80 -145.96 82.74 9.07 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-O 121.571 0.7 . . . . 0.23000000000000001 110.642 -171.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.84 -6.13 3.19 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 123.803 3.002 . . . . 0.35999999999999999 113.675 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.9 t -80.17 -25.78 39.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.651 0.263 . . . . 1.3799999999999999 111.297 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.812 HD21 HG21 ' A' ' 46' ' ' ILE . 32.0 mt -70.11 -35.1 73.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.57 0.7 . . . . 0.48999999999999999 112.158 -170.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 37' ' ' GLN . 2.8 pt20 -65.35 -46.98 78.08 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 122.847 1.308 . . . . 1.95 110.296 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.67 -49.74 74.17 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 111.982 -2.372 . . . . 0.48999999999999999 110.479 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.26 179.36 48.89 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 114.715 -1.129 . . . . 0.41999999999999998 111.332 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 157.09 19.76 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.39 0.614 . . . . 0.40999999999999998 110.895 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.596 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 39.7 m -143.31 126.26 16.27 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.231 -0.895 . . . . 0.41999999999999998 110.706 -176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' CB ' ' HG2' ' A' ' 11' ' ' GLN . . . -75.86 116.62 16.75 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.561 0.696 . . . . 0.46999999999999997 109.735 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 105.34 -0.85 40.26 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.192 -1.163 . . . . 0.40999999999999998 110.192 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.568 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.4 tt0 -75.51 123.82 26.11 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.961 -0.62 . . . . 1.3 109.733 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 58.8 p -80.89 133.13 35.51 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.589 -0.732 . . . . 0.84999999999999998 109.864 176.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.812 HG21 HD21 ' A' ' 36' ' ' LEU . 11.7 pt -134.28 141.61 43.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.498 -1.228 . . . . 0.25 109.22 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.434 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.68 152.22 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.173 0.511 . . . . 0.67000000000000004 110.713 -179.392 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.413 HG13 ' CE2' ' A' ' 22' ' ' PHE . 38.0 mm -115.89 92.5 34.78 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.97 -1.014 . . . . 0.16 109.412 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.653 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -57.41 132.69 52.32 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.727 2.285 . . . . 0.17999999999999999 112.598 -175.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.65 -2.27 80.01 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 114.825 -1.079 . . . . 0.26000000000000001 112.527 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.695 HD12 ' HD2' ' A' ' 52' ' ' PRO . 34.0 tp -125.4 114.94 25.5 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-O 121.314 0.578 . . . . 0.60999999999999999 111.139 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.695 ' HD2' HD12 ' A' ' 51' ' ' LEU . 57.6 Cg_endo -79.79 -177.64 3.98 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.716 2.944 . . . . 0.28000000000000003 114.577 -171.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.58 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.7 t70 -80.52 130.97 62.79 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 114.055 -1.429 . . . . 0.48999999999999999 111.602 -173.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 44.1 Cg_endo -71.29 -20.01 28.48 Favored 'Trans proline' 0 CA--C 1.519 -0.263 0 C-N-CA 123.381 2.72 . . . . 0.46000000000000002 113.121 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -96.79 -0.89 47.33 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.418 0.628 . . . . 1.3799999999999999 111.88 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.58 HG23 ' HB3' ' A' ' 53' ' ' ASP . 29.5 p -89.31 -15.58 33.13 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.228 -1.397 . . . . 0.46000000000000002 107.228 169.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 59' ' ' TYR . 18.2 mt -82.53 134.36 48.1 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 112.5 -2.136 . . . . 0.69999999999999996 110.317 175.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -84.1 -16.95 5.93 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.282 1.988 . . . . 0.39000000000000001 113.239 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.567 ' H ' HG22 ' A' ' 57' ' ' ILE . 61.2 m-85 -93.93 155.15 17.31 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.751 -0.38 . . . . 0.23999999999999999 111.859 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -146.33 131.72 18.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.77 -0.826 . . . . 2.8900000000000001 108.77 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 71' ' ' THR . 91.1 mt -114.95 133.98 59.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.072 0.397 . . . . 0.16 112.072 -175.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.1 121.55 42.48 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.17 -0.612 . . . . 0.16 110.903 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.43 114.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.884 0.85 . . . . 0.19 111.444 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 68' ' ' LYS . 46.9 m -95.02 102.29 14.09 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.606 -1.179 . . . . 0.20000000000000001 110.743 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.9 mm -50.99 -57.74 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 122.25 1.024 . . . . 0.23000000000000001 111.536 169.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.25 -10.13 5.08 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 112.788 -2.005 . . . . 0.16 113.414 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.57 -18.54 4.79 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.51 0.724 . . . . 0.14999999999999999 112.318 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.534 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.26 56.27 4.58 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.325 0.511 . . . . 0.68999999999999995 111.003 -173.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.7 p -137.31 161.73 35.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 112.719 0.636 . . . . 0.13 112.719 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.456 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.5 tt -130.54 110.74 11.65 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.659 -1.155 . . . . 0.40000000000000002 109.928 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.604 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 36.2 m -92.12 123.47 35.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.022 0.439 . . . . 0.16 111.126 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.3 tp -98.88 104.32 16.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.413 -0.812 . . . . 0.58999999999999997 109.481 172.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 19.4 m -105.22 160.18 15.29 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.324 -0.95 . . . . 1.05 110.814 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.745 HD13 ' ND2' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -125.85 127.4 46.01 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.476 -0.935 . . . . 0.26000000000000001 108.476 169.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.745 ' ND2' HD13 ' A' ' 74' ' ' LEU . 8.6 p30 44.64 50.65 8.4 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.075 1.35 . . . . 1.8400000000000001 111.419 -166.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 72.84 -11.83 0.82 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.892 -1.049 . . . . 1.8899999999999999 112.041 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -94.56 120.68 35.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.249 0.547 . . . . 3.4399999999999999 110.009 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.46 HG22 ' CG2' ' A' ' 71' ' ' THR . 57.5 t -57.67 132.54 22.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 122.38 1.086 . . . . 0.23999999999999999 112.869 -173.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 6.9 mtm -103.46 -42.86 5.56 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 112.995 -1.911 . . . . 0.81000000000000005 109.447 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -158.53 172.81 17.64 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 113.215 -1.811 . . . . 1.46 109.84 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.3 m -148.65 123.23 9.78 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.228 -1.351 . . . . 0.17000000000000001 109.41 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.521 ' HD2' ' OD2' ' A' ' 149' ' ' ASP . 25.1 m-85 -103.93 148.55 36.03 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.312 -0.858 . . . . 1.05 109.453 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.435 ' HB2' HG22 ' A' ' 134' ' ' ILE . 46.5 Cg_endo -77.58 141.06 19.45 Favored 'Trans proline' 0 CA--C 1.5 -1.209 0 C-N-CA 121.497 1.465 . . . . 0.20000000000000001 110.488 169.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.627 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -139.9 173.25 11.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.934 -0.575 . . . . 0.13 110.907 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.9 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.83 143.34 47.01 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.227 -0.442 . . . . 0.26000000000000001 110.436 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.534 HG22 ' HG3' ' A' ' 68' ' ' LYS . 7.5 m -126.58 126.04 68.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.451 0.643 . . . . 0.56000000000000005 112.057 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -89.16 157.17 26.77 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.71 -1.356 . . . . 0.17000000000000001 109.71 173.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -57.05 6.61 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 114.582 1.327 . . . . 3.0499999999999998 114.582 -177.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.839 HG23 HD22 ' A' ' 90' ' ' LEU . 1.2 tp -96.88 -14.08 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.525 0.679 . . . . 0.23000000000000001 110.565 -177.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.839 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -91.2 -18.09 25.0 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.146 -0.687 . . . . 0.17999999999999999 109.146 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.3 p -67.09 -24.52 65.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.777 -1.101 . . . . 0.33000000000000002 112.132 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.479 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 8.7 mp0 -56.26 -44.35 79.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.118 1.367 . . . . 1.52 111.61 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -100.45 119.7 58.17 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.471 -0.786 . . . . 0.42999999999999999 111.635 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.599 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 1.9 Cg_endo -77.36 -19.64 13.12 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.874 2.383 . . . . 0.72999999999999998 113.068 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 t -105.48 -40.52 5.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.358 -0.608 . . . . 0.47999999999999998 109.358 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 43.69 45.89 7.23 Favored Glycine 0 C--N 1.338 0.682 0 O-C-N 124.565 1.165 . . . . 0.33000000000000002 113.903 170.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -83.59 113.09 20.59 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.901 0.858 . . . . 0.83999999999999997 109.723 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 15.9 m-85 -137.32 175.85 9.24 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.065 -1.425 . . . . 0.22 112.484 -170.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.69 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 79.9 m-85 -142.85 133.07 24.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.54000000000000004 110.896 -174.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.579 HD12 ' HB ' ' A' ' 161' ' ' THR . 82.6 mt -58.02 121.85 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.576 -0.738 . . . . 0.17000000000000001 110.84 172.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.556 HG21 ' HA ' ' A' ' 22' ' ' PHE . 22.7 pt -86.8 -35.25 8.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 113.157 0.799 . . . . 0.20999999999999999 113.157 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.536 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 11.6 p30 179.97 174.03 0.91 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.932 -1.136 . . . . 2.0299999999999998 107.932 -176.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.662 ' CB ' HD12 ' A' ' 116' ' ' LEU . 6.7 mtt180 -122.21 161.66 22.82 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.112 -0.635 . . . . 1.52 111.503 -170.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -143.84 102.41 3.9 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.222 0.534 . . . . 0.58999999999999997 110.898 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 63.7 ttt180 -65.95 166.89 10.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.38 -0.827 . . . . 2.8199999999999998 110.63 173.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.497 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 24.6 m-80 -35.49 104.52 0.26 Allowed Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 125.529 1.532 . . . . 0.34999999999999998 113.806 -160.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.3 Cg_endo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.785 2.324 . . . . 0.47999999999999998 111.745 171.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.597 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.569 1.675 0 N-CA-C 117.97 2.582 . . . . 0.47999999999999998 117.97 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.599 ' CE2' ' HB1' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -163.29 151.77 13.97 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.085 0.857 . . . . 0.28000000000000003 110.117 -176.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -135.16 98.3 3.95 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.227 -1.027 . . . . 0.48999999999999999 108.227 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.662 HD12 ' CB ' ' A' ' 103' ' ' ARG . 0.6 OUTLIER -85.79 118.56 25.37 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 121.097 -1.002 . . . . 0.66000000000000003 109.877 174.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.523 ' HB3' HD11 ' A' ' 101' ' ' ILE . 36.9 m -83.45 145.63 28.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.638 -0.71 . . . . 0.19 111.411 -170.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.764 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -109.73 170.5 8.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.13 110.797 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.567 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -62.87 -13.11 30.02 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.936 0.717 . . . . 1.1699999999999999 112.936 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.602 ' HB3' ' CG ' ' A' ' 123' ' ' TYR . 5.2 tptp -126.06 130.9 52.05 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.52 -0.472 . . . . 1.22 110.756 175.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.452 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 67.6 mt-30 -30.97 -58.99 0.22 Allowed 'General case' 0 C--N 1.317 -0.827 0 O-C-N 124.733 1.271 . . . . 1.51 114.054 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.643 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -96.08 8.19 44.42 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.551 -0.86 . . . . 2.5299999999999998 111.706 -171.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.764 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.3 m-85 -94.88 37.48 1.14 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.877 1.065 . . . . 0.83999999999999997 113.877 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -114.57 143.74 18.13 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 116.865 -2.588 . . . . 0.32000000000000001 112.665 -153.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -97.09 112.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.937 0.875 . . . . 0.17999999999999999 110.451 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.756 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.0 p80 -142.64 172.21 13.0 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.078 -0.964 . . . . 0.20999999999999999 109.592 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.7 -179.92 38.87 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 119.969 -1.11 . . . . 0.27000000000000002 111.791 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.5 t -142.89 170.96 14.73 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.79 -0.448 . . . . 0.40999999999999998 109.79 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -114.48 -4.75 12.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.9 0.857 . . . . 1.99 108.705 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -112.26 87.91 9.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.563 -1.198 . . . . 1.3600000000000001 108.178 168.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -73.4 -19.69 21.77 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.744 2.296 . . . . 0.34999999999999998 113.601 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.97 0.19 28.52 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.227 0.537 . . . . 0.33000000000000002 111.112 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 52.6 m -94.51 -1.49 53.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 1.3500000000000001 109.628 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 44.0 mm -82.83 137.82 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.98 -0.555 . . . . 0.20999999999999999 110.5 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.89 0.82 77.54 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.922 -1.271 . . . . 0.14999999999999999 109.922 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -111.68 167.42 10.36 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 122.932 1.349 . . . . 2.5 113.73 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.468 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -96.27 120.06 35.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.174 -2.285 . . . . 0.17000000000000001 107.442 173.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.35 160.47 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.508 -0.923 . . . . 0.66000000000000003 108.508 -172.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.588 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.1 m -52.55 -60.93 2.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 111.974 0.361 . . . . 0.42999999999999999 111.974 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -131.62 -46.57 0.97 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.09 -1.444 . . . . 2.02 113.78 -172.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.48 133.69 0.2 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 117.758 1.863 . . . . 0.17999999999999999 117.758 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.608 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 6.3 p -68.56 166.02 17.93 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 112.291 -1.954 . . . . 0.16 111.756 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.9 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 59.5 mt -59.48 98.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 122.596 1.189 . . . . 0.40000000000000002 112.114 -163.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.756 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 75.5 mtt180 -87.06 147.76 25.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.461 -1.7 . . . . 1.8700000000000001 110.7 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.627 ' HG2' HG22 ' A' ' 84' ' ' ILE . 12.7 mtp -125.29 -165.5 1.41 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.295 -0.632 . . . . 0.79000000000000004 109.295 173.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.657 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 25.4 t-80 -95.86 153.99 17.46 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.538 -0.755 . . . . 2.3199999999999998 108.997 173.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.646 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.5 m120 -57.11 -54.4 47.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.193 -0.908 . . . . 0.68000000000000005 110.856 -174.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.411 ' HG2' ' ND1' ' A' ' 146' ' ' HIS . 0.8 OUTLIER -63.93 -23.81 67.49 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 121.516 1.962 . . . . 2.1800000000000002 111.823 -175.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.657 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.3 m-20 -78.5 -46.72 18.95 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.01 -0.996 . . . . 0.68999999999999995 110.725 -176.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.583 HG13 HD12 ' A' ' 151' ' ' ILE . 13.7 p -67.97 -24.15 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.094 -0.957 . . . . 0.11 111.663 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.646 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -78.71 -39.41 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.483 -0.562 . . . . 0.38 109.483 171.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 156' ' ' ILE . 22.7 mt-10 -46.54 -72.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.901 0.773 . . . . 1.99 112.261 168.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.508 HD21 ' CE1' ' A' ' 82' ' ' TYR . 43.4 mt -49.79 -40.31 41.16 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.751 0.786 . . . . 1.27 111.532 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.599 ' HB1' ' CE2' ' A' ' 114' ' ' TYR . . . -56.14 -39.97 73.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.968 -1.469 . . . . 0.17999999999999999 111.415 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.2 t -87.86 -33.65 18.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.542 0.942 . . . . 0.20999999999999999 113.542 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 152' ' ' GLU . 43.7 mt -80.57 -60.2 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.617 0.723 . . . . 0.16 112.034 -170.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.9 m -86.61 145.69 39.91 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.793 -1.094 . . . . 0.16 112.049 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.493 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 63.8 Cg_endo -90.72 173.0 3.13 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.875 3.05 . . . . 0.20000000000000001 110.91 172.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.536 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 22.0 m-20 -64.87 158.23 25.72 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.744 -0.782 . . . . 1.1000000000000001 109.134 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 97.41 -19.63 53.95 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.079 -1.058 . . . . 0.17999999999999999 112.529 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' HD12 ' A' ' 100' ' ' ILE . 59.1 m -62.76 136.81 58.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.15 -0.685 . . . . 0.14000000000000001 109.15 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.69 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -92.61 122.7 35.28 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.771 1.272 . . . . 3.6299999999999999 111.18 -169.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.13 108.63 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 112.25 -2.25 . . . . 0.14000000000000001 109.159 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.3 m -94.23 107.7 19.62 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.521 0.563 . . . . 0.20999999999999999 112.521 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.428 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -86.14 97.41 5.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.991 0.9 . . . . 0.23999999999999999 110.253 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -110.98 135.52 51.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.853 -1.067 . . . . 1.0900000000000001 111.203 -173.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.599 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 14.8 mmm-85 . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.474 0.654 . . . . 2.0800000000000001 109.701 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.576 HD13 ' HA ' ' A' ' 49' ' ' PRO . 20.3 mt . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.047 0.451 . . . . 0.65000000000000002 110.872 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.8 tt -88.81 129.18 35.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.505 -0.77 . . . . 0.28000000000000003 109.756 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.14 161.11 14.11 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.138 -0.937 . . . . 0.31 112.944 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.6 ' HB3' HG13 ' A' ' 46' ' ' ILE . 86.2 t80 -129.6 140.66 51.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.715 -1.584 . . . . 0.44 107.781 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.438 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 63.3 tt0 -114.23 111.79 22.09 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.907 -1.145 . . . . 0.76000000000000001 107.907 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.653 HG13 ' HB2' ' A' ' 13' ' ' ASP . 97.7 t -66.2 151.2 10.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.353 1.073 . . . . 0.39000000000000001 112.697 -169.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -108.02 158.07 17.7 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.554 -1.657 . . . . 2.0099999999999998 108.325 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.62 107.34 0.38 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.183 0.516 . . . . 1.8300000000000001 112.092 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.77 11.79 39.49 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.686 -0.688 . . . . 0.47999999999999998 113.57 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.653 ' HB2' HG13 ' A' ' 9' ' ' VAL . 70.9 m-20 -55.97 167.63 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.953 0.376 . . . . 1.46 110.961 172.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -128.19 152.96 47.42 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.914 0.388 . . . . 0.40999999999999998 111.176 174.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.526 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -64.38 -38.86 92.52 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.103 -1.073 . . . . 0.85999999999999999 108.103 -177.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.409 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 65.3 t30 -86.44 -22.04 26.74 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.512 -1.222 . . . . 1.1499999999999999 110.715 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.446 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 17.4 t -67.98 -40.12 83.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.177 -0.675 . . . . 1.21 109.177 171.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.2 mt -75.32 -27.78 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.146 0.498 . . . . 0.20999999999999999 109.937 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.54 -10.01 59.72 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.517 -0.31 . . . . 0.16 110.795 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.707 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.09 -40.27 9.31 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 107.929 -1.137 . . . . 0.20999999999999999 107.929 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 3.0 m-20 -62.19 -42.77 99.59 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.544 -2.116 . . . . 0.53000000000000003 112.303 173.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 119' ' ' SER . 57.5 m-85 -99.42 6.73 45.93 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 118.876 -1.13 . . . . 0.17999999999999999 111.129 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.707 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.76 41.06 32.2 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.765 0.793 . . . . 1.78 109.541 176.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.62 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.8 pt -116.8 -165.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.287 -1.324 . . . . 0.19 110.215 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.52 143.88 40.19 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.99 -1.005 . . . . 0.94999999999999996 110.244 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.526 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 44.3 p -72.18 -31.76 66.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.037 -1.097 . . . . 0.25 108.037 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -31.09 69.98 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.703 -0.68 . . . . 0.20000000000000001 111.659 171.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.32 -28.27 17.85 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.641 0.734 . . . . 0.17000000000000001 109.029 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.568 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -73.67 -28.04 61.55 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.046 -0.979 . . . . 1.1599999999999999 109.404 174.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 36' ' ' LEU . 42.5 mt -76.63 -30.99 57.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.836 0.827 . . . . 1.05 109.991 170.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 43.3 tt0 -65.61 -33.75 76.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.19 -1.368 . . . . 1.8100000000000001 110.095 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -88.57 -22.74 23.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 119.849 -0.74 . . . . 0.20000000000000001 111.805 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.643 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 19.1 m-80 -147.85 82.7 7.76 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.41 0.624 . . . . 0.23000000000000001 110.517 -171.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.26 -15.93 16.07 Favored 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 124.124 3.216 . . . . 0.35999999999999999 114.03 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 t -74.72 -22.65 58.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.75 0.31 . . . . 1.3799999999999999 111.391 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.71 HD21 HG21 ' A' ' 46' ' ' ILE . 35.6 mt -69.45 -36.11 76.31 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.568 0.581 . . . . 0.48999999999999999 112.568 -169.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 5.4 pt20 -64.07 -45.17 89.93 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 122.917 1.342 . . . . 1.95 110.135 -175.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.64 -49.04 79.12 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 111.796 -2.456 . . . . 0.48999999999999999 110.712 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.87 -179.85 48.11 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 114.932 -1.031 . . . . 0.41999999999999998 111.693 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.43 158.97 22.69 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.204 0.526 . . . . 0.40999999999999998 110.66 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.546 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 60.4 m -139.35 127.89 23.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.542 -0.754 . . . . 0.41999999999999998 110.385 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.49 121.51 21.61 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.576 0.703 . . . . 0.46999999999999997 110.313 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.7 3.56 60.89 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 114.733 -1.121 . . . . 0.40999999999999998 110.468 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.546 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -80.22 124.93 29.24 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.202 -0.499 . . . . 1.3 109.91 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.8 m -77.7 130.35 36.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.152 -0.931 . . . . 0.84999999999999998 109.781 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.71 HG21 HD21 ' A' ' 36' ' ' LEU . 6.7 pt -132.01 143.63 39.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.671 -1.15 . . . . 0.25 109.085 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -90.69 153.74 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.311 0.576 . . . . 0.67000000000000004 111.612 -178.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.5 mm -118.24 93.6 45.3 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.597 -1.183 . . . . 0.16 109.03 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.576 ' HA ' HD13 ' A' ' 4' ' ' LEU . 2.5 Cg_endo -59.05 137.39 79.28 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.775 2.316 . . . . 0.17999999999999999 112.745 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.46 -6.24 83.8 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.906 -1.043 . . . . 0.26000000000000001 112.387 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.743 HD12 ' HD2' ' A' ' 52' ' ' PRO . 26.9 tp -122.73 118.05 28.57 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.904 0.383 . . . . 0.60999999999999999 110.721 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.743 ' HD2' HD12 ' A' ' 51' ' ' LEU . 57.9 Cg_endo -80.3 -176.68 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.649 2.9 . . . . 0.28000000000000003 114.037 -172.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.538 ' HB3' HG23 ' A' ' 56' ' ' THR . 13.3 t70 -80.69 132.25 58.48 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.726 -1.124 . . . . 0.48999999999999999 111.629 -171.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.577 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.8 Cg_endo -76.28 -16.13 17.63 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 123.395 2.73 . . . . 0.46000000000000002 112.694 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -95.58 -1.04 51.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.706 0.765 . . . . 1.3799999999999999 110.135 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 53' ' ' ASP . 27.1 p -94.66 -16.98 22.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.657 1.217 . . . . 0.46000000000000002 107.822 173.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 59' ' ' TYR . 25.6 mt -78.64 128.73 76.35 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 112.947 -1.933 . . . . 0.69999999999999996 111.132 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.417 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 97.8 Cg_endo -76.75 -17.23 15.99 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.444 2.096 . . . . 0.39000000000000001 113.194 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.533 ' H ' HG22 ' A' ' 57' ' ' ILE . 61.4 m-85 -94.74 164.91 12.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.392 -0.523 . . . . 0.23999999999999999 112.153 -176.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -152.68 128.01 9.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.533 -0.914 . . . . 2.8900000000000001 108.533 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 71' ' ' THR . 95.4 mt -110.02 132.67 57.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.135 -0.484 . . . . 0.16 111.759 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.21 117.01 28.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.004 -0.678 . . . . 0.16 111.09 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.84 112.85 31.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.814 0.816 . . . . 0.19 111.273 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 16.5 m -93.23 102.73 15.02 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.682 -1.145 . . . . 0.20000000000000001 110.543 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.546 HD13 HG11 ' A' ' 86' ' ' VAL . 50.5 mm -52.15 -58.49 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 122.04 0.924 . . . . 0.23000000000000001 111.213 169.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.22 -11.39 3.34 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 112.955 -1.93 . . . . 0.16 113.244 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.72 -18.6 4.71 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.572 0.749 . . . . 0.14999999999999999 112.455 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER 57.77 56.39 4.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.555 0.616 . . . . 0.68999999999999995 111.431 -172.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.5 p -137.66 161.49 36.34 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 112.669 0.618 . . . . 0.13 112.669 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -131.49 113.4 13.64 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.704 -1.135 . . . . 0.40000000000000002 110.122 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 66.7 m -94.23 122.95 37.3 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.324 0.583 . . . . 0.16 111.542 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 79' ' ' MET . 15.5 tp -97.56 103.2 15.12 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.906 -1.043 . . . . 0.58999999999999997 109.369 172.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.2 m -105.47 159.93 15.54 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.475 -0.89 . . . . 1.05 110.579 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.918 HD13 HD22 ' A' ' 75' ' ' ASN . 1.2 tm? -126.73 128.37 46.55 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.853 -0.795 . . . . 0.26000000000000001 108.853 169.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.918 HD22 HD13 ' A' ' 74' ' ' LEU . 6.6 p30 43.61 49.01 6.53 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.128 1.371 . . . . 1.8400000000000001 111.574 -167.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 84.2 m-20 75.85 -11.99 1.05 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.127 -0.942 . . . . 1.8899999999999999 112.317 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -96.99 120.82 38.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.207 0.527 . . . . 3.4399999999999999 110.095 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.494 HG22 ' CG2' ' A' ' 71' ' ' THR . 55.1 t -56.15 132.44 20.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 122.316 1.055 . . . . 0.23999999999999999 112.998 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 7.9 mtm -102.59 -43.83 5.51 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.074 -1.875 . . . . 0.81000000000000005 109.285 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.6 mmtt -157.92 172.15 18.98 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 113.107 -1.861 . . . . 1.46 109.874 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.0 m -149.8 122.28 8.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.417 -1.265 . . . . 0.17000000000000001 109.808 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -109.71 145.82 32.77 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 115.454 -0.794 . . . . 1.05 109.637 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.446 ' HB2' HG22 ' A' ' 134' ' ' ILE . 41.7 Cg_endo -74.61 142.12 28.78 Favored 'Trans proline' 0 CA--C 1.499 -1.26 0 C-N-CA 121.902 1.734 . . . . 0.20000000000000001 110.903 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.663 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.01 175.71 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.922 -0.581 . . . . 0.13 110.717 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.879 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -120.76 148.55 43.82 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.418 -0.355 . . . . 0.26000000000000001 110.092 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.546 HG11 HD13 ' A' ' 65' ' ' ILE . 9.6 m -128.75 129.76 68.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.481 0.658 . . . . 0.56000000000000005 111.899 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.6 154.6 27.23 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.21 -1.156 . . . . 0.17000000000000001 110.21 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -56.27 3.08 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.321 0.86 . . . . 3.0499999999999998 113.321 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.917 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -89.17 -19.96 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 121.534 0.683 . . . . 0.23000000000000001 110.417 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.917 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -89.72 -18.25 26.73 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.716 0.77 . . . . 0.17999999999999999 109.288 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.9 p -66.81 -14.47 62.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.385 -1.279 . . . . 0.33000000000000002 111.649 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.3 -39.56 89.41 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.74 -1.118 . . . . 1.52 111.973 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.51 130.97 22.17 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.571 -0.452 . . . . 0.42999999999999999 111.028 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.658 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 87.0 Cg_endo -90.1 -13.87 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.7 2.267 . . . . 0.72999999999999998 112.73 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.0 t -104.92 -41.0 5.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.758 -0.656 . . . . 0.47999999999999998 109.25 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.553 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 44.87 46.04 9.21 Favored Glycine 0 N--CA 1.446 -0.644 0 O-C-N 124.404 1.065 . . . . 0.33000000000000002 113.692 171.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.79 111.37 19.13 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.891 0.853 . . . . 0.83999999999999997 109.557 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.719 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 21.4 m-85 -139.41 171.94 13.53 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.89 -1.505 . . . . 0.22 112.366 -171.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.58 ' CD1' ' HB3' ' A' ' 162' ' ' ARG . 28.2 m-85 -140.99 136.15 31.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.739 -0.664 . . . . 0.54000000000000004 110.131 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.55 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.1 mt -58.62 123.23 10.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.421 -0.809 . . . . 0.17000000000000001 110.55 172.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.55 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.8 pt -88.05 -44.08 15.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 113.014 0.746 . . . . 0.20999999999999999 113.014 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.462 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 56.2 m-80 -171.69 169.54 5.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 106.783 -1.562 . . . . 2.0299999999999998 106.783 -169.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.596 ' HB3' HD23 ' A' ' 116' ' ' LEU . 5.6 mtt180 -128.17 163.45 24.65 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.773 -0.771 . . . . 1.52 112.198 -173.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.4 tt0 -136.85 99.91 4.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.921 -1.036 . . . . 0.58999999999999997 109.713 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.475 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 30.8 ttp180 -67.05 166.52 13.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.24 -0.891 . . . . 2.8199999999999998 111.006 176.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.475 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 29.1 m-80 -36.44 102.23 0.23 Allowed Pre-proline 0 CA--C 1.518 -0.28 0 C-N-CA 125.439 1.496 . . . . 0.34999999999999998 113.951 -152.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 14.5 Cg_exo . . . . . 0 N--CA 1.457 -0.648 0 C-N-CA 123.513 2.809 . . . . 0.47999999999999998 111.528 170.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.533 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.489 0 N-CA-C 116.915 2.191 . . . . 0.47999999999999998 116.915 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.44 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -166.06 161.35 17.2 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.385 -0.822 . . . . 0.28000000000000003 110.028 -177.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 12.6 t-105 -141.83 98.93 3.43 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.25 -1.018 . . . . 0.48999999999999999 108.25 166.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 103' ' ' ARG . 4.4 mt -91.95 114.49 27.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.521 0.677 . . . . 0.66000000000000003 109.414 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.425 ' HB3' HD11 ' A' ' 101' ' ' ILE . 26.0 m -84.23 144.55 28.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.986 -0.552 . . . . 0.19 111.368 -169.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -108.35 172.14 7.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.903 -0.59 . . . . 0.13 110.568 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.533 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -64.49 -11.14 30.77 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.894 0.701 . . . . 1.1699999999999999 112.894 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.735 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.3 tmtp? -126.51 130.61 50.94 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 120.626 -0.43 . . . . 1.22 110.405 174.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.735 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.2 mt-30 -34.77 -54.88 0.57 Allowed 'General case' 0 C--N 1.311 -1.074 0 O-C-N 124.953 1.408 . . . . 1.51 113.555 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.59 ' CB ' HG12 ' A' ' 89' ' ' ILE . 46.8 m80 -91.19 -1.49 57.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.867 -0.606 . . . . 2.5299999999999998 111.216 -169.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.777 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -94.29 37.88 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.534 0.938 . . . . 0.83999999999999997 113.534 -171.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.644 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.23 144.41 18.42 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 117.026 -2.511 . . . . 0.32000000000000001 112.601 -153.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.507 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -96.78 114.89 34.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 123.775 0.83 . . . . 0.17999999999999999 110.763 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.445 ' O ' ' N ' ' A' ' 145' ' ' MET . 26.8 p80 -143.53 175.97 9.54 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.4 -0.818 . . . . 0.20999999999999999 109.721 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.65 -166.98 37.8 Favored Glycine 0 C--N 1.314 -0.672 0 C-N-CA 120.49 -0.862 . . . . 0.27000000000000002 111.816 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.3 t -157.24 171.4 20.49 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.063 -0.669 . . . . 0.40999999999999998 110.627 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -115.12 -2.16 12.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.286 -1.005 . . . . 1.99 108.286 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -113.19 85.78 8.75 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.506 -1.224 . . . . 1.3600000000000001 108.669 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -74.25 -19.07 20.2 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.363 2.042 . . . . 0.34999999999999998 113.102 -170.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.51 -2.29 49.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.733 -0.667 . . . . 0.33000000000000002 110.35 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.2 t -89.33 -6.33 56.77 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.042 -0.725 . . . . 1.3500000000000001 109.042 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' ' 83' ' ' PRO . 39.6 mm -81.82 137.11 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.485 -0.78 . . . . 0.20999999999999999 110.392 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.91 2.19 69.5 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.172 -1.171 . . . . 0.14999999999999999 110.172 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.41 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 42.9 mttt -115.12 171.77 7.47 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 123.178 1.466 . . . . 2.5 114.0 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.51 126.73 50.84 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 111.613 -2.54 . . . . 0.17000000000000001 107.736 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.407 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -122.5 159.73 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 108.662 -0.866 . . . . 0.66000000000000003 108.662 -174.467 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.9 m -49.5 -60.01 3.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.699 0.629 . . . . 0.42999999999999999 112.699 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -132.74 -44.79 0.88 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.614 -1.234 . . . . 2.02 113.549 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.46 133.19 0.21 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 117.077 1.591 . . . . 0.17999999999999999 117.077 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.457 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.8 p -70.59 165.72 22.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.353 -1.923 . . . . 0.16 111.808 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.879 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 57.6 mt -59.7 98.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 122.393 1.092 . . . . 0.40000000000000002 112.002 -163.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 134' ' ' ILE . 9.8 mtp180 -85.06 148.52 26.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.515 -1.675 . . . . 1.8700000000000001 109.937 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.663 ' HG2' HG22 ' A' ' 84' ' ' ILE . 14.8 mtp -127.52 -165.9 1.54 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.33 -0.619 . . . . 0.79000000000000004 109.33 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.735 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 10.5 t-160 -95.96 154.49 17.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.523 -0.917 . . . . 2.3199999999999998 108.523 172.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.9 m120 -58.2 -51.1 71.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 118.388 -0.815 . . . . 0.68000000000000005 110.641 -176.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -64.42 -22.64 67.02 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 121.223 1.829 . . . . 2.1800000000000002 112.516 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.735 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 13.3 m-20 -85.3 -42.46 14.59 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.036 -0.529 . . . . 0.68999999999999995 111.263 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.637 HG13 HD12 ' A' ' 151' ' ' ILE . 14.7 p -67.78 -23.03 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.913 -0.585 . . . . 0.11 111.193 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.637 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.78 -40.66 16.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 118.846 -0.597 . . . . 0.38 110.02 171.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.8 mm-40 -44.59 -72.57 0.06 Allowed 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 119.426 1.012 . . . . 1.99 112.293 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.529 ' O ' HG22 ' A' ' 157' ' ' VAL . 49.7 mt -47.42 -40.08 17.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.686 0.755 . . . . 1.27 111.269 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.05 77.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.098 -1.41 . . . . 0.17999999999999999 111.785 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.3 t -89.01 -31.78 17.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.56 -0.713 . . . . 0.20999999999999999 112.694 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 152' ' ' GLU . 28.5 mt -82.0 -60.53 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.612 0.72 . . . . 0.16 111.339 -172.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.3 m -89.19 140.74 28.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.786 -1.097 . . . . 0.16 111.907 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -88.17 173.84 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.969 3.113 . . . . 0.20000000000000001 111.062 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.462 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 77.4 m-20 -65.41 155.76 34.41 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 119.723 -0.791 . . . . 1.1000000000000001 109.187 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.6 -20.02 52.07 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.125 -1.036 . . . . 0.17999999999999999 112.494 -173.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.55 ' HB ' HD12 ' A' ' 100' ' ' ILE . 91.2 m -63.21 138.03 58.41 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 117.419 0.61 . . . . 0.14000000000000001 109.476 -174.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.58 ' HB3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -93.03 123.31 36.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.784 1.278 . . . . 3.6299999999999999 111.002 -169.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.95 108.56 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 111.94 -2.391 . . . . 0.14000000000000001 109.022 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.8 m -94.43 108.05 19.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.069 -0.514 . . . . 0.20999999999999999 112.307 -171.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.553 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.19 101.15 7.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.152 0.977 . . . . 0.23999999999999999 109.963 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -108.43 128.36 54.71 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.389 -1.278 . . . . 1.0900000000000001 109.794 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.658 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 18.3 mmm180 . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 120.838 0.351 . . . . 2.0800000000000001 111.008 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp . . . . . 0 CA--C 1.52 -0.201 0 CA-C-O 121.701 0.762 . . . . 0.65000000000000002 112.824 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.646 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.0 tt -102.54 133.04 48.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.5 -1.227 . . . . 0.28000000000000003 110.265 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.39 162.96 12.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.41 1.1 . . . . 0.31 113.839 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.644 ' HB3' HG13 ' A' ' 46' ' ' ILE . 87.8 t80 -129.14 140.29 51.6 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.243 -1.799 . . . . 0.44 107.596 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.442 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.9 tt0 -112.89 112.64 24.26 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.185 -1.042 . . . . 0.76000000000000001 108.185 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.605 HG13 ' HB2' ' A' ' 13' ' ' ASP . 92.7 t -65.7 149.67 11.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 122.264 1.031 . . . . 0.39000000000000001 112.679 -171.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -106.27 159.48 16.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.768 -1.56 . . . . 2.0099999999999998 108.487 171.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -61.41 106.06 0.59 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.213 0.53 . . . . 1.8300000000000001 112.379 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.7 11.2 35.84 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.518 -0.765 . . . . 0.47999999999999998 113.395 172.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.605 ' HB2' HG13 ' A' ' 9' ' ' VAL . 84.1 m-20 -53.69 167.62 0.23 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.829 0.347 . . . . 1.46 111.006 172.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -125.95 150.86 47.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.229 0.538 . . . . 0.40999999999999998 111.145 175.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.66 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.95 -38.14 89.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.16 -1.052 . . . . 0.85999999999999999 108.16 -178.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.52 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -84.69 -25.9 28.09 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.37 -1.286 . . . . 1.1499999999999999 110.532 -177.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.466 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 30.7 t -64.62 -43.25 94.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.396 -0.594 . . . . 1.21 109.396 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.7 mt -72.8 -26.69 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.15 0.5 . . . . 0.20999999999999999 109.692 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.73 -11.18 59.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.251 -0.431 . . . . 0.16 110.531 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.691 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -90.9 -41.94 10.87 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.595 0.712 . . . . 0.20999999999999999 109.77 171.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.749 ' HB3' ' O ' ' A' ' 119' ' ' SER . 83.6 m-20 -61.65 -44.65 96.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.247 -1.342 . . . . 0.53000000000000003 111.473 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.594 ' CE2' ' HB3' ' A' ' 119' ' ' SER . 54.3 m-85 -99.47 6.63 45.88 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.69 -1.204 . . . . 0.17999999999999999 111.471 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.691 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER 53.87 43.26 31.18 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.71 0.767 . . . . 1.78 109.616 177.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 36.2 pt -115.75 -165.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.773 -1.103 . . . . 0.19 110.35 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.71 142.87 40.29 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.916 -1.038 . . . . 0.94999999999999996 109.801 174.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.574 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 68.2 p -72.95 -30.88 64.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.626 -0.879 . . . . 0.25 108.626 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.05 -27.06 69.15 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.494 -0.776 . . . . 0.20000000000000001 111.625 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.618 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -94.31 -27.11 16.28 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.573 0.701 . . . . 0.17000000000000001 109.148 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.66 HD23 HD23 ' A' ' 15' ' ' LEU . 17.8 tp -73.55 -28.43 61.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.153 -0.93 . . . . 1.1599999999999999 108.636 172.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 26' ' ' THR . 7.7 tp -78.52 -28.79 46.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.582 0.706 . . . . 1.05 109.769 175.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.618 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -58.48 -60.48 3.74 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.472 -1.307 . . . . 1.8100000000000001 107.472 167.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.439 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -71.57 -17.41 62.3 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 120.313 -0.555 . . . . 0.20000000000000001 110.973 -169.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.61 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.7 m-80 -146.99 81.04 9.19 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 115.729 -0.669 . . . . 0.23000000000000001 110.532 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.87 -10.32 5.41 Favored 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 124.065 3.177 . . . . 0.35999999999999999 113.411 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -78.62 -19.91 51.59 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.841 0.312 . . . . 1.3799999999999999 111.841 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.704 HD21 HG21 ' A' ' 46' ' ' ILE . 63.1 mt -70.63 -34.49 72.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.312 0.577 . . . . 0.48999999999999999 112.205 -171.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.438 ' CB ' HD11 ' A' ' 30' ' ' LEU . 3.8 pt20 -64.4 -47.21 80.07 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 122.805 1.288 . . . . 1.95 110.539 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.59 -49.67 75.65 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 111.729 -2.487 . . . . 0.48999999999999999 110.242 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.38 178.93 48.65 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 114.775 -1.102 . . . . 0.41999999999999998 111.912 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 157.35 19.43 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.392 0.615 . . . . 0.40999999999999998 110.619 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.616 ' HB ' ' HB2' ' A' ' 44' ' ' GLN . 83.5 m -143.62 130.89 20.83 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.169 -0.923 . . . . 0.41999999999999998 110.062 -176.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.75 120.08 20.64 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.526 0.679 . . . . 0.46999999999999997 110.221 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.442 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 101.35 0.97 53.82 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.709 -1.356 . . . . 0.40999999999999998 109.709 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.616 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 47.4 tt0 -72.74 123.62 23.68 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.148 -1.026 . . . . 1.3 109.915 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 15.7 p -84.11 127.28 33.81 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 122.019 0.914 . . . . 0.84999999999999998 110.068 175.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.704 HG21 HD21 ' A' ' 36' ' ' LEU . 10.9 pt -127.33 140.72 48.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.178 -1.374 . . . . 0.25 109.033 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.15 150.7 3.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 120.995 0.426 . . . . 0.67000000000000004 110.885 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.2 mm -114.83 92.9 31.84 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.731 -1.122 . . . . 0.16 108.845 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.652 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.8 Cg_endo -58.65 132.96 51.13 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.69 2.26 . . . . 0.17999999999999999 112.835 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.05 -5.79 72.3 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 114.703 -1.135 . . . . 0.26000000000000001 111.983 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.658 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 38.7 tp -123.82 115.67 27.89 Favored Pre-proline 0 N--CA 1.448 -0.569 0 CA-C-O 121.222 0.534 . . . . 0.60999999999999999 111.75 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.653 ' HD2' HD12 ' A' ' 51' ' ' LEU . 61.1 Cg_endo -81.57 -176.74 3.22 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 124.204 3.27 . . . . 0.28000000000000003 114.808 -172.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.562 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.6 t70 -81.04 128.96 69.3 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 113.968 -1.469 . . . . 0.48999999999999999 112.269 -170.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 52.3 Cg_endo -73.87 -14.36 24.03 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.629 2.886 . . . . 0.46000000000000002 113.139 -177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.84 -5.6 37.92 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.891 -0.595 . . . . 1.3799999999999999 111.402 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.562 HG23 ' HB3' ' A' ' 53' ' ' ASP . 28.0 p -89.15 -21.87 23.11 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.49 -1.3 . . . . 0.46000000000000002 107.49 171.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 59' ' ' TYR . 21.2 mt -75.23 128.04 85.32 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 112.847 -1.979 . . . . 0.69999999999999996 111.119 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.4 -18.29 15.93 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.473 2.115 . . . . 0.39000000000000001 113.216 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.531 ' H ' HG22 ' A' ' 57' ' ' ILE . 56.4 m-85 -94.82 161.48 14.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.297 -0.561 . . . . 0.23999999999999999 111.628 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -151.15 124.65 8.95 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.655 -0.869 . . . . 2.8900000000000001 108.655 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 71' ' ' THR . 97.5 mt -106.44 131.38 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.867 -0.606 . . . . 0.16 111.391 -176.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.66 117.28 29.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.834 -0.746 . . . . 0.16 111.341 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 69' ' ' THR . 60.0 t -97.5 117.04 41.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.573 0.702 . . . . 0.19 111.207 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 19.3 m -95.31 106.2 18.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.974 -1.012 . . . . 0.20000000000000001 110.61 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.584 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.6 mm -54.46 -58.65 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 122.202 1.001 . . . . 0.23000000000000001 111.099 167.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.95 -7.86 3.94 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 112.836 -1.984 . . . . 0.16 113.292 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -127.96 -19.4 4.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.399 0.679 . . . . 0.14999999999999999 112.671 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.518 ' HD2' ' CG2' ' A' ' 86' ' ' VAL . 0.0 OUTLIER 58.5 56.37 4.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.669 0.668 . . . . 0.68999999999999995 111.624 -171.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 42.4 p -137.62 162.23 34.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.009 0.744 . . . . 0.13 113.009 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.466 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -130.16 113.83 14.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.632 -1.167 . . . . 0.40000000000000002 110.023 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.708 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 22.0 m -94.81 122.97 37.98 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.172 0.511 . . . . 0.16 111.391 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 79' ' ' MET . 15.3 tp -98.35 104.39 16.42 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.416 -0.811 . . . . 0.58999999999999997 109.628 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 7.7 m -105.22 159.98 15.45 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.531 -0.867 . . . . 1.05 110.78 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.817 HD13 HD22 ' A' ' 75' ' ' ASN . 1.1 tm? -128.92 128.55 44.01 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.856 -0.794 . . . . 0.26000000000000001 108.856 169.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.817 HD22 HD13 ' A' ' 74' ' ' LEU . 8.9 p30 46.54 48.64 14.01 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.132 1.373 . . . . 1.8400000000000001 111.287 -166.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.9 t30 72.93 -9.45 1.11 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.038 -0.983 . . . . 1.8899999999999999 111.333 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -96.3 120.7 37.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.737 -0.665 . . . . 3.4399999999999999 109.764 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 69.7 t -58.3 132.25 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-O 122.311 1.053 . . . . 0.23999999999999999 112.606 -174.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 12.1 mtm -101.18 -45.5 5.35 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.206 -1.816 . . . . 0.81000000000000005 109.151 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 13.7 mmmt -157.75 171.15 20.83 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.423 -1.717 . . . . 1.46 109.571 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -148.74 123.33 9.79 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.677 -1.147 . . . . 0.17000000000000001 109.848 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -111.11 148.29 38.38 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.743 -0.662 . . . . 1.05 109.995 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.445 ' HB2' HG22 ' A' ' 134' ' ' ILE . 48.1 Cg_endo -75.43 142.71 26.91 Favored 'Trans proline' 0 CA--C 1.498 -1.295 0 C-N-CA 122.113 1.875 . . . . 0.20000000000000001 110.848 175.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.643 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.6 175.0 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.718 -0.674 . . . . 0.13 110.754 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.89 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.17 146.39 45.2 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.311 -0.404 . . . . 0.26000000000000001 110.153 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.518 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 7.5 m -127.23 130.18 70.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.558 0.694 . . . . 0.56000000000000005 111.625 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.4 153.38 26.27 Favored Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 110.012 -1.235 . . . . 0.17000000000000001 110.012 172.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -56.12 3.3 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.238 0.829 . . . . 3.0499999999999998 113.238 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.868 HG23 HD22 ' A' ' 90' ' ' LEU . 1.8 tp -91.48 -18.55 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 121.555 0.693 . . . . 0.23000000000000001 110.46 -178.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.868 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -88.86 -18.19 28.12 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.757 -0.656 . . . . 0.17999999999999999 109.398 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.8 p -65.56 -19.4 65.91 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.627 -1.17 . . . . 0.33000000000000002 111.778 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -57.64 -42.47 83.47 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.14 -0.936 . . . . 1.52 111.941 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.37 120.9 48.03 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-O 120.867 0.365 . . . . 0.42999999999999999 111.582 -174.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 2.2 Cg_endo -76.84 -16.18 16.41 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.794 2.329 . . . . 0.72999999999999998 113.262 177.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 t -106.58 -41.25 5.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.491 -0.559 . . . . 0.47999999999999998 109.491 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.472 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 46.6 48.6 17.12 Favored Glycine 0 N--CA 1.446 -0.636 0 O-C-N 124.374 1.047 . . . . 0.33000000000000002 113.585 170.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.01 111.83 19.22 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.808 0.813 . . . . 0.83999999999999997 109.728 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -137.7 169.44 17.78 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.141 -1.391 . . . . 0.22 112.326 -172.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.502 ' CG ' HD11 ' A' ' 5' ' ' LEU . 19.3 m-85 -141.25 134.84 30.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.656 -0.702 . . . . 0.54000000000000004 110.241 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.555 HD12 ' HB ' ' A' ' 161' ' ' THR . 81.1 mt -58.62 117.83 2.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.507 -0.77 . . . . 0.17000000000000001 110.695 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.53 HG21 ' HA ' ' A' ' 22' ' ' PHE . 22.4 pt -82.87 -43.56 18.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 112.604 0.594 . . . . 0.20999999999999999 112.604 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.564 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 52.9 m-80 -170.7 168.97 7.27 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.787 -1.56 . . . . 2.0299999999999998 106.787 -170.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.576 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -133.95 152.97 52.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.207 -0.597 . . . . 1.52 111.944 -175.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 50.7 tt0 -128.46 103.0 6.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.45 -0.796 . . . . 0.58999999999999997 110.161 175.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.461 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 38.0 ttt180 -62.92 166.85 5.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.334 -0.848 . . . . 2.8199999999999998 110.411 173.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.497 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 19.9 m-80 -35.32 103.51 0.24 Allowed Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 125.097 1.359 . . . . 0.34999999999999998 113.373 -156.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.497 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.8 Cg_endo . . . . . 0 C--N 1.347 0.457 0 C-N-CA 123.026 2.484 . . . . 0.47999999999999998 111.084 172.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.558 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.563 1.47 0 N-CA-C 117.334 2.346 . . . . 0.47999999999999998 117.334 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.465 ' CD1' HG13 ' A' ' 151' ' ' ILE . 0.5 OUTLIER -164.63 160.79 20.44 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.426 -0.796 . . . . 0.28000000000000003 110.372 -175.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 24.4 t-105 -141.62 98.67 3.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.693 -0.854 . . . . 0.48999999999999999 108.693 168.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 103' ' ' ARG . 2.4 mt -90.69 114.49 26.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.342 0.591 . . . . 0.66000000000000003 109.428 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.44 ' C ' HG12 ' A' ' 101' ' ' ILE . 14.5 m -84.8 144.83 28.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.014 -0.539 . . . . 0.19 111.384 -170.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.781 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -109.58 168.98 9.0 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.32 -0.4 . . . . 0.13 111.145 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.749 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -60.68 -10.87 5.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.074 0.768 . . . . 1.1699999999999999 113.074 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.548 ' HG3' ' H ' ' A' ' 122' ' ' HIS . 14.8 tppt? -127.38 131.38 50.34 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.642 0.734 . . . . 1.22 110.185 171.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.467 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 8.5 pt20 -47.44 -31.61 4.3 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.323 -1.762 . . . . 1.51 114.872 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.548 ' H ' ' HG3' ' A' ' 120' ' ' LYS . 60.5 m80 -97.37 -8.48 29.46 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.692 -0.803 . . . . 2.5299999999999998 112.312 -177.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.781 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.4 m-30 -94.82 40.07 1.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.185 1.18 . . . . 0.83999999999999997 114.185 -168.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.694 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -112.0 145.17 17.85 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 116.376 -2.821 . . . . 0.32000000000000001 112.509 -153.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.32 115.99 37.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.787 0.803 . . . . 0.17999999999999999 110.762 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.643 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.3 p80 -145.12 172.2 13.43 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.344 -0.844 . . . . 0.20999999999999999 109.462 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.28 -168.2 38.76 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 120.157 -1.021 . . . . 0.27000000000000002 111.724 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.7 t -154.6 171.45 19.45 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.908 -0.76 . . . . 0.40999999999999998 111.325 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -113.48 -11.44 13.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.564 -0.902 . . . . 1.99 108.564 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -107.45 86.97 3.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.216 -1.031 . . . . 1.3600000000000001 108.216 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.37 -18.6 29.75 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.355 2.037 . . . . 0.34999999999999998 112.906 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.46 -0.12 40.28 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.402 -0.817 . . . . 0.33000000000000002 111.077 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.473 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 98.2 p -91.59 -6.58 52.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.022 -0.733 . . . . 1.3500000000000001 109.022 171.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 83' ' ' PRO . 40.5 mm -78.82 135.69 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.399 -0.819 . . . . 0.20999999999999999 110.141 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.18 0.71 70.48 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.366 -1.093 . . . . 0.14999999999999999 110.366 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 50.3 mttm -115.02 176.31 5.12 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 123.629 1.68 . . . . 2.5 114.088 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -105.61 129.31 53.88 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.655 -2.975 . . . . 0.17000000000000001 108.157 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.469 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -125.22 158.85 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.95 -0.759 . . . . 0.66000000000000003 108.95 -175.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 67.9 m -47.45 -59.61 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.712 0.634 . . . . 0.42999999999999999 112.712 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -131.44 -44.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.014 -1.075 . . . . 2.02 113.304 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.27 132.7 0.21 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 117.082 1.593 . . . . 0.17999999999999999 117.082 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.489 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.9 p -71.5 165.15 24.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.359 -1.921 . . . . 0.16 111.874 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.89 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 60.6 mt -59.83 98.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 114.841 -1.072 . . . . 0.40000000000000002 111.857 -163.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.643 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 74.8 mtt180 -84.52 149.58 25.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.676 -1.602 . . . . 1.8700000000000001 110.33 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.643 ' HG2' HG22 ' A' ' 84' ' ' ILE . 15.9 mtp -129.29 -165.4 1.51 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.002 -0.74 . . . . 0.79000000000000004 109.002 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.645 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 3.5 t-160 -96.28 157.36 15.93 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.59 -0.893 . . . . 2.3199999999999998 108.59 171.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.644 ' O ' HD13 ' A' ' 151' ' ' ILE . 3.7 m120 -59.03 -51.07 71.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 118.285 -0.864 . . . . 0.68000000000000005 110.549 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -64.42 -27.09 68.76 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 121.562 1.983 . . . . 2.1800000000000002 112.491 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.645 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 5.8 m-20 -79.03 -43.23 24.68 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.048 0.452 . . . . 0.68999999999999995 110.658 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.638 HG13 HD12 ' A' ' 151' ' ' ILE . 14.4 p -69.08 -23.85 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.645 -0.707 . . . . 0.11 111.539 177.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.06 -42.09 18.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 119.126 -0.464 . . . . 0.38 109.954 171.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 156' ' ' ILE . 22.5 mt-10 -46.79 -69.42 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 119.058 0.845 . . . . 1.99 112.407 170.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 157' ' ' VAL . 37.0 mt -47.71 -40.2 19.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.509 0.671 . . . . 1.27 111.517 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.68 -35.6 76.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.21 -1.359 . . . . 0.17999999999999999 111.41 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.8 t -87.29 -29.77 21.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.603 0.638 . . . . 0.20999999999999999 112.521 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.6 mt -84.87 -60.38 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.471 0.653 . . . . 0.16 112.025 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.1 m -90.51 143.01 28.6 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 114.994 -1.003 . . . . 0.16 112.161 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.424 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 44.0 Cg_endo -91.91 176.1 1.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 124.273 3.315 . . . . 0.20000000000000001 111.378 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 77.0 m-20 -66.92 157.94 31.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.554 -0.859 . . . . 1.1000000000000001 109.454 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 95.85 -16.64 60.79 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.238 -0.982 . . . . 0.17999999999999999 112.02 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.555 ' HB ' HD12 ' A' ' 100' ' ' ILE . 91.5 m -66.38 139.0 57.98 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.199 -0.667 . . . . 0.14000000000000001 109.199 -175.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.492 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 2.2 ptt180 -92.69 117.72 30.29 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.665 1.221 . . . . 3.6299999999999999 110.932 -169.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.77 107.2 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 111.992 -2.367 . . . . 0.14000000000000001 108.806 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.4 m -95.24 109.48 21.59 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.609 0.596 . . . . 0.20999999999999999 112.609 -170.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.472 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.48 100.58 7.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 122.215 1.007 . . . . 0.23999999999999999 110.062 178.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -109.44 134.64 51.61 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.234 -1.348 . . . . 1.0900000000000001 109.795 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.584 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.7 mmm180 . . . . . 0 C--N 1.32 -0.699 0 N-CA-C 109.867 -0.42 . . . . 2.0800000000000001 109.867 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 121.33 0.586 . . . . 0.65000000000000002 111.851 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.8 tt -99.69 129.53 45.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.018 -0.992 . . . . 0.28000000000000003 110.32 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.39 162.2 13.59 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.02 0.914 . . . . 0.31 112.88 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.652 ' HB3' HG13 ' A' ' 46' ' ' ILE . 80.9 t80 -130.38 143.84 51.02 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.106 -1.406 . . . . 0.44 108.122 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -114.74 114.53 25.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.464 -0.939 . . . . 0.76000000000000001 108.464 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 41' ' ' THR . 95.2 t -67.97 151.44 10.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 122.383 1.087 . . . . 0.39000000000000001 113.611 -171.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -106.55 158.47 16.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.359 -1.746 . . . . 2.0099999999999998 108.392 172.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -61.89 115.42 4.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.058 0.456 . . . . 1.8300000000000001 111.799 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.33 12.86 47.15 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.976 -0.63 . . . . 0.47999999999999998 113.255 173.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' HB3' HG13 ' A' ' 9' ' ' VAL . 1.8 p-10 -50.63 170.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.019 0.914 . . . . 1.46 111.864 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.8 150.02 52.17 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.186 -0.915 . . . . 0.40999999999999998 110.959 169.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.646 HD13 ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -64.66 -34.27 77.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.519 -1.219 . . . . 0.85999999999999999 108.242 -178.204 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.523 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 4.2 t30 -85.02 -27.74 26.2 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.621 -1.172 . . . . 1.1499999999999999 111.192 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.9 t -65.32 -42.31 93.11 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.307 -0.557 . . . . 1.21 109.921 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.6 mt -74.4 -25.93 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 121.381 0.61 . . . . 0.20999999999999999 109.822 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.655 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.93 -9.94 59.66 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.269 -0.423 . . . . 0.16 110.793 174.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.645 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.45 -40.14 9.23 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.399 1.095 . . . . 0.20999999999999999 108.079 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -61.84 -40.89 96.91 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 112.885 -1.962 . . . . 0.53000000000000003 111.897 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.563 ' HA ' HG21 ' A' ' 101' ' ' ILE . 65.5 m-85 -101.46 5.51 42.03 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 118.611 -1.235 . . . . 0.17999999999999999 111.872 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.9 mpt_? 54.53 40.43 31.82 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.828 0.823 . . . . 1.78 109.553 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.0 pt -112.99 -165.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.486 -1.234 . . . . 0.19 109.957 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.32 142.26 42.2 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.086 -0.961 . . . . 0.94999999999999996 110.106 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.652 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 43.4 p -72.95 -30.7 64.06 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.383 -0.969 . . . . 0.25 108.383 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.3 -24.25 67.59 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.559 -0.746 . . . . 0.20000000000000001 111.872 170.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.35 -29.2 14.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.993 -0.743 . . . . 0.17000000000000001 108.993 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.594 HD23 HD23 ' A' ' 15' ' ' LEU . 21.7 tp -71.9 -28.49 63.53 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.96 -1.018 . . . . 1.1599999999999999 108.414 172.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.652 ' HB2' ' O ' ' A' ' 26' ' ' THR . 8.2 tp -76.75 -31.73 57.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.939 0.876 . . . . 1.05 109.575 175.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 44.6 tt0 -65.9 -43.23 88.81 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.112 -1.404 . . . . 1.8100000000000001 110.603 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.422 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -80.35 -17.98 50.41 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.193 -0.603 . . . . 0.20000000000000001 111.42 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.615 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 38.7 m-80 -144.21 81.59 11.37 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-O 121.554 0.692 . . . . 0.23000000000000001 110.641 -173.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.6 Cg_endo -56.57 -10.07 4.64 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 124.124 3.216 . . . . 0.35999999999999999 113.829 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.5 m -79.0 -24.84 43.44 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 122.097 -0.377 . . . . 1.3799999999999999 111.409 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.615 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 61.5 mt -67.12 -33.38 75.34 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.553 0.692 . . . . 0.48999999999999999 111.92 -170.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.524 ' HB3' HD11 ' A' ' 30' ' ' LEU . 1.7 pp0? -64.82 -44.92 88.32 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 122.742 1.258 . . . . 1.95 110.591 -174.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.98 -47.62 76.93 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 111.772 -2.467 . . . . 0.48999999999999999 110.752 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.9 178.01 48.64 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.923 -1.035 . . . . 0.41999999999999998 112.139 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' HG ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -110.99 159.02 18.12 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.109 0.481 . . . . 0.40999999999999998 110.628 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 62.6 m -145.08 129.03 17.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.866 -0.606 . . . . 0.41999999999999998 111.378 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.31 120.83 22.1 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.441 0.638 . . . . 0.46999999999999997 110.057 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.83 0.49 57.55 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.215 -1.154 . . . . 0.40999999999999998 110.215 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.631 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -75.84 125.31 28.84 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.925 -0.638 . . . . 1.3 109.842 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 35.1 p -81.03 131.16 35.29 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.778 0.799 . . . . 0.84999999999999998 110.023 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.652 HG13 ' HB3' ' A' ' 7' ' ' TYR . 12.2 pt -131.28 140.64 47.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.354 -1.293 . . . . 0.25 109.259 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.91 150.29 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.964 0.411 . . . . 0.67000000000000004 110.853 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.416 HG21 ' CD2' ' A' ' 22' ' ' PHE . 37.1 mm -114.71 93.18 32.36 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 114.91 -1.041 . . . . 0.16 109.172 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.638 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -59.67 134.23 56.37 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.862 2.375 . . . . 0.17999999999999999 113.029 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.36 -6.25 80.79 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.932 -1.031 . . . . 0.26000000000000001 112.266 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.707 HD12 ' HD2' ' A' ' 52' ' ' PRO . 32.6 tp -122.64 115.69 29.53 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-O 121.26 0.553 . . . . 0.60999999999999999 111.398 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.707 ' HD2' HD12 ' A' ' 51' ' ' LEU . 53.5 Cg_endo -79.16 -177.41 3.87 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.668 2.912 . . . . 0.28000000000000003 114.288 -172.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.599 ' HB3' HG23 ' A' ' 56' ' ' THR . 14.1 t70 -77.42 134.43 66.42 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.015 -1.448 . . . . 0.48999999999999999 112.552 -170.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.4 -15.78 24.87 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.683 2.922 . . . . 0.46000000000000002 113.279 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -95.96 -9.36 31.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.43 0.633 . . . . 1.3799999999999999 111.309 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.599 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.0 p -85.74 -18.47 32.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.053 0.93 . . . . 0.46000000000000002 108.713 173.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 59' ' ' TYR . 7.8 mm -63.99 125.43 87.95 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 113.638 -1.619 . . . . 0.69999999999999996 109.755 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.74 -13.53 13.09 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.984 1.789 . . . . 0.39000000000000001 112.699 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.654 ' H ' HG22 ' A' ' 57' ' ' ILE . 58.7 m-85 -103.45 169.79 8.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.892 0.377 . . . . 0.23999999999999999 111.756 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -154.13 127.76 8.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.701 -0.851 . . . . 2.8900000000000001 108.701 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 71' ' ' THR . 93.6 mt -107.19 130.92 58.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.831 -0.622 . . . . 0.16 111.352 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.08 115.39 26.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.781 -0.768 . . . . 0.16 110.882 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 48.2 t -95.89 116.28 37.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.641 0.734 . . . . 0.19 111.053 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 68' ' ' LYS . 51.9 m -94.61 105.18 17.13 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.016 -0.993 . . . . 0.20000000000000001 110.401 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.557 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.0 mm -53.59 -58.53 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 122.13 0.967 . . . . 0.23000000000000001 111.104 167.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.05 -8.68 6.36 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 112.941 -1.936 . . . . 0.16 113.049 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.73 -17.72 4.92 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.589 0.756 . . . . 0.14999999999999999 112.359 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.512 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.55 57.52 4.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.473 0.579 . . . . 0.68999999999999995 111.302 -173.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 57.3 p -138.88 160.93 38.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 112.899 0.703 . . . . 0.13 112.899 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.465 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -129.07 113.44 15.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.538 -1.21 . . . . 0.40000000000000002 109.999 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 9.9 m -94.05 122.86 37.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.081 0.467 . . . . 0.16 111.135 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.8 tp -99.03 103.22 15.14 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.367 -0.833 . . . . 0.58999999999999997 109.455 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 19.5 m -105.18 159.83 15.55 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.406 -0.918 . . . . 1.05 110.594 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -128.11 127.88 43.85 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.993 -0.743 . . . . 0.26000000000000001 108.993 168.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.582 ' N ' HD22 ' A' ' 74' ' ' LEU . 6.3 m-80 53.98 44.44 29.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.792 -1.095 . . . . 1.8400000000000001 110.78 -174.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 71.37 -4.31 1.87 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.57 -0.741 . . . . 1.8899999999999999 111.558 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -102.77 120.85 41.31 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.681 -0.69 . . . . 3.4399999999999999 110.119 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 62.9 t -57.98 133.31 22.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 122.296 1.046 . . . . 0.23999999999999999 112.527 -175.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 14.5 mtm -103.04 -43.43 5.5 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 113.32 -1.764 . . . . 0.81000000000000005 109.329 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -159.41 171.43 19.76 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 113.297 -1.774 . . . . 1.46 110.014 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.1 m -149.1 123.68 9.77 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.091 -1.413 . . . . 0.17000000000000001 109.748 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -113.61 146.42 35.42 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.694 -0.685 . . . . 1.05 110.303 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.434 ' HB2' HG22 ' A' ' 134' ' ' ILE . 35.0 Cg_endo -72.59 142.2 35.84 Favored 'Trans proline' 0 CA--C 1.495 -1.438 0 C-N-CA 122.038 1.825 . . . . 0.20000000000000001 110.775 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.583 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.38 172.64 11.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.828 -0.624 . . . . 0.13 110.853 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.928 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.93 140.32 49.89 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 110.032 -0.359 . . . . 0.26000000000000001 110.032 -176.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.512 HG22 ' HG3' ' A' ' 68' ' ' LYS . 9.6 m -122.91 126.19 73.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.508 0.67 . . . . 0.56000000000000005 111.672 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -80.58 150.42 31.35 Favored Glycine 0 N--CA 1.423 -2.168 0 N-CA-C 109.544 -1.423 . . . . 0.17000000000000001 109.544 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -57.7 4.74 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.951 0.723 . . . . 3.0499999999999998 112.951 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.922 HG23 HD22 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -89.13 -18.72 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-O 121.546 0.689 . . . . 0.23000000000000001 110.081 178.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.922 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -88.96 -17.28 29.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.793 0.806 . . . . 0.17999999999999999 109.115 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.1 p -66.39 -18.49 65.39 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.535 -1.212 . . . . 0.33000000000000002 111.302 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.73 -42.11 92.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.774 -1.103 . . . . 1.52 112.165 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.61 134.66 19.55 Favored Pre-proline 0 C--N 1.325 -0.497 0 C-N-CA 120.539 -0.465 . . . . 0.42999999999999999 110.889 -175.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.523 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 84.7 Cg_endo -87.55 -16.1 3.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.472 2.114 . . . . 0.72999999999999998 112.437 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.7 t -107.97 -38.75 5.73 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.31 -0.626 . . . . 0.47999999999999998 109.31 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 45.16 31.93 3.27 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 124.785 1.303 . . . . 0.33000000000000002 113.799 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB3' HG23 ' A' ' 164' ' ' THR . 8.2 pt-20 -84.55 115.74 22.77 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 122.801 1.286 . . . . 0.83999999999999997 109.174 -173.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 13.2 m-85 -136.46 179.47 6.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 112.89 -1.959 . . . . 0.22 111.305 -167.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 45.7 m-85 -140.1 134.31 31.12 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.217 -0.447 . . . . 0.54000000000000004 110.445 -172.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.609 HD12 ' HB ' ' A' ' 161' ' ' THR . 93.0 mt -61.58 118.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.413 -0.812 . . . . 0.17000000000000001 110.511 171.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.563 HG21 ' HA ' ' A' ' 22' ' ' PHE . 24.1 pt -84.18 -44.54 18.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 112.816 0.673 . . . . 0.20999999999999999 112.816 -176.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.535 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 54.5 m-80 -171.99 171.14 5.14 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.042 -1.836 . . . . 2.0299999999999998 106.042 -168.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.942 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 3.4 mtt180 -130.51 174.59 9.74 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.433 -0.907 . . . . 1.52 112.167 -174.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -149.64 100.78 3.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.628 -1.169 . . . . 0.58999999999999997 109.838 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.501 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 26.9 ttt85 -64.09 166.58 7.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.47 -0.786 . . . . 2.8199999999999998 110.446 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.501 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 18.6 m-80 -34.77 102.64 0.23 Allowed Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 125.296 1.438 . . . . 0.34999999999999998 113.315 -157.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.5 Cg_endo . . . . . 0 N--CA 1.459 -0.551 0 C-N-CA 123.107 2.538 . . . . 0.47999999999999998 111.289 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.565 1.522 0 N-CA-C 117.57 2.433 . . . . 0.47999999999999998 117.57 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.471 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -166.28 159.72 15.22 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.43 -0.794 . . . . 0.28000000000000003 110.289 -177.187 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -140.37 98.1 3.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.449 -0.945 . . . . 0.48999999999999999 108.449 167.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.57 HD12 HG23 ' A' ' 150' ' ' VAL . 2.6 mt -90.04 115.49 27.36 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.709 -0.62 . . . . 0.66000000000000003 109.524 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 101' ' ' ILE . 17.4 m -84.81 143.49 29.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.953 -0.567 . . . . 0.19 111.609 -169.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.77 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.82 169.68 8.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.543 . . . . 0.13 111.374 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 t -63.77 -9.82 16.53 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.036 -0.984 . . . . 1.1699999999999999 113.299 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.578 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 9.1 tptm -127.86 134.76 49.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.547 -0.461 . . . . 1.22 110.564 171.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.517 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 29.9 mm-40 -33.68 -59.61 0.39 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.982 1.105 . . . . 1.51 113.982 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.489 ' CB ' HG12 ' A' ' 89' ' ' ILE . 64.5 m80 -87.64 -2.32 58.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.313 -0.555 . . . . 2.5299999999999998 111.703 -169.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.77 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -93.97 38.57 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.001 1.112 . . . . 0.83999999999999997 114.001 -171.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.603 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -113.67 145.08 18.35 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 117.089 -2.482 . . . . 0.32000000000000001 112.617 -154.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.518 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -98.98 115.32 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.891 0.853 . . . . 0.17999999999999999 110.833 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.561 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 31.0 p80 -144.43 171.88 13.73 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.08 -0.964 . . . . 0.20999999999999999 109.886 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.36 -167.93 38.55 Favored Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.422 -0.894 . . . . 0.27000000000000002 111.723 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.5 t -154.86 170.34 21.89 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.013 -0.698 . . . . 0.40999999999999998 110.551 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -115.01 -5.32 12.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.982 0.896 . . . . 1.99 108.639 175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -112.45 88.53 11.11 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 114.46 -1.246 . . . . 1.3600000000000001 108.307 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.27 -18.25 26.87 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.438 2.092 . . . . 0.34999999999999998 113.474 -170.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.03 -0.55 35.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.852 -0.613 . . . . 0.33000000000000002 111.389 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 78.9 p -90.86 -9.13 47.46 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.054 -0.721 . . . . 1.3500000000000001 109.054 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 83' ' ' PRO . 37.3 mm -78.95 136.75 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.259 -0.882 . . . . 0.20999999999999999 110.263 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.09 -0.04 75.04 Favored Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 110.366 -1.094 . . . . 0.14999999999999999 110.366 -176.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -112.04 170.08 8.4 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 123.071 1.415 . . . . 2.5 114.098 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.32 124.14 46.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 111.969 -2.378 . . . . 0.17000000000000001 108.154 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.415 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -120.91 159.95 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.36 -0.978 . . . . 0.66000000000000003 108.36 -173.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.5 m -50.62 -59.35 4.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.508 0.558 . . . . 0.42999999999999999 112.508 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -132.03 -45.1 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 118.633 -1.227 . . . . 2.02 113.851 -174.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.36 133.19 0.2 Allowed Glycine 0 N--CA 1.466 0.692 0 N-CA-C 117.232 1.653 . . . . 0.17999999999999999 117.232 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.442 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.9 p -70.95 165.4 23.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 112.471 -1.865 . . . . 0.16 112.348 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.928 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 66.7 mt -60.15 98.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 122.449 1.118 . . . . 0.40000000000000002 112.056 -163.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.561 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 13.1 mtp180 -85.34 145.62 27.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.523 -1.672 . . . . 1.8700000000000001 110.493 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.583 ' HG2' HG22 ' A' ' 84' ' ' ILE . 18.3 mtp -125.03 -164.81 1.32 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.717 -0.846 . . . . 0.79000000000000004 108.717 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.593 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 89.2 m-70 -93.65 161.64 14.27 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.629 -0.508 . . . . 2.3199999999999998 109.629 170.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.3 m120 -60.43 -51.96 67.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 118.744 -0.646 . . . . 0.68000000000000005 109.726 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -64.18 -27.04 68.8 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 120.782 1.628 . . . . 2.1800000000000002 112.244 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.593 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 68.8 m-20 -77.45 -46.68 21.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.261 0.553 . . . . 0.68999999999999995 110.489 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.641 HG13 HD12 ' A' ' 151' ' ' ILE . 14.2 p -67.19 -22.8 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.222 -0.899 . . . . 0.11 111.754 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.641 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -84.27 -41.78 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 119.087 -0.482 . . . . 0.38 110.071 171.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 156' ' ' ILE . 24.6 mt-10 -49.26 -66.16 0.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 119.23 0.923 . . . . 1.99 112.278 170.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.47 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.3 mp -48.69 -35.02 13.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.612 0.72 . . . . 1.27 111.125 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.516 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -66.38 -31.17 71.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.624 -1.171 . . . . 0.17999999999999999 111.4 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.2 t -88.28 -31.86 18.78 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.581 -0.7 . . . . 0.20999999999999999 112.696 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.1 mt -84.95 -61.21 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.457 0.646 . . . . 0.16 112.33 -171.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -90.55 145.38 32.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.012 -0.994 . . . . 0.16 111.792 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.942 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 19.0 Cg_endo -95.12 178.32 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 124.901 3.734 . . . . 0.20000000000000001 111.752 174.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 80.0 m-20 -68.66 158.23 34.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.227 -0.989 . . . . 1.1000000000000001 108.966 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.12 -14.11 65.82 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.056 -1.069 . . . . 0.17999999999999999 111.869 -173.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.609 ' HB ' HD12 ' A' ' 100' ' ' ILE . 85.2 m -66.73 139.01 57.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.44 -0.578 . . . . 0.14000000000000001 109.44 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 2.0 ptt180 -92.34 115.69 28.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 122.726 1.251 . . . . 3.6299999999999999 110.815 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.4 t -106.11 108.42 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 112.21 -2.268 . . . . 0.14000000000000001 109.122 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.539 HG23 ' HB3' ' A' ' 97' ' ' GLU . 3.8 m -97.08 108.57 21.33 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 112.859 0.689 . . . . 0.20999999999999999 112.859 -171.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.486 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -83.72 94.46 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 122.573 1.177 . . . . 0.23999999999999999 110.327 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.406 ' O ' HG12 ' A' ' 65' ' ' ILE . 79.5 m-20 -104.9 142.38 34.86 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.234 -1.348 . . . . 1.0900000000000001 109.86 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.557 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.8 mmm180 . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.957 0.408 . . . . 2.0800000000000001 110.49 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 tp . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.066 0.46 . . . . 0.65000000000000002 111.578 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.699 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.5 tt -91.58 129.97 37.47 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.283 -0.872 . . . . 0.28000000000000003 110.757 -174.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.77 162.03 13.33 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.3 1.048 . . . . 0.31 113.067 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 45' ' ' SER . 70.9 t80 -132.54 142.82 49.35 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.432 -1.713 . . . . 0.44 108.057 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.426 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 34.0 tt0 -113.97 113.22 24.52 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.05 -1.092 . . . . 0.76000000000000001 108.05 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.651 HG13 ' HB2' ' A' ' 13' ' ' ASP . 95.9 t -66.13 149.5 11.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.327 1.06 . . . . 0.39000000000000001 113.039 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -104.06 158.74 16.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.307 -1.769 . . . . 2.0099999999999998 108.479 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.48 109.26 0.85 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.731 0.301 . . . . 1.8300000000000001 111.235 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.66 10.2 50.78 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.807 -0.633 . . . . 0.47999999999999998 113.925 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.651 ' HB2' HG13 ' A' ' 9' ' ' VAL . 43.9 m-20 -55.45 169.14 0.32 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.371 0.586 . . . . 1.46 110.865 172.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.32 152.43 50.58 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.562 0.696 . . . . 0.40999999999999998 112.26 174.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.675 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -67.52 -29.76 69.25 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.184 -1.371 . . . . 0.85999999999999999 109.901 -177.154 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.497 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 5.4 t30 -93.49 -24.99 17.8 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.879 -1.055 . . . . 1.1499999999999999 110.669 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 t -69.22 -39.55 78.51 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.36 -0.607 . . . . 1.21 109.36 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.434 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.5 mt -72.93 -26.59 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.219 0.533 . . . . 0.20999999999999999 109.688 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.25 -9.93 59.69 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.2 -0.312 . . . . 0.16 110.987 175.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.622 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.99 -39.33 9.41 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.609 1.195 . . . . 0.20999999999999999 108.148 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 119' ' ' SER . 11.2 m-20 -63.66 -44.78 92.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.536 -2.12 . . . . 0.53000000000000003 112.041 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.556 ' HA ' HG21 ' A' ' 101' ' ' ILE . 64.4 m-85 -97.96 4.97 49.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 118.57 -1.252 . . . . 0.17999999999999999 111.613 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.622 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.1 mpt_? 54.04 46.92 24.49 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.782 0.801 . . . . 1.78 109.947 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.64 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.0 pt -118.38 -165.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 114.45 -1.25 . . . . 0.19 109.902 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.02 142.2 41.77 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.06 -0.973 . . . . 0.94999999999999996 109.746 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.675 ' HB ' HD11 ' A' ' 15' ' ' LEU . 71.4 p -73.14 -33.19 65.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.166 -1.05 . . . . 0.25 108.166 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.22 -27.45 67.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.2 -0.909 . . . . 0.20000000000000001 111.55 169.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -92.24 -28.32 17.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.914 -0.773 . . . . 0.17000000000000001 108.914 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.646 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 21.3 tp -73.84 -26.95 60.85 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.328 -0.851 . . . . 1.1599999999999999 109.47 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 26' ' ' THR . 43.1 mt -78.54 -31.28 47.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.835 0.826 . . . . 1.05 109.699 172.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 6.1 tt0 -63.98 -38.97 93.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.364 -1.289 . . . . 1.8100000000000001 110.154 173.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -85.08 -20.94 29.61 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 119.965 -0.694 . . . . 0.20000000000000001 111.591 176.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.632 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.1 m-80 -149.12 82.73 6.93 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-O 121.195 0.522 . . . . 0.23000000000000001 110.466 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.7 Cg_endo -56.93 -11.73 7.95 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.928 3.086 . . . . 0.35999999999999999 113.013 175.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -77.35 -19.86 55.67 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.223 -0.444 . . . . 1.3799999999999999 112.017 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.876 HD21 HG21 ' A' ' 46' ' ' ILE . 38.2 mt -77.03 -34.03 57.34 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.318 0.58 . . . . 0.48999999999999999 112.137 -171.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.421 ' H ' ' HG3' ' A' ' 37' ' ' GLN . 1.7 pp0? -63.24 -46.01 88.89 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 122.768 1.27 . . . . 1.95 110.926 -170.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.43 86.58 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 112.067 -2.333 . . . . 0.48999999999999999 111.016 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.81 178.43 48.44 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 114.731 -1.122 . . . . 0.41999999999999998 110.94 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.86 157.62 21.18 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.264 0.554 . . . . 0.40999999999999998 111.186 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 47.0 m -138.06 127.94 25.46 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.161 -0.927 . . . . 0.41999999999999998 110.299 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 120.56 21.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.348 0.594 . . . . 0.46999999999999997 109.669 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.426 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 99.6 -0.51 56.77 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.305 -1.118 . . . . 0.40999999999999998 110.305 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.4 tt0 -74.86 125.28 28.49 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 114.892 -0.654 . . . . 1.3 109.518 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 43.0 m -86.25 132.6 33.95 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.603 0.716 . . . . 0.84999999999999998 109.877 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.876 HG21 HD21 ' A' ' 36' ' ' LEU . 12.1 pt -133.1 143.39 39.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.414 -1.266 . . . . 0.25 109.327 -176.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.468 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.67 151.48 3.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.079 0.466 . . . . 0.67000000000000004 110.96 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.8 mm -115.41 91.97 30.76 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.706 -1.133 . . . . 0.16 109.31 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.623 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.1 Cg_endo -58.15 134.36 61.41 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.898 2.399 . . . . 0.17999999999999999 112.741 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.43 -5.91 77.74 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.766 -1.106 . . . . 0.26000000000000001 112.405 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.696 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 21.3 tp -129.21 120.29 20.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 121.048 0.451 . . . . 0.60999999999999999 111.407 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.699 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_endo -80.91 -177.81 3.98 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.488 2.792 . . . . 0.28000000000000003 114.166 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.58 ' HB3' HG23 ' A' ' 56' ' ' THR . 13.6 t70 -74.49 134.11 76.62 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 114.265 -1.334 . . . . 0.48999999999999999 112.915 -168.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.91 -15.4 16.69 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 124.105 3.203 . . . . 0.46000000000000002 112.951 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -95.38 -16.05 22.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.918 0.39 . . . . 1.3799999999999999 111.131 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.58 HG23 ' HB3' ' A' ' 53' ' ' ASP . 22.2 p -79.04 -13.95 59.46 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.96 0.886 . . . . 0.46000000000000002 109.445 175.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.568 HG22 ' H ' ' A' ' 59' ' ' TYR . 14.6 mm -63.86 126.08 89.17 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 113.813 -1.539 . . . . 0.69999999999999996 110.193 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.2 -15.04 11.71 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.342 2.028 . . . . 0.39000000000000001 112.895 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.568 ' H ' HG22 ' A' ' 57' ' ' ILE . 66.2 m-85 -100.08 174.02 6.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.894 0.378 . . . . 0.23999999999999999 110.794 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -157.08 132.88 9.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.064 -0.717 . . . . 2.8900000000000001 109.064 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.688 ' HA ' ' O ' ' A' ' 71' ' ' THR . 89.5 mt -113.66 134.68 55.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.132 -0.486 . . . . 0.16 111.497 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.01 116.09 26.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.829 -0.748 . . . . 0.16 111.018 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.6 t -96.46 113.96 32.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.669 0.747 . . . . 0.19 111.066 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 68' ' ' LYS . 49.6 m -91.52 108.48 19.92 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.071 -0.968 . . . . 0.20000000000000001 110.62 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.56 HD13 HG11 ' A' ' 86' ' ' VAL . 50.6 mm -54.97 -59.69 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 122.038 0.923 . . . . 0.23000000000000001 111.001 166.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.8 -13.86 6.78 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 112.846 -1.979 . . . . 0.16 113.071 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -125.02 -16.45 6.07 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 123.196 0.598 . . . . 0.14999999999999999 112.491 -178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER 56.27 55.53 6.6 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.747 0.703 . . . . 0.68999999999999995 111.493 -174.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.9 p -138.25 162.02 35.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.805 0.669 . . . . 0.13 112.805 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.485 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.9 tt -129.89 113.06 14.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.893 -1.049 . . . . 0.40000000000000002 110.062 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.688 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.2 m -93.13 122.86 35.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.097 0.475 . . . . 0.16 111.228 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.417 HD21 ' HE3' ' A' ' 79' ' ' MET . 14.1 tp -100.39 106.11 17.67 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.318 -0.855 . . . . 0.58999999999999997 109.764 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 89.1 p -107.68 161.29 15.01 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.185 -1.006 . . . . 1.05 110.735 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.781 HD13 HD22 ' A' ' 75' ' ' ASN . 1.1 tm? -128.46 129.38 46.03 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.781 -0.822 . . . . 0.26000000000000001 108.781 169.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.781 HD22 HD13 ' A' ' 74' ' ' LEU . 9.7 p30 46.98 46.13 15.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.345 -1.298 . . . . 1.8400000000000001 111.181 -166.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 73.55 -8.53 1.35 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.84 -1.073 . . . . 1.8899999999999999 111.785 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -94.96 119.82 34.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.767 -0.651 . . . . 3.4399999999999999 109.776 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 68.4 t -58.38 133.43 23.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 122.392 1.092 . . . . 0.23999999999999999 112.33 -174.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.417 ' HE3' HD21 ' A' ' 72' ' ' LEU . 18.6 mtm -102.56 -43.51 5.6 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.165 -1.834 . . . . 0.81000000000000005 109.26 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -160.23 173.11 16.22 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.311 -1.768 . . . . 1.46 110.408 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.4 m -149.86 124.53 9.77 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 113.999 -1.455 . . . . 0.17000000000000001 109.604 173.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -116.42 146.28 37.07 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.821 -0.627 . . . . 1.05 109.904 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.456 ' HB2' HG22 ' A' ' 134' ' ' ILE . 37.9 Cg_endo -72.07 142.86 39.11 Favored 'Trans proline' 0 CA--C 1.494 -1.477 0 C-N-CA 122.34 2.026 . . . . 0.20000000000000001 111.26 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.665 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.94 173.71 8.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.665 -0.698 . . . . 0.13 110.609 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.887 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.63 147.39 43.81 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.989 -0.375 . . . . 0.26000000000000001 109.989 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.56 HG11 HD13 ' A' ' 65' ' ' ILE . 8.1 m -128.2 127.66 67.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.714 0.769 . . . . 0.56000000000000005 111.933 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -84.15 153.68 29.54 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 109.9 -1.28 . . . . 0.17000000000000001 109.9 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -56.52 2.97 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.147 0.795 . . . . 3.0499999999999998 113.147 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.94 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -87.76 -22.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.479 0.657 . . . . 0.23000000000000001 110.503 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.94 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -87.49 -14.93 39.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.663 0.744 . . . . 0.17999999999999999 109.314 -175.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.4 p -69.27 -17.47 63.75 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.72 -1.127 . . . . 0.33000000000000002 111.278 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -67.6 -38.62 84.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.055 -0.975 . . . . 1.52 112.313 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 95' ' ' THR . 0.2 OUTLIER -107.02 109.4 63.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 120.415 -0.514 . . . . 0.42999999999999999 111.171 -177.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.421 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 6.0 Cg_exo -73.79 -14.51 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.918 2.412 . . . . 0.72999999999999998 113.381 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 93' ' ' THR . 9.2 t -91.96 -42.92 9.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.308 -0.627 . . . . 0.47999999999999998 109.308 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.574 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 55.97 29.49 55.48 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.969 -1.469 . . . . 0.33000000000000002 114.134 168.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.41 111.03 19.08 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.842 0.83 . . . . 0.83999999999999997 109.396 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.675 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.0 m-85 -140.13 161.51 37.46 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.68 -1.6 . . . . 0.22 111.914 -172.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.691 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 16.0 m-85 -129.89 137.74 50.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.935 0.398 . . . . 0.54000000000000004 110.719 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.619 HD12 ' HB ' ' A' ' 161' ' ' THR . 78.9 mt -60.52 121.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.476 -0.784 . . . . 0.17000000000000001 110.971 172.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.556 HG21 ' HA ' ' A' ' 22' ' ' PHE . 22.0 pt -88.23 -34.88 7.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 113.243 0.831 . . . . 0.20999999999999999 113.243 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.478 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 9.8 p30 178.95 178.22 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.536 -1.283 . . . . 2.0299999999999998 107.536 -176.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.513 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -134.75 154.6 51.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.558 0.694 . . . . 1.52 112.536 -174.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 49.0 tt0 -127.05 100.82 6.28 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.782 -1.099 . . . . 0.58999999999999997 109.617 174.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.487 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 71.0 ttt180 -65.2 166.13 10.27 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.417 -0.811 . . . . 2.8199999999999998 110.341 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.5 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 19.7 m-80 -35.42 103.33 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 125.24 1.416 . . . . 0.34999999999999998 113.794 -155.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 8.4 Cg_endo . . . . . 0 N--CA 1.457 -0.628 0 C-N-CA 122.861 2.374 . . . . 0.47999999999999998 111.458 172.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.566 1.568 0 N-CA-C 117.125 2.269 . . . . 0.47999999999999998 117.125 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.487 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -165.31 157.38 15.21 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.328 -0.857 . . . . 0.28000000000000003 110.305 -176.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 16.9 t-105 -138.32 97.88 3.48 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.31 -0.996 . . . . 0.48999999999999999 108.31 167.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.524 HD12 HG23 ' A' ' 150' ' ' VAL . 2.6 mt -88.48 114.43 25.08 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.105 -0.702 . . . . 0.66000000000000003 109.105 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.435 ' HB3' HD11 ' A' ' 101' ' ' ILE . 30.1 m -85.0 143.75 28.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.885 -0.598 . . . . 0.19 111.29 -169.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.79 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.4 170.78 7.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.13 111.113 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.5 t -61.6 -13.14 19.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.264 -0.88 . . . . 1.1699999999999999 112.7 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.678 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.5 tmtp? -127.11 134.01 50.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.288 -0.565 . . . . 1.22 110.682 173.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.678 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 27.1 mt-30 -35.97 -56.91 0.71 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.559 -1.2 . . . . 1.51 114.166 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.588 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -97.59 12.38 33.73 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.458 -0.897 . . . . 2.5299999999999998 111.613 -172.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.79 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -97.63 37.28 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.01 0.744 . . . . 0.83999999999999997 113.01 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.651 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.56 143.26 18.03 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 117.112 -2.471 . . . . 0.32000000000000001 112.79 -152.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -94.38 115.22 32.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.818 0.818 . . . . 0.17999999999999999 110.691 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 145' ' ' MET . 29.9 p80 -144.56 170.8 15.36 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.238 -0.892 . . . . 0.20999999999999999 109.579 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.45 -168.46 38.6 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 120.184 -1.008 . . . . 0.27000000000000002 112.073 178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.8 t -155.89 173.75 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.216 -0.579 . . . . 0.40999999999999998 111.008 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -110.98 -6.16 14.72 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.619 -0.882 . . . . 1.99 108.619 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.19 86.41 20.9 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 108.492 -0.929 . . . . 1.3600000000000001 108.492 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.435 ' HA ' HG12 ' A' ' 134' ' ' ILE . 32.0 Cg_endo -74.23 -17.27 21.8 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.82 2.347 . . . . 0.34999999999999998 113.894 -168.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.465 ' O ' ' HE2' ' A' ' 136' ' ' LYS . . . -78.69 -6.01 54.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.085 -0.507 . . . . 0.33000000000000002 110.826 -177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.9 t -88.71 -9.53 51.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.58 -0.896 . . . . 1.3500000000000001 108.58 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 39.7 mm -76.88 138.92 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.127 -0.942 . . . . 0.20999999999999999 109.581 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.49 3.01 78.66 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.793 -0.923 . . . . 0.14999999999999999 110.793 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 132' ' ' ALA . 25.2 mttm -113.89 172.33 7.05 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 123.039 1.4 . . . . 2.5 113.755 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.07 126.33 50.2 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 111.895 -2.412 . . . . 0.17000000000000001 108.006 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.42 160.23 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.025 -0.731 . . . . 0.66000000000000003 109.025 -173.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.5 m -47.71 -61.0 2.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.521 0.563 . . . . 0.42999999999999999 112.521 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.429 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 46.7 pttt -132.65 -44.2 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.783 -1.167 . . . . 2.02 113.623 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.08 132.51 0.2 Allowed Glycine 0 N--CA 1.466 0.665 0 N-CA-C 117.056 1.583 . . . . 0.17999999999999999 117.056 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.577 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.0 p -71.09 165.42 23.56 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 112.164 -2.018 . . . . 0.16 112.02 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.887 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 53.8 mt -59.64 98.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 122.518 1.152 . . . . 0.40000000000000002 112.114 -163.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.47 ' HB2' ' CD1' ' A' ' 134' ' ' ILE . 13.6 mtp180 -87.38 148.24 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.568 -1.651 . . . . 1.8700000000000001 110.217 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.665 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.4 mtp -127.99 -164.8 1.41 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.773 -0.825 . . . . 0.79000000000000004 108.773 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.713 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 2.8 t60 -94.79 158.74 15.36 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.896 -0.779 . . . . 2.3199999999999998 108.896 171.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.7 m120 -57.69 -53.26 60.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.397 -0.811 . . . . 0.68000000000000005 110.408 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -63.15 -27.06 69.11 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 121.244 1.838 . . . . 2.1800000000000002 112.427 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.713 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 4.6 m-20 -79.42 -44.48 21.31 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.147 0.499 . . . . 0.68999999999999995 110.814 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.634 HG13 HD12 ' A' ' 151' ' ' ILE . 14.3 p -67.31 -23.6 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.488 -0.778 . . . . 0.11 111.589 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.634 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.34 -42.0 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 119.01 -0.519 . . . . 0.38 110.045 171.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 156' ' ' ILE . 25.3 mt-10 -47.52 -69.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.232 0.924 . . . . 1.99 112.365 170.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.572 ' O ' HG22 ' A' ' 157' ' ' VAL . 8.6 mp -46.31 -39.18 9.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.48 0.657 . . . . 1.27 111.261 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.8 78.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.424 -1.262 . . . . 0.17999999999999999 111.724 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.1 t -87.69 -30.62 20.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 118.702 0.683 . . . . 0.20999999999999999 112.284 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.0 mt -83.98 -60.14 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.43 0.633 . . . . 0.16 112.154 -172.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.6 m -87.38 143.32 34.13 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.026 -0.988 . . . . 0.16 112.129 178.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -89.74 172.9 3.77 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 124.128 3.219 . . . . 0.20000000000000001 111.111 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.478 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 68.8 m-20 -67.67 157.26 34.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 118.955 -1.098 . . . . 1.1000000000000001 109.037 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.36 -16.28 61.58 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.183 -1.008 . . . . 0.17999999999999999 112.219 -172.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.619 ' HB ' HD12 ' A' ' 100' ' ' ILE . 98.5 m -63.98 139.71 58.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.12 0.486 . . . . 0.14000000000000001 109.9 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.691 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -93.48 124.82 37.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.559 1.171 . . . . 3.6299999999999999 111.63 -170.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.56 107.21 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 112.168 -2.287 . . . . 0.14000000000000001 109.104 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.6 m -95.33 107.16 19.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 112.837 0.68 . . . . 0.20999999999999999 112.837 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.574 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -80.84 107.14 12.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 122.153 0.978 . . . . 0.23999999999999999 109.898 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -110.27 128.06 55.32 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.278 -1.328 . . . . 1.0900000000000001 110.016 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.469 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 15.1 mmm-85 . . . . . 0 C--N 1.318 -0.777 0 CA-C-O 121.219 0.533 . . . . 2.0800000000000001 110.042 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.798 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 tp . . . . . 0 N--CA 1.449 -0.489 0 CA-C-O 121.102 0.477 . . . . 0.65000000000000002 111.07 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.9 tt -88.68 127.03 35.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.259 -0.882 . . . . 0.28000000000000003 110.728 -172.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.72 161.2 13.98 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.78 -1.1 . . . . 0.31 112.444 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 45' ' ' SER . 86.2 t80 -131.71 140.01 49.18 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.912 -1.495 . . . . 0.44 107.939 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.454 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.3 tt0 -112.69 110.56 20.77 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.807 -1.183 . . . . 0.76000000000000001 107.807 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 44' ' ' GLN . 90.3 t -66.48 151.59 10.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 122.466 1.127 . . . . 0.39000000000000001 113.433 -167.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 10' ' ' LYS . 8.1 mtpm? -102.53 158.94 15.87 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 113.486 -1.688 . . . . 2.0099999999999998 108.997 173.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.604 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 2.2 tt0 -62.73 112.87 2.71 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.07 -0.514 . . . . 1.8300000000000001 112.087 -172.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.51 12.95 42.95 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.922 -0.656 . . . . 0.47999999999999998 113.768 173.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.575 ' CG ' HD11 ' A' ' 18' ' ' ILE . 2.4 t70 -50.4 168.26 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 112.524 0.564 . . . . 1.46 112.524 174.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.547 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -127.12 149.5 49.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.147 0.499 . . . . 0.40999999999999998 110.86 166.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -62.24 -38.5 89.49 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.344 1.069 . . . . 0.85999999999999999 108.405 -175.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.439 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 63.5 t30 -83.57 -19.25 35.92 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.324 -1.307 . . . . 1.1499999999999999 110.98 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -68.38 -42.69 78.72 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.487 -0.485 . . . . 1.21 110.227 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.575 HD11 ' CG ' ' A' ' 13' ' ' ASP . 18.6 mt -72.81 -26.64 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.435 0.636 . . . . 0.20999999999999999 109.887 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.68 -9.5 59.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.213 -0.449 . . . . 0.16 110.792 175.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.626 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.18 -40.88 8.97 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.836 1.303 . . . . 0.20999999999999999 108.528 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.529 ' HB3' ' O ' ' A' ' 119' ' ' SER . 26.5 m-20 -61.94 -42.93 99.67 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.937 -2.392 . . . . 0.53000000000000003 111.979 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.594 ' HA ' HG21 ' A' ' 101' ' ' ILE . 66.3 m-85 -100.22 4.79 44.52 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.639 -1.224 . . . . 0.17999999999999999 111.822 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.626 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.6 mpt_? 54.59 42.25 31.41 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.828 0.823 . . . . 1.78 109.681 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.616 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.4 pt -114.99 -164.6 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.513 -1.221 . . . . 0.19 109.129 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 22.0 t -110.76 157.35 19.87 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.357 1.075 . . . . 0.94999999999999996 110.154 168.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.601 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 62.5 p -80.11 -28.54 38.98 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 112.792 -2.004 . . . . 0.25 107.243 176.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.44 77.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.421 -0.809 . . . . 0.20000000000000001 111.958 171.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -88.08 -29.22 20.8 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.88 -0.785 . . . . 0.17000000000000001 108.88 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.637 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -71.9 -28.48 63.53 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.093 -0.958 . . . . 1.1599999999999999 109.279 174.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 26' ' ' THR . 35.7 mt -76.83 -29.95 56.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.685 0.755 . . . . 1.05 110.611 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 27.8 tt0 -65.47 -39.89 92.5 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.621 -1.172 . . . . 1.8100000000000001 109.998 174.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.443 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.93 -19.87 31.54 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 120.26 -0.576 . . . . 0.20000000000000001 111.614 177.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.624 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 21.5 m-80 -148.76 82.46 7.28 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-O 121.457 0.646 . . . . 0.23000000000000001 110.586 -173.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 21.4 Cg_endo -58.88 -5.94 3.07 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 124.169 3.246 . . . . 0.35999999999999999 113.872 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -81.94 -23.35 36.2 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.173 -0.329 . . . . 1.3799999999999999 111.42 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.68 HD21 HG21 ' A' ' 46' ' ' ILE . 28.9 mt -70.34 -32.38 70.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.521 0.677 . . . . 0.48999999999999999 112.149 -170.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 3.4 pt20 -65.99 -48.7 70.36 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.681 1.229 . . . . 1.95 110.022 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.77 -46.31 87.79 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.043 -2.344 . . . . 0.48999999999999999 111.005 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.91 -178.69 47.61 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 114.79 -1.095 . . . . 0.41999999999999998 111.153 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.11 156.94 24.3 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.244 0.545 . . . . 0.40999999999999998 111.181 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.546 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 37.1 m -139.94 128.94 23.53 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.159 -0.928 . . . . 0.41999999999999998 110.469 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.604 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -78.82 126.21 30.4 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.288 0.566 . . . . 0.46999999999999997 110.212 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 91.24 4.65 68.37 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.406 -1.078 . . . . 0.40999999999999998 110.406 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.546 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.22 123.79 28.76 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.104 -0.548 . . . . 1.3 109.805 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 19.1 p -77.97 127.62 32.62 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.909 0.862 . . . . 0.84999999999999998 110.667 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.68 HG21 HD21 ' A' ' 36' ' ' LEU . 12.0 pt -129.21 143.28 41.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.247 -1.342 . . . . 0.25 109.417 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.35 151.45 3.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.271 0.558 . . . . 0.67000000000000004 111.074 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.472 HG21 ' CD2' ' A' ' 22' ' ' PHE . 38.9 mm -116.85 94.61 44.65 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.628 -1.169 . . . . 0.16 108.896 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.554 ' HA ' HD21 ' A' ' 4' ' ' LEU . 3.9 Cg_exo -61.5 136.03 60.78 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.599 2.199 . . . . 0.17999999999999999 112.539 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.4 -0.54 81.0 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.477 -0.783 . . . . 0.26000000000000001 112.317 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.798 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 25.2 tp -131.02 117.53 17.17 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 121.08 0.467 . . . . 0.60999999999999999 111.241 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.7 ' HD2' HD12 ' A' ' 51' ' ' LEU . 32.1 Cg_endo -75.26 168.86 23.73 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.546 2.831 . . . . 0.28000000000000003 113.543 -171.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.502 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 11.5 t70 -73.8 129.44 85.09 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 114.252 -1.34 . . . . 0.48999999999999999 111.307 -175.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.639 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 66.4 Cg_endo -73.76 -15.52 24.01 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 123.752 2.968 . . . . 0.46000000000000002 112.711 -174.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -95.66 -3.65 45.77 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.389 -0.823 . . . . 1.3799999999999999 109.574 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 8.6 p -93.56 -14.87 26.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.534 -1.284 . . . . 0.46000000000000002 107.534 171.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.486 HG22 ' H ' ' A' ' 59' ' ' TYR . 36.1 mt -84.72 130.14 54.21 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 113.311 -1.768 . . . . 0.69999999999999996 110.915 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.71 -23.12 11.35 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.388 2.059 . . . . 0.39000000000000001 113.301 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.486 ' H ' HG22 ' A' ' 57' ' ' ILE . 66.4 m-85 -86.37 150.7 24.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.89 -0.324 . . . . 0.23999999999999999 111.322 -176.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -143.55 135.2 26.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.07 -0.715 . . . . 2.8900000000000001 109.07 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.6 mt -117.2 134.19 61.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 112.534 0.568 . . . . 0.16 112.534 -175.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.91 119.84 35.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.116 -0.634 . . . . 0.16 111.357 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.72 HG22 HD12 ' A' ' 70' ' ' LEU . 90.8 t -102.89 115.43 44.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.858 0.837 . . . . 0.19 111.382 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 68' ' ' LYS . 20.5 m -94.67 100.28 12.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.44 -1.255 . . . . 0.20000000000000001 110.628 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.3 mm -50.04 -58.47 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 122.056 0.932 . . . . 0.23000000000000001 111.624 170.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.77 -9.82 2.93 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 112.896 -1.956 . . . . 0.16 113.477 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.08 -18.8 4.93 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.773 0.829 . . . . 0.14999999999999999 112.173 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.33 56.99 4.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.396 0.544 . . . . 0.68999999999999995 111.505 -173.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.0 p -138.15 159.77 41.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 113.011 0.745 . . . . 0.13 113.011 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.726 HD22 ' SD ' ' A' ' 145' ' ' MET . 4.3 tp -126.3 117.53 23.22 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.782 -1.099 . . . . 0.40000000000000002 110.944 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 62.6 m -100.63 121.92 42.43 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.959 -0.696 . . . . 0.16 111.485 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 79' ' ' MET . 3.6 tp -101.74 106.72 17.77 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.243 -0.889 . . . . 0.58999999999999997 109.262 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 87.2 p -104.99 163.69 12.35 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.585 -0.846 . . . . 1.05 110.722 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.1 tm? -124.64 126.57 45.96 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.901 -0.778 . . . . 0.26000000000000001 108.901 168.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.548 ' N ' HD22 ' A' ' 74' ' ' LEU . 38.5 m-80 49.74 46.76 23.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.71 -1.132 . . . . 1.8400000000000001 111.015 -171.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 71.75 -7.75 1.2 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.566 0.746 . . . . 1.8899999999999999 111.849 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -98.12 119.96 37.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.986 -0.552 . . . . 3.4399999999999999 110.0 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 50.5 t -56.62 131.53 20.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 122.287 1.041 . . . . 0.23999999999999999 113.314 -172.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.579 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 3.3 mmt -95.42 -46.78 6.55 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 112.989 -1.914 . . . . 0.81000000000000005 107.941 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.3 mmtt -164.12 174.03 11.76 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.041 -1.89 . . . . 1.46 110.64 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 16.4 m -147.9 123.66 10.56 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.832 -1.531 . . . . 0.17000000000000001 109.318 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -108.7 144.88 30.48 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.676 -0.693 . . . . 1.05 109.204 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HB2' HG22 ' A' ' 134' ' ' ILE . 38.5 Cg_endo -72.37 140.99 34.46 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 121.848 1.699 . . . . 0.20000000000000001 110.207 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.47 HG21 ' HB2' ' A' ' 70' ' ' LEU . 2.1 pp -139.44 171.42 14.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 120.442 -0.503 . . . . 0.13 111.291 -177.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.92 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -116.23 142.27 47.05 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.144 -0.48 . . . . 0.26000000000000001 109.781 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.521 HG22 ' HG3' ' A' ' 68' ' ' LYS . 12.9 m -126.08 113.96 36.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.675 0.75 . . . . 0.56000000000000005 110.621 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -76.26 155.54 45.85 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 109.048 -1.621 . . . . 0.17000000000000001 109.048 175.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 139' ' ' SER . 64.9 mttp -54.74 4.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 114.135 1.161 . . . . 3.0499999999999998 114.135 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.845 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -89.66 -21.82 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 O-C-N 121.591 -0.693 . . . . 0.23000000000000001 110.479 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.845 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -86.64 -18.88 30.24 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.019 0.914 . . . . 0.17999999999999999 108.633 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -69.37 -12.9 62.05 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.053 -1.431 . . . . 0.33000000000000002 111.456 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.472 ' NE2' HD12 ' A' ' 89' ' ' ILE . 76.2 mt-30 -75.07 -36.59 61.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.579 -1.192 . . . . 1.52 113.16 -177.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.74 132.5 26.0 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 119.779 -0.768 . . . . 0.42999999999999999 111.286 -175.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 96.9 Cg_endo -89.13 -6.14 5.56 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.858 2.372 . . . . 0.72999999999999998 113.105 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 96' ' ' GLY . 8.8 t -123.35 -42.46 2.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.057 0.456 . . . . 0.47999999999999998 110.48 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 53.48 34.0 48.33 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.622 -1.172 . . . . 0.33000000000000002 114.121 167.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.443 ' HG2' HG23 ' A' ' 164' ' ' THR . 44.8 mt-10 -84.37 113.01 20.85 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.955 0.884 . . . . 0.83999999999999997 109.556 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.687 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 23.9 m-85 -137.38 -179.76 5.92 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.774 -1.557 . . . . 0.22 111.526 -170.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 80.9 m-85 -143.49 141.11 30.63 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 116.364 -0.38 . . . . 0.54000000000000004 110.381 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.624 HD12 ' HB ' ' A' ' 161' ' ' THR . 75.6 mt -65.86 114.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 115.568 -0.742 . . . . 0.17000000000000001 110.081 171.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.594 HG21 ' HA ' ' A' ' 22' ' ' PHE . 16.6 pt -83.55 -44.13 18.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.627 0.603 . . . . 0.20999999999999999 112.627 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.868 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 51.9 m-80 -169.32 172.98 6.88 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.382 -1.34 . . . . 2.0299999999999998 107.382 -170.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.653 HH21 ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -135.7 151.99 50.73 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.872 -0.731 . . . . 1.52 111.968 -178.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 49.7 tt0 -123.52 101.04 7.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.097 -0.956 . . . . 0.58999999999999997 109.719 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.501 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 67.4 ttt180 -64.55 165.74 9.59 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.907 0.861 . . . . 2.8199999999999998 110.656 176.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.501 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 20.7 m-80 -37.55 102.75 0.25 Allowed Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-N 113.048 -1.887 . . . . 0.34999999999999998 114.756 -147.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.0 Cg_endo . . . . . 0 C--N 1.348 0.552 0 C-N-CA 123.188 2.592 . . . . 0.47999999999999998 111.641 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.506 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.507 0 N-CA-C 116.61 2.078 . . . . 0.47999999999999998 116.61 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -165.32 169.11 16.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.898 0.879 . . . . 0.28000000000000003 109.144 -178.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 11.6 t-105 -147.82 97.48 2.82 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.78 -1.193 . . . . 0.48999999999999999 107.78 165.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.579 HD12 HG23 ' A' ' 150' ' ' VAL . 2.1 mt -86.75 114.24 23.26 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.031 -0.729 . . . . 0.66000000000000003 109.031 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.492 ' O ' HG12 ' A' ' 101' ' ' ILE . 11.9 m -84.0 142.6 30.36 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.606 -0.725 . . . . 0.19 110.724 -170.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.672 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.9 mm? -108.08 163.12 13.43 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.13 111.856 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.529 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 12.3 t -58.89 -9.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.563 1.165 . . . . 1.1699999999999999 112.632 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.687 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 18.7 tptt -125.29 128.89 48.95 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 119.92 -0.712 . . . . 1.22 109.586 166.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.549 ' HA ' ' NH1' ' A' ' 23' ' ' ARG . 7.1 pt20 -52.9 -23.46 7.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.265 -1.334 . . . . 1.51 113.653 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.578 ' O ' ' HB3' ' A' ' 142' ' ' CYS . 41.4 m80 -96.85 -9.55 28.4 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.793 -0.763 . . . . 2.5299999999999998 112.63 -177.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.532 ' CG ' ' HB3' ' A' ' 120' ' ' LYS . 3.2 m-30 -91.1 -37.01 13.67 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.586 0.958 . . . . 0.83999999999999997 113.586 -169.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.672 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -4.14 128.95 0.01 OUTLIER Glycine 0 C--N 1.296 -1.655 0 N-CA-C 119.695 2.638 . . . . 0.32000000000000001 119.695 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -97.27 114.21 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 113.128 -1.536 . . . . 0.17999999999999999 109.699 175.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.701 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 24.2 p80 -140.56 177.81 7.76 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 115.473 -0.785 . . . . 0.20999999999999999 109.937 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.73 -166.46 37.51 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.782 -0.723 . . . . 0.27000000000000002 111.578 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.3 t -158.91 175.78 13.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.907 0.853 . . . . 0.40999999999999998 110.61 177.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -115.16 -3.12 12.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.807 -0.812 . . . . 1.99 108.807 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -118.14 87.87 30.47 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.254 -0.884 . . . . 1.3600000000000001 108.863 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.413 ' HA ' HG12 ' A' ' 134' ' ' ILE . 28.8 Cg_endo -73.55 -17.52 23.45 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.298 1.999 . . . . 0.34999999999999998 113.405 -169.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.98 -1.03 42.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.867 -0.606 . . . . 0.33000000000000002 111.13 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.524 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 38.9 t -93.64 -4.38 50.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.819 -0.808 . . . . 1.3500000000000001 108.819 171.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 83' ' ' PRO . 45.2 mm -82.76 137.06 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.496 -0.774 . . . . 0.20999999999999999 110.497 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.73 5.36 68.81 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 109.953 -1.259 . . . . 0.14999999999999999 109.953 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 90.4 mttt -113.24 168.08 10.02 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 123.173 1.463 . . . . 2.5 114.1 -176.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -97.54 123.09 41.29 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 111.747 -2.478 . . . . 0.17000000000000001 107.487 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.504 HG23 ' C ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -100.59 -166.15 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.954 -0.387 . . . . 0.66000000000000003 109.954 -170.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.497 ' H ' HG12 ' A' ' 138' ' ' VAL . 67.6 m -84.98 -59.94 2.19 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 110.119 -0.326 . . . . 0.42999999999999999 110.119 167.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -133.51 -43.99 0.83 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.357 -0.937 . . . . 2.02 112.572 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.34 134.09 0.18 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 117.047 1.579 . . . . 0.17999999999999999 117.047 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 5.9 p -69.4 166.16 19.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 112.141 -2.029 . . . . 0.16 112.174 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.92 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 49.2 mt -60.4 99.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.374 -1.284 . . . . 0.40000000000000002 111.77 -161.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.701 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 70.6 mtt180 -88.11 146.97 25.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.003 -1.453 . . . . 1.8700000000000001 110.28 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.726 ' SD ' HD22 ' A' ' 70' ' ' LEU . 1.8 mtm -130.79 -163.61 1.34 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.861 -0.792 . . . . 0.79000000000000004 108.861 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.546 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 87.6 m-70 -93.31 162.48 13.98 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.451 -0.5 . . . . 2.3199999999999998 109.828 170.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.679 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.8 m120 -64.33 -47.42 79.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 118.784 -0.627 . . . . 0.68000000000000005 110.234 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -65.9 -25.36 67.12 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 120.884 1.675 . . . . 2.1800000000000002 112.688 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.546 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 71.0 m-20 -79.11 -46.82 17.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.192 0.52 . . . . 0.68999999999999995 110.914 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.659 HG13 HD12 ' A' ' 151' ' ' ILE . 14.8 p -66.24 -24.27 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.347 -0.842 . . . . 0.11 111.685 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.679 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.19 -40.82 17.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 118.941 -0.552 . . . . 0.38 110.187 172.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.427 ' O ' HG13 ' A' ' 156' ' ' ILE . 14.0 mt-10 -47.73 -67.72 0.25 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.505 1.048 . . . . 1.99 112.54 170.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.577 HD11 ' CD2' ' A' ' 70' ' ' LEU . 95.8 mt -43.67 -40.52 4.21 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.748 0.785 . . . . 1.27 111.417 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.43 -37.34 86.93 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.875 -1.511 . . . . 0.17999999999999999 111.591 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.0 t -86.35 -30.64 22.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.76 0.709 . . . . 0.20999999999999999 112.401 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.6 mt -82.66 -60.55 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.521 0.676 . . . . 0.16 111.633 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.4 m -91.9 142.35 26.4 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.84 -1.073 . . . . 0.16 112.558 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.653 ' HA ' HH21 ' A' ' 103' ' ' ARG . 62.6 Cg_endo -89.21 173.9 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.872 3.048 . . . . 0.20000000000000001 111.123 172.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.868 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -62.4 157.63 19.56 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.437 -0.949 . . . . 1.1000000000000001 108.437 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 99.65 -27.07 21.87 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.931 -1.128 . . . . 0.17999999999999999 112.73 -176.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.624 ' HB ' HD12 ' A' ' 100' ' ' ILE . 51.6 m -59.73 135.12 57.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.07 -0.715 . . . . 0.14000000000000001 109.07 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.585 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 11.9 ptm180 -92.97 130.51 38.52 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.586 1.184 . . . . 3.6299999999999999 111.776 -168.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.7 t -108.96 107.12 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 112.323 -2.217 . . . . 0.14000000000000001 108.918 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 97' ' ' GLU . 25.5 m -94.25 106.73 18.7 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.152 -0.476 . . . . 0.20999999999999999 112.105 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.479 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -83.55 98.01 5.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 122.304 1.05 . . . . 0.23999999999999999 109.957 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -102.47 130.73 49.36 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.044 -1.435 . . . . 1.0900000000000001 108.9 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.532 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 15.9 mmm180 . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 116.339 -0.391 . . . . 2.0800000000000001 109.96 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.517 -0.294 0 CA-C-O 121.681 0.753 . . . . 0.65000000000000002 112.432 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.1 tt -98.51 129.29 45.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.628 -1.169 . . . . 0.28000000000000003 110.61 -175.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.31 162.24 13.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.056 0.931 . . . . 0.31 112.974 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.652 ' O ' ' HA ' ' A' ' 45' ' ' SER . 82.1 t80 -130.17 140.99 50.7 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.023 -1.444 . . . . 0.44 108.133 176.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.464 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 56.4 tt0 -113.32 113.4 25.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.107 -1.071 . . . . 0.76000000000000001 108.107 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.614 HG13 ' HB2' ' A' ' 13' ' ' ASP . 94.7 t -68.39 150.36 10.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 122.651 1.215 . . . . 0.39000000000000001 113.463 -168.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.414 ' O ' HG12 ' A' ' 9' ' ' VAL . 44.1 mtpt -101.48 159.15 15.53 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.198 -1.819 . . . . 2.0099999999999998 108.623 172.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -63.8 103.02 0.52 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.944 0.402 . . . . 1.8300000000000001 111.883 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.59 11.0 31.96 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.782 -0.723 . . . . 0.47999999999999998 113.152 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.614 ' HB2' HG13 ' A' ' 9' ' ' VAL . 86.9 m-20 -52.74 166.8 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.851 0.357 . . . . 1.46 111.136 171.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.51 149.76 49.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.0 0.428 . . . . 0.40999999999999998 111.028 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.565 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.66 -39.75 91.7 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.448 -0.945 . . . . 0.85999999999999999 108.448 -177.217 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.467 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 16.9 t-20 -82.35 -26.4 32.99 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.451 -1.249 . . . . 1.1499999999999999 110.256 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -65.19 -41.98 94.02 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.217 -0.66 . . . . 1.21 109.217 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.443 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.6 mt -74.18 -26.62 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.238 0.542 . . . . 0.20999999999999999 109.65 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.627 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.83 -10.05 59.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.319 -0.401 . . . . 0.16 110.831 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.66 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.75 -40.22 9.07 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 122.52 1.152 . . . . 0.20999999999999999 108.045 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 119' ' ' SER . 7.2 m-20 -63.01 -45.76 90.83 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 112.265 -2.243 . . . . 0.53000000000000003 112.082 173.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 60.7 m-85 -96.09 5.29 51.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 118.596 -1.242 . . . . 0.17999999999999999 111.36 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.66 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.4 mpt_? 54.52 42.51 31.28 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.793 0.806 . . . . 1.78 109.92 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.627 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.5 pt -117.14 -165.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.678 -1.147 . . . . 0.19 109.887 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.49 143.47 40.78 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.117 -0.947 . . . . 0.94999999999999996 110.279 175.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.471 ' HB ' HD13 ' A' ' 15' ' ' LEU . 37.0 p -73.32 -31.14 63.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.824 -1.176 . . . . 0.25 107.824 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.81 -33.01 71.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.336 -0.847 . . . . 0.20000000000000001 111.815 169.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -90.26 -27.92 19.15 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.795 0.807 . . . . 0.17000000000000001 108.886 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -72.93 -30.63 64.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.757 -1.11 . . . . 1.1599999999999999 109.168 174.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 36' ' ' LEU . 46.0 mt -76.71 -29.24 56.16 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.579 0.704 . . . . 1.05 110.624 171.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 20.0 tt0 -63.78 -39.98 95.57 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.72 -1.127 . . . . 1.8100000000000001 109.787 172.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.48 -19.76 32.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 120.248 -0.581 . . . . 0.20000000000000001 111.693 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.648 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.2 m-80 -150.55 82.59 6.15 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 110.482 -172.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.6 Cg_endo -56.2 -16.52 17.48 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 123.807 3.005 . . . . 0.35999999999999999 113.609 176.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 m -71.37 -22.21 61.92 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.162 0.43 . . . . 1.3799999999999999 112.162 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.782 HD21 HG21 ' A' ' 46' ' ' ILE . 28.9 mt -69.59 -35.48 75.37 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 112.563 0.579 . . . . 0.48999999999999999 112.563 -170.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -64.69 -46.62 81.6 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 122.818 1.294 . . . . 1.95 110.304 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.21 -48.97 77.45 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 111.845 -2.434 . . . . 0.48999999999999999 110.622 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.28 176.96 48.16 Favored Glycine 0 N--CA 1.428 -1.886 0 CA-C-N 114.595 -1.184 . . . . 0.41999999999999998 111.341 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.47 157.49 19.53 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.452 0.644 . . . . 0.40999999999999998 110.91 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.645 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 49.0 m -138.33 128.11 25.2 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.134 -0.939 . . . . 0.41999999999999998 110.512 -176.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.12 118.8 19.23 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.546 0.689 . . . . 0.46999999999999997 109.992 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.61 0.33 55.43 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 110.2 -1.16 . . . . 0.40999999999999998 110.2 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.645 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -75.74 124.06 26.63 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.835 -0.682 . . . . 1.3 109.797 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 51.4 p -83.84 128.68 34.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.577 -0.738 . . . . 0.84999999999999998 110.425 177.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.782 HG21 HD21 ' A' ' 36' ' ' LEU . 10.8 pt -129.42 142.8 43.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.432 -1.258 . . . . 0.25 109.459 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.11 150.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.465 0.65 . . . . 0.67000000000000004 111.268 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.4 mm -115.77 94.6 41.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.285 -1.325 . . . . 0.16 108.669 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.654 ' HA ' HD21 ' A' ' 4' ' ' LEU . 5.9 Cg_exo -60.91 137.06 69.84 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.646 2.231 . . . . 0.17999999999999999 112.76 -172.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.23 83.82 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.895 -1.048 . . . . 0.26000000000000001 112.432 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.725 HD12 ' HD2' ' A' ' 52' ' ' PRO . 37.5 tp -120.36 116.97 31.97 Favored Pre-proline 0 N--CA 1.449 -0.502 0 O-C-N 122.415 -0.462 . . . . 0.60999999999999999 111.295 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.725 ' HD2' HD12 ' A' ' 51' ' ' LEU . 43.2 Cg_endo -77.18 -177.25 3.69 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.891 3.061 . . . . 0.28000000000000003 114.205 -172.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.603 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.1 t70 -86.31 127.84 59.71 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.266 -1.334 . . . . 0.48999999999999999 111.836 -169.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.54 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.8 Cg_endo -75.8 -10.03 19.83 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.29 2.66 . . . . 0.46000000000000002 112.891 -176.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -92.55 -15.86 26.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.831 -0.622 . . . . 1.3799999999999999 110.271 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.603 HG23 ' HB3' ' A' ' 53' ' ' ASP . 27.1 p -84.62 -26.33 27.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.586 1.184 . . . . 0.46000000000000002 108.286 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.559 HG22 ' H ' ' A' ' 59' ' ' TYR . 27.0 mt -68.02 129.27 93.18 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 112.966 -1.924 . . . . 0.69999999999999996 111.155 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.419 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 86.7 Cg_endo -78.76 -14.34 14.04 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.474 2.116 . . . . 0.39000000000000001 113.492 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.559 ' H ' HG22 ' A' ' 57' ' ' ILE . 45.1 m-85 -99.16 162.95 12.77 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.549 -0.46 . . . . 0.23999999999999999 111.622 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -151.37 139.49 20.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.026 -0.731 . . . . 2.8900000000000001 109.026 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.654 ' HA ' ' O ' ' A' ' 71' ' ' THR . 88.4 mt -120.81 136.74 56.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.276 0.473 . . . . 0.16 112.276 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.56 24.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.946 -0.702 . . . . 0.16 110.902 171.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' THR . 90.6 t -91.19 108.87 20.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.566 0.698 . . . . 0.19 110.78 173.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 68' ' ' LYS . 75.3 m -85.43 107.32 17.34 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.088 -0.96 . . . . 0.20000000000000001 110.563 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.8 mm -53.98 -58.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 122.17 0.986 . . . . 0.23000000000000001 111.164 166.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.65 -13.55 8.1 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 112.926 -1.943 . . . . 0.16 113.337 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.02 -17.01 5.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.523 0.729 . . . . 0.14999999999999999 112.267 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.498 ' HD2' ' CG2' ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.5 56.87 4.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.287 0.494 . . . . 0.68999999999999995 111.376 -173.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 44.8 p -138.79 167.22 22.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 113.037 0.755 . . . . 0.13 113.037 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 70' ' ' LEU . 7.7 tt -133.94 111.14 10.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.617 -1.174 . . . . 0.40000000000000002 109.855 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.654 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 63.8 m -92.95 122.43 35.31 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.177 0.513 . . . . 0.16 111.15 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.7 tp -98.77 107.53 19.99 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.042 -0.981 . . . . 0.58999999999999997 109.309 173.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 75.2 p -109.14 158.8 17.44 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.989 -1.084 . . . . 1.05 110.998 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.784 ' HB2' ' SD ' ' A' ' 79' ' ' MET . 1.2 tm? -128.21 126.4 40.89 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.092 -0.707 . . . . 0.26000000000000001 109.092 171.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.761 ' ND2' HD13 ' A' ' 74' ' ' LEU . 9.0 p30 43.76 52.99 6.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 113.952 -1.476 . . . . 1.8400000000000001 112.146 -167.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 53.9 t30 75.46 -10.35 1.26 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.527 -0.76 . . . . 1.8899999999999999 111.623 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -100.58 120.7 40.42 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.141 0.496 . . . . 3.4399999999999999 110.126 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 45.4 t -55.82 132.72 19.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.249 1.024 . . . . 0.23999999999999999 112.32 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.784 ' SD ' ' HB2' ' A' ' 74' ' ' LEU . 97.4 mtp -97.06 -48.24 5.47 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 113.364 -1.744 . . . . 0.81000000000000005 108.405 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -158.67 171.97 19.13 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.498 -2.137 . . . . 1.46 109.902 -174.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.0 m -148.63 122.2 9.17 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.064 -1.425 . . . . 0.17000000000000001 109.656 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.614 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 24.6 m-85 -105.21 156.5 36.09 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 115.214 -0.903 . . . . 1.05 109.729 -174.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.491 ' O ' ' HG2' ' A' ' 145' ' ' MET . 59.1 Cg_endo -84.93 142.98 9.15 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.046 1.831 . . . . 0.20000000000000001 111.439 169.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.547 HG22 ' CG ' ' A' ' 145' ' ' MET . 2.2 pp -138.14 174.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.701 -0.681 . . . . 0.13 110.863 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.905 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.8 140.72 49.5 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.304 -0.407 . . . . 0.26000000000000001 109.972 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.498 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 7.7 m -125.74 125.37 68.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.547 0.689 . . . . 0.56000000000000005 111.829 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -82.76 157.58 36.0 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 114.899 -1.046 . . . . 0.17000000000000001 110.631 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 139' ' ' SER . 74.7 mmtt -55.48 3.21 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.894 0.701 . . . . 3.0499999999999998 112.894 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.954 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -92.55 -20.19 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.522 0.677 . . . . 0.23000000000000001 110.28 -177.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.954 HD22 HG23 ' A' ' 89' ' ' ILE . 3.6 mm? -89.22 -18.16 27.63 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.707 0.765 . . . . 0.17999999999999999 108.969 -176.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.1 p -66.61 -19.21 65.72 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.53 -1.214 . . . . 0.33000000000000002 111.73 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -59.1 -42.01 89.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.885 -1.052 . . . . 1.52 112.372 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.94 133.54 20.23 Favored Pre-proline 0 C--N 1.324 -0.525 0 C-N-CA 120.449 -0.5 . . . . 0.42999999999999999 111.497 -172.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 97.2 Cg_endo -90.59 -15.27 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.665 2.243 . . . . 0.72999999999999998 112.755 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.416 HG23 ' N ' ' A' ' 96' ' ' GLY . 7.9 t -102.43 -43.54 5.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.23 0.538 . . . . 0.47999999999999998 109.828 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.536 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 52.92 35.17 47.33 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.286 -1.325 . . . . 0.33000000000000002 113.622 167.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -82.91 111.93 19.24 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 122.039 0.923 . . . . 0.83999999999999997 109.478 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.621 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 26.1 m-85 -138.54 177.54 7.81 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.496 -1.684 . . . . 0.22 111.42 -173.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.469 ' CG ' HD11 ' A' ' 5' ' ' LEU . 28.5 m-85 -141.99 138.0 31.58 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.316 -0.402 . . . . 0.54000000000000004 110.49 -174.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.586 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.3 mt -61.92 121.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.577 -0.738 . . . . 0.17000000000000001 110.284 170.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 20.0 pt -88.63 -44.18 15.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 113.219 0.822 . . . . 0.20999999999999999 113.219 -175.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.55 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 51.7 m-80 -170.95 170.35 6.34 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.044 -1.465 . . . . 2.0299999999999998 107.044 -168.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.742 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 26.5 mtt180 -126.15 159.06 33.93 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.713 -0.795 . . . . 1.52 111.929 -173.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 60.7 tt0 -133.31 99.97 4.7 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.554 -0.748 . . . . 0.58999999999999997 110.058 169.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 34.1 ttt85 -66.07 166.06 12.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.647 -0.706 . . . . 2.8199999999999998 110.146 173.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.497 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 17.0 m-80 -35.26 101.92 0.22 Allowed Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 125.093 1.357 . . . . 0.34999999999999998 113.255 -156.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.497 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.1 Cg_endo . . . . . 0 C--N 1.345 0.384 0 C-N-CA 123.205 2.603 . . . . 0.47999999999999998 111.688 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.523 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.565 1.528 0 N-CA-C 117.398 2.37 . . . . 0.47999999999999998 117.398 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.482 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -166.17 149.38 7.36 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.412 -0.805 . . . . 0.28000000000000003 110.087 -176.162 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 9.9 t-105 -130.18 98.95 4.88 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.959 -1.126 . . . . 0.48999999999999999 107.959 167.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.4 mt -91.51 114.46 26.99 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.08 -0.711 . . . . 0.66000000000000003 109.08 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.405 ' C ' HG12 ' A' ' 101' ' ' ILE . 16.9 m -84.08 144.68 28.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.533 -0.758 . . . . 0.19 111.341 -168.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.778 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.5 mm? -108.91 170.1 8.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.13 111.407 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.2 t -62.0 -12.14 17.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.918 -1.037 . . . . 1.1699999999999999 112.779 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.621 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 5.5 tptp -126.73 132.59 51.08 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.58 -0.448 . . . . 1.22 110.42 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.532 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 76.7 mt-30 -31.89 -60.86 0.25 Allowed 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.554 1.159 . . . . 1.51 113.94 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.582 ' HB3' HG12 ' A' ' 89' ' ' ILE . 1.7 t-160 -94.01 5.4 51.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.954 -0.698 . . . . 2.5299999999999998 111.597 -169.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.778 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -93.9 38.43 1.07 Allowed 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 113.88 1.067 . . . . 0.83999999999999997 113.88 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.644 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.92 143.57 18.12 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 116.9 -2.571 . . . . 0.32000000000000001 112.67 -154.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 2.1 mp -96.52 114.04 32.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.808 0.814 . . . . 0.17999999999999999 110.596 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.757 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.8 p80 -140.17 171.73 13.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.082 -0.963 . . . . 0.20999999999999999 109.01 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.25 -170.31 39.49 Favored Glycine 0 C--N 1.315 -0.583 0 C-N-CA 119.891 -1.147 . . . . 0.27000000000000002 111.613 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.7 t -153.23 168.74 24.96 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.35 -0.5 . . . . 0.40999999999999998 110.332 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -112.05 2.94 17.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.18 -1.044 . . . . 1.99 108.18 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.9 84.67 26.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.384 -1.28 . . . . 1.3600000000000001 107.935 169.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.79 -22.32 11.9 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.679 2.253 . . . . 0.34999999999999998 114.495 -167.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.29 -10.19 59.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.923 -0.581 . . . . 0.33000000000000002 110.749 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.593 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 45.5 m -91.5 1.28 57.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 1.3500000000000001 110.375 176.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.409 HG22 ' HB2' ' A' ' 83' ' ' PRO . 47.5 mm -79.56 141.41 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.089 -0.505 . . . . 0.20999999999999999 110.152 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.7 6.4 63.9 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.463 -1.055 . . . . 0.14999999999999999 110.463 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.593 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 59.2 mttm -114.85 176.75 4.92 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 123.603 1.668 . . . . 2.5 114.078 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.77 125.46 51.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 110.813 -2.903 . . . . 0.17000000000000001 108.406 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.575 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -121.51 162.67 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.798 -1.186 . . . . 0.66000000000000003 107.798 -176.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.452 ' HA ' ' HG2' ' A' ' 88' ' ' LYS . 43.5 m -61.22 -50.95 71.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 118.845 0.748 . . . . 0.42999999999999999 112.691 -178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -130.57 -45.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 117.889 -1.524 . . . . 2.02 114.112 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.29 132.78 0.21 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 117.071 1.588 . . . . 0.17999999999999999 117.071 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.418 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 3.4 p -72.28 165.41 24.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 112.544 -1.828 . . . . 0.16 112.028 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.905 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 56.9 mt -60.41 98.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.535 -1.211 . . . . 0.40000000000000002 112.276 -162.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.757 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 64.2 mtt180 -87.32 150.85 23.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.006 -1.452 . . . . 1.8700000000000001 110.92 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.614 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -133.67 -163.65 1.39 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.081 -0.509 . . . . 0.79000000000000004 109.994 174.293 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.518 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 26.2 m80 -91.39 162.07 14.74 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.167 -0.613 . . . . 2.3199999999999998 109.937 172.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.688 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.4 m120 -61.71 -54.81 37.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 118.63 -0.7 . . . . 0.68000000000000005 110.125 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -63.56 -24.79 67.95 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 121.119 1.782 . . . . 2.1800000000000002 112.071 -174.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 45.2 m-20 -87.12 -45.36 10.77 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.547 -0.751 . . . . 0.68999999999999995 111.281 -173.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.617 HG13 HD12 ' A' ' 151' ' ' ILE . 11.1 p -59.44 -25.13 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 111.781 0.289 . . . . 0.11 111.781 170.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.688 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -80.26 -40.27 19.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 118.95 -0.548 . . . . 0.38 109.876 171.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.477 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.2 mm-40 -44.66 -72.64 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.237 0.926 . . . . 1.99 112.094 168.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 157' ' ' VAL . 44.2 mt -46.61 -39.67 11.58 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.649 0.738 . . . . 1.27 111.514 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.3 80.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.098 -1.41 . . . . 0.17999999999999999 111.466 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 25.5 t -86.29 -34.05 20.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.791 -0.568 . . . . 0.20999999999999999 112.219 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 152' ' ' GLU . 30.3 mt -79.84 -60.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.61 0.719 . . . . 0.16 111.37 -171.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -91.95 141.64 25.59 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.882 -1.054 . . . . 0.16 112.4 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.742 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 53.2 Cg_endo -89.06 175.71 3.4 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 124.143 3.229 . . . . 0.20000000000000001 111.062 173.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 75.7 m-20 -66.46 159.49 27.02 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 119.274 -0.971 . . . . 1.1000000000000001 109.107 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.16 -19.87 52.61 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.231 -0.985 . . . . 0.17999999999999999 112.3 -174.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.586 ' HB ' HD12 ' A' ' 100' ' ' ILE . 67.7 m -64.15 137.85 58.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.419 -0.586 . . . . 0.14000000000000001 109.419 -175.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -92.97 123.49 36.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.715 1.245 . . . . 3.6299999999999999 111.246 -169.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.82 111.39 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 112.221 -2.263 . . . . 0.14000000000000001 109.613 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 63' ' ' VAL . 13.6 m -93.34 108.66 20.28 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.051 -0.522 . . . . 0.20999999999999999 112.188 -174.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.536 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -79.95 100.23 4.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 123.201 1.477 . . . . 0.23999999999999999 108.362 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -113.47 123.92 51.17 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 112.287 -2.233 . . . . 1.0900000000000001 109.22 -164.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.504 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 9.1 mmm180 . . . . . 0 C--N 1.321 -0.652 0 C-N-CA 120.811 -0.356 . . . . 2.0800000000000001 111.379 -177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 121.179 0.514 . . . . 0.65000000000000002 110.821 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.616 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 2.9 tt -95.33 127.69 41.58 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.341 -0.845 . . . . 0.28000000000000003 110.33 -176.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.14 162.33 13.41 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.202 1.001 . . . . 0.31 113.473 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 45' ' ' SER . 84.0 t80 -130.67 141.1 50.4 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.441 -1.709 . . . . 0.44 107.932 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.411 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 56.7 tt0 -114.03 114.21 25.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.02 -1.104 . . . . 0.76000000000000001 108.02 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.686 HG13 ' HB2' ' A' ' 13' ' ' ASP . 95.7 t -68.35 150.47 10.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 122.338 1.066 . . . . 0.39000000000000001 113.194 -169.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -103.38 157.85 16.74 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.505 -1.68 . . . . 2.0099999999999998 108.042 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 2.3 mm-40 -58.64 110.17 0.94 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.104 0.478 . . . . 1.8300000000000001 111.548 -176.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.22 11.71 51.32 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.548 -0.751 . . . . 0.47999999999999998 114.004 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.686 ' HB2' HG13 ' A' ' 9' ' ' VAL . 30.7 m-20 -54.0 170.5 0.13 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 117.392 0.596 . . . . 1.46 111.222 171.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.6 154.58 47.7 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.449 -0.5 . . . . 0.40999999999999998 111.424 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 26' ' ' THR . 4.6 tp -67.35 -38.04 84.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.853 0.835 . . . . 0.85999999999999999 110.031 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 6.3 t30 -86.96 -23.22 25.17 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.434 -1.257 . . . . 1.1499999999999999 110.13 -174.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -69.7 -37.64 76.65 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.802 -0.444 . . . . 1.21 109.802 172.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.43 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.0 mt -76.68 -28.71 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.188 0.518 . . . . 0.20999999999999999 109.997 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.637 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.81 -9.51 59.08 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.122 -0.361 . . . . 0.16 110.538 175.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.708 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -95.92 -40.54 9.25 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.279 1.038 . . . . 0.20999999999999999 108.449 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.445 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 1.4 m-20 -61.29 -44.11 97.76 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.849 -1.978 . . . . 0.53000000000000003 112.0 174.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.497 ' HA ' HG21 ' A' ' 101' ' ' ILE . 59.0 m-85 -98.7 6.16 47.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.706 -1.198 . . . . 0.17999999999999999 111.436 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.708 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.21 43.81 30.04 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.916 0.865 . . . . 1.78 109.328 177.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.637 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 30.9 pt -116.96 -164.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.385 -1.279 . . . . 0.19 110.23 -178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 144.28 38.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.997 -1.001 . . . . 0.94999999999999996 110.523 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.594 ' HB ' HD21 ' A' ' 15' ' ' LEU . 75.8 p -73.98 -32.23 63.34 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.619 -0.882 . . . . 0.25 108.619 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.38 -27.66 67.6 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.26 -0.882 . . . . 0.20000000000000001 111.629 169.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.98 -28.52 17.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.289 -0.564 . . . . 0.17000000000000001 109.538 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.552 HD21 HD12 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -72.36 -30.55 64.81 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.781 -0.645 . . . . 1.1599999999999999 109.432 173.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 36' ' ' LEU . 41.4 mt -75.16 -30.14 60.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.872 0.844 . . . . 1.05 109.721 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 47.2 tt0 -65.61 -39.83 91.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.112 -1.403 . . . . 1.8100000000000001 110.527 173.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.48 -20.45 31.68 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 120.06 -0.656 . . . . 0.20000000000000001 111.563 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.64 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 20.8 m-80 -148.94 82.66 7.07 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-O 121.206 0.527 . . . . 0.23000000000000001 110.625 -172.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.57 -12.4 8.47 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 123.971 3.114 . . . . 0.35999999999999999 113.667 175.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 m -72.53 -26.43 61.75 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.996 0.427 . . . . 1.3799999999999999 111.661 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.64 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 36.4 mt -70.71 -33.69 71.13 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.89 -0.595 . . . . 0.48999999999999999 112.564 -167.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.421 ' H ' ' HG3' ' A' ' 37' ' ' GLN . 1.8 pp0? -63.46 -44.4 94.56 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 122.979 1.371 . . . . 1.95 110.582 -174.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.68 81.96 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 111.818 -2.446 . . . . 0.48999999999999999 110.985 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.66 179.0 48.84 Favored Glycine 0 N--CA 1.428 -1.898 0 CA-C-N 114.835 -1.075 . . . . 0.41999999999999998 111.173 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.35 156.99 21.55 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.151 0.5 . . . . 0.40999999999999998 110.978 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.547 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 31.7 m -134.89 127.58 30.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.076 -0.965 . . . . 0.41999999999999998 110.243 -177.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -75.99 122.83 24.78 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.261 0.553 . . . . 0.46999999999999997 110.114 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.411 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.76 1.17 61.93 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.543 -1.023 . . . . 0.40999999999999998 110.543 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.547 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -79.96 123.85 28.17 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.271 -0.464 . . . . 1.3 110.177 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 31.0 p -76.8 126.67 31.38 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 122.175 0.988 . . . . 0.84999999999999998 110.349 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.608 HG21 HD21 ' A' ' 36' ' ' LEU . 8.8 pt -125.85 141.26 46.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 113.875 -1.511 . . . . 0.25 108.878 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.85 151.18 3.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.357 0.598 . . . . 0.67000000000000004 111.167 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.6 mm -115.36 93.4 35.93 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.385 -1.279 . . . . 0.16 108.794 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.579 ' HA ' HD21 ' A' ' 4' ' ' LEU . 5.6 Cg_exo -61.64 136.26 61.6 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.719 2.279 . . . . 0.17999999999999999 112.726 -172.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.15 -6.0 82.77 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 114.725 -1.125 . . . . 0.26000000000000001 112.435 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.701 HD12 ' HD2' ' A' ' 52' ' ' PRO . 29.8 tp -122.94 116.24 28.95 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-O 121.192 0.52 . . . . 0.60999999999999999 110.948 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.701 ' HD2' HD12 ' A' ' 51' ' ' LEU . 52.3 Cg_endo -78.19 -177.14 3.66 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.491 2.794 . . . . 0.28000000000000003 114.119 -171.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.624 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.0 t70 -79.3 133.59 60.13 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 114.202 -1.363 . . . . 0.48999999999999999 112.454 -170.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.35 -16.01 24.89 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.577 2.851 . . . . 0.46000000000000002 113.115 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -96.66 1.74 51.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.159 0.504 . . . . 1.3799999999999999 111.701 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.624 HG23 ' HB3' ' A' ' 53' ' ' ASP . 26.8 p -95.74 -16.04 22.22 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.395 -0.965 . . . . 0.46000000000000002 108.395 172.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.676 HG22 ' H ' ' A' ' 59' ' ' TYR . 9.1 mm -64.62 129.24 94.19 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 113.422 -1.717 . . . . 0.69999999999999996 110.08 176.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.435 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 60.4 Cg_endo -78.65 -17.71 12.41 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.057 1.838 . . . . 0.39000000000000001 113.037 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.676 ' H ' HG22 ' A' ' 57' ' ' ILE . 60.4 m-85 -104.13 172.99 6.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.066 0.46 . . . . 0.23999999999999999 111.67 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -155.53 138.24 15.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.595 -0.729 . . . . 2.8900000000000001 109.397 173.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 71' ' ' THR . 82.9 mt -113.55 131.97 63.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.108 -0.496 . . . . 0.16 111.789 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.44 118.27 32.72 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.169 -0.612 . . . . 0.16 111.13 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 59.0 t -98.1 120.91 48.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.538 0.685 . . . . 0.19 110.888 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 45.2 m -98.31 104.34 16.36 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.909 -1.041 . . . . 0.20000000000000001 110.989 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.561 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 35.2 mm -50.89 -58.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 122.053 0.93 . . . . 0.23000000000000001 111.263 166.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.21 -11.18 3.17 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 112.774 -2.012 . . . . 0.16 113.462 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -127.5 -21.52 3.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.982 0.734 . . . . 0.14999999999999999 112.982 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.529 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 60.24 57.2 3.0 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.989 0.813 . . . . 0.68999999999999995 111.249 -170.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -137.64 161.94 35.13 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.951 0.723 . . . . 0.13 112.951 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.478 ' CD2' HD21 ' A' ' 153' ' ' LEU . 7.8 tt -130.46 113.58 14.47 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.54 -1.209 . . . . 0.40000000000000002 109.702 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 52.7 m -95.12 123.88 38.86 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.157 0.504 . . . . 0.16 111.317 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 79' ' ' MET . 11.6 tp -99.16 107.91 20.38 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.12 -0.946 . . . . 0.58999999999999997 109.197 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 90.0 p -107.73 160.72 15.5 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.233 -0.987 . . . . 1.05 110.804 177.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.637 HD13 ' ND2' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -126.46 124.75 40.82 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.707 0.765 . . . . 0.26000000000000001 109.221 170.254 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.637 ' ND2' HD13 ' A' ' 74' ' ' LEU . 9.3 p30 37.83 59.21 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.531 -1.668 . . . . 1.8400000000000001 111.899 -164.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 75.49 -13.73 0.84 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.883 -1.053 . . . . 1.8899999999999999 112.156 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -96.0 121.59 37.91 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.699 -0.482 . . . . 3.4399999999999999 109.699 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 46.5 t -58.49 129.82 21.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 122.318 1.056 . . . . 0.23999999999999999 112.517 -176.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 48.4 mmm -93.9 -49.92 5.58 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.161 -1.836 . . . . 0.81000000000000005 107.881 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -159.73 172.06 18.4 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.779 -2.01 . . . . 1.46 109.634 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.4 m -149.34 125.09 10.48 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.418 -1.265 . . . . 0.17000000000000001 109.592 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -116.31 150.42 45.32 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.555 -0.748 . . . . 1.05 110.077 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.433 ' HB2' HG22 ' A' ' 134' ' ' ILE . 53.9 Cg_endo -75.5 145.57 29.92 Favored 'Trans proline' 0 CA--C 1.494 -1.492 0 C-N-CA 122.188 1.926 . . . . 0.20000000000000001 110.957 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.636 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -141.22 173.25 9.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.689 -0.687 . . . . 0.13 110.782 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.898 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.65 142.99 46.59 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.438 -0.346 . . . . 0.26000000000000001 110.176 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 68' ' ' LYS . 13.0 m -126.28 128.27 71.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.417 0.627 . . . . 0.56000000000000005 111.622 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -92.01 160.14 25.96 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.067 -0.97 . . . . 0.17000000000000001 110.714 173.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -55.62 2.88 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 113.539 0.94 . . . . 3.0499999999999998 113.539 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.91 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -91.15 -18.89 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 O-C-N 121.051 -1.031 . . . . 0.23000000000000001 109.793 -177.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.91 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -91.63 -22.31 20.35 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.898 0.856 . . . . 0.17999999999999999 108.693 -177.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.2 p -67.29 -11.76 58.38 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.263 -1.335 . . . . 0.33000000000000002 111.404 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -71.14 -42.11 69.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.61 -1.177 . . . . 1.52 112.287 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -96.74 125.78 45.46 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.274 -0.571 . . . . 0.42999999999999999 110.659 -176.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.551 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.9 Cg_endo -75.19 -15.24 20.45 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.771 2.314 . . . . 0.72999999999999998 112.837 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 96' ' ' GLY . 14.9 t -115.65 -41.62 3.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.649 -0.25 . . . . 0.47999999999999998 110.381 -177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.475 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 47.43 42.72 19.33 Favored Glycine 0 C--O 1.225 -0.447 0 O-C-N 124.045 0.841 . . . . 0.33000000000000002 113.778 169.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.57 113.54 21.32 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.793 0.806 . . . . 0.83999999999999997 109.237 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.733 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 25.6 m-85 -136.53 178.32 7.16 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.137 -1.392 . . . . 0.22 112.275 -171.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.486 ' CD2' ' HB3' ' A' ' 162' ' ' ARG . 32.5 m-85 -144.28 139.12 28.41 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.197 -0.456 . . . . 0.54000000000000004 110.703 -171.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.634 HD12 ' HB ' ' A' ' 161' ' ' THR . 75.6 mt -65.68 116.02 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 115.424 -0.807 . . . . 0.17000000000000001 110.674 171.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.523 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 20.6 pt -84.16 -44.09 17.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 112.901 0.704 . . . . 0.20999999999999999 112.901 -175.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.84 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 44.9 m-80 -170.45 169.84 7.25 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.003 -1.48 . . . . 2.0299999999999998 107.003 -169.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.656 HH21 ' HA ' ' A' ' 158' ' ' PRO . 14.0 mtt180 -129.27 158.13 39.93 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.819 -0.752 . . . . 1.52 111.536 -175.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.9 tt0 -131.89 100.87 5.22 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.711 -0.677 . . . . 0.58999999999999997 109.969 169.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.492 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 20.7 ttt85 -62.86 166.0 6.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.339 -0.846 . . . . 2.8199999999999998 111.01 174.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.492 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 21.5 m-80 -35.01 103.03 0.23 Allowed Pre-proline 0 C--O 1.234 0.274 0 C-N-CA 125.361 1.464 . . . . 0.34999999999999998 113.717 -153.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 13.9 Cg_exo . . . . . 0 N--CA 1.458 -0.584 0 C-N-CA 123.594 2.863 . . . . 0.47999999999999998 111.238 170.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.524 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.563 1.474 0 N-CA-C 117.055 2.243 . . . . 0.47999999999999998 117.055 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.479 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -167.26 162.67 15.12 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.583 -0.698 . . . . 0.28000000000000003 109.925 -176.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 22.1 t-105 -142.52 98.61 3.33 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.176 -1.046 . . . . 0.48999999999999999 108.176 166.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.6 HD12 HG23 ' A' ' 150' ' ' VAL . 4.6 mt -91.3 113.74 26.09 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.101 -0.703 . . . . 0.66000000000000003 109.101 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 101' ' ' ILE . 23.5 m -83.82 143.81 29.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.86 -0.609 . . . . 0.19 111.325 -169.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.791 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.3 167.99 9.63 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.921 -0.581 . . . . 0.13 111.407 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 t -58.87 -13.87 7.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.583 -1.19 . . . . 1.1699999999999999 112.967 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.733 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 4.0 tmtm? -127.01 130.12 49.4 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.016 0.436 . . . . 1.22 110.127 172.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.712 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.9 mt-30 -34.37 -55.02 0.53 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.097 -1.411 . . . . 1.51 114.151 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.529 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -99.91 11.93 38.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.958 -0.697 . . . . 2.5299999999999998 111.997 -173.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.791 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -96.48 37.65 1.26 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.755 0.65 . . . . 0.83999999999999997 112.755 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.612 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -114.45 142.68 17.7 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 117.379 -2.343 . . . . 0.32000000000000001 112.58 -151.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.529 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -94.63 114.44 31.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.743 0.783 . . . . 0.17999999999999999 110.568 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.679 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.8 p80 -145.05 171.44 14.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.20999999999999999 109.75 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.83 -168.03 37.89 Favored Glycine 0 C--N 1.316 -0.537 0 C-N-CA 120.287 -0.958 . . . . 0.27000000000000002 111.892 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.2 t -156.69 172.7 18.13 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.2 -0.588 . . . . 0.40999999999999998 110.175 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -114.26 -0.1 14.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.952 -0.759 . . . . 1.99 108.952 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -114.83 86.8 13.72 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 107.916 -1.142 . . . . 1.3600000000000001 107.916 169.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -73.47 -18.18 23.09 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.486 2.124 . . . . 0.34999999999999998 113.53 -169.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.98 -1.82 45.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.778 -0.647 . . . . 0.33000000000000002 110.67 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 41.1 t -91.03 -4.06 56.69 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.049 -0.722 . . . . 1.3500000000000001 109.049 171.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.433 HG22 ' HB2' ' A' ' 83' ' ' PRO . 37.0 mm -83.3 134.14 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.81 -0.632 . . . . 0.20999999999999999 110.251 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.95 1.19 70.54 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.867 -1.293 . . . . 0.14999999999999999 109.867 -174.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 3.3 tttt -110.82 161.53 15.71 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 122.859 1.314 . . . . 2.5 113.46 -176.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.445 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -96.52 126.95 42.07 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 112.551 -2.113 . . . . 0.17000000000000001 108.239 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.495 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 1.2 p -122.19 166.91 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.585 -1.265 . . . . 0.66000000000000003 107.585 -176.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.4 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 45.2 m -64.17 -52.17 60.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.823 0.738 . . . . 0.42999999999999999 112.605 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -130.23 -45.46 1.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 118.067 -1.453 . . . . 2.02 113.805 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.06 133.7 0.17 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 117.023 1.569 . . . . 0.17999999999999999 117.023 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.598 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 3.0 p -74.67 165.6 24.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 112.573 -1.813 . . . . 0.16 111.676 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.898 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 61.5 mt -59.59 99.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 122.378 1.085 . . . . 0.40000000000000002 112.239 -162.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.679 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 70.9 mtt180 -86.85 145.83 26.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.752 -1.567 . . . . 1.8700000000000001 110.494 -177.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.636 ' HG2' HG22 ' A' ' 84' ' ' ILE . 10.9 mtp -126.23 -165.51 1.45 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.011 -0.737 . . . . 0.79000000000000004 109.011 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.472 ' O ' HG12 ' A' ' 150' ' ' VAL . 40.0 m80 -90.47 165.1 13.99 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.113 -0.699 . . . . 2.3199999999999998 109.113 169.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.663 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.8 m120 -63.57 -48.99 75.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 118.258 -0.877 . . . . 0.68000000000000005 110.145 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -64.48 -29.27 70.31 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 121.58 1.991 . . . . 2.1800000000000002 111.903 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.541 ' HB3' ' HE2' ' A' ' 145' ' ' MET . 68.1 m-20 -76.68 -45.67 28.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.06 0.457 . . . . 0.68999999999999995 110.435 -175.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.657 HG13 HD12 ' A' ' 151' ' ' ILE . 14.4 p -67.02 -23.46 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.387 -0.824 . . . . 0.11 111.308 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.663 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -84.08 -42.52 17.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 119.05 -0.5 . . . . 0.38 110.142 171.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.478 ' O ' HG13 ' A' ' 156' ' ' ILE . 29.9 mt-10 -48.22 -68.55 0.17 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 119.392 0.996 . . . . 1.99 112.305 171.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.2 mp -47.09 -39.02 12.35 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.455 0.645 . . . . 1.27 111.436 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.73 -32.62 74.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.579 -1.191 . . . . 0.17999999999999999 111.606 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.1 t -87.34 -32.25 19.72 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.487 -0.758 . . . . 0.20999999999999999 112.316 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 152' ' ' GLU . 36.9 mt -82.88 -60.11 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.528 0.68 . . . . 0.16 111.547 -172.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.8 m -89.52 138.16 28.5 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.812 -1.086 . . . . 0.16 112.28 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.656 ' HA ' HH21 ' A' ' 103' ' ' ARG . 43.3 Cg_endo -89.01 176.04 3.34 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 C-N-CA 124.194 3.263 . . . . 0.20000000000000001 111.525 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.84 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.8 m-20 -67.24 154.42 41.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.13 -1.063 . . . . 1.1000000000000001 108.13 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.97 -15.35 63.18 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.789 -1.196 . . . . 0.17999999999999999 112.565 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.634 ' HB ' HD12 ' A' ' 100' ' ' ILE . 88.3 m -65.8 136.88 56.78 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.091 -0.707 . . . . 0.14000000000000001 109.091 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.486 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 1.1 ptm180 -93.3 127.31 38.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.55 1.166 . . . . 3.6299999999999999 111.51 -171.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.5 t -111.69 108.61 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 112.327 -2.215 . . . . 0.14000000000000001 109.215 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.8 m -95.54 109.89 22.05 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.459 0.541 . . . . 0.20999999999999999 112.459 -172.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.475 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -83.69 96.08 4.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 122.504 1.145 . . . . 0.23999999999999999 109.946 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -101.56 138.32 38.72 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.724 -1.58 . . . . 1.0900000000000001 108.663 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.561 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 5.2 mmt85 . . . . . 0 C--N 1.313 -0.983 0 N-CA-C 108.988 -0.745 . . . . 2.0800000000000001 108.988 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.515 -0.398 0 CA-C-O 121.661 0.743 . . . . 0.65000000000000002 112.097 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.62 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.2 tt -96.19 129.67 43.44 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.644 -1.162 . . . . 0.28000000000000003 110.219 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.81 162.04 13.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.207 -0.906 . . . . 0.31 112.663 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 45' ' ' SER . 74.0 t80 -131.2 145.38 51.91 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.956 -1.475 . . . . 0.44 108.193 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.425 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 59.0 tt0 -116.02 114.55 24.73 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.436 -0.95 . . . . 0.76000000000000001 108.436 177.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 13' ' ' ASP . 97.5 t -68.04 151.46 10.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 122.567 1.175 . . . . 0.39000000000000001 113.364 -171.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -103.96 159.87 15.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.256 -1.793 . . . . 2.0099999999999998 108.837 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.07 105.3 0.67 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.972 0.415 . . . . 1.8300000000000001 111.751 -176.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.35 10.93 32.67 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.933 -0.651 . . . . 0.47999999999999998 113.215 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.598 ' HB2' HG13 ' A' ' 9' ' ' VAL . 87.8 m-20 -55.93 171.09 0.26 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.709 0.254 . . . . 1.46 111.26 172.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.2 154.3 50.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.599 0.714 . . . . 0.40999999999999998 111.893 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.708 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -69.14 -28.73 66.7 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.346 -1.297 . . . . 0.85999999999999999 109.995 -176.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.459 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -93.51 -26.12 17.3 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.025 -0.989 . . . . 1.1499999999999999 110.788 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -66.06 -40.6 91.06 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.604 -0.438 . . . . 1.21 109.927 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.431 HG23 ' CE1' ' A' ' 22' ' ' PHE . 14.6 mt -73.47 -27.1 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.185 -0.461 . . . . 0.20999999999999999 109.928 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.651 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.39 -11.37 59.92 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.809 -0.356 . . . . 0.16 111.147 176.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.644 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -93.51 -40.02 10.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.458 0.647 . . . . 0.20999999999999999 109.885 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.67 ' HB3' ' O ' ' A' ' 119' ' ' SER . 47.1 m-20 -63.46 -40.54 97.4 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.726 -1.125 . . . . 0.53000000000000003 112.054 174.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 51.4 m-85 -99.25 4.81 46.74 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 118.506 -1.278 . . . . 0.17999999999999999 111.44 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.644 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.7 mpt_? 54.83 44.6 28.15 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.711 0.767 . . . . 1.78 109.619 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.651 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 32.4 pt -117.46 -165.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.624 -1.171 . . . . 0.19 110.028 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.42 142.55 41.98 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.91 -1.041 . . . . 0.94999999999999996 110.125 175.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.708 ' HB ' HD11 ' A' ' 15' ' ' LEU . 78.8 p -73.57 -32.75 64.32 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.409 -0.96 . . . . 0.25 108.409 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.59 -24.4 66.65 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.095 -0.957 . . . . 0.20000000000000001 111.636 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -95.31 -28.2 15.1 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.983 -0.747 . . . . 0.17000000000000001 108.983 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.646 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 21.3 tp -74.23 -27.01 60.57 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.486 -0.779 . . . . 1.1599999999999999 109.503 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 36' ' ' LEU . 72.6 mt -80.19 -26.81 39.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.698 0.761 . . . . 1.05 110.117 172.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.475 HE21 ' HA ' ' A' ' 28' ' ' ALA . 7.1 tt0 -66.03 -41.18 91.26 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.573 -1.194 . . . . 1.8100000000000001 110.13 171.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.1 -21.67 31.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.115 -0.634 . . . . 0.20000000000000001 111.456 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.656 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.2 m-80 -148.27 78.49 9.41 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.532 0.682 . . . . 0.23000000000000001 110.328 -172.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 20.3 Cg_endo -58.36 -7.79 4.41 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 124.331 3.354 . . . . 0.35999999999999999 114.149 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.6 m -84.69 -17.89 37.01 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 111.815 0.302 . . . . 1.3799999999999999 111.815 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.742 HD21 HG21 ' A' ' 46' ' ' ILE . 41.8 mt -67.74 -34.49 76.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.513 0.673 . . . . 0.48999999999999999 111.704 -173.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.422 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 5.7 pt20 -65.05 -46.64 80.4 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.819 1.295 . . . . 1.95 110.36 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' A' ' 37' ' ' GLN . . . -58.86 -47.66 84.12 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 111.771 -2.468 . . . . 0.48999999999999999 110.648 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.48 47.43 Favored Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 114.753 -1.112 . . . . 0.41999999999999998 111.318 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.26 156.8 20.95 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.273 0.558 . . . . 0.40999999999999998 111.006 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 62.3 m -138.05 127.32 24.53 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.17 -0.923 . . . . 0.41999999999999998 110.576 -175.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.7 118.06 19.71 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.511 0.672 . . . . 0.46999999999999997 109.943 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 101.67 1.76 52.86 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.195 -1.162 . . . . 0.40999999999999998 110.195 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -77.95 123.7 27.11 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.633 -0.783 . . . . 1.3 109.715 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 46.2 p -82.18 128.04 33.76 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.434 -0.803 . . . . 0.84999999999999998 110.275 176.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.742 HG21 HD21 ' A' ' 36' ' ' LEU . 12.4 pt -127.7 141.72 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.186 -1.37 . . . . 0.25 109.326 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.36 150.61 3.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.094 0.473 . . . . 0.67000000000000004 110.898 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.4 mm -114.8 92.1 28.57 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.709 -1.132 . . . . 0.16 108.992 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.635 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -58.94 133.81 56.0 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.903 2.402 . . . . 0.17999999999999999 112.918 -174.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.07 -6.38 78.88 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.8 -1.091 . . . . 0.26000000000000001 112.339 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.727 HD12 ' HD2' ' A' ' 52' ' ' PRO . 30.0 tp -123.47 116.97 27.97 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 121.106 0.479 . . . . 0.60999999999999999 111.213 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.727 ' HD2' HD12 ' A' ' 51' ' ' LEU . 43.7 Cg_endo -76.86 -177.28 3.68 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.605 2.87 . . . . 0.28000000000000003 113.907 -172.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.508 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.1 t70 -83.54 129.56 59.53 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 114.483 -1.235 . . . . 0.48999999999999999 111.97 -168.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.557 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.2 Cg_endo -75.23 -17.49 19.01 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.333 2.689 . . . . 0.46000000000000002 112.411 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -93.96 -5.41 47.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.476 0.655 . . . . 1.3799999999999999 110.404 -172.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.2 p -89.24 -20.84 23.65 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.6 1.19 . . . . 0.46000000000000002 107.993 173.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.497 HG22 ' H ' ' A' ' 59' ' ' TYR . 27.1 mt -74.05 130.02 83.61 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 112.906 -1.952 . . . . 0.69999999999999996 111.232 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.82 -17.06 9.86 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.48 2.12 . . . . 0.39000000000000001 113.153 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.497 ' H ' HG22 ' A' ' 57' ' ' ILE . 70.0 m-85 -92.26 159.5 15.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.823 -0.351 . . . . 0.23999999999999999 111.661 -177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -147.2 134.44 20.58 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.883 -0.784 . . . . 2.8900000000000001 108.883 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' A' ' 71' ' ' THR . 86.3 mt -113.68 131.89 64.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.948 -0.569 . . . . 0.16 111.676 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.32 30.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.937 -0.705 . . . . 0.16 110.843 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 69' ' ' THR . 91.2 t -97.62 111.31 27.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.765 0.793 . . . . 0.19 111.117 175.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 68' ' ' LYS . 58.8 m -93.64 101.25 13.39 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.508 -1.223 . . . . 0.20000000000000001 110.702 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.52 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.6 mm -49.26 -57.89 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 122.067 0.937 . . . . 0.23000000000000001 111.306 170.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.22 -9.1 2.85 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 112.764 -2.016 . . . . 0.16 113.208 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.07 -22.53 3.76 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.532 0.733 . . . . 0.14999999999999999 112.517 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HG3' HG22 ' A' ' 86' ' ' VAL . 1.1 mppt? 60.61 58.44 2.45 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 118.067 0.394 . . . . 0.68999999999999995 111.354 -170.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 63.0 p -137.68 160.83 38.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 113.09 0.774 . . . . 0.13 113.09 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.435 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.4 tt -128.18 107.95 10.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.672 -1.149 . . . . 0.40000000000000002 109.534 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.7 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 61.7 m -90.37 122.02 32.87 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.082 0.468 . . . . 0.16 110.837 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 79' ' ' MET . 17.1 tp -97.88 105.21 17.32 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.446 -0.797 . . . . 0.58999999999999997 109.273 173.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 96.9 p -105.65 160.47 15.18 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 118.829 -1.148 . . . . 1.05 110.318 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.5 tm? -126.1 125.45 42.57 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.705 -0.85 . . . . 0.26000000000000001 108.705 168.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.538 ' N ' HD22 ' A' ' 74' ' ' LEU . 24.4 m-80 50.54 50.06 19.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.435 -1.257 . . . . 1.8400000000000001 111.008 -171.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 71.74 -10.18 0.87 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.571 0.749 . . . . 1.8899999999999999 111.816 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -98.79 120.42 39.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.021 -0.536 . . . . 3.4399999999999999 109.82 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 54.6 t -57.74 132.98 22.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 122.493 1.139 . . . . 0.23999999999999999 112.768 -174.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -102.01 -45.01 5.31 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 112.837 -1.983 . . . . 0.81000000000000005 108.732 177.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -154.27 174.49 14.72 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 113.2 -1.818 . . . . 1.46 110.102 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 27.9 m -149.29 121.21 8.19 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.481 -1.69 . . . . 0.17000000000000001 109.46 168.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.503 ' HD2' ' OD2' ' A' ' 149' ' ' ASP . 12.9 m-85 -101.19 151.28 37.67 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 115.142 -0.935 . . . . 1.05 109.165 -175.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HB2' HG22 ' A' ' 134' ' ' ILE . 57.3 Cg_endo -81.2 140.51 12.36 Favored 'Trans proline' 0 CA--C 1.5 -1.212 0 C-N-CA 121.499 1.466 . . . . 0.20000000000000001 111.062 169.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.674 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -139.81 176.13 6.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.516 -0.765 . . . . 0.13 110.393 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.878 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -120.14 150.17 41.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.126 -0.324 . . . . 0.26000000000000001 110.126 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.513 HG11 HD13 ' A' ' 65' ' ' ILE . 9.8 m -130.95 127.47 61.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.58 0.705 . . . . 0.56000000000000005 112.107 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -85.67 156.16 29.98 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.044 -1.222 . . . . 0.17000000000000001 110.044 172.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -57.46 3.96 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.236 0.828 . . . . 3.0499999999999998 113.236 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.947 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -90.28 -19.49 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 O-C-N 121.638 -0.664 . . . . 0.23000000000000001 110.291 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.947 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -89.78 -18.13 26.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.765 0.793 . . . . 0.17999999999999999 109.256 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.5 p -68.04 -14.36 62.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.427 -1.26 . . . . 0.33000000000000002 111.362 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -71.52 -37.67 71.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.47 -1.241 . . . . 1.52 112.862 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -105.8 115.89 60.76 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 120.055 -0.658 . . . . 0.42999999999999999 110.793 -177.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.558 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.8 Cg_endo -75.58 -11.69 20.43 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.792 2.328 . . . . 0.72999999999999998 113.63 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.439 HG23 ' N ' ' A' ' 96' ' ' GLY . 10.1 t -105.02 -43.56 5.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.185 0.516 . . . . 0.47999999999999998 110.107 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.557 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 53.54 33.48 47.81 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.257 -1.338 . . . . 0.33000000000000002 113.93 167.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.16 112.61 20.4 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.969 0.89 . . . . 0.83999999999999997 109.721 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.715 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 19.0 m-85 -138.05 176.81 8.37 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.764 -1.562 . . . . 0.22 111.949 -170.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.455 ' CG ' HD11 ' A' ' 5' ' ' LEU . 45.3 m-85 -139.33 144.08 38.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.257 0.551 . . . . 0.54000000000000004 110.452 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.564 HD12 ' HB ' ' A' ' 161' ' ' THR . 83.8 mt -68.84 116.89 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 115.613 -0.721 . . . . 0.17000000000000001 110.557 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 30.4 pt -85.93 -35.81 9.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 112.877 0.695 . . . . 0.20999999999999999 112.877 -175.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.782 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 11.0 p30 -178.53 -179.21 0.65 Allowed 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 107.695 -1.224 . . . . 2.0299999999999998 107.695 -176.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.674 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -140.38 159.6 41.83 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.16 -0.616 . . . . 1.52 112.599 -176.041 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.8 tt0 -128.37 100.07 5.66 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.9 -1.046 . . . . 0.58999999999999997 109.428 172.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.518 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 61.5 ttt180 -64.73 165.91 9.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.341 -0.845 . . . . 2.8199999999999998 110.663 176.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.518 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 23.3 m-80 -35.07 102.05 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 125.282 1.433 . . . . 0.34999999999999998 113.743 -152.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 16.3 Cg_exo . . . . . 0 N--CA 1.456 -0.69 0 C-N-CA 123.504 2.803 . . . . 0.47999999999999998 111.469 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.514 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.566 1.582 0 N-CA-C 116.977 2.214 . . . . 0.47999999999999998 116.977 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.49 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -166.54 162.88 16.96 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.684 -0.635 . . . . 0.28000000000000003 110.04 -176.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 18.0 t-105 -143.9 97.85 3.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.302 -0.999 . . . . 0.48999999999999999 108.302 167.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.468 HD12 HG23 ' A' ' 150' ' ' VAL . 2.1 mt -89.48 115.19 26.72 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.381 0.61 . . . . 0.66000000000000003 109.739 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.449 ' C ' HG12 ' A' ' 101' ' ' ILE . 24.3 m -86.01 144.3 27.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.956 -0.565 . . . . 0.19 111.19 -171.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.807 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.1 mm? -109.29 168.14 9.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.13 110.46 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.67 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.1 m -65.11 -2.38 2.79 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.937 0.718 . . . . 1.1699999999999999 112.937 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.773 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 5.0 tmtm? -128.8 136.37 50.42 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.941 -0.392 . . . . 1.22 109.941 168.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.773 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 25.5 mm-40 -36.46 -58.03 0.73 Allowed 'General case' 0 C--N 1.312 -1.041 0 O-C-N 124.222 0.951 . . . . 1.51 113.458 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.538 ' CB ' HG12 ' A' ' 89' ' ' ILE . 56.2 m80 -89.92 0.78 56.88 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.451 -0.499 . . . . 2.5299999999999998 111.83 -167.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.807 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.1 m-30 -96.73 37.93 1.25 Allowed 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 113.419 0.896 . . . . 0.83999999999999997 113.419 -170.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.699 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -114.41 142.95 17.85 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 116.693 -2.67 . . . . 0.32000000000000001 112.642 -152.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -93.35 115.21 31.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.773 0.797 . . . . 0.17999999999999999 110.661 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.555 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 31.5 p80 -142.05 170.57 15.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.451 -0.795 . . . . 0.20999999999999999 109.394 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -92.35 -167.27 39.61 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.375 -0.917 . . . . 0.27000000000000002 111.687 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.2 t -156.79 169.82 23.86 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 122.039 -0.683 . . . . 0.40999999999999998 110.346 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -114.68 -5.22 12.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.643 -0.873 . . . . 1.99 108.643 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -116.04 87.33 18.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 114.832 -1.077 . . . . 1.3600000000000001 108.231 171.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -72.78 -21.21 21.79 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.131 2.554 . . . . 0.34999999999999998 114.484 -167.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -75.83 -2.58 30.69 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.147 0.499 . . . . 0.33000000000000002 111.116 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.483 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 15.9 m -91.91 -5.52 53.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.275 0.559 . . . . 1.3500000000000001 109.673 173.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 83' ' ' PRO . 37.8 mm -81.89 134.96 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.20999999999999999 110.085 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.89 2.28 66.91 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.954 -1.259 . . . . 0.14999999999999999 109.954 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 54.6 mttp -113.93 170.08 8.53 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.988 1.375 . . . . 2.5 113.466 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.07 124.92 49.45 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.118 -2.31 . . . . 0.17000000000000001 108.191 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.43 162.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.757 -0.831 . . . . 0.66000000000000003 108.757 -173.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -51.55 -60.17 3.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.389 0.514 . . . . 0.42999999999999999 112.389 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.416 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 18.8 pttp -133.5 -44.36 0.83 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 118.357 -1.337 . . . . 2.02 113.765 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.88 133.24 0.17 Allowed Glycine 0 N--CA 1.464 0.54 0 N-CA-C 117.014 1.565 . . . . 0.17999999999999999 117.014 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.547 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 5.4 p -69.53 165.75 20.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 112.411 -1.894 . . . . 0.16 112.202 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.878 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 45.9 mt -59.8 98.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.566 -1.197 . . . . 0.40000000000000002 112.047 -162.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.555 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 11.4 mtp180 -86.27 150.03 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.874 -1.512 . . . . 1.8700000000000001 110.25 -177.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.674 ' HG2' HG22 ' A' ' 84' ' ' ILE . 6.3 mtp -129.31 -165.79 1.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.973 -0.751 . . . . 0.79000000000000004 108.973 173.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.724 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 5.1 t60 -92.91 159.54 15.3 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.605 -0.887 . . . . 2.3199999999999998 108.605 170.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.645 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.6 m120 -57.9 -53.21 60.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.357 -0.83 . . . . 0.68000000000000005 110.365 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -63.56 -27.15 69.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 121.376 1.898 . . . . 2.1800000000000002 112.005 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.724 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.9 m-20 -75.67 -51.31 13.06 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.72 -0.673 . . . . 0.68999999999999995 110.63 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.648 HG13 HD12 ' A' ' 151' ' ' ILE . 14.7 p -62.94 -22.63 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 115.285 -0.87 . . . . 0.11 111.746 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.648 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.58 -39.95 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 118.911 -0.566 . . . . 0.38 110.569 172.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -45.79 -72.34 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.219 0.918 . . . . 1.99 112.674 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.587 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.1 mm? -49.0 -35.05 14.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.768 0.794 . . . . 1.27 111.325 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.508 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -63.94 -35.09 79.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.561 -1.2 . . . . 0.17999999999999999 112.048 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.3 t -90.99 -29.01 17.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 119.03 0.832 . . . . 0.20999999999999999 113.099 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.4 mt -83.19 -60.44 2.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.509 0.671 . . . . 0.16 111.772 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.4 m -86.76 141.83 34.04 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.955 -1.02 . . . . 0.16 111.53 177.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.674 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 77.9 Cg_endo -85.19 172.64 8.34 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.992 3.128 . . . . 0.20000000000000001 111.351 175.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.782 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.4 m-20 -63.65 156.3 27.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.243 -1.021 . . . . 1.1000000000000001 108.243 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.77 -22.08 42.42 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 119.634 -1.27 . . . . 0.17999999999999999 112.951 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.564 ' HB ' HD12 ' A' ' 100' ' ' ILE . 48.9 m -60.78 135.48 57.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.077 -0.712 . . . . 0.14000000000000001 109.077 -174.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.637 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -94.16 129.91 40.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.589 1.185 . . . . 3.6299999999999999 111.403 -167.42 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.3 t -110.95 110.57 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 112.373 -2.194 . . . . 0.14000000000000001 109.571 -173.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 15.7 m -94.24 105.58 17.56 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.512 0.56 . . . . 0.20999999999999999 112.512 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.557 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -82.42 99.96 5.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-O 122.412 1.101 . . . . 0.23999999999999999 110.005 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -107.47 130.91 54.78 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.04 -1.436 . . . . 1.0900000000000001 109.61 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.558 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 17.3 mmm180 . . . . . 0 C--N 1.322 -0.593 0 CA-C-O 120.967 0.413 . . . . 2.0800000000000001 111.184 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.692 HD21 ' HA ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER . . . . . 0 CA--C 1.514 -0.426 0 CA-C-O 121.64 0.733 . . . . 0.65000000000000002 112.076 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.9 tt -95.42 130.42 42.23 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.525 -1.216 . . . . 0.28000000000000003 110.124 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.55 162.97 13.23 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.135 0.969 . . . . 0.31 113.21 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 45' ' ' SER . 84.8 t80 -130.44 140.95 50.54 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.791 -1.549 . . . . 0.44 107.959 175.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.403 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.8 tt0 -113.36 113.19 24.88 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.063 -1.088 . . . . 0.76000000000000001 108.063 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' A' ' 13' ' ' ASP . 93.6 t -67.11 150.99 10.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 122.38 1.086 . . . . 0.39000000000000001 112.999 -170.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -107.49 159.05 16.71 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 113.376 -1.738 . . . . 2.0099999999999998 108.21 171.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -58.66 110.0 0.91 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.964 0.411 . . . . 1.8300000000000001 111.94 -174.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.99 11.32 43.39 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.766 -0.652 . . . . 0.47999999999999998 113.7 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.643 ' HB2' HG13 ' A' ' 9' ' ' VAL . 86.9 m-20 -55.85 167.95 0.51 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.193 0.497 . . . . 1.46 111.177 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.59 152.56 48.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.036 0.446 . . . . 0.40999999999999998 111.746 176.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.56 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.39 -32.72 74.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.082 -0.963 . . . . 0.85999999999999999 108.643 -178.046 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.433 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 64.1 t30 -93.05 -22.21 19.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.789 -1.096 . . . . 1.1499999999999999 111.114 -177.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.7 t -65.64 -45.85 81.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.206 -0.664 . . . . 1.21 109.206 171.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.436 HG23 ' CE1' ' A' ' 22' ' ' PHE . 17.3 mt -71.84 -26.61 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.881 -0.6 . . . . 0.20999999999999999 110.056 -176.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.638 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.45 -10.17 59.75 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.833 -0.347 . . . . 0.16 111.111 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.607 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.32 -39.1 9.38 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.502 1.144 . . . . 0.20999999999999999 108.057 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 119' ' ' SER . 6.2 m-20 -63.32 -44.38 95.08 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 112.402 -2.181 . . . . 0.53000000000000003 111.911 173.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.569 ' HA ' HG21 ' A' ' 101' ' ' ILE . 55.3 m-85 -97.72 4.66 49.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 118.725 -1.19 . . . . 0.17999999999999999 111.658 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.4 mpt_? 54.68 43.28 30.4 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.866 0.841 . . . . 1.78 109.928 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.638 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.4 pt -116.39 -165.18 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 114.529 -1.214 . . . . 0.19 109.702 -178.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.1 142.34 41.7 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.023 -0.99 . . . . 0.94999999999999996 110.227 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.633 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 67.1 p -72.68 -32.82 66.1 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.916 -1.142 . . . . 0.25 107.916 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.45 67.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.188 -0.915 . . . . 0.20000000000000001 111.745 169.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.98 -26.64 18.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.662 0.744 . . . . 0.17000000000000001 108.997 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.635 HD11 HD12 ' A' ' 46' ' ' ILE . 19.2 tp -76.35 -20.45 57.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.282 -0.872 . . . . 1.1599999999999999 109.554 174.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 26' ' ' THR . 28.9 mt -83.91 -29.54 27.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.396 0.617 . . . . 1.05 110.606 170.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -59.97 -61.25 2.75 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.945 -1.132 . . . . 1.8100000000000001 107.945 169.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -71.61 -17.39 62.28 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.514 0.673 . . . . 0.20000000000000001 110.415 -169.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.659 ' HB3' HD23 ' A' ' 36' ' ' LEU . 33.9 m-80 -150.69 85.26 5.28 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.189 -0.914 . . . . 0.23000000000000001 110.579 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.46 -9.18 6.43 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.964 2.443 . . . . 0.35999999999999999 112.952 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 m -69.79 -34.66 74.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.154 0.502 . . . . 1.3799999999999999 111.319 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -61.37 -51.37 69.07 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 122.209 1.004 . . . . 0.48999999999999999 112.152 -169.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 30' ' ' LEU . 3.9 pt20 -56.32 -48.53 76.52 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 113.231 -1.804 . . . . 1.95 110.93 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.43 ' H ' ' HG3' ' A' ' 37' ' ' GLN . . . -54.5 -52.52 61.7 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 111.893 -2.412 . . . . 0.48999999999999999 109.938 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.88 168.0 37.93 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 114.439 -1.255 . . . . 0.41999999999999998 112.164 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.03 158.25 16.28 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.266 0.555 . . . . 0.40999999999999998 110.501 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 39.6 m -145.72 129.19 16.94 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.262 -0.881 . . . . 0.41999999999999998 110.427 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.89 117.64 16.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.495 0.664 . . . . 0.46999999999999997 109.953 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 101.15 0.54 54.47 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 114.716 -1.129 . . . . 0.40999999999999998 110.289 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.3 tt0 -75.24 125.38 28.84 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.856 -0.672 . . . . 1.3 110.338 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 56.3 p -83.54 131.46 34.99 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.831 0.824 . . . . 0.84999999999999998 110.322 175.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.635 HD12 HD11 ' A' ' 29' ' ' LEU . 10.0 pt -132.37 143.57 39.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.366 -1.288 . . . . 0.25 109.306 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.61 151.73 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.16 0.505 . . . . 0.67000000000000004 111.455 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.3 mm -116.45 92.89 38.4 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.628 -1.169 . . . . 0.16 109.404 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.692 ' HA ' HD21 ' A' ' 4' ' ' LEU . 4.0 Cg_exo -57.34 134.88 66.65 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.853 2.369 . . . . 0.17999999999999999 113.174 -175.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.01 -7.58 80.93 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.317 -1.311 . . . . 0.26000000000000001 112.532 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.718 HD12 ' HD2' ' A' ' 52' ' ' PRO . 33.6 tp -120.87 115.2 32.07 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-O 121.2 0.524 . . . . 0.60999999999999999 111.184 -177.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.718 ' HD2' HD12 ' A' ' 51' ' ' LEU . 54.7 Cg_endo -78.09 -176.12 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 124.05 3.167 . . . . 0.28000000000000003 114.402 -171.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.594 ' HB3' HG23 ' A' ' 56' ' ' THR . 15.5 t70 -82.74 129.0 63.9 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 114.19 -1.368 . . . . 0.48999999999999999 112.045 -169.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 46.2 Cg_endo -72.92 -13.87 26.47 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 123.371 2.714 . . . . 0.46000000000000002 112.61 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.444 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 59.7 m-85 -96.26 -0.53 49.62 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.451 0.643 . . . . 1.3799999999999999 111.398 -175.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.594 HG23 ' HB3' ' A' ' 53' ' ' ASP . 19.6 p -95.33 -20.4 19.18 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.751 -1.203 . . . . 0.46000000000000002 107.751 171.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 59' ' ' TYR . 19.1 mt -75.69 131.5 76.74 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 113.168 -1.833 . . . . 0.69999999999999996 111.147 177.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 95.5 Cg_endo -82.72 -18.26 6.76 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.233 1.956 . . . . 0.39000000000000001 113.486 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.504 ' H ' HG22 ' A' ' 57' ' ' ILE . 61.6 m-85 -95.2 158.47 15.45 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.499 0.555 . . . . 0.23999999999999999 112.499 -175.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -146.64 128.83 15.68 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.322 -0.853 . . . . 2.8900000000000001 108.975 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.655 ' HA ' ' O ' ' A' ' 71' ' ' THR . 87.2 mt -110.32 135.95 47.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.225 -0.443 . . . . 0.16 111.701 -176.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.09 119.04 33.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 119.955 -0.698 . . . . 0.16 110.968 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.2 t -98.96 116.38 41.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.525 0.679 . . . . 0.19 110.869 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 68' ' ' LYS . 70.3 m -95.06 105.89 17.84 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.046 -0.979 . . . . 0.20000000000000001 110.352 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.7 mm -54.22 -58.92 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 122.079 0.942 . . . . 0.23000000000000001 111.2 167.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.68 -10.65 4.7 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 112.789 -2.005 . . . . 0.16 113.351 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.426 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.67 -18.74 4.7 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.453 0.701 . . . . 0.14999999999999999 112.213 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.506 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.64 55.74 4.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.373 0.533 . . . . 0.68999999999999995 111.421 -173.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.8 p -138.02 160.52 39.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.84 0.681 . . . . 0.13 112.84 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.503 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.7 tt -128.54 113.29 15.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.778 -1.101 . . . . 0.40000000000000002 110.178 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.655 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 41.3 m -93.95 122.66 36.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.273 0.559 . . . . 0.16 111.43 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 79' ' ' MET . 12.9 tp -97.55 103.27 15.19 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.862 -1.063 . . . . 0.58999999999999997 109.45 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 7.5 m -105.49 160.64 15.0 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.474 -0.89 . . . . 1.05 110.77 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.2 tm? -127.18 126.99 43.79 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.981 -0.748 . . . . 0.26000000000000001 108.981 169.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.54 ' N ' HD22 ' A' ' 74' ' ' LEU . 50.4 m-80 47.65 51.44 13.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.561 -1.199 . . . . 1.8400000000000001 111.228 -171.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 t30 71.8 -12.24 0.68 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.57 -0.741 . . . . 1.8899999999999999 111.695 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -96.22 120.27 36.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.17 0.509 . . . . 3.4399999999999999 110.221 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 64.1 t -59.53 131.85 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 122.32 1.057 . . . . 0.23999999999999999 112.468 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 8.7 mtm -100.59 -46.01 5.33 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 113.246 -1.797 . . . . 0.81000000000000005 108.903 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -156.35 173.03 17.47 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.518 -1.673 . . . . 1.46 110.037 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.7 m -149.4 124.6 10.13 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.354 -1.293 . . . . 0.17000000000000001 109.848 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -111.2 153.11 44.12 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.871 -0.604 . . . . 1.05 109.439 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.443 ' HB2' HG22 ' A' ' 134' ' ' ILE . 60.4 Cg_endo -79.7 143.11 16.52 Favored 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 122.194 1.929 . . . . 0.20000000000000001 111.495 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.682 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.92 175.1 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.746 -0.661 . . . . 0.13 110.948 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.887 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.51 146.08 45.76 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.309 -0.405 . . . . 0.26000000000000001 110.067 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.533 HG11 HD13 ' A' ' 65' ' ' ILE . 8.8 m -127.04 128.81 70.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.532 0.682 . . . . 0.56000000000000005 111.784 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -87.31 154.66 26.46 Favored Glycine 0 N--CA 1.425 -2.039 0 N-CA-C 110.09 -1.204 . . . . 0.17000000000000001 110.09 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -56.18 2.93 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.266 0.839 . . . . 3.0499999999999998 113.266 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.953 HG23 HD22 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -88.68 -19.92 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 O-C-N 121.587 -0.696 . . . . 0.23000000000000001 110.177 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.953 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -89.42 -18.28 27.1 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.715 0.769 . . . . 0.17999999999999999 109.314 -176.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.5 p -65.99 -14.9 62.44 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.553 -1.203 . . . . 0.33000000000000002 111.767 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -67.08 -39.06 86.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.051 -0.977 . . . . 1.52 112.327 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -107.95 117.55 54.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.668 -0.413 . . . . 0.42999999999999999 111.222 -175.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.598 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 1.8 Cg_endo -77.63 -13.83 16.17 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.674 2.25 . . . . 0.72999999999999998 113.083 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.1 t -103.67 -41.84 5.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.677 -0.49 . . . . 0.47999999999999998 109.677 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.567 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.46 39.59 22.38 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.419 -1.264 . . . . 0.33000000000000002 114.024 168.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -84.11 112.12 19.94 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.907 0.86 . . . . 0.83999999999999997 109.507 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.9 m-85 -138.78 174.72 10.23 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.003 -1.453 . . . . 0.22 112.12 -171.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.687 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 86.6 m-85 -139.69 136.3 34.1 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.058 -0.519 . . . . 0.54000000000000004 110.732 -175.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.571 HD12 ' HB ' ' A' ' 161' ' ' THR . 86.7 mt -59.74 121.68 8.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.361 -0.836 . . . . 0.17000000000000001 110.44 170.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.569 HG21 ' HA ' ' A' ' 22' ' ' PHE . 19.1 pt -87.3 -44.6 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.83 0.678 . . . . 0.20999999999999999 112.83 -176.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.569 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 44.1 m-80 -171.54 172.08 5.18 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.976 -1.49 . . . . 2.0299999999999998 106.976 -168.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.655 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 39.8 mtt180 -124.28 171.56 9.78 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.531 -0.867 . . . . 1.52 111.592 -173.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' A' ' 107' ' ' PRO . 52.6 tt0 -148.28 99.91 3.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.08 -0.964 . . . . 0.58999999999999997 109.758 170.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.467 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 48.4 ttp180 -66.18 166.17 12.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.284 -0.871 . . . . 2.8199999999999998 110.421 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.51 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 25.4 m-80 -35.66 103.03 0.24 Allowed Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 125.323 1.449 . . . . 0.34999999999999998 113.405 -157.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.51 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.9 Cg_endo . . . . . 0 C--N 1.346 0.4 0 C-N-CA 122.99 2.46 . . . . 0.47999999999999998 111.756 173.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.542 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.569 1.682 0 N-CA-C 117.294 2.331 . . . . 0.47999999999999998 117.294 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.467 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.5 OUTLIER -166.02 151.37 8.63 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.272 -0.892 . . . . 0.28000000000000003 110.594 -176.073 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.5 t-105 -132.09 99.62 4.78 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.41 -0.959 . . . . 0.48999999999999999 108.41 168.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.547 HD12 HG23 ' A' ' 150' ' ' VAL . 5.3 mt -93.92 114.27 26.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.624 0.726 . . . . 0.66000000000000003 109.358 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.413 ' HB3' HD11 ' A' ' 101' ' ' ILE . 19.5 m -83.9 144.22 29.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.593 -0.731 . . . . 0.19 111.466 -168.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -108.53 170.66 7.88 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.821 -0.627 . . . . 0.13 111.243 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 2.9 t -62.38 -13.73 32.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.112 -0.949 . . . . 1.1699999999999999 112.729 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.688 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 1.4 tmtp? -126.63 132.3 51.26 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 120.446 -0.501 . . . . 1.22 110.594 173.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.688 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 55.3 mt-30 -34.2 -56.87 0.49 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.003 -1.453 . . . . 1.51 113.869 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.497 ' HB2' HG12 ' A' ' 89' ' ' ILE . 75.0 m-70 -92.22 2.01 56.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.154 0.502 . . . . 2.5299999999999998 111.556 -171.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.793 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -94.0 37.44 1.09 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.405 0.891 . . . . 0.83999999999999997 113.405 -172.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.604 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.05 143.27 18.06 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 117.016 -2.516 . . . . 0.32000000000000001 112.717 -152.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.52 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -96.12 114.64 33.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.722 0.772 . . . . 0.17999999999999999 110.766 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.648 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.0 p80 -143.99 172.12 13.31 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.432 -0.804 . . . . 0.20999999999999999 109.663 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.75 -176.68 39.8 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.982 -1.104 . . . . 0.27000000000000002 111.66 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -147.0 168.13 22.28 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.387 -0.478 . . . . 0.40999999999999998 110.387 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -111.25 -0.7 16.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.126 -1.065 . . . . 1.99 108.126 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -116.05 85.86 15.86 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 114.537 -1.21 . . . . 1.3600000000000001 108.385 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -72.85 -21.19 21.58 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.164 1.909 . . . . 0.34999999999999998 113.727 -169.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.23 -2.58 38.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.156 0.503 . . . . 0.33000000000000002 110.845 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 44.7 t -91.42 -3.2 56.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.308 -0.627 . . . . 1.3500000000000001 109.308 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 83' ' ' PRO . 42.8 mm -80.88 139.37 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.932 -0.576 . . . . 0.20999999999999999 110.133 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.46 1.37 74.83 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 110.159 -1.176 . . . . 0.14999999999999999 110.159 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -111.65 167.86 10.01 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 123.24 1.495 . . . . 2.5 114.414 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.21 48.52 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 111.541 -2.572 . . . . 0.17000000000000001 107.697 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.469 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -124.66 160.58 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.954 -0.758 . . . . 0.66000000000000003 108.954 -174.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.5 m -49.36 -59.78 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.616 0.598 . . . . 0.42999999999999999 112.616 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.533 ' HD3' ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -132.62 -43.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 118.411 -1.316 . . . . 2.02 113.744 -175.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.533 ' N ' ' HD3' ' A' ' 140' ' ' LYS . . . -32.24 133.55 0.19 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 117.236 1.654 . . . . 0.17999999999999999 117.236 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.504 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.0 p -73.39 165.52 24.91 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 112.636 -1.782 . . . . 0.16 111.843 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.887 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 53.3 mt -59.77 98.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 122.316 1.055 . . . . 0.40000000000000002 112.018 -162.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.648 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 74.6 mtt180 -85.07 147.69 26.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.777 -1.556 . . . . 1.8700000000000001 110.281 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.682 ' HG2' HG22 ' A' ' 84' ' ' ILE . 12.3 mtp -127.51 -166.31 1.59 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.401 -0.592 . . . . 0.79000000000000004 109.401 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.696 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 6.8 t60 -94.9 156.18 16.45 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.448 -0.945 . . . . 2.3199999999999998 108.448 172.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.653 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.7 m120 -58.7 -50.03 75.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 118.339 -0.839 . . . . 0.68000000000000005 110.736 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -63.34 -26.16 68.63 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 121.26 1.845 . . . . 2.1800000000000002 112.462 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.696 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 16.8 m-20 -83.95 -39.92 19.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.937 0.399 . . . . 0.68999999999999995 111.25 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.619 HG13 HD12 ' A' ' 151' ' ' ILE . 14.6 p -70.07 -23.58 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.956 -0.565 . . . . 0.11 111.146 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.653 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.01 -39.8 16.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 118.966 -0.54 . . . . 0.38 109.592 171.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -45.52 -71.36 0.08 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.139 0.881 . . . . 1.99 112.238 167.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 157' ' ' VAL . 8.2 mp -46.32 -38.13 8.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.521 0.677 . . . . 1.27 111.262 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.37 83.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.372 -1.286 . . . . 0.17999999999999999 111.629 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.1 t -87.94 -34.48 18.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.513 -0.742 . . . . 0.20999999999999999 112.47 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.2 mt -80.38 -59.56 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.177 0.513 . . . . 0.16 111.451 -172.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 153' ' ' LEU . 2.6 m -92.39 141.51 24.93 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.448 -0.797 . . . . 0.16 112.112 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.655 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 69.4 Cg_endo -89.02 173.6 4.02 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.767 2.978 . . . . 0.20000000000000001 111.144 173.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.569 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 73.6 m-20 -66.91 157.1 34.04 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.611 -0.836 . . . . 1.1000000000000001 109.16 177.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.35 -19.19 55.42 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.196 -1.002 . . . . 0.17999999999999999 112.666 -173.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.571 ' HB ' HD12 ' A' ' 100' ' ' ILE . 59.0 m -63.48 139.77 58.8 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.496 -0.557 . . . . 0.14000000000000001 109.496 -176.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.687 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 3.5 ptm180 -92.52 120.43 32.98 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.787 1.28 . . . . 3.6299999999999999 111.112 -170.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.1 t -106.96 109.4 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 112.205 -2.271 . . . . 0.14000000000000001 109.149 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.8 m -95.49 108.12 20.33 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.484 0.55 . . . . 0.20999999999999999 112.484 -172.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.567 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -81.78 101.52 6.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 122.35 1.072 . . . . 0.23999999999999999 109.77 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -106.62 129.54 54.52 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.905 -1.498 . . . . 1.0900000000000001 109.027 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.598 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 18.0 mmm180 . . . . . 0 C--N 1.321 -0.67 0 CA-C-O 120.865 0.364 . . . . 2.0800000000000001 110.637 179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.308 0.575 . . . . 0.65000000000000002 111.845 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.5 tt -92.21 127.64 37.76 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.999 -1.0 . . . . 0.28000000000000003 110.605 -172.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.82 162.19 13.38 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.188 0.994 . . . . 0.31 113.401 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.633 ' HB3' HG13 ' A' ' 46' ' ' ILE . 80.2 t80 -131.01 141.91 50.28 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.547 -1.66 . . . . 0.44 107.884 175.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 36.2 tt0 -113.23 115.32 28.02 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.218 -1.031 . . . . 0.76000000000000001 108.218 177.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 13' ' ' ASP . 98.2 t -68.73 150.3 10.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.53 1.157 . . . . 0.39000000000000001 113.254 -170.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.409 ' O ' HG12 ' A' ' 9' ' ' VAL . 43.8 mtpt -102.36 158.56 16.11 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.335 -1.757 . . . . 2.0099999999999998 108.541 172.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.33 105.34 0.49 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.879 0.371 . . . . 1.8300000000000001 111.622 -177.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.96 12.24 30.29 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.62 -0.8 . . . . 0.47999999999999998 113.366 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.611 ' HB2' HG13 ' A' ' 9' ' ' VAL . 90.2 m-20 -56.23 170.6 0.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.872 0.368 . . . . 1.46 111.171 170.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.89 155.47 45.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.326 0.584 . . . . 0.40999999999999998 111.146 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.598 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.97 -34.25 77.68 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.334 -0.987 . . . . 0.85999999999999999 108.334 178.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.508 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -88.38 -28.0 21.24 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.911 -1.04 . . . . 1.1499999999999999 111.442 -175.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.0 p -68.88 -37.67 79.18 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 118.422 0.556 . . . . 1.21 110.181 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.447 HG23 ' CE1' ' A' ' 22' ' ' PHE . 14.5 mt -73.89 -27.12 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 121.254 0.549 . . . . 0.20999999999999999 109.796 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.645 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.26 -9.79 59.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.355 -0.384 . . . . 0.16 110.684 175.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.728 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.55 -41.19 8.68 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.024 -1.102 . . . . 0.20999999999999999 108.024 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 5.6 m-20 -63.59 -41.96 98.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 112.797 -2.001 . . . . 0.53000000000000003 112.5 173.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 24' ' ' ILE . 56.3 m-85 -98.84 6.22 46.97 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 118.655 -1.218 . . . . 0.17999999999999999 110.858 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.728 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.06 41.04 32.18 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.927 0.87 . . . . 1.78 109.606 176.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.645 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.3 pt -114.43 -165.9 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 114.263 -1.335 . . . . 0.19 109.976 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.81 142.65 40.78 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.106 -0.952 . . . . 0.94999999999999996 109.996 175.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.672 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 70.8 p -72.82 -29.9 63.62 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.702 -0.851 . . . . 0.25 108.702 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.93 -25.01 67.7 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.68 -0.691 . . . . 0.20000000000000001 111.816 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.37 -28.65 14.85 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.854 -0.795 . . . . 0.17000000000000001 108.854 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.598 HD23 HD23 ' A' ' 15' ' ' LEU . 20.9 tp -72.29 -27.65 62.6 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.127 -0.942 . . . . 1.1599999999999999 108.584 172.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.672 ' HB2' ' O ' ' A' ' 26' ' ' THR . 7.6 tp -77.42 -31.73 54.23 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.812 0.815 . . . . 1.05 109.462 175.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 5.8 tt0 -66.05 -40.94 91.35 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.167 -1.378 . . . . 1.8100000000000001 110.336 173.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -82.01 -17.78 45.64 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.988 -0.685 . . . . 0.20000000000000001 111.518 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.634 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.0 m-80 -146.64 81.5 9.23 Favored Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-O 121.246 0.546 . . . . 0.23000000000000001 110.754 -173.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.8 Cg_endo -55.81 -11.78 5.78 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 124.098 3.199 . . . . 0.35999999999999999 113.401 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m -78.89 -17.52 55.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.801 0.334 . . . . 1.3799999999999999 111.834 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.634 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 58.1 mt -75.36 -31.8 60.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.333 0.587 . . . . 0.48999999999999999 112.072 -171.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.44 ' HB3' HD11 ' A' ' 30' ' ' LEU . 1.7 pp0? -62.4 -45.53 92.7 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 122.755 1.264 . . . . 1.95 110.772 -172.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.41 -48.53 77.45 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 111.893 -2.412 . . . . 0.48999999999999999 110.749 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.13 -179.57 48.74 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 114.78 -1.1 . . . . 0.41999999999999998 111.255 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.88 156.37 20.49 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.135 0.493 . . . . 0.40999999999999998 110.789 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 31.3 m -137.26 129.76 29.9 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.348 -0.842 . . . . 0.41999999999999998 110.491 -175.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.11 123.36 26.28 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.403 0.62 . . . . 0.46999999999999997 110.235 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.53 0.18 62.93 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.272 -1.131 . . . . 0.40999999999999998 110.272 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.634 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.1 tt0 -74.05 124.12 25.66 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.644 -0.778 . . . . 1.3 109.87 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 53.9 p -82.39 128.92 34.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.804 0.811 . . . . 0.84999999999999998 109.876 176.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.633 HG13 ' HB3' ' A' ' 7' ' ' TYR . 7.6 pt -128.55 141.38 46.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.57 -1.195 . . . . 0.25 109.428 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.39 151.69 3.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.128 0.489 . . . . 0.67000000000000004 111.048 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.6 mm -114.99 91.98 28.92 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.638 -1.164 . . . . 0.16 109.05 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.496 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . 1.7 Cg_endo -59.59 134.39 57.67 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.738 2.292 . . . . 0.17999999999999999 112.778 -174.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.62 -6.74 80.14 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.893 -1.048 . . . . 0.26000000000000001 112.156 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.772 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.5 tp -124.74 116.13 26.47 Favored Pre-proline 0 N--CA 1.446 -0.63 0 CA-C-O 121.404 0.621 . . . . 0.60999999999999999 111.504 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.658 ' HD2' HD12 ' A' ' 51' ' ' LEU . 59.0 Cg_endo -79.71 -176.09 3.06 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.14 3.227 . . . . 0.28000000000000003 114.208 -172.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.556 ' HB3' HG23 ' A' ' 56' ' ' THR . 17.7 t70 -81.14 130.5 62.62 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 114.225 -1.352 . . . . 0.48999999999999999 112.879 -169.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.45 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 40.1 Cg_endo -73.0 -14.98 26.28 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.852 3.035 . . . . 0.46000000000000002 113.134 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 80.2 m-85 -96.13 -8.6 32.83 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.902 -0.59 . . . . 1.3799999999999999 111.427 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.556 HG23 ' HB3' ' A' ' 53' ' ' ASP . 24.7 p -86.49 -20.39 28.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.784 -1.191 . . . . 0.46000000000000002 107.784 172.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 59' ' ' TYR . 24.6 mt -76.73 129.13 80.07 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 112.912 -1.949 . . . . 0.69999999999999996 111.036 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.38 -13.05 12.49 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.538 2.159 . . . . 0.39000000000000001 113.63 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.565 ' H ' HG22 ' A' ' 57' ' ' ILE . 62.7 m-85 -96.11 164.61 12.61 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.498 -0.481 . . . . 0.23999999999999999 111.786 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -154.09 130.65 10.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.852 -0.796 . . . . 2.8900000000000001 108.852 177.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 71' ' ' THR . 72.8 mt -112.06 136.75 47.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.155 -0.475 . . . . 0.16 111.607 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.25 116.84 27.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.926 -0.71 . . . . 0.16 111.223 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.8 t -96.04 113.6 30.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.565 0.698 . . . . 0.19 110.777 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 22.2 m -90.89 104.0 16.64 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.943 -1.026 . . . . 0.20000000000000001 110.45 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.5 mm -53.44 -58.54 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 122.262 1.03 . . . . 0.23000000000000001 111.208 168.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.16 -10.13 3.62 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 112.699 -2.046 . . . . 0.16 113.521 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.88 -18.02 4.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.596 0.758 . . . . 0.14999999999999999 112.17 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.511 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 59.07 54.53 4.9 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.219 0.463 . . . . 0.68999999999999995 111.078 -172.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 64' ' ' SER . 41.6 p -136.85 167.71 20.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 112.707 0.632 . . . . 0.13 112.707 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.465 HD21 HD21 ' A' ' 153' ' ' LEU . 8.0 tt -135.84 112.76 10.28 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.729 -1.123 . . . . 0.40000000000000002 110.0 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 22.1 m -93.07 123.31 36.24 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.157 0.504 . . . . 0.16 110.781 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 79' ' ' MET . 16.1 tp -99.95 106.51 18.32 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.298 -0.864 . . . . 0.58999999999999997 109.125 172.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 83.4 p -105.44 161.46 14.31 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 119.234 -0.986 . . . . 1.05 110.498 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.72 HD13 ' ND2' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -125.61 125.33 42.98 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.657 -0.868 . . . . 0.26000000000000001 108.657 168.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.72 ' ND2' HD13 ' A' ' 74' ' ' LEU . 9.2 p30 41.98 53.03 4.27 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.769 -1.56 . . . . 1.8400000000000001 112.126 -165.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 46.8 m-80 75.24 -9.53 1.38 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.02 -0.991 . . . . 1.8899999999999999 112.226 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -97.16 121.84 39.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.037 0.446 . . . . 3.4399999999999999 109.903 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 55.7 t -58.4 131.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 122.39 1.091 . . . . 0.23999999999999999 112.806 -175.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.523 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -100.91 -45.84 5.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 113.116 -1.856 . . . . 0.81000000000000005 109.112 178.419 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -159.95 173.19 16.28 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.039 -1.892 . . . . 1.46 110.214 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -149.67 123.45 9.27 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.172 -1.376 . . . . 0.17000000000000001 109.458 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -112.86 148.64 39.79 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.897 -0.592 . . . . 1.05 109.734 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.42 ' HB2' HG22 ' A' ' 134' ' ' ILE . 32.7 Cg_endo -74.5 142.71 29.91 Favored 'Trans proline' 0 CA--C 1.498 -1.32 0 C-N-CA 122.231 1.954 . . . . 0.20000000000000001 110.938 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.622 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.67 172.77 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-N 115.777 -0.647 . . . . 0.13 110.761 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.94 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.16 137.6 52.87 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.762 0.315 . . . . 0.26000000000000001 110.188 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.511 HG22 ' HG3' ' A' ' 68' ' ' LYS . 10.7 m -120.88 127.75 75.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.6 0.714 . . . . 0.56000000000000005 111.776 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.501 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.19 151.48 28.52 Favored Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 110.067 -1.213 . . . . 0.17000000000000001 110.067 171.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.47 4.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.262 0.838 . . . . 3.0499999999999998 113.262 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.875 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -90.81 -19.12 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.385 0.612 . . . . 0.23000000000000001 110.158 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.875 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -86.89 -17.47 33.19 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.687 -0.857 . . . . 0.17999999999999999 108.687 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.1 p -69.38 -16.1 63.45 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.369 -1.287 . . . . 0.33000000000000002 111.345 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.405 ' OE1' HD12 ' A' ' 89' ' ' ILE . 24.8 mt-30 -69.95 -37.76 75.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.859 -1.064 . . . . 1.52 112.845 -175.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 95' ' ' THR . 1.5 m -107.33 127.51 27.75 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 119.746 -0.782 . . . . 0.42999999999999999 111.161 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -89.41 -14.19 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.727 2.284 . . . . 0.72999999999999998 113.172 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 93' ' ' THR . 6.3 t -90.33 -44.52 9.63 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.584 0.707 . . . . 0.47999999999999998 109.417 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.576 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 61.58 18.46 56.19 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 114.066 -1.425 . . . . 0.33000000000000002 113.979 168.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.4 111.33 19.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 122.206 1.003 . . . . 0.83999999999999997 109.593 -175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.669 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 26.6 m-85 -138.42 177.51 7.83 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.359 -1.746 . . . . 0.22 111.279 -171.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.457 ' CG ' HD11 ' A' ' 5' ' ' LEU . 39.8 m-85 -140.98 137.38 33.0 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.135 0.493 . . . . 0.54000000000000004 110.765 -173.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.575 HD12 ' HB ' ' A' ' 161' ' ' THR . 78.8 mt -63.01 114.62 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-N 115.185 -0.916 . . . . 0.17000000000000001 110.268 170.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.565 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.4 pt -83.33 -45.43 18.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 113.367 0.877 . . . . 0.20999999999999999 113.367 -175.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -168.75 165.88 11.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.0 -1.482 . . . . 2.0299999999999998 107.0 -169.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.701 ' HB3' HD23 ' A' ' 116' ' ' LEU . 51.9 mtt-85 -132.1 155.68 47.68 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.902 -0.719 . . . . 1.52 112.408 -168.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.519 ' NE2' ' HB3' ' A' ' 107' ' ' PRO . 51.6 tt0 -137.62 102.27 4.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.359 0.599 . . . . 0.58999999999999997 110.808 176.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.467 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 46.8 ttp180 -62.76 166.18 5.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.952 -1.022 . . . . 2.8199999999999998 111.279 174.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.786 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 28.7 m-80 -35.93 101.31 0.21 Allowed Pre-proline 0 C--O 1.232 0.158 0 C-N-CA 125.802 1.641 . . . . 0.34999999999999998 113.122 -159.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.519 ' HB3' ' NE2' ' A' ' 104' ' ' GLN . 24.1 Cg_endo . . . . . 0 C--N 1.344 0.327 0 C-N-CA 123.499 2.799 . . . . 0.47999999999999998 113.604 176.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.865 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 N--CA 1.44 -0.94 0 CA-C-O 120.813 0.34 . . . . 0.47999999999999998 110.18 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.461 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.7 OUTLIER -162.99 154.28 17.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.457 -0.338 . . . . 0.28000000000000003 110.169 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 7.6 t-105 -132.09 104.68 6.94 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.687 -1.227 . . . . 0.48999999999999999 107.687 165.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.701 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.0 mt -100.11 114.83 28.48 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.57 -0.706 . . . . 0.66000000000000003 109.859 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.459 ' HB3' HD11 ' A' ' 101' ' ' ILE . 43.6 m -81.81 143.28 31.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.817 -0.629 . . . . 0.19 110.901 -170.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.728 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.4 mm? -108.02 164.88 11.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.535 -0.757 . . . . 0.13 110.416 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.1 p -65.13 -5.18 6.05 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.985 0.803 . . . . 1.1699999999999999 112.72 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.707 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 4.2 tmtm? -127.41 129.42 47.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.111 0.958 . . . . 1.22 109.849 166.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.707 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.0 mt-30 -37.2 -47.75 0.81 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 112.249 -2.25 . . . . 1.51 113.903 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.549 ' CB ' HG12 ' A' ' 89' ' ' ILE . 58.0 m80 -96.33 3.23 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.849 -0.614 . . . . 2.5299999999999998 111.915 -170.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.578 ' HA ' HD11 ' A' ' 90' ' ' LEU . 2.5 m-30 -92.99 -35.48 13.26 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.807 0.813 . . . . 0.83999999999999997 111.946 -173.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.728 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -10.46 131.01 0.01 OUTLIER Glycine 0 C--N 1.298 -1.58 0 N-CA-C 119.392 2.517 . . . . 0.32000000000000001 119.392 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -100.54 117.5 45.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 112.449 -1.876 . . . . 0.17999999999999999 110.366 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.76 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 33.6 p80 -145.83 -176.79 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.318 0.488 . . . . 0.20999999999999999 112.318 -175.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.94 -167.72 37.63 Favored Glycine 0 C--O 1.22 -0.759 0 C-N-CA 121.22 -0.514 . . . . 0.27000000000000002 111.86 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.2 t -160.76 166.51 28.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 117.796 0.798 . . . . 0.40999999999999998 110.704 -176.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -116.53 0.19 12.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.831 0.824 . . . . 1.99 109.288 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -126.03 89.21 52.82 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.39 -1.277 . . . . 1.3600000000000001 108.819 170.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -72.19 -20.75 24.4 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.753 2.302 . . . . 0.34999999999999998 114.008 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.96 -5.48 48.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.21 -0.45 . . . . 0.33000000000000002 111.008 -175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -91.29 -2.48 57.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.08 -0.509 . . . . 1.3500000000000001 110.016 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 83' ' ' PRO . 38.8 mm -78.55 137.61 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-N 115.872 -0.604 . . . . 0.20999999999999999 109.934 176.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.7 3.16 68.91 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.151 -1.18 . . . . 0.14999999999999999 110.151 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.426 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 21.3 mtpt -113.74 169.07 9.25 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 123.223 1.487 . . . . 2.5 114.395 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.16 126.59 46.44 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 111.509 -2.587 . . . . 0.17000000000000001 107.946 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.42 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -123.47 159.44 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.541 -0.911 . . . . 0.66000000000000003 108.541 -174.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.1 m -48.08 -59.87 3.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.763 0.653 . . . . 0.42999999999999999 112.763 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -132.13 -44.46 0.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 118.446 -1.302 . . . . 2.02 114.033 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.69 133.92 0.21 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 117.464 1.746 . . . . 0.17999999999999999 117.464 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 3.0 p -70.78 165.41 23.17 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 112.734 -1.733 . . . . 0.16 111.956 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.94 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.8 mt -60.87 99.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.386 -1.279 . . . . 0.40000000000000002 112.154 -162.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.76 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 42.7 mtt180 -86.48 143.32 27.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.317 -1.311 . . . . 1.8700000000000001 110.161 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.622 ' HG2' HG22 ' A' ' 84' ' ' ILE . 20.8 mtp -118.97 -168.98 1.65 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.851 -0.796 . . . . 0.79000000000000004 108.851 173.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.543 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 81.8 m-70 -83.77 155.67 22.93 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.747 -0.835 . . . . 2.3199999999999998 108.747 167.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.797 ' O ' HD13 ' A' ' 151' ' ' ILE . 9.2 m120 -65.02 -44.16 90.09 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 118.283 -0.865 . . . . 0.68000000000000005 110.999 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -66.06 -25.46 67.04 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 121.902 2.137 . . . . 2.1800000000000002 112.068 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 37.8 m-20 -86.79 -35.4 19.15 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.235 -0.438 . . . . 0.68999999999999995 111.188 -174.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.59 HG13 HD12 ' A' ' 151' ' ' ILE . 11.8 p -67.98 -21.91 27.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 0.11 110.747 172.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.865 HD11 ' HB1' ' A' ' 113' ' ' ALA . 1.6 mp -83.08 -40.97 16.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.667 -0.494 . . . . 0.38 109.667 170.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -47.14 -70.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.203 0.91 . . . . 1.99 112.428 168.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.489 HD22 ' SD ' ' A' ' 145' ' ' MET . 7.3 mp -49.86 -30.75 10.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.594 0.711 . . . . 1.27 111.529 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.673 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -67.5 -41.22 84.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.805 -1.089 . . . . 0.17999999999999999 111.528 176.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.0 t -85.13 -37.66 19.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.789 0.663 . . . . 0.20999999999999999 112.789 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.58 -60.23 2.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.613 0.721 . . . . 0.16 111.377 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.643 HG23 HH22 ' A' ' 103' ' ' ARG . 3.8 m -92.06 145.81 31.58 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.0 -1.0 . . . . 0.16 112.126 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.457 ' C ' HH21 ' A' ' 103' ' ' ARG . 50.4 Cg_endo -89.86 172.62 3.76 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 124.466 3.444 . . . . 0.20000000000000001 111.175 173.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -66.4 161.65 22.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 118.689 -1.204 . . . . 1.1000000000000001 109.897 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.51 -17.11 59.86 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.561 -0.828 . . . . 0.17999999999999999 111.825 -172.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.575 ' HB ' HD12 ' A' ' 100' ' ' ILE . 67.2 m -67.45 139.44 57.07 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.457 -0.571 . . . . 0.14000000000000001 109.457 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.2 117.89 30.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.571 1.176 . . . . 3.6299999999999999 111.022 -168.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.2 t -104.03 109.66 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 112.316 -2.22 . . . . 0.14000000000000001 109.358 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.431 HG22 ' ND2' ' A' ' 166' ' ' ASN . 32.6 m -95.71 107.68 19.92 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.727 0.64 . . . . 0.20999999999999999 112.727 -172.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.576 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mp -80.54 108.77 14.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 122.039 0.923 . . . . 0.23999999999999999 109.855 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.431 ' ND2' HG22 ' A' ' 164' ' ' THR . 38.6 m-80 -110.97 124.46 52.18 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.489 -1.232 . . . . 1.0900000000000001 109.796 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.519 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 15.6 mmm180 . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 121.244 0.545 . . . . 2.0800000000000001 110.192 178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.656 HD21 ' HA ' ' A' ' 49' ' ' PRO . 1.1 tp . . . . . 0 CA--C 1.517 -0.32 0 CA-C-O 121.296 0.57 . . . . 0.65000000000000002 111.555 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.7 tt -95.54 126.74 41.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.049 -0.978 . . . . 0.28000000000000003 110.258 -175.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.07 161.47 13.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.055 0.931 . . . . 0.31 112.632 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 45' ' ' SER . 90.6 t80 -130.74 139.8 50.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.935 -1.484 . . . . 0.44 107.83 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.4 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.8 tt0 -112.66 112.8 24.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.131 -1.063 . . . . 0.76000000000000001 108.131 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 13' ' ' ASP . 98.4 t -67.09 149.46 11.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 122.395 1.093 . . . . 0.39000000000000001 113.169 -169.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HE2' ' OH ' ' A' ' 7' ' ' TYR . 42.2 mtmt -103.24 158.85 16.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 113.369 -1.741 . . . . 2.0099999999999998 108.718 174.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.456 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -62.85 104.26 0.53 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.198 0.523 . . . . 1.8300000000000001 112.308 -173.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.29 11.29 36.73 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.848 -0.692 . . . . 0.47999999999999998 113.356 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB2' HG13 ' A' ' 9' ' ' VAL . 83.9 m-20 -53.58 170.67 0.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.978 0.389 . . . . 1.46 111.307 172.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.3 153.21 48.05 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.296 0.569 . . . . 0.40999999999999998 111.558 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.598 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.38 -35.03 79.72 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.33 -0.989 . . . . 0.85999999999999999 108.33 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.442 ' HA ' HG22 ' A' ' 26' ' ' THR . 65.0 t30 -88.96 -25.89 21.81 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.916 -1.038 . . . . 1.1499999999999999 111.438 -176.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.3 p -68.17 -36.9 80.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.902 -0.719 . . . . 1.21 109.674 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.409 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.1 mt -75.62 -28.19 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.164 0.507 . . . . 0.20999999999999999 110.023 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.59 -10.05 59.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.539 -0.301 . . . . 0.16 110.872 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.607 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.71 -39.49 9.45 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.607 1.194 . . . . 0.20999999999999999 108.38 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 119' ' ' SER . 10.0 m-20 -62.19 -45.79 91.81 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.453 -2.158 . . . . 0.53000000000000003 111.856 172.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 63.2 m-85 -97.2 5.12 50.66 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.681 -1.208 . . . . 0.17999999999999999 111.602 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.5 mpt_? 54.15 43.29 30.87 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.776 0.798 . . . . 1.78 109.891 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.62 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.0 pt -116.19 -165.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.535 -1.211 . . . . 0.19 109.771 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.87 143.02 38.62 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.177 -0.919 . . . . 0.94999999999999996 109.992 174.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.608 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 69.4 p -71.75 -32.19 67.44 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.759 -1.2 . . . . 0.25 107.759 177.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.98 -32.2 70.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.277 -0.874 . . . . 0.20000000000000001 112.008 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -90.5 -25.94 20.02 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.657 0.741 . . . . 0.17000000000000001 109.112 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.647 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 17.2 tp -75.55 -26.19 57.77 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.999 -1.001 . . . . 1.1599999999999999 109.361 173.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 26' ' ' THR . 30.7 mt -77.49 -31.71 53.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.792 0.806 . . . . 1.05 109.67 171.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 45.0 tt0 -64.05 -41.13 97.49 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.282 -1.326 . . . . 1.8100000000000001 110.034 174.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.18 -20.64 32.04 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 120.118 -0.633 . . . . 0.20000000000000001 111.633 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.624 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 27.0 m-80 -147.11 80.69 9.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.46 0.648 . . . . 0.23000000000000001 110.64 -172.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 23.7 Cg_endo -58.97 -5.79 3.02 Favored 'Trans proline' 0 C--N 1.326 -0.644 0 C-N-CA 124.372 3.382 . . . . 0.35999999999999999 114.145 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 t -84.7 -23.31 29.41 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.215 -0.303 . . . . 1.3799999999999999 111.025 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.852 HD21 HG21 ' A' ' 46' ' ' ILE . 52.4 mt -67.01 -35.36 79.76 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.841 0.829 . . . . 0.48999999999999999 111.632 -172.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.452 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 2.9 pt20 -65.33 -46.72 79.17 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 114.239 -1.346 . . . . 1.95 110.298 -174.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.55 -50.86 71.73 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 111.905 -2.407 . . . . 0.48999999999999999 110.282 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.56 177.95 48.55 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 114.742 -1.117 . . . . 0.41999999999999998 111.656 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.59 157.63 18.84 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.349 0.595 . . . . 0.40999999999999998 111.235 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 82.6 m -140.35 128.64 22.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.141 -0.936 . . . . 0.41999999999999998 110.601 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -76.16 120.07 20.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.449 0.642 . . . . 0.46999999999999997 110.234 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 99.26 0.05 57.09 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.181 -1.168 . . . . 0.40999999999999998 110.181 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.63 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.8 tt0 -74.31 123.7 25.07 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.758 -0.721 . . . . 1.3 109.599 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 34.4 p -85.37 125.93 33.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.646 0.736 . . . . 0.84999999999999998 110.596 177.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.852 HG21 HD21 ' A' ' 36' ' ' LEU . 9.6 pt -125.63 143.59 38.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.393 -1.276 . . . . 0.25 109.554 -176.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.4 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.24 150.99 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-O 121.113 0.482 . . . . 0.67000000000000004 111.124 -179.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.7 mm -115.86 92.87 35.98 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.643 -1.162 . . . . 0.16 109.147 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.656 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -58.16 135.41 68.19 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.847 2.365 . . . . 0.17999999999999999 112.819 -175.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.19 -6.0 81.26 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 114.992 -1.004 . . . . 0.26000000000000001 112.515 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.698 HD12 ' HD2' ' A' ' 52' ' ' PRO . 25.6 tp -126.74 119.87 22.82 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-O 120.972 0.415 . . . . 0.60999999999999999 111.395 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.698 ' HD2' HD12 ' A' ' 51' ' ' LEU . 58.9 Cg_endo -80.89 178.69 6.66 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.438 2.759 . . . . 0.28000000000000003 113.923 -172.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.588 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.9 t70 -75.17 131.8 77.73 Favored Pre-proline 0 N--CA 1.443 -0.819 0 CA-C-N 114.255 -1.339 . . . . 0.48999999999999999 111.646 -173.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 162' ' ' ARG . 60.5 Cg_endo -74.13 -16.73 22.42 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.415 2.743 . . . . 0.46000000000000002 113.02 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -96.53 -2.68 44.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.35 0.595 . . . . 1.3799999999999999 111.169 -176.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.588 HG23 ' HB3' ' A' ' 53' ' ' ASP . 17.2 p -93.37 -14.54 26.72 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.493 -0.928 . . . . 0.46000000000000002 108.493 173.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.703 HG22 ' H ' ' A' ' 59' ' ' TYR . 7.9 mm -64.05 129.21 93.82 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 113.633 -1.621 . . . . 0.69999999999999996 109.873 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 51.4 Cg_endo -73.08 -19.12 23.28 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.017 1.811 . . . . 0.39000000000000001 112.852 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.703 ' H ' HG22 ' A' ' 57' ' ' ILE . 41.0 m-85 -107.36 161.67 14.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.871 0.367 . . . . 0.23999999999999999 111.548 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -145.8 140.32 27.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.761 -0.829 . . . . 2.8900000000000001 108.761 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 71' ' ' THR . 88.1 mt -119.3 133.02 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.306 -0.407 . . . . 0.16 112.083 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.53 116.54 27.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.963 -0.695 . . . . 0.16 111.014 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 69' ' ' THR . 85.5 t -95.12 115.68 34.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.684 0.754 . . . . 0.19 110.703 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.537 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 44.1 m -89.66 109.81 20.75 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.119 -0.946 . . . . 0.20000000000000001 110.85 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 167' ' ' ARG . 23.3 mm -55.5 -60.21 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.186 0.993 . . . . 0.23000000000000001 110.844 164.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.83 -13.63 6.55 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 112.722 -2.036 . . . . 0.16 113.52 -175.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.537 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.66 -16.92 5.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 118.659 -0.686 . . . . 0.14999999999999999 112.515 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 57.21 54.62 6.61 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.202 0.91 . . . . 0.68999999999999995 111.527 -174.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 40.9 p -138.05 164.91 27.91 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.816 0.673 . . . . 0.13 112.816 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.7 tt -132.67 113.14 12.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.023 -0.989 . . . . 0.40000000000000002 110.093 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 38.4 m -92.89 123.69 36.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.992 0.425 . . . . 0.16 111.219 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' MET . 12.7 tp -98.59 106.61 18.91 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.498 -0.774 . . . . 0.58999999999999997 108.948 170.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 78.5 p -106.93 160.02 15.83 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 119.28 -0.968 . . . . 1.05 110.85 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.718 HD13 ' ND2' ' A' ' 75' ' ' ASN . 1.1 tm? -127.16 126.44 42.87 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.211 -0.663 . . . . 0.26000000000000001 109.211 171.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.718 ' ND2' HD13 ' A' ' 74' ' ' LEU . 7.8 p30 39.13 56.17 2.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 113.991 -1.459 . . . . 1.8400000000000001 111.998 -166.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.3 m-80 74.76 -8.97 1.42 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.144 -0.935 . . . . 1.8899999999999999 112.429 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -101.57 119.45 38.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.012 0.434 . . . . 3.4399999999999999 110.296 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 50.8 t -55.04 131.64 18.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 122.444 1.116 . . . . 0.23999999999999999 112.54 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 67.8 mmm -96.81 -47.82 5.71 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 113.315 -1.766 . . . . 0.81000000000000005 108.28 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -161.08 172.44 16.81 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 112.703 -2.044 . . . . 1.46 110.169 -176.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -149.5 125.42 10.57 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 113.973 -1.467 . . . . 0.17000000000000001 109.532 173.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -117.28 150.54 46.52 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.087 -0.506 . . . . 1.05 110.565 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.73 142.71 32.58 Favored 'Trans proline' 0 CA--C 1.495 -1.473 0 C-N-CA 122.351 2.034 . . . . 0.20000000000000001 111.201 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.643 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.72 173.34 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.452 -0.795 . . . . 0.13 110.433 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.918 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.61 143.74 45.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.927 -0.309 . . . . 0.26000000000000001 110.167 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.516 HG22 ' HG3' ' A' ' 68' ' ' LYS . 11.4 m -125.99 125.83 68.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.583 0.706 . . . . 0.56000000000000005 111.354 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -85.28 155.65 29.97 Favored Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 109.58 -1.408 . . . . 0.17000000000000001 109.58 171.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -57.6 4.9 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.224 0.824 . . . . 3.0499999999999998 113.224 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.915 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -87.02 -20.02 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 121.437 -0.789 . . . . 0.23000000000000001 109.684 178.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.915 HD22 HG23 ' A' ' 89' ' ' ILE . 3.6 mm? -89.44 -20.99 23.24 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.634 -0.876 . . . . 0.17999999999999999 108.634 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.7 p -66.49 -16.75 64.36 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.512 -1.222 . . . . 0.33000000000000002 110.938 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.414 ' NE2' ' HA ' ' A' ' 89' ' ' ILE . 78.1 mt-30 -72.19 -32.64 66.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.472 -1.24 . . . . 1.52 112.966 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -108.54 120.41 46.48 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.008 -0.677 . . . . 0.42999999999999999 110.359 178.061 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 93' ' ' THR . 4.2 Cg_exo -70.37 -23.59 27.82 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.803 2.336 . . . . 0.72999999999999998 112.881 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -99.23 -41.36 7.52 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.514 -0.55 . . . . 0.47999999999999998 109.514 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.541 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 51.44 21.06 5.91 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.514 -1.221 . . . . 0.33000000000000002 114.336 169.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 164' ' ' THR . 12.8 pt-20 -85.05 116.99 23.75 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 122.608 1.194 . . . . 0.83999999999999997 110.05 -172.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.728 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 13.0 m-85 -137.92 -171.83 3.1 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.362 -1.744 . . . . 0.22 111.442 -166.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CG ' HD11 ' A' ' 5' ' ' LEU . 28.6 m-85 -143.84 137.92 28.3 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.76 0.314 . . . . 0.54000000000000004 110.776 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.733 HD12 ' HB ' ' A' ' 161' ' ' THR . 76.3 mt -65.21 119.07 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.745 -0.661 . . . . 0.17000000000000001 110.529 170.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 23.3 pt -88.14 -32.85 6.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.028 0.751 . . . . 0.20999999999999999 113.028 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.568 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 11.9 p30 179.27 179.3 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.846 -1.168 . . . . 2.0299999999999998 107.846 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.594 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 22.9 mtt180 -127.63 160.62 31.06 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.675 -0.81 . . . . 1.52 111.877 -175.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.544 HE21 ' HB3' ' A' ' 107' ' ' PRO . 54.7 tt0 -135.7 98.96 4.05 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.112 -0.949 . . . . 0.58999999999999997 109.665 171.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.47 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 40.4 ttp180 -65.74 164.98 13.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.427 -0.806 . . . . 2.8199999999999998 110.555 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.753 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 30.0 m-80 -36.05 101.28 0.21 Allowed Pre-proline 0 N--CA 1.461 0.098 0 C-N-CA 125.141 1.377 . . . . 0.34999999999999998 112.334 -158.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.544 ' HB3' HE21 ' A' ' 104' ' ' GLN . 15.7 Cg_endo . . . . . 0 N--CA 1.464 -0.255 0 C-N-CA 123.027 2.484 . . . . 0.47999999999999998 113.1 176.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.753 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . . . . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 109.565 -0.531 . . . . 0.47999999999999998 109.565 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.47 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 1.5 m-85 -161.27 152.26 18.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.911 -0.586 . . . . 0.28000000000000003 110.109 -176.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 6.2 t-105 -129.48 99.15 5.08 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.019 -1.474 . . . . 0.48999999999999999 107.019 164.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.9 mt -90.71 114.03 26.26 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.234 -1.025 . . . . 0.66000000000000003 108.234 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.454 ' HB3' HD11 ' A' ' 101' ' ' ILE . 19.4 m -83.68 143.88 29.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.772 -0.649 . . . . 0.19 111.023 -166.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 3.1 mm? -108.88 165.1 11.82 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.102 -0.499 . . . . 0.13 111.445 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.5 t -60.36 -10.96 5.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.632 -1.167 . . . . 1.1699999999999999 112.609 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.746 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.8 tmtm? -127.31 132.13 50.34 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.504 -0.478 . . . . 1.22 109.885 171.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.746 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 21.5 mt-30 -35.25 -59.12 0.53 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 114.278 1.214 . . . . 1.51 114.278 -178.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.582 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -97.09 12.95 30.81 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.581 -0.848 . . . . 2.5299999999999998 111.852 -171.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.784 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.2 m-30 -98.67 38.46 1.36 Allowed 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 112.077 0.399 . . . . 0.83999999999999997 112.077 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.751 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -116.6 143.22 17.97 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 117.165 -2.445 . . . . 0.32000000000000001 112.523 -151.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -96.43 116.04 37.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 123.954 0.901 . . . . 0.17999999999999999 110.934 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.639 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 31.2 p80 -146.65 -178.17 6.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.873 -0.603 . . . . 0.20999999999999999 112.16 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.23 -167.62 37.18 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 111.733 -0.547 . . . . 0.27000000000000002 111.733 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.6 t -162.73 167.97 22.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.878 0.839 . . . . 0.40999999999999998 110.391 -175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -113.29 -8.51 13.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.646 -0.872 . . . . 1.99 108.646 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -120.32 88.11 41.47 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 114.874 -1.057 . . . . 1.3600000000000001 108.856 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -71.91 -21.81 24.08 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.979 2.453 . . . . 0.34999999999999998 114.294 -167.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.57 -1.93 29.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.0 0.428 . . . . 0.33000000000000002 111.253 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 20.1 m -90.26 -5.77 55.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.021 -0.536 . . . . 1.3500000000000001 109.964 172.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 34.3 mm -77.44 131.3 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.181 -0.463 . . . . 0.20999999999999999 110.486 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.01 3.51 60.47 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.235 -1.146 . . . . 0.14999999999999999 110.235 -175.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.459 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 56.9 mttt -114.81 168.72 9.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 122.982 1.373 . . . . 2.5 114.207 -176.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.17 127.24 45.11 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 112.011 -2.359 . . . . 0.17000000000000001 107.759 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -123.6 160.79 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.5 -0.926 . . . . 0.66000000000000003 108.5 -175.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.7 m -49.1 -59.83 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.639 0.607 . . . . 0.42999999999999999 112.639 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.74 -44.86 0.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 118.464 -1.295 . . . . 2.02 114.131 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.24 134.36 0.17 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 117.193 1.637 . . . . 0.17999999999999999 117.193 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.534 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 2.4 p -72.25 165.55 24.21 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 112.735 -1.732 . . . . 0.16 112.002 -178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.918 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 46.4 mt -60.55 96.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 122.384 1.087 . . . . 0.40000000000000002 112.208 -162.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.639 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 68.0 mtt180 -83.63 147.23 27.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.889 -1.505 . . . . 1.8700000000000001 109.726 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.643 ' HG2' HG22 ' A' ' 84' ' ' ILE . 12.0 mtp -123.8 -169.9 2.03 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.407 -0.96 . . . . 0.79000000000000004 108.407 171.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.434 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 41.1 m80 -82.37 161.74 22.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.944 -0.762 . . . . 2.3199999999999998 108.944 168.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.627 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . 13.4 m120 -66.94 -41.65 86.62 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 118.232 -0.89 . . . . 0.68000000000000005 110.805 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -69.66 -29.05 66.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 121.301 1.864 . . . . 2.1800000000000002 112.021 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 64.3 m-20 -76.31 -45.23 33.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.379 0.609 . . . . 0.68999999999999995 109.822 -174.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.16 -25.04 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 114.819 -1.082 . . . . 0.11 111.562 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 147' ' ' ASN . 19.4 mt -83.41 -43.31 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 118.893 -0.575 . . . . 0.38 111.538 174.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.424 ' O ' HG13 ' A' ' 156' ' ' ILE . 20.3 mt-10 -46.41 -70.39 0.1 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.529 1.058 . . . . 1.99 112.644 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.564 ' O ' HG22 ' A' ' 157' ' ' VAL . 26.2 mt -45.79 -39.69 8.66 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.698 0.761 . . . . 1.27 111.556 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.442 ' HB1' ' CE2' ' A' ' 114' ' ' TYR . . . -61.22 -32.29 72.07 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.114 -1.403 . . . . 0.17999999999999999 111.951 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.1 t -87.84 -30.81 19.91 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.511 -0.743 . . . . 0.20999999999999999 112.198 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 152' ' ' GLU . 38.0 mt -82.91 -59.42 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.547 0.689 . . . . 0.16 111.747 -172.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 153' ' ' LEU . 5.4 m -88.39 139.81 30.14 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.73 -1.123 . . . . 0.16 112.373 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.594 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 48.1 Cg_endo -88.87 173.89 4.06 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.324 3.349 . . . . 0.20000000000000001 111.118 174.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.568 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 60.9 m-20 -67.05 156.8 35.13 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 119.214 -0.994 . . . . 1.1000000000000001 108.687 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.02 -20.85 49.18 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.833 -1.175 . . . . 0.17999999999999999 111.921 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.733 ' HB ' HD12 ' A' ' 100' ' ' ILE . 85.8 m -59.82 128.9 39.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.724 -0.843 . . . . 0.14000000000000001 108.724 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -93.32 123.45 36.62 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 122.809 1.29 . . . . 3.6299999999999999 110.833 -167.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.18 112.13 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 112.365 -2.198 . . . . 0.14000000000000001 110.023 -171.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 97' ' ' GLU . 16.2 m -95.69 115.12 26.97 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.798 -0.761 . . . . 0.20999999999999999 112.202 -175.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.541 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mp -84.19 93.14 3.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.87 1.319 . . . . 0.23999999999999999 109.421 172.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -93.0 125.32 37.53 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.262 -1.79 . . . . 1.0900000000000001 108.139 -175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.48 ' HA ' HG13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.613 0 C-N-CA 120.291 -0.563 . . . . 2.0800000000000001 110.697 -177.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.516 -0.339 0 CA-C-O 121.307 0.575 . . . . 0.65000000000000002 111.379 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.1 tt -95.94 128.68 43.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.091 -0.959 . . . . 0.28000000000000003 110.432 -175.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 161.29 13.85 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.084 0.945 . . . . 0.31 112.932 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' A' ' 45' ' ' SER . 72.7 t80 -130.01 141.79 50.7 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.726 -1.579 . . . . 0.44 108.071 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 34.9 tt0 -114.01 112.2 22.88 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.863 -1.162 . . . . 0.76000000000000001 107.863 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' ' 41' ' ' THR . 92.3 t -65.11 149.81 11.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 122.476 1.131 . . . . 0.39000000000000001 112.806 -170.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -106.05 159.59 15.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.235 -1.802 . . . . 2.0099999999999998 108.6 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 108.02 0.99 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.071 0.462 . . . . 1.8300000000000001 111.949 -175.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.4 10.89 37.52 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.534 -0.757 . . . . 0.47999999999999998 113.283 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.605 ' HB2' HG13 ' A' ' 9' ' ' VAL . 91.5 m-20 -58.08 168.65 0.95 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.864 0.332 . . . . 1.46 110.765 172.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.66 153.61 49.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.577 0.703 . . . . 0.40999999999999998 112.011 174.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.734 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -68.2 -31.08 70.35 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.463 -1.244 . . . . 0.85999999999999999 109.75 -176.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.442 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 65.3 t30 -93.34 -20.67 20.14 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.854 -1.066 . . . . 1.1499999999999999 110.544 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.6 t -68.49 -43.22 77.35 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.152 -0.684 . . . . 1.21 109.152 171.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 17.2 mt -72.47 -25.84 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 121.354 0.597 . . . . 0.20999999999999999 109.916 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.643 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.4 -9.91 59.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.401 -0.363 . . . . 0.16 111.035 175.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.606 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.27 -38.87 9.51 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.677 1.227 . . . . 0.20999999999999999 107.982 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.6 m-20 -62.93 -49.16 75.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.255 -2.248 . . . . 0.53000000000000003 111.562 172.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.569 ' HA ' HG21 ' A' ' 101' ' ' ILE . 63.5 m-85 -94.5 5.52 51.58 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.605 -1.238 . . . . 0.17999999999999999 111.527 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.0 mpt_? 53.4 44.51 29.92 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.661 0.744 . . . . 1.78 109.873 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.643 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.0 pt -116.2 -164.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 114.63 -1.168 . . . . 0.19 109.855 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.64 141.7 41.82 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.088 -0.96 . . . . 0.94999999999999996 110.137 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.734 ' HB ' HD11 ' A' ' 15' ' ' LEU . 67.0 p -72.67 -33.64 66.68 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.201 -1.037 . . . . 0.25 108.201 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.46 68.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.981 -1.009 . . . . 0.20000000000000001 111.788 169.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -89.11 -27.88 20.45 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.955 -0.757 . . . . 0.17000000000000001 108.955 -177.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.654 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.8 tp -74.76 -28.38 60.73 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.028 -0.987 . . . . 1.1599999999999999 109.461 175.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 26' ' ' THR . 55.9 mt -77.85 -30.47 51.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.785 0.802 . . . . 1.05 109.86 172.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 39.4 tt0 -63.86 -41.47 97.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.29 -1.323 . . . . 1.8100000000000001 109.976 172.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.16 -22.08 33.38 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 121.91 -0.494 . . . . 0.20000000000000001 111.455 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.658 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 19.8 m-80 -150.11 98.34 3.33 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-O 121.26 0.553 . . . . 0.23000000000000001 109.75 -171.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 12.9 Cg_exo -79.67 -9.97 14.5 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.475 3.45 . . . . 0.35999999999999999 111.903 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -76.08 -25.78 55.84 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.852 -1.067 . . . . 1.3799999999999999 111.802 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.863 HD21 HG21 ' A' ' 46' ' ' ILE . 44.0 mt -65.04 -39.07 92.81 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.557 0.694 . . . . 0.48999999999999999 112.103 -171.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 3.5 pt20 -64.01 -46.27 85.24 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 122.917 1.342 . . . . 1.95 110.447 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.98 83.62 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 111.808 -2.451 . . . . 0.48999999999999999 110.59 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.49 173.21 45.62 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 114.829 -1.078 . . . . 0.41999999999999998 111.815 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.8 157.81 18.24 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.343 0.592 . . . . 0.40999999999999998 110.877 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.625 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 47.2 m -140.51 127.22 20.37 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.43 -0.804 . . . . 0.41999999999999998 110.912 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.71 118.85 18.14 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.291 0.567 . . . . 0.46999999999999997 109.931 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.419 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.48 -1.13 55.73 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.33 -1.108 . . . . 0.40999999999999998 110.33 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -75.29 123.69 25.78 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.394 -0.595 . . . . 1.3 109.394 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 68.1 p -83.94 132.28 34.78 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.827 0.823 . . . . 0.84999999999999998 110.14 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.863 HG21 HD21 ' A' ' 36' ' ' LEU . 11.7 pt -132.11 142.83 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.235 -1.348 . . . . 0.25 109.273 -177.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.39 150.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.17 0.51 . . . . 0.67000000000000004 111.055 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.6 mm -114.36 91.72 25.09 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.694 -1.139 . . . . 0.16 109.056 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.641 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -58.41 135.93 71.04 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.907 2.405 . . . . 0.17999999999999999 112.756 -174.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.47 -5.95 82.42 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.889 -1.05 . . . . 0.26000000000000001 112.269 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.694 HD12 ' HD2' ' A' ' 52' ' ' PRO . 31.0 tp -125.41 116.95 25.12 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-O 121.207 0.527 . . . . 0.60999999999999999 111.395 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.694 ' HD2' HD12 ' A' ' 51' ' ' LEU . 55.4 Cg_endo -79.25 -177.31 3.8 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.698 2.932 . . . . 0.28000000000000003 114.075 -172.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.7 t70 -82.98 130.29 58.14 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.433 -1.258 . . . . 0.48999999999999999 112.089 -170.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.629 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 69.5 Cg_endo -75.23 -16.14 19.88 Favored 'Trans proline' 0 CA--C 1.52 -0.211 0 C-N-CA 123.49 2.793 . . . . 0.46000000000000002 112.867 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -95.3 0.3 53.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.752 0.787 . . . . 1.3799999999999999 110.198 -172.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 53' ' ' ASP . 20.2 p -96.97 -19.66 18.63 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 122.508 1.146 . . . . 0.46000000000000002 108.095 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 59' ' ' TYR . 20.5 mt -74.98 133.38 75.81 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 113.198 -1.819 . . . . 0.69999999999999996 111.296 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.76 -15.5 12.05 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.561 2.174 . . . . 0.39000000000000001 113.742 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.581 ' H ' HG22 ' A' ' 57' ' ' ILE . 51.3 m-85 -100.81 158.34 16.04 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.542 -0.463 . . . . 0.23999999999999999 112.059 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -146.0 133.08 20.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.594 -0.891 . . . . 2.8900000000000001 108.594 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.645 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.9 mt -113.66 134.36 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.343 -0.39 . . . . 0.16 111.937 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.54 118.94 32.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.831 -0.748 . . . . 0.16 111.473 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.8 t -96.99 116.01 38.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.825 0.822 . . . . 0.19 111.107 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 68' ' ' LYS . 27.7 m -95.68 103.12 14.99 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.754 -1.112 . . . . 0.20000000000000001 110.579 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.8 mm -51.02 -58.44 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.968 0.889 . . . . 0.23000000000000001 111.548 169.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.43 -12.51 4.6 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 112.782 -2.008 . . . . 0.16 113.208 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.31 -19.83 4.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.403 0.681 . . . . 0.14999999999999999 112.554 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.83 57.99 3.42 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.552 0.615 . . . . 0.68999999999999995 111.154 -172.225 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -138.57 163.76 31.2 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 112.969 0.729 . . . . 0.13 112.969 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.452 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -131.29 112.92 13.2 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.527 -1.215 . . . . 0.40000000000000002 110.041 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.645 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 23.4 m -92.06 122.95 35.04 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.243 0.544 . . . . 0.16 111.245 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.0 tp -99.43 103.29 15.06 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.1 -0.955 . . . . 0.58999999999999997 109.338 171.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 94.5 p -105.57 161.48 14.33 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.047 -1.061 . . . . 1.05 110.518 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.864 HD13 HD22 ' A' ' 75' ' ' ASN . 1.1 tm? -127.55 128.63 45.94 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.498 -0.927 . . . . 0.26000000000000001 108.498 169.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.864 HD22 HD13 ' A' ' 74' ' ' LEU . 8.4 p30 45.93 51.29 10.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.097 1.359 . . . . 1.8400000000000001 111.48 -167.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 79.4 m-20 72.05 -13.62 0.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.587 -0.733 . . . . 1.8899999999999999 111.936 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -96.67 119.07 34.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.309 0.576 . . . . 3.4399999999999999 109.934 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 69.9 t -57.91 132.49 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.313 1.054 . . . . 0.23999999999999999 112.852 -172.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 12.9 mtm -102.28 -45.66 5.05 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 112.994 -1.912 . . . . 0.81000000000000005 108.85 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.19 171.41 20.22 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.088 -1.869 . . . . 1.46 110.085 -176.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.0 m -149.24 123.73 9.71 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.136 -1.393 . . . . 0.17000000000000001 109.743 172.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -107.45 151.49 40.96 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.333 -0.849 . . . . 1.05 109.291 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HB2' HG22 ' A' ' 134' ' ' ILE . 55.9 Cg_endo -78.9 144.32 18.97 Favored 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 121.871 1.714 . . . . 0.20000000000000001 111.059 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.656 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -141.01 173.33 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.777 -0.647 . . . . 0.13 111.098 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.895 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.23 145.17 45.2 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.342 -0.39 . . . . 0.26000000000000001 110.299 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.496 HG22 ' HG3' ' A' ' 68' ' ' LYS . 7.1 m -127.97 131.26 69.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.132 0.491 . . . . 0.56000000000000005 111.773 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -91.6 157.04 24.32 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 109.755 -1.338 . . . . 0.17000000000000001 109.755 171.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.897 ' HG3' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -57.5 8.1 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 114.449 1.278 . . . . 3.0499999999999998 114.449 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.915 HG23 HD22 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -97.03 -13.0 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.641 0.734 . . . . 0.23000000000000001 110.339 -177.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.915 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -92.67 -15.17 27.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.692 -0.685 . . . . 0.17999999999999999 109.342 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.1 p -69.06 -21.9 64.05 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.889 -1.05 . . . . 0.33000000000000002 111.797 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 6.8 mp0 -56.74 -44.3 81.55 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.44 1.496 . . . . 1.52 112.332 -176.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -106.49 117.05 58.02 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.799 -0.637 . . . . 0.42999999999999999 111.36 -178.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.492 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 5.9 Cg_exo -73.1 -16.64 25.28 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.73 2.287 . . . . 0.72999999999999998 113.132 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.411 HG23 ' N ' ' A' ' 96' ' ' GLY . 12.1 t -104.0 -41.58 5.82 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.711 -0.477 . . . . 0.47999999999999998 109.711 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.534 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.26 40.19 21.79 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.343 -1.299 . . . . 0.33000000000000002 113.81 168.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 164' ' ' THR . 49.0 mt-10 -84.08 113.42 21.02 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.026 0.917 . . . . 0.83999999999999997 109.624 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.702 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.8 m-85 -136.73 178.08 7.35 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 113.604 -1.635 . . . . 0.22 111.566 -171.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 66.0 m-85 -142.06 136.57 30.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.067 0.461 . . . . 0.54000000000000004 110.902 -172.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.597 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.3 mt -62.46 117.56 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.223 -0.899 . . . . 0.17000000000000001 110.916 171.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.569 HG21 ' HA ' ' A' ' 22' ' ' PHE . 16.3 pt -87.52 -34.36 7.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 113.138 0.792 . . . . 0.20999999999999999 113.138 -175.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.5 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 12.7 p30 -178.57 179.58 0.74 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.666 -1.235 . . . . 2.0299999999999998 107.666 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.657 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -135.65 163.14 30.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.622 0.725 . . . . 1.52 112.423 -177.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.445 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 53.7 tt0 -133.07 101.05 5.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.466 -1.243 . . . . 0.58999999999999997 109.819 172.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.492 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 13.6 ttt180 -63.77 166.27 7.37 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.665 -0.698 . . . . 2.8199999999999998 110.356 174.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.492 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 16.3 m-80 -36.74 101.28 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 113.869 -1.514 . . . . 0.34999999999999998 114.079 -151.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 16.1 Cg_exo . . . . . 0 N--CA 1.455 -0.77 0 C-N-CA 123.588 2.858 . . . . 0.47999999999999998 110.723 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.564 1.514 0 N-CA-C 116.663 2.097 . . . . 0.47999999999999998 116.663 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.437 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -165.56 166.37 18.24 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.465 0.706 . . . . 0.28000000000000003 109.717 -177.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 21.8 t-105 -146.68 98.73 3.1 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.96 -1.126 . . . . 0.48999999999999999 107.96 166.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.626 HD23 ' HG2' ' A' ' 103' ' ' ARG . 1.5 mt -89.39 114.12 25.53 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.337 0.589 . . . . 0.66000000000000003 109.503 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 101' ' ' ILE . 49.9 m -82.98 143.63 30.53 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.991 -0.549 . . . . 0.19 111.017 -172.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -109.36 167.59 10.01 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.13 111.696 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.538 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.2 t -59.71 -12.86 7.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.686 -1.143 . . . . 1.1699999999999999 113.175 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.702 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 3.3 tptp -126.87 133.22 50.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.45 -0.5 . . . . 1.22 111.075 173.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.482 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 76.9 mt-30 -31.31 -57.41 0.25 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.02 1.118 . . . . 1.51 114.02 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.552 ' CB ' HG12 ' A' ' 89' ' ' ILE . 87.9 m-70 -95.7 3.15 54.15 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.231 -0.588 . . . . 2.5299999999999998 111.902 -170.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.793 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -95.14 38.19 1.14 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.661 0.985 . . . . 0.83999999999999997 113.661 -172.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.617 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -112.65 143.15 17.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 117.319 -2.372 . . . . 0.32000000000000001 112.565 -153.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.544 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -98.94 115.15 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.868 0.842 . . . . 0.17999999999999999 110.801 -176.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.628 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 28.8 p80 -144.28 171.82 13.78 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-N 115.166 -0.925 . . . . 0.20999999999999999 109.789 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.02 -166.64 38.57 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 120.799 -0.715 . . . . 0.27000000000000002 111.73 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.1 t -156.98 169.16 25.45 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.266 -0.549 . . . . 0.40999999999999998 110.486 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -111.39 0.11 16.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.682 -0.859 . . . . 1.99 108.682 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -118.07 86.22 25.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.755 -1.111 . . . . 1.3600000000000001 108.199 171.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -72.5 -19.92 24.31 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.77 2.313 . . . . 0.34999999999999998 114.175 -166.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.1 -4.01 42.21 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.034 0.445 . . . . 0.33000000000000002 110.839 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.0 t -85.71 -13.11 49.45 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.906 -0.776 . . . . 1.3500000000000001 108.906 172.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 83' ' ' PRO . 28.6 mm -77.54 134.71 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 115.257 -0.883 . . . . 0.20999999999999999 110.413 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.8 -1.38 71.23 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.217 -1.153 . . . . 0.14999999999999999 110.217 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 85' ' ' ALA . 48.4 mttt -112.1 172.3 6.99 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 123.012 1.387 . . . . 2.5 113.887 -177.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.32 127.72 45.36 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 112.189 -2.278 . . . . 0.17000000000000001 108.046 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.501 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 1.4 p -118.57 167.91 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.054 -1.462 . . . . 0.66000000000000003 107.054 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.897 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 45.2 m -64.48 -59.68 4.04 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 119.731 -0.788 . . . . 0.42999999999999999 111.949 177.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -127.34 -44.14 1.58 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 117.207 -1.797 . . . . 2.02 113.9 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -33.39 132.56 0.31 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.67 1.428 . . . . 0.17999999999999999 116.67 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.617 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.2 p -68.75 166.36 17.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.41 -1.895 . . . . 0.16 112.141 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.895 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 66.9 mt -59.07 99.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 122.569 1.176 . . . . 0.40000000000000002 111.991 -163.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.628 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 50.3 mtt180 -86.09 147.1 26.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.371 -1.74 . . . . 1.8700000000000001 110.389 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.656 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.0 mtp -128.12 -166.21 1.59 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.29 -0.633 . . . . 0.79000000000000004 109.29 175.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.602 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 5.5 t60 -95.55 156.38 16.35 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.909 -0.775 . . . . 2.3199999999999998 108.909 171.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.613 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.1 m120 -57.1 -52.69 64.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 118.422 -0.799 . . . . 0.68000000000000005 110.293 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.87 -25.82 68.48 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 121.154 1.797 . . . . 2.1800000000000002 112.522 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.602 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 7.5 m-20 -84.67 -41.38 16.35 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.303 -0.408 . . . . 0.68999999999999995 111.186 -175.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.649 HG13 HD12 ' A' ' 151' ' ' ILE . 13.3 p -67.94 -23.75 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.016 -0.538 . . . . 0.11 111.143 175.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.649 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.24 -39.67 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 119.042 -0.504 . . . . 0.38 109.739 171.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.0 mm-40 -45.86 -72.06 0.06 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.171 0.896 . . . . 1.99 112.366 168.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 157' ' ' VAL . 44.8 mt -47.27 -38.46 12.5 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.675 0.75 . . . . 1.27 111.495 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.35 79.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.126 -1.397 . . . . 0.17999999999999999 111.664 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.9 t -88.44 -33.0 18.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 118.58 0.627 . . . . 0.20999999999999999 112.416 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 152' ' ' GLU . 30.4 mt -81.24 -59.63 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.551 0.691 . . . . 0.16 111.193 -172.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 153' ' ' LEU . 2.8 m -92.58 140.12 23.86 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.845 -1.071 . . . . 0.16 112.227 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.657 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 57.3 Cg_endo -89.86 177.14 2.64 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.114 3.209 . . . . 0.20000000000000001 111.122 173.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.507 HD21 ' CG ' ' A' ' 103' ' ' ARG . 12.7 m120 -67.07 157.8 32.64 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 119.658 -0.817 . . . . 1.1000000000000001 109.525 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 99.39 -25.58 27.69 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.211 -0.995 . . . . 0.17999999999999999 112.289 -173.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.597 ' HB ' HD12 ' A' ' 100' ' ' ILE . 36.1 m -61.41 138.31 58.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.383 -0.599 . . . . 0.14000000000000001 109.383 -173.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.538 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 9.8 ptm180 -92.81 127.71 38.41 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.964 1.364 . . . . 3.6299999999999999 111.369 -170.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.3 t -109.58 108.34 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 111.915 -2.402 . . . . 0.14000000000000001 109.008 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.438 HG23 ' HG2' ' A' ' 97' ' ' GLU . 30.6 m -94.76 107.05 19.06 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.524 0.564 . . . . 0.20999999999999999 112.524 -171.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.534 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -82.86 100.75 6.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 122.29 1.043 . . . . 0.23999999999999999 109.992 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -110.17 133.31 53.35 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.229 -1.35 . . . . 1.0900000000000001 109.832 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.558 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.6 mmm180 . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 116.465 -0.334 . . . . 2.0800000000000001 110.829 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 mp . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 121.453 0.644 . . . . 0.65000000000000002 111.745 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.621 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.4 tt -94.63 130.87 40.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.857 -1.065 . . . . 0.28000000000000003 110.142 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.75 162.25 13.51 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.129 0.966 . . . . 0.31 113.171 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.624 ' O ' ' HA ' ' A' ' 45' ' ' SER . 84.7 t80 -129.57 139.98 51.34 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.469 -1.696 . . . . 0.44 107.902 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.486 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.1 tt0 -112.93 110.89 21.25 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.242 -1.021 . . . . 0.76000000000000001 108.242 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 13' ' ' ASP . 92.7 t -66.05 149.45 11.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 122.564 1.173 . . . . 0.39000000000000001 113.578 -167.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.409 ' O ' HG12 ' A' ' 9' ' ' VAL . 57.9 mttt -98.93 159.97 14.59 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.211 -1.813 . . . . 2.0099999999999998 109.799 172.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.4 mm-40 -62.43 105.37 0.61 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.886 -1.052 . . . . 1.8300000000000001 111.432 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.94 11.66 49.05 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.485 -0.779 . . . . 0.47999999999999998 113.542 175.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.618 ' HB2' HG13 ' A' ' 9' ' ' VAL . 59.3 m-20 -52.38 169.52 0.08 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 117.423 0.611 . . . . 1.46 111.362 171.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.84 154.69 44.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.475 0.655 . . . . 0.40999999999999998 111.271 175.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.539 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.97 -33.23 75.34 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.394 -0.965 . . . . 0.85999999999999999 108.394 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 17.8 t-20 -88.62 -25.12 22.6 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.883 -1.053 . . . . 1.1499999999999999 111.391 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.4 p -68.76 -38.56 80.18 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 119.72 -0.792 . . . . 1.21 109.601 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 mt -75.47 -26.89 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.219 0.533 . . . . 0.20999999999999999 109.75 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.643 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.91 -9.86 59.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.326 -0.397 . . . . 0.16 110.646 174.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.729 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.44 -41.37 8.63 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.274 -1.01 . . . . 0.20999999999999999 108.274 176.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.463 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 1.5 m-20 -61.68 -39.45 91.47 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.015 -1.902 . . . . 0.53000000000000003 112.073 174.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.469 ' O ' HD12 ' A' ' 101' ' ' ILE . 68.4 m-85 -103.32 5.9 37.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 118.566 -1.254 . . . . 0.17999999999999999 111.487 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.729 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER 54.74 41.5 31.88 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.972 0.891 . . . . 1.78 109.559 176.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.643 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.8 pt -114.42 -165.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.208 -1.36 . . . . 0.19 110.024 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 142.62 41.07 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.241 -0.891 . . . . 0.94999999999999996 110.21 174.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.544 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 72.3 p -71.97 -34.01 68.61 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.007 -1.108 . . . . 0.25 108.007 178.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.27 69.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.42 -0.809 . . . . 0.20000000000000001 111.816 170.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.37 -26.26 18.99 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.689 0.757 . . . . 0.17000000000000001 109.093 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.667 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.1 tp -75.19 -26.29 58.89 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.09 -0.959 . . . . 1.1599999999999999 109.261 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 26' ' ' THR . 33.6 mt -77.86 -29.89 50.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.765 0.793 . . . . 1.05 109.828 171.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 40.8 tt0 -64.49 -43.28 94.63 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.413 -1.267 . . . . 1.8100000000000001 109.95 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.18 -20.35 34.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.105 -0.638 . . . . 0.20000000000000001 111.495 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.64 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.3 m-80 -148.16 81.05 8.34 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.509 0.671 . . . . 0.23000000000000001 110.442 -172.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.4 Cg_endo -57.71 -10.93 8.09 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 124.077 3.185 . . . . 0.35999999999999999 114.057 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.5 t -80.67 -22.12 40.72 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.053 -0.404 . . . . 1.3799999999999999 111.249 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 46' ' ' ILE . 38.1 mt -66.41 -35.67 80.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.526 0.679 . . . . 0.48999999999999999 111.883 -171.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 3.7 pt20 -65.51 -47.92 74.31 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 122.871 1.32 . . . . 1.95 110.167 -175.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.51 82.56 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 111.934 -2.394 . . . . 0.48999999999999999 110.594 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.17 -179.53 48.19 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.857 -1.065 . . . . 0.41999999999999998 111.541 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.01 158.22 23.44 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.212 0.529 . . . . 0.40999999999999998 110.791 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.61 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 29.4 m -139.05 128.11 23.81 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.493 -0.776 . . . . 0.41999999999999998 110.406 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -75.27 118.89 18.67 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.566 0.698 . . . . 0.46999999999999997 109.772 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.486 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.39 0.74 55.65 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.374 -1.09 . . . . 0.40999999999999998 110.374 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.2 OUTLIER -76.42 124.16 27.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.985 -0.607 . . . . 1.3 109.469 179.366 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 24.4 p -84.45 126.17 33.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.967 0.889 . . . . 0.84999999999999998 110.752 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.859 HG21 HD21 ' A' ' 36' ' ' LEU . 10.6 pt -126.94 144.38 37.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.133 -1.394 . . . . 0.25 109.377 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.68 151.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.125 0.488 . . . . 0.67000000000000004 111.164 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.3 mm -116.35 91.69 33.93 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.885 -1.052 . . . . 0.16 109.425 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.528 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.6 Cg_endo -56.93 133.7 59.67 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.834 2.356 . . . . 0.17999999999999999 112.551 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.18 -5.79 78.4 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.701 -1.136 . . . . 0.26000000000000001 112.569 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.688 HD12 ' HD2' ' A' ' 52' ' ' PRO . 25.6 tp -125.71 115.56 24.73 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.949 0.404 . . . . 0.60999999999999999 111.452 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.688 ' HD2' HD12 ' A' ' 51' ' ' LEU . 36.4 Cg_endo -76.79 -177.82 4.07 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.565 2.844 . . . . 0.28000000000000003 114.331 -172.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.67 ' HB3' HG23 ' A' ' 56' ' ' THR . 16.1 t70 -78.31 133.05 64.67 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 113.94 -1.482 . . . . 0.48999999999999999 112.139 -170.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.47 -9.36 18.72 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.314 2.676 . . . . 0.46000000000000002 112.717 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.507 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 16.4 m-30 -93.9 -8.28 40.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.119 0.485 . . . . 1.3799999999999999 110.52 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.67 HG23 ' HB3' ' A' ' 53' ' ' ASP . 19.0 p -88.72 -17.67 29.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.065 0.936 . . . . 0.46000000000000002 108.674 174.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.655 HG22 ' H ' ' A' ' 59' ' ' TYR . 9.6 mm -64.72 126.14 90.28 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 113.838 -1.528 . . . . 0.69999999999999996 109.989 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.71 -13.48 10.62 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.999 1.799 . . . . 0.39000000000000001 112.608 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.655 ' H ' HG22 ' A' ' 57' ' ' ILE . 67.0 m-85 -103.68 170.56 7.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.281 0.562 . . . . 0.23999999999999999 111.825 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -153.81 134.07 13.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.117 -0.947 . . . . 2.8900000000000001 108.536 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 71' ' ' THR . 93.1 mt -111.54 130.34 65.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.342 -0.39 . . . . 0.16 111.322 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.87 115.48 28.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.937 -0.705 . . . . 0.16 110.847 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 47.8 t -96.64 114.04 32.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.79 0.805 . . . . 0.19 110.571 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 68' ' ' LYS . 27.1 m -94.76 100.35 12.27 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.49 -1.232 . . . . 0.20000000000000001 110.359 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.0 mm -50.47 -57.32 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 122.028 0.918 . . . . 0.23000000000000001 111.13 170.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.34 -11.53 3.63 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 112.787 -2.006 . . . . 0.16 113.131 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.49 -17.53 5.07 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.436 0.694 . . . . 0.14999999999999999 112.595 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.498 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.97 54.25 6.18 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.505 0.593 . . . . 0.68999999999999995 111.488 -173.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.6 p -136.7 163.48 30.48 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.798 0.666 . . . . 0.13 112.798 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.501 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.5 tt -128.13 111.52 13.56 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.595 -1.184 . . . . 0.40000000000000002 109.549 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.631 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 31.2 m -93.41 121.77 35.15 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.261 0.553 . . . . 0.16 110.962 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' A' ' 79' ' ' MET . 16.0 tp -96.79 104.96 17.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.179 -0.918 . . . . 0.58999999999999997 109.078 172.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 97.9 p -106.8 159.23 16.39 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.981 -1.088 . . . . 1.05 110.368 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.707 HD13 ' ND2' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -123.73 125.51 44.88 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.561 -0.903 . . . . 0.26000000000000001 108.561 170.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.707 ' ND2' HD13 ' A' ' 74' ' ' LEU . 9.4 p30 41.06 54.83 3.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.713 -1.585 . . . . 1.8400000000000001 111.58 -164.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 6.7 m-20 74.7 -13.62 0.8 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.008 -0.996 . . . . 1.8899999999999999 112.146 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -95.28 120.39 35.43 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.231 0.539 . . . . 3.4399999999999999 110.025 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 58.9 t -56.93 131.04 20.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 122.357 1.075 . . . . 0.23999999999999999 113.002 -173.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 2.8 mmm -97.99 -46.88 5.74 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.947 -1.933 . . . . 0.81000000000000005 108.854 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.8 mmtt -160.56 173.99 14.7 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.046 -1.888 . . . . 1.46 110.037 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.8 m -149.6 123.7 9.46 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.224 -1.353 . . . . 0.17000000000000001 109.699 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -114.94 145.06 33.21 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.6 -0.727 . . . . 1.05 109.959 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HB2' HG22 ' A' ' 134' ' ' ILE . 37.3 Cg_endo -72.42 142.28 36.63 Favored 'Trans proline' 0 CA--C 1.496 -1.418 0 C-N-CA 122.259 1.973 . . . . 0.20000000000000001 111.173 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.661 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.32 172.56 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 115.517 -0.765 . . . . 0.13 110.959 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.929 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.04 139.66 50.88 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.237 -0.438 . . . . 0.26000000000000001 109.88 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.498 HG22 ' HG3' ' A' ' 68' ' ' LYS . 10.9 m -121.74 126.87 75.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.713 0.768 . . . . 0.56000000000000005 111.541 -177.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -82.18 150.63 29.1 Favored Glycine 0 N--CA 1.419 -2.452 0 N-CA-C 109.186 -1.566 . . . . 0.17000000000000001 109.186 171.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -57.19 4.39 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.809 0.67 . . . . 3.0499999999999998 112.809 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.944 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -87.46 -19.04 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.481 0.658 . . . . 0.23000000000000001 110.077 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.944 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -88.84 -16.36 32.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.694 0.759 . . . . 0.17999999999999999 109.228 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.5 p -69.23 -18.51 63.9 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.565 -1.198 . . . . 0.33000000000000002 111.194 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.25 -40.17 93.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.536 -1.211 . . . . 1.52 112.704 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.67 131.26 29.75 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 119.799 -0.76 . . . . 0.42999999999999999 110.956 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 83.8 Cg_endo -86.97 -1.86 8.04 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.43 2.087 . . . . 0.72999999999999998 112.314 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.3 t -119.62 -41.48 2.69 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.418 -0.586 . . . . 0.47999999999999998 109.418 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 165' ' ' ILE . . . 54.87 16.86 8.28 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 114.716 -1.129 . . . . 0.33000000000000002 114.413 169.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.596 ' HB3' HG23 ' A' ' 164' ' ' THR . 10.6 pt-20 -84.42 116.7 23.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.495 1.14 . . . . 0.83999999999999997 109.816 -173.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 11.3 m-85 -137.58 -174.78 3.86 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.278 -1.783 . . . . 0.22 111.436 -166.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 162' ' ' ARG . 39.2 m-85 -142.18 137.95 31.19 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 120.945 0.402 . . . . 0.54000000000000004 110.991 -173.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.662 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.2 mt -65.04 125.04 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.542 -0.753 . . . . 0.17000000000000001 110.308 169.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.57 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 21.9 pt -91.45 -42.13 13.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 113.024 0.75 . . . . 0.20999999999999999 113.024 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 57.6 m-80 -170.13 173.0 6.08 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.009 -1.478 . . . . 2.0299999999999998 107.009 -170.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.61 HH21 ' HA ' ' A' ' 158' ' ' PRO . 40.7 mtt180 -125.8 167.9 14.56 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.696 -0.802 . . . . 1.52 111.739 -175.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -145.44 100.76 3.5 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.148 -0.933 . . . . 0.58999999999999997 110.019 171.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.469 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 25.9 ttp180 -66.02 166.31 11.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.302 -0.863 . . . . 2.8199999999999998 110.735 175.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 33.8 m-80 -36.37 101.51 0.22 Allowed Pre-proline 0 C--O 1.233 0.207 0 C-N-CA 124.942 1.297 . . . . 0.34999999999999998 113.104 -156.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.516 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.4 Cg_endo . . . . . 0 C--N 1.347 0.47 0 C-N-CA 123.453 2.768 . . . . 0.47999999999999998 112.601 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.788 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 121.157 0.503 . . . . 0.47999999999999998 110.111 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.429 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -157.37 157.51 34.2 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.66 0.384 . . . . 0.28000000000000003 110.079 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -136.52 100.22 4.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.973 -1.121 . . . . 0.48999999999999999 107.973 165.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.547 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.0 mt -93.52 114.18 26.49 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.64 -0.874 . . . . 0.66000000000000003 108.64 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.406 ' C ' HG12 ' A' ' 101' ' ' ILE . 9.2 m -84.25 144.45 28.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.675 -0.693 . . . . 0.19 111.213 -165.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.815 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -109.54 169.46 8.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 0.13 111.394 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.0 t -63.97 -12.21 35.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.848 -1.069 . . . . 1.1699999999999999 112.787 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.746 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 3.9 tmtm? -127.65 132.31 49.74 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.158 0.98 . . . . 1.22 109.704 171.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.746 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.0 mt-30 -37.57 -47.23 0.91 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.524 -2.126 . . . . 1.51 114.211 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.486 ' HB2' HG12 ' A' ' 89' ' ' ILE . 37.2 m80 -97.9 2.22 48.92 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.366 0.603 . . . . 2.5299999999999998 111.024 -171.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.815 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.6 m-85 -99.38 37.35 1.58 Allowed 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.495 0.924 . . . . 0.83999999999999997 113.495 -171.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.672 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -117.03 142.27 17.31 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 116.874 -2.584 . . . . 0.32000000000000001 112.668 -152.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -95.64 116.12 36.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 123.966 0.906 . . . . 0.17999999999999999 110.868 -175.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.724 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 26.7 p80 -146.36 -179.01 6.45 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.186 -0.461 . . . . 0.20999999999999999 111.822 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.39 -167.98 37.05 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 111.19 -0.764 . . . . 0.27000000000000002 111.19 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.4 t -156.95 172.29 18.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 117.912 0.856 . . . . 0.40999999999999998 110.911 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -115.42 -2.43 12.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.528 -0.916 . . . . 1.99 108.528 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -124.86 89.17 52.93 Favored Pre-proline 0 C--O 1.235 0.333 0 CA-C-N 114.426 -1.261 . . . . 1.3600000000000001 108.858 171.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -74.32 -21.04 17.95 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.627 2.218 . . . . 0.34999999999999998 114.113 -169.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.02 -3.65 40.14 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.034 0.445 . . . . 0.33000000000000002 111.337 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.9 m -91.13 -2.33 57.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.125 0.488 . . . . 1.3500000000000001 109.812 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 83' ' ' PRO . 33.5 mm -77.23 136.34 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.20999999999999999 110.026 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.59 2.12 65.57 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.314 -1.114 . . . . 0.14999999999999999 110.314 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.428 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 30.2 mttm -114.87 169.96 8.69 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 123.315 1.531 . . . . 2.5 114.635 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.4 126.51 48.18 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.67 -2.514 . . . . 0.17000000000000001 108.203 176.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.77 161.23 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.446 -0.946 . . . . 0.66000000000000003 108.446 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.0 m -49.8 -60.1 3.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.794 0.664 . . . . 0.42999999999999999 112.794 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -132.61 -44.46 0.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.36 -1.336 . . . . 2.02 113.984 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.49 133.65 0.2 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 117.19 1.636 . . . . 0.17999999999999999 117.19 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.616 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 2.4 p -71.22 165.6 23.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 112.545 -1.827 . . . . 0.16 112.026 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.929 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 56.0 mt -60.01 96.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 122.538 1.161 . . . . 0.40000000000000002 111.783 -162.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.724 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 80.5 mtt180 -84.93 141.76 30.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.681 -1.6 . . . . 1.8700000000000001 109.399 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.661 ' HG2' HG22 ' A' ' 84' ' ' ILE . 24.4 mtp -118.6 179.22 4.19 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.477 0.656 . . . . 0.79000000000000004 109.857 175.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.569 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 9.5 t-80 -81.45 145.83 30.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.882 -1.155 . . . . 2.3199999999999998 107.882 168.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.789 ' O ' HD13 ' A' ' 151' ' ' ILE . 6.9 m120 -66.17 -40.47 90.52 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 114.883 -1.053 . . . . 0.68000000000000005 112.566 -166.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -67.54 -23.83 65.48 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 121.801 2.091 . . . . 2.1800000000000002 112.241 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 12.2 m-20 -85.19 -38.23 19.22 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.216 -0.447 . . . . 0.68999999999999995 110.851 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.62 HG13 HD12 ' A' ' 151' ' ' ILE . 12.2 p -67.55 -21.98 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.852 -0.613 . . . . 0.11 111.176 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.789 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.19 -43.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 118.948 -0.549 . . . . 0.38 109.923 171.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 156' ' ' ILE . 23.5 mt-10 -46.81 -70.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 119.385 0.993 . . . . 1.99 112.761 170.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.473 ' O ' HG22 ' A' ' 157' ' ' VAL . 27.3 mt -47.07 -38.62 11.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.631 0.729 . . . . 1.27 111.658 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.65 -31.96 71.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.079 -1.419 . . . . 0.17999999999999999 111.712 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.7 t -88.34 -31.77 18.75 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.481 -0.762 . . . . 0.20999999999999999 112.324 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 152' ' ' GLU . 24.2 mt -82.31 -60.84 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.534 0.683 . . . . 0.16 111.828 -171.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 153' ' ' LEU . 8.7 m -88.35 139.46 30.16 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 114.783 -1.099 . . . . 0.16 112.342 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.61 ' HA ' HH21 ' A' ' 103' ' ' ARG . 42.4 Cg_endo -88.54 174.55 4.13 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 124.37 3.38 . . . . 0.20000000000000001 111.119 176.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 54.0 m-20 -68.18 156.93 36.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.905 -1.118 . . . . 1.1000000000000001 108.219 175.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.78 -16.07 61.9 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.772 -1.204 . . . . 0.17999999999999999 111.928 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.662 ' HB ' HD12 ' A' ' 100' ' ' ILE . 95.2 m -64.91 135.29 55.54 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.203 -0.666 . . . . 0.14000000000000001 109.203 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.443 ' HB3' ' CD1' ' A' ' 99' ' ' TYR . 1.7 ptt180 -92.82 122.42 35.19 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.685 1.231 . . . . 3.6299999999999999 111.078 -170.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 39.8 t -110.14 109.56 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 112.204 -2.271 . . . . 0.14000000000000001 109.475 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.596 HG23 ' HB3' ' A' ' 97' ' ' GLU . 6.9 m -97.35 110.28 22.86 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.082 0.771 . . . . 0.20999999999999999 113.082 -172.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.488 HG12 HD12 ' A' ' 90' ' ' LEU . 2.3 mp -83.17 102.16 8.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.11 0.957 . . . . 0.23999999999999999 109.792 176.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -109.22 129.84 55.5 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.979 -1.009 . . . . 1.0900000000000001 110.037 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 9.9 mmm180 . . . . . 0 C--N 1.321 -0.652 0 CA-C-O 121.362 0.601 . . . . 2.0800000000000001 109.432 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.771 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 tp . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.189 0.519 . . . . 0.65000000000000002 111.186 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.9 tt -94.28 126.42 39.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.521 -0.763 . . . . 0.28000000000000003 110.615 -174.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.71 161.62 13.8 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.051 0.929 . . . . 0.31 113.064 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.651 ' O ' ' HA ' ' A' ' 45' ' ' SER . 78.7 t80 -131.29 141.48 49.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.808 -1.542 . . . . 0.44 108.058 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.457 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.5 tt0 -113.27 111.04 21.37 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.055 -1.091 . . . . 0.76000000000000001 108.055 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' A' ' 13' ' ' ASP . 94.3 t -66.52 150.49 10.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 122.155 0.978 . . . . 0.39000000000000001 113.032 -168.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -104.14 158.85 16.15 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.869 -1.514 . . . . 2.0099999999999998 108.658 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.427 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.1 tt0 -61.54 101.62 0.19 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.974 0.416 . . . . 1.8300000000000001 112.09 -175.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.79 11.97 27.27 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.754 -0.736 . . . . 0.47999999999999998 113.237 174.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.647 ' HB2' HG13 ' A' ' 9' ' ' VAL . 35.7 m-20 -55.54 170.48 0.25 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.912 0.356 . . . . 1.46 111.348 171.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.7 155.11 49.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.459 0.647 . . . . 0.40999999999999998 111.893 174.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.754 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -69.21 -29.71 67.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.526 -1.216 . . . . 0.85999999999999999 109.897 -177.255 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.441 ' HA ' HG22 ' A' ' 26' ' ' THR . 65.9 t30 -93.79 -23.26 18.23 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.927 -1.033 . . . . 1.1499999999999999 111.164 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.3 m -70.0 -39.84 75.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.553 -0.459 . . . . 1.21 109.886 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.443 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.2 mt -73.2 -27.4 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.112 0.482 . . . . 0.20999999999999999 109.977 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.654 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.76 -10.42 59.77 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.811 -0.356 . . . . 0.16 110.928 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.565 ' O ' ' HD3' ' A' ' 23' ' ' ARG . . . -97.16 -40.3 8.87 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 122.214 1.007 . . . . 0.20999999999999999 108.404 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 4.4 m-20 -61.44 -43.43 98.88 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.227 -1.806 . . . . 0.53000000000000003 111.867 173.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.568 ' C ' HD12 ' A' ' 101' ' ' ILE . 67.8 m-85 -98.01 8.19 45.14 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.574 -1.25 . . . . 0.17999999999999999 111.571 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.565 ' HD3' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER 52.08 40.65 28.95 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.613 0.721 . . . . 1.78 110.215 177.439 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.654 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.6 pt -113.63 -164.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 114.511 -1.222 . . . . 0.19 109.28 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -109.9 157.17 19.52 Favored 'General case' 0 CA--C 1.491 -1.318 0 CA-C-O 122.375 1.083 . . . . 0.94999999999999996 110.168 169.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.754 ' HB ' HD11 ' A' ' 15' ' ' LEU . 75.7 p -80.68 -31.12 36.4 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 112.914 -1.948 . . . . 0.25 107.553 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 -30.72 71.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.098 -0.956 . . . . 0.20000000000000001 111.76 172.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.51 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -89.95 -26.87 20.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.728 -0.842 . . . . 0.17000000000000001 108.728 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.6 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 20.0 tp -74.14 -28.18 61.2 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.355 -0.839 . . . . 1.1599999999999999 109.789 175.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 36' ' ' LEU . 48.3 mt -77.79 -29.31 50.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.959 0.885 . . . . 1.05 109.919 172.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 53.9 tt0 -67.9 -39.65 83.59 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.082 -1.417 . . . . 1.8100000000000001 110.572 174.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.67 -19.94 32.06 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.075 -0.65 . . . . 0.20000000000000001 111.409 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 26.8 m-80 -147.05 80.64 9.34 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-O 121.217 0.532 . . . . 0.23000000000000001 110.351 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.418 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 18.5 Cg_endo -57.15 -11.2 7.36 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 123.889 3.059 . . . . 0.35999999999999999 113.305 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 m -74.05 -25.72 60.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.848 0.356 . . . . 1.3799999999999999 111.53 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.663 HD21 HG21 ' A' ' 46' ' ' ILE . 40.6 mt -70.91 -32.46 69.4 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.353 0.596 . . . . 0.48999999999999999 112.462 -168.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 1.7 pp0? -63.59 -44.64 93.43 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 123.057 1.408 . . . . 1.95 110.395 -175.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.37 79.19 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 111.722 -2.49 . . . . 0.48999999999999999 110.693 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.41 178.33 48.65 Favored Glycine 0 N--CA 1.425 -2.094 0 CA-C-N 115.117 -0.947 . . . . 0.41999999999999998 111.929 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.67 158.05 19.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.225 0.536 . . . . 0.40999999999999998 110.569 178.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.556 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 74.4 m -140.91 127.55 20.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.355 -0.839 . . . . 0.41999999999999998 110.301 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -75.07 122.71 23.96 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.364 0.602 . . . . 0.46999999999999997 110.028 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.457 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.67 3.02 61.18 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 110.533 -1.027 . . . . 0.40999999999999998 110.533 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.556 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.52 123.12 28.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.626 -0.509 . . . . 1.3 109.626 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 17.0 p -77.78 126.36 30.74 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.852 0.834 . . . . 0.84999999999999998 110.657 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.663 HG21 HD21 ' A' ' 36' ' ' LEU . 9.1 pt -126.13 144.07 37.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.138 -1.392 . . . . 0.25 109.198 -178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.426 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.15 151.44 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.347 0.594 . . . . 0.67000000000000004 111.191 -179.023 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.82 93.38 41.23 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.554 -1.203 . . . . 0.16 109.227 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.613 ' HA ' HD21 ' A' ' 4' ' ' LEU . 3.1 Cg_exo -56.12 133.91 60.97 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.488 2.125 . . . . 0.17999999999999999 112.535 -176.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.77 -6.88 79.76 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 114.412 -1.267 . . . . 0.26000000000000001 112.363 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.771 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER -112.98 118.49 44.41 Favored Pre-proline 0 C--O 1.217 -0.637 0 CA-C-N 116.98 0.39 . . . . 0.60999999999999999 111.186 178.172 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.592 ' HD2' HD23 ' A' ' 51' ' ' LEU . 37.0 Cg_endo -80.0 -176.8 3.41 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.083 2.522 . . . . 0.28000000000000003 112.65 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.552 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.7 t70 -86.72 127.37 60.49 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-N 115.363 -0.835 . . . . 0.48999999999999999 112.044 -168.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.566 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.1 Cg_endo -75.65 -10.39 20.17 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 123.626 2.884 . . . . 0.46000000000000002 112.934 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -94.08 -13.92 26.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.549 0.69 . . . . 1.3799999999999999 110.186 -176.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.552 HG23 ' HB3' ' A' ' 53' ' ' ASP . 23.7 p -87.32 -21.23 25.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.507 1.146 . . . . 0.46000000000000002 108.176 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 59' ' ' TYR . 35.8 mt -73.89 129.08 85.58 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.124 -1.853 . . . . 0.69999999999999996 111.018 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.06 -16.22 14.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.424 2.083 . . . . 0.39000000000000001 113.416 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.531 ' H ' HG22 ' A' ' 57' ' ' ILE . 62.9 m-85 -94.66 160.12 14.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.582 -0.447 . . . . 0.23999999999999999 111.591 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -150.99 132.03 14.31 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.902 -0.777 . . . . 2.8900000000000001 108.902 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 71' ' ' THR . 80.2 mt -112.49 136.38 48.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.233 -0.44 . . . . 0.16 111.889 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.77 117.39 29.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 119.957 -0.697 . . . . 0.16 110.924 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.2 t -97.33 112.88 30.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.775 0.797 . . . . 0.19 110.53 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 68' ' ' LYS . 49.6 m -93.6 100.75 12.95 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.717 -1.129 . . . . 0.20000000000000001 110.546 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.8 mm -50.79 -58.77 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.894 0.854 . . . . 0.23000000000000001 111.443 170.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.92 -8.21 2.09 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 112.922 -1.945 . . . . 0.16 113.245 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.46 -19.17 4.27 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.697 0.799 . . . . 0.14999999999999999 112.267 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.554 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 59.24 54.51 4.77 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.335 0.516 . . . . 0.68999999999999995 111.293 -172.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.6 p -137.29 166.2 24.34 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 112.787 0.662 . . . . 0.13 112.787 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.431 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.9 tt -136.26 112.22 9.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.861 -1.063 . . . . 0.40000000000000002 110.197 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 86.6 m -93.24 124.3 37.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.146 0.498 . . . . 0.16 110.879 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.9 tp -99.78 107.3 19.31 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.173 -0.921 . . . . 0.58999999999999997 109.25 172.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 88.8 p -105.42 161.4 14.35 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.013 -1.075 . . . . 1.05 110.546 176.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -125.99 126.69 44.72 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.575 -0.898 . . . . 0.26000000000000001 108.575 167.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.566 ' N ' HD22 ' A' ' 74' ' ' LEU . 29.1 m-80 51.15 48.61 22.73 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.607 -1.179 . . . . 1.8400000000000001 111.067 -172.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.0 t30 71.71 -5.89 1.56 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.339 0.656 . . . . 1.8899999999999999 111.414 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -104.94 120.64 41.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.125 0.488 . . . . 3.4399999999999999 110.582 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 54.7 t -55.23 132.85 18.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 122.361 1.077 . . . . 0.23999999999999999 113.399 -174.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 6.9 mmm -100.85 -44.43 5.77 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.229 -1.805 . . . . 0.81000000000000005 109.275 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -159.37 173.43 16.26 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 113.189 -1.823 . . . . 1.46 110.156 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.0 m -149.3 123.08 9.27 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.986 -1.461 . . . . 0.17000000000000001 109.391 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.459 ' HE2' HD21 ' A' ' 153' ' ' LEU . 19.0 m-85 -108.85 156.6 38.72 Favored Pre-proline 0 C--N 1.312 -1.04 0 N-CA-C 109.386 -0.598 . . . . 1.05 109.386 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HB2' HG22 ' A' ' 134' ' ' ILE . 50.7 Cg_endo -80.69 144.2 15.41 Favored 'Trans proline' 0 CA--C 1.497 -1.372 0 C-N-CA 121.975 1.783 . . . . 0.20000000000000001 110.83 170.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.631 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -140.08 172.75 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.614 -0.721 . . . . 0.13 110.551 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.85 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.05 137.69 52.73 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.846 0.355 . . . . 0.26000000000000001 110.321 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.554 HG22 ' HG3' ' A' ' 68' ' ' LYS . 13.2 m -121.11 130.16 74.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.678 -0.692 . . . . 0.56000000000000005 111.527 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 140' ' ' LYS . . . -88.91 154.26 24.46 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.988 -1.245 . . . . 0.17000000000000001 109.988 171.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -57.08 4.55 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 113.133 0.79 . . . . 3.0499999999999998 113.133 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.936 HG23 HD22 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -88.78 -18.97 7.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.78 0.8 . . . . 0.23000000000000001 110.074 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.936 HD22 HG23 ' A' ' 89' ' ' ILE . 3.5 mm? -88.66 -18.53 27.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.791 0.805 . . . . 0.17999999999999999 108.909 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.8 p -68.51 -15.05 63.41 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.376 -1.284 . . . . 0.33000000000000002 111.658 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -69.6 -42.26 74.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.918 -1.037 . . . . 1.52 112.127 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -99.72 111.94 62.7 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.42999999999999999 111.108 -175.105 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.509 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 1.9 Cg_endo -77.43 -11.87 17.19 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.831 2.354 . . . . 0.72999999999999998 113.126 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.425 HG23 ' N ' ' A' ' 96' ' ' GLY . 10.2 t -98.88 -43.58 6.68 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.468 -0.567 . . . . 0.47999999999999998 109.468 176.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.55 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 54.44 27.21 40.19 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.255 -1.339 . . . . 0.33000000000000002 114.228 168.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -84.59 111.86 19.91 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.988 0.899 . . . . 0.83999999999999997 109.363 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.692 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 22.4 m-85 -138.46 -176.9 4.62 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.66 -1.609 . . . . 0.22 111.661 -170.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.401 ' CE1' ' HG3' ' A' ' 54' ' ' PRO . 46.5 m-85 -143.96 144.12 31.55 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.974 0.416 . . . . 0.54000000000000004 110.552 -173.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.586 HD12 ' HB ' ' A' ' 161' ' ' THR . 82.3 mt -68.75 113.01 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.336 -0.847 . . . . 0.17000000000000001 109.995 168.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.568 HD12 ' C ' ' A' ' 22' ' ' PHE . 18.7 pt -80.65 -43.54 21.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.569 -0.741 . . . . 0.20999999999999999 112.552 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.824 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 52.1 m-80 -169.12 169.47 9.38 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.007 -1.479 . . . . 2.0299999999999998 107.007 -170.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.608 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -134.76 157.59 46.34 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.99 -0.684 . . . . 1.52 112.396 -177.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.524 ' NE2' ' HB3' ' A' ' 107' ' ' PRO . 29.8 tt0 -130.86 100.92 5.43 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.723 -1.126 . . . . 0.58999999999999997 109.85 174.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.459 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 52.0 ttt180 -61.45 165.31 4.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.35 -0.841 . . . . 2.8199999999999998 110.137 173.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.77 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 29.9 m-80 -34.99 100.91 0.2 Allowed Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 125.12 1.368 . . . . 0.34999999999999998 112.657 -156.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.524 ' HB3' ' NE2' ' A' ' 104' ' ' GLN . 19.7 Cg_endo . . . . . 0 N--CA 1.463 -0.308 0 C-N-CA 123.25 2.633 . . . . 0.47999999999999998 112.827 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.9 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . . . . . . 0 N--CA 1.439 -0.985 0 N-CA-C 110.221 -0.288 . . . . 0.47999999999999998 110.221 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.454 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -161.06 157.24 25.8 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.57 0.348 . . . . 0.28000000000000003 110.206 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -135.68 99.05 4.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.129 -1.063 . . . . 0.48999999999999999 108.129 165.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.608 HD23 ' HB3' ' A' ' 103' ' ' ARG . 2.7 mt -89.69 113.52 25.02 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.692 -0.855 . . . . 0.66000000000000003 108.692 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.497 ' O ' HG12 ' A' ' 101' ' ' ILE . 11.0 m -82.02 142.63 32.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.718 -0.674 . . . . 0.19 110.153 -171.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.722 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.3 mm? -108.14 163.81 12.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.282 -0.417 . . . . 0.13 111.725 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.3 t -57.6 -14.01 4.72 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 124.621 1.201 . . . . 1.1699999999999999 112.546 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.692 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 5.9 tmtm? -125.94 130.33 51.06 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.266 -0.574 . . . . 1.22 109.458 169.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.64 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 54.0 mt-30 -33.69 -60.29 0.37 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 125.438 1.711 . . . . 1.51 113.19 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.503 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -92.08 13.79 17.85 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.01 -0.676 . . . . 2.5299999999999998 112.412 -169.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.949 ' O ' HG12 ' A' ' 143' ' ' ILE . 2.5 m-30 -92.68 -35.13 13.66 Favored 'General case' 0 C--O 1.202 -1.441 0 CA-C-O 121.896 0.855 . . . . 0.83999999999999997 111.392 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.722 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -10.3 129.46 0.01 OUTLIER Glycine 0 C--N 1.286 -2.197 0 N-CA-C 119.414 2.526 . . . . 0.32000000000000001 119.414 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -98.43 116.52 41.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 112.538 -1.831 . . . . 0.17999999999999999 110.149 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.633 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.2 p80 -144.13 -175.82 4.76 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 112.762 0.653 . . . . 0.20999999999999999 112.762 -174.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.17 -166.73 36.98 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 111.651 -0.579 . . . . 0.27000000000000002 111.651 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.8 t -160.92 165.6 29.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 117.99 0.895 . . . . 0.40999999999999998 110.826 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -114.42 -2.04 13.34 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.806 -1.183 . . . . 1.99 107.806 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -123.73 96.47 43.07 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 114.187 -1.369 . . . . 1.3600000000000001 108.157 170.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -74.54 -20.32 18.14 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.238 1.958 . . . . 0.34999999999999998 112.767 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.53 -0.16 40.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.414 0.626 . . . . 0.33000000000000002 110.674 -176.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 43.0 t -91.94 -5.17 53.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.928 -0.767 . . . . 1.3500000000000001 108.928 170.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 30.6 mm -84.56 133.66 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.768 -0.651 . . . . 0.20999999999999999 110.498 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.1 1.45 69.84 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.804 -1.319 . . . . 0.14999999999999999 109.804 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 0.1 OUTLIER -113.69 161.79 17.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.913 1.34 . . . . 2.5 114.067 -176.023 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -95.85 129.04 43.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 112.244 -2.253 . . . . 0.17000000000000001 108.305 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 139' ' ' SER . 0.2 OUTLIER -126.02 165.07 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.618 -0.882 . . . . 0.66000000000000003 108.618 -175.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 66.0 m -50.02 -60.09 3.27 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.706 0.632 . . . . 0.42999999999999999 112.706 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.47 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -133.87 -43.2 0.81 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 118.414 -1.314 . . . . 2.02 113.802 -175.427 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.7 134.09 0.14 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 117.645 1.818 . . . . 0.17999999999999999 117.645 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 4.9 p -71.29 166.47 21.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 112.493 -1.853 . . . . 0.16 112.037 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.949 HG12 ' O ' ' A' ' 123' ' ' TYR . 9.3 mm -58.9 101.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 115.118 -0.946 . . . . 0.40000000000000002 111.622 -162.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.633 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 28.6 mtp85 -88.17 141.13 28.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.178 -0.919 . . . . 1.8700000000000001 109.279 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.631 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.2 mtp -120.01 -168.49 1.62 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.959 -0.756 . . . . 0.79000000000000004 108.959 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . 0.424 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 7.5 t-160 -88.89 155.52 19.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.414 -0.958 . . . . 2.3199999999999998 108.414 170.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.875 ' O ' HD13 ' A' ' 151' ' ' ILE . 7.9 m120 -73.38 -18.27 61.18 Favored 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 112.745 0.646 . . . . 0.68000000000000005 112.745 -172.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -82.02 -27.56 33.01 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 120.551 1.523 . . . . 2.1800000000000002 112.831 164.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.424 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 67.1 m-20 -82.57 -38.64 23.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.992 0.425 . . . . 0.68999999999999995 111.001 -173.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.659 HG13 HD12 ' A' ' 151' ' ' ILE . 12.2 p -67.22 -21.65 28.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.11 111.13 174.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.9 HD11 ' HB1' ' A' ' 113' ' ' ALA . 1.6 mp -84.6 -40.86 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 119.029 -0.51 . . . . 0.38 110.203 172.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 156' ' ' ILE . 4.4 mm-40 -44.7 -72.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.105 0.866 . . . . 1.99 112.203 168.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.587 ' O ' HG22 ' A' ' 157' ' ' VAL . 41.6 mt -46.32 -39.12 9.67 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.669 0.747 . . . . 1.27 111.644 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HB1' ' CE2' ' A' ' 114' ' ' TYR . . . -62.4 -37.66 86.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.159 -1.382 . . . . 0.17999999999999999 111.764 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 34.6 t -86.79 -33.16 19.99 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.581 0.586 . . . . 0.20999999999999999 112.581 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 152' ' ' GLU . 24.6 mt -81.24 -59.39 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.659 0.742 . . . . 0.16 111.367 -172.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.0 m -89.57 141.89 29.01 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.743 -1.117 . . . . 0.16 111.899 177.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -89.4 175.27 3.34 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.099 3.199 . . . . 0.20000000000000001 110.911 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.824 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.5 m-20 -65.38 158.63 26.07 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.831 -0.803 . . . . 1.1000000000000001 108.831 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 95.04 -17.9 58.41 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.108 -1.044 . . . . 0.17999999999999999 112.569 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.586 ' HB ' HD12 ' A' ' 100' ' ' ILE . 80.6 m -63.95 137.33 57.96 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.299 -0.63 . . . . 0.14000000000000001 109.299 -175.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.15 119.82 32.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 122.673 1.225 . . . . 3.6299999999999999 111.137 -168.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.5 t -104.42 110.86 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 112.4 -2.182 . . . . 0.14000000000000001 109.398 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.0 m -96.3 108.21 20.68 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 112.757 0.651 . . . . 0.20999999999999999 112.757 -173.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.55 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -81.28 106.64 12.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 122.198 0.999 . . . . 0.23999999999999999 109.905 177.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -112.36 123.65 50.76 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.42 -1.264 . . . . 1.0900000000000001 109.806 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.543 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 17.7 mmm180 . . . . . 0 C--N 1.318 -0.762 0 N-CA-C 109.707 -0.479 . . . . 2.0800000000000001 109.707 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.717 -0.553 . . . . 2.7999999999999998 111.717 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -112.86 155.23 25.02 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.826 0.346 . . . . 4.4400000000000004 110.248 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -91.59 102.32 14.96 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.979 -0.555 . . . . 2.46 110.147 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.654 HD21 ' HA ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -109.21 174.7 5.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.58 0.705 . . . . 0.65000000000000002 112.661 -172.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.9 tt -98.99 129.05 45.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.581 -1.19 . . . . 0.28000000000000003 110.466 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.32 162.18 13.45 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.076 0.941 . . . . 0.31 113.347 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 45' ' ' SER . 82.6 t80 -131.96 141.5 49.32 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.676 -1.602 . . . . 0.44 107.973 178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.433 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.9 tt0 -114.64 115.23 26.79 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.198 -1.038 . . . . 0.76000000000000001 108.198 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 13' ' ' ASP . 99.5 t -67.01 148.84 11.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 122.482 1.134 . . . . 0.39000000000000001 113.125 -172.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -103.1 158.84 16.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 113.171 -1.831 . . . . 2.0099999999999998 108.12 171.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -60.98 106.26 0.57 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 120.808 0.337 . . . . 1.8300000000000001 111.754 -175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.35 11.67 38.18 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.689 -0.767 . . . . 0.47999999999999998 113.553 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB2' HG13 ' A' ' 9' ' ' VAL . 65.3 m-20 -53.15 165.14 0.35 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.169 0.485 . . . . 1.46 111.646 172.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.1 147.69 47.72 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.43 0.633 . . . . 0.40999999999999998 111.171 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.534 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.89 -40.69 87.84 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.901 -1.045 . . . . 0.85999999999999999 108.446 -176.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -84.28 -18.08 37.58 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.576 -1.193 . . . . 1.1499999999999999 110.266 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.9 t -71.66 -43.31 66.3 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.151 -0.685 . . . . 1.21 109.151 170.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.423 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.0 mt -72.19 -27.66 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.37 0.605 . . . . 0.20999999999999999 109.502 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.07 -9.04 59.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.161 -0.472 . . . . 0.16 110.942 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.69 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.52 -40.79 8.48 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 122.631 1.205 . . . . 0.20999999999999999 107.965 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.1 m-20 -62.2 -45.8 91.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 112.417 -2.174 . . . . 0.53000000000000003 111.883 174.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.586 ' HA ' HG21 ' A' ' 101' ' ' ILE . 60.6 m-85 -96.23 5.63 50.59 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 118.624 -1.23 . . . . 0.17999999999999999 111.213 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.69 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.7 mpt_? 54.2 45.86 26.5 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.648 0.737 . . . . 1.78 109.772 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.616 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 37.1 pt -120.53 -165.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 114.671 -1.149 . . . . 0.19 110.206 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.91 142.94 40.55 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.998 -1.001 . . . . 0.94999999999999996 110.252 174.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.534 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 68.4 p -71.4 -33.38 69.43 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.914 -1.143 . . . . 0.25 107.914 177.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.01 68.08 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.443 -0.799 . . . . 0.20000000000000001 111.954 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.539 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.63 -27.73 16.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.717 0.77 . . . . 0.17000000000000001 109.198 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.576 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -74.83 -29.75 61.16 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 114.707 -1.133 . . . . 1.1599999999999999 109.357 174.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.551 HD23 ' HB2' ' A' ' 36' ' ' LEU . 48.2 mt -76.6 -33.02 58.44 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.83 0.824 . . . . 1.05 110.117 171.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 5.2 tt0 -61.49 -39.21 90.14 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.356 -1.293 . . . . 1.8100000000000001 109.522 172.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.632 ' HB1' HG13 ' A' ' 47' ' ' VAL . . . -86.47 -19.31 29.76 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 120.337 -0.545 . . . . 0.20000000000000001 112.217 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.633 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 26.4 m-80 -149.61 81.32 7.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.359 0.6 . . . . 0.23000000000000001 110.448 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.417 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 18.1 Cg_endo -56.63 -14.74 13.97 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 124.328 3.352 . . . . 0.35999999999999999 114.054 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -73.69 -23.92 59.88 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.16 -0.337 . . . . 1.3799999999999999 111.766 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.899 HD21 HG21 ' A' ' 46' ' ' ILE . 29.0 mt -67.91 -37.14 81.34 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.346 0.593 . . . . 0.48999999999999999 112.199 -170.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 1.6 pp0? -63.43 -44.14 95.44 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-O 123.01 1.386 . . . . 1.95 110.764 -173.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.3 -47.71 81.13 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 111.722 -2.49 . . . . 0.48999999999999999 110.705 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.57 48.44 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 114.887 -1.051 . . . . 0.41999999999999998 111.488 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.94 157.83 20.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.424 0.631 . . . . 0.40999999999999998 111.217 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.623 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 58.1 m -139.09 128.9 24.84 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.118 -0.946 . . . . 0.41999999999999998 110.193 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.96 120.44 21.3 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.035 -0.666 . . . . 0.46999999999999997 109.916 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 97.73 2.44 58.53 Favored Glycine 0 N--CA 1.432 -1.608 0 N-CA-C 110.365 -1.094 . . . . 0.40999999999999998 110.365 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.623 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.3 OUTLIER -78.15 124.53 28.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.228 -0.656 . . . . 1.3 109.228 178.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 37.4 p -81.48 124.12 29.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.956 0.884 . . . . 0.84999999999999998 110.842 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.899 HG21 HD21 ' A' ' 36' ' ' LEU . 1.4 pp -129.87 132.8 65.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 113.933 -1.485 . . . . 0.25 108.974 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.632 HG13 ' HB1' ' A' ' 32' ' ' ALA . 14.7 p -93.79 163.65 2.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 114.857 -1.065 . . . . 0.67000000000000004 111.025 -169.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.481 HG13 ' CE2' ' A' ' 22' ' ' PHE . 39.3 mm -121.24 102.48 43.13 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 114.698 -1.137 . . . . 0.16 109.894 -173.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.654 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -66.27 135.85 41.56 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.928 1.752 . . . . 0.17999999999999999 112.341 -175.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.45 -5.94 80.52 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.065 -0.97 . . . . 0.26000000000000001 112.42 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.701 HD12 ' HD2' ' A' ' 52' ' ' PRO . 36.1 tp -122.72 116.1 29.28 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-O 121.218 0.532 . . . . 0.60999999999999999 111.408 -177.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.701 ' HD2' HD12 ' A' ' 51' ' ' LEU . 53.5 Cg_endo -78.12 -176.91 3.5 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.918 3.079 . . . . 0.28000000000000003 114.362 -171.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.613 ' HB3' HG23 ' A' ' 56' ' ' THR . 8.9 t70 -84.96 128.02 62.16 Favored Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-N 114.302 -1.317 . . . . 0.48999999999999999 111.975 -169.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 37.4 Cg_endo -69.94 -18.19 36.3 Favored 'Trans proline' 0 CA--C 1.519 -0.248 0 C-N-CA 123.619 2.879 . . . . 0.46000000000000002 112.69 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.411 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 69.3 m-85 -96.09 2.36 53.17 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.529 0.681 . . . . 1.3799999999999999 111.451 -173.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 53' ' ' ASP . 18.5 p -98.45 -20.58 17.03 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.897 -1.149 . . . . 0.46000000000000002 107.897 171.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 59' ' ' TYR . 19.4 mt -73.17 133.02 81.66 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 113.254 -1.794 . . . . 0.69999999999999996 111.335 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.42 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 92.4 Cg_endo -79.33 -15.86 12.42 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.381 2.054 . . . . 0.39000000000000001 113.883 -178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.604 ' H ' HG22 ' A' ' 57' ' ' ILE . 50.7 m-85 -104.09 164.04 11.98 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 113.023 0.749 . . . . 0.23999999999999999 113.023 -176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -147.67 139.48 24.04 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 114.982 -1.008 . . . . 2.8900000000000001 108.795 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.671 ' HA ' ' O ' ' A' ' 71' ' ' THR . 79.2 mt -116.09 132.27 66.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.316 -0.402 . . . . 0.16 111.718 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.23 116.57 27.51 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 119.897 -0.721 . . . . 0.16 111.122 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 65.0 t -98.57 112.99 32.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.647 0.737 . . . . 0.19 111.163 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 68' ' ' LYS . 53.3 m -95.74 100.87 12.53 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.893 -1.049 . . . . 0.20000000000000001 110.748 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.58 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.1 mm -48.93 -58.76 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.987 0.899 . . . . 0.23000000000000001 111.788 171.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.58 -9.38 3.44 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 112.925 -1.943 . . . . 0.16 113.055 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.57 -19.57 4.55 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.581 0.752 . . . . 0.14999999999999999 112.087 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.519 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.68 55.93 4.47 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.27 0.486 . . . . 0.68999999999999995 111.236 -173.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.7 p -137.24 159.67 41.26 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 112.861 0.689 . . . . 0.13 112.861 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.503 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.7 tt -126.77 112.58 15.56 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.559 -1.2 . . . . 0.40000000000000002 110.004 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.671 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 29.6 m -93.62 122.4 36.04 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.226 0.536 . . . . 0.16 111.288 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.5 tp -98.0 103.74 15.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.003 -0.998 . . . . 0.58999999999999997 109.464 172.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 82.2 p -105.75 161.11 14.7 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 119.086 -1.045 . . . . 1.05 110.612 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.77 HD13 HD22 ' A' ' 75' ' ' ASN . 0.9 OUTLIER -127.08 128.23 45.93 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.541 -0.911 . . . . 0.26000000000000001 108.541 170.285 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.77 HD22 HD13 ' A' ' 74' ' ' LEU . 7.9 p30 43.8 51.15 6.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 114.303 -1.317 . . . . 1.8400000000000001 111.892 -166.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.7 t30 74.76 -13.19 0.85 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.1 -0.954 . . . . 1.8899999999999999 111.382 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -95.76 121.37 37.41 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.92 -0.582 . . . . 3.4399999999999999 109.888 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 78.0 t -59.55 132.48 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 122.362 1.077 . . . . 0.23999999999999999 112.499 -173.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 18.3 mtm -100.55 -46.91 5.05 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 113.022 -1.899 . . . . 0.81000000000000005 108.805 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -155.56 172.97 17.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.42 -1.718 . . . . 1.46 110.019 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 78.6 m -148.75 123.02 9.58 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.082 -1.417 . . . . 0.17000000000000001 109.783 173.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -108.01 145.34 31.22 Favored Pre-proline 0 C--N 1.313 -1.004 0 CA-C-N 115.487 -0.779 . . . . 1.05 109.274 -176.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.435 ' HB2' HG22 ' A' ' 134' ' ' ILE . 42.7 Cg_endo -74.94 141.96 27.47 Favored 'Trans proline' 0 CA--C 1.499 -1.238 0 C-N-CA 122.031 1.82 . . . . 0.20000000000000001 111.285 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.668 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.44 175.09 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.92 -0.582 . . . . 0.13 111.051 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.876 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.13 147.32 44.31 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.306 -0.406 . . . . 0.26000000000000001 110.15 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.519 HG22 ' HG3' ' A' ' 68' ' ' LYS . 11.4 m -129.64 128.44 65.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.47 0.653 . . . . 0.56000000000000005 112.004 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -89.06 157.9 27.53 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 110.624 -0.99 . . . . 0.17000000000000001 110.624 173.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -56.37 2.68 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.309 0.855 . . . . 3.0499999999999998 113.309 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.927 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -89.9 -20.52 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-O 121.83 0.824 . . . . 0.23000000000000001 110.149 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.927 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -90.85 -19.53 23.29 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.442 -0.799 . . . . 0.17999999999999999 109.211 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.1 p -66.74 -16.51 64.29 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.419 -1.264 . . . . 0.33000000000000002 111.715 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -64.64 -42.32 95.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.841 -1.072 . . . . 1.52 112.343 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.31 119.42 56.39 Favored Pre-proline 0 C--N 1.325 -0.482 0 C-N-CA 120.574 -0.45 . . . . 0.42999999999999999 110.966 -175.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.445 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 1.1 Cg_endo -78.8 -1.92 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.839 2.359 . . . . 0.72999999999999998 113.239 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 96' ' ' GLY . 11.0 t -119.73 -42.46 2.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.838 0.351 . . . . 0.47999999999999998 110.408 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.478 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.68 38.87 22.84 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 114.717 -1.129 . . . . 0.33000000000000002 114.063 168.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.485 ' HG2' HG23 ' A' ' 164' ' ' THR . 45.9 mt-10 -83.86 113.02 20.65 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.969 0.89 . . . . 0.83999999999999997 109.606 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.683 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 23.6 m-85 -137.61 176.15 8.97 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.909 -1.496 . . . . 0.22 111.914 -170.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.622 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 82.7 m-85 -140.95 136.9 32.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.243 -0.435 . . . . 0.54000000000000004 110.603 -173.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.579 HD12 ' HB ' ' A' ' 161' ' ' THR . 81.6 mt -61.24 117.56 2.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.23 -0.895 . . . . 0.17000000000000001 110.816 172.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.586 HG21 ' HA ' ' A' ' 22' ' ' PHE . 20.8 pt -84.5 -35.43 10.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 112.766 0.654 . . . . 0.20999999999999999 112.766 -176.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.477 ' ND2' HG13 ' A' ' 101' ' ' ILE . 9.3 p30 178.82 179.18 0.41 Allowed 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.32 -1.363 . . . . 2.0299999999999998 107.32 -176.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.16 155.58 49.4 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.873 -0.731 . . . . 1.52 112.303 -174.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -128.21 100.69 5.94 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.048 -0.978 . . . . 0.58999999999999997 109.872 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.496 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 71.2 ttt180 -62.77 166.31 5.66 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.162 -0.926 . . . . 2.8199999999999998 110.693 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.512 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 18.1 m-80 -34.75 102.97 0.23 Allowed Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 125.189 1.395 . . . . 0.34999999999999998 113.195 -155.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.512 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.8 Cg_endo -60.2 -39.64 66.81 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.045 2.496 . . . . 0.47999999999999998 111.695 174.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.32 -37.63 2.9 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.295 -0.722 . . . . 0.67000000000000004 111.295 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.62 -176.31 48.94 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.225 -0.487 . . . . 0.62 112.813 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.69 5.16 0.12 Allowed 'Trans proline' 0 N--CA 1.485 1.012 1 C-N-CA 125.454 4.103 . . . . 0.93999999999999995 115.801 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -70.37 10.13 0.51 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.295 0.479 . . . . 1.23 112.295 -174.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.728 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 75.84 64.34 2.26 Favored Glycine 0 CA--C 1.501 -0.832 0 C-N-CA 119.649 -1.263 . . . . 1.6899999999999999 115.211 171.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.527 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 39.31 -2.2 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 117.177 2.288 . . . . 0.47999999999999998 117.177 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.496 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -165.4 158.41 16.02 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 121.204 -0.935 . . . . 0.28000000000000003 110.297 -175.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 20.9 t-105 -138.54 98.1 3.51 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.241 -1.022 . . . . 0.48999999999999999 108.241 167.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.533 HD23 ' HB3' ' A' ' 103' ' ' ARG . 2.4 mt -89.02 114.27 25.46 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.033 -0.728 . . . . 0.66000000000000003 109.033 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.418 ' C ' HG12 ' A' ' 101' ' ' ILE . 20.0 m -85.24 143.58 28.65 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.808 -0.633 . . . . 0.19 111.424 -169.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.794 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.9 mm? -108.3 166.4 10.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.13 111.7 -177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.0 t -60.52 -13.27 12.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.793 -1.094 . . . . 1.1699999999999999 112.816 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.683 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 4.9 tptm -126.27 130.27 50.54 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 120.492 -0.483 . . . . 1.22 110.138 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 52.9 mt-30 -34.44 -57.61 0.5 Allowed 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.548 1.155 . . . . 1.51 113.994 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.534 ' CB ' HG12 ' A' ' 89' ' ' ILE . 32.5 m-70 -88.91 -1.78 58.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.317 0.58 . . . . 2.5299999999999998 111.635 -171.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.794 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -91.31 38.16 0.96 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.523 0.934 . . . . 0.83999999999999997 113.523 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.62 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -112.97 145.08 18.19 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 117.222 -2.418 . . . . 0.32000000000000001 112.783 -152.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.528 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -98.69 116.32 41.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 123.739 0.816 . . . . 0.17999999999999999 110.833 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.637 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 27.5 p80 -145.62 171.15 15.12 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.229 -0.896 . . . . 0.20999999999999999 109.585 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.728 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.1 -168.62 39.19 Favored Glycine 0 C--N 1.316 -0.563 0 C-N-CA 120.107 -1.044 . . . . 0.27000000000000002 111.51 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.513 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 15.0 t -153.23 175.0 13.55 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.962 -0.728 . . . . 0.40999999999999998 110.27 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -116.79 0.41 12.52 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.61 -0.885 . . . . 1.99 108.61 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -118.9 86.75 31.74 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 114.928 -1.033 . . . . 1.3600000000000001 108.476 172.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -72.72 -17.52 25.91 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.293 1.996 . . . . 0.34999999999999998 113.283 -169.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.37 -1.1 35.5 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.968 -0.56 . . . . 0.33000000000000002 111.094 -177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.476 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 98.1 p -91.57 -6.8 51.78 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.983 -0.747 . . . . 1.3500000000000001 108.983 170.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 44.2 mm -80.49 136.42 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.54 -0.755 . . . . 0.20999999999999999 110.217 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.61 80.14 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.906 -1.277 . . . . 0.14999999999999999 109.906 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 5.7 tttt -111.67 161.64 16.05 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 122.952 1.358 . . . . 2.5 113.743 -176.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.429 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -97.44 124.27 41.58 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 112.193 -2.276 . . . . 0.17000000000000001 107.659 175.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.442 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -120.74 160.86 21.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.894 -0.78 . . . . 0.66000000000000003 108.894 -173.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.9 m -51.5 -58.76 5.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.688 0.625 . . . . 0.42999999999999999 112.688 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -132.56 -43.32 0.92 Allowed 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 118.329 -1.348 . . . . 2.02 113.555 -176.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.453 ' N ' ' HD3' ' A' ' 140' ' ' LYS . . . -31.5 133.23 0.14 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 116.958 1.543 . . . . 0.17999999999999999 116.958 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . . . . . . . . . 2.7 p -74.5 164.84 26.12 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.489 -1.855 . . . . 0.16 111.571 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.876 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.0 mt -59.9 98.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 122.48 1.133 . . . . 0.40000000000000002 112.111 -162.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.637 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 79.9 mtt180 -84.33 151.66 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.601 -1.636 . . . . 1.8700000000000001 110.537 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.668 ' HG2' HG22 ' A' ' 84' ' ' ILE . 14.7 mtp -130.94 -166.57 1.71 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.799 -0.637 . . . . 0.79000000000000004 109.333 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.643 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 15.8 t-80 -97.81 152.89 18.7 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.825 -0.806 . . . . 2.3199999999999998 108.825 172.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.616 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.3 m120 -56.17 -53.39 57.63 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 118.247 -0.882 . . . . 0.68000000000000005 110.629 -175.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -64.66 -24.18 67.5 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 121.6 2.0 . . . . 2.1800000000000002 112.04 -175.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.643 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 4.6 m-20 -81.59 -43.36 18.77 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.661 -0.7 . . . . 0.68999999999999995 110.818 -176.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.637 HG13 HD12 ' A' ' 151' ' ' ILE . 14.6 p -68.58 -23.03 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.731 -0.668 . . . . 0.11 111.297 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.637 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.68 -37.9 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 119.062 -0.494 . . . . 0.38 110.091 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.458 ' O ' HG13 ' A' ' 156' ' ' ILE . 9.3 mm-40 -45.09 -72.71 0.05 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 119.279 0.945 . . . . 1.99 112.022 167.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 157' ' ' VAL . 52.4 mt -46.81 -40.42 13.73 Favored 'General case' 0 C--O 1.223 -0.324 0 O-C-N 123.85 0.719 . . . . 1.27 111.479 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.73 -37.07 80.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.119 -1.4 . . . . 0.17999999999999999 111.758 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.0 t -88.16 -31.94 18.88 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.51 -0.744 . . . . 0.20999999999999999 112.506 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.2 mt -81.07 -59.94 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.561 0.695 . . . . 0.16 111.561 -172.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.1 m -89.38 142.96 30.11 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 114.871 -1.059 . . . . 0.16 112.097 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -90.72 175.03 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 124.015 3.143 . . . . 0.20000000000000001 110.939 172.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.416 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 37.1 m-20 -65.99 157.86 29.74 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 119.655 -0.818 . . . . 1.1000000000000001 109.078 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.35 -18.53 57.31 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.119 -1.038 . . . . 0.17999999999999999 112.423 -174.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' HD12 ' A' ' 100' ' ' ILE . 78.2 m -65.12 138.89 58.58 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.035 -0.728 . . . . 0.14000000000000001 109.035 -176.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.622 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 11.3 ptm180 -92.44 127.25 37.86 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.741 1.258 . . . . 3.6299999999999999 111.211 -170.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.4 t -109.02 107.45 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 112.088 -2.324 . . . . 0.14000000000000001 108.631 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.485 HG23 ' HG2' ' A' ' 97' ' ' GLU . 13.8 m -94.35 104.72 16.7 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 112.49 0.552 . . . . 0.20999999999999999 112.49 -171.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.478 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -83.36 96.47 4.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 122.342 1.068 . . . . 0.23999999999999999 109.955 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -107.6 132.49 53.23 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.009 -1.451 . . . . 1.0900000000000001 109.215 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.58 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 19.2 mmm180 -65.68 -30.77 71.5 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.2 -0.667 . . . . 2.0800000000000001 109.2 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.59 -93.88 0.93 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.055 -0.975 . . . . 1.97 112.414 173.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--N 1.322 -0.62 0 N-CA-C 109.804 -0.443 . . . . 3.9100000000000001 109.804 178.751 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.908 -0.477 . . . . 2.7999999999999998 111.908 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -153.35 152.78 31.48 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.71 -0.478 . . . . 4.4400000000000004 109.71 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -97.57 114.9 26.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.923 0.392 . . . . 2.46 110.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp -101.85 175.37 5.57 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.75 -0.659 . . . . 0.65000000000000002 111.392 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.667 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.0 tt -92.12 130.08 37.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.284 -0.871 . . . . 0.28000000000000003 110.445 -175.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.33 162.14 13.33 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 122.36 1.076 . . . . 0.31 113.239 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.64 ' O ' ' HA ' ' A' ' 45' ' ' SER . 72.0 t80 -131.96 142.25 49.56 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 113.294 -1.776 . . . . 0.44 107.89 175.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.491 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 33.8 tt0 -113.25 112.71 24.2 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.091 -1.078 . . . . 0.76000000000000001 108.091 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.632 HG13 ' HB2' ' A' ' 13' ' ' ASP . 96.1 t -66.67 151.35 10.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.364 1.078 . . . . 0.39000000000000001 112.74 -170.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -106.58 158.21 17.1 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.431 -1.713 . . . . 2.0099999999999998 108.372 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.23 107.68 0.51 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.782 0.325 . . . . 1.8300000000000001 111.819 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.67 11.77 46.23 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.857 -0.687 . . . . 0.47999999999999998 113.895 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.632 ' HB2' HG13 ' A' ' 9' ' ' VAL . 68.9 m-20 -54.46 170.16 0.16 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 117.181 0.49 . . . . 1.46 111.391 172.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -129.23 152.07 49.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.086 0.469 . . . . 0.40999999999999998 111.603 176.136 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.597 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.03 -36.37 83.07 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.044 -0.98 . . . . 0.85999999999999999 108.574 -177.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.475 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 4.5 t30 -87.62 -26.04 23.26 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.764 -1.107 . . . . 1.1499999999999999 110.552 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.423 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 13.0 t -66.05 -40.92 91.33 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.515 -0.55 . . . . 1.21 109.515 174.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.477 HG23 ' CE1' ' A' ' 22' ' ' PHE . 13.8 mt -73.86 -28.15 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.116 0.484 . . . . 0.20999999999999999 109.783 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.644 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.43 -11.37 59.91 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.699 -0.4 . . . . 0.16 110.896 176.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.723 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -93.12 -40.98 10.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.406 0.622 . . . . 0.20999999999999999 109.784 174.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.643 ' HB3' ' O ' ' A' ' 119' ' ' SER . 23.0 m-20 -63.42 -42.87 98.73 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.485 -1.234 . . . . 0.53000000000000003 111.922 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.532 ' HA ' HG21 ' A' ' 101' ' ' ILE . 47.8 m-85 -96.33 4.85 51.99 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 118.597 -1.241 . . . . 0.17999999999999999 111.112 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.723 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER 54.51 40.77 32.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.961 0.886 . . . . 1.78 109.418 176.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.644 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.6 pt -114.3 -165.52 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.102 -1.408 . . . . 0.19 109.86 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.48 142.91 41.58 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.205 -0.907 . . . . 0.94999999999999996 110.212 175.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.537 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 71.4 p -73.21 -32.72 64.95 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.057 -1.09 . . . . 0.25 108.057 178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.7 -27.06 67.6 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.182 -0.917 . . . . 0.20000000000000001 111.796 170.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.95 -27.28 16.45 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.972 -0.751 . . . . 0.17000000000000001 108.972 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.653 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 17.8 tp -74.71 -26.2 59.65 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.298 -0.865 . . . . 1.1599999999999999 109.331 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 26' ' ' THR . 35.9 mt -77.31 -29.98 53.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.695 0.759 . . . . 1.05 110.076 171.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.479 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 4.7 tt0 -65.14 -41.63 94.58 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.393 -1.276 . . . . 1.8100000000000001 110.103 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.27 -20.67 31.8 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 119.937 -0.705 . . . . 0.20000000000000001 111.594 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.65 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.8 m-80 -147.15 80.67 9.25 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 121.615 0.721 . . . . 0.23000000000000001 110.693 -172.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.8 Cg_endo -56.79 -14.89 14.87 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 C-N-CA 124.099 3.199 . . . . 0.35999999999999999 114.199 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.2 t -79.59 -20.9 45.79 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.809 -0.356 . . . . 1.3799999999999999 111.115 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.825 HD21 HG21 ' A' ' 46' ' ' ILE . 67.6 mt -65.31 -39.19 92.18 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.542 0.687 . . . . 0.48999999999999999 111.826 -172.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 5.9 pt20 -64.05 -44.59 91.98 Favored 'General case' 0 CA--C 1.494 -1.181 0 CA-C-O 122.88 1.324 . . . . 1.95 110.251 -174.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.05 -50.15 74.43 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 111.795 -2.457 . . . . 0.48999999999999999 110.439 176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.23 175.16 46.97 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 114.779 -1.101 . . . . 0.41999999999999998 111.74 177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -107.9 155.99 19.67 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.229 0.538 . . . . 0.40999999999999998 110.876 178.178 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.644 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 34.5 m -139.46 128.64 23.9 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.218 -0.901 . . . . 0.41999999999999998 110.513 -175.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 119.99 20.71 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.634 0.731 . . . . 0.46999999999999997 110.396 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.491 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 98.13 0.73 58.44 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 114.738 -1.119 . . . . 0.40999999999999998 110.325 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.644 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.2 tt0 -74.8 123.41 24.95 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.672 -0.764 . . . . 1.3 109.654 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 54.8 p -82.34 128.49 34.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.776 0.798 . . . . 0.84999999999999998 110.067 176.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.825 HG21 HD21 ' A' ' 36' ' ' LEU . 9.0 pt -128.52 142.35 44.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 114.306 -1.316 . . . . 0.25 109.477 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.77 151.27 3.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.208 0.527 . . . . 0.67000000000000004 111.019 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.1 mm -115.13 92.71 32.46 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 114.842 -1.072 . . . . 0.16 109.439 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.673 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.4 Cg_endo -58.46 134.89 64.13 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.812 2.341 . . . . 0.17999999999999999 112.693 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.03 -4.06 81.09 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 114.948 -1.023 . . . . 0.26000000000000001 112.405 -176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.696 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.7 tp -129.28 117.97 19.07 Favored Pre-proline 0 N--CA 1.446 -0.638 0 CA-C-O 121.223 0.535 . . . . 0.60999999999999999 111.341 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.685 ' HD2' HD12 ' A' ' 51' ' ' LEU . 55.5 Cg_endo -79.23 -177.96 4.27 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.585 2.857 . . . . 0.28000000000000003 114.155 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.613 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.4 t0 -80.72 126.64 77.55 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.513 -1.222 . . . . 0.48999999999999999 111.542 -171.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 60.5 Cg_endo -73.22 -16.73 24.92 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.204 2.603 . . . . 0.46000000000000002 112.459 -177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -89.22 -10.33 47.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.842 -0.617 . . . . 1.3799999999999999 110.438 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 53' ' ' ASP . 25.1 p -88.15 -23.35 23.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.535 1.159 . . . . 0.46000000000000002 108.427 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 59' ' ' TYR . 15.3 mt -72.94 129.51 86.42 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 112.973 -1.922 . . . . 0.69999999999999996 111.354 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.69 -19.73 14.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.336 2.024 . . . . 0.39000000000000001 113.386 -178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.512 ' H ' HG22 ' A' ' 57' ' ' ILE . 60.5 m-85 -91.91 158.68 16.16 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.546 -0.462 . . . . 0.23999999999999999 111.558 -176.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -148.77 129.87 14.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.026 -0.731 . . . . 2.8900000000000001 109.026 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.5 mt -111.38 130.96 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.946 -0.57 . . . . 0.16 111.609 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.96 119.88 38.02 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 120.001 -0.68 . . . . 0.16 111.028 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -98.85 116.42 41.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.446 0.641 . . . . 0.19 110.833 175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 68' ' ' LYS . 69.0 m -95.81 104.27 16.2 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.011 -0.995 . . . . 0.20000000000000001 110.8 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.534 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.9 mm -51.64 -59.38 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.937 0.875 . . . . 0.23000000000000001 111.59 168.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.82 -11.94 4.72 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 113.051 -1.886 . . . . 0.16 113.18 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -126.18 -18.87 4.87 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.369 0.668 . . . . 0.14999999999999999 112.444 -177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.522 ' HG2' ' C ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER 58.89 54.97 4.79 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.522 0.601 . . . . 0.68999999999999995 111.26 -173.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.5 p -136.77 160.99 37.19 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 112.811 0.671 . . . . 0.13 112.811 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.433 HD23 ' C ' ' A' ' 70' ' ' LEU . 8.1 tt -129.04 113.51 15.23 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.765 -1.107 . . . . 0.40000000000000002 110.044 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.699 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.4 m -93.77 123.67 37.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.976 0.417 . . . . 0.16 111.337 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.8 tp -98.78 104.92 17.01 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.58 -0.737 . . . . 0.58999999999999997 109.434 171.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.6 m -104.96 159.61 15.67 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.541 -0.863 . . . . 1.05 110.519 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -127.88 127.26 43.09 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 108.903 -0.777 . . . . 0.26000000000000001 108.903 168.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.558 ' N ' HD22 ' A' ' 74' ' ' LEU . 46.4 m-80 48.21 50.36 16.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.584 -1.189 . . . . 1.8400000000000001 111.076 -171.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 71.9 -10.03 0.91 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.755 0.822 . . . . 1.8899999999999999 111.662 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -96.43 120.52 36.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.067 -0.515 . . . . 3.4399999999999999 109.893 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 55.8 t -59.31 131.58 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 CA-C-O 122.295 1.045 . . . . 0.23999999999999999 112.017 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 5.4 mtm -103.08 -43.85 5.37 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.342 -1.754 . . . . 0.81000000000000005 109.368 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -157.94 170.69 21.75 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.264 -1.789 . . . . 1.46 110.209 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 83.5 m -149.38 128.03 12.41 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.129 -1.396 . . . . 0.17000000000000001 109.517 173.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -115.94 147.46 39.22 Favored Pre-proline 0 C--N 1.313 -0.979 0 CA-C-N 116.243 -0.435 . . . . 1.05 110.729 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HB2' HG22 ' A' ' 134' ' ' ILE . 36.8 Cg_endo -71.86 144.33 43.16 Favored 'Trans proline' 0 CA--C 1.491 -1.645 0 C-N-CA 122.333 2.022 . . . . 0.20000000000000001 110.284 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.595 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.3 pp -139.34 166.33 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-N 115.902 -0.59 . . . . 0.13 110.797 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.819 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -112.85 128.17 56.38 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.732 -0.84 . . . . 0.26000000000000001 108.732 -176.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.413 HG12 ' HD2' ' A' ' 68' ' ' LYS . 1.7 p -124.15 130.93 73.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-N 114.076 -1.42 . . . . 0.56000000000000005 111.168 -162.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -96.03 151.05 19.82 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 114.277 -1.329 . . . . 0.17000000000000001 111.896 -175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 139' ' ' SER . 45.7 mmtm -57.71 2.7 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.525 -0.838 . . . . 3.0499999999999998 113.145 176.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.882 HG23 HD22 ' A' ' 90' ' ' LEU . 1.6 tp -89.79 -19.65 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.725 0.774 . . . . 0.23000000000000001 110.27 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.882 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -88.4 -11.56 45.75 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.396 -0.82 . . . . 0.17999999999999999 109.431 -177.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -70.11 -16.53 63.13 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.952 -1.022 . . . . 0.33000000000000002 111.55 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -71.83 -27.33 62.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.8 -1.091 . . . . 1.52 112.972 -172.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.8 130.7 22.64 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 119.976 -0.69 . . . . 0.42999999999999999 110.771 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.46 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 89.9 Cg_endo -88.48 -2.24 6.74 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.707 2.271 . . . . 0.72999999999999998 112.357 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 96' ' ' GLY . 13.6 t -122.99 -41.83 2.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.884 -0.598 . . . . 0.47999999999999998 109.634 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 47.16 42.79 17.47 Favored Glycine 0 N--CA 1.45 -0.377 0 O-C-N 123.832 0.708 . . . . 0.33000000000000002 113.89 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -84.84 112.64 20.72 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 121.729 0.776 . . . . 0.83999999999999997 109.484 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.756 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 25.2 m-85 -137.06 177.76 7.61 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.158 -1.383 . . . . 0.22 111.985 -170.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.491 ' CG ' HD11 ' A' ' 5' ' ' LEU . 21.2 m-85 -140.4 143.05 35.46 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.54000000000000004 110.521 -174.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.599 HD12 ' HB ' ' A' ' 161' ' ' THR . 76.6 mt -66.98 113.72 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 115.488 -0.778 . . . . 0.17000000000000001 110.132 169.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.559 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 26.0 pt -84.33 -34.25 9.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 112.967 0.728 . . . . 0.20999999999999999 112.967 -175.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.501 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 10.0 p30 179.97 177.79 0.63 Allowed 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.488 -1.301 . . . . 2.0299999999999998 107.488 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.456 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.11 153.81 50.44 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 120.177 -0.609 . . . . 1.52 111.959 -175.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -125.38 100.97 6.74 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.097 -0.956 . . . . 0.58999999999999997 109.655 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.491 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 34.1 ttp180 -60.85 166.33 3.46 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.151 -0.931 . . . . 2.8199999999999998 110.59 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.491 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 20.6 m-80 -34.86 102.33 0.22 Allowed Pre-proline 0 C--N 1.332 -0.166 0 C-N-CA 124.997 1.319 . . . . 0.34999999999999998 113.33 -155.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.488 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 8.6 Cg_endo -58.36 -39.3 85.36 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.075 2.517 . . . . 0.47999999999999998 111.365 174.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.95 -41.15 2.07 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 110.807 -0.917 . . . . 0.67000000000000004 110.807 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.4 -176.99 36.82 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 121.055 -0.593 . . . . 0.62 112.46 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.6 5.36 0.2 Allowed 'Trans proline' 0 N--CA 1.481 0.743 1 C-N-CA 125.322 4.015 . . . . 0.93999999999999995 115.635 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -70.24 8.73 0.71 Allowed 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.363 0.505 . . . . 1.23 112.363 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.724 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 80.8 64.03 1.85 Allowed Glycine 0 CA--C 1.498 -1.001 0 C-N-CA 119.729 -1.224 . . . . 1.6899999999999999 115.456 169.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.515 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 37.75 0.31 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 117.216 2.302 . . . . 0.47999999999999998 117.216 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.477 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.3 OUTLIER -165.69 164.76 18.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.426 -0.796 . . . . 0.28000000000000003 109.929 -177.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.5 t-105 -145.09 96.72 2.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 108.054 -1.091 . . . . 0.48999999999999999 108.054 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.528 HD12 HG23 ' A' ' 150' ' ' VAL . 2.0 mt -87.28 114.12 23.6 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.24 -0.652 . . . . 0.66000000000000003 109.24 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 101' ' ' ILE . 27.1 m -83.48 143.89 29.93 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.684 -0.689 . . . . 0.19 111.044 -170.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.797 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -108.99 165.26 11.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.032 -0.531 . . . . 0.13 110.789 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.643 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 8.8 m -64.73 -1.8 2.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.171 0.804 . . . . 1.1699999999999999 113.171 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.757 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 3.6 tmtm? -129.71 132.19 46.56 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 109.958 -0.386 . . . . 1.22 109.958 167.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.757 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 55.5 mt-30 -33.27 -57.97 0.4 Allowed 'General case' 0 C--N 1.309 -1.17 0 O-C-N 124.692 1.245 . . . . 1.51 114.324 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.621 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -94.51 5.04 53.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.315 0.578 . . . . 2.5299999999999998 111.423 -170.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.797 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -94.8 37.42 1.14 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.504 0.927 . . . . 0.83999999999999997 113.504 -174.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.598 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -113.23 144.2 18.02 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 116.963 -2.542 . . . . 0.32000000000000001 112.749 -152.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.518 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -96.79 115.13 35.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.895 0.855 . . . . 0.17999999999999999 110.644 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.734 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.9 p80 -144.96 173.48 11.84 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.262 -0.881 . . . . 0.20999999999999999 109.648 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.724 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.26 -168.03 38.73 Favored Glycine 0 C--O 1.223 -0.582 0 C-N-CA 120.252 -0.975 . . . . 0.27000000000000002 111.57 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.48 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 12.2 t -155.01 172.06 18.73 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.942 -0.74 . . . . 0.40999999999999998 110.756 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -114.08 -2.06 13.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.961 0.886 . . . . 1.99 108.652 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -115.92 86.55 16.65 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 114.754 -1.112 . . . . 1.3600000000000001 108.09 170.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -73.3 -19.47 22.3 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.225 1.95 . . . . 0.34999999999999998 113.191 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.27 -2.72 42.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.788 -0.642 . . . . 0.33000000000000002 110.869 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 33.4 t -90.25 -6.79 54.8 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.275 -0.639 . . . . 1.3500000000000001 109.275 171.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.421 HG22 ' HB2' ' A' ' 83' ' ' PRO . 38.2 mm -78.6 132.48 32.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-N 115.855 -0.611 . . . . 0.20999999999999999 111.209 -178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.61 1.84 63.65 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 110.109 -1.196 . . . . 0.14999999999999999 110.109 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.522 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 23.9 mttp -112.44 169.96 8.51 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 122.798 1.285 . . . . 2.5 114.047 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.17 126.56 44.98 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 112.317 -2.22 . . . . 0.17000000000000001 108.248 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.56 158.66 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.473 -0.936 . . . . 0.66000000000000003 108.473 -176.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 49.4 m -51.46 -59.29 4.41 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.286 0.476 . . . . 0.42999999999999999 112.286 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 ptmm? -131.17 -44.59 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.628 -1.229 . . . . 2.02 113.813 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.29 133.58 0.19 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 116.999 1.56 . . . . 0.17999999999999999 116.999 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.453 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.8 p -73.23 166.06 23.86 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.519 -1.84 . . . . 0.16 112.13 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.819 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 44.7 mt -59.75 96.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 122.406 1.098 . . . . 0.40000000000000002 112.027 -163.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.734 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 79.1 mtt180 -86.08 146.75 26.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.53 -1.668 . . . . 1.8700000000000001 110.724 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.595 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.1 mtp -126.45 -164.82 1.37 Allowed 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.901 -0.777 . . . . 0.79000000000000004 108.901 175.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.467 ' O ' HG12 ' A' ' 150' ' ' VAL . 41.5 m80 -91.53 162.9 14.35 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.575 -0.528 . . . . 2.3199999999999998 109.575 169.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.644 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.2 m120 -62.03 -49.92 74.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 118.537 -0.745 . . . . 0.68000000000000005 110.007 177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -63.81 -28.27 69.75 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 121.021 1.737 . . . . 2.1800000000000002 112.106 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -78.1 -46.46 20.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.157 0.503 . . . . 0.68999999999999995 110.401 -176.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.675 HG13 HD12 ' A' ' 151' ' ' ILE . 13.4 p -67.11 -23.21 30.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.248 -0.887 . . . . 0.11 111.62 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.675 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -84.27 -42.63 17.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 118.764 -0.636 . . . . 0.38 110.409 172.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 156' ' ' ILE . 24.9 mt-10 -47.98 -68.69 0.16 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 119.514 1.052 . . . . 1.99 112.467 171.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.506 ' O ' HG22 ' A' ' 157' ' ' VAL . 27.4 mt -47.6 -39.89 17.96 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.638 0.732 . . . . 1.27 111.463 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.33 72.09 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.156 -1.384 . . . . 0.17999999999999999 111.57 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 24.6 t -88.37 -32.07 18.57 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.573 -0.704 . . . . 0.20999999999999999 112.523 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.8 mt -82.01 -59.93 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.673 0.749 . . . . 0.16 111.506 -172.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.506 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.9 m -90.42 143.79 29.85 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 114.739 -1.119 . . . . 0.16 111.918 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -90.98 175.21 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 124.174 3.249 . . . . 0.20000000000000001 111.136 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 73.4 m-20 -66.8 157.24 33.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 119.668 -0.813 . . . . 1.1000000000000001 109.196 177.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.593 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.16 -24.29 32.46 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.042 -1.075 . . . . 0.17999999999999999 112.154 -172.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.599 ' HB ' HD12 ' A' ' 100' ' ' ILE . 84.6 m -60.35 132.07 52.75 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.675 -0.861 . . . . 0.14000000000000001 108.675 -176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.634 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -93.59 128.98 39.99 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 122.581 1.182 . . . . 3.6299999999999999 111.012 -166.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.24 110.77 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-N 112.337 -2.21 . . . . 0.14000000000000001 109.706 -173.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 m -94.79 108.89 20.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.045 -0.525 . . . . 0.20999999999999999 112.172 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.457 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -82.51 100.68 6.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 122.51 1.148 . . . . 0.23999999999999999 109.687 176.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -104.33 129.92 52.19 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 113.688 -1.597 . . . . 1.0900000000000001 108.749 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.534 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 16.1 mmm180 -69.29 -24.4 63.95 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.995 0.426 . . . . 2.0800000000000001 110.029 178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 64.55 -136.91 39.28 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.317 -0.856 . . . . 1.97 113.472 169.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 109.892 -0.411 . . . . 3.9100000000000001 109.892 179.32 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.911 -0.476 . . . . 2.7999999999999998 111.911 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -146.88 144.63 29.42 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.99 -0.374 . . . . 4.4400000000000004 109.99 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -99.64 105.85 17.74 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.174 -0.466 . . . . 2.46 110.833 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp -112.58 174.9 5.66 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.52 -0.763 . . . . 0.65000000000000002 111.307 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.3 tt -94.54 127.52 40.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.222 -0.899 . . . . 0.28000000000000003 110.437 -174.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.84 162.64 13.33 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 122.265 1.031 . . . . 0.31 113.347 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.608 ' HB3' HG13 ' A' ' 46' ' ' ILE . 87.4 t80 -130.82 140.77 50.29 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.622 -1.626 . . . . 0.44 107.876 175.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.424 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 58.7 tt0 -114.03 113.46 24.8 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.353 -0.98 . . . . 0.76000000000000001 108.353 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.599 HG13 ' HB2' ' A' ' 13' ' ' ASP . 96.7 t -67.88 150.89 10.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-O 122.553 1.168 . . . . 0.39000000000000001 113.325 -168.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -105.43 158.58 16.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 113.096 -1.866 . . . . 2.0099999999999998 108.211 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -63.42 104.69 0.65 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.416 0.524 . . . . 1.8300000000000001 112.416 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.87 10.7 27.91 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.885 -0.674 . . . . 0.47999999999999998 113.203 173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.599 ' HB2' HG13 ' A' ' 9' ' ' VAL . 82.1 m-20 -54.94 167.53 0.38 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.871 0.367 . . . . 1.46 111.172 172.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.78 153.1 46.03 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.485 0.66 . . . . 0.40999999999999998 111.419 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.588 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -66.26 -34.88 79.0 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.466 -0.939 . . . . 0.85999999999999999 108.466 -179.211 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.451 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 32.6 t-20 -88.8 -25.87 22.0 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.878 -1.056 . . . . 1.1499999999999999 111.098 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p -66.99 -41.02 87.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 119.866 -0.734 . . . . 1.21 109.402 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.412 HG23 ' CE1' ' A' ' 22' ' ' PHE . 16.8 mt -72.82 -26.63 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.285 0.564 . . . . 0.20999999999999999 109.747 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.628 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.34 -9.94 59.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.374 -0.375 . . . . 0.16 111.199 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.646 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.43 -39.08 9.76 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 122.683 1.23 . . . . 0.20999999999999999 107.911 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.777 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 7.8 m-20 -63.96 -46.42 84.72 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 112.097 -2.319 . . . . 0.53000000000000003 112.239 173.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 58.5 m-85 -95.92 5.91 50.12 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 118.58 -1.248 . . . . 0.17999999999999999 111.183 -178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.646 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 6.0 mpt_? 54.06 43.12 31.2 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.82 0.819 . . . . 1.78 109.69 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.628 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.1 pt -116.78 -165.78 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 114.521 -1.218 . . . . 0.19 110.121 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.49 142.57 40.34 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.912 -1.04 . . . . 0.94999999999999996 110.067 175.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.563 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 66.9 p -73.11 -31.62 64.44 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 108.089 -1.078 . . . . 0.25 108.089 178.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.14 -29.79 69.99 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.314 -0.857 . . . . 0.20000000000000001 111.64 169.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.75 -26.83 18.4 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.991 -0.744 . . . . 0.17000000000000001 108.991 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.616 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.5 tp -74.9 -27.28 60.16 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.198 -0.91 . . . . 1.1599999999999999 109.528 173.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 26' ' ' THR . 32.3 mt -76.98 -30.84 56.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.745 0.784 . . . . 1.05 109.822 171.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 27.6 tt0 -62.92 -43.32 99.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.374 -1.284 . . . . 1.8100000000000001 109.867 173.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.62 -20.08 34.33 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.072 -0.651 . . . . 0.20000000000000001 111.716 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.638 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 30.0 m-80 -146.62 81.76 9.11 Favored Pre-proline 0 N--CA 1.449 -0.485 0 CA-C-O 121.578 0.704 . . . . 0.23000000000000001 110.932 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 20.4 Cg_endo -58.24 -9.94 7.45 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 124.26 3.306 . . . . 0.35999999999999999 113.971 176.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.6 t -79.16 -24.92 42.95 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.175 -0.328 . . . . 1.3799999999999999 110.83 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.829 HD21 HG21 ' A' ' 46' ' ' ILE . 45.0 mt -67.11 -35.46 79.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.425 0.631 . . . . 0.48999999999999999 111.913 -170.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.428 ' NE2' ' HB2' ' A' ' 38' ' ' ALA . 1.6 pp0? -63.02 -46.05 89.42 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 122.96 1.362 . . . . 1.95 110.147 -174.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.428 ' HB2' ' NE2' ' A' ' 37' ' ' GLN . . . -64.9 -47.42 77.86 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 111.554 -2.566 . . . . 0.48999999999999999 110.749 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.33 177.86 48.49 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.246 -0.888 . . . . 0.41999999999999998 111.858 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.99 157.77 22.04 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.322 0.582 . . . . 0.40999999999999998 110.786 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 43.2 m -141.6 130.07 22.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.252 -0.886 . . . . 0.41999999999999998 110.336 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.43 120.37 20.78 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 119.956 -0.698 . . . . 0.46999999999999997 109.518 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.424 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 98.66 1.38 57.6 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.331 -1.108 . . . . 0.40999999999999998 110.331 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.603 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -75.9 126.19 30.54 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 109.14 -0.689 . . . . 1.3 109.14 177.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 16.1 m -88.87 127.58 35.64 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.789 0.804 . . . . 0.84999999999999998 109.987 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.829 HG21 HD21 ' A' ' 36' ' ' LEU . 7.5 pt -127.07 142.72 42.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.246 -1.343 . . . . 0.25 109.565 -176.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.18 153.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.073 0.463 . . . . 0.67000000000000004 111.141 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.2 mm -116.93 92.5 39.07 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 114.836 -1.075 . . . . 0.16 109.152 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.1 Cg_endo -58.47 136.15 72.38 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.953 2.436 . . . . 0.17999999999999999 112.723 -175.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.49 -6.02 83.48 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.116 -0.947 . . . . 0.26000000000000001 112.19 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.768 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.1 tp -123.91 114.03 28.24 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-O 121.35 0.595 . . . . 0.60999999999999999 111.232 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.683 ' HD2' HD12 ' A' ' 51' ' ' LEU . 50.0 Cg_endo -78.11 -176.88 3.48 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.713 2.942 . . . . 0.28000000000000003 113.965 -171.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.557 ' HB3' HG23 ' A' ' 56' ' ' THR . 14.8 t70 -80.46 129.7 67.98 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 114.656 -1.156 . . . . 0.48999999999999999 112.007 -171.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.588 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.4 Cg_endo -76.5 -13.58 18.32 Favored 'Trans proline' 0 CA--C 1.518 -0.295 0 C-N-CA 123.632 2.888 . . . . 0.46000000000000002 112.881 -177.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.443 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 18.1 m-30 -93.48 -9.59 37.91 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.663 -0.699 . . . . 1.3799999999999999 110.037 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.557 HG23 ' HB3' ' A' ' 53' ' ' ASP . 29.5 p -87.96 -25.52 23.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.61 1.195 . . . . 0.46000000000000002 108.183 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.55 HG22 ' H ' ' A' ' 59' ' ' TYR . 33.4 mt -67.79 129.18 93.41 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 112.988 -1.914 . . . . 0.69999999999999996 111.553 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.25 -19.64 22.22 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.571 2.181 . . . . 0.39000000000000001 113.557 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.55 ' H ' HG22 ' A' ' 57' ' ' ILE . 58.6 m-85 -98.17 163.31 12.79 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.29 -0.564 . . . . 0.23999999999999999 112.134 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -150.91 131.69 14.08 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.188 -0.915 . . . . 2.8900000000000001 108.858 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.689 ' HA ' ' O ' ' A' ' 71' ' ' THR . 96.9 mt -112.9 131.75 63.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.384 -0.371 . . . . 0.16 111.844 -176.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.39 117.62 31.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 120.044 -0.663 . . . . 0.16 110.975 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.453 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 64.4 t -95.82 119.72 44.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.62 0.724 . . . . 0.19 110.681 175.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.473 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 38.5 m -96.66 107.63 20.11 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.004 -0.998 . . . . 0.20000000000000001 110.689 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.583 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 38.6 mm -54.01 -59.33 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 122.187 0.994 . . . . 0.23000000000000001 111.074 165.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.7 -12.77 7.01 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 112.72 -2.036 . . . . 0.16 113.379 -175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.34 -17.27 5.21 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.161 0.584 . . . . 0.14999999999999999 112.548 -178.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.548 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.41 55.52 5.7 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 118.703 0.683 . . . . 0.68999999999999995 111.419 -174.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.8 p -137.59 163.7 30.56 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 113.09 0.774 . . . . 0.13 113.09 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 81' ' ' THR . 8.0 tt -127.78 115.42 18.63 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.51 -1.223 . . . . 0.40000000000000002 109.443 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.689 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 48.0 m -95.53 119.63 34.37 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.304 0.573 . . . . 0.16 111.313 177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.614 ' O ' ' HB2' ' A' ' 79' ' ' MET . 0.5 OUTLIER -92.32 103.83 16.24 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.726 -1.212 . . . . 0.58999999999999997 107.726 174.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.6 m -106.8 158.32 17.08 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 118.924 -1.111 . . . . 1.05 111.371 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.606 HD22 ' N ' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -127.96 124.63 37.76 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.462 0.648 . . . . 0.26000000000000001 109.622 170.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.606 ' N ' HD22 ' A' ' 74' ' ' LEU . 8.7 p30 30.97 68.07 0.11 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 113.918 -1.492 . . . . 1.8400000000000001 112.804 -166.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 72.09 -9.41 1.0 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.034 -0.984 . . . . 1.8899999999999999 112.887 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -107.58 120.3 41.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.148 0.499 . . . . 3.4399999999999999 110.776 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 41.9 t -55.64 131.91 19.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.618 1.199 . . . . 0.23999999999999999 112.862 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.614 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 22.4 mmm -97.56 -46.86 5.87 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 112.816 -1.993 . . . . 0.81000000000000005 108.538 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.673 ' HG2' ' CZ ' ' A' ' 82' ' ' TYR . 2.3 tptm -157.39 174.41 15.45 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.277 -1.783 . . . . 1.46 110.5 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 55.3 m -150.2 123.93 9.19 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.498 -1.683 . . . . 0.17000000000000001 109.575 168.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.673 ' CZ ' ' HG2' ' A' ' 80' ' ' LYS . 29.9 m-85 -115.46 152.18 46.79 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 115.996 -0.547 . . . . 1.05 110.163 -175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HB2' HG22 ' A' ' 134' ' ' ILE . 55.2 Cg_endo -76.06 144.03 26.46 Favored 'Trans proline' 0 CA--C 1.496 -1.414 0 C-N-CA 122.003 1.802 . . . . 0.20000000000000001 110.981 176.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.668 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -141.31 172.62 10.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.685 -0.689 . . . . 0.13 110.496 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.953 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -116.87 140.41 49.48 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.852 -0.339 . . . . 0.26000000000000001 110.215 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 68' ' ' LYS . 12.9 m -124.02 126.08 71.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.618 0.723 . . . . 0.56000000000000005 111.702 -177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.77 157.03 29.42 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 114.954 -1.021 . . . . 0.17000000000000001 110.621 173.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 139' ' ' SER . 27.6 mtpp -57.13 3.6 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 113.013 0.745 . . . . 3.0499999999999998 113.013 177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.927 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -89.12 -20.72 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 O-C-N 121.467 -0.771 . . . . 0.23000000000000001 109.821 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.927 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -88.78 -21.62 23.69 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.545 -0.909 . . . . 0.17999999999999999 108.545 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.2 p -69.17 -13.32 62.35 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.209 -1.36 . . . . 0.33000000000000002 111.297 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -66.51 -42.95 86.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.103 -0.953 . . . . 1.52 112.225 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.41 134.12 22.99 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.378 -0.529 . . . . 0.42999999999999999 110.49 -176.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.574 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 93.9 Cg_endo -86.44 -6.58 8.01 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.452 2.101 . . . . 0.72999999999999998 112.307 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.6 t -123.92 -38.71 2.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.989 -0.55 . . . . 0.47999999999999998 110.317 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.442 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 44.98 46.22 9.42 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 124.165 0.915 . . . . 0.33000000000000002 114.131 171.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.73 112.91 20.91 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.741 0.781 . . . . 0.83999999999999997 109.874 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 17.5 m-85 -137.7 174.21 10.83 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.355 -1.293 . . . . 0.22 112.86 -170.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.479 ' CE2' ' HB3' ' A' ' 162' ' ' ARG . 37.4 m-85 -141.99 137.31 31.08 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.589 -0.732 . . . . 0.54000000000000004 110.527 -175.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.576 HD12 ' HB ' ' A' ' 161' ' ' THR . 84.9 mt -61.33 123.88 14.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 115.779 -0.646 . . . . 0.17000000000000001 110.444 171.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 17.7 pt -87.44 -43.75 15.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 112.637 0.606 . . . . 0.20999999999999999 112.637 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.506 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 55.3 m-80 -172.1 176.09 3.57 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 106.72 -1.585 . . . . 2.0299999999999998 106.72 -169.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.607 ' HB3' HD23 ' A' ' 116' ' ' LEU . 5.2 mtt180 -133.01 155.96 48.21 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.878 -0.729 . . . . 1.52 112.122 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 49.3 tt0 -129.31 99.86 5.37 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.218 -0.901 . . . . 0.58999999999999997 109.538 172.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.483 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 20.7 ttt180 -66.33 166.26 12.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.427 -0.806 . . . . 2.8199999999999998 110.504 175.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.513 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 23.5 m-80 -35.27 104.9 0.27 Allowed Pre-proline 0 C--O 1.234 0.247 0 C-N-CA 125.198 1.399 . . . . 0.34999999999999998 113.605 -156.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.513 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.8 Cg_endo -60.28 -41.4 50.81 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.847 2.365 . . . . 0.47999999999999998 111.215 170.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.88 -40.25 2.13 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.938 -0.865 . . . . 0.67000000000000004 110.938 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.69 -176.15 36.19 Favored Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 121.21 -0.519 . . . . 0.62 112.745 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.52 2.42 0.28 Allowed 'Trans proline' 0 N--CA 1.48 0.684 0 C-N-CA 125.231 3.954 . . . . 0.93999999999999995 115.762 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.84 16.08 0.07 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 112.483 0.549 . . . . 1.23 112.483 -175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.747 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 70.8 63.91 3.01 Favored Glycine 0 CA--C 1.499 -0.951 0 C-N-CA 120.212 -0.994 . . . . 1.6899999999999999 115.362 168.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 39.38 -3.9 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 117.392 2.367 . . . . 0.47999999999999998 117.392 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.476 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -166.01 154.14 10.76 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.243 -0.91 . . . . 0.28000000000000003 110.549 -175.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.405 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.4 t-105 -134.23 98.59 4.15 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.064 -1.087 . . . . 0.48999999999999999 108.064 167.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 103' ' ' ARG . 4.5 mt -89.6 114.11 25.64 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.017 -0.735 . . . . 0.66000000000000003 109.017 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.7 m -84.46 144.27 28.85 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.76 -0.654 . . . . 0.19 111.385 -167.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.789 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.5 mm? -108.84 171.61 7.33 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.975 -0.557 . . . . 0.13 110.625 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.63 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.5 OUTLIER -63.14 -13.84 41.56 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.93 0.715 . . . . 1.1699999999999999 112.93 -179.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.777 ' HD3' ' OD1' ' A' ' 21' ' ' ASP . 5.3 tppp? -126.3 132.29 51.68 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.094 0.473 . . . . 1.22 110.828 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.512 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 56.3 mt-30 -33.29 -57.42 0.41 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.907 -1.497 . . . . 1.51 114.308 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.567 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -99.74 12.13 37.42 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.569 -0.852 . . . . 2.5299999999999998 111.547 -172.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.789 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.1 m-85 -96.33 37.5 1.25 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.857 0.688 . . . . 0.83999999999999997 112.857 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.678 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -117.04 144.2 18.32 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 117.328 -2.367 . . . . 0.32000000000000001 112.649 -152.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -95.57 114.53 32.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.754 0.788 . . . . 0.17999999999999999 110.778 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.558 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 27.5 p80 -143.34 171.97 13.39 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 115.389 -0.823 . . . . 0.20999999999999999 109.372 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.747 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.98 -169.4 38.08 Favored Glycine 0 C--N 1.316 -0.579 0 C-N-CA 119.847 -1.168 . . . . 0.27000000000000002 112.067 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.569 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 15.0 t -154.13 172.64 17.22 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 122.472 -0.428 . . . . 0.40999999999999998 110.009 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -113.0 -2.52 14.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.442 -0.947 . . . . 1.99 108.442 175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -115.71 88.17 19.76 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.004 -0.998 . . . . 1.3600000000000001 108.532 170.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.419 ' HA ' HG12 ' A' ' 134' ' ' ILE . 21.5 Cg_endo -72.74 -16.87 26.37 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.248 1.965 . . . . 0.34999999999999998 112.779 -171.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.41 -0.61 33.58 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.546 -0.752 . . . . 0.33000000000000002 111.215 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.0 p -93.42 -6.45 47.04 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.134 -0.691 . . . . 1.3500000000000001 109.134 169.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' A' ' 83' ' ' PRO . 42.5 mm -81.18 130.78 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.255 -0.884 . . . . 0.20999999999999999 110.627 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.73 2.58 59.76 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 109.944 -1.263 . . . . 0.14999999999999999 109.944 -175.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.434 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 23.3 mttp -114.81 170.57 8.23 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 123.146 1.45 . . . . 2.5 114.431 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.43 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -101.91 127.66 48.65 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 111.887 -2.415 . . . . 0.17000000000000001 108.006 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.418 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.4 OUTLIER -123.23 162.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.643 -0.873 . . . . 0.66000000000000003 108.643 -176.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 58.7 m -52.18 -59.38 4.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.471 0.545 . . . . 0.42999999999999999 112.471 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.93 -45.57 0.95 Allowed 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 118.766 -1.174 . . . . 2.02 113.726 -174.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.83 133.54 0.16 Allowed Glycine 0 CA--C 1.527 0.785 0 N-CA-C 116.955 1.542 . . . . 0.17999999999999999 116.955 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.546 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.2 p -73.85 166.65 22.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 112.606 -1.797 . . . . 0.16 112.066 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.953 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 54.0 mt -59.87 97.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 122.468 1.127 . . . . 0.40000000000000002 112.034 -163.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.558 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 34.3 mtt180 -84.12 152.98 24.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.694 -1.594 . . . . 1.8700000000000001 110.054 -177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.668 ' HG2' HG22 ' A' ' 84' ' ' ILE . 11.1 mtp -133.26 -165.88 1.68 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.545 -0.539 . . . . 0.79000000000000004 109.545 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.619 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 24.8 t-80 -97.54 151.3 20.18 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.569 -0.741 . . . . 2.3199999999999998 109.181 173.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.633 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.3 m120 -55.35 -53.52 55.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 118.132 -0.937 . . . . 0.68000000000000005 111.043 -174.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -62.28 -28.23 69.57 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 121.592 1.996 . . . . 2.1800000000000002 111.827 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.619 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 3.5 m-20 -78.23 -44.36 25.8 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.773 -0.649 . . . . 0.68999999999999995 110.903 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.606 HG13 HD12 ' A' ' 151' ' ' ILE . 14.2 p -67.27 -21.78 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.598 -0.728 . . . . 0.11 111.342 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.633 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.86 -42.37 17.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 119.124 -0.465 . . . . 0.38 110.069 171.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.412 ' O ' HG13 ' A' ' 156' ' ' ILE . 31.2 mt-10 -46.84 -71.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.904 0.774 . . . . 1.99 112.87 171.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.558 ' O ' HG22 ' A' ' 157' ' ' VAL . 11.5 mt -43.54 -43.85 5.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.702 0.763 . . . . 1.27 110.61 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.19 -37.35 74.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.701 -1.591 . . . . 0.17999999999999999 111.722 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.3 t -85.94 -32.28 21.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.678 0.672 . . . . 0.20999999999999999 112.032 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 152' ' ' GLU . 52.0 mt -81.13 -59.87 2.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.561 0.696 . . . . 0.16 111.408 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.6 m -88.61 144.77 33.99 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 114.76 -1.109 . . . . 0.16 111.728 175.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -91.63 177.21 1.89 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 124.09 3.193 . . . . 0.20000000000000001 111.266 172.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.506 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 61.0 m-20 -67.13 159.46 28.84 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.532 -0.867 . . . . 1.1000000000000001 109.339 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.588 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 94.84 -19.63 52.95 Favored Glycine 0 N--CA 1.44 -1.071 0 C-N-CA 120.213 -0.994 . . . . 0.17999999999999999 112.125 -174.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.576 ' HB ' HD12 ' A' ' 100' ' ' ILE . 87.0 m -60.62 137.72 58.14 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.472 -0.566 . . . . 0.14000000000000001 109.472 -175.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.479 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 1.9 ptt180 -92.05 116.4 28.9 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.769 1.271 . . . . 3.6299999999999999 110.51 -168.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.5 t -107.42 107.05 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 112.056 -2.338 . . . . 0.14000000000000001 109.158 -175.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.0 m -94.74 109.92 21.82 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.038 -0.528 . . . . 0.20999999999999999 112.148 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.453 ' HA ' ' HB ' ' A' ' 63' ' ' VAL . 2.4 mp -82.65 95.07 3.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 122.47 1.129 . . . . 0.23999999999999999 109.694 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -101.58 136.57 41.19 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.607 -1.633 . . . . 1.0900000000000001 108.879 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.583 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 5.8 mmt85 -70.74 -33.29 70.66 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.446 -0.576 . . . . 2.0800000000000001 109.446 176.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 67.01 -97.76 0.38 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.327 -0.851 . . . . 1.97 112.399 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.5 m . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 109.651 -0.5 . . . . 3.9100000000000001 109.651 177.638 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.878 -0.489 . . . . 2.7999999999999998 111.878 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -107.37 156.63 18.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.892 0.377 . . . . 4.4400000000000004 110.664 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -88.48 98.04 11.41 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.913 -0.773 . . . . 2.46 108.913 172.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 tp -114.06 174.15 6.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.027 -0.533 . . . . 0.65000000000000002 110.988 -176.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.615 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.2 tt -95.47 126.26 40.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.529 -0.76 . . . . 0.28000000000000003 110.338 -174.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.68 161.68 13.93 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.787 -1.097 . . . . 0.31 112.511 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.646 ' O ' ' HA ' ' A' ' 45' ' ' SER . 80.8 t80 -129.34 140.98 51.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.152 -1.386 . . . . 0.44 107.987 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -112.92 112.74 24.43 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.936 -1.135 . . . . 0.76000000000000001 107.936 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 13' ' ' ASP . 99.6 t -65.37 148.16 12.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-O 122.556 1.17 . . . . 0.39000000000000001 112.372 -170.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -106.29 158.16 17.07 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.287 -1.779 . . . . 2.0099999999999998 108.184 174.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -59.65 111.96 1.63 Allowed 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.952 0.406 . . . . 1.8300000000000001 111.786 -173.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.21 11.53 54.13 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.744 -0.662 . . . . 0.47999999999999998 113.827 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.592 ' HB2' HG13 ' A' ' 9' ' ' VAL . 91.8 m-20 -55.61 168.2 0.44 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.198 0.499 . . . . 1.46 111.255 172.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.82 151.85 47.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.858 0.361 . . . . 0.40999999999999998 110.95 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.528 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.56 -40.53 97.24 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.097 -1.075 . . . . 0.85999999999999999 108.097 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.436 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 64.4 t30 -84.21 -22.65 30.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.353 -1.294 . . . . 1.1499999999999999 110.434 -175.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.6 t -65.09 -45.3 85.81 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.958 -0.756 . . . . 1.21 108.958 171.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.435 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 15.4 mt -72.52 -27.06 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-O 121.201 0.524 . . . . 0.20999999999999999 109.84 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.655 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.27 -10.56 59.76 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.481 -0.327 . . . . 0.16 110.912 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.652 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.5 -39.63 9.06 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 122.669 1.223 . . . . 0.20999999999999999 108.092 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.623 ' HB3' ' O ' ' A' ' 119' ' ' SER . 8.8 m-20 -62.46 -46.01 90.46 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 112.293 -2.23 . . . . 0.53000000000000003 111.904 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.607 ' HA ' HG21 ' A' ' 101' ' ' ILE . 55.3 m-85 -95.83 5.68 50.72 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 118.81 -1.156 . . . . 0.17999999999999999 111.551 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.652 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.1 mpt_? 54.13 43.33 30.83 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.758 0.79 . . . . 1.78 109.838 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.5 pt -118.34 -165.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 114.442 -1.254 . . . . 0.19 109.799 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.7 142.73 42.22 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.156 -0.929 . . . . 0.94999999999999996 110.429 174.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.581 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 82.3 p -71.01 -33.34 70.29 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.198 -1.038 . . . . 0.25 108.198 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.91 69.27 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.373 -0.831 . . . . 0.20000000000000001 112.008 170.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -93.42 -27.76 16.53 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.914 -0.773 . . . . 0.17000000000000001 108.914 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.607 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -73.95 -28.86 61.7 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.956 -1.02 . . . . 1.1599999999999999 109.113 174.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 26' ' ' THR . 40.5 mt -76.1 -31.66 58.81 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.659 0.742 . . . . 1.05 110.071 171.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 5.5 tt0 -63.78 -37.57 87.85 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.335 -1.302 . . . . 1.8100000000000001 110.084 174.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.442 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -85.97 -20.35 29.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 120.001 -0.68 . . . . 0.20000000000000001 111.679 176.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.635 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.7 m-80 -149.78 83.08 6.41 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-O 121.194 0.521 . . . . 0.23000000000000001 110.751 -172.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.2 Cg_endo -56.26 -15.46 14.75 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 123.927 3.085 . . . . 0.35999999999999999 113.834 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -73.2 -25.12 60.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.684 0.278 . . . . 1.3799999999999999 111.31 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.891 HD21 HG21 ' A' ' 46' ' ' ILE . 29.7 mt -67.88 -39.84 83.62 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.324 0.583 . . . . 0.48999999999999999 112.397 -170.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -63.6 -44.79 92.96 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.933 1.349 . . . . 1.95 110.275 -174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.17 -48.16 82.63 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 111.691 -2.504 . . . . 0.48999999999999999 110.614 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.06 176.55 48.01 Favored Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 115.048 -0.978 . . . . 0.41999999999999998 111.951 178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.03 157.69 19.05 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.163 0.506 . . . . 0.40999999999999998 110.791 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.594 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 49.9 m -141.39 127.93 20.12 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.33 -0.85 . . . . 0.41999999999999998 110.222 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -76.45 117.21 17.87 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.492 0.663 . . . . 0.46999999999999997 109.986 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.66 -0.12 49.26 Favored Glycine 0 N--CA 1.429 -1.818 0 CA-C-N 114.775 -1.102 . . . . 0.40999999999999998 110.389 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.594 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -75.14 124.69 27.47 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.921 -0.639 . . . . 1.3 109.63 179.046 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 61.8 p -85.67 131.79 34.27 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 122.099 0.952 . . . . 0.84999999999999998 110.448 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.891 HG21 HD21 ' A' ' 36' ' ' LEU . 10.2 pt -132.3 143.78 38.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.157 -1.383 . . . . 0.25 109.521 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.24 151.87 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 121.2 0.524 . . . . 0.67000000000000004 111.224 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.3 mm -116.74 93.37 40.89 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 114.614 -1.175 . . . . 0.16 108.948 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.3 Cg_endo -60.12 136.89 71.95 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.705 2.27 . . . . 0.17999999999999999 112.881 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.12 -6.23 83.79 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.114 -0.948 . . . . 0.26000000000000001 112.269 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.75 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 28.9 tp -121.46 114.53 31.6 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.287 0.565 . . . . 0.60999999999999999 111.077 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.688 ' HD2' HD12 ' A' ' 51' ' ' LEU . 53.8 Cg_endo -78.67 -177.07 3.63 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.702 2.935 . . . . 0.28000000000000003 114.135 -171.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.613 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.0 t70 -82.81 131.96 52.88 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 114.028 -1.442 . . . . 0.48999999999999999 112.317 -169.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 57.1 Cg_endo -73.98 -14.69 23.71 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 123.571 2.847 . . . . 0.46000000000000002 112.89 -177.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.465 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 22.0 m-85 -89.61 -15.47 32.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.082 -0.508 . . . . 1.3799999999999999 110.73 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 53' ' ' ASP . 20.8 p -83.22 -20.71 34.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 122.481 1.134 . . . . 0.46000000000000002 108.147 176.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.563 HG22 ' H ' ' A' ' 59' ' ' TYR . 26.4 mt -76.34 135.45 69.3 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 113.06 -1.882 . . . . 0.69999999999999996 110.99 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.519 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 30.5 Cg_endo -84.7 -17.26 5.14 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 122.361 2.041 . . . . 0.39000000000000001 112.863 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.563 ' H ' HG22 ' A' ' 57' ' ' ILE . 42.9 m-85 -100.6 155.83 17.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.91 0.386 . . . . 0.23999999999999999 111.541 -175.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -144.98 135.05 23.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.555 -0.748 . . . . 2.8900000000000001 109.102 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 71' ' ' THR . 84.1 mt -114.19 134.88 55.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.25 -0.432 . . . . 0.16 111.891 -175.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.05 118.88 33.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 119.89 -0.724 . . . . 0.16 111.124 175.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.5 t -98.3 113.9 34.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.748 0.785 . . . . 0.19 111.166 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 40.2 m -92.29 105.35 17.57 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.783 -1.099 . . . . 0.20000000000000001 110.336 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.7 mm -53.14 -58.73 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 122.055 0.931 . . . . 0.23000000000000001 111.314 168.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.01 -11.2 4.31 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-N 112.701 -2.045 . . . . 0.16 113.082 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.23 -16.53 5.45 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.653 0.781 . . . . 0.14999999999999999 112.19 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.509 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER 57.01 54.94 6.48 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.412 0.551 . . . . 0.68999999999999995 111.28 -174.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.3 p -137.0 165.65 25.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.928 0.714 . . . . 0.13 112.928 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.9 tt -132.8 111.66 11.29 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.68 -1.146 . . . . 0.40000000000000002 109.822 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.638 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.9 m -93.31 123.25 36.46 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.924 0.392 . . . . 0.16 111.101 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' A' ' 79' ' ' MET . 11.6 tp -98.97 107.29 19.68 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.322 -0.854 . . . . 0.58999999999999997 108.791 172.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 88.3 p -105.37 161.89 13.92 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.324 -0.95 . . . . 1.05 110.591 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.749 HD13 ' ND2' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -126.31 126.33 43.76 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.522 -0.918 . . . . 0.26000000000000001 108.522 169.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.749 ' ND2' HD13 ' A' ' 74' ' ' LEU . 9.8 p30 43.0 48.1 5.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.021 -1.445 . . . . 1.8400000000000001 111.647 -165.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.8 t30 78.15 -13.89 0.91 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.794 -1.094 . . . . 1.8899999999999999 111.591 177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -92.51 122.78 35.28 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.193 -0.669 . . . . 3.4399999999999999 109.193 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 53.6 t -56.66 132.52 20.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 122.37 1.081 . . . . 0.23999999999999999 112.834 -173.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 57.2 mmm -96.91 -47.63 5.75 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.096 -1.865 . . . . 0.81000000000000005 107.838 175.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -163.3 174.05 12.53 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 112.871 -1.968 . . . . 1.46 110.358 -175.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.3 m -148.47 124.57 10.74 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.029 -1.441 . . . . 0.17000000000000001 109.395 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -111.59 151.02 43.05 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 109.56 -0.533 . . . . 1.05 109.56 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HB2' HG22 ' A' ' 134' ' ' ILE . 44.3 Cg_endo -76.63 140.82 21.5 Favored 'Trans proline' 0 CA--C 1.499 -1.247 0 C-N-CA 122.103 1.869 . . . . 0.20000000000000001 111.235 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.667 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.33 173.07 12.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.495 -0.775 . . . . 0.13 110.584 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.913 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.94 144.3 45.61 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 110.13 -0.322 . . . . 0.26000000000000001 110.13 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 65' ' ' ILE . 9.0 m -126.39 126.71 69.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.676 0.75 . . . . 0.56000000000000005 111.801 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.28 152.41 29.41 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 109.771 -1.332 . . . . 0.17000000000000001 109.771 171.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -57.27 4.63 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.06 0.763 . . . . 3.0499999999999998 113.06 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.938 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -89.57 -19.65 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-O 121.504 0.669 . . . . 0.23000000000000001 110.235 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.938 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -88.09 -16.73 32.73 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.749 0.785 . . . . 0.17999999999999999 109.097 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.9 p -68.95 -16.43 63.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.396 -1.274 . . . . 0.33000000000000002 111.352 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -62.03 -42.06 98.76 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 114.945 -1.025 . . . . 1.52 111.788 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -108.33 116.75 56.08 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.814 0.34 . . . . 0.42999999999999999 110.644 -176.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 6.0 Cg_exo -72.62 -21.25 22.29 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.604 2.202 . . . . 0.72999999999999998 112.842 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.3 t -99.88 -40.44 7.69 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.529 -0.545 . . . . 0.47999999999999998 109.529 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.535 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 45.42 48.09 11.58 Favored Glycine 0 N--CA 1.446 -0.639 0 O-C-N 124.393 1.058 . . . . 0.33000000000000002 113.557 171.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -82.75 110.98 18.27 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.738 0.78 . . . . 0.83999999999999997 109.172 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 21.5 m-85 -139.53 169.29 18.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.01 -1.45 . . . . 0.22 112.49 -171.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' A' ' 162' ' ' ARG . 43.6 m-85 -139.11 139.06 37.56 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.863 -0.608 . . . . 0.54000000000000004 110.377 -175.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.583 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.9 mt -61.63 118.93 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 115.412 -0.813 . . . . 0.17000000000000001 110.492 172.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.607 HG21 ' HA ' ' A' ' 22' ' ' PHE . 21.4 pt -85.28 -32.76 7.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 113.198 0.814 . . . . 0.20999999999999999 113.198 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.571 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 10.4 p30 177.99 176.05 0.47 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 107.613 -1.254 . . . . 2.0299999999999998 107.613 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.703 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 19.6 mtt180 -125.2 161.25 27.29 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.509 -0.876 . . . . 1.52 111.914 -174.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.45 HE21 ' HB3' ' A' ' 107' ' ' PRO . 52.0 tt0 -135.99 100.17 4.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.216 -0.902 . . . . 0.58999999999999997 109.832 170.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.471 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 24.8 ttp180 -67.5 165.48 16.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.378 -0.828 . . . . 2.8199999999999998 110.843 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.748 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 34.5 m-80 -36.1 101.08 0.21 Allowed Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 125.32 1.448 . . . . 0.34999999999999998 112.706 -156.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 18.1 Cg_endo -64.52 -51.24 2.01 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.985 2.456 . . . . 0.47999999999999998 112.392 175.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.74 -31.3 5.24 Favored Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 110.963 -0.855 . . . . 0.67000000000000004 110.963 -177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.13 -173.38 3.03 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.579 -0.811 . . . . 0.62 112.306 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -52.15 -22.75 15.8 Favored 'Trans proline' 0 N--CA 1.478 0.591 0 C-N-CA 124.679 3.586 . . . . 0.93999999999999995 113.494 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -63.84 -37.4 87.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 122.056 0.931 . . . . 1.23 108.868 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 113' ' ' ALA . . . 55.93 29.89 56.06 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 117.367 1.707 . . . . 1.6899999999999999 117.367 158.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 173.92 -54.23 0.01 OUTLIER 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 118.653 1.226 . . . . 0.47999999999999998 110.518 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.471 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.8 OUTLIER -162.09 157.3 23.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.786 0.327 . . . . 0.28000000000000003 110.424 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -135.39 99.84 4.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.627 -1.249 . . . . 0.48999999999999999 107.627 164.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.7 mt -92.18 113.95 26.36 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.579 -0.897 . . . . 0.66000000000000003 108.579 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.455 ' HB3' HD11 ' A' ' 101' ' ' ILE . 13.2 m -83.55 144.88 29.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.775 -0.648 . . . . 0.19 111.561 -166.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.9 mm? -110.28 166.53 10.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.13 110.936 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.623 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.8 OUTLIER -62.65 -8.2 6.14 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.028 0.751 . . . . 1.1699999999999999 113.028 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.773 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.9 tmtm? -126.84 133.01 50.84 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 122.362 1.077 . . . . 1.22 109.833 172.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.773 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 52.9 mt-30 -39.08 -46.39 1.4 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 112.439 -2.164 . . . . 1.51 114.227 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.483 ' CB ' HG12 ' A' ' 89' ' ' ILE . 79.6 m-70 -97.38 -0.67 45.95 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.212 -0.595 . . . . 2.5299999999999998 111.51 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.746 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -97.21 38.19 1.27 Allowed 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.365 1.246 . . . . 0.83999999999999997 114.365 -169.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.684 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -117.19 146.0 18.73 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 116.457 -2.783 . . . . 0.32000000000000001 113.111 -153.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.73 116.58 39.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 124.053 0.941 . . . . 0.17999999999999999 111.004 -176.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.5 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.5 p80 -146.23 -177.05 5.41 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 112.593 0.59 . . . . 0.20999999999999999 112.593 -176.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.98 -167.19 37.4 Favored Glycine 0 C--O 1.225 -0.452 0 N-CA-C 111.436 -0.666 . . . . 0.27000000000000002 111.436 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.6 t -161.68 164.05 29.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 117.727 0.764 . . . . 0.40999999999999998 110.589 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -115.18 -3.79 12.51 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.118 -1.067 . . . . 1.99 108.118 177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -121.74 91.43 48.62 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 114.148 -1.387 . . . . 1.3600000000000001 108.673 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -73.66 -22.27 18.2 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.346 2.031 . . . . 0.34999999999999998 113.769 -172.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.24 2.26 25.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.103 0.477 . . . . 0.33000000000000002 111.163 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.471 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 43.6 t -95.07 -4.89 45.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.718 -0.674 . . . . 1.3500000000000001 109.364 170.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 31.8 mm -78.76 138.17 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 115.899 -0.591 . . . . 0.20999999999999999 110.106 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.56 1.81 80.19 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.119 -1.192 . . . . 0.14999999999999999 110.119 -175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.471 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 91.8 mttt -113.36 167.94 10.15 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 123.161 1.457 . . . . 2.5 114.253 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.1 126.63 46.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 111.699 -2.501 . . . . 0.17000000000000001 107.961 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.417 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -125.24 161.95 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.909 -0.774 . . . . 0.66000000000000003 108.909 -174.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 68.7 m -49.72 -60.35 2.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.114 0.783 . . . . 0.42999999999999999 113.114 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -133.52 -43.99 0.83 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 118.533 -1.267 . . . . 2.02 113.619 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.42 133.49 0.2 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 117.055 1.582 . . . . 0.17999999999999999 117.055 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.535 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 2.9 p -70.05 165.19 22.41 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 112.575 -1.813 . . . . 0.16 112.419 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.913 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 49.4 mt -60.61 97.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 114.494 -1.23 . . . . 0.40000000000000002 112.077 -163.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.5 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 10.4 mtp180 -83.97 144.06 29.39 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.702 -1.59 . . . . 1.8700000000000001 109.501 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.667 ' HG2' HG22 ' A' ' 84' ' ' ILE . 14.9 mtp -121.38 -169.0 1.78 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.188 -0.671 . . . . 0.79000000000000004 109.188 173.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.622 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 1.5 t60 -89.85 153.91 20.28 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.158 -1.053 . . . . 2.3199999999999998 108.158 170.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.877 ' O ' HD13 ' A' ' 151' ' ' ILE . 9.2 m120 -72.45 -20.29 61.42 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 118.474 -0.774 . . . . 0.68000000000000005 113.069 -171.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -81.61 -28.75 33.58 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 121.364 1.893 . . . . 2.1800000000000002 112.734 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.622 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 5.0 m-20 -77.62 -41.21 39.34 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.186 0.517 . . . . 0.68999999999999995 110.63 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.61 HG13 HD12 ' A' ' 151' ' ' ILE . 12.5 p -66.34 -19.69 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 115.245 -0.889 . . . . 0.11 111.349 175.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.888 HD11 ' HB1' ' A' ' 113' ' ' ALA . 1.6 mp -86.26 -42.98 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 118.801 -0.618 . . . . 0.38 110.727 172.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.424 ' O ' HG13 ' A' ' 156' ' ' ILE . 16.2 mt-10 -45.12 -70.87 0.09 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.369 0.986 . . . . 1.99 112.578 170.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.554 ' O ' HG22 ' A' ' 157' ' ' VAL . 48.0 mt -46.07 -39.9 9.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.627 0.727 . . . . 1.27 111.53 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.26 -36.07 79.0 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.01 -1.45 . . . . 0.17999999999999999 111.775 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.3 t -86.97 -31.11 20.8 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 118.811 0.732 . . . . 0.20999999999999999 112.501 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.1 mt -82.49 -60.35 2.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.652 0.739 . . . . 0.16 111.756 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -88.38 141.93 31.02 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.837 -1.074 . . . . 0.16 112.252 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.703 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 56.9 Cg_endo -89.28 175.38 3.37 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 124.024 3.149 . . . . 0.20000000000000001 110.997 174.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.571 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 75.3 m-20 -65.53 156.04 33.81 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 119.371 -0.931 . . . . 1.1000000000000001 108.972 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 97.91 -19.78 53.21 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.008 -1.091 . . . . 0.17999999999999999 112.358 -174.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.583 ' HB ' HD12 ' A' ' 100' ' ' ILE . 50.5 m -64.1 137.4 57.95 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.902 -0.777 . . . . 0.14000000000000001 108.902 -176.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.523 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 20.0 ttt180 -92.15 127.6 37.68 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 122.52 1.152 . . . . 3.6299999999999999 110.745 -169.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.31 107.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-N 112.374 -2.193 . . . . 0.14000000000000001 109.086 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.1 m -93.92 107.91 19.77 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.377 0.51 . . . . 0.20999999999999999 112.377 -172.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.535 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.04 99.63 5.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 122.171 0.986 . . . . 0.23999999999999999 109.955 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -110.77 133.38 53.39 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.391 -1.277 . . . . 1.0900000000000001 109.879 -175.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.575 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 19.5 mmm180 -70.1 -22.01 63.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.239 -0.437 . . . . 2.0800000000000001 110.394 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 159.52 -75.24 0.2 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.916 -0.584 . . . . 1.97 112.285 173.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 C--N 1.322 -0.621 0 N-CA-C 110.732 -0.099 . . . . 3.9100000000000001 110.732 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 111.627 -0.589 . . . . 2.7999999999999998 111.627 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -89.28 162.79 15.67 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.178 0.513 . . . . 4.4400000000000004 110.714 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -103.18 98.16 8.13 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.463 -0.79 . . . . 2.46 109.404 175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 mp -119.89 174.48 6.42 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.664 -0.698 . . . . 0.65000000000000002 111.643 -175.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.0 tt -98.18 128.67 44.79 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.904 -1.043 . . . . 0.28000000000000003 110.392 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.19 162.96 13.3 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.209 1.004 . . . . 0.31 113.075 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.631 ' HB3' HG13 ' A' ' 46' ' ' ILE . 86.9 t80 -130.32 139.36 50.7 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.768 -1.56 . . . . 0.44 107.753 175.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.436 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 58.7 tt0 -112.39 113.14 25.18 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.013 -1.106 . . . . 0.76000000000000001 108.013 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.673 HG13 ' HB2' ' A' ' 13' ' ' ASP . 94.9 t -67.23 148.15 12.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 122.528 1.156 . . . . 0.39000000000000001 113.283 -169.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -102.35 158.6 16.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 113.312 -1.767 . . . . 2.0099999999999998 108.367 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.61 104.22 0.4 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.059 0.457 . . . . 1.8300000000000001 112.068 -174.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.83 10.96 36.11 Favored Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.718 -0.674 . . . . 0.47999999999999998 113.502 174.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.673 ' HB2' HG13 ' A' ' 9' ' ' VAL . 29.8 m-20 -53.06 169.3 0.1 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.137 0.494 . . . . 1.46 111.671 173.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.35 150.47 50.7 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.105 0.479 . . . . 0.40999999999999998 111.95 177.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.635 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.56 -36.45 83.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.055 -0.975 . . . . 0.85999999999999999 108.808 -177.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.426 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 2.7 t-20 -87.75 -24.5 23.79 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.812 -1.086 . . . . 1.1499999999999999 110.855 -176.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.0 m -70.1 -38.1 75.55 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.322 -0.551 . . . . 1.21 110.176 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.5 mt -74.67 -28.39 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.43 -0.581 . . . . 0.20999999999999999 109.43 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.662 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.66 -9.54 59.43 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.281 -0.418 . . . . 0.16 110.81 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.677 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.64 -40.8 8.83 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.38 1.086 . . . . 0.20999999999999999 108.116 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 119' ' ' SER . 7.5 m-20 -62.39 -44.41 96.52 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.462 -2.154 . . . . 0.53000000000000003 112.19 173.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' HA ' HG21 ' A' ' 101' ' ' ILE . 53.0 m-85 -96.98 6.39 48.72 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 118.627 -1.229 . . . . 0.17999999999999999 111.03 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.677 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER 54.3 41.44 31.98 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-O 121.916 0.865 . . . . 1.78 109.25 176.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.662 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.1 pt -113.87 -165.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.442 -1.254 . . . . 0.19 110.214 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.06 142.61 41.28 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.206 -0.906 . . . . 0.94999999999999996 110.225 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.49 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 60.3 p -72.97 -33.29 65.77 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.804 -1.184 . . . . 0.25 107.804 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.04 -27.2 66.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.34 -0.845 . . . . 0.20000000000000001 111.824 170.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HA ' ' HB2' ' A' ' 31' ' ' GLN . . . -95.21 -25.3 16.43 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.649 0.737 . . . . 0.17000000000000001 109.636 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.635 HD23 HD23 ' A' ' 15' ' ' LEU . 17.5 tp -75.23 -27.43 59.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.241 -0.89 . . . . 1.1599999999999999 109.054 173.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.521 HD23 ' HB2' ' A' ' 36' ' ' LEU . 35.3 mt -78.04 -26.69 48.51 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.36 0.6 . . . . 1.05 110.372 172.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.479 ' HB2' ' HA ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -59.81 -61.56 2.52 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 108.129 -1.063 . . . . 1.8100000000000001 108.129 169.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -71.29 -18.57 62.41 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.491 -0.777 . . . . 0.20000000000000001 110.86 -170.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.614 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 28.5 m-80 -147.61 80.65 8.93 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-N 115.642 -0.708 . . . . 0.23000000000000001 110.385 -174.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 24.6 Cg_endo -59.5 -4.41 2.49 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 C-N-CA 123.787 2.991 . . . . 0.35999999999999999 113.145 174.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.6 p -79.96 -25.75 40.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.052 0.453 . . . . 1.3799999999999999 111.542 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.861 HD21 HG21 ' A' ' 46' ' ' ILE . 33.6 mt -70.81 -33.66 70.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.733 -0.667 . . . . 0.48999999999999999 112.387 -170.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.429 ' HG3' ' H ' ' A' ' 37' ' ' GLN . 1.7 pp0? -63.56 -44.72 93.3 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 122.822 1.296 . . . . 1.95 110.76 -172.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.19 -49.12 73.28 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 111.795 -2.457 . . . . 0.48999999999999999 110.404 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.6 176.23 47.87 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 114.683 -1.144 . . . . 0.41999999999999998 111.405 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.51 157.99 18.44 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.37 0.605 . . . . 0.40999999999999998 110.626 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 53.2 m -138.39 128.8 26.1 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.317 -0.856 . . . . 0.41999999999999998 110.192 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.25 119.74 19.79 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 119.996 -0.682 . . . . 0.46999999999999997 109.535 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.436 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 99.44 1.51 56.67 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.254 -1.138 . . . . 0.40999999999999998 110.254 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.63 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -76.65 123.6 26.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.918 -0.641 . . . . 1.3 109.824 179.387 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 29.8 p -84.32 125.93 32.73 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.491 -0.777 . . . . 0.84999999999999998 110.771 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.861 HG21 HD21 ' A' ' 36' ' ' LEU . 8.9 pt -126.3 143.23 40.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 114.241 -1.345 . . . . 0.25 109.443 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.64 152.12 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-O 121.164 0.507 . . . . 0.67000000000000004 111.185 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.9 mm -116.28 92.03 34.75 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.648 -1.16 . . . . 0.16 109.268 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.557 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -57.98 135.06 66.38 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.811 2.341 . . . . 0.17999999999999999 112.71 -175.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.98 -5.77 83.06 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.067 -0.97 . . . . 0.26000000000000001 112.279 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.72 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 27.7 tp -122.54 113.37 30.61 Favored Pre-proline 0 N--CA 1.446 -0.626 0 CA-C-O 121.253 0.549 . . . . 0.60999999999999999 110.978 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.675 ' HD2' HD12 ' A' ' 51' ' ' LEU . 48.6 Cg_endo -78.05 -176.22 3.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.77 2.98 . . . . 0.28000000000000003 114.295 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.571 ' HB3' HG23 ' A' ' 56' ' ' THR . 22.5 t70 -79.9 129.76 69.4 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 113.967 -1.47 . . . . 0.48999999999999999 112.648 -169.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 41.1 Cg_endo -73.06 -14.01 26.11 Favored 'Trans proline' 0 C--N 1.34 0.118 0 C-N-CA 123.396 2.731 . . . . 0.46000000000000002 112.687 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.539 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 75.5 m-85 -92.58 -10.28 38.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.971 -0.558 . . . . 1.3799999999999999 111.332 -174.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.571 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.0 p -85.46 -24.69 27.3 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 122.586 1.184 . . . . 0.46000000000000002 108.153 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 59' ' ' TYR . 15.9 mt -72.53 136.34 80.98 Favored Pre-proline 0 C--N 1.314 -0.971 0 CA-C-N 112.82 -1.991 . . . . 0.69999999999999996 111.246 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.539 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 36.8 Cg_endo -86.38 -16.49 3.94 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.459 2.106 . . . . 0.39000000000000001 113.319 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.594 ' H ' HG22 ' A' ' 57' ' ' ILE . 56.0 m-85 -98.43 158.15 15.77 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.199 0.444 . . . . 0.23999999999999999 112.199 -174.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.612 ' CD2' ' HE ' ' A' ' 162' ' ' ARG . 40.5 m80 -147.01 132.44 18.61 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.67 -0.695 . . . . 2.8900000000000001 109.15 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.703 ' HA ' ' O ' ' A' ' 71' ' ' THR . 76.1 mt -114.99 135.93 53.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.261 -0.427 . . . . 0.16 111.914 -176.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.79 117.6 28.63 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 120.11 -0.636 . . . . 0.16 111.249 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 69' ' ' THR . 88.9 t -96.77 117.93 42.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.511 0.672 . . . . 0.19 111.168 175.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 65.1 m -92.84 109.56 21.0 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.253 -0.885 . . . . 0.20000000000000001 111.262 177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 36.2 mm -54.48 -59.58 2.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 122.255 1.026 . . . . 0.23000000000000001 111.081 165.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.13 -12.75 6.0 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 112.783 -2.008 . . . . 0.16 113.362 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.469 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.94 -18.62 4.61 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.866 0.691 . . . . 0.14999999999999999 112.866 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.96 56.3 4.08 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.811 0.732 . . . . 0.68999999999999995 111.438 -172.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 46.8 p -137.89 164.6 28.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.897 0.703 . . . . 0.13 112.897 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.445 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.4 tt -133.13 110.67 10.34 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.713 -1.131 . . . . 0.40000000000000002 109.81 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 53.1 m -93.42 121.77 35.16 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.288 0.566 . . . . 0.16 111.188 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.1 tp -96.5 107.37 19.77 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.909 -1.041 . . . . 0.58999999999999997 109.054 173.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 4.3 m -107.61 158.11 17.52 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.453 -0.899 . . . . 1.05 110.645 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.738 HD13 ' ND2' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -126.19 126.15 43.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.826 -0.805 . . . . 0.26000000000000001 108.826 170.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.738 ' ND2' HD13 ' A' ' 74' ' ' LEU . 8.9 p30 41.48 54.81 3.57 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.04 -1.436 . . . . 1.8400000000000001 111.539 -165.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.5 t30 73.86 -14.98 0.61 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.173 -0.921 . . . . 1.8899999999999999 111.709 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.5 tpp180 -91.84 118.99 31.23 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.81 -0.441 . . . . 3.4399999999999999 109.81 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 43.0 t -58.05 130.32 21.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 122.479 1.133 . . . . 0.23999999999999999 112.412 -175.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.518 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 64.0 mmm -96.27 -48.68 5.52 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 113.014 -1.903 . . . . 0.81000000000000005 108.214 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 14.3 mmmt -160.72 174.06 14.49 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 112.669 -2.06 . . . . 1.46 109.477 -176.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.3 m -148.58 124.49 10.62 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 114.602 -1.181 . . . . 0.17000000000000001 109.072 174.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 149' ' ' ASP . 12.9 m-85 -106.01 147.21 34.39 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 115.118 -0.946 . . . . 1.05 109.588 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.435 ' HB2' HG22 ' A' ' 134' ' ' ILE . 37.4 Cg_endo -75.12 140.61 25.33 Favored 'Trans proline' 0 CA--C 1.498 -1.305 0 C-N-CA 121.445 1.43 . . . . 0.20000000000000001 110.24 168.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.633 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -141.06 174.68 6.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.764 -0.653 . . . . 0.13 110.554 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.893 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.16 143.55 47.16 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.793 0.33 . . . . 0.26000000000000001 110.424 -177.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.508 HG22 ' HG3' ' A' ' 68' ' ' LYS . 8.7 m -125.64 126.21 69.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.525 0.678 . . . . 0.56000000000000005 111.779 -178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.03 154.41 31.91 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 109.609 -1.396 . . . . 0.17000000000000001 109.609 171.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -55.79 0.18 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.042 0.756 . . . . 3.0499999999999998 113.042 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.876 HG23 HD22 ' A' ' 90' ' ' LEU . 1.2 tp -85.04 -19.11 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 O-C-N 121.353 -0.842 . . . . 0.23000000000000001 110.068 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.876 HD22 HG23 ' A' ' 89' ' ' ILE . 3.5 mm? -87.17 -17.25 33.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.766 -0.827 . . . . 0.17999999999999999 108.766 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 34.6 p -70.41 -15.66 62.86 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.461 -1.245 . . . . 0.33000000000000002 111.23 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.17 -43.21 98.9 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 115.477 -0.783 . . . . 1.52 111.594 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.07 132.95 27.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.477 -0.489 . . . . 0.42999999999999999 110.72 -174.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 84.3 Cg_endo -88.7 4.3 5.51 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.73 2.286 . . . . 0.72999999999999998 111.66 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -128.39 -41.51 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.161 -0.681 . . . . 0.47999999999999998 109.161 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.622 ' O ' ' HB ' ' A' ' 165' ' ' ILE . . . 53.13 16.92 4.86 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 124.595 1.184 . . . . 0.33000000000000002 114.377 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.674 ' CB ' HG23 ' A' ' 164' ' ' THR . 12.9 pt-20 -86.3 119.64 26.8 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.331 1.062 . . . . 0.83999999999999997 110.223 -171.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.667 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 9.3 m-85 -138.67 -170.56 2.87 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.679 -1.601 . . . . 0.22 111.764 -163.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.626 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 85.7 m-85 -142.9 139.2 30.68 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.237 0.541 . . . . 0.54000000000000004 110.938 -174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.568 HD12 ' HB ' ' A' ' 161' ' ' THR . 85.5 mt -63.74 123.4 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.463 -0.79 . . . . 0.17000000000000001 110.39 168.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.546 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.8 pt -89.64 -43.9 14.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 113.621 0.971 . . . . 0.20999999999999999 113.621 -178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.591 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 49.1 m-80 -171.22 174.14 4.69 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.047 -1.464 . . . . 2.0299999999999998 107.047 -169.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.655 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 40.3 mtt180 -127.1 169.47 13.38 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.252 -0.979 . . . . 1.52 111.961 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 55.0 tt0 -147.13 99.8 3.21 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.075 -0.966 . . . . 0.58999999999999997 109.629 170.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.517 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 46.5 ttt180 -65.74 166.11 11.52 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.205 -0.907 . . . . 2.8199999999999998 110.826 175.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.517 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 19.3 m-80 -35.41 102.74 0.23 Allowed Pre-proline 0 C--O 1.232 0.168 0 C-N-CA 125.269 1.428 . . . . 0.34999999999999998 113.305 -157.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.515 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.4 Cg_endo -61.26 -36.03 81.84 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.153 2.568 . . . . 0.47999999999999998 111.78 173.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.89 -33.82 4.89 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.151 -0.779 . . . . 0.67000000000000004 111.151 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.39 -176.88 49.45 Favored Glycine 0 N--CA 1.438 -1.218 0 CA-C-N 115.199 -0.5 . . . . 0.62 112.614 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.47 6.16 0.16 Allowed 'Trans proline' 0 N--CA 1.482 0.848 0 C-N-CA 125.024 3.816 . . . . 0.93999999999999995 115.515 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -71.26 13.25 0.24 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 112.273 0.472 . . . . 1.23 112.273 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.746 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 73.67 64.04 2.57 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.912 -1.137 . . . . 1.6899999999999999 115.316 170.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.513 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.96 -3.48 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 117.482 2.401 . . . . 0.47999999999999998 117.482 -177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.494 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.3 OUTLIER -165.83 154.78 11.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.417 -0.802 . . . . 0.28000000000000003 110.449 -176.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.3 t-105 -135.25 99.28 4.2 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.115 -1.069 . . . . 0.48999999999999999 108.115 168.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.516 HD12 HG23 ' A' ' 150' ' ' VAL . 4.9 mt -93.15 114.69 27.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.584 0.707 . . . . 0.66000000000000003 109.245 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.436 ' C ' HG12 ' A' ' 101' ' ' ILE . 19.6 m -83.54 144.23 29.65 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.666 -0.697 . . . . 0.19 111.502 -167.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.714 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.7 mm? -108.72 165.04 11.85 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 115.454 -0.794 . . . . 0.13 110.791 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.468 ' OG ' ' HD2' ' A' ' 98' ' ' PHE . 3.7 p -68.16 -4.58 14.3 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 124.008 0.817 . . . . 1.1699999999999999 112.546 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.689 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 4.3 tmtm? -126.66 128.33 46.56 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 120.213 -0.595 . . . . 1.22 109.581 166.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.689 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 52.9 mt-30 -33.19 -58.28 0.39 Allowed 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.431 -1.713 . . . . 1.51 113.847 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.588 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -96.67 13.18 29.2 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.964 -0.694 . . . . 2.5299999999999998 112.17 -170.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.587 ' HA ' HD11 ' A' ' 90' ' ' LEU . 2.8 m-30 -90.38 -34.29 15.72 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-O 121.923 0.868 . . . . 0.83999999999999997 111.081 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.714 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -6.87 128.71 0.01 OUTLIER Glycine 0 C--N 1.297 -1.601 0 N-CA-C 119.262 2.465 . . . . 0.32000000000000001 119.262 174.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.642 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -99.96 115.67 41.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 112.822 -1.689 . . . . 0.17999999999999999 109.815 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.691 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.0 p80 -143.27 175.16 10.11 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 115.501 -0.772 . . . . 0.20999999999999999 109.653 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.746 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.58 -168.81 38.52 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 120.016 -1.088 . . . . 0.27000000000000002 111.991 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.597 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 13.0 t -156.03 168.04 28.53 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.89 -0.771 . . . . 0.40999999999999998 110.367 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -110.33 -9.21 14.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.507 -0.923 . . . . 1.99 108.507 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -111.21 88.33 8.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 114.816 -1.084 . . . . 1.3600000000000001 108.356 169.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -72.89 -19.64 23.27 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.754 2.303 . . . . 0.34999999999999998 113.326 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.6 -2.07 33.94 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.03 -0.532 . . . . 0.33000000000000002 111.002 -176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.5 m -91.97 -4.16 54.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.544 -0.539 . . . . 1.3500000000000001 109.544 170.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 43.5 mm -82.31 131.4 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.845 -0.616 . . . . 0.20999999999999999 110.401 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.7 1.4 65.87 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.811 -1.316 . . . . 0.14999999999999999 109.811 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 137' ' ' ALA . 2.0 tttm -114.29 163.27 15.5 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 122.759 1.266 . . . . 2.5 113.388 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -94.54 126.9 40.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 112.424 -2.171 . . . . 0.17000000000000001 107.889 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.432 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -121.64 159.25 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 108.6 -0.889 . . . . 0.66000000000000003 108.6 -175.176 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.0 m -49.34 -59.35 3.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.406 0.521 . . . . 0.42999999999999999 112.406 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.434 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 21.0 pttm -132.36 -45.96 0.91 Allowed 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.506 -1.278 . . . . 2.02 114.186 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.34 134.01 0.18 Allowed Glycine 0 N--CA 1.468 0.815 0 N-CA-C 117.648 1.819 . . . . 0.17999999999999999 117.648 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 2.1 p -69.77 165.5 21.28 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 112.601 -1.8 . . . . 0.16 111.916 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.893 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 57.8 mt -60.37 99.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 114.711 -1.131 . . . . 0.40000000000000002 112.008 -162.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.691 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 60.8 mtt180 -87.69 148.97 24.53 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.988 -1.46 . . . . 1.8700000000000001 110.685 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.633 ' HG2' HG22 ' A' ' 84' ' ' ILE . 17.5 mtp -126.34 -165.4 1.44 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.217 -0.661 . . . . 0.79000000000000004 109.217 173.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.615 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 12.8 t-80 -93.77 153.39 18.33 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.068 -0.715 . . . . 2.3199999999999998 109.068 172.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.657 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.2 m120 -57.41 -54.8 42.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 118.188 -0.911 . . . . 0.68000000000000005 110.907 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -65.22 -21.97 66.82 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 121.543 1.974 . . . . 2.1800000000000002 112.149 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.615 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.9 m-20 -80.9 -45.79 16.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.096 -0.956 . . . . 0.68999999999999995 111.169 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.591 HG13 HD12 ' A' ' 151' ' ' ILE . 14.9 p -65.8 -20.73 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.554 -0.748 . . . . 0.11 111.052 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.657 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.26 -41.0 16.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 119.006 -0.521 . . . . 0.38 109.889 170.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -45.92 -70.73 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.164 0.893 . . . . 1.99 112.339 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.479 HD22 ' SD ' ' A' ' 145' ' ' MET . 9.4 mp -46.18 -38.56 8.48 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.49 0.662 . . . . 1.27 111.486 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.75 -33.52 76.17 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.376 -1.284 . . . . 0.17999999999999999 111.598 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -88.79 -31.68 18.25 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.487 -0.758 . . . . 0.20999999999999999 112.711 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.2 mt -83.38 -60.1 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.451 0.643 . . . . 0.16 111.679 -172.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.1 m -91.26 139.99 25.6 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 114.969 -1.014 . . . . 0.16 112.158 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.655 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 61.2 Cg_endo -89.09 174.4 3.74 Favored 'Trans proline' 0 CA--C 1.514 -0.492 0 C-N-CA 123.899 3.066 . . . . 0.20000000000000001 111.286 174.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.591 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 58.5 m-20 -67.75 156.07 37.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 119.423 -0.911 . . . . 1.1000000000000001 108.876 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.69 -20.53 50.02 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.246 -0.978 . . . . 0.17999999999999999 112.523 -172.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.568 ' HB ' HD12 ' A' ' 100' ' ' ILE . 53.2 m -63.75 137.74 58.19 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.006 -0.739 . . . . 0.14000000000000001 109.006 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.626 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 18.8 ptt180 -92.48 120.6 33.12 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.944 1.354 . . . . 3.6299999999999999 111.22 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 37.6 t -102.78 106.48 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-N 111.951 -2.386 . . . . 0.14000000000000001 108.875 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.674 HG23 ' CB ' ' A' ' 97' ' ' GLU . 1.8 m -93.74 104.59 16.68 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.257 -0.577 . . . . 0.20999999999999999 112.327 -170.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.622 ' HB ' ' O ' ' A' ' 96' ' ' GLY . 2.4 mp -81.45 93.29 2.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 122.509 1.147 . . . . 0.23999999999999999 109.552 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -103.31 139.15 39.12 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.865 -1.516 . . . . 1.0900000000000001 109.432 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.535 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 6.5 mmt85 -72.14 -14.95 61.96 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.057 -0.52 . . . . 2.0800000000000001 111.115 -176.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.23 22.47 27.17 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 121.137 -0.554 . . . . 1.97 112.064 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 109.225 -0.657 . . . . 3.9100000000000001 109.225 -178.753 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.817 -0.513 . . . . 2.7999999999999998 111.817 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -98.06 125.73 43.17 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.874 -0.417 . . . . 4.4400000000000004 109.874 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.428 ' HB3' ' HE3' ' A' ' 3' ' ' LYS . 28.9 mmmt -128.92 99.44 5.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.886 -0.597 . . . . 2.46 111.191 -175.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.653 HD21 ' HA ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -105.58 175.05 5.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.488 0.661 . . . . 0.65000000000000002 111.969 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.655 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.2 tt -99.09 131.82 44.86 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.717 -1.129 . . . . 0.28000000000000003 110.238 -175.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.7 162.37 13.47 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 122.218 1.008 . . . . 0.31 113.201 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.631 ' HB3' HG13 ' A' ' 46' ' ' ILE . 80.8 t80 -130.72 144.86 51.73 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.723 -1.581 . . . . 0.44 107.859 175.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.425 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 61.5 tt0 -115.85 113.53 23.48 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 108.483 -0.932 . . . . 0.76000000000000001 108.483 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.596 ' HB ' ' O ' ' A' ' 41' ' ' THR . 86.0 t -66.39 152.32 9.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 122.735 1.255 . . . . 0.39000000000000001 113.27 -171.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.0 mtmm -108.68 159.35 16.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.036 -1.893 . . . . 2.0099999999999998 108.54 175.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.453 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 2.2 mm-40 -62.13 113.8 3.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.041 0.448 . . . . 1.8300000000000001 112.044 -174.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.38 10.76 56.73 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.582 -0.735 . . . . 0.47999999999999998 113.669 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.545 ' HB2' HG13 ' A' ' 9' ' ' VAL . 86.3 m-20 -56.2 169.38 0.41 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 117.109 0.454 . . . . 1.46 111.161 173.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.43 ' HB ' ' H ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -128.81 156.69 43.19 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.432 -0.507 . . . . 0.40999999999999998 110.916 173.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.61 HD12 HD23 ' A' ' 29' ' ' LEU . 3.0 tp -66.07 -36.36 83.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.986 0.898 . . . . 0.85999999999999999 109.539 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.461 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 5.1 t30 -85.87 -24.98 26.46 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.342 -1.299 . . . . 1.1499999999999999 110.248 -176.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.43 ' H ' ' HB ' ' A' ' 14' ' ' THR . 39.6 t -65.88 -42.11 90.71 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.127 -0.694 . . . . 1.21 109.127 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 14.8 mt -74.69 -27.01 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.171 0.51 . . . . 0.20999999999999999 109.908 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.636 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.32 -9.98 59.71 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.532 -0.304 . . . . 0.16 110.679 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.621 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.73 -38.62 9.83 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.642 1.21 . . . . 0.20999999999999999 108.155 176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.567 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.3 m-20 -62.28 -45.55 92.76 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.277 -2.238 . . . . 0.53000000000000003 111.689 172.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.556 ' HA ' HG21 ' A' ' 101' ' ' ILE . 58.8 m-85 -98.62 4.8 48.06 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 118.685 -1.206 . . . . 0.17999999999999999 111.667 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.621 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.0 mpt_? 54.78 42.84 30.86 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.689 0.757 . . . . 1.78 109.738 177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.636 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.7 pt -115.41 -165.63 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.548 -1.205 . . . . 0.19 109.883 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.39 142.82 39.8 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.123 -0.944 . . . . 0.94999999999999996 110.118 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.597 ' HB ' HD21 ' A' ' 15' ' ' LEU . 70.6 p -73.23 -31.95 64.44 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.364 -0.976 . . . . 0.25 108.364 178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.67 68.16 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.049 -0.978 . . . . 0.20000000000000001 111.512 169.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -92.89 -27.66 16.97 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.359 0.599 . . . . 0.17000000000000001 109.461 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.647 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 15.2 tp -74.79 -26.64 59.89 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.662 -0.699 . . . . 1.1599999999999999 109.299 174.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 36' ' ' LEU . 42.8 mt -77.62 -30.51 52.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.62 0.724 . . . . 1.05 109.772 171.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 22.6 tt0 -63.74 -43.16 97.3 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.326 -1.306 . . . . 1.8100000000000001 110.002 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.41 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.47 -21.35 32.88 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.357 -0.537 . . . . 0.20000000000000001 111.715 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.601 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.1 m-80 -145.96 82.74 9.07 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-O 121.571 0.7 . . . . 0.23000000000000001 110.642 -171.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.84 -6.13 3.19 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 123.803 3.002 . . . . 0.35999999999999999 113.675 175.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.9 t -80.17 -25.78 39.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.651 0.263 . . . . 1.3799999999999999 111.297 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.812 HD21 HG21 ' A' ' 46' ' ' ILE . 32.0 mt -70.11 -35.1 73.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.57 0.7 . . . . 0.48999999999999999 112.158 -170.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.402 ' H ' ' HG2' ' A' ' 37' ' ' GLN . 2.8 pt20 -65.35 -46.98 78.08 Favored 'General case' 0 CA--C 1.496 -1.111 0 CA-C-O 122.847 1.308 . . . . 1.95 110.296 -175.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.67 -49.74 74.17 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 111.982 -2.372 . . . . 0.48999999999999999 110.479 177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.26 179.36 48.89 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 114.715 -1.129 . . . . 0.41999999999999998 111.332 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.16 157.09 19.76 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.39 0.614 . . . . 0.40999999999999998 110.895 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.596 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 39.7 m -143.31 126.26 16.27 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.231 -0.895 . . . . 0.41999999999999998 110.706 -176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' CB ' ' HG2' ' A' ' 11' ' ' GLN . . . -75.86 116.62 16.75 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.561 0.696 . . . . 0.46999999999999997 109.735 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 105.34 -0.85 40.26 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.192 -1.163 . . . . 0.40999999999999998 110.192 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.568 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.4 tt0 -75.51 123.82 26.11 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.961 -0.62 . . . . 1.3 109.733 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.625 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 58.8 p -80.89 133.13 35.51 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.589 -0.732 . . . . 0.84999999999999998 109.864 176.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.812 HG21 HD21 ' A' ' 36' ' ' LEU . 11.7 pt -134.28 141.61 43.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.498 -1.228 . . . . 0.25 109.22 -178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.434 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -88.68 152.22 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.173 0.511 . . . . 0.67000000000000004 110.713 -179.392 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.413 HG13 ' CE2' ' A' ' 22' ' ' PHE . 38.0 mm -115.89 92.5 34.78 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.97 -1.014 . . . . 0.16 109.412 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.653 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -57.41 132.69 52.32 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.727 2.285 . . . . 0.17999999999999999 112.598 -175.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.65 -2.27 80.01 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 114.825 -1.079 . . . . 0.26000000000000001 112.527 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.695 HD12 ' HD2' ' A' ' 52' ' ' PRO . 34.0 tp -125.4 114.94 25.5 Favored Pre-proline 0 N--CA 1.446 -0.663 0 CA-C-O 121.314 0.578 . . . . 0.60999999999999999 111.139 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.695 ' HD2' HD12 ' A' ' 51' ' ' LEU . 57.6 Cg_endo -79.79 -177.64 3.98 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.716 2.944 . . . . 0.28000000000000003 114.577 -171.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.58 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.7 t70 -80.52 130.97 62.79 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 114.055 -1.429 . . . . 0.48999999999999999 111.602 -173.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 44.1 Cg_endo -71.29 -20.01 28.48 Favored 'Trans proline' 0 CA--C 1.519 -0.263 0 C-N-CA 123.381 2.72 . . . . 0.46000000000000002 113.121 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -96.79 -0.89 47.33 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.418 0.628 . . . . 1.3799999999999999 111.88 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.58 HG23 ' HB3' ' A' ' 53' ' ' ASP . 29.5 p -89.31 -15.58 33.13 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.228 -1.397 . . . . 0.46000000000000002 107.228 169.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 59' ' ' TYR . 18.2 mt -82.53 134.36 48.1 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 112.5 -2.136 . . . . 0.69999999999999996 110.317 175.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -84.1 -16.95 5.93 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.282 1.988 . . . . 0.39000000000000001 113.239 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.567 ' H ' HG22 ' A' ' 57' ' ' ILE . 61.2 m-85 -93.93 155.15 17.31 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.751 -0.38 . . . . 0.23999999999999999 111.859 -177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -146.33 131.72 18.62 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.77 -0.826 . . . . 2.8900000000000001 108.77 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 71' ' ' THR . 91.1 mt -114.95 133.98 59.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.072 0.397 . . . . 0.16 112.072 -175.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.1 121.55 42.48 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.17 -0.612 . . . . 0.16 110.903 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.7 t -101.43 114.59 41.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.884 0.85 . . . . 0.19 111.444 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 68' ' ' LYS . 46.9 m -95.02 102.29 14.09 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.606 -1.179 . . . . 0.20000000000000001 110.743 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.9 mm -50.99 -57.74 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 122.25 1.024 . . . . 0.23000000000000001 111.536 169.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.25 -10.13 5.08 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 112.788 -2.005 . . . . 0.16 113.414 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.57 -18.54 4.79 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.51 0.724 . . . . 0.14999999999999999 112.318 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.534 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.26 56.27 4.58 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.325 0.511 . . . . 0.68999999999999995 111.003 -173.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.7 p -137.31 161.73 35.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 112.719 0.636 . . . . 0.13 112.719 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.456 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.5 tt -130.54 110.74 11.65 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.659 -1.155 . . . . 0.40000000000000002 109.928 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.604 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 36.2 m -92.12 123.47 35.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.022 0.439 . . . . 0.16 111.126 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.3 tp -98.88 104.32 16.35 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.413 -0.812 . . . . 0.58999999999999997 109.481 172.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 19.4 m -105.22 160.18 15.29 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.324 -0.95 . . . . 1.05 110.814 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.745 HD13 ' ND2' ' A' ' 75' ' ' ASN . 1.0 OUTLIER -125.85 127.4 46.01 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.476 -0.935 . . . . 0.26000000000000001 108.476 169.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.745 ' ND2' HD13 ' A' ' 74' ' ' LEU . 8.6 p30 44.64 50.65 8.4 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.075 1.35 . . . . 1.8400000000000001 111.419 -166.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 72.84 -11.83 0.82 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 114.892 -1.049 . . . . 1.8899999999999999 112.041 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -94.56 120.68 35.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.249 0.547 . . . . 3.4399999999999999 110.009 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.46 HG22 ' CG2' ' A' ' 71' ' ' THR . 57.5 t -57.67 132.54 22.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 122.38 1.086 . . . . 0.23999999999999999 112.869 -173.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 6.9 mtm -103.46 -42.86 5.56 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 112.995 -1.911 . . . . 0.81000000000000005 109.447 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -158.53 172.81 17.64 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 113.215 -1.811 . . . . 1.46 109.84 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.3 m -148.65 123.23 9.78 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.228 -1.351 . . . . 0.17000000000000001 109.41 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.521 ' HD2' ' OD2' ' A' ' 149' ' ' ASP . 25.1 m-85 -103.93 148.55 36.03 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.312 -0.858 . . . . 1.05 109.453 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.435 ' HB2' HG22 ' A' ' 134' ' ' ILE . 46.5 Cg_endo -77.58 141.06 19.45 Favored 'Trans proline' 0 CA--C 1.5 -1.209 0 C-N-CA 121.497 1.465 . . . . 0.20000000000000001 110.488 169.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.627 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -139.9 173.25 11.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.934 -0.575 . . . . 0.13 110.907 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.9 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.83 143.34 47.01 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.227 -0.442 . . . . 0.26000000000000001 110.436 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG22 ' HG3' ' A' ' 68' ' ' LYS . 7.5 m -126.58 126.04 68.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.451 0.643 . . . . 0.56000000000000005 112.057 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -89.16 157.17 26.77 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 109.71 -1.356 . . . . 0.17000000000000001 109.71 173.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -57.05 6.61 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 114.582 1.327 . . . . 3.0499999999999998 114.582 -177.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.839 HG23 HD22 ' A' ' 90' ' ' LEU . 1.2 tp -96.88 -14.08 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 121.525 0.679 . . . . 0.23000000000000001 110.565 -177.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.839 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -91.2 -18.09 25.0 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.146 -0.687 . . . . 0.17999999999999999 109.146 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.3 p -67.09 -24.52 65.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.777 -1.101 . . . . 0.33000000000000002 112.132 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.479 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 8.7 mp0 -56.26 -44.35 79.61 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.118 1.367 . . . . 1.52 111.61 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -100.45 119.7 58.17 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.471 -0.786 . . . . 0.42999999999999999 111.635 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.599 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 1.9 Cg_endo -77.36 -19.64 13.12 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.874 2.383 . . . . 0.72999999999999998 113.068 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 t -105.48 -40.52 5.77 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.358 -0.608 . . . . 0.47999999999999998 109.358 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.428 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 43.69 45.89 7.23 Favored Glycine 0 C--N 1.338 0.682 0 O-C-N 124.565 1.165 . . . . 0.33000000000000002 113.903 170.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -83.59 113.09 20.59 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.901 0.858 . . . . 0.83999999999999997 109.723 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.562 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 15.9 m-85 -137.32 175.85 9.24 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.065 -1.425 . . . . 0.22 112.484 -170.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.69 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 79.9 m-85 -142.85 133.07 24.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.652 . . . . 0.54000000000000004 110.896 -174.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.579 HD12 ' HB ' ' A' ' 161' ' ' THR . 82.6 mt -58.02 121.85 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.576 -0.738 . . . . 0.17000000000000001 110.84 172.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.556 HG21 ' HA ' ' A' ' 22' ' ' PHE . 22.7 pt -86.8 -35.25 8.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 113.157 0.799 . . . . 0.20999999999999999 113.157 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.536 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 11.6 p30 179.97 174.03 0.91 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 107.932 -1.136 . . . . 2.0299999999999998 107.932 -176.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.662 ' CB ' HD12 ' A' ' 116' ' ' LEU . 6.7 mtt180 -122.21 161.66 22.82 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.112 -0.635 . . . . 1.52 111.503 -170.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -143.84 102.41 3.9 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.222 0.534 . . . . 0.58999999999999997 110.898 175.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 63.7 ttt180 -65.95 166.89 10.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.38 -0.827 . . . . 2.8199999999999998 110.63 173.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.497 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 24.6 m-80 -35.49 104.52 0.26 Allowed Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 125.529 1.532 . . . . 0.34999999999999998 113.806 -160.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.3 Cg_endo -61.9 -35.58 77.14 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.785 2.324 . . . . 0.47999999999999998 111.745 171.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.97 -35.59 3.88 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.398 -0.681 . . . . 0.67000000000000004 111.398 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.97 -175.89 42.78 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.229 -0.485 . . . . 0.62 112.437 176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 112' ' ' GLY . 25.8 Cg_endo -59.05 -0.34 0.57 Allowed 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 124.91 3.74 . . . . 0.93999999999999995 115.035 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -69.21 30.88 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 112.967 0.728 . . . . 1.23 112.967 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.81 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 58.65 64.9 3.89 Favored Glycine 0 C--O 1.217 -0.927 0 N-CA-C 116.202 1.241 . . . . 1.6899999999999999 116.202 161.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.597 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.34 -8.18 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 117.97 2.582 . . . . 0.47999999999999998 117.97 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.599 ' CE2' ' HB1' ' A' ' 154' ' ' ALA . 0.8 OUTLIER -163.29 151.77 13.97 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.085 0.857 . . . . 0.28000000000000003 110.117 -176.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -135.16 98.3 3.95 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.227 -1.027 . . . . 0.48999999999999999 108.227 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.662 HD12 ' CB ' ' A' ' 103' ' ' ARG . 0.6 OUTLIER -85.79 118.56 25.37 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 121.097 -1.002 . . . . 0.66000000000000003 109.877 174.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.523 ' HB3' HD11 ' A' ' 101' ' ' ILE . 36.9 m -83.45 145.63 28.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.638 -0.71 . . . . 0.19 111.411 -170.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.764 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -109.73 170.5 8.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 0.13 110.797 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.567 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -62.87 -13.11 30.02 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.936 0.717 . . . . 1.1699999999999999 112.936 -178.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.602 ' HB3' ' CG ' ' A' ' 123' ' ' TYR . 5.2 tptp -126.06 130.9 52.05 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.52 -0.472 . . . . 1.22 110.756 175.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.452 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 67.6 mt-30 -30.97 -58.99 0.22 Allowed 'General case' 0 C--N 1.317 -0.827 0 O-C-N 124.733 1.271 . . . . 1.51 114.054 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.643 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -96.08 8.19 44.42 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 119.551 -0.86 . . . . 2.5299999999999998 111.706 -171.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.764 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.3 m-85 -94.88 37.48 1.14 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.877 1.065 . . . . 0.83999999999999997 113.877 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.608 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -114.57 143.74 18.13 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 116.865 -2.588 . . . . 0.32000000000000001 112.665 -153.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -97.09 112.29 28.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.937 0.875 . . . . 0.17999999999999999 110.451 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.756 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.0 p80 -142.64 172.21 13.0 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.078 -0.964 . . . . 0.20999999999999999 109.592 -177.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.81 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.7 -179.92 38.87 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 119.969 -1.11 . . . . 0.27000000000000002 111.791 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.565 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 11.5 t -142.89 170.96 14.73 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.79 -0.448 . . . . 0.40999999999999998 109.79 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -114.48 -4.75 12.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.9 0.857 . . . . 1.99 108.705 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -112.26 87.91 9.86 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 114.563 -1.198 . . . . 1.3600000000000001 108.178 168.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -73.4 -19.69 21.77 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.744 2.296 . . . . 0.34999999999999998 113.601 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.97 0.19 28.52 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.227 0.537 . . . . 0.33000000000000002 111.112 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 52.6 m -94.51 -1.49 53.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 1.3500000000000001 109.628 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.435 HG22 ' HB2' ' A' ' 83' ' ' PRO . 44.0 mm -82.83 137.82 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.98 -0.555 . . . . 0.20999999999999999 110.5 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.89 0.82 77.54 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.922 -1.271 . . . . 0.14999999999999999 109.922 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -111.68 167.42 10.36 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 122.932 1.349 . . . . 2.5 113.73 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.468 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -96.27 120.06 35.88 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 112.174 -2.285 . . . . 0.17000000000000001 107.442 173.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.35 160.47 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 108.508 -0.923 . . . . 0.66000000000000003 108.508 -172.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.588 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.1 m -52.55 -60.93 2.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 111.974 0.361 . . . . 0.42999999999999999 111.974 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -131.62 -46.57 0.97 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.09 -1.444 . . . . 2.02 113.78 -172.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.48 133.69 0.2 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 117.758 1.863 . . . . 0.17999999999999999 117.758 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.608 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 6.3 p -68.56 166.02 17.93 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 112.291 -1.954 . . . . 0.16 111.756 176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.9 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 59.5 mt -59.48 98.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 122.596 1.189 . . . . 0.40000000000000002 112.114 -163.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.756 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 75.5 mtt180 -87.06 147.76 25.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.461 -1.7 . . . . 1.8700000000000001 110.7 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.627 ' HG2' HG22 ' A' ' 84' ' ' ILE . 12.7 mtp -125.29 -165.5 1.41 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.295 -0.632 . . . . 0.79000000000000004 109.295 173.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.657 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 25.4 t-80 -95.86 153.99 17.46 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.538 -0.755 . . . . 2.3199999999999998 108.997 173.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.646 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.5 m120 -57.11 -54.4 47.15 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.193 -0.908 . . . . 0.68000000000000005 110.856 -174.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.411 ' HG2' ' ND1' ' A' ' 146' ' ' HIS . 0.8 OUTLIER -63.93 -23.81 67.49 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 121.516 1.962 . . . . 2.1800000000000002 111.823 -175.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.657 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.3 m-20 -78.5 -46.72 18.95 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.01 -0.996 . . . . 0.68999999999999995 110.725 -176.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.583 HG13 HD12 ' A' ' 151' ' ' ILE . 13.7 p -67.97 -24.15 30.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.094 -0.957 . . . . 0.11 111.663 177.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.646 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -78.71 -39.41 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 109.483 -0.562 . . . . 0.38 109.483 171.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 156' ' ' ILE . 22.7 mt-10 -46.54 -72.01 0.06 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.901 0.773 . . . . 1.99 112.261 168.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.508 HD21 ' CE1' ' A' ' 82' ' ' TYR . 43.4 mt -49.79 -40.31 41.16 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.751 0.786 . . . . 1.27 111.532 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.599 ' HB1' ' CE2' ' A' ' 114' ' ' TYR . . . -56.14 -39.97 73.07 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.968 -1.469 . . . . 0.17999999999999999 111.415 176.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.2 t -87.86 -33.65 18.48 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.542 0.942 . . . . 0.20999999999999999 113.542 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 152' ' ' GLU . 43.7 mt -80.57 -60.2 2.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.617 0.723 . . . . 0.16 112.034 -170.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.9 m -86.61 145.69 39.91 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.793 -1.094 . . . . 0.16 112.049 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.493 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 63.8 Cg_endo -90.72 173.0 3.13 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.875 3.05 . . . . 0.20000000000000001 110.91 172.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.536 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 22.0 m-20 -64.87 158.23 25.72 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.744 -0.782 . . . . 1.1000000000000001 109.134 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 97.41 -19.63 53.95 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.079 -1.058 . . . . 0.17999999999999999 112.529 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' HD12 ' A' ' 100' ' ' ILE . 59.1 m -62.76 136.81 58.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.15 -0.685 . . . . 0.14000000000000001 109.15 -175.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.69 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -92.61 122.7 35.28 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.771 1.272 . . . . 3.6299999999999999 111.18 -169.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.13 108.63 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 112.25 -2.25 . . . . 0.14000000000000001 109.159 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.3 m -94.23 107.7 19.62 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.521 0.563 . . . . 0.20999999999999999 112.521 -171.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.428 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -86.14 97.41 5.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.991 0.9 . . . . 0.23999999999999999 110.253 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -110.98 135.52 51.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.853 -1.067 . . . . 1.0900000000000001 111.203 -173.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.599 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 14.8 mmm-85 -78.3 64.84 3.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.474 0.654 . . . . 2.0800000000000001 109.701 172.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -140.28 158.67 25.99 Favored Glycine 0 N--CA 1.433 -1.553 0 CA-C-N 115.124 -0.944 . . . . 1.97 111.404 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.836 0.318 . . . . 3.9100000000000001 110.356 -179.68 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 111.686 -0.565 . . . . 2.7999999999999998 111.686 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -78.3 161.92 26.88 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.222 0.534 . . . . 4.4400000000000004 110.883 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -108.61 105.19 14.69 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.4 -0.818 . . . . 2.46 110.699 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.576 HD13 ' HA ' ' A' ' 49' ' ' PRO . 20.3 mt -96.01 174.84 6.73 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.569 -0.741 . . . . 0.65000000000000002 110.872 177.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.8 tt -88.81 129.18 35.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.505 -0.77 . . . . 0.28000000000000003 109.756 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.14 161.11 14.11 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.138 -0.937 . . . . 0.31 112.944 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.6 ' HB3' HG13 ' A' ' 46' ' ' ILE . 86.2 t80 -129.6 140.66 51.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.715 -1.584 . . . . 0.44 107.781 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.438 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 63.3 tt0 -114.23 111.79 22.09 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.907 -1.145 . . . . 0.76000000000000001 107.907 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.653 HG13 ' HB2' ' A' ' 13' ' ' ASP . 97.7 t -66.2 151.2 10.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.353 1.073 . . . . 0.39000000000000001 112.697 -169.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -108.02 158.07 17.7 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 113.554 -1.657 . . . . 2.0099999999999998 108.325 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.62 107.34 0.38 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.183 0.516 . . . . 1.8300000000000001 112.092 -175.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.77 11.79 39.49 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.686 -0.688 . . . . 0.47999999999999998 113.57 172.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.653 ' HB2' HG13 ' A' ' 9' ' ' VAL . 70.9 m-20 -55.97 167.63 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.953 0.376 . . . . 1.46 110.961 172.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -128.19 152.96 47.42 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.914 0.388 . . . . 0.40999999999999998 111.176 174.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.526 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -64.38 -38.86 92.52 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.103 -1.073 . . . . 0.85999999999999999 108.103 -177.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.409 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 65.3 t30 -86.44 -22.04 26.74 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.512 -1.222 . . . . 1.1499999999999999 110.715 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.446 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 17.4 t -67.98 -40.12 83.18 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 109.177 -0.675 . . . . 1.21 109.177 171.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.2 mt -75.32 -27.78 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-O 121.146 0.498 . . . . 0.20999999999999999 109.937 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.54 -10.01 59.72 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.517 -0.31 . . . . 0.16 110.795 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.707 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.09 -40.27 9.31 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 107.929 -1.137 . . . . 0.20999999999999999 107.929 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 3.0 m-20 -62.19 -42.77 99.59 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 112.544 -2.116 . . . . 0.53000000000000003 112.303 173.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 119' ' ' SER . 57.5 m-85 -99.42 6.73 45.93 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 118.876 -1.13 . . . . 0.17999999999999999 111.129 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.707 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.76 41.06 32.2 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-O 121.765 0.793 . . . . 1.78 109.541 176.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.62 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.8 pt -116.8 -165.33 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 114.287 -1.324 . . . . 0.19 110.215 -178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.52 143.88 40.19 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.99 -1.005 . . . . 0.94999999999999996 110.244 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.526 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 44.3 p -72.18 -31.76 66.21 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.037 -1.097 . . . . 0.25 108.037 177.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -31.09 69.98 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.703 -0.68 . . . . 0.20000000000000001 111.659 171.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.32 -28.27 17.85 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 121.641 0.734 . . . . 0.17000000000000001 109.029 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.568 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -73.67 -28.04 61.55 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.046 -0.979 . . . . 1.1599999999999999 109.404 174.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 36' ' ' LEU . 42.5 mt -76.63 -30.99 57.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.836 0.827 . . . . 1.05 109.991 170.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 43.3 tt0 -65.61 -33.75 76.63 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.19 -1.368 . . . . 1.8100000000000001 110.095 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -88.57 -22.74 23.39 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 119.849 -0.74 . . . . 0.20000000000000001 111.805 173.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.643 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 19.1 m-80 -147.85 82.7 7.76 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.41 0.624 . . . . 0.23000000000000001 110.517 -171.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.26 -15.93 16.07 Favored 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 124.124 3.216 . . . . 0.35999999999999999 114.03 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 t -74.72 -22.65 58.71 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.75 0.31 . . . . 1.3799999999999999 111.391 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.71 HD21 HG21 ' A' ' 46' ' ' ILE . 35.6 mt -69.45 -36.11 76.31 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.568 0.581 . . . . 0.48999999999999999 112.568 -169.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 5.4 pt20 -64.07 -45.17 89.93 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 122.917 1.342 . . . . 1.95 110.135 -175.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.64 -49.04 79.12 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 111.796 -2.456 . . . . 0.48999999999999999 110.712 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.87 -179.85 48.11 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 114.932 -1.031 . . . . 0.41999999999999998 111.693 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.43 158.97 22.69 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.204 0.526 . . . . 0.40999999999999998 110.66 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.546 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 60.4 m -139.35 127.89 23.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.542 -0.754 . . . . 0.41999999999999998 110.385 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.49 121.51 21.61 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.576 0.703 . . . . 0.46999999999999997 110.313 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.438 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.7 3.56 60.89 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 114.733 -1.121 . . . . 0.40999999999999998 110.468 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.546 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -80.22 124.93 29.24 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.202 -0.499 . . . . 1.3 109.91 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 14.8 m -77.7 130.35 36.68 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.152 -0.931 . . . . 0.84999999999999998 109.781 176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.71 HG21 HD21 ' A' ' 36' ' ' LEU . 6.7 pt -132.01 143.63 39.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.671 -1.15 . . . . 0.25 109.085 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.422 HG12 ' HB2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -90.69 153.74 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.311 0.576 . . . . 0.67000000000000004 111.612 -178.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.5 mm -118.24 93.6 45.3 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.597 -1.183 . . . . 0.16 109.03 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.576 ' HA ' HD13 ' A' ' 4' ' ' LEU . 2.5 Cg_endo -59.05 137.39 79.28 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.775 2.316 . . . . 0.17999999999999999 112.745 -174.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.46 -6.24 83.8 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.906 -1.043 . . . . 0.26000000000000001 112.387 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.743 HD12 ' HD2' ' A' ' 52' ' ' PRO . 26.9 tp -122.73 118.05 28.57 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 120.904 0.383 . . . . 0.60999999999999999 110.721 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.743 ' HD2' HD12 ' A' ' 51' ' ' LEU . 57.9 Cg_endo -80.3 -176.68 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.649 2.9 . . . . 0.28000000000000003 114.037 -172.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.538 ' HB3' HG23 ' A' ' 56' ' ' THR . 13.3 t70 -80.69 132.25 58.48 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-N 114.726 -1.124 . . . . 0.48999999999999999 111.629 -171.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.577 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.8 Cg_endo -76.28 -16.13 17.63 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 123.395 2.73 . . . . 0.46000000000000002 112.694 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -95.58 -1.04 51.23 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.706 0.765 . . . . 1.3799999999999999 110.135 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 53' ' ' ASP . 27.1 p -94.66 -16.98 22.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 122.657 1.217 . . . . 0.46000000000000002 107.822 173.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.533 HG22 ' H ' ' A' ' 59' ' ' TYR . 25.6 mt -78.64 128.73 76.35 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 112.947 -1.933 . . . . 0.69999999999999996 111.132 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.417 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 97.8 Cg_endo -76.75 -17.23 15.99 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.444 2.096 . . . . 0.39000000000000001 113.194 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.533 ' H ' HG22 ' A' ' 57' ' ' ILE . 61.4 m-85 -94.74 164.91 12.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.392 -0.523 . . . . 0.23999999999999999 112.153 -176.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -152.68 128.01 9.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.533 -0.914 . . . . 2.8900000000000001 108.533 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 71' ' ' THR . 95.4 mt -110.02 132.67 57.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.135 -0.484 . . . . 0.16 111.759 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.21 117.01 28.85 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.004 -0.678 . . . . 0.16 111.09 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.84 112.85 31.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.814 0.816 . . . . 0.19 111.273 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 16.5 m -93.23 102.73 15.02 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 114.682 -1.145 . . . . 0.20000000000000001 110.543 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.546 HD13 HG11 ' A' ' 86' ' ' VAL . 50.5 mm -52.15 -58.49 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 122.04 0.924 . . . . 0.23000000000000001 111.213 169.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.22 -11.39 3.34 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 112.955 -1.93 . . . . 0.16 113.244 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.72 -18.6 4.71 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.572 0.749 . . . . 0.14999999999999999 112.455 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER 57.77 56.39 4.84 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.555 0.616 . . . . 0.68999999999999995 111.431 -172.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.5 p -137.66 161.49 36.34 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 112.669 0.618 . . . . 0.13 112.669 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -131.49 113.4 13.64 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.704 -1.135 . . . . 0.40000000000000002 110.122 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 66.7 m -94.23 122.95 37.3 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.324 0.583 . . . . 0.16 111.542 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 79' ' ' MET . 15.5 tp -97.56 103.2 15.12 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.906 -1.043 . . . . 0.58999999999999997 109.369 172.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 13.2 m -105.47 159.93 15.54 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.475 -0.89 . . . . 1.05 110.579 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.918 HD13 HD22 ' A' ' 75' ' ' ASN . 1.2 tm? -126.73 128.37 46.55 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.853 -0.795 . . . . 0.26000000000000001 108.853 169.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.918 HD22 HD13 ' A' ' 74' ' ' LEU . 6.6 p30 43.61 49.01 6.53 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.128 1.371 . . . . 1.8400000000000001 111.574 -167.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 84.2 m-20 75.85 -11.99 1.05 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.127 -0.942 . . . . 1.8899999999999999 112.317 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -96.99 120.82 38.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.207 0.527 . . . . 3.4399999999999999 110.095 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.494 HG22 ' CG2' ' A' ' 71' ' ' THR . 55.1 t -56.15 132.44 20.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 122.316 1.055 . . . . 0.23999999999999999 112.998 -174.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 7.9 mtm -102.59 -43.83 5.51 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.074 -1.875 . . . . 0.81000000000000005 109.285 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.6 mmtt -157.92 172.15 18.98 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 113.107 -1.861 . . . . 1.46 109.874 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.0 m -149.8 122.28 8.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.417 -1.265 . . . . 0.17000000000000001 109.808 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -109.71 145.82 32.77 Favored Pre-proline 0 C--N 1.308 -1.205 0 CA-C-N 115.454 -0.794 . . . . 1.05 109.637 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.446 ' HB2' HG22 ' A' ' 134' ' ' ILE . 41.7 Cg_endo -74.61 142.12 28.78 Favored 'Trans proline' 0 CA--C 1.499 -1.26 0 C-N-CA 121.902 1.734 . . . . 0.20000000000000001 110.903 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.663 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.01 175.71 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.922 -0.581 . . . . 0.13 110.717 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.879 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -120.76 148.55 43.82 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.418 -0.355 . . . . 0.26000000000000001 110.092 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG11 HD13 ' A' ' 65' ' ' ILE . 9.6 m -128.75 129.76 68.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.481 0.658 . . . . 0.56000000000000005 111.899 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.6 154.6 27.23 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.21 -1.156 . . . . 0.17000000000000001 110.21 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -56.27 3.08 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.321 0.86 . . . . 3.0499999999999998 113.321 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.917 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -89.17 -19.96 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 121.534 0.683 . . . . 0.23000000000000001 110.417 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.917 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -89.72 -18.25 26.73 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.716 0.77 . . . . 0.17999999999999999 109.288 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.9 p -66.81 -14.47 62.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.385 -1.279 . . . . 0.33000000000000002 111.649 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.3 -39.56 89.41 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.74 -1.118 . . . . 1.52 111.973 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.51 130.97 22.17 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.571 -0.452 . . . . 0.42999999999999999 111.028 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.658 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 87.0 Cg_endo -90.1 -13.87 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.7 2.267 . . . . 0.72999999999999998 112.73 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.0 t -104.92 -41.0 5.74 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.758 -0.656 . . . . 0.47999999999999998 109.25 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.553 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 44.87 46.04 9.21 Favored Glycine 0 N--CA 1.446 -0.644 0 O-C-N 124.404 1.065 . . . . 0.33000000000000002 113.692 171.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.79 111.37 19.13 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.891 0.853 . . . . 0.83999999999999997 109.557 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.719 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 21.4 m-85 -139.41 171.94 13.53 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 113.89 -1.505 . . . . 0.22 112.366 -171.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.58 ' CD1' ' HB3' ' A' ' 162' ' ' ARG . 28.2 m-85 -140.99 136.15 31.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.739 -0.664 . . . . 0.54000000000000004 110.131 -176.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.55 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.1 mt -58.62 123.23 10.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.421 -0.809 . . . . 0.17000000000000001 110.55 172.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.55 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.8 pt -88.05 -44.08 15.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 113.014 0.746 . . . . 0.20999999999999999 113.014 -176.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.462 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 56.2 m-80 -171.69 169.54 5.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 106.783 -1.562 . . . . 2.0299999999999998 106.783 -169.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.596 ' HB3' HD23 ' A' ' 116' ' ' LEU . 5.6 mtt180 -128.17 163.45 24.65 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.773 -0.771 . . . . 1.52 112.198 -173.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.4 tt0 -136.85 99.91 4.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.921 -1.036 . . . . 0.58999999999999997 109.713 172.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.475 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 30.8 ttp180 -67.05 166.52 13.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.24 -0.891 . . . . 2.8199999999999998 111.006 176.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.475 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 29.1 m-80 -36.44 102.23 0.23 Allowed Pre-proline 0 CA--C 1.518 -0.28 0 C-N-CA 125.439 1.496 . . . . 0.34999999999999998 113.951 -152.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 14.5 Cg_exo -54.69 -51.68 9.85 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.513 2.809 . . . . 0.47999999999999998 111.528 170.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.73 -31.83 5.95 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.279 -1.128 . . . . 0.67000000000000004 110.279 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.91 -174.81 37.54 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 114.48 -0.86 . . . . 0.62 112.477 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -57.64 -10.03 6.45 Favored 'Trans proline' 0 N--CA 1.479 0.629 0 C-N-CA 124.879 3.719 . . . . 0.93999999999999995 114.766 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -63.45 -3.56 2.15 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.434 1.272 . . . . 1.23 114.434 -172.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.682 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 90.11 64.53 1.23 Allowed Glycine 0 CA--C 1.497 -1.032 0 C-N-CA 119.053 -1.546 . . . . 1.6899999999999999 115.182 167.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.533 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.89 -1.97 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 116.915 2.191 . . . . 0.47999999999999998 116.915 -175.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.507 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.3 OUTLIER -166.06 161.35 17.2 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.385 -0.822 . . . . 0.28000000000000003 110.028 -177.007 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 12.6 t-105 -141.83 98.93 3.43 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.25 -1.018 . . . . 0.48999999999999999 108.25 166.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 103' ' ' ARG . 4.4 mt -91.95 114.49 27.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.521 0.677 . . . . 0.66000000000000003 109.414 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.425 ' HB3' HD11 ' A' ' 101' ' ' ILE . 26.0 m -84.23 144.55 28.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.986 -0.552 . . . . 0.19 111.368 -169.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -108.35 172.14 7.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.903 -0.59 . . . . 0.13 110.568 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.533 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -64.49 -11.14 30.77 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.894 0.701 . . . . 1.1699999999999999 112.894 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.735 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.3 tmtp? -126.51 130.61 50.94 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 120.626 -0.43 . . . . 1.22 110.405 174.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.735 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.2 mt-30 -34.77 -54.88 0.57 Allowed 'General case' 0 C--N 1.311 -1.074 0 O-C-N 124.953 1.408 . . . . 1.51 113.555 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.59 ' CB ' HG12 ' A' ' 89' ' ' ILE . 46.8 m80 -91.19 -1.49 57.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.867 -0.606 . . . . 2.5299999999999998 111.216 -169.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.777 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -94.29 37.88 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.534 0.938 . . . . 0.83999999999999997 113.534 -171.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.644 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.23 144.41 18.42 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 117.026 -2.511 . . . . 0.32000000000000001 112.601 -153.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.507 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -96.78 114.89 34.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 123.775 0.83 . . . . 0.17999999999999999 110.763 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.445 ' O ' ' N ' ' A' ' 145' ' ' MET . 26.8 p80 -143.53 175.97 9.54 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.4 -0.818 . . . . 0.20999999999999999 109.721 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.682 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.65 -166.98 37.8 Favored Glycine 0 C--N 1.314 -0.672 0 C-N-CA 120.49 -0.862 . . . . 0.27000000000000002 111.816 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.546 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 14.3 t -157.24 171.4 20.49 Favored 'General case' 0 C--N 1.317 -0.819 0 O-C-N 122.063 -0.669 . . . . 0.40999999999999998 110.627 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -115.12 -2.16 12.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.286 -1.005 . . . . 1.99 108.286 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -113.19 85.78 8.75 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 114.506 -1.224 . . . . 1.3600000000000001 108.669 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -74.25 -19.07 20.2 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.363 2.042 . . . . 0.34999999999999998 113.102 -170.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.51 -2.29 49.26 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.733 -0.667 . . . . 0.33000000000000002 110.35 -178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.2 t -89.33 -6.33 56.77 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.042 -0.725 . . . . 1.3500000000000001 109.042 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' ' 83' ' ' PRO . 39.6 mm -81.82 137.11 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.485 -0.78 . . . . 0.20999999999999999 110.392 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.91 2.19 69.5 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 110.172 -1.171 . . . . 0.14999999999999999 110.172 -174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.41 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 42.9 mttt -115.12 171.77 7.47 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 123.178 1.466 . . . . 2.5 114.0 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.51 126.73 50.84 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 111.613 -2.54 . . . . 0.17000000000000001 107.736 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.407 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -122.5 159.73 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 108.662 -0.866 . . . . 0.66000000000000003 108.662 -174.467 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.9 m -49.5 -60.01 3.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.699 0.629 . . . . 0.42999999999999999 112.699 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -132.74 -44.79 0.88 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.614 -1.234 . . . . 2.02 113.549 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.46 133.19 0.21 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 117.077 1.591 . . . . 0.17999999999999999 117.077 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.457 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.8 p -70.59 165.72 22.19 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 112.353 -1.923 . . . . 0.16 111.808 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.879 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 57.6 mt -59.7 98.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 122.393 1.092 . . . . 0.40000000000000002 112.002 -163.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 134' ' ' ILE . 9.8 mtp180 -85.06 148.52 26.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.515 -1.675 . . . . 1.8700000000000001 109.937 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.663 ' HG2' HG22 ' A' ' 84' ' ' ILE . 14.8 mtp -127.52 -165.9 1.54 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.33 -0.619 . . . . 0.79000000000000004 109.33 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.735 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 10.5 t-160 -95.96 154.49 17.21 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.523 -0.917 . . . . 2.3199999999999998 108.523 172.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.9 m120 -58.2 -51.1 71.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 118.388 -0.815 . . . . 0.68000000000000005 110.641 -176.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -64.42 -22.64 67.02 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 121.223 1.829 . . . . 2.1800000000000002 112.516 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.735 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 13.3 m-20 -85.3 -42.46 14.59 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.036 -0.529 . . . . 0.68999999999999995 111.263 -176.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.637 HG13 HD12 ' A' ' 151' ' ' ILE . 14.7 p -67.78 -23.03 28.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.913 -0.585 . . . . 0.11 111.193 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.637 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.78 -40.66 16.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 118.846 -0.597 . . . . 0.38 110.02 171.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.8 mm-40 -44.59 -72.57 0.06 Allowed 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 119.426 1.012 . . . . 1.99 112.293 168.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.529 ' O ' HG22 ' A' ' 157' ' ' VAL . 49.7 mt -47.42 -40.08 17.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.686 0.755 . . . . 1.27 111.269 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.05 77.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.098 -1.41 . . . . 0.17999999999999999 111.785 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.3 t -89.01 -31.78 17.93 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.56 -0.713 . . . . 0.20999999999999999 112.694 176.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 152' ' ' GLU . 28.5 mt -82.0 -60.53 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.612 0.72 . . . . 0.16 111.339 -172.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.3 m -89.19 140.74 28.86 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.786 -1.097 . . . . 0.16 111.907 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -88.17 173.84 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.969 3.113 . . . . 0.20000000000000001 111.062 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.462 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 77.4 m-20 -65.41 155.76 34.41 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 119.723 -0.791 . . . . 1.1000000000000001 109.187 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.6 -20.02 52.07 Favored Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.125 -1.036 . . . . 0.17999999999999999 112.494 -173.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.55 ' HB ' HD12 ' A' ' 100' ' ' ILE . 91.2 m -63.21 138.03 58.41 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 117.419 0.61 . . . . 0.14000000000000001 109.476 -174.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.58 ' HB3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -93.03 123.31 36.19 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.784 1.278 . . . . 3.6299999999999999 111.002 -169.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.95 108.56 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 111.94 -2.391 . . . . 0.14000000000000001 109.022 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.8 m -94.43 108.05 19.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.069 -0.514 . . . . 0.20999999999999999 112.307 -171.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.553 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.19 101.15 7.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 122.152 0.977 . . . . 0.23999999999999999 109.963 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -108.43 128.36 54.71 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.389 -1.278 . . . . 1.0900000000000001 109.794 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.658 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 18.3 mmm180 -69.5 -20.77 63.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.838 0.351 . . . . 2.0800000000000001 111.008 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 91.39 15.87 54.35 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 120.984 -0.627 . . . . 1.97 112.202 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.326 -0.426 0 N-CA-C 110.768 -0.086 . . . . 3.9100000000000001 110.768 -177.806 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 112.105 -0.398 . . . . 2.7999999999999998 112.105 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -124.44 171.66 9.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.368 0.604 . . . . 4.4400000000000004 110.975 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -122.78 101.95 7.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.957 -1.019 . . . . 2.46 108.668 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp -101.06 173.85 6.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.701 0.762 . . . . 0.65000000000000002 112.824 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.646 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.0 tt -102.54 133.04 48.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.5 -1.227 . . . . 0.28000000000000003 110.265 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.39 162.96 12.73 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.41 1.1 . . . . 0.31 113.839 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.644 ' HB3' HG13 ' A' ' 46' ' ' ILE . 87.8 t80 -129.14 140.29 51.6 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.243 -1.799 . . . . 0.44 107.596 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.442 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.9 tt0 -112.89 112.64 24.26 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.185 -1.042 . . . . 0.76000000000000001 108.185 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.605 HG13 ' HB2' ' A' ' 13' ' ' ASP . 92.7 t -65.7 149.67 11.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 122.264 1.031 . . . . 0.39000000000000001 112.679 -171.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -106.27 159.48 16.08 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.768 -1.56 . . . . 2.0099999999999998 108.487 171.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -61.41 106.06 0.59 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.213 0.53 . . . . 1.8300000000000001 112.379 -172.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.7 11.2 35.84 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.518 -0.765 . . . . 0.47999999999999998 113.395 172.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.605 ' HB2' HG13 ' A' ' 9' ' ' VAL . 84.1 m-20 -53.69 167.62 0.23 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.829 0.347 . . . . 1.46 111.006 172.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 17' ' ' SER . 0.0 OUTLIER -125.95 150.86 47.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.229 0.538 . . . . 0.40999999999999998 111.145 175.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.66 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -63.95 -38.14 89.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.16 -1.052 . . . . 0.85999999999999999 108.16 -178.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.52 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -84.69 -25.9 28.09 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.37 -1.286 . . . . 1.1499999999999999 110.532 -177.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.466 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 30.7 t -64.62 -43.25 94.34 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.396 -0.594 . . . . 1.21 109.396 173.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.7 mt -72.8 -26.69 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 121.15 0.5 . . . . 0.20999999999999999 109.692 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.601 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.73 -11.18 59.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.251 -0.431 . . . . 0.16 110.531 174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.691 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -90.9 -41.94 10.87 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.595 0.712 . . . . 0.20999999999999999 109.77 171.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.749 ' HB3' ' O ' ' A' ' 119' ' ' SER . 83.6 m-20 -61.65 -44.65 96.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.247 -1.342 . . . . 0.53000000000000003 111.473 176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.594 ' CE2' ' HB3' ' A' ' 119' ' ' SER . 54.3 m-85 -99.47 6.63 45.88 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 118.69 -1.204 . . . . 0.17999999999999999 111.471 -177.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.691 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER 53.87 43.26 31.18 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.71 0.767 . . . . 1.78 109.616 177.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.601 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 36.2 pt -115.75 -165.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.773 -1.103 . . . . 0.19 110.35 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.71 142.87 40.29 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.916 -1.038 . . . . 0.94999999999999996 109.801 174.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.574 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 68.2 p -72.95 -30.88 64.2 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.626 -0.879 . . . . 0.25 108.626 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.05 -27.06 69.15 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.494 -0.776 . . . . 0.20000000000000001 111.625 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.618 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -94.31 -27.11 16.28 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.573 0.701 . . . . 0.17000000000000001 109.148 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.66 HD23 HD23 ' A' ' 15' ' ' LEU . 17.8 tp -73.55 -28.43 61.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.153 -0.93 . . . . 1.1599999999999999 108.636 172.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 26' ' ' THR . 7.7 tp -78.52 -28.79 46.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.582 0.706 . . . . 1.05 109.769 175.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.618 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -58.48 -60.48 3.74 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.472 -1.307 . . . . 1.8100000000000001 107.472 167.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.439 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -71.57 -17.41 62.3 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 120.313 -0.555 . . . . 0.20000000000000001 110.973 -169.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.61 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.7 m-80 -146.99 81.04 9.19 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-N 115.729 -0.669 . . . . 0.23000000000000001 110.532 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.87 -10.32 5.41 Favored 'Trans proline' 0 C--N 1.324 -0.752 0 C-N-CA 124.065 3.177 . . . . 0.35999999999999999 113.411 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.3 m -78.62 -19.91 51.59 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 111.841 0.312 . . . . 1.3799999999999999 111.841 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.704 HD21 HG21 ' A' ' 46' ' ' ILE . 63.1 mt -70.63 -34.49 72.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.312 0.577 . . . . 0.48999999999999999 112.205 -171.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.438 ' CB ' HD11 ' A' ' 30' ' ' LEU . 3.8 pt20 -64.4 -47.21 80.07 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-O 122.805 1.288 . . . . 1.95 110.539 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.59 -49.67 75.65 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 111.729 -2.487 . . . . 0.48999999999999999 110.242 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.38 178.93 48.65 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 114.775 -1.102 . . . . 0.41999999999999998 111.912 177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 157.35 19.43 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.392 0.615 . . . . 0.40999999999999998 110.619 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.616 ' HB ' ' HB2' ' A' ' 44' ' ' GLN . 83.5 m -143.62 130.89 20.83 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.169 -0.923 . . . . 0.41999999999999998 110.062 -176.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.75 120.08 20.64 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.526 0.679 . . . . 0.46999999999999997 110.221 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.442 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 101.35 0.97 53.82 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.709 -1.356 . . . . 0.40999999999999998 109.709 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.616 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 47.4 tt0 -72.74 123.62 23.68 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 114.148 -1.026 . . . . 1.3 109.915 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 15.7 p -84.11 127.28 33.81 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-O 122.019 0.914 . . . . 0.84999999999999998 110.068 175.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.704 HG21 HD21 ' A' ' 36' ' ' LEU . 10.9 pt -127.33 140.72 48.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 114.178 -1.374 . . . . 0.25 109.033 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.15 150.7 3.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 120.995 0.426 . . . . 0.67000000000000004 110.885 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.2 mm -114.83 92.9 31.84 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 114.731 -1.122 . . . . 0.16 108.845 -178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.652 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.8 Cg_endo -58.65 132.96 51.13 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.69 2.26 . . . . 0.17999999999999999 112.835 -174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.05 -5.79 72.3 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 114.703 -1.135 . . . . 0.26000000000000001 111.983 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.658 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 38.7 tp -123.82 115.67 27.89 Favored Pre-proline 0 N--CA 1.448 -0.569 0 CA-C-O 121.222 0.534 . . . . 0.60999999999999999 111.75 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.653 ' HD2' HD12 ' A' ' 51' ' ' LEU . 61.1 Cg_endo -81.57 -176.74 3.22 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 124.204 3.27 . . . . 0.28000000000000003 114.808 -172.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.562 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.6 t70 -81.04 128.96 69.3 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 113.968 -1.469 . . . . 0.48999999999999999 112.269 -170.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 52.3 Cg_endo -73.87 -14.36 24.03 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 123.629 2.886 . . . . 0.46000000000000002 113.139 -177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.84 -5.6 37.92 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.891 -0.595 . . . . 1.3799999999999999 111.402 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.562 HG23 ' HB3' ' A' ' 53' ' ' ASP . 28.0 p -89.15 -21.87 23.11 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.49 -1.3 . . . . 0.46000000000000002 107.49 171.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 59' ' ' TYR . 21.2 mt -75.23 128.04 85.32 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 112.847 -1.979 . . . . 0.69999999999999996 111.119 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -76.4 -18.29 15.93 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.473 2.115 . . . . 0.39000000000000001 113.216 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.531 ' H ' HG22 ' A' ' 57' ' ' ILE . 56.4 m-85 -94.82 161.48 14.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.297 -0.561 . . . . 0.23999999999999999 111.628 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -151.15 124.65 8.95 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.655 -0.869 . . . . 2.8900000000000001 108.655 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 71' ' ' THR . 97.5 mt -106.44 131.38 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.867 -0.606 . . . . 0.16 111.391 -176.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.66 117.28 29.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 119.834 -0.746 . . . . 0.16 111.341 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 69' ' ' THR . 60.0 t -97.5 117.04 41.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.573 0.702 . . . . 0.19 111.207 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 19.3 m -95.31 106.2 18.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.974 -1.012 . . . . 0.20000000000000001 110.61 178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.584 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.6 mm -54.46 -58.65 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 122.202 1.001 . . . . 0.23000000000000001 111.099 167.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.95 -7.86 3.94 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 112.836 -1.984 . . . . 0.16 113.292 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -127.96 -19.4 4.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.399 0.679 . . . . 0.14999999999999999 112.671 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.518 ' HD2' ' CG2' ' A' ' 86' ' ' VAL . 0.0 OUTLIER 58.5 56.37 4.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.669 0.668 . . . . 0.68999999999999995 111.624 -171.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 42.4 p -137.62 162.23 34.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 113.009 0.744 . . . . 0.13 113.009 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.466 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -130.16 113.83 14.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.632 -1.167 . . . . 0.40000000000000002 110.023 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.708 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 22.0 m -94.81 122.97 37.98 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.172 0.511 . . . . 0.16 111.391 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 79' ' ' MET . 15.3 tp -98.35 104.39 16.42 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.416 -0.811 . . . . 0.58999999999999997 109.628 172.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 7.7 m -105.22 159.98 15.45 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.531 -0.867 . . . . 1.05 110.78 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.817 HD13 HD22 ' A' ' 75' ' ' ASN . 1.1 tm? -128.92 128.55 44.01 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.856 -0.794 . . . . 0.26000000000000001 108.856 169.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.817 HD22 HD13 ' A' ' 74' ' ' LEU . 8.9 p30 46.54 48.64 14.01 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.132 1.373 . . . . 1.8400000000000001 111.287 -166.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.9 t30 72.93 -9.45 1.11 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.038 -0.983 . . . . 1.8899999999999999 111.333 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.2 tpp180 -96.3 120.7 37.08 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.737 -0.665 . . . . 3.4399999999999999 109.764 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 69.7 t -58.3 132.25 22.92 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-O 122.311 1.053 . . . . 0.23999999999999999 112.606 -174.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 12.1 mtm -101.18 -45.5 5.35 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.206 -1.816 . . . . 0.81000000000000005 109.151 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HD2' ' HA ' ' A' ' 80' ' ' LYS . 13.7 mmmt -157.75 171.15 20.83 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.423 -1.717 . . . . 1.46 109.571 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -148.74 123.33 9.79 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.677 -1.147 . . . . 0.17000000000000001 109.848 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -111.11 148.29 38.38 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.743 -0.662 . . . . 1.05 109.995 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.445 ' HB2' HG22 ' A' ' 134' ' ' ILE . 48.1 Cg_endo -75.43 142.71 26.91 Favored 'Trans proline' 0 CA--C 1.498 -1.295 0 C-N-CA 122.113 1.875 . . . . 0.20000000000000001 110.848 175.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.643 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.6 175.0 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.718 -0.674 . . . . 0.13 110.754 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.89 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.17 146.39 45.2 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.311 -0.404 . . . . 0.26000000000000001 110.153 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.518 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 7.5 m -127.23 130.18 70.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.558 0.694 . . . . 0.56000000000000005 111.625 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -86.4 153.38 26.27 Favored Glycine 0 N--CA 1.424 -2.122 0 N-CA-C 110.012 -1.235 . . . . 0.17000000000000001 110.012 172.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -56.12 3.3 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.238 0.829 . . . . 3.0499999999999998 113.238 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.868 HG23 HD22 ' A' ' 90' ' ' LEU . 1.8 tp -91.48 -18.55 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 121.555 0.693 . . . . 0.23000000000000001 110.46 -178.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.868 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -88.86 -18.19 28.12 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.757 -0.656 . . . . 0.17999999999999999 109.398 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.8 p -65.56 -19.4 65.91 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.627 -1.17 . . . . 0.33000000000000002 111.778 -176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -57.64 -42.47 83.47 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.14 -0.936 . . . . 1.52 111.941 -177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.37 120.9 48.03 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-O 120.867 0.365 . . . . 0.42999999999999999 111.582 -174.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 2.2 Cg_endo -76.84 -16.18 16.41 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.794 2.329 . . . . 0.72999999999999998 113.262 177.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.8 t -106.58 -41.25 5.32 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.491 -0.559 . . . . 0.47999999999999998 109.491 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.472 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 46.6 48.6 17.12 Favored Glycine 0 N--CA 1.446 -0.636 0 O-C-N 124.374 1.047 . . . . 0.33000000000000002 113.585 170.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.01 111.83 19.22 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.808 0.813 . . . . 0.83999999999999997 109.728 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -137.7 169.44 17.78 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.141 -1.391 . . . . 0.22 112.326 -172.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.502 ' CG ' HD11 ' A' ' 5' ' ' LEU . 19.3 m-85 -141.25 134.84 30.0 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.656 -0.702 . . . . 0.54000000000000004 110.241 -174.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.555 HD12 ' HB ' ' A' ' 161' ' ' THR . 81.1 mt -58.62 117.83 2.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.507 -0.77 . . . . 0.17000000000000001 110.695 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.53 HG21 ' HA ' ' A' ' 22' ' ' PHE . 22.4 pt -82.87 -43.56 18.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 112.604 0.594 . . . . 0.20999999999999999 112.604 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.564 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 52.9 m-80 -170.7 168.97 7.27 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 106.787 -1.56 . . . . 2.0299999999999998 106.787 -170.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.576 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -133.95 152.97 52.05 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.207 -0.597 . . . . 1.52 111.944 -175.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 50.7 tt0 -128.46 103.0 6.88 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.45 -0.796 . . . . 0.58999999999999997 110.161 175.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.461 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 38.0 ttt180 -62.92 166.85 5.23 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.334 -0.848 . . . . 2.8199999999999998 110.411 173.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.497 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 19.9 m-80 -35.32 103.51 0.24 Allowed Pre-proline 0 C--N 1.331 -0.223 0 C-N-CA 125.097 1.359 . . . . 0.34999999999999998 113.373 -156.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.497 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.8 Cg_endo -60.93 -32.19 92.26 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.026 2.484 . . . . 0.47999999999999998 111.084 172.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.49 -39.16 2.93 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.94 -0.864 . . . . 0.67000000000000004 110.94 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -73.74 -177.2 34.95 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 121.082 -0.58 . . . . 0.62 112.542 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.64 7.73 0.11 Allowed 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 125.117 3.878 . . . . 0.93999999999999995 115.436 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' A' ' 109' ' ' GLY . 12.6 m-85 -73.08 13.83 0.36 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 112.244 0.461 . . . . 1.23 112.244 -174.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.759 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 75.32 63.64 2.46 Favored Glycine 0 CA--C 1.5 -0.87 0 C-N-CA 119.737 -1.221 . . . . 1.6899999999999999 115.298 170.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.558 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.76 -2.68 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 117.334 2.346 . . . . 0.47999999999999998 117.334 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.5 OUTLIER -164.63 160.79 20.44 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.426 -0.796 . . . . 0.28000000000000003 110.372 -175.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 24.4 t-105 -141.62 98.67 3.39 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.693 -0.854 . . . . 0.48999999999999999 108.693 168.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 103' ' ' ARG . 2.4 mt -90.69 114.49 26.82 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.342 0.591 . . . . 0.66000000000000003 109.428 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.44 ' C ' HG12 ' A' ' 101' ' ' ILE . 14.5 m -84.8 144.83 28.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.014 -0.539 . . . . 0.19 111.384 -170.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.781 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -109.58 168.98 9.0 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.32 -0.4 . . . . 0.13 111.145 -177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.749 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -60.68 -10.87 5.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.074 0.768 . . . . 1.1699999999999999 113.074 -179.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.548 ' HG3' ' H ' ' A' ' 122' ' ' HIS . 14.8 tppt? -127.38 131.38 50.34 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.642 0.734 . . . . 1.22 110.185 171.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.467 ' HG2' ' OD1' ' A' ' 21' ' ' ASP . 8.5 pt20 -47.44 -31.61 4.3 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.323 -1.762 . . . . 1.51 114.872 -176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.548 ' H ' ' HG3' ' A' ' 120' ' ' LYS . 60.5 m80 -97.37 -8.48 29.46 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 119.692 -0.803 . . . . 2.5299999999999998 112.312 -177.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.781 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.4 m-30 -94.82 40.07 1.1 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.185 1.18 . . . . 0.83999999999999997 114.185 -168.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.694 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -112.0 145.17 17.85 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 116.376 -2.821 . . . . 0.32000000000000001 112.509 -153.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -96.32 115.99 37.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.787 0.803 . . . . 0.17999999999999999 110.762 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.643 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.3 p80 -145.12 172.2 13.43 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.344 -0.844 . . . . 0.20999999999999999 109.462 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.759 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.28 -168.2 38.76 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 120.157 -1.021 . . . . 0.27000000000000002 111.724 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.524 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 8.7 t -154.6 171.45 19.45 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.908 -0.76 . . . . 0.40999999999999998 111.325 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -113.48 -11.44 13.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.564 -0.902 . . . . 1.99 108.564 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -107.45 86.97 3.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.216 -1.031 . . . . 1.3600000000000001 108.216 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -71.37 -18.6 29.75 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.355 2.037 . . . . 0.34999999999999998 112.906 -169.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.46 -0.12 40.28 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.402 -0.817 . . . . 0.33000000000000002 111.077 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.473 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 98.2 p -91.59 -6.58 52.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.022 -0.733 . . . . 1.3500000000000001 109.022 171.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 83' ' ' PRO . 40.5 mm -78.82 135.69 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.399 -0.819 . . . . 0.20999999999999999 110.141 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.18 0.71 70.48 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.366 -1.093 . . . . 0.14999999999999999 110.366 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 50.3 mttm -115.02 176.31 5.12 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 123.629 1.68 . . . . 2.5 114.088 -177.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -105.61 129.31 53.88 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 110.655 -2.975 . . . . 0.17000000000000001 108.157 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.469 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -125.22 158.85 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.95 -0.759 . . . . 0.66000000000000003 108.95 -175.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 67.9 m -47.45 -59.61 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.712 0.634 . . . . 0.42999999999999999 112.712 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -131.44 -44.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.014 -1.075 . . . . 2.02 113.304 -174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.27 132.7 0.21 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 117.082 1.593 . . . . 0.17999999999999999 117.082 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.489 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.9 p -71.5 165.15 24.44 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 112.359 -1.921 . . . . 0.16 111.874 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.89 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 60.6 mt -59.83 98.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 114.841 -1.072 . . . . 0.40000000000000002 111.857 -163.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.643 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 74.8 mtt180 -84.52 149.58 25.82 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.676 -1.602 . . . . 1.8700000000000001 110.33 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.643 ' HG2' HG22 ' A' ' 84' ' ' ILE . 15.9 mtp -129.29 -165.4 1.51 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.002 -0.74 . . . . 0.79000000000000004 109.002 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.645 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 3.5 t-160 -96.28 157.36 15.93 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.59 -0.893 . . . . 2.3199999999999998 108.59 171.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.644 ' O ' HD13 ' A' ' 151' ' ' ILE . 3.7 m120 -59.03 -51.07 71.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 118.285 -0.864 . . . . 0.68000000000000005 110.549 -177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -64.42 -27.09 68.76 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 121.562 1.983 . . . . 2.1800000000000002 112.491 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.645 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 5.8 m-20 -79.03 -43.23 24.68 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.048 0.452 . . . . 0.68999999999999995 110.658 -176.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.638 HG13 HD12 ' A' ' 151' ' ' ILE . 14.4 p -69.08 -23.85 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.645 -0.707 . . . . 0.11 111.539 177.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.644 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.06 -42.09 18.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 119.126 -0.464 . . . . 0.38 109.954 171.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 156' ' ' ILE . 22.5 mt-10 -46.79 -69.42 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 119.058 0.845 . . . . 1.99 112.407 170.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 157' ' ' VAL . 37.0 mt -47.71 -40.2 19.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.509 0.671 . . . . 1.27 111.517 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.68 -35.6 76.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.21 -1.359 . . . . 0.17999999999999999 111.41 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.8 t -87.29 -29.77 21.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 118.603 0.638 . . . . 0.20999999999999999 112.521 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.6 mt -84.87 -60.38 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.471 0.653 . . . . 0.16 112.025 -173.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.1 m -90.51 143.01 28.6 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 114.994 -1.003 . . . . 0.16 112.161 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.424 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 44.0 Cg_endo -91.91 176.1 1.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 124.273 3.315 . . . . 0.20000000000000001 111.378 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 77.0 m-20 -66.92 157.94 31.99 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.554 -0.859 . . . . 1.1000000000000001 109.454 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 95.85 -16.64 60.79 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.238 -0.982 . . . . 0.17999999999999999 112.02 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.555 ' HB ' HD12 ' A' ' 100' ' ' ILE . 91.5 m -66.38 139.0 57.98 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 109.199 -0.667 . . . . 0.14000000000000001 109.199 -175.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.492 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 2.2 ptt180 -92.69 117.72 30.29 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 122.665 1.221 . . . . 3.6299999999999999 110.932 -169.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.6 t -106.77 107.2 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-N 111.992 -2.367 . . . . 0.14000000000000001 108.806 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.4 m -95.24 109.48 21.59 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.609 0.596 . . . . 0.20999999999999999 112.609 -170.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.472 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -83.48 100.58 7.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 122.215 1.007 . . . . 0.23999999999999999 110.062 178.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -109.44 134.64 51.61 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.234 -1.348 . . . . 1.0900000000000001 109.795 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.584 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.7 mmm180 -73.26 -27.91 61.84 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.867 -0.42 . . . . 2.0800000000000001 109.867 175.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 156.52 65.25 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.836 -0.62 . . . . 1.97 112.066 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 C--N 1.323 -0.584 0 N-CA-C 110.611 -0.144 . . . . 3.9100000000000001 110.611 -178.591 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.896 -0.482 . . . . 2.7999999999999998 111.896 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -152.37 140.79 20.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.131 -0.322 . . . . 4.4400000000000004 110.131 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -116.91 133.04 56.51 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.126 -0.488 . . . . 2.46 110.577 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -105.25 174.66 5.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.33 0.586 . . . . 0.65000000000000002 111.851 -179.051 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.8 tt -99.69 129.53 45.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.018 -0.992 . . . . 0.28000000000000003 110.32 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.39 162.2 13.59 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 122.02 0.914 . . . . 0.31 112.88 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.652 ' HB3' HG13 ' A' ' 46' ' ' ILE . 80.9 t80 -130.38 143.84 51.02 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.106 -1.406 . . . . 0.44 108.122 175.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -114.74 114.53 25.73 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.464 -0.939 . . . . 0.76000000000000001 108.464 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 41' ' ' THR . 95.2 t -67.97 151.44 10.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 122.383 1.087 . . . . 0.39000000000000001 113.611 -171.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -106.55 158.47 16.91 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.359 -1.746 . . . . 2.0099999999999998 108.392 172.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -61.89 115.42 4.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.058 0.456 . . . . 1.8300000000000001 111.799 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.33 12.86 47.15 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.976 -0.63 . . . . 0.47999999999999998 113.255 173.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' HB3' HG13 ' A' ' 9' ' ' VAL . 1.8 p-10 -50.63 170.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 122.019 0.914 . . . . 1.46 111.864 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.8 150.02 52.17 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.186 -0.915 . . . . 0.40999999999999998 110.959 169.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.646 HD13 ' HB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -64.66 -34.27 77.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.519 -1.219 . . . . 0.85999999999999999 108.242 -178.204 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.523 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 4.2 t30 -85.02 -27.74 26.2 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.621 -1.172 . . . . 1.1499999999999999 111.192 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.9 t -65.32 -42.31 93.11 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 120.307 -0.557 . . . . 1.21 109.921 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.6 mt -74.4 -25.93 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 121.381 0.61 . . . . 0.20999999999999999 109.822 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.655 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.93 -9.94 59.66 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.269 -0.423 . . . . 0.16 110.793 174.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.645 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.45 -40.14 9.23 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.399 1.095 . . . . 0.20999999999999999 108.079 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -61.84 -40.89 96.91 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 112.885 -1.962 . . . . 0.53000000000000003 111.897 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.563 ' HA ' HG21 ' A' ' 101' ' ' ILE . 65.5 m-85 -101.46 5.51 42.03 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 118.611 -1.235 . . . . 0.17999999999999999 111.872 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.9 mpt_? 54.53 40.43 31.82 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.828 0.823 . . . . 1.78 109.553 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.655 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.0 pt -112.99 -165.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 114.486 -1.234 . . . . 0.19 109.957 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.32 142.26 42.2 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.086 -0.961 . . . . 0.94999999999999996 110.106 174.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.652 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 43.4 p -72.95 -30.7 64.06 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.383 -0.969 . . . . 0.25 108.383 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.3 -24.25 67.59 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.559 -0.746 . . . . 0.20000000000000001 111.872 170.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.35 -29.2 14.58 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.993 -0.743 . . . . 0.17000000000000001 108.993 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.594 HD23 HD23 ' A' ' 15' ' ' LEU . 21.7 tp -71.9 -28.49 63.53 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.96 -1.018 . . . . 1.1599999999999999 108.414 172.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.652 ' HB2' ' O ' ' A' ' 26' ' ' THR . 8.2 tp -76.75 -31.73 57.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.939 0.876 . . . . 1.05 109.575 175.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 44.6 tt0 -65.9 -43.23 88.81 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.112 -1.404 . . . . 1.8100000000000001 110.603 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.422 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -80.35 -17.98 50.41 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 120.193 -0.603 . . . . 0.20000000000000001 111.42 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.615 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 38.7 m-80 -144.21 81.59 11.37 Favored Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-O 121.554 0.692 . . . . 0.23000000000000001 110.641 -173.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.6 Cg_endo -56.57 -10.07 4.64 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 C-N-CA 124.124 3.216 . . . . 0.35999999999999999 113.829 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.5 m -79.0 -24.84 43.44 Favored 'General case' 0 C--N 1.32 -0.677 0 O-C-N 122.097 -0.377 . . . . 1.3799999999999999 111.409 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.615 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 61.5 mt -67.12 -33.38 75.34 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.553 0.692 . . . . 0.48999999999999999 111.92 -170.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.524 ' HB3' HD11 ' A' ' 30' ' ' LEU . 1.7 pp0? -64.82 -44.92 88.32 Favored 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 122.742 1.258 . . . . 1.95 110.591 -174.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.98 -47.62 76.93 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 111.772 -2.467 . . . . 0.48999999999999999 110.752 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.9 178.01 48.64 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.923 -1.035 . . . . 0.41999999999999998 112.139 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' HG ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -110.99 159.02 18.12 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.109 0.481 . . . . 0.40999999999999998 110.628 -178.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 62.6 m -145.08 129.03 17.45 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.866 -0.606 . . . . 0.41999999999999998 111.378 -177.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.31 120.83 22.1 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.441 0.638 . . . . 0.46999999999999997 110.057 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.83 0.49 57.55 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.215 -1.154 . . . . 0.40999999999999998 110.215 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.631 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.6 OUTLIER -75.84 125.31 28.84 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.925 -0.638 . . . . 1.3 109.842 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 35.1 p -81.03 131.16 35.29 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.778 0.799 . . . . 0.84999999999999998 110.023 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.652 HG13 ' HB3' ' A' ' 7' ' ' TYR . 12.2 pt -131.28 140.64 47.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.354 -1.293 . . . . 0.25 109.259 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.91 150.29 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.964 0.411 . . . . 0.67000000000000004 110.853 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.416 HG21 ' CD2' ' A' ' 22' ' ' PHE . 37.1 mm -114.71 93.18 32.36 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 114.91 -1.041 . . . . 0.16 109.172 -178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.638 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -59.67 134.23 56.37 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.862 2.375 . . . . 0.17999999999999999 113.029 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.36 -6.25 80.79 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.932 -1.031 . . . . 0.26000000000000001 112.266 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.707 HD12 ' HD2' ' A' ' 52' ' ' PRO . 32.6 tp -122.64 115.69 29.53 Favored Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-O 121.26 0.553 . . . . 0.60999999999999999 111.398 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.707 ' HD2' HD12 ' A' ' 51' ' ' LEU . 53.5 Cg_endo -79.16 -177.41 3.87 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.668 2.912 . . . . 0.28000000000000003 114.288 -172.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.599 ' HB3' HG23 ' A' ' 56' ' ' THR . 14.1 t70 -77.42 134.43 66.42 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.015 -1.448 . . . . 0.48999999999999999 112.552 -170.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -73.4 -15.78 24.87 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.683 2.922 . . . . 0.46000000000000002 113.279 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -95.96 -9.36 31.39 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.43 0.633 . . . . 1.3799999999999999 111.309 -176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.599 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.0 p -85.74 -18.47 32.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 122.053 0.93 . . . . 0.46000000000000002 108.713 173.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 59' ' ' TYR . 7.8 mm -63.99 125.43 87.95 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 113.638 -1.619 . . . . 0.69999999999999996 109.755 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.74 -13.53 13.09 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.984 1.789 . . . . 0.39000000000000001 112.699 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.654 ' H ' HG22 ' A' ' 57' ' ' ILE . 58.7 m-85 -103.45 169.79 8.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.892 0.377 . . . . 0.23999999999999999 111.756 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -154.13 127.76 8.69 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.701 -0.851 . . . . 2.8900000000000001 108.701 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 71' ' ' THR . 93.6 mt -107.19 130.92 58.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.831 -0.622 . . . . 0.16 111.352 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.08 115.39 26.72 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 119.781 -0.768 . . . . 0.16 110.882 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 48.2 t -95.89 116.28 37.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.641 0.734 . . . . 0.19 111.053 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 68' ' ' LYS . 51.9 m -94.61 105.18 17.13 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.016 -0.993 . . . . 0.20000000000000001 110.401 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.557 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.0 mm -53.59 -58.53 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 122.13 0.967 . . . . 0.23000000000000001 111.104 167.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 169' ' ' SER . . . -59.05 -8.68 6.36 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 112.941 -1.936 . . . . 0.16 113.049 -175.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.73 -17.72 4.92 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.589 0.756 . . . . 0.14999999999999999 112.359 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.512 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.55 57.52 4.28 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.473 0.579 . . . . 0.68999999999999995 111.302 -173.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 57.3 p -138.88 160.93 38.55 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 112.899 0.703 . . . . 0.13 112.899 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.465 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -129.07 113.44 15.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.538 -1.21 . . . . 0.40000000000000002 109.999 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 9.9 m -94.05 122.86 37.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.081 0.467 . . . . 0.16 111.135 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.8 tp -99.03 103.22 15.14 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.367 -0.833 . . . . 0.58999999999999997 109.455 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 19.5 m -105.18 159.83 15.55 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.406 -0.918 . . . . 1.05 110.594 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -128.11 127.88 43.85 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.993 -0.743 . . . . 0.26000000000000001 108.993 168.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.582 ' N ' HD22 ' A' ' 74' ' ' LEU . 6.3 m-80 53.98 44.44 29.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.792 -1.095 . . . . 1.8400000000000001 110.78 -174.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 71.37 -4.31 1.87 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.57 -0.741 . . . . 1.8899999999999999 111.558 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -102.77 120.85 41.31 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.681 -0.69 . . . . 3.4399999999999999 110.119 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 62.9 t -57.98 133.31 22.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 122.296 1.046 . . . . 0.23999999999999999 112.527 -175.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 14.5 mtm -103.04 -43.43 5.5 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 113.32 -1.764 . . . . 0.81000000000000005 109.329 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -159.41 171.43 19.76 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 113.297 -1.774 . . . . 1.46 110.014 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.1 m -149.1 123.68 9.77 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.091 -1.413 . . . . 0.17000000000000001 109.748 173.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -113.61 146.42 35.42 Favored Pre-proline 0 C--N 1.311 -1.106 0 CA-C-N 115.694 -0.685 . . . . 1.05 110.303 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.434 ' HB2' HG22 ' A' ' 134' ' ' ILE . 35.0 Cg_endo -72.59 142.2 35.84 Favored 'Trans proline' 0 CA--C 1.495 -1.438 0 C-N-CA 122.038 1.825 . . . . 0.20000000000000001 110.775 176.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.583 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.38 172.64 11.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.828 -0.624 . . . . 0.13 110.853 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.928 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.93 140.32 49.89 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 110.032 -0.359 . . . . 0.26000000000000001 110.032 -176.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.512 HG22 ' HG3' ' A' ' 68' ' ' LYS . 9.6 m -122.91 126.19 73.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.508 0.67 . . . . 0.56000000000000005 111.672 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.491 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -80.58 150.42 31.35 Favored Glycine 0 N--CA 1.423 -2.168 0 N-CA-C 109.544 -1.423 . . . . 0.17000000000000001 109.544 171.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -57.7 4.74 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 112.951 0.723 . . . . 3.0499999999999998 112.951 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.922 HG23 HD22 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -89.13 -18.72 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-O 121.546 0.689 . . . . 0.23000000000000001 110.081 178.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.922 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -88.96 -17.28 29.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.793 0.806 . . . . 0.17999999999999999 109.115 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 59.1 p -66.39 -18.49 65.39 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.535 -1.212 . . . . 0.33000000000000002 111.302 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.73 -42.11 92.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.774 -1.103 . . . . 1.52 112.165 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.61 134.66 19.55 Favored Pre-proline 0 C--N 1.325 -0.497 0 C-N-CA 120.539 -0.465 . . . . 0.42999999999999999 110.889 -175.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.523 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 84.7 Cg_endo -87.55 -16.1 3.2 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.472 2.114 . . . . 0.72999999999999998 112.437 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.7 t -107.97 -38.75 5.73 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.31 -0.626 . . . . 0.47999999999999998 109.31 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 45.16 31.93 3.27 Favored Glycine 0 C--N 1.344 1.01 0 O-C-N 124.785 1.303 . . . . 0.33000000000000002 113.799 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB3' HG23 ' A' ' 164' ' ' THR . 8.2 pt-20 -84.55 115.74 22.77 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 122.801 1.286 . . . . 0.83999999999999997 109.174 -173.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 13.2 m-85 -136.46 179.47 6.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 112.89 -1.959 . . . . 0.22 111.305 -167.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 45.7 m-85 -140.1 134.31 31.12 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 116.217 -0.447 . . . . 0.54000000000000004 110.445 -172.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.609 HD12 ' HB ' ' A' ' 161' ' ' THR . 93.0 mt -61.58 118.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.413 -0.812 . . . . 0.17000000000000001 110.511 171.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.563 HG21 ' HA ' ' A' ' 22' ' ' PHE . 24.1 pt -84.18 -44.54 18.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 112.816 0.673 . . . . 0.20999999999999999 112.816 -176.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.535 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 54.5 m-80 -171.99 171.14 5.14 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.042 -1.836 . . . . 2.0299999999999998 106.042 -168.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.942 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 3.4 mtt180 -130.51 174.59 9.74 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.433 -0.907 . . . . 1.52 112.167 -174.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -149.64 100.78 3.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.628 -1.169 . . . . 0.58999999999999997 109.838 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.501 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 26.9 ttt85 -64.09 166.58 7.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.47 -0.786 . . . . 2.8199999999999998 110.446 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.501 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 18.6 m-80 -34.77 102.64 0.23 Allowed Pre-proline 0 C--O 1.235 0.298 0 C-N-CA 125.296 1.438 . . . . 0.34999999999999998 113.315 -157.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.5 Cg_endo -60.41 -32.27 93.69 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.107 2.538 . . . . 0.47999999999999998 111.289 174.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.23 -37.19 3.58 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 111.099 -0.8 . . . . 0.67000000000000004 111.099 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.75 -176.91 46.31 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.163 -0.519 . . . . 0.62 112.742 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.3 7.76 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 125.281 3.988 . . . . 0.93999999999999995 115.631 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -72.1 12.86 0.36 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 111.973 0.36 . . . . 1.23 111.973 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.71 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 75.46 64.03 2.36 Favored Glycine 0 CA--C 1.499 -0.912 0 C-N-CA 119.647 -1.263 . . . . 1.6899999999999999 114.971 170.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 37.48 0.23 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 117.57 2.433 . . . . 0.47999999999999998 117.57 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.4 OUTLIER -166.28 159.72 15.22 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.43 -0.794 . . . . 0.28000000000000003 110.289 -177.187 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.6 t-105 -140.37 98.1 3.36 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.449 -0.945 . . . . 0.48999999999999999 108.449 167.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.57 HD12 HG23 ' A' ' 150' ' ' VAL . 2.6 mt -90.04 115.49 27.36 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.709 -0.62 . . . . 0.66000000000000003 109.524 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 101' ' ' ILE . 17.4 m -84.81 143.49 29.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.953 -0.567 . . . . 0.19 111.609 -169.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.77 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.82 169.68 8.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.004 -0.543 . . . . 0.13 111.374 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 t -63.77 -9.82 16.53 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.036 -0.984 . . . . 1.1699999999999999 113.299 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.578 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 9.1 tptm -127.86 134.76 49.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.547 -0.461 . . . . 1.22 110.564 171.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.517 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 29.9 mm-40 -33.68 -59.61 0.39 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 113.982 1.105 . . . . 1.51 113.982 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.489 ' CB ' HG12 ' A' ' 89' ' ' ILE . 64.5 m80 -87.64 -2.32 58.54 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.313 -0.555 . . . . 2.5299999999999998 111.703 -169.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.77 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -93.97 38.57 1.08 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.001 1.112 . . . . 0.83999999999999997 114.001 -171.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.603 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -113.67 145.08 18.35 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 117.089 -2.482 . . . . 0.32000000000000001 112.617 -154.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.518 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -98.98 115.32 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.891 0.853 . . . . 0.17999999999999999 110.833 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.561 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 31.0 p80 -144.43 171.88 13.73 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.08 -0.964 . . . . 0.20999999999999999 109.886 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.71 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.36 -167.93 38.55 Favored Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.422 -0.894 . . . . 0.27000000000000002 111.723 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.554 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 12.5 t -154.86 170.34 21.89 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.013 -0.698 . . . . 0.40999999999999998 110.551 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -115.01 -5.32 12.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.982 0.896 . . . . 1.99 108.639 175.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -112.45 88.53 11.11 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 114.46 -1.246 . . . . 1.3600000000000001 108.307 169.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.27 -18.25 26.87 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.438 2.092 . . . . 0.34999999999999998 113.474 -170.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.03 -0.55 35.94 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.852 -0.613 . . . . 0.33000000000000002 111.389 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 78.9 p -90.86 -9.13 47.46 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.054 -0.721 . . . . 1.3500000000000001 109.054 171.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 83' ' ' PRO . 37.3 mm -78.95 136.75 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.259 -0.882 . . . . 0.20999999999999999 110.263 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.09 -0.04 75.04 Favored Glycine 0 N--CA 1.439 -1.153 0 N-CA-C 110.366 -1.094 . . . . 0.14999999999999999 110.366 -176.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -112.04 170.08 8.4 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 123.071 1.415 . . . . 2.5 114.098 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.32 124.14 46.54 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 111.969 -2.378 . . . . 0.17000000000000001 108.154 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.415 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -120.91 159.95 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.36 -0.978 . . . . 0.66000000000000003 108.36 -173.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.5 m -50.62 -59.35 4.14 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.508 0.558 . . . . 0.42999999999999999 112.508 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.8 ptmt -132.03 -45.1 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 118.633 -1.227 . . . . 2.02 113.851 -174.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.36 133.19 0.2 Allowed Glycine 0 N--CA 1.466 0.692 0 N-CA-C 117.232 1.653 . . . . 0.17999999999999999 117.232 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.442 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 1.9 p -70.95 165.4 23.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 112.471 -1.865 . . . . 0.16 112.348 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.928 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 66.7 mt -60.15 98.79 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-O 122.449 1.118 . . . . 0.40000000000000002 112.056 -163.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.561 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 13.1 mtp180 -85.34 145.62 27.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.523 -1.672 . . . . 1.8700000000000001 110.493 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.583 ' HG2' HG22 ' A' ' 84' ' ' ILE . 18.3 mtp -125.03 -164.81 1.32 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.717 -0.846 . . . . 0.79000000000000004 108.717 174.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.593 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 89.2 m-70 -93.65 161.64 14.27 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.629 -0.508 . . . . 2.3199999999999998 109.629 170.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.3 m120 -60.43 -51.96 67.28 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 118.744 -0.646 . . . . 0.68000000000000005 109.726 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -64.18 -27.04 68.8 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 120.782 1.628 . . . . 2.1800000000000002 112.244 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.593 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 68.8 m-20 -77.45 -46.68 21.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.261 0.553 . . . . 0.68999999999999995 110.489 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.641 HG13 HD12 ' A' ' 151' ' ' ILE . 14.2 p -67.19 -22.8 29.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.222 -0.899 . . . . 0.11 111.754 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.641 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -84.27 -41.78 16.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 119.087 -0.482 . . . . 0.38 110.071 171.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 156' ' ' ILE . 24.6 mt-10 -49.26 -66.16 0.44 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 119.23 0.923 . . . . 1.99 112.278 170.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.47 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.3 mp -48.69 -35.02 13.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.612 0.72 . . . . 1.27 111.125 178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.516 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -66.38 -31.17 71.78 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.624 -1.171 . . . . 0.17999999999999999 111.4 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.2 t -88.28 -31.86 18.78 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.581 -0.7 . . . . 0.20999999999999999 112.696 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.1 mt -84.95 -61.21 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.457 0.646 . . . . 0.16 112.33 -171.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -90.55 145.38 32.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.012 -0.994 . . . . 0.16 111.792 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.942 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 19.0 Cg_endo -95.12 178.32 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 124.901 3.734 . . . . 0.20000000000000001 111.752 174.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 80.0 m-20 -68.66 158.23 34.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.227 -0.989 . . . . 1.1000000000000001 108.966 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.12 -14.11 65.82 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.056 -1.069 . . . . 0.17999999999999999 111.869 -173.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.609 ' HB ' HD12 ' A' ' 100' ' ' ILE . 85.2 m -66.73 139.01 57.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.44 -0.578 . . . . 0.14000000000000001 109.44 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.404 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 2.0 ptt180 -92.34 115.69 28.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 122.726 1.251 . . . . 3.6299999999999999 110.815 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.4 t -106.11 108.42 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-N 112.21 -2.268 . . . . 0.14000000000000001 109.122 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.539 HG23 ' HB3' ' A' ' 97' ' ' GLU . 3.8 m -97.08 108.57 21.33 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 112.859 0.689 . . . . 0.20999999999999999 112.859 -171.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.486 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -83.72 94.46 3.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 122.573 1.177 . . . . 0.23999999999999999 110.327 177.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.406 ' O ' HG12 ' A' ' 65' ' ' ILE . 79.5 m-20 -104.9 142.38 34.86 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.234 -1.348 . . . . 1.0900000000000001 109.86 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.557 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.8 mmm180 -80.74 15.73 1.64 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.957 0.408 . . . . 2.0800000000000001 110.49 176.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -58.93 131.88 52.27 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.402 -0.817 . . . . 1.97 112.611 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.458 ' HA ' ' HA3' ' A' ' 66' ' ' GLY . 13.0 m . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 110.237 -0.282 . . . . 3.9100000000000001 110.237 -178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 112.165 -0.374 . . . . 2.7999999999999998 112.165 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -120.01 165.56 14.52 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.859 -0.423 . . . . 4.4400000000000004 109.859 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -110.57 98.99 8.04 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.977 0.418 . . . . 2.46 110.106 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 tp -94.48 175.09 6.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.648 -0.706 . . . . 0.65000000000000002 111.578 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.699 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.5 tt -91.58 129.97 37.47 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.283 -0.872 . . . . 0.28000000000000003 110.757 -174.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.77 162.03 13.33 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.3 1.048 . . . . 0.31 113.067 177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 45' ' ' SER . 70.9 t80 -132.54 142.82 49.35 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.432 -1.713 . . . . 0.44 108.057 175.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.426 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 34.0 tt0 -113.97 113.22 24.52 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.05 -1.092 . . . . 0.76000000000000001 108.05 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.651 HG13 ' HB2' ' A' ' 13' ' ' ASP . 95.9 t -66.13 149.5 11.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 122.327 1.06 . . . . 0.39000000000000001 113.039 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -104.06 158.74 16.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.307 -1.769 . . . . 2.0099999999999998 108.479 173.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.48 109.26 0.85 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 120.731 0.301 . . . . 1.8300000000000001 111.235 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.66 10.2 50.78 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.807 -0.633 . . . . 0.47999999999999998 113.925 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.651 ' HB2' HG13 ' A' ' 9' ' ' VAL . 43.9 m-20 -55.45 169.14 0.32 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.371 0.586 . . . . 1.46 110.865 172.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.32 152.43 50.58 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.562 0.696 . . . . 0.40999999999999998 112.26 174.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.675 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -67.52 -29.76 69.25 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.184 -1.371 . . . . 0.85999999999999999 109.901 -177.154 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.497 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 5.4 t30 -93.49 -24.99 17.8 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 114.879 -1.055 . . . . 1.1499999999999999 110.669 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 t -69.22 -39.55 78.51 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.36 -0.607 . . . . 1.21 109.36 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.434 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.5 mt -72.93 -26.59 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.219 0.533 . . . . 0.20999999999999999 109.688 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.25 -9.93 59.69 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 122.2 -0.312 . . . . 0.16 110.987 175.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.622 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.99 -39.33 9.41 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.609 1.195 . . . . 0.20999999999999999 108.148 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 119' ' ' SER . 11.2 m-20 -63.66 -44.78 92.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 112.536 -2.12 . . . . 0.53000000000000003 112.041 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.556 ' HA ' HG21 ' A' ' 101' ' ' ILE . 64.4 m-85 -97.96 4.97 49.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 118.57 -1.252 . . . . 0.17999999999999999 111.613 -178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.622 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.1 mpt_? 54.04 46.92 24.49 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 121.782 0.801 . . . . 1.78 109.947 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.64 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.0 pt -118.38 -165.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 114.45 -1.25 . . . . 0.19 109.902 -179.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.02 142.2 41.77 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.06 -0.973 . . . . 0.94999999999999996 109.746 173.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.675 ' HB ' HD11 ' A' ' 15' ' ' LEU . 71.4 p -73.14 -33.19 65.37 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 108.166 -1.05 . . . . 0.25 108.166 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.22 -27.45 67.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.2 -0.909 . . . . 0.20000000000000001 111.55 169.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -92.24 -28.32 17.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.914 -0.773 . . . . 0.17000000000000001 108.914 -179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.646 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 21.3 tp -73.84 -26.95 60.85 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.328 -0.851 . . . . 1.1599999999999999 109.47 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 26' ' ' THR . 43.1 mt -78.54 -31.28 47.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.835 0.826 . . . . 1.05 109.699 172.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 6.1 tt0 -63.98 -38.97 93.04 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.364 -1.289 . . . . 1.8100000000000001 110.154 173.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -85.08 -20.94 29.61 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 119.965 -0.694 . . . . 0.20000000000000001 111.591 176.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.632 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.1 m-80 -149.12 82.73 6.93 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-O 121.195 0.522 . . . . 0.23000000000000001 110.466 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.7 Cg_endo -56.93 -11.73 7.95 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.928 3.086 . . . . 0.35999999999999999 113.013 175.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.7 m -77.35 -19.86 55.67 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 116.223 -0.444 . . . . 1.3799999999999999 112.017 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.876 HD21 HG21 ' A' ' 46' ' ' ILE . 38.2 mt -77.03 -34.03 57.34 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.318 0.58 . . . . 0.48999999999999999 112.137 -171.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.421 ' H ' ' HG3' ' A' ' 37' ' ' GLN . 1.7 pp0? -63.24 -46.01 88.89 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 122.768 1.27 . . . . 1.95 110.926 -170.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.43 86.58 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 112.067 -2.333 . . . . 0.48999999999999999 111.016 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.81 178.43 48.44 Favored Glycine 0 N--CA 1.43 -1.739 0 CA-C-N 114.731 -1.122 . . . . 0.41999999999999998 110.94 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.86 157.62 21.18 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.264 0.554 . . . . 0.40999999999999998 111.186 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 47.0 m -138.06 127.94 25.46 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.161 -0.927 . . . . 0.41999999999999998 110.299 -177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.99 120.56 21.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.348 0.594 . . . . 0.46999999999999997 109.669 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.426 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 99.6 -0.51 56.77 Favored Glycine 0 N--CA 1.433 -1.525 0 N-CA-C 110.305 -1.118 . . . . 0.40999999999999998 110.305 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.6 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.4 tt0 -74.86 125.28 28.49 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 114.892 -0.654 . . . . 1.3 109.518 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 43.0 m -86.25 132.6 33.95 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 121.603 0.716 . . . . 0.84999999999999998 109.877 177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.876 HG21 HD21 ' A' ' 36' ' ' LEU . 12.1 pt -133.1 143.39 39.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.414 -1.266 . . . . 0.25 109.327 -176.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.468 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.67 151.48 3.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.079 0.466 . . . . 0.67000000000000004 110.96 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.8 mm -115.41 91.97 30.76 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 114.706 -1.133 . . . . 0.16 109.31 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.623 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.1 Cg_endo -58.15 134.36 61.41 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.898 2.399 . . . . 0.17999999999999999 112.741 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.43 -5.91 77.74 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 114.766 -1.106 . . . . 0.26000000000000001 112.405 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.696 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 21.3 tp -129.21 120.29 20.02 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 121.048 0.451 . . . . 0.60999999999999999 111.407 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.699 ' O ' ' HB2' ' A' ' 5' ' ' LEU . 58.0 Cg_endo -80.91 -177.81 3.98 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.488 2.792 . . . . 0.28000000000000003 114.166 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.58 ' HB3' HG23 ' A' ' 56' ' ' THR . 13.6 t70 -74.49 134.11 76.62 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 114.265 -1.334 . . . . 0.48999999999999999 112.915 -168.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.91 -15.4 16.69 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 124.105 3.203 . . . . 0.46000000000000002 112.951 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -95.38 -16.05 22.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.918 0.39 . . . . 1.3799999999999999 111.131 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.58 HG23 ' HB3' ' A' ' 53' ' ' ASP . 22.2 p -79.04 -13.95 59.46 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.96 0.886 . . . . 0.46000000000000002 109.445 175.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.568 HG22 ' H ' ' A' ' 59' ' ' TYR . 14.6 mm -63.86 126.08 89.17 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 113.813 -1.539 . . . . 0.69999999999999996 110.193 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.2 -15.04 11.71 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.342 2.028 . . . . 0.39000000000000001 112.895 178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.568 ' H ' HG22 ' A' ' 57' ' ' ILE . 66.2 m-85 -100.08 174.02 6.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.894 0.378 . . . . 0.23999999999999999 110.794 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -157.08 132.88 9.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.064 -0.717 . . . . 2.8900000000000001 109.064 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.688 ' HA ' ' O ' ' A' ' 71' ' ' THR . 89.5 mt -113.66 134.68 55.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.132 -0.486 . . . . 0.16 111.497 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.01 116.09 26.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.829 -0.748 . . . . 0.16 111.018 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.6 t -96.46 113.96 32.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.669 0.747 . . . . 0.19 111.066 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 68' ' ' LYS . 49.6 m -91.52 108.48 19.92 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.071 -0.968 . . . . 0.20000000000000001 110.62 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.56 HD13 HG11 ' A' ' 86' ' ' VAL . 50.6 mm -54.97 -59.69 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 122.038 0.923 . . . . 0.23000000000000001 111.001 166.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.8 -13.86 6.78 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 112.846 -1.979 . . . . 0.16 113.071 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.442 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -125.02 -16.45 6.07 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 123.196 0.598 . . . . 0.14999999999999999 112.491 -178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER 56.27 55.53 6.6 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.747 0.703 . . . . 0.68999999999999995 111.493 -174.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.9 p -138.25 162.02 35.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.805 0.669 . . . . 0.13 112.805 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.485 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.9 tt -129.89 113.06 14.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.893 -1.049 . . . . 0.40000000000000002 110.062 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.688 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 25.2 m -93.13 122.86 35.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.097 0.475 . . . . 0.16 111.228 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.417 HD21 ' HE3' ' A' ' 79' ' ' MET . 14.1 tp -100.39 106.11 17.67 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.318 -0.855 . . . . 0.58999999999999997 109.764 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 89.1 p -107.68 161.29 15.01 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.185 -1.006 . . . . 1.05 110.735 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.781 HD13 HD22 ' A' ' 75' ' ' ASN . 1.1 tm? -128.46 129.38 46.03 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.781 -0.822 . . . . 0.26000000000000001 108.781 169.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.781 HD22 HD13 ' A' ' 74' ' ' LEU . 9.7 p30 46.98 46.13 15.71 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.345 -1.298 . . . . 1.8400000000000001 111.181 -166.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 73.55 -8.53 1.35 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.84 -1.073 . . . . 1.8899999999999999 111.785 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.3 tpt180 -94.96 119.82 34.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.767 -0.651 . . . . 3.4399999999999999 109.776 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 68.4 t -58.38 133.43 23.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 122.392 1.092 . . . . 0.23999999999999999 112.33 -174.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.417 ' HE3' HD21 ' A' ' 72' ' ' LEU . 18.6 mtm -102.56 -43.51 5.6 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 113.165 -1.834 . . . . 0.81000000000000005 109.26 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -160.23 173.11 16.22 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 113.311 -1.768 . . . . 1.46 110.408 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.4 m -149.86 124.53 9.77 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 113.999 -1.455 . . . . 0.17000000000000001 109.604 173.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -116.42 146.28 37.07 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.821 -0.627 . . . . 1.05 109.904 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.456 ' HB2' HG22 ' A' ' 134' ' ' ILE . 37.9 Cg_endo -72.07 142.86 39.11 Favored 'Trans proline' 0 CA--C 1.494 -1.477 0 C-N-CA 122.34 2.026 . . . . 0.20000000000000001 111.26 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.665 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.94 173.71 8.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.665 -0.698 . . . . 0.13 110.609 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.887 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.63 147.39 43.81 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.989 -0.375 . . . . 0.26000000000000001 109.989 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.56 HG11 HD13 ' A' ' 65' ' ' ILE . 8.1 m -128.2 127.66 67.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-O 121.714 0.769 . . . . 0.56000000000000005 111.933 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.473 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -84.15 153.68 29.54 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 109.9 -1.28 . . . . 0.17000000000000001 109.9 171.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -56.52 2.97 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.147 0.795 . . . . 3.0499999999999998 113.147 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.94 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -87.76 -22.26 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 121.479 0.657 . . . . 0.23000000000000001 110.503 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.94 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -87.49 -14.93 39.05 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.663 0.744 . . . . 0.17999999999999999 109.314 -175.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.4 p -69.27 -17.47 63.75 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.72 -1.127 . . . . 0.33000000000000002 111.278 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -67.6 -38.62 84.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.055 -0.975 . . . . 1.52 112.313 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 95' ' ' THR . 0.2 OUTLIER -107.02 109.4 63.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 120.415 -0.514 . . . . 0.42999999999999999 111.171 -177.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.421 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 6.0 Cg_exo -73.79 -14.51 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.918 2.412 . . . . 0.72999999999999998 113.381 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 93' ' ' THR . 9.2 t -91.96 -42.92 9.74 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.308 -0.627 . . . . 0.47999999999999998 109.308 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.574 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 55.97 29.49 55.48 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.969 -1.469 . . . . 0.33000000000000002 114.134 168.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.41 111.03 19.08 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.842 0.83 . . . . 0.83999999999999997 109.396 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.675 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.0 m-85 -140.13 161.51 37.46 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 113.68 -1.6 . . . . 0.22 111.914 -172.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.691 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 16.0 m-85 -129.89 137.74 50.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.935 0.398 . . . . 0.54000000000000004 110.719 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.619 HD12 ' HB ' ' A' ' 161' ' ' THR . 78.9 mt -60.52 121.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.476 -0.784 . . . . 0.17000000000000001 110.971 172.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.556 HG21 ' HA ' ' A' ' 22' ' ' PHE . 22.0 pt -88.23 -34.88 7.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 113.243 0.831 . . . . 0.20999999999999999 113.243 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.478 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 9.8 p30 178.95 178.22 0.46 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.536 -1.283 . . . . 2.0299999999999998 107.536 -176.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.513 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -134.75 154.6 51.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.558 0.694 . . . . 1.52 112.536 -174.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 49.0 tt0 -127.05 100.82 6.28 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.782 -1.099 . . . . 0.58999999999999997 109.617 174.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.487 ' HG3' ' CE2' ' A' ' 114' ' ' TYR . 71.0 ttt180 -65.2 166.13 10.27 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.417 -0.811 . . . . 2.8199999999999998 110.341 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.5 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 19.7 m-80 -35.42 103.33 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 C-N-CA 125.24 1.416 . . . . 0.34999999999999998 113.794 -155.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.5 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 8.4 Cg_endo -58.98 -39.38 81.33 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.861 2.374 . . . . 0.47999999999999998 111.458 172.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.97 -31.7 5.59 Favored Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 110.763 -0.935 . . . . 0.67000000000000004 110.763 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.99 -176.5 51.23 Favored Glycine 0 N--CA 1.437 -1.247 0 CA-C-N 114.72 -0.74 . . . . 0.62 112.949 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.29 6.05 0.15 Allowed 'Trans proline' 0 N--CA 1.482 0.807 1 C-N-CA 125.41 4.073 . . . . 0.93999999999999995 115.596 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -72.39 10.95 0.68 Allowed 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 111.846 0.313 . . . . 1.23 111.846 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.746 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 75.38 64.16 2.34 Favored Glycine 0 CA--C 1.497 -1.047 0 C-N-CA 119.688 -1.244 . . . . 1.6899999999999999 115.212 170.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.543 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.37 -1.44 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 117.125 2.269 . . . . 0.47999999999999998 117.125 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.487 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -165.31 157.38 15.21 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.328 -0.857 . . . . 0.28000000000000003 110.305 -176.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 16.9 t-105 -138.32 97.88 3.48 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.31 -0.996 . . . . 0.48999999999999999 108.31 167.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.524 HD12 HG23 ' A' ' 150' ' ' VAL . 2.6 mt -88.48 114.43 25.08 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.105 -0.702 . . . . 0.66000000000000003 109.105 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.435 ' HB3' HD11 ' A' ' 101' ' ' ILE . 30.1 m -85.0 143.75 28.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.885 -0.598 . . . . 0.19 111.29 -169.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.79 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.4 170.78 7.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.13 111.113 -178.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.5 t -61.6 -13.14 19.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.264 -0.88 . . . . 1.1699999999999999 112.7 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.678 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.5 tmtp? -127.11 134.01 50.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.288 -0.565 . . . . 1.22 110.682 173.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.678 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 27.1 mt-30 -35.97 -56.91 0.71 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.559 -1.2 . . . . 1.51 114.166 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.588 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -97.59 12.38 33.73 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.458 -0.897 . . . . 2.5299999999999998 111.613 -172.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.79 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.8 m-85 -97.63 37.28 1.39 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.01 0.744 . . . . 0.83999999999999997 113.01 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.651 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.56 143.26 18.03 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 117.112 -2.471 . . . . 0.32000000000000001 112.79 -152.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -94.38 115.22 32.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.818 0.818 . . . . 0.17999999999999999 110.691 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 145' ' ' MET . 29.9 p80 -144.56 170.8 15.36 Favored 'General case' 0 C--O 1.214 -0.806 0 CA-C-N 115.238 -0.892 . . . . 0.20999999999999999 109.579 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.746 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.45 -168.46 38.6 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 120.184 -1.008 . . . . 0.27000000000000002 112.073 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.49 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 13.8 t -155.89 173.75 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.216 -0.579 . . . . 0.40999999999999998 111.008 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -110.98 -6.16 14.72 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.619 -0.882 . . . . 1.99 108.619 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -117.19 86.41 20.9 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 108.492 -0.929 . . . . 1.3600000000000001 108.492 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.435 ' HA ' HG12 ' A' ' 134' ' ' ILE . 32.0 Cg_endo -74.23 -17.27 21.8 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.82 2.347 . . . . 0.34999999999999998 113.894 -168.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.465 ' O ' ' HE2' ' A' ' 136' ' ' LYS . . . -78.69 -6.01 54.63 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.085 -0.507 . . . . 0.33000000000000002 110.826 -177.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 37.9 t -88.71 -9.53 51.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.58 -0.896 . . . . 1.3500000000000001 108.58 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 39.7 mm -76.88 138.92 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 115.127 -0.942 . . . . 0.20999999999999999 109.581 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.49 3.01 78.66 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.793 -0.923 . . . . 0.14999999999999999 110.793 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 132' ' ' ALA . 25.2 mttm -113.89 172.33 7.05 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 123.039 1.4 . . . . 2.5 113.755 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.07 126.33 50.2 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 111.895 -2.412 . . . . 0.17000000000000001 108.006 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.42 160.23 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 109.025 -0.731 . . . . 0.66000000000000003 109.025 -173.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.5 m -47.71 -61.0 2.15 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.521 0.563 . . . . 0.42999999999999999 112.521 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 46.7 pttt -132.65 -44.2 0.9 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.783 -1.167 . . . . 2.02 113.623 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.08 132.51 0.2 Allowed Glycine 0 N--CA 1.466 0.665 0 N-CA-C 117.056 1.583 . . . . 0.17999999999999999 117.056 -177.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.577 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.0 p -71.09 165.42 23.56 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 112.164 -2.018 . . . . 0.16 112.02 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.887 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 53.8 mt -59.64 98.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 122.518 1.152 . . . . 0.40000000000000002 112.114 -163.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.47 ' HB2' ' CD1' ' A' ' 134' ' ' ILE . 13.6 mtp180 -87.38 148.24 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.568 -1.651 . . . . 1.8700000000000001 110.217 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.665 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.4 mtp -127.99 -164.8 1.41 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.773 -0.825 . . . . 0.79000000000000004 108.773 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.713 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 2.8 t60 -94.79 158.74 15.36 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.896 -0.779 . . . . 2.3199999999999998 108.896 171.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.626 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.7 m120 -57.69 -53.26 60.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.397 -0.811 . . . . 0.68000000000000005 110.408 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -63.15 -27.06 69.11 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 121.244 1.838 . . . . 2.1800000000000002 112.427 -176.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.713 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 4.6 m-20 -79.42 -44.48 21.31 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.147 0.499 . . . . 0.68999999999999995 110.814 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.634 HG13 HD12 ' A' ' 151' ' ' ILE . 14.3 p -67.31 -23.6 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.488 -0.778 . . . . 0.11 111.589 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.634 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.34 -42.0 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 119.01 -0.519 . . . . 0.38 110.045 171.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 156' ' ' ILE . 25.3 mt-10 -47.52 -69.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 119.232 0.924 . . . . 1.99 112.365 170.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.572 ' O ' HG22 ' A' ' 157' ' ' VAL . 8.6 mp -46.31 -39.18 9.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.48 0.657 . . . . 1.27 111.261 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.8 78.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.424 -1.262 . . . . 0.17999999999999999 111.724 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 18.1 t -87.69 -30.62 20.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 118.702 0.683 . . . . 0.20999999999999999 112.284 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 152' ' ' GLU . 41.0 mt -83.98 -60.14 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-O 121.43 0.633 . . . . 0.16 112.154 -172.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.6 m -87.38 143.32 34.13 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.026 -0.988 . . . . 0.16 112.129 178.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -89.74 172.9 3.77 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 124.128 3.219 . . . . 0.20000000000000001 111.111 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.478 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 68.8 m-20 -67.67 157.26 34.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 118.955 -1.098 . . . . 1.1000000000000001 109.037 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.36 -16.28 61.58 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.183 -1.008 . . . . 0.17999999999999999 112.219 -172.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.619 ' HB ' HD12 ' A' ' 100' ' ' ILE . 98.5 m -63.98 139.71 58.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.12 0.486 . . . . 0.14000000000000001 109.9 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.691 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -93.48 124.82 37.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.559 1.171 . . . . 3.6299999999999999 111.63 -170.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.56 107.21 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-N 112.168 -2.287 . . . . 0.14000000000000001 109.104 -176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.6 m -95.33 107.16 19.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 112.837 0.68 . . . . 0.20999999999999999 112.837 -171.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.574 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -80.84 107.14 12.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 122.153 0.978 . . . . 0.23999999999999999 109.898 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -110.27 128.06 55.32 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.278 -1.328 . . . . 1.0900000000000001 110.016 -177.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.469 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 15.1 mmm-85 -71.62 -15.71 62.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.219 0.533 . . . . 2.0800000000000001 110.042 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 101.04 17.49 22.64 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.244 -0.889 . . . . 1.97 111.788 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--N 1.323 -0.554 0 N-CA-C 110.228 -0.286 . . . . 3.9100000000000001 110.228 -179.744 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 112.064 -0.414 . . . . 2.7999999999999998 112.064 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.414 ' HG2' ' N ' ' A' ' 3' ' ' LYS . 72.7 ttt180 -149.84 158.34 44.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.869 -0.419 . . . . 4.4400000000000004 109.869 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' N ' ' HG2' ' A' ' 2' ' ' ARG . 7.3 mmpt? -85.26 152.3 23.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.192 0.52 . . . . 2.46 110.511 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.798 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 tp -117.85 171.89 7.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.973 -1.012 . . . . 0.65000000000000002 111.07 -172.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.633 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.9 tt -88.68 127.03 35.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.259 -0.882 . . . . 0.28000000000000003 110.728 -172.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.72 161.2 13.98 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.78 -1.1 . . . . 0.31 112.444 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.644 ' O ' ' HA ' ' A' ' 45' ' ' SER . 86.2 t80 -131.71 140.01 49.18 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 113.912 -1.495 . . . . 0.44 107.939 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.454 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.3 tt0 -112.69 110.56 20.77 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 107.807 -1.183 . . . . 0.76000000000000001 107.807 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 44' ' ' GLN . 90.3 t -66.48 151.59 10.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 122.466 1.127 . . . . 0.39000000000000001 113.433 -167.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 10' ' ' LYS . 8.1 mtpm? -102.53 158.94 15.87 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 113.486 -1.688 . . . . 2.0099999999999998 108.997 173.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.604 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 2.2 tt0 -62.73 112.87 2.71 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.07 -0.514 . . . . 1.8300000000000001 112.087 -172.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.51 12.95 42.95 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.922 -0.656 . . . . 0.47999999999999998 113.768 173.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.575 ' CG ' HD11 ' A' ' 18' ' ' ILE . 2.4 t70 -50.4 168.26 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 112.524 0.564 . . . . 1.46 112.524 174.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.547 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -127.12 149.5 49.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.147 0.499 . . . . 0.40999999999999998 110.86 166.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -62.24 -38.5 89.49 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 122.344 1.069 . . . . 0.85999999999999999 108.405 -175.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.439 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 63.5 t30 -83.57 -19.25 35.92 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.324 -1.307 . . . . 1.1499999999999999 110.98 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.5 m -68.38 -42.69 78.72 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.487 -0.485 . . . . 1.21 110.227 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.575 HD11 ' CG ' ' A' ' 13' ' ' ASP . 18.6 mt -72.81 -26.64 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.435 0.636 . . . . 0.20999999999999999 109.887 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.616 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.68 -9.5 59.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.213 -0.449 . . . . 0.16 110.792 175.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.626 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.18 -40.88 8.97 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.836 1.303 . . . . 0.20999999999999999 108.528 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.529 ' HB3' ' O ' ' A' ' 119' ' ' SER . 26.5 m-20 -61.94 -42.93 99.67 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.937 -2.392 . . . . 0.53000000000000003 111.979 174.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.594 ' HA ' HG21 ' A' ' 101' ' ' ILE . 66.3 m-85 -100.22 4.79 44.52 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 118.639 -1.224 . . . . 0.17999999999999999 111.822 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.626 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.6 mpt_? 54.59 42.25 31.41 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.828 0.823 . . . . 1.78 109.681 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.616 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.4 pt -114.99 -164.6 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.513 -1.221 . . . . 0.19 109.129 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 22.0 t -110.76 157.35 19.87 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 122.357 1.075 . . . . 0.94999999999999996 110.154 168.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.601 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 62.5 p -80.11 -28.54 38.98 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 112.792 -2.004 . . . . 0.25 107.243 176.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.44 77.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.421 -0.809 . . . . 0.20000000000000001 111.958 171.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -88.08 -29.22 20.8 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.88 -0.785 . . . . 0.17000000000000001 108.88 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.637 HD22 ' CD1' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -71.9 -28.48 63.53 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.093 -0.958 . . . . 1.1599999999999999 109.279 174.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 26' ' ' THR . 35.7 mt -76.83 -29.95 56.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.685 0.755 . . . . 1.05 110.611 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 27.8 tt0 -65.47 -39.89 92.5 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.621 -1.172 . . . . 1.8100000000000001 109.998 174.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.443 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.93 -19.87 31.54 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 120.26 -0.576 . . . . 0.20000000000000001 111.614 177.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.624 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 21.5 m-80 -148.76 82.46 7.28 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-O 121.457 0.646 . . . . 0.23000000000000001 110.586 -173.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 21.4 Cg_endo -58.88 -5.94 3.07 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 124.169 3.246 . . . . 0.35999999999999999 113.872 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -81.94 -23.35 36.2 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.173 -0.329 . . . . 1.3799999999999999 111.42 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.68 HD21 HG21 ' A' ' 46' ' ' ILE . 28.9 mt -70.34 -32.38 70.08 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.521 0.677 . . . . 0.48999999999999999 112.149 -170.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.411 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 3.4 pt20 -65.99 -48.7 70.36 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.681 1.229 . . . . 1.95 110.022 -176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.77 -46.31 87.79 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.043 -2.344 . . . . 0.48999999999999999 111.005 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -177.91 -178.69 47.61 Favored Glycine 0 N--CA 1.432 -1.592 0 CA-C-N 114.79 -1.095 . . . . 0.41999999999999998 111.153 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.11 156.94 24.3 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.244 0.545 . . . . 0.40999999999999998 111.181 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.546 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 37.1 m -139.94 128.94 23.53 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.159 -0.928 . . . . 0.41999999999999998 110.469 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.604 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -78.82 126.21 30.4 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.288 0.566 . . . . 0.46999999999999997 110.212 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.454 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 91.24 4.65 68.37 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.406 -1.078 . . . . 0.40999999999999998 110.406 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.546 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.22 123.79 28.76 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.104 -0.548 . . . . 1.3 109.805 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 19.1 p -77.97 127.62 32.62 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.909 0.862 . . . . 0.84999999999999998 110.667 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.68 HG21 HD21 ' A' ' 36' ' ' LEU . 12.0 pt -129.21 143.28 41.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.247 -1.342 . . . . 0.25 109.417 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.35 151.45 3.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.271 0.558 . . . . 0.67000000000000004 111.074 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.472 HG21 ' CD2' ' A' ' 22' ' ' PHE . 38.9 mm -116.85 94.61 44.65 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 114.628 -1.169 . . . . 0.16 108.896 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.554 ' HA ' HD21 ' A' ' 4' ' ' LEU . 3.9 Cg_exo -61.5 136.03 60.78 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.599 2.199 . . . . 0.17999999999999999 112.539 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.4 -0.54 81.0 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.477 -0.783 . . . . 0.26000000000000001 112.317 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.798 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 25.2 tp -131.02 117.53 17.17 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 121.08 0.467 . . . . 0.60999999999999999 111.241 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.7 ' HD2' HD12 ' A' ' 51' ' ' LEU . 32.1 Cg_endo -75.26 168.86 23.73 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.546 2.831 . . . . 0.28000000000000003 113.543 -171.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.502 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 11.5 t70 -73.8 129.44 85.09 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 114.252 -1.34 . . . . 0.48999999999999999 111.307 -175.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.639 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 66.4 Cg_endo -73.76 -15.52 24.01 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 123.752 2.968 . . . . 0.46000000000000002 112.711 -174.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -95.66 -3.65 45.77 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.389 -0.823 . . . . 1.3799999999999999 109.574 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 53' ' ' ASP . 8.6 p -93.56 -14.87 26.05 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.534 -1.284 . . . . 0.46000000000000002 107.534 171.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.486 HG22 ' H ' ' A' ' 59' ' ' TYR . 36.1 mt -84.72 130.14 54.21 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 113.311 -1.768 . . . . 0.69999999999999996 110.915 177.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.71 -23.12 11.35 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.388 2.059 . . . . 0.39000000000000001 113.301 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.486 ' H ' HG22 ' A' ' 57' ' ' ILE . 66.4 m-85 -86.37 150.7 24.13 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.89 -0.324 . . . . 0.23999999999999999 111.322 -176.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -143.55 135.2 26.33 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.07 -0.715 . . . . 2.8900000000000001 109.07 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.6 mt -117.2 134.19 61.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 112.534 0.568 . . . . 0.16 112.534 -175.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.91 119.84 35.54 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 120.116 -0.634 . . . . 0.16 111.357 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.72 HG22 HD12 ' A' ' 70' ' ' LEU . 90.8 t -102.89 115.43 44.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.858 0.837 . . . . 0.19 111.382 175.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 68' ' ' LYS . 20.5 m -94.67 100.28 12.24 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.44 -1.255 . . . . 0.20000000000000001 110.628 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.3 mm -50.04 -58.47 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-O 122.056 0.932 . . . . 0.23000000000000001 111.624 170.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.77 -9.82 2.93 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 112.896 -1.956 . . . . 0.16 113.477 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.08 -18.8 4.93 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.773 0.829 . . . . 0.14999999999999999 112.173 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.33 56.99 4.12 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.396 0.544 . . . . 0.68999999999999995 111.505 -173.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.0 p -138.15 159.77 41.15 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 113.011 0.745 . . . . 0.13 113.011 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.726 HD22 ' SD ' ' A' ' 145' ' ' MET . 4.3 tp -126.3 117.53 23.22 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.782 -1.099 . . . . 0.40000000000000002 110.944 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 62.6 m -100.63 121.92 42.43 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.959 -0.696 . . . . 0.16 111.485 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 79' ' ' MET . 3.6 tp -101.74 106.72 17.77 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.243 -0.889 . . . . 0.58999999999999997 109.262 173.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 87.2 p -104.99 163.69 12.35 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.585 -0.846 . . . . 1.05 110.722 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.548 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.1 tm? -124.64 126.57 45.96 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.901 -0.778 . . . . 0.26000000000000001 108.901 168.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.548 ' N ' HD22 ' A' ' 74' ' ' LEU . 38.5 m-80 49.74 46.76 23.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.71 -1.132 . . . . 1.8400000000000001 111.015 -171.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 71.75 -7.75 1.2 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.566 0.746 . . . . 1.8899999999999999 111.849 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -98.12 119.96 37.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.986 -0.552 . . . . 3.4399999999999999 110.0 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 50.5 t -56.62 131.53 20.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 122.287 1.041 . . . . 0.23999999999999999 113.314 -172.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.579 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 3.3 mmt -95.42 -46.78 6.55 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 112.989 -1.914 . . . . 0.81000000000000005 107.941 176.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.476 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.3 mmtt -164.12 174.03 11.76 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 113.041 -1.89 . . . . 1.46 110.64 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 70' ' ' LEU . 16.4 m -147.9 123.66 10.56 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 113.832 -1.531 . . . . 0.17000000000000001 109.318 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -108.7 144.88 30.48 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.676 -0.693 . . . . 1.05 109.204 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HB2' HG22 ' A' ' 134' ' ' ILE . 38.5 Cg_endo -72.37 140.99 34.46 Favored 'Trans proline' 0 CA--C 1.497 -1.373 0 C-N-CA 121.848 1.699 . . . . 0.20000000000000001 110.207 175.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.47 HG21 ' HB2' ' A' ' 70' ' ' LEU . 2.1 pp -139.44 171.42 14.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 120.442 -0.503 . . . . 0.13 111.291 -177.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.92 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -116.23 142.27 47.05 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.144 -0.48 . . . . 0.26000000000000001 109.781 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.521 HG22 ' HG3' ' A' ' 68' ' ' LYS . 12.9 m -126.08 113.96 36.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.675 0.75 . . . . 0.56000000000000005 110.621 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -76.26 155.54 45.85 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 109.048 -1.621 . . . . 0.17000000000000001 109.048 175.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 139' ' ' SER . 64.9 mttp -54.74 4.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 114.135 1.161 . . . . 3.0499999999999998 114.135 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.845 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -89.66 -21.82 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 O-C-N 121.591 -0.693 . . . . 0.23000000000000001 110.479 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.845 HD22 HG23 ' A' ' 89' ' ' ILE . 3.8 mm? -86.64 -18.88 30.24 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.019 0.914 . . . . 0.17999999999999999 108.633 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -69.37 -12.9 62.05 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.053 -1.431 . . . . 0.33000000000000002 111.456 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.472 ' NE2' HD12 ' A' ' 89' ' ' ILE . 76.2 mt-30 -75.07 -36.59 61.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.579 -1.192 . . . . 1.52 113.16 -177.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.74 132.5 26.0 Favored Pre-proline 0 C--N 1.326 -0.417 0 C-N-CA 119.779 -0.768 . . . . 0.42999999999999999 111.286 -175.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 96.9 Cg_endo -89.13 -6.14 5.56 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.858 2.372 . . . . 0.72999999999999998 113.105 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 96' ' ' GLY . 8.8 t -123.35 -42.46 2.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.057 0.456 . . . . 0.47999999999999998 110.48 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 53.48 34.0 48.33 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.622 -1.172 . . . . 0.33000000000000002 114.121 167.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.443 ' HG2' HG23 ' A' ' 164' ' ' THR . 44.8 mt-10 -84.37 113.01 20.85 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.955 0.884 . . . . 0.83999999999999997 109.556 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.687 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 23.9 m-85 -137.38 -179.76 5.92 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.774 -1.557 . . . . 0.22 111.526 -170.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 80.9 m-85 -143.49 141.11 30.63 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 116.364 -0.38 . . . . 0.54000000000000004 110.381 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.624 HD12 ' HB ' ' A' ' 161' ' ' THR . 75.6 mt -65.86 114.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 115.568 -0.742 . . . . 0.17000000000000001 110.081 171.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.594 HG21 ' HA ' ' A' ' 22' ' ' PHE . 16.6 pt -83.55 -44.13 18.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 N-CA-C 112.627 0.603 . . . . 0.20999999999999999 112.627 -176.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.868 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 51.9 m-80 -169.32 172.98 6.88 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.382 -1.34 . . . . 2.0299999999999998 107.382 -170.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.653 HH21 ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -135.7 151.99 50.73 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.872 -0.731 . . . . 1.52 111.968 -178.353 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 49.7 tt0 -123.52 101.04 7.11 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.097 -0.956 . . . . 0.58999999999999997 109.719 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.501 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 67.4 ttt180 -64.55 165.74 9.59 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.907 0.861 . . . . 2.8199999999999998 110.656 176.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.501 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 20.7 m-80 -37.55 102.75 0.25 Allowed Pre-proline 0 CA--C 1.517 -0.297 0 CA-C-N 113.048 -1.887 . . . . 0.34999999999999998 114.756 -147.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 10.0 Cg_endo -58.33 -43.11 49.3 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.188 2.592 . . . . 0.47999999999999998 111.641 170.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.03 -36.57 4.27 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.554 -1.018 . . . . 0.67000000000000004 110.554 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -71.91 -174.72 22.73 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.748 -0.726 . . . . 0.62 112.557 175.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.498 ' O ' ' HA ' ' A' ' 128' ' ' THR . 19.1 Cg_endo -55.21 -6.17 0.74 Allowed 'Trans proline' 0 N--CA 1.477 0.534 0 C-N-CA 124.845 3.697 . . . . 0.93999999999999995 115.081 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -67.69 -12.43 60.47 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.991 0.737 . . . . 1.23 112.991 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.672 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 95.93 64.45 0.95 Allowed Glycine 0 CA--C 1.495 -1.177 0 C-N-CA 119.036 -1.554 . . . . 1.6899999999999999 114.929 168.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.506 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 37.57 1.56 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 116.61 2.078 . . . . 0.47999999999999998 116.61 -174.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.53 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.3 OUTLIER -165.32 169.11 16.2 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 123.898 0.879 . . . . 0.28000000000000003 109.144 -178.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 11.6 t-105 -147.82 97.48 2.82 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.78 -1.193 . . . . 0.48999999999999999 107.78 165.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.579 HD12 HG23 ' A' ' 150' ' ' VAL . 2.1 mt -86.75 114.24 23.26 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.031 -0.729 . . . . 0.66000000000000003 109.031 178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.492 ' O ' HG12 ' A' ' 101' ' ' ILE . 11.9 m -84.0 142.6 30.36 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.606 -0.725 . . . . 0.19 110.724 -170.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.672 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.9 mm? -108.08 163.12 13.43 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.891 -0.595 . . . . 0.13 111.856 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.529 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 12.3 t -58.89 -9.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 O-C-N 124.563 1.165 . . . . 1.1699999999999999 112.632 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.687 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 18.7 tptt -125.29 128.89 48.95 Favored 'General case' 0 CA--C 1.502 -0.87 0 C-N-CA 119.92 -0.712 . . . . 1.22 109.586 166.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.549 ' HA ' ' NH1' ' A' ' 23' ' ' ARG . 7.1 pt20 -52.9 -23.46 7.16 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.265 -1.334 . . . . 1.51 113.653 -177.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.578 ' O ' ' HB3' ' A' ' 142' ' ' CYS . 41.4 m80 -96.85 -9.55 28.4 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.793 -0.763 . . . . 2.5299999999999998 112.63 -177.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.532 ' CG ' ' HB3' ' A' ' 120' ' ' LYS . 3.2 m-30 -91.1 -37.01 13.67 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.586 0.958 . . . . 0.83999999999999997 113.586 -169.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.672 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -4.14 128.95 0.01 OUTLIER Glycine 0 C--N 1.296 -1.655 0 N-CA-C 119.695 2.638 . . . . 0.32000000000000001 119.695 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -97.27 114.21 33.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 113.128 -1.536 . . . . 0.17999999999999999 109.699 175.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.701 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 24.2 p80 -140.56 177.81 7.76 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 115.473 -0.785 . . . . 0.20999999999999999 109.937 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.672 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.73 -166.46 37.51 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.782 -0.723 . . . . 0.27000000000000002 111.578 176.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 110' ' ' PRO . 11.3 t -158.91 175.78 13.14 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.907 0.853 . . . . 0.40999999999999998 110.61 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -115.16 -3.12 12.59 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.807 -0.812 . . . . 1.99 108.807 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -118.14 87.87 30.47 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.254 -0.884 . . . . 1.3600000000000001 108.863 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.413 ' HA ' HG12 ' A' ' 134' ' ' ILE . 28.8 Cg_endo -73.55 -17.52 23.45 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.298 1.999 . . . . 0.34999999999999998 113.405 -169.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.98 -1.03 42.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.867 -0.606 . . . . 0.33000000000000002 111.13 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.524 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 38.9 t -93.64 -4.38 50.8 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.819 -0.808 . . . . 1.3500000000000001 108.819 171.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 83' ' ' PRO . 45.2 mm -82.76 137.06 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.496 -0.774 . . . . 0.20999999999999999 110.497 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.73 5.36 68.81 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 109.953 -1.259 . . . . 0.14999999999999999 109.953 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 90.4 mttt -113.24 168.08 10.02 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 123.173 1.463 . . . . 2.5 114.1 -176.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -97.54 123.09 41.29 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 111.747 -2.478 . . . . 0.17000000000000001 107.487 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.504 HG23 ' C ' ' A' ' 86' ' ' VAL . 0.3 OUTLIER -100.59 -166.15 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 109.954 -0.387 . . . . 0.66000000000000003 109.954 -170.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.497 ' H ' HG12 ' A' ' 138' ' ' VAL . 67.6 m -84.98 -59.94 2.19 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 110.119 -0.326 . . . . 0.42999999999999999 110.119 167.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.9 ptmm? -133.51 -43.99 0.83 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.357 -0.937 . . . . 2.02 112.572 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.34 134.09 0.18 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 117.047 1.579 . . . . 0.17999999999999999 117.047 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 5.9 p -69.4 166.16 19.26 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 112.141 -2.029 . . . . 0.16 112.174 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.92 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 49.2 mt -60.4 99.67 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.374 -1.284 . . . . 0.40000000000000002 111.77 -161.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.701 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 70.6 mtt180 -88.11 146.97 25.15 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.003 -1.453 . . . . 1.8700000000000001 110.28 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.726 ' SD ' HD22 ' A' ' 70' ' ' LEU . 1.8 mtm -130.79 -163.61 1.34 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.861 -0.792 . . . . 0.79000000000000004 108.861 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.546 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 87.6 m-70 -93.31 162.48 13.98 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.451 -0.5 . . . . 2.3199999999999998 109.828 170.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.679 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.8 m120 -64.33 -47.42 79.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 118.784 -0.627 . . . . 0.68000000000000005 110.234 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -65.9 -25.36 67.12 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 120.884 1.675 . . . . 2.1800000000000002 112.688 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.546 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 71.0 m-20 -79.11 -46.82 17.26 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.192 0.52 . . . . 0.68999999999999995 110.914 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.659 HG13 HD12 ' A' ' 151' ' ' ILE . 14.8 p -66.24 -24.27 33.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.347 -0.842 . . . . 0.11 111.685 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.679 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.19 -40.82 17.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 118.941 -0.552 . . . . 0.38 110.187 172.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.427 ' O ' HG13 ' A' ' 156' ' ' ILE . 14.0 mt-10 -47.73 -67.72 0.25 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 119.505 1.048 . . . . 1.99 112.54 170.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.577 HD11 ' CD2' ' A' ' 70' ' ' LEU . 95.8 mt -43.67 -40.52 4.21 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.748 0.785 . . . . 1.27 111.417 178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.43 -37.34 86.93 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.875 -1.511 . . . . 0.17999999999999999 111.591 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.0 t -86.35 -30.64 22.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 118.76 0.709 . . . . 0.20999999999999999 112.401 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 152' ' ' GLU . 33.6 mt -82.66 -60.55 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.521 0.676 . . . . 0.16 111.633 -173.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.4 m -91.9 142.35 26.4 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.84 -1.073 . . . . 0.16 112.558 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.653 ' HA ' HH21 ' A' ' 103' ' ' ARG . 62.6 Cg_endo -89.21 173.9 3.82 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.872 3.048 . . . . 0.20000000000000001 111.123 172.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.868 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.0 OUTLIER -62.4 157.63 19.56 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.437 -0.949 . . . . 1.1000000000000001 108.437 178.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 99.65 -27.07 21.87 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.931 -1.128 . . . . 0.17999999999999999 112.73 -176.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.624 ' HB ' HD12 ' A' ' 100' ' ' ILE . 51.6 m -59.73 135.12 57.59 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.07 -0.715 . . . . 0.14000000000000001 109.07 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.585 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 11.9 ptm180 -92.97 130.51 38.52 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.586 1.184 . . . . 3.6299999999999999 111.776 -168.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.7 t -108.96 107.12 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 112.323 -2.217 . . . . 0.14000000000000001 108.918 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 97' ' ' GLU . 25.5 m -94.25 106.73 18.7 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.152 -0.476 . . . . 0.20999999999999999 112.105 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.479 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -83.55 98.01 5.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 122.304 1.05 . . . . 0.23999999999999999 109.957 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -102.47 130.73 49.36 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.044 -1.435 . . . . 1.0900000000000001 108.9 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.532 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 15.9 mmm180 -67.47 -31.0 70.86 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.339 -0.391 . . . . 2.0800000000000001 109.96 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 59.63 -104.25 0.54 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.297 -0.865 . . . . 1.97 112.629 175.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--N 1.32 -0.691 0 N-CA-C 109.976 -0.379 . . . . 3.9100000000000001 109.976 179.302 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.768 -0.533 . . . . 2.7999999999999998 111.768 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -102.43 176.37 5.2 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.318 -0.623 . . . . 4.4400000000000004 109.318 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -86.82 105.05 16.75 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.335 -0.617 . . . . 2.46 109.335 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -106.92 174.88 5.7 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.681 0.753 . . . . 0.65000000000000002 112.432 -172.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.1 tt -98.51 129.29 45.08 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.628 -1.169 . . . . 0.28000000000000003 110.61 -175.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.31 162.24 13.28 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 122.056 0.931 . . . . 0.31 112.974 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.652 ' O ' ' HA ' ' A' ' 45' ' ' SER . 82.1 t80 -130.17 140.99 50.7 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.023 -1.444 . . . . 0.44 108.133 176.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.464 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 56.4 tt0 -113.32 113.4 25.2 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.107 -1.071 . . . . 0.76000000000000001 108.107 178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.614 HG13 ' HB2' ' A' ' 13' ' ' ASP . 94.7 t -68.39 150.36 10.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 122.651 1.215 . . . . 0.39000000000000001 113.463 -168.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.414 ' O ' HG12 ' A' ' 9' ' ' VAL . 44.1 mtpt -101.48 159.15 15.53 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 113.198 -1.819 . . . . 2.0099999999999998 108.623 172.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -63.8 103.02 0.52 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.944 0.402 . . . . 1.8300000000000001 111.883 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.59 11.0 31.96 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.782 -0.723 . . . . 0.47999999999999998 113.152 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.614 ' HB2' HG13 ' A' ' 9' ' ' VAL . 86.9 m-20 -52.74 166.8 0.18 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.851 0.357 . . . . 1.46 111.136 171.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.51 149.76 49.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.0 0.428 . . . . 0.40999999999999998 111.028 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.565 HD23 HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.66 -39.75 91.7 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.448 -0.945 . . . . 0.85999999999999999 108.448 -177.217 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 16.9 t-20 -82.35 -26.4 32.99 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.451 -1.249 . . . . 1.1499999999999999 110.256 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -65.19 -41.98 94.02 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.217 -0.66 . . . . 1.21 109.217 173.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.443 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.6 mt -74.18 -26.62 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.238 0.542 . . . . 0.20999999999999999 109.65 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.627 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.83 -10.05 59.74 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.319 -0.401 . . . . 0.16 110.831 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.66 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.75 -40.22 9.07 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 122.52 1.152 . . . . 0.20999999999999999 108.045 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 119' ' ' SER . 7.2 m-20 -63.01 -45.76 90.83 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 112.265 -2.243 . . . . 0.53000000000000003 112.082 173.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 60.7 m-85 -96.09 5.29 51.46 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 118.596 -1.242 . . . . 0.17999999999999999 111.36 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.66 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.4 mpt_? 54.52 42.51 31.28 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.793 0.806 . . . . 1.78 109.92 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.627 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 33.5 pt -117.14 -165.82 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.678 -1.147 . . . . 0.19 109.887 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.49 143.47 40.78 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.117 -0.947 . . . . 0.94999999999999996 110.279 175.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.471 ' HB ' HD13 ' A' ' 15' ' ' LEU . 37.0 p -73.32 -31.14 63.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.824 -1.176 . . . . 0.25 107.824 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.81 -33.01 71.18 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.336 -0.847 . . . . 0.20000000000000001 111.815 169.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.504 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -90.26 -27.92 19.15 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.795 0.807 . . . . 0.17000000000000001 108.886 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -72.93 -30.63 64.03 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.757 -1.11 . . . . 1.1599999999999999 109.168 174.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 36' ' ' LEU . 46.0 mt -76.71 -29.24 56.16 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.579 0.704 . . . . 1.05 110.624 171.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 20.0 tt0 -63.78 -39.98 95.57 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.72 -1.127 . . . . 1.8100000000000001 109.787 172.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.48 -19.76 32.81 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 120.248 -0.581 . . . . 0.20000000000000001 111.693 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.648 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.2 m-80 -150.55 82.59 6.15 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 110.482 -172.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.6 Cg_endo -56.2 -16.52 17.48 Favored 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 123.807 3.005 . . . . 0.35999999999999999 113.609 176.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 m -71.37 -22.21 61.92 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.162 0.43 . . . . 1.3799999999999999 112.162 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.782 HD21 HG21 ' A' ' 46' ' ' ILE . 28.9 mt -69.59 -35.48 75.37 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 112.563 0.579 . . . . 0.48999999999999999 112.563 -170.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -64.69 -46.62 81.6 Favored 'General case' 0 CA--C 1.492 -1.268 0 CA-C-O 122.818 1.294 . . . . 1.95 110.304 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.21 -48.97 77.45 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 111.845 -2.434 . . . . 0.48999999999999999 110.622 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.28 176.96 48.16 Favored Glycine 0 N--CA 1.428 -1.886 0 CA-C-N 114.595 -1.184 . . . . 0.41999999999999998 111.341 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.47 157.49 19.53 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.452 0.644 . . . . 0.40999999999999998 110.91 177.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.645 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 49.0 m -138.33 128.11 25.2 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.134 -0.939 . . . . 0.41999999999999998 110.512 -176.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.12 118.8 19.23 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.546 0.689 . . . . 0.46999999999999997 109.992 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.464 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.61 0.33 55.43 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 110.2 -1.16 . . . . 0.40999999999999998 110.2 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.645 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -75.74 124.06 26.63 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.835 -0.682 . . . . 1.3 109.797 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.652 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 51.4 p -83.84 128.68 34.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.577 -0.738 . . . . 0.84999999999999998 110.425 177.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.782 HG21 HD21 ' A' ' 36' ' ' LEU . 10.8 pt -129.42 142.8 43.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.432 -1.258 . . . . 0.25 109.459 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.11 150.52 3.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.465 0.65 . . . . 0.67000000000000004 111.268 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.4 mm -115.77 94.6 41.37 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 114.285 -1.325 . . . . 0.16 108.669 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.654 ' HA ' HD21 ' A' ' 4' ' ' LEU . 5.9 Cg_exo -60.91 137.06 69.84 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.646 2.231 . . . . 0.17999999999999999 112.76 -172.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.23 83.82 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 114.895 -1.048 . . . . 0.26000000000000001 112.432 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.725 HD12 ' HD2' ' A' ' 52' ' ' PRO . 37.5 tp -120.36 116.97 31.97 Favored Pre-proline 0 N--CA 1.449 -0.502 0 O-C-N 122.415 -0.462 . . . . 0.60999999999999999 111.295 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.725 ' HD2' HD12 ' A' ' 51' ' ' LEU . 43.2 Cg_endo -77.18 -177.25 3.69 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.891 3.061 . . . . 0.28000000000000003 114.205 -172.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.603 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.1 t70 -86.31 127.84 59.71 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 114.266 -1.334 . . . . 0.48999999999999999 111.836 -169.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.54 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.8 Cg_endo -75.8 -10.03 19.83 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.29 2.66 . . . . 0.46000000000000002 112.891 -176.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -92.55 -15.86 26.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.831 -0.622 . . . . 1.3799999999999999 110.271 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.603 HG23 ' HB3' ' A' ' 53' ' ' ASP . 27.1 p -84.62 -26.33 27.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.586 1.184 . . . . 0.46000000000000002 108.286 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.559 HG22 ' H ' ' A' ' 59' ' ' TYR . 27.0 mt -68.02 129.27 93.18 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 112.966 -1.924 . . . . 0.69999999999999996 111.155 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.419 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 86.7 Cg_endo -78.76 -14.34 14.04 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.474 2.116 . . . . 0.39000000000000001 113.492 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.559 ' H ' HG22 ' A' ' 57' ' ' ILE . 45.1 m-85 -99.16 162.95 12.77 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.549 -0.46 . . . . 0.23999999999999999 111.622 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -151.37 139.49 20.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.026 -0.731 . . . . 2.8900000000000001 109.026 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.654 ' HA ' ' O ' ' A' ' 71' ' ' THR . 88.4 mt -120.81 136.74 56.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 112.276 0.473 . . . . 0.16 112.276 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.39 115.56 24.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.946 -0.702 . . . . 0.16 110.902 171.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' THR . 90.6 t -91.19 108.87 20.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.566 0.698 . . . . 0.19 110.78 173.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 68' ' ' LYS . 75.3 m -85.43 107.32 17.34 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.088 -0.96 . . . . 0.20000000000000001 110.563 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.503 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.8 mm -53.98 -58.94 2.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 122.17 0.986 . . . . 0.23000000000000001 111.164 166.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.65 -13.55 8.1 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 112.926 -1.943 . . . . 0.16 113.337 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.02 -17.01 5.43 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 123.523 0.729 . . . . 0.14999999999999999 112.267 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.498 ' HD2' ' CG2' ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.5 56.87 4.69 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.287 0.494 . . . . 0.68999999999999995 111.376 -173.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 44.8 p -138.79 167.22 22.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 113.037 0.755 . . . . 0.13 113.037 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 70' ' ' LEU . 7.7 tt -133.94 111.14 10.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.617 -1.174 . . . . 0.40000000000000002 109.855 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.654 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 63.8 m -92.95 122.43 35.31 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.177 0.513 . . . . 0.16 111.15 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.7 tp -98.77 107.53 19.99 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.042 -0.981 . . . . 0.58999999999999997 109.309 173.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 75.2 p -109.14 158.8 17.44 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 118.989 -1.084 . . . . 1.05 110.998 177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.784 ' HB2' ' SD ' ' A' ' 79' ' ' MET . 1.2 tm? -128.21 126.4 40.89 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 109.092 -0.707 . . . . 0.26000000000000001 109.092 171.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.761 ' ND2' HD13 ' A' ' 74' ' ' LEU . 9.0 p30 43.76 52.99 6.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 113.952 -1.476 . . . . 1.8400000000000001 112.146 -167.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 75' ' ' ASN . 53.9 t30 75.46 -10.35 1.26 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.527 -0.76 . . . . 1.8899999999999999 111.623 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -100.58 120.7 40.42 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.141 0.496 . . . . 3.4399999999999999 110.126 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 45.4 t -55.82 132.72 19.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.249 1.024 . . . . 0.23999999999999999 112.32 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.784 ' SD ' ' HB2' ' A' ' 74' ' ' LEU . 97.4 mtp -97.06 -48.24 5.47 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 113.364 -1.744 . . . . 0.81000000000000005 108.405 177.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt -158.67 171.97 19.13 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.498 -2.137 . . . . 1.46 109.902 -174.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.0 m -148.63 122.2 9.17 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.064 -1.425 . . . . 0.17000000000000001 109.656 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.614 ' HB3' ' SD ' ' A' ' 145' ' ' MET . 24.6 m-85 -105.21 156.5 36.09 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 115.214 -0.903 . . . . 1.05 109.729 -174.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.491 ' O ' ' HG2' ' A' ' 145' ' ' MET . 59.1 Cg_endo -84.93 142.98 9.15 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.046 1.831 . . . . 0.20000000000000001 111.439 169.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.547 HG22 ' CG ' ' A' ' 145' ' ' MET . 2.2 pp -138.14 174.29 10.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.701 -0.681 . . . . 0.13 110.863 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.905 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.8 140.72 49.5 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.304 -0.407 . . . . 0.26000000000000001 109.972 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.498 ' CG2' ' HD2' ' A' ' 68' ' ' LYS . 7.7 m -125.74 125.37 68.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.547 0.689 . . . . 0.56000000000000005 111.829 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -82.76 157.58 36.0 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 114.899 -1.046 . . . . 0.17000000000000001 110.631 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 139' ' ' SER . 74.7 mmtt -55.48 3.21 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.894 0.701 . . . . 3.0499999999999998 112.894 176.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.954 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -92.55 -20.19 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-O 121.522 0.677 . . . . 0.23000000000000001 110.28 -177.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.954 HD22 HG23 ' A' ' 89' ' ' ILE . 3.6 mm? -89.22 -18.16 27.63 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.707 0.765 . . . . 0.17999999999999999 108.969 -176.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.1 p -66.61 -19.21 65.72 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.53 -1.214 . . . . 0.33000000000000002 111.73 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -59.1 -42.01 89.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.885 -1.052 . . . . 1.52 112.372 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.94 133.54 20.23 Favored Pre-proline 0 C--N 1.324 -0.525 0 C-N-CA 120.449 -0.5 . . . . 0.42999999999999999 111.497 -172.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 97.2 Cg_endo -90.59 -15.27 1.83 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.665 2.243 . . . . 0.72999999999999998 112.755 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.416 HG23 ' N ' ' A' ' 96' ' ' GLY . 7.9 t -102.43 -43.54 5.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.23 0.538 . . . . 0.47999999999999998 109.828 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.536 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 52.92 35.17 47.33 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 114.286 -1.325 . . . . 0.33000000000000002 113.622 167.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -82.91 111.93 19.24 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 122.039 0.923 . . . . 0.83999999999999997 109.478 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.621 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 26.1 m-85 -138.54 177.54 7.81 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.496 -1.684 . . . . 0.22 111.42 -173.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.469 ' CG ' HD11 ' A' ' 5' ' ' LEU . 28.5 m-85 -141.99 138.0 31.58 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.316 -0.402 . . . . 0.54000000000000004 110.49 -174.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.586 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.3 mt -61.92 121.28 9.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.577 -0.738 . . . . 0.17000000000000001 110.284 170.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 20.0 pt -88.63 -44.18 15.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 113.219 0.822 . . . . 0.20999999999999999 113.219 -175.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.55 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 51.7 m-80 -170.95 170.35 6.34 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 107.044 -1.465 . . . . 2.0299999999999998 107.044 -168.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.742 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 26.5 mtt180 -126.15 159.06 33.93 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.713 -0.795 . . . . 1.52 111.929 -173.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 60.7 tt0 -133.31 99.97 4.7 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 115.554 -0.748 . . . . 0.58999999999999997 110.058 169.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 34.1 ttt85 -66.07 166.06 12.35 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.647 -0.706 . . . . 2.8199999999999998 110.146 173.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.497 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 17.0 m-80 -35.26 101.92 0.22 Allowed Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 125.093 1.357 . . . . 0.34999999999999998 113.255 -156.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.497 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.1 Cg_endo -63.24 -28.29 72.68 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.205 2.603 . . . . 0.47999999999999998 111.688 174.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 114.3 -36.09 4.14 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.266 -0.734 . . . . 0.67000000000000004 111.266 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 111' ' ' PHE . . . -79.32 -176.22 48.42 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.211 -0.494 . . . . 0.62 112.703 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.75 8.06 0.11 Allowed 'Trans proline' 0 N--CA 1.483 0.879 0 C-N-CA 125.15 3.9 . . . . 0.93999999999999995 115.429 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.404 ' H ' ' C ' ' A' ' 109' ' ' GLY . 9.1 m-85 -72.0 14.72 0.19 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 112.229 0.455 . . . . 1.23 112.229 -174.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.77 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 72.2 63.19 3.03 Favored Glycine 0 CA--C 1.496 -1.149 0 C-N-CA 120.123 -1.037 . . . . 1.6899999999999999 114.894 170.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.523 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.21 -2.78 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 117.398 2.37 . . . . 0.47999999999999998 117.398 -177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -166.17 149.38 7.36 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.412 -0.805 . . . . 0.28000000000000003 110.087 -176.162 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 9.9 t-105 -130.18 98.95 4.88 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 107.959 -1.126 . . . . 0.48999999999999999 107.959 167.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.4 mt -91.51 114.46 26.99 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.08 -0.711 . . . . 0.66000000000000003 109.08 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.405 ' C ' HG12 ' A' ' 101' ' ' ILE . 16.9 m -84.08 144.68 28.89 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.533 -0.758 . . . . 0.19 111.341 -168.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.778 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.5 mm? -108.91 170.1 8.25 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.094 -0.503 . . . . 0.13 111.407 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.2 t -62.0 -12.14 17.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.918 -1.037 . . . . 1.1699999999999999 112.779 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.621 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 5.5 tptp -126.73 132.59 51.08 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.58 -0.448 . . . . 1.22 110.42 172.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.532 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 76.7 mt-30 -31.89 -60.86 0.25 Allowed 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.554 1.159 . . . . 1.51 113.94 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.582 ' HB3' HG12 ' A' ' 89' ' ' ILE . 1.7 t-160 -94.01 5.4 51.83 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.954 -0.698 . . . . 2.5299999999999998 111.597 -169.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.778 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 3.0 m-85 -93.9 38.43 1.07 Allowed 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 113.88 1.067 . . . . 0.83999999999999997 113.88 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.644 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.92 143.57 18.12 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 116.9 -2.571 . . . . 0.32000000000000001 112.67 -154.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 2.1 mp -96.52 114.04 32.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.808 0.814 . . . . 0.17999999999999999 110.596 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.757 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.8 p80 -140.17 171.73 13.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.082 -0.963 . . . . 0.20999999999999999 109.01 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.77 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.25 -170.31 39.49 Favored Glycine 0 C--N 1.315 -0.583 0 C-N-CA 119.891 -1.147 . . . . 0.27000000000000002 111.613 177.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.562 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 13.7 t -153.23 168.74 24.96 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.35 -0.5 . . . . 0.40999999999999998 110.332 177.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -112.05 2.94 17.06 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.18 -1.044 . . . . 1.99 108.18 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.9 84.67 26.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.384 -1.28 . . . . 1.3600000000000001 107.935 169.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -76.79 -22.32 11.9 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.679 2.253 . . . . 0.34999999999999998 114.495 -167.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -74.29 -10.19 59.35 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.923 -0.581 . . . . 0.33000000000000002 110.749 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.593 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 45.5 m -91.5 1.28 57.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 1.3500000000000001 110.375 176.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.409 HG22 ' HB2' ' A' ' 83' ' ' PRO . 47.5 mm -79.56 141.41 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.089 -0.505 . . . . 0.20999999999999999 110.152 177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.7 6.4 63.9 Favored Glycine 0 N--CA 1.441 -1.011 0 N-CA-C 110.463 -1.055 . . . . 0.14999999999999999 110.463 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.593 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 59.2 mttm -114.85 176.75 4.92 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 123.603 1.668 . . . . 2.5 114.078 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -106.77 125.46 51.03 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 110.813 -2.903 . . . . 0.17000000000000001 108.406 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.575 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.7 OUTLIER -121.51 162.67 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 107.798 -1.186 . . . . 0.66000000000000003 107.798 -176.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.452 ' HA ' ' HG2' ' A' ' 88' ' ' LYS . 43.5 m -61.22 -50.95 71.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 118.845 0.748 . . . . 0.42999999999999999 112.691 -178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -130.57 -45.52 1.08 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 117.889 -1.524 . . . . 2.02 114.112 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.29 132.78 0.21 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 117.071 1.588 . . . . 0.17999999999999999 117.071 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.418 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 3.4 p -72.28 165.41 24.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 112.544 -1.828 . . . . 0.16 112.028 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.905 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 56.9 mt -60.41 98.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.535 -1.211 . . . . 0.40000000000000002 112.276 -162.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.757 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 64.2 mtt180 -87.32 150.85 23.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.006 -1.452 . . . . 1.8700000000000001 110.92 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.614 ' SD ' ' HB3' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -133.67 -163.65 1.39 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.081 -0.509 . . . . 0.79000000000000004 109.994 174.293 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.518 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 26.2 m80 -91.39 162.07 14.74 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.167 -0.613 . . . . 2.3199999999999998 109.937 172.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.688 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.4 m120 -61.71 -54.81 37.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 118.63 -0.7 . . . . 0.68000000000000005 110.125 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -63.56 -24.79 67.95 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 121.119 1.782 . . . . 2.1800000000000002 112.071 -174.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 45.2 m-20 -87.12 -45.36 10.77 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.547 -0.751 . . . . 0.68999999999999995 111.281 -173.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.617 HG13 HD12 ' A' ' 151' ' ' ILE . 11.1 p -59.44 -25.13 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 N-CA-C 111.781 0.289 . . . . 0.11 111.781 170.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.688 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -80.26 -40.27 19.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 118.95 -0.548 . . . . 0.38 109.876 171.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.477 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.2 mm-40 -44.66 -72.64 0.05 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.237 0.926 . . . . 1.99 112.094 168.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 157' ' ' VAL . 44.2 mt -46.61 -39.67 11.58 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-O 121.649 0.738 . . . . 1.27 111.514 -178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.3 80.14 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.098 -1.41 . . . . 0.17999999999999999 111.466 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 25.5 t -86.29 -34.05 20.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.791 -0.568 . . . . 0.20999999999999999 112.219 176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 152' ' ' GLU . 30.3 mt -79.84 -60.54 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.61 0.719 . . . . 0.16 111.37 -171.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.0 m -91.95 141.64 25.59 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 114.882 -1.054 . . . . 0.16 112.4 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.742 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 53.2 Cg_endo -89.06 175.71 3.4 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 124.143 3.229 . . . . 0.20000000000000001 111.062 173.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 75.7 m-20 -66.46 159.49 27.02 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 119.274 -0.971 . . . . 1.1000000000000001 109.107 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.16 -19.87 52.61 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.231 -0.985 . . . . 0.17999999999999999 112.3 -174.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.586 ' HB ' HD12 ' A' ' 100' ' ' ILE . 67.7 m -64.15 137.85 58.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.419 -0.586 . . . . 0.14000000000000001 109.419 -175.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -92.97 123.49 36.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.715 1.245 . . . . 3.6299999999999999 111.246 -169.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.82 111.39 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 112.221 -2.263 . . . . 0.14000000000000001 109.613 -175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 63' ' ' VAL . 13.6 m -93.34 108.66 20.28 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.051 -0.522 . . . . 0.20999999999999999 112.188 -174.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.536 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -79.95 100.23 4.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 123.201 1.477 . . . . 0.23999999999999999 108.362 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -113.47 123.92 51.17 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 112.287 -2.233 . . . . 1.0900000000000001 109.22 -164.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.504 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 9.1 mmm180 -76.09 -0.21 21.09 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.811 -0.356 . . . . 2.0800000000000001 111.379 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.95 33.41 6.65 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.9 -0.667 . . . . 1.97 112.235 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.1 m . . . . . 0 C--N 1.322 -0.61 0 N-CA-C 110.004 -0.369 . . . . 3.9100000000000001 110.004 178.044 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 112.255 -0.338 . . . . 2.7999999999999998 112.255 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -79.3 131.72 36.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.16 0.505 . . . . 4.4400000000000004 110.232 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 70.8 mmtt -90.31 97.93 11.48 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.546 -0.752 . . . . 2.46 111.834 -174.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -116.04 175.22 5.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.384 -0.825 . . . . 0.65000000000000002 110.821 175.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.616 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 2.9 tt -95.33 127.69 41.58 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.341 -0.845 . . . . 0.28000000000000003 110.33 -176.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.14 162.33 13.41 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 122.202 1.001 . . . . 0.31 113.473 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 45' ' ' SER . 84.0 t80 -130.67 141.1 50.4 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.441 -1.709 . . . . 0.44 107.932 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.411 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 56.7 tt0 -114.03 114.21 25.83 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.02 -1.104 . . . . 0.76000000000000001 108.02 177.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.686 HG13 ' HB2' ' A' ' 13' ' ' ASP . 95.7 t -68.35 150.47 10.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 122.338 1.066 . . . . 0.39000000000000001 113.194 -169.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -103.38 157.85 16.74 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.505 -1.68 . . . . 2.0099999999999998 108.042 172.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 2.3 mm-40 -58.64 110.17 0.94 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.104 0.478 . . . . 1.8300000000000001 111.548 -176.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.22 11.71 51.32 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.548 -0.751 . . . . 0.47999999999999998 114.004 173.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.686 ' HB2' HG13 ' A' ' 9' ' ' VAL . 30.7 m-20 -54.0 170.5 0.13 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 117.392 0.596 . . . . 1.46 111.222 171.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.6 154.58 47.7 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.449 -0.5 . . . . 0.40999999999999998 111.424 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 26' ' ' THR . 4.6 tp -67.35 -38.04 84.19 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.853 0.835 . . . . 0.85999999999999999 110.031 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 6.3 t30 -86.96 -23.22 25.17 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.434 -1.257 . . . . 1.1499999999999999 110.13 -174.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -69.7 -37.64 76.65 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.802 -0.444 . . . . 1.21 109.802 172.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.43 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.0 mt -76.68 -28.71 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-O 121.188 0.518 . . . . 0.20999999999999999 109.997 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.637 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -77.81 -9.51 59.08 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 122.122 -0.361 . . . . 0.16 110.538 175.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.708 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -95.92 -40.54 9.25 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 122.279 1.038 . . . . 0.20999999999999999 108.449 175.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.445 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 1.4 m-20 -61.29 -44.11 97.76 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.849 -1.978 . . . . 0.53000000000000003 112.0 174.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.497 ' HA ' HG21 ' A' ' 101' ' ' ILE . 59.0 m-85 -98.7 6.16 47.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 118.706 -1.198 . . . . 0.17999999999999999 111.436 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.708 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.21 43.81 30.04 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.916 0.865 . . . . 1.78 109.328 177.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.637 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 30.9 pt -116.96 -164.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 114.385 -1.279 . . . . 0.19 110.23 -178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 144.28 38.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.997 -1.001 . . . . 0.94999999999999996 110.523 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.594 ' HB ' HD21 ' A' ' 15' ' ' LEU . 75.8 p -73.98 -32.23 63.34 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.619 -0.882 . . . . 0.25 108.619 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.38 -27.66 67.6 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.26 -0.882 . . . . 0.20000000000000001 111.629 169.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.98 -28.52 17.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 120.289 -0.564 . . . . 0.17000000000000001 109.538 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.552 HD21 HD12 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -72.36 -30.55 64.81 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.781 -0.645 . . . . 1.1599999999999999 109.432 173.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 36' ' ' LEU . 41.4 mt -75.16 -30.14 60.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.872 0.844 . . . . 1.05 109.721 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 47.2 tt0 -65.61 -39.83 91.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.112 -1.403 . . . . 1.8100000000000001 110.527 173.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.477 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.48 -20.45 31.68 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 120.06 -0.656 . . . . 0.20000000000000001 111.563 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.64 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 20.8 m-80 -148.94 82.66 7.07 Favored Pre-proline 0 N--CA 1.451 -0.424 0 CA-C-O 121.206 0.527 . . . . 0.23000000000000001 110.625 -172.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 19.4 Cg_endo -56.57 -12.4 8.47 Favored 'Trans proline' 0 C--N 1.323 -0.777 0 C-N-CA 123.971 3.114 . . . . 0.35999999999999999 113.667 175.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.0 m -72.53 -26.43 61.75 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.996 0.427 . . . . 1.3799999999999999 111.661 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.64 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 36.4 mt -70.71 -33.69 71.13 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.89 -0.595 . . . . 0.48999999999999999 112.564 -167.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.421 ' H ' ' HG3' ' A' ' 37' ' ' GLN . 1.8 pp0? -63.46 -44.4 94.56 Favored 'General case' 0 CA--C 1.496 -1.125 0 CA-C-O 122.979 1.371 . . . . 1.95 110.582 -174.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.68 81.96 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 111.818 -2.446 . . . . 0.48999999999999999 110.985 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.66 179.0 48.84 Favored Glycine 0 N--CA 1.428 -1.898 0 CA-C-N 114.835 -1.075 . . . . 0.41999999999999998 111.173 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.35 156.99 21.55 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.151 0.5 . . . . 0.40999999999999998 110.978 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.547 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 31.7 m -134.89 127.58 30.97 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.076 -0.965 . . . . 0.41999999999999998 110.243 -177.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -75.99 122.83 24.78 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 121.261 0.553 . . . . 0.46999999999999997 110.114 -178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.411 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.76 1.17 61.93 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 110.543 -1.023 . . . . 0.40999999999999998 110.543 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.547 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -79.96 123.85 28.17 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.271 -0.464 . . . . 1.3 110.177 -179.05 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 31.0 p -76.8 126.67 31.38 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 122.175 0.988 . . . . 0.84999999999999998 110.349 175.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.608 HG21 HD21 ' A' ' 36' ' ' LEU . 8.8 pt -125.85 141.26 46.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 113.875 -1.511 . . . . 0.25 108.878 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.85 151.18 3.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.357 0.598 . . . . 0.67000000000000004 111.167 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.6 mm -115.36 93.4 35.93 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.385 -1.279 . . . . 0.16 108.794 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.579 ' HA ' HD21 ' A' ' 4' ' ' LEU . 5.6 Cg_exo -61.64 136.26 61.6 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.719 2.279 . . . . 0.17999999999999999 112.726 -172.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.15 -6.0 82.77 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 114.725 -1.125 . . . . 0.26000000000000001 112.435 -177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.701 HD12 ' HD2' ' A' ' 52' ' ' PRO . 29.8 tp -122.94 116.24 28.95 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-O 121.192 0.52 . . . . 0.60999999999999999 110.948 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.701 ' HD2' HD12 ' A' ' 51' ' ' LEU . 52.3 Cg_endo -78.19 -177.14 3.66 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.491 2.794 . . . . 0.28000000000000003 114.119 -171.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.624 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.0 t70 -79.3 133.59 60.13 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 114.202 -1.363 . . . . 0.48999999999999999 112.454 -170.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.35 -16.01 24.89 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 123.577 2.851 . . . . 0.46000000000000002 113.115 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -96.66 1.74 51.41 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.159 0.504 . . . . 1.3799999999999999 111.701 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.624 HG23 ' HB3' ' A' ' 53' ' ' ASP . 26.8 p -95.74 -16.04 22.22 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.395 -0.965 . . . . 0.46000000000000002 108.395 172.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.676 HG22 ' H ' ' A' ' 59' ' ' TYR . 9.1 mm -64.62 129.24 94.19 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 113.422 -1.717 . . . . 0.69999999999999996 110.08 176.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.435 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 60.4 Cg_endo -78.65 -17.71 12.41 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.057 1.838 . . . . 0.39000000000000001 113.037 176.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.676 ' H ' HG22 ' A' ' 57' ' ' ILE . 60.4 m-85 -104.13 172.99 6.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.066 0.46 . . . . 0.23999999999999999 111.67 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -155.53 138.24 15.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.595 -0.729 . . . . 2.8900000000000001 109.397 173.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 71' ' ' THR . 82.9 mt -113.55 131.97 63.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.108 -0.496 . . . . 0.16 111.789 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.44 118.27 32.72 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.169 -0.612 . . . . 0.16 111.13 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 59.0 t -98.1 120.91 48.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.538 0.685 . . . . 0.19 110.888 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 45.2 m -98.31 104.34 16.36 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.909 -1.041 . . . . 0.20000000000000001 110.989 177.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.561 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 35.2 mm -50.89 -58.96 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 122.053 0.93 . . . . 0.23000000000000001 111.263 166.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.21 -11.18 3.17 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 112.774 -2.012 . . . . 0.16 113.462 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -127.5 -21.52 3.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.982 0.734 . . . . 0.14999999999999999 112.982 -178.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 60.24 57.2 3.0 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 118.989 0.813 . . . . 0.68999999999999995 111.249 -170.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -137.64 161.94 35.13 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.951 0.723 . . . . 0.13 112.951 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.478 ' CD2' HD21 ' A' ' 153' ' ' LEU . 7.8 tt -130.46 113.58 14.47 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.54 -1.209 . . . . 0.40000000000000002 109.702 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.692 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 52.7 m -95.12 123.88 38.86 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.157 0.504 . . . . 0.16 111.317 178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 79' ' ' MET . 11.6 tp -99.16 107.91 20.38 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.12 -0.946 . . . . 0.58999999999999997 109.197 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 90.0 p -107.73 160.72 15.5 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.233 -0.987 . . . . 1.05 110.804 177.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.637 HD13 ' ND2' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -126.46 124.75 40.82 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.707 0.765 . . . . 0.26000000000000001 109.221 170.254 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.637 ' ND2' HD13 ' A' ' 74' ' ' LEU . 9.3 p30 37.83 59.21 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.531 -1.668 . . . . 1.8400000000000001 111.899 -164.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 75.49 -13.73 0.84 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.883 -1.053 . . . . 1.8899999999999999 112.156 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -96.0 121.59 37.91 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.699 -0.482 . . . . 3.4399999999999999 109.699 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 46.5 t -58.49 129.82 21.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 122.318 1.056 . . . . 0.23999999999999999 112.517 -176.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 48.4 mmm -93.9 -49.92 5.58 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.161 -1.836 . . . . 0.81000000000000005 107.881 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 mmtt -159.73 172.06 18.4 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.779 -2.01 . . . . 1.46 109.634 -174.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.4 m -149.34 125.09 10.48 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.418 -1.265 . . . . 0.17000000000000001 109.592 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -116.31 150.42 45.32 Favored Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.555 -0.748 . . . . 1.05 110.077 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.433 ' HB2' HG22 ' A' ' 134' ' ' ILE . 53.9 Cg_endo -75.5 145.57 29.92 Favored 'Trans proline' 0 CA--C 1.494 -1.492 0 C-N-CA 122.188 1.926 . . . . 0.20000000000000001 110.957 177.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.636 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -141.22 173.25 9.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.689 -0.687 . . . . 0.13 110.782 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.898 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.65 142.99 46.59 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.438 -0.346 . . . . 0.26000000000000001 110.176 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.529 HG22 ' HG3' ' A' ' 68' ' ' LYS . 13.0 m -126.28 128.27 71.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.417 0.627 . . . . 0.56000000000000005 111.622 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -92.01 160.14 25.96 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 115.067 -0.97 . . . . 0.17000000000000001 110.714 173.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -55.62 2.88 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 113.539 0.94 . . . . 3.0499999999999998 113.539 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.91 HG23 HD22 ' A' ' 90' ' ' LEU . 1.3 tp -91.15 -18.89 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 O-C-N 121.051 -1.031 . . . . 0.23000000000000001 109.793 -177.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.91 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -91.63 -22.31 20.35 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.898 0.856 . . . . 0.17999999999999999 108.693 -177.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.2 p -67.29 -11.76 58.38 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.263 -1.335 . . . . 0.33000000000000002 111.404 -177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -71.14 -42.11 69.6 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.61 -1.177 . . . . 1.52 112.287 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -96.74 125.78 45.46 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.274 -0.571 . . . . 0.42999999999999999 110.659 -176.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.551 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.9 Cg_endo -75.19 -15.24 20.45 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.771 2.314 . . . . 0.72999999999999998 112.837 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 96' ' ' GLY . 14.9 t -115.65 -41.62 3.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.649 -0.25 . . . . 0.47999999999999998 110.381 -177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.475 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 47.43 42.72 19.33 Favored Glycine 0 C--O 1.225 -0.447 0 O-C-N 124.045 0.841 . . . . 0.33000000000000002 113.778 169.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.57 113.54 21.32 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.793 0.806 . . . . 0.83999999999999997 109.237 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.733 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 25.6 m-85 -136.53 178.32 7.16 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.137 -1.392 . . . . 0.22 112.275 -171.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.486 ' CD2' ' HB3' ' A' ' 162' ' ' ARG . 32.5 m-85 -144.28 139.12 28.41 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 116.197 -0.456 . . . . 0.54000000000000004 110.703 -171.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.634 HD12 ' HB ' ' A' ' 161' ' ' THR . 75.6 mt -65.68 116.02 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 115.424 -0.807 . . . . 0.17000000000000001 110.674 171.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.523 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 20.6 pt -84.16 -44.09 17.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 112.901 0.704 . . . . 0.20999999999999999 112.901 -175.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.84 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 44.9 m-80 -170.45 169.84 7.25 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 107.003 -1.48 . . . . 2.0299999999999998 107.003 -169.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.656 HH21 ' HA ' ' A' ' 158' ' ' PRO . 14.0 mtt180 -129.27 158.13 39.93 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.819 -0.752 . . . . 1.52 111.536 -175.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.9 tt0 -131.89 100.87 5.22 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.711 -0.677 . . . . 0.58999999999999997 109.969 169.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.492 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 20.7 ttt85 -62.86 166.0 6.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.339 -0.846 . . . . 2.8199999999999998 111.01 174.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.492 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 21.5 m-80 -35.01 103.03 0.23 Allowed Pre-proline 0 C--O 1.234 0.274 0 C-N-CA 125.361 1.464 . . . . 0.34999999999999998 113.717 -153.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 13.9 Cg_exo -52.41 -49.6 16.87 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.594 2.863 . . . . 0.47999999999999998 111.238 170.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 118.33 -33.74 4.71 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 110.44 -1.064 . . . . 0.67000000000000004 110.44 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.79 -177.93 45.68 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.811 -0.695 . . . . 0.62 112.431 175.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.06 -0.75 0.99 Allowed 'Trans proline' 0 N--CA 1.479 0.675 0 C-N-CA 125.056 3.837 . . . . 0.93999999999999995 115.365 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -71.43 7.06 1.49 Allowed 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 112.919 0.711 . . . . 1.23 112.919 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.697 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 88.03 63.47 1.38 Allowed Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 119.502 -1.332 . . . . 1.6899999999999999 115.673 165.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.524 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 37.16 0.66 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 117.055 2.243 . . . . 0.47999999999999998 117.055 -177.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.495 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.3 OUTLIER -167.26 162.67 15.12 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.583 -0.698 . . . . 0.28000000000000003 109.925 -176.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 22.1 t-105 -142.52 98.61 3.33 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.176 -1.046 . . . . 0.48999999999999999 108.176 166.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.6 HD12 HG23 ' A' ' 150' ' ' VAL . 4.6 mt -91.3 113.74 26.09 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.101 -0.703 . . . . 0.66000000000000003 109.101 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 101' ' ' ILE . 23.5 m -83.82 143.81 29.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.86 -0.609 . . . . 0.19 111.325 -169.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.791 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -108.3 167.99 9.63 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.921 -0.581 . . . . 0.13 111.407 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.5 t -58.87 -13.87 7.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.583 -1.19 . . . . 1.1699999999999999 112.967 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.733 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 4.0 tmtm? -127.01 130.12 49.4 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.016 0.436 . . . . 1.22 110.127 172.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.712 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.9 mt-30 -34.37 -55.02 0.53 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 114.097 -1.411 . . . . 1.51 114.151 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.529 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -99.91 11.93 38.04 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.958 -0.697 . . . . 2.5299999999999998 111.997 -173.381 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.791 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -96.48 37.65 1.26 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.755 0.65 . . . . 0.83999999999999997 112.755 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.612 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -114.45 142.68 17.7 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 117.379 -2.343 . . . . 0.32000000000000001 112.58 -151.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.529 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -94.63 114.44 31.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.743 0.783 . . . . 0.17999999999999999 110.568 -177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.679 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 32.8 p80 -145.05 171.44 14.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.20999999999999999 109.75 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.697 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.83 -168.03 37.89 Favored Glycine 0 C--N 1.316 -0.537 0 C-N-CA 120.287 -0.958 . . . . 0.27000000000000002 111.892 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.445 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 14.2 t -156.69 172.7 18.13 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.2 -0.588 . . . . 0.40999999999999998 110.175 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -114.26 -0.1 14.0 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.952 -0.759 . . . . 1.99 108.952 175.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -114.83 86.8 13.72 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 107.916 -1.142 . . . . 1.3600000000000001 107.916 169.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -73.47 -18.18 23.09 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.486 2.124 . . . . 0.34999999999999998 113.53 -169.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.98 -1.82 45.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.778 -0.647 . . . . 0.33000000000000002 110.67 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 41.1 t -91.03 -4.06 56.69 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.049 -0.722 . . . . 1.3500000000000001 109.049 171.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.433 HG22 ' HB2' ' A' ' 83' ' ' PRO . 37.0 mm -83.3 134.14 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.81 -0.632 . . . . 0.20999999999999999 110.251 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.95 1.19 70.54 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 109.867 -1.293 . . . . 0.14999999999999999 109.867 -174.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 3.3 tttt -110.82 161.53 15.71 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 122.859 1.314 . . . . 2.5 113.46 -176.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.445 ' N ' ' HE2' ' A' ' 68' ' ' LYS . . . -96.52 126.95 42.07 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 112.551 -2.113 . . . . 0.17000000000000001 108.239 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.495 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 1.2 p -122.19 166.91 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.585 -1.265 . . . . 0.66000000000000003 107.585 -176.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.4 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 45.2 m -64.17 -52.17 60.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.823 0.738 . . . . 0.42999999999999999 112.605 -179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -130.23 -45.46 1.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 118.067 -1.453 . . . . 2.02 113.805 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.06 133.7 0.17 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 117.023 1.569 . . . . 0.17999999999999999 117.023 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.598 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 3.0 p -74.67 165.6 24.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 112.573 -1.813 . . . . 0.16 111.676 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.898 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 61.5 mt -59.59 99.12 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 122.378 1.085 . . . . 0.40000000000000002 112.239 -162.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.679 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 70.9 mtt180 -86.85 145.83 26.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 113.752 -1.567 . . . . 1.8700000000000001 110.494 -177.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.636 ' HG2' HG22 ' A' ' 84' ' ' ILE . 10.9 mtp -126.23 -165.51 1.45 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.011 -0.737 . . . . 0.79000000000000004 109.011 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.472 ' O ' HG12 ' A' ' 150' ' ' VAL . 40.0 m80 -90.47 165.1 13.99 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.113 -0.699 . . . . 2.3199999999999998 109.113 169.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.663 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.8 m120 -63.57 -48.99 75.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 118.258 -0.877 . . . . 0.68000000000000005 110.145 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -64.48 -29.27 70.31 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 121.58 1.991 . . . . 2.1800000000000002 111.903 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.541 ' HB3' ' HE2' ' A' ' 145' ' ' MET . 68.1 m-20 -76.68 -45.67 28.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.06 0.457 . . . . 0.68999999999999995 110.435 -175.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.657 HG13 HD12 ' A' ' 151' ' ' ILE . 14.4 p -67.02 -23.46 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.387 -0.824 . . . . 0.11 111.308 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.663 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -84.08 -42.52 17.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 119.05 -0.5 . . . . 0.38 110.142 171.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.478 ' O ' HG13 ' A' ' 156' ' ' ILE . 29.9 mt-10 -48.22 -68.55 0.17 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 119.392 0.996 . . . . 1.99 112.305 171.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 157' ' ' VAL . 9.2 mp -47.09 -39.02 12.35 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.455 0.645 . . . . 1.27 111.436 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.73 -32.62 74.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.579 -1.191 . . . . 0.17999999999999999 111.606 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.1 t -87.34 -32.25 19.72 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.487 -0.758 . . . . 0.20999999999999999 112.316 175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 152' ' ' GLU . 36.9 mt -82.88 -60.11 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.528 0.68 . . . . 0.16 111.547 -172.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.8 m -89.52 138.16 28.5 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 114.812 -1.086 . . . . 0.16 112.28 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.656 ' HA ' HH21 ' A' ' 103' ' ' ARG . 43.3 Cg_endo -89.01 176.04 3.34 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 C-N-CA 124.194 3.263 . . . . 0.20000000000000001 111.525 176.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.84 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.8 m-20 -67.24 154.42 41.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.13 -1.063 . . . . 1.1000000000000001 108.13 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.97 -15.35 63.18 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.789 -1.196 . . . . 0.17999999999999999 112.565 -174.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.634 ' HB ' HD12 ' A' ' 100' ' ' ILE . 88.3 m -65.8 136.88 56.78 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 109.091 -0.707 . . . . 0.14000000000000001 109.091 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.486 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 1.1 ptm180 -93.3 127.31 38.85 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.55 1.166 . . . . 3.6299999999999999 111.51 -171.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.5 t -111.69 108.61 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 112.327 -2.215 . . . . 0.14000000000000001 109.215 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.8 m -95.54 109.89 22.05 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.459 0.541 . . . . 0.20999999999999999 112.459 -172.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.475 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.3 mp -83.69 96.08 4.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-O 122.504 1.145 . . . . 0.23999999999999999 109.946 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -101.56 138.32 38.72 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.724 -1.58 . . . . 1.0900000000000001 108.663 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.561 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 5.2 mmt85 -73.97 -24.51 59.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.988 -0.745 . . . . 2.0800000000000001 108.988 175.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.26 -48.04 3.72 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.154 -0.93 . . . . 1.97 112.226 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.323 -0.583 0 N-CA-C 109.623 -0.51 . . . . 3.9100000000000001 109.623 175.515 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.867 -0.493 . . . . 2.7999999999999998 111.867 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -108.41 147.67 31.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.003 0.43 . . . . 4.4400000000000004 110.222 177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -86.57 109.34 19.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.618 -0.719 . . . . 2.46 109.826 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -105.9 174.45 5.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.661 0.743 . . . . 0.65000000000000002 112.097 -177.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.62 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.2 tt -96.19 129.67 43.44 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.644 -1.162 . . . . 0.28000000000000003 110.219 -175.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.81 162.04 13.45 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.207 -0.906 . . . . 0.31 112.663 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 45' ' ' SER . 74.0 t80 -131.2 145.38 51.91 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.956 -1.475 . . . . 0.44 108.193 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.425 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 59.0 tt0 -116.02 114.55 24.73 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.436 -0.95 . . . . 0.76000000000000001 108.436 177.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 13' ' ' ASP . 97.5 t -68.04 151.46 10.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 122.567 1.175 . . . . 0.39000000000000001 113.364 -171.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -103.96 159.87 15.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.256 -1.793 . . . . 2.0099999999999998 108.837 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.07 105.3 0.67 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.972 0.415 . . . . 1.8300000000000001 111.751 -176.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.35 10.93 32.67 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.933 -0.651 . . . . 0.47999999999999998 113.215 173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.598 ' HB2' HG13 ' A' ' 9' ' ' VAL . 87.8 m-20 -55.93 171.09 0.26 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.709 0.254 . . . . 1.46 111.26 172.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.2 154.3 50.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.599 0.714 . . . . 0.40999999999999998 111.893 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.708 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -69.14 -28.73 66.7 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.346 -1.297 . . . . 0.85999999999999999 109.995 -176.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.459 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -93.51 -26.12 17.3 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.025 -0.989 . . . . 1.1499999999999999 110.788 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -66.06 -40.6 91.06 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.604 -0.438 . . . . 1.21 109.927 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.431 HG23 ' CE1' ' A' ' 22' ' ' PHE . 14.6 mt -73.47 -27.1 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 116.185 -0.461 . . . . 0.20999999999999999 109.928 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.651 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.39 -11.37 59.92 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.809 -0.356 . . . . 0.16 111.147 176.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.644 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -93.51 -40.02 10.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.458 0.647 . . . . 0.20999999999999999 109.885 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.67 ' HB3' ' O ' ' A' ' 119' ' ' SER . 47.1 m-20 -63.46 -40.54 97.4 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.726 -1.125 . . . . 0.53000000000000003 112.054 174.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 51.4 m-85 -99.25 4.81 46.74 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 118.506 -1.278 . . . . 0.17999999999999999 111.44 -178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.644 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.7 mpt_? 54.83 44.6 28.15 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.711 0.767 . . . . 1.78 109.619 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.651 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 32.4 pt -117.46 -165.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.624 -1.171 . . . . 0.19 110.028 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.42 142.55 41.98 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.91 -1.041 . . . . 0.94999999999999996 110.125 175.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.708 ' HB ' HD11 ' A' ' 15' ' ' LEU . 78.8 p -73.57 -32.75 64.32 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.409 -0.96 . . . . 0.25 108.409 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.59 -24.4 66.65 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.095 -0.957 . . . . 0.20000000000000001 111.636 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HA ' HE21 ' A' ' 31' ' ' GLN . . . -95.31 -28.2 15.1 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.983 -0.747 . . . . 0.17000000000000001 108.983 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.646 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 21.3 tp -74.23 -27.01 60.57 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.486 -0.779 . . . . 1.1599999999999999 109.503 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 36' ' ' LEU . 72.6 mt -80.19 -26.81 39.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.698 0.761 . . . . 1.05 110.117 172.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.475 HE21 ' HA ' ' A' ' 28' ' ' ALA . 7.1 tt0 -66.03 -41.18 91.26 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.573 -1.194 . . . . 1.8100000000000001 110.13 171.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.1 -21.67 31.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.115 -0.634 . . . . 0.20000000000000001 111.456 178.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.656 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 18.2 m-80 -148.27 78.49 9.41 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 121.532 0.682 . . . . 0.23000000000000001 110.328 -172.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 20.3 Cg_endo -58.36 -7.79 4.41 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 124.331 3.354 . . . . 0.35999999999999999 114.149 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.6 m -84.69 -17.89 37.01 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 111.815 0.302 . . . . 1.3799999999999999 111.815 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.742 HD21 HG21 ' A' ' 46' ' ' ILE . 41.8 mt -67.74 -34.49 76.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.513 0.673 . . . . 0.48999999999999999 111.704 -173.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.422 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 5.7 pt20 -65.05 -46.64 80.4 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 122.819 1.295 . . . . 1.95 110.36 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' A' ' 37' ' ' GLN . . . -58.86 -47.66 84.12 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 111.771 -2.468 . . . . 0.48999999999999999 110.648 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.48 47.43 Favored Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 114.753 -1.112 . . . . 0.41999999999999998 111.318 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.26 156.8 20.95 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.273 0.558 . . . . 0.40999999999999998 111.006 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.622 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 62.3 m -138.05 127.32 24.53 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.17 -0.923 . . . . 0.41999999999999998 110.576 -175.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.7 118.06 19.71 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.511 0.672 . . . . 0.46999999999999997 109.943 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 101.67 1.76 52.86 Favored Glycine 0 N--CA 1.431 -1.642 0 N-CA-C 110.195 -1.162 . . . . 0.40999999999999998 110.195 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -77.95 123.7 27.11 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.633 -0.783 . . . . 1.3 109.715 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 46.2 p -82.18 128.04 33.76 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.434 -0.803 . . . . 0.84999999999999998 110.275 176.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.742 HG21 HD21 ' A' ' 36' ' ' LEU . 12.4 pt -127.7 141.72 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.186 -1.37 . . . . 0.25 109.326 -177.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.36 150.61 3.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 121.094 0.473 . . . . 0.67000000000000004 110.898 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.4 mm -114.8 92.1 28.57 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 114.709 -1.132 . . . . 0.16 108.992 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.635 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -58.94 133.81 56.0 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.903 2.402 . . . . 0.17999999999999999 112.918 -174.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.07 -6.38 78.88 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.8 -1.091 . . . . 0.26000000000000001 112.339 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.727 HD12 ' HD2' ' A' ' 52' ' ' PRO . 30.0 tp -123.47 116.97 27.97 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 121.106 0.479 . . . . 0.60999999999999999 111.213 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.727 ' HD2' HD12 ' A' ' 51' ' ' LEU . 43.7 Cg_endo -76.86 -177.28 3.68 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.605 2.87 . . . . 0.28000000000000003 113.907 -172.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.508 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.1 t70 -83.54 129.56 59.53 Favored Pre-proline 0 N--CA 1.44 -0.962 0 CA-C-N 114.483 -1.235 . . . . 0.48999999999999999 111.97 -168.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.557 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.2 Cg_endo -75.23 -17.49 19.01 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.333 2.689 . . . . 0.46000000000000002 112.411 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -93.96 -5.41 47.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.476 0.655 . . . . 1.3799999999999999 110.404 -172.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 53' ' ' ASP . 30.2 p -89.24 -20.84 23.65 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.6 1.19 . . . . 0.46000000000000002 107.993 173.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.497 HG22 ' H ' ' A' ' 59' ' ' TYR . 27.1 mt -74.05 130.02 83.61 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 112.906 -1.952 . . . . 0.69999999999999996 111.232 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.82 -17.06 9.86 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.48 2.12 . . . . 0.39000000000000001 113.153 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.497 ' H ' HG22 ' A' ' 57' ' ' ILE . 70.0 m-85 -92.26 159.5 15.59 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.823 -0.351 . . . . 0.23999999999999999 111.661 -177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -147.2 134.44 20.58 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.883 -0.784 . . . . 2.8900000000000001 108.883 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' A' ' 71' ' ' THR . 86.3 mt -113.68 131.89 64.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.948 -0.569 . . . . 0.16 111.676 -178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.16 117.32 30.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.937 -0.705 . . . . 0.16 110.843 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 69' ' ' THR . 91.2 t -97.62 111.31 27.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.765 0.793 . . . . 0.19 111.117 175.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 68' ' ' LYS . 58.8 m -93.64 101.25 13.39 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.508 -1.223 . . . . 0.20000000000000001 110.702 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.52 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.6 mm -49.26 -57.89 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 122.067 0.937 . . . . 0.23000000000000001 111.306 170.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.22 -9.1 2.85 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 112.764 -2.016 . . . . 0.16 113.208 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.07 -22.53 3.76 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.532 0.733 . . . . 0.14999999999999999 112.517 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HG3' HG22 ' A' ' 86' ' ' VAL . 1.1 mppt? 60.61 58.44 2.45 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 118.067 0.394 . . . . 0.68999999999999995 111.354 -170.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 63.0 p -137.68 160.83 38.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 113.09 0.774 . . . . 0.13 113.09 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.435 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.4 tt -128.18 107.95 10.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.672 -1.149 . . . . 0.40000000000000002 109.534 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.7 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 61.7 m -90.37 122.02 32.87 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.082 0.468 . . . . 0.16 110.837 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 79' ' ' MET . 17.1 tp -97.88 105.21 17.32 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.446 -0.797 . . . . 0.58999999999999997 109.273 173.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 96.9 p -105.65 160.47 15.18 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 118.829 -1.148 . . . . 1.05 110.318 178.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.5 tm? -126.1 125.45 42.57 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.705 -0.85 . . . . 0.26000000000000001 108.705 168.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.538 ' N ' HD22 ' A' ' 74' ' ' LEU . 24.4 m-80 50.54 50.06 19.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.435 -1.257 . . . . 1.8400000000000001 111.008 -171.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 71.74 -10.18 0.87 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.571 0.749 . . . . 1.8899999999999999 111.816 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -98.79 120.42 39.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 116.021 -0.536 . . . . 3.4399999999999999 109.82 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 54.6 t -57.74 132.98 22.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 122.493 1.139 . . . . 0.23999999999999999 112.768 -174.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.495 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -102.01 -45.01 5.31 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 112.837 -1.983 . . . . 0.81000000000000005 108.732 177.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -154.27 174.49 14.72 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 113.2 -1.818 . . . . 1.46 110.102 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 71' ' ' THR . 27.9 m -149.29 121.21 8.19 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.481 -1.69 . . . . 0.17000000000000001 109.46 168.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.503 ' HD2' ' OD2' ' A' ' 149' ' ' ASP . 12.9 m-85 -101.19 151.28 37.67 Favored Pre-proline 0 C--N 1.308 -1.232 0 CA-C-N 115.142 -0.935 . . . . 1.05 109.165 -175.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.429 ' HB2' HG22 ' A' ' 134' ' ' ILE . 57.3 Cg_endo -81.2 140.51 12.36 Favored 'Trans proline' 0 CA--C 1.5 -1.212 0 C-N-CA 121.499 1.466 . . . . 0.20000000000000001 111.062 169.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.674 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -139.81 176.13 6.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.516 -0.765 . . . . 0.13 110.393 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.878 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -120.14 150.17 41.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.126 -0.324 . . . . 0.26000000000000001 110.126 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.513 HG11 HD13 ' A' ' 65' ' ' ILE . 9.8 m -130.95 127.47 61.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.58 0.705 . . . . 0.56000000000000005 112.107 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -85.67 156.16 29.98 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.044 -1.222 . . . . 0.17000000000000001 110.044 172.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -57.46 3.96 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.236 0.828 . . . . 3.0499999999999998 113.236 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.947 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -90.28 -19.49 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 O-C-N 121.638 -0.664 . . . . 0.23000000000000001 110.291 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.947 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -89.78 -18.13 26.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.765 0.793 . . . . 0.17999999999999999 109.256 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.5 p -68.04 -14.36 62.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.427 -1.26 . . . . 0.33000000000000002 111.362 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -71.52 -37.67 71.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.47 -1.241 . . . . 1.52 112.862 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.449 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -105.8 115.89 60.76 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 120.055 -0.658 . . . . 0.42999999999999999 110.793 -177.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.558 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.8 Cg_endo -75.58 -11.69 20.43 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.792 2.328 . . . . 0.72999999999999998 113.63 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.439 HG23 ' N ' ' A' ' 96' ' ' GLY . 10.1 t -105.02 -43.56 5.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.185 0.516 . . . . 0.47999999999999998 110.107 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.557 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 53.54 33.48 47.81 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 114.257 -1.338 . . . . 0.33000000000000002 113.93 167.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.16 112.61 20.4 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 121.969 0.89 . . . . 0.83999999999999997 109.721 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.715 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 19.0 m-85 -138.05 176.81 8.37 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 113.764 -1.562 . . . . 0.22 111.949 -170.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.455 ' CG ' HD11 ' A' ' 5' ' ' LEU . 45.3 m-85 -139.33 144.08 38.1 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.257 0.551 . . . . 0.54000000000000004 110.452 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.564 HD12 ' HB ' ' A' ' 161' ' ' THR . 83.8 mt -68.84 116.89 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 CA-C-N 115.613 -0.721 . . . . 0.17000000000000001 110.557 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 30.4 pt -85.93 -35.81 9.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 112.877 0.695 . . . . 0.20999999999999999 112.877 -175.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.782 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 11.0 p30 -178.53 -179.21 0.65 Allowed 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 107.695 -1.224 . . . . 2.0299999999999998 107.695 -176.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.674 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -140.38 159.6 41.83 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.16 -0.616 . . . . 1.52 112.599 -176.041 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 51.8 tt0 -128.37 100.07 5.66 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.9 -1.046 . . . . 0.58999999999999997 109.428 172.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.518 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 61.5 ttt180 -64.73 165.91 9.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.341 -0.845 . . . . 2.8199999999999998 110.663 176.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.518 ' H ' ' HG2' ' A' ' 105' ' ' ARG . 23.3 m-80 -35.07 102.05 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 125.282 1.433 . . . . 0.34999999999999998 113.743 -152.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 16.3 Cg_exo -53.84 -51.53 10.55 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.504 2.803 . . . . 0.47999999999999998 111.469 169.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 119.26 -33.84 4.53 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.152 -1.179 . . . . 0.67000000000000004 110.152 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.49 -175.16 33.57 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 114.636 -0.782 . . . . 0.62 112.745 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.69 -8.47 7.46 Favored 'Trans proline' 0 N--CA 1.479 0.675 0 C-N-CA 124.877 3.718 . . . . 0.93999999999999995 114.844 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -63.99 -0.11 1.04 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 114.08 1.141 . . . . 1.23 114.08 -172.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.684 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 89.18 63.32 1.32 Allowed Glycine 0 CA--C 1.494 -1.277 0 C-N-CA 119.287 -1.435 . . . . 1.6899999999999999 114.884 166.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.514 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 37.68 0.77 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 116.977 2.214 . . . . 0.47999999999999998 116.977 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.49 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.4 OUTLIER -166.54 162.88 16.96 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.684 -0.635 . . . . 0.28000000000000003 110.04 -176.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 18.0 t-105 -143.9 97.85 3.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.302 -0.999 . . . . 0.48999999999999999 108.302 167.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.468 HD12 HG23 ' A' ' 150' ' ' VAL . 2.1 mt -89.48 115.19 26.72 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.381 0.61 . . . . 0.66000000000000003 109.739 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.449 ' C ' HG12 ' A' ' 101' ' ' ILE . 24.3 m -86.01 144.3 27.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.956 -0.565 . . . . 0.19 111.19 -171.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.807 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.1 mm? -109.29 168.14 9.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.13 110.46 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.67 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.1 m -65.11 -2.38 2.79 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.937 0.718 . . . . 1.1699999999999999 112.937 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.773 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 5.0 tmtm? -128.8 136.37 50.42 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 109.941 -0.392 . . . . 1.22 109.941 168.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.773 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 25.5 mm-40 -36.46 -58.03 0.73 Allowed 'General case' 0 C--N 1.312 -1.041 0 O-C-N 124.222 0.951 . . . . 1.51 113.458 177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.538 ' CB ' HG12 ' A' ' 89' ' ' ILE . 56.2 m80 -89.92 0.78 56.88 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.451 -0.499 . . . . 2.5299999999999998 111.83 -167.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.807 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.1 m-30 -96.73 37.93 1.25 Allowed 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 113.419 0.896 . . . . 0.83999999999999997 113.419 -170.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.699 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -114.41 142.95 17.85 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 116.693 -2.67 . . . . 0.32000000000000001 112.642 -152.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -93.35 115.21 31.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.773 0.797 . . . . 0.17999999999999999 110.661 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.555 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 31.5 p80 -142.05 170.57 15.46 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.451 -0.795 . . . . 0.20999999999999999 109.394 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.684 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -92.35 -167.27 39.61 Favored Glycine 0 C--N 1.314 -0.661 0 C-N-CA 120.375 -0.917 . . . . 0.27000000000000002 111.687 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.501 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 9.2 t -156.79 169.82 23.86 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 122.039 -0.683 . . . . 0.40999999999999998 110.346 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -114.68 -5.22 12.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.643 -0.873 . . . . 1.99 108.643 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -116.04 87.33 18.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 114.832 -1.077 . . . . 1.3600000000000001 108.231 171.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -72.78 -21.21 21.79 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 123.131 2.554 . . . . 0.34999999999999998 114.484 -167.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -75.83 -2.58 30.69 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.147 0.499 . . . . 0.33000000000000002 111.116 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.483 ' HA ' ' HD2' ' A' ' 136' ' ' LYS . 15.9 m -91.91 -5.52 53.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.275 0.559 . . . . 1.3500000000000001 109.673 173.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 83' ' ' PRO . 37.8 mm -81.89 134.96 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.713 -0.676 . . . . 0.20999999999999999 110.085 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.89 2.28 66.91 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.954 -1.259 . . . . 0.14999999999999999 109.954 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 133' ' ' SER . 54.6 mttp -113.93 170.08 8.53 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.988 1.375 . . . . 2.5 113.466 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -103.07 124.92 49.45 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 112.118 -2.31 . . . . 0.17000000000000001 108.191 177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.43 162.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.757 -0.831 . . . . 0.66000000000000003 108.757 -173.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -51.55 -60.17 3.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 112.389 0.514 . . . . 0.42999999999999999 112.389 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.416 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 18.8 pttp -133.5 -44.36 0.83 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 118.357 -1.337 . . . . 2.02 113.765 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.88 133.24 0.17 Allowed Glycine 0 N--CA 1.464 0.54 0 N-CA-C 117.014 1.565 . . . . 0.17999999999999999 117.014 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.547 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 5.4 p -69.53 165.75 20.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 112.411 -1.894 . . . . 0.16 112.202 -178.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.878 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 45.9 mt -59.8 98.9 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.566 -1.197 . . . . 0.40000000000000002 112.047 -162.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.555 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 11.4 mtp180 -86.27 150.03 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 113.874 -1.512 . . . . 1.8700000000000001 110.25 -177.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.674 ' HG2' HG22 ' A' ' 84' ' ' ILE . 6.3 mtp -129.31 -165.79 1.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.973 -0.751 . . . . 0.79000000000000004 108.973 173.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.724 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 5.1 t60 -92.91 159.54 15.3 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.605 -0.887 . . . . 2.3199999999999998 108.605 170.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.645 ' O ' HD13 ' A' ' 151' ' ' ILE . 1.6 m120 -57.9 -53.21 60.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.357 -0.83 . . . . 0.68000000000000005 110.365 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -63.56 -27.15 69.06 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 121.376 1.898 . . . . 2.1800000000000002 112.005 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.724 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 2.9 m-20 -75.67 -51.31 13.06 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.72 -0.673 . . . . 0.68999999999999995 110.63 -176.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.648 HG13 HD12 ' A' ' 151' ' ' ILE . 14.7 p -62.94 -22.63 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 115.285 -0.87 . . . . 0.11 111.746 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.648 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.58 -39.95 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 118.911 -0.566 . . . . 0.38 110.569 172.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -45.79 -72.34 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.219 0.918 . . . . 1.99 112.674 169.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.587 ' O ' HG22 ' A' ' 157' ' ' VAL . 1.1 mm? -49.0 -35.05 14.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.768 0.794 . . . . 1.27 111.325 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.508 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -63.94 -35.09 79.52 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.561 -1.2 . . . . 0.17999999999999999 112.048 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.3 t -90.99 -29.01 17.63 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 119.03 0.832 . . . . 0.20999999999999999 113.099 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.4 mt -83.19 -60.44 2.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.509 0.671 . . . . 0.16 111.772 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 153' ' ' LEU . 4.4 m -86.76 141.83 34.04 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.955 -1.02 . . . . 0.16 111.53 177.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.674 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 77.9 Cg_endo -85.19 172.64 8.34 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 123.992 3.128 . . . . 0.20000000000000001 111.351 175.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.782 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.4 m-20 -63.65 156.3 27.23 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.243 -1.021 . . . . 1.1000000000000001 108.243 176.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.77 -22.08 42.42 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 119.634 -1.27 . . . . 0.17999999999999999 112.951 -174.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.564 ' HB ' HD12 ' A' ' 100' ' ' ILE . 48.9 m -60.78 135.48 57.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.077 -0.712 . . . . 0.14000000000000001 109.077 -174.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.637 ' H ' ' HD3' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -94.16 129.91 40.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 122.589 1.185 . . . . 3.6299999999999999 111.403 -167.42 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.3 t -110.95 110.57 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-N 112.373 -2.194 . . . . 0.14000000000000001 109.571 -173.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 15.7 m -94.24 105.58 17.56 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.512 0.56 . . . . 0.20999999999999999 112.512 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.557 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.6 mp -82.42 99.96 5.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-O 122.412 1.101 . . . . 0.23999999999999999 110.005 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -107.47 130.91 54.78 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.04 -1.436 . . . . 1.0900000000000001 109.61 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.558 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 17.3 mmm180 -72.62 -7.74 51.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.967 0.413 . . . . 2.0800000000000001 111.184 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.98 8.14 69.55 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.804 -0.712 . . . . 1.97 112.033 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 C--N 1.321 -0.663 0 N-CA-C 109.552 -0.536 . . . . 3.9100000000000001 109.552 177.622 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 111.697 -0.561 . . . . 2.7999999999999998 111.697 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -117.04 133.02 56.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.009 0.433 . . . . 4.4400000000000004 110.232 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -90.83 119.06 30.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.696 -0.684 . . . . 2.46 110.637 -177.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.692 HD21 ' HA ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -113.89 175.12 5.6 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.64 0.733 . . . . 0.65000000000000002 112.076 -175.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.9 tt -95.42 130.42 42.23 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.525 -1.216 . . . . 0.28000000000000003 110.124 -176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.55 162.97 13.23 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 122.135 0.969 . . . . 0.31 113.21 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 45' ' ' SER . 84.8 t80 -130.44 140.95 50.54 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.791 -1.549 . . . . 0.44 107.959 175.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.403 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.8 tt0 -113.36 113.19 24.88 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.063 -1.088 . . . . 0.76000000000000001 108.063 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' A' ' 13' ' ' ASP . 93.6 t -67.11 150.99 10.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 122.38 1.086 . . . . 0.39000000000000001 112.999 -170.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -107.49 159.05 16.71 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 113.376 -1.738 . . . . 2.0099999999999998 108.21 171.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -58.66 110.0 0.91 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.964 0.411 . . . . 1.8300000000000001 111.94 -174.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.99 11.32 43.39 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.766 -0.652 . . . . 0.47999999999999998 113.7 172.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.643 ' HB2' HG13 ' A' ' 9' ' ' VAL . 86.9 m-20 -55.85 167.95 0.51 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 117.193 0.497 . . . . 1.46 111.177 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.59 152.56 48.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.036 0.446 . . . . 0.40999999999999998 111.746 176.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.56 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.39 -32.72 74.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.082 -0.963 . . . . 0.85999999999999999 108.643 -178.046 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 64.1 t30 -93.05 -22.21 19.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.789 -1.096 . . . . 1.1499999999999999 111.114 -177.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.7 t -65.64 -45.85 81.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.206 -0.664 . . . . 1.21 109.206 171.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.436 HG23 ' CE1' ' A' ' 22' ' ' PHE . 17.3 mt -71.84 -26.61 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.881 -0.6 . . . . 0.20999999999999999 110.056 -176.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.638 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.45 -10.17 59.75 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.833 -0.347 . . . . 0.16 111.111 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.607 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.32 -39.1 9.38 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.502 1.144 . . . . 0.20999999999999999 108.057 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 119' ' ' SER . 6.2 m-20 -63.32 -44.38 95.08 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 112.402 -2.181 . . . . 0.53000000000000003 111.911 173.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.569 ' HA ' HG21 ' A' ' 101' ' ' ILE . 55.3 m-85 -97.72 4.66 49.92 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 118.725 -1.19 . . . . 0.17999999999999999 111.658 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.4 mpt_? 54.68 43.28 30.4 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.866 0.841 . . . . 1.78 109.928 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.638 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.4 pt -116.39 -165.18 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 114.529 -1.214 . . . . 0.19 109.702 -178.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.1 142.34 41.7 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.023 -0.99 . . . . 0.94999999999999996 110.227 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.633 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 67.1 p -72.68 -32.82 66.1 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.916 -1.142 . . . . 0.25 107.916 178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.45 67.5 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.188 -0.915 . . . . 0.20000000000000001 111.745 169.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.548 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.98 -26.64 18.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.662 0.744 . . . . 0.17000000000000001 108.997 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.635 HD11 HD12 ' A' ' 46' ' ' ILE . 19.2 tp -76.35 -20.45 57.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.282 -0.872 . . . . 1.1599999999999999 109.554 174.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 26' ' ' THR . 28.9 mt -83.91 -29.54 27.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.396 0.617 . . . . 1.05 110.606 170.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -59.97 -61.25 2.75 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 107.945 -1.132 . . . . 1.8100000000000001 107.945 169.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.427 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -71.61 -17.39 62.28 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-O 121.514 0.673 . . . . 0.20000000000000001 110.415 -169.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.659 ' HB3' HD23 ' A' ' 36' ' ' LEU . 33.9 m-80 -150.69 85.26 5.28 Favored Pre-proline 0 N--CA 1.439 -1.021 0 CA-C-N 115.189 -0.914 . . . . 0.23000000000000001 110.579 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.46 -9.18 6.43 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.964 2.443 . . . . 0.35999999999999999 112.952 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 m -69.79 -34.66 74.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.154 0.502 . . . . 1.3799999999999999 111.319 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -61.37 -51.37 69.07 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 122.209 1.004 . . . . 0.48999999999999999 112.152 -169.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 30' ' ' LEU . 3.9 pt20 -56.32 -48.53 76.52 Favored 'General case' 0 CA--C 1.494 -1.199 0 CA-C-N 113.231 -1.804 . . . . 1.95 110.93 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.43 ' H ' ' HG3' ' A' ' 37' ' ' GLN . . . -54.5 -52.52 61.7 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 111.893 -2.412 . . . . 0.48999999999999999 109.938 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 179.88 168.0 37.93 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 114.439 -1.255 . . . . 0.41999999999999998 112.164 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.03 158.25 16.28 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.266 0.555 . . . . 0.40999999999999998 110.501 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.621 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 39.6 m -145.72 129.19 16.94 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.262 -0.881 . . . . 0.41999999999999998 110.427 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.89 117.64 16.96 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.495 0.664 . . . . 0.46999999999999997 109.953 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 101.15 0.54 54.47 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 114.716 -1.129 . . . . 0.40999999999999998 110.289 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.621 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.3 tt0 -75.24 125.38 28.84 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.856 -0.672 . . . . 1.3 110.338 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 56.3 p -83.54 131.46 34.99 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.831 0.824 . . . . 0.84999999999999998 110.322 175.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.635 HD12 HD11 ' A' ' 29' ' ' LEU . 10.0 pt -132.37 143.57 39.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.366 -1.288 . . . . 0.25 109.306 -178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.61 151.73 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-O 121.16 0.505 . . . . 0.67000000000000004 111.455 -179.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.3 mm -116.45 92.89 38.4 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 114.628 -1.169 . . . . 0.16 109.404 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.692 ' HA ' HD21 ' A' ' 4' ' ' LEU . 4.0 Cg_exo -57.34 134.88 66.65 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.853 2.369 . . . . 0.17999999999999999 113.174 -175.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.01 -7.58 80.93 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.317 -1.311 . . . . 0.26000000000000001 112.532 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.718 HD12 ' HD2' ' A' ' 52' ' ' PRO . 33.6 tp -120.87 115.2 32.07 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-O 121.2 0.524 . . . . 0.60999999999999999 111.184 -177.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.718 ' HD2' HD12 ' A' ' 51' ' ' LEU . 54.7 Cg_endo -78.09 -176.12 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 124.05 3.167 . . . . 0.28000000000000003 114.402 -171.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.594 ' HB3' HG23 ' A' ' 56' ' ' THR . 15.5 t70 -82.74 129.0 63.9 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 114.19 -1.368 . . . . 0.48999999999999999 112.045 -169.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 46.2 Cg_endo -72.92 -13.87 26.47 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 123.371 2.714 . . . . 0.46000000000000002 112.61 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.444 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 59.7 m-85 -96.26 -0.53 49.62 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.451 0.643 . . . . 1.3799999999999999 111.398 -175.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.594 HG23 ' HB3' ' A' ' 53' ' ' ASP . 19.6 p -95.33 -20.4 19.18 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.751 -1.203 . . . . 0.46000000000000002 107.751 171.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 59' ' ' TYR . 19.1 mt -75.69 131.5 76.74 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 113.168 -1.833 . . . . 0.69999999999999996 111.147 177.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HB2' ' CD2' ' A' ' 74' ' ' LEU . 95.5 Cg_endo -82.72 -18.26 6.76 Favored 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.233 1.956 . . . . 0.39000000000000001 113.486 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.504 ' H ' HG22 ' A' ' 57' ' ' ILE . 61.6 m-85 -95.2 158.47 15.45 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.499 0.555 . . . . 0.23999999999999999 112.499 -175.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.5 m80 -146.64 128.83 15.68 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.322 -0.853 . . . . 2.8900000000000001 108.975 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.655 ' HA ' ' O ' ' A' ' 71' ' ' THR . 87.2 mt -110.32 135.95 47.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.225 -0.443 . . . . 0.16 111.701 -176.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.09 119.04 33.06 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 119.955 -0.698 . . . . 0.16 110.968 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.2 t -98.96 116.38 41.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-O 121.525 0.679 . . . . 0.19 110.869 175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 68' ' ' LYS . 70.3 m -95.06 105.89 17.84 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.046 -0.979 . . . . 0.20000000000000001 110.352 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.7 mm -54.22 -58.92 2.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 122.079 0.942 . . . . 0.23000000000000001 111.2 167.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.68 -10.65 4.7 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 112.789 -2.005 . . . . 0.16 113.351 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.426 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.67 -18.74 4.7 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.453 0.701 . . . . 0.14999999999999999 112.213 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.506 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 58.64 55.74 4.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.373 0.533 . . . . 0.68999999999999995 111.421 -173.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.8 p -138.02 160.52 39.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 112.84 0.681 . . . . 0.13 112.84 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.503 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.7 tt -128.54 113.29 15.29 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.778 -1.101 . . . . 0.40000000000000002 110.178 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.655 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 41.3 m -93.95 122.66 36.68 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.273 0.559 . . . . 0.16 111.43 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 79' ' ' MET . 12.9 tp -97.55 103.27 15.19 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.862 -1.063 . . . . 0.58999999999999997 109.45 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 7.5 m -105.49 160.64 15.0 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.474 -0.89 . . . . 1.05 110.77 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.54 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.2 tm? -127.18 126.99 43.79 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.981 -0.748 . . . . 0.26000000000000001 108.981 169.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.54 ' N ' HD22 ' A' ' 74' ' ' LEU . 50.4 m-80 47.65 51.44 13.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.561 -1.199 . . . . 1.8400000000000001 111.228 -171.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 t30 71.8 -12.24 0.68 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.57 -0.741 . . . . 1.8899999999999999 111.695 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -96.22 120.27 36.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.17 0.509 . . . . 3.4399999999999999 110.221 -178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 64.1 t -59.53 131.85 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 122.32 1.057 . . . . 0.23999999999999999 112.468 -175.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 8.7 mtm -100.59 -46.01 5.33 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 113.246 -1.797 . . . . 0.81000000000000005 108.903 178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -156.35 173.03 17.47 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 113.518 -1.673 . . . . 1.46 110.037 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.7 m -149.4 124.6 10.13 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 114.354 -1.293 . . . . 0.17000000000000001 109.848 173.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -111.2 153.11 44.12 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 115.871 -0.604 . . . . 1.05 109.439 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.443 ' HB2' HG22 ' A' ' 134' ' ' ILE . 60.4 Cg_endo -79.7 143.11 16.52 Favored 'Trans proline' 0 CA--C 1.501 -1.143 0 C-N-CA 122.194 1.929 . . . . 0.20000000000000001 111.495 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.682 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.92 175.1 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-N 115.746 -0.661 . . . . 0.13 110.948 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.887 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -119.51 146.08 45.76 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.309 -0.405 . . . . 0.26000000000000001 110.067 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.533 HG11 HD13 ' A' ' 65' ' ' ILE . 8.8 m -127.04 128.81 70.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 121.532 0.682 . . . . 0.56000000000000005 111.784 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -87.31 154.66 26.46 Favored Glycine 0 N--CA 1.425 -2.039 0 N-CA-C 110.09 -1.204 . . . . 0.17000000000000001 110.09 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -56.18 2.93 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.266 0.839 . . . . 3.0499999999999998 113.266 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.953 HG23 HD22 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -88.68 -19.92 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 O-C-N 121.587 -0.696 . . . . 0.23000000000000001 110.177 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.953 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -89.42 -18.28 27.1 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.715 0.769 . . . . 0.17999999999999999 109.314 -176.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.5 p -65.99 -14.9 62.44 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.553 -1.203 . . . . 0.33000000000000002 111.767 -176.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -67.08 -39.06 86.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.051 -0.977 . . . . 1.52 112.327 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -107.95 117.55 54.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.668 -0.413 . . . . 0.42999999999999999 111.222 -175.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.598 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 1.8 Cg_endo -77.63 -13.83 16.17 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.674 2.25 . . . . 0.72999999999999998 113.083 177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.1 t -103.67 -41.84 5.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.677 -0.49 . . . . 0.47999999999999998 109.677 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.567 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.46 39.59 22.38 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.419 -1.264 . . . . 0.33000000000000002 114.024 168.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -84.11 112.12 19.94 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.907 0.86 . . . . 0.83999999999999997 109.507 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.9 m-85 -138.78 174.72 10.23 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.003 -1.453 . . . . 0.22 112.12 -171.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.687 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 86.6 m-85 -139.69 136.3 34.1 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.058 -0.519 . . . . 0.54000000000000004 110.732 -175.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.571 HD12 ' HB ' ' A' ' 161' ' ' THR . 86.7 mt -59.74 121.68 8.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.361 -0.836 . . . . 0.17000000000000001 110.44 170.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.569 HG21 ' HA ' ' A' ' 22' ' ' PHE . 19.1 pt -87.3 -44.6 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.83 0.678 . . . . 0.20999999999999999 112.83 -176.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.569 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 44.1 m-80 -171.54 172.08 5.18 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.976 -1.49 . . . . 2.0299999999999998 106.976 -168.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.655 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 39.8 mtt180 -124.28 171.56 9.78 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.531 -0.867 . . . . 1.52 111.592 -173.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' A' ' 107' ' ' PRO . 52.6 tt0 -148.28 99.91 3.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.08 -0.964 . . . . 0.58999999999999997 109.758 170.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.467 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 48.4 ttp180 -66.18 166.17 12.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.284 -0.871 . . . . 2.8199999999999998 110.421 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.51 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 25.4 m-80 -35.66 103.03 0.24 Allowed Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 125.323 1.449 . . . . 0.34999999999999998 113.405 -157.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.51 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 9.9 Cg_endo -61.36 -31.44 88.75 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.99 2.46 . . . . 0.47999999999999998 111.756 173.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.14 -34.15 5.34 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.746 -0.942 . . . . 0.67000000000000004 110.746 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.08 -177.16 45.21 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.969 -0.615 . . . . 0.62 112.437 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 112' ' ' GLY . 30.8 Cg_endo -62.1 6.23 0.18 Allowed 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 125.002 3.802 . . . . 0.93999999999999995 115.662 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -73.29 21.64 0.08 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.506 0.558 . . . . 1.23 112.506 -175.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.778 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 68.31 63.69 3.46 Favored Glycine 0 CA--C 1.499 -0.914 0 N-CA-C 115.568 0.987 . . . . 1.6899999999999999 115.568 168.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.542 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.61 -4.48 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 117.294 2.331 . . . . 0.47999999999999998 117.294 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.5 OUTLIER -166.02 151.37 8.63 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.272 -0.892 . . . . 0.28000000000000003 110.594 -176.073 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 10.5 t-105 -132.09 99.62 4.78 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.41 -0.959 . . . . 0.48999999999999999 108.41 168.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.547 HD12 HG23 ' A' ' 150' ' ' VAL . 5.3 mt -93.92 114.27 26.45 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.624 0.726 . . . . 0.66000000000000003 109.358 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.413 ' HB3' HD11 ' A' ' 101' ' ' ILE . 19.5 m -83.9 144.22 29.35 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.593 -0.731 . . . . 0.19 111.466 -168.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.3 mm? -108.53 170.66 7.88 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.821 -0.627 . . . . 0.13 111.243 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 2.9 t -62.38 -13.73 32.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.112 -0.949 . . . . 1.1699999999999999 112.729 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.688 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 1.4 tmtp? -126.63 132.3 51.26 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 120.446 -0.501 . . . . 1.22 110.594 173.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.688 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 55.3 mt-30 -34.2 -56.87 0.49 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.003 -1.453 . . . . 1.51 113.869 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.497 ' HB2' HG12 ' A' ' 89' ' ' ILE . 75.0 m-70 -92.22 2.01 56.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.154 0.502 . . . . 2.5299999999999998 111.556 -171.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.793 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -94.0 37.44 1.09 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.405 0.891 . . . . 0.83999999999999997 113.405 -172.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.604 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -115.05 143.27 18.06 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 117.016 -2.516 . . . . 0.32000000000000001 112.717 -152.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.52 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -96.12 114.64 33.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.722 0.772 . . . . 0.17999999999999999 110.766 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.648 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 29.0 p80 -143.99 172.12 13.31 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.432 -0.804 . . . . 0.20999999999999999 109.663 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.778 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.75 -176.68 39.8 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.982 -1.104 . . . . 0.27000000000000002 111.66 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.537 ' N ' ' HA3' ' A' ' 112' ' ' GLY . 15.0 t -147.0 168.13 22.28 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 122.387 -0.478 . . . . 0.40999999999999998 110.387 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -111.25 -0.7 16.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.126 -1.065 . . . . 1.99 108.126 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -116.05 85.86 15.86 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 114.537 -1.21 . . . . 1.3600000000000001 108.385 170.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -72.85 -21.19 21.58 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.164 1.909 . . . . 0.34999999999999998 113.727 -169.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.23 -2.58 38.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.156 0.503 . . . . 0.33000000000000002 110.845 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 44.7 t -91.42 -3.2 56.92 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.308 -0.627 . . . . 1.3500000000000001 109.308 171.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.443 HG22 ' HB2' ' A' ' 83' ' ' PRO . 42.8 mm -80.88 139.37 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 115.932 -0.576 . . . . 0.20999999999999999 110.133 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 90.46 1.37 74.83 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 110.159 -1.176 . . . . 0.14999999999999999 110.159 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 mttt -111.65 167.86 10.01 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 123.24 1.495 . . . . 2.5 114.414 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.21 48.52 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 111.541 -2.572 . . . . 0.17000000000000001 107.697 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.469 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -124.66 160.58 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.954 -0.758 . . . . 0.66000000000000003 108.954 -174.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 50.5 m -49.36 -59.78 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.616 0.598 . . . . 0.42999999999999999 112.616 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.533 ' HD3' ' N ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER -132.62 -43.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 118.411 -1.316 . . . . 2.02 113.744 -175.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.533 ' N ' ' HD3' ' A' ' 140' ' ' LYS . . . -32.24 133.55 0.19 Allowed Glycine 0 CA--C 1.523 0.58 0 N-CA-C 117.236 1.654 . . . . 0.17999999999999999 117.236 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.504 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.0 p -73.39 165.52 24.91 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 112.636 -1.782 . . . . 0.16 111.843 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.887 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 53.3 mt -59.77 98.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 122.316 1.055 . . . . 0.40000000000000002 112.018 -162.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.648 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 74.6 mtt180 -85.07 147.69 26.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.777 -1.556 . . . . 1.8700000000000001 110.281 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.682 ' HG2' HG22 ' A' ' 84' ' ' ILE . 12.3 mtp -127.51 -166.31 1.59 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.401 -0.592 . . . . 0.79000000000000004 109.401 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.696 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 6.8 t60 -94.9 156.18 16.45 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.448 -0.945 . . . . 2.3199999999999998 108.448 172.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.653 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.7 m120 -58.7 -50.03 75.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 118.339 -0.839 . . . . 0.68000000000000005 110.736 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -63.34 -26.16 68.63 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 121.26 1.845 . . . . 2.1800000000000002 112.462 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.696 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 16.8 m-20 -83.95 -39.92 19.15 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 120.937 0.399 . . . . 0.68999999999999995 111.25 -175.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.619 HG13 HD12 ' A' ' 151' ' ' ILE . 14.6 p -70.07 -23.58 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.956 -0.565 . . . . 0.11 111.146 175.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.653 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -82.01 -39.8 16.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 118.966 -0.54 . . . . 0.38 109.592 171.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -45.52 -71.36 0.08 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.139 0.881 . . . . 1.99 112.238 167.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 157' ' ' VAL . 8.2 mp -46.32 -38.13 8.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.521 0.677 . . . . 1.27 111.262 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.37 83.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.372 -1.286 . . . . 0.17999999999999999 111.629 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.1 t -87.94 -34.48 18.09 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.513 -0.742 . . . . 0.20999999999999999 112.47 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 28.2 mt -80.38 -59.56 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 121.177 0.513 . . . . 0.16 111.451 -172.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 153' ' ' LEU . 2.6 m -92.39 141.51 24.93 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.448 -0.797 . . . . 0.16 112.112 177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.655 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 69.4 Cg_endo -89.02 173.6 4.02 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.767 2.978 . . . . 0.20000000000000001 111.144 173.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.569 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 73.6 m-20 -66.91 157.1 34.04 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.611 -0.836 . . . . 1.1000000000000001 109.16 177.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 98.35 -19.19 55.42 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.196 -1.002 . . . . 0.17999999999999999 112.666 -173.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.571 ' HB ' HD12 ' A' ' 100' ' ' ILE . 59.0 m -63.48 139.77 58.8 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.496 -0.557 . . . . 0.14000000000000001 109.496 -176.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.687 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 3.5 ptm180 -92.52 120.43 32.98 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 122.787 1.28 . . . . 3.6299999999999999 111.112 -170.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.1 t -106.96 109.4 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 112.205 -2.271 . . . . 0.14000000000000001 109.149 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.8 m -95.49 108.12 20.33 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 112.484 0.55 . . . . 0.20999999999999999 112.484 -172.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.567 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -81.78 101.52 6.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 122.35 1.072 . . . . 0.23999999999999999 109.77 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -106.62 129.54 54.52 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.905 -1.498 . . . . 1.0900000000000001 109.027 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.598 ' CG ' ' HA ' ' A' ' 94' ' ' PRO . 18.0 mmm180 -69.7 -19.62 63.56 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.865 0.364 . . . . 2.0800000000000001 110.637 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 161.18 -80.93 0.14 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 121.16 -0.543 . . . . 1.97 111.776 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.32 -0.695 0 N-CA-C 110.251 -0.278 . . . . 3.9100000000000001 110.251 179.412 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.848 0 N-CA-C 112.211 -0.355 . . . . 2.7999999999999998 112.211 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -83.62 161.72 21.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.433 0.635 . . . . 4.4400000000000004 110.943 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -86.67 99.1 11.51 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.167 -0.924 . . . . 2.46 108.667 172.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 mp -104.39 174.33 5.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.308 0.575 . . . . 0.65000000000000002 111.845 -175.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.627 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.5 tt -92.21 127.64 37.76 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.999 -1.0 . . . . 0.28000000000000003 110.605 -172.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.82 162.19 13.38 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.188 0.994 . . . . 0.31 113.401 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.633 ' HB3' HG13 ' A' ' 46' ' ' ILE . 80.2 t80 -131.01 141.91 50.28 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.547 -1.66 . . . . 0.44 107.884 175.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 36.2 tt0 -113.23 115.32 28.02 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.218 -1.031 . . . . 0.76000000000000001 108.218 177.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 13' ' ' ASP . 98.2 t -68.73 150.3 10.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.53 1.157 . . . . 0.39000000000000001 113.254 -170.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.409 ' O ' HG12 ' A' ' 9' ' ' VAL . 43.8 mtpt -102.36 158.56 16.11 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.335 -1.757 . . . . 2.0099999999999998 108.541 172.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.33 105.34 0.49 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.879 0.371 . . . . 1.8300000000000001 111.622 -177.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.96 12.24 30.29 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.62 -0.8 . . . . 0.47999999999999998 113.366 173.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.611 ' HB2' HG13 ' A' ' 9' ' ' VAL . 90.2 m-20 -56.23 170.6 0.33 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.872 0.368 . . . . 1.46 111.171 170.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.89 155.47 45.98 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.326 0.584 . . . . 0.40999999999999998 111.146 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.598 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.97 -34.25 77.68 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.334 -0.987 . . . . 0.85999999999999999 108.334 178.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.508 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 0.2 OUTLIER -88.38 -28.0 21.24 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.911 -1.04 . . . . 1.1499999999999999 111.442 -175.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.0 p -68.88 -37.67 79.18 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 118.422 0.556 . . . . 1.21 110.181 175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.447 HG23 ' CE1' ' A' ' 22' ' ' PHE . 14.5 mt -73.89 -27.12 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-O 121.254 0.549 . . . . 0.20999999999999999 109.796 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.645 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -79.26 -9.79 59.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.355 -0.384 . . . . 0.16 110.684 175.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.728 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.55 -41.19 8.68 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.024 -1.102 . . . . 0.20999999999999999 108.024 177.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 5.6 m-20 -63.59 -41.96 98.31 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 112.797 -2.001 . . . . 0.53000000000000003 112.5 173.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 24' ' ' ILE . 56.3 m-85 -98.84 6.22 46.97 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 118.655 -1.218 . . . . 0.17999999999999999 110.858 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.728 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER 54.06 41.04 32.18 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.927 0.87 . . . . 1.78 109.606 176.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.645 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.3 pt -114.43 -165.9 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 114.263 -1.335 . . . . 0.19 109.976 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.81 142.65 40.78 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.106 -0.952 . . . . 0.94999999999999996 109.996 175.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.672 ' O ' ' HB2' ' A' ' 30' ' ' LEU . 70.8 p -72.82 -29.9 63.62 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.702 -0.851 . . . . 0.25 108.702 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.93 -25.01 67.7 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.68 -0.691 . . . . 0.20000000000000001 111.816 170.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -95.37 -28.65 14.85 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 108.854 -0.795 . . . . 0.17000000000000001 108.854 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.598 HD23 HD23 ' A' ' 15' ' ' LEU . 20.9 tp -72.29 -27.65 62.6 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.127 -0.942 . . . . 1.1599999999999999 108.584 172.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.672 ' HB2' ' O ' ' A' ' 26' ' ' THR . 7.6 tp -77.42 -31.73 54.23 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.812 0.815 . . . . 1.05 109.462 175.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 5.8 tt0 -66.05 -40.94 91.35 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.167 -1.378 . . . . 1.8100000000000001 110.336 173.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -82.01 -17.78 45.64 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.988 -0.685 . . . . 0.20000000000000001 111.518 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.634 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 31.0 m-80 -146.64 81.5 9.23 Favored Pre-proline 0 N--CA 1.447 -0.581 0 CA-C-O 121.246 0.546 . . . . 0.23000000000000001 110.754 -173.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.434 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 14.8 Cg_endo -55.81 -11.78 5.78 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 124.098 3.199 . . . . 0.35999999999999999 113.401 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.1 m -78.89 -17.52 55.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.801 0.334 . . . . 1.3799999999999999 111.834 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.634 ' CD1' ' HB2' ' A' ' 33' ' ' ASN . 58.1 mt -75.36 -31.8 60.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.333 0.587 . . . . 0.48999999999999999 112.072 -171.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.44 ' HB3' HD11 ' A' ' 30' ' ' LEU . 1.7 pp0? -62.4 -45.53 92.7 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-O 122.755 1.264 . . . . 1.95 110.772 -172.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.41 -48.53 77.45 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 111.893 -2.412 . . . . 0.48999999999999999 110.749 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.13 -179.57 48.74 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 114.78 -1.1 . . . . 0.41999999999999998 111.255 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.88 156.37 20.49 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.135 0.493 . . . . 0.40999999999999998 110.789 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 31.3 m -137.26 129.76 29.9 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.348 -0.842 . . . . 0.41999999999999998 110.491 -175.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.11 123.36 26.28 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.403 0.62 . . . . 0.46999999999999997 110.235 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.53 0.18 62.93 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.272 -1.131 . . . . 0.40999999999999998 110.272 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.634 ' HB3' ' O ' ' A' ' 41' ' ' THR . 2.1 tt0 -74.05 124.12 25.66 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.644 -0.778 . . . . 1.3 109.87 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 53.9 p -82.39 128.92 34.71 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.804 0.811 . . . . 0.84999999999999998 109.876 176.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.633 HG13 ' HB3' ' A' ' 7' ' ' TYR . 7.6 pt -128.55 141.38 46.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.57 -1.195 . . . . 0.25 109.428 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.39 151.69 3.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.128 0.489 . . . . 0.67000000000000004 111.048 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.6 mm -114.99 91.98 28.92 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 114.638 -1.164 . . . . 0.16 109.05 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.496 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . 1.7 Cg_endo -59.59 134.39 57.67 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.738 2.292 . . . . 0.17999999999999999 112.778 -174.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.62 -6.74 80.14 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.893 -1.048 . . . . 0.26000000000000001 112.156 -176.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.772 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 31.5 tp -124.74 116.13 26.47 Favored Pre-proline 0 N--CA 1.446 -0.63 0 CA-C-O 121.404 0.621 . . . . 0.60999999999999999 111.504 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.658 ' HD2' HD12 ' A' ' 51' ' ' LEU . 59.0 Cg_endo -79.71 -176.09 3.06 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 124.14 3.227 . . . . 0.28000000000000003 114.208 -172.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.556 ' HB3' HG23 ' A' ' 56' ' ' THR . 17.7 t70 -81.14 130.5 62.62 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 114.225 -1.352 . . . . 0.48999999999999999 112.879 -169.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.45 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 40.1 Cg_endo -73.0 -14.98 26.28 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 123.852 3.035 . . . . 0.46000000000000002 113.134 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 54' ' ' PRO . 80.2 m-85 -96.13 -8.6 32.83 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.902 -0.59 . . . . 1.3799999999999999 111.427 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.556 HG23 ' HB3' ' A' ' 53' ' ' ASP . 24.7 p -86.49 -20.39 28.15 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.784 -1.191 . . . . 0.46000000000000002 107.784 172.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 59' ' ' TYR . 24.6 mt -76.73 129.13 80.07 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 112.912 -1.949 . . . . 0.69999999999999996 111.036 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.38 -13.05 12.49 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.538 2.159 . . . . 0.39000000000000001 113.63 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.565 ' H ' HG22 ' A' ' 57' ' ' ILE . 62.7 m-85 -96.11 164.61 12.61 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.498 -0.481 . . . . 0.23999999999999999 111.786 -177.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -154.09 130.65 10.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.852 -0.796 . . . . 2.8900000000000001 108.852 177.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 71' ' ' THR . 72.8 mt -112.06 136.75 47.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.155 -0.475 . . . . 0.16 111.607 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.25 116.84 27.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.926 -0.71 . . . . 0.16 111.223 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.8 t -96.04 113.6 30.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.565 0.698 . . . . 0.19 110.777 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 67' ' ' ALA . 22.2 m -90.89 104.0 16.64 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.943 -1.026 . . . . 0.20000000000000001 110.45 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 50.5 mm -53.44 -58.54 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 122.262 1.03 . . . . 0.23000000000000001 111.208 168.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.16 -10.13 3.62 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 112.699 -2.046 . . . . 0.16 113.521 -176.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.88 -18.02 4.78 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.596 0.758 . . . . 0.14999999999999999 112.17 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.511 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 59.07 54.53 4.9 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.219 0.463 . . . . 0.68999999999999995 111.078 -172.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 64' ' ' SER . 41.6 p -136.85 167.71 20.94 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 112.707 0.632 . . . . 0.13 112.707 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.465 HD21 HD21 ' A' ' 153' ' ' LEU . 8.0 tt -135.84 112.76 10.28 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.729 -1.123 . . . . 0.40000000000000002 110.0 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 22.1 m -93.07 123.31 36.24 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.157 0.504 . . . . 0.16 110.781 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 79' ' ' MET . 16.1 tp -99.95 106.51 18.32 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.298 -0.864 . . . . 0.58999999999999997 109.125 172.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 83.4 p -105.44 161.46 14.31 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 119.234 -0.986 . . . . 1.05 110.498 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.72 HD13 ' ND2' ' A' ' 75' ' ' ASN . 0.9 OUTLIER -125.61 125.33 42.98 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 108.657 -0.868 . . . . 0.26000000000000001 108.657 168.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.72 ' ND2' HD13 ' A' ' 74' ' ' LEU . 9.2 p30 41.98 53.03 4.27 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.769 -1.56 . . . . 1.8400000000000001 112.126 -165.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 46.8 m-80 75.24 -9.53 1.38 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.02 -0.991 . . . . 1.8899999999999999 112.226 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -97.16 121.84 39.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.037 0.446 . . . . 3.4399999999999999 109.903 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 55.7 t -58.4 131.45 22.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 122.39 1.091 . . . . 0.23999999999999999 112.806 -175.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.523 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -100.91 -45.84 5.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 113.116 -1.856 . . . . 0.81000000000000005 109.112 178.419 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -159.95 173.19 16.28 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.039 -1.892 . . . . 1.46 110.214 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -149.67 123.45 9.27 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.172 -1.376 . . . . 0.17000000000000001 109.458 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -112.86 148.64 39.79 Favored Pre-proline 0 C--N 1.313 -1.006 0 CA-C-N 115.897 -0.592 . . . . 1.05 109.734 -175.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.42 ' HB2' HG22 ' A' ' 134' ' ' ILE . 32.7 Cg_endo -74.5 142.71 29.91 Favored 'Trans proline' 0 CA--C 1.498 -1.32 0 C-N-CA 122.231 1.954 . . . . 0.20000000000000001 110.938 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.622 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -139.67 172.77 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-N 115.777 -0.647 . . . . 0.13 110.761 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.94 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.16 137.6 52.87 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.762 0.315 . . . . 0.26000000000000001 110.188 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.511 HG22 ' HG3' ' A' ' 68' ' ' LYS . 10.7 m -120.88 127.75 75.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.6 0.714 . . . . 0.56000000000000005 111.776 -176.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.501 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -83.19 151.48 28.52 Favored Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 110.067 -1.213 . . . . 0.17000000000000001 110.067 171.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.47 4.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.262 0.838 . . . . 3.0499999999999998 113.262 175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.875 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -90.81 -19.12 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.385 0.612 . . . . 0.23000000000000001 110.158 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.875 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -86.89 -17.47 33.19 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.687 -0.857 . . . . 0.17999999999999999 108.687 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.1 p -69.38 -16.1 63.45 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.369 -1.287 . . . . 0.33000000000000002 111.345 -178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.405 ' OE1' HD12 ' A' ' 89' ' ' ILE . 24.8 mt-30 -69.95 -37.76 75.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.859 -1.064 . . . . 1.52 112.845 -175.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 95' ' ' THR . 1.5 m -107.33 127.51 27.75 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 119.746 -0.782 . . . . 0.42999999999999999 111.161 -176.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -89.41 -14.19 2.66 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.727 2.284 . . . . 0.72999999999999998 113.172 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 93' ' ' THR . 6.3 t -90.33 -44.52 9.63 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.584 0.707 . . . . 0.47999999999999998 109.417 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.576 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 61.58 18.46 56.19 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 114.066 -1.425 . . . . 0.33000000000000002 113.979 168.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.4 111.33 19.35 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 122.206 1.003 . . . . 0.83999999999999997 109.593 -175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.669 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 26.6 m-85 -138.42 177.51 7.83 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 113.359 -1.746 . . . . 0.22 111.279 -171.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.457 ' CG ' HD11 ' A' ' 5' ' ' LEU . 39.8 m-85 -140.98 137.38 33.0 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.135 0.493 . . . . 0.54000000000000004 110.765 -173.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.575 HD12 ' HB ' ' A' ' 161' ' ' THR . 78.8 mt -63.01 114.62 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-N 115.185 -0.916 . . . . 0.17000000000000001 110.268 170.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.565 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 23.4 pt -83.33 -45.43 18.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 113.367 0.877 . . . . 0.20999999999999999 113.367 -175.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -168.75 165.88 11.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.0 -1.482 . . . . 2.0299999999999998 107.0 -169.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.701 ' HB3' HD23 ' A' ' 116' ' ' LEU . 51.9 mtt-85 -132.1 155.68 47.68 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 119.902 -0.719 . . . . 1.52 112.408 -168.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.519 ' NE2' ' HB3' ' A' ' 107' ' ' PRO . 51.6 tt0 -137.62 102.27 4.71 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.359 0.599 . . . . 0.58999999999999997 110.808 176.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.467 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 46.8 ttp180 -62.76 166.18 5.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.952 -1.022 . . . . 2.8199999999999998 111.279 174.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.786 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 28.7 m-80 -35.93 101.31 0.21 Allowed Pre-proline 0 C--O 1.232 0.158 0 C-N-CA 125.802 1.641 . . . . 0.34999999999999998 113.122 -159.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.519 ' HB3' ' NE2' ' A' ' 104' ' ' GLN . 24.1 Cg_endo -69.43 -49.6 0.59 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.499 2.799 . . . . 0.47999999999999998 113.604 176.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 122.32 -33.06 4.3 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.67000000000000004 111.54 -175.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.2 -172.61 2.76 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.956 -0.622 . . . . 0.62 112.589 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 128' ' ' THR . 35.9 Cg_endo -56.65 -14.21 12.74 Favored 'Trans proline' 0 N--CA 1.475 0.441 0 C-N-CA 124.207 3.271 . . . . 0.93999999999999995 113.13 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' CD2' ' HB2' ' A' ' 115' ' ' TRP . 5.8 m-30 -65.82 -37.9 87.47 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 107.573 -1.269 . . . . 1.23 107.573 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 113' ' ' ALA . . . 58.99 23.69 57.35 Favored Glycine 0 CA--C 1.491 -1.444 0 CA-C-N 113.21 -1.814 . . . . 1.6899999999999999 117.177 160.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.865 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 173.35 -48.37 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 118.341 1.071 . . . . 0.47999999999999998 110.18 -177.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.461 ' CE2' ' HG3' ' A' ' 105' ' ' ARG . 0.7 OUTLIER -162.99 154.28 17.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.457 -0.338 . . . . 0.28000000000000003 110.169 179.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.438 ' HB2' ' CD2' ' A' ' 111' ' ' PHE . 7.6 t-105 -132.09 104.68 6.94 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.687 -1.227 . . . . 0.48999999999999999 107.687 165.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.701 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.0 mt -100.11 114.83 28.48 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.57 -0.706 . . . . 0.66000000000000003 109.859 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.459 ' HB3' HD11 ' A' ' 101' ' ' ILE . 43.6 m -81.81 143.28 31.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.817 -0.629 . . . . 0.19 110.901 -170.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.728 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.4 mm? -108.02 164.88 11.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.535 -0.757 . . . . 0.13 110.416 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 7.1 p -65.13 -5.18 6.05 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.985 0.803 . . . . 1.1699999999999999 112.72 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.707 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 4.2 tmtm? -127.41 129.42 47.51 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.111 0.958 . . . . 1.22 109.849 166.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.707 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.0 mt-30 -37.2 -47.75 0.81 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 112.249 -2.25 . . . . 1.51 113.903 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.549 ' CB ' HG12 ' A' ' 89' ' ' ILE . 58.0 m80 -96.33 3.23 53.11 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.849 -0.614 . . . . 2.5299999999999998 111.915 -170.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.578 ' HA ' HD11 ' A' ' 90' ' ' LEU . 2.5 m-30 -92.99 -35.48 13.26 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 121.807 0.813 . . . . 0.83999999999999997 111.946 -173.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.728 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -10.46 131.01 0.01 OUTLIER Glycine 0 C--N 1.298 -1.58 0 N-CA-C 119.392 2.517 . . . . 0.32000000000000001 119.392 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -100.54 117.5 45.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 112.449 -1.876 . . . . 0.17999999999999999 110.366 177.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.76 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 33.6 p80 -145.83 -176.79 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.318 0.488 . . . . 0.20999999999999999 112.318 -175.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -93.94 -167.72 37.63 Favored Glycine 0 C--O 1.22 -0.759 0 C-N-CA 121.22 -0.514 . . . . 0.27000000000000002 111.86 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 110' ' ' PRO . 9.2 t -160.76 166.51 28.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 117.796 0.798 . . . . 0.40999999999999998 110.704 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -116.53 0.19 12.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.831 0.824 . . . . 1.99 109.288 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -126.03 89.21 52.82 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.39 -1.277 . . . . 1.3600000000000001 108.819 170.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -72.19 -20.75 24.4 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.753 2.302 . . . . 0.34999999999999998 114.008 -169.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.96 -5.48 48.78 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.21 -0.45 . . . . 0.33000000000000002 111.008 -175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -91.29 -2.48 57.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.08 -0.509 . . . . 1.3500000000000001 110.016 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 83' ' ' PRO . 38.8 mm -78.55 137.61 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-N 115.872 -0.604 . . . . 0.20999999999999999 109.934 176.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 91.7 3.16 68.91 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.151 -1.18 . . . . 0.14999999999999999 110.151 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.426 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 21.3 mtpt -113.74 169.07 9.25 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 123.223 1.487 . . . . 2.5 114.395 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.16 126.59 46.44 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 111.509 -2.587 . . . . 0.17000000000000001 107.946 176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.42 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.2 OUTLIER -123.47 159.44 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.541 -0.911 . . . . 0.66000000000000003 108.541 -174.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.1 m -48.08 -59.87 3.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.763 0.653 . . . . 0.42999999999999999 112.763 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -132.13 -44.46 0.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 118.446 -1.302 . . . . 2.02 114.033 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.69 133.92 0.21 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 117.464 1.746 . . . . 0.17999999999999999 117.464 -178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 3.0 p -70.78 165.41 23.17 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 112.734 -1.733 . . . . 0.16 111.956 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.94 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 58.8 mt -60.87 99.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.386 -1.279 . . . . 0.40000000000000002 112.154 -162.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.76 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 42.7 mtt180 -86.48 143.32 27.8 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.317 -1.311 . . . . 1.8700000000000001 110.161 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.622 ' HG2' HG22 ' A' ' 84' ' ' ILE . 20.8 mtp -118.97 -168.98 1.65 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.851 -0.796 . . . . 0.79000000000000004 108.851 173.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.543 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 81.8 m-70 -83.77 155.67 22.93 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.747 -0.835 . . . . 2.3199999999999998 108.747 167.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.797 ' O ' HD13 ' A' ' 151' ' ' ILE . 9.2 m120 -65.02 -44.16 90.09 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 118.283 -0.865 . . . . 0.68000000000000005 110.999 -177.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -66.06 -25.46 67.04 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 121.902 2.137 . . . . 2.1800000000000002 112.068 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.543 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 37.8 m-20 -86.79 -35.4 19.15 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.235 -0.438 . . . . 0.68999999999999995 111.188 -174.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.59 HG13 HD12 ' A' ' 151' ' ' ILE . 11.8 p -67.98 -21.91 27.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.124 -0.489 . . . . 0.11 110.747 172.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.865 HD11 ' HB1' ' A' ' 113' ' ' ALA . 1.6 mp -83.08 -40.97 16.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.667 -0.494 . . . . 0.38 109.667 170.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -47.14 -70.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 119.203 0.91 . . . . 1.99 112.428 168.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.489 HD22 ' SD ' ' A' ' 145' ' ' MET . 7.3 mp -49.86 -30.75 10.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.594 0.711 . . . . 1.27 111.529 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.673 ' HA ' ' NH1' ' A' ' 103' ' ' ARG . . . -67.5 -41.22 84.82 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.805 -1.089 . . . . 0.17999999999999999 111.528 176.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 33.0 t -85.13 -37.66 19.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.789 0.663 . . . . 0.20999999999999999 112.789 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.58 -60.23 2.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.613 0.721 . . . . 0.16 111.377 -169.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.643 HG23 HH22 ' A' ' 103' ' ' ARG . 3.8 m -92.06 145.81 31.58 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.0 -1.0 . . . . 0.16 112.126 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.457 ' C ' HH21 ' A' ' 103' ' ' ARG . 50.4 Cg_endo -89.86 172.62 3.76 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 124.466 3.444 . . . . 0.20000000000000001 111.175 173.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -66.4 161.65 22.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 118.689 -1.204 . . . . 1.1000000000000001 109.897 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 96.51 -17.11 59.86 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.561 -0.828 . . . . 0.17999999999999999 111.825 -172.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.575 ' HB ' HD12 ' A' ' 100' ' ' ILE . 67.2 m -67.45 139.44 57.07 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.457 -0.571 . . . . 0.14000000000000001 109.457 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -93.2 117.89 30.6 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.571 1.176 . . . . 3.6299999999999999 111.022 -168.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.2 t -104.03 109.66 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 112.316 -2.22 . . . . 0.14000000000000001 109.358 -176.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.431 HG22 ' ND2' ' A' ' 166' ' ' ASN . 32.6 m -95.71 107.68 19.92 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 112.727 0.64 . . . . 0.20999999999999999 112.727 -172.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.576 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mp -80.54 108.77 14.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 122.039 0.923 . . . . 0.23999999999999999 109.855 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.431 ' ND2' HG22 ' A' ' 164' ' ' THR . 38.6 m-80 -110.97 124.46 52.18 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.489 -1.232 . . . . 1.0900000000000001 109.796 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.519 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 15.6 mmm180 -70.28 -19.23 63.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.244 0.545 . . . . 2.0800000000000001 110.192 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.89 173.69 21.32 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 115.434 -0.803 . . . . 1.97 112.504 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 C--N 1.331 -0.206 0 O-C-N 123.999 0.47 . . . . 3.9100000000000001 110.95 179.99 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 111.992 -0.443 . . . . 2.7999999999999998 111.992 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -145.48 144.87 30.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.983 0.42 . . . . 4.4400000000000004 110.515 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.8 106.77 16.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.098 -0.501 . . . . 2.46 109.884 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.656 HD21 ' HA ' ' A' ' 49' ' ' PRO . 1.1 tp -101.4 172.53 6.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.296 0.57 . . . . 0.65000000000000002 111.555 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 6.7 tt -95.54 126.74 41.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.049 -0.978 . . . . 0.28000000000000003 110.258 -175.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.07 161.47 13.96 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.055 0.931 . . . . 0.31 112.632 179.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 45' ' ' SER . 90.6 t80 -130.74 139.8 50.29 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.935 -1.484 . . . . 0.44 107.83 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.4 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.8 tt0 -112.66 112.8 24.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.131 -1.063 . . . . 0.76000000000000001 108.131 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 13' ' ' ASP . 98.4 t -67.09 149.46 11.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 122.395 1.093 . . . . 0.39000000000000001 113.169 -169.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HE2' ' OH ' ' A' ' 7' ' ' TYR . 42.2 mtmt -103.24 158.85 16.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 113.369 -1.741 . . . . 2.0099999999999998 108.718 174.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.456 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -62.85 104.26 0.53 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.198 0.523 . . . . 1.8300000000000001 112.308 -173.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.29 11.29 36.73 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.848 -0.692 . . . . 0.47999999999999998 113.356 175.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB2' HG13 ' A' ' 9' ' ' VAL . 83.9 m-20 -53.58 170.67 0.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.978 0.389 . . . . 1.46 111.307 172.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.3 153.21 48.05 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.296 0.569 . . . . 0.40999999999999998 111.558 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.598 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.38 -35.03 79.72 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.33 -0.989 . . . . 0.85999999999999999 108.33 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.442 ' HA ' HG22 ' A' ' 26' ' ' THR . 65.0 t30 -88.96 -25.89 21.81 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 114.916 -1.038 . . . . 1.1499999999999999 111.438 -176.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.3 p -68.17 -36.9 80.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.902 -0.719 . . . . 1.21 109.674 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.409 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.1 mt -75.62 -28.19 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 121.164 0.507 . . . . 0.20999999999999999 110.023 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.59 -10.05 59.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.539 -0.301 . . . . 0.16 110.872 175.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.607 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.71 -39.49 9.45 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 122.607 1.194 . . . . 0.20999999999999999 108.38 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 119' ' ' SER . 10.0 m-20 -62.19 -45.79 91.81 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 112.453 -2.158 . . . . 0.53000000000000003 111.856 172.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HA ' HG21 ' A' ' 101' ' ' ILE . 63.2 m-85 -97.2 5.12 50.66 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.681 -1.208 . . . . 0.17999999999999999 111.602 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.5 mpt_? 54.15 43.29 30.87 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-O 121.776 0.798 . . . . 1.78 109.891 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.62 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 35.0 pt -116.19 -165.93 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.535 -1.211 . . . . 0.19 109.771 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.87 143.02 38.62 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.177 -0.919 . . . . 0.94999999999999996 109.992 174.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.608 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 69.4 p -71.75 -32.19 67.44 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.759 -1.2 . . . . 0.25 107.759 177.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.98 -32.2 70.61 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.277 -0.874 . . . . 0.20000000000000001 112.008 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -90.5 -25.94 20.02 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-O 121.657 0.741 . . . . 0.17000000000000001 109.112 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.647 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 17.2 tp -75.55 -26.19 57.77 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.999 -1.001 . . . . 1.1599999999999999 109.361 173.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 26' ' ' THR . 30.7 mt -77.49 -31.71 53.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.792 0.806 . . . . 1.05 109.67 171.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.477 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 45.0 tt0 -64.05 -41.13 97.49 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.282 -1.326 . . . . 1.8100000000000001 110.034 174.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -84.18 -20.64 32.04 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 120.118 -0.633 . . . . 0.20000000000000001 111.633 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.624 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 27.0 m-80 -147.11 80.69 9.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 121.46 0.648 . . . . 0.23000000000000001 110.64 -172.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 23.7 Cg_endo -58.97 -5.79 3.02 Favored 'Trans proline' 0 C--N 1.326 -0.644 0 C-N-CA 124.372 3.382 . . . . 0.35999999999999999 114.145 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.2 t -84.7 -23.31 29.41 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 122.215 -0.303 . . . . 1.3799999999999999 111.025 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.852 HD21 HG21 ' A' ' 46' ' ' ILE . 52.4 mt -67.01 -35.36 79.76 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.841 0.829 . . . . 0.48999999999999999 111.632 -172.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.452 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 2.9 pt20 -65.33 -46.72 79.17 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 114.239 -1.346 . . . . 1.95 110.298 -174.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.55 -50.86 71.73 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 111.905 -2.407 . . . . 0.48999999999999999 110.282 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.56 177.95 48.55 Favored Glycine 0 N--CA 1.433 -1.551 0 CA-C-N 114.742 -1.117 . . . . 0.41999999999999998 111.656 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.59 157.63 18.84 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.349 0.595 . . . . 0.40999999999999998 111.235 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 82.6 m -140.35 128.64 22.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.141 -0.936 . . . . 0.41999999999999998 110.601 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -76.16 120.07 20.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.449 0.642 . . . . 0.46999999999999997 110.234 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 99.26 0.05 57.09 Favored Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 110.181 -1.168 . . . . 0.40999999999999998 110.181 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.63 ' HB3' ' O ' ' A' ' 41' ' ' THR . 1.8 tt0 -74.31 123.7 25.07 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.758 -0.721 . . . . 1.3 109.599 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 34.4 p -85.37 125.93 33.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.646 0.736 . . . . 0.84999999999999998 110.596 177.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.852 HG21 HD21 ' A' ' 36' ' ' LEU . 9.6 pt -125.63 143.59 38.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.393 -1.276 . . . . 0.25 109.554 -176.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.4 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.24 150.99 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-O 121.113 0.482 . . . . 0.67000000000000004 111.124 -179.218 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.7 mm -115.86 92.87 35.98 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 114.643 -1.162 . . . . 0.16 109.147 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.656 ' HA ' HD21 ' A' ' 4' ' ' LEU . 1.9 Cg_endo -58.16 135.41 68.19 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.847 2.365 . . . . 0.17999999999999999 112.819 -175.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.19 -6.0 81.26 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 114.992 -1.004 . . . . 0.26000000000000001 112.515 -177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.698 HD12 ' HD2' ' A' ' 52' ' ' PRO . 25.6 tp -126.74 119.87 22.82 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-O 120.972 0.415 . . . . 0.60999999999999999 111.395 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.698 ' HD2' HD12 ' A' ' 51' ' ' LEU . 58.9 Cg_endo -80.89 178.69 6.66 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.438 2.759 . . . . 0.28000000000000003 113.923 -172.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.588 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.9 t70 -75.17 131.8 77.73 Favored Pre-proline 0 N--CA 1.443 -0.819 0 CA-C-N 114.255 -1.339 . . . . 0.48999999999999999 111.646 -173.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.51 ' HB2' ' HB3' ' A' ' 162' ' ' ARG . 60.5 Cg_endo -74.13 -16.73 22.42 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.415 2.743 . . . . 0.46000000000000002 113.02 -174.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -96.53 -2.68 44.58 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.35 0.595 . . . . 1.3799999999999999 111.169 -176.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.588 HG23 ' HB3' ' A' ' 53' ' ' ASP . 17.2 p -93.37 -14.54 26.72 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.493 -0.928 . . . . 0.46000000000000002 108.493 173.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.703 HG22 ' H ' ' A' ' 59' ' ' TYR . 7.9 mm -64.05 129.21 93.82 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 113.633 -1.621 . . . . 0.69999999999999996 109.873 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 51.4 Cg_endo -73.08 -19.12 23.28 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.017 1.811 . . . . 0.39000000000000001 112.852 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.703 ' H ' HG22 ' A' ' 57' ' ' ILE . 41.0 m-85 -107.36 161.67 14.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.871 0.367 . . . . 0.23999999999999999 111.548 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -145.8 140.32 27.03 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.761 -0.829 . . . . 2.8900000000000001 108.761 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 71' ' ' THR . 88.1 mt -119.3 133.02 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.306 -0.407 . . . . 0.16 112.083 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.53 116.54 27.81 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.963 -0.695 . . . . 0.16 111.014 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 69' ' ' THR . 85.5 t -95.12 115.68 34.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.684 0.754 . . . . 0.19 110.703 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.537 ' CB ' ' HB3' ' A' ' 67' ' ' ALA . 44.1 m -89.66 109.81 20.75 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.119 -0.946 . . . . 0.20000000000000001 110.85 178.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 167' ' ' ARG . 23.3 mm -55.5 -60.21 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.186 0.993 . . . . 0.23000000000000001 110.844 164.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.83 -13.63 6.55 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 112.722 -2.036 . . . . 0.16 113.52 -175.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.537 ' HB3' ' CB ' ' A' ' 64' ' ' SER . . . -126.66 -16.92 5.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 118.659 -0.686 . . . . 0.14999999999999999 112.515 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 57.21 54.62 6.61 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.202 0.91 . . . . 0.68999999999999995 111.527 -174.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 40.9 p -138.05 164.91 27.91 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 112.816 0.673 . . . . 0.13 112.816 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.7 tt -132.67 113.14 12.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.023 -0.989 . . . . 0.40000000000000002 110.093 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.68 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 38.4 m -92.89 123.69 36.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.992 0.425 . . . . 0.16 111.219 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 79' ' ' MET . 12.7 tp -98.59 106.61 18.91 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.498 -0.774 . . . . 0.58999999999999997 108.948 170.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 78.5 p -106.93 160.02 15.83 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 119.28 -0.968 . . . . 1.05 110.85 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.718 HD13 ' ND2' ' A' ' 75' ' ' ASN . 1.1 tm? -127.16 126.44 42.87 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.211 -0.663 . . . . 0.26000000000000001 109.211 171.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.718 ' ND2' HD13 ' A' ' 74' ' ' LEU . 7.8 p30 39.13 56.17 2.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 113.991 -1.459 . . . . 1.8400000000000001 111.998 -166.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 44.3 m-80 74.76 -8.97 1.42 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.144 -0.935 . . . . 1.8899999999999999 112.429 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -101.57 119.45 38.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.012 0.434 . . . . 3.4399999999999999 110.296 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 50.8 t -55.04 131.64 18.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 122.444 1.116 . . . . 0.23999999999999999 112.54 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 67.8 mmm -96.81 -47.82 5.71 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 113.315 -1.766 . . . . 0.81000000000000005 108.28 177.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -161.08 172.44 16.81 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 112.703 -2.044 . . . . 1.46 110.169 -176.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.6 m -149.5 125.42 10.57 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 113.973 -1.467 . . . . 0.17000000000000001 109.532 173.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -117.28 150.54 46.52 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.087 -0.506 . . . . 1.05 110.565 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.73 142.71 32.58 Favored 'Trans proline' 0 CA--C 1.495 -1.473 0 C-N-CA 122.351 2.034 . . . . 0.20000000000000001 111.201 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.643 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.72 173.34 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.452 -0.795 . . . . 0.13 110.433 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.918 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -117.61 143.74 45.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.927 -0.309 . . . . 0.26000000000000001 110.167 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.516 HG22 ' HG3' ' A' ' 68' ' ' LYS . 11.4 m -125.99 125.83 68.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 121.583 0.706 . . . . 0.56000000000000005 111.354 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -85.28 155.65 29.97 Favored Glycine 0 N--CA 1.425 -2.071 0 N-CA-C 109.58 -1.408 . . . . 0.17000000000000001 109.58 171.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -57.6 4.9 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.224 0.824 . . . . 3.0499999999999998 113.224 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.915 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -87.02 -20.02 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 O-C-N 121.437 -0.789 . . . . 0.23000000000000001 109.684 178.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.915 HD22 HG23 ' A' ' 89' ' ' ILE . 3.6 mm? -89.44 -20.99 23.24 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.634 -0.876 . . . . 0.17999999999999999 108.634 -177.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.7 p -66.49 -16.75 64.36 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.512 -1.222 . . . . 0.33000000000000002 110.938 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.414 ' NE2' ' HA ' ' A' ' 89' ' ' ILE . 78.1 mt-30 -72.19 -32.64 66.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.472 -1.24 . . . . 1.52 112.966 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -108.54 120.41 46.48 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.008 -0.677 . . . . 0.42999999999999999 110.359 178.061 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 93' ' ' THR . 4.2 Cg_exo -70.37 -23.59 27.82 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.803 2.336 . . . . 0.72999999999999998 112.881 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.9 t -99.23 -41.36 7.52 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.514 -0.55 . . . . 0.47999999999999998 109.514 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.541 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 51.44 21.06 5.91 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.514 -1.221 . . . . 0.33000000000000002 114.336 169.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 164' ' ' THR . 12.8 pt-20 -85.05 116.99 23.75 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 122.608 1.194 . . . . 0.83999999999999997 110.05 -172.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.728 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 13.0 m-85 -137.92 -171.83 3.1 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.362 -1.744 . . . . 0.22 111.442 -166.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.53 ' CG ' HD11 ' A' ' 5' ' ' LEU . 28.6 m-85 -143.84 137.92 28.3 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.76 0.314 . . . . 0.54000000000000004 110.776 -172.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.733 HD12 ' HB ' ' A' ' 161' ' ' THR . 76.3 mt -65.21 119.07 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.745 -0.661 . . . . 0.17000000000000001 110.529 170.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.571 HG21 ' HA ' ' A' ' 22' ' ' PHE . 23.3 pt -88.14 -32.85 6.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.028 0.751 . . . . 0.20999999999999999 113.028 -175.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.568 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 11.9 p30 179.27 179.3 0.45 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 107.846 -1.168 . . . . 2.0299999999999998 107.846 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.594 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 22.9 mtt180 -127.63 160.62 31.06 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.675 -0.81 . . . . 1.52 111.877 -175.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.544 HE21 ' HB3' ' A' ' 107' ' ' PRO . 54.7 tt0 -135.7 98.96 4.05 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.112 -0.949 . . . . 0.58999999999999997 109.665 171.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.47 ' HG3' ' CE1' ' A' ' 114' ' ' TYR . 40.4 ttp180 -65.74 164.98 13.52 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.427 -0.806 . . . . 2.8199999999999998 110.555 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.753 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 30.0 m-80 -36.05 101.28 0.21 Allowed Pre-proline 0 N--CA 1.461 0.098 0 C-N-CA 125.141 1.377 . . . . 0.34999999999999998 112.334 -158.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.544 ' HB3' HE21 ' A' ' 104' ' ' GLN . 15.7 Cg_endo -64.5 -49.07 3.65 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.027 2.484 . . . . 0.47999999999999998 113.1 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.8 -33.31 3.95 Favored Glycine 0 CA--C 1.506 -0.507 0 N-CA-C 110.851 -0.9 . . . . 0.67000000000000004 110.851 -174.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.02 -173.29 3.69 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 114.771 -0.714 . . . . 0.62 112.412 174.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -55.82 -15.71 13.76 Favored 'Trans proline' 0 C--O 1.222 -0.296 0 C-N-CA 124.062 3.175 . . . . 0.93999999999999995 113.151 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -64.38 -41.4 96.7 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.36 -0.978 . . . . 1.23 108.36 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 60.06 28.48 66.46 Favored Glycine 0 CA--C 1.495 -1.168 0 N-CA-C 116.905 1.522 . . . . 1.6899999999999999 116.905 160.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.753 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . . . 175.85 -60.36 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 118.311 1.056 . . . . 0.47999999999999998 109.565 -176.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.47 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 1.5 m-85 -161.27 152.26 18.42 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.911 -0.586 . . . . 0.28000000000000003 110.109 -176.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 6.2 t-105 -129.48 99.15 5.08 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.019 -1.474 . . . . 0.48999999999999999 107.019 164.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.512 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.9 mt -90.71 114.03 26.26 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.234 -1.025 . . . . 0.66000000000000003 108.234 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.454 ' HB3' HD11 ' A' ' 101' ' ' ILE . 19.4 m -83.68 143.88 29.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.772 -0.649 . . . . 0.19 111.023 -166.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 3.1 mm? -108.88 165.1 11.82 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.102 -0.499 . . . . 0.13 111.445 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.5 t -60.36 -10.96 5.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.632 -1.167 . . . . 1.1699999999999999 112.609 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.746 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 2.8 tmtm? -127.31 132.13 50.34 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 120.504 -0.478 . . . . 1.22 109.885 171.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.746 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 21.5 mt-30 -35.25 -59.12 0.53 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 114.278 1.214 . . . . 1.51 114.278 -178.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.582 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -97.09 12.95 30.81 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.581 -0.848 . . . . 2.5299999999999998 111.852 -171.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.784 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.2 m-30 -98.67 38.46 1.36 Allowed 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 112.077 0.399 . . . . 0.83999999999999997 112.077 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.751 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -116.6 143.22 17.97 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 117.165 -2.445 . . . . 0.32000000000000001 112.523 -151.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.9 mp -96.43 116.04 37.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 123.954 0.901 . . . . 0.17999999999999999 110.934 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.639 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 31.2 p80 -146.65 -178.17 6.03 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.873 -0.603 . . . . 0.20999999999999999 112.16 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.23 -167.62 37.18 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 111.733 -0.547 . . . . 0.27000000000000002 111.733 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.6 t -162.73 167.97 22.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.878 0.839 . . . . 0.40999999999999998 110.391 -175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -113.29 -8.51 13.49 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.646 -0.872 . . . . 1.99 108.646 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -120.32 88.11 41.47 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 114.874 -1.057 . . . . 1.3600000000000001 108.856 173.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -71.91 -21.81 24.08 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.979 2.453 . . . . 0.34999999999999998 114.294 -167.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.57 -1.93 29.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.0 0.428 . . . . 0.33000000000000002 111.253 -174.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 20.1 m -90.26 -5.77 55.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.021 -0.536 . . . . 1.3500000000000001 109.964 172.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 34.3 mm -77.44 131.3 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.181 -0.463 . . . . 0.20999999999999999 110.486 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.01 3.51 60.47 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.235 -1.146 . . . . 0.14999999999999999 110.235 -175.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.459 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 56.9 mttt -114.81 168.72 9.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 122.982 1.373 . . . . 2.5 114.207 -176.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.17 127.24 45.11 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 112.011 -2.359 . . . . 0.17000000000000001 107.759 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 0.5 OUTLIER -123.6 160.79 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.5 -0.926 . . . . 0.66000000000000003 108.5 -175.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.7 m -49.1 -59.83 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.639 0.607 . . . . 0.42999999999999999 112.639 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.74 -44.86 0.81 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 118.464 -1.295 . . . . 2.02 114.131 -174.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.24 134.36 0.17 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 117.193 1.637 . . . . 0.17999999999999999 117.193 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.534 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 2.4 p -72.25 165.55 24.21 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 112.735 -1.732 . . . . 0.16 112.002 -178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.918 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 46.4 mt -60.55 96.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 122.384 1.087 . . . . 0.40000000000000002 112.208 -162.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.639 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 68.0 mtt180 -83.63 147.23 27.83 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.889 -1.505 . . . . 1.8700000000000001 109.726 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.643 ' HG2' HG22 ' A' ' 84' ' ' ILE . 12.0 mtp -123.8 -169.9 2.03 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.407 -0.96 . . . . 0.79000000000000004 108.407 171.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.434 ' HB2' ' OD2' ' A' ' 149' ' ' ASP . 41.1 m80 -82.37 161.74 22.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.944 -0.762 . . . . 2.3199999999999998 108.944 168.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.627 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . 13.4 m120 -66.94 -41.65 86.62 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 118.232 -0.89 . . . . 0.68000000000000005 110.805 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -69.66 -29.05 66.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 121.301 1.864 . . . . 2.1800000000000002 112.021 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 146' ' ' HIS . 64.3 m-20 -76.31 -45.23 33.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.379 0.609 . . . . 0.68999999999999995 109.822 -174.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.16 -25.04 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 114.819 -1.082 . . . . 0.11 111.562 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 147' ' ' ASN . 19.4 mt -83.41 -43.31 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 118.893 -0.575 . . . . 0.38 111.538 174.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.424 ' O ' HG13 ' A' ' 156' ' ' ILE . 20.3 mt-10 -46.41 -70.39 0.1 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.529 1.058 . . . . 1.99 112.644 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.564 ' O ' HG22 ' A' ' 157' ' ' VAL . 26.2 mt -45.79 -39.69 8.66 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.698 0.761 . . . . 1.27 111.556 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.442 ' HB1' ' CE2' ' A' ' 114' ' ' TYR . . . -61.22 -32.29 72.07 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.114 -1.403 . . . . 0.17999999999999999 111.951 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.1 t -87.84 -30.81 19.91 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 121.511 -0.743 . . . . 0.20999999999999999 112.198 174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 152' ' ' GLU . 38.0 mt -82.91 -59.42 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.547 0.689 . . . . 0.16 111.747 -172.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 153' ' ' LEU . 5.4 m -88.39 139.81 30.14 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.73 -1.123 . . . . 0.16 112.373 178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.594 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 48.1 Cg_endo -88.87 173.89 4.06 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.324 3.349 . . . . 0.20000000000000001 111.118 174.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.568 ' CG ' ' HA ' ' A' ' 102' ' ' ASN . 60.9 m-20 -67.05 156.8 35.13 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 119.214 -0.994 . . . . 1.1000000000000001 108.687 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.02 -20.85 49.18 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.833 -1.175 . . . . 0.17999999999999999 111.921 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.733 ' HB ' HD12 ' A' ' 100' ' ' ILE . 85.8 m -59.82 128.9 39.23 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.724 -0.843 . . . . 0.14000000000000001 108.724 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -93.32 123.45 36.62 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 122.809 1.29 . . . . 3.6299999999999999 110.833 -167.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.18 112.13 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 112.365 -2.198 . . . . 0.14000000000000001 110.023 -171.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 97' ' ' GLU . 16.2 m -95.69 115.12 26.97 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 119.798 -0.761 . . . . 0.20999999999999999 112.202 -175.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.541 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.2 mp -84.19 93.14 3.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 122.87 1.319 . . . . 0.23999999999999999 109.421 172.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -93.0 125.32 37.53 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.262 -1.79 . . . . 1.0900000000000001 108.139 -175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.48 ' HA ' HG13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -68.99 -28.33 66.5 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.291 -0.563 . . . . 2.0800000000000001 110.697 -177.391 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 166.63 91.47 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.458 -0.877 . . . . 1.97 112.889 175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 61.5 m . . . . . 0 C--N 1.322 -0.59 0 N-CA-C 110.071 -0.344 . . . . 3.9100000000000001 110.071 176.921 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.849 0 N-CA-C 112.276 -0.33 . . . . 2.7999999999999998 112.276 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -74.63 145.37 43.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.977 -0.379 . . . . 4.4400000000000004 109.977 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -87.74 123.56 32.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.873 -0.603 . . . . 2.46 111.149 -172.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -105.76 174.07 6.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.847 -0.615 . . . . 0.65000000000000002 111.379 178.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 5.1 tt -95.94 128.68 43.05 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.091 -0.959 . . . . 0.28000000000000003 110.432 -175.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.53 161.29 13.85 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 122.084 0.945 . . . . 0.31 112.932 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.66 ' O ' ' HA ' ' A' ' 45' ' ' SER . 72.7 t80 -130.01 141.79 50.7 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.726 -1.579 . . . . 0.44 108.071 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 34.9 tt0 -114.01 112.2 22.88 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.863 -1.162 . . . . 0.76000000000000001 107.863 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.613 ' HB ' ' O ' ' A' ' 41' ' ' THR . 92.3 t -65.11 149.81 11.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 122.476 1.131 . . . . 0.39000000000000001 112.806 -170.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -106.05 159.59 15.94 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 113.235 -1.802 . . . . 2.0099999999999998 108.6 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 108.02 0.99 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.071 0.462 . . . . 1.8300000000000001 111.949 -175.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.4 10.89 37.52 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.534 -0.757 . . . . 0.47999999999999998 113.283 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.605 ' HB2' HG13 ' A' ' 9' ' ' VAL . 91.5 m-20 -58.08 168.65 0.95 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.864 0.332 . . . . 1.46 110.765 172.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.66 153.61 49.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.577 0.703 . . . . 0.40999999999999998 112.011 174.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.734 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -68.2 -31.08 70.35 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.463 -1.244 . . . . 0.85999999999999999 109.75 -176.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.442 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 65.3 t30 -93.34 -20.67 20.14 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.854 -1.066 . . . . 1.1499999999999999 110.544 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.6 t -68.49 -43.22 77.35 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.152 -0.684 . . . . 1.21 109.152 171.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 17.2 mt -72.47 -25.84 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 121.354 0.597 . . . . 0.20999999999999999 109.916 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.643 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -80.4 -9.91 59.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.401 -0.363 . . . . 0.16 111.035 175.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.606 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -97.27 -38.87 9.51 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 122.677 1.227 . . . . 0.20999999999999999 107.982 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 119' ' ' SER . 9.6 m-20 -62.93 -49.16 75.86 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.255 -2.248 . . . . 0.53000000000000003 111.562 172.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.569 ' HA ' HG21 ' A' ' 101' ' ' ILE . 63.5 m-85 -94.5 5.52 51.58 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 118.605 -1.238 . . . . 0.17999999999999999 111.527 -177.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 5.0 mpt_? 53.4 44.51 29.92 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 121.661 0.744 . . . . 1.78 109.873 178.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.643 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.0 pt -116.2 -164.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 114.63 -1.168 . . . . 0.19 109.855 -178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.64 141.7 41.82 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.088 -0.96 . . . . 0.94999999999999996 110.137 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.734 ' HB ' HD11 ' A' ' 15' ' ' LEU . 67.0 p -72.67 -33.64 66.68 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.201 -1.037 . . . . 0.25 108.201 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.08 -31.46 68.92 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.981 -1.009 . . . . 0.20000000000000001 111.788 169.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -89.11 -27.88 20.45 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.955 -0.757 . . . . 0.17000000000000001 108.955 -177.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.654 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.8 tp -74.76 -28.38 60.73 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.028 -0.987 . . . . 1.1599999999999999 109.461 175.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 26' ' ' THR . 55.9 mt -77.85 -30.47 51.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.785 0.802 . . . . 1.05 109.86 172.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 39.4 tt0 -63.86 -41.47 97.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.29 -1.323 . . . . 1.8100000000000001 109.976 172.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.423 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.16 -22.08 33.38 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 121.91 -0.494 . . . . 0.20000000000000001 111.455 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.658 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 19.8 m-80 -150.11 98.34 3.33 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-O 121.26 0.553 . . . . 0.23000000000000001 109.75 -171.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 12.9 Cg_exo -79.67 -9.97 14.5 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 124.475 3.45 . . . . 0.35999999999999999 111.903 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -76.08 -25.78 55.84 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.852 -1.067 . . . . 1.3799999999999999 111.802 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.863 HD21 HG21 ' A' ' 46' ' ' ILE . 44.0 mt -65.04 -39.07 92.81 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.557 0.694 . . . . 0.48999999999999999 112.103 -171.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.424 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 3.5 pt20 -64.01 -46.27 85.24 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 122.917 1.342 . . . . 1.95 110.447 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.98 83.62 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 111.808 -2.451 . . . . 0.48999999999999999 110.59 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.49 173.21 45.62 Favored Glycine 0 N--CA 1.429 -1.786 0 CA-C-N 114.829 -1.078 . . . . 0.41999999999999998 111.815 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.8 157.81 18.24 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.343 0.592 . . . . 0.40999999999999998 110.877 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.625 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 47.2 m -140.51 127.22 20.37 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.43 -0.804 . . . . 0.41999999999999998 110.912 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.71 118.85 18.14 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.291 0.567 . . . . 0.46999999999999997 109.931 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.419 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.48 -1.13 55.73 Favored Glycine 0 N--CA 1.433 -1.501 0 N-CA-C 110.33 -1.108 . . . . 0.40999999999999998 110.33 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.625 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -75.29 123.69 25.78 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.394 -0.595 . . . . 1.3 109.394 179.212 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.66 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 68.1 p -83.94 132.28 34.78 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.827 0.823 . . . . 0.84999999999999998 110.14 176.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.863 HG21 HD21 ' A' ' 36' ' ' LEU . 11.7 pt -132.11 142.83 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.235 -1.348 . . . . 0.25 109.273 -177.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.39 150.06 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-O 121.17 0.51 . . . . 0.67000000000000004 111.055 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.6 mm -114.36 91.72 25.09 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 114.694 -1.139 . . . . 0.16 109.056 -178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.641 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.0 Cg_endo -58.41 135.93 71.04 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.907 2.405 . . . . 0.17999999999999999 112.756 -174.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.47 -5.95 82.42 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.889 -1.05 . . . . 0.26000000000000001 112.269 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.694 HD12 ' HD2' ' A' ' 52' ' ' PRO . 31.0 tp -125.41 116.95 25.12 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-O 121.207 0.527 . . . . 0.60999999999999999 111.395 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.694 ' HD2' HD12 ' A' ' 51' ' ' LEU . 55.4 Cg_endo -79.25 -177.31 3.8 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.698 2.932 . . . . 0.28000000000000003 114.075 -172.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.544 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.7 t70 -82.98 130.29 58.14 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 114.433 -1.258 . . . . 0.48999999999999999 112.089 -170.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.629 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 69.5 Cg_endo -75.23 -16.14 19.88 Favored 'Trans proline' 0 CA--C 1.52 -0.211 0 C-N-CA 123.49 2.793 . . . . 0.46000000000000002 112.867 -177.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -95.3 0.3 53.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.752 0.787 . . . . 1.3799999999999999 110.198 -172.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.544 HG23 ' HB3' ' A' ' 53' ' ' ASP . 20.2 p -96.97 -19.66 18.63 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 122.508 1.146 . . . . 0.46000000000000002 108.095 173.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.581 HG22 ' H ' ' A' ' 59' ' ' TYR . 20.5 mt -74.98 133.38 75.81 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 113.198 -1.819 . . . . 0.69999999999999996 111.296 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.76 -15.5 12.05 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.561 2.174 . . . . 0.39000000000000001 113.742 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.581 ' H ' HG22 ' A' ' 57' ' ' ILE . 51.3 m-85 -100.81 158.34 16.04 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.542 -0.463 . . . . 0.23999999999999999 112.059 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -146.0 133.08 20.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.594 -0.891 . . . . 2.8900000000000001 108.594 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.645 ' HA ' ' O ' ' A' ' 71' ' ' THR . 83.9 mt -113.66 134.36 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.343 -0.39 . . . . 0.16 111.937 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.54 118.94 32.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.831 -0.748 . . . . 0.16 111.473 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.8 t -96.99 116.01 38.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 121.825 0.822 . . . . 0.19 111.107 175.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 68' ' ' LYS . 27.7 m -95.68 103.12 14.99 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.754 -1.112 . . . . 0.20000000000000001 110.579 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.8 mm -51.02 -58.44 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.968 0.889 . . . . 0.23000000000000001 111.548 169.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.43 -12.51 4.6 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 112.782 -2.008 . . . . 0.16 113.208 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.418 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.31 -19.83 4.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.403 0.681 . . . . 0.14999999999999999 112.554 -177.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 68' ' ' LYS . 0.1 OUTLIER 58.83 57.99 3.42 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.552 0.615 . . . . 0.68999999999999995 111.154 -172.225 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 p -138.57 163.76 31.2 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 112.969 0.729 . . . . 0.13 112.969 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.452 ' HB2' HG21 ' A' ' 84' ' ' ILE . 8.5 tt -131.29 112.92 13.2 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.527 -1.215 . . . . 0.40000000000000002 110.041 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.645 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 23.4 m -92.06 122.95 35.04 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.243 0.544 . . . . 0.16 111.245 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 79' ' ' MET . 14.0 tp -99.43 103.29 15.06 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.1 -0.955 . . . . 0.58999999999999997 109.338 171.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 94.5 p -105.57 161.48 14.33 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 119.047 -1.061 . . . . 1.05 110.518 178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.864 HD13 HD22 ' A' ' 75' ' ' ASN . 1.1 tm? -127.55 128.63 45.94 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.498 -0.927 . . . . 0.26000000000000001 108.498 169.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.864 HD22 HD13 ' A' ' 74' ' ' LEU . 8.4 p30 45.93 51.29 10.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.097 1.359 . . . . 1.8400000000000001 111.48 -167.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 79.4 m-20 72.05 -13.62 0.59 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.587 -0.733 . . . . 1.8899999999999999 111.936 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -96.67 119.07 34.47 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.309 0.576 . . . . 3.4399999999999999 109.934 -175.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 69.9 t -57.91 132.49 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.313 1.054 . . . . 0.23999999999999999 112.852 -172.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 12.9 mtm -102.28 -45.66 5.05 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 112.994 -1.912 . . . . 0.81000000000000005 108.85 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.19 171.41 20.22 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.088 -1.869 . . . . 1.46 110.085 -176.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.0 m -149.24 123.73 9.71 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 114.136 -1.393 . . . . 0.17000000000000001 109.743 172.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -107.45 151.49 40.96 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 115.333 -0.849 . . . . 1.05 109.291 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HB2' HG22 ' A' ' 134' ' ' ILE . 55.9 Cg_endo -78.9 144.32 18.97 Favored 'Trans proline' 0 CA--C 1.5 -1.225 0 C-N-CA 121.871 1.714 . . . . 0.20000000000000001 111.059 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.656 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -141.01 173.33 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.777 -0.647 . . . . 0.13 111.098 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.895 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.23 145.17 45.2 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.342 -0.39 . . . . 0.26000000000000001 110.299 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.496 HG22 ' HG3' ' A' ' 68' ' ' LYS . 7.1 m -127.97 131.26 69.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.132 0.491 . . . . 0.56000000000000005 111.773 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 138' ' ' VAL . . . -91.6 157.04 24.32 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 109.755 -1.338 . . . . 0.17000000000000001 109.755 171.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.897 ' HG3' ' O ' ' A' ' 139' ' ' SER . 0.0 OUTLIER -57.5 8.1 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 114.449 1.278 . . . . 3.0499999999999998 114.449 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.915 HG23 HD22 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -97.03 -13.0 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.641 0.734 . . . . 0.23000000000000001 110.339 -177.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.915 HD22 HG23 ' A' ' 89' ' ' ILE . 3.3 mm? -92.67 -15.17 27.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.692 -0.685 . . . . 0.17999999999999999 109.342 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.1 p -69.06 -21.9 64.05 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.889 -1.05 . . . . 0.33000000000000002 111.797 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.5 ' OE1' ' N ' ' A' ' 92' ' ' GLN . 6.8 mp0 -56.74 -44.3 81.55 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.44 1.496 . . . . 1.52 112.332 -176.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -106.49 117.05 58.02 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.799 -0.637 . . . . 0.42999999999999999 111.36 -178.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.492 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 5.9 Cg_exo -73.1 -16.64 25.28 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.73 2.287 . . . . 0.72999999999999998 113.132 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.411 HG23 ' N ' ' A' ' 96' ' ' GLY . 12.1 t -104.0 -41.58 5.82 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.711 -0.477 . . . . 0.47999999999999998 109.711 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.534 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 48.26 40.19 21.79 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 114.343 -1.299 . . . . 0.33000000000000002 113.81 168.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.438 ' HG2' HG23 ' A' ' 164' ' ' THR . 49.0 mt-10 -84.08 113.42 21.02 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 122.026 0.917 . . . . 0.83999999999999997 109.624 -177.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.702 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 24.8 m-85 -136.73 178.08 7.35 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 113.604 -1.635 . . . . 0.22 111.566 -171.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 162' ' ' ARG . 66.0 m-85 -142.06 136.57 30.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.067 0.461 . . . . 0.54000000000000004 110.902 -172.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.597 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.3 mt -62.46 117.56 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 115.223 -0.899 . . . . 0.17000000000000001 110.916 171.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.569 HG21 ' HA ' ' A' ' 22' ' ' PHE . 16.3 pt -87.52 -34.36 7.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 113.138 0.792 . . . . 0.20999999999999999 113.138 -175.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.5 ' HA ' ' CG ' ' A' ' 159' ' ' ASN . 12.7 p30 -178.57 179.58 0.74 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.666 -1.235 . . . . 2.0299999999999998 107.666 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.657 ' NH2' ' HA ' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -135.65 163.14 30.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.622 0.725 . . . . 1.52 112.423 -177.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.445 ' HB3' ' HB3' ' A' ' 115' ' ' TRP . 53.7 tt0 -133.07 101.05 5.07 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.466 -1.243 . . . . 0.58999999999999997 109.819 172.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.492 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 13.6 ttt180 -63.77 166.27 7.37 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.665 -0.698 . . . . 2.8199999999999998 110.356 174.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.492 ' H ' ' CG ' ' A' ' 105' ' ' ARG . 16.3 m-80 -36.74 101.28 0.22 Allowed Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 113.869 -1.514 . . . . 0.34999999999999998 114.079 -151.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 16.1 Cg_exo -54.73 -50.9 11.74 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.588 2.858 . . . . 0.47999999999999998 110.723 169.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.18 -34.71 4.46 Favored Glycine 0 N--CA 1.442 -0.936 0 N-CA-C 110.156 -1.177 . . . . 0.67000000000000004 110.156 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.4 -175.21 25.98 Favored Glycine 0 N--CA 1.437 -1.24 0 CA-C-N 114.509 -0.846 . . . . 0.62 112.83 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.537 ' O ' ' HA ' ' A' ' 128' ' ' THR . 35.7 Cg_endo -58.3 -9.01 5.83 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 125.009 3.806 . . . . 0.93999999999999995 114.463 -177.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -65.55 -3.68 4.89 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.689 0.996 . . . . 1.23 113.689 -172.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.718 ' HA3' ' C ' ' A' ' 127' ' ' GLY . . . 92.29 64.63 1.12 Allowed Glycine 0 CA--C 1.493 -1.304 0 C-N-CA 118.95 -1.595 . . . . 1.6899999999999999 115.272 165.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 151' ' ' ILE . . . 38.41 0.95 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.514 0 N-CA-C 116.663 2.097 . . . . 0.47999999999999998 116.663 -175.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.51 ' H ' ' C ' ' A' ' 112' ' ' GLY . 0.3 OUTLIER -165.56 166.37 18.24 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 123.465 0.706 . . . . 0.28000000000000003 109.717 -177.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 104' ' ' GLN . 21.8 t-105 -146.68 98.73 3.1 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.96 -1.126 . . . . 0.48999999999999999 107.96 166.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.626 HD23 ' HG2' ' A' ' 103' ' ' ARG . 1.5 mt -89.39 114.12 25.53 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.337 0.589 . . . . 0.66000000000000003 109.503 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 101' ' ' ILE . 49.9 m -82.98 143.63 30.53 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.991 -0.549 . . . . 0.19 111.017 -172.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.793 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.4 mm? -109.36 167.59 10.01 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.13 111.696 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.538 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 4.2 t -59.71 -12.86 7.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.686 -1.143 . . . . 1.1699999999999999 113.175 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.702 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 3.3 tptp -126.87 133.22 50.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 120.45 -0.5 . . . . 1.22 111.075 173.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.482 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 76.9 mt-30 -31.31 -57.41 0.25 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.02 1.118 . . . . 1.51 114.02 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.552 ' CB ' HG12 ' A' ' 89' ' ' ILE . 87.9 m-70 -95.7 3.15 54.15 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.231 -0.588 . . . . 2.5299999999999998 111.902 -170.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.793 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.9 m-85 -95.14 38.19 1.14 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.661 0.985 . . . . 0.83999999999999997 113.661 -172.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.617 ' H ' ' HB2' ' A' ' 142' ' ' CYS . . . -112.65 143.15 17.59 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 117.319 -2.372 . . . . 0.32000000000000001 112.565 -153.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.544 ' H ' HD23 ' A' ' 118' ' ' LEU . 1.8 mp -98.94 115.15 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.868 0.842 . . . . 0.17999999999999999 110.801 -176.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.628 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 28.8 p80 -144.28 171.82 13.78 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-N 115.166 -0.925 . . . . 0.20999999999999999 109.789 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.718 ' C ' ' HA3' ' A' ' 112' ' ' GLY . . . -93.02 -166.64 38.57 Favored Glycine 0 C--N 1.317 -0.474 0 C-N-CA 120.799 -0.715 . . . . 0.27000000000000002 111.73 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 110' ' ' PRO . 13.1 t -156.98 169.16 25.45 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.266 -0.549 . . . . 0.40999999999999998 110.486 176.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -111.39 0.11 16.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.682 -0.859 . . . . 1.99 108.682 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -118.07 86.22 25.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 114.755 -1.111 . . . . 1.3600000000000001 108.199 171.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -72.5 -19.92 24.31 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.77 2.313 . . . . 0.34999999999999998 114.175 -166.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.1 -4.01 42.21 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.034 0.445 . . . . 0.33000000000000002 110.839 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.0 t -85.71 -13.11 49.45 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.906 -0.776 . . . . 1.3500000000000001 108.906 172.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 83' ' ' PRO . 28.6 mm -77.54 134.71 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 CA-C-N 115.257 -0.883 . . . . 0.20999999999999999 110.413 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.8 -1.38 71.23 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 110.217 -1.153 . . . . 0.14999999999999999 110.217 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 85' ' ' ALA . 48.4 mttt -112.1 172.3 6.99 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 123.012 1.387 . . . . 2.5 113.887 -177.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -99.32 127.72 45.36 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 112.189 -2.278 . . . . 0.17000000000000001 108.046 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.501 ' O ' ' HA2' ' A' ' 87' ' ' GLY . 1.4 p -118.57 167.91 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.054 -1.462 . . . . 0.66000000000000003 107.054 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.897 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 45.2 m -64.48 -59.68 4.04 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 119.731 -0.788 . . . . 0.42999999999999999 111.949 177.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -127.34 -44.14 1.58 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 117.207 -1.797 . . . . 2.02 113.9 -169.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -33.39 132.56 0.31 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.67 1.428 . . . . 0.17999999999999999 116.67 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.617 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 4.2 p -68.75 166.36 17.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 112.41 -1.895 . . . . 0.16 112.141 177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.895 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 66.9 mt -59.07 99.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-O 122.569 1.176 . . . . 0.40000000000000002 111.991 -163.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.628 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 50.3 mtt180 -86.09 147.1 26.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.371 -1.74 . . . . 1.8700000000000001 110.389 -177.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.656 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.0 mtp -128.12 -166.21 1.59 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.29 -0.633 . . . . 0.79000000000000004 109.29 175.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.602 ' HB3' ' OD1' ' A' ' 149' ' ' ASP . 5.5 t60 -95.55 156.38 16.35 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.909 -0.775 . . . . 2.3199999999999998 108.909 171.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.613 ' O ' HD13 ' A' ' 151' ' ' ILE . 2.1 m120 -57.1 -52.69 64.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 118.422 -0.799 . . . . 0.68000000000000005 110.293 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.87 -25.82 68.48 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 121.154 1.797 . . . . 2.1800000000000002 112.522 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.602 ' OD1' ' HB3' ' A' ' 146' ' ' HIS . 7.5 m-20 -84.67 -41.38 16.35 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.303 -0.408 . . . . 0.68999999999999995 111.186 -175.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.649 HG13 HD12 ' A' ' 151' ' ' ILE . 13.3 p -67.94 -23.75 29.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 116.016 -0.538 . . . . 0.11 111.143 175.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.649 HD12 HG13 ' A' ' 150' ' ' VAL . 1.7 mp -82.24 -39.67 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 119.042 -0.504 . . . . 0.38 109.739 171.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 156' ' ' ILE . 5.0 mm-40 -45.86 -72.06 0.06 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.171 0.896 . . . . 1.99 112.366 168.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 157' ' ' VAL . 44.8 mt -47.27 -38.46 12.5 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.675 0.75 . . . . 1.27 111.495 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.69 -35.35 79.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.126 -1.397 . . . . 0.17999999999999999 111.664 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.9 t -88.44 -33.0 18.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 118.58 0.627 . . . . 0.20999999999999999 112.416 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 152' ' ' GLU . 30.4 mt -81.24 -59.63 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.551 0.691 . . . . 0.16 111.193 -172.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 153' ' ' LEU . 2.8 m -92.58 140.12 23.86 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 114.845 -1.071 . . . . 0.16 112.227 177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.657 ' HA ' ' NH2' ' A' ' 103' ' ' ARG . 57.3 Cg_endo -89.86 177.14 2.64 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 124.114 3.209 . . . . 0.20000000000000001 111.122 173.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.507 HD21 ' CG ' ' A' ' 103' ' ' ARG . 12.7 m120 -67.07 157.8 32.64 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 119.658 -0.817 . . . . 1.1000000000000001 109.525 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 99.39 -25.58 27.69 Favored Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.211 -0.995 . . . . 0.17999999999999999 112.289 -173.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.597 ' HB ' HD12 ' A' ' 100' ' ' ILE . 36.1 m -61.41 138.31 58.26 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.383 -0.599 . . . . 0.14000000000000001 109.383 -173.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.538 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 9.8 ptm180 -92.81 127.71 38.41 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 122.964 1.364 . . . . 3.6299999999999999 111.369 -170.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 41.3 t -109.58 108.34 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 111.915 -2.402 . . . . 0.14000000000000001 109.008 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.438 HG23 ' HG2' ' A' ' 97' ' ' GLU . 30.6 m -94.76 107.05 19.06 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.524 0.564 . . . . 0.20999999999999999 112.524 -171.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.534 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.5 mp -82.86 100.75 6.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 122.29 1.043 . . . . 0.23999999999999999 109.992 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -110.17 133.31 53.35 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.229 -1.35 . . . . 1.0900000000000001 109.832 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.558 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 8.6 mmm180 -70.68 -18.75 62.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.465 -0.334 . . . . 2.0800000000000001 110.829 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.44 -144.21 18.98 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.938 -0.574 . . . . 1.97 112.101 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 110.281 -0.266 . . . . 3.9100000000000001 110.281 178.572 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.157 -0.377 . . . . 2.7999999999999998 112.157 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -102.93 169.67 8.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.048 0.451 . . . . 4.4400000000000004 111.065 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -87.2 98.96 11.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.253 -0.885 . . . . 2.46 108.895 172.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 mp -105.34 175.21 5.57 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.453 0.644 . . . . 0.65000000000000002 111.745 -175.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.621 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 4.4 tt -94.63 130.87 40.92 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.857 -1.065 . . . . 0.28000000000000003 110.142 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.75 162.25 13.51 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.129 0.966 . . . . 0.31 113.171 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.624 ' O ' ' HA ' ' A' ' 45' ' ' SER . 84.7 t80 -129.57 139.98 51.34 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.469 -1.696 . . . . 0.44 107.902 175.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.486 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 35.1 tt0 -112.93 110.89 21.25 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.242 -1.021 . . . . 0.76000000000000001 108.242 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 13' ' ' ASP . 92.7 t -66.05 149.45 11.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 122.564 1.173 . . . . 0.39000000000000001 113.578 -167.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.409 ' O ' HG12 ' A' ' 9' ' ' VAL . 57.9 mttt -98.93 159.97 14.59 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.211 -1.813 . . . . 2.0099999999999998 109.799 172.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.4 mm-40 -62.43 105.37 0.61 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.886 -1.052 . . . . 1.8300000000000001 111.432 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.94 11.66 49.05 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.485 -0.779 . . . . 0.47999999999999998 113.542 175.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.618 ' HB2' HG13 ' A' ' 9' ' ' VAL . 59.3 m-20 -52.38 169.52 0.08 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 117.423 0.611 . . . . 1.46 111.362 171.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.84 154.69 44.03 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.475 0.655 . . . . 0.40999999999999998 111.271 175.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.539 HD23 HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -65.97 -33.23 75.34 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.394 -0.965 . . . . 0.85999999999999999 108.394 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' HA ' ' CG2' ' A' ' 26' ' ' THR . 17.8 t-20 -88.62 -25.12 22.6 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.883 -1.053 . . . . 1.1499999999999999 111.391 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 93.4 p -68.76 -38.56 80.18 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 119.72 -0.792 . . . . 1.21 109.601 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.8 mt -75.47 -26.89 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-O 121.219 0.533 . . . . 0.20999999999999999 109.75 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.643 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.91 -9.86 59.63 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.326 -0.397 . . . . 0.16 110.646 174.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.729 ' O ' ' HD2' ' A' ' 23' ' ' ARG . . . -96.44 -41.37 8.63 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.274 -1.01 . . . . 0.20999999999999999 108.274 176.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.463 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 1.5 m-20 -61.68 -39.45 91.47 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.015 -1.902 . . . . 0.53000000000000003 112.073 174.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.469 ' O ' HD12 ' A' ' 101' ' ' ILE . 68.4 m-85 -103.32 5.9 37.61 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 118.566 -1.254 . . . . 0.17999999999999999 111.487 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.729 ' HD2' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER 54.74 41.5 31.88 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.972 0.891 . . . . 1.78 109.559 176.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.643 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 31.8 pt -114.42 -165.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-N 114.208 -1.36 . . . . 0.19 110.024 -177.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.95 142.62 41.07 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.241 -0.891 . . . . 0.94999999999999996 110.21 174.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.544 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 72.3 p -71.97 -34.01 68.61 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.007 -1.108 . . . . 0.25 108.007 178.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.0 -30.27 69.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.42 -0.809 . . . . 0.20000000000000001 111.816 170.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -91.37 -26.26 18.99 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.689 0.757 . . . . 0.17000000000000001 109.093 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.667 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 18.1 tp -75.19 -26.29 58.89 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.09 -0.959 . . . . 1.1599999999999999 109.261 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 26' ' ' THR . 33.6 mt -77.86 -29.89 50.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.765 0.793 . . . . 1.05 109.828 171.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.464 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 40.8 tt0 -64.49 -43.28 94.63 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.413 -1.267 . . . . 1.8100000000000001 109.95 173.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . . . -83.18 -20.35 34.85 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 120.105 -0.638 . . . . 0.20000000000000001 111.495 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.64 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 24.3 m-80 -148.16 81.05 8.34 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.509 0.671 . . . . 0.23000000000000001 110.442 -172.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 33' ' ' ASN . 18.4 Cg_endo -57.71 -10.93 8.09 Favored 'Trans proline' 0 C--N 1.322 -0.847 0 C-N-CA 124.077 3.185 . . . . 0.35999999999999999 114.057 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.5 t -80.67 -22.12 40.72 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 122.053 -0.404 . . . . 1.3799999999999999 111.249 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 46' ' ' ILE . 38.1 mt -66.41 -35.67 80.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.526 0.679 . . . . 0.48999999999999999 111.883 -171.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.426 ' HG2' ' H ' ' A' ' 37' ' ' GLN . 3.7 pt20 -65.51 -47.92 74.31 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-O 122.871 1.32 . . . . 1.95 110.167 -175.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.51 82.56 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 111.934 -2.394 . . . . 0.48999999999999999 110.594 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.17 -179.53 48.19 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.857 -1.065 . . . . 0.41999999999999998 111.541 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.01 158.22 23.44 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.212 0.529 . . . . 0.40999999999999998 110.791 178.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.61 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 29.4 m -139.05 128.11 23.81 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.493 -0.776 . . . . 0.41999999999999998 110.406 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -75.27 118.89 18.67 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.566 0.698 . . . . 0.46999999999999997 109.772 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.486 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 100.39 0.74 55.65 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.374 -1.09 . . . . 0.40999999999999998 110.374 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.2 OUTLIER -76.42 124.16 27.12 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.985 -0.607 . . . . 1.3 109.469 179.366 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 24.4 p -84.45 126.17 33.02 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.967 0.889 . . . . 0.84999999999999998 110.752 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.859 HG21 HD21 ' A' ' 36' ' ' LEU . 10.6 pt -126.94 144.38 37.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 114.133 -1.394 . . . . 0.25 109.377 -176.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.68 151.51 3.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.125 0.488 . . . . 0.67000000000000004 111.164 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.3 mm -116.35 91.69 33.93 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 114.885 -1.052 . . . . 0.16 109.425 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.528 ' HA ' HD21 ' A' ' 4' ' ' LEU . 2.6 Cg_endo -56.93 133.7 59.67 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.834 2.356 . . . . 0.17999999999999999 112.551 -175.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.18 -5.79 78.4 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.701 -1.136 . . . . 0.26000000000000001 112.569 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.688 HD12 ' HD2' ' A' ' 52' ' ' PRO . 25.6 tp -125.71 115.56 24.73 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.949 0.404 . . . . 0.60999999999999999 111.452 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.688 ' HD2' HD12 ' A' ' 51' ' ' LEU . 36.4 Cg_endo -76.79 -177.82 4.07 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.565 2.844 . . . . 0.28000000000000003 114.331 -172.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.67 ' HB3' HG23 ' A' ' 56' ' ' THR . 16.1 t70 -78.31 133.05 64.67 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 113.94 -1.482 . . . . 0.48999999999999999 112.139 -170.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.47 -9.36 18.72 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.314 2.676 . . . . 0.46000000000000002 112.717 -176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.507 ' HB2' ' OD2' ' A' ' 53' ' ' ASP . 16.4 m-30 -93.9 -8.28 40.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.119 0.485 . . . . 1.3799999999999999 110.52 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.67 HG23 ' HB3' ' A' ' 53' ' ' ASP . 19.0 p -88.72 -17.67 29.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.065 0.936 . . . . 0.46000000000000002 108.674 174.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.655 HG22 ' H ' ' A' ' 59' ' ' TYR . 9.6 mm -64.72 126.14 90.28 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 113.838 -1.528 . . . . 0.69999999999999996 109.989 175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.71 -13.48 10.62 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.999 1.799 . . . . 0.39000000000000001 112.608 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.655 ' H ' HG22 ' A' ' 57' ' ' ILE . 67.0 m-85 -103.68 170.56 7.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.281 0.562 . . . . 0.23999999999999999 111.825 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -153.81 134.07 13.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.117 -0.947 . . . . 2.8900000000000001 108.536 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 71' ' ' THR . 93.1 mt -111.54 130.34 65.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.342 -0.39 . . . . 0.16 111.322 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.87 115.48 28.52 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.937 -0.705 . . . . 0.16 110.847 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 165' ' ' ILE . 47.8 t -96.64 114.04 32.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.79 0.805 . . . . 0.19 110.571 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 68' ' ' LYS . 27.1 m -94.76 100.35 12.27 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.49 -1.232 . . . . 0.20000000000000001 110.359 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.0 mm -50.47 -57.32 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 122.028 0.918 . . . . 0.23000000000000001 111.13 170.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.34 -11.53 3.63 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 112.787 -2.006 . . . . 0.16 113.131 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' HB3' ' HB2' ' A' ' 64' ' ' SER . . . -126.49 -17.53 5.07 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.436 0.694 . . . . 0.14999999999999999 112.595 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.498 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.0 OUTLIER 57.97 54.25 6.18 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.505 0.593 . . . . 0.68999999999999995 111.488 -173.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 43.6 p -136.7 163.48 30.48 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.798 0.666 . . . . 0.13 112.798 -177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.501 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.5 tt -128.13 111.52 13.56 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.595 -1.184 . . . . 0.40000000000000002 109.549 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.631 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 31.2 m -93.41 121.77 35.15 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.261 0.553 . . . . 0.16 110.962 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' A' ' 79' ' ' MET . 16.0 tp -96.79 104.96 17.01 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.179 -0.918 . . . . 0.58999999999999997 109.078 172.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 97.9 p -106.8 159.23 16.39 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.981 -1.088 . . . . 1.05 110.368 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.707 HD13 ' ND2' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -123.73 125.51 44.88 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 108.561 -0.903 . . . . 0.26000000000000001 108.561 170.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.707 ' ND2' HD13 ' A' ' 74' ' ' LEU . 9.4 p30 41.06 54.83 3.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.713 -1.585 . . . . 1.8400000000000001 111.58 -164.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 6.7 m-20 74.7 -13.62 0.8 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.008 -0.996 . . . . 1.8899999999999999 112.146 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -95.28 120.39 35.43 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.231 0.539 . . . . 3.4399999999999999 110.025 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 58.9 t -56.93 131.04 20.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 122.357 1.075 . . . . 0.23999999999999999 113.002 -173.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 2.8 mmm -97.99 -46.88 5.74 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.947 -1.933 . . . . 0.81000000000000005 108.854 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 7.8 mmtt -160.56 173.99 14.7 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.046 -1.888 . . . . 1.46 110.037 -177.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.8 m -149.6 123.7 9.46 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.224 -1.353 . . . . 0.17000000000000001 109.699 174.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -114.94 145.06 33.21 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.6 -0.727 . . . . 1.05 109.959 -174.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HB2' HG22 ' A' ' 134' ' ' ILE . 37.3 Cg_endo -72.42 142.28 36.63 Favored 'Trans proline' 0 CA--C 1.496 -1.418 0 C-N-CA 122.259 1.973 . . . . 0.20000000000000001 111.173 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.661 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.0 pp -140.32 172.56 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 115.517 -0.765 . . . . 0.13 110.959 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.929 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.04 139.66 50.88 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.237 -0.438 . . . . 0.26000000000000001 109.88 -177.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.498 HG22 ' HG3' ' A' ' 68' ' ' LYS . 10.9 m -121.74 126.87 75.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.713 0.768 . . . . 0.56000000000000005 111.541 -177.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 89' ' ' ILE . . . -82.18 150.63 29.1 Favored Glycine 0 N--CA 1.419 -2.452 0 N-CA-C 109.186 -1.566 . . . . 0.17000000000000001 109.186 171.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -57.19 4.39 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.809 0.67 . . . . 3.0499999999999998 112.809 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.944 HG23 HD22 ' A' ' 90' ' ' LEU . 1.1 tp -87.46 -19.04 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.481 0.658 . . . . 0.23000000000000001 110.077 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.944 HD22 HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -88.84 -16.36 32.21 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.694 0.759 . . . . 0.17999999999999999 109.228 -177.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.5 p -69.23 -18.51 63.9 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.565 -1.198 . . . . 0.33000000000000002 111.194 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.25 -40.17 93.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.536 -1.211 . . . . 1.52 112.704 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.67 131.26 29.75 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 119.799 -0.76 . . . . 0.42999999999999999 110.956 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 83.8 Cg_endo -86.97 -1.86 8.04 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.43 2.087 . . . . 0.72999999999999998 112.314 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.3 t -119.62 -41.48 2.69 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.418 -0.586 . . . . 0.47999999999999998 109.418 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 165' ' ' ILE . . . 54.87 16.86 8.28 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-N 114.716 -1.129 . . . . 0.33000000000000002 114.413 169.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.596 ' HB3' HG23 ' A' ' 164' ' ' THR . 10.6 pt-20 -84.42 116.7 23.2 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.495 1.14 . . . . 0.83999999999999997 109.816 -173.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 11.3 m-85 -137.58 -174.78 3.86 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.278 -1.783 . . . . 0.22 111.436 -166.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 162' ' ' ARG . 39.2 m-85 -142.18 137.95 31.19 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 120.945 0.402 . . . . 0.54000000000000004 110.991 -173.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.662 HD12 ' HB ' ' A' ' 161' ' ' THR . 80.2 mt -65.04 125.04 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-N 115.542 -0.753 . . . . 0.17000000000000001 110.308 169.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.57 ' CD1' ' HD3' ' A' ' 23' ' ' ARG . 21.9 pt -91.45 -42.13 13.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 113.024 0.75 . . . . 0.20999999999999999 113.024 -177.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.507 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 57.6 m-80 -170.13 173.0 6.08 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.009 -1.478 . . . . 2.0299999999999998 107.009 -170.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.61 HH21 ' HA ' ' A' ' 158' ' ' PRO . 40.7 mtt180 -125.8 167.9 14.56 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.696 -0.802 . . . . 1.52 111.739 -175.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -145.44 100.76 3.5 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.148 -0.933 . . . . 0.58999999999999997 110.019 171.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.469 ' CG ' ' H ' ' A' ' 106' ' ' ASN . 25.9 ttp180 -66.02 166.31 11.77 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.302 -0.863 . . . . 2.8199999999999998 110.735 175.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 33.8 m-80 -36.37 101.51 0.22 Allowed Pre-proline 0 C--O 1.233 0.207 0 C-N-CA 124.942 1.297 . . . . 0.34999999999999998 113.104 -156.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.516 ' HD2' ' HA ' ' A' ' 106' ' ' ASN . 17.4 Cg_endo -63.41 -44.55 14.2 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.453 2.768 . . . . 0.47999999999999998 112.601 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.58 -33.95 5.26 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.87 -0.892 . . . . 0.67000000000000004 110.87 -177.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -72.75 -174.46 25.84 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.735 -0.733 . . . . 0.62 112.592 175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -56.09 -5.73 1.05 Allowed 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 125.064 3.842 . . . . 0.93999999999999995 114.461 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.444 ' HB2' ' CG ' ' A' ' 107' ' ' PRO . 5.2 m-85 -70.4 -16.19 62.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 122.506 1.146 . . . . 1.23 108.366 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 113' ' ' ALA . . . 84.13 -12.75 53.14 Favored Glycine 0 N--CA 1.433 -1.56 0 N-CA-C 118.465 2.146 . . . . 1.6899999999999999 118.465 152.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.788 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 166.36 -36.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 119.629 1.715 . . . . 0.47999999999999998 110.111 -175.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.429 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 0.6 OUTLIER -157.37 157.51 34.2 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.66 0.384 . . . . 0.28000000000000003 110.079 179.178 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -136.52 100.22 4.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.973 -1.121 . . . . 0.48999999999999999 107.973 165.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.547 HD23 ' HB3' ' A' ' 103' ' ' ARG . 5.0 mt -93.52 114.18 26.49 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.64 -0.874 . . . . 0.66000000000000003 108.64 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.406 ' C ' HG12 ' A' ' 101' ' ' ILE . 9.2 m -84.25 144.45 28.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.675 -0.693 . . . . 0.19 111.213 -165.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.815 ' HG ' ' O ' ' A' ' 123' ' ' TYR . 2.6 mm? -109.54 169.46 8.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.069 -0.514 . . . . 0.13 111.394 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.0 t -63.97 -12.21 35.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.848 -1.069 . . . . 1.1699999999999999 112.787 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.746 ' HD3' ' N ' ' A' ' 121' ' ' GLN . 3.9 tmtm? -127.65 132.31 49.74 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 122.158 0.98 . . . . 1.22 109.704 171.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.746 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 53.0 mt-30 -37.57 -47.23 0.91 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 112.524 -2.126 . . . . 1.51 114.211 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.486 ' HB2' HG12 ' A' ' 89' ' ' ILE . 37.2 m80 -97.9 2.22 48.92 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.366 0.603 . . . . 2.5299999999999998 111.024 -171.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.815 ' O ' ' HG ' ' A' ' 118' ' ' LEU . 2.6 m-85 -99.38 37.35 1.58 Allowed 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.495 0.924 . . . . 0.83999999999999997 113.495 -171.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.672 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -117.03 142.27 17.31 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 116.874 -2.584 . . . . 0.32000000000000001 112.668 -152.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -95.64 116.12 36.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 123.966 0.906 . . . . 0.17999999999999999 110.868 -175.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.724 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 26.7 p80 -146.36 -179.01 6.45 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.186 -0.461 . . . . 0.20999999999999999 111.822 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.39 -167.98 37.05 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 111.19 -0.764 . . . . 0.27000000000000002 111.19 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.4 t -156.95 172.29 18.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 117.912 0.856 . . . . 0.40999999999999998 110.911 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -115.42 -2.43 12.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.528 -0.916 . . . . 1.99 108.528 177.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -124.86 89.17 52.93 Favored Pre-proline 0 C--O 1.235 0.333 0 CA-C-N 114.426 -1.261 . . . . 1.3600000000000001 108.858 171.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -74.32 -21.04 17.95 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.627 2.218 . . . . 0.34999999999999998 114.113 -169.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -77.02 -3.65 40.14 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.034 0.445 . . . . 0.33000000000000002 111.337 -175.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.9 m -91.13 -2.33 57.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.125 0.488 . . . . 1.3500000000000001 109.812 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 83' ' ' PRO . 33.5 mm -77.23 136.34 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.919 -0.582 . . . . 0.20999999999999999 110.026 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.59 2.12 65.57 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.314 -1.114 . . . . 0.14999999999999999 110.314 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.428 ' C ' ' HG2' ' A' ' 68' ' ' LYS . 30.2 mttm -114.87 169.96 8.69 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 123.315 1.531 . . . . 2.5 114.635 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.4 126.51 48.18 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 111.67 -2.514 . . . . 0.17000000000000001 108.203 176.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.77 161.23 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.446 -0.946 . . . . 0.66000000000000003 108.446 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.0 m -49.8 -60.1 3.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.794 0.664 . . . . 0.42999999999999999 112.794 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -132.61 -44.46 0.9 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 118.36 -1.336 . . . . 2.02 113.984 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -32.49 133.65 0.2 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 117.19 1.636 . . . . 0.17999999999999999 117.19 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.616 ' HB2' ' H ' ' A' ' 124' ' ' GLY . 2.4 p -71.22 165.6 23.29 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 112.545 -1.827 . . . . 0.16 112.026 -179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.929 ' HA ' ' O ' ' A' ' 85' ' ' ALA . 56.0 mt -60.01 96.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-O 122.538 1.161 . . . . 0.40000000000000002 111.783 -162.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.724 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 80.5 mtt180 -84.93 141.76 30.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.681 -1.6 . . . . 1.8700000000000001 109.399 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.661 ' HG2' HG22 ' A' ' 84' ' ' ILE . 24.4 mtp -118.6 179.22 4.19 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.477 0.656 . . . . 0.79000000000000004 109.857 175.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.569 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 9.5 t-80 -81.45 145.83 30.56 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.882 -1.155 . . . . 2.3199999999999998 107.882 168.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.789 ' O ' HD13 ' A' ' 151' ' ' ILE . 6.9 m120 -66.17 -40.47 90.52 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 114.883 -1.053 . . . . 0.68000000000000005 112.566 -166.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -67.54 -23.83 65.48 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 121.801 2.091 . . . . 2.1800000000000002 112.241 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 12.2 m-20 -85.19 -38.23 19.22 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.216 -0.447 . . . . 0.68999999999999995 110.851 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.62 HG13 HD12 ' A' ' 151' ' ' ILE . 12.2 p -67.55 -21.98 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.852 -0.613 . . . . 0.11 111.176 174.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.789 HD13 ' O ' ' A' ' 147' ' ' ASN . 1.7 mp -83.19 -43.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 118.948 -0.549 . . . . 0.38 109.923 171.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.443 ' O ' HG13 ' A' ' 156' ' ' ILE . 23.5 mt-10 -46.81 -70.01 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 119.385 0.993 . . . . 1.99 112.761 170.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.473 ' O ' HG22 ' A' ' 157' ' ' VAL . 27.3 mt -47.07 -38.62 11.5 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.631 0.729 . . . . 1.27 111.658 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.65 -31.96 71.16 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.079 -1.419 . . . . 0.17999999999999999 111.712 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.7 t -88.34 -31.77 18.75 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 121.481 -0.762 . . . . 0.20999999999999999 112.324 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 152' ' ' GLU . 24.2 mt -82.31 -60.84 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.534 0.683 . . . . 0.16 111.828 -171.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 153' ' ' LEU . 8.7 m -88.35 139.46 30.16 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 114.783 -1.099 . . . . 0.16 112.342 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.61 ' HA ' HH21 ' A' ' 103' ' ' ARG . 42.4 Cg_endo -88.54 174.55 4.13 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 124.37 3.38 . . . . 0.20000000000000001 111.119 176.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 54.0 m-20 -68.18 156.93 36.53 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 118.905 -1.118 . . . . 1.1000000000000001 108.219 175.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.78 -16.07 61.9 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 119.772 -1.204 . . . . 0.17999999999999999 111.928 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.662 ' HB ' HD12 ' A' ' 100' ' ' ILE . 95.2 m -64.91 135.29 55.54 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.203 -0.666 . . . . 0.14000000000000001 109.203 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.443 ' HB3' ' CD1' ' A' ' 99' ' ' TYR . 1.7 ptt180 -92.82 122.42 35.19 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.685 1.231 . . . . 3.6299999999999999 111.078 -170.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 39.8 t -110.14 109.56 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 112.204 -2.271 . . . . 0.14000000000000001 109.475 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.596 HG23 ' HB3' ' A' ' 97' ' ' GLU . 6.9 m -97.35 110.28 22.86 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.082 0.771 . . . . 0.20999999999999999 113.082 -172.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.488 HG12 HD12 ' A' ' 90' ' ' LEU . 2.3 mp -83.17 102.16 8.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 122.11 0.957 . . . . 0.23999999999999999 109.792 176.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -109.22 129.84 55.5 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.979 -1.009 . . . . 1.0900000000000001 110.037 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.498 ' HG3' ' HA ' ' A' ' 94' ' ' PRO . 9.9 mmm180 -77.7 -23.17 49.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.362 0.601 . . . . 2.0800000000000001 109.432 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 153.6 -177.89 30.88 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.925 -1.034 . . . . 1.97 111.572 176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--N 1.321 -0.64 0 N-CA-C 110.114 -0.328 . . . . 3.9100000000000001 110.114 178.931 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 111.768 -0.533 . . . . 2.7999999999999998 111.768 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -99.59 140.37 33.88 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.063 0.459 . . . . 4.4400000000000004 110.671 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 6.1 mmpt? -91.36 100.88 13.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.777 -0.647 . . . . 2.46 110.671 -177.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.771 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.3 tp -107.47 174.43 5.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.891 -0.595 . . . . 0.65000000000000002 111.186 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 52' ' ' PRO . 3.9 tt -94.28 126.42 39.52 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.521 -0.763 . . . . 0.28000000000000003 110.615 -174.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.71 161.62 13.8 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-O 122.051 0.929 . . . . 0.31 113.064 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.651 ' O ' ' HA ' ' A' ' 45' ' ' SER . 78.7 t80 -131.29 141.48 49.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.808 -1.542 . . . . 0.44 108.058 176.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.457 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 60.5 tt0 -113.27 111.04 21.37 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.055 -1.091 . . . . 0.76000000000000001 108.055 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.647 HG13 ' HB2' ' A' ' 13' ' ' ASP . 94.3 t -66.52 150.49 10.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 122.155 0.978 . . . . 0.39000000000000001 113.032 -168.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -104.14 158.85 16.15 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.869 -1.514 . . . . 2.0099999999999998 108.658 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 1.1 tt0 -61.54 101.62 0.19 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.974 0.416 . . . . 1.8300000000000001 112.09 -175.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.79 11.97 27.27 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.754 -0.736 . . . . 0.47999999999999998 113.237 174.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.647 ' HB2' HG13 ' A' ' 9' ' ' VAL . 35.7 m-20 -55.54 170.48 0.25 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.912 0.356 . . . . 1.46 111.348 171.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.7 155.11 49.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.459 0.647 . . . . 0.40999999999999998 111.893 174.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.754 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -69.21 -29.71 67.73 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.526 -1.216 . . . . 0.85999999999999999 109.897 -177.255 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.441 ' HA ' HG22 ' A' ' 26' ' ' THR . 65.9 t30 -93.79 -23.26 18.23 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.927 -1.033 . . . . 1.1499999999999999 111.164 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.3 m -70.0 -39.84 75.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 120.553 -0.459 . . . . 1.21 109.886 172.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.443 HG23 ' CE1' ' A' ' 22' ' ' PHE . 15.2 mt -73.2 -27.4 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 121.112 0.482 . . . . 0.20999999999999999 109.977 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.654 ' HA ' ' CG1' ' A' ' 24' ' ' ILE . . . -78.76 -10.42 59.77 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 120.811 -0.356 . . . . 0.16 110.928 175.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.565 ' O ' ' HD3' ' A' ' 23' ' ' ARG . . . -97.16 -40.3 8.87 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 122.214 1.007 . . . . 0.20999999999999999 108.404 177.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' A' ' 121' ' ' GLN . 4.4 m-20 -61.44 -43.43 98.88 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 113.227 -1.806 . . . . 0.53000000000000003 111.867 173.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.568 ' C ' HD12 ' A' ' 101' ' ' ILE . 67.8 m-85 -98.01 8.19 45.14 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 118.574 -1.25 . . . . 0.17999999999999999 111.571 -178.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.565 ' HD3' ' O ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER 52.08 40.65 28.95 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.613 0.721 . . . . 1.78 110.215 177.439 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.654 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 34.6 pt -113.63 -164.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 114.511 -1.222 . . . . 0.19 109.28 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -109.9 157.17 19.52 Favored 'General case' 0 CA--C 1.491 -1.318 0 CA-C-O 122.375 1.083 . . . . 0.94999999999999996 110.168 169.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.754 ' HB ' HD11 ' A' ' 15' ' ' LEU . 75.7 p -80.68 -31.12 36.4 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 112.914 -1.948 . . . . 0.25 107.553 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.84 -30.72 71.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.098 -0.956 . . . . 0.20000000000000001 111.76 172.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.51 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -89.95 -26.87 20.17 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.728 -0.842 . . . . 0.17000000000000001 108.728 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.6 ' HG ' ' CD1' ' A' ' 36' ' ' LEU . 20.0 tp -74.14 -28.18 61.2 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.355 -0.839 . . . . 1.1599999999999999 109.789 175.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 36' ' ' LEU . 48.3 mt -77.79 -29.31 50.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.959 0.885 . . . . 1.05 109.919 172.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.51 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 53.9 tt0 -67.9 -39.65 83.59 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.082 -1.417 . . . . 1.8100000000000001 110.572 174.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.67 -19.94 32.06 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 120.075 -0.65 . . . . 0.20000000000000001 111.409 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HB2' ' CD1' ' A' ' 36' ' ' LEU . 26.8 m-80 -147.05 80.64 9.34 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-O 121.217 0.532 . . . . 0.23000000000000001 110.351 -173.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.418 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 18.5 Cg_endo -57.15 -11.2 7.36 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 123.889 3.059 . . . . 0.35999999999999999 113.305 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 m -74.05 -25.72 60.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.848 0.356 . . . . 1.3799999999999999 111.53 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.663 HD21 HG21 ' A' ' 46' ' ' ILE . 40.6 mt -70.91 -32.46 69.4 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.353 0.596 . . . . 0.48999999999999999 112.462 -168.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 34' ' ' PRO . 1.7 pp0? -63.59 -44.64 93.43 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 123.057 1.408 . . . . 1.95 110.395 -175.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.37 79.19 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 111.722 -2.49 . . . . 0.48999999999999999 110.693 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -179.41 178.33 48.65 Favored Glycine 0 N--CA 1.425 -2.094 0 CA-C-N 115.117 -0.947 . . . . 0.41999999999999998 111.929 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.67 158.05 19.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.225 0.536 . . . . 0.40999999999999998 110.569 178.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.556 ' O ' ' HB3' ' A' ' 44' ' ' GLN . 74.4 m -140.91 127.55 20.19 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.355 -0.839 . . . . 0.41999999999999998 110.301 -179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 11' ' ' GLN . . . -75.07 122.71 23.96 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.364 0.602 . . . . 0.46999999999999997 110.028 -178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.457 ' HA2' ' HG2' ' A' ' 8' ' ' GLN . . . 95.67 3.02 61.18 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 110.533 -1.027 . . . . 0.40999999999999998 110.533 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.556 ' HB3' ' O ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -81.52 123.12 28.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.626 -0.509 . . . . 1.3 109.626 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 7' ' ' TYR . 17.0 p -77.78 126.36 30.74 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.852 0.834 . . . . 0.84999999999999998 110.657 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.663 HG21 HD21 ' A' ' 36' ' ' LEU . 9.1 pt -126.13 144.07 37.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 114.138 -1.392 . . . . 0.25 109.198 -178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.426 HG12 ' HB3' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -89.15 151.44 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.347 0.594 . . . . 0.67000000000000004 111.191 -179.023 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.82 93.38 41.23 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.554 -1.203 . . . . 0.16 109.227 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.613 ' HA ' HD21 ' A' ' 4' ' ' LEU . 3.1 Cg_exo -56.12 133.91 60.97 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.488 2.125 . . . . 0.17999999999999999 112.535 -176.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.77 -6.88 79.76 Favored Glycine 0 N--CA 1.436 -1.315 0 CA-C-N 114.412 -1.267 . . . . 0.26000000000000001 112.363 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.771 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.8 OUTLIER -112.98 118.49 44.41 Favored Pre-proline 0 C--O 1.217 -0.637 0 CA-C-N 116.98 0.39 . . . . 0.60999999999999999 111.186 178.172 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.592 ' HD2' HD23 ' A' ' 51' ' ' LEU . 37.0 Cg_endo -80.0 -176.8 3.41 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.083 2.522 . . . . 0.28000000000000003 112.65 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.552 ' HB3' HG23 ' A' ' 56' ' ' THR . 9.7 t70 -86.72 127.37 60.49 Favored Pre-proline 0 N--CA 1.441 -0.878 0 CA-C-N 115.363 -0.835 . . . . 0.48999999999999999 112.044 -168.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.566 ' HB3' ' O ' ' A' ' 160' ' ' GLY . 72.1 Cg_endo -75.65 -10.39 20.17 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 123.626 2.884 . . . . 0.46000000000000002 112.934 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -94.08 -13.92 26.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.549 0.69 . . . . 1.3799999999999999 110.186 -176.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.552 HG23 ' HB3' ' A' ' 53' ' ' ASP . 23.7 p -87.32 -21.23 25.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.507 1.146 . . . . 0.46000000000000002 108.176 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 59' ' ' TYR . 35.8 mt -73.89 129.08 85.58 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 113.124 -1.853 . . . . 0.69999999999999996 111.018 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.06 -16.22 14.25 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.424 2.083 . . . . 0.39000000000000001 113.416 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.531 ' H ' HG22 ' A' ' 57' ' ' ILE . 62.9 m-85 -94.66 160.12 14.76 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.582 -0.447 . . . . 0.23999999999999999 111.591 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -150.99 132.03 14.31 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.902 -0.777 . . . . 2.8900000000000001 108.902 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 71' ' ' THR . 80.2 mt -112.49 136.38 48.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.233 -0.44 . . . . 0.16 111.889 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.77 117.39 29.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 119.957 -0.697 . . . . 0.16 110.924 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 90.2 t -97.33 112.88 30.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.775 0.797 . . . . 0.19 110.53 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 68' ' ' LYS . 49.6 m -93.6 100.75 12.95 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.717 -1.129 . . . . 0.20000000000000001 110.546 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 167' ' ' ARG . 49.8 mm -50.79 -58.77 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 CA-C-O 121.894 0.854 . . . . 0.23000000000000001 111.443 170.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.92 -8.21 2.09 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 112.922 -1.945 . . . . 0.16 113.245 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.46 -19.17 4.27 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.697 0.799 . . . . 0.14999999999999999 112.267 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.554 ' HG3' HG22 ' A' ' 86' ' ' VAL . 0.1 OUTLIER 59.24 54.51 4.77 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 118.335 0.516 . . . . 0.68999999999999995 111.293 -172.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 40.6 p -137.29 166.2 24.34 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 112.787 0.662 . . . . 0.13 112.787 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.431 ' HB2' HG21 ' A' ' 84' ' ' ILE . 7.9 tt -136.26 112.22 9.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.861 -1.063 . . . . 0.40000000000000002 110.197 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 86.6 m -93.24 124.3 37.12 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.146 0.498 . . . . 0.16 110.879 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 79' ' ' MET . 13.9 tp -99.78 107.3 19.31 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.173 -0.921 . . . . 0.58999999999999997 109.25 172.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 88.8 p -105.42 161.4 14.35 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.013 -1.075 . . . . 1.05 110.546 176.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 75' ' ' ASN . 1.3 tm? -125.99 126.69 44.72 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 108.575 -0.898 . . . . 0.26000000000000001 108.575 167.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.566 ' N ' HD22 ' A' ' 74' ' ' LEU . 29.1 m-80 51.15 48.61 22.73 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.607 -1.179 . . . . 1.8400000000000001 111.067 -172.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.0 t30 71.71 -5.89 1.56 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.339 0.656 . . . . 1.8899999999999999 111.414 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -104.94 120.64 41.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.125 0.488 . . . . 3.4399999999999999 110.582 -178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 73' ' ' SER . 54.7 t -55.23 132.85 18.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 122.361 1.077 . . . . 0.23999999999999999 113.399 -174.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 72' ' ' LEU . 6.9 mmm -100.85 -44.43 5.77 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 113.229 -1.805 . . . . 0.81000000000000005 109.275 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -159.37 173.43 16.26 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 113.189 -1.823 . . . . 1.46 110.156 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.0 m -149.3 123.08 9.27 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.986 -1.461 . . . . 0.17000000000000001 109.391 171.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.459 ' HE2' HD21 ' A' ' 153' ' ' LEU . 19.0 m-85 -108.85 156.6 38.72 Favored Pre-proline 0 C--N 1.312 -1.04 0 N-CA-C 109.386 -0.598 . . . . 1.05 109.386 -176.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HB2' HG22 ' A' ' 134' ' ' ILE . 50.7 Cg_endo -80.69 144.2 15.41 Favored 'Trans proline' 0 CA--C 1.497 -1.372 0 C-N-CA 121.975 1.783 . . . . 0.20000000000000001 110.83 170.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.631 HG22 ' HG2' ' A' ' 145' ' ' MET . 2.1 pp -140.08 172.75 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.614 -0.721 . . . . 0.13 110.551 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.85 ' O ' ' HA ' ' A' ' 143' ' ' ILE . . . -118.05 137.69 52.73 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.846 0.355 . . . . 0.26000000000000001 110.321 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.554 HG22 ' HG3' ' A' ' 68' ' ' LYS . 13.2 m -121.11 130.16 74.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.678 -0.692 . . . . 0.56000000000000005 111.527 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 140' ' ' LYS . . . -88.91 154.26 24.46 Favored Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.988 -1.245 . . . . 0.17000000000000001 109.988 171.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mmmm -57.08 4.55 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 113.133 0.79 . . . . 3.0499999999999998 113.133 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.936 HG23 HD22 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -88.78 -18.97 7.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.78 0.8 . . . . 0.23000000000000001 110.074 179.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.936 HD22 HG23 ' A' ' 89' ' ' ILE . 3.5 mm? -88.66 -18.53 27.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.791 0.805 . . . . 0.17999999999999999 108.909 -176.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.8 p -68.51 -15.05 63.41 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.376 -1.284 . . . . 0.33000000000000002 111.658 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -69.6 -42.26 74.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.918 -1.037 . . . . 1.52 112.127 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -99.72 111.94 62.7 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 121.016 0.436 . . . . 0.42999999999999999 111.108 -175.105 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.509 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 1.9 Cg_endo -77.43 -11.87 17.19 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.831 2.354 . . . . 0.72999999999999998 113.126 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.425 HG23 ' N ' ' A' ' 96' ' ' GLY . 10.2 t -98.88 -43.58 6.68 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.468 -0.567 . . . . 0.47999999999999998 109.468 176.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.55 ' HA3' ' HB ' ' A' ' 165' ' ' ILE . . . 54.44 27.21 40.19 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.255 -1.339 . . . . 0.33000000000000002 114.228 168.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -84.59 111.86 19.91 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.988 0.899 . . . . 0.83999999999999997 109.363 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.692 ' CE2' ' HB2' ' A' ' 120' ' ' LYS . 22.4 m-85 -138.46 -176.9 4.62 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.66 -1.609 . . . . 0.22 111.661 -170.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.401 ' CE1' ' HG3' ' A' ' 54' ' ' PRO . 46.5 m-85 -143.96 144.12 31.55 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.974 0.416 . . . . 0.54000000000000004 110.552 -173.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.586 HD12 ' HB ' ' A' ' 161' ' ' THR . 82.3 mt -68.75 113.01 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.336 -0.847 . . . . 0.17000000000000001 109.995 168.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.568 HD12 ' C ' ' A' ' 22' ' ' PHE . 18.7 pt -80.65 -43.54 21.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.569 -0.741 . . . . 0.20999999999999999 112.552 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.824 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 52.1 m-80 -169.12 169.47 9.38 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.007 -1.479 . . . . 2.0299999999999998 107.007 -170.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.608 ' HB3' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -134.76 157.59 46.34 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.99 -0.684 . . . . 1.52 112.396 -177.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.524 ' NE2' ' HB3' ' A' ' 107' ' ' PRO . 29.8 tt0 -130.86 100.92 5.43 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.723 -1.126 . . . . 0.58999999999999997 109.85 174.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.459 ' HG2' ' H ' ' A' ' 106' ' ' ASN . 52.0 ttt180 -61.45 165.31 4.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.35 -0.841 . . . . 2.8199999999999998 110.137 173.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.77 ' OD1' ' HA ' ' A' ' 113' ' ' ALA . 29.9 m-80 -34.99 100.91 0.2 Allowed Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 125.12 1.368 . . . . 0.34999999999999998 112.657 -156.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.524 ' HB3' ' NE2' ' A' ' 104' ' ' GLN . 19.7 Cg_endo -67.04 -50.89 0.91 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.25 2.633 . . . . 0.47999999999999998 112.827 176.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.56 -32.88 4.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.793 -0.718 . . . . 0.67000000000000004 111.336 -175.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.06 -173.77 3.14 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.179 -0.51 . . . . 0.62 112.512 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.437 ' O ' ' HA ' ' A' ' 128' ' ' THR . 36.2 Cg_endo -57.06 -11.57 7.89 Favored 'Trans proline' 0 N--CA 1.478 0.595 0 C-N-CA 124.307 3.338 . . . . 0.93999999999999995 113.071 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' A' ' 115' ' ' TRP . 6.2 m-30 -67.36 -37.99 84.06 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.802 -1.184 . . . . 1.23 107.802 174.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 113' ' ' ALA . . . 54.2 29.65 45.68 Favored Glycine 0 CA--C 1.492 -1.405 0 CA-C-N 113.256 -1.793 . . . . 1.6899999999999999 117.232 161.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.9 ' HB1' HD11 ' A' ' 151' ' ' ILE . . . 173.27 -51.19 0.01 OUTLIER 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 118.32 1.06 . . . . 0.47999999999999998 110.221 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.454 ' CE1' ' HG3' ' A' ' 105' ' ' ARG . 1.0 OUTLIER -161.06 157.24 25.8 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.57 0.348 . . . . 0.28000000000000003 110.206 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.439 ' HB2' ' CD2' ' A' ' 111' ' ' PHE . 8.6 t-105 -135.68 99.05 4.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.129 -1.063 . . . . 0.48999999999999999 108.129 165.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.608 HD23 ' HB3' ' A' ' 103' ' ' ARG . 2.7 mt -89.69 113.52 25.02 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.692 -0.855 . . . . 0.66000000000000003 108.692 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.497 ' O ' HG12 ' A' ' 101' ' ' ILE . 11.0 m -82.02 142.63 32.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.718 -0.674 . . . . 0.19 110.153 -171.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.722 HD23 ' HA2' ' A' ' 124' ' ' GLY . 1.3 mm? -108.14 163.81 12.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.282 -0.417 . . . . 0.13 111.725 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.3 t -57.6 -14.01 4.72 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 124.621 1.201 . . . . 1.1699999999999999 112.546 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.692 ' HB2' ' CE2' ' A' ' 98' ' ' PHE . 5.9 tmtm? -125.94 130.33 51.06 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.266 -0.574 . . . . 1.22 109.458 169.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.64 ' N ' ' HD3' ' A' ' 120' ' ' LYS . 54.0 mt-30 -33.69 -60.29 0.37 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 125.438 1.711 . . . . 1.51 113.19 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.503 ' HB3' HG12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -92.08 13.79 17.85 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.01 -0.676 . . . . 2.5299999999999998 112.412 -169.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.949 ' O ' HG12 ' A' ' 143' ' ' ILE . 2.5 m-30 -92.68 -35.13 13.66 Favored 'General case' 0 C--O 1.202 -1.441 0 CA-C-O 121.896 0.855 . . . . 0.83999999999999997 111.392 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.722 ' HA2' HD23 ' A' ' 118' ' ' LEU . . . -10.3 129.46 0.01 OUTLIER Glycine 0 C--N 1.286 -2.197 0 N-CA-C 119.414 2.526 . . . . 0.32000000000000001 119.414 177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 143' ' ' ILE . 1.8 mp -98.43 116.52 41.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 112.538 -1.831 . . . . 0.17999999999999999 110.149 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.633 ' CE1' ' HG2' ' A' ' 144' ' ' ARG . 30.2 p80 -144.13 -175.82 4.76 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 112.762 0.653 . . . . 0.20999999999999999 112.762 -174.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.17 -166.73 36.98 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 111.651 -0.579 . . . . 0.27000000000000002 111.651 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 110' ' ' PRO . 13.8 t -160.92 165.6 29.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 117.99 0.895 . . . . 0.40999999999999998 110.826 -174.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -114.42 -2.04 13.34 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.806 -1.183 . . . . 1.99 107.806 175.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -123.73 96.47 43.07 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 114.187 -1.369 . . . . 1.3600000000000001 108.157 170.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -74.54 -20.32 18.14 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.238 1.958 . . . . 0.34999999999999998 112.767 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.53 -0.16 40.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.414 0.626 . . . . 0.33000000000000002 110.674 -176.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 136' ' ' LYS . 43.0 t -91.94 -5.17 53.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.928 -0.767 . . . . 1.3500000000000001 108.928 170.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.449 ' CD1' ' HB2' ' A' ' 144' ' ' ARG . 30.6 mm -84.56 133.66 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.768 -0.651 . . . . 0.20999999999999999 110.498 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.1 1.45 69.84 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 109.804 -1.319 . . . . 0.14999999999999999 109.804 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 0.1 OUTLIER -113.69 161.79 17.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 122.913 1.34 . . . . 2.5 114.067 -176.023 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 136' ' ' LYS . . . -95.85 129.04 43.21 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 112.244 -2.253 . . . . 0.17000000000000001 108.305 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 139' ' ' SER . 0.2 OUTLIER -126.02 165.07 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.618 -0.882 . . . . 0.66000000000000003 108.618 -175.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 138' ' ' VAL . 66.0 m -50.02 -60.09 3.27 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.706 0.632 . . . . 0.42999999999999999 112.706 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.47 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -133.87 -43.2 0.81 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 118.414 -1.314 . . . . 2.02 113.802 -175.427 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -31.7 134.09 0.14 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 117.645 1.818 . . . . 0.17999999999999999 117.645 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 122' ' ' HIS . 4.9 p -71.29 166.47 21.51 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 112.493 -1.853 . . . . 0.16 112.037 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.949 HG12 ' O ' ' A' ' 123' ' ' TYR . 9.3 mm -58.9 101.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 115.118 -0.946 . . . . 0.40000000000000002 111.622 -162.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.633 ' HG2' ' CE1' ' A' ' 126' ' ' HIS . 28.6 mtp85 -88.17 141.13 28.81 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.178 -0.919 . . . . 1.8700000000000001 109.279 178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.631 ' HG2' HG22 ' A' ' 84' ' ' ILE . 13.2 mtp -120.01 -168.49 1.62 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.959 -0.756 . . . . 0.79000000000000004 108.959 173.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.424 ' HB3' ' OD2' ' A' ' 149' ' ' ASP . 7.5 t-160 -88.89 155.52 19.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.414 -0.958 . . . . 2.3199999999999998 108.414 170.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.875 ' O ' HD13 ' A' ' 151' ' ' ILE . 7.9 m120 -73.38 -18.27 61.18 Favored 'General case' 0 C--O 1.214 -0.788 0 N-CA-C 112.745 0.646 . . . . 0.68000000000000005 112.745 -172.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -82.02 -27.56 33.01 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 120.551 1.523 . . . . 2.1800000000000002 112.831 164.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.424 ' OD2' ' HB3' ' A' ' 146' ' ' HIS . 67.1 m-20 -82.57 -38.64 23.41 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.992 0.425 . . . . 0.68999999999999995 111.001 -173.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.659 HG13 HD12 ' A' ' 151' ' ' ILE . 12.2 p -67.22 -21.65 28.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.11 111.13 174.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.9 HD11 ' HB1' ' A' ' 113' ' ' ALA . 1.6 mp -84.6 -40.86 15.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 119.029 -0.51 . . . . 0.38 110.203 172.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 156' ' ' ILE . 4.4 mm-40 -44.7 -72.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.105 0.866 . . . . 1.99 112.203 168.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.587 ' O ' HG22 ' A' ' 157' ' ' VAL . 41.6 mt -46.32 -39.12 9.67 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.669 0.747 . . . . 1.27 111.644 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HB1' ' CE2' ' A' ' 114' ' ' TYR . . . -62.4 -37.66 86.64 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.159 -1.382 . . . . 0.17999999999999999 111.764 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 34.6 t -86.79 -33.16 19.99 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.581 0.586 . . . . 0.20999999999999999 112.581 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 152' ' ' GLU . 24.6 mt -81.24 -59.39 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.659 0.742 . . . . 0.16 111.367 -172.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 153' ' ' LEU . 3.0 m -89.57 141.89 29.01 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 114.743 -1.117 . . . . 0.16 111.899 177.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -89.4 175.27 3.34 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.099 3.199 . . . . 0.20000000000000001 110.911 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.824 ' ND2' ' HA ' ' A' ' 102' ' ' ASN . 1.5 m-20 -65.38 158.63 26.07 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.831 -0.803 . . . . 1.1000000000000001 108.831 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 54' ' ' PRO . . . 95.04 -17.9 58.41 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.108 -1.044 . . . . 0.17999999999999999 112.569 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.586 ' HB ' HD12 ' A' ' 100' ' ' ILE . 80.6 m -63.95 137.33 57.96 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.299 -0.63 . . . . 0.14000000000000001 109.299 -175.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -93.15 119.82 32.77 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 122.673 1.225 . . . . 3.6299999999999999 111.137 -168.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 38.5 t -104.42 110.86 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 112.4 -2.182 . . . . 0.14000000000000001 109.398 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.0 m -96.3 108.21 20.68 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 112.757 0.651 . . . . 0.20999999999999999 112.757 -173.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.55 ' HB ' ' HA3' ' A' ' 96' ' ' GLY . 2.4 mp -81.28 106.64 12.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 122.198 0.999 . . . . 0.23999999999999999 109.905 177.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -112.36 123.65 50.76 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.42 -1.264 . . . . 1.0900000000000001 109.806 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.543 ' HA ' ' HB ' ' A' ' 65' ' ' ILE . 17.7 mmm180 -68.48 -31.7 71.17 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.707 -0.479 . . . . 2.0800000000000001 109.707 175.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 162.32 57.11 0.02 OUTLIER Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.651 -0.704 . . . . 1.97 112.418 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 110.213 -0.292 . . . . 3.9100000000000001 110.213 179.514 . . . . . . . . 0 0 . 1 stop_ save_